<SEC-DOCUMENT>0001513162-19-000041.txt : 20190206
<SEC-HEADER>0001513162-19-000041.hdr.sgml : 20190206
<ACCEPTANCE-DATETIME>20190206165203
ACCESSION NUMBER:		0001513162-19-000041
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		111
CONFORMED PERIOD OF REPORT:	20181231
FILED AS OF DATE:		20190206
DATE AS OF CHANGE:		20190206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		19572096

	BUSINESS ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10k.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<HTML>
<head><title>Form 10-K</title> </head> <body vlink=purple link=blue lang=EN-US> <div style=page:WordSection1> <div style="BORDER-TOP:windowtext 3pt solid; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:1pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>UNITED STATES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>SECURITIES AND EXCHANGE COMMISSION</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>Washington</font><font style=FONT-SIZE:8pt>, D.C. 20549</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>FORM </font></b><b><font style=FONT-SIZE:8pt>10-K</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <table width=35% bordercolor=transparent style="WIDTH:35%; BORDER-COLLAPSE:collapse; MARGIN-LEFT:9pt" cellpadding=0 cellspacing=0 align=center> <tr> <td width=100% colspan=3 style="WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>(Mark One)</font></p></td></tr> <tr> <td width=3% style="WIDTH:3.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in -5.5pt 0pt 0in' align=center><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">&#254; </font></p></td> <td width=5% style="WIDTH:5.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in -5.4pt 0pt 0in'>&nbsp;</p></td> <td width=91% style="WIDTH:91.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>For the fiscal year ended December&nbsp;31, 2018</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>OR</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <table width=35% bordercolor=transparent style="WIDTH:35%; BORDER-COLLAPSE:collapse; MARGIN-LEFT:9pt" cellpadding=0 cellspacing=0 align=center> <tr> <td width=3% style="WIDTH:3.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in -5.5pt 0pt 0in' align=center><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">o </font></p></td> <td width=5% style="WIDTH:5.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in -5.4pt 0pt 0in'>&nbsp;</p></td> <td width=91% style="WIDTH:91.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:8pt; COLOR:black">For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u>to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Commission file number: 001-35285</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <div align=center> <table width=80% bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:80%; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=26% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:26.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in -5.4pt 0pt 0in' align=center>&nbsp;</p></td> <td width=46% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:46.66%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in -5.4pt 0pt 0in' align=center><b><font style=FONT-SIZE:8pt>Vaxart, Inc.</font></b></p></td> <td width=26% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:26.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in -5.4pt 0pt 0in' align=center>&nbsp;</p></td></tr> <tr> <td width=26% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:26.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in -5.4pt 0pt 0in' align=center>&nbsp;</p></td> <td width=46% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:46.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in -5.4pt 0pt 0in' align=center><font style=FONT-SIZE:8pt>(Exact Name of Registrant as Specified in its Charter)</font></p></td> <td width=26% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:26.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in -5.4pt 0pt 0in' align=center>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <div align=center><table width=80% bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:80%; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=19 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.2in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=192 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Delaware</font></b></p></td> <td width=10 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.1in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=192 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>59-1212264</font></b></p></td> <td width=19 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.2in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=19 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.2in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=192 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(State or other jurisdiction of incorporation or organization)</font></p></td> <td width=10 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.1in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=192 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(IRS Employer Identification No.)</font></p></td> <td width=19 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.2in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <div align=center> <table width=80% bordercolor=transparent style="WIDTH:80%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=19 style="WIDTH:0.2in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=192 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" align=center valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>290 Utah Ave., Suite 200, South San Francisco</font></b><font style=FONT-SIZE:8pt>, <b>CA</b></font></p></td> <td width=10 style="WIDTH:0.1in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=192 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>94080</font></b></p></td> <td width=19 style="WIDTH:0.2in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=19 style="WIDTH:0.2in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=192 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(Address of principal executive offices)</font></p></td> <td width=10 style="WIDTH:0.1in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=192 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(Zip Code)</font></p></td> <td width=19 style="WIDTH:0.2in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <div align=center> <table width=15% bordercolor=transparent style="WIDTH:15%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=288 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>(650) 550-3500</font></b></p></td></tr> <tr> <td width=288 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(Registrant&#146;s telephone number, including area code)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 4pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:#231f20">Securities registered pursuant to Section 12(b) of the Act:</font></b></p> <div align=center> <table width=80% bordercolor=transparent style="WIDTH:80%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=49% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:49.96%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:7pt; COLOR:#231f20">Title of Each Class:</font></b></p></td> <td width=2% nowrap style="WIDTH:2.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:7pt>&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=47% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:47.36%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:7pt; COLOR:#231f20">Name of Each Exchange on Which Registered:</font></b></p></td> <td nowrap style="WIDTH:0.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=49% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:49.96%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:#231f20">Common Stock, par value $0.10 per share</font></b></p></td> <td width=2% nowrap style="WIDTH:2.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=47% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:47.36%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:#231f20">The Nasdaq Capital Market</font></b></p></td> <td nowrap style="WIDTH:0.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 4pt' align=center><font style="FONT-SIZE:8pt; COLOR:#231f20">Securities registered pursuant to Section 12(g) of the Act: None</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&nbsp;405 of the Securities Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;Yes&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">o</font><font style=FONT-SIZE:8pt>&nbsp;&nbsp;&nbsp;No&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">&#254;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Indicate by check mark if the registrant is not required to file reports pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;Yes&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">o</font><font style=FONT-SIZE:8pt>&nbsp;&nbsp;&nbsp;No&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">&#254;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90&nbsp;days.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">&#254;</font><font style=FONT-SIZE:8pt>&nbsp;&nbsp;&nbsp;No&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&nbsp;405 of Regulation&nbsp;S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style=COLOR:black>Yes&nbsp;</font></font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">&#254;</font><font style="FONT-SIZE:8pt; COLOR:black">&nbsp;&nbsp;&nbsp;No&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Indicate by check mark if disclosure of delinquent filers in response to Item&nbsp;405 of Regulation&nbsp;S-K (&#167;229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant&#146;s knowledge, in definitive proxy or information statements incorporated by reference in Part&nbsp;III of this Form&nbsp;10-K or any amendment to this Form&nbsp;10-K.<font style=COLOR:black>&nbsp;</font></font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the Exchange Act.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <table width=80% bordercolor=transparent style="WIDTH:80%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=433 style="WIDTH:324.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Large accelerated filer&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p></td> <td width=289 style="WIDTH:216.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Accelerated filer&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p></td></tr> <tr> <td width=433 style="WIDTH:324.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Non-accelerated filer&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">&#254;</font></p></td> <td width=289 style="WIDTH:216.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Smaller reporting company&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">&#254;</font></p></td></tr> <tr> <td width=433 style="WIDTH:324.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=289 style="WIDTH:216.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Emerging growth company&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings; COLOR:black">&#168;</font></p></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 3pt'><font style="FONT-SIZE:8pt; COLOR:#231f20">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">o</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>Indicate by check mark whether the registrant is a shell company (as defined in Rule&nbsp;12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;Yes&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">o</font><font style=FONT-SIZE:8pt>&nbsp;&nbsp;&nbsp;No&nbsp;</font><font style="FONT-SIZE:8pt; FONT-FAMILY:Wingdings">&#254;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:8pt; COLOR:#231f20">The aggregate market value of the Registrant&#146;s common stock held by non-affiliates of the Registrant as of the last business day of the Registrant&#146;s most recently completed second fiscal quarter, June 30, 2018, based on the last reported sales price of the Registrant&#146;s common stock of $3.03 per share was $12,181,506</font><font style=FONT-SIZE:8pt>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>As of February&nbsp;4, 2019, the registrant had a total of 7,141,189 shares of common stock issued and outstanding.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 6pt' align=center><b><font style=FONT-SIZE:8pt>DOCUMENTS INCORPORATED BY REFERENCE</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>None.</font></p> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 3pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style=FONT-SIZE:11pt><a name=toc>TABLE OF CONTENTS</a></font></u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Page</font></b></p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href="#FOR L S">FORWARD-LOOKING STATEMENTS</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1</font></p></td> <td width=1% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.36%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt><a href=#P1>PART I</a></font></b></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#BUSIN>ITEM 1.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#BUSIN>Business</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href="#RISK F">ITEM 1A.</a></font></p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href="#RISK F">Risk Factors</a></font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>37</font></p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#UNRESOL>ITEM 1B.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#UNRESOL>Unresolved Staff Comments</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>74</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#PROPER>ITEM 2.</a></font></p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#PROPER>Properties</a></font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>74</font></p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href="#LEGAL PRO">ITEM 3.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href="#LEGAL PRO">Legal Proceedings</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>74</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href="#MINE SEFTY DIS">ITEM 4.</a></font></p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href="#MINE SEFTY DIS">Mine Safety Disclosures</a></font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>74</font></p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt><a href=#P2>PART II</a></font></b></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM5>ITEM 5.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM5>Market for Registrant&#146;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>75</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM6>ITEM 6.</a></font></p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM6>Selected Financial Data</a></font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>75</font></p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM7>ITEM 7.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM7>Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>76</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM8>ITEM 8.</a></font></p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM8>Financial Statements and Supplementary Data</a></font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>84</font></p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM9>ITEM 9.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM9>Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>116</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM9A>ITEM 9A.</a></font></p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM9A>Controls and Procedures</a></font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>116</font></p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM9B>ITEM 9B.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM9B>Other Information</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>117</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in' align=center><b><font style=FONT-SIZE:10pt><a href=#PART3>PART III</a></font></b></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM10>ITEM 10.</a></font></p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM10>Directors, Executive Officers and Corporate Governance</a></font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>118</font></p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM11>ITEM 11.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM11>Executive Compensation</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>122</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM12>ITEM 12.</a></font></p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM12>Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>128</font></p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM13>ITEM 13.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt><a href=#ITEM13>Certain Relationships and Related Transactions, and Director Independence</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>129</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM14>ITEM 14.</a></font></p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM14>Principal Accounting Fees and Services</a></font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>130</font></p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt><a href=#PART4>&nbsp;PART IV</a></font></b></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM15>ITEM 15.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM15>Exhibits and Financial Statement Schedules</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>134</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href="#EXHIBIT IND">EXHIBIT INDEX</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>135</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM16>ITEM 16.</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#ITEM16>Form 10-K Summary</a></font></p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>137</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><a href=#SIGNTU>SIGNATURES</a></font></p></td> <td width=80% style="WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>138</font></p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=20% style="WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80% style="WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style=FONT-SIZE:10pt><a href=#toc>Table of Contents</a></font></u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:11pt><a name="FOR L S">FORWARD-LOOKING STATEMENTS</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><i><font style=FONT-SIZE:10pt>This Annual Report on Form 10-K for the year ended December 31, 2018, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which are subject to the &#147;safe harbor&#148; created by those sections, concerning our business, operations, and financial performance and condition as well as our plans, objectives, and expectations for business operations and financial performance and condition. Any statements contained herein that are not of historical facts may be deemed to be forward-looking statements. You can identify these statements by words such as &#147;anticipate,&#148; &#147;assume,&#148; &#147;believe,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;should,&#148; &#147;will,&#148; &#147;would,&#148; and other similar expressions that are predictions of or indicate future events and future trends. These forward-looking statements are based on current expectations, estimates, forecasts, and projections about our business and the industry in which we operate and management's beliefs and assumptions and are not guarantees of future performance or development and involve known and unknown risks, uncertainties, and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking statements in this Annual Report on Form 10-K may turn out to be inaccurate. Factors that could materially affect our business operations and financial performance and condition include, but are not limited to, those risks and uncertainties described herein under &#147;Item 1A - Risk Factors.&#148; You are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on the forward-looking statements. The forward-looking statements are based on information available to us as of the filing date of this Annual Report on Form 10-K. Unless required by law, we do not intend to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise. You should, however, review the factors and risks we describe in the reports we will file from time to time with the Securities and Exchange Commission, or the SEC, after the date of this Annual Report on Form 10-K.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>In addition, statements that &#147;we believe&#148; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this prospectus, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt>This Annual Report on also contains market data related to our business and industry. These market data include projections that are based on a number of assumptions. If these assumptions turn out to be incorrect, actual results may differ from the projections based on these assumptions. As a result, our markets may not grow at the rates projected by these data, or at all. The failure of these markets to grow at these projected rates may harm on our business, results of operations, financial condition and the market price of our common stock<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>1</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:11pt><a name=P1>PART I</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 0pt; page:WordSection2'><b><font style=FONT-SIZE:10pt><a name=BUSIN>Item&nbsp;1.&nbsp;&nbsp;Business</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Overview</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">Vaxart Biosciences, Inc. was originally incorporated in California in March&nbsp;2004, under the name West Coast Biologicals, Inc. and changed its name to Vaxart, Inc., or Private Vaxart, in July&nbsp;2007, and reincorporated in the state of Delaware.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt>On February 13,&nbsp;2018, <font style=COLOR:black>Private Vaxart</font> <font style=COLOR:black>completed a reverse merger, or the Merger, </font>with <font style=COLOR:black>Aviragen Therapeutics, Inc.,</font> or Aviragen, pursuant to which <font style=COLOR:black>Private Vaxart survived as a wholly owned subsidiary of Aviragen. Under the terms of the Merger, Aviragen changed its name to Vaxart, Inc. and Private Vaxart changed its name to Vaxart Biosciences, Inc.&nbsp; Unless otherwise indicated, all references to &#147;Vaxart,&#148; &#147;we,&#148; &#147;us,&#148; &#147;our&#148; or the &#147;Company&#148; in this Annual Report on Form 10-K mean Vaxart, Inc., the combined company.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">We are a clinical-stage biotechnology company focused on the development of oral recombinant vaccines based on our proprietary oral vaccine platform. Our oral vaccines are designed to generate broad and durable immune responses that protect against a wide range of infectious diseases and may be useful for the treatment of chronic viral infections and cancer. Our vaccines are administered using a convenient room temperature-stable tablet, rather than by injection. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">We are developing prophylactic vaccine candidates that target a range of infectious diseases. These include norovirus, a widespread cause of acute gastro-intestinal enteritis, for which two Phase 1 human studies have been completed; seasonal influenza, for which our vaccine protected patients in a recent Phase 2 challenge study; and respiratory syncytial virus, or RSV, a common cause of respiratory tract infections. In addition, we are developing our first therapeutic immune-oncology vaccine targeting cervical cancer and dysplasia caused by human papillomavirus, or HPV. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">Vaccines have been essential in eradicating or significantly reducing multiple devastating infectious diseases, including polio, smallpox, mumps, measles, diphtheria, hepatitis B, influenza, human papillomavirus and several others. According to a recent MarketsandMarkets research report &#147;Vaccines Market - Global Forecast to 2023&#148;, the global market for vaccines is expected to reach $50.42 billion by 2023 from $36.45 billion in 2018, at a compound annual growth rate of 6.7%.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">We believe our oral tablet vaccine candidates offer several important advantages:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">First, they are designed to generate broad and durable immune responses, including systemic, mucosal and T cell responses, which may enhance protection against certain infectious diseases, such as influenza, norovirus and RSV, and may have potential clinical benefit for certain cancers and chronic viral infections, such as those caused by HPV. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">Second, our tablet vaccine candidates are designed to provide a more efficient and convenient method of administration, enhance patient acceptance and reduce distribution bottlenecks, which we believe will improve the effectiveness of vaccination campaigns. For example, according to the U.S. Centers for Disease Control and Prevention, or CDC, in the 2017/2018 seasonal influenza season, only approximately 42% of the U.S. population was vaccinated against influenza, with particularly low vaccination rates among adults between ages 18 and 49.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">Finally, we believe that utilizing our recombinant methods and production process will allow us to manufacture vaccines at scale more efficiently and within shorter time frames than conventional vaccines manufactured using traditional methods.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><b><font style="FONT-SIZE:10pt; COLOR:black">Our Product Pipeline</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 12pt">We are developing the following tablet vaccine candidates, which are all based on our proprietary platform:</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><b><i>Norovirus Vaccine.</i></b> We are developing an oral tablet vaccine for norovirus, a leading cause of acute gastroenteritis in the United States and Europe. Because norovirus infects the small intestine, we believe that our vaccine, which is designed to produce mucosal antibodies locally in the intestine in addition to systemic antibodies in the blood, will better protect against norovirus infection than an injectable vaccine. Clinical evidence that vaccines based on our platform technology can protect against infection is described under &#147;Clinical Trial Update&#148; in the &#147;Seasonal Influenza Vaccine&#148; section below. </p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:0in">Norovirus is the leading cause of vomiting and diarrhea from acute gastroenteritis among people of all ages in the United States. Each year, on average, norovirus causes 19 to 21 million cases of acute gastroenteritis and contributes to 56,000 to 71,000 hospitalizations and 570 to 800 deaths, mostly among young children and older adults. Typical symptoms include dehydration, vomiting, diarrhea with abdominal cramps, and nausea. In a study conducted by Pittsburg School of Medicine in 2012, the total economic burden of norovirus in the United States was estimated at $5.5 billion. In a more recent study by CDC and Johns Hopkins University, the global economic impact of norovirus disease was estimated at $60 billion, $34 billion of which occurred in high income countries including the United States, Europe and Japan. Virtually all norovirus disease is caused by norovirus GI and GII genotypes, and we are developing a bivalent vaccine designed to protect against both.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>2</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in"><i><u>Clinical Trial Update</u></i>. We have completed two Phase 1 clinical trials with our monovalent oral tablet vaccine for the GI.1 norovirus strain. The vaccine was well-tolerated and generated broad systemic and mucosal immune responses. In the clinical Phase 1b dose optimization study in healthy adults in which we evaluated four different dosing regimens, all vaccine recipients (100%) in the high dose group responded as measured by a significant increase in norovirus-specific B cells of both IgA and IgG subtypes. In the same group, there was at least a two-fold increase of norovirus-specific antibody titers in serum in more than 90% of recipients.</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in">We are preparing for two norovirus clinical trials, a bivalent Phase 1 study designed to assess safety and immunogenicity of our norovirus GI.1 and GII.4 vaccines administered concurrently, and a monovalent Phase 2 challenge study designed to assess the protective efficacy of our norovirus GI.1 vaccine against live norovirus GI.1 challenge in humans. The Phase 1 bivalent study and the Phase 2 challenge study will both be conducted under an open IND. Clinical protocols for both studies have been submitted to the FDA.&nbsp;In preparation for the Phase 2 challenge study, we have conducted a virus titration study to help determine the appropriate quantity of the norovirus GI.1 virus to be used to challenge patients in the study.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in; page:WordSection2'><font style=FONT-SIZE:10pt>The bivalent study is conducted using both the norovirus GI.1 and GII.4 vaccines.&nbsp; The challenge study is conducted using only the norovirus GI.1 vaccine. As announced in November 2018, the norovirus GI.1 vaccine tablets that we manufactured in 2018 failed release testing, causing both studies that were scheduled to begin before the end of 2018 to be delayed. <font style='FONT-FAMILY:"Times New Roman",serif'>Since then, we have manufactured two new lots of bulk GI.1 vaccine that are scheduled to be processed and tableted in the coming weeks. If processing and tableting is successful and the vaccine passes all required release testing, the norovirus GI.1 vaccine tablets are expected to become available for the currently planned clinical trials during the second quarter</font> of 2019. The norovirus GII.4 vaccine tablets we manufactured in 2018 have passed all required&nbsp;release testing and are available for use in our clinical&nbsp;trials, subject to final review <font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman",serif'><font style=FONT-SIZE:10pt>of the Certificate of Analysis by the FDA. For more information on our manufacturing process, capabilities and strategy, <font style=FONT-SIZE:10pt>please see the paragraph &#147;Manufacturing&#148; in this business section below</font></font></font><font style=FONT-SIZE:10pt>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Seasonal Influenza Vaccine.</i></b> Influenza is a major cause of morbidity and mortality in the U.S. and worldwide and, according to the CDC, only 42% of eligible U.S. citizens were vaccinated in 2017/2018, with particularly low vaccination rates among adults between ages 18 and 49. We believe our oral tablet vaccine has the potential to improve the protective efficacy of currently available influenza vaccines and increase flu vaccination rates.</font></font></font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:0in"><font style=FONT-SIZE:10pt>Influenza is one of the most common global infectious diseases, causing mild to life-threatening illness and even death. It is estimated that at least 350 million cases of seasonal influenza occur annually worldwide, of which three to five million cases are considered severe, causing 290,000 to 650,000 deaths per year globally. During the most recent flu season 2017 &#150; 2018, there were 79,400 flu related deaths in the U.S. alone, according to the CDC. Very young children and the elderly are at the greatest risk. In the United States, between 5% and 20% of the population contracts influenza, 226,000 people are hospitalized with complications of influenza, and between 3,000 and 49,000 people die from influenza and its complications each year, with up to 90% of the influenza-related deaths occurring in adults older than 65. The total economic burden of seasonal influenza has been estimated to be $87.1 billion, including medical costs which average $10.4 billion annually, while lost earnings due to illness and loss of life amount to $16.3 billion annually.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in; page:WordSection2'><font style=FONT-SIZE:10pt>We believe our tablet vaccine candidate has the potential to address many of the limitations of current injectable egg-based influenza vaccines, because: our tablet vaccine candidates are designed to create broad and durable immune responses, which may provide more effective immunity and protect against additional strain variants; our vaccine is delivered as a room temperature-stable tablet, which should provide a more convenient method of administration to enhance patient acceptance, and should simplify distribution and administration; and, by using recombinant methods, we believe our tablet vaccine may be manufactured more rapidly than vaccines manufactured using egg-based methods and should eliminate the risk of allergic reactions to egg protein.</font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in"><font style=FONT-SIZE:10pt><i><u>Clinical Trial Update</u></i>. In September 2018, we completed a $15.7 million contract with the U.S. Government through the Office of Biomedical Advanced Research and Development Authority, or BARDA, under which a Phase 2 challenge study of our H1N1 flu vaccine candidate was conducted. Previously, we had announced that, in healthy volunteers immunized and then experimentally infected with H1 influenza, our H1 influenza oral tablet vaccine reduced clinical disease by 39% relative to placebo, a result that was superior to that of Fluzone, the market-leading injectable quadrivalent influenza vaccine, which reduced clinical disease by only 27%. Our tablet vaccine also showed a favorable safety profile, indistinguishable from placebo. On October 4, 2018, we presented data from the study demonstrating that our vaccine elicited a significant expansion of mucosal homing receptor plasmablasts to approximately 60% of all activated B cells, while Fluzone only maintained baseline levels of 20%. We believe plasmablasts are a key indicator of a protective mucosal immune response and a unique feature of our vaccines. This data also provided evidence that our vaccines protect through mucosal immunity, the first line of defense against mucosal infections such as flu, norovirus, RSV and others, a potential key advantage over injectable vaccines for these indications.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>3</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in; page:WordSection2'><font style=FONT-SIZE:10pt>At this time, we aim to finance development and commercialization of our seasonal quadrivalent influenza oral tablet vaccine through third-party collaboration and licensing arrangements, and/or non-dilutive funding. In the future, we may also consider equity offerings and/or debt financings to fund the program.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i><font style=COLOR:black>HPV Therapeutic Vaccine</font></i><font style=COLOR:black>.&nbsp;</font></b><font style=COLOR:black>Our<b> </b>first therapeutic oral vaccine candidate targets HPV-16 and HPV-18, the two strains responsible for 70% of cervical cancers and precancerous cervical dysplasia.</font></font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in; page:WordSection2'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman",serif'><font style=FONT-SIZE:10pt>Cervical cancer is the fourth most common cancer in women worldwide and in the United States with about 13,000 new cases diagnosed annually in the United States according to the National Cervical Cancer Coalition.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in; page:WordSection2'><font style=FONT-SIZE:10pt>We have tested our HPV-16 vaccine candidate in two different HPV-16 solid tumor models in mice. The vaccine elicited T cell responses and promoted migration of the activated T cells into the tumors, leading to tumor cell killing. Mice that received our HPV-16 vaccine showed a significant reduction in volume of their established tumors.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:0in; page:WordSection2'>&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in"><font style=FONT-SIZE:10pt>In October 2018, we filed a pre-IND meeting request for our HPV therapeutic vaccines, VXA-HPV16.1 and VXA-HPV18.1, with the FDA, and we subsequently submitted a pre-IND briefing package. We received feedback from the FDA in January 2019 providing guidance for the IND we plan to submit. Based on this feedback, we expect to be able to file an IND for this product candidate in the course of 2019. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>RSV Vaccine.</i></b> RSV is a major respiratory pathogen with a significant burden of disease in the very young and in the elderly.</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in; page:WordSection2'>&nbsp;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in"><font style=FONT-SIZE:10pt>Based on the positive results of our cotton rat study, we believe our proprietary oral vaccine platform is the optimal vaccine delivery system for RSV, offering significant advantages over injectable vaccines. We aim to develop a tablet RSV vaccine by licensing one or more RSV protein antigens that have demonstrated protection against RSV infection in clinical studies, or by partnering with a third party with RSV antigens that can be delivered with our platform.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Additional Objectives</font></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Develop Other Tablet Vaccine Candidates</i></b> <b><i>Based On Our Proprietary Platform.</i></b> Our technology platform employs a modular approach using the Ad5 vector-adjuvant construct with disease-specific antigens and can be used to create new tablet vaccine candidates for a wide range of infectious diseases. We may consider exploring additional infectious diseases including RSV, Chikungunya, Hepatitis B and Herpes Simplex Virus 2, or HSV-2. In addition, we intend to leverage our vaccine formulation expertise to develop oral formulations suitable for pediatric populations.</font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Further Strengthen Our Intellectual Property Portfolio</i></b>. We intend to continue to strengthen our patent portfolio by filing and prosecuting current and future patent applications in the United States and international jurisdictions. In addition, we have established in-house formulation and tableting capabilities which we believe will allow us to further improve and optimize our proprietary techniques and know-how.</font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Maximize the Commercial Value of Our Tablet Vaccine Candidates</i></b>. We believe that we own worldwide rights for the research, development, manufacturing, marketing and commercialization of our tablet vaccine candidates. As we further develop our product candidates, we may seek partners to maximize the commercial opportunity of such tablet vaccine candidates.</font><a name=_Toc500438791></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in; page:WordSection2' /> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><b><font style=FONT-SIZE:10pt>Anti-Virals</font></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>Through our merger with Aviragen Therapeutics, Inc., or Aviragen, we acquired two royalty earning products, Relenza and Inavir, and three Phase 2 clinical stage antiviral compounds. </font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>Relenza and Inavir are antivirals for the treatment of influenza that are marketed by GSK and Daiichi Sankyo, respectively. We earn royalties on the net sales of Relenza and Inavir in Japan. Sales of Relenza and Inavir vary significantly from one year to the next, depending on the intensity of the flu season and competition from other antivirals such as Tamiflu. Importantly, on February 23, 2018, Xofluza, a new drug to treat influenza developed by Shionogi, was approved in Japan. The drug may gain significant market share, substantially reducing sales of Inavir.</font><a name=_Hlk536625719></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>The three Phase 2 antiviral compounds obtained through the merger with Aviragen are: 1) BTA074, or teslexivir, an antiviral treatment for condyloma caused by human papillomavirus types 6 &amp; 11; 2) vapendavir, a capsid inhibitor for the prevention or treatment of rhinovirus upper respiratory infections; and 3) BTA585, or enzaplatovir, a fusion protein inhibitor for the treatment of RSV infections. We have discontinued all three programs.</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in; page:WordSection2'><font style=FONT-WEIGHT:normal>4</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in; page:WordSection2'> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:left; MARGIN:0in 0in 0pt; TEXT-INDENT:0in; page:WordSection2' align=left><a href=#toc><font color=#0066cc>Table of Contents</font></a></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our Pipeline</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b>Fig. 1.</b>&nbsp; The following table outlines the status of our oral vaccine development programs and our two marketed products: </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><img width=699 height=324 style="HEIGHT:324px; WIDTH:854px" src=j1.jpg></p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our Tablet Vaccine Platform</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt">Vaccines based on our oral adjuvant-vector platform are designed to generate broad local and systemic immune responses, which may offer important advantages in addressing a wide range of infectious diseases.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Platform Components</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Our platform technology employs a vector-based approach and consists of the following components:</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>A vector, which is a virus used as a carrier to deliver DNA coding for vaccine antigens and an adjuvant selected to activate the immune system of the gut. Specifically, we use non-replicating adenovirus type 5, or Ad5, which delivers the DNA for both the antigen and adjuvant to the cells of the small intestine, where both the antigen and adjuvant are co-expressed.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>A protein antigen, which is a viral or bacterial protein that stimulates an immune response to the selected pathogen. We use a different antigen for each of our current clinical vaccine candidates.</font></font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>An adjuvant, which is a substance that enhances the immune-stimulating properties of the vaccine. We use a Toll-like receptor 3, or TLR3, agonist, which was selected specifically for its ability to activate the immune system of the gut.</font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>Our proprietary enteric-coated tablet which is designed to deliver the Ad5 vector to the small intestine.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>5</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b>Fig. 2.</b>&nbsp; Our VAAST Platform.</p> <div style=page:WordSection2><img width=879 height=437 style="HEIGHT:432px; WIDTH:845px" src=j2.jpg></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; VERTICAL-ALIGN:baseline; MARGIN:0in 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. Vector-Adjuvant-Antigen Standardized Technology Platform</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our Platform. <font style=FONT-WEIGHT:normal>Combination of the vector-based delivery system, with antigen and adjuvant expressed by the vector.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Adenovirus 5 Vector</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt">Ad5 is an extensively studied and well-characterized vector. Over 200 clinical trials conducted by others have used Ad5 for a wide range of applications, and we believe that using the same adenovirus in our tablet vaccine candidates will reduce regulatory risk, given that it is known to regulatory authorities.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Recombinant Antigen</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Our vector contains cloning space where DNA encoding for any recombinant antigen can be inserted. In the vaccine programs pursued to date, we have chosen recombinant antigens that are known to be key targets of the immune system with the ability to generate protection against the corresponding pathogen. The Ad5 vector-adjuvant gene cassette allows for a modular approach.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Adjuvant</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We use a short section of double-stranded RNA, or dsRNA, as an adjuvant to enhance the immunogenicity of our tablet vaccine candidates. dsRNA is a Toll Like Receptor 3 (TLR3) agonist and is recognized by the innate immune system as a signal that an undesired viral replication is ongoing, triggering it to mount an immune response in defense. dsRNA is one of the few signals available for use in the intestine as the natural large reservoir of bacteria (the &#147;microbiome&#148;) makes it difficult to use bacteria- related signals. We chose this adjuvant because of its ability to complement the non-replicating adenovirus when administered orally, and because very few pathways of immune system recognition signals occur in the small intestine. Importantly, our adjuvant is expressed within a cell, not provided as a separate component, resulting in a more localized response when compared with adjuvants contained in injectable vaccines.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Enteric-Coated Tablet</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>While tablets are typically used to deliver small molecules to the intestine, we have designed our tablets to deliver the much larger adenovirus particles. We hold intellectual property related to the composition and formulation of our tablet vaccine candidates. Our tablet manufacturing does not require sterile fill and finish processing, such as for injectables, but rather uses standard tableting equipment.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>How Our Tablet Vaccine Candidates Work</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Our tablets are designed to deliver vaccines to the small intestine. The tablets are covered with a protective coating that remains intact in the low pH environment of the stomach and protects the active ingredient contained in the tablet core from the acidic environment in the stomach. The coating is designed to dissolve in the neutral pH environment of the small intestine which we are targeting to generate an optimal immune response. Once the coating has dissolved, the tablets disintegrate, and the vaccine is released into the small intestine where it can reach and enter the mucosal cells lining the intestine. Once inside the mucosal cells, the antigen protein and adjuvant are expressed, or manufactured, by the cells. The adjuvant is molecular in nature and always produced within the exact same intestinal cells that also produce the antigen. Importantly, unlike current recombinant vaccines that are manufactured in insect cells or yeast which may introduce subtle structural changes to the protein antigen, the production of antigens delivered using our approach is identical to that of the actual pathogen when it invades the mucosa. In addition, we believe that delivering the replication incompetent Ad5-vectored vaccine via tablet directly to the gut avoids neutralization by blood or muscle tissue-based immune cells, an advantage over injected vector-based vaccines.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>6</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b>Fig. 3.</b> Our Oral Recombinant Vaccine Platform.</p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><img width=687 height=467 style="HEIGHT:461px; WIDTH:850px" src=j3.jpg></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><i>Caption. 1. Enteric-coated tablet is administered. The tablet coating protects the active ingredient from stomach acid degradation. 2. When the tablet reaches the small intestine, it releases the active ingredient, the viral vector, that can then transfect the epithelial cells in the mucosal epithelium and deliver the genes for the two payloads (antigen and adjuvant). 3. Expression of the antigen and adjuvant in the epithelial cells then leads to the TLR3 signaling cascade that can activate B and T cells.</i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Immune cells come in contact with proteins, and if the protein elicits an immune recognition signal, the immune cell becomes activated. This eventually leads to an immune response, producing either memory cells or large quantities of antibodies that bind to a key antigen. The expressed antigen and adjuvant of its platform, like other vaccines, cause induction of B and T cells specific for the antigen. Induction is believed to begin when an immature dendritic cell (specialized immune cell) absorbs an epithelial cell expressing both the antigen and adjuvant that were delivered by the Ad5 vector. Upon induction, dendritic cells migrate to the regional lymph nodes where they interact with recirculating naive B and T cells. The dendritic cell presents pieces of the antigen on its surface to stimulate T cells, and some of the antigen drains into the lymph node to stimulate B cells. Upon recognizing its specific antigen, small B or T cells stop migrating and enlarge. These then multiply in a clonal fashion and eventually recirculate to the tissues. B cells secrete antibodies that recognize the antigen and T cells find cells that have antigen presented on their surface and either kill the presenting cell or stimulate a local inflammatory response. A successful vaccination occurs if the B cells and T cells can form either memory cells (cells specialized to respond quickly to the protective antigen upon subsequent exposure) or enough antibody to a key antigen is made in large quantity to block infection.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>The Significance of Mucosal Immunity and T Cell Responses</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The immune system has developed defenses against pathogens by creating a special class of immune effectors, such as mucosal antibodies that are directed to wet surfaces and killer T cells that can kill pathogen infected cells. Most vaccines available today have been developed primarily to elicit blood circulating, or systemic B cell responses. However, there remain many infections, such as norovirus and RSV for which no vaccines exist. These and other pathogens may need greater immune responses outside of serum antibodies. Organisms that cause these infections largely evade the antibody immune response generated by serum antibodies in the blood because the pathogenic organism can pass through cells that line the open, mucosal membranes without coming into direct contact with blood. Alternatively, the serum antibodies are unable to penetrate into the cells infected by the pathogen.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Injectable vaccines available today typically do not induce mucosal immune responses, and subunit vaccines do not typically induce strong killer T cell immune responses, which are required to produce an effective level of immunization against several difficult pathogens. Administering vaccines through non-mucosal routes often leads to poor protection against mucosal pathogens primarily because such vaccines do not generate memory lymphocytes that migrate to mucosal surfaces. Although mucosal vaccination induces mucosa homing memory lymphocytes, we believe no complete mucosal recombinant oral vaccines are commercially available. Live attenuated vaccines can pose safety risks, whereas killed pathogens or molecular antigens are usually weak immunogens when applied to intact mucosa. Moreover, the immune mechanisms of protection against many mucosal infections are poorly understood.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>7</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>One of the key benefits of our technology is delivery to the gastrointestinal tract, enabling the vaccine to directly enter the mucosal surface of the intestine and activate the immune system of the gut. Mucosal vaccine delivery is believed to enhance protection against mucosal pathogens by generating immunity at the very surface where such pathogens invade. Our tablet vaccine candidates target the mucosal immune cells with a vector-based approach and are designed to create a more potent cytotoxic T cell response and mucosal antibody response, which may provide more effective immunity for certain diseases. Besides robust mucosal and systemic antibody responses, we observed potent and poly-functional T cell responses in our human clinical trials, demonstrating that our tablet vaccine candidates efficiently activate both B and T cells.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b><i>Oral Non-Replicating Ad5 Vector is Designed to Circumvent Anti-Vector Issues</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Injected Ad5 vectored vaccines generate strong anti-Ad5 responses, with up to a 100-fold increase in the anti-Ad5 neutralizing antibody titers. In contrast, our oral Ad5 vectored vaccine is designed to circumvent the complications related to anti-Ad5 immunity, allowing the platform to be used for multiple vaccines and repeat annual and booster vaccinations. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Anti-vector responses have been studied in our H1 influenza Phase 1 and Phase 2 studies, as well as in the two norovirus Phase 1 studies. In the first H1 influenza oral tablet vaccine study in 12 subjects, there were no significant rises in the neutralizing antibody titers to Ad5 following immunization. A challenge study was recently performed using the same H1 flu oral tablet vaccine in more than 60 subjects. This study found a 2.2 geometric fold rise in neutralizing antibody titers to Ad5, compared to a rise of 1.1-fold in the placebo group. Finally, the rise in vaccine anti-vector immune responses were monitored in the two Phase 1 norovirus vaccine studies, study #101 and study #102. There were no significant increases in the neutralizing anti-Ad5 antibody titers following either one or two doses of vaccine, even at the high dose (see figure below). </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 4. </font></b><font style=FONT-SIZE:10pt>Anti-vector titers pre- and post-immunization. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><img width=847 height=386 style="HEIGHT:375px; WIDTH:801px" src=j4.jpg></p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. In the single dose 101 study, anti-vector titers were measured 28 days after the only dose. In the two-dose 102 study, these were measured 28 days after the second dose. No significant increase in Ad5 titers were observed in any group in the two studies.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'><font style=FONT-SIZE:10pt>In addition, in all studies to date, immune responses to the antigen of choice appeared to be independent from the recipient&#146;s pre-existing anti-Ad5 immune status. In studies with our Ad5 vectored H1 influenza oral tablet vaccine, the pre-existing antibody titers to Ad5 had no effect on the ability of the vaccine to induce a neutralizing antibody response (by hemagglutinin inhibition or microneutralization assay) to influenza. In the two recently completed Phase 1 studies with our Ad5 vectored norovirus GI.1 oral tablet vaccine, the ability of the vaccine to generate a rise in antibody titers to norovirus or specifically blocking titers to norovirus virus-like particles, or VLP (BT50 assay), was not reduced in subjects with pre-existing anti-Ad5 antibody titers. These results are shown below. In conclusion, performance of our Ad5 vectored vaccine delivered orally does not appear to be adversely affected by the pre-existing serum antibody status of the recipient.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>8</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><b>Fig. 5.</b> Anti-vector immunity had no effect on the ability of the norovirus vaccine to induce BT50 titers.</p> <div style=page:WordSection2><img width=834 height=338 style="HEIGHT:328px; WIDTH:735px" src=j5.jpg></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt><em>Caption. Subjects in the high dose groups were divided based on the preexisting anti-Ad5 titers on day 0. Those with titers </em><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><em>&#8805;</em></font><em> 100 were considered Ad5 positive, those &lt;100 were considered Ad5 negative. The fold increase in BT50 titers for each subject were plotted. Average increase in the BT50 titers for the Ad5 positive group were not lower than the BT50 Ad5 negative group.</em></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our Norovirus Program</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Market Overview</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Norovirus is the leading cause of vomiting and diarrhea from acute gastroenteritis among people of all ages in the United States. Each year, on average, norovirus causes 19 to 21 million cases of acute gastroenteritis, and contributes to 56,000 to 71,000 hospitalizations and 570 to 800 deaths, mostly among young children and older adults. Typical symptoms include dehydration, which is the most common complication, vomiting, diarrhea with abdominal cramps, and nausea. In a study conducted by the CDC and Pittsburg School of Medicine in 2012, the total economic burden of norovirus in the United States has been estimated at $5.5 billion. In the U.S., we believe a norovirus vaccine would be beneficial for high risk groups such as children 0-5 years old, older adults and the elderly, as well as for workers in the food and travel industries, for healthcare, childcare and elderly care workers, first responders, the military, and finally leisure travelers as well as business travelers. In a study published by Johns Hopkins University and the CDC in 2016, the total global economic burden of norovirus was estimated at $60 billion, $34 billion of which occurred in high income countries including the United States, Europe and Japan. There are currently no approved vaccines or therapies to prevent or treat norovirus infection.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b><i>Our Norovirus Vaccine Candidate</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We plan to develop a VP1-based bivalent oral tablet vaccine that protects against norovirus GI and norovirus GII, the two major norovirus genogroups affecting humans, by targeting the norovirus GI.1 Norwalk strain and the norovirus GII.4 Sydney strain. We believe that our tablet vaccine would have important advantages over the injectable vaccine in development by Takeda. Because norovirus is an enteric pathogen that infects epithelial cells of the small intestine, we believe that a vaccine that produces antibodies in the intestine against norovirus locally in the intestine, such as our tablet vaccine candidate which is delivered directly to the gut, may be optimal at protecting against infection. The main isotype of antibodies found at the intestinal mucosal surface is IgA, whereas the main isotype of protective antibodies found in serum is IgG. We have demonstrated in our seasonal influenza clinical trials and in preclinical norovirus studies that our vaccine candidates can generate mucosal IgA antibodies to the antigen encoded in our vaccine.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Preclinical Results</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We have conducted multiple preclinical studies of our norovirus vaccine candidate in mice and ferrets. Overall, as compared with injectable VP1 protein vaccine, our norovirus vaccine candidate generated comparable levels of serum antibody and superior levels of mucosal antibody to the VP1 injectable protein vaccine. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Clinical Trials</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We have completed two Phase 1 studies with our monovalent norovirus GI.1 oral tablet vaccine, one of the two strains that will be included in the bivalent vaccine. In both Phase 1 studies, the primary endpoint was safety and the secondary endpoint was immunogenicity.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>9</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>Study 101. Placebo Controlled Study</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In the Phase 1 study designed to evaluate the norovirus vaccine (VXA-GI.1-NN), 66 healthy adults were randomized in three groups, with 23 subjects receiving a single low dose of 1 x 10<sup>10</sup> infectious units, or IU, 23 subjects receiving a single high dose of 1 x 10<sup>11</sup> IU, and 20 subjects randomized to the placebo control. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>Safety Results. 101 Study</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><i>Solicited Events.</i> In the first 7 days following study drug administration, 35 study subjects had at least one solicited adverse event (AE) reported with 25/46 (54%) subjects in the VXA-GI.1-NN vaccine groups and 10/20 (50%) of subjects in the placebo group (See table below). All of the solicited AEs reported (n=46) were grade 1 or 2 in severity with the majority being mild events (44 grade 1 and 2 grade 2 events). The percentage of subjects with any solicited symptoms was similar among treatments (See table below). Diarrhea and headache were the most common solicited symptoms following VXA&#8209;GI.1&#8209;NN administration, both reported by 15 (33%) subjects in the treated groups. Headache and nausea were reported evenly across treatments, including placebo. The only solicited symptom demonstrating a statistically significant difference from placebo was diarrhea (p = 0.0275), reported by 11&nbsp;subjects in the high dose group.&nbsp;Nine of the 11 subjects reported mild severity diarrhea, while 2 subjects reported moderate severity episodes following the high dose vaccine. Onset of diarrhea (verbatim term &#147;loose stools&#148;) ranged from day 1 to day 6 following vaccine administration, and most episodes resolved within 1 day. At no point did any of the loose stools impact normal activity such as work or school, and none required treatment with anti-diarrheal medications or rehydration therapy. In summary, the vaccine appeared well-tolerated without causing any dose limiting toxicities. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'><b>Table 1. </b>Norovirus Study 101 Solicited Systems &#150; Number and Percent of Subjects Reporting Treatment Emergent Adverse Events.</p><br> <div style=page:WordSection2> <table width=1000 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:750pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=258 style="BORDER-TOP:black 1pt solid; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Adverse Events*</font></b></p></td> <td width=132 style="BORDER-TOP:black 1pt solid; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Placebo<br>N=20</font></b></p></td> <td width=126 style="BORDER-TOP:black 1pt solid; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Low Dose<br>N=23</font></b></p></td> <td width=114 style="BORDER-TOP:black 1pt solid; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>High Dose<br>N=23</font></b></p></td></tr> <tr> <td width=258 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Number of Subjects with Any Symptoms</font></b></p></td> <td width=132 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>10 (50%)</font></p></td> <td width=126 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>11 (48%)</font></p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>14 (61%)</font></p></td></tr> <tr> <td width=258 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Gastrointestinal disorders</font></b></p></td> <td width=132 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td> <td width=126 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td></tr> <tr> <td width=258 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Abdominal pain</font></p></td> <td width=132 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>2 (10%)</font></p></td> <td width=126 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>5 (22%)</font></p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>0 (0%)</font></p></td></tr> <tr style=HEIGHT:13.2pt> <td width=258 style="BORDER-TOP:0px; HEIGHT:13.2pt; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Diarrhea</font></p></td> <td width=132 style="BORDER-TOP:0px; HEIGHT:13.2pt; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>3 (15%)</font></p></td> <td width=126 style="BORDER-TOP:0px; HEIGHT:13.2pt; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>4 (17%)</font></p></td> <td width=114 style="BORDER-TOP:0px; HEIGHT:13.2pt; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>11 (48%)</font></p></td></tr> <tr> <td width=258 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Nausea</font></p></td> <td width=132 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>4 (20%)</font></p></td> <td width=126 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>4 (17%)</font></p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>3 (13%)</font></p></td></tr> <tr> <td width=258 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>General disorders and administration site conditions</font></b></p></td> <td width=132 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td> <td width=126 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td></tr> <tr> <td width=258 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Malaise</font></p></td> <td width=132 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>2 (10%)</font></p></td> <td width=126 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>1 (4%)</font></p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>3 (13%)</font></p></td></tr> <tr> <td width=258 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Nervous system disorders</font></b></p></td> <td width=132 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td> <td width=126 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td></tr> <tr> <td width=258 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:193.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Headache</font></p></td> <td width=132 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:99pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>8 (40%)</font></p></td> <td width=126 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>8 (35%)</font></p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style=FONT-SIZE:9pt>7 (30%)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Solicited symptoms were collected from subjects for 7 days following immunization. </font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><i>Unsolicited Events.</i> A total of 83 unsolicited Treatment Emergent Adverse Events, or TEAEs, were reported by 33 of the 66 subjects within the first 28 days post dosing, with slightly more placebo subjects 12/20 (60%) reporting AEs than low dose 11/23 (48%) or high dose vaccinated subjects 10/23 (44%). Headache was the most common AE reported in all treatments. Most TEAEs were mild or moderate in severity. The PI considered 28&nbsp;TEAEs possibly related, 42 unlikely related, and 13 not related.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>Study 102. Dose and Schedule Optimization</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The study was designed to evaluate the norovirus vaccine (VXA-GI.1-NN) in 60 subjects given multiple doses, with some differences in schedule for the lower dose groups. The first three groups enrolled (N=15 each) used low doses of 1 x 10<sup>10</sup> infectious units (IU). Group A received two doses of VXA-GI.1-NN on days 0 and 7, group B received three doses on days 0, 2, and 4, and group C received two doses on days 0 and 28. The fourth group, group D (N=15), evaluated two high doses of 1 x 10<sup>11</sup> IU given on days 0 and 28. The vaccine study was an open labeled study, and enrolled more or less sequentially from group A to group D. The primary endpoint of the study was to evaluate the safety of all dosing regimens and the secondary endpoint was to compare immunogenicity between groups by BT50 titers and antibody secreting cells (ASC) counts.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>10</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div><p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p><p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>Safety Results. 102 Study</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In the first 7 days following study drug administration, there were 27 subjects reporting adverse events, distributed across the groups with the highest number of reporting adverse events in group C (11/15) and the lowest in group D (3/15). The most common adverse event reported was headache, reported in 21 subjects out of 60. Group C reported the highest number of headaches, and adverse events overall. This group was given two low dose vaccines 28 days apart. This was not observed in group D, a vaccine group given the exact same dosing schedule, but receiving two 10-fold higher doses of vaccine.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Table 2. </font></b><font style=FONT-SIZE:10pt>Norovirus Study 102 Solicited Systems &#150; Number and Percent of Subjects Reporting Treatment Emergent Adverse Events.</font></p> <div style=page:WordSection2> <table width=1000 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:750pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; MARGIN-LEFT:5.4pt; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr style=HEIGHT:27.85pt> <td width=288 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:27.85pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>SYSTEMIC ORGAN CLASS /Preferred Term</font></b></p></td> <td width=84 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:27.85pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Group A</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N=15</font></b></p></td> <td width=78 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:27.85pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Group B</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N=15</font></b></p></td> <td width=90 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:27.85pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Group C</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N=15</font></b></p></td> <td width=84 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:27.85pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.75pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Group D</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N=15</font></b></p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Total Number Reporting an Adverse Event</font></b></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>5 (33.3%)</font></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>8 (53.3%)</font></p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>11 (73.3%)</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>3 (20%)</font></p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>GASTROINTESTINAL DISORDERS</font></b></p></td> <td width=336 colspan=4 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:251.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Diarrhea</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1 (7%)</font></p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>5 (33%)</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1 (7%)</font></p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Abdominal Pain</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1 (7%)</font></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>3 (20%)</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1 (7%)</font></p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Nausea</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1 (7%)</font></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2 (13%)</font></p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2 (13.3%)</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Abdominal Pain, Upper</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1 (7%)</font></p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>GENERAL DISORDERS</font></b></p></td> <td width=336 colspan=4 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:251.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Malaise</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2 (13%)</font></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2 (13%)</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1(7%)</font></p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Feeling Hot</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1 (7%)</font></p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0</font></p></td></tr> <tr> <td width=288 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>NERVOUS SYSTEM DISORDERS</font></b></p></td> <td width=336 colspan=4 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:251.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:11.65pt> <td width=288 style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:215.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&nbsp;&nbsp;&nbsp;&nbsp; Headache</font></p></td> <td width=84 style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>4 (27%)</font></p></td> <td width=78 style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>7 (47%)</font></p></td> <td width=90 style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>9 (60%)</font></p></td> <td width=84 style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1 (7%)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 0pt; page:WordSection2'> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt; page:WordSection2'>&nbsp;</p> <table width=70% bordercolor=transparent style=WIDTH:70% cellpadding=0 cellspacing=0> <tr> <td style="BORDER-TOP:#000000 1px solid; BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid"> <div> <p style="VERTICAL-ALIGN:baseline; MARGIN:0in 0in 0pt; LINE-HEIGHT:95%"><font style=FONT-SIZE:10pt><b><font style='FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:#404040; LINE-HEIGHT:95%'>Group A: </font></b>&nbsp; Low Dose - Day 0, 7&nbsp; <b>Group B: </b>&nbsp; Low Dose - Day 0, 2, 4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; <b>Group C: </b>Low Dose - Day 0, 28<b> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Group D:&nbsp;</b> High Dose - Day 0, 28</font></p></div></td></tr></table> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Solicited symptoms were collected from subjects for 7 days following immunization. </font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><b>Safety Summary from the Two Studies.</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>106 subjects were treated with VXA-GI.1-NN in the two norovirus vaccine studies. The vaccine was well tolerated, with no severe adverse events reported in either study. The most common solicited adverse event was headache, but this was relatively similar among all the dosing groups including 40% of subjects receiving the placebo in the 101 study. In the 101 study, there was a higher incidence of diarrhea reported in the high dose group versus the other groups. However, in the high dose group in the 102 study, there was only 1 subject (6.7%) reporting diarrhea even after receiving two high doses. These results in total suggest that there were no dose dependent effects that impacted safety. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Immunogenicity Results-Study 101</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>BT50 Titers</b>. The primary immunological endpoint was to measure antibody titers by an assay that assessed the ability of antibodies to block interaction of a norovirus VLP to histogroup blood antigen (HGBA). This assay is known as the BT50 (for 50% inhibition of blocking titer) assay. BT50 titers were assessed using Le<sup>b</sup> synthetic glycan as the coating antigen. Titers rose in the vaccine recipients, and at all timepoints (Figure 6). By the Le<sup>b </sup>BT50 assay, 14/23 (61%) of the subjects in the low dose group, and 18/23 (78%) in the high dose group, had at least a two-fold rise. One subject in the placebo group had a greater than two-fold rise. On Day 28, the geometric mean titer (GMT) for the low dose vaccine group was 59.0, a 2.3-fold geometric mean fold rise (GMFR) over the initial GMT of 26.2 at baseline. The GMT for the high dose vaccine group was 98.5, a 3.8-fold GMFR over the initial GMT of 25.8 at baseline. The high dose group was significantly increased over placebo on day 28 (P=0.0003). Complete results are given in the table below.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>11</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt><em><strong>GMT for Le<sup>b</sup> BT50 assays</strong></em></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in 6pt; TEXT-INDENT:0in; page:WordSection2'><font style=FONT-STYLE:normal>Table 3. </font><font style="FONT-WEIGHT:normal; FONT-STYLE:normal">Study 101, Least Squared Geometric Mean Titer (LSGMT) for Le<sup>b</sup> BT50 assay.</font></p> <div style=page:WordSection2> <table width=1000 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:750pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; MARGIN-LEFT:26.75pt; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=124 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:93.3pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>HBGA</font></b></p></td> <td width=464 colspan=4 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:347.7pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Le<sup>b</sup></font></b></p></td></tr> <tr> <td width=124 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:93.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Group</font></b></p></td> <td width=128 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:95.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>D0 LSGMT </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(95 CI)</font></b></p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>D28 LSGMT</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(95 CI)</font></b></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>LSGMR</font></b></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>p value*</font></b></p></td></tr> <tr> <td width=124 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:93.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Low</font></b></p></td> <td width=128 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:95.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>26.2</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(16.6-41.2)</font></p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>59.0</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(33.0-105.4)</font></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2.3</font></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.0459</font></p></td></tr> <tr> <td width=124 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:93.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>High</font></b></p></td> <td width=128 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:95.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>25.8</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(18.3-36.2)</font></p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>98.5</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(64.4-150.7)</font></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>3.8</font></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.0003</font></p></td></tr> <tr> <td width=124 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:93.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Placebo</font></b></p></td> <td width=128 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:95.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>24.6</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(15.3-39.3)</font></p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>27.4</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(17.0-44.2)</font></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1.1</font></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Reference</font></p></td></tr> <tr> <td width=124 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:93.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.75pt 0in'>&nbsp;</p></td> <td width=356 colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:266.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Overall significance</font></b></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.0017</font></b></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 12pt; page:WordSection2'><i>*Significance by Mann-Whitney vs placebo; overall significance by Kruskal-Wallis Test.</i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>Antibody Secreting Cell (ASC).</b> The ability of the vaccine to induce norovirus specific B cells in the peripheral blood was measured by ASC assay. This assay essentially counts the number of B cells that emerge after immunization and recognize norovirus in the peripheral blood. The number that circulate in the blood pre-immunization is very low, so the assay is a meaningful way to evaluate the vaccine specific effects. In the low dose group, 16/23 (70%) of subjects responded and in the high dose group, 19/23 (83%) of subjects responded on day 7 for both IgA and IgG ASCs (Figure 7). Background ASCs were generally negligible on day 0. For the high dose vaccine treated group, an average of 561 IgA ASCs and 278 IgG ASCs each per 1 x 10<sup>6</sup> peripheral blood mononuclear cells, or PBMC, were found on day 7. For the low dose vaccine treated group, an average of 372 IgA ASCs and 107 IgG ASCs were found on day 7. The placebo group had no responders with an average of 3.3 spots for IgA ASCs and 2.2 spots for IgG ASCs per 1 x 10<sup>6</sup> PBMC on day 7. The treated groups were significantly different than placebo in terms of the ability to elicit an IgG or an IgA ASC response at day 7 (P&lt;0.0001, Mann-Whitney). There was no statistical difference in the number of spots for IgA and IgG ASCs between the high and low dose groups (P=0.21 for IgA, P=0.28 for IgG). </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>Enzyme-linked immunosorbent assay</b> (<b>ELISA) IgA and IgG.</b> Serum antibody responses were measured by IgG and IgA ELISA, and the changes in titers at EC50 between days 0 and 28 were calculated for each subject. Most subjects had an increase in antibody titers post immunization. The average change in EC50 for the low dose group was 16 and 7.1-fold in IgA and IgG respectively. Similarly, the average change in the EC50 for the high dose group were 9 and 5.4-fold for IgA and IgG respectively. The change in EC50 are plotted for each subject, separated by group (Figure 8).</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>Memory Cells.</b> Memory cells are long-lived cells that are important for the rapid induction of immunity following infection. A goal of most vaccines is to safely induce immunological memory to protect people from actual infection. Antigen specific memory B cells were investigated after culturing PMBCs with polyclonal stimulators. VP1 specific IgG memory B cells were higher than IgA memory B cells in the day 0 samples (Figure 9). Post immunization, the response at day 7 was higher for IgA memory B cells, with a geometric mean fold rise, or GMFR, of 15.3 for IgA versus 6.5 for IgG between day 0 and 7, before declining again at day 28. In the low dose group, the GMFR was 7.4 for IgA and 3.7 for IgG was observed between days 0 and 7. This decline from day 7 to day 28 may have resulted from homing of circulating B cells from the peripheral blood to the intestinal lymphoid tissues via expression of high levels of the mucosal homing receptor, <font style=FONT-FAMILY:Symbol>a</font>4<font style=FONT-FAMILY:Symbol>b</font>7. In the high dose group at day 7, 20/23 (87%) IgA and 19/23 (83%) for IgG showed &#8805;<u> </u>2-fold increase over day 0. In the low dose group at day 7, 18/23 (78%) for IgA and 13/23 (57%) for IgG showed &#8805;2-fold increase over day 0. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><b>Fecal and Saliva IgA.</b> Norovirus VP1 specific mucosal IgA was explored directly by looking at fecal and saliva samples. Because the quantity of IgA is highly variable within these samples, total IgA was also measured and the ratio between VP1- specific IgA/total IgA for each sample was examined. Samples with IgA levels below the detection limit were excluded from analysis. The increase in the ratio of specific IgA to total IgA was measured between baseline and day 28 (and baseline and day 180 for fecal IgA). In the high dose group, 9/19 (47%) fecal samples were responders with a four-fold rise or greater IgA response at day 28, and 9/21 (43%) at day 180 (Figure 10). The average fold increases in specific IgA/total IgA ratio were 17.2 and 9.7. These results are significantly higher than the placebo group where 2/18 (11%) and 0/16 (0%) were found to have 4-fold or better increases on days 28 and 180 (P=0.029 and P=0.0049 respectively), with average increases of 1.8 and 1.0 (Figure 10). The low dose group had a similar response as the high dose, with 7/20 (35%) and 5/16 (31%) with 4-fold or greater increases on days 28, and 180 respectively. The number of responders trended higher than placebo on day 28, but the difference was statistically significant on day 180 (P=0.13 and 0.043). The low dose group had a 36.2-fold increase on day 28, and a 5.6-fold increase on day 180 (Figure 10). Fewer subjects had detectable increases in the specific IgA to total IgA ratios in saliva samples of treated subjects at day 28 (Figure 11). The average increase in the specific IgA/total IgA ratio was 2.0 for the low dose, 2.9 for the high dose group, and 1.2 for the placebo group. The high dose and low dose groups had each had 4 subjects with a 4-fold rise in the specific response, versus none for the placebo group. These results demonstrate that the vaccine can induce antibody responses that are measured in the mucosa, particularly in the intestinal mucosa, which is the site of norovirus infection.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>12</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 6. </font></b><font style=FONT-SIZE:10pt>Geometric Mean Titers vs Time.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><img width=660 height=490 style="HEIGHT:464px; WIDTH:704px" src=j6.jpg></p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. Geomean Serum BT50 Titers over time for Le<sup>b</sup>.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 7. </font></b><font style=FONT-SIZE:10pt>ASC Titers on Day 7 post immunization.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><img width=672 height=477 style="HEIGHT:440px; WIDTH:658px" src=j7.jpg></p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption: ASC counts on day 7 for both IgG and IgA responses to norovirus VLP. This assay measures antigen specific B cells in the peripheral blood that occur post vaccination.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 8. </font></b><font style=FONT-SIZE:10pt>ELISA antibody changes post immunization<i>.</i></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 6pt; page:WordSection2'><img src=j8.jpg></p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. Change in IgA or IgG ELISA titers post immunization between days 0 and 28 for all subjects divided by treatment group. Each symbol represents an individual subject. The long horizontal line represents the mean, with the smaller lines the 95% confidence interval.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>13</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt color=#0066cc><a href=#toc><strong>Table of Contents</strong></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 0pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 9. </font></b><font style=FONT-SIZE:10pt>Memory Cell Responses pre- and post-immunization.</font></p> <div style=page:WordSection2>&nbsp;</div> <div style=page:WordSection2><img width=993 height=422 style="HEIGHT:383px; WIDTH:709px" src=j9.jpg></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption: Norovirus VP1 specific memory B cell counts were plotted for each time point. Each symbol represents an individual subject. The long horizontal line represents the geometric mean.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 10. </font></b><font style=FONT-SIZE:10pt>Fold Induction in Norovirus Specific Fecal IgA Responses Post Immunization</font><font style=FONT-SIZE:10pt>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 6pt; page:WordSection2'><img src=j10.jpg></p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. Fecal responses to the vaccine, with fold increase in specific IgA/total IgA for each subject (divided by group and each timepoint) plotted. Average increase is the black bar.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 11. </font></b><font style=FONT-SIZE:10pt>Fold Rise in Norovirus Specific Responses in Saliva.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 6pt; page:WordSection2'><img width=687 height=460 style="HEIGHT:421px; WIDTH:699px" src=j11.jpg></p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. Saliva IgA responses were measured. The plot shows fold rise of specific IgA/ total IgA post immunization. Responses were compared between days 0 and 28.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Immunological Results - 102 Study</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>BT50 Titers.</b> The objective of the study was to compare schedules and dosing for the ability to elicit immune responses, particularly by evaluating BT50 titers. BT50 titers were assessed at multiple times points, given that multiple doses were given. In the high dose group, 12 of 15 subjects had a 2-fold or greater increase in BT50 titers after the first dose and 14 of 15 subjects (92%) had a 2-fold or greater increase in BT50 titers after 2 doses. The GMT titer rose from 21.3 on day to 85.1 on day 28 for a 3.8 GMFR. The GMT at day 56 were measured to be 75.8, a GMFR of 3.6 over the baseline values. Other groups given lower doses of vaccine had lower response rates. Groups A and C had higher increases in the titers compared to Group B, although this is not statistically significant. An ANCOVA model was used to determine the statistical significance of the increases in GMFR. Least-squares, or LS, geometric mean titers, or LSGMTs, and LS geometric mean fold rises (LSGMFRs) were calculated by exponentiating the LSMs from the ANCOVA model, which included log-transformed post baseline titer or log-transformed change from baseline titer as a dependent variable, cohort as a factor, and baseline log-titer as a covariate. The significance in the different groups to increase the GMFR (test is LSGMFR=0), was found to be P=0.0008, 0.1224, 0.0004, and &lt;0.0001 for groups A through D respectively at day 56. This means all groups had statistically significant increases in the GMT with the exception of group B, which had a more modest increase in the titers.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>14</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>102 Study. BT50 Titers, Le<sup>b</sup></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in 6pt; TEXT-INDENT:0in; page:WordSection2'><font style=FONT-STYLE:normal>Table 4. </font><font style="FONT-WEIGHT:normal; FONT-STYLE:normal">Study 102, Geometric Mean Titer</font><font style=FONT-STYLE:normal>(</font><font style="FONT-WEIGHT:normal; FONT-STYLE:normal">GMT) for Le<sup>b</sup> BT50 assay roger.</font></p> <div style=page:WordSection2> <table width=1000 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:750pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=60 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.7pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Group</font></b></p></td> <td width=180 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135.05pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Description</font></b></p></td> <td width=78 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>DO GMT</font></b></p></td> <td width=96 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:71.9pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>D28 (or D36)</font></b></p></td> <td width=62 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:46.15pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>GMFR</font></b></p></td> <td width=71 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:53.4pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>GMT D56</font></b></p></td> <td width=77 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.8pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>GMFR D56</font></b></p></td></tr> <tr> <td width=60 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>A</font></b></p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in; LINE-HEIGHT:150%' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LINE-HEIGHT:150%'>Low, 2X, 7 days apart</font></b></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>32.2</font></p></td> <td width=96 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:71.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>64.5</font></p></td> <td width=62 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:46.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2.0</font></p></td> <td width=71 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:53.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>66.0</font></p></td> <td width=77 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2.0</font></p></td></tr> <tr> <td width=60 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>B</font></b></p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in; LINE-HEIGHT:150%' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LINE-HEIGHT:150%'>Low, 3X, 2 days apart</font></b></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>31.5</font></p></td> <td width=96 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:71.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>51.2</font></p></td> <td width=62 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:46.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1.6</font></p></td> <td width=71 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:53.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>42.5</font></p></td> <td width=77 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1.4</font></p></td></tr> <tr> <td width=60 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>C</font></b></p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in; LINE-HEIGHT:150%' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LINE-HEIGHT:150%'>Low, 2X, 28 days apart</font></b></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>29.4</font></p></td> <td width=96 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:71.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>66.0</font></p></td> <td width=62 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:46.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2.2</font></p></td> <td width=71 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:53.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>64.5</font></p></td> <td width=77 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2.2</font></p></td></tr> <tr> <td width=60 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:44.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>D</font></b></p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in; LINE-HEIGHT:150%' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LINE-HEIGHT:150%'>High, 2X, 28 days apart</font></b></p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>21.3</font></p></td> <td width=96 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:71.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>85.1</font></p></td> <td width=62 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:46.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>3.8</font></p></td> <td width=71 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:53.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>75.8</font></p></td> <td width=77 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:57.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>3.6</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b>ASCs.</b> Additional immunological analysis was performed by comparing the ASC responders between groups. The high dose group had 14 out of 15 subjects respond to the vaccine, with an average IgA ASC count of 698 per 1X10<sup>6</sup> cells. Following a second dose, the subject that didn&#146;t respond the first time had a significant increase in ASC counts so all 15 subjects (100%) were able to elicit an ASC response following two doses. As typical, subjects that had a high number of ASC counts after the first immunization had a low response after the 2<sup>nd</sup> dose. The low dose groups were compared by examining the overall response rate, since the dosing and the analysis were performed at different intermediate timepoints. Group A had the highest overall response rate where 12/14 subjects (86%) were able to induce meaningful ASC responses after 1 or 2 doses. Slightly lower responders were observed in group B, where only a few subjects had a response after the first dose, but more subjects responded after additional vaccine doses. Group C had the most variable responses of any group. The average number of spots was 839 per 1X10<sup>6</sup> cells after the first dose, but this was the result of several subjects having extremely high numbers of spots (3 subjects had greater than 1500 per 1X10<sup>6</sup>), mixed with many subjects that didn&#146;t respond at all.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>By Fisher&#146;s Exact test, the high dose group induced a higher number of responders than group C p=0.02), but only trended higher than groups A and B (0.22, 0.07). Similar results were observed for the IgG ASC responses, with slightly lower values on average.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 12. </font></b><font style=FONT-SIZE:10pt>IgA ASC Counts for the 102 study.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><img width=1060 height=549 style="HEIGHT:400px; WIDTH:807px" src=j12.jpg></p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 12pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. The different groups were assessed for IgA ASC counts at each time point taken for each group. Because there were different dosing regiments for each group, there were different timepoints assessed. Response rates at each timepoint are indicated by a fraction and a percentage below each timepoint. The overall response rate (the total number of subjects that responded at any time point) is given near the top of each group. For example, in the last group, 15/15 (100%) subjects responded at either D7 or D35.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>15</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 13. </font></b><font style=FONT-SIZE:10pt>IgG ASC Counts for the 102 Study.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><img width=905 height=488 style="HEIGHT:429px; WIDTH:821px" src=j13.jpg></p> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 12pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. The different groups were assessed IgG ASC counts at each time point taken for each group. Because there were different dosing regiments for each group, there were different timepoints assessed. Response rates at each timepoint are indicated by a fraction and a percentage below each timepoint. The overall response rate (the total number of subjects that responded at any time point) is given near the top of each group. For example, in the last group, 15/15 (100%) subjects responded at either D7 or D35.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'><font style=FONT-STYLE:normal>Norovirus Oral Tablet Vaccine Clinical Development Pathway</font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><b><i>Phase 1 Bivalent Norovirus Trial</i></b>. The bivalent Phase 1 trial is designed to assess the safety and immunogenicity of the two individual GI.1 and GII.4 norovirus vaccines, and to<b> </b>evaluate potential interference between the two vaccines. The trial is scheduled to begin during the first half of 2019. </p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><b><i>Phase 2 Norovirus GI.1 strain Challenge Study.</i></b> We plan to commence a challenge study with our monovalent GI.1 norovirus vaccine candidate in the first half of 2019. </p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0in"><b><i>Phase 2 Efficacy and Safety Trial</i></b>. After successfully completing the trials described above, a Phase 2 trial would be conducted. This trial will be designed to assess the safety, immunogenicity and possibly the efficacy of the bivalent vaccine in an expanded population of adults ranging in age from 18 to 49 years.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0in; page:WordSection2'><b><i>Path to Approval</i></b>. After completing the Phase 2 trial, we expect to request an End-of-Phase 2 meeting with the FDA to discuss the design of a Phase 3 trial that would support licensure. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Additional Age Groups</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Older Adults, Elderly Population</i></b>. Following successful completion of the bivalent Phase 1 trial in healthy adults age 18 &#150; 49, we plan to conduct sequential Phase 1 and Phase 2 clinical trials in healthy adults age 50 &#150; 64 years and age 65 and older, designed to support licensure of our tablet vaccine candidate for these age groups. Following these studies, we expect to engage in discussions with the FDA to determine the requirements for Phase 3 and licensure.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Pediatric Population</i></b>. Our current tablet vaccine candidates are designed for delivery to the gut in solid dosage form using an enteric-coated tablet which we believe is the optimal vaccine delivery system for the adult population and children 8 years and older. For children 6 months to 8 years in age, we plan to develop proprietary liquid formulations that can deliver the vectored vaccine intact to the gut. Development of our norovirus vaccine product candidate in the pediatric population will proceed stepwise through progressively younger age segments (i.e. 9-17 years, 5-8 years, 2-4 years, 6 weeks-2 years).</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our Seasonal Influenza Program</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Market Overview</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Influenza is one of the most common global infectious diseases, causing mild to life-threatening illness with symptoms such as sore throat, nasal discharge, fever, and even death. It is estimated that at least 350 million cases of seasonal influenza occur annually worldwide, of which 3 million to 5 million cases are considered severe, causing 290,000 to 650,000 deaths per year globally. Very young children and the elderly are at greatest risk from death. In the United States, between 5% and 20% of the population contracts influenza, 226,000 people are hospitalized with complications of influenza, and between 3,000 and 49,000 people die from influenza and its complications each year, with up to 90% of influenza-related deaths occurring in adults older than 65.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>16</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>According to a CDC commissioned-report based on 2003 population figures, in the United States, seasonal influenza costs an average of over 600,000 life-years lost, 3.1 million hospitalized days, and 31.4 million outpatient visits annually. The total economic burden of seasonal influenza has been estimated to be $87.1 billion, including medical costs which average $10.4 billion annually, while lost earnings due to illness and loss of life amount to $16.3 billion annually.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The CDC generally recommends that individuals 6 months and older be vaccinated annually against influenza. In the U.S., this means an influenza vaccination is recommended for more than 300 million people. During the 2017/2018 influenza season, approximately 137 million doses of the influenza vaccine were delivered in the United States. Differentiated flu vaccines in the U.S. market continue to demonstrate the ability to ask for premium prices based on the additional value they provide to public health. According to a 2017 Datamonitor Healthcare report the seasonal influenza vaccines market within the United States and five major European Union markets (France, Germany, Italy, Spain, and the UK) will increase from $2.7 billion in the 2016/17 season to $3.4 billion in the 2025/26 season. We believe, worldwide, the primary drivers of market growth include increasing awareness, increasing vaccination coverage in emerging countries, rising government support for immunization against seasonal influenza, pricing increases due to product differentiation and increased focus on the production and advancement of vaccination treatments.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Limitations of Current Seasonal Influenza Vaccines</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Despite the number of cases of influenza diagnosed in the United States, according to the CDC, in the 2017/2018 seasonal influenza season, only approximately 42% of the total U.S. population was vaccinated against influenza, with particularly low vaccination rates among adults between ages 18 and 49. According to the CDC, less than 27% of adults between ages 18 and 49 were vaccinated during the 2017/2018 influenza season. We believe the low vaccination rates among this population are largely attributed to the following limitations of injectable vaccine administration:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Limitations for Providers</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>longer manufacturing, shipping and handling time for suppliers;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>cold storage requirement throughout the logistics chain;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the need for healthcare professional oversight during and after the vaccination procedure;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>potential for needle injuries; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>medical waste.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Limitations for Users</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>inconvenience and time commitment required to obtain vaccine at a clinic or pharmacy;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>fear of needles;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>pain at injection site; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>potential for allergic reactions to the egg component of the vaccine.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our Seasonal Influenza Vaccine Candidate</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We are developing a tablet vaccine candidate for the immunization of healthy adults against seasonal influenza. Our seasonal influenza vaccine candidate is being designed to cover the four-strain, or quadrivalent, seasonal influenza vaccine consisting of two circulating influenza A lineage viruses as well as two circulating influenza B lineage viruses, matching the seasonally updated recommendations by the FDA. We envision formulating our tablet vaccine candidate as one tablet per strain, or four tablets in total for the quadrivalent vaccine. We believe this modularity will allow for enhanced flexibility. For instance, in the event of a late season strain change, the tablet containing the obsolete strain could be easily replaced without having to discard the three correctly matched vaccine tablets. Further, given stability of the tablets, excess tablets from one season could be stored and utilized in the next season, while fully formulated quadrivalent vaccines would have to be discarded at the end of each season as is the case with currently marketed influenza vaccines. Alternatively, we have the option to formulate all four strains into a single tablet. This format would be the simplest to administer, but would take away some of the flexibility advantages that separate tablets would afford. We will assess the final formulation of our tablet vaccine candidates after conducting market studies to evaluate market acceptance closer to commercialization.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>17</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt>We believe our tablet vaccine candidates have the potential to address many of the limitations of current injectable, egg-based seasonal influenza vaccines. First, our tablet vaccine candidates are designed to create broad and durable immune responses, which may provide more effective immunity and protect against additional strain variants. Second, by providing a more convenient method of administration to enhance patient acceptance and simplify distribution and administration. Finally, by using recombinant methods, we believe our tablet vaccine candidates may be manufactured more rapidly than vaccines manufactured using egg-based methods, eliminate the risk of allergic reactions to egg protein, and alleviate issues caused by egg-adaptation of a mammalian virus.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Seasonal Influenza Clinical Trials</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>To date, we have completed two Phase 1 trials and have conducted the active portion of a Phase 2 challenge trial of our H1N1 influenza vaccine candidate. We have also completed a Phase 1 trial of an influenza B vaccine candidate.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Phase 1 Trial, VXA02-001, H1N1 Influenza Vaccine Candidate, 10<sup>9</sup> and 10<sup>10</sup> IU Doses</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The first Phase 1 H1N1 trial was conducted at doses of 1 x 10<sup>9</sup> and 1 x 10<sup>10</sup> IU. Two doses were given one month apart. The tablet vaccine candidate generated a favorable safety and tolerability profile. The trial also demonstrated robust T cell responses and modest hemagglutination inhibition assay, or HAI, responses, each dependent on the dosage level. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Phase 1 Trial VXA02-003, H1N1 Influenza Vaccine Candidate, 10<sup>11</sup> IU Dose</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt">The second H1N1 trial was a tablet vaccine trial at a dose of 1 x 10<sup>11</sup> IU, delivered in a single administration. We observed a favorable safety and tolerability profile at this dose level. An HAI seroconversion rate of 75% was measured in the vaccine group, compared to 0% in the placebo group. 92% of subjects had a four-fold increase in Micro Neutralization, or MN, titer after the single administration of tablets. Both the HAI seroconversion rate and the MN responses were substantially higher than the respective rates that we observed at lower doses in Trial VXA02-001. The side effects of the vaccine or placebo in the first seven days following administration were mild with no serious adverse effects. In the first seven days following administration, there were eight total solicited adverse events, or AEs, reported in the vaccine and placebo groups (four in each group). All of these AEs were grade 1 in severity. The most frequent AE was headache (two in placebo, and one in the vaccine group). There were no serious adverse events and no new onsets of chronic illnesses related to the adjuvant recorded during the entire one year follow up period of the study.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The table below summarizes the trial design and results (serum antibody responses) of our two placebo-controlled Phase 1 H1N1 clinical trials.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b>Table 5. </b>Overview: H1 Influenza Phase 1 Placebo-Controlled Studies.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'>&nbsp;</p> <div style=page:WordSection2> <table width=1000 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:750pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=116 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:87.05pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>TRIAL NO./<br># SUBJECTS</font></b></p></td> <td width=124 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:92.7pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>TRIAL DESIGN</font></b></p></td> <td width=159 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:119.4pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>STUDY GROUPS DOSE/SCHEDULE</font></b></p></td> <td width=224 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:168.35pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>KEY IMMUNOGENICITY FINDINGS</font></b></p></td></tr> <tr> <td width=116 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:87.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Phase 1</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Trial VXA02-001</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N = 36</font></b></p></td> <td width=124 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:92.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Dose-escalation, placebo-controlled, double-blind with enteric-coated capsules</font></p></td> <td width=159 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:119.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>10<sup>9</sup>, 10<sup>10</sup> IU of VXA-A1.1 (H1) vaccine or placebo on Day 0 and Day 28, administered in tablet form</font></p></td> <td width=224 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:168.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>10<sup>9</sup> dose level:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&#149;&nbsp;&nbsp;&nbsp; No HAI seroconversion</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>10<sup>10</sup> dose level:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&#149;&nbsp;&nbsp;&nbsp; 27% HAI seroconversion</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&#149;&nbsp;&nbsp;&nbsp; 64% MN (4X rise)</font></p></td></tr> <tr> <td width=116 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:87.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Phase 1</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Trial VXA02-003</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N = 24</font></b></p></td> <td width=124 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:92.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Placebo-controlled, double-blind, with enteric-coated tablets</font></p></td> <td width=159 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:119.4pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>10<sup>11</sup> IU VXA-A1.1 (H1) vaccine or placebo on Day 0, single administration in table form</font></p></td> <td width=224 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:168.35pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&#149;&nbsp;&nbsp;&nbsp; 75% HAI seroconversion</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>&#149;&nbsp;&nbsp;&nbsp; 92% MN (4X rise)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Phase 1 Trial. Influenza B</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In 2015 and 2016, we conducted a randomized, double-blind, placebo-controlled Phase 1 trial to test the safety and immunogenicity of an influenza B tablet vaccine. A total of 54 healthy adults age 18-49 were enrolled, with 38 receiving the vaccine and 16 receiving placebo. To participate in this trial, subjects were required to have an initial HAI measure of no greater than 1:20. The active phase of the trial was through day 28, with the follow-up phase for monitoring safety to continue for one year. All subjects who received the vaccine received a single dose of either 1 x 10 <sup>10</sup> IU or 1 x 10<sup>11</sup> IU on Day 0.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>18</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b><i>Safety</i></b>. The side effects of the vaccine or placebo in the first seven days following administration were generally mild with no serious adverse events. There were no notable differences between the active dose groups and placebo in safety and tolerability.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b><i>HAI</i></b>. In the placebo group, HAI GMT remained essentially unchanged (1:33) at day 28 post dosing. The GMFR of HAI titers both active treated groups at day&nbsp;28 post dosing was about 2&#8209;fold, and independent of dose. For the vaccinated groups receiving either 1&#215;10<sup>10</sup>&nbsp;IU&nbsp;or 1&#215;10<sup>11 </sup>IU, seroconversion was observed in 5/19&nbsp;subjects (26.3%) and 3/19&nbsp;subjects (15.8%), respectively. There were no seroconversions in the placebo group.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b><i>Antibody Secreting Cells (ASCs).</i></b> In order to measure total antibody responses to HA, the numbers of circulating B&nbsp;cells that recognize influenza HA in peripheral blood were measured by ASC assay on days&nbsp;0 and 7 after immunization. Results show that ASCs could be reliably measured on day&nbsp;7 in the vaccine-treated groups. Background ASCs were generally negligible on day&nbsp;0. By IgG ASC, 68% of 1&#215;10<sup>10&nbsp;</sup>IU dose subjects responded, and 84% of subjects in the 1&#215;10<sup>11</sup>&nbsp;IU dose group responded. For the 1&#215;10<sup>11</sup>&nbsp;IU dose vaccine treated group, an average of 21&nbsp;IgA ASCs (95%&nbsp;CI: 7 &#150; 35) and 73&nbsp;IgG ASCs (95%&nbsp;CI: 35 &#150; 111) each per 1&#215;10<sup>6</sup> peripheral blood mononuclear cell (PBMC) were found at day&nbsp;7. For the 1&#215;10<sup>10&nbsp;</sup>IU dose vaccine treated group, an average of 16 IgA ASCs (95%&nbsp;CI: 2 &#150; 29) and 44&nbsp;IgG ASCs (95% CI: 21 &#150; 66) were found at day&nbsp;7. The placebo group had no responders, and negligible average number of spots (1 or less) on Day&nbsp;7 (95%&nbsp;CI: -0.6 &#150; -2).</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>H1N1 Influenza Phase 2 Challenge Study Funded by BARDA</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In 2015, we were awarded a $13.9 million contract by BARDA, part of the U.S. Department of Health and Human Services. This two-year contract was awarded under a Broad Agency Announcement issued to support the advanced development of more effective influenza vaccines to improve seasonal and pandemic influenza preparedness. The contract primarily funded a Phase 2 challenge study in human volunteers, designed to evaluate whether our H1N1 tablet vaccine candidate offers broader and more durable protection than currently marketed injectable vaccines. The contract with BARDA was subsequently increased to $15.7 million and the term was extended until September 2018.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In this Phase 2 study, volunteers were randomized into three groups. One group received our oral H1N1 influenza tablet vaccine candidate, a second group received a commercially licensed inactivated influenza vaccine by intramuscular injection, and a third group received placebo. Three months following immunization, volunteers were challenged (deliberate experimental administration) with live H1N1 (A/H1N1 pdm09) influenza virus by intranasal administration. The placebo group served as the control group to determine how many unvaccinated volunteers became infected and how severe their influenza symptoms became. Data from our vaccine candidate group and the commercially licensed inactivated vaccine group were compared to placebo to determine each vaccine&#146;s efficacy in this challenge study. Importantly, the two vaccines were also compared head-to-head. The goal of the study is to compare the efficacy of our vaccine to protect volunteers from illness caused by H1N1 influenza challenge, compared to both the injectable vaccine and placebo three months after immunization.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Clinical Trial Results VXA-CHAL-201</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The Phase 2 challenge study was enrolled during 2016 and 2017. During this time, 179 subjects that cleared the screening requirements were randomized to receive a single dose of our tablet vaccine, the commercial injectable vaccine, or placebo. Of these 179 subjects, 143 subjects were subsequently challenged with live H1N1 influenza virus 90 to 120 days months after dosing. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Safety. </i></b>The side effects of the vaccines or placebo in the first seven days following administration were generally mild. In the first seven days following administration, the solicited adverse events (AEs) reported in the vaccine and placebo groups were mostly grade 1 in severity, and none were above grade 2. The most frequent solicited AE was headache in our tablet vaccine group (7%), injection site tenderness in the commercially licensed inactivated vaccine group (26%) and headache in the placebo group (19%). There were no serious adverse events and no new onsets of chronic illnesses related to our vaccine adjuvant recorded during the follow up period of the study. The graphs below show the distribution and severity over time of local and systemic (Figures 14 and 15) solicited AEs.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>19</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 14. </font></b><font style=FONT-SIZE:10pt>Maximum Severity of Solicited Local Symptoms.</font></p> <div style=page:WordSection2><img width=783 height=638 style="HEIGHT:384px; WIDTH:736px" src=j14.jpg></div> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. Solicited local symptoms were collected for seven days following immunization. The severity of solicited symptoms is indicated for each treatment group over time. All events were mild. </font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 15. </font></b><font style=FONT-SIZE:10pt>Maximum Severity of Solicited Systemic Symptoms.</font></p> <div style=page:WordSection2><img width=839 height=682 style="HEIGHT:458px; WIDTH:736px" src=j15.jpg></div> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption. Solicited systemic symptoms were collected for seven days following immunization. The severity of solicited symptoms is indicated for each treatment group over time. </font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Efficacy &#150; Reduction of PCR Confirmed Influenza Illness. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The primary efficacy objective was to determine vaccine efficacy of our tablet vaccine following the challenge with the wild-type influenza A H1 virus strain (A/H1N1 pdm09). The primary efficacy endpoint was illness.<b> </b>The illness rate was 29% for our tablet vaccine, 35% for the commercial inactivated influenza vaccine, and 48% for subjects in the placebo group. Our tablet vaccine had a lower rate of illness than the commercial vaccine (-6% difference in illness rate in favor of our vaccine), although given the small size of the study, these differences were not statistically significant. Similarly, the difference in illness rates between our tablet vaccine and placebo (-19.1%) and the commercial injected vaccine and placebo (-13.2%) trended toward protection but were not statistically significant. These results suggest that our vaccine is no worse, and trended better than the commercial vaccine for protection. The ability to show clinical efficacy in humans is a major step forward for our oral influenza product. These results are summarized in the table below.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>20</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><b>Table 6. </b>H1 Influenza Phase 2 Challenge Study: Illness Rates*.</p> <div style=page:WordSection2> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:16pt> <td width=193 colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:144.9pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>VAXART</font></b></p></td> <td width=172 colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:129.35pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Commercial</font></b></p></td> <td width=156 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:117pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>VAXART-Commercial</font></b></p></td> <td width=162 colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:121.5pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Placebo</font></b></p></td></tr> <tr style=HEIGHT:18.4pt> <td width=41 nowrap style="BORDER-TOP:0px; HEIGHT:18.4pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>n</font></p></td> <td width=152 style="BORDER-TOP:0px; HEIGHT:18.4pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:113.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; LINE-HEIGHT:115%; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LINE-HEIGHT:115%'>% (95% CI)</font></p></td> <td width=46 nowrap style="BORDER-TOP:0px; HEIGHT:18.4pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:34.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>n</font></p></td> <td width=126 style="BORDER-TOP:0px; HEIGHT:18.4pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:94.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>% (95% CI)</font></p></td> <td width=156 style="BORDER-TOP:0px; HEIGHT:18.4pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:117pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Rate Difference (95% CI)</font></p></td> <td width=30 nowrap style="BORDER-TOP:0px; HEIGHT:18.4pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>n</font></p></td> <td width=132 style="BORDER-TOP:0px; HEIGHT:18.4pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:99.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>% (95% CI)</font></p></td></tr> <tr style=HEIGHT:16pt> <td width=41 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:30.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>58</font></p></td> <td width=152 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:113.95pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; LINE-HEIGHT:115%; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LINE-HEIGHT:115%'>29.3 (18.1, 42.7)</font></p></td> <td width=46 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:34.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; LINE-HEIGHT:115%; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; LINE-HEIGHT:115%'>54</font></p></td> <td width=126 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:94.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>35.2 (22.7, 49.4)</font></p></td> <td width=156 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:117pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>-5.9 (-24.3, 12.5)</font></p></td> <td width=30 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:22.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>31</font></p></td> <td width=132 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:99.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0.75pt 0in 0.75pt 14.7pt; TEXT-INDENT:-14.7pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>48.4 (30.2, 66.9)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>*Illness was defined as a combination of symptoms reported on a patient reported outcome tool (Flu-PRO<sup>TM</sup>) and quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) detectable shed influenza virus.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Efficacy &#150; Flu-PRO symptom Scores</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>There were no statistically significant differences between the commercial inactivated influenza vaccine and our tablet vaccine for the Flu-PRO questionnaire, a validated patient recorded outcome tool used in influenza clinical trials in the community. However, our vaccine trended lower for overall symptom severity. Subjects in the VXA-A1.1 group showed a lower overall median Flu-PRO score (2.0 [0, 72]) than the QIV group (5.0 [0, 59]) or the placebo group (5.0 [0, 52]). </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Efficacy &#150; Shedding</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Shedding represents influenza virus that is detected in nasal swabs post infection and is representative of viral infection and replication. In the study, 44.8% of subjects in VXA-A1.1 had at least one day positive for shedding, versus the commercial injected vaccine where 53.7% were positive for shedding and where 71.0% of placebo subjects were positive for shedding. There were no statistically significant differences observed between our tablet vaccine and the commercial inactivated influenza vaccine for viral shedding area under the curve (AUC). However, AUC was calculated using a standard logarithmic trapezoidal method and included only detectable shedding during the first 5 days of the duration of shedding, with subjects removed from the analysis that didn&#146;t shed influenza for 5 days (a zero value cannot be used in log calculations and integrated). This may have led to an underestimate of the effect on viral shedding for the two vaccines relative to placebo. Therefore, in order to better determine the effect of the vaccines on shedding, an alternative method was used in which volunteers were defined as infected if they had detectable viral shedding at any time 36 hours after challenge. This approach eliminated possible issues related to calculations (log calculations of zero values) and of large doses of challenge virus (first 36 hours might be pass through rather than replicating influenza). In a Bayesian analysis, both vaccines significantly reduced the probability of shedding relative to placebo (Bayesian posterior p=0.001 for our tablet vaccine and p=0.009 for the commercial inactivated influenza vaccine). There is also trend toward greater efficacy for our vaccine with an ~80% posterior probability (Table 7).</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b>Table 7. </b>H1 Influenza Phase 2 Challenge Study: Infection Rates*.</p> <div style=page:WordSection2> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:16pt> <td width=132 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:99pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Treatment Arm</font></b></p></td> <td width=87 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N</font></b></p></td> <td width=131 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:98pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Number Infected</font></b></p></td> <td width=129 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:97pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Percent (95% CI)</font></b></p></td> <td width=140 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:105pt; BACKGROUND:#fbe4d5; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Posterior P </font></b></p></td></tr> <tr style=HEIGHT:16pt> <td width=132 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:99pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Placebo</font></p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>31</font></p></td> <td width=131 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:98pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>22</font></p></td> <td width=129 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:97pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>71% (55-85%)</font></p></td> <td width=140 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:105pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>-</font></p></td></tr> <tr style=HEIGHT:16pt> <td width=132 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:99pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Commercial</font></p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>54</font></p></td> <td width=131 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:98pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>24</font></p></td> <td width=129 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:97pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>44% (32-58%)</font></p></td> <td width=140 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:105pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.009</font></p></td></tr> <tr style=HEIGHT:16pt> <td width=132 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:99pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Vaxart Vaccine</font></p></td> <td width=87 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>58</font></p></td> <td width=131 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:98pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>21</font></p></td> <td width=129 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:97pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>36% (24-49%)</font></p></td> <td width=140 nowrap style="BORDER-TOP:0px; HEIGHT:16pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:105pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.001</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>*Infection was defined as any positive quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) detectable shed influenza virus on any day after 36 hours from viral challenge. In a Bayesian analysis, both vaccines provide a statistically significant protection against infection. There is also trend toward greater efficacy for our vaccine with an ~80% posterior probability.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Immunogenicity</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b><i>HAI responses.</i></b> HAI measures the ability of serum antibodies that can disrupt binding of influenza virus to red blood cells. Historically, HAI correlates to protection for injected influenza vaccines. HAI responses were measured 30 days following immunization to determine the number and percentage of volunteers that seroconverted. In our tablet vaccine group, 32% of volunteers achieved seroconversion. In the commercial inactivated influenza vaccine group 84% of volunteers achieved HAI seroconversion at 30 days post vaccination. This difference was statistically significant (P &lt; 0.001, Fisher&#146;s Exact test). There were no subjects in the placebo group who achieved seroconversion at 30 days post vaccination. Since 32% of subjects seroconverted in the Vaxart tablet vaccine group achieved HAI seroconversion, but 71% of subjects were protected from illness following influenza challenge, HAI seroconversion appeared not to be a reliable indicator of protection for the Vaxart vaccine. The table below summarizes the HAI data. The GMT, GMFR, percentage of volunteers who had a 4-fold rise in their HAI and the percentage of subjects who seroconverted are reported.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>21</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <h4 style='FONT-SIZE:10pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in 6pt; page:WordSection2'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; FONT-STYLE:normal' lang=EN-GB>Table 8. </font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; COLOR:black; FONT-STYLE:normal' lang=EN-GB>Hemagglutination Antibody Inhibition (HAI) Geometric Mean Titer (GMT) and Geometric Mean Fold Rise (GMFR) Results Post Dosing with 95% Confidence Intervals by Strain, Study Day and Treatment Group.</font></h4> <div style=page:WordSection2 align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0 align=left> <tr> <td width=100% colspan=8 style="BORDER-TOP:black 1pt solid; BORDER-RIGHT:black 1pt solid; WIDTH:100%; BACKGROUND:#fbe4d5; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Full Analysis Set - Vaccination Phase</font></b></p></td></tr> <tr> <td width=21% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:21.58%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=17% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:17.34%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Baseline (Pre-Dosing)</font></b></p></td> <td width=61% colspan=5 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:61.08%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>30 Days Post Dosing</font></b></p></td></tr> <tr> <td width=21% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:21.58%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Treatment Group</font></b></p></td> <td width=4% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:4.5%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N</font></b></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>GMT (95% CI)</font></b></p></td> <td width=4% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:4.5%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N</font></b></p></td> <td width=15% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:15.04%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>GMT (95% CI)</font></b></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>GMFR (95% CI)</font></b></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>% 4-Fold Rise (95% CI)</font></b></p></td> <td width=15% style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:15.86%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>% Seroconversion</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>(95% CI)</font></b></p></td></tr> <tr> <td width=100% colspan=8 style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:100%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3pt 0in; TEXT-AUTOSPACE:'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Strain:&nbsp;A/California/7/2009</font></b></p></td></tr> <tr> <td width=21% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:21.58%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3pt 0in; TEXT-AUTOSPACE:'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Vaxart Tablet Vaccine</font></p></td> <td width=4% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:4.5%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>70</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>11.13<br>(9.55, 12.96)</font></p></td> <td width=4% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:4.5%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>69</font></p></td> <td width=15% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:15.04%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>29.99<br>(23.72, 37.93)</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2.72<br>(2.18, 3.39)</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>36.2<br>(25.0, 48.7)</font></p></td> <td width=15% style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:15.86%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>31.9<br>(21.2, 44.2)</font></p></td></tr> <tr> <td width=21% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:21.58%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3pt 0in; TEXT-AUTOSPACE:'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Commercial Inactivated Influenza Vaccine</font></p></td> <td width=4% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:4.5%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>72</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>9.84<br>(8.33, 11.63)</font></p></td> <td width=4% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:4.5%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>70</font></p></td> <td width=15% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:15.04%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>273.13<br>(182.15, 409.54)</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>27.50<br>(19.44, 38.90)</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>90.0<br>(80.5, 95.9)</font></p></td> <td width=15% style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:15.86%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>84.3<br>(73.6, 91.9)</font></p></td></tr> <tr> <td width=21% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:21.58%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3pt 0in; TEXT-AUTOSPACE:'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Placebo</font></p></td> <td width=4% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:4.5%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>35</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>10.49<br>(8.37, 13.15)</font></p></td> <td width=4% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:4.5%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>35</font></p></td> <td width=15% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:15.04%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>10.40<br>(8.15, 13.29)</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.99<br>(0.88, 1.11)</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.0<br>(0.0, 10.0)</font></p></td> <td width=15% style="BORDER-TOP:0px; BORDER-RIGHT:black 1pt solid; WIDTH:15.86%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.0<br>(0.0, 10.0)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><b><i>IgA Antibody Secreting Cells. </i></b>B cells specific for influenza HA (IgA antibody secreting cells or IgA ASCs) were measured at baseline and 8 days following immunization in order to determine the B cell responses to the vaccines. <font style=COLOR:#212121>At 8 days following vaccination, subjects in the </font>commercial inactivated influenza vaccine group <font style=COLOR:#212121>had significantly higher mean numbers of spots per 10<sup>6</sup> cells (p&lt;0.001, Wilcoxon test) and significantly higher percentages of subjects with greater than 8 spots per 10<sup>6</sup> cells (p&lt;0.001, Fisher exact). At Day 8, the </font>commercial inactivated influenza vaccine <font style=COLOR:#212121>group had mean spots 286 per 10<sup>6</sup> cells compared to mean spots of 116 per 10<sup>6</sup> cells for the Vaxart tablet vaccine. Additionally, the </font>commercial inactivated influenza vaccine <font style=COLOR:#212121>group had a 96% response rate compared to 71% in the Vaxart tablet vaccine group. The table below summarizes these data.</font></p> <h4 style='FONT-SIZE:10pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in 6pt; page:WordSection2'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; FONT-STYLE:normal' lang=EN-GB>Table 9. </font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; COLOR:black; FONT-STYLE:normal' lang=EN-GB>ASC Response for IgA and IgG Assays by Study Day and Treatment Group &#150; Vaccination Phase.</font></h4> <div style=page:WordSection2> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:13.9pt> <td width=23% colspan=2 style="BORDER-TOP:black 1pt solid; HEIGHT:13.9pt; BORDER-RIGHT:0px; WIDTH:23.5%; BACKGROUND:#fbe4d5; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=76% colspan=8 style="BORDER-TOP:black 1pt solid; HEIGHT:13.9pt; BORDER-RIGHT:black 1pt solid; WIDTH:76.5%; BACKGROUND:#fbe4d5; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Vaccination Phase</font></b></p></td></tr> <tr style=HEIGHT:12.8pt> <td width=23% colspan=2 style="BORDER-TOP:0px; HEIGHT:12.8pt; BORDER-RIGHT:0px; WIDTH:23.5%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=36% colspan=4 style="BORDER-TOP:0px; HEIGHT:12.8pt; BORDER-RIGHT:0px; WIDTH:36.24%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Baseline (Pre-Dosing)</font></b></p></td> <td width=40% colspan=4 style="BORDER-TOP:0px; HEIGHT:12.8pt; BORDER-RIGHT:black 1pt solid; WIDTH:40.28%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Day 8 (Post-Dosing)</font></b></p></td></tr> <tr style=HEIGHT:31.1pt> <td width=8% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:0px; WIDTH:8.96%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Assay</font></b></p></td> <td width=14% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:0px; WIDTH:14.54%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Treatment Group</font></b></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N</font></b></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Mean</font></b></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:0px; WIDTH:10.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Median [Range]</font></b></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:0px; WIDTH:11.12%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>At Least 8 Spots<br>n (%)</font></b></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>N</font></b></p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:0px; WIDTH:8.94%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Mean</font></b></p></td> <td width=13% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:0px; WIDTH:13.08%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Median [Range]</font></b></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:31.1pt; BORDER-RIGHT:black 1pt solid; WIDTH:11.12%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>At Least 8 Spots<br>n (%)</font></b></p></td></tr> <tr style=HEIGHT:21.85pt> <td width=8% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:0px; WIDTH:8.96%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" rowspan=3 valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3pt 0in; TEXT-AUTOSPACE:'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>IgA ASC</font></p></td> <td width=14% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:0px; WIDTH:14.54%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3pt 0in; TEXT-AUTOSPACE:'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Vaxart Tablet Vaccine</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>70</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2.0</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:0px; WIDTH:10.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.0 [0, 18]</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:0px; WIDTH:11.12%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>6 (8.6)</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>70</font></p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:0px; WIDTH:8.94%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>116.0</font></p></td> <td width=13% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:0px; WIDTH:13.08%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>32.0 </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>[0, 3251]</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:21.85pt; BORDER-RIGHT:black 1pt solid; WIDTH:11.12%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>50 (71.4)</font></p></td></tr> <tr style=HEIGHT:5.9pt> <td width=14% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:14.54%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3pt 0in; TEXT-AUTOSPACE:'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Commercial Inactivated Influenza Vaccine</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>71</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1.5</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:10.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.0 [0, 13]</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:11.12%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>8 (11.3)</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>71</font></p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:8.94%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>286.4</font></p></td> <td width=13% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:13.08%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>153.0 </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>[3, 1753]</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:black 1pt solid; WIDTH:11.12%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>68 (95.8)</font></p></td></tr> <tr style=HEIGHT:5.9pt> <td width=14% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:14.54%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3pt 0in; TEXT-AUTOSPACE:'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>Placebo</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>36</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>2.8</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:10.84%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>0.0 [0, 26]</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:11.12%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>6 (16.7)</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:7.14%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>36</font></p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:8.94%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>16.3</font></p></td> <td width=13% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:0px; WIDTH:13.08%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>1.0 [0, 256]</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:5.9pt; BORDER-RIGHT:black 1pt solid; WIDTH:11.12%; BACKGROUND:white; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:black 1pt solid; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3pt 0in; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>8 (22.2)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><b><i>Correlation of IgA ASCs with Illness for the Vaxart Tablet Vaccine.</i></b> As stated above the absolute mean number of ASCs was higher for the commercial inactivated influenza vaccine group (286 spots <font style=COLOR:#212121>per 10<sup>6</sup> cells</font>) than for the Vaxart tablet vaccine (116 spots <font style=COLOR:#212121>per 10<sup>6</sup> cells</font>). However, when a comparison was made between the two vaccines of the ratio of IgA ASCs in volunteers that were not ill divided by volunteers that were ill following challenge, the Vaxart tablet vaccine group had a ratio of 4.7 versus a ratio of 1.4 for the commercial injected vaccine. In a logistics fit model with illness versus non-illness as the outcome, and IgA ASC as the independent variable, the model showed that the Vaxart tablet vaccine IgA ASC could predict ill versus non-ill, but the logistics fit model for the commercial inactivated influenza vaccine could not (p=0.0005 for our vaccine, p=0.3066 for the commercial injected vaccine for whole logistic model). These data suggest that IgA ASC is important for protection against influenza for our oral vaccine, but not for injected commercial vaccines. These data also suggest that there are <b><i>qualitative</i></b> differences between B cells induced post immunization by different methods. We are actively exploring these qualitative differences.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>22</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 16. </font></b><font style=FONT-SIZE:10pt>IgA ASCs Correlate with Illness for Vaxart Tablet Vaccine.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vaxart Tablet Vaccine&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commercial Inactivated Vaccine</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><img width=1384 height=766 style="HEIGHT:315px; WIDTH:699px" src=j16.jpg></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 12pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption.&nbsp; Logistic fit regression analysis demonstrates a statistically significant fit for the Vaxart Tablet Vaccine for IgA ASCs and illness. The correlation between higher ASCs and a lower rate of illness is observed. The same model fit is not observed with the commercial inactivated vaccine.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>This work was funded in whole or in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Preclinical Results</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We have completed several animal challenge studies for influenza. In an H1N1 influenza challenge study, mice immunized orally with our tablet vaccine candidate were protected against sickness and death compared to unimmunized, control animals. Similarly, our oral H5N1 vaccine candidate protected ferrets and mice against a lethal avian influenza challenge compared to unimmunized animals when the vaccine construct expressed an avian influenza HA construct.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Cross Protection of Vaxart Quadrivalent Seasonal Flu Vaccine against Avian Flu in Ferret Challenge Model</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>A more recent ferret challenge experiment was completed in 2017 to compare an oral quadrivalent vaccine that we designed with the commercial vaccine Fluzone for protection against a virulent avian influenza strain. There are no components of seasonal influenza vaccines that are matched to the HA made by avian influenza virus, so the virus represents a severe case of vaccine mismatched to virus. Our quadrivalent vaccine was made by mixing four recombinant adenoviruses, each expressing a different HA that matches the HAs in the commercial vaccine, not the HA of the challenge. Two different doses were evaluated; the high dose was used at 1:10 of a Vaxart human dose (Vaxart Quad) and the low dose (Vaxart Quad Low) was used at 1:100 of the human dose. The Fluzone group (QIV) was given at 1:10 of the human dose to directly compare to the Vaxart quadrivalent high dose group. Vaxart animals and the negative control (PBS) animals were given vaccine delivered by endoscope. The QIV animals were intramuscularly injected. Animals were vaccinated on days 0 and 28. Animals were challenged on day 56 with approximately 10<sup>2.69</sup> TCID<sub>50</sub>/mL of wild type A/Vietnam/1203/2004 (A/VN). Results show that the Vaxart quadrivalent vaccines were able to protect against mismatched A/VN, trending better than Fluzone. The high dose group was able to protect all ferrets against death whereas the low dose Vaxart group protected 75% of ferrets. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>23</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b>Fig. 17.</b>&nbsp; Survival in ferrets vaccinated with seasonal influenza and challenged with H5N1 Vietnam.</p> <div style=page:WordSection2><img width=692 height=305 style="HEIGHT:224px; WIDTH:615px" src=j17.jpg></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 12pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption.&nbsp; The percent survival was measured for each group at each time point. The Vaxart Quad vaccine group were 100% protected against mismatched avian influenza over the 14 days that survival was assessed. The other groups were not as well protected.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>This work was funded in whole or in part with federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Seasonal Influenza Clinical Development Strategy and Pathway</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We aim to partner and/or to obtain funding from the U.S. federal government to finance the development and commercialization of our seasonal quadrivalent influenza oral tablet vaccine. In the future, we may also consider equity offerings and/or debt financings to fund the program. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our Human Papillomavirus (HPV) Therapeutic Vaccine Candidate </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In previous clinical studies with our H5 influenza vaccine candidate, we observed robust T-cell responses that appeared to compare favorably with published results of other flu vaccines, including an adjuvanted vaccine as well as an attenuated live viral vaccine. Specifically, our vaccine generated high levels of polyfunctional cytotoxic CD4 and CD8 cells, T-cells that are likely required to obtain a therapeutic benefit in chronic viral infection and cancer. It was based on these observations that we embarked on the development of our first therapeutic vaccine, targeting HPV -associated dysplasia and cervical cancer. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Medical Need, Commercial Opportunity</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>HPV is a family of more than 120 viruses which are extremely common globally. At least 13 HPV types are cancer-causing. HPV is primarily transmitted through sexual contact and infection is very prevalent following the onset of sexual activity. Nearly all cases of cervical cancer are attributable to HPV infection, with two HPV types &#150; HPV16 and HPV18 &#150; responsible for 70% of cervical cancers and precancerous cervical lesions. Cervical cancer is the fourth most common cancer in women worldwide, and about 13,000 new cases are diagnosed annually in the United States&nbsp;according to the National Cervical Cancer Coalition. Studies have indicated a high lifetime probability of any HPV infection by both men and women in the United States, with some estimates indicating at least 80% of women and men acquire HPV by age 45. The CDC estimates 80 million U.S. citizens are currently infected with HPV, representing 25% of the population, with about 14 million new infections per year. A report by BCC Research expects the global cervical cancer drug and diagnostic market to exceed $15 billion by 2018. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>In women, many HPV infections of the cervix will spontaneously resolve and clear within 2-3 years, but women who have a persistent infection are at high risk of developing cellular abnormalities known as cervical intraepithelial neoplasia (CIN) which can progress to invasive cancer over time. </font><font style=FONT-SIZE:10pt>More than 400,000 women are diagnosed with CIN annually in the United States, with an annual incidence estimate for CIN1 and CIN2/3 at 1.6 and 1.2 per 1,000 women, respectively.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>There are currently no approved therapeutic vaccines to treat HPV infection. Current treatment options for women infected with HPV (see below) include monitoring CIN status, surgical procedures to remove affected tissue, and chemotherapeutic or radiation therapies to treat localized or metastatic cervical cancer. Thus, a medical need remains for a therapeutic vaccine to treat women presenting with CIN, or who have progressed to cervical cancer.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>24</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our HPV Therapeutic Vaccine Candidate</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Our plan is to develop a bivalent HPV vaccine against HPV 16 and 18, the strains responsible for approximately 70% of cases of cervical cancer. We plan to target the E6 and E7 gene products of each strain, which are the primary oncogenic proteins responsible for progression through the stages of CIN to invasive cervical cancer. In pre-clinical studies, we have demonstrated immunogenicity for both our HPV16 and our HPV18 vaccine candidates. Specifically, mice given our HPV16 or HPV18 vaccines induced T cell responses to HPV as measured by IFN gamma ELISPOT. In addition, our HPV16 vaccine has demonstrated tumor growth suppression as well as increased survival in a robust HPV tumor model in mice. We believe that our HPV vaccine has several advantages over current treatment options for both CIN and cervical cancer. Current treatment options for CIN are invasive and can lead to serious contraindications for pregnancy. In addition, surgical treatments for CIN do not treat the underlying HPV, but rather remove infected tissue. As a result, current CIN treatment options have a significant failure rate which can increase the risk for progression to cervical cancer. Our vaccines have demonstrated a favorable safety and tolerability profile in clinical subjects dosed to date. Current treatment options for cervical cancer, such as chemotherapy and radiation treatment, have multiple side effects such as hair loss, loss of appetite, and severe nausea.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>T cells responses to HPV-16 can shrink solid tumors derived from transformed HPV</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The ability of T cell responses to HPV-16 to produce a therapeutic response was tested in a solid tumor growth model. TC-1 cells (an HPV-16 transformed cell-line) were injected subcutaneously into the hind flank of B6 mice, and allowed to grow for several days before mice were immunized with vaccine or controls. In study 1, mice were immunized on days 7, 14, and 21. For groups 4 and 5, the vaccine expressed the HPV16 antigens E6/E7 (Ad-HPV). A checkpoint inhibitor (an antibody to PD-1) was used along with the vaccine in group 5, and an isotype control (Iso) to the checkpoint inhibitor was used in group 4. A recombinant rAd vector identical to Ad-HPV, but which doesn&#146;t express the HPV antigens (Ad-nr), was used in groups 1 or 2 to control for non-specific effects. Untreated animals were not given any vaccine.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The results in study 1 showed that Ad-HPV groups were able to the stop tumor growth, and actually shrink the tumor. This occurred whether the checkpoint inhibitor was used or not. The checkpoint inhibitor alone was not able to stop tumor progression, and eventually all these animals perished. Other control animals without Ad-HPV didn&#146;t survive as well. The use of the checkpoint inhibitor with the Ad-HPV vaccine trended slightly better for survival (10/10 versus 9/10 survived), but this was not significant.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In study 2, the TC-1 tumor was transplanted as before, but allowed to grow longer before immunization occurred. Immunizations occurred on days 13, 20, and 27. In this study, mice that received the Ad-HPV vaccine plus the checkpoint inhibitor were able to control the tumor, up through day 40 before a few mice started to perish. More than 70% of animals in this group survived through the end of the experiment on day 80. Ad-HPV immunized mice in the absence of the checkpoint inhibitor were also able to substantially control the tumor through 60 days (33 days after the last immunization), before several additional animals perished. No control groups in the absence of the Ad-HPV were able to control any of the tumors, and all mice perished before day 40.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 18.</font></b><font style=FONT-SIZE:10pt>&nbsp; Small Tumor Vaccine Study.<br></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><img width=683 height=531 style="HEIGHT:346px; WIDTH:519px" src=j18i.jpg><img width=848 height=449 style="HEIGHT:398px; WIDTH:554px" src=j18ii.jpg></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption.&nbsp; In the small tumor vaccine study (Study 1), tumors were allowed to grow for 7 days before beginning the immunization schedule. Animals given the Vaxart HPV vaccine (Ad-HPV) were protected against tumor growth and survived better. This was the case whether or not a checkpoint inhibitor was used.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>25</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 6pt; page:WordSection2'><b>Fig. 19.</b>&nbsp; Large Tumor Vaccine Study.</p> <div style=page:WordSection2><img width=767 height=560 style="HEIGHT:297px; WIDTH:544px" src=j19i.jpg><img width=706 height=534 style="HEIGHT:316px; WIDTH:554px" src=j19ii.jpg></div> <div style=page:WordSection2>&nbsp;</div> <div style=page:WordSection2>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption.&nbsp; In the large tumor vaccine study (Study 2), tumors were allowed to grow for 13 days before the vaccines were given. Again, animals given the Ad-HPV were better protected against tumor growth. The addition of the checkpoint inhibitor improved survival.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>The T cells induced post immunization in the tumor model were believed to traffic back to the solid tumor to attack and destroy the cancer cells. This was tested in an additional tumor model experiment. Tumors were transplanted as before, and immunizations were performed on days 13 and 21. Tumors were harvested from the experiment on day 24, and flow cytometry was used to enumerate the T cells infiltrating the tumors. The HPV16 vaccine groups (with either the checkpoint inhibitor or an isotype control antibody) had T cell infiltrates of both CD4 and CD8 positive T cells. The CD8 T cell numbers from the Ad-HPV groups were significantly better than control treated animals in terms of infiltrating lymphocytes. The CD4 T cells were significantly better in the Ad-HPV + checkpoint group, and trended higher in the Ad-HPV + isotype control group.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Fig. 20.</font></b><font style=FONT-SIZE:10pt>&nbsp; The Ad-HPV vaccine induces T cells that migrate to the tumors.</font></p> <div style=page:WordSection2><img width=808 height=329 style="HEIGHT:250px; WIDTH:678px" src=j20.jpg></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 12pt; page:WordSection2'><i><font style=FONT-SIZE:10pt>Caption.&nbsp; The number of CD4 and CD8 T cells found within the tumor were analyzed by flow cytometry. The Ad-HPV groups were found to elicit T cells that transited to the tumor, with the Ad-HPV plus checkpoint inhibitor creating slightly more T cell transit than the Ad-HPV vaccine alone.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>26</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Near Term HPV Vaccine Development Strategy</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Preclinical </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The next steps in the vaccine development are to complete the nonclinical studies, which may include a Good Laboratory Practices, GLP, toxicology study, to support an investigational new drug, or IND, filing for this vaccine.&nbsp;The exact nature of these studies will be determined in consultation with the FDA. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Clinical </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We will propose to test the vaccine in subjects with cervical dysplasia related to HPV16 or HPV18, and to evaluate the ability of the vaccine to clear HPV infection, reduce the cervical dysplasia score, and induce T cells known to be important in the clearance of HPV. T cells will be measured by flow cytometry as well as by IFN-g ELISPOT. The primary endpoint will be safety and the secondary endpoint will be immunogenicity by examining T cell responses. Although clinical responses will be tracked, it is expected that the first study may not be powered to obtain statistically significant efficacy readouts. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Other Indications</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'><font style=FONT-SIZE:10pt>We currently have preliminary data in animal models for indications such as RSV, Chikungunya, Hepatitis B and HSV-2.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt; TEXT-INDENT:0in; page:WordSection2'>Manufacturing </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Manufacturing our oral tablet vaccines consists of two main stages, the production of bulk vaccine (drug substance), and the formulation and tableting thereof (drug product). Drug substance manufacturing consists primarily of the production and purification of the active ingredient. Bulk drug substance is <a name=_cp_text_1_74>then lyophilized, formulated and subsequently tableted and coated</a>&nbsp;using a proprietary formulation and tableting process that we developed. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>From 2012 through December of 2017, we relied on a third-party contract manufacturer, Lonza Houston, Inc. or Lonza Houston, to manufacture clinical bulk drug substance for our tablet vaccine candidates. During 2017 and early&nbsp;2018, we developed our own bulk vaccine manufacturing process and then established a cGMP bulk manufacturing facility at our corporate headquarters in California. We believe having an in-house bulk facility provides a number of important strategic advantages, including control of our manufacturing schedule and enhanced integration of process development and cGMP manufacturing operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'>Our facility is fully operational and was used to make our norovirus GII.4 vaccine tablets and the norovirus GI.1 bulk vaccine lots that are scheduled to be processed and tableted in the first quarter of 2019.&nbsp; However, we have not yet achieved the productivity levels we initially projected and we continue to seek improvements in productivity. We are also making modifications to our purification process to further improve purity and yield.</p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style=FONT-SIZE:10pt>Our facility and equipment is sized to support manufacturing of cGMP product for our Phase 1 and Phase 2a trials, but is not adequate to support larger Phase 2b and Phase 3 trials.&nbsp; Accordingly, we are exploring opportunities to establish a long-term relationship with an established CMO to develop large scale bulk vaccine production capabilities adequate to support larger trials and commercial product launch.&nbsp; We believe such a relationship would also allow us to access additional manufacturing expertise and further improve our manufacturing process.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>From 2012 through December of 2017, we also contracted with Lonza Houston for the manufacture, labeling, packaging, storage and distribution of our drug product.&nbsp;The tablets used for our&nbsp;clinical studies to date, including the influenza A and&nbsp;B phase 1 studies, the norovirus phase 1 studies, the RSV phase 1 study and the H1 influenza phase 2 challenge study, as well as all placebo for those studies, were manufactured at Lonza Houston.&nbsp;During 2016, we established drug product manufacturing capabilities at our corporate headquarters and all drug product has been manufactured at our facility since then. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Our&nbsp;facility is licensed by the State of California Department of Public Health Food and Drug Branch to manufacture drug product for clinical trials.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We have limited experience with process development, and the manufacture, testing, quality release, storage and distribution of drug substance and drug product according to current Good Manufacturing Practices, or cGMP, and regulatory filings. The cGMP regulations include requirements relating to the organization of personnel, buildings and facilities, equipment, control of components and drug product containers and closures, production and process controls, packaging and labeling controls, holding and distribution, laboratory controls, records and reports, and returned or salvaged products. Our facility, and our third-party manufacturers, are subject to periodic inspections by FDA and local authorities, which include, but are not limited to procedures and operations used in the testing and manufacture of our vaccine candidates to assess our compliance with applicable regulations. If we or our third-part manufacturers fail to comply with statutory and regulatory requirements we and they could be subject to possible legal or regulatory action, including warning letters, the seizure or recall of products, injunctions, consent decrees placing significant restrictions on or suspending manufacturing operations and civil and criminal penalties. These actions could have a material adverse&nbsp;impact on the availability of our tablet vaccine candidates. Similar to contract manufactures, we have in the past encountered difficulties involving production yields, quality control and quality assurance, and if we are not able to produce drug product or drug substance in sufficient quantities are ability to conduct our clinical trials and commercialize our tablet vaccine candidates, if approved, will be impaired.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>27</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Research and Development</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In the ordinary course of business, we enter into agreements with third parties, such as clinical research organizations, medical institutions, clinical investigators and contract laboratories, to conduct our clinical trials and aspects of our research and preclinical testing. These third parties provide project management and monitoring services and regulatory consulting and investigative services.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Competition</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The biotechnology and pharmaceutical industries are characterized by intense competition to develop new technologies and proprietary products. While we believe that our proprietary tablet vaccine candidates provide competitive advantages, we face competition from many different sources, including biotechnology and pharmaceutical companies, academic institutions, government agencies, as well as public and private research institutions. Any products that we may commercialize will have to compete with existing products and therapies as well as new products and therapies that may become available in the future.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>There are other organizations working to improve existing therapies, vaccines or delivery methods, or to develop new vaccines, therapies or delivery methods for their selected indications. Depending on how successful these efforts are, it is possible they may increase the barriers to adoption and success of our vaccine candidates, if approved.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We anticipate that we will face intense and increasing competition as new vaccines enter the market and advanced technologies become available. We expect any tablet or other oral delivery vaccine candidates that we develop and commercialize to compete on the basis of, among other things, efficacy, safety, convenience of administration and delivery, price, availability of therapeutics, the level of generic competition and the availability of reimbursement from government and other third-party payors.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that we may develop. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we can obtain approval for our vaccine candidates, which could result in our competitors establishing a strong market position before we are able to enter the market. In addition, our ability to compete may be affected in many cases by insurers or other third-party payors seeking to encourage the use of generic products.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Seasonal Influenza Vaccine Candidate</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We believe our seasonal influenza vaccine candidate will compete directly with approved vaccines in the market, which include non-recombinant and recombinant products that are administered via injection or intranasally. The major global non-recombinant injectable vaccine competitors include Astellas Pharma Inc., Abbott Laboratories, AstraZeneca UK Limited, Baxter International Inc., Research Foundation for Microbial Diseases of Osaka University, Seqirus-bioCSL Inc., GlaxoSmithKline plc, or GlaxoSmithKline, Sanofi S.A., or Sanofi, Pfizer Inc., and Takeda Pharmaceutical Company Limited, or Takeda. Non-recombinant intranasal competition includes MedImmune, Inc., or MedImmune, and potentially others. Recombinant injectable competitors include Sanofi, Medicago and Novavax, Inc., or Novavax. Many other groups are developing new or improved flu vaccine or delivery methods.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Norovirus Vaccine Candidate</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>There is currently no approved norovirus vaccine for sale globally. While we are not aware of all of our competitors&#146; efforts, we believe that Takeda is developing a norovirus vaccine that would be delivered by injection.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>HPV Therapeutic Vaccine Candidate</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>There is currently no approved HPV therapeutic vaccine for sale globally; however, a number of vaccine manufacturers, academic institutions and other organizations currently have, or have had, programs to develop such a vaccine. We believe that several companies are in various stages of developing an HPV therapeutic vaccine including Inovio, Advaxis, Genexine, and several others.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>28</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Inavir</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Other anti influenza antivirals are marketed in Japan, including Tamiflu and Relenza. On February 23, 2018, Osaka-based drug maker Shionogi &amp; Co gained marketing approval for Xofluza, a new drug to treat influenza in Japan. The drug was approved for use against type A and B influenza viruses and requires only a single dose regardless of age. Xofluza may gain significant market share from Inavir in Japan, substantially reducing the sales of Inavir. This would significantly decrease the royalty payments we receive from Daiichi <font style=FONT-SIZE:10pt>Sankyo<font style='FONT-FAMILY:"Times New Roman",serif'>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Intellectual Property</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We strive to protect and enhance the proprietary technology, inventions and improvements that are commercially important to our business, including seeking, maintaining, and defending patent rights. We also rely on trade secrets relating to our platform and on know-how, continuing technological innovation to develop, strengthen and maintain our proprietary position in the vaccine field. In addition, we rely on regulatory protection afforded through data exclusivity, market exclusivity and patent term extensions where available. We also utilize trademark protection for our company name and expect to do so for products and/or services as they are marketed.</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt">Our commercial success will depend in part on our ability to obtain and maintain patent and other proprietary protection for commercially important technology, inventions and know-how related to our business; defend and enforce our patents; preserve the confidentiality of our trade secrets; and operate without infringing the valid enforceable patents and proprietary rights of third parties. Our ability to stop third parties from making, using, selling, offering to sell or importing our tablet vaccine candidates may depend on the extent to which we have rights under valid and enforceable patents or trade secrets that cover these activities. With respect to company-owned intellectual property, we cannot be sure that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications we may file in the future, nor can we be sure that any of our existing patents or any patents that may be granted to us in the future will be commercially useful in protecting our commercial products and methods of manufacturing the same.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We have developed numerous patents and patent applications and own substantial know-how and trade secrets related to our platform and tablet vaccine candidates.</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Vaccine Platform Technology</i></b>. As of December 31, 2018, we hold three U.S. patents with granted claims relating to our platform technology. Two of these U.S. patents include claims related to our seasonal influenza vaccine candidate. These patents will expire in 2027, or later if patent term extension applies. As of December 31, 2018, we hold more than 50 issued foreign patents and one pending foreign patent application related to our platform technology and/or our vaccine candidates. These patents will expire in 2027, or later if patent term extension applies.</font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Tablet Vaccine Formulation</i></b>. We own considerable know-how and hold one Singapore patent and 16 pending applications in the United States and around the world related to our tablet vaccine formulation technology. This patent and any patents issuing from these applications will expire in 2035, or later if patent term extension applies.</font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><b><i>Influenza, Norovirus and RSV Vaccine Candidates</i></b>. As of December 31, 2018, we have filed 12 applications in the United States and around the world relating to our norovirus and RSV vaccine candidates. Any patents issuing from these applications will expire in 2036, or later if patent term extension applies. We have been issued 13 foreign patents related to our current H1N1 influenza vaccine candidate. These patents will expire in 2030,or later if patent term extension applies.</font></font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><font face=Symbol>&#183;</font><font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><b><i>Relenza</i></b>. <font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman",serif'><font style=FONT-SIZE:10pt>As of December 31, 2018, we own one Japanese patent related to Relenza, which is exclusively licensed to GSK. This patent will expire in July 2019. All other Relenza patents have expired.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In addition to the above, we have established expertise and development capabilities focused in the areas of preclinical research and development, manufacturing and manufacturing process scale-up, quality control, quality assurance, regulatory affairs and clinical trial design and implementation. We believe that our focus and expertise will help us develop products based on our proprietary intellectual property.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>29</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file, the patent term is 20 years from the date of filing the non-provisional application. In the United States, a patent&#146;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the U.S. Patent and Trademark Office in granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier-filed patent.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The term of a patent that covers an FDA-approved drug may also be eligible for patent term extension, which permits patent term restoration of a U.S. patent as compensation for the patent term lost during the FDA regulatory review process. The Hatch-Waxman Act permits a patent term extension of up to five years beyond the expiration of the patent. The length of the patent term extension is related to the length of time the drug is under regulatory review. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval and only one patent applicable to an approved drug may be extended. Moreover, a patent can only be extended once, and thus, if a single patent is applicable to multiple products, it can only be extended based on one product. Similar provisions are available in Europe and other foreign jurisdictions to extend the term of a patent that covers an approved drug. When possible, depending upon the length of clinical trials and other factors involved in the filing of a new drug application, or NDA, we expect to apply for patent term extensions for patents covering our vaccine candidates and their methods of use.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Trade Secrets</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We rely, in some circumstances, on trade secrets to protect our technology. However, trade secrets can be difficult to protect. We seek to protect our proprietary technology and processes, in part, by entering into confidentiality agreements with our employees, consultants, scientific advisors and contractors. We also seek to preserve the integrity and confidentiality of our data and trade secrets by maintaining physical security of our premises and physical and electronic security of our information technology systems. While we have confidence in these procedures, agreements or security measures may be breached, and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our consultants, contractors or collaborators use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Government Regulation and Product Approval</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Federal, state and local government authorities in the United States and in other countries extensively regulate, among other things, the research, development, testing, manufacturing, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, post-approval monitoring and reporting, marketing and export and import of biological and pharmaceutical products such as those we are developing. Our vaccine candidates must be approved by the FDA before they may be legally marketed in the United States and by the appropriate foreign regulatory agency before they may be legally marketed in foreign countries. Generally, our activities in other countries will be subject to regulation that is similar in nature and scope as that imposed in the United States. The process for obtaining regulatory marketing approvals and the subsequent compliance with appropriate federal, state, local and foreign statutes and regulations require the expenditure of substantial time and financial resources.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>U.S. Product Development Process</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In the United States, the FDA regulates pharmaceutical and biological products under the Federal Food, Drug and Cosmetic Act, Public Health Service Act, or PHSA, and implementing regulations. Products are also subject to other federal, state and local statutes and regulations. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local and foreign statutes and regulations require the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant to administrative or judicial sanctions. FDA sanctions could include, among other actions, refusal to approve pending applications, withdrawal of an approval, a clinical hold, warning letters, product recalls or withdrawals from the market, product seizures, total or partial suspension of production or distribution injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or criminal penalties. Any agency or judicial enforcement action could have a material adverse effect on us. The process required by the FDA before a drug or biological product may be marketed in the United States generally involves the following:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>completion of nonclinical laboratory tests and animal studies according to good laboratory practices, or GLPs, and applicable requirements for the humane use of laboratory animals or other applicable regulations;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>submission to the FDA of an IND which must become effective before human clinical trials may begin;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>performance of adequate and well-controlled human clinical trials according to the FDA&#146;s regulations commonly referred to as good clinical practices, or GCPs, and any additional requirements for the protection of human research subjects and their health information, to establish the safety and efficacy of the proposed biological product for its intended use;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>submission to the FDA of a Biologics License Application, or BLA, for marketing approval that meets applicable requirements to ensure the continued safety, purity, and potency of the product that is the subject of the BLA based on results of nonclinical testing and clinical trials;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>satisfactory completion of an FDA inspection of the manufacturing facility or facilities where the biological product is produced, to assess compliance with cGMP, to assure that the facilities, methods and controls are adequate to preserve the biological product&#146;s identity, strength, quality and purity;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>potential FDA audit of the nonclinical study and clinical trial sites that generated the data in support of the BLA; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font face=Symbol>&#183;</font><font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;</font><font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>FDA review and approval, or licensure, of the BLA.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>30</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Before testing any biological vaccine candidate, including our tablet vaccine candidates, in humans, the vaccine candidate enters the preclinical testing stage. Preclinical tests, also referred to as nonclinical studies, include laboratory evaluations of product chemistry, toxicity and formulation, as well as animal studies to assess the potential safety and activity of the vaccine candidate. The conduct of the preclinical tests must comply with federal regulations and requirements including GLPs. The clinical trial sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature and a proposed clinical protocol, to the FDA as part of the IND. Some preclinical testing may continue even after the IND is submitted. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA raises concerns or questions regarding the proposed clinical trials and places the trial on a clinical hold within that 30-day time period. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. The FDA may also impose clinical holds on a biological product candidate at any time before or during clinical trials due to safety concerns or non-compliance. If the FDA imposes a clinical hold, trials may not recommence without FDA authorization and then only under terms authorized by the FDA. Accordingly, we cannot be sure that submission of an IND will result in the FDA allowing clinical trials to begin, or that, once begun, issues will not arise that suspend or terminate such trials.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Clinical trials involve the administration of the biological product candidate to healthy volunteers or patients under the supervision of qualified investigators, generally physicians not employed by or under the trial sponsor&#146;s control. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria, and the parameters to be used to monitor subject safety, including stopping rules that assure a clinical trial will be stopped if certain adverse events should occur. Each protocol and any amendments to the protocol must be submitted to the FDA as part of the IND. Clinical trials must be conducted and monitored in accordance with the FDA&#146;s regulations composing the GCP requirements, including the requirement that all research subjects provide informed consent. Further, each clinical trial must be reviewed and approved by an independent institutional review board, or IRB, at or servicing each institution at which the clinical trial will be conducted. An IRB is charged with protecting the welfare and rights of trial participants and considers such items as whether the risks to individuals participating in the clinical trials are minimized and are reasonable in relation to anticipated benefits. The IRB also approves the form and content of the informed consent that must be signed by each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed. Human clinical trials are typically conducted in three sequential phases that may overlap or be combined:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><i>Phase 1</i>. The biological product is initially introduced into healthy human subjects and tested for safety. In the case of some products for severe or life-threatening diseases, especially when the product may be too inherently toxic to ethically administer to healthy volunteers, the initial human testing is often conducted in subjects.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><i>Phase 2</i>. The biological product is evaluated in a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance, optimal dosage and dosing schedule.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><i>Phase 3</i>. Clinical trials are undertaken to further evaluate dosage, clinical efficacy, potency, and safety in an expanded patient population at geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk to benefit ratio of the product and provide an adequate basis for product labeling.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Post-approval clinical trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial marketing approval. These clinical trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication, particularly for long-term safety follow-up.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>31</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>During all phases of clinical development, regulatory agencies require extensive monitoring and auditing of all clinical activities, clinical data, and clinical trial investigators. Annual progress reports detailing the results of the clinical trials must be submitted to the FDA. Written IND safety reports must be promptly submitted to the FDA and the investigators for serious and unexpected adverse events, any findings from other studies, tests in laboratory animals or in vitro testing that suggest a significant risk for human subjects, or any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must submit an IND safety report within 15 calendar days after the sponsor determines that the information qualifies for reporting. The sponsor also must notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction within seven calendar days after the sponsor&#146;s initial receipt of the information. Phase 1, Phase 2 and Phase 3 clinical trials may not be completed successfully within any specified period, if at all. The FDA or the sponsor or its data safety monitoring board may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#146;s requirements or if the biological product has been associated with unexpected serious harm to subjects.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Concurrently with clinical trials, companies usually complete additional studies and must also develop additional information about the physical characteristics of the biological product as well as finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. To help reduce the risk of the introduction of adventitious agents with use of biological products, the PHSA emphasizes the importance of manufacturing control for products whose attributes cannot be precisely defined. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other criteria, the sponsor must develop methods for testing the identity, strength, quality, potency and purity of the final biological product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the biological product candidate does not undergo unacceptable deterioration over its shelf life.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>U.S. Review and Approval Processes</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>After the completion of clinical trials of a biological product, FDA approval of a BLA must be obtained before commercial marketing of the biological product. The BLA must include results of product development, laboratory and animal studies, human trials, information on the manufacture and composition of the product, proposed labeling and other relevant information. The FDA may grant deferrals for submission of data, or full or partial waivers. The testing and approval processes require substantial time and effort and there can be no assurance that the FDA will accept the BLA for filing and, even if filed, that any approval will be granted on a timely basis, if at all.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Under the Prescription Drug User Fee Act, or PDUFA, as amended, each BLA must be accompanied by a significant user fee. The FDA adjusts the PDUFA user fees on an annual basis. PDUFA also imposes an annual program fee for biological products. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Within 60 days following submission of the application, the FDA reviews a BLA submitted to determine if it is substantially complete before the agency accepts it for filing. The FDA may refuse to file any BLA that it deems incomplete or not properly reviewable at the time of submission, and may request additional information. In this event, the BLA must be resubmitted with the additional information. The resubmitted application also is subject to review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an in-depth substantive review of the BLA. The FDA reviews the BLA to determine, among other things, whether the proposed product is safe, potent, and/or effective for its intended use, and has an acceptable purity profile, and whether the product is being manufactured in accordance with cGMP to assure and preserve the product&#146;s identity, safety, strength, quality, potency and purity. The FDA may refer applications for novel biological products or biological products that present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation and a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. During the biological product approval process, the FDA also will determine whether a Risk Evaluation and Mitigation Strategy, or REMS, is necessary to assure the safe use of the biological product. If the FDA concludes a REMS is needed, the sponsor of the BLA must submit a proposed REMS. The FDA will not approve a BLA without a REMS, if required.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Before approving a BLA, the FDA will inspect the facilities at which the product is manufactured. The FDA will not approve the product unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure that the clinical trials were conducted in compliance with IND trial requirements and GCP requirements. To assure cGMP and GCP compliance, an applicant must incur significant expenditure of time, money and effort in the areas of training, record keeping, production, and quality control.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>32</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Notwithstanding the submission of relevant data and information, the FDA may ultimately decide that the BLA does not satisfy its regulatory criteria for approval and deny approval. Data obtained from clinical trials are not always conclusive and the FDA may interpret data differently than we interpret the same data. If the agency decides not to approve the BLA in its present form, the FDA will issue a complete response letter that describes all of the specific deficiencies in the BLA identified by the FDA. The deficiencies identified may be minor, for example, requiring labeling changes, or major, for example, requiring additional clinical trials. Additionally, the complete response letter may include recommended actions that the applicant might take to place the application in a condition for approval. If a complete response letter is issued, the applicant may either resubmit the BLA, addressing all of the deficiencies identified in the letter, or withdraw the application.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>If a product receives regulatory approval, the approval may be significantly limited to specific diseases and dosages or the indications for use may otherwise be limited, which could restrict the commercial value of the product.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>33</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'>Further, the FDA may require that certain contraindications, warnings or precautions be included in the product labeling. The FDA may impose restrictions and conditions on product distribution, prescribing, or dispensing in the form of a risk management plan, or otherwise limit the scope of any approval. In addition, the FDA may require post marketing clinical trials, sometimes referred to as Phase 4 clinical trials, designed to further assess a biological product&#146;s safety and effectiveness, and testing and surveillance programs to monitor the safety of approved products that have been commercialized.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In addition, under the Pediatric Research Equity Act, a BLA or supplement to a BLA must contain data to assess the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission of data or full or partial waivers.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Post-Approval Requirements</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Any products for which we receive FDA approvals are subject to continuing regulation by the FDA, including, among other things, record-keeping requirements, reporting of adverse experiences with the product, providing the FDA with updated safety and efficacy information, product sampling and distribution requirements, and complying with FDA promotion and advertising requirements, which include, among others, standards for direct-to-consumer advertising, restrictions on promoting products for uses or in patient populations that are not described in the product&#146;s approved uses, known as &#145;off-label&#146; use, limitations on industry-sponsored scientific and educational activities, and requirements for promotional activities involving the internet. Although physicians may prescribe legally available products for off-label uses, if the physicians deem to be appropriate in their professional medical judgment, manufacturers may not market or promote such off-label uses.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In addition, quality control and manufacturing procedures must continue to conform to applicable manufacturing requirements after approval to ensure the long-term stability of the product. cGMP regulations require among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities involved in the manufacture and distribution of approved products are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and other laws. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance. Discovery of problems with a product after approval may result in restrictions on a product, manufacturer, or holder of an approved BLA, including, among other things, recall or withdrawal of the product from the market. In addition, changes to the manufacturing process are strictly regulated, and depending on the significance of the change, may require prior FDA approval before being implemented. Other types of changes to the approved product, such as adding new indications and claims, are also subject to further FDA review and approval.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Discovery of previously unknown problems with a product or the failure to comply with applicable FDA requirements can have negative consequences, including adverse publicity, judicial or administrative enforcement, warning letters from the FDA, mandated corrective advertising or communications with doctors, and civil or criminal penalties, among others. Newly discovered or developed safety or effectiveness data may require changes to a product&#146;s approved labeling, including the addition of new warnings and contraindications, and also may require the implementation of other risk management measures. Also, new government requirements, including those resulting from new legislation, may be established, or the FDA&#146;s policies may change, which could delay or prevent regulatory approval of our tablet vaccine candidates under development.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Other U.S. Healthcare Laws and Compliance Requirements</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In the United States, our activities are potentially subject to regulation by various federal, state and local authorities in addition to the FDA, including but not limited to, the Centers for Medicare and Medicaid Services, or CMS, other divisions of the U.S. Department of Health and Human Services, for instance the Office of Inspector General, the U.S. Department of Justice, or DOJ, and individual U.S. Attorney offices within the DOJ, and state and local governments. For example, sales, marketing and scientific/educational grant programs must comply with the anti-fraud and abuse provisions of the Social Security Act, the false claims laws, the physician payment transparency laws, the privacy and security provisions of the Health Insurance Portability and Accountability Act, or HIPAA, as amended by the Health Information Technology and Clinical Health Act, or HITECH, and similar state laws, each as amended.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The federal anti-kickback statute prohibits, among other things, any person or entity, from knowingly and willfully offering, paying, soliciting or receiving any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or in return for purchasing, leasing, ordering or arranging for the purchase, lease or order of any item or service reimbursable under Medicare, Medicaid or other federal healthcare programs. The term remuneration has been interpreted broadly to include anything of value. The anti-kickback statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on one hand and prescribers, purchasers, and formulary managers on the other. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution. The exceptions and safe harbors are drawn narrowly and practices that involve remuneration that may be alleged to be intended to induce prescribing, purchasing or recommending may be subject to scrutiny if they do not qualify for an exception or safe harbor. Our practices may not in all cases meet all of the criteria for protection under a statutory exception or regulatory safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor, however, does not make the conduct per se illegal under the anti-kickback statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>34</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Additionally, the intent standard under the anti-kickback statute was amended by the Affordable Care Act to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the Affordable Care Act codified case law that a claim including items or services resulting from a violation of the federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the federal False Claims Act, as discussed below.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The civil monetary penalties statute imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to a federal health program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The federal False Claims Act prohibits, among other things, any person or entity from knowingly presenting, or causing to be presented, a false claim for payment to, or approval by, the federal government or knowingly making, using, or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#147;any request or demand&#148; for money or property presented to the U.S. government. Recently, several pharmaceutical and other healthcare companies have been prosecuted under these laws for allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product. Other companies have been prosecuted for causing false claims to be submitted because of the companies&#146; marketing of the product for unapproved, and thus non-reimbursable, uses.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>HIPAA created new federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud or to obtain, by means of false or fraudulent pretenses, representations or promises, any money or property owned by, or under the control or custody of, any healthcare benefit program, including private third-party payors and knowingly and willfully falsifying, concealing or covering up by trick, scheme or device, a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal anti-kickback statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Also, many states have similar fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We may be subject to data privacy and security regulations by both the federal government and the states in which we conduct our business. HIPAA, as amended by the HITECH Act, imposes requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#146;s privacy and security standards directly applicable to business associates independent contractors or agents of covered entities that receive or obtain protected health information in connection with providing a service on behalf of a covered entity. HITECH also created four new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal civil actions. In addition, state laws govern the privacy and security of health information in specified circumstances, many of which differ from each other in significant ways, thus complicating compliance efforts.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Additionally, the Federal Physician Payments Sunshine Act under the Affordable Care Act, and its implementing regulations, require that certain manufacturers of drugs, devices, biological and medical supplies for which payment is available under Medicare, Medicaid or the Children&#146;s Health Insurance Program, with certain exceptions, to report information related to certain payments or other transfers of value made or distributed to physicians and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals and to report annually certain ownership and investment interests held by physicians and their immediate family members. Failure to submit timely, accurately, and completely the required information may result in civil monetary penalties of up to an aggregate of $150,000 per year and up to an aggregate of $1 million per year for &#147;knowing failures&#148;. Certain states also mandate implementation of compliance programs, impose restrictions on pharmaceutical manufacturer marketing practices and/or require the tracking and reporting of gifts, compensation and other remuneration to healthcare providers and entities.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>35</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In order to distribute products commercially, we must also comply with state laws that require the registration of manufacturers and wholesale distributors of drug and biological products in a state, including, in certain states, manufacturers and distributors who ship products into the state even if such manufacturers or distributors have no place of business within the state. Some states also impose requirements on manufacturers and distributors to establish the pedigree of product in the chain of distribution, including some states that require manufacturers and others to adopt new technology capable of tracking and tracing product as it moves through the distribution chain. Several states have enacted legislation requiring pharmaceutical and biotechnology companies to establish marketing compliance programs, file periodic reports with the state, make periodic public disclosures on sales, marketing, pricing, clinical trials and other activities, and/or register their sales representatives, as well as to prohibit pharmacies and other healthcare entities from providing certain physician prescribing data to pharmaceutical and biotechnology companies for use in sales and marketing, and to prohibit certain other sales and marketing practices. All of our activities are potentially subject to federal and state consumer protection and unfair competition laws.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>If our operations are found to be in violation of any of the federal and state healthcare laws described above or any other governmental regulations that apply to us, we may be subject to penalties, including without limitation, civil, criminal and/or administrative penalties, damages, fines, disgorgement, exclusion from participation in government programs, such as Medicare and Medicaid, injunctions, private &#147;qui tam&#148; actions brought by individual whistleblowers in the name of the government, or refusal to allow us to enter into government contracts, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Coverage, Pricing and Reimbursement</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Significant uncertainty exists as to the coverage and reimbursement status of any tablet vaccine candidates for which we obtain regulatory approval. In the United States and markets in other countries, sales of any products for which we receive regulatory approval for commercial sale will depend, in part, on the extent to which third-party payors provide coverage, and establish adequate reimbursement levels for such products. In the United States, third-party payors include federal and state healthcare programs, private managed care providers, health insurers and other organizations. The process for determining whether a third-party payor will provide coverage for a product may be separate from the process for setting the price of a product or for establishing the reimbursement rate that such a payor will pay for the product. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the FDA-approved products for a particular indication. Third-party payors are increasingly challenging the price, examining the medical necessity and reviewing the cost-effectiveness of medical products, therapies and services, in addition to questioning their safety and efficacy. We may need to conduct expensive pharmaco-economic studies in order to demonstrate the medical necessity and cost-effectiveness of our tablet vaccine candidates, in addition to the costs required to obtain the FDA approvals. Our tablet vaccine candidates may not be considered medically necessary or cost-effective. A payor&#146;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#146;s determination to provide coverage for a product does not assure that other payors will also provide coverage for the product. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>Different pricing and reimbursement schemes exist in other countries. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost-effectiveness of a particular product candidate to currently available therapies. Other countries allow companies to fix their own prices for medicines, but monitor and control company profits. The downward pressure on health care costs has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. In addition, in some countries, cross-border imports from low-priced markets exert a commercial pressure on pricing within a country.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>The marketability of any tablet vaccine candidates for which it receives regulatory approval for commercial sale may suffer if the government and third-party payors fail to provide adequate coverage and reimbursement. In addition, emphasis on managed care in the United States has increased and we expect the pressure on healthcare pricing will continue to increase. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>36</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'>US Healthcare Reform</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>We anticipate that current and future U.S. legislative healthcare reforms may result in additional downward pressure on the price that we receive for any approved product, if covered, and could seriously harm our business. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our tablet vaccine candidates. In addition, it is possible that there will be further legislation or regulation that could harm our business, financial condition and results of operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Foreign Regulation</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'>In order to market any product outside of the United States, we would need to comply with numerous and varying regulatory requirements of other countries and jurisdictions regarding quality, safety and efficacy and governing, among other things, clinical trials, marketing authorization, commercial sales and distribution of our products. Whether or not we obtain FDA approval for a product, we would need to obtain the necessary approvals by the comparable foreign regulatory authorities before we can commence clinical trials or marketing of the product in foreign countries and jurisdictions. Although many of the issues discussed above with respect to the United States apply similarly in the context of the European Union, the approval process varies between countries and jurisdictions and can involve additional product testing and additional administrative review periods. The time required to obtain approval in other countries and jurisdictions might differ from and be longer than that required to obtain FDA approval. Regulatory approval in one country or jurisdiction does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country or jurisdiction may negatively impact the regulatory process in others.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Employees</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>Our management and scientific teams possess considerable experience in vaccine and anti-infective research, manufacturing, clinical development and regulatory matters. Our research team includes Ph.D.-level scientists with expertise in mucosal immunology, T cells, viral vectors and virology. As of December 31, 2018, we had 34 full-time employees. Of these, 26 employees are engaged in research and development and eight employees are engaged in finance, human resources, administration, business and general management. We have no collective bargaining agreements with our employees and we have not experienced any work stoppages. We consider our relations with our employees to be good.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; page:WordSection2'><b><font style=FONT-SIZE:10pt><a name="RISK F">Item&nbsp;1A.&nbsp;&nbsp;Risk Factors</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">You should carefully consider the following risk factors, as well as the other information in this Annual Report on Form 10-K, including our financial statements and the related notes and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148;, as well as our other public filings. The occurrence of any of the following risks could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this Annual Report on Form 10-K and those we may make from time to time. You should consider all of the risk factors described when evaluating our business.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><i><font style=FONT-SIZE:10pt>We operate in a rapidly changing environment that involves a number of risks, some of which are beyond our control. This discussion highlights some of the risks that may affect future operating results. These are the risks and uncertainties we believe are most important to consider. We cannot be certain that we will successfully address these risks. If we are unable to address these risks, our business may not grow, our stock price may suffer and we may be unable to stay in business. Additional risks and uncertainties not presently known to us, which we currently deem immaterial or which are similar to those faced by other companies in our industry or business in general, may also impair our business operations</font></i><font style=FONT-SIZE:10pt>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.25in 0in 12pt; page:WordSection2'><b>Risks Related to Our Business, Financial Position and Capital Requirements</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We have a limited operating history and have generated only limited product revenue.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Even though we generate royalty revenue from our two commercialized influenza products, we are at an early stage in our clinical development process and have not yet successfully completed a large-scale, pivotal clinical trial, obtained marketing approval, manufactured our tablet vaccine or small-molecule antiviral drug candidates at commercial scale, or conducted sales and marketing activities that will be necessary to successfully commercialize our product candidates. Consequently, predictions about our future success or viability may not be as accurate as they could be if we had a longer operating history or a history of successfully developing and commercializing product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>37</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our ability to generate significant revenue and achieve and maintain profitability will depend upon our ability to successfully complete the development of our tablet vaccine candidates for the treatment of norovirus, seasonal influenza, respiratory syncytial virus, or RSV, cervical cancer and dysplasia caused by human papillomavirus, or HPV, and other infectious diseases, and to obtain the necessary regulatory approvals.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Even if we receive regulatory approval for the sale of any of our product candidates, we do not know when we will begin to generate significant revenue, if at all. Our ability to generate significant revenue depends on a number of factors, including our ability to:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>set an acceptable price for our product candidates and obtain coverage and adequate reimbursement from third-party payors;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>receive royalties on our products and product candidates including in connection with sales of Relenza and Inavir;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>establish sales, marketing, manufacturing and distribution systems;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>add operational, financial and management information systems and personnel, including personnel to support our clinical, manufacturing and planned future clinical development and commercialization efforts and operations as a public company;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>develop manufacturing capabilities for bulk materials and manufacture commercial quantities of our product candidates at acceptable cost levels;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>achieve broad market acceptance of our product candidates in the medical community and with third-party payors and consumers;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>attract and retain an experienced management and advisory team;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>launch commercial sales of our product candidates, whether alone or in collaboration with others; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>maintain, expand and protect our intellectual property portfolio.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Because of the numerous risks and uncertainties associated with vaccine development and manufacturing, we are unable to predict the timing or amount of increased development expenses, or when we will be able to achieve or maintain profitability, if at all. Our expenses could increase beyond expectations if we are required by the U.S. Food and Drug Administration, or the FDA, or comparable non-U.S. regulatory authorities, to perform studies or clinical trials in addition to those we currently anticipate. Even if our product candidates are approved for commercial sale, we anticipate incurring significant costs associated with the commercial launch of and the related commercial-scale manufacturing requirements for our product candidates. If we cannot successfully execute on any of the factors listed above, our business may not succeed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We have incurred significant losses since our inception and expect to continue to incur significant losses for the foreseeable future and may never achieve or maintain profitability.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We have generated only limited product revenues and we expect to continue to incur substantial and increasing losses as we continue to develop our product candidates. Our product candidates have not been approved for marketing in the United States and may never receive such approval. As a result, we are uncertain when or if we will achieve profitability and, if so, whether we will be able to sustain it. Our ability to generate significant revenue and achieve profitability is dependent on our ability to complete development, obtain necessary regulatory approvals, and have our product candidates manufactured and successfully marketed. We cannot be sure that we will be profitable even if we successfully commercialize one of our product candidates. If we do successfully obtain regulatory approval to market our tablet vaccine candidates, our revenues will be dependent, in part, upon the size of the markets in the territories for which regulatory approval is received, the number of competitors in such markets, the price at which we can offer our product candidates and whether we own the commercial rights for that territory. If the indication approved by regulatory authorities is narrower than we expect, or the treatment population is narrowed by competition, physician choice or treatment guidelines, we may not generate significant revenue from sales of our product candidates, even if approved. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. If we fail to become and remain profitable, the market price of our common stock and our ability to raise capital and continue operations will be adversely affected.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We expect research and development expenses to increase significantly for any of our tablet vaccines, including those for the prevention of norovirus, influenza and RSV infection, as well as those for the treatment of HPV related dysplasia and cancer, and any other chronic viral infections and cancer. In addition, even if we obtain regulatory approval, significant sales and marketing expenses will be required to commercialize the tablet vaccine candidates. As a result, we expect to continue to incur significant and increasing operating losses and negative cash flows for the foreseeable future. These losses have had and will continue to have an adverse effect on our financial position and working capital. As of December 31, 2018, we had an accumulated deficit of $98.0 million.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>38</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><b><i>We recently completed the Merger with Aviragen and the failure to successfully integrate could adversely affect our future results.</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our success will depend, in significant part, on our ability to integrate successfully and to manage successfully the challenges presented by the integration process in the Merger with Aviragen that was completed in February 2018. Potential difficulties that may be encountered in the integration process include the following:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>using our cash and assets efficiently to develop our business;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>appropriately managing our liabilities;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>potential unknown or currently unquantifiable liabilities associated with the Merger and our operations;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>difficulties in operating with a new management team as a public company; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>performance shortfalls as a result of the diversion of the management&#146;s attention caused by integrating the companies&#146; operations, in particular operating as a public company immediately post-merger with Aviragen.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We are largely dependent on the success of our tablet vaccine for the prevention of norovirus infection which is still in early-stage clinical development, and if this tablet vaccine does not receive regulatory approval or is not successfully commercialized, our business may be harmed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>None of our product candidates are in late-stage clinical development or approved for commercial sale and we may never be able to develop marketable tablet vaccine candidates. We expect that a substantial portion of our efforts and expenditures over the next few years will be devoted to our tablet vaccine candidate for norovirus. Accordingly, our business currently depends heavily on the successful development, regulatory approval and commercialization of our norovirus tablet vaccine. Our norovirus tablet vaccine may not receive regulatory approval or be successfully commercialized even if regulatory approval is received. The research, testing, manufacturing, labeling, approval, sale, marketing and distribution of tablet vaccine candidates are and will remain subject to extensive regulation by the FDA and other regulatory authorities in the United States and other countries that each have differing regulations. We are not permitted to market our norovirus tablet vaccine in the United States until we receive approval of a biologics license application, or BLA, from the FDA, or in any foreign countries until we receive the requisite approval from such countries. To date, we have only completed Phase 1 clinical trials for one of the two strains necessary for our bivalent norovirus tablet vaccine candidate. As a result, we have not submitted a BLA to the FDA or comparable applications to other regulatory authorities and do not expect to be in a position to do so for the foreseeable future. Obtaining approval of a BLA is an extensive, lengthy, expensive and inherently uncertain process, and the FDA may delay, limit or deny approval of our norovirus tablet vaccine for many reasons, including:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>We may not be able to demonstrate that our norovirus tablet vaccine is safe and effective to the satisfaction of the FDA;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the FDA may not agree that the completed Phase 1 clinical trials of the norovirus vaccine satisfy the FDA&#146;s requirements and may require us to conduct additional testing;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the results of our clinical trials may not meet the level of statistical or clinical significance required by the FDA for marketing approval;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the FDA may disagree with the number, design, size, conduct or implementation of one or more of our clinical trials;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the contract research organizations, or CROs, that we retain to conduct clinical trials may take actions outside of our control that materially and adversely impact our clinical trials;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the FDA may not find the data from our preclinical studies and clinical trials sufficient to demonstrate that the clinical and other benefits of our tablet vaccines outweigh the safety risks;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the FDA may disagree with our interpretation of data from our preclinical studies and clinical trials;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the FDA may not accept data generated at our clinical trial sites;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font face=Symbol>&#183;</font><font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>if our NDA or BLA is reviewed by an advisory committee, the FDA may have difficulties scheduling an advisory committee meeting in a timely manner or the advisory committee may recommend against approval of our application or may recommend that the FDA require, as a condition of approval, additional preclinical studies or clinical trials, limitations on approved labeling or distribution and use restrictions;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the FDA may require development of a risk evaluation and mitigation strategy, or REMS, as a condition of approval;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the FDA may identify deficiencies in our manufacturing processes or facilities; or</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the FDA may change its approval policies or adopt new regulations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>39</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'><b><i>We believe that there is substantial doubt about our ability to continue as a going concern. </i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. Our independent auditors included an explanatory paragraph in their report on our financial statements as of and for the year ended December&nbsp;31, 2018, indicating that, because we have experienced losses and negative cash flows from operations and have an accumulated deficit and debt obligations, there is substantial doubt about our ability to continue as a going concern. We do not believe that this substantial doubt has been alleviated. As of December 31, 2018, we had $11.5&nbsp;million of cash and cash equivalents. We believe these funds, along&nbsp;with our projected revenue,&nbsp;<font style=COLOR:black>are sufficient to fund our operations into, but possibly not beyond, the second quarter of 2019. </font>If we are unable to continue as a going concern, we may be forced to liquidate our assets and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our financial statements.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We will require additional capital to fund our operations, and if we fail to obtain necessary financing, we may not be able to complete the development and commercialization of our tablet vaccine candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We expect to spend substantial amounts to complete the development of, seek regulatory approvals for and commercialize our tablet vaccine candidates. Even with the cash acquired in the Merger and from the acquired royalty streams, we will require substantial additional capital to complete the development and potential commercialization of our tablet vaccine candidates for norovirus, seasonal influenza, RSV, HPV, and the development of other product candidates. If we are unable to raise capital or find appropriate partnering or licensing collaborations, when needed or on acceptable terms, we could be forced to delay, reduce or eliminate one or more of our development programs or any future commercialization efforts. In addition, attempting to secure additional financing may divert the time and attention of our management from day-to-day activities and harm our development efforts. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Raising finance via the issuance of securities to the public generally entails filing documents with the SEC and, in the normal course of business, obtaining regulatory approval. The process is time-consuming and can result in delays in seeking potential investors. Further, the ongoing partial shutdown of the government means that SEC staff have been furloughed and are not available to review registration statements. This has already caused, and continues to cause, a delay in one potential source of financing via a registration statement that we filed with the SEC on December 27, 2018, and will continue to restrict our ability to raise finance via this and other potential alternatives until the SEC is fully staffed, and possibly beyond as a backlog is cleared.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>As of December 31, 2018, we had $11.5&nbsp;million of cash and cash equivalents. We believe these funds, along with our projected revenue,&nbsp;<font style=COLOR:black>are sufficient to fund our operations under our current operating plan into, but possibly not beyond, the second quarter of 2019</font>. Our estimate as to what we will be able to accomplish is based on assumptions that may prove to be inaccurate, and we could exhaust our available capital resources sooner than is currently expected. Because the length of time and activities associated with successful development of our product candidates is highly uncertain, we are unable to estimate the actual funds we will require for development and any approved marketing and commercialization activities. Our future funding requirements, both near and long-term, will depend on many factors, including, but not limited to:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the initiation, progress, timing, costs and results of our planned clinical trials;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the outcome, timing and cost of meeting regulatory requirements established by the FDA, the European Medicines Agency, or EMA, and other comparable foreign regulatory authorities;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the cost of filing, prosecuting, defending and enforcing our patent claims and other intellectual property rights;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the cost of defending potential intellectual property disputes, including any patent infringement actions brought by third parties against us now or in the future;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the effect of competing technological and market developments;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the cost of establishing sales, marketing and distribution capabilities in regions where we choose to commercialize our product candidates on our own; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the initiation, progress, timing and results of the commercialization of our product candidates, if approved, for commercial sale.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>40</font> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Additional funding may not be available on acceptable terms, or at all. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of our product candidates or potentially discontinue operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Raising additional funds by issuing securities may cause dilution to existing stockholders, and raising funds through lending and licensing arrangements may restrict our operations or require us to relinquish proprietary rights.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We expect that significant additional capital will be needed in the future to continue our planned operations. Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, royalties, debt financings, strategic alliances and license and development agreements in connection with any collaborations. We do not currently have any committed external source of funds. To the extent that we raise additional capital by issuing equity securities, our existing stockholders&#146; ownership may experience substantial dilution, and the terms of these securities may include liquidation or other preferences that adversely affect our common stockholders&#146; rights. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, declaring dividends, creating liens, redeeming our stock or making investments.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, or through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties on acceptable terms, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise develop and market ourselves.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><b><i><font style=FONT-SIZE:10pt>The terms of our debt facility place restrictions on our operating and financial flexibility</font></i></b><font style=FONT-SIZE:10pt>.</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style=FONT-SIZE:10pt>In December&nbsp;2016, we entered into a loan and security agreement, or the&nbsp;Loan Agreement, with Oxford Finance, LLC, or Oxford, as amended, under which we borrowed $5&nbsp;million. Our outstanding debt facility with Oxford is collateralized by substantially all of our assets, except for intellectual property, which is subject to a negative pledge, and contains customary financial and operating covenants limiting our ability to transfer or dispose of assets, merge with or acquire other companies, make investments, pay dividends, incur additional indebtedness and liens and conduct transactions with affiliates. We therefore may not be able to engage in any of the foregoing transactions until our current debt obligations are paid in full or we obtain the consent from Oxford. Compliance with these covenants may limit our flexibility in operating our business and our ability to take actions that might be advantageous to us and our stockholders.</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style=FONT-SIZE:10pt>Under the Loan Agreement, an event of default will occur if, among other things:</font></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>we fail to make payments when due under the Loan Agreement; </p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>we breach any of our covenants under the Loan Agreement, subject to specified cure periods with respect to certain breaches; </p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>there occurs an event that has a material adverse effect on: </p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.75in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>our business, operations, properties, assets or financial condition;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.75in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>our ability to perform or satisfy our obligations under the Loan Agreement as they become due or Oxford&#146;s ability to enforce its rights or remedies with respect to our obligations under the Loan Agreement; or </p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.75in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>the collateral or liens securing our obligations under the Loan Agreement; </p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>we or our assets become subject to certain legal proceedings, such as bankruptcy or insolvency proceedings, or attachments;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>we are unable to pay our debts as they become due; or </p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT:7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>we default on certain contracts with third parties which would permit Oxford to accelerate the maturity of such indebtedness or that could have a material adverse effect on us. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>41</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in"><font style="FONT-WEIGHT:normal; FONT-STYLE:normal">We may not have enough available cash or be able to raise additional funds through equity or debt financings to repay such indebtedness to Oxford at the time any such event of default occurs. In that case, we may be required to delay, limit, reduce or terminate our clinical development efforts or grant rights to develop and market product candidates to others that we would otherwise prefer to develop and market ourselves. Oxford could also exercise its rights as collateral agent to take possession and dispose of the collateral securing the Loan Agreement for its benefit as the secured lender. Our business would be harmed as a result of any of these events.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our stock price is expected to be volatile, and the market price of our common stock has fallen since the Merger.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The market price of our common stock has been subject to significant fluctuations following the Merger. Market prices for securities of early-stage pharmaceutical, biotechnology and other life sciences companies have historically been particularly volatile. Some of the factors that cause the market price of our common stock to fluctuate include:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our ability to develop product candidates and conduct clinical trials that demonstrate our product candidates are safe and effective;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our ability to negotiate and receive royalty payments on the sales of our product candidates including Relenza and Inavir;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our ability to obtain regulatory approvals for our product candidates, and delays or failures to obtain such approvals;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>failure of any of our product candidates to demonstrate safety and efficacy, receive regulatory approval and achieve commercial success;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>failure to maintain our existing third-party license, manufacturing and supply agreements;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our failure, or that of our licensors, to prosecute, maintain, or enforce our intellectual property rights;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>changes in laws or regulations applicable to our product candidates;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>any inability to obtain adequate supply of product candidates or the inability to do so at acceptable prices;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>adverse regulatory authority decisions;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>introduction of new or competing products by our competitors;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>failure to meet or exceed financial and development projections that we may provide to the public;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the perception of the pharmaceutical industry by the public, legislatures, regulators and the investment community;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>announcements of significant acquisitions, strategic partnerships, joint ventures, or capital commitments by us or our competitors;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>disputes or other developments relating to proprietary rights, including patents, litigation matters, and our ability to obtain intellectual property protection for our technologies;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>additions or departures of key personnel;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>significant lawsuits, including intellectual property or stockholder litigation;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>if securities or industry analysts do not publish research or reports about us, or if they issue adverse or misleading opinions regarding our business and stock;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>changes in the market valuations of similar companies;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>general market or macroeconomic conditions;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>sales of our common stock by our existing stockholders in the future;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>trading volume of our common stock;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>adverse publicity relating to our markets generally, including with respect to other products and potential products in such markets;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>changes in the structure of health care payment systems; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>period-to-period fluctuations in our financial results.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-INDENT:-0.25in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>42</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Moreover, the stock markets in general have experienced substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations may also adversely affect the trading price of our common stock.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In the past, following periods of volatility in the market price of a company&#146;s securities, stockholders have often instituted class action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly harm our operations, financial performance and reputation.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We do not anticipate that we will pay any cash dividends in the foreseeable future.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The current expectation is that we will retain our future earnings, if any, to fund the development and growth of our business. As a result, capital appreciation, if any, of our common stock will be the sole source of gain, if any, for our stockholders.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Future sales of shares by existing stockholders could cause our stock price to decline.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market, the trading price of our common stock could decline. As of December 31, 2018, our officers, directors and their affiliate entities held 3.1 million shares of our common stock. Sales of a substantial number of shares of our common stock in the public market, or the perception that the sales might occur, could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict the effect that sales may have on the prevailing market price of our common stock.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>One stockholder owns a significant&nbsp;percentage of our stock and, together with our management, will be able to exert significant control over matters subject to stockholder approval.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>As of December&nbsp;31, 2018, entities affiliated with Care Capital, a venture capital fund, owned 39.2% of our common stock, and Care Capital together with our executive officers and directors owned 44.2% of our common stock. Therefore, these stockholders may be able to determine all matters requiring stockholder approval, and the entities affiliated with Care Capital alone will have significant ability to influence decisions through their ownership position. For example, this concentration of ownership may enable a small number of stockholders to influence or control elections of directors, amendments to our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Because the Merger resulted in an ownership change under Section&nbsp;382 of the Code for Aviragen, pre-merger U.S. net operating loss carryforwards and certain other tax attributes are subject to limitations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If a corporation undergoes an &#147;ownership change&#148; within the meaning of Section&nbsp;382 of the Code, the corporation&#146;s U.S. net operating loss carryforwards and certain other tax attributes arising from before the ownership change are subject to limitations on use after the ownership change. In general, an ownership change occurs if there is a cumulative change in the corporation&#146;s equity ownership by certain stockholders that exceeds 50% over a three-year period. Similar rules may apply under state and foreign tax laws. <a name=_Hlk536541421>The Merger resulted in an ownership change for Aviragen, and probably Vaxart; accordingly, Aviragen&#146;s U.S. net operating loss carryforwards and certain other tax attributes are subject to limitations on their use</a>. Annual usage may be restricted to 1.97% of Aviragen&#146;s value on February 13, 2018. Additional ownership changes in the future could result in additional limitations on the combined organization&#146;s net operating loss carryforwards. Consequently, even if we achieve profitability, we may not be able to utilize a material portion of our net operating loss carryforwards and other tax attributes, which could have a material adverse effect on cash flow and results of operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><b><i>Changes in tax laws and regulations or in our operations may impact our effective tax rate and may adversely affect our business, financial condition and operating results.</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Changes in tax laws in any jurisdiction in which we operate, or adverse outcomes from any tax audits that we may be subject to in any such jurisdictions, could result in an unfavorable change in our effective tax rate in the future, which could adversely affect our business, financial condition, and operating results.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Anti-takeover provisions under Delaware law could make an acquisition more difficult and may prevent attempts by our stockholders to replace or remove our management.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>Because we are incorporated in Delaware, we are governed by the provisions of Section&nbsp;203 of the DGCL, which prohibits stockholders owning in excess of 15% of the outstanding company voting stock from merging or combining with the company. Although we believe these provisions collectively provide for an opportunity to receive higher bids by requiring potential acquirers to negotiate with our board of directors, they would apply even if the offer was considered beneficial by some stockholders. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of management<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>43</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If we fail to obtain or maintain adequate reimbursement and insurance coverage for our product candidates, our ability to generate significant revenue could be limited.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The availability and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford expensive treatments. Sales of any of our product candidates that receive marketing approval will depend substantially, both in the United States and internationally, on the extent to which the costs of our product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. If reimbursement is not available, or is available only on a limited basis, we may not be able to successfully commercialize our product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain adequate pricing that will allow us to realize a sufficient return on our investment.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Europe, Canada and other countries may cause us to price our product candidates on less favorable terms that we currently anticipate. In many countries, particularly the countries of the European Union, the prices of medical products are subject to varying price control mechanisms as part of national health systems. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product. To obtain reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidates to other available therapies. In general, the prices of products under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for products, but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the United States, the level of reimbursement for our products is likely to be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Moreover, increasing efforts by governmental and third-party payors, in the United States and internationally, to cap or reduce healthcare costs may cause such organizations to limit both coverage and level of reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for our product candidates. We expect to experience pricing pressures in connection with the sale of any of our product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products into the healthcare market.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our future success depends on our ability to retain executive officers and attract, retain and motivate qualified personnel.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We are highly dependent on our executive officers and the other principal members of the executive and scientific teams, particularly our President and Chief Executive Officer, Wouter W. Latour and our Chief Scientific Officer, Sean N. Tucker. The employment of our executive officers is at-will and our executive officers may terminate their employment at any time. The loss of the services of any of our senior executive officers could impede the achievement of our research, development and commercialization objectives. We do not maintain &#147;key person&#148; insurance for any executive officer or employee.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Recruiting and retaining qualified scientific, clinical, manufacturing and sales and marketing personnel is also critical to our success. We may not be able to attract and retain these personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. Our industry has experienced an increasing rate of turnover of management and scientific personnel in recent years. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in devising our research and development and commercialization strategy. Our consultants and advisors may be employed by third parties and have commitments under consulting or advisory contracts with other entities that may limit their availability to advance our strategic objectives. If any of these advisors or consultants can no longer dedicate a sufficient amount of time to us, our business may be harmed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>44</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><b><i><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font></i></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We will need to expand our organization, and may experience difficulties in managing this growth, which could disrupt operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our future financial performance and our ability to commercialize our product candidates, continue to earn royalties and compete effectively will depend, in part, on our ability to effectively manage any future growth. As of December 31, 2018, we had 34 full-time employees. We expect to hire additional employees for our managerial, clinical, scientific and engineering, operational, manufacturing, sales and marketing teams. We may have operational difficulties in connection with identifying, hiring and integrating new personnel. Future growth would impose significant additional responsibilities on our management, including the need to identify, recruit, maintain, motivate and integrate additional employees, consultants and contractors. Also, our management may need to divert a disproportionate amount of its attention away from our day-to-day activities and devote a substantial amount of time to managing these growth activities. We may not be able to effectively manage the expansion of our operations, which may result in weaknesses in our infrastructure, give rise to operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. Our expected growth could require significant capital expenditures and may divert financial resources from other projects, such as the development of our product candidates. If we are unable to effectively manage our growth, our expenses may increase more than expected, our ability to generate and/or grow revenues could be reduced, and we may not be able to implement our business strategy.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Many of the other pharmaceutical companies that we compete against for qualified personnel and consultants have greater financial and other resources, different risk profiles and a longer history in the industry than us. They may also provide more diverse opportunities and better chances for career advancement. Some of these characteristics may be more appealing to high-quality candidates and consultants than what we are able to offer. If we are unable to continue to attract and retain high-quality personnel and consultants, the rate and success at which we can select and develop our product candidates and our business will be limited.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our employees, independent contractors, principal investigators, consultants, commercial collaborators, service providers and other vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have an adverse effect on our results of operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We are exposed to the risk that our employees and contractors, including principal investigators, consultants, commercial collaborators, service providers and other vendors may engage in fraudulent or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or other unauthorized activities that violate the laws and regulations of the FDA and other similar regulatory bodies, including those laws that require the reporting of true, complete and accurate information to such regulatory bodies, manufacturing standards, federal and state healthcare fraud and abuse and health regulatory laws and other similar foreign fraudulent misconduct laws, or laws that require the true, complete and accurate reporting of financial information or data. Misconduct by these parties may also involve the improper use or misrepresentation of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter third-party misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and financial results, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our business and operations would suffer in the event of system failures.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our computer systems and those of our service providers, including our CROs, are vulnerable to damage from computer viruses, unauthorized access, natural disasters (including earthquakes), terrorism, war and telecommunication and electrical failures. If such an event were to occur and cause interruptions in our or their operations, it could result in a material disruption of our development programs. For example, the loss of preclinical or clinical trial data from completed, ongoing or planned trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach were to result in a loss of or damage to data or applications, or inappropriate disclosure of personal, confidential or proprietary information, we could incur liability and the further development of our product candidates could be delayed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>45</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><b><i>We have identified a material weakness in our internal control over financial reporting, and if we are unable to maintain proper and effective internal controls over financial reporting, the accuracy and timeliness of our financial reporting may be adversely affected</i></b><b><i>.</i></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">In connection with the audits of our financial statements for each of the years ended December 31, 2015 through 2018, our management and our independent auditors identified a material weakness in our internal control over financial reporting. A &#147;material weakness&#148; is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness relates to us lacking consistent processes to appropriately perform effective and timely review of account reconciliations and non-routine transactions.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>We have already taken steps to remediate this material weakness. We have increased the depth and experience within our accounting and finance organization, in part by hiring a Corporate Controller and an Associate Director of SEC Reporting. We are also designing and implementing improved processes and internal controls. However, our efforts to remediate this material weakness may not be effective or prevent any future material weakness or significant deficiency in our internal control over financial reporting. If our efforts are not successful, or other material weaknesses or control deficiencies occur in the future, we may be unable to report our financial results accurately on a timely basis, which could cause our reported financial results to be materially misstated and result in the loss of investor confidence and cause the market price of our common stock to decline.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We are required, pursuant to Section 404 of the Sarbanes-Oxley Act, to furnish a quarterly report by management on, among other things, the effectiveness of our internal control over financial reporting. This assessment needs to include disclosure of any material weaknesses identified by our management in our internal control over financial reporting. Our independent registered public accounting firm will be required to attest annually to the effectiveness of our internal control over financial reporting in the future should our public float exceed $75 million. We are required to disclose changes made in our internal control over financial reporting on a quarterly basis.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We are incurring significant additional costs and demands upon management as a result of complying with the laws and regulations affecting public companies.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We incur significant legal, accounting and other expenses associated with public company reporting requirements. We also incur costs associated with corporate governance requirements, including requirements under the Sarbanes-Oxley Act, as well as rules implemented by the SEC and The Nasdaq Stock Market LLC. These rules and regulations impose significant legal and financial compliance costs and make some activities more time-consuming and costlier. For example, our management team includes certain executive officers who have not previously managed and operated a public company. These executive officers and other personnel need to devote substantial time to gaining expertise regarding operations as a public company and compliance with applicable laws and regulations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We may be subject to securities litigation, which is expensive and could divert management attention.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The market price of our common stock has been and may continue to be volatile, and in the past companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert management&#146;s attention from other business concerns, which could seriously harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If securities or industry analysts do not publish research, or publish inaccurate or unfavorable rating, about our business, our stock price and trading volume could decline.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The trading market for our common stock is influenced by independent research and reports that securities or industry analysts publish about us or our business from time to time. At present, there are no analysts covering our stock, which means we have low visibility in the financial markets, which could cause a low trading volume, which would tend to cause our stock price to decline. There can be no assurance that analysts will cover our stock in the future or, if they do, provide favorable ratings. If any analysts who cover us downgrade our stock, change their opinion of our stock or disseminate negative information regarding our business, our share price may decline.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>46</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:0.25in 0in 12pt; TEXT-INDENT:0in; page:WordSection2'>Risks Related to Clinical Development, Regulatory Approval and Commercialization</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If we fail to continue to develop and refine the formulations of our tablet vaccine candidates, we may not obtain regulatory approvals, and even if approved, the commercial acceptance of our tablet vaccine candidates would likely be limited.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>In our H1N1 influenza Phase 2 trial we used vaccine tablets that contained approximately 1.5 x 10<sup>10</sup> IU of vaccine. Accordingly, subjects in this trial were required to take 7 tablets in a single setting to reach the aggregate dose of 1 x 10<sup>11</sup> IU, the target dose for this trial. We believe that in order to fully capture the commercial success of our seasonal influenza vaccine candidate, we will need to continue to refine our formulation and develop influenza vaccine tablets that contain the desired dose for each vaccine strain in a single tablet, resulting in a vaccination regime of no more than four tablets. Increasing the potency of the vaccine tablets may affect the stability profile of the vaccine and we may not be able to reduce the vaccination regime for an influenza strain to a single tablet or combine the four influenza strains into one vaccine tablet. In addition, increasing the potency of the vaccine tablets or combining the influenza strains necessary to create a quadrivalent vaccine may adversely affect manufacturing yields and render such tablets too costly to manufacture at commercial scale. Our efforts to develop tablet vaccine candidates for norovirus and RSV face similar formulation challenges. If we are unable to further develop and refine the formulations of our tablet vaccine candidates, we may be unable to obtain regulatory approval from the FDA or other regulatory authorities, and even if approved, the commercial acceptance of our tablet vaccine candidates would likely be limited.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Clinical trials are very expensive, time-consuming, difficult to design and implement and involve an uncertain outcome, and if they fail to demonstrate safety and efficacy to the satisfaction of the FDA, or similar regulatory authorities, we will be unable to commercialize our tablet vaccine candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our tablet vaccine candidates for norovirus and seasonal influenza are still in early-stage clinical development. Both will require extensive additional clinical testing before we are prepared to submit a BLA for regulatory approval for either indication or for any other treatment regime. We cannot predict with any certainty if or when we might submit a BLA for regulatory approval for any of our tablet vaccine candidates, which are currently in clinical development, or whether any such BLAs will be approved by the FDA. Human clinical trials are very expensive and difficult to design and implement, in part because they are subject to rigorous regulatory requirements. For instance, the FDA may not agree with our proposed endpoints for any clinical trial we propose, which may delay the commencement of our clinical trials. The clinical trial process is also time-consuming. We estimate that the clinical trials we need to conduct to be in a position to submit BLAs for our tablet vaccine candidates for seasonal influenza, norovirus and RSV will take several years to complete. Furthermore, failure can occur at any stage of the trials, and we could encounter problems that cause us to abandon or repeat clinical trials. Our vaccine candidates in the later stages of clinical trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical trials. Also, the results of early clinical trials of the tablet vaccine candidates for seasonal influenza, norovirus and RSV may not be predictive of the results of subsequent clinical trials. Furthermore, the FDA may impose additional requirements to conduct preclinical studies to advance the HPV therapeutic vaccine candidates which could delay initiation of Phase 1 studies. A number of companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier trials.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Moreover, preclinical and clinical data are often susceptible to multiple interpretations and analyses. Many companies that have believed their vaccine candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their products. Success in preclinical testing and early clinical trials does not ensure that later clinical trials, which involve many more subjects and, for influenza, all four strains rather than the one strain we have studied in Phase 1 clinical trials to date and the results of later clinical trials may not replicate the results of prior clinical trials and preclinical testing.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>We may experience numerous unforeseen events during, or as a result of, clinical trials that could delay or prevent our ability to receive marketing approval or commercialize our tablet vaccine candidates, including that:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;r</font></font>egulators or institutional review boards may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>we may experience delays in reaching or fail to reach agreement on acceptable clinical trial contracts or clinical trial protocols with prospective trial sites;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>clinical trials of our tablet vaccine candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon product development programs;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>47</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the number of subjects required for clinical trials of our tablet vaccine candidates may be larger than we anticipate; enrollment in these clinical trials may be slower than we anticipate, or participants may drop out of these clinical trials at a higher rate than we anticipate;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>Our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>regulators or institutional review boards may require that we or our investigators suspend or terminate clinical research for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the cost of clinical trials of our tablet vaccine candidates may be greater than we anticipate; and</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-INDENT:-0.25in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the supply or quality of our tablet vaccine candidates or other materials necessary to conduct clinical trials may be insufficient or inadequate.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If we are required to conduct additional clinical trials or other testing of our tablet vaccine candidates beyond those that we currently contemplate, if we are unable to successfully complete clinical trials of our tablet vaccine candidates or other testing, if the results of these trials or tests are not positive or are only modestly positive or if there are safety concerns, we may:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>be delayed in obtaining marketing approval for our tablet vaccine candidates;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>not obtain marketing approval at all;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>obtain approval for indications or patient populations that are not as broad as intended or desired;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>obtain approval with labeling that includes significant use or distribution restrictions or safety warnings, including boxed warnings;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>be subject to additional post-marketing testing requirements; or</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>have the product removed from the market after obtaining marketing approval.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Product development costs will also increase if we experience delays in testing or in receiving marketing approvals. We do not know whether any clinical trials will begin as planned, will need to be restructured or will be completed on schedule, or at all. Significant clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize our tablet vaccine candidates, could allow our competitors to bring products to market before we do, and could impair our ability to successfully commercialize our tablet vaccine candidates, any of which may harm our business and results of operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our platform includes a novel vaccine adjuvant and all of our current tablet vaccine candidates include this novel adjuvant, which may make it difficult for us to predict the time and cost of tablet vaccine development as well as the requirements the FDA or other regulatory agencies may impose to demonstrate the safety of the tablet vaccine candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Novel vaccine adjuvants, included in some of our tablet vaccine candidates, may pose an increased safety risk to patients. Adjuvants are compounds that are added to vaccine antigens to enhance the activation and improve immune response and efficacy of vaccines. Development of vaccines with novel adjuvants requires evaluation in larger numbers of patients prior to approval than would be typical for therapeutic drugs. Guidelines for evaluation of vaccines with novel adjuvants have been established by the FDA and other regulatory bodies and expert committees. Our current tablet vaccine candidates, including for norovirus, include a novel adjuvant, and future vaccine candidates may also include one or more novel vaccine adjuvants. Any vaccine, because of the presence of an adjuvant, may have side effects considered to pose too great a risk to patients to warrant approval of the vaccine. Traditionally, regulatory authorities have required extensive study of novel adjuvants because vaccines typically get administered to healthy populations, in particular infants, children and the elderly, rather than to people with disease. Such extensive study has often included long-term monitoring of safety in large general populations that has at times exceeded 10,000 subjects. This contrasts with the few thousand subjects typically necessary for approval of novel therapeutics. To date, the FDA and other major regulatory agencies have only approved vaccines containing five adjuvants, which makes it difficult to determine how long it will take or how much it will cost to obtain regulatory approvals for our tablet vaccine candidates in the United States or elsewhere.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>48</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><font style=FONT-SIZE:10pt> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Enrollment and retention of subjects in clinical trials is an expensive and time-consuming process and could be made more difficult or rendered impossible by multiple factors outside our control.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We may encounter delays in enrolling, or be unable to enroll, a sufficient number of participants to complete any of our clinical trials. Once enrolled, we may be unable to retain a sufficient number of participants to complete any of our trials. Late-stage clinical trials of our tablet vaccine candidate for norovirus, in particular, will require the enrollment and retention of large numbers of subjects. Subject enrollment and retention in clinical trials depends on many factors, including the size of the subject population, the nature of the trial protocol, the existing body of safety and efficacy data with respect to the study drug, the number and nature of competing treatments and ongoing clinical trials of competing drugs for the same indication, the proximity of subjects to clinical sites and the eligibility criteria for the study. Further, since there are no reliable animal models to norovirus infection, human challenge studies have been used to understand viral activity and possible immune correlates that prevent infection making trials costlier than animal-based studies.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Furthermore, any negative results we may report in clinical trials of our tablet vaccine candidates may make it difficult or impossible to recruit and retain participants in other clinical trials of that same tablet vaccine candidate. Delays or failures in planned subject enrollment or retention may result in increased costs, program delays or both, which could have a harmful effect on our ability to develop our tablet vaccine candidates, or could render further development impossible. In addition, we expect to rely on CROs and clinical trial sites to ensure proper and timely conduct of our future clinical trials and, while we intend to enter into agreements governing their services, we will be limited in our ability to compel their actual performance in compliance with applicable regulations. Enforcement actions brought against these third parties may cause further delays and expenses related to our clinical development programs.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We face significant competition from other biotechnology and pharmaceutical companies, and our operating results will suffer if we fail to compete effectively.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Vaccine development is highly competitive and subject to rapid and significant technological advancements. We face competition from various sources, including larger and better funded pharmaceutical, specialty pharmaceutical and biotechnology companies, as well as academic institutions, governmental agencies and public and private research institutions. In particular, our influenza vaccine candidate would compete with products that are available and have gained market acceptance as the standard treatment protocol. Further, it is likely that additional drugs or other treatments will become available in the future for the treatment of the diseases we are targeting.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>For tablet vaccines, we face competition from approved vaccines, against which new tablet vaccines must demonstrate compelling advantages in efficacy, convenience, tolerability and safety, and from competitors working to patent, discover, develop or commercialize medicines before we can do the same with tablet vaccines.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Many of our existing or potential competitors have substantially greater financial, technical and human resources than we do and significantly greater experience in the discovery and development of products for the treatment of diseases, as well as in obtaining regulatory approvals of those products in the United States and in foreign countries. Our current and potential future competitors also have significantly more experience commercializing drugs that have been approved for marketing. Mergers and acquisitions in the pharmaceutical and biotechnology industries could result in even more resources being concentrated among a small number of our competitors.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Competition may increase further as a result of advances in the commercial applicability of technologies and greater availability of capital for investment in these industries. Our competitors may succeed in developing, acquiring or licensing, on an exclusive basis, drugs that are more effective or less costly than any tablet vaccine candidate that we may develop.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We will face competition from other drugs currently approved or that will be approved in the future for the treatment of the other infectious diseases we are currently targeting. Therefore, our ability to compete successfully will depend largely on our ability to:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>develop and commercialize tablet vaccine candidates that are superior to other vaccines in the market;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>demonstrate through our clinical trials that our tablet vaccine candidates are differentiated from existing and future therapies;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>attract qualified scientific, vaccine development and commercial personnel;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>obtain patent or other proprietary protection for our tablet vaccine candidates;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>obtain required regulatory approvals;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'>&nbsp;</p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>49</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>obtain coverage and adequate reimbursement from, and negotiate competitive pricing with, third-party payors; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>successfully develop and commercialize, independently or with collaborators, new tablet vaccine candidates.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>The availability of our competitors&#146; vaccines could limit the demand, and the price we are able to charge, for any tablet vaccine candidate we develop. The inability to compete with existing or subsequently introduced vaccines would have an adverse impact on our business, financial condition and prospects.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Established pharmaceutical companies may invest heavily to accelerate discovery and development of novel compounds or to in-license novel compounds that could make any of our tablet vaccine candidates less competitive. In addition, any new vaccine that competes with an approved vaccine must demonstrate compelling advantages in efficacy, convenience, tolerability and safety in order to overcome price competition and to be commercially successful. Accordingly, our competitors may succeed in obtaining patent protection, discovering, developing, receiving the FDA&#146;s approval for or commercializing medicines before we do, which would have an adverse impact on our business and results of operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>The biotechnology and pharmaceutical industries are characterized by intense competition to develop new technologies and proprietary products. While we believe that our proprietary tablet vaccine candidates provide competitive advantages, we face competition from many different sources, including biotechnology and pharmaceutical companies, academic institutions, government agencies, as well as public and private research institutions. Any products that we may commercialize will have to compete with existing products and therapies as well as new products and therapies that may become available in the future.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>There are other organizations working to improve existing therapies, vaccines or delivery methods, or to develop new vaccines, therapies or delivery methods for their selected indications. Depending on how successful these efforts are, it is possible they may increase the barriers to adoption and success of our vaccine candidates, if approved.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>We anticipate that we will face intense and increasing competition as new vaccines enter the market and advanced technologies become available. We expect any tablet or other oral delivery vaccine candidates that we develop and commercialize to compete on the basis of, among other things, efficacy, safety, convenience of administration and delivery, price, availability of therapeutics, the level of generic competition and the availability of reimbursement from government and other third-party payors.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that we may develop. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for our vaccine candidates, which could result in our competitors establishing a strong market position before we are able to enter the market. In addition, our ability to compete may be affected in many cases by insurers or other third-party payors seeking to encourage the use of generic products.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>We believe our seasonal influenza vaccine candidate will compete directly with approved vaccines in the market, which include non-recombinant and recombinant products that are administered via injection or intranasally. The major non-recombinant injectable vaccine competitors include Astellas Pharma Inc., Abbott Laboratories, AstraZeneca UK Limited, Baxter International Inc., Research Foundation for Microbial Diseases of Osaka University, Seqirus-bioCSL Inc., GlaxoSmithKline plc, or GlaxoSmithKline, Sanofi S.A., or Sanofi, Pfizer Inc., and Takeda Pharmaceutical Company Limited, or Takeda. Non-recombinant intranasal competition includes MedImmune, Inc., or MedImmune, and potentially others. Recombinant injectable competitors include Sanofi and Novavax, Inc., or Novavax. Many other groups are developing new or improved flu vaccine or delivery methods.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>There is currently no approved norovirus vaccine for sale globally. While we are not aware of all of our competitors&#146; efforts, we believe that Takeda is also developing a virus-like particle-based norovirus vaccine that would be delivered by injection.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>There is currently no approved RSV vaccine for sale globally; however, a number of vaccine manufacturers, academic institutions and other organizations currently have, or have had, programs to develop such a vaccine. In addition, many other companies are developing products to prevent disease caused by RSV using a variety of technology platforms, including monoclonal antibodies, small molecule therapeutics, as well as various viral vector and VLP based vaccine technologies. While we are not aware of all of our competitors&#146; efforts, we believe that several companies are in various stages of developing an RSV vaccine including GlaxoSmithKline, Johnson &amp; Johnson, Bavarian Nordic, Astellas, MedImmune, Novavax, and Sanofi, as well as the National Institute of Allergy and Infectious Diseases, an institute under the U.S. National Institutes of Health, and possibly others.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>50</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>There is currently no approved HPV therapeutic vaccine for sale globally; however, a number of vaccine manufacturers, academic institutions and other organizations currently have, or have had, programs to develop such a vaccine. We believe that several companies are in various stages of developing an HPV therapeutic vaccine including Inovio, Advaxis, Genexine, and possibly others.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our tablet vaccine candidates may cause adverse effects or have other properties that could delay or prevent their regulatory approval or limit the scope of any approved label or market acceptance.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Adverse events caused by our tablet vaccine candidates could cause reviewing entities, clinical trial sites or regulatory authorities to interrupt, delay or halt clinical trials and could result in the denial of regulatory approval. If an unacceptable frequency or severity of adverse events are reported in clinical trials for our tablet vaccine candidates, our ability to obtain regulatory approval for such tablet vaccine candidates may be negatively impacted.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Furthermore, if any of our tablet vaccines are approved and then cause serious or unexpected side effects, a number of potentially significant negative consequences could result, including:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>regulatory authorities may withdraw their approval of the tablet vaccine candidates or impose restrictions on their distribution or other risk management measures;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>regulatory authorities may require the addition of labeling statements, such as warnings or contraindications;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>we may be required to change the way our tablet vaccine candidates are administered or to conduct additional clinical trials;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>we could be sued and held liable for injuries sustained by patients;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>we could be subject to the Vaccine Injury Compensation Program;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>we could elect to discontinue the sale of our tablet vaccine candidates; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our reputation may suffer.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Any of these events could prevent us from achieving or maintaining market acceptance of the affected tablet vaccine candidate and could substantially increase the costs of commercialization.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals, we will not be able to commercialize, or will be delayed in commercializing, our tablet vaccine candidates, and our ability to generate significant revenue will be impaired.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our tablet vaccine and small-molecule antiviral candidates and the activities associated with their development and commercialization, including their design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale and distribution, are subject to comprehensive regulation by the FDA and other regulatory agencies in the United States and by comparable authorities in other countries. Failure to obtain marketing approval for a tablet vaccine candidate will prevent us from commercializing the tablet vaccine candidate. We have not received approval to market any of our tablet vaccine candidates from regulatory authorities in any jurisdiction. We have only limited experience in filing and supporting the applications necessary to gain marketing approvals and expect to rely on CROs to assist us in this process. Securing regulatory approval requires the submission of extensive preclinical and clinical data and supporting information to the various regulatory authorities for each therapeutic indication to establish the tablet vaccine candidate&#146;s safety and efficacy. Securing regulatory approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the relevant regulatory authority. Our tablet vaccine candidates may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude us obtaining marketing approval or prevent or limit commercial use.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The process of obtaining marketing approvals, both in the United States and elsewhere, is expensive, may take many years and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the tablet vaccine candidates involved. We cannot be sure that we will ever obtain any marketing approvals in any jurisdiction. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations or changes in regulatory review for each submitted product application may cause delays in the approval or rejection of an application. The FDA and comparable authorities in other countries have substantial discretion in the approval process and may refuse to accept any application or may decide that our data is insufficient for approval and require additional preclinical or other studies, and clinical trials. In addition, varying interpretations of the data obtained from preclinical testing and clinical trials could delay, limit or prevent marketing approval of a tablet vaccine candidate. Additionally, any marketing approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>51</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Even if we obtain FDA approval in the United States, we may never obtain approval for or commercialize our tablet vaccine candidates in any other jurisdiction, which would limit our ability to realize each product&#146;s full market potential.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In order to market any of our tablet vaccine candidates in a particular jurisdiction, we must establish and comply with numerous and varying regulatory requirements on a country-by-country basis regarding safety and efficacy. Approval by the FDA in the United States does not ensure approval by regulatory authorities in other countries or jurisdictions. In addition, clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not guarantee regulatory approval in any other country. Approval processes vary among countries and can involve additional tablet vaccine candidate testing and validation and additional administrative review periods. Seeking foreign regulatory approval could result in difficulties and costs for us and require additional preclinical studies or clinical trials which could be costly and time consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of our tablet vaccine candidates in those countries. We do not have any tablet vaccine candidates approved for sale in any jurisdiction, including in international markets, and we do not have experience in obtaining regulatory approval in international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approvals in international markets are delayed, our target market will be reduced and our ability to realize the full market potential of any tablet vaccine candidate we develop will be unrealized.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Even if we obtain regulatory approval, we will still face extensive ongoing regulatory requirements and our tablet vaccine candidates may face future development and regulatory difficulties.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Any tablet vaccine candidate for which we obtain marketing approval, along with the manufacturing processes, post- approval clinical data, labeling, packaging, distribution, adverse event reporting, storage, recordkeeping, export, import, advertising and promotional activities for such tablet vaccine candidate, among other things, will be subject to extensive and ongoing requirements of and review by the FDA and other regulatory authorities. These requirements include submissions of safety, efficacy and other post-marketing information and reports, establishment registration and drug listing requirements, continued compliance with current Good Manufacturing Practice, or cGMP, requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, requirements regarding the distribution of samples to physicians and recordkeeping and current GCP requirements for any clinical trials that we conduct post-approval. Even if marketing approval of a tablet vaccine candidate is granted, the approval may be subject to limitations on the indicated uses for which the tablet vaccine candidates may be marketed or to the conditions of approval. If a tablet vaccine candidate receives marketing approval, the accompanying label may limit the approved use of that tablet vaccine, which could limit sales.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The FDA may also impose requirements for costly post-marketing studies or clinical trials and surveillance to monitor the safety and/or efficacy of our tablet vaccine candidates. The FDA closely regulates the post-approval marketing and promotion of drugs to ensure drugs are marketed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA imposes stringent restrictions on manufacturers&#146; communications regarding off-label use and if we do not market our tablet vaccine candidates for their approved indications, we may be subject to enforcement action for off-label marketing. Violations of the Federal Food, Drug, and Cosmetic Act relating to the promotion of prescription drugs may lead to FDA enforcement actions and investigations alleging violations of federal and state health care fraud and abuse laws, as well as state consumer protection laws.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In addition, later discovery of previously unknown adverse events or other problems with our tablet vaccine candidates, manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various results, including:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>restrictions on manufacturing such tablet vaccine candidate;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>restrictions on the labeling or marketing of a tablet vaccine candidate;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>restrictions on tablet vaccine distribution or use;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>requirements to conduct post-marketing studies or clinical trials;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>warning letters;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>withdrawal of the tablet vaccine candidate from the market;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>refusal to approve pending applications or supplements to approved applications that we submit;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>52</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>recall of such tablet vaccine candidate;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>fines, restitution or disgorgement of profits or revenues;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>suspension or withdrawal of marketing approvals;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>refusal to permit the import or export of such tablet vaccine candidate;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>tablet vaccine candidate seizure; or</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>injunctions or the imposition of civil or criminal penalties.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The FDA&#146;s policies may change, and additional government regulations may be enacted, that could prevent, limit or delay regulatory approval of any of our tablet vaccine candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Even if our tablet vaccine candidates receive marketing approval, they may fail to achieve market acceptance by physicians, patients, third-party payors or others in the medical community necessary for commercial success.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If our tablet vaccine candidates, including our vaccine for norovirus, receive marketing approval, they may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. If they do not achieve an adequate level of acceptance, we may not generate significant revenues and become profitable. The degree of market acceptance, if approved for commercial sale, will depend on a number of factors, including but not limited to:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the efficacy and potential advantages compared to alternative treatments;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>effectiveness of sales and marketing efforts;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the cost of treatment in relation to alternative treatments;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our ability to offer our tablet vaccine candidates for sale at competitive prices;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the convenience and ease of administration compared to alternative treatments;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the willingness of the medical community to offer customers our tablet vaccine candidate option in addition to, or in the place of, injectable vaccines;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the strength of marketing and distribution support;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the availability of third-party coverage and adequate reimbursement;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the prevalence and severity of any side effects; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>any restrictions on the use of our tablet vaccine together with other medications.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Because we expect sales of our tablet vaccine candidate for norovirus, if approved, to generate substantially all of our revenues for the foreseeable future, the failure of this tablet vaccine to achieve market acceptance would harm our business and could require us to seek additional financing sooner than we would otherwise plan.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If we fail to comply with state and federal healthcare regulatory laws, we could face substantial penalties, damages, fines, disgorgement, exclusion from participation in governmental healthcare programs, and the curtailment of our operations, any of which could harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Although we do not provide healthcare services or submit claims for third-party reimbursement, we are subject to healthcare fraud and abuse regulation and enforcement by federal and state governments, which could significantly impact our business. The laws that may affect our ability to operate include, but are not limited to:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the federal anti-kickback statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, receiving, offering, or paying remuneration, directly or indirectly, in cash or in kind, in exchange for or to induce either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service for which payment may be made, in whole or in part, under federal healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of this statute or specific intent to violate it;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>53</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the civil False Claims Act, or FCA, which prohibits, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid or other third-party payors that are false or fraudulent; knowingly making, using, or causing to be made or used, a false record or statement to get a false or fraudulent claim paid or approved by the government; or knowingly making, using, or causing to be made or used, a false record or statement to avoid, decrease or conceal an obligation to pay money to the federal government;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the criminal FCA, which imposes criminal fines or imprisonment against individuals or entities who make or present a claim to the government knowing such claim to be false, fictitious or fraudulent;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created federal criminal laws that prohibit executing a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the federal civil monetary penalties statute, which prohibits, among other things, the offering or giving of remuneration to a Medicare or Medicaid beneficiary that the person knows or should know is likely to influence the beneficiary&#146;s selection of a particular supplier of items or services reimbursable by a Federal or state governmental program;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the federal physician sunshine requirements under the Affordable Care Act, which require certain manufacturers of drugs, devices, biologics, and medical supplies to report annually to the U.S. Department of Health and Human Services information related to payments and other transfers of value to physicians, other healthcare providers, and teaching hospitals, and ownership and investment interests held by physicians and other healthcare providers and their immediate family members; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws that may apply to items or services reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the device industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; and state laws that require device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Further, the Affordable Care Act, among other things, amended the intent requirements of the federal anti-kickback statute and certain criminal statutes governing healthcare fraud. A person or entity can now be found guilty of violating the statute without actual knowledge of the statute or specific intent to violate it. In addition, Affordable Care Act provided that the government may assert that a claim including items or services resulting from a violation of the federal Anti- Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. Moreover, while we do not, and will not, submit claims and our customers will make the ultimate decision on how to submit claims, we may provide reimbursement guidance to our customers from time to time. If a government authority were to conclude that we provided improper advice to our customers or encouraged the submission of false claims for reimbursement, we could face action against us by government authorities. Any violations of these laws, or any action against us for violation of these laws, even if we successfully defend against it, could result in a material adverse effect on our reputation, business, results of operations and financial condition.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We have entered into consulting and scientific advisory board arrangements with physicians and other healthcare providers. Compensation for some of these arrangements includes the provision of stock options. While we have worked to structure our arrangements to comply with applicable laws, because of the complex and far-reaching nature of these laws, regulatory agencies may view these transactions as prohibited arrangements that must be restructured, or discontinued, or for which we could be subject to other significant penalties. We could be adversely affected if regulatory agencies interpret our financial relationships with providers who influence the ordering of and use our products to be in violation of applicable laws.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Responding to investigations can be time- and resource-consuming and can divert management&#146;s attention from the business. Additionally, as a result of these investigations, healthcare providers and entities may have to agree to additional onerous compliance and reporting requirements as part of a consent decree or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>54</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Product liability lawsuits against us could cause us to incur substantial liabilities and could limit the commercialization of any tablet vaccine candidates we may develop.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We face an inherent risk of product liability exposure related to the testing of our tablet vaccine candidates in human clinical trials and will face an even greater risk if we commercially sell any products that we may develop after approval. For instance, since our norovirus tablet challenge study is being conducted in healthy human volunteers, any adverse reactions could result in claims from these injuries and we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>decreased demand for any tablet vaccine candidates that it may develop;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>injury to our reputation and significant negative media attention;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>withdrawal of clinical trial participants;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>significant costs to defend any related litigation;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>substantial monetary awards to trial subjects or patients;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>loss of revenue; and</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the inability to commercialize any products we may develop.</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Although we maintain product liability insurance coverage in the amount of up to $5 million per claim and in the aggregate, it may not be adequate to cover all liabilities that we may incur. Additionally, seasonal influenza is a covered vaccine of the National Vaccine Injury Compensation Program, and our participation in that program may require time and resources that impede product uptake, if approved. We anticipate that we will need to increase our insurance coverage as we continue clinical trials and if we successfully commercialize any products. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If a product liability claim is successfully brought against us for uninsured liabilities, or such claim exceeds our insurance coverage, we could be forced to pay substantial damage awards that could materially harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The use of any of our existing or future product candidates in clinical trials and the sale of any approved pharmaceutical products may expose us to significant product liability claims. We currently have product liability insurance coverage for our ongoing clinical trials in the amount of $5 million. Further, we also require clinical research and manufacturing organizations that assist us in the conduct of our trials or manufacture materials used in these trials to carry product liability insurance against such claims. This insurance coverage may not protect us against any or all of the product liability claims that may be brought against us in the future. We may not be able to acquire or maintain adequate product liability insurance coverage at a commercially reasonable cost or in sufficient amounts or scope to protect ourselves against potential losses. In the event a product liability claim is brought against us, we may be required to pay legal and other expenses to defend the claim, as well as uncovered damage awards resulting from a claim brought successfully against us. In the event any of our product candidates are approved for sale by the FDA or similar regulatory authorities in other countries and commercialized, we may need to substantially increase the amount of our product liability coverage. Defending any product liability claim or claims could require us to expend significant financial and managerial resources, which could have an adverse effect on our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If we are unable to establish sales, marketing and distribution capabilities either on our own or in collaboration with third parties, we may not be successful in commercializing our tablet vaccine candidates, if approved.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We do not have any infrastructure for the sales, marketing or distribution of our tablet vaccine candidates, and the cost of establishing and maintaining such an organization may exceed the cost-effectiveness of doing so. In order to market any tablet vaccine candidates that may be approved, it must build our sales, distribution, marketing, managerial and other non-technical capabilities or make arrangements with third parties to perform these services. To achieve commercial success for any tablet vaccine candidates for which we have obtained marketing approval, we will need a sales and marketing organization. While we expect to partner our tablet vaccines for seasonal influenza and RSV, we expect to build a focused sales, distribution and marketing infrastructure to market our other tablet vaccine candidates in the United States, if approved. There are significant expenses and risks involved with establishing our own sales, marketing and distribution capabilities, including our ability to hire, retain and appropriately incentivize qualified individuals, generate sufficient sales leads, provide adequate training to sales and marketing personnel, and effectively manage a geographically dispersed sales and marketing team. Any failure or delay in the development of our internal sales, marketing and distribution capabilities could delay any tablet vaccine candidate launch, which would adversely impact commercialization.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>55</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Factors that may inhibit our efforts to commercialize our tablet vaccine candidates on our own include:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our inability to recruit, train and retain adequate numbers of effective sales and marketing personnel;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the inability of sales personnel to obtain access to physicians or attain adequate numbers of physicians to administer our tablet vaccines; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>unforeseen costs and expenses associated with creating an independent sales and marketing organization.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We intend to pursue collaborative arrangements regarding the sale and marketing of our tablet vaccine candidates, if approved, for certain international markets; however, we may not be able to establish or maintain such collaborative arrangements and, if able to do so, our collaborators may not have effective sales. To the extent that we depend on third parties for marketing and distribution, any revenues we receive will depend upon the efforts of such third parties, and there can be no assurance that such efforts will be successful.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If we are unable to build our own sales force in the United States or negotiate a collaborative relationship for the commercialization of our tablet vaccine candidates outside the United States we may be forced to delay the potential commercialization or reduce the scope of our sales and marketing activities. We could have to enter into arrangements with third parties at an earlier stage than we would otherwise choose and we may be required to relinquish rights to our intellectual property or otherwise agree to terms unfavorable to us, any of which may have an adverse effect on our business, operating results and prospects.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We may be competing with many companies that currently have extensive and well-funded marketing and sales operations. Without an internal team or the support of a third-party to perform marketing and sales functions, we may be unable to compete successfully against these more established companies.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If we obtain approval to commercialize any tablet vaccine candidates outside of the United States, a variety of risks associated with international operations could harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If our tablet vaccine candidates are approved for commercialization, we intend to enter into agreements with third parties to market them in certain jurisdictions outside the United States. We expect that we will be subject to additional risks related to international operations or entering into international business relationships, including:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>different regulatory requirements for drug approvals and rules governing drug commercialization in foreign countries;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>reduced protection for intellectual property rights;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>unexpected changes in tariffs, trade barriers and regulatory requirements;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>economic weakness, including inflation, or political instability in particular foreign economies and markets;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>foreign reimbursement, pricing and insurance regimes;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>foreign taxes;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>foreign currency fluctuations, which could result in increased operating expenses and reduced revenues, and other obligations incident to doing business in another country;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>workforce uncertainty in countries where labor unrest is more common than in the United States;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>potential noncompliance with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act 2010 and similar anti-bribery and anticorruption laws in other jurisdictions;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>tablet vaccination shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>business interruptions resulting from geopolitical actions, including war and terrorism, or natural disasters including earthquakes, typhoons, floods and fires.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>We have no prior experience in these areas. In addition, there are complex regulatory, tax, labor and other legal requirements imposed by both the European Union and many of the individual countries in Europe with which we will need to comply.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>56</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Recently enacted and future legislation may increase the difficulty and cost for us to obtain marketing approval of, and to commercialize, our tablet vaccine candidates and affect the prices we may obtain.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In the United States and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could, among other things, prevent or delay marketing approval of our tablet vaccine candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any tablet vaccine candidates for which it obtains marketing approval.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>For example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care Education Reconciliation Act, collectively the Affordable Care Act, was enacted to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for health care and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. Although the full effect of the Affordable Care Act may not yet be fully understood, the law has continued the downward pressure on pharmaceutical pricing, especially under the Medicare program, and increased the industry&#146;s regulatory burdens and operating costs.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Moreover, the Drug Supply Chain Security Act imposes obligations on manufacturers of prescription drugs in finished dosage forms. We have not yet adopted the significant measures that will be required to comply with this law. We are not sure whether additional legislative changes will be enacted, or whether the current regulations, guidance or interpretations will be changed, or what the impact of such changes on our business, if any, may be.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare vaccines, which could result in reduced demand for our tablet vaccine candidates or additional pricing pressures.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Government involvement may limit the commercial success of our tablet vaccine candidates for influenza.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If an influenza outbreak occurs and is classified as a pandemic or large epidemic by public health authorities, it is possible that one or more government entities may take actions that directly or indirectly have the effect of abrogating some of our rights or opportunities. We have not manufactured a pandemic vaccine to date, but if we were to do so, the economic value of such a vaccine to us could be limited.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Various government entities, including the U.S. government, are offering incentives, grants and contracts to encourage additional investment by commercial organizations into preventative and therapeutic agents against influenza, which may have the effect of increasing the number of competitors and/or providing advantages to known competitors. Accordingly, there can be no assurance that we will be able to successfully establish a competitive market share for our influenza vaccines.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In addition, current influenza vaccines are generally trivalent (containing three strains) or quadrivalent (containing four strains). If the FDA requires or recommends, changes in influenza vaccines, for example for a monovalent vaccine or for use of a strain that is not currently circulating in the human population, it is uncertain whether we will be able to produce or manufacture such a vaccine at commercially reasonable rates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>The seasonal nature of our target indications, in particular influenza, and competition from new products may cause unpredictable royalty revenues from Relenza and Inavir and significant fluctuations in our operating results.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Influenza is seasonal in nature with sales of current vaccines occurring primarily in the first and fourth quarters of the calendar year. In addition, outbreaks of norovirus and RSV typically occur in the winter season. This seasonal concentration of product sales could cause quarter-to-quarter operating results to vary widely and can exaggerate the consequences of revenues of any manufacturing or supply delays, any sudden loss of inventory, any inability to satisfy product demand, the inability to estimate the effect of returns and rebates, normal or unusual fluctuations in customer buying patterns, or of any unsuccessful sales or marketing strategies during the sales seasons.</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in">We currently earn royalty revenue from the net sales of Relenza and Inavir, which are marketed by our licensees. Although the royalty rates paid to us by our licensees are fixed at a proportion of the licensees&#146; net sales of these products, our periodic and annual revenues from these royalties have historically been variable and subject to fluctuation based on the seasonal incidence and severity of influenza. In addition, returns of products to our licensees that were sold in prior years are taken into account in the calculation of net sales for purposes of determining the royalty revenue we receive and the amount of such returns are generally unpredictable. Our licensees may encounter competition from new products entering the market, including generic copies of Relenza and Inavir, which could adversely affect our royalty income. <font style=COLOR:black>The last patent related to Inavir is set to expire in December 2029 in Japan, at which time royalty revenue will cease. However, the patent covering the laninamivir octanoate compound expires in 2024, at which time generic competition may enter the market, potentially decreasing or eliminating the royalties received. </font><font style=COLOR:#212121>On February 23, 2018, Osaka-based drug maker Shionogi &amp; Co gained marketing approval for Xofluza, a new drug to treat influenza in Japan. The drug was approved for use against type A and B influenza viruses and requires only a single dose regardless of age. Xofluza may gain significant market share from </font>Inavir<font style=COLOR:#212121> in Japan, substantially reducing the sales of </font>Inavir<font style=COLOR:#212121>. This would significantly decrease the royalty payments we receive from Daiichi Sankyo.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>57</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In addition, most of our Relenza patents have expired and the only substantial remaining intellectual property related to the Relenza patent portfolio is scheduled to expire in July 2019 in Japan.&nbsp;Further, we sold a portion of our Inavir royalties to <font style=COLOR:black>HealthCare Royalty Partners III, L.P., or HCRP, </font>in April 2016.&nbsp;We cannot predict with any certainty what our royalty revenues are likely to be in any given year.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If safety, tolerability, resistance, drug-drug interactions, competing products or efficacy concerns should arise with Relenza or Inavir, our future royalty revenue may be reduced, which would adversely affect our financial condition and business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We currently earn royalty revenue from Relenza and Inavir, which are marketed by our licensees. Data supporting the marketing approvals and forming the basis for the safety warnings in the product labels for these products were obtained in controlled clinical trials of limited duration in limited patient populations and, in some cases, from post-approval use. As these marketed products are used over longer periods of time and by more patients, some with underlying health problems or taking other medicines, new issues such as safety, tolerability, resistance or drug-drug interaction issues could arise, which may require our licensees to provide additional warnings or contraindications on their product labels, or otherwise narrow the approved indications. Further, additional information from ongoing research or clinical trials of these products that raise any doubts or concerns about their efficacy may arise, or competing products may be introduced and limit the market penetration of our product candidates. If serious safety, tolerability, resistance, drug-drug interaction, efficacy, competing products, or any other concerns or issues arise with respect to Relenza and Inavir, sales of these products could be impaired, limited or abandoned by our licensees or by regulatory authorities, in which case our royalty revenue would decrease.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our success depends largely upon our ability to advance our product candidates through the various stages of drug development. If we are unable to successfully advance or develop our product candidates, our business will be materially harmed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Even though we generate royalty revenue from our two commercialized influenza products, all of our remaining product candidates are in early stages of development and their commercial viability remains subject to the successful outcome of future preclinical studies, clinical trials, manufacturing processes, regulatory approvals and the risks generally inherent in the development of pharmaceutical product candidates. Failure to advance the development of one or more of our product candidates may have a material adverse effect on our business. For example, the Phase 2 trial of teslexivir, a product acquired through the merger with Aviragen, was costly and diverted resources from our other product candidates, did not achieve the primary efficacy endpoint. The long-term success of our business ultimately depends upon our ability to advance the development of our product candidates through preclinical studies and clinical trials, appropriately formulate and consistently manufacture them in accordance with strict specifications and regulations, obtain approval of our product candidates for sale by the FDA or similar regulatory authorities in other countries, and ultimately have our product candidates successfully commercialized, either by us or by a strategic partner or licensee. We cannot be sure that the results of our ongoing or future research, preclinical studies or clinical trials will support or justify the continued development of our product candidates, or that we will ultimately receive approval from the FDA, or similar regulatory authorities in other countries, to advance the development of our product candidates<i>.</i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our product candidates must satisfy rigorous regulatory standards of safety, efficacy and manufacturing before we can advance or complete their development and before they can be approved for sale by the FDA or similar regulatory authorities in other countries. To satisfy these standards, we must engage in expensive and lengthy studies and clinical trials, develop acceptable and cost-effective manufacturing processes, and obtain regulatory approval of our product candidates. Despite these efforts, our product candidates may not:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>demonstrate clinically meaningful therapeutic or other medical benefits as compared to a patient receiving no treatment or over existing drugs or other product candidates in development to treat the same patient population;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>be shown to be safe and effective in future preclinical studies or clinical trials;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>have the desired therapeutic or medical effects;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>be tolerable or free from undesirable or unexpected side effects;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>meet applicable regulatory standards;</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>be capable of being appropriately formulated and manufactured in commercially suitable quantities or scale and at an acceptable cost; or</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>58</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>be successfully commercialized, either by us or by our licensees or collaborators.</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Even if we demonstrate favorable results in preclinical studies and early-stage clinical trials, we cannot be sure that the results of late-stage clinical trials will be sufficient to support the continued development of our product candidates. Many, if not most, companies in the pharmaceutical and biopharmaceutical industries have experienced significant delays, setbacks and failures in all stages of development, including late-stage clinical trials, even after achieving promising results in preclinical testing or early-stage clinical trials. Accordingly, results from completed preclinical studies and early-stage clinical trials of our product candidates may not be predictive of the results we may obtain in future late-stage trials. Furthermore, even if the data collected from preclinical studies and clinical trials involving any of our product candidates demonstrate a satisfactory safety, tolerability and efficacy profile, such results may not be sufficient to obtain regulatory approval from the FDA in the United States, or other similar regulatory agencies in other jurisdictions, which is required to market and sell the product.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If the actual or perceived therapeutic benefits, or the safety or tolerability profile of any of our product candidates are not equal to or superior to other competing treatments approved for sale or in clinical development, we may terminate the development of any of our product candidates at any time, and our business prospects and potential profitability could be harmed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We are aware of a number of companies marketing or developing various classes of anti-infective product candidates or products for the treatment of patients infected with HPV and RSV that are either approved for sale or further advanced in clinical development than ours, such that their time to approval and commercialization may be shorter than that for our product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Effective treatments of RSV infections in pediatrics, the elderly, and the immunocompromised are very limited. Currently, only Virazole (ribavirin) is indicated for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due to RSV. We are aware that the following compounds are under development to treat RSV infections: Gilead&#146;s presatovir, Johnson &amp; Johnson&#146;s JJ-53718678 (ALS-8176), Ablynx&#146;s ALX-0171 and Ark Biosciences&#146; AK0529. The only approved drug for the prevention of RSV infections in high risk infants is MedImmune&#146;s palivizumab (Synagis), a monoclonal antibody. There are several vaccines and antibody products designed to prevent RSV infections in clinical development. Among the clinical stage product candidates in development are Novavax&#146;s RSV F vaccine, GSK&#146;s GSK3003898A vaccine, GSK&#146;s GSK3389245A vaccine, Bavarian Nordic&#146;s BN RSV vaccine, MedImmune&#146;s MEDI &#196;M2-2 vaccine and MedImmune&#146;s monoclonal antibody MEDI8897.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If at any time we believe that any of our product candidates may not provide meaningful or differentiated therapeutic benefits, perceived or real, equal to or better than our competitors&#146; products or product candidates, or we believe that our product candidates may not have as favorable a safety or tolerability profile as potentially competitive compounds, we may delay or terminate the future development of any of our product candidates. We cannot provide any assurance that the future development of any of our product candidates will demonstrate any meaningful therapeutic benefits over potentially competitive compounds currently approved for sale or in development, or an acceptable safety or tolerability profile sufficient to justify their continued development.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our product candidates may exhibit undesirable side effects when used alone or in combination with other approved pharmaceutical products, which may delay or preclude their development or regulatory approval or limit their use if ever approved.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Throughout the drug development process, we must continually demonstrate the activity, safety and tolerability of our product candidates in order to obtain regulatory approval to further advance their clinical development, or to eventually market them. Even if our product candidates demonstrate adequate biologic activity and clear clinical benefit, any unacceptable side effects or adverse events, when administered alone or in the presence of other pharmaceutical products, may outweigh these potential benefits. We may observe adverse or serious adverse events or drug-drug interactions in preclinical studies or clinical trials of our product candidates, which could result in the delay or termination of their development, prevent regulatory approval, or limit their market acceptance if they are ultimately approved.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If the results from preclinical studies or clinical trials of our product candidates, including those that are subject to existing or future license or collaboration agreements, are unfavorable, we could be delayed or precluded from the further development or commercialization of our product candidates, which could materially harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In order to further advance the development of, and ultimately receive marketing approval to sell our product candidates, we must conduct extensive preclinical studies and clinical trials to demonstrate their safety and efficacy to the satisfaction of the FDA or similar regulatory authorities in other countries, as the case may be. Preclinical studies and clinical trials are expensive, complex, can take many years to complete, and have highly uncertain outcomes. Delays, setbacks, or failures can and do occur at any time, and in any phase of preclinical or clinical testing, and can result from concerns about safety, tolerability, toxicity, a lack of demonstrated biologic activity or improved efficacy over similar products that have been approved for sale or are in more advanced stages of development, poor study or trial design, and issues related to the formulation or manufacturing process of the materials used to conduct the trials. The results of prior preclinical studies or early-stage clinical trials are not predictive of the results we may observe in late-stage clinical trials. In many cases, product candidates in clinical development may fail to show the desired tolerability, safety and efficacy characteristics, despite having favorably demonstrated such characteristics in preclinical studies or early-stage clinical trials.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>59</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>In addition, we may experience numerous unforeseen events during, or as a result of, preclinical studies and the clinical trial process, which could delay or impede our ability to advance the development of, receive marketing approval for, or commercialize our product candidates, including, but not limited to:&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>communications with the FDA, or similar regulatory authorities in different countries, regarding the scope or design of a trial or trials, or placing the development of a product candidate on clinical hold or delaying the next phase of development until questions or issues are satisfactorily resolved, including performing additional studies to answer their queries;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>regulatory authorities or institutional review boards, or IRBs, not authorizing us to commence or conduct a clinical trial at a prospective trial site;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>enrollment in our clinical trials being delayed, or proceeding at a slower pace than we expected, because we have difficulty recruiting participants or participants drop out of our clinical trials at a higher rate than we anticipated;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our third-party contractors, upon whom we rely to conduct preclinical studies, clinical trials and the manufacturing of our clinical trial materials, failing to comply with regulatory requirements or meet their contractual obligations to us in a timely manner;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>having to suspend or ultimately terminate a clinical trial if participants are being exposed to unacceptable health or safety risks;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>regulatory authorities or IRBs requiring that we hold, suspend or terminate our preclinical studies and clinical trials for various reasons, including non-compliance with regulatory requirements; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the supply or quality of material necessary to conduct our preclinical studies or clinical trials being insufficient, inadequate or unavailable.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Even if the data collected from preclinical studies or clinical trials involving our product candidates demonstrate a satisfactory tolerability, safety and efficacy profile, such results may not be sufficient to support the submission of a BLA or NDA to obtain regulatory approval from the FDA in the United States, or other similar regulatory authorities in other foreign jurisdictions, which is required for us to market and sell our product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'><font style=COLOR:black>We intend to manufacture the vaccine tablets for the upcoming clinical studies for the foreseeable future at our own facility. If we are unable to do so, or we are delayed, or if the cost of manufacturing is not economically feasible or if we cannot find a third-party supplier, we may be unable to produce tablet vaccine candidates in a sufficient quantity to meet future demand.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in'><font style=COLOR:black>From 2012 through the end of December 2017, we relied on a third-party contract manufacturer, Lonza Houston, Inc., for the manufacture, labeling, packaging, storage, and distribution of vaccine tablets to supply the clinical Phase 1 and Phase 2 trials we have conducted to date. We have developed and continue to develop manufacturing processes under cGMP, which we are currently using to manufacture bulk product and vaccine tablets, for future Phase 1 and Phase 2 clinical trials, at our own facility in South San Francisco, California. This transition has resulted in unanticipated delays and lower yields, may result in further unanticipated delays or lower yields or both and may cost more than expected due to a number of factors, including regulatory requirements.</font><font style=COLOR:black>If we are unable to manufacture sufficient quantities of our tablet vaccine candidates in a timely manner, our development activities would be impaired and we may need to partner with a third-party supplier.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style=FONT-SIZE:10pt>Our manufacturing facility and equipment is sized to support manufacturing of cGMP product for our Phase 1 and Phase 2a trials, but is not adequate to support larger Phase 2b and Phase 3 trials. Accordingly, we intend to explore opportunities to establish a long-term relationship with an established CMO to develop large scale bulk vaccine production capabilities adequate to support larger trials and commercial product launch.<b> </b>We may be unable to enter into a third-party supplier agreement that is economically feasible or without significant delay.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>60</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=COLOR:black>Our manufacturing facility&nbsp;is subject to ongoing, periodic inspection by the FDA or other comparable regulatory agencies to ensure compliance with cGMP. Any failure to follow and document our adherence to such cGMP regulations or other regulatory requirements may lead to significant delays in the availability of </font>clinical bulk drug substance and finished vaccine tablets <font style=COLOR:black>for clinical trials, which may result in the termination of, or a hold on, a clinical trial, and may delay or prevent filing or approval of marketing applications for our tablet vaccine candidates. We also may encounter problems with the following:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>achieving adequate or clinical-grade materials that meet FDA or other comparable regulatory agency standards or specifications with consistent and acceptable production yield and costs;</font> </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>shortages of qualified personnel, raw materials or key contractors; and </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>ongoing compliance with cGMP regulations and other requirements of the FDA or other comparable regulatory agencies.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If we encounter any of these problems or are otherwise delayed, or if the cost of manufacturing at our South San Francisco facility is not economically feasible and we cannot find a third-party contract manufacturer, we may not be able to produce our&nbsp;tablet vaccine candidates in a sufficient quantity to <a name=_cp_text_1_160>conduct our planned clinical trials and commercialize our vaccine tablet candidates, if approved</a>.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'><b><i>In the event that we need to engage or subsequently change a third-party contract manufacturer, our preclinical studies or our clinical trial</i></b><i>s<b> and the commercialization of our product candidates could be delayed, adversely affected or terminated, or such a change may result in the need for us to incur significantly higher costs, which could materially harm our business.</b></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Due to various regulatory restrictions in the United States and many other countries, as well as potential capacity constraints on manufacturing that occur from time-to-time in our industry, various steps in the manufacture of our product candidates are sole-sourced to certain contract manufacturers. In accordance with cGMPs, changing manufacturers may require the re-validation of manufacturing processes and procedures, and may require further preclinical studies or clinical trials to show comparability between the materials produced by different manufacturers. Engaging a third-party contract manufacturer or changing a future contract manufacturer may be difficult and could be extremely costly and time consuming, which could result in our inability to manufacture our product candidates for an extended period of time and a delay in the development of our product candidates. Further, in order to maintain our development timelines in the event of a change in a third-party contract manufacturer, we may incur significantly higher costs to manufacture our product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If third-party vendors, upon whom we rely to conduct our preclinical studies or clinical trials, do not perform or fail to comply with strict regulations, these studies or trials may be delayed, terminated, or fail, or we could incur significant additional expenses, which could materially harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We have limited resources dedicated to designing, conducting and managing our preclinical studies and clinical trials. We have historically relied on, and intend to continue to rely on, third parties, including clinical research organizations, consultants and principal investigators, to assist us in designing, managing, conducting, monitoring and analyzing the data from our preclinical studies and clinical trials. We rely on these vendors and individuals to perform many facets of the clinical development process on our behalf, including conducting preclinical studies, the recruitment of sites and patients for participation in our clinical trials, maintenance of good relations with the clinical sites, and ensuring that these sites are conducting our trials in compliance with the trial protocol and applicable regulations. If these third parties fail to perform satisfactorily, or do not adequately fulfill their obligations under the terms of our agreements with them, we may not be able to enter into alternative arrangements without undue delay or additional expenditures, and therefore the preclinical studies and clinical trials of our product candidates may be delayed or prove unsuccessful.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Further, the FDA, or similar regulatory authorities in other countries, may inspect some of the clinical sites participating in our clinical trials or our third-party vendors&#146; sites to determine if our clinical trials are being conducted according to GCP or similar regulations. If we, or a regulatory authority, determine that our third-party vendors are not in compliance with, or have not conducted our clinical trials according to, applicable regulations, we may be forced to exclude certain data from the results of the trial, or delay, repeat or terminate such clinical trials.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We have a limited capacity for managing clinical trials, which could delay or impair our ability to initiate or complete clinical trials of our product candidates on a timely basis and materially harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We have a limited capacity to recruit and manage all of the clinical trials necessary to obtain approval for our product candidates by the FDA or similar regulatory authorities in other countries. By contrast, larger pharmaceutical and biopharmaceutical companies often have substantial staff or departments with extensive experience in conducting clinical trials with multiple product candidates across multiple indications and obtaining regulatory approval in various countries. In addition, these companies may have greater financial resources to compete for the same clinical investigators, sites and patients that we are attempting to recruit for our clinical trials. As a result, we may be at a competitive disadvantage that could delay the initiation, recruitment, timing and completion of our clinical trials and obtaining of marketing approvals, if achieved at all, for our product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>61</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our industry is highly competitive and subject to rapid technological changes. As a result, we may be unable to compete successfully or develop innovative or differentiated products, which could harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our industry is highly competitive and characterized by rapid technological change. Key competitive factors in our industry include, among others, the ability to successfully advance the development of a product candidate through preclinical and clinical trials; the efficacy, toxicology, tolerability, safety, resistance or cross-resistance, interaction or dosing profile of a product or product candidate; the timing and scope of marketing approvals, if ever achieved; reimbursement rates for and the average selling price of competing products and pharmaceutical products in general; the availability of raw materials and qualified contract manufacturing and manufacturing capacity to produce our product candidates; relative manufacturing costs; establishing, maintaining and protecting our intellectual property and patent rights; and sales and marketing capabilities.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Developing pharmaceutical product candidates is a highly competitive, expensive and risky activity with a long business cycle. Many organizations, including the large pharmaceutical and biopharmaceutical companies that have existing products on the market or in clinical development that may compete with our product candidates, have substantially more resources than us, as well as much greater capabilities and experience than we have in research and discovery, designing and conducting preclinical studies and clinical trials, operating in a highly regulated environment, formulating and manufacturing drug substances, products and devices, and marketing and sales. Our competitors may be more successful than us in obtaining regulatory approvals for their product candidates and achieving broad market acceptance once they are approved. Our competitors&#146; products or product candidates may be more effective, have fewer adverse effects, be more convenient to administer, have a more favorable resistance profile, or be more effectively marketed and sold than any product that we, or our potential future licensees or collaborators, may develop or commercialize. New drugs or classes of drugs from competitors may render our product candidates obsolete or non-competitive before we are able to successfully develop them or, if approved, before we can recover the expenses of developing and commercializing them. We anticipate that we, or our potential future licensees or collaborators, will face intense and increasing competition as new drugs and drug classes enter the market and advanced technologies or new drug targets become available. If our product candidates do not demonstrate any meaningful competitive advantages over existing products, or new products or product candidates, we may terminate the development or commercialization of our product candidates at any time.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our competitors, either alone or with their collaborators, may succeed in developing product candidates or products that are more effective, safer, less expensive or easier to administer than ours. Accordingly, our competitors may succeed in obtaining regulatory approval for their product candidates more rapidly than we can. Companies that can complete clinical trials, obtain required marketing approvals and commercialize their products before their competitors do so may achieve a significant competitive advantage, including certain patent and marketing exclusivity rights that could delay the ability of competitors to market certain products.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We also face, and expect that we will continue to face, intense competition from other companies in a number of other areas, including (i) attracting larger pharmaceutical and biopharmaceutical companies to enter into collaborative arrangements with us to acquire, license or co-develop our product candidates, (ii) identifying and obtaining additional clinical-stage development programs to bolster our pipeline, (iii) attracting investigators and clinical sites capable of conducting our clinical trials, and (iv) recruiting patients to participate in our clinical trials. There can be no assurance that product candidates resulting from our research and development efforts,<b> </b>or from joint efforts with our potential future licensees or collaborators, will be able to compete successfully with our competitors&#146; existing products or product candidates in development.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We may be unable to successfully develop a product candidate that is the subject of an existing or future license agreement or collaboration if our licensee or collaborator does not perform or fulfill its contractual obligations, delays the development of our product candidate, or terminates the agreement.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We expect to continue to enter into and rely on license and collaboration agreements in the future, or other similar business arrangements with third parties, to further develop and/or commercialize some or all of our existing and future product candidates. Such licensees or collaborators may not perform as agreed upon or anticipated, may fail to comply with strict regulations, or may elect to delay or terminate their efforts in developing or commercializing our product candidates even though we have met our obligations under the arrangement.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>62</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>A majority of the potential revenue from existing and any future licenses and collaborations we may enter into will likely consist of contingent milestone payments, such as payments received for achieving development or regulatory milestones, and royalties payable on the sales of approved products. Milestone and royalty revenues that we may receive under these licenses and collaborations will depend primarily upon our licensees&#146; or collaborators&#146; ability to successfully develop and commercialize our product candidates. In addition, our licensees or collaborators may decide to enter into arrangements with third parties to commercialize products developed under our existing or future collaborations using our technologies, which could reduce the milestone and royalty revenue that we may receive, if any. In many cases, we will not be directly or closely involved in the development or commercialization of our product candidates that are subject to licenses or collaborations and, accordingly, we will depend largely on our licensees or collaborators to develop or commercialize our product candidates. Our licensees may encounter competition from new products entering the market, which could adversely affect our royalty income. Our licensees or collaborators may fail to develop or effectively commercialize our product candidates because they:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>do not allocate the necessary resources due to internal constraints, such as limited personnel with the requisite scientific expertise, limited capital resources, or the belief that other product candidates or internal programs may have a higher likelihood of obtaining regulatory approval, or may potentially generate a greater return on investment;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>do not have sufficient resources necessary to fully support the product candidate through clinical development, regulatory approval and commercialization;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>are unable to obtain the necessary regulatory approvals; or</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>prioritize other programs or otherwise diminish their support for developing and/or marketing our product candidate or product due to a change in management, business operations or strategy.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Should any of these events occur, we may not realize the full potential or intended benefit of our license or collaboration arrangements, and our results of operations may be adversely affected. In addition, a licensee or collaborator may decide to pursue the development of a competitive product candidate developed outside of our agreement with them. Conflicts may also arise if there is a dispute about the progress of, or other activities related to, the clinical development or commercialization of a product candidate, the achievement and payment of a milestone amount, the ownership of intellectual property that is developed during the course of the arrangement, or other license agreement terms. If a licensee or collaborator fails to develop or effectively commercialize our product candidates for any of these reasons, we may not be able to replace them with another third party willing to develop and commercialize our product candidates under similar terms, if at all. Similarly, we may disagree with a licensee or collaborator as to which party owns newly or jointly-developed intellectual property. Should an agreement be revised or terminated as a result of a dispute and before we have realized the anticipated benefits of the arrangement, we may not be able to obtain certain development support or revenues that we anticipated receiving. We may also be unable to obtain, on terms acceptable to us, a license from such collaboration partner to any of its intellectual property that may be necessary or useful for us to continue to develop and commercialize the product candidate. There can be no assurance that any product candidates will emerge from any existing or future license or collaboration agreements we may enter into for any of our product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If government and third-party payers fail to provide adequate reimbursement or coverage for our products or those that are developed through licenses or collaborations, our revenues and potential for profitability may be harmed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In the United States and most foreign markets, product revenues or related royalty revenue, and therefore the inherent value of our products, will depend largely upon the reimbursement rates established by third-party payers for such products. Third-party payers include government health administration authorities, managed-care organizations, private health insurers and other similar organizations. Third-party payers are increasingly examining the cost effectiveness of medical products, services and pharmaceutical drugs and challenging the price of these products and services. In addition, significant uncertainty exists as to the reimbursement status, if any, of newly approved pharmaceutical products. Further, the comparative effectiveness of new products over existing therapies and the assessment of other non-clinical outcomes are increasingly being considered in the decision by payers to establish reimbursement rates. We, or our licensees or collaborators if applicable, may also be required to conduct post-marketing clinical trials in order to demonstrate the cost-effectiveness of our products. Such studies may require us to commit a significant amount of management time and financial resources. There can be no assurance that any products that we or our licensees or collaborators may successfully develop will be reimbursed in part, or at all, by any third-party payers in any country.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Many governments continue to propose legislation designed to expand the coverage, yet reduce the cost, of healthcare, including pharmaceutical products. In many foreign markets, governmental agencies control the pricing of prescription drugs. In the United States, significant changes in federal health care policy were approved over the past several years and continue to evolve and will likely result in reduced reimbursement rates for many pharmaceutical products in the future. We expect that there will continue to be federal and state proposals to implement increased government control over reimbursement rates of pharmaceutical products. In addition, we expect that increasing emphasis on managed care and government intervention in the U.S. healthcare system will continue to put downward pressure on the pricing of pharmaceutical products there. Recent events have resulted in increased public and governmental scrutiny of the cost of drugs, especially in connection with price increases following companies&#146; acquisitions of the rights to certain drug products. In particular, U.S. federal prosecutors recently issued subpoenas to a pharmaceutical company seeking information about its drug pricing practices, among other issues, and members of the U.S. Congress have sought information from certain pharmaceutical companies relating to post-acquisition drug-price increases. Our revenue and future profitability could be negatively affected if these inquiries were to result in legislative or regulatory proposals that limit our ability to increase the prices of our products that may be approved for sale in the future. Legislation and regulations affecting the pricing of pharmaceutical products may change before our product candidates are approved for sale, which could further limit or eliminate their reimbursement rates. Further, social and patient activist groups, whose goal it is to reduce the cost of healthcare, and in particular the price of pharmaceutical products, may also place downward pressure on the price of these products, which could result in decreases in the price of our products.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>63</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If any product candidates that we develop independently, or through licensees or collaborators if applicable, are approved but do not gain meaningful acceptance in their intended markets, we are not likely to generate significant revenues.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Even if our product candidates are successfully developed and we or a licensee or collaborator obtains the requisite regulatory approvals to market them in the future, they may not gain market acceptance or broad utilization among physicians, patients or third-party payers. The degree of market acceptance that any of our products may achieve will depend on a number of factors, including:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the efficacy or perceived clinical benefit of the product, if any, relative to existing therapies;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the timing of market approval and the existing market for competitive drugs, including the presence of generic drugs;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the level of reimbursement provided by third-party payers to cover the cost of the product to patients;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the net cost of the product to the user or third-party payer;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the convenience and ease of administration of the product;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the product&#146;s potential advantages over existing or alternative therapies;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the actual or perceived safety of similar classes of products;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the actual or perceived existence, incidence and severity of adverse effects;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the effectiveness of sales, marketing and distribution capabilities; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the scope of the product label approved by the FDA or similar regulatory agencies in other jurisdictions.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>There can be no assurance that physicians will choose to prescribe or administer our products, if approved, to the intended patient population. If our products do not achieve meaningful market acceptance, or if the market for our products proves to be smaller than anticipated, we may never generate significant revenues.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our headquarters is located near known earthquake fault zones. The occurrence of an earthquake, fire or any other catastrophic event could disrupt our operations or the operations of third parties who provide vital support functions to us, which could have a material adverse effect on our business and financial condition.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We are vulnerable to damage from catastrophic events, such as power loss, natural disasters, terrorism and similar unforeseen events beyond our control. Our corporate headquarters and other facilities are located in the San Francisco Bay Area, which in the past has experienced severe earthquakes and fires.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We do not have a disaster recovery and business continuity plan in place. Earthquakes or other natural disasters could severely disrupt our operations and have a material adverse effect on our business, results of operations, financial condition and prospects.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If a natural disaster, power outage or other event occurred that prevented us from using all or a significant portion of our headquarters, damaged critical infrastructure, such as our financial systems or manufacturing facility, or that otherwise disrupted our operations, it may be difficult or, in certain cases, impossible for us to continue business operations for a substantial period of time.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>64</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><strong><em>Changes in funding for the FDA, the SEC and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal functions on which the operation of our business may rely, which could negatively impact our business.</em></strong></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including most recently on December 22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:0.25in 0in 12pt; TEXT-INDENT:0in; page:WordSection2'>Risks Related to Dependence on Third Parties</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If third-party contract manufacturers, upon whom we may have to rely to formulate and manufacture our product candidates, do not perform, fail to manufacture according to our specifications, or fail to comply with strict government regulations, our preclinical studies or clinical trials could be adversely affected and the development of our product candidates could be delayed or terminated, or we could incur significant additional expenses.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In the event that we place reliance on third-party contract manufacturers, which in some cases may be sole sourced, we would be exposed to a number of risks, any of which could delay or prevent the completion of our preclinical studies or clinical trials, or the regulatory approval or commercialization of our product candidates, result in higher costs, or deprive us of potential product revenues in the future. Some of these risks include, but are not limited to:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our potential contract manufacturers failing to develop an acceptable formulation to support late-stage clinical trials for, or the commercialization of, our product candidates;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our potential contract manufacturers failing to manufacture our product candidates according to their own standards, our specifications, current good manufacturing practices, or cGMP, or regulatory guidelines, or otherwise manufacturing material that we or regulatory authorities deem to be unsuitable for our clinical trials or commercial use;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our potential contract manufacturers being unable to increase the scale of or the capacity for, or reformulate the form of, our product candidates, which may cause us to experience a shortage in supply or cause the cost to manufacture our product candidates to increase. There can be no assurance that our potential contract manufacturers will be able to manufacture our product candidates at a suitable commercial scale, or that we will be able to find alternative manufacturers acceptable to us that can do so;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our potential contract manufacturers placing a priority on the manufacture of other customers&#146; or their own products, rather than our products;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our potential contract manufacturers failing to perform as agreed or exiting from the contract manufacturing business; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our potential contract manufacturers&#146; plants being closed as a result of regulatory sanctions or a natural disaster.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Manufacturers of pharmaceutical drug products are subject to ongoing periodic inspections by the FDA, the U.S. Drug Enforcement Administration, or DEA, and corresponding state and other foreign agencies to ensure strict compliance with FDA-mandated cGMPs, other government regulations and corresponding foreign standards. We do not have control over our third-party contract manufacturers&#146; compliance with these regulations and standards and accordingly, failure by our third-party manufacturers, or us, to comply with applicable regulations could result in sanctions being imposed on us or our manufacturers, which could significantly and adversely affect our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>65</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><strong><em>In the event that we need to engage or subsequently change a third-party contract manufacturer, our preclinical studies or our clinical trials, and the commercialization of our product candidates could be delayed, adversely affected or terminated, or such a change may result in the need for us to incur significantly higher costs, which could materially harm our business.</em></strong></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Due to various regulatory restrictions in the United States and many other countries, as well as potential capacity constraints on manufacturing that occur from time-to-time in our industry, various steps in the manufacture of our product candidates are sole-sourced to certain contract manufacturers. In accordance with cGMPs, changing manufacturers may require the re-validation of manufacturing processes and procedures, and may require further preclinical studies or clinical trials to show comparability between the materials produced by different manufacturers. Engaging a third-party contract manufacturer or changing a future contract manufacturer may be difficult and could be extremely costly and time-consuming, which could result in our inability to manufacture our product candidates for an extended period of time and a delay, as well as an increase in costs, in the development of our product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We may not be able to manufacture our product candidates in sufficient quantities to commercialize them.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">In order to receive FDA approval of our product candidates, we will need to manufacture such product candidates in larger quantities. We may not be able to increase successfully the manufacturing capacity for our product candidates in a timely or economic manner, or at all. In the event FDA approval is received, we will need to increase production of our product candidates. Significant&nbsp;scale-up&nbsp;of manufacturing may require additional validation studies, which the FDA must review and approve. If we are unable to successfully increase the manufacturing capacity for our product candidates, the clinical trials, the regulatory approval and the commercial launch of our product candidates may be delayed, or there may be a shortage in supply. Our product candidates require precise, high-quality manufacturing. Failure to achieve and maintain high-quality manufacturing, including the incidence of manufacturing errors, could result in patient injury or death, delays or failures in testing or delivery, cost overruns or other problems that could harm our business, financial condition and results of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>The manufacture of pharmaceutical products in compliance with cGMP regulations requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Manufacturers of pharmaceutical products often encounter difficulties in production, including difficulties with production costs and yields, quality control, including stability of the product candidates and quality assurance testing, or shortages of qualified personnel. If we were to encounter any of these difficulties or otherwise fail to comply with our obligations under applicable regulations, our ability to provide study materials in our clinical trials would be jeopardized. Any delay or interruption in the supply of clinical trial materials could delay the completion of our clinical trials, increase the costs associated with maintaining our clinical trial programs and, depending upon the period of delay, require us to commence new trials at significant additional expense or to terminate the studies and trials completely.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We must comply with cGMP requirements enforced by the FDA through its facilities inspection program. These requirements include, among other things, quality control, quality assurance and the maintenance of records and documentation. Manufacturers of our component materials may be unable to comply with these cGMP requirements and with other FDA, state and foreign regulatory requirements. The FDA or similar foreign regulatory agencies at any time may also implement new standards, or change their interpretation and enforcement of existing standards, for manufacture, packaging or testing of products. We have little control over our manufacturers&#146; compliance with these regulations and standards. A failure to comply with these requirements may result in fines and civil penalties, suspension of production, suspension or delay in product approval, product seizure or recall, or withdrawal of product approval. If the safety of any product supplied is compromised due to our failure, or that our third-party manufacturers, to adhere to applicable laws or for other reasons, we may not be able to obtain regulatory approval for or successfully commercialize our products, and we may be held liable for any injuries sustained as a result. Any of these factors could cause a delay of clinical trials, regulatory submissions, approvals or commercialization of any product candidates we may develop or acquire in the future, or entail higher costs, or impair our reputation.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We currently rely on single source vendors for key tablet vaccine components and certain strains needed in our tablet vaccine candidates, which could impair our ability to manufacture and supply our tablet vaccine candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We currently depend on single source vendors for certain raw materials used in the manufacture of our tablet vaccine candidates. Any production shortfall that impairs the supply of the relevant raw materials could have a material adverse effect on our business, financial condition and results of operations. An inability to continue to source product from these suppliers, which could be due to regulatory actions or requirements affecting the supplier, adverse financial or other strategic developments experienced by a supplier, labor disputes or shortages, unexpected demands or quality issues, could materially adversely affect our operating results or our ability to conduct clinical trials, either of which could significantly harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>66</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We intend to rely on third parties to conduct, supervise and monitor our clinical trials, and if those third parties perform in an unsatisfactory manner, it may harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We intend to rely on CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials, and we expect to have limited influence over their actual performance.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We intend to rely upon CROs to monitor and manage data for our clinical programs, as well as the execution of future nonclinical studies. We expect to control only certain aspects of our CROs&#146; activities. Nevertheless, we will be responsible for ensuring that each of our studies is conducted in accordance with the applicable protocol, legal, regulatory and scientific standards and our reliance on the CROs does not relieve us of these regulatory responsibilities.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We and our CROs will be required to comply with the Good Laboratory Practices and GCPs, which are regulations and guidelines enforced by the FDA and are also required by the Competent Authorities of the Member States of the European Economic Area and comparable foreign regulatory authorities in the form of International Conference on Harmonization guidelines for any of our product candidates that are in preclinical and clinical development. The Regulatory authorities enforce GCPs through periodic inspections of trial sponsors, principal investigators and clinical trial sites. If we or our CROs fail to comply with GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. Accordingly, if our CROs fail to comply with these regulations or fail to recruit a sufficient number of subjects, we may be required to repeat clinical trials, which would delay the regulatory approval process.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our CROs will not be our employees, and we will not control whether or not they devote sufficient time and resources to our future clinical and nonclinical programs. These CROs may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials, or other drug development activities which could harm our competitive position. We face the risk of potential unauthorized disclosure or misappropriation of our intellectual property by CROs, which may reduce our trade secret protection and allow our potential competitors to access and exploit our proprietary technology. If our CROs do not successfully carry out their contractual duties or obligations, fail to meet expected deadlines, or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for any other reasons, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain regulatory approval for, or successfully commercialize, any product candidate that we develop. As a result, our financial results and the commercial prospects for any product candidate that we develop would be harmed, our costs could increase, and our ability to generate significant revenues could be delayed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If our relationship with these CROs terminate, we may not be able to enter into arrangements with alternative CROs or do so on commercially reasonable terms. Switching or adding additional CROs involves substantial cost and requires management time and focus. In addition, there is a natural transition period when a new CRO commences work. As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines. Though we intend to carefully manage our relationships with our CROs, there can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not have an adverse impact on our business, financial condition and prospects.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We may seek to selectively establish collaborations, and, if we are unable to establish them on commercially reasonable terms, we may have to alter our development and commercialization plans.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our product development programs and the potential commercialization of our product candidates will require substantial additional cash to fund expenses. For some of our product candidates, including our seasonable influenza and RSV tablets, we may decide to collaborate with governmental entities or additional pharmaceutical and biotechnology companies for the development and potential commercialization of those product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We face significant competition in seeking appropriate collaborators. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#146;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#146;s evaluation of a number of factors. Those factors may include the design or results of clinical trials, the likelihood of approval by the FDA or similar regulatory authorities outside the United States, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge and industry and market conditions generally. The collaborator may also consider alternative product candidates for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us for our product candidate.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>67</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our relationships with customers and third-party payors will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Healthcare providers, physicians and third-party payors play a primary role in the recommendation and prescription of any product candidates for which we obtain marketing approval. Our future arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we market, sell and distribute our medicines for which we obtain marketing approval. Restrictions under applicable federal and state healthcare laws and regulations include the following:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the federal healthcare anti-kickback statute prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under federal and state healthcare programs such as Medicare and Medicaid;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the federal FCA imposes criminal and civil penalties, including civil whistleblower or qui tam actions, against individuals or entities for knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the federal HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, imposes criminal and civil liability for executing a scheme to defraud any healthcare benefit program and also imposes obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the federal false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the federal transparency requirements under the Affordable Care Act requires manufacturers of drugs, devices, biologics and medical supplies to report to the Department of Health and Human Services information related to physician payments and other transfers of value and physician ownership and investment interests; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>analogous state laws and regulations, such as state anti-kickback and false claims laws, may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non- governmental third-party payors, including private insurers, and some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government in addition to requiring vaccine manufacturers to report information related to payments to physicians and other health care providers or marketing expenditures.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:0.25in 0in 12pt; TEXT-INDENT:0in; page:WordSection2'>Risks Related to Intellectual Property</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in">If we are unable to obtain and maintain patent protection for our oral vaccine platform technology and product candidates or if the scope of the patent protection obtained is not sufficiently broad, we may not be able to compete effectively in our markets.</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in">Our success depends in large part on our ability to obtain and maintain patent protection in the United States and other countries. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our development programs and product candidates. The patent prosecution process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications, or maintain and enforce any patents that may issue from such patent applications, at a reasonable cost or in a timely manner.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. The patent applications that we own may fail to result in issued patents with claims that cover any of our product candidates in the United States or in other countries. There is no assurance that the entire potentially relevant prior art relating to our patents and patent applications has been found, which can invalidate a patent or prevent a patent from issuing from a pending patent application. Even if patents do successfully issue, third parties may challenge their validity, enforceability or scope, which may result in such patents being narrowed, invalidated, or held unenforceable. Any successful challenge to these patents or any other patents owned by or licensed to us could deprive us of rights necessary for the successful commercialization of any product candidates or companion diagnostic that we may develop. Further, if we encounter delays in regulatory approvals, the period of time during which we could market a product candidate and companion diagnostic under patent protection could be reduced.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>68</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>If the patent applications we hold with respect to our platform technology and product candidates fail to issue, if their breadth or strength of protection is threatened, or if they fail to provide meaningful exclusivity for our product candidates, it could dissuade companies from collaborating with us to develop product candidates and threaten our ability to commercialize future drugs. Any such outcome could harm our business.</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. For example, European patent law restricts the patentability of methods of treatment of the human body more than U.S. law does. Publications of discoveries in scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot know with certainty whether we were the first to make the inventions claimed in our owned or licensed patents or pending patent applications, or that we were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued which protect our technology or product candidates, in whole or in part, or which effectively prevent others from commercializing competitive technologies and vaccines. Even if our patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors from competing with us or otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our patents by developing similar or alternative product candidates in a non-infringing manner. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Recent patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents. On September 16, 2011, the Leahy-Smith America Invents Act, or the Leahy-Smith Act, was signed into law. The Leahy-Smith Act includes a number of significant changes to United States patent law. These include provisions that affect the way patent applications are prosecuted and may also affect patent litigation. The U.S. Patent Office recently developed new regulations and procedures to govern administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, and in particular, the first to file provisions, only became effective on March 16, 2013. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. However, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have an adverse effect on our business and financial condition.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Moreover, we may be subject to a third-party pre-issuance submission of prior art to the U.S. Patent and Trademark Office, or USPTO, or become involved in derivation, reexamination, inter partes review, post-grant review or interference proceedings challenging our patent rights or the patent rights of others. In other countries, we may be subject to or become involved in opposition proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission or proceeding could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or product candidates and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize product candidates without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our owned and licensed patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical technology and tablet vaccines, or limit the duration of the patent protection of our technology and product candidates. Moreover, patents have a limited lifespan. In the United States and other countries, the natural expiration of a patent is generally 20 years after it is filed. Various extensions may be available, however, the life of a patent, and the protection it affords, is limited. Without patent protection for our current or future tablet vaccine candidates, we may be open to competition from generic versions of such product candidates. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing product candidates similar or identical to ours.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>69</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If we are unable to adequately protect or expand our intellectual property related to products acquired in the Merger, our business prospects could be harmed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We can protect our proprietary intellectual property rights from unauthorized use by third parties only to the extent that our proprietary rights are covered by valid and enforceable patents or are effectively maintained as trade secrets. The patent position of pharmaceutical and biopharmaceutical companies involves complex legal and factual questions, and, therefore, we cannot predict with certainty whether we will be able to ultimately enforce our patents or proprietary rights or avoid infringing on the patents or proprietary rights of others. Any issued patents that we own or otherwise have rights to may be challenged, invalidated or circumvented, and may not provide us with the protection against competitors that we anticipate.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The degree of future protection of our proprietary intellectual property rights is uncertain because issued patents and other legal means of establishing proprietary rights afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage. Our future patent position will be influenced by the following factors:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>we, or our licensors, may not have been the first to discover the inventions covered by each of our, or our licensors&#146;, pending patent applications and issued patents, and we may have to engage in expensive and protracted interference proceedings to determine priority of invention;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our, or our licensors&#146;, pending patent applications may be denied and may not result in issued patents;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our, or our licensors&#146;, issued patents may not provide a basis for commercially viable products, may not provide us with any competitive advantages, or may be challenged by third parties; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>third parties may develop intellectual property that circumvents our, or our licensors&#146;, patent claims, or design competitive intellectual property and ultimately product candidates that fall outside the scope of our, or our licensors&#146;, patents.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Due to the extensive time required for the development, testing and regulatory review and approval of a product candidate, it is possible that before our product candidates may be approved for sale and commercialized, our relevant patent rights may expire, or such patent rights may remain in force for only a short period following marketing approval. We currently rely on certain patents to provide us and our licensees with exclusive rights for certain of our products. When all patents underlying a license expire, our revenue from that license may cease, and there can be no assurance that we will be able to replace it with revenue from new or existing licenses.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Zanamivir, a neuraminidase inhibitor (&#147;NI&#148;) approved for the treatment and prevention of influenza A and B, is marketed worldwide as Relenza by GSK. Most of our Relenza patents have expired and the only substantial remaining intellectual property related to the Relenza patent portfolio, which we own and have exclusively licensed to GSK, is scheduled to expire in July 2019 in Japan.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Patent rights may not provide us with adequate proprietary protection or competitive advantages against competitors with or developing similar technologies or approaches to ours. The laws of certain foreign countries do not protect intellectual property rights to the same extent as do the laws of the United States, and certain countries may lack adequate rules and procedures for defending our intellectual property rights. For example, we may not be able to prevent a third-party from infringing our patents in a country that does not recognize or enforce patent rights, or that imposes compulsory licenses on, or restricts the prices of, drugs. Changes in either patent laws or in interpretations of patent laws in the United States and other countries may diminish the value of our intellectual property. We may need to in-license certain technologies to successfully develop and commercialize our product candidates. We may not develop or obtain rights to products or processes that are patentable. Even if we, or our licensors, do obtain patents, such patents may not adequately protect the products or technologies licensed, or may otherwise be limited in scope. In addition, we may not have total control over the patent prosecution of subject matter that we license from others. Accordingly, we may be unable to exercise the same degree of control over this intellectual property as we would over our own. Others may challenge, seek to invalidate, infringe or circumvent any pending or issued patents we own or license, and rights we receive under those issued patents may not provide us with competitive advantages. There can be no assurance of the degree of protection that will be afforded by any of our issued or pending patents, or those we license.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>There can be no assurance that any patents will be issued from the patent applications we own or have licensed or, should any patents be issued, that we will be provided with adequate protection against potentially competitive products. Furthermore, we cannot be sure that patents issued or licensed to us will be of any commercial value, or that private parties or competitors will not successfully challenge these patents or circumvent our patent position in the United States or abroad. In the absence of adequate patent protection, our business may be adversely affected by competitors who develop comparable technology or products.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>70</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We may be involved in lawsuits to protect or enforce our patents, the patents of our licensors or our other intellectual property rights, which could be expensive, time consuming and unsuccessful.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Competitors may infringe or otherwise violate our patents, the patents of our licensors or our other intellectual property rights. To counter infringement or unauthorized use, we may be required to file legal claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours or our licensors is not valid, or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that such patents do not cover the technology in question. An adverse result in any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or interpreted narrowly and could put our patent applications at risk of not issuing. The initiation of a claim against a third-party may also cause the third-party to bring counter claims against us such as claims asserting that our patents are invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, non-enablement or lack of statutory subject matter. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant material information from the USPTO, or made a materially misleading statement, during prosecution. Third parties may also raise similar validity claims before the USPTO in post-grant proceedings such as inter partes review, or post-grant review, or oppositions or similar proceedings outside the United States, in parallel with litigation or even outside the context of litigation. The outcome following legal assertions of invalidity and unenforceability is unpredictable. We cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. For the patents and patent applications that we have licensed, we may have limited or no right to participate in the defense of any licensed patents against challenge by a third-party. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of any future patent protection on our current or future product candidates. Such a loss of patent protection could harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We may not be able to prevent, alone or with our licensors, misappropriation of our intellectual property rights, particularly in countries where the laws may not protect those rights as fully as in the United States. Our business could be harmed if in litigation the prevailing party does not offer us a license on commercially reasonable terms. Any litigation or other proceedings to enforce our intellectual property rights may fail, and even if successful, may result in substantial costs and distract our management and other employees.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have an adverse effect on the price of our common stock.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>If a third party claims we are infringing on its intellectual property rights, we could incur significant expenses, or be prevented from further developing or commercializing our product candidates, which could materially harm our business.</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in">Our success will largely depend on our ability to operate without infringing the patents and other proprietary intellectual property rights of third parties. This is generally referred to as having the &#147;freedom to operate.&#148; However, our research, development and commercialization activities may be subject to claims that we infringe or otherwise violate patents or other intellectual property rights owned or controlled by third parties. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are pursuing development candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our current or future product candidates may be subject to claims of infringement of the patent rights of third parties. The biotechnology and pharmaceutical industries are characterized by extensive litigation regarding patents and other intellectual property rights. The defense and prosecution of intellectual property claims, interference proceedings and related legal and administrative proceedings, both in the United States and internationally, involve complex legal and factual questions. As a result, such proceedings are lengthy, costly and time-consuming, and their outcome is highly uncertain. We may become involved in protracted and expensive litigation in order to determine the enforceability, scope and validity of the proprietary rights of others, or to determine whether we have the freedom to operate with respect to the intellectual property rights of others.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Patent applications in the United States are, in most cases, maintained in secrecy until approximately 18 months after the patent application is filed. The publication of discoveries in scientific or patent literature frequently occurs substantially later than the date on which the underlying discoveries were made. Therefore, patent applications relating to product candidates similar to ours may have already been filed by others without our knowledge. In the event that a third party has also filed a patent application covering our product candidate or other claims, we may have to participate in an adversarial proceeding, known as an interference proceeding, in the USPTO, or similar proceedings in other countries, to determine the priority of invention. In the event an infringement claim is brought against us, we may be required to pay substantial legal fees and other expenses to defend such a claim and, should we be unsuccessful in defending the claim, we may be prevented from pursuing the development and commercialization of a product candidate and may be subject to injunctions and/or damage awards.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>71</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>In the future, the USPTO or a foreign patent office may grant patent rights to our product candidates or other claims to third parties. Subject to the issuance of these future patents, the claims of which will be unknown until issued, we may need to obtain a license or sublicense to these rights in order to have the appropriate freedom to further develop or commercialize them. Any required licenses may not be available to us on acceptable terms, if at all. If we need to obtain such licenses or sublicenses, but are unable to do so, we could encounter delays in the development of our product candidates, or be prevented from developing, manufacturing and commercializing our product candidates at all. If it is determined that we have infringed an issued patent and do not have the freedom to operate, we could be subject to injunctions, and/or compelled to pay significant damages, including punitive damages. In cases where we have in-licensed intellectual property, our failure to comply with the terms and conditions of such agreements could harm our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>It is becoming common for third parties to challenge patent claims on any successfully developed product candidate or approved drug. If we or our licensees or collaborators become involved in any patent litigation, interference or other legal proceedings, we could incur substantial expense, and the efforts and attention of our technical and management personnel could be significantly diverted. A negative outcome of such litigation or proceedings may expose us to the loss of our proprietary position or to significant liabilities or require us to seek licenses that may not be available from third parties on commercially acceptable terms, if at all. We may be restricted or prevented from developing, manufacturing and selling our product candidates in the event of an adverse determination in a judicial or administrative proceeding, or if we fail to obtain necessary licenses.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Obtaining and maintaining our patent protection depends on compliance with various procedures, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Periodic maintenance fees on any issued patent are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of the patent. The USPTO and various foreign governmental patent agencies require compliance with a number of procedures, documentary fee payments and other provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. If we and our licensors fail to maintain the patents and patent applications covering our product candidates, our competitive position would be adversely affected.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our product candidates.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>The United States has recently enacted and implemented wide-ranging patent reform legislation. The United States Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce patents that we have licensed or that we might obtain in the future.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>We may not be able to protect our intellectual property rights throughout the world, which could impair our business.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Filing, prosecuting and defending patents covering our product candidates throughout the world would be prohibitively expensive. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own vaccines and, further, may export otherwise infringing vaccines to territories where we may obtain patent protection, but where patent enforcement is not as strong as that in the United States. These vaccines may compete with our product candidates in jurisdictions where we do not have any issued or licensed patents and any future patent claims or other intellectual property rights may not be effective or sufficient to prevent them from so competing.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>72</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in">Many of our employees, including our senior management, were previously employed at universities or other biotechnology or pharmaceutical companies. These employees typically executed proprietary rights, non-disclosure and non-competition agreements in connection with their previous employment. Although we try to ensure that our employees do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that it or these employees have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such employee&#146;s former employer. We are not aware of any threatened or pending claims related to these matters, but in the future litigation may be necessary to defend against such claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; FONT-STYLE:italic; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We seek to protect our proprietary technology in part by entering into confidentiality agreements with third parties and, if applicable, material transfer agreements, consulting agreements or other similar agreements with our advisors, employees, third-party contractors and consultants prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, including our trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&#146;s discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may have an adverse effect on our business and results of operations.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>In addition, these agreements typically restrict the ability of our advisors, employees, third-party contractors and consultants to publish data potentially relating to our trade secrets, although our agreements may contain certain limited publication rights. Despite our efforts to protect our trade secrets, our competitors may discover our trade secrets, either through breach of our agreements with third parties, independent development, or publication of information by any of our third-party collaborators. A competitor&#146;s discovery of our trade secrets would impair our competitive position and have an adverse impact on our business.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 12pt; page:WordSection2'><b><i><font style=FONT-SIZE:10pt>Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20&nbsp;years from its earliest U.S.&nbsp;non-provisional&nbsp;filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired for a product candidate, we may be open to competition from competitive vaccines and medications, including generic medications. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such product candidates might expire before or shortly after such product candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing product candidates similar or identical to ours.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>Depending upon the timing, duration and conditions of any FDA marketing approval of our product candidates, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Amendments, and similar legislation in the European Union. The Hatch-Waxman Amendments permit a patent term extension of up to five years for a patent covering an approved product as compensation for effective patent term lost during product development and the FDA regulatory review process. However, we may not receive an extension if we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable requirements. Moreover, the length of the extension could be less than we request. Only one patent per approved product can be extended, the extension cannot extend the total patent term beyond 14 years from approval and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. If we are unable to obtain patent term extension or the term of any such extension is less than we request, the period during which we can enforce our patent rights for the applicable product candidate will be shortened and our competitors may obtain approval to market competing products sooner. As a result, our revenue from applicable products could be reduced. Further, if this occurs, our competitors may take advantage of our investment in development and trials by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case, and our competitive position, business, financial condition, results of operations and prospects could be materially harmed.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>73</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><b><i><font style=FONT-SIZE:10pt>We may be subject to claims challenging the inventorship of our patents and other intellectual property.</font></i></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style=FONT-SIZE:10pt>We or our licensors may be subject to claims that former employees, collaborators or other third parties have an interest in our patents, trade secrets, or other intellectual property as an inventor or co-inventor. For example, we or our licensors may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or our or our licensors&#146; ownership of our patents, trade secrets or other intellectual property. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our product candidates. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; page:WordSection2'><b><font style=FONT-SIZE:10pt><a name=UNRESOL>Item&nbsp;1B.&nbsp;&nbsp;Unresolved Staff Comments </a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>None<b>.</b></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection2'><b><font style=FONT-SIZE:10pt><a name=PROPER>Item&nbsp;2.&nbsp;&nbsp;Properties</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>We do not own any real property. Our leased facilities as of December&nbsp;31, 2018, are as follows:</font></p> <div style=page:WordSection2 align=center> <table width=933 bordercolor=transparent style="WIDTH:700pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=16% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:16.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:8pt>Location</font></b></p></td> <td width=3% style="WIDTH:3.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:19.04%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:8pt>Square Feet</font></b></p></td> <td width=3% style="WIDTH:3.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=26% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:26.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:8pt>Primary Use</font></b></p></td> <td width=3% style="WIDTH:3.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:27.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:8pt>Lease Terms</font></b></p></td></tr> <tr> <td width=16% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:16.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:19.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=26% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:26.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:27.38%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=16% style="WIDTH:16.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>South San Francisco, CA</font></p></td> <td width=3% style="WIDTH:3.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% style="WIDTH:19.04%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>22,427 sq ft</font></p></td> <td width=3% style="WIDTH:3.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=26% style="WIDTH:26.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Laboratory and office</font></p></td> <td width=3% style="WIDTH:3.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27% style="WIDTH:27.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Four leases expiring between August 2019 and April&nbsp;2020</font></p></td></tr> <tr> <td width=16% style="WIDTH:16.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% style="WIDTH:19.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=26% style="WIDTH:26.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.58%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27% style="WIDTH:27.38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=16% style="WIDTH:16.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Alpharetta, GA </font></p></td> <td width=3% style="WIDTH:3.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% style="WIDTH:19.04%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>11,788 sq ft</font></p></td> <td width=3% style="WIDTH:3.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=26% style="WIDTH:26.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Office</font></p></td> <td width=3% style="WIDTH:3.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27% style="WIDTH:27.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Lease expires February&nbsp;2021; entire office subleased</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">We believe that our existing facilities are adequate for our current needs. We plan to consolidate our facilities in South San Francisco in 2019 and believe that sufficient options are available to us on commercially reasonable terms.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 0pt; page:WordSection2'><b><font style=FONT-SIZE:10pt><a name="LEGAL PRO">Item&nbsp;3.&nbsp;&nbsp;Legal Proceedings</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>From <font style=COLOR:black>time to time we may be involved in claims arising in connection with our business. Based on information currently available, we believe that the amount, or range, of reasonably possible losses in connection with any pending actions against us, in excess of established reserves, in the aggregate, not to be material to our consolidated financial condition or cash flows. However, losses may be material to the Company&#146;s operating results for any particular future period, depending on the level of income for such period.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection2'><b><font style=FONT-SIZE:10pt><a name="MINE SEFTY DIS">Item&nbsp;4.&nbsp;&nbsp;Mine Safety Disclosures</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>Not applicable.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>74</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:11pt><a name=P2>PART II</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; page:WordSection2'><b><font style=FONT-SIZE:10pt><a name=ITEM5>Item&nbsp;5.&nbsp;&nbsp;Market for Registrant&#146;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection2'><b><font style=FONT-SIZE:10pt>Trading Information</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>Since February 14, 2018, our common stock has traded on the Nasdaq Capital Market under the symbol &#147;VXRT&#148;. Prior to that, since April 13, 2016, our common stock traded under the symbol &#147;AVIR&#148;, prior to which it had traded under the symbol &#147;BOTA&#148; since November 8, 2012, prior to which it had traded under the symbol &#147;NABI&#148;. The transfer agent for our common stock is American Stock Transfer &amp; Trust Company, LLC at 6201 15<sup>th</sup> Avenue, Brooklyn, NY 11219. All of our electronic filings are available on the SEC&#146;s website at www.sec.gov. We maintain our own website on the internet at www.vaxart.com.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>As of January 31, 2019, there were approximately 6,608 holders of record of our common stock. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><b><font style=FONT-SIZE:10pt>Dividend Policy</font></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style=FONT-SIZE:10pt>We have never declared or paid dividends on shares of our common stock. We intend to retain future earnings, if any, to support the development of our business and therefore do not anticipate paying cash dividends for the foreseeable future. Payment of future dividends, if any, will be at the discretion of our board of directors after taking into account various factors, including current financial condition, operating results and current and anticipated cash needs. <a name=_cp_text_1_165><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif'>Our ability to declare and pay dividends on shares of our common stock is restricted by our credit facility with Oxford Finance, LLC.</font></a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; page:WordSection2'><b><font style=FONT-SIZE:10pt><a name=ITEM6>Item&nbsp;6.&nbsp;&nbsp;Selected Financial Data</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide the information under this item.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'></font>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>75</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black"><b><a name=ITEM7>Item&nbsp;7.&nbsp;&nbsp;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</a></b><b> </b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><i><font style=FONT-SIZE:10pt>The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the other sections of this Annual Report on Form 10-K, including our consolidated financial statements and notes thereto included elsewhere. This discussion contains a number of forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in the Annual Report on Form 10-K, particularly in Item 1A &#150; &#147;Risk Factors.&#148; The forward-looking statements made in this Annual Report on Form 10-K are made only as of the date hereof.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><b><font style=FONT-SIZE:10pt>Company Overview</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We are a clinical-stage biotechnology company focused on the development of oral recombinant vaccines based on our proprietary oral vaccine platform. Our oral vaccines are designed to generate broad and durable immune responses that protect against a wide range of infectious diseases and may be useful for the treatment of chronic viral infections and cancer. Our vaccines are administered using a convenient room temperature-stable tablet, rather than by injection.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>We are developing prophylactic vaccine candidates that target a range of infectious diseases. These include norovirus, a widespread cause of acute gastro-intestinal enteritis, for which two Phase 1 human studies have been completed; seasonal influenza, for which our vaccine protected patients in a recent Phase 2 challenge study; and respiratory syncytial virus, or RSV, a common cause of respiratory tract infections. In addition, we are developing our first therapeutic immune-oncology vaccine targeting cervical cancer and dysplasia caused by human papillomavirus, or HPV.</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in">Through <font style=COLOR:black>our merger with Aviragen Therapeutics, Inc., or Aviragen, we acquired three Phase 2 clinical stage antiviral compounds, which we are no longer actively pursuing: (</font>1) BTA074, or teslexivir, an antiviral treatment for condyloma caused by human papillomavirus types 6 &amp; 11; (2) vapendavir, a capsid inhibitor for the prevention or treatment of rhinovirus upper respiratory infections; and (3) BTA585, or enzaplatovir, a fusion protein inhibitor for the treatment of RSV infections. We have discontinued all three programs.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection2'><b><font style="FONT-SIZE:10pt; COLOR:black">Merger with Aviragen</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">Vaxart Biosciences, Inc. was originally incorporated in California in March&nbsp;2004, under the name West Coast Biologicals, Inc. and changed its name to Vaxart, Inc., or Private Vaxart, in July&nbsp;2007, and reincorporated in the state of Delaware.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>On February 13,&nbsp;2018, <font style=COLOR:black>Private Vaxart</font> <font style=COLOR:black>completed a reverse merger, or the Merger, </font>with <font style=COLOR:black>Aviragen,</font> pursuant to which <font style=COLOR:black>Private Vaxart survived as a wholly owned subsidiary of Aviragen. Under the terms of the Merger, Aviragen changed its name to Vaxart, Inc. and Private Vaxart changed its name to Vaxart Biosciences, Inc</font>. <font style=COLOR:black>Immediately prior to the Merger, </font>all of Private Vaxart&#146;s convertible promissory notes and convertible preferred stock were converted into common stock, following which each share of common stock was converted into approximately 0.22148 shares of common stock. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>I<font style=COLOR:black>mmediately following the completion of the Merger, we effected a reverse stock split at a ratio of one new share for every eleven shares of our common stock outstanding, or</font> the Reverse Stock Split.All share, equity security and per share amounts are presented to give retroactive effect to the <font style=COLOR:black>Reverse</font><font style=COLOR:black> Stock Split</font>. </font><font style="FONT-SIZE:10pt; COLOR:black">Immediately after the Merger and the </font><font style=FONT-SIZE:10pt>Reverse Stock Split</font><font style="FONT-SIZE:10pt; COLOR:black"> there were approximately 7.1&nbsp;million shares of common stock outstanding. In addition, immediately after the Merger, Private Vaxart&#146;s stockholders, warrantholders and optionholders owned approximately 51% of the common stock of the combined company and the stockholders and optionholders of Aviragen immediately prior to the Merger owned approximately 49% of the common stock</font> <font style="FONT-SIZE:10pt; COLOR:black">of the combined company (on a fully diluted basis)</font><font style=FONT-SIZE:10pt>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><b><font style=FONT-SIZE:10pt>Financial Operations Overview</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Revenue</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Revenue from Government Contract</font></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt"><font style=FONT-SIZE:10pt>The government contract with HHS BARDA, as modified, was a cost-plus-fixed-fee contract, under which we were reimbursed for allowable direct contract costs plus allowable indirect costs and a fixed-fee totaling $15.7&nbsp;million from September 2015 through September 30, 2018. <font style=COLOR:black>Activities were completed in 2018 and no future revenue is expected from this contract.</font></font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt">&nbsp;</p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>76</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Royalty Revenue</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>We earn royalty revenue on sales of <font style=COLOR:black>Relenza<sup> </sup>and Inavir<sup> </sup>both treatments for influenza, by our licensees GlaxoSmithKline, plc and Daiichi Sankyo Company, Limited, respectively, based on fixed percentages of net sales of these drugs.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Non-Cash Royalty Revenue Related to the Sale of Future Royalties</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">In April 2016, Aviragen sold certain royalty rights related to Inavir in the Japanese market for $20.0 million to HealthCare Royalty Partners III, L.P., or HCRP. At the time of the Merger, the estimated future benefit to HCRP was remeasured at fair value and was estimated to be $15.9 million, which we account for as a liability and amortize using the effective interest method over the remaining estimated life of the arrangement. Even though we did not retain the related royalties under the transaction, as the amounts are remitted to HCRP, we will continue to record revenue related to these royalties until the amount of the associated liability and related interest is fully amortized.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><b><i><font style="FONT-SIZE:10pt; COLOR:black">Research and Development Expenses</font></i></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style=FONT-SIZE:10pt>Research and development expenses represent costs incurred to conduct research, including the development of our tablet vaccine platform, and the manufacturing, preclinical and clinical development activities of our tablet vaccine candidates. We recognize all research and development costs as they are incurred. Research and development expenses consist primarily of the following:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 3pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>employee-related expenses, which include salaries, benefits and stock-based compensation;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 3pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>expenses incurred under agreements with contract research organizations, or CROs, that conduct clinical trials on our behalf;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 3pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>manufacturing materials, analytical and release testing services required for our production of vaccine candidates used primarily in clinical trials;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 3pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>process development expenses incurred internally and externally to improve the efficiency and yield of the bulk vaccine and tablet manufacturing activities;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 3pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>laboratory supplies and vendor expenses related to its preclinical research activities;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 3pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>consultant expenses for services supporting our clinical, regulatory and manufacturing activities; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>facilities, depreciation and allocated overhead expenses.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>We do not allocate our internal expenses to specific programs. Our employees and other internal resources are not directly tied to any one research program and are typically deployed across multiple projects. Internal research and development expenses are presented as one total.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>We incur significant external costs on manufacturing our tablet vaccine candidates, and on CROs that conduct clinical trials on our behalf. We capture these expenses for each vaccine program. We do not allocate external costs incurred on preclinical research or process development to specific programs.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>The following table shows our research and development expenses for 2018 and 2017, identifying external costs that were incurred in each of our vaccine programs and, separately, on preclinical research and process development:</font></p> <div style=page:WordSection2 align=center> <table width=70% bordercolor=transparent style="WIDTH:70.92%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% nowrap style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2017</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=5 nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>(in thousands)</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>External program costs:</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Influenza program, funded by BARDA</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:9.5pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>749</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:9.5pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>4,451</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Influenza program, non-BARDA</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>44</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Norovirus program</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>2,578</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>1,431</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>RSV program</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>53</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>325</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Teslexivir and vapendavir programs</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>1,902</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Preclinical research and process development</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>285</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>242</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Total external costs</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>5,567</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>6,493</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Internal costs</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>11,708</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>5,862</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 19.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:9.5pt>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>17,275</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:9.5pt>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>12,355</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>77</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style=FONT-SIZE:10pt>We expect that our research and development expenses will increase significantly over the next several years as we advance our tablet vaccine candidates into and through clinical trials, pursue regulatory approval of our tablet vaccine candidates and prepare for a possible commercial launch, all of which will also require a significant investment in manufacturing and inventory related costs.</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style=FONT-SIZE:10pt>The process of conducting clinical trials necessary to obtain regulatory approval is costly and time consuming. We may never succeed in achieving marketing approval for our tablet vaccine candidates. The probability of successful commercialization of our tablet vaccine candidates may be affected by numerous factors, including clinical data obtained in future trials, competition, manufacturing capability and commercial viability. As a result, we are unable to determine the duration and completion costs of our research and development projects or when and to what extent we will generate revenue from the commercialization and sale of any of our tablet vaccine candidates.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><b><i><font style=FONT-SIZE:10pt>General and Administrative Expense</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>General and administrative expenses consist of personnel costs, allocated expenses and expenses for outside professional services, including legal, audit, accounting, public relations, market research and other consulting services. Personnel costs consist of salaries, benefits and stock-based compensation. Allocated expenses consist of rent, depreciation and other facilities related expenses. We expect to continue to incur additional expenses as a public company, including expenses related to compliance with the rules and regulations of the Securities and Exchange Commission, or SEC, the Nasdaq Capital Market as well as additional insurance, investor relations and other professional expenses.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'><b>Results of Operations</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The following table presents selected items in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2018 and 2017, which include the operations of Aviragen for the period from February 13, 2018 to December 31, 2018: </font></p> <div style=page:WordSection2 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% nowrap style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2017</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=5 nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Revenue:</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Revenue from government contract</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:9.5pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>1,344</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:9.5pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>5,839</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Royalty revenue</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>1,340</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9.5pt>Non-cash royalty revenue related to the sale of future royalties</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>1,475</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 45pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Total revenue</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>4,159</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>5,839</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 11.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Operating </font><font style=FONT-SIZE:9.5pt>expenses:</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Research and development</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>17,275</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>12,355</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">General and administrative</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>6,681</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>3,499</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9.5pt>Impairment of intangible assets</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>1,600</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9.5pt>Costs of exit from leased premises</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>359</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 27.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Total operating expenses</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>25,915</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>15,854</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Operating loss</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(21,756)</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(10,015)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 81.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Other income and (expenses):</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Bargain purchase gain</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>6,760</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Interest income </font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>58</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>53</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Interest expense </font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(821)</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(3,036)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">Non-cash interest expense related to sale of future royalties</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(1,859)</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">(Loss) gain on sale of equipment</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(11)</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>69</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">(Loss) gain on revaluation of financial instruments, net</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(3)</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>3,347</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Foreign exchange loss</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(266)</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Total other income and (expenses)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>3,858</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>433</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 62.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Net loss before provision for income taxes</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(17,898)</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(9,582)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 13pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Provision for income taxes</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>109</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 80.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:12.15pt> <td width=70% style="HEIGHT:12.15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9.5pt; COLOR:black">Net loss</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:12.15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:9.5pt>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:12.15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(18,007)</font></p></td> <td width=2% nowrap style="HEIGHT:12.15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:12.15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:9.5pt>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:12.15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>(9,582)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>78</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><font style="FONT-SIZE:10pt; COLOR:black"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Revenue from Government Contract</font></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt; COLOR:black">The following table presents revenue from our government contract for 2018 and 2017:</font></p> <div style=page:WordSection2 align=center> <table width=745 bordercolor=transparent style="WIDTH:558.45pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=100% colspan=7 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.74%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.74%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">%&nbsp;Change</font></b></p></td></tr> <tr> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=61% colspan=4 style="WIDTH:61.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:7.5pt>(dollars in&nbsp;thousands)</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,344</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">5,839</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">(77)%</font></p></td></tr> <tr> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=222 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">For 2018, revenue from our government contract decreased by $4.5 million, or 77%, compared to 2017. The active phase of the contract occurred in 2016 and 2017. In 2018 activities were wound down and completed and no future revenue is expected from this contract.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Royalty Revenue</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The following table presents our royalty revenue for 2018 and 2017:</font></p> <div style=page:WordSection2 align=center> <table width=745 bordercolor=transparent style="WIDTH:558.55pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=100% colspan=7 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.72%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">%&nbsp;Change</font></b></p></td></tr> <tr> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=61% colspan=4 style="WIDTH:61.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:7.5pt>(dollars in&nbsp;thousands)</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,340</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">N/A</font></p></td></tr> <tr> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=222 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">For 2018, royalty revenue was $1.3 million in the post-Merger period. We recorded no such revenue prior to the Merger.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Non-cash Royalty Revenue Related to the Sale of Future Royalties</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The following table presents our non-cash royalty revenue related to the sale of future royalties for 2018 and 2017:</font></p> <div style=page:WordSection2 align=center> <table width=745 bordercolor=transparent style="WIDTH:558.55pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=100% colspan=7 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.72%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">%&nbsp;Change</font></b></p></td></tr> <tr> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=61% colspan=4 style="WIDTH:61.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:7.5pt>(dollars in&nbsp;thousands)</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,475</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">N/A</font></p></td></tr> <tr> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=222 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">For 2018, non-cash royalty revenue related to the sale of future royalties was $1.5 million in the post-Merger period. We recorded no such revenue prior to the Merger.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Research and Development</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The following table presents our research and development expenses for 2018 and 2017:</font></p> <div style=page:WordSection2 align=center> <table width=745 bordercolor=transparent style="WIDTH:558.55pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=100% colspan=7 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.72%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">%&nbsp;Change</font></b></p></td></tr> <tr> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=61% colspan=4 style="WIDTH:61.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:7.5pt>(dollars in&nbsp;thousands)</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">17,275</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">12,355</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">40%</font></p></td></tr> <tr> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=222 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt"><font style="FONT-SIZE:10pt; COLOR:black">For 2018, research and development expenses increased by $4.9 million, or 40%, compared to 2017. The increase in 2018 is principally due to amortization of intangible assets acquired in the Merger, clinical trials of teslexivir and vapendavir, higher personnel costs due to an increase in headcount and increased costs for facilities, manufacturing costs and laboratory supplies for tablet vaccine research. These increases were partially offset by lower expenditures incurred under the HHS BARDA contract. We expect that research and development expenses will increase in the near term as we plan to conduct two norovirus clinical trials in 2019, which will only be partially offset by the elimination of expenses that we were formerly incurring under the HHS BARDA contract.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">General and Administrative</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The following table presents our general and administrative expenses for 2018 and 2017:</font></p> <div style=page:WordSection2 align=center> <table width=745 bordercolor=transparent style="WIDTH:558.55pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=100% colspan=7 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.72%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">%&nbsp;Change</font></b></p></td></tr> <tr> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=61% colspan=4 style="WIDTH:61.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:7.5pt>(dollars in&nbsp;thousands)</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">6,681</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=FONT-SIZE:9.5pt>3,499</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">91%</font></p></td></tr> <tr> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=222 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>79</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><font style="FONT-SIZE:10pt; COLOR:black"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">General and administrative expenses consist of personnel costs, allocated overhead expenses and expenses for outside professional services, including legal, audit, accounting, investor relations, market research and other consulting services. Personnel costs consist of salaries, benefits and stock-based compensation. Allocated overhead expenses consist of rent, depreciation and other facilities related expenses. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">For 2018, general and administrative expenses increased by $3.2 million, or 91%, compared to 2017. The increase in 2018 is due principally due to an increase in legal and other professional costs and additional expenses incurred as a public company, including expenses related to compliance with the rules and regulations of the SEC and the Nasdaq Capital Market, as well as additional insurance, investor relations and directors&#146; fees. Personnel and related facilities costs also increased due to an increased headcount and the overlap of personnel due to transitioning following the Merger. Approximately $0.5 million and $0.9 million in 2018 and 2017, respectively, were incurred for legal, accounting and other third-party costs related directly to the Merger and are not expected to recur.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Impairment of Intangible Assets</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The following table presents the impairment of our intangible assets for 2018 and 2017:</font></p> <div style=page:WordSection2 align=center> <table width=745 bordercolor=transparent style="WIDTH:558.55pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=100% colspan=7 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.72%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">%&nbsp;Change</font></b></p></td></tr> <tr> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=61% colspan=4 style="WIDTH:61.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:7.5pt>(dollars in&nbsp;thousands)</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,600</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">N/A</font></p></td></tr> <tr> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=222 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">Impairment of intangible assets represents the write-off of the </font><font style=FONT-SIZE:10pt>in-process research and development related to teslexivir that we acquired in the Merger. Since the Phase 2 trial completed in May 2018 did not achieve the primary efficacy endpoint and we have suspended development activities, we now consider this asset to be fully impaired. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Costs of Exit from Leased Premises</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The following table presents the costs of exit from leased premises for 2018 and 2017:</font></p> <div style=page:WordSection2 align=center> <table width=745 bordercolor=transparent style="WIDTH:558.55pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=100% colspan=7 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.72%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">%&nbsp;Change</font></b></p></td></tr> <tr> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=61% colspan=4 style="WIDTH:61.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:7.5pt>(dollars in&nbsp;thousands)</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">359</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">N/A</font></p></td></tr> <tr> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=222 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt; COLOR:black">Costs of exit from leasehold premises comprise both our lease loss accrual and our write-down of leasehold improvements and furniture at our leased premises in Alpharetta, Georgia. <a name=_Hlk528968057>Since this facility had surplus capacity</a>, we subleased these premises, commencing in November 2018, for the remainder of the lease term for less than we are presently paying. Accordingly, we recorded an exit charge consisting of loss on lease obligations for the net discounted future cash flows for rental and associated costs at the cease-use date of $253,000 and a property and equipment impairment charge of $106,000. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Other Income and (Expenses)</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The following table presents our net non-operating income and (expenses) for 2018 and 2017:</font></p> <div style=page:WordSection2 align=center> <table width=745 bordercolor=transparent style="WIDTH:558.55pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=100% colspan=7 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.72%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">%&nbsp;Change</font></b></p></td></tr> <tr> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=61% colspan=4 style="WIDTH:61.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:7.5pt>(dollars in&nbsp;thousands)</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,858</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=FONT-SIZE:9.5pt>433</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">791%</font></p></td></tr> <tr> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=222 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">For 2018 and 2017, we recorded net non-operating income of $3.9 million and $433,000, respectively. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt; page:WordSection2'><font style=FONT-SIZE:10pt>The principal source of non-operating income in <font style=COLOR:black>2018 was a bargain purchase gain of $6.8</font> million, representing the excess of our valuation of the fair value of net assets acquired over the fair value of the common stock issued to acquire them in the Merger<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">Interest expense was $821</font><font style=FONT-SIZE:10pt>,000 in 2018, decreasing from $3.0 million in 2017 due to Private Vaxart&#146;s convertible promissory notes being outstanding for only 43 days prior to the Merger, whereas they earned interest for 365 days in 2017. <font style=COLOR:black>Non-cash interest expense on liability related to sale of future royalties of $1.9 million in 2018 relates to accounting for sums that will become payable to HCRP for royalty revenue earned from Inavir in the post-Merger period as debt. </font></font></p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>80</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The gain on revaluation of financial instruments in 2017 was principally caused by an embedded derivative liability related to the conversion feature on Private Vaxart&#146;s </font><font style=FONT-SIZE:10pt>convertible promissory notes, which had a fair value of<font style=COLOR:black>$</font>3.3 million as of December 31, 2016, and zero as of December 31, 2017. Since Private Vaxart&#146;s convertible promissory notes and warrants converted to equity on the Merger, there are no longer any comparable financial instruments outstanding on which a change in fair value will be recorded.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt; page:WordSection2'><font style=FONT-SIZE:10pt>The foreign exchange loss of $266,000 in 2018 relates to the revaluation of cash and receivables denominated in Australian dollars and British pounds at their <font style=COLOR:black>December</font> 31, 2018, exchange rates and resulted from the strengthening U.S. dollar.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Provision for Income Taxes</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">The following table presents our provision for income taxes for 2018 and 2017:</font></p> <div style=page:WordSection2 align=center> <table width=745 bordercolor=transparent style="WIDTH:558.55pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=100% colspan=7 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.72%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">%&nbsp;Change</font></b></p></td></tr> <tr> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=61% colspan=4 style="WIDTH:61.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:7.5pt>(dollars in&nbsp;thousands)</font></b></p></td> <td width=5% style="WIDTH:5.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">109</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=3% style="WIDTH:3.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=26% style="WIDTH:26.58%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=5% style="WIDTH:5.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=29% style="WIDTH:29.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">N/A</font></p></td></tr> <tr> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=24 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=198 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=40 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=222 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:11.4pt; page:WordSection2'><font style=FONT-SIZE:10pt>The provision for income taxes for 2018 comprises $102,000 of withholding tax on royalty revenue earned on sales of <font style=COLOR:black>Inavir in Japan, which is potentially recoverable</font> as a foreign tax credit but expensed because we record a 100% valuation allowance against our deferred tax assets, $4,000 relating to interest on an intercompany loan from a foreign subsidiary, plus $3,000 for state income taxes<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection2'>Liquidity and Capital Resources</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Since inception, Private Vaxart&#146;s operations have been financed primarily by net proceeds of $38.9&nbsp;million and $29.4&nbsp;million from the sale of convertible preferred stock and the issuance of convertible promissory notes, respectively, all of which were converted into Aviragen common stock in the Merger, and $4.9 million from the issuance of secured promissory notes to Oxford Finance, repayable by January 2021. Vaxart gained $25.5 million in cash from Aviragen in the Merger, of which $4.9 million was used to pay for severance, financial advisory fees, director and officer insurance, legal and other professional costs incurred by Aviragen prior to, or upon the closing of, the Merger. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>As of December 31, 2018, we had $11.5&nbsp;million of cash and cash equivalents. We believe these funds, along with our projected revenue, <font style=COLOR:black>are sufficient to fund us into, but possibly not beyond, the second quarter of 2019. Our independent auditors have included an explanatory paragraph in their report on our financial statements as of and for the year ended December&nbsp;31, 2018, indicating that, because we have experienced losses and negative cash flows from operations and have an accumulated deficit and debt obligations, there is substantial doubt about our ability to continue as a going concern<font style=COLOR:black>.</font></p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>To continue operations thereafter, we will need to raise further capital, through the sale of additional securities or otherwise. Our operating needs include the planned costs to operate our business, including amounts required to fund working capital and capital expenditures. As of December 31, 2018, we <font style=COLOR:black>had commitments for capital expenditures totaling $0.5 million</font>. Our future capital requirements and the adequacy of our available funds will depend on many factors, most notably our ability to successfully commercialize our products and services.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>We plan to continue to fund our operations and capital funding needs through equity and/or debt financing. We may also enter into government funding programs and consider selectively partnering for clinical development and commercialization. The sale of additional equity would result in additional dilution to our stockholders. Incurring debt financing would result in debt service obligations, and the instruments governing such debt could provide for operating and financing covenants that would restrict our operations. If we are unable to raise additional capital in sufficient amounts or on acceptable terms, we may be required to delay, limit, reduce, or terminate our product development or future commercialization efforts or grant rights to develop and market vaccine candidates that we would otherwise prefer to develop and market ourselves. Any of these actions could harm our business, results of operations and prospects.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'>Our future funding requirements will depend on many factors, including the following:</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in"><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style="FONT-FAMILY:'Times New Roman'; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the timing and costs of our planned clinical trials for our product candidates;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the timing and costs of our planned preclinical studies of our product candidates;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>our success in establishing and scaling commercial manufacturing capabilities;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the amount and timing of royalties received on sales of <font style=COLOR:black>Relenza<sup> </sup>and Inavir</font>;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>81</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><font style="FONT-SIZE:10pt; COLOR:black"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the number and characteristics of product candidates that we pursue;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the outcome, timing and costs of seeking regulatory approvals;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>revenue received from commercial sales of our future products, which will be subject to receipt of regulatory approval;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>the terms and timing of any future collaborations, licensing, consulting or other arrangements that we may enter into;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>the amount and timing of any payments that may be required in connection with the licensing, filing, prosecution, maintenance, defense and enforcement of any patents or patent applications or other intellectual property rights; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in; page:WordSection2'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the extent to which we in-license or acquire other products and technologies.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><b><font style=FONT-SIZE:10pt>Cash Flows</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>The following table summarizes our cash flows for the periods indicated:</font></p> <div style=page:WordSection2 align=center> <table width=800 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:600pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr style=HEIGHT:12.1pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:12.1pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; HEIGHT:12.1pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year Ended December 31,</font></b></p></td></tr> <tr style=HEIGHT:8.95pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:8.95pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:8.95pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:8.95pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:8.95pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td></tr> <tr> <td width=70% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">(in thousands)</font></b></p></td></tr> <tr style=HEIGHT:13.05pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:13.05pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cash used in operating activities</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:13.05pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:13.05pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(14,548)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:13.05pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:13.05pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:13.05pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;(10,040)</font></p></td></tr> <tr> <td width=70% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cash provided by investing activities</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style="FONT-SIZE:10pt; COLOR:black">26,212</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;3,182</font></p></td></tr> <tr> <td width=70% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cash (used in) provided by financing activities</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,729)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;</font><font style=FONT-SIZE:10pt>24</font></p></td></tr> <tr> <td width=70% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net increase (decrease) in cash and cash equivalents</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:black 1.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:black 1.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style="FONT-SIZE:10pt; COLOR:black">9,935</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:black 1.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:black 1.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(6,834)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Net Cash Used in Operating Activities</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">We experienced negative cash flow from operating activities in 2018 and 2017 in the amounts of $14.5 million and $10.0 million, respectively. The cash used in operating activities in 2018 was due to a net loss of $18.0 million, partially offset by $1.0 million of adjustments for net non-cash income related to the bargain purchase gain, depreciation and amortization, loss on sale of equipment, impairment charges, stock-based compensation, loss on revaluation of financial instruments, non-cash interest,</font><font style=FONT-SIZE:10pt>amortization of note discount and n<font style=COLOR:black>on-cash interest expense and revenue related to sale of future royalties and $2.5 million provided by a change in working capital, principally due to the receipt of accounts receivable of $14.7 million acquired in the Merger. The cash used in operating activities in 2017 was due to cash used to fund a net loss of $9.6 million and a decrease in working capital of $624,000, partially offset by net non-cash expenses related to depreciation and amortization, gain on sale of equipment, stock-based compensation, amortization of discount on short-term investments, gain on revaluation of financial instruments, non-cash interest and</font> amortization of note discount <font style=COLOR:black>totaling $166,000.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Net Cash Provided by Investing Activities</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">In 2018 we received cash of $25.5 million in the Merger and $1.4 million from maturities of short-term investments, net of purchases. This was partially offset by $707,000 to purchase property and equipment and $21,000 to pay for fractional shares of common stock in the Merger. In 2017 Vaxart received $3.2 million from maturities of short-term investments, net of purchases, and $70,000 from the sale of equipment, partially offset by $117,000 used to purchase property and equipment.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><i><font style="FONT-SIZE:10pt; COLOR:black">Net Cash (Used in) Provided by Financing Activities</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">We used $1.5 million in 2018 to repay principal on the secured </font><font style=FONT-SIZE:10pt>promissory note payable to Oxford Finance and $214,000 to repay principal on a short-term note, partially offset by $13,000 received upon the exercise of stock options<font style=COLOR:black>. In 2017 we </font>received $24,000 upon the exercise of stock options<font style=COLOR:black>.</font></font></p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection2'><b><font style="FONT-SIZE:10pt; COLOR:black">Critical Accounting Policies and Estimates </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">Our management&#146;s discussion and analysis of financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities and expenses. On an ongoing basis, we evaluate these estimates and judgments. We base our estimates on historical experience and on various assumptions that we believe to be reasonable under the circumstances. These estimates and assumptions form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#146;s judgments and estimates.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>82</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection2'><b><font style="FONT-SIZE:10pt; COLOR:black">Accrued Research and Development Expenses </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">We record accrued expenses for estimated costs of research and development activities conducted by </font><font style=FONT-SIZE:10pt>third-party service providers, which include the conduct of preclinical studies and clinical trials, and contract manufacturing activities. We record the estimated costs of research and development activities based upon the estimated amount of services provided and include the costs incurred but not yet invoiced within other accrued liabilities in the balance sheets and within research and development expense in the consolidated statements of operations and comprehensive loss. These costs can be a significant component of our research and development expenses<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">We estimate the amount of work completed through discussions with internal personnel and external service providers as to the progress or stage of completion of the services and the agreed-upon fee to be paid for such services. We make significant judgments and estimates in determining the accrued balance in each reporting period. As actual costs become known, we adjust our accrued estimates. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection2'><b><font style="FONT-SIZE:10pt; COLOR:black">Intangible Assets</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style="FONT-SIZE:10pt; COLOR:black">Intangible assets acquired in the Merger were recorded at their estimated fair values of $20.3 million and $1.8 million for developed technologies Inavir and Relenza, respectively, which are being amortized on a straight-line basis over the estimated periods of future royalties of 11.75 and 1.3 years, respectively, and $1.6 million for in-process research and development related to teslexivir which was considered indefinite-lived until it was assessed as impaired in the three months ended June 30, 2018. These valuations were prepared by an independent third party based on estimated discounted cash flows based on probability-weighted future development expenditures and revenue streams, which are highly subjective.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><b><font style=FONT-SIZE:10pt>Off-Balance Sheet Arrangements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>During 2017 and 2018, we did not have any off-balance sheet arrangements.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection2'><b><font style=FONT-SIZE:10pt>Recently Issued Accounting Pronouncements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection2'><font style=FONT-SIZE:10pt>See the &#147;Recent Accounting Pronouncements&#148; in Note&nbsp;2 to the Consolidated Financial Statements in Part&nbsp;II, Item&nbsp;8 for information related to the adoption of new accounting standards in 2018, none of which had a material impact on our financial statements, and the future adoption of recently issued accounting pronouncements, which we do not expect will have a material impact on our financial statements.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection2'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>83</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection2'><b><font style=FONT-SIZE:10pt><a name=ITEM8>Item&nbsp;8.&nbsp;&nbsp;Financial Statements and Supplementary Data</a></font></b></p> <div style=page:WordSection2 align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BACKGROUND:white; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=93% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:93.44%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:8pt; COLOR:black">Index to Consolidated Financial Statements</font></b></p></td> <td width=2% style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:4.06%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Page</font></b></p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#report>Report of Independent Registered Public Accounting Firm</a></font></p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>85</font></p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#bs>Consolidated Balance Sheets</a></font></p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>86</font></p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#is>Consolidated Statements of Operations and Comprehensive Loss</a></font></p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>87</font></p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#se>Consolidated Statements of Stockholders&#146; Equity (Deficit)</a></font></p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>88</font></p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#cf>Consolidated Statements of Cash Flows</a></font></p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>89</font></p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND-IMAGE:none; BACKGROUND-REPEAT:repeat; BACKGROUND-ATTACHMENT:scroll; BACKGROUND-POSITION:0% 0%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=93% style="WIDTH:93.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt color=#0066cc><a href=#note>Notes to the Consolidated Financial Statements</a></font></p></td> <td width=2% style="WIDTH:2.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=4% style="WIDTH:4.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>91</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>84</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:10pt><a name=report>Report of Independent Registered Public Accounting Firm</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>The Stockholders and Board of Directors</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>Vaxart, Inc.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Opinion on the Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'><font style=FONT-SIZE:10pt>We have audited the accompanying consolidated balance sheets of Vaxart, Inc. and subsidiaries (the Company) as of December 31, 2018 and 2017, and the related consolidated statements of operations and comprehensive loss, stockholders&#146; equity (deficit) and cash flows for each of the years in the two-year period ended December 31, 2018, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018 and 2017, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2018, in conformity with U.S. generally accepted accounting principles.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Going Concern </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'><font style=FONT-SIZE:10pt>The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note&nbsp;1 to the consolidated financial statements, the Company has experienced losses and negative cash flows from operations since its inception, has an accumulated deficit, and has debt obligations that raise substantial doubt about its ability to continue as a going concern. Management&#146;s plans in regard to these matters are also described in Note&nbsp;1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'><b><font style=FONT-SIZE:10pt>Basis for Opinion</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection2'><font style=FONT-SIZE:10pt>These consolidated financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'><font style=FONT-SIZE:10pt>We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting. Accordingly, we express no such opinion.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection2'><font style=FONT-SIZE:10pt>Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>/<i>s/ KPMG LLP</i></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>We have served as the Company&#146;s auditor since 2014.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'><font style=FONT-SIZE:10pt>San Francisco, California</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style=FONT-SIZE:10pt>February&nbsp;6, 2019</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>85</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p> <div style=page:WordSection2 align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=12% colspan=6 style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:11pt; COLOR:black"><a name=bs>Consolidated Balance Sheets</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">(In thousands, except share and per share amounts)</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">December&nbsp;31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">December&nbsp;31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style="FONT-SIZE:10pt; COLOR:black">Assets</font></u></b></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Current assets:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cash and cash equivalents</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">11,506 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,571 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Short-term investments</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,415 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Accounts receivable</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,796 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">630 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Prepaid expenses and other current assets</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,343 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">137 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total current assets</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">14,645 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,753 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Property and equipment, net</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,066 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">730 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Intangible assets, net </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">19,413 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">40 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Other long-term assets</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">103 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total assets</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">35,227 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,523 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style="FONT-SIZE:10pt; COLOR:black">Liabilities and Stockholders&#146; Equity (Deficit)</font></u></b></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Current liabilities:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Accounts payable </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">962 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,390 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Current portion of secured promissory note payable to Oxford Finance </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,667 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,528 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Liability related to sale of future royalties, current portion</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,328 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Other accrued current liabilities </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,518 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,605 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:10pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total current liabilities</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">7,475 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,523 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:40pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Convertible promissory notes, long-term, related parties</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">35,282 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Liability related to sale of future royalties, net of current portion</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">14,413 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Secured promissory note payable to Oxford Finance, net of current portion</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,944 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,440 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Other long-term liabilities</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">157 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total liabilities</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">23,989 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">43,245 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Commitments and contingencies (Note&nbsp;10)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Stockholders&#146; equity (deficit):</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:30.75pt> <td width=70% style="HEIGHT:30.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Preferred Stock: $0.10 par value; 5,000,000 shares authorized; none</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; &nbsp;issued and outstanding as of December 31, 2018; 1,221,064 issued </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; and outstanding as of December&nbsp;31, 2017, with aggregate liquidation </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; value of $39,956</font></p></td> <td width=2% style="HEIGHT:30.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:30.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=2% style="HEIGHT:30.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:30.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:30.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1 </font></p></td></tr> <tr style=HEIGHT:25.5pt> <td width=70% style="HEIGHT:25.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Common Stock: $0.10 par value; 200,000,000 shares authorized; </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;&nbsp;&nbsp;<font style=FONT-SIZE:10pt>7,141,189 and 138,492 shares issued and outstanding as of December&nbsp;<br>&nbsp;&nbsp;&nbsp;31, 2018 and 2017, respectively</font></p></td> <td width=2% style="HEIGHT:25.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:25.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">714 </font></p></td> <td width=2% style="HEIGHT:25.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:25.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:25.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Additional paid-in capital</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">108,513 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">41,259 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Accumulated deficit</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(97,989)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(79,982)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total stockholders&#146; equity (deficit)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">11,238 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(38,722)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total liabilities and stockholders&#146; equity (deficit)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">35,227</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,523 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=12% colspan=6 style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">The accompanying notes are an integral part of these consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>86</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p> <div style=page:WordSection2 align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=12% colspan=6 style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:11pt; COLOR:black"><a name=is>Consolidated Statements of Operations and Comprehensive Loss</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">(In thousands, except share and per share amounts)</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">2018</font></b></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">2017</font></b></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Revenue:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Revenue from government contract</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,344 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">5,839 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Royalty revenue</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,340 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Non-cash royalty revenue related to the sale of future royalties</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,475 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total revenue</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,159 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">5,839 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Operating expenses:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Research and development</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">17,275 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">12,355 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">General and administrative</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">6,681 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,499 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Impairment of intangible assets</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,600 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Costs of exit from leased premises</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">359 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total operating expenses</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">25,915 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">15,854 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Operating loss</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(21,756)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(10,015)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Other income and (expenses):</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Bargain purchase gain</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">6,760 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Interest income</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">58 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">53 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Interest expense</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(821)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(3,036)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Non-cash interest expense related to sale of future royalties</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,859)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">(Loss) gain on sale of equipment</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(11)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">69 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">(Loss) gain on revaluation of financial instruments, net</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(3)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,347 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Foreign exchange loss, net</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(266)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total other income and (expenses)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,858 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">433 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net loss before provision for income taxes</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(17,898)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(9,582)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Provision for income taxes</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">109 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font style=FONT-SIZE:10pt>Net loss</font></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(18,007)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(9,582)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Series&nbsp;B and C preferred dividend</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(339)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(2,878)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net comprehensive loss attributable to common stockholders</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(18,346)</font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(12,460)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net loss per share&nbsp;&#150; basic and diluted</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(2.90)</font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(91.65)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Shares used to compute net loss per share&nbsp;&#150; basic and diluted</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">6,316,065 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">135,953 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=12% colspan=6 style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">The accompanying notes are an integral part of these consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>87</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p> <div style=page:WordSection2 align=center> <table width=1067 bordercolor=transparent style="WIDTH:800pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=100% colspan=19 style="HEIGHT:30pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:11pt; COLOR:black"><a name=se>Consolidated Statements of Stockholders&#146; Equity (Deficit)</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">(In thousands, except share amounts)</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Additional</strong></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Paid-in</strong></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Capital</strong></font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Total</strong></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Stockholders&#146;</strong></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Equity (Deficit)</strong></font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=19% colspan=4 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:19%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Preferred&nbsp;Stock</strong></font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=19% colspan=4 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:19%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Common&nbsp;Stock</strong></font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Accumulated</strong></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Deficit</strong></font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Shares</strong></font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Amount</strong></font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Shares</strong></font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>Amount</strong></font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Balances as of </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp; January&nbsp;1,&nbsp;2017</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,221,064 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">135,658 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">40,758 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(70,400)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(29,641)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Issuance of common stock </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp; upon exercise of stock options</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,834 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">24 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">24 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Stock-based compensation</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">477 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">477 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net loss</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(9,582)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(9,582)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Balances as of </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp; December&nbsp;31,&nbsp;2017</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,221,064 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">138,492 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">41,259 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(79,982)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(38,722)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Issuance of common stock <br>&nbsp;&nbsp;&nbsp;&nbsp; upon conversion of <br>&nbsp;&nbsp;&nbsp; &nbsp;convertible promissory notes, </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; &nbsp;related parties</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,571,702 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">157 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">35,420 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">35,577 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Issuance of common stock </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; upon conversion of </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; convertible preferred stock</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,221,064)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,918,543 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">192 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(191)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Reclassification of warrant </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; to equity</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">70 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">70 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Issuance of common stock </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; upon reverse merger</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,510,439 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">365 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">31,403 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">31,768 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Issuance of common stock </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp; upon exercise of stock options</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,013 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">13 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">13 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Stock-based compensation</font></p></td> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">539 </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">539 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net loss</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(18,007)</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(18,007)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=28% style="HEIGHT:15pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=28% style="HEIGHT:15.75pt; WIDTH:28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Balances as of </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp; December 31,&nbsp;2018</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">7,141,189 </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=8% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">714 </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">108,513 </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(97,989)</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">11,238 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=28% style="HEIGHT:15.75pt; WIDTH:28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15.75pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:15.75pt; WIDTH:8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=100% colspan=19 style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">The accompanying notes are an integral part of these consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>88</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p> <div style=page:WordSection2 align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=100% colspan=6 style="HEIGHT:30pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=COLOR:black><a name=cf>Consolidated Statements of Cash Flows</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">(In thousands)</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=30% colspan=5 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year&nbsp;Ended&nbsp;December 31,</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 style="HEIGHT:15pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 style="HEIGHT:15pt; WIDTH:14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cash flows from operating activities:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net loss</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(18,007)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(9,582)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Adjustments to reconcile net loss to net cash used in operating activities:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Bargain purchase gain</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(6,760)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Depreciation and amortization</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,203 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">380 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Loss (gain) on sale of equipment</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">11 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(69)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9.5pt; COLOR:black">Impairment of intangible assets</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,600 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9.5pt; COLOR:black">Impairment of property and equipment</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">106 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Stock-based compensation </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">539 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">477 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Amortization of discount on short-term investments</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">24 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Loss (gain) on revaluation of financial instruments, net</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(3,347)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Non-cash interest expense</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">448 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,557 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Amortization of note discount</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">18 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">144 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Non-cash interest expense related to sale of future royalties</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,859 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Non-cash revenue related to sale of future royalties</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(18)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Change in operating assets and liabilities:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Accounts receivable </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">13,500 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">960 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Prepaid expenses and other assets </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(873)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">52 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Accounts payable </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(3,784)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,559)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Accrued liabilities </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(6,393)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(77)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net cash used in operating activities</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(14,548)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(10,040)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cash flows from investing activities:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Purchase of property and equipment </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(707)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(117)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;&nbsp;&nbsp;<font style="FONT-SIZE:10pt; COLOR:black">Proceeds from sale of equipment </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">70 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Cash acquired in reverse merger </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">25,525 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Cash paid for fractional shares in merger </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(21)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Purchases of short-term investments </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(573)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(7,351)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Proceeds from maturities of short-term investments</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,988 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">10,580 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net cash provided by investing activities </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">26,212 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,182 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cash flows from financing activities:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Repayment of principal on secured promissory note payable to Oxford Finance </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,528)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Repayment of short-term note</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(214)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Proceeds from issuance of common stock upon exercise of stock options </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">13 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">24 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net cash (used in) provided by financing activities</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,729)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">24 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net increase (decrease) in cash and cash equivalents</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">9,935 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(6,834)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cash and cash equivalents at beginning of the period</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,571 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">8,405 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cash and cash equivalents at end of the period</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">11,506 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,571 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=100% colspan=6 style="HEIGHT:15pt; WIDTH:100%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">The accompanying notes are an integral part of these consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><font style=FONT-SIZE:10pt>89</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection2' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection2'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p> <div style=page:WordSection2 align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:30pt> <td width=12% colspan=6 style="HEIGHT:30pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=COLOR:black>Consolidated Statements of Cash Flows (continued)</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">(In thousands)</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Year&nbsp;Ended&nbsp;December 31,</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Supplemental disclosure of cash flow information:</font></b></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Interest paid</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">356</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">335</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">Supplemental disclosure of non-cash investing and financing activity:</font></b></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock upon reverse merger, net of cash paid for partial shares</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">31,768</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:20.25pt> <td width=70% style="HEIGHT:20.25pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Conversion of convertible promissory notes, related parties into common stock </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp; upon reverse merger</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:20.25pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:20.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">35,577</font></p></td> <td width=2% style="HEIGHT:20.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:20.25pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:20.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Reclassification of convertible preferred stock warrant liability to equity</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">70</font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Acquisition of property and equipment included in accounts payable</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">52</font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">&#151;</font></p></td></tr> <tr style=HEIGHT:13.5pt> <td width=70% style="HEIGHT:13.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:13.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:13.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:13.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:13.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:13.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=12% colspan=6 style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">The accompanying notes are an integral part of these consolidated financial statements.</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection2'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>90</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection2><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center><b><font style=FONT-SIZE:10pt><a name=note>Notes to the Consolidated Financial Statements</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection2' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all></font>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;1.&nbsp;&nbsp;Organization and Basis of Presentation</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; FONT-STYLE:italic; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'><font style='FONT-FAMILY:"Times New Roman","serif"'>General&nbsp;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">Vaxart Biosciences, Inc. was originally incorporated in California in March&nbsp;2004, under the name West Coast Biologicals, Inc. The Company changed its name to Vaxart, Inc. (&#147;Private Vaxart&#148;) in July&nbsp;2007, and reincorporated in the state of Delaware. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>On February 13,&nbsp;2018, Private Vaxart <font style=COLOR:black>completed a business combination </font>with <font style=COLOR:black>Aviragen Therapeutics, Inc. (&#147;Aviragen&#148;)</font>, <font style=COLOR:black>pursuant to which Aviragen merged with Private Vaxart, with Private Vaxart surviving as a wholly-owned subsidiary of Aviragen (the &#147;Merger&#148;). Pursuant to the terms of the Merger, Aviragen changed its name to Vaxart, Inc. (together with its subsidiaries, the &#147;Company&#148; or &#147;Vaxart&#148;) and Private Vaxart changed its name to Vaxart Biosciences, Inc</font>. All of Private Vaxart&#146;s convertible promissory notes and convertible preferred stock was converted into common stock, following which each share of common stock was converted into approximately 0.22148 shares of the Company&#146;s common stock (the &#147;Conversion&#148;). Except as otherwise noted in these Financial Statements, all shares, equity securities and per share amounts of Private Vaxart are presented to give retroactive effect to the <font style=COLOR:black>Conversion</font>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>I<font style=COLOR:black>mmediately following the completion of the Merger, the Company effected a reverse stock split at a ratio of one new share for every eleven shares of the Company&#146;s common stock outstanding</font> (the &#147;Reverse Stock Split&#148;).Except as otherwise noted in these Financial Statements, all share, equity security and per share amounts are presented to give retroactive effect to the <font style=COLOR:black>Reverse</font><font style=COLOR:black> Stock Split</font>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">Immediately after the </font><font style=FONT-SIZE:10pt>Reverse Stock Split</font><font style="FONT-SIZE:10pt; COLOR:black"> there were approximately 7.1&nbsp;million shares of the Company&#146;s common stock outstanding. Private Vaxart&#146;s stockholders, warrantholders and optionholders owned approximately 51% of the fully-diluted common stock of the Company, with Aviragen&#146;s stockholders and optionholders immediately prior to the Merger owning approximately 49% of the fully-diluted common stock of the Company</font><font style=FONT-SIZE:10pt>. The Company also assumed all of Private Vaxart&#146;s outstanding stock options and warrants with proportionate adjustments to the number of underlying shares and exercise prices based on an exchange ratio, based on the combined impact of the Conversion and the Reverse Stock Split, of <font style=COLOR:black>approximately 0.0201346 shares of the Company for each share of Private Vaxart.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The Company&#146;s principal operations are based in South San Francisco, California, and it operates in one&nbsp;reportable segment, which is the discovery and development of oral recombinant protein vaccines, based on its proprietary oral vaccine platform.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","sans-serif"; FONT-STYLE:italic; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'><font style='FONT-FAMILY:"Times New Roman","serif"'>Liquidity and Going Concern</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'><font style=COLOR:black>Since incorporation, the Company has been involved primarily in performing research and development activities, hiring personnel, and raising capital to support these activities. The Company has experienced losses and negative cash flows from operations since its inception. As of December 31, 2018, the Company had an accumulated deficit of $98.0&nbsp;million and a loan with an outstanding balance of $3.6 million from Oxford Finance, LLC (&#147;Oxford Finance&#148;), repayable in monthly installments by January 2021 (see Note 9).</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'><font style=COLOR:black>The Company expects to incur increasing costs as research and clinical trials are advanced and, therefore, expects to continue to incur losses and negative operating cash flows for the next several years. Absent additional funding or adjustments to currently planned operating activities, and in view of the uncertainties regarding future royalty revenue on sales of Relenza and Inavir, management believes that the Company&#146;s cash and cash equivalents of $11.5 million held as of December 31, 2018, are sufficient to fund the Company into, but possibly not beyond, the second quarter of 2019.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'><font style=COLOR:black>The Company reviews its operations and clinical plans on a continuing basis, including its commitments for upcoming clinical trials. The Company plans to finance its operations with royalty revenue on sales of Relenza and Inavir, additional equity or debt financing arrangements, </font>and potentially with additional funding from government contracts or strategic alliances with partner companies. The availability and amount of such funding is not certain.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'><font style=COLOR:black>The uncertainties inherent in the Company&#146;s future operations and in its ability to obtain additional funding raise substantial doubt about its ability to continue as a going concern beyond one year from the date these financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>91</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in -0.9pt 0pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>While management believes its plan to raise additional funds will alleviate the conditions that raise substantial doubt, these plans are not entirely within its control and cannot be assessed as being probable of occurring.&nbsp;If adequate funds are not available, the Company may be required to reduce operating expenses, delay or reduce the scope of its product development programs, obtain funds through arrangements with others that may require the Company to relinquish rights to certain of its technologies or products that the Company would otherwise seek to develop or commercialize itself, or cease operations</font><font style=FONT-SIZE:10pt>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;2.&nbsp;&nbsp;Summary of Significant Accounting Policies</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Basis of Presentation</font></b><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&#150;&nbsp;</font><font style=FONT-SIZE:10pt>The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America <font style=COLOR:black>(&#147;U.S. GAAP&#148;)</font>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Basis of Consolidation</font></b><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&#150;&nbsp;The consolidated financial statements include the financial statements of Vaxart, Inc. and its subsidiaries. All significant transactions and balances between Vaxart, Inc. and its subsidiaries have been eliminated in consolidation.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Use of Estimates</font></b><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&#150;&nbsp;</font><font style=FONT-SIZE:10pt>The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Actual results and outcomes could differ from these estimates and assumptions<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Foreign Currencies</font></b><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&#150;&nbsp;</font><font style=FONT-SIZE:10pt>Foreign exchange gains and losses for assets and liabilities of the Company&#146;s <font style=COLOR:black>non-U.S. </font>subsidiaries for which the functional currency is the U.S. dollar are recorded in <font style=COLOR:black>foreign exchange gain or loss, net</font> within other income and (expenses) in the Company&#146;s statements of operations and comprehensive loss<font style=COLOR:black>. The Company has no subsidiaries </font>for which the local currency is the functional currency.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Cash and Cash Equivalents</font></b><font style=FONT-SIZE:10pt>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;The Company considers all highly liquid debt investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents, which may consist of amounts invested in money market funds, corporate bonds and commercial paper, are stated at fair value. Cash and cash equivalents as of December 31, 2018 and 2017, includes $50,000 of restricted cash.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Short-Term Investments</font></b><font style=FONT-SIZE:10pt>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;The Company&#146;s short-term investments have only comprised commercial paper and corporate bonds. The short-term investments are classified as held-to-maturity based on the Company&#146;s positive intent and ability to hold the securities to maturity. This classification is reevaluated at each balance sheet date. Short-term investments are stated at amortized cost, adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is presented as interest income in the statement of operations and comprehensive loss. The specific identification method is used to determine the realized gain or loss on securities sold or otherwise disposed. When the fair value of a debt security classified as held-to-maturity is less than its amortized cost, the Company assesses whether or not: (i)&nbsp;it has the intent to sell the security or (ii)&nbsp;it is more likely than not that the Company will be required to sell the security before its anticipated recovery. If either of these conditions is met, the Company must recognize an other-than-temporary impairment through earnings for the difference between the debt security&#146;s amortized cost basis and its fair value. Gains and losses are recognized in earnings when the investments are sold or impaired.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'><b><font style=COLOR:black>Concentration of Credit Risk</font></b>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. The Company places its cash, cash equivalents and short&#8209;term investments at financial institutions that management believes are of high credit quality. The Company is exposed to credit risk in the event of default by the financial institutions holding the cash and cash equivalents to the extent such amounts are in excess of the federally insured limits. The Company has not experienced any losses on its deposits since inception.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The primary focus of the Company&#146;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#146;s investment policy addresses the level of credit exposure by limiting the concentration in any one&nbsp;corporate issuer or sector and establishing a minimum allowable credit rating. The Company generally requires no collateral from its customers.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>92</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Accounts Receivable</font></b><font style=FONT-SIZE:10pt>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;Accounts receivable arise from the Company&#146;s royalty revenue receivable for sales,<font style=COLOR:black>net of estimated returns,</font> of <font style=COLOR:black>Inavir and Relenza, and from its </font>contract with the Department of Health and Human Services, Office of Biomedical Advanced Research and Development Authority (&#147;HHS BARDA&#148;) (see Note 6), and are reported at amounts expected to be collected in future periods. An allowance for uncollectible accounts will be recorded based on a combination of historical experience, aging analysis, and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. Account balances will be written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company has provided no allowance for uncollectible accounts as of December 31, 2018 and 2017.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Property and Equipment</font></b><font style=FONT-SIZE:10pt>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;Property and equipment is carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Depreciation begins at the time the asset is placed in service. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is reflected in other income and (expenses) in the period realized.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The useful lives of the property and equipment are as follows:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=242 style="WIDTH:181.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Laboratory equipment</font></p></td> <td width=431 style="WIDTH:322.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>5 years</font></p></td></tr> <tr> <td width=242 style="WIDTH:181.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Office and computer equipment</font></p></td> <td width=431 style="WIDTH:322.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>3 years</font></p></td></tr> <tr> <td width=242 style="WIDTH:181.75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Leasehold improvements</font></p></td> <td width=431 style="WIDTH:322.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Shorter of remaining lease term or estimated useful life</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Intangible Assets</font></b><font style=FONT-SIZE:10pt>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;<font style=COLOR:black>Intangible assets comprise developed technology, intellectual property and, until it was considered fully impaired (see Note 5), in-process research and development. Intangible assets are carried at cost less accumulated amortization. Amortization is computed using the straight-line method over useful lives ranging from 1.3 to 11.75 years for developed technology and 20&nbsp;years for intellectual property. In-process research and development is considered to be indefinite-lived and is not amortized, but is subject to impairment testing</font>. The Company assessed its in-process research and development as fully impaired in the year ended December&nbsp;31, 2018 (see Note 5)<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Impairment of Long-Lived Assets</font></b><font style=FONT-SIZE:10pt>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;The Company reviews its long-lived assets, including property and equipment and intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate over its remaining life. When indications of impairment are present and the estimated undiscounted future cash flows from the use of these assets is less than the assets&#146; carrying value, the related assets will be written down to fair value. The Company assessed leasehold improvements and furniture at its leased offices in Alpharetta, Georgia as impaired in the year ended December&nbsp;31, 2018 (see Notes 5 and 10). There have been no other impairments of the Company&#146;s long-lived assets for the periods presented<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Accrued Clinical and Manufacturing Expenses</font></b><font style=FONT-SIZE:10pt>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;The Company accrues for estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials, and contract manufacturing activities. The Company records the estimated costs of research and development activities based upon the estimated amount of services provided and includes the costs incurred but not yet invoiced within other accrued liabilities in the balance sheets and within research and development expense in the consolidated statements of operations and comprehensive loss. These costs can be a significant component of the Company&#146;s research and development expenses<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The </font><font style=FONT-SIZE:10pt>Company estimates the amount of services provided through discussions with internal personnel and external service providers as to the progress or stage of completion of the services and the agreed-upon fee to be paid for such services. The Company makes significant judgments and estimates in determining the accrued balance in each reporting period. As actual costs become known, it adjusts its accrued estimates. Although the Company does not expect its estimates to be materially different from amounts actually incurred, its understanding of the status and timing of services performed, the number of subjects enrolled, and the rate of enrollment may vary from its estimates and could result in the Company reporting amounts that are too high or too low in any particular period. The Company&#146;s accrued expenses are dependent, in part, upon the receipt of timely and accurate reporting from contract research organizations and other third-party service providers. To date, the Company has not experienced any material differences between accrued costs and actual costs incurred<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>93</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Convertible Preferred Stock Warrant Liability</font></b><font style=FONT-SIZE:10pt>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;The Company has issued certain convertible preferred stock warrants. These warrants were recorded within other accrued liabilities in the balance sheets at fair value due to down-round protection features contained in the convertible preferred stock into which the warrants were exercisable. At the end of each reporting period, changes in fair value of the warrants since the prior period were recorded as a component of (loss) gain on revaluation of financial instruments, net within other income and (expenses) in the consolidated statements of operations and comprehensive loss<font style=COLOR:black>. In the event that the terms of the warrant change such that liability accounting is no longer required, the fair value on the date of such change is released to equity.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Convertible Promissory Notes Embedded Derivative Liability</font></b><font style=FONT-SIZE:10pt>&nbsp;<font style=COLOR:black>&#150;</font>&nbsp;The Company recorded derivative instruments related to redemption features embedded within the outstanding convertible promissory notes. The embedded derivatives were accounted for as liabilities at their estimated fair value when the convertible promissory notes were issued and were re-measured to fair value as of each balance sheet date, with the related re-measurement adjustment being recognized as a component of (loss) gain on revaluation of <font style=COLOR:black>financial instruments</font> in the consolidated statements of operations and comprehensive loss<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Revenue Recognition</font></b><font style=COLOR:black>&nbsp;</font><font style=FONT-SIZE:10pt>&#150;&nbsp;The Company recognizes revenue when it transfers control of promised goods or services to its customers, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition, the Company performs the following five steps:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in; page:WordSection3'><font style=FONT-SIZE:10pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>identification of the promised goods or services in the contract;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in; page:WordSection3'><font style=FONT-SIZE:10pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in; page:WordSection3'><font style=FONT-SIZE:10pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>measurement of the transaction price, including the constraint on variable consideration;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in; page:WordSection3'><font style=FONT-SIZE:10pt>(iv)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>allocation of the transaction price to the performance obligations based on estimated selling prices; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in; page:WordSection3'><font style=FONT-SIZE:10pt>(v)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:normal; page:WordSection3'><font style=COLOR:black>Revenue from royalties earned as a percentage of sales, including milestone payments based on achieving a specified level of sales, where a license is deemed to be the predominant item to which the royalties relate, is recognized as revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied), as required under the sales- and usage-based royalty exception.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'>The Company performed research and development work under its cost&#8209;plus&#8209;fixed&#8209;fee contract with HHS BARDA. The Company recognizes revenue under research contracts only when a contract has been executed and the contract price is fixed or determinable. <font style=COLOR:#212121>Revenue from the HHS BARDA contract is recognized in the period during which the related costs are incurred and the related services are rendered, provided that the applicable conditions under the contract have been met. Costs of contract revenue are recorded as a component of operating expenses in the consolidated statements of operations</font> and comprehensive loss<font style=COLOR:#212121>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>Under the cost reimbursable contract with HHS BARDA, the Company is reimbursed for allowable costs, and recognizes revenue as allowable costs are incurred and the fixed-fee is earned. Reimbursable costs under the contract primarily include direct labor, subcontract costs, materials, equipment, travel, and approved overhead and indirect costs. Fixed fees under cost reimbursable contracts are earned in proportion to the allowable costs incurred in performance of the work relative to total estimated contract costs, with such costs incurred representing a reasonable measurement of the proportional performance of the work completed. Under the HHS BARDA contract, certain activities must be pre-approved in order for their costs to be deemed allowable direct costs. The HHS BARDA contract provides the U.S.&nbsp;government the ability to terminate the contract for convenience or to terminate for default if the Company fails to meet its obligations as set forth in the statement of work. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>Payments to the Company under cost reimbursable contracts, such as this contract, are provisional payments subject to adjustment upon annual audit by the government. Management believes that revenue for periods not yet audited has been recorded in amounts that are expected to be realized upon final audit and settlement. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly in the period that the adjustment is known.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Research and Development Costs</font></b><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&#150;&nbsp;</font><font style=FONT-SIZE:10pt>Research and development costs are expensed as incurred. Research and development costs consist primarily of salaries and benefits, stock-based compensation, consultant fees, third-party costs for conducting clinical trials and the manufacture of clinical trial materials, certain facility costs and other costs associated with clinical trials. Payments made to other entities are under agreements that are generally cancelable by the Company. Advance payments for research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related services are performed.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>94</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Stock-Based Compensation</font></b><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&#150;&nbsp;The Company measures the fair value of all stock-based awards, including stock options, to employees and, since April 1, 2018, to nonemployees, on the grant date and records the fair value of these awards, net of estimated forfeitures, to compensation expense over the service period. Prior to April 1, 2018, the </font><font style=FONT-SIZE:10pt>fair value of awards to nonemployees was measured on the date of performance at the fair value of the consideration received or the fair value of the equity instruments issued, whichever was more reliably measured. The fair value of options is estimated using the Black-Scholes valuation model<font style=COLOR:black>. The expected term of each option is estimated by taking the arithmetic average of its original contractual term and its average vesting term.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Net Income (Loss) Per Share Attributable to Common Stockholders</font></b><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&#150;&nbsp;Basic net income (loss) per share is computed by dividing net income (loss), as adjusted for dividends on the Series&nbsp;B and Series&nbsp;C convertible preferred stock in the period, by the weighted average number of common shares outstanding during the period, without consideration of potential common shares.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">Diluted net income (loss) per common share is computed giving effect to all potential dilutive common shares, comprising common stock issuable upon exercise of stock options and warrants. The Company uses the treasury-stock method to compute diluted income (loss) per share with respect to its stock options and warrants. For purposes of this calculation, options and warrants to purchase common stock are considered to be potential common shares and are only included in the calculation of diluted net income per share when their effect is dilutive. In the event of a net loss, the effects of all potentially dilutive shares are excluded from the diluted net loss per share calculation as their inclusion would be antidilutive.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Recently Adopted Accounting Pronouncements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>In June 2018, the FASB issued ASU 2018-07, <i>Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. </i>This update simplifies the accounting for share-based payment transactions by changing the guidance for accounting for nonemployee share-based awards so that, instead of revaluing each award at each balance sheet date during the period over which it vests, the value will be fixed on the grant date and expensed over the vesting period in the same way that employee awards are already accounted for. This guidance is effective for annual periods beginning after December 15, 2018, including interim periods within that year, with early adoption permitted for entities that had already adopted Topic 606 (see ASU 2014-09 below). The Company adopted ASU 2018-07 effective April 1, 2018, and since it had no unvested awards granted to nonemployees, its adoption had no effect on the Company&#146;s financial condition or results of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>In May 2017, the FASB issued ASU 2017-09, <i>Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. </i>This update provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. This guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that year, and must be applied prospectively to an award modified on or after the adoption date. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&#146;s financial condition or results of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>In January&nbsp;2017, the FASB&nbsp;issued ASU No.&nbsp;2017-04, <i>Intangibles-Goodwill and Other (Topic&nbsp;350) Simplifying the Test for Goodwill Impairment</i>&nbsp;(&#147;ASU&nbsp;2017-04&#148;), which will simplify the goodwill impairment calculation by eliminating Step 2 from the current goodwill impairment test. The new standard does not change how a goodwill impairment is identified. The standard will be effective January&nbsp;1, 2020, with early adoption permitted, and is to be applied prospectively from the date of adoption. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&#146;s financial condition or results of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>In January&nbsp;2017, the FASB&nbsp;issued ASU No.&nbsp;2017-01, <i>Business Combinations (Topic&nbsp;805) Clarifying the Definition of a Business</i>&nbsp;(&#147;ASU&nbsp;2017-01&#148;). The new standard <font style=COLOR:black>clarifies the definition of a business to help companies evaluate whether acquisition or disposal transactions should be accounted for as asset groups or as businesses</font>. The Company adopted this standard when it became effective on January 1, 2018, and it was applied in connection with the Company&#146;s accounting for the Merger as a business combination.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>In August 2016, the FASB issued Accounting Standards Update (ASU) 2016-15, <i>Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</i>, which provides additional guidance on the presentation and classification of certain items in the statement of cash flows. The standard is effective for fiscal years beginning after December&nbsp;15, 2017, with early adoption permitted. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&#146;s financial condition or results of operations.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>95</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">In May&nbsp;2014, the FASB issued ASU&nbsp;2014-09</font><font style=FONT-SIZE:10pt>, <i>Revenue from Contracts with Customers (Topic&nbsp;606)</i>, which supersedes nearly all existing revenue recognition guidance under Topic&nbsp;605, <i>Revenue</i> <i>Recognition</i>. The new standard requires a company to recognize revenue when it transfers goods and services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. ASU&nbsp;2014-09 defines a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when (or as) the entity satisfies the performance obligations. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The Company has <font style=COLOR:#212121>determined that its HHS BARDA government contract is not within the scope of ASU 2014-09 as the government entity is not a customer under the agreement. </font>The Company adopted <font style=COLOR:#212121>ASU 2014-09</font> with respect to its royalty revenue using the modified retrospective method on January&nbsp;1, 2018. Under the modified retrospective transition method, the cumulative effect of applying the standard is recognized at the date of initial application for all contracts not completed as of the date of adoption. The adoption of ASU&nbsp;2014-09&nbsp;did not have any effect on the Company&#146;s financial condition or results of operations and therefore no cumulative effect adjustment was recorded, although the Company has modified its accounting policies to reflect the requirements of this standard and make additional disclosures<font style=COLOR:black>.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">Recent Accounting Pronouncements</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>In February&nbsp;2016, the FASB&nbsp;issued ASU&nbsp;2016-02 <i>Leases (Topic&nbsp;842)</i>, which replaces most current lease guidance when it becomes effective. This standard update intends to increase transparency and improve comparability by requiring entities to recognize assets and liabilities on the balance sheet for all leases, with certain exceptions. The new standard states that a lessee will recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statements of operations. The new guidance will be effective for the Company starting in the first quarter of fiscal 2019, with early adoption permitted. The Company plans to adopt the new guidance effective January&nbsp;1, 2019, using the modified retrospective method, and to use the effective date method of adoption, as permitted by ASU 2018-11, <i>Targeted Improvements</i>, which the FASB issued in July 2018, which reduces the disclosure requirements on transition. The Company has elected the short-term lease recognition exemption <a name=_Hlk536727602>for all classes of assets</a>, which means that it will not recognize right-of-use assets or lease liabilities for leases with a duration of one year or less. Further, the Company has elected to use all of the practical expedients available on transition, whereby it has not reassessed under the new standard its prior conclusions about lease identification, lease classification and initial direct costs.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>We expect that this standard will have a material effect on our consolidated financial statements. The most significant effects relate to the recognition of new right-of-use assets and lease liabilities on our consolidated balance sheet.&nbsp;The Company currently expects to recognize lease liabilities of $1,207,000, $766,000 of which is current, and right-of-use assets of $941,000 based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases, to derecognize liabilities of $239,000, $100,000 of which is current, and recognize an increase of $27,000 to accumulated deficit on adoption of&nbsp;the new accounting policy.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>The increase in accumulated deficit arises because the <a name=_Hlk536721226>right-of-use </a>asset impairment charge that would have been recorded in the three months ended December 31, 2018, under Topic 842 exceeds the lease loss accrual, net of accretion, that was recorded (see Note 10). This impact aside, the adoption will have no effect on the Company&#146;s statements of operations or cash flows, other than on related disclosures.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The Company has reviewed all other significant newly-issued accounting pronouncements and concluded that they either are not applicable to the Company&#146;s operations or no material effect is expected on its consolidated financial statements as a result of future adoption.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>96</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p><font style=FONT-SIZE:10pt> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">NOTE 3.&nbsp;&nbsp;Business Combination</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">On February&nbsp;13, 2018, the Company acquired Aviragen in a reverse merger (see Note&nbsp;1). On the date of the Merger, </font><font style=FONT-SIZE:10pt>Aviragen had in-process research and development as it was conducting a Phase 2 trial, it had previously developed drugs that were licensed to others who brought them to market and it had a workforce that was considered to have the necessary skills, knowledge, and experience to perform a process that, when applied to the in-process research and development, was critical to the ability to convert it into outputs. Based on this evaluation, the Company determined that the Merger should be accounted for as a business combination.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">Since the date of the Merger, the results of Aviragen&#146;s operations have been included in the consolidated financial statements. As a result of the acquisition, the Company eliminated the majority of its debt and acquired a significant cash balance in exchange for equity securities.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The total purchase price for Aviragen is summarized as follows (in thousands):</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=82% style="WIDTH:82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Common stock</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=16% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:16%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>31,789</font></p></td></tr> <tr> <td width=82% style="WIDTH:82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=16% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:16%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=82% style="WIDTH:82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total </font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=16% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:16%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>31,789</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>In connection with the Aviragen acquisition, the Company allocated the total purchase consideration to the net assets and liabilities acquired, including identifiable intangible assets, based on their respective fair values at the acquisition date. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>The following table summarizes the preliminary allocation of the purchase price to the fair value of the respective assets and liabilities acquired, adjustments made since the acquisition date and the final allocation as of December 31, 2018:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">As of February 13, </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Adjustments</font></b></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">As of December 31, </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p 0in text-align: roman?,?serif?; center; new margin: 0pt? style="FONT-SIZE:10pt; FONT-FAMILY:" times align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Cash and cash equivalents</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>25,525</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>25,525</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Accounts receivable</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>14,666</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>14,666</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Prepaid expenses</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>446</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(10)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>436</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Property and equipment</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>170</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>170</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Intangible assets:</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Developed technology <sup>(1)</sup></font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">22,400</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(300)</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">22,100</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>In-process research and development <sup>(2)</sup></font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,600</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,600</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total assets</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">64,807</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(310)</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">64,497</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp; Accounts payable</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(3,379)</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>75</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(3,304)</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp; Other current liabilities</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(6,351)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(393)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(6,744) </font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp; L<font style=COLOR:black>iability related to sale of future royalties</font></font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(16,300)</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>400</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(15,900)</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net assets acquired</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>38,777</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(228)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>38,549</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp; Purchase price</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(31,789)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(31,789)</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp; Bargain purchase gain <sup>(3)</sup></font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6,988</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(228)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6,760</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection3'>__________</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.25in; TEXT-INDENT:-0.25in; page:WordSection3'><font style=FONT-SIZE:10pt>(1)&nbsp;&nbsp; <font style=COLOR:black>Developed technology comprises Inavir and Relenza, both influenza vaccines on which the Company is presently receiving royalty revenue, which, based on valuations prepared by an independent third party based on estimated discounted cash flows based on probability-weighted future development expenditures and revenue streams provided by the Company&#146;s management, are being amortized on a straight-line basis over the estimated periods of future royalties of 11.75 and 1.3 years, respectively.</font> </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.25in; TEXT-INDENT:-0.25in; page:WordSection3'><font style=FONT-SIZE:10pt>(2)&nbsp;&nbsp; In-process research and development (see Note 5) related to teslexivir, or BTA074, a direct-acting antiviral that, at the time of the Merger, was being actively developed as a treatment for genital warts. The <font style=COLOR:black>valuation was prepared by an independent third party based on estimated discounted cash flows based on probability-weighted future development expenditures and revenue streams provided by the Company&#146;s management.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.25in; TEXT-INDENT:-0.25in; page:WordSection3'><font style=FONT-SIZE:10pt>(3)&nbsp;&nbsp; <font style=COLOR:black>The bargain purchase gain represents the excess of the fair value of tangible and identified intangible assets, less liabilities, acquired over the purchase price.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>97</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>In addition, the Company incurred and expensed costs directly related to the Merger totaling approximately <font style=COLOR:black>$0.5 million and $0.9 million in the years ended </font>December&nbsp;31<font style=COLOR:black>, 2018 and 2017, respectively, which are included in </font>general and administrative expenses <font style=COLOR:black>in the consolidated statement of operations and comprehensive loss</font>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>Selected amounts related to Aviragen&#146;s business included in the Company&#146;s consolidated statement of operations for the year ended December 31, 2018, are as follows (in thousands):</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:600pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=80% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:80.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Revenue</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>$</p></td> <td width=17% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:17.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>2,815</p></td></tr> <tr> <td width=80% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:80.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.76%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:17.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=80% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:80.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Net loss</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>$</p></td> <td width=17% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:17.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>(3,847)</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The unaudited pro forma information in the table below summarizes the combined results of operations of Vaxart Biosciences, Inc. with those of Aviragen as though these entities were combined as of January&nbsp;1, 2017. The results of Aviragen&#146;s business for the year ended </font><font style=FONT-SIZE:10pt>December</font><font style="FONT-SIZE:10pt; COLOR:black"> 31, 2017, are based on information used to prepare its audited consolidated financial statements prepared for the year ended </font><font style=FONT-SIZE:10pt>June 30</font><font style="FONT-SIZE:10pt; COLOR:black">, 2017, as adjusted by information used to prepare its unaudited condensed consolidated financial statements prepared for the six months ended </font><font style=FONT-SIZE:10pt>December 31</font><font style="FONT-SIZE:10pt; COLOR:black">, 2017 and 2016. The results of Aviragen&#146;s business for the year ended </font><font style=FONT-SIZE:10pt>December</font><font style="FONT-SIZE:10pt; COLOR:black"> 31, 2018, are based on the Company&#146;s results of operations, with the results increased by Aviragen&#146;s activities in the forty-three days prior to the closing of the Merger. The pro forma financial information for both years presented also includes the removal of direct acquisition-related costs, the reduction in interest expense on borrowing converted into equity in the reverse merger, and the actual depreciation and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets had been applied as of January&nbsp;1, 2017. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">This unaudited pro forma information is summarized as follows:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=5 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Year&nbsp;Ended&nbsp;December 31,</font></b></p></td></tr> <tr style=HEIGHT:2.15pt> <td width=70% style="HEIGHT:2.15pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:2.15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% nowrap style="HEIGHT:2.15pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:2.15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2017</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=5 nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td></tr> <tr style=HEIGHT:12.25pt> <td width=70% style="HEIGHT:12.25pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">Total revenue</font></p></td> <td width=2% nowrap style="HEIGHT:12.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>$</p></td> <td width=12% nowrap style="HEIGHT:12.25pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>15,695</p></td> <td width=2% nowrap style="HEIGHT:12.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:12.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>$</p></td> <td width=12% nowrap style="HEIGHT:12.25pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>13,527</p></td></tr> <tr style=HEIGHT:12.25pt> <td width=70% style="HEIGHT:12.25pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 27pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:12.25pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:12.25pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:12.25pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:12.25pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:12.25pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:12.25pt> <td width=70% style="HEIGHT:12.25pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">Net loss</font></p></td> <td width=2% nowrap style="HEIGHT:12.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>$</p></td> <td width=12% nowrap style="HEIGHT:12.25pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>(13,162)</p></td> <td width=2% nowrap style="HEIGHT:12.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:12.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>$</p></td> <td width=12% nowrap style="HEIGHT:12.25pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>(29,270)</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style='FONT-SIZE:10pt; FONT-FAMILY:"inherit","serif"'>The pro forma financial information as presented above is for informational purposes only and is not indicative of the consolidated results of operations of future periods or the results of operations that would have been achieved had the acquisition had taken place on January&nbsp;1, 2017. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">NOTE 4.&nbsp;&nbsp;</font></b><b><font style=FONT-SIZE:10pt>Fair Value of Financial Instruments</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'>Fair value accounting is applied for all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). Financial instruments include cash and cash equivalents, short&#8209;term investments, accounts receivable, accounts payable and accrued liabilities that approximate fair value due to their relatively short maturities. As short&#8209;term investments are classified as held&#8209;to&#8209;maturity, they are recorded at their amortized cost.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'>Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance also establishes a three&#8209;level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows<font style=COLOR:black>:</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>98</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.45pt 12pt 0.5in; page:WordSection3'><font style=FONT-SIZE:10pt>Level&nbsp;1&nbsp;&#150;&nbsp;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.45pt 12pt 0.5in; page:WordSection3'><font style=FONT-SIZE:10pt>Level&nbsp;2&nbsp;&#150;&nbsp;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt -0.45pt 12pt 0.5in; page:WordSection3'><font style=FONT-SIZE:10pt>Level&nbsp;3&nbsp;&#150;&nbsp;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The Company&#146;s money market funds are classified within Level&nbsp;1 of the fair value hierarchy and are valued based on quoted prices in active markets for identical securities. The Company&#146;s corporate bonds and commercial paper are classified within Level&nbsp;2 of the fair value hierarchy and are valued based on quoted prices for similar assets or prices derived from observable market data. Level&nbsp;3 liabilities consist of convertible promissory notes embedded derivative liabilities and a convertible preferred stock warrant liability as they are valued by using inputs that are unobservable in the market. The determination of the fair values of the convertible promissory notes embedded derivative is discussed in Note&nbsp;8.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The following tables present the Company&#146;s financial assets and liabilities that are measured at fair value at December 31, 2018 and 2017:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.7%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Level&nbsp;1</font></b></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Level&nbsp;2</font></b></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Level&nbsp;3</font></b></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Total</font></b></p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:10pt>December 31<font style=COLOR:black>, 2018</font></font></b></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=24% colspan=4 style="WIDTH:24.12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Recurring Financial Assets:</font></p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Money Market Funds</font></p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Corporate Bonds</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.8in; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total assets</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Recurring Financial Liabilities:</font></p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible promissory notes embedded </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp; derivative liability</font></p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.28%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.36%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible preferred stock warrant liability</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.36%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.8in; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.36%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total liabilities</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.36%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.7%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Level&nbsp;1</font></b></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Level&nbsp;2</font></b></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Level&nbsp;3</font></b></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.62%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Total</font></b></p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:10pt>December 31, 2017</font></b></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=24% colspan=4 style="WIDTH:24.12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:10.38%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Recurring Financial Assets:</font></p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Money Market Funds</font></p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,192</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.38%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,192</font></p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Corporate Bonds</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,415</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.38%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,415</font></p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.8in; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.38%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total assets</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,192</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,415</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.38%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,607</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Recurring Financial Liabilities:</font></p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible promissory notes embedded </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp; derivative liability</font></p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.28%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.36%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.4%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible preferred stock warrant liability</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.36%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td></tr> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.8in; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.36%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=47% style="WIDTH:47.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total liabilities</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.3%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.36%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td> <td width=2% style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>99</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><font style=FONT-SIZE:10pt> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The following tables present a reconciliation of all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level&nbsp;3) for the years ended </font><font style=FONT-SIZE:10pt>December 31<font style=COLOR:black>, 2018 and 2017:</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:9.35pt> <td width=57% style="HEIGHT:9.35pt; WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=11% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible </font></p> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Preferred Stock</font></p> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Warrant Liability</font></p></td> <td width=2% nowrap style="HEIGHT:9.35pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=11% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible Promissory</font></p> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Notes Embedded</font></p> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Derivative Liability</font></p></td> <td width=2% nowrap style="HEIGHT:9.35pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=11% colspan=2 nowrap style="HEIGHT:9.35pt; WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:9.95pt> <td width=57% style="HEIGHT:9.95pt; WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.95pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.95pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=11% colspan=2 nowrap style="HEIGHT:9.95pt; WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:9.35pt> <td width=57% style="HEIGHT:9.35pt; WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.35pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.35pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=11% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total</font></p></td></tr> <tr style=HEIGHT:9.95pt> <td width=57% style="HEIGHT:9.95pt; WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.95pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="HEIGHT:9.95pt; WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.95pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:9.95pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:9.95pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>(in thousands)</font></p></td> <td width=2% nowrap style="HEIGHT:9.95pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:9.95pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:9.95pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:11.1pt> <td width=57% style="HEIGHT:11.1pt; WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Balance at January&nbsp;1, 2018</font></p></td> <td width=2% nowrap style="HEIGHT:11.1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="HEIGHT:11.1pt; WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td> <td width=2% nowrap style="HEIGHT:11.1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:11.1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="HEIGHT:11.1pt; WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:11.1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:11.1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="HEIGHT:11.1pt; WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td></tr> <tr style=HEIGHT:10.55pt> <td width=57% style="HEIGHT:10.55pt; WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Issuances</font></p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="HEIGHT:10.55pt; WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="HEIGHT:10.55pt; WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="HEIGHT:10.55pt; WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:9.9pt> <td width=57% style="HEIGHT:9.9pt; WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Revaluation loss included in (loss) gain on revaluation </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp; of financial instruments, net</font></p></td> <td width=2% nowrap style="HEIGHT:9.9pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="HEIGHT:9.9pt; WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>3</font></p></td> <td width=2% nowrap style="HEIGHT:9.9pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.9pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="HEIGHT:9.9pt; WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:9.9pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.9pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="HEIGHT:9.9pt; WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>3</font></p></td></tr> <tr style=HEIGHT:10.55pt> <td width=57% style="HEIGHT:10.55pt; WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Settlements</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(70)</font></p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(70)</font></p></td></tr> <tr style=HEIGHT:11.1pt> <td width=57% style="HEIGHT:11.1pt; WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Balance at December 31, 2018</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:11.1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:11.1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:10.55pt> <td width=57% style="HEIGHT:10.55pt; WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:22.3pt> <td width=57% style="HEIGHT:22.3pt; WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total losses included in other income and (expenses) <br>&nbsp;&nbsp;&nbsp; attributable to liabilities still held as of December 31, 2018</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:22.3pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:22.3pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:9.35pt> <td width=56% style="HEIGHT:9.35pt; WIDTH:56.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:12.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible </font></p> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Preferred Stock</font></p> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Warrant Liability</font></p></td> <td width=1% nowrap style="HEIGHT:9.35pt; WIDTH:1.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:14.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible Promissory</font></p> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Notes Embedded</font></p> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Derivative Liability</font></p></td> <td width=1% nowrap style="HEIGHT:9.35pt; WIDTH:1.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="HEIGHT:9.35pt; WIDTH:12.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:9.95pt> <td width=56% style="HEIGHT:9.95pt; WIDTH:56.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:9.95pt; WIDTH:1.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:9.95pt; WIDTH:1.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="HEIGHT:9.95pt; WIDTH:12.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:9.35pt> <td width=56% style="HEIGHT:9.35pt; WIDTH:56.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:9.35pt; WIDTH:1.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:9.35pt; WIDTH:1.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in' align=center>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:12.62%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:8pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total</font></p></td></tr> <tr style=HEIGHT:9.95pt> <td width=56% style="HEIGHT:9.95pt; WIDTH:56.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:9.95pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="HEIGHT:9.95pt; WIDTH:10.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:9.95pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:9.95pt; BORDER-RIGHT:0px; WIDTH:2.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:9.95pt; BORDER-RIGHT:0px; WIDTH:12.16%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>(in thousands)</font></p></td> <td width=1% nowrap style="HEIGHT:9.95pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:9.95pt; BORDER-RIGHT:0px; WIDTH:1.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:9.95pt; BORDER-RIGHT:0px; WIDTH:10.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:11.1pt> <td width=56% style="HEIGHT:11.1pt; WIDTH:56.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Balance at January&nbsp;1, 2017</font></p></td> <td width=1% nowrap style="HEIGHT:11.1pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% nowrap style="HEIGHT:11.1pt; WIDTH:10.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>134</font></p></td> <td width=1% nowrap style="HEIGHT:11.1pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:11.1pt; WIDTH:2.22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="HEIGHT:11.1pt; WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>3,280</font></p></td> <td width=1% nowrap style="HEIGHT:11.1pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:11.1pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% nowrap style="HEIGHT:11.1pt; WIDTH:10.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>3,414</font></p></td></tr> <tr style=HEIGHT:10.55pt> <td width=56% style="HEIGHT:10.55pt; WIDTH:56.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Issuances</font></p></td> <td width=1% nowrap style="HEIGHT:10.55pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="HEIGHT:10.55pt; WIDTH:10.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% nowrap style="HEIGHT:10.55pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:10.55pt; WIDTH:2.22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:10.55pt; WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% nowrap style="HEIGHT:10.55pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:10.55pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="HEIGHT:10.55pt; WIDTH:10.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:9.9pt> <td width=56% style="HEIGHT:9.9pt; WIDTH:56.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Revaluation gains included in (loss) gain on revaluation </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'><font style=FONT-SIZE:10pt>of financial instruments, net</font></p></td> <td width=1% nowrap style="HEIGHT:9.9pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="HEIGHT:9.9pt; WIDTH:10.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(67)</font></p></td> <td width=1% nowrap style="HEIGHT:9.9pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.9pt; WIDTH:2.22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:9.9pt; WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(3,280)</font></p></td> <td width=1% nowrap style="HEIGHT:9.9pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:9.9pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="HEIGHT:9.9pt; WIDTH:10.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(3,347)</font></p></td></tr> <tr style=HEIGHT:10.55pt> <td width=56% style="HEIGHT:10.55pt; WIDTH:56.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Settlements</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:1.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:10.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% nowrap style="HEIGHT:10.55pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:2.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:12.16%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% nowrap style="HEIGHT:10.55pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:1.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:10.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:11.1pt> <td width=56% style="HEIGHT:11.1pt; WIDTH:56.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Balance at December 31, 2017</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:1.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:10.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td> <td width=1% nowrap style="HEIGHT:11.1pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:2.22%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:12.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% nowrap style="HEIGHT:11.1pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:1.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:10.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td></tr> <tr style=HEIGHT:10.55pt> <td width=56% style="HEIGHT:10.55pt; WIDTH:56.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:1.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:10.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:10.55pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:2.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:12.16%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:10.55pt; WIDTH:1.8%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:1.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:10.55pt; BORDER-RIGHT:0px; WIDTH:10.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:22.3pt> <td width=56% style="HEIGHT:22.3pt; WIDTH:56.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total gains included in other income and (expenses) <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; attributable to liabilities still held as of December&nbsp;31, 2017</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:1.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:10.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td> <td width=1% nowrap style="HEIGHT:22.3pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:2.22%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:12.16%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>3,280</font></p></td> <td width=1% nowrap style="HEIGHT:22.3pt; WIDTH:1.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:1.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% nowrap style="BORDER-TOP:0px; HEIGHT:22.3pt; BORDER-RIGHT:0px; WIDTH:10.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>3,347</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;5.&nbsp;&nbsp;Balance Sheet Components</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection3'><b><i><font style=FONT-SIZE:10pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></font></i></b><b><i><font style=FONT-SIZE:10pt>Cash</font></i></b><b><i><font style=FONT-SIZE:10pt> Equivalents and Short-Term Investments</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection3'>Cash equivalents and short&#8209;term investments, all of which are classified as held&#8209;to&#8209;maturity securities and mature within one year, consisted of the following:</p> <div style=page:WordSection3> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0 align=center> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=64% colspan=14 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:64.9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:9pt; COLOR:black">December 31, 2018</font></b></p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=9% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:9.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=1% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Gross</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Unrecognized</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Gains</font></b></p></td> <td width=1% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Gross</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Unrecognized</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Losses</font></b></p></td> <td width=1% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Estimated</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Fair</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Value</font></b></p></td> <td width=1% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.04%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Carrying</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Value</font></b></p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.92%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" rowspan=2 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Amortized</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Cost</font></b></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:9.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.72%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:10.46%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:10.74%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>(in thousands)</font></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.48%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:9.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:9.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Money market funds</font></p></td> <td width=1% style="WIDTH:1.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Corporate bonds</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:10.75pt> <td width=35% style="HEIGHT:10.75pt; WIDTH:35.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=1% style="HEIGHT:10.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="HEIGHT:10.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="HEIGHT:10.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=1% style="HEIGHT:10.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td></tr> <tr style=HEIGHT:11.1pt> <td width=35% style="HEIGHT:11.1pt; WIDTH:35.1%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Reported as:</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="HEIGHT:11.1pt; WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="HEIGHT:11.1pt; WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="HEIGHT:11.1pt; WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="HEIGHT:11.1pt; WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:11.1pt; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Cash equivalents</font></p></td> <td width=1% style="WIDTH:1.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Short-term investments</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:11.65pt> <td width=35% style="HEIGHT:11.65pt; WIDTH:35.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=1% style="HEIGHT:11.65pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="HEIGHT:11.65pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="HEIGHT:11.65pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td> <td width=1% style="HEIGHT:11.65pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection3'>&nbsp;</p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>100</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <div style=page:WordSection3> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0 align=center> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=64% colspan=14 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:64.9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:9pt; COLOR:black">December 31, 2017</font></b></p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=9% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:9.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=1% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12.18%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Gross</font></b></p></td> <td width=1% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Gross</font></b></p></td> <td width=1% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Estimated</font></b></p></td> <td width=1% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% colspan=2 style="WIDTH:10.92%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Amortized</font></b></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="WIDTH:12.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Unrecognized</font></b></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="WIDTH:11.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Unrecognized</font></b></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="WIDTH:11.12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Fair</font></b></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="WIDTH:11.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Carrying</font></b></p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.92%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Cost</font></b></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">Gains</font></b></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Losses</font></b></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Value</font></b></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.04%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Value</font></b></p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:9.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.72%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:10.46%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:10.74%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:8pt>(in thousands)</font></p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.48%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:9.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:9.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Money market funds</font></p></td> <td width=1% style="WIDTH:1.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,192</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,192</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,192</font></p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Corporate bonds</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,415</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,415</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,415</font></p></td></tr> <tr style=HEIGHT:10.75pt> <td width=35% style="HEIGHT:10.75pt; WIDTH:35.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,607</font></p></td> <td width=1% style="HEIGHT:10.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="HEIGHT:10.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="HEIGHT:10.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,607</font></p></td> <td width=1% style="HEIGHT:10.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,607</font></p></td></tr> <tr style=HEIGHT:9.75pt> <td width=35% style="HEIGHT:9.75pt; WIDTH:35.1%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Reported as:</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="HEIGHT:9.75pt; WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="HEIGHT:9.75pt; WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="HEIGHT:9.75pt; WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="HEIGHT:9.75pt; WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:9.75pt; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Cash equivalents</font></p></td> <td width=1% style="WIDTH:1.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,192</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,192</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="WIDTH:9.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,192</font></p></td></tr> <tr> <td width=35% style="WIDTH:35.1%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Short-term investments</font></p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,415</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,415</font></p></td> <td width=1% style="WIDTH:1.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,415</font></p></td></tr> <tr style=HEIGHT:11.65pt> <td width=35% style="HEIGHT:11.65pt; WIDTH:35.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,607</font></p></td> <td width=1% style="HEIGHT:11.65pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:10.46%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="HEIGHT:11.65pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:10.74%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=1% style="HEIGHT:11.65pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.48%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:9.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,607</font></p></td> <td width=1% style="HEIGHT:11.65pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:1.14%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=9% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:9.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,607</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection3'><b></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection3'><b><i>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b><b><i>Accounts Receivable</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection3'>Accounts receivable comprises the following:</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 1in' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:9pt; COLOR:black">December</font></b><b><font style=FONT-SIZE:8pt> 31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>December&nbsp;31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2017</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 1in' align=center>&nbsp;</p></td> <td width=12% colspan=5 style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Royalties receivable</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,776</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Government contract &#150; billed</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>20</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>477</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Government contract &#150; unbilled</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>153</font></p></td></tr> <tr style=HEIGHT:10.75pt> <td width=70% style="HEIGHT:10.75pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Accounts receivable</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,796</font></p></td> <td width=2% style="HEIGHT:10.75pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:10.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>630</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.25in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection3'><b><i>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b><b><i>Property and Equipment, Net</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection3'>Property and equipment, net consists of the following:</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:10.9pt> <td width=70% style="HEIGHT:10.9pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 1in' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:10.9pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:9pt; COLOR:black">December</font></b><b><font style=FONT-SIZE:8pt> 31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% style="HEIGHT:10.9pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:10.9pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>December&nbsp;31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2017</font></b></p></td></tr> <tr style=HEIGHT:8.95pt> <td width=70% style="HEIGHT:8.95pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 1in' align=center>&nbsp;</p></td> <td width=37% colspan=5 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td></tr> <tr style=HEIGHT:11.5pt> <td width=70% style="HEIGHT:11.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Laboratory equipment</font></p></td> <td width=2% style="HEIGHT:11.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="HEIGHT:11.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,076</font></p></td> <td width=2% style="HEIGHT:11.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:11.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="HEIGHT:11.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,565</font></p></td></tr> <tr style=HEIGHT:12.2pt> <td width=70% style="HEIGHT:12.2pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Office and computer equipment</font></p></td> <td width=2% style="HEIGHT:12.2pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:12.2pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>227</font></p></td> <td width=2% style="HEIGHT:12.2pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:12.2pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:12.2pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>175</font></p></td></tr> <tr style=HEIGHT:11.5pt> <td width=70% style="HEIGHT:11.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Leasehold improvements</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>333</font></p></td> <td width=2% style="HEIGHT:11.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>226</font></p></td></tr> <tr style=HEIGHT:11.5pt> <td width=70% style="HEIGHT:11.5pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:11.5pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:11.5pt> <td width=70% style="HEIGHT:11.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp; Total property and equipment</font></p></td> <td width=2% style="HEIGHT:11.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:11.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,636</font></p></td> <td width=2% style="HEIGHT:11.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:11.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:11.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,966</font></p></td></tr> <tr style=HEIGHT:19.35pt> <td width=70% style="HEIGHT:19.35pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Less: accumulated depreciation</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:19.35pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:19.35pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(1,570)</font></p></td> <td width=2% style="HEIGHT:19.35pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:19.35pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:19.35pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(1,236)</font></p></td></tr> <tr style=HEIGHT:20.25pt> <td width=70% style="HEIGHT:20.25pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Property and equipment, net</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:20.25pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:20.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,066</font></p></td> <td width=2% style="HEIGHT:20.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:20.25pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:20.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>730</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Depreciation expense was $476,000 and $376,000 for the years ended December&nbsp;31, 2018 and 2017, respectively. Leasehold improvements and furniture at the Company&#146;s leased premises in Georgia, which has been subleased, commencing in November 2018, for less than the rental that the Company is obligated to pay (see Note 10), were assessed as impaired as of September 30, 2018, and accordingly an impairment charge of $106,000 was recorded as a component of costs of <font style=FONT-SIZE:9.5pt>exit from leased premises</font> within operating expenses.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>101</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.25in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection3'><b><i>(d)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b><b><i>Intangible Assets</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection3'>Intangible assets consist of the following:</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 36.55pt; TEXT-INDENT:-9pt'>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:9pt; COLOR:black">December</font></b><b><font style=FONT-SIZE:8pt>&nbsp;31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>February 13,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.7pt; TEXT-INDENT:-0.7pt'>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>December&nbsp;31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2017</font></b></p></td></tr> <tr style=HEIGHT:9.35pt> <td width=57% style="HEIGHT:9.35pt; WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 36.55pt; TEXT-INDENT:-9pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:9.35pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td> <td width=2% style="HEIGHT:9.35pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:9.35pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Purchased technology</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>22,100</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>22,400</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>In-process research and development</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,600</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Intellectual property</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>80</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>80</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>80</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total cost</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>22,180</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>24,080</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>80</font></p></td></tr> <tr style=HEIGHT:0.2in> <td width=57% style="HEIGHT:0.2in; WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Less accumulated amortization</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,767</font></p></td> <td width=2% style="HEIGHT:0.2in; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>40</font></p></td> <td width=2% style="HEIGHT:0.2in; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:11%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>40</font></p></td></tr> <tr style=HEIGHT:17.5pt> <td width=57% style="HEIGHT:17.5pt; WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0.7pt; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Intangible assets, net</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>19,413</font></p></td> <td width=2% style="HEIGHT:17.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>24,040</font></p></td> <td width=2% style="HEIGHT:17.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>40</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Intangible asset amortization expense was $2,727,000 and $4,000 for the years ended December 31, 2018 and 2017, respectively. Following the results of Phase 2 trials in June 2018, the in-process research and development was assessed as fully impaired in the three months ended June&nbsp;30, 2018, with the $1.6 million acquired in the Merger (see Note 3) being charged to operating expenses. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>As of December 31, 2018, the estimated future amortization expense by year is as follows (in thousands):</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=82% style="WIDTH:82%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Year Ending December 31,</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=16% nowrap style="WIDTH:16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=82% style="WIDTH:82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>2019</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=16% nowrap style="WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,320</font></p></td></tr> <tr> <td width=82% style="WIDTH:82%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>2020</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=16% nowrap style="WIDTH:16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,732</font></p></td></tr> <tr> <td width=82% style="WIDTH:82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>2021</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=16% nowrap style="WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,732</font></p></td></tr> <tr> <td width=82% style="WIDTH:82%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>2022</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=16% nowrap style="WIDTH:16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,732</font></p></td></tr> <tr> <td width=82% style="WIDTH:82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>2023</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=16% nowrap style="WIDTH:16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,731</font></p></td></tr> <tr> <td width=82% style="WIDTH:82%; BACKGROUND:white; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Thereafter</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=16% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:16%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>10,166</font></p></td></tr> <tr style=HEIGHT:13pt> <td width=82% style="HEIGHT:13pt; WIDTH:82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=16% nowrap style="BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:16%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>19,413</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0.25in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection3'><b><i>(e)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b><b><i>Other Accrued Liabilities</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection3'>Accrued liabilities consist of the following:</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 1in' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>December&nbsp;31,&nbsp;2018</font></b></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>December&nbsp;31,&nbsp;2017</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 1in' align=center>&nbsp;</p></td> <td width=12% colspan=5 style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Accrued compensation</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>632</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,320</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Accrued clinical and manufacturing expenses</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>75</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>69</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Accrued professional and consulting services</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>166</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>113</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Reserve for return of royalties</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>339</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Deferred rent and lease loss accrual, current portion</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>111</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>21</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible preferred stock warrant liability</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>67</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Other</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>195</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,518</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,605</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;6.&nbsp;&nbsp;Revenue</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection3'><i><font style=FONT-SIZE:10pt>U.S. Government HHS BARDA Contract</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>In September&nbsp;2015, HHS BARDA awarded the Company a contract to support the advanced development of a more effective and universal influenza vaccine to improve seasonal and pandemic influenza preparedness. On each of May&nbsp;25 and July 18, 2017, and June 28, 2018, the Company entered into a Modification of Contract with HHS BARDA, the combined effect being to increase the value of the existing $14&nbsp;million contract by $1.7&nbsp;million and to extend it through September 30, 2018. The modified contract is a cost-plus-fixed-fee contract, which reimburses the Company for allowable direct contract costs plus allowable indirect costs and a fixed-fee, totaling $15.7&nbsp;million. The Company recognized revenue of $1,344,000 and $5,839,000 during the years ended December 31, 2018 and 2017, respectively. As of December 31, 2018, the cumulative revenue recorded from inception under the HHS BARDA contract represents the maximum amount billable under the contract as presently modified, with no further change orders envisaged.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>102</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>Billings under the contract are based on approved provisional indirect billing rates, which permit recovery of fringe benefits, overhead and general and administrative expenses. Indirect rates as well as allowable costs are subject to audit by HHS BARDA on an annual basis. Management believes that revenues recognized to date have been recorded in amounts that are expected to be realized upon final audit and settlement. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly in the period that the adjustments are known and collection is probable. Costs relating to contract acquisition are expensed as incurred. The Company does not consider any of the revenue recorded as of December 31, 2018 or 2017, to be at risk of reversal. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><i><font style="FONT-SIZE:10pt; COLOR:black">Royalty agreements</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">Aviragen entered into a royalty-bearing research and license agreement with GlaxoSmithKline, plc (&#147;GSK&#148;) in 1990 for the development and commercialization of zanamivir, a neuraminidase inhibitor marketed by GSK as Relenza<sup> </sup>to treat influenza. Most of the Company&#146;s Relenza patents have expired and the only substantial remaining intellectual property related to the Relenza patent portfolio, which is solely owned by the Company and exclusively licensed to GSK, is scheduled to expire in July 2019 in Japan<font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif; COLOR:black'>, at which time royalty revenue will cease</font>. The post-Merger royalty revenue related to Relenza<sup> </sup>recognized in the year ended </font><font style=FONT-SIZE:10pt>December <font style=COLOR:black>31, 2018, was $788,000, representing 7% of net sales in Japan.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The Company also generates royalty revenue from the sale of Inavir in Japan, pursuant to a collaboration and license agreement that Aviragen entered into with Daiichi Sankyo Company, Limited, or Daiichi Sankyo, in 2009. In September 2010, laninamivir octanoate was approved for sale by the Japanese Ministry of Health and Welfare for the treatment of influenza in adults and children, which Daiichi Sankyo markets as Inavir. Under the agreement, the Company currently receives a 4% royalty on net sales of Inavir in Japan and was eligible to earn sales milestone payments, including a one-off payment of $5.0 million if net sales exceeded 20 billion Yen in one year. This target was achieved in the three months ended March 31, 2018, prior to the Merger, and Aviragen recognized the related $5.0 million as royalty revenue prior to the Merger. The last patent related to Inavir is set to expire in December 2029 in Japan, at which time royalty revenue will cease. The post-Merger royalty revenue related to Inavir<sup> </sup>recognized in the year ended </font><font style=FONT-SIZE:10pt>December <font style=COLOR:black>31, 2018, was $552,000. In addition, the Company recognized </font></font><font style=FONT-SIZE:9.5pt>non-cash royalty revenue related to the sale of future royalties (see Note 7) of $1,475,000.</font><font style=FONT-SIZE:10pt>Both the royalty revenue and the </font><font style=FONT-SIZE:9.5pt>non-cash royalty revenue related to the sale of future royalties</font><font style=FONT-SIZE:10pt>have been subjected to a 5% withholding tax <font style=COLOR:black>in Japan, for which $102,000 was included in income tax expense in the year ended </font>December <font style=COLOR:black>31, 2018.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;7.&nbsp; <font style=COLOR:black>Liabilities Related to Sale of Future Royalties</font></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">In April 2016, Aviragen entered into a Royalty Interest Acquisition Agreement (the &#147;HCRP Agreement&#148;) with HCRP. Under the Agreement, HCRP made a $20.0 million cash payment to Aviragen in consideration for acquiring certain royalty rights (&#147;Royalty Rights&#148;) related to the approved product Inavir in the Japanese market. The Royalty Rights were obtained pursuant to the collaboration and license agreements (the &#147;License Agreement&#148;) and a commercialization agreement that the Company entered into with Daiichi Sankyo. Per the terms of the HCRP Agreement, HCRP is entitled to the first $3.0 million plus 15% of the next $1.0 million in royalties earned in each year commencing on April 1, with any excess revenue being retained by the Company.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">Under the relevant accounting guidance, due to a limit on the amount of royalties that HCRP can earn under the arrangement, this transaction was accounted for as a liability that will be amortized using the interest method over the life of the arrangement. The Company has no obligation to pay any amounts to HCRP other than to pass through to HCRP its share of royalties as they are received from Daiichi Sankyo. In order to record the amortization of the liability, the Company is required to estimate the total amount of future royalty payments to be received under the License Agreement and the payments that will be passed through to HCRP over the life of this agreement. The sum of the pass-through amounts less the net proceeds received will be recorded as non-cash interest expense over the life of the liability. Consequently, the Company imputes interest on the unamortized portion of the liability and records non-cash interest expense using an estimated effective interest rate. The Company will periodically assess the expected royalty payments, and to the extent such payments are greater or less than the initial estimate, the Company will adjust the amortization of the liability and interest rate. As a result of this accounting, even though the Company does not retain HCRP&#146;s share of the royalties, it will continue to record non-cash revenue related to those royalties until the amount of the associated liability and related interest is fully amortized.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>103</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The following table shows the activity within the liability account since the Merger (in thousands):</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=84% style="WIDTH:84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total Liability related to sale of future royalties, February 13, 2018</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=14% nowrap style="WIDTH:14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>15,900</font></p></td></tr> <tr> <td width=84% style="WIDTH:84%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Non-cash royalty revenue paid to HCRP</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% nowrap style="WIDTH:14%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(18)</font></p></td></tr> <tr> <td width=84% style="WIDTH:84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Non-cash interest expense recognized</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,859</font></p></td></tr> <tr style=HEIGHT:11.65pt> <td width=84% style="HEIGHT:11.65pt; WIDTH:84%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total<font style=COLOR:black> Liability related to sale of future royalties, </font>December <font style=COLOR:black>31, 2018</font></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:11.65pt; BORDER-RIGHT:0px; WIDTH:14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>17,741</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 0pt; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;8.&nbsp;&nbsp;Convertible Promissory Notes, Related Parties</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>On December&nbsp;10, 2014, the Company entered into a note purchase agreement with certain existing preferred stockholders under which the Company issued convertible promissory notes during December&nbsp;2014 for total proceeds of $18.4&nbsp;million.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>On November&nbsp;20, 2015, the Company entered into a second note purchase agreement with certain existing preferred stockholders under which the Company issued convertible promissory notes during November&nbsp;and December&nbsp;2015 for total proceeds of $11.0&nbsp;million. These notes were issued with the same terms as the notes issued in 2014.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>As the holders of the convertible promissory notes each have an equity ownership in the Company, the convertible promissory notes were considered to be a related&#8209;party transaction.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The convertible promissory notes bore interest at a rate of 8.0% per annum. The principal and accrued interest on the notes were automatically convertible, upon a future issuance of convertible preferred stock having total proceeds of at least $25.0&nbsp;million, into that same stock at a conversion price equal to 90% of the price paid by other investors in the financing event. Upon a liquidation event, such as an acquisition or initial public offering, at the election of the majority of the noteholders in each issuance, the principal and accrued interest on the notes could either (i)&nbsp;be paid in full at the initial closing of the liquidation event, or (ii)&nbsp;automatically convert into the Company&#146;s Series&nbsp;C convertible preferred stock at a conversion price based on a specified valuation.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>After two&nbsp;years, if the notes had not been converted, the holders of a majority of the principal amount had the option to require the entire principal balance and accrued interest to become due and payable. However, in December&nbsp;2016, in conjunction with the loan agreement with Oxford Finance (see note&nbsp;9), all of the holders of convertible promissory notes signed subordination agreements, under which they agreed not to demand or receive any payment until all amounts owed to Oxford Finance under the loan agreement were fully paid in cash, thus extending the due dates of the promissory notes potentially to January 2021. This change reflected a <font style=COLOR:black>debt modification that was not considered substantially significant. Accordingly, the Company did not apply extinguishment accounting, but accounted for the modification on a prospective basis.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The convertible promissory notes had redemption features that were determined to be a compound embedded derivative requiring bifurcation and separate accounting at estimated fair value. The estimated fair value of the embedded derivative upon issuance was a liability of $1.9&nbsp;million for the notes issued in 2014 and $1.3&nbsp;million for the notes issued in 2015. The estimated fair value of these derivative instruments was recognized as a debt discount and as an embedded derivative liability on the balance sheet upon issuance of the convertible promissory notes. The embedded derivative required periodic re&#8209;measurements to fair value while the instruments were still outstanding (see Note 4). There was no beneficial conversion feature as the conversion feature value was accounted for in the embedded derivative.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The Company estimated the fair value of the compound embedded derivative utilizing a Monte Carlo Simulation model. The inputs used to determine the estimated fair value of the embedded derivative instrument included the probability of an underlying event triggering the redemption event and its timing prior to the maturity date of the convertible promissory notes. The fair value measurement was based upon significant inputs not observable in the market, including a valuation of the Company performed by an independent third-party at each balance sheet date. By December 31, 2017, the embedded derivative had zero value because the Merger (see Note 1), which was considered 90% probable of occurring, would not have triggered redemption and, had the Merger not occurred, it was unlikely that the Company would have found an alternative source of financing on favorable terms, so there would have been zero redemption value. The embedded derivative was extinguished when the Merger occurred on February 13, 2018.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>104</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The Company incurred total debt issuance costs of $20,000 in connection with the 2014 issuance and $7,000 in connection with the 2015 issuance. The debt issuance costs, which were recorded as an additional debt discount, were being amortized over the term of the notes.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>As of December 31, 2017, the balance of the convertible promissory notes was $35.3 million, comprising principal of $29.4 million plus accrued interest associated with the convertible promissory notes of $6.3&nbsp;million, offset by unamortized debt discount of $0.4 million. Interest expense related to the convertible promissory notes, including amortization of debt discount, totaled $0.3 million and $2.5 million in the years ended December 31, 2018 and 2017, respectively. The charge in 2018 related to the 43 days prior to the Merger, whereas the charge in 2017 related the full year.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>On February&nbsp;13, 2018, the balance of the convertible promissory notes was $35.6 million, comprising accrued interest associated with the convertible promissory notes amounted to $6.6&nbsp;million plus principal of $29.4 million, offset by the unamortized debt discount to $0.4 million. On that date, in conjunction with the Merger, the convertible promissory notes were exchanged for 1,571,702 shares of the Company&#146;s common stock which, based on the closing stock price of $9.05, had a value of $14.2 million. The difference of $21.4 million was recorded as a capital contribution<font style=COLOR:black>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;9.&nbsp;&nbsp;</font></b><b><font style=FONT-SIZE:10pt>Secured Promissory Note Payable to Oxford Finance</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>On December&nbsp;22, 2016, the Company entered into a loan and security agreement (the&nbsp;&#147;Loan Agreement&#148;) with Oxford Finance, under which the Company borrowed $5.0&nbsp;million. The $5.0&nbsp;million loan, which bears interest at 30-day U.S. LIBOR plus 6.17%, is evidenced by a secured promissory note and is repayable over four&nbsp;years, with interest only payable over the first 12 months and the balance fully amortized over the subsequent 36 months. The loan is secured by substantially all the Company&#146;s assets, except for intellectual property.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>In conjunction with the execution of the Loan Agreement, all the holders of convertible promissory notes signed subordination agreements, under which they agreed to subordinate in favor of Oxford Finance all amounts due under their promissory notes and any security interest in the Company&#146;s property. In addition, the holders of the notes agreed that they would not demand or receive any payment until all amounts owed to Oxford Finance under the Loan Agreement have been fully paid in cash. Upon repayment, an additional final payment equal to $325,000 is due, which is being accreted as interest expense over the term of the loan using the effective&#8209;interest method.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>In connection with the Loan Agreement, the Company issued a warrant to Oxford Finance to purchase 7,563&nbsp;shares of its Series&nbsp;C convertible preferred stock at an exercise price of $33.11&nbsp;per share (the&nbsp;&#147;Warrant&#148;). The fair value of the Warrant at the date of issuance was approximately $134,000, which was recorded as debt discount and is being amortized as interest expense over the term of the loan using the effective&#8209;interest method. The annual effective interest rate of the note, including the accretion of the final payment and the amortization of the debt discount, is approximately 10.5%. The Company recorded interest expense related to the Loan Agreement of $469,000 and $518,000 during the years ended December 31, 2018 and 2017, respectively, of which $356,000 and $335,000 was paid, respectively.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The Warrant provided that if the share price at the next equity financing was less than the Warrant exercise price, then the Warrant would be for the new class of shares, the exercise price would be the new class share price, and the number of shares would be calculated by dividing $250,000 by the new class share price. Due to this anti-dilution protection, the Company determined that the Warrant needed to be recorded as a liability, and therefore estimated the fair value of the Warrant upon issuance and at each balance sheet date, with any changes in the fair value being recorded within (loss) gain on revaluation of financial instruments, net in other income and (expenses) in the statements of operations and comprehensive loss. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Due to the antidilution protection, following the Merger, the Warrant was amended to allow the holder to purchase 10,914 shares of common stock at an exercise price of $22.99 per share. Since the amended Warrant contains no non-standard antidilution protections or similar features, the fair value of approximately $70,000 on February 13, 2018, was reclassified to equity.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>105</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 0pt; page:WordSection3'><b>NOTE 10.&nbsp; Commitments and Contingencies</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection3'><b><i>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b><b><i>Leases</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The Company has four&nbsp;office and research and development facilities in South San Francisco, California, under noncancelable operating leases. The principal lease, for office and research and development premises, expires on April&nbsp;30, 2020, subject to the Company&#146;s option to extend the lease at the then market rate for an additional five&#8209;year period. The remaining three leases all expire on August 31, 2019. In addition, as a result of the Merger, the Company also leases office space in Alpharetta, Georgia, under a lease expiring on February 28, 2021, which, commencing in November 2018, the Company has subleased for the remainder of the lease term for less than it is required to pay under the head lease and accordingly it recorded a lease loss charge of $253,000 on the cease-use date in the three months ending December 31, 2018, which, along with the related impairment of property and equipment (see Note 5), was recorded as a component of costs of <font style=FONT-SIZE:9.5pt>exit from leased premises</font> within operating expenses.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; page:WordSection3'>Liabilities related to costs of exit from leased premises are summarized as follows (in thousands):</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; page:WordSection3'>&nbsp;</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=78% style="WIDTH:78.74%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 27pt; TEXT-INDENT:-9pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% nowrap style="WIDTH:19.48%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=78% style="WIDTH:78.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>Balance as of January 1, 2018</font></p></td> <td width=1% style="WIDTH:1.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=19% nowrap style="WIDTH:19.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=78% style="WIDTH:78.74%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9.5pt>Costs of exit from leased premises</font></p></td> <td width=1% style="WIDTH:1.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% nowrap style="WIDTH:19.48%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>359</font></p></td></tr> <tr> <td width=78% style="WIDTH:78.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Deferred rent on cease-use date</font></p></td> <td width=1% style="WIDTH:1.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% nowrap style="WIDTH:19.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>19</font></p></td></tr> <tr> <td width=78% style="WIDTH:78.74%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Impairment of property and equipment</font></p></td> <td width=1% style="WIDTH:1.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% nowrap style="WIDTH:19.48%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(106)</font></p></td></tr> <tr> <td width=78% style="WIDTH:78.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Cash paid, net of receipts</font></p></td> <td width=1% style="WIDTH:1.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% nowrap style="WIDTH:19.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(41)</font></p></td></tr> <tr style=HEIGHT:11.5pt> <td width=78% style="HEIGHT:11.5pt; WIDTH:78.74%; BACKGROUND:white; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Accretion charges, included in rent expense</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.78%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% nowrap style="BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:19.48%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2</font></p></td></tr> <tr style=HEIGHT:0.2in> <td width=78% style="HEIGHT:0.2in; WIDTH:78.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Balance as of December 31, 2018</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:1.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=19% nowrap style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:19.48%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>233</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Rent expense is recognized on a straight&#8209;line basis over the noncancelable term of each operating lease and, accordingly, the Company records the difference between cash rent payments and the recognition of rent expense as a deferred rent liability, which is included within accrued expenses. Rent expense was $875,000 and $564,000 for the years ended December&nbsp;31, 2018 and 2017, respectively. Under the terms of the lease agreements, the Company is also responsible for certain insurance, property tax and maintenance expenses. The Company also leases equipment under three operating leases that expire between May and September 2019.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Future minimum payments and sublease income under operating leases as of December&nbsp;31, 2018, are as follows: </p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Years Ending December 31,</font></p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Lease Payments</font></b></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Sublease Income</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 1in' align=center>&nbsp;</p></td> <td width=12% colspan=5 style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>(in thousands)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp; 2019</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>859</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>213</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp; 2020</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>411</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>219</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp; 2021</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>56</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>38</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;Thereafter</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:14.35pt> <td width=70% style="HEIGHT:14.35pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp; Total</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:14.35pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:14.35pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,326</font></p></td> <td width=2% style="HEIGHT:14.35pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:14.35pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:14.35pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:1.45pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>470</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection3'><b><i>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b><b><i>Indemnifications</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend indemnified parties for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third&#8209;party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors&#146; and officers&#146; insurance.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection3'><b><i>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b><b><i>Litigation</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style=COLOR:black>From time to time the Company may be involved in claims arising in connection with its business. Based on information currently available, the Company believes that the amount, or range, of reasonably possible losses in connection with any pending actions against it in excess of established reserves, in the aggregate, not to be material to its consolidated financial condition or cash flows. However, losses may be material to the Company&#146;s operating results for any particular future period, depending on the level of income or loss for such period.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>106</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p><font style=FONT-SIZE:10pt> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:9.5pt; COLOR:black">NOTE&nbsp;11.&nbsp;&nbsp;Stockholders&#146; Equity</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection3'><b><i>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b><b><i>Convertible Preferred Stock</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'>The Company is authorized to issue 5,000,000 shares of preferred stock, $0.10 par value per share. The Company&#146;s board of directors may, without further action by the stockholders, fix the rights, preferences, privileges and restrictions of up to an aggregate of 5,000,000 shares of preferred stock in one or more series and authorize their issuance. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of our common stock. The issuance of preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deterring or preventing a change of control or other corporate action. No shares of preferred stock are currently outstanding, and the Company has no present plan to issue any shares of preferred stock.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'>All of Private Vaxart&#146;s convertible preferred stock was converted into common stock on February 13, 2018, in conjunction with the Merger. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt; page:WordSection3'>As of December&nbsp;31, 2017, convertible preferred stock consisted of the following:</p> <div style=page:WordSection3> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:0.5in" cellpadding=0 cellspacing=0> <tr style=HEIGHT:33.3pt> <td width=100 style="HEIGHT:33.3pt; WIDTH:75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=17 style="HEIGHT:33.3pt; WIDTH:13pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=99 style="BORDER-TOP:0px; HEIGHT:33.3pt; BORDER-RIGHT:0px; WIDTH:74pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:9pt; COLOR:black">Shares<br>authorized</font></b></p></td> <td width=17 style="HEIGHT:33.3pt; WIDTH:13pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=97 style="BORDER-TOP:0px; HEIGHT:33.3pt; BORDER-RIGHT:0px; WIDTH:73pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:9pt; COLOR:black">Shares<br>outstanding</font></b></p></td> <td width=22 style="HEIGHT:33.3pt; WIDTH:16.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=99 colspan=2 style="BORDER-TOP:0px; HEIGHT:33.3pt; BORDER-RIGHT:0px; WIDTH:74.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:9pt; COLOR:black">Net<br>carrying<br>value</font></b></p></td> <td width=21 style="HEIGHT:33.3pt; WIDTH:15.8pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=103 colspan=2 style="BORDER-TOP:0px; HEIGHT:33.3pt; BORDER-RIGHT:0px; WIDTH:77.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:9pt; COLOR:black">Liquidation<br>preference</font></b></p></td></tr> <tr style=HEIGHT:8.5pt> <td width=100 style="HEIGHT:8.5pt; WIDTH:75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17 style="HEIGHT:8.5pt; WIDTH:13pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=99 style="HEIGHT:8.5pt; WIDTH:74pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=17 style="HEIGHT:8.5pt; WIDTH:13pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=97 style="HEIGHT:8.5pt; WIDTH:73pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=22 style="HEIGHT:8.5pt; WIDTH:16.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=99 colspan=2 style="BORDER-TOP:0px; HEIGHT:8.5pt; BORDER-RIGHT:0px; WIDTH:74.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:8pt; COLOR:black">(in thousands)</font></p></td> <td width=21 style="HEIGHT:8.5pt; WIDTH:15.8pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=103 colspan=2 style="BORDER-TOP:0px; HEIGHT:8.5pt; BORDER-RIGHT:0px; WIDTH:77.2pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:8pt; COLOR:black">(in thousands)</font></p></td></tr> <tr style=HEIGHT:0.1in> <td width=100 style="HEIGHT:0.1in; WIDTH:75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Series A</font></p></td> <td width=17 style="HEIGHT:0.1in; WIDTH:13pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=99 style="HEIGHT:0.1in; WIDTH:74pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">94,988</font></p></td> <td width=17 style="HEIGHT:0.1in; WIDTH:13pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=97 style="HEIGHT:0.1in; WIDTH:73pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">94,988</font></p></td> <td width=22 style="HEIGHT:0.1in; WIDTH:16.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=21 style="HEIGHT:0.1in; WIDTH:15.8pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=78 style="HEIGHT:0.1in; WIDTH:58.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,949</font></p></td> <td width=21 style="HEIGHT:0.1in; WIDTH:15.8pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=21 style="HEIGHT:0.1in; WIDTH:15.8pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=82 style="HEIGHT:0.1in; WIDTH:61.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,737</font></p></td></tr> <tr style=HEIGHT:0.1in> <td width=100 style="HEIGHT:0.1in; WIDTH:75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Series B</font></p></td> <td width=17 style="HEIGHT:0.1in; WIDTH:13pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=99 style="HEIGHT:0.1in; WIDTH:74pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">747,095</font></p></td> <td width=17 style="HEIGHT:0.1in; WIDTH:13pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=97 style="HEIGHT:0.1in; WIDTH:73pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">520,973</font></p></td> <td width=22 style="HEIGHT:0.1in; WIDTH:16.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=21 style="HEIGHT:0.1in; WIDTH:15.8pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=78 style="HEIGHT:0.1in; WIDTH:58.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">16,115</font></p></td> <td width=21 style="HEIGHT:0.1in; WIDTH:15.8pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=21 style="HEIGHT:0.1in; WIDTH:15.8pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=82 style="HEIGHT:0.1in; WIDTH:61.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">17,219</font></p></td></tr> <tr style=HEIGHT:0.1in> <td width=100 style="HEIGHT:0.1in; WIDTH:75pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Series C</font></p></td> <td width=17 style="HEIGHT:0.1in; WIDTH:13pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=99 style="BORDER-TOP:0px; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:74pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">820,088</font></p></td> <td width=17 style="HEIGHT:0.1in; WIDTH:13pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=97 style="BORDER-TOP:0px; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:73pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">605,103</font></p></td> <td width=22 style="HEIGHT:0.1in; WIDTH:16.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=21 style="BORDER-TOP:0px; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:15.8pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=78 style="BORDER-TOP:0px; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:58.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">19,877</font></p></td> <td width=21 style="HEIGHT:0.1in; WIDTH:15.8pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=21 style="BORDER-TOP:0px; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:15.8pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=82 style="BORDER-TOP:0px; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:61.4pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">20,000</font></p></td></tr> <tr style=HEIGHT:15.7pt> <td width=100 style="HEIGHT:15.7pt; WIDTH:75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total</font></p></td> <td width=17 style="HEIGHT:15.7pt; WIDTH:13pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=99 style="BORDER-TOP:0px; HEIGHT:15.7pt; BORDER-RIGHT:0px; WIDTH:74pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,662,171</font></p></td> <td width=17 style="HEIGHT:15.7pt; WIDTH:13pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=97 style="BORDER-TOP:0px; HEIGHT:15.7pt; BORDER-RIGHT:0px; WIDTH:73pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,221,064</font></p></td> <td width=22 style="HEIGHT:15.7pt; WIDTH:16.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=21 style="BORDER-TOP:0px; HEIGHT:15.7pt; BORDER-RIGHT:0px; WIDTH:15.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=78 style="BORDER-TOP:0px; HEIGHT:15.7pt; BORDER-RIGHT:0px; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">38,941</font></p></td> <td width=21 style="HEIGHT:15.7pt; WIDTH:15.8pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=21 style="BORDER-TOP:0px; HEIGHT:15.7pt; BORDER-RIGHT:0px; WIDTH:15.8pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$</font></p></td> <td width=82 style="BORDER-TOP:0px; HEIGHT:15.7pt; BORDER-RIGHT:0px; WIDTH:61.4pt; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">39,956</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Significant provisions of the convertible preferred stock were as follows:</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><i>Dividends</i> &#150; The holders of Series&nbsp;C convertible preferred stock were entitled to receive non-compounding cumulative dividends, in preference to any dividends payable to holders of Series&nbsp;B and Series&nbsp;A convertible preferred stock or common stock, at an annual dividend rate of $2.64416 per share, as adjusted for any stock splits, stock dividends, recapitalizations, or the like. Such cumulative dividends were payable within ten days of demand of the holders of at least a majority of the then outstanding Series&nbsp;C convertible preferred stock, or automatically upon a liquidation event. Dividends accumulated from the date of issuance and were payable, whether or not declared, before any dividend on Series&nbsp;B and Series&nbsp;A convertible preferred stock or common stock could be paid or declared. Series&nbsp;C convertible preferred stock shares issued as stock dividends were not entitled to cumulative dividends. The holders of Series&nbsp;C convertible preferred stock could elect whether the cumulative dividends would be paid in cash or in shares of Series&nbsp;C convertible preferred stock based on the original issue price of Series&nbsp;C convertible preferred stock of $33.05196 per share. In the event the board of directors declared a cash dividend in addition to the above cumulative dividends (a Special Dividend), the holders of Series&nbsp;C convertible preferred stock would have been entitled to receive, in preference to any dividends payable to the holders of Series&nbsp;B and Series&nbsp;A convertible preferred stock or common stock, a per share amount equal to the sum of: (a)&nbsp;the original issue price of Series&nbsp;C convertible preferred stock, and (b)&nbsp;all accrued and/or declared but unpaid dividends on such Series&nbsp;C convertible preferred stock, including the cumulative dividends. No dividends were declared during any of the periods presented. As of February 13, 2018, when the convertible preferred stock was converted into common stock, and December&nbsp;31, 2017, accumulated and undeclared dividends for Series&nbsp;C convertible preferred stock were $7.3&nbsp;million and $7.1&nbsp;million, respectively ($12.06 per share and $11.74 per share, respectively, of the outstanding Series&nbsp;C convertible preferred stock). On February 13, 2018, in conjunction with the Merger, the Series&nbsp;C convertible preferred stock and the related accumulated dividends were converted into 696,028 and 253,851 shares of common stock, respectively.</p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>107</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The holders of Series&nbsp;B convertible preferred stock were entitled to receive non-compounding cumulative dividends, in preference to any dividends payable to holders of Series&nbsp;A convertible preferred stock or common stock, at the annual dividend rate of $2.64416 per share, as adjusted for any stock splits, stock dividends, recapitalizations, or the like. Such cumulative dividends were payable within ten days of demand of the holders of at least a majority of the then outstanding Series&nbsp;B convertible preferred stock or automatically upon a liquidation event. Dividends accumulated from the date of issuance and were payable, whether or not declared, before any dividend on Series&nbsp;A convertible preferred stock or common stock could be paid or declared. Series&nbsp;B convertible preferred shares issued as stock dividends were not entitled to cumulative dividends. The holders of Series&nbsp;B convertible preferred stock could elect whether the cumulative dividends would be paid in cash or in shares of Series&nbsp;B convertible preferred stock based on the original issue price of Series&nbsp;B convertible preferred stock of $33.05196 per share. In the event the board of directors declared a cash dividend in addition to the above cumulative dividends (a Special Dividend), the holders of Series&nbsp;B convertible preferred stock would have been entitled to receive, in preference to any dividends payable to the holders of Series&nbsp;A convertible preferred stock or common stock, a per share amount equal to the sum of: (a)&nbsp;the original issue price of Series&nbsp;B convertible preferred stock, and (b)&nbsp;all accrued and/or declared but unpaid dividends on such Series&nbsp;B convertible preferred stock, including the cumulative dividends. No dividends were declared during any of the periods presented. As of February 13, 2018, when the convertible preferred stock was converted into common stock, and December&nbsp;31, 2017, accumulated and undeclared dividends for Series&nbsp;B convertible preferred stock were $7.6&nbsp;million and $7.5&nbsp;million, respectively ($15.78 per share and $15.46 per share, respectively, of the 483,387 shares of outstanding Series&nbsp;B convertible preferred stock on which dividends accrued). On February 13, 2018, in conjunction with the Merger, the Series&nbsp;B convertible preferred stock and the related accumulated dividends were converted into 599,259 and 265,340 shares of common stock, respectively.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The holders of Series&nbsp;A convertible preferred stock were entitled to receive noncumulative dividends, in preference to any dividends payable to holders of common stock, at the annual dividend rate of $2.30449 per share, as adjusted for any stock splits, stock dividends, recapitalizations, or the like, if declared by the board of directors. On February 13, 2018, in conjunction with the Merger, the Series&nbsp;A convertible preferred stock was converted into 104,065 shares of common stock.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><i>Conversion</i> &#150; At the option of the holder, each share of convertible preferred stock was convertible, one&#8209;for&#8209;one, subject to adjustment for anti&#8209;dilution protection, into shares of common stock. Each share automatically converted into the number of shares of common stock into which the shares were convertible at the then applicable conversion ratio upon: (1)&nbsp;the closing of the sale of the Company&#146;s common stock in a public offering provided the offering price per share was not less than three&nbsp;times the Series&nbsp;C convertible preferred stock original issue price of $33.05196 and the aggregate gross proceeds were not less than $30.0&nbsp;million, or (2)&nbsp;upon receipt of a written consent of the holders of a majority of the then outstanding shares of convertible preferred stock voting as a single class on an as&#8209;converted basis.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><i>Liquidation</i> &#150; In the event of any liquidation, dissolution or winding up of the Company, including a merger or acquisition where the beneficial owners of the Company&#146;s common and convertible preferred stock owned less than 50% of the surviving entity, or a sale of all or substantially all assets, the holders of Series&nbsp;C convertible preferred stock would have been entitled to receive a per share amount equal to $33.05196 (subject to adjustment for stock splits, stock dividends, recapitalizations, or the like), plus all dividends accrued, payable and/or in arrears (whether or not declared) minus the amount of any Special Dividends previously paid. After payment of the full liquidation preference of Series&nbsp;C convertible preferred stock, the holders of Series&nbsp;B convertible preferred stock would have been entitled to receive a per share amount equal to $33.05196 (subject to adjustment for stock splits, stock dividends, recapitalizations, or the like), plus all dividends accrued, payable and/or in arrears (whether or not declared) minus the amount of any Special Dividends previously paid. After payment of the full liquidation preference of Series&nbsp;B convertible preferred stock, the holders of Series&nbsp;A convertible preferred stock would have been entitled to receive an amount equal to $28.80613 per share, as adjusted, plus all declared but unpaid dividends prior and in preference to any distribution to the holders of common stock. In each case, if the proceeds of such an event were insufficient to permit the liquidation payment to a particular class, any proceeds legally available for distribution to that class would have been distributed ratably among the holders of that class in proportion to the preferential amounts that each holder was entitled to receive. Following payment of all convertible preferred stock preferences, any remaining legally available assets of the Company would have been distributed to the holders of common stock and convertible preferred stock pro rata, based on the greatest number of shares of common stock held on an as&#8209;converted basis.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>108</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p><i><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font></i> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection3'><i>Voting</i> &#150; The holders of convertible preferred stock were entitled to the number of votes equal to the number of shares of common stock into which each share of Series&nbsp;A, Series&nbsp;B, and Series&nbsp;C convertible preferred stock could have been converted on the record date for the vote or consent of the stockholders, except as otherwise required by law, and had voting rights and powers equal to the voting rights and powers of the common stockholders. The holders of Series&nbsp;A convertible preferred stock, voting as a separate class, were entitled to elect one&nbsp;member of the board of directors. As long as a specified investor held at least one&nbsp;share of Series&nbsp;C convertible preferred stock, the specified investor was able to designate one&nbsp;member of the board of directors, who would have been elected by the holders of Series&nbsp;C convertible preferred stock voting as a separate class. As long as a specified investor held least one&nbsp;share of Series&nbsp;B convertible preferred stock, the specified investor was able to designate one&nbsp;member of the board of directors, who would have been elected by the holders of Series&nbsp;B convertible preferred stock voting as a separate class. The holders of common stock, voting as a separate class, were entitled to elect two&nbsp;members of the board of directors, one of whom was the duly appointed chief executive officer of the Company.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><i>Protective Provisions</i> &#150; So long as at least 20,134&nbsp;shares of Series&nbsp;C convertible preferred stock remained outstanding and for so long as at least 20,134&nbsp;shares of Series&nbsp;B convertible preferred stock remained outstanding, Series&nbsp;C holders and Series&nbsp;B holders, voting as a single class on an as&#8209;converted basis, needed to approve certain specified corporate actions such as amending the certificate of incorporation, authorizing additional shares of stock or additional directors, redeeming stock and entering into certain strategic relationships.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><i>Redemption</i> &#150; The convertible preferred stock was not redeemable. There were no liquidation events under the control of preferred stockholders that could have resulted in liquidation in which only the preferred stockholders would have participated. Accordingly, the convertible preferred stock was classified within stockholders&#146; equity (deficit) on the Company&#146;s consolidated balance sheets.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection3'><b><i>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </font></i></b><b><i>Common Stock</i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Except as otherwise required by law or as otherwise provided in any certificate of designation for any series of preferred stock, the holders of common stock possess all voting power for the election of the Company&#146;s directors and all other matters requiring stockholder action. Holders of common stock are entitled to one vote per share on matters to be voted on by stockholders. Holders of common stock are entitled to receive such dividends, if any, as may be declared from time to time by the Company&#146;s board of directors in its discretion out of funds legally available therefore. In no event will any stock dividends or stock splits or combinations of stock be declared or made on common stock unless the shares of common stock at the time outstanding are treated equally and identically. As of December&nbsp;31, 2018, no dividends had been declared by the board of directors.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>In the event of the Company&#146;s voluntary or involuntary liquidation, dissolution, distribution of assets or winding-up, the holders of the common stock will be entitled to receive an equal amount per share of all of the Company&#146;s assets of whatever kind available for distribution to stockholders, after the rights of the holders of the preferred stock have been satisfied. There are no sinking fund provisions applicable to the common stock.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The Company had shares of common stock reserved for issuance as follows:</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:11.25pt> <td width=70% nowrap style="HEIGHT:11.25pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">December 31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2018</font></b></p></td> <td width=2% nowrap style="HEIGHT:11.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">December 31,</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style="FONT-SIZE:8pt; COLOR:black">2017</font></b></p></td></tr> <tr style=HEIGHT:9.2pt> <td width=70% nowrap style="HEIGHT:9.2pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:9.2pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:9.2pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:9.2pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:11.35pt> <td width=70% nowrap style="HEIGHT:11.35pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Convertible preferred stock outstanding</font></p></td> <td width=12% nowrap style="HEIGHT:11.35pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:11.35pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:11.35pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,221,064</font></p></td></tr> <tr style=HEIGHT:10.35pt> <td width=70% nowrap style="HEIGHT:10.35pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Options issued and outstanding</font></p></td> <td width=12% nowrap style="HEIGHT:10.35pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>865,163</font></p></td> <td width=2% nowrap style="HEIGHT:10.35pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:10.35pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>304,850</font></p></td></tr> <tr style=HEIGHT:10.35pt> <td width=70% nowrap style="HEIGHT:10.35pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Available for future grants of equity awards</font></p></td> <td width=12% nowrap style="HEIGHT:10.35pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>223,377</font></p></td> <td width=2% nowrap style="HEIGHT:10.35pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:10.35pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:3.5pt> <td width=70% nowrap style="HEIGHT:3.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Cumulative convertible preferred stock dividends</font></p></td> <td width=12% nowrap style="HEIGHT:3.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="HEIGHT:3.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:3.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">441,096</font></p></td></tr> <tr style=HEIGHT:7.4pt> <td width=70% nowrap style="HEIGHT:7.4pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Common stock warrants</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:7.4pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">10,914</font></p></td> <td width=2% nowrap style="HEIGHT:7.4pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:7.4pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">10,914</font></p></td></tr> <tr style=HEIGHT:16.75pt> <td width=70% nowrap style="HEIGHT:16.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Total</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,099,454</font></p></td> <td width=2% nowrap style="HEIGHT:16.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:16.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,977,924</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>109</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;12.&nbsp;&nbsp;Equity Incentive Plans</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Prior to the Merger, the Company issued equity awards for compensation purposes to employees, directors and consultants under the Company&#146;s 2007 Equity Incentive Plan (the &#147;2007 Plan&#148;). The 2007 Plan expired in July 2017, since when the Company has had no shares of common stock available for issuance under the 2007 Plan since awards under the 2007 Plan no longer become available for future issuance if such awards are forfeited or otherwise terminate. Each outstanding stock option to acquire shares of Private Vaxart stock, whether vested or unvested, was assumed in the Merger after adjustment for the impact of the Conversion and the Reverse Stock Split.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>In November 2016, Aviragen&#146;s stockholders approved the 2016 Equity Incentive Plan (&#147;2016 Equity Plan&#148;), under which all outstanding awards under their previous plans became available for issuance under the 2016 Equity Plan if such awards are forfeited or otherwise terminate. The purpose of the 2016 Equity Plan is to assist the Company in attracting and retaining valued employees, consultants and non-employee directors by offering them a greater stake in the Company&#146;s success and a closer identity with it, and to encourage ownership of the Company&#146;s shares by such persons.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Under the 2016 Equity Plan, the Company is authorized to issue incentive stock options (&#147;ISOs&#148;), non-qualified stock options (&#147;NQSOs&#148;), restricted stock (&#147;RSAs&#148;) and restricted stock units (&#147;RSUs&#148;). Awards that expire or are canceled generally become available for issuance again under the 2016 Equity Plan. All awards outstanding, along with the number of shares of the Company&#146;s common stock available under the 2016 Equity Plan, were adjusted for the impact of the Reverse Stock Split and remain subject to adjustment in the event of a stock split, stock dividend or other extraordinary dividend, or other similar change in the Company&#146;s common stock or capital structure. Awards may vest over varying periods, as specified by the Company&#146;s Board of Directors for each grant, and have a maximum term of ten years from the grant date.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>A summary of stock option <font style=COLOR:black>transactions in each of the two years ended December 31, 2018, is as follows:</font></font></p> <div style=page:WordSection3> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:0.5in" cellpadding=0 cellspacing=0> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=13% style="WIDTH:13%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" rowspan=4 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Weighted</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Average</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Exercise</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Price</font></b></p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Shares</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Available</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>For&nbsp;Grant</font></b></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Number&nbsp;of</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Options</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Outstanding</font></b></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:5.75pt> <td width=57% style="HEIGHT:5.75pt; WIDTH:57%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; HEIGHT:5.75pt; BORDER-RIGHT:0px; WIDTH:13%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:5.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; HEIGHT:5.75pt; BORDER-RIGHT:0px; WIDTH:13%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:5.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:5.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:5.75pt; BORDER-RIGHT:0px; WIDTH:11%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Balance at January&nbsp;1, 2017</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>99,644</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">275,539</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>11.32</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Granted</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(78,406)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>78,406</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>4.07</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Exercised</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(2,834)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8.58</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Forfeited</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>33,012</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(33,012)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>11.49</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Canceled</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>13,249</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(13,249)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>12.00</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Termination of Plan</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(67,499)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.25in'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Balance at December&nbsp;31, 2017</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>304,850</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>9.50</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 27pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Assumed on consummation of Merger</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>291,102</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>627,106</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>26.33</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Granted</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(431,100)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>431,100</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>5.17</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Exercised</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(2,013)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6.49</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Forfeited</font></p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>71,500</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="WIDTH:13%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(89,903)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>5.90</font></p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Canceled</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>269,148</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(405,977)</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>34.64</font></p></td></tr> <tr style=HEIGHT:0.1in> <td width=57% style="HEIGHT:0.1in; WIDTH:57%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.25in'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:0.1in; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:0.1in; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:0.1in; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="HEIGHT:0.1in; WIDTH:11%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=57% style="WIDTH:57%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Balance at <font style=COLOR:black>December</font> 31, 2018</font></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>200,650</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>865,163</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8.13</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>In addition, the 2016 Equity Plan has a reserve of 22,727 shares available for future issuance as RSAs and RSUs. As of <font style=COLOR:black>December</font> 31, 2018, no such awards have been granted under the 2016 Equity Plan.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>As of December&nbsp;31, 2018, there were 865,163 options outstanding with a weighted average exercise price of $8.13, a weighted average remaining term of 6.14 years and zero aggregate intrinsic value. Of these options, 452,905 were vested, with a weighted average exercise price of $10.58, a weighted average remaining term of 3.35 years and zero aggregate intrinsic value.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in -0.9pt 0pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>The aggregate intrinsic value represents the total pre-tax value (i.e., the difference between the Company&#146;s stock price and the exercise price) of stock options outstanding as of December&nbsp;31, 2018, based on our common stock closing price of $1.88, which would have been received by the option holders had all their in-the-money options been exercised as of that date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in -0.9pt 0pt 0in; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>110</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in -0.9pt 0pt 0in; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>The grant date fair value of options vested in the years ended December&nbsp;31, 2018 and 2017, was $332,000 and $533,000, respectively. The intrinsic value of options exercised in the years ended December&nbsp;31, 2018 and 2017, was zero and $1,000, respectively.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The weighted average grant date fair value of options awarded in the years ended December&nbsp;31, 2018 and 2017, was $3.59 and $2.99, respectively. Fair values were estimated using the following assumptions:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:9.5pt> <td width=67% style="HEIGHT:9.5pt; WIDTH:67.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=32% colspan=3 style="BORDER-TOP:0px; HEIGHT:9.5pt; BORDER-RIGHT:0px; WIDTH:32.74%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td></tr> <tr style=HEIGHT:10pt> <td width=67% style="HEIGHT:10pt; WIDTH:67.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:10pt; BORDER-RIGHT:0px; WIDTH:15.34%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">2018</font></b></p></td> <td width=2% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:10pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=15% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:10pt; BORDER-RIGHT:0px; WIDTH:15.36%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">2017</font></b></p></td></tr> <tr style=HEIGHT:9.5pt> <td width=67% style="HEIGHT:9.5pt; WIDTH:67.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:9.5pt; BORDER-RIGHT:0px; WIDTH:15.34%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% style="HEIGHT:9.5pt; WIDTH:2.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:9.5pt; BORDER-RIGHT:0px; WIDTH:15.36%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr style=HEIGHT:13.65pt> <td width=67% style="HEIGHT:13.65pt; WIDTH:67.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Risk-free interest rate</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:13.65pt; BORDER-RIGHT:0px; WIDTH:15.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:#cceeff; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">2.80%</font></p></td> <td width=2% style="HEIGHT:13.65pt; WIDTH:2.04%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:#cceeff; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:13.65pt; BORDER-RIGHT:0px; WIDTH:15.36%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1.87%</font></p></td></tr> <tr style=HEIGHT:13.65pt> <td width=67% style="HEIGHT:13.65pt; WIDTH:67.26%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Expected term</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:13.65pt; BORDER-RIGHT:0px; WIDTH:15.34%; BACKGROUND:white; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">5.96&nbsp;Years</font></p></td> <td width=2% style="HEIGHT:13.65pt; WIDTH:2.04%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:13.65pt; BORDER-RIGHT:0px; WIDTH:15.36%; BACKGROUND:white; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6.09&nbsp;Years</font></p></td></tr> <tr style=HEIGHT:13.65pt> <td width=67% style="HEIGHT:13.65pt; WIDTH:67.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Expected volatility</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:13.65pt; BORDER-RIGHT:0px; WIDTH:15.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:#cceeff; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">79%</font></p></td> <td width=2% style="HEIGHT:13.65pt; WIDTH:2.04%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:#cceeff; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:13.65pt; BORDER-RIGHT:0px; WIDTH:15.36%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt><font style=COLOR:black>91</font>%</font></p></td></tr> <tr style=HEIGHT:13.65pt> <td width=67% style="HEIGHT:13.65pt; WIDTH:67.26%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Dividend yield</font></p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:13.65pt; BORDER-RIGHT:0px; WIDTH:15.34%; BACKGROUND:white; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right><font style="FONT-SIZE:10pt; COLOR:black">0%</font></p></td> <td width=2% style="HEIGHT:13.65pt; WIDTH:2.04%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=15% nowrap style="BORDER-TOP:0px; HEIGHT:13.65pt; BORDER-RIGHT:0px; WIDTH:15.36%; BACKGROUND:white; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>0%</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'>Total stock&#8209;based compensation recognized for options was as follows:</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=65% style="WIDTH:65.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=34% colspan=5 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:34.2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td></tr> <tr style=HEIGHT:2.15pt> <td width=65% style="HEIGHT:2.15pt; WIDTH:65.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=16% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:2.15pt; BORDER-RIGHT:0px; WIDTH:16.22%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>2018</font></b></p></td> <td width=2% nowrap style="HEIGHT:2.15pt; WIDTH:2.34%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:2.15pt; BORDER-RIGHT:0px; WIDTH:15.62%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>2017</font></b></p></td></tr> <tr> <td width=65% style="WIDTH:65.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.1in; TEXT-INDENT:-0.1in'>&nbsp;</p></td> <td width=34% colspan=5 nowrap style="WIDTH:34.2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>(in thousands)</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">Research and development</font></p></td> <td width=1% nowrap style="WIDTH:1.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=14% nowrap style="WIDTH:14.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>254</font></p></td> <td width=2% nowrap style="WIDTH:2.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.22%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=13% nowrap style="WIDTH:13.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>262</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.8%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>General and administrative</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.5%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>285</font></p></td> <td width=2% nowrap style="WIDTH:2.34%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.22%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.4%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>215</font></p></td></tr> <tr style=HEIGHT:0.2in> <td width=65% style="HEIGHT:0.2in; WIDTH:65.8%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">Total stock-based compensation</font></p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:1.72%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:14.5%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>539</font></p></td> <td width=2% nowrap style="HEIGHT:0.2in; WIDTH:2.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:2.22%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=13% nowrap style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:13.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>477</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>As of December 31, 2018, the unrecognized stock-based compensation cost related to outstanding stock options that are expected to vest was $1.1&nbsp;million, which the Company expects to recognize over an estimated weighted average period of 2.75 years.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;13.&nbsp;&nbsp;Income Taxes</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The provision for income taxes consists of the following for the years ended December&nbsp;31, 2018 and 2017:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=34% colspan=5 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:34.06%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=16% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:16.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>2018</font></b></p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=15% colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:15.3%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>2017</font></b></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=34% colspan=5 nowrap style="WIDTH:34.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>(In thousands)</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Current:</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="WIDTH:14.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="WIDTH:13.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Federal</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=14% nowrap style="WIDTH:14.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=13% nowrap style="WIDTH:13.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>State</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="WIDTH:14.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="WIDTH:13.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Foreign</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>106</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.06%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 37pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Total Current</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">109</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.06%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 37pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Deferred:</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="WIDTH:14.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="WIDTH:13.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Federal</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=14% nowrap style="WIDTH:14.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=13% nowrap style="WIDTH:13.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>State</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="WIDTH:14.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="WIDTH:13.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Foreign</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 37pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Total Deferred</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 37pt; TEXT-AUTOSPACE:'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left>&nbsp;</p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=65% style="WIDTH:65.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt>Provision for income taxes</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=14% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>109</font></p></td> <td width=2% nowrap style="WIDTH:2.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=13% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>111</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The components of the deferred tax assets as of December&nbsp;31, 2018 and 2017, are as follows:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>December&nbsp;31, 2018</font></b></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>December&nbsp;31, 2017</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Deferred tax assets:</font></p></td> <td width=12% colspan=5 style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>(In thousands)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Net operating loss carry-forwards</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>43,822</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>19,441</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Research and development tax credits</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>3,357</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,979</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Capitalized research and development</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,326</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Sale of future royalties</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8,383</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Accruals, reserves and other</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>714</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>544</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total deferred tax assets</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>58,602</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>22,964</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Valuation allowance</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(48,626)</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(22,964)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Deferred tax assets net of valuation allowance</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>9,976</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Deferred tax liabilities:</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Intangible assets</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(9,976)</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total deferred tax liabilities</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(9,976)</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 22.85pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Net deferred tax assets</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>A reconciliation of the provision for income taxes with the expected provision for income taxes computed by applying the federal statutory income tax rate of 21% and 34% to the net loss before provision for income taxes for the years ended December&nbsp;31, 2018 and 2017, respectively:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 24pt'>&nbsp;</p></td> <td width=12% colspan=5 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 24pt'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>2018</font></b></p></td> <td width=2% nowrap style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>2017</font></b></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 24pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>U.S. federal taxes at statutory rate</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>21.0&nbsp; %</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>34.0 %</font></p></td></tr> <tr style=HEIGHT:17.1pt> <td width=70% style="HEIGHT:17.1pt; WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>State taxes (net of federal benefit)</font></p></td> <td width=2% style="HEIGHT:17.1pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:17.1pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>0.6</font></p></td> <td width=2% nowrap style="HEIGHT:17.1pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="HEIGHT:17.1pt; WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="HEIGHT:17.1pt; WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>14.2</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Foreign rate differential</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>3.1</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Global intangible low-taxed income</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(8.8)</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Permanent items:</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible note interest</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(0.4)</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(10.8)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Revaluation of derivative liabilities</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>11.9</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Others</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(2.1)</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(1.4)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Tax credits</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2.1</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8.0</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Change in valuation allowance</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(20.4)</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>43.4</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Impact of tax reform rate change</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(97.0)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>NOL and credit adjustments</font></p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(3.8)</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:5.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(2.4)</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Bargain purchase gain</font></p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8.1</font></p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Other</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:8.65pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>0.1</font></p></td></tr> <tr> <td width=70% style="WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 24pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=70% style="WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Provision for income taxes</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(0.6)%</font></p></td> <td width=2% nowrap style="WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in' align=right><font style=FONT-SIZE:10pt>&#151;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>%</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The Company&#146;s actual tax expense differed from the statutory federal income tax expense using a tax rate of 21% for the year ended December 31, 2018, primarily due to, state and foreign income taxes, nondeductible expenses, research and development tax credits, and the change in valuation allowance. The Company&#146;s actual tax expense differed from the statutory federal income tax expense using a tax rate of 21% for the year ended December 31, 2017, primarily due to remeasurement of deferred taxes due to change in federal tax rate under the Tax Cuts and Jobs Act </font><font style="FONT-SIZE:10pt; COLOR:black">(the &#147;TCJA&#148;)</font><font style=FONT-SIZE:10pt>, state income taxes, nondeductible expenses, research and development tax credits, and the change in valuation allowance.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:'><font style="FONT-SIZE:10pt; COLOR:black">On December 22, 2017, the TCJA was signed into law. The TCJA decreased the U.S. corporate federal income tax rate from 35% to 21% effective January 1, 2018. The TCJA also includes a number of other provisions including the elimination of loss carrybacks and limitations on the use of future losses, repeal of the Alternative Minimum Tax regime, and the introduction of a base erosion, anti-abuse tax and 100% expense allowance for certain properties. These provisions are not expected to have immediate effect on the Company.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>112</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in'><font style="FONT-SIZE:10pt; COLOR:black">The key impact of the TCJA on the Company&#146;s financial statements was the re-measurement of the deferred tax balances to the new corporate tax rate in the year ended December 31, 2017. U.S. GAAP requires the re-measurement of the Company&#146;s deferred tax balances as of the enactment date of the TCJA, based on the rates at which the balances are expected to reverse in the future. The TCJA reduced the corporate tax rate to 21%, effective January 1, 2018. The Company recorded a decrease in its deferred tax assets of $4.2 million with a corresponding reduction to its valuation allowance of $4.2 million for the year ending December 31, 2017, primarily related to the impact of the TCJA.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>As of December 31, 2018 and 2017, the Company had a net operating loss (&#147;NOL&#148;) carryforwards of $92.3 million and $69.5 million for federal purposes, and $76.9 million and $75.0 million for state purposes, respectively. If not utilized, these carryforwards will begin to expire in 2024 for federal, and 2028 for state purposes.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>As of December 31, 2018, the Company also has accumulated tax losses of $14.4 million for Australia, $24.7 million for the United Kingdom and $37.7 million for France available for carry forward against future earnings, which under relevant tax laws do not expire but may not be available under certain circumstances. As of December 31, 2018, the Company&#146;s foreign subsidiaries have no positive accumulated earnings. As such, no federal or state income taxes have been provided on the losses of its foreign subsidiaries. If in the future there are positive earnings generated from the Company&#146;s foreign subsidiaries, the Company will evaluate whether to record any applicable federal and state income taxes on such earnings.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>As of December 31, 2018 and 2017, the Company had federal research and development tax credit carryforwards of $3.0 million and $2.7 million, respectively and state research and development tax credit carryforwards of $2.3 million and $2.0 million, respectively, before offset for unrecognized tax benefits, to offset future income tax liabilities. The federal research and development tax credits will start to expire in 2027, if not utilized, while the state research and development tax credit can be carried forward indefinitely.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>Sections 382 and 383 of the Internal Revenue Code provides for a limitation on the annual use of NOL and research and development tax credit carryforwards following certain ownership changes that could limit the Company&#146;s ability to utilize these carryforwards. The Company&#146;s losses and credit carryforwards may be subject to these limitations. The Company has not performed an analysis to determine if such ownership changes have occurred. An analysis will be performed prior to recognizing the benefits of any losses or credits in the financial statements</font><font style=FONT-SIZE:10pt>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The Company is required to reduce its deferred tax assets by a valuation allowance if it is more likely than not that some or all of its deferred tax assets will not be realized. Management must use judgment in assessing the potential need for a valuation allowance, which requires an evaluation of both negative and positive evidence. The weight given to the potential effect of negative and positive evidence should be commensurate with the extent to which it can be objectively verified. In determining the need for and amount of the valuation allowance, if any, the Company assesses the likelihood that it will be able to recover its deferred tax assets using historical levels of income, estimates of future income and tax planning strategies. As a result of historical cumulative losses, the Company determined that, based on all available evidence, there was substantial uncertainty as to whether it will recover recorded net deferred taxes in future periods. Accordingly, the Company recorded a valuation allowance against all of its net deferred tax assets as of December 31, 2018 and 2017. The net change in total valuation allowance was an increase of approximately $25.7 million for the year ended December 31, 2018</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=68% style="WIDTH:68.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 24pt'>&nbsp;</p></td> <td width=31% colspan=5 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:31.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td></tr> <tr> <td width=68% style="WIDTH:68.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 24pt'>&nbsp;</p></td> <td width=14% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% style="WIDTH:2.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:14.58%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2017</font></b></p></td></tr> <tr> <td width=68% style="WIDTH:68.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 24pt'>&nbsp;</p></td> <td width=31% colspan=5 style="WIDTH:31.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:8pt>(in thousands)</font></p></td></tr> <tr> <td width=68% style="WIDTH:68.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Beginning Balance</font></p></td> <td width=2% style="WIDTH:2.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="WIDTH:12.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,404</font></p></td> <td width=2% style="WIDTH:2.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11.72%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,231</font></p></td></tr> <tr> <td width=68% style="WIDTH:68.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Additions based on tax positions related to the current year</font></p></td> <td width=2% style="WIDTH:2.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="WIDTH:12.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>181</font></p></td> <td width=2% style="WIDTH:2.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11.72%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>173</font></p></td></tr> <tr> <td width=68% style="WIDTH:68.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Decreases related to prior years&#146; tax positions</font></p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.32%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(3)</font></p></td> <td width=2% style="WIDTH:2.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.86%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.72%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=68% style="WIDTH:68.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 24pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.32%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.72%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:0.2in> <td width=68% style="HEIGHT:0.2in; WIDTH:68.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Ending Balance</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:2.32%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:12.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,582</font></p></td> <td width=2% style="HEIGHT:0.2in; WIDTH:2.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:2.86%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:0.2in; BORDER-RIGHT:0px; WIDTH:11.72%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.5pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,404</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection3'><font style=FONT-SIZE:10pt>The Company&#146;s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. During the year ended December 31, 2017 and 2018, the Company recognized no interest and penalties associated with unrecognized tax benefits. There are no tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within twelve months of the reporting date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>113</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection3><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The Company files income tax returns in the U.S, Australia, France and the United Kingdom, as well as with various U.S. states. The Company is subject to tax audits in all jurisdictions in which it files income tax returns. Tax audits by their very nature are often complex and can require several years to complete. There are currently no tax audits that have commenced with respect to income tax returns in any jurisdiction.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>Under the tax statute of limitations applicable to the Internal Revenue Code, the Company and its U.S. subsidiary, either standalone or as part of the consolidated group, is no longer subject to U.S. federal income tax examinations by the Internal Revenue Service for tax years before tax year 2016. Under the statute of limitations applicable to most state income tax laws, the Company is no longer subject to state income tax examinations by tax authorities for tax years before 2015 in states in which it has filed income tax returns. However, because the Company is carrying forward income tax attributes, such as net operating losses and tax credits from 2004 and earlier tax years, these attributes can still be audited when utilized on returns filed in the future. The Company is subject to foreign tax examinations by tax authorities for fiscal year 2014 and forward</font><font style=FONT-SIZE:10pt>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:; page:WordSection3'><b><font style="FONT-SIZE:10pt; COLOR:black">NOTE 14.&nbsp;&nbsp;Net Loss Per Share Attributable to Common Stockholders</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>The <font style=COLOR:black>f</font>ollowing table presents the calculation of basic and diluted net loss per share (in thousands, except share and per share amounts):</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:600pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr style=HEIGHT:10.05pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:10.05pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=12% colspan=5 style="BORDER-TOP:0px; HEIGHT:10.05pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td></tr> <tr style=HEIGHT:9.3pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.3pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:9.3pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:9.3pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:9.3pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2017</font></b></p></td></tr> <tr style=HEIGHT:9.3pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.3pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:9.3pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.3pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:9.3pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:9.1pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Net loss</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(18,007)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(9,582)</font></p></td></tr> <tr style=HEIGHT:9.1pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:9.1pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Series B and C preferred dividend</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in -0.5pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>(339)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(2,878)</font></p></td></tr> <tr style=HEIGHT:9.1pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:9.1pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Net loss attributable to common stockholders</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(18,346)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(12,460)</font></p></td></tr> <tr style=HEIGHT:9.1pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:9.1pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Shares used to compute net loss per share, basic and diluted</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6,316,065</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>135,953</font></p></td></tr> <tr style=HEIGHT:9.1pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:9.1pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:18.9pt> <td width=70% style="BORDER-TOP:0px; HEIGHT:18.9pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Net loss per share attributable to common stockholders, basic and diluted</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:18.9pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:18.9pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(2.90)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:18.9pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:18.9pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:18.9pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>(91.65)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">No adjustment has been made to the net loss </font><font style=FONT-SIZE:10pt>attributable to common stockholders<font style=COLOR:black> as the effect would be anti-dilutive due to the net loss. </font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style="FONT-SIZE:10pt; COLOR:black">The following potentially dilutive securities were excluded from the computation of diluted weighted average shares outstanding because they would have been antidilutive:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:600pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=30% colspan=5 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Year&nbsp;Ended&nbsp;December&nbsp;31,</font></b></p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:0px"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=14% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2018</font></b></p></td> <td width=2% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2.5%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:13.8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>2017</font></b></p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Options to purchase common stock </font></p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>839,396</font></p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>295,243</font></p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Warrant to purchase common stock</font></p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>9,658</font></p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Warrant to purchase convertible preferred stock</font></p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>891</font></p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>7,563</font></p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Series B and C convertible preferred stock outstanding, </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp;&nbsp; including cumulative dividends</font></p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>213,760</font></p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,567,172</font></p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Series A convertible preferred stock outstanding</font></p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>12,260</font></p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>94,988</font></p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Convertible promissory notes, related party (as converted)</font></p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>185,159</font></p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>754,289</font></p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-0.2in'>&nbsp;</p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=68% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Total potentially dilutive securities excluded from </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>&nbsp; denominator of the diluted earnings per share computation</font></p></td> <td width=14% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,261,124</font></p></td> <td width=2% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.5%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=14% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:14.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,719,255</font></p></td></tr> <tr> <td width=550 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px">&nbsp; <td width=117 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=18 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><font style=FONT-SIZE:10pt>114</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection3' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection3'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>VAXART, INC. AND SUBSIDIARIES</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection3' align=center><b><font style=FONT-SIZE:10pt>Notes to the Consolidated Financial Statements</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection3'><b><font style=FONT-SIZE:10pt>NOTE&nbsp;15.&nbsp;&nbsp;Quarterly Financial Data (Unaudited)</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection3'><font style=FONT-SIZE:10pt>Selected summarized quarterly financial information for fiscal 2018 and 2017 is as follows:</font></p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=58% colspan=11 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:58.52%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Year&nbsp;Ended December&nbsp;31,&nbsp;2018</font></b></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=13% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:10pt>First</font></b></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.48%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Second</font></b></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=13% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:10pt>Third</font></b></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=13% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.38%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Fourth</font></b></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 12pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Revenue</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,503</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">608</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">281</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,767</font></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Operating expenses</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">5,418</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">8,383</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">6,161</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">5,953</font></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net income (loss)</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,314</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(8,871)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(6,548)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(4,902)</font></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net income (loss) attributable to common stockholders</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,975</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(8,871)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(6,548)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(4,902)</font></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net income (loss) per share &#150; basic</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">0.54</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1.24)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(0.92)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(0.69)</font></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net income (loss) per share &#150; diluted</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">0.49</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1.24)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(0.92)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(0.69)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection3'>&nbsp;</p> <div style=page:WordSection3 align=center> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=58% colspan=11 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:58.52%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Year Ended December 31, 2017</font></b></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=13% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:10pt>First</font></b></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.48%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Second</font></b></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=13% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:10pt>Third</font></b></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=13% colspan=2 nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.36%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Fourth</font></b></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 12pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=right>&nbsp;</p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% nowrap style="WIDTH:12.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Revenue</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,310</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,854</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">915</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">760</font></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Operating expenses</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,557</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">4,977</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">2,871</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.05in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">3,449</font></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net loss</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(2,796)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(3,538)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(2,173)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,075)</font></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net loss attributable to common stockholders</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(3,506)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(4,256)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(2,898)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.3%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(1,800)</font></p></td></tr> <tr> <td width=41% style="WIDTH:41.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Net loss per share &#150; basic and diluted</font></p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(25.84)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% nowrap style="WIDTH:11.42%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(31.37)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(21.36)</font></p></td> <td width=2% nowrap style="WIDTH:2.08%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="WIDTH:1.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:left; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">(13.16)</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection3'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all>&nbsp;</p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>115</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; page:WordSection4'><b><font style=FONT-SIZE:10pt><a name=ITEM9>Item&nbsp;9.&nbsp;&nbsp;Changes In and Disagreements with Accountants on Accounting and Financial Disclosure</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection4'><font style=FONT-SIZE:10pt>None.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; page:WordSection4'><b><font style=FONT-SIZE:10pt><a name=ITEM9A>Item&nbsp;9A.&nbsp;&nbsp;Controls and Procedures</a></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in'><font style=FONT-SIZE:10pt>As of the end of the period covered by this Annual Report, management performed, with the participation of our President and Chief Executive Officer (who serves as our principal executive officer and principal financial officer), an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act rules 13a-15(e) and 15(d)-15e)). <font style="BACKGROUND:white; COLOR:black">Based on such evaluation, our management concluded that as of December&nbsp;31, 2018, our disclosure controls and procedures were not effective at a reasonable assurance level as </font><font style=COLOR:black>a result of the material weakness described below<font style=BACKGROUND:white>.</font></font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style="FONT-SIZE:10pt; COLOR:black">Material Weakness</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt; COLOR:black">We identified the following material weakness in our internal control over financial reporting as of December&nbsp;31, 2018:</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&nbsp;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 30.1pt 0pt 0.5in"><font style=FONT-SIZE:10pt>We lacked consistent processes to appropriately perform effective and timely review of account reconciliations and non-routine transactions. Therefore, there was a<font style=COLOR:black> risk that a potential material misstatement of the financial statements would occur without being prevented or detected on a timely basis.</font></font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt; COLOR:black">We have taken certain steps to remediate this material weakness, including increasing the depth and experience within our accounting and finance organization and designing and implementing improved processes and internal controls. However, our efforts to remediate this material weakness may not be effective or prevent any future material weakness or significant deficiency in our internal control over financial reporting. If our efforts are not successful, or other material weaknesses or control deficiencies occur in the future, we may be unable to report our financial results accurately on a timely basis, which could cause our reported financial results to be materially misstated and result in the loss of investor confidence and cause the market price of our common stock to decline.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Management&#146;s Report on Internal Control Over Financial Reporting</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection4'><font style=FONT-SIZE:10pt>Management has conducted, with the participation of our President and Chief Executive Officer (who serves as our principal executive officer and principal financial officer), an assessment, including testing of the effectiveness, of our internal control over financial reporting as of December&nbsp;31, 2018. Management&#146;s assessment of internal control over financial reporting was conducted using the criteria of the Committee of Sponsoring Organizations of the Treadway Commission (&#147;COSO&#148;) in <em>Internal Control &#150; Integrated Framework (2013),</em> while utilizing the additional guidance contained in COSO&#146;s <em>Internal Control over Financial Reporting &#150; Guidance for Smaller Public Companies</em>. Based on that assessment, due to the material weakness described above, our management concluded that our internal control over financial reporting was not effective as of December&nbsp;31, 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection4'><b><font style=FONT-SIZE:10pt>Attestation Report of Registered Public Accounting Firm</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection4'><font style=FONT-SIZE:10pt>This Annual Report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting pursuant to SEC rules that permit us to provide only management&#146;s report in this Annual Report.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Changes in Internal Control over Financial Reporting</font></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style=FONT-SIZE:10pt>During 2018, we <font style=COLOR:black>hired a full-time Corporate Controller and a full-time Associate Director of SEC Reporting, both Certified Public Accountants with active licenses. We have implemented procedures in our finance department including- &nbsp;formal approval procedures for all journal entries and account reconciliations, and increased management oversight of financial reporting. </font>This was done to address a material weakness relating to our lack of sufficient qualified resources and adequate processes to appropriately segregate duties and perform effective and timely review of account reconciliations and non-routine transactions that <font style=COLOR:black>was originally identified in the audit of our financial statements for the year ended December 31, 2015 and was previously reported in Item&nbsp;4 in our Quarterly Report on Form&nbsp;10-Q for the quarter ended September&nbsp;30, 2018. While we believe these procedures will be effective in remediating the material weakness, they were not yet fully operational as of December 31, 2018.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>116</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection4'><b><font style=FONT-SIZE:10pt>Inherent Limitations on Effectiveness of Controls</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection4'><font style=FONT-SIZE:10pt>Our management, including our President and Chief Executive Officer, does not expect that our disclosure controls and procedures or our internal controls, will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within Vaxart have been detected.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; page:WordSection4'><b><font style=FONT-SIZE:10pt><a name=ITEM9B>Item&nbsp;9B.&nbsp;&nbsp;Other Information</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>None.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>117</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><b><font style=FONT-SIZE:11pt><a name=PART3>PART III</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><b><font style=FONT-SIZE:10pt><a name=ITEM10>Item&nbsp;10.&nbsp;&nbsp;Directors, Executive Officers and Corporate Governance</a></font></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style=FONT-SIZE:10pt>Set forth below is certain information regarding our directors and executive officers as of February 1, 2019:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <div style=page:WordSection4 align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=28% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:28.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:8pt>Name</font></b></p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8.14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Age</font></b></p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:58.56%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Position</font></b></p></td></tr> <tr> <td width=28% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:28.18%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><i><font style=FONT-SIZE:9pt>Executive Officers</font></i></b></p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8.14%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:58.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=28% style="WIDTH:28.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Wouter W. Latour, M.D.</font></p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>61</font></p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="WIDTH:58.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>President, Chief Executive Officer and Director</font></p></td></tr> <tr> <td width=28% style="WIDTH:28.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Sean N. Tucker, Ph.D.</font></p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>51</font></p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="WIDTH:58.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Chief Scientific Officer</font></p></td></tr> <tr> <td width=28% style="WIDTH:28.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><i><font style=FONT-SIZE:9pt>Directors</font></i></b></p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="WIDTH:58.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=28% style="WIDTH:28.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Geoffrey F. Cox, Ph.D.</font></p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>75</font></p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="WIDTH:58.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Director</font></p></td></tr> <tr> <td width=28% style="WIDTH:28.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Michael J. Finney, Ph.D.</font></p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>60</font></p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="WIDTH:58.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Director</font></p></td></tr> <tr> <td width=28% style="WIDTH:28.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Richard J. Markham</font></p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>68</font></p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="WIDTH:58.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Chairman of the Board</font></p></td></tr> <tr> <td width=28% style="WIDTH:28.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>John P. Richard</font></p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>61</font></p></td> <td width=2% style="WIDTH:2.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="WIDTH:58.56%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Director</font></p></td></tr> <tr> <td width=28% style="WIDTH:28.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Anne M. VanLent</font></p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.14%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>70</font></p></td> <td width=2% style="WIDTH:2.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=58% style="WIDTH:58.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Director</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>Our board of directors is composed of six members all of whom were previously elected by our stockholders. All of our directors have one-year terms and stand for election annually. Vacancies on the board of directors may be filled only by persons elected by a majority of the remaining directors. A director elected by the board of directors to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of the full term and until the director&#146;s successor is duly elected and qualified.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=FONT-SIZE:10pt>Executive Officers</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><b><i><font style=FONT-SIZE:10pt>Wouter W. Latour, M.D.</font></i></b><font style=FONT-SIZE:10pt> has served as our President and Chief Executive Officer </font><font style=FONT-SIZE:10pt>and as a member of our board of directors since February 2018. Dr. Latour previously served as the President and Chief Executive Officer of Private Vaxart</font><font style=FONT-SIZE:10pt> since September 2011 and served as a member of Private Vaxart&#146;s board of directors since October 2011. From June 2011 to September 2011, Dr. Latour served as Private Vaxart&#146;s Chief Operating Officer. From June 2009 until joining Vaxart, Dr. Latour was an independent consultant to life sciences companies. From January 2005 to May 2009, Dr. Latour was Chief Executive Officer and a member of the board of directors of Trinity Biosystems, Inc., a biopharmaceutical company. Prior to these roles, Dr. Latour held numerous executive positions at various pharmaceutical and biotechnology companies. Dr. Latour received an M.D. from the University of Amsterdam and an M.B.A. from Stanford University.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>We believe Dr. Latour is qualified to serve on the board of directors because of his extensive experience within the life sciences industry and because of the perspective and background that he brings as Vaxart&#146;s President, Chief Executive Officer and Director.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><b><i><font style=FONT-SIZE:10pt>Sean N. Tucker, Ph.D.</font></i></b><font style=FONT-SIZE:10pt> has served as </font><font style=FONT-SIZE:10pt>our Chief Scientific Officer since February 2018 and previously served as </font><font style=FONT-SIZE:10pt>Private Vaxart&#146;s Chief Scientific Officer since February 2010 and as a member of the Private Vaxart board of directors from March 2004 to February 2018. From March 2004 to February 2010, Dr.&nbsp;Tucker served as Private Vaxart&#146;s Vice President of Research and Director of Immunology. Prior to these roles, Dr.&nbsp;Tucker held numerous scientific and engineering roles at various biotechnology companies. Dr.&nbsp;Tucker received a B.S. in chemical engineering from the University of Washington, an M.S. in chemical engineering from the University of California, Berkeley and a Ph.D. in immunology from the University of Washington.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=FONT-SIZE:10pt>Directors</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><b><i><font style=FONT-SIZE:10pt>Geoffrey F. Cox, Ph.D.</font></i></b><font style=FONT-SIZE:10pt> has served as a member of the board of directors since 2000. He was a director (2000-2012) and the Non-Executive Chairman (2007 to 2012) of Nabi Biopharmaceuticals, Inc. prior to its merger with Biota Pharmaceuticals, Inc. (subsequently Aviragen) in 2012 and then with Vaxart in 2018. He served as the interim Chief Executive Officer of QLT Inc., an ophthalmology company based in Vancouver, BC, (from October 23, 2014 to November 30, 2016) and a director (from 2012 to August 2017). Dr. Cox has extensive pharmaceutical and biotechnology experience holding a broad range of senior management and board positions with private and public companies. Dr. Cox remains the Principal of Beacon Street Advisors LLC (since 2013) which provides corporate, operational and organizational strategic advice and interim management support to life sciences companies. Previously, he was a partner with Red Sky Partners LLC, a life sciences consulting firm (from 2011 to 2013). He also served as a director of Gallus Biopharmaceuticals LLC (2011 &#150; 2014), a biologics contract manufacturing and development company, Immunomedics, Inc., a development stage oncology company (January 2017 &#150; March 2017) and currently serves as a director of Lakewood-Amedex LLC (since 2013), a company developing novel antibiotics and RNA silencing technology. He is also cofounder of Actu8 Immunotherapeutics Ltd., a development stage immuno-oncology technology company. Dr. Cox was Chairman, President and Chief Executive Officer of GTC Biotherapeutics Inc. (2001 to 2010), a company focused on the development of recombinant therapeutic proteins, including proteins for the treatment of rare diseases, using transgenic animal production technology. Prior to 2001, Dr. Cox was Executive Vice President, Operations of Genzyme Corporation and later Chairman, President and Chief Executive Officer of Aronex Pharmaceuticals Inc. Dr. Cox is a past Chairman of the Board of the Massachusetts Biotechnology Council. He previously served on the Board of Biotechnology Industries Association and as a member of its Health Governing and Emerging Companies Sections. Dr. Cox received a B.Sc. (Hons) in biochemistry from the University of Birmingham, U.K. and a Ph.D. in biochemistry from the University of East Anglia, U.K.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>118</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>We believe Dr. Cox is qualified to serve on the board because of his extensive biotechnology industry expertise, including his many years of experience as an executive officer and board member of publicly-traded biotechnology companies.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><b><i><font style=FONT-SIZE:10pt>Michael J. Finney, Ph.D.</font></i></b><font style=FONT-SIZE:10pt> has </font><font style=FONT-SIZE:10pt>served as a member of our board of directors since February 2018 and previously </font><font style=FONT-SIZE:10pt>served as a member of Private Vaxart&#146;s board of directors since 2007. Since October 2004, Dr. Finney has served as the Managing Director of Finney Capital, an investment firm. Since 1986, Dr. Finney has served as a founder, director and/or investor in various life sciences companies. Currently, he sits on six private company boards. From 2009 to 2011, Dr. Finney served as Vaxart&#146;s Chief Executive Officer. Dr. Finney received an A.B. in biochemical sciences from Harvard University and a Ph.D. in biology (genetics) from the Massachusetts Institute of Technology.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>We believe Dr. Finney is qualified to serve on the board of directors because of his extensive experience within the life sciences industry, including as a venture capitalist.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><b><i><font style=FONT-SIZE:10pt>Richard J. Markham </font></i></b><font style=FONT-SIZE:10pt>has </font><font style=FONT-SIZE:10pt>served as a member of our board of directors since February 2018 and previously </font><font style=FONT-SIZE:10pt>served as a member of Private Vaxart&#146;s board of directors since 2009. From November 2004 to December 2018, Mr.&nbsp;Markham was a partner at Care Capital, LLC, a venture capital firm. From May 2002 to August 2004, he was the Vice Chairman of the Management Board and Chief Operating Officer of Aventis SA, a pharmaceutical company. From December 1999 to May 2002, he was the Chief Executive Officer of Aventis Pharma AG, a pharmaceutical company. Previously he was the Chief Executive Officer of Hoechst Marion Roussel Inc., a pharmaceutical company, and the President and Chief Operating Officer of Marion Merrell Dow, Inc., a pharmaceutical company, and a member of its board of directors. From 1973 to 1993, Mr. Markham was associated with Merck &amp; Co., a pharmaceutical company, culminating in his position as President and Chief Operating Officer. Since 2007, Mr. Markham has served as a member of the board of directors of NephroGenex, Inc. and as its board chairman since October 2013. From 2008 until 2016 he also served on the board of directors of CoLuid Pharmaceuticals, Inc. Mr. Markham also served on the board of directors of Acura Pharmaceuticals, Inc. from 2006 to 2013, Anacor Pharmaceuticals, Inc. from 2005 to 2012. Mr. Markham received a B.S. in pharmacy and pharmaceutical sciences from Purdue University.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>We believe that Mr. Markham is qualified to serve on the board of directors because of his extensive experience within the life sciences industry, his knowledge of finance and transactions and his historic knowledge of Vaxart&#146;s company and its vaccine candidates.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><b><i><font style=FONT-SIZE:10pt>John P. Richard </font></i></b><font style=FONT-SIZE:10pt>has served as a member of our board of directors since 2013. Mr. Richard is co-founder and Head of Corporate Development for Mereo BioPharma Group plc, a London-based biopharmaceutical company started in 2015. From 2005 until 2015 Mr. Richard was also a partner with Georgia Venture Partners, a seed venture capital firm focused on the biotechnology industry. He currently serves as a non-executive director of Phase4 Partners and serves as a director of Catalyst Biosciences (Nasdaq: CBIO) and QUE Oncology, Inc. Earlier in his career he headed business development for the public companies SEQUUS Pharmaceuticals, VIVUS and Genome Therapeutics, and was co-founder and CEO of Impath. Mr. Richard received his B.S. from Stanford University and an M.B.A. from the Harvard Business School. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>We believe Mr. Richard is qualified to serve on the board because of his extensive executive, strategic, financial and business development experience within the biotechnology industry, and having led the business development function at several companies resulting in numerous pharmaceutical alliances.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>119</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-VARIANT:small-caps; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><a name=_Hlk536353365><i><font style="FONT-VARIANT:normal !important">Anne M. VanLent </font></i></a><font style="FONT-VARIANT:normal !important; FONT-WEIGHT:normal">has served as a member of our board of directors since 2013. Ms. VanLent is President of AMV Advisors, providing corporate strategy and financial consulting services to emerging growth life sciences companies. Ms. VanLent also serves as a director and audit committee chair of Applied Genetics Technologies Corporation (Nasdaq: AGTC) and as a director of Trevi Therapeutics, Inc. Ms. VanLent was the Executive Vice President and Chief Financial Officer of Barrier Therapeutics, Inc., a publicly-traded pharmaceutical company that develops and markets prescription dermatology products, from May 2002 through April 2008. From July 1997 to October 2001, she was the Executive Vice President &#150; Portfolio Management for Sarnoff Corporation, a multidisciplinary research and development firm. From 1985 to 1993, she served as Senior Vice President and Chief Financial Officer of The Liposome Company, Inc., a publicly-traded biopharmaceutical company. During the past five years, Ms. VanLent served as a director, audit committee chair and nominating and governance committee chair of Ocera Pharmaceuticals, Inc. from March 2011 to December 2017, a director of Novelion Pharmaceuticals, Inc. (formerly Aegerion Pharmaceuticals, Inc.) from March 2013 to June 2017, and of Onconova Therapeutics, Inc. from July 2013 to May 2016. Ms. VanLent received a B.A. in Physics from Mount Holyoke College.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><a name=_Hlk536353453><font style=FONT-SIZE:10pt>We believe Ms. VanLent is qualified to serve on the board of directors because of her extensive leadership and finance experience, and her extensive experience serving as a board member, audit committee member and audit committee chair of numerous public companies in the life sciences industry.</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Family Relationships</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>There are no family relationships among the members of the board of directors and executive officers. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Information Regarding Committees of the Board of Directors</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>The board of directors has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The board of directors has adopted a written charter for each committee that is available to stockholders<b> </b>on the Investors section of our website at <font style=FONT-SIZE:10pt><i><font style=COLOR:windowtext>www.vaxart.com</font></i></font>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>The following table provides membership and meeting information for each of the committees of the Aviragen board of directors from January 1, 2018 to the closing of the Merger on February 13, 2018:</font></p> <div style=page:WordSection4> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=64% style="WIDTH:64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 6pt; BORDER-LEFT:0px; PADDING-RIGHT:0in'><b><font style=FONT-SIZE:10pt>Name</font></b></p></div></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 6pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Audit</font></b></p></div></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 6pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Compensation</font></b></p></div></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 6pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Nominating and Corporate Governance</font></b></p></div></td></tr> <tr> <td width=64% style="WIDTH:64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Armando Amido<sup>(1)</sup></font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom><font style=FONT-SIZE:10pt> <p align=center>&#8730;*</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=64% style="WIDTH:64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Geoffrey F. Cox, Ph.D</font></p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;*</p></td></tr> <tr> <td width=64% style="WIDTH:64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Michael R. Dougherty<sup>(1)</sup></font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=64% style="WIDTH:64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Michael W. Dunne, M.D.<sup>(1)</sup></font></p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td></tr> <tr> <td width=64% style="WIDTH:64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Joseph M. Patti, M.D.<sup>(1)</sup></font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=64% style="WIDTH:64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Russell H. Plumb<sup>(1)</sup></font></p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=64% style="WIDTH:64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>John P. Richard</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td></tr> <tr> <td width=64% style="WIDTH:64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Anne M. VanLent</font></p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom><font style=FONT-SIZE:10pt> <p align=center>&#8730;*</font></p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><u><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></u></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Committee Chairperson</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt 0.25in; TEXT-INDENT:-0.25in; page:WordSection4'><sup><font style=FONT-SIZE:10pt>(1)</font></sup><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp; Resigned in February 2018 upon the closing of the Merger.</font></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'> <div style=page:WordSection4><br clear=all></div></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>120</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>Upon the closing of the Merger on February 13, 2018, the committees of the board of directors were re-constituted. The following table provides membership for the remainder of 2018 for each of the committees of the board of directors: </font></p> <div style=page:WordSection4> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=313 style="WIDTH:234.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 6pt; BORDER-LEFT:0px; PADDING-RIGHT:0in'><b><font style=FONT-SIZE:10pt>Name</font></b></p></div></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 6pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Audit</font></b></p></div></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 6pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Compensation</font></b></p></div></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 6pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Nominating and Corporate Governance</font></b></p></div></td></tr> <tr> <td width=313 style="WIDTH:234.7pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Wouter W. Latour, M.D.</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=313 style="WIDTH:234.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Geoffrey F. Cox, Ph.D.<sup>(1)</sup></font></p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom><font style=FONT-SIZE:10pt> <p align=center>&#8730;*</font></p></td></tr> <tr> <td width=313 style="WIDTH:234.7pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Michael J. Finney, Ph.D.</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=313 style="WIDTH:234.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Jan Leschly<sup>(2)</sup></font></p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;*</p></td></tr> <tr> <td width=313 style="WIDTH:234.7pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Richard J. Markham<sup>(3)</sup></font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom><font style=FONT-SIZE:10pt> <p align=center>&#8730;*</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td></tr> <tr> <td width=313 style="WIDTH:234.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>John P. Richard</font></p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td> <td width=12% style="WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=313 style="WIDTH:234.7pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Anne M. VanLent</font></p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;*</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p align=center>&#8730;</p></td> <td width=12% style="WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><u><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></u></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Committee Chairperson</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dr. Cox was appointed chairman of the Nominating and Corporate Governance Committee in December 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mr. Leschly resigned from the board of directors in November 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mr. Markham was appointed to the Nominating and Corporate Governance Committee in December 2018.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in'><b><font style=FONT-SIZE:10pt>Audit Committee</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>We have a standing audit committee that is currently composed of three directors (Dr. Finney, Mr. Richard and Ms. VanLent).&nbsp; The board of directors has also determined that Ms. VanLent qualifies as an &#147;audit committee financial expert,&#148; as defined in applicable SEC rules. The board of directors made a qualitative assessment of Ms. VanLent&#146;s level of knowledge and experience based on a number of factors, including her experience as a chief financial officer for public reporting companies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in'><b><font style=FONT-SIZE:10pt>Director Nominations</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>No material changes have been made to the procedures by which stockholders may recommend nominees to our board of directors.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><b><font style=FONT-SIZE:10pt>Section 16(a) Beneficial Ownership Reporting Compliance</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than ten percent of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of Vaxart. Officers, directors and greater than ten percent stockholders are required by SEC regulation to furnish us with copies of all Section 16(a) forms they file.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, during the year ended <font style="FONT-SIZE:10pt; COLOR:windowtext">December 31, 2018</font></font>, all Section 16(a) filing requirements applicable to our officers, directors and greater than ten percent beneficial owners were complied with, except as follows: </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>Two late Form 4&#146;s were filed by Dr. Finney covering (i) a pro rata distribution by Life Science Angel Investors II, LLC and LSA Investors Side Fund 2006, LLC of an aggregate of 34,958 shares of our common stock to Dr. Finney in September 2018, and (ii) the purchase of 5,000 shares of our common stock in June 2018. &nbsp;In addition, Dr. Finney filed an amended Form 4 to reflect an additional 1,818 shares of our common stock that were not previously included in his Form 4 filed in connection with the closing of the Merger</font><font style=FONT-SIZE:10pt>; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in'><a name=_cp_blt_1_221><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; COLOR:windowtext">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>A </font></a><font style=FONT-SIZE:10pt>late Form 4 was filed by Mr. Harland covering a pro rata distribution by Life Science Angel Investors II, LLC and LSA Investors Side Fund 2006, LLC of an aggregate of 761 shares of our common stock to Mr. Harland in September 2018</font><font style=FONT-SIZE:10pt>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:'><a name=_Toc535333041><b><font style=FONT-SIZE:10pt>Code of Ethics</font></b></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>We have adopted a Code of Conduct that applies to all officers, directors and employees. The Code of Conduct is available on the Investors section of our website at <i><font style=COLOR:windowtext>www.vaxart.com</font></i></font><font style=TEXT-TRANSFORM:uppercase>.<b> </b></font><font style=FONT-SIZE:10pt>If we make any substantive amendments to the Code of Conduct or grant any waiver from a provision of the Code of Conduct to any executive officer or director, we will promptly disclose the nature of the amendment or waiver on our website. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>121</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><b><a name=ITEM11>Item&nbsp;11.&nbsp;&nbsp;Executive Compensation</a></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>The following tables and accompanying narrative disclosure set forth information about the compensation paid or earned by our executive officers during the year ended December 31, 2018. These executive officers were:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>Wouter W. Latour, M.D., our President <font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>and Chief Executive Officer;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>Sean N. Tucker, Ph.D., our Chief Scientific Officer<font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>John M. Harland, our former Chief Financial Officer<font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>;</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>Joseph M. Patti, M.S.P.H, Ph.D., former President and Chief Executive Officer of Aviragen<font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>; and</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>Mark P. Colonnese, former Executive President and Chief Financial Officer of Aviragen.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>We refer to these individuals as the &#147;named executive officers.&#148;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Summary Compensation Table</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection4'><font style=FONT-SIZE:10pt>The following table provides information regarding the total compensation for services rendered in all capacities that was earned by our named executive officers during the year ended December 31, 2018. Upon the closing of the Merger, each of the Aviragen named executive officers resigned.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <div style=page:WordSection4 align=center> <table width=800 bordercolor=transparent style=WIDTH:600pt cellpadding=0 cellspacing=0> <tr> <td width=34% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:34.64%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in'><b><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>Name and Principal Position<sup>(1)</sup></font></font></b></p></div></td> <td style="WIDTH:0.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=6% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:6.16%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Year</font></b></p></div></td> <td style="WIDTH:0.44%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:7.22%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Salary</font></b></p></div></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.84%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>Bonus<sup>(2)</sup></font></font></b></p></div></td> <td style="WIDTH:0.7%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.58%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>Option Awards<sup>(3)</sup></font></font></b></p></div></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.96%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt>All Other</font> Compensation</font></b></p></div></td> <td width=2% style="WIDTH:2.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=9% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:9.62%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Total</font></b></p></div></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=34% style="WIDTH:34.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Wouter W. Latour, M.D.</font></p></td> <td style="WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=6% style="WIDTH:6.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2018</font></p></td> <td style="WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=6% style="WIDTH:6.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>450,000</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>$</font></p></td> <td width=8% style="WIDTH:8.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td nowrap style="WIDTH:0.7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>$</font></p></td> <td width=11% style="WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>392,162</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>$</font></p></td> <td width=10% style="WIDTH:10.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8,250</font></p></td> <td width=2% style="WIDTH:2.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><sup><font style=FONT-SIZE:10pt>(4)</font></sup></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>$</font></p></td> <td width=8% style="WIDTH:8.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>850,412</font></p></td> <td nowrap style="WIDTH:0.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=34% style="WIDTH:34.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><font style=FONT-SIZE:10pt><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"'><em>President and Chief Executive Officer</em></font></font></p></td> <td style="WIDTH:0.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=6% style="WIDTH:6.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=6% style="WIDTH:6.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=11% style="WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=10% style="WIDTH:10.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td></tr> <tr> <td width=34% style="WIDTH:34.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Sean N. Tucker, Ph.D.</font></p></td> <td style="WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=6% style="WIDTH:6.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2018</font></p></td> <td style="WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=6% style="WIDTH:6.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>319,000</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td nowrap style="WIDTH:0.7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=11% style="WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>50,398</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=10% style="WIDTH:10.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8,610</font></p></td> <td width=2% style="WIDTH:2.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><sup><font style=FONT-SIZE:10pt>(5)</font></sup></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>378,008</font></p></td> <td nowrap style="WIDTH:0.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=34% style="WIDTH:34.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><i><font style=FONT-SIZE:10pt>Chief Scientific Officer</font></i></p></td> <td style="WIDTH:0.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=6% style="WIDTH:6.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=6% style="WIDTH:6.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=11% style="WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=10% style="WIDTH:10.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td></tr> <tr> <td width=34% style="WIDTH:34.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>John M. Harland <sup>(6)</sup></font></font></p></td> <td style="WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=6% style="WIDTH:6.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2018</font></p></td> <td style="WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=6% style="WIDTH:6.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>310,000</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>35,000</font></p></td> <td nowrap style="WIDTH:0.7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=11% style="WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>64,798</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=10% style="WIDTH:10.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8,250</font></p></td> <td width=2% style="WIDTH:2.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><sup><font style=FONT-SIZE:10pt>(4)</font></sup></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>418,048</font></p></td> <td nowrap style="WIDTH:0.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=34% style="WIDTH:34.64%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><i><font style=FONT-SIZE:10pt>Former Chief Financial Officer</font></i></p></td> <td style="WIDTH:0.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=6% style="WIDTH:6.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="WIDTH:0.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=6% style="WIDTH:6.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=11% style="WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=10% style="WIDTH:10.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=2% style="WIDTH:2.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.46%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td width=8% style="WIDTH:8.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right>&nbsp;</p></td> <td nowrap style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:5.85pt> <td width=34% style="HEIGHT:5.85pt; WIDTH:34.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>Joseph M. Patti, M.S.P.H, Ph.D.<b><sup> </sup></b></font></font></p></td> <td style="HEIGHT:5.85pt; WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=6% style="HEIGHT:5.85pt; WIDTH:6.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2018</font></p></td> <td style="HEIGHT:5.85pt; WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:5.85pt; WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% style="HEIGHT:5.85pt; WIDTH:6.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>64,375</font></p></td> <td nowrap style="HEIGHT:5.85pt; WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:5.85pt; WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:5.85pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:5.85pt; WIDTH:8.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td nowrap style="HEIGHT:5.85pt; WIDTH:0.7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td style="HEIGHT:5.85pt; WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="HEIGHT:5.85pt; WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:5.85pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td nowrap style="HEIGHT:5.85pt; WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:5.85pt; WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="HEIGHT:5.85pt; WIDTH:1.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10% style="HEIGHT:5.85pt; WIDTH:10.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,093,873</font></p></td> <td width=2% style="HEIGHT:5.85pt; WIDTH:2.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><sup><font style=FONT-SIZE:10pt>(7)</font></sup></p></td> <td nowrap style="HEIGHT:5.85pt; WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:5.85pt; WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td style="HEIGHT:5.85pt; WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8% style="HEIGHT:5.85pt; WIDTH:8.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,158,248</font></p></td> <td nowrap style="HEIGHT:5.85pt; WIDTH:0.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:13.05pt> <td width=34% style="HEIGHT:13.05pt; WIDTH:34.64%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><font style=FONT-SIZE:10pt><i>Former President </i>and<i> Chief Executive Officer</i></font></p></td> <td style="HEIGHT:13.05pt; WIDTH:0.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=6% style="HEIGHT:13.05pt; WIDTH:6.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2017</font></p></td> <td style="HEIGHT:13.05pt; WIDTH:0.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="HEIGHT:13.05pt; WIDTH:0.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=6% style="HEIGHT:13.05pt; WIDTH:6.28%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>515,000</font></p></td> <td nowrap style="HEIGHT:13.05pt; WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="HEIGHT:13.05pt; WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="HEIGHT:13.05pt; WIDTH:0.96%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=8% style="HEIGHT:13.05pt; WIDTH:8.86%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 6pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td nowrap style="HEIGHT:13.05pt; WIDTH:0.7%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td style="HEIGHT:13.05pt; WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=1% style="HEIGHT:13.05pt; WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=11% style="HEIGHT:13.05pt; WIDTH:11.34%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>426,630</font></p></td> <td nowrap style="HEIGHT:13.05pt; WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="HEIGHT:13.05pt; WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=1% style="HEIGHT:13.05pt; WIDTH:1.48%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=10% style="HEIGHT:13.05pt; WIDTH:10.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>13,973</font></p></td> <td width=2% style="HEIGHT:13.05pt; WIDTH:2.96%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><sup><font style=FONT-SIZE:10pt>(8)</font></sup></p></td> <td nowrap style="HEIGHT:13.05pt; WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="HEIGHT:13.05pt; WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td style="HEIGHT:13.05pt; WIDTH:0.96%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=8% style="HEIGHT:13.05pt; WIDTH:8.66%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>955,603</font></p></td> <td nowrap style="HEIGHT:13.05pt; WIDTH:0.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td></tr> <tr> <td width=34% style="WIDTH:34.64%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Mark P. Colonnese</font></p></td> <td style="WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=6% style="WIDTH:6.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2018</font></p></td> <td style="WIDTH:0.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=6% style="WIDTH:6.28%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>43,725</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.86%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td nowrap style="WIDTH:0.7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>595,656</font></p></td> <td width=2% style="WIDTH:2.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><sup><font style=FONT-SIZE:10pt>(9)</font></sup></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>639,381</font></p></td> <td nowrap style="WIDTH:0.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=34% style="WIDTH:34.64%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><i><font style=FONT-SIZE:10pt>Former Executive Vice President and Chief Financial Officer</font></i></p></td> <td style="WIDTH:0.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=6% style="WIDTH:6.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2017<br><br></font></p></td> <td style="WIDTH:0.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=6% style="WIDTH:6.28%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>349,800</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.86%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td nowrap style="WIDTH:0.7%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td style="WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% style="WIDTH:11.34%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>262,541</font></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.48%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10% style="WIDTH:10.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>13,656</font></p></td> <td width=2% style="WIDTH:2.96%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><sup><font style=FONT-SIZE:10pt>(10)</font></sup></p></td> <td nowrap style="WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.46%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.96%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% style="WIDTH:8.66%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>625,997</font></p></td> <td nowrap style="WIDTH:0.16%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; MARGIN-RIGHT:6.75in; page:WordSection4"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 6pt; BORDER-LEFT:0px; PADDING-RIGHT:0in'>&nbsp;</p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style=FONT-SIZE:10pt>Each of Dr. Latour, Dr. Tucker, and Mr. Harland commenced service with Vaxart&nbsp; in February 2018 upon the closing of the Merger. Amounts disclosed for such officers include amounts paid for service with Private Vaxart in 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Compensation Committee of our Board of Directors did not approve any bonuses for 2018 for our named executive officers except for Mr. Harland, who was awarded a discretionary bonus in June 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font style=FONT-SIZE:10pt>Represents the grant date valuation of the awards computed in accordance with the Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 718. See Note <font style=COLOR:black>12</font> to the Consolidated Financial Statements for a discussion of the relevant assumptions used in calculating value pursuant to FASB ASC Topic 718. In addition, please see Note 10 to the Consolidated Financial Statements included in Aviragen&#146;s Annual Report on Form 10-K </font><font style=FONT-SIZE:10pt>for the fiscal year ended June 30, 2017, </font><font style=FONT-SIZE:10pt>filed with the SEC on September 1, 2017, for a discussion of the relevant assumptions used in calculating value pursuant to FASB ASC Topic 718. As required by SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. Our named executive officers will only realize compensation to the extent the trading price of our common stock is greater than the exercise price of such stock options.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'>(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amount shown consists solely of a 401(k) match.&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>122</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Consists of a 401(k) match of $8,250 and </font><font style=FONT-SIZE:10pt>travel reimbursements of $360.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(6)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mr. Harland resigned as our Chief Financial Officer effective December 31, 2018.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt'><font style=FONT-SIZE:10pt>(7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Consists of accrued vacation of $5,118, cash severance benefits of $1,086,922, healthcare benefits of $1,375 and <font style="BACKGROUND:white; COLOR:black">supplemental disability payments of $458</font>.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt'><font style=FONT-SIZE:10pt>(8)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font style="BACKGROUND:white; COLOR:black">Consists of healthcare benefits of $5,500, supplemental life premiums of $5,724 and supplemental disability payments of$2,749.</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt'><font style=FONT-SIZE:10pt>(9)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Consists of accrued vacation of 28,589, cash severance benefits of $565,116, healthcare benefits of $1,375 <font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>and <font style="BACKGROUND:white; COLOR:black">supplemental disability payments</font></font> of $576.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 27pt; TEXT-AUTOSPACE:; TEXT-INDENT:-27pt'><font style=FONT-SIZE:10pt>(10)&nbsp;&nbsp;&nbsp;&nbsp; <font style="BACKGROUND:white; COLOR:black">Consists of healthcare benefits of $5,500, supplemental life premiums of $4,700 and supplemental disability payments of $3,456.</font></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:'><font style=FONT-SIZE:10pt><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><strong>Employment, Severance and Change in Control Arrangements</strong></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><b><i><font style=FONT-SIZE:10pt>Vaxart</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><i><font style=FONT-SIZE:10pt>Wouter W. Latour, M.D.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>In May 2011, we extended an offer letter to Wouter W. Latour, M.D., our President and Chief Executive Officer. The offer letter was subsequently amended in October 2011. The offer letter has no specific term and constitutes an at-will employment arrangement. Dr. Latour&#146;s current annual base salary is $450,000 and his annual target bonus is 50% of his base salary. The offer letter provided Dr. Latour with a $25,000 signing bonus.</font> </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><i><font style=FONT-SIZE:10pt>Sean N. Tucker, Ph.D.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>In May 2006, we extended an offer letter to Sean N. Tucker, Ph.D., our Chief Scientific Officer. The offer letter has no specific term and constitutes an at-will employment arrangement. Dr. Tucker&#146;s current annual base salary is $319,000 and his annual target bonus is 30% of his base salary.</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><i><font style=FONT-SIZE:10pt>John M. Harland</font></i></p><font style=FONT-SIZE:10pt> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>In March 2014, we extended an offer letter to John M. Harland, our former Chief Financial Officer. The offer letter has no specific term and constitutes an at-will employment arrangement. In December 2018, Mr.&nbsp;Harland resigned as our Chief Financial Officer effective as of December 31, 2018. Following Mr. Harland&#146;s resignation, </font><a name=_cp_text_1_187><font style=FONT-SIZE:10pt>in January 2019 we extended an offer letter to </font></a><font style=FONT-SIZE:10pt>Mr. Harland and he assumed the position of Vice President, Financial Planning and Administration. Mr.&nbsp;Harland&#146;s current annual base salary is $260,000 and his annual target bonus is 30% of his base salary. </font></p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in; page:WordSection4'><i><font style=FONT-SIZE:10pt>Vaxart Severance Benefit Plan</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>In May 2018, we adopted a Severance Benefit Plan pursuant to which selected current and future employees, including the named executive officers, will be eligible for severance benefits under certain circumstances. The Severance Benefit Plan supersedes any acceleration upon change of control benefits that a participant would have been entitled to under any pre-existing agreement between the individual and Vaxart. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>The actual amounts that would be paid or distributed to an eligible named executive officer as a result of a termination of employment occurring in the future may be different than those presented below as many factors will affect the amount of any payments and benefits upon a termination of employment. For example, some of the factors that could affect the amounts payable include the named executive officer&#146;s base salary and the market price of our common stock. Although we have entered into a participation notice to provide severance payments and benefits in connection with a termination of employment under particular circumstances, Vaxart, or an acquirer, may mutually agree with the named executive officer s to provide payments and benefits on terms that vary from those currently contemplated. In addition to the amounts presented below, each named executive officer would also be able to exercise any previously-vested stock options that he held, in accordance with the terms of those grants and the respective plans pursuant to which they were granted. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>To receive any of the severance benefits under these agreements, the named executive officer is required to execute a release of claims against us within 60 days of the qualifying termination and comply with confidentiality provisions.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>123</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><i><font style=FONT-SIZE:10pt>Severance Absent a Change in Control</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>Under the Severance Plan, a participating individual shall be entitled to receive, in the event of a termination other than in connection with a change in control, (a)&nbsp;cash severance in accordance with our standard payroll practices and subject to standard payroll deductions and withholdings, equal to his annual base salary multiplied by a fraction, the numerator of which is the number of months set forth in his Participation Notice, and the denominator of which is 12<font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>,</font> and (b)&nbsp;continuation of his current health insurance coverage, or payment of the premiums for such coverage, for up to the number of months specified in his participation notice. Each named executive officer is eligible to receive the following payments and benefits:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>in the case of Dr.&nbsp;Latour, 100% of annual base salary;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>in the case of Dr. Tucker, 50% of annual base salary;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>in the case of Mr. Harland, 25% of annual base salary; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>the portion of health insurance premiums paid by Vaxart, prior to the termination, under our group health insurance plans as provided under COBRA, until the earlier of (i)&nbsp;six months (12 months in the case of Dr.&nbsp;Latour, three months in the case of Mr. Harland) after termination, (ii) the expiration of the named executive officer&#146;s eligibility for the continuation coverage under COBRA, or (iii)&nbsp;such time as the named executive officer is eligible for health insurance coverage with a subsequent employer.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><i><font style=FONT-SIZE:10pt>Severance in Connection with a Change in Control</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>In&nbsp;the case of a termination (following a change in control), if a participating individual is terminated without cause or resigns for good reason (as such terms are defined in the Severance Benefit Plan, either during the three months before or in the 12 months after a change in control, then he will be entitled to receive<font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>:</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>a lump sum cash severance payment on the first payroll date that occurs more than five (5) days following the effective date of the release signed by the named executive officer, subject to standard payroll deductions and withholdings, equal to a percentage of his annual base salary multiplied by a fraction, the numerator of which is the number of months set forth in his participation notice, and the denominator of which is 12; </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>in the case of Dr. Tucker and Mr. Harland, a pro rata amount of their target bonus&nbsp;for the calendar year in which the termination occurs calculated at 100% of target levels as specified in our annual bonus plan or program in effect immediately prior to the effective date of the change in control and a fraction, the numerator of which is the number of months of the participant&#146;s employment during the calendar year in which the change of control occurs, and the denominator of which is 12; </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>continuation of his current health insurance coverage, or payment of the premiums for such coverage, for up to the number of months specified in his participation notice under the Severance Benefit Plan; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol"><font style=FONT-SIZE:10pt>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font></font><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt>accelerated vesting of then outstanding compensatory equity awards as to all unvested shares.</font> </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>Each named executive officer is eligible to receive the following payments and benefits:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>in the case of Dr.&nbsp;Latour, 150% of annual base salary;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>in the case of Dr.&nbsp;Tucker, 100% of annual base salary;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>in the case of Mr. Harland, 50% of annual base salary;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>in the case of Dr. Tucker and Mr. Harland, prorated target bonus for the calendar year in which the termination occurs;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>full acceleration of vesting of any stock options to purchase common stock granted to the named executive officer; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>health insurance premiums under our group health insurance plans as provided under COBRA, to the extent such COBRA premiums exceed the costs previously paid by the named executive officer for group health insurance coverage while employed by us, until the earlier of (i)&nbsp;12 months (18 months in the case of Dr. Latour, six months in the case of Mr. Harland) after a change in control, (ii) the expiration of the named executive officer&#146;s eligibility for the continuation coverage under COBRA, or (iii)&nbsp;such time as the named executive officer is eligible for health insurance coverage with a subsequent employer.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>124</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><b><i><font style=FONT-SIZE:10pt>Aviragen</font></i></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><i><font style=FONT-SIZE:10pt>Joseph M. Patti, Ph.D.</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>Joseph M. Patti, Ph.D., ceased to be President and Chief Executive Officer of Aviragen and an employee of Aviragen upon the closing of the Merger. Under the terms of Dr. Patti&#146;s employment agreement, in the event Dr. Patti&#146;s employment was terminated by Dr. Patti for good reason (as defined in Dr. Patti&#146;s employment agreement) or by Aviragen for any reason other than cause, death or disability, in either case, within three months prior to or one year after the consummation of a change in control, Aviragen would pay Dr. Patti, subject to Dr. Patti&#146;s execution, delivery and non-revocation of a release, a lump sum equal to the sum of (i) any cash incentive compensation earned and unpaid through such termination; plus (ii) Dr. Patti&#146;s salary for 24 months; plus (iii) the product of two times (2x) the cash incentive compensation paid to Dr. Patti in respect of the most recent fiscal year prior to the year in which such termination occurs; plus (iv) an amount equal to the present value of the premium payments that would be made by Aviragen if Dr. Patti were to continue to be covered under Aviragen&#146;s group health, life and disability insurance for 24 months, which amount will be determined by Aviragen in its sole discretion. Dr. Patti resigned with good cause upon the closing of the Merger and received an aggregate of $1,086,922 in cash severance benefits.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><i><font style=FONT-SIZE:10pt>Mark P. Colonnese </font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>Mark P. Colonnese ceased to be Executive Vice President and Chief Financial Officer and an employee of Aviragen upon the closing of the Merger. Under the terms of Mr.&nbsp;Colonnese&#146;s employment agreement, in the event Mr.&nbsp;Colonnese&#146;s employment was terminated by Mr.&nbsp;Colonnese for good reason (as defined in Mr.&nbsp;Colonnese&#146;s employment agreement) or by Aviragen for any reason other than cause, death or disability, in either case, within 60 days prior to or one year after the consummation of a change in control, Aviragen would pay Mr.&nbsp;Colonnese, subject to Mr.&nbsp;Colonnese&#146;s execution, delivery and nonrevocation of a release, a lump sum equal to the sum of (i)&nbsp;any earned but unpaid cash incentive compensation for the fiscal year immediately preceding the fiscal year in which such termination occurs; plus (ii)&nbsp;Mr.&nbsp;Colonnese&#146;s base salary for 18 months; plus (iii)&nbsp;the product of one and a half times (1.5x) the cash incentive compensation paid to Mr.&nbsp;Colonnese in respect of the most recent fiscal year prior to the year in which such termination occurs, plus (iv)&nbsp;an amount equal to the present value of the premium payments that would be made by Aviragen if Mr.&nbsp;Colonnese were to continue to be covered under Aviragen&#146;s group health, life and disability insurance for 18 months, which amount will be determined by Aviragen in its sole discretion. Mr.&nbsp;Colonnese resigned with good cause upon the closing of the Merger and received an aggregate of $565,116 in cash severance benefits.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-VARIANT:small-caps; FONT-WEIGHT:bold; MARGIN:0in 0in 6pt; TEXT-INDENT:0in; page:WordSection4'><i><font style="FONT-VARIANT:normal !important; FONT-WEIGHT:normal">Acceleration of Unvested Aviragen Equity Awards</font></i></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>All outstanding stock options held by Aviragen&#146;s executive officers and directors were accelerated and fully vested in accordance with their terms upon the closing of the Merger and/or the termination of optionees&#146; employment in connection therewith. Please see the section above titled &#147;<i>Outstanding Equity Awards at December 31, 2018&#148; </i>for information regarding stock options held by Dr. Patti and Mr. Colonnese.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>401(k) Plan</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0in; page:WordSection4'><font style=FONT-SIZE:10pt>Aviragen did not provide pension arrangements or post-retirement health coverage for its executive officers or employees. Aviragen&#146;s executive officers and other eligible employees were eligible to participate in its 401(k) defined contribution plan. Aviragen made matching contributions to participants in the 401(k) plan in an amount equal to <font style=BACKGROUND:white>25%</font> of the employee&#146;s deferral up to a maximum of 4% of an employee&#146;s salary, subject to statutory limits.</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt"><font style=FONT-SIZE:10pt>We maintain a tax-qualified retirement plan that provides eligible employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees are able to defer eligible compensation up to certain Code limits, which are updated annually. We have the ability to make matching and discretionary contributions to the 401(k) plan, but have not done so to date. Employee contributions are allocated to each participant&#146;s individual account and are then invested in selected investment alternatives according to the participant&#146;s directions. Employees are immediately and fully vested in their own contributions. The 401(k) plan is intended to be qualified under Section 401(a) of the Code, with the related trust intended to be tax exempt under Section 501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan are deductible by us when made, and contributions and earnings on those amounts are not taxable to the employees until withdrawn or distributed from the 401(k) plan. </font><font style=FONT-SIZE:10pt>Vaxart makes matching contributions to participants in the 401(k) plan in an amount equal to the employee&#146;s deferral up to a maximum of 3% of the employee&#146;s annual eligible earnings.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Pension Benefits</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>The named executive officers did not participate in, or otherwise receive any benefits under any pension or retirement plan Vaxart or Aviragen sponsored during 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><strong>Nonqualified Deferred Compensation</strong></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>125</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt; page:WordSection4'><font style=FONT-SIZE:10pt>The named executive officers did not participate in, or earn any benefits under, a nonqualified deferred compensation plan Vaxart or Aviragen sponsored during 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Outstanding Equity Awards at December 31, 2018</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0in; page:WordSection4'><font style=FONT-SIZE:10pt>The following table presents, for each of our named executive officers, information regarding outstanding stock options held as of December 31, 2018.</font></p> <div style=page:WordSection4> <table width=786 bordercolor=transparent style=WIDTH:589.3pt cellpadding=0 cellspacing=0> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=532 colspan=13 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:399.05pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Option Awards</font></b></p></td></tr> <tr> <td width=244 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:182.65pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in'><b><font style=FONT-SIZE:10pt>Name</font></b></p></div></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.35pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Grant Date of Option Award</font></b></p></div></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=106 colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:79.35pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Number of Securities Underlying Unexercised Options (#) Exercisable</font></b></p></div></td> <td width=19 style="WIDTH:14pt; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=109 colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:82pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Number of Securities Underlying Unexercised Options (#) Unexercisable</font></b></p></div></td> <td width=29 style="WIDTH:21.65pt; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=69 colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:51.55pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Options Exercise Price ($)</font></b></p></div></td> <td width=15 style="WIDTH:11.4pt; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:60.25pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:10pt>Option Expiration Date</font></b></p></div></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Wouter W. Latour, M.D.</font></p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>6/29/2011 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;6,535 </font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;&nbsp;&nbsp; </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>$</font></p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;8.03 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>6/28/2021</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>11/3/2011 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;9,441 </font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;&nbsp;&nbsp; </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;8.03 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>11/2/2021</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>8/8/2013 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;13,255 </font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;&nbsp;&nbsp; </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;6.49 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>8/7/2023</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>5/8/2014 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;14,908 </font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;&nbsp;&nbsp; </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;8.03 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>5/7/2024</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>7/23/2015 <sup>(2)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;10,576 </font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;2,265 </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;17.49 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>7/22/2025</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>7/23/2015 <sup>(2)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;5,279 </font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;&nbsp;&nbsp; </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;17.49 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>7/22/2025</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>3/25/2016<sup> (3)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;717 </font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;3,354 </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;12.98 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>3/24/2026</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>3/25/2016 <sup>(3)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;6,660</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;&nbsp;&nbsp; </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;12.98 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>3/24/2026</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>6/24/2017 <sup>(4)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;14,782 </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;4.07 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>6/23/2027</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>6/24/2017 <sup>(4)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;8,869 </font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;&nbsp; </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;4.07 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>6/23/2027</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>5/25/2018 <sup>(5)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;35,284 </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;5.17 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>5/24/2028</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>5/25/2018 <sup>(5)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=73 style="WIDTH:55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;75,416 </font></p></td> <td width=30 colspan=2 nowrap style="WIDTH:22.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;5.17 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>5/24/2028</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>John M. Harland</font></p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>5/8/2014 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;9,563</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;&nbsp; </font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;8.03 </font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>5/7/2024</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>7/23/2015 <sup>(2)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;7,223</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;1,032 </font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>17.49</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>7/22/2025</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>3/25/2016 <sup>(3)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;2,810</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;1,277 </font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>12.98</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>3/24/2026</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>6/24/2017 <sup>(4)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&nbsp;2,642</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;4,405 </font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>4.07</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>6/23/2027</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>5/25/2018 <sup>(5)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;18,000 </font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>5.17</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>5/24/2028</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Sean N. Tucker, Ph.D.</font></p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>8/27/2010 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>4,026</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6.49</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>8/26/2020</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>3/30/2011 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>1,006</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6.49</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>3/29/2021</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>4/13/2012 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>3,020</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8.03</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>4/12/2022</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>8/8/2013 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>10,523</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6.49</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>8/7/2023</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>5/8/2014 <sup>(1)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>11,604</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8.03</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>5/7/2024</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>7/23/2015 <sup>(2)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>8,396</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,259</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>17.49</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>7/22/2025</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>7/23/2015 <sup>(2)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>412</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>17.49</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>7/22/2025</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>3/25/2016 <sup>(3)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>3,694</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,416</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>12.98</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>3/24/2026</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>3/25/2016 <sup>(3)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>1,621</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>12.98</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>3/24/2026</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>6/24/2017 <sup>(4)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>3,397</font></p></td> <td width=19 nowrap style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>5,663</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>4.07</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>6/23/2027</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>5/25/2018 <sup>(5)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>14,000</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>5.17</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>5/24/2028</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Joseph M. Patti, M.S.P.H., Ph.D.</font></p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>4/3/2017 <sup>(6)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>59,090</font></p></td> <td width=19 style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=29 style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>7.22</font></p></td> <td width=15 style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>8/13/2019</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Mark P. Colonnese</font></p></td> <td width=10 style="WIDTH:7.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right><font style=FONT-SIZE:9pt><font style=FONT-SIZE:10pt>4/3/2017 <sup>(7)</sup></font></font></p></td> <td width=9 style="WIDTH:6.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>36,363</font></p></td> <td width=19 nowrap style="WIDTH:14pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=29 nowrap style="WIDTH:21.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>7.22</font></p></td> <td width=15 nowrap style="WIDTH:11.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right><font style=FONT-SIZE:10pt>8/13/2019</font></p></td></tr> <tr> <td width=244 style="WIDTH:182.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=10 style="WIDTH:7.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3.75pt 0pt 0in' align=right>&nbsp;</p></td> <td width=96 style="WIDTH:72.35pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 6pt 0pt 0in' align=right>&nbsp;</p></td> <td width=9 style="WIDTH:6.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=27 style="WIDTH:19.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 5.25pt 0pt 0in'>&nbsp;</p></td> <td width=79 style="WIDTH:59.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 5.25pt 0pt 0in' align=right>&nbsp;</p></td> <td width=19 style="WIDTH:14pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=35 style="WIDTH:26.05pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=75 colspan=2 style="WIDTH:55.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=29 style="WIDTH:21.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8 style="WIDTH:5.95pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=61 style="WIDTH:45.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=15 style="WIDTH:11.4pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=80 style="WIDTH:60.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 3pt 0pt 0in' align=right>&nbsp;</p></td></tr> <tr> <td width=244 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=10 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=96 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=9 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=27 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=79 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=19 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=35 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=73 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=1 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=29 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=8 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=61 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=15 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=80 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <div style=page:WordSection4>&nbsp;</div> <div style=page:WordSection4> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The shares subject to this option are fully vested.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The unvested shares vest in equal monthly installments through July 23, 2019, subject to the executive officer&#146;s continued service with us through each relevant vesting date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The unvested shares vest in equal monthly installments through March 25, 2020, subject to the executive officer&#146;s continued service with us through each relevant vesting date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The unvested shares vest in equal monthly installments through June 24, 2021, subject to the executive officer&#146;s continued service with us through each relevant vesting date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(5) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The unvested shares vest in equal monthly installments through May 25, 2022, subject to the executive officer&#146;s continued service with us through each relevant vesting date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(6)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The vesting of all shares under this stock option was accelerated in full upon <font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Dr. Patti&#146;s resignation following the Merger</font>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The vesting of all shares under this stock option was accelerated in full <font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>upon Mr. Colonnese&#146;s resignation following</font> the Merger.</font></p></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>126</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><b><font style=FONT-SIZE:10pt>Director Compensation</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>During 2018, our non-employee directors were compensated in the following manner under our director compensation program.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><i><font style=FONT-SIZE:10pt>Annual and Meeting Fees.</font></i><font style=FONT-SIZE:10pt>During 2018, our non-employee directors received the following cash compensation for their service on the board of directors and its committees:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>$37,000 annual cash retainer;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>$20,000 for the non-executive chairman of the board and $15,000 for lead director (if applicable);</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>$17,500 for the chair of the Audit Committee and $8,750 for each of its other members;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>$12,500 for the chair of the Compensation Committee and $6,250 for each of its other members; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>$9,000 for the chair of the Nominating and Corporate Governance Committee and $4,500 for each of its other members.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:-0.25in; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-FAMILY:Symbol>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font>$13,000 for the chair of the Aviragen Transactions Committee and $10,000 for each of its other members was paid in connection with and at the conclusion of the Merger.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><i><font style=FONT-SIZE:10pt>Equity Awards</font></i><font style=FONT-SIZE:10pt>. The Aviragen non-employee director equity compensation policy provided that each non-employee director would receive, upon the initial effective date of such director&#146;s appointment, a stock option award to purchase 3,182 shares of Aviragen&#146;s common stock under its 2016 Equity Incentive Plan, 33% of which would vest on the first, second and third anniversary of the grant date. In addition, each non<font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>-</font>employee director would receive an annual award of options to purchase 1,818 shares of the Aviragen&#146;s common stock under its 2016 Equity Incentive Plan that will vest on the one year anniversary of the grant date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>The exercise price of all stock options granted to the Aviragen directors was equal to the fair market value of Aviragen&#146;s common stock on the date of the grant. As of the closing of the Merger, Aviragen&#146;s non-employee directors held 14,888 unvested stock options and 92,745 vested stock options in the aggregate, with a weighted average exercise price of $34.93.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>Since the closing of the Merger in February 2018, we have not granted any stock options to our directors.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>Non-employee directors receive no other form of remuneration, perquisites or benefits, but are reimbursed for their expenses in attending meetings, including travel, meal and other expenses incurred to attend meetings solely among the non-employee directors.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Director Compensation &#151; 2018</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>The following table provides director compensation information for each of the non-employee directors of the Aviragen board of directors serving from January 1, 2018 until their resignation in connection with the closing of the Merger in February 2018:</font></p> <div style=page:WordSection4> <table width=786 bordercolor=transparent style=WIDTH:589.45pt cellpadding=0 cellspacing=0> <tr> <td width=53% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:53.26%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style=FONT-SIZE:9pt>Name</font></u></b></p></td> <td style="WIDTH:0.84%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=21% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:21.78%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Fees Earned</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>or Paid in</font></b></p> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:9pt>Cash</font></b></p></div></td> <td style="WIDTH:0.76%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.2%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=20% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:20.62%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:9pt>Total</font></b></p></div></td></tr> <tr> <td width=53% style="WIDTH:53.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Michael Dougherty</font></p></td> <td style="WIDTH:0.84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$&nbsp;</font></p></td> <td width=19% style="WIDTH:19.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6,345</font></p></td> <td nowrap style="WIDTH:0.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="WIDTH:0.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$&nbsp;</font></p></td> <td width=1% style="WIDTH:1.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17% style="WIDTH:17.6%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6,345</font></p></td></tr> <tr> <td width=53% style="WIDTH:53.26%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Russell Plumb </font></p></td> <td style="WIDTH:0.84%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% style="WIDTH:19.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6,955</font></p></td> <td nowrap style="WIDTH:0.76%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.2%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="WIDTH:0.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.84%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.18%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17% style="WIDTH:17.6%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6,955</font></p></td></tr> <tr> <td width=53% style="WIDTH:53.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Armando Anido</font></p></td> <td style="WIDTH:0.84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% style="WIDTH:19.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6,040</font></p></td> <td nowrap style="WIDTH:0.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="WIDTH:0.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17% style="WIDTH:17.6%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>6,040</font></p></td></tr> <tr> <td width=53% style="WIDTH:53.26%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Michael W. Dunne, M.D.</font></p></td> <td style="WIDTH:0.84%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.84%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=19% style="WIDTH:19.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>5,064</font></p></td> <td nowrap style="WIDTH:0.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="WIDTH:0.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.84%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17% style="WIDTH:17.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>5,064</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>127</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'> </p> <p style="MARGIN:0in 0in 6pt"><font style=FONT-SIZE:10pt>The following table provides director compensation information for each of our non-employee directors</font><a name=_cp_text_1_210><font style=FONT-SIZE:10pt>, including the non-employee directors of Aviragen who continued to serve on the board of directors following the closing of the Merger</font></a><font style=FONT-SIZE:10pt>:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'>&nbsp;</p> <div style=page:WordSection4> <table width=784 bordercolor=transparent style=WIDTH:588.35pt cellpadding=0 cellspacing=0> <tr> <td width=53% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:53.5%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style=FONT-SIZE:9pt>Name</font></u></b></p></td> <td style="WIDTH:0.96%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=21% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:21.48%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Fees Earned</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>or Paid in</font></b></p> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:9pt>Cash</font></b></p></div></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.32%; PADDING-BOTTOM:0.75pt; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=20% colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:20.06%; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; TEXT-ALIGN:center; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in' align=center><b><font style=FONT-SIZE:9pt>Total</font></b></p></div></td></tr> <tr> <td width=53% style="WIDTH:53.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Geoffrey F. Cox, Ph.D.</font></p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=20% style="WIDTH:20.12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>42,804</font></p></td> <td nowrap style="WIDTH:0.88%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="WIDTH:0.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>$</font></p></td> <td width=17% style="WIDTH:17.84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>42,804</font></p></td></tr> <tr> <td width=53% style="WIDTH:53.5%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Michael J. Finney, Ph.D.</font></p></td> <td style="WIDTH:0.96%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=20% style="WIDTH:20.12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>40,158</font></p></td> <td nowrap style="WIDTH:0.88%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.32%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="WIDTH:0.9%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17% style="WIDTH:17.84%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>40,158</font></p></td></tr> <tr> <td width=53% style="WIDTH:53.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Jan Leschly<sup>(1)</sup></font></p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=20% style="WIDTH:20.12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>34,878</font></p></td> <td nowrap style="WIDTH:0.88%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="WIDTH:0.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17% style="WIDTH:17.84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>34,878</font></p></td></tr> <tr> <td width=53% style="WIDTH:53.5%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Richard J. Markham</font></p></td> <td style="WIDTH:0.96%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=20% style="WIDTH:20.12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>61,006</font></p></td> <td nowrap style="WIDTH:0.88%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.32%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="WIDTH:0.9%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17% style="WIDTH:17.84%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>61,006</font></p></td></tr> <tr> <td width=53% style="WIDTH:53.5%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>John P. Richard</font></p></td> <td style="WIDTH:0.96%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=20% style="WIDTH:20.12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>51,776</font></p></td> <td nowrap style="WIDTH:0.88%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.32%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="WIDTH:0.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="WIDTH:1.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=17% style="WIDTH:17.84%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>51,776</font></p></td></tr> <tr> <td width=53% style="WIDTH:53.5%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Anne M. VanLent</font></p></td> <td style="WIDTH:0.96%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="WIDTH:1.36%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=20% style="WIDTH:20.12%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>62,355</font></p></td> <td nowrap style="WIDTH:0.88%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td style="WIDTH:0.9%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="WIDTH:1.32%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="WIDTH:0.9%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td style="WIDTH:0.9%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="WIDTH:1.3%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=17% style="WIDTH:17.84%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>62,355</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'>&nbsp;</p> <div style=page:WordSection4><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br><br></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Resigned as a member of the board of directors in November 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection4'><b><font style=FONT-SIZE:10pt><a name=ITEM12>Item&nbsp;12.</a>&nbsp;&nbsp;<a name=security>Security Ownership of Certain Beneficial</a> Owners and Management and Related Stockholder Matters</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Equity Compensation Plans at December 31, 2018</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>The following table provides certain information with respect to all equity compensation plans in effect as of December 31, 2018.</font></p> <div style=page:WordSection4> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="WIDTH:12.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="WIDTH:13.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=13 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Number&nbsp;of</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Securities</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Remaining</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Available&nbsp;for</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Future&nbsp;Issuance</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Under&nbsp;Equity</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Compensation</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Plans</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>(Excluding</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Securities</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Reflected&nbsp;in</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Column&nbsp;(a))</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>(c)</font></b></p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="WIDTH:12.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="WIDTH:13.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="WIDTH:12.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="WIDTH:13.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="WIDTH:12.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="WIDTH:13.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="WIDTH:12.2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="WIDTH:13.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=8 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Number&nbsp;of</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Securities&nbsp;to</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Be&nbsp;Issued</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Upon</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Exercise&nbsp;of</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Outstanding</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Options</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>(a)</font></b></p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="WIDTH:13.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="WIDTH:13.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="WIDTH:13.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.5%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=5 valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Weighted-Average</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Exercise&nbsp;Price&nbsp;of</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Outstanding</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>Options</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:8pt>(b)</font></b></p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:3.5pt> <td width=52% style="HEIGHT:3.5pt; WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:3.5pt; WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="HEIGHT:3.5pt; WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:3.5pt; WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:3.5pt; WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:3.5pt; WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="HEIGHT:3.5pt; WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:52.52%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:8pt>Plan Category</font></b></p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:52.52%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=3% style="WIDTH:3.06%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="WIDTH:0.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td style="WIDTH:0.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt"><font style=FONT-SIZE:10pt>Equity compensation plans approved by security holders</font></p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right><font style=FONT-SIZE:10pt>615,961</font></p></td> <td width=3% style="WIDTH:3.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt"><sup><font style=FONT-SIZE:10pt>(1)</font></sup></p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt"><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right><font style=FONT-SIZE:10pt>7.57</font></p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.26%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right><font style=FONT-SIZE:10pt>223,377</font></p></td> <td width=2% colspan=2 style="WIDTH:2.3%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt"><sup><font style=FONT-SIZE:10pt>(2)</font></sup></p></td> <td width=1% style="WIDTH:1.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt"><font style=FONT-SIZE:10pt>Equity compensation plans not approved by security holders</font></p></td> <td style="WIDTH:0.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.26%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right><font style=FONT-SIZE:10pt>249,202</font></p></td> <td width=3% style="WIDTH:3.06%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt"><sup><font style=FONT-SIZE:10pt>(3)</font></sup></p></td> <td style="WIDTH:0.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt"><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.56%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right><font style=FONT-SIZE:10pt>9.50</font></p></td> <td style="WIDTH:0.94%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right>&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.26%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td style="WIDTH:0.88%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width=1% style="WIDTH:1.42%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width=52% style="WIDTH:52.52%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt"><font style=FONT-SIZE:10pt>Total</font></p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right><font style=FONT-SIZE:10pt>865,163 </font></p></td> <td width=3% style="WIDTH:3.06%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt"><font style=FONT-SIZE:10pt>$</font></p></td> <td width=12% nowrap style="WIDTH:12.56%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right><font style=FONT-SIZE:10pt>8.13</font></p></td> <td style="WIDTH:0.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width=11% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:black 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt" valign=bottom> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align=right><font style=FONT-SIZE:10pt>223,377</font></p></td> <td style="WIDTH:0.88%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width=1% style="WIDTH:1.42%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 0pt">&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br><br></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt"><font style=FONT-SIZE:10pt>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reflects shares of common stock issuable upon the exercise of outstanding stock options granted under <font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>various</font> plans that were formerly approved by Aviragen&#146;s stockholders. </font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 12pt 27pt; TEXT-INDENT:-27pt"><font style=FONT-SIZE:10pt>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Reflects shares of common stock that are available for future issuance under the 2016 Equity Incentive Plan</font>.</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; MARGIN:0in 0in 12pt 27pt; TEXT-INDENT:-27pt"><font style=FONT-SIZE:10pt>(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Reflects shares of common stock issuable upon the exercise of outstanding stock options granted under </font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>the Vaxart, Inc. Amended and Restated</font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;2007 Equity Incentive Plan, which </font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>we assumed upon the closing of the Merger in February 2018. This plan </font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>expired in July 2017 and no further awards </font><a name=_cp_text_1_230><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>may be made under this plan</font></a>.</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:12pt 0in"><b><font style=FONT-SIZE:10pt>Principal Stockholders</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>The following table sets forth certain information regarding the ownership of our common stock as of <font style=COLOR:windowtext>December 31, 2018 </font></font>by: </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 31.5pt; LINE-HEIGHT:150%; TEXT-INDENT:-13.5pt; page:WordSection4'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; LINE-HEIGHT:150%"><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;</font></font></font></font><font style="FONT-SIZE:10pt; LINE-HEIGHT:150%"><font style=FONT-SIZE:10pt>each director;</font> </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 31.5pt; LINE-HEIGHT:150%; TEXT-INDENT:-13.5pt; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; LINE-HEIGHT:150%">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;</font></font><font style=LINE-HEIGHT:150%>each current executive officer</font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 31.5pt; LINE-HEIGHT:150%; TEXT-INDENT:-13.5pt; page:WordSection4'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt><font style="FONT-FAMILY:Symbol; LINE-HEIGHT:150%">&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;</font></font><font style=LINE-HEIGHT:150%>all <font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>of our&nbsp;</font> executive officers and directors as a group; and </font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 31.5pt; LINE-HEIGHT:150%; TEXT-INDENT:-13.5pt; page:WordSection4'><font style="FONT-SIZE:10pt; FONT-FAMILY:Symbol; LINE-HEIGHT:150%"><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt>&#183;<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;</font></font></font></font><font style="FONT-SIZE:10pt; LINE-HEIGHT:150%"><font style=FONT-SIZE:10pt>all those known by us to be beneficial owners of more than five percent of our outstanding common stock.</font> </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>This table is based upon information supplied by officers, directors and principal stockholders and Schedules 13G filed with the SEC. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, the Company we believe that each of the stockholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable percentages are based on 7,141,189 shares outstanding on December 31, 2018, adjusted as required by rules promulgated by the SEC.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>Unless otherwise indicated, the address of each beneficial owner listed in the table below is c/o Vaxart, Inc., 290 Utah Ave., Suite 200<font style=COLOR:windowtext>, South San Francisco, California 94080</font></font>.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>128</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <div style=page:WordSection4 align=center> <table width=785 bordercolor=transparent style="WIDTH:588.4pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=530 style="WIDTH:397.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=227 colspan=6 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:170.35pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Beneficial Ownership</font></b></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <div style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; BORDER-TOP:0px; FONT-FAMILY:"Times New Roman","serif"; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; MARGIN:0in 0in 0pt; BORDER-LEFT:0px; PADDING-RIGHT:0in'><b><font style=FONT-SIZE:9pt>Name of Beneficial Owner</font></b></p></div></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=101 colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:76.05pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Shares</font></b></p></td> <td width=15 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.6pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:20.85pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=82 colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:61.85pt; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; BORDER-LEFT:0px; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>%</font></b></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 10pt; TEXT-INDENT:-10pt'><i><font style=FONT-SIZE:10pt>Greater than 5% Stockholders:</font></i></p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>Entities affiliated with Care Capital <sup>(1)</sup></font></p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>2,799,424</font></p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>39.2<font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>%</font></font></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 10pt; TEXT-INDENT:-10pt'><i><font style=FONT-SIZE:10pt>Executive Officers and Directors:</font></i></p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>Geoffrey F. Cox, Ph.D. <sup>(2)</sup></font></p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>8,567</font></p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>Michael J. Finney, Ph.D.</font></p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>270,754</font></p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>3.8</font></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>John M. Harland <sup>(3)</sup></font></p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>23,636</font></p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>Wouter W. Latour, M.D. <sup>(4)</sup></font></p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>78,051</font></p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1.1</font></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>Richard J. Markham <sup>(5)</sup></font></p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>John P. Richard <sup>(6)</sup></font></p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>9,543</font></p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>Sean N. Tucker, Ph.D. <sup>(7)</sup></font></p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>130,710</font></p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1.8</font></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>Anne M. VanLent <sup>(8)</sup></font></p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>12,724</font></p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>*</font></p></td></tr> <tr> <td width=530 style="WIDTH:397.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 30pt; TEXT-INDENT:-10pt'><font style=FONT-SIZE:10pt>All executive officers and directors as a group (8 persons)</font></p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=86 style="WIDTH:64.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>533,985</font></p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=28 style="WIDTH:20.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15 style="WIDTH:11.6pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=67 style="WIDTH:50.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:3pt; PADDING-RIGHT:3pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>7.3</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br><br></u><font style=FONT-SIZE:10pt>* Represents beneficial ownership of less than one percent.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Includes (a) 2,753,441 shares held by Care Capital Investments III, LP (&#147;Investments III&#148;) and (b) 45,983 shares held by Care Capital Offshore Investments III, LP (&#147;Offshore III&#148;). Care Capital III LLC is the general partner of Investments III LP and Offshore III (collectively, &#147;Care Capital&#148;) and as a result, Care Capital III LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. The address for each of these entities is P.O. Box 276, Avon by the Sea, New Jersey 07717.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Includes (a) 388 shares held by Dr. Cox&#146;s spouse, and (b) 8,179 shares issuable pursuant to stock options exercisable within 60 days of December 31, 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Includes (a) 761 shares held directly by Mr. Harland, and (b) 22,875 shares issuable pursuant to stock options exercisable within 60 days of December 31, 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Consists of 78,051 shares issuable pursuant to stock options exercisable within 60 days of December 31, 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mr. Markham ceased to serve as a managing member of Care Capital effective December 31, 2018, and does not beneficially own any shares.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(6)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Consists of 9,543 shares issuable pursuant to stock options exercisable within 60 days of December 31, 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(7)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Includes (a) 47,653 shares held directly by Dr. Tucker, (b) 25,388 shares held by Frances Chang and Sean Tucker, (c) 9,060 shares held by Dr. Tucker&#146;s spouse, and (d) 48,609 shares issuable pursuant to stock options exercisable within 60 days of December 31, 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 27pt; TEXT-INDENT:-27pt; page:WordSection4'><font style=FONT-SIZE:10pt>(8)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Includes (a) 3,181 shares held directly by Ms. VanLent, and (b) 9,543 shares issuable pursuant to stock options exercisable within 60 days of December 31, 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection4'><b><font style=FONT-SIZE:10pt><a name=ITEM13>Item&nbsp;13.</a>&nbsp;&nbsp;<a name=certain>Certain Relationships and Related Transactions</a>, and Director Independence</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Related-Party Transaction Policy and Procedures</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>We have adopted a written Related Party Transaction Policy that sets forth our policies and procedures regarding the identification, review, consideration and approval or ratification of &#147;related party transactions.&#148; For purposes of our policy only, a &#147;related party transaction&#148; is a transaction, arrangement or relationship (</font><a name=_cp_text_1_248><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>including indebtedness or a guarantee of indebtedness) </font></a><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>or any series of similar transactions, arrangements or relationships in which we and any &#147;related party&#148; are, were or will be participants involving an amount that exceeds $120,000 </font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>and in which any &#147;related party&#148; has a direct or indirect material interest</font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>. Transactions involving compensation for services provided to us as an employee, director, consultant or similar capacity by a related party are not covered by this policy. A related party is any executive officer, director, </font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>nominee to become a director </font><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>or more than 5% stockholder of us, including any of their immediate family members, and any entity owned or controlled by such persons</font>.</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-INDENT:0in; page:WordSection4'>&nbsp;</div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>129</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Under the policy, where a transaction has been identified as a related party transaction, management must present information regarding the proposed related party transaction to the Audit Committee (or, where Audit Committee approval would be inappropriate, to another independent body of the Board) for consideration and approval or ratification. The presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the related parties, the benefits to us of the transaction and whether any alternative transactions were available. To identify related party transactions in advance, we rely on information supplied by its executive officers, directors and certain significant stockholders. In considering related party transactions, the Audit Committee takes into account the relevant available facts and circumstances including, but not limited to (a) the risks, costs and benefits to us, (b) the impact on a director&#146;s independence in the event the related party is a director, immediate family member of a director or an entity with which a director is affiliated, (c) the terms of the transaction, (d) the availability of other sources for comparable services or products and (e) the terms available to or from, as the case may be, unrelated third parties or to or from employees generally. In the event a director has an interest in the proposed transaction, the director must recuse himself or herself from the deliberations and approval. The policy requires that, in determining whether to approve, ratify or reject a related party transaction, the Audit Committee consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, the best interests of us and our stockholders, as the Audit Committee determines in the good faith exercise of its discretion</font>.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Certain Related-Person Transactions</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in'><b><i><font style=FONT-SIZE:10pt>Indemnity Agreements</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in'><font style=FONT-SIZE:10pt>We have entered into indemnity agreements with our executive officers and directors which provide, among other things, that we will indemnify such officer or director, under the circumstances and to the extent provided for therein, for expenses, damages, judgments, fines and settlements he or she may be required to pay in actions or proceedings which he or she is or may be made a party by reason of his or her position as a director, officer or other agent of ours, and otherwise to the fullest extent permitted under Delaware law and our Bylaws. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt'><b><i><font style=FONT-SIZE:10pt>Offer Letters </font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>We have entered into offer letters, employment agreements and change in control arrangements with our executive officers. For more information regarding these agreements, see &#147;Item&nbsp;11.&nbsp;Executive Compensation&#151;Employment, Severance and Change in Control Agreements.&#148; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt'><a name=_Hlk284297><b><i><font style=FONT-SIZE:10pt>Equity Grants </font></i></b></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in'><font style=FONT-SIZE:10pt>We have granted stock options to our executive officers and certain members of our board of directors. For a description of our executive officers&#146; options, see &#147;Item&nbsp;11.&nbsp;&nbsp;Executive Compensation&#151;Outstanding Equity Awards at December 31, 2018.&#148; There were no awards to non-employee directors in 2018.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Independence of The Board of Directors</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>As required under <font style=COLOR:windowtext><font style=FONT-SIZE:10pt>the Nasdaq Stock Market, or Nasdaq</font>,</font></font><b> </b>listing standards, a majority of the members of a listed company&#146;s board of directors must qualify as &#147;independent,&#148; as affirmatively determined by the board of directors. The board of directors consults with our counsel to ensure that its determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#147;independent,&#148; including those set forth in pertinent listing standards of <font style="FONT-SIZE:10pt; COLOR:windowtext">Nasdaq</font>, as in effect from time to time. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection4'><font style=FONT-SIZE:10pt><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Consistent with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members, and Vaxart, our senior management and our independent auditors, the board of directors has affirmatively determined that all of our directors, other than Dr. Latour due to his position as our President and Chief Executive Officer, are independent within the meaning of the applicable Nasdaq </font></font><b></b>listing standards</font></font>.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:24pt 0in 12pt; page:WordSection4'><b><font style=FONT-SIZE:10pt><a name=ITEM14>Item&nbsp;14.&nbsp;&nbsp;Principal Accounting Fees and Services</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Current Principal Accountant Fees and Services</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>130</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>KPMG LLP</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>In February 2018, upon the closing of the Merger, the combined company dismissed Ernst &amp; Young LLP as our independent registered accounting firm and appointed KPMG LLP as our new independent registered accounting firm. KPMG LLP has audited the financial statements of Private Vaxart since February 2014. Private Vaxart was determined to be the accounting acquirer based upon the terms of the merger agreement resulting in a change to the combined company&#146;s fiscal year to December 31, effective as of the closing of the Merger</font>.</font></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Times New Roman','serif'; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style=FONT-SIZE:10pt><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>The following table represents aggregate fees billed to Private Vaxart for the year ended December 31, 2017, and to the combined company for the year ended December 31, 2018, by KPMG LLP</font>. </font></p> <div style=page:WordSection4> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:10.05pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:0.1in> <td width=386 style="HEIGHT:0.1in; WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=232 colspan=3 style="BORDER-TOP:0px; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:174.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Year Ended December 31,</font></b></p></td></tr> <tr style=HEIGHT:13.05pt> <td width=386 style="HEIGHT:13.05pt; WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=112 style="BORDER-TOP:0px; HEIGHT:13.05pt; BORDER-RIGHT:0px; WIDTH:84.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>2017</font></b></p></td> <td width=18 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:13.05pt; BORDER-RIGHT:0px; WIDTH:13.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=102 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:13.05pt; BORDER-RIGHT:0px; WIDTH:76.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>2018</font></b></p></td></tr> <tr style=HEIGHT:0.1in> <td width=386 style="HEIGHT:0.1in; WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=232 colspan=3 style="HEIGHT:0.1in; WIDTH:174.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:0.1in> <td width=386 style="HEIGHT:0.1in; WIDTH:289.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Audit Fees<sup>(1)</sup></font></p></td> <td width=112 style="HEIGHT:0.1in; WIDTH:84.15pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>$&nbsp;&nbsp; 290,760</font></p></td> <td width=18 style="HEIGHT:0.1in; WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="HEIGHT:0.1in; WIDTH:76.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt 12.55pt' align=right><font style=FONT-SIZE:10pt>$ &nbsp;&nbsp;559,000</font></p></td></tr> <tr style=HEIGHT:0.1in> <td width=386 style="HEIGHT:0.1in; WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Audit-Related Fees</font></p></td> <td width=112 style="HEIGHT:0.1in; WIDTH:84.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=18 style="HEIGHT:0.1in; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="HEIGHT:0.1in; WIDTH:76.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:0.1in> <td width=386 style="HEIGHT:0.1in; WIDTH:289.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Tax Fees</font></p></td> <td width=112 style="HEIGHT:0.1in; WIDTH:84.15pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=18 style="HEIGHT:0.1in; WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="HEIGHT:0.1in; WIDTH:76.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr style=HEIGHT:0.1in> <td width=386 style="HEIGHT:0.1in; WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>All Other Fees<sup>(2)</sup></font></p></td> <td width=112 style="HEIGHT:0.1in; WIDTH:84.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=18 style="HEIGHT:0.1in; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="HEIGHT:0.1in; WIDTH:76.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>1,780</font></p></td></tr> <tr style=HEIGHT:0.1in> <td width=386 style="HEIGHT:0.1in; WIDTH:289.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 21.3pt; TEXT-INDENT:1.05pt'><font style=FONT-SIZE:10pt>Total Fees</font></p></td> <td width=112 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:84.15pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>$&nbsp;&nbsp; 290,760</font></p></td> <td width=18 style="HEIGHT:0.1in; WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:0.1in; BORDER-RIGHT:0px; WIDTH:76.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt 12.55pt' align=right><font style=FONT-SIZE:10pt>$&nbsp; &nbsp;560,780</font></p></td></tr></table></div> <p><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection4'><font style=FONT-SIZE:10pt>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Audit Fees consisted of fees for professional services rendered for the audits of our financial statements which were billed during the respective year, including the audits of our annual financial statements and reviews of our interim quarterly reports, and services provided in connection with SEC filings, including consents and comfort letters. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'><font style="FONT-SIZE:9.5pt; COLOR:black">(2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>All Other Fees consisted of access to KPMG&#146;s Accounting Research Online website.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:10pt>As Vaxart was private during 2017, none of the </font><a name=_cp_text_1_303><font style=FONT-SIZE:10pt>KPMG LLP fees were pre-approved. Following the Merger, all the KPMG LLP</font></a><font style=FONT-SIZE:10pt>&nbsp;fees incurred were pre-approved by our Audit Committee. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>During the years ended December 31, 2017 and 2018, and the subsequent interim period through February 13, 2018, neither Vaxart, Aviragen, nor anyone on their behalf consulted with KPMG LLP, regarding either (i) the application of accounting principles to a specific transaction, completed or proposed, or the type of audit opinion that might be rendered on Vaxart&#146;s financial statements, and neither a written report nor oral advice was provided to Vaxart that KPMG LLP concluded was an important factor considered by Vaxart in reaching a decision as to any accounting, auditing or financial reporting issue or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K). </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Former Principal Accountant Fees and Services</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; page:WordSection4'><font style=FONT-SIZE:10pt>PricewaterhouseCoopers LLP, an independent registered public accounting firm, audited Aviragen Therapeutics, Inc.&#146;s financial statements for the fiscal years ended June 30, 2014 and 2015. PricewaterhouseCoopers LLP was dismissed and Ernst &amp; Young LLP was engaged by Aviragen in March 2016. In February 2018, upon the closing of the Merger, the combined company dismissed Ernst &amp; Young LLP as its independent registered public accounting firm and appointed KPMG LLP as the new independent registered public accounting firm.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>131</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Ernst &amp; Young LLP</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>The following table represents aggregate fees billed to Aviragen for the fiscal year ended <font style=COLOR:windowtext>June 30, 2017 and for the period July 1, 2017 to the closing of the Merger on February 13, 2018 </font></font>by <font style=COLOR:windowtext>Ernst &amp; Young LLP.</font></p> <div style=page:WordSection4> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:10.05pt" cellpadding=0 cellspacing=0> <tr> <td width=386 style="WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=112 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:84.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Fiscal Year Ended June 30<br>2017</font></b></p></td> <td width=18 style="WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:76.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>For the Period July 1, 2017 to February 13, 2018</font></b></p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=232 colspan=3 style="WIDTH:174.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Audit Fees<sup>(1)</sup></font></p></td> <td width=112 style="WIDTH:84.15pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411,351</font></p></td> <td width=18 style="WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="WIDTH:76.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;134,046</font></p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Audit-Related Fees</font></p></td> <td width=112 style="WIDTH:84.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=18 style="WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="WIDTH:76.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Tax Fees</font></p></td> <td width=112 style="WIDTH:84.15pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=18 style="WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="WIDTH:76.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>All Other Fees</font></p></td> <td width=112 style="WIDTH:84.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td> <td width=18 style="WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="WIDTH:76.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 21.3pt; TEXT-INDENT:1.05pt'><font style=FONT-SIZE:10pt>Total Fees</font></p></td> <td width=112 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:84.15pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;411,351</font></p></td> <td width=18 style="WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=102 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:76.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;134,046</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br><br></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection4'><font style="FONT-SIZE:9.5pt; COLOR:black">(1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:10pt>Audit Fees consisted of fees for professional services rendered for the audits of Aviragen financial statements which were billed during the respective fiscal year, including the audits of Aviragen&#146;s annual financial statements and reviews of Aviragen&#146;s interim quarterly reports, and services provided in connection with SEC filings, including consents and comfort letters</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>All the fees incurred were pre-approved by the Aviragen Audit Committee. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>The reports of Ernst &amp; Young LLP on Aviragen&#146;s consolidated financial statements for the fiscal years ended June 30, 2017 and 2016 did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles. During the fiscal years ended June 30, 2017 and 2016, and the subsequent interim period through February 13, 2018 there were no: (1) disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) with Ernst &amp; Young LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreement if not resolved to the satisfaction of Ernst &amp; Young LLP would have caused Ernst &amp; Young LLP to make reference thereto in its reports on the consolidated financial statements for such years, or (2) reportable events (as described in Item 304(a)(1)(v) of Regulation S-K).</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>During the two most recent fiscal years and through March 23, 2016, the date of the engagement of Ernst&nbsp;&amp; Young LLP, neither Aviragen nor any person on its behalf consulted with Ernst&nbsp;&amp; Young LLP with respect to either (i)&nbsp;the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on Aviragen&#146;s consolidated financial statements or (ii)&nbsp;any matter that was either the subject of a &#147;disagreement&#148; or a &#147;reportable event&#148; as such terms are described in Items 304(a)(1)(iv)&nbsp;or 304(a)(1)(v), respectively, of Regulation S-K promulgated under the Exchange Act.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>PricewaterhouseCoopers LLP</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt; page:WordSection4'><font style=FONT-SIZE:10pt>The following table represents aggregate fees billed to Aviragen for the fiscal year ended <font style="FONT-SIZE:10pt; COLOR:windowtext">June 30, 2017</font></font> by <font style="FONT-SIZE:10pt; COLOR:windowtext">PricewaterhouseCoopers LLP</font>. No fees were billed to Aviragen for the period of July 1, 2017 to February 13, 2018.</p> <div style=page:WordSection4> <table width=800 bordercolor=transparent style="WIDTH:600pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:10.05pt" cellpadding=0 cellspacing=0> <tr> <td width=386 style="WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18 style="WIDTH:13.5pt; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=118 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:88.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>Fiscal Year Ended June 30, 2017</font></b></p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18 style="WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=118 style="WIDTH:88.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Audit Fees</font></p></td> <td width=18 style="WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=118 style="WIDTH:88.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#151;</font></p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:10pt>Audit-Related Fees<sup>(1)</sup></font></font></p></td> <td width=18 style="WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=118 style="WIDTH:88.65pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>19,000</font></p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Tax Fees</font></p></td> <td width=18 style="WIDTH:13.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=118 style="WIDTH:88.65pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=386 style="WIDTH:289.2pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>All Other Fees</font></p></td> <td width=18 style="WIDTH:13.5pt; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=118 style="WIDTH:88.65pt; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&#151;</font></p></td></tr> <tr> <td width=386 style="BORDER-TOP:0px; WIDTH:289.2pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 21.3pt; TEXT-INDENT:1.05pt'><font style=FONT-SIZE:10pt>Total Fees</font></p></td> <td width=18 style="BORDER-TOP:0px; WIDTH:13.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=left><font style=FONT-SIZE:10pt>$</font></p></td> <td width=118 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:88.65pt; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style=FONT-SIZE:10pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19,000 </font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br><br></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 6pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in; page:WordSection4'>(1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style=FONT-SIZE:10pt>Audit-Related Fees consisted of fees for professional services which were billed during the year, including services provided in connection with SEC filings, including consents.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><font style=FONT-SIZE:10pt>All the fees incurred were pre-approved by the Aviragen Audit Committee and no fees were incurred subsequent to June 30, 2017.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection4'><font style=FONT-SIZE:10pt>The reports of PricewaterhouseCoopers LLP on Aviragen Therapeutics, Inc.&#146;s consolidated financial statements as of and for the fiscal years ended June 30, 2014 and 2015 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principle.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection4'><font style=FONT-SIZE:10pt>During Aviragen Therapeutics, Inc.&#146;s fiscal years ended June 30, 2014 and 2015 and in the subsequent interim period through March 23, 2016, there were no disagreements with PricewaterhouseCoopers LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements if not resolved to the satisfaction of PricewaterhouseCoopers LLP would have caused them to make reference to the subject matter of the disagreements in connection with their audit reports on the consolidated financial statements for such years, nor were there any &#147;reportable events&#148; as such term is defined in Item 304(a)(1)(v)&nbsp;of Regulation S-K promulgated under the Exchange Act. </font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'><b><font style=FONT-SIZE:10pt>Pre-Approval Policies and Procedures</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>132</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection4'><font style=FONT-SIZE:10pt>The Audit Committee has adopted a policy and procedures for the pre-approval of audit and non-audit services rendered by our independent registered public accounting firm, <font style="FONT-SIZE:10pt; COLOR:windowtext">KPMG LLP</font></font>. The policy generally pre-approves specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts. Pre-approval may also be given as part of the Audit Committee&#146;s approval of the scope of the engagement of the independent auditor or on an individual, explicit, case-by-case basis before the independent auditor is engaged to provide each service. The pre-approval of services may be delegated to one or more of the Audit Committee&#146;s members, but the decision must be reported to the full Audit Committee at its next scheduled meeting. </p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; page:WordSection4'><font style=FONT-SIZE:10pt>The Audit Committee has determined that the rendering of services other than audit services by <font style="FONT-SIZE:10pt; COLOR:windowtext">KPMG LLP</font></font> is compatible with maintaining the principal accountant&#146;s independence.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>133</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><b><font style=FONT-SIZE:11pt><a name=PART4>PART IV</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><a name=ITEM15><b><font style=FONT-SIZE:10pt>Item&nbsp;15</font></b><font style=FONT-SIZE:10pt>.&nbsp;&nbsp;<b>Exhibits and Financial Statement Schedules</b></font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><b><font style=FONT-SIZE:10pt>Financial Statement Schedules</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection4'><font style=FONT-SIZE:10pt>All financial statement schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><b><font style=FONT-SIZE:10pt>Exhibits</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection4'><font style=FONT-SIZE:10pt>The following documents are being filed with this Annual Report on Form&nbsp;10-K.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 31.5pt; TEXT-INDENT:-31.5pt; page:WordSection4'><font style=FONT-SIZE:10pt>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Statements (see &#147;Financial Statements and Supplementary Data&#148; at Item&nbsp;8 and incorporated herein by reference).</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 31.5pt; TEXT-INDENT:-31.5pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 31.5pt; TEXT-INDENT:-31.5pt; page:WordSection4'><font style=FONT-SIZE:10pt>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Statement Schedules (Schedules to the Financial Statements have been omitted because the information required to be set forth therein is not applicable or is shown in the accompanying Financial Statements or notes thereto).</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 31.5pt; TEXT-INDENT:-31.5pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 31.5pt; TEXT-INDENT:-31.5pt; page:WordSection4'><font style=FONT-SIZE:10pt>(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibits.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:; page:WordSection4'>&nbsp;</p><font style=FONT-SIZE:10pt> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>134</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p></font> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</p></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center><b><a name="EXHIBIT IND">EXHIBIT INDEX</a></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:14.4pt; page:WordSection4' align=center>&nbsp;</p> <div style=page:WordSection4> <table width=80% bordercolor=transparent style="WIDTH:80%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=7% style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=bottom> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=50% colspan=4 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:50.36%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Incorporated by Reference</font></b></p></td></tr> <tr> <td width=7% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Exhibit<br>Number</font></b></p></td> <td width=41% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:41.82%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:9pt>Description of Document</font></b></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.48%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Schedule/Form</font></b></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.6%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>File<br>Number</font></b></p></td> <td width=8% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8.14%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Exhibit</font></b></p></td> <td width=17% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:17.14%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Filing Date</font></b></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>2.1</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:black"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774917017777/ex_97866.htm>Agreement and Plan of Merger and Reorganization dated October 27, 2017, by and among Aviragen Therapeutics, Inc., Vaxart, Inc. and Agora Merger Sub, Inc.</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>2.1</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>October 30, 2017</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>2.2</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774918001951/ex_104594.htm><font style=FONT-SIZE:9pt>Amendment No. 1, dated as of February 7, 2018, to the Agreement and Plan of Merger and Reorganization dated October 27, 2017, by and among Aviragen Therapeutics, Inc., Vaxart, Inc. and Agora Merger Sub, Inc. </font></a></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>2.1</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>February 7, 2018</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>3.1</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774916038645/ex3-1.htm><font style=FONT-SIZE:9pt>Restated Certificate of Incorporation of Aviragen Therapeutics, Inc.</font></a></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>3.1</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>September 13, 2016</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>3.2</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><a href=http://www.sec.gov/Archives/edgar/data/72444/000119312518049470/d536843dex31.htm><font style=FONT-SIZE:9pt>Certificate of Amendment to Restated Certificate of Incorporation of AviragenTherapeutics, Inc.</font></a></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>3.1</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>February 20, 2018</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>3.3</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><a href=http://www.sec.gov/Archives/edgar/data/72444/000119312518049470/d536843dex32.htm><font style=FONT-SIZE:9pt>Certificate of Amendment to Restated Certificate of Incorporation of Vaxart, Inc.</font></a></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>3.2</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>February 20, 2018</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>3.4</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774916038645/ex3-2.htm><font style=FONT-SIZE:9pt>Restated By-laws of Aviragen Therapeutics,Inc.</font></a></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>3.2</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>September 13, 2016</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>4.1</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext">Reference is made to Exhibits 3.1 to 3.3</font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>4.2</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:black"><a href=http://www.sec.gov/Archives/edgar/data/72444/000151316218000319/exhibit4_2.htm>Specimen Common Stock Certificate</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>S-3</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>333-228910</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>4.2</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>December 20, 2018</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.1+</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-5.htm>Collaboration and License Agreement dated September 29, 2003, between Biota Holdings Limited and Sankyo Co., Ltd.</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10-Q</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.5</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>May 10, 2013</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.2+</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-6.htm>Amendment #1 to Collaboration and License Agreement dated June 30, 2005, between Biota Holdings Limited, Biota Scientific Management Pty. Ltd. and Sankyo Company, Ltd.</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10-Q</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.6</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>May 10, 2013</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.3</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-7.htm>Amendment #2 to Collaboration and License Agreement, dated March 27, 2009, between Biota Holdings Limited, Biota Scientific Management Pty. Ltd. and Daiichi Sankyo Company, Limited</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10-Q</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.7</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>May 10, 2013</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.4+</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-8.htm>Commercialization Agreement dated March 27, 2009, between Biota Holdings Limited, Biota Scientific Management Pty. Ltd and Daiichi Sankyo Company, Ltd.</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10-Q</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.8</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>May 10, 2013</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.5+</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-9.htm>Contract dated March 31, 2011, between Biota Scientific Management Pty. Ltd. and Office of Biomedical Advanced Research and Development Authority within the Office of the Assistant Secretary for preparedness and Response at the U.S. Department of Health and Human Services</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10-Q</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.9</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>May 10, 2013</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.6+</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774913012393/ex10-6.htm>Research and License Agreement dated February 21, 1990, by and among Biota Scientific Management Pty. Ltd., Biota Holdings Limited, Glaxo Australia Pty. Ltd. and Glaxo Group Limited</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.6</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>September 27, 2013</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.7#</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000119312507079679/ddef14a.htm>2007 Omnibus Equity and Incentive Plan (included as Appendix A to the proxy statement)</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>DEF 14A</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>000-04829</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>-</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>April 12, 2007</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.8#</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774913015786/ex10-1.htm>Form of Employee Stock Option Agreement under the 2007 Omnibus Equity and Incentive Plan</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.1</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>December 10, 2013</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>135</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <div style=page:WordSection4> <table width=80% bordercolor=transparent style="WIDTH:80%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=7% style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=bottom> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=50% colspan=4 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:50.36%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Incorporated by Reference</font></b></p></td></tr> <tr> <td width=7% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Exhibit<br>Number</font></b></p></td> <td width=41% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:41.82%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:9pt>Description of Document</font></b></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.48%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Schedule/Form</font></b></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.6%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>File<br>Number</font></b></p></td> <td width=8% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8.14%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Exhibit</font></b></p></td> <td width=17% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:17.14%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Filing Date</font></b></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <div style=page:WordSection4> <table width=80% bordercolor=transparent style="WIDTH:80%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.9+</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774916029948/ex10-1.htm>Royalty Interest Acquisition Agreement by and between Aviragen Therapeutics, Inc., Biota Holdings Pty Ltd, Biota Scientific Management Pty. Ltd. and HealthCare Royalty Partners III, L.P. dated April 22, 2016</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.1</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>April 26, 2016</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.10</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774916029948/ex10-2.htm>Protective Rights Agreement between Aviragen Therapeutics, Inc. and HealthCare Royalty Partners III, L.P. dated April 22, 2016</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.2</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>April 26, 2016</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.11#</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774917008297/ex10-1.htm>Form of Employee Stock Option Agreement under the 2016 Equity Incentive Plan</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10-Q</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.1</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>May 8, 2017</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.12#</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774916039160/bota20160927_def14a.htm>2016 Equity Incentive Plan (included as Appendix A to the proxy statement)</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>DEF 14A</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>-</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>September 27, 2016</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.13#</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774917020581/ex_101915.htm>Director Stock Option Agreement</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>S-4</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>333-222009</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.22</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>December 12, 2017</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.14</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000119312518049470/d536843dex103.htm>Form of Indemnification Agreement by and between Vaxart, Inc. and its Directors and Executive Officers</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.3</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>February 20, 2018</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.15#</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102435.htm>Vaxart, Inc. Amended and Restated 2007 Equity Incentive Plan, Stock Option Agreement, form of Notice of Stock Option Grant, form of Additional Terms and Conditions to Option and Stock Option Exercise Agreement</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>S-4/A</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>333-222009</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.24</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>December 29, 2017</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.16#</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102447.htm>Offer Letter, dated May 25, 2011, and Amendment to Offer Letter and Option Grant Agreement, dated October 1, 2011, by and between Vaxart, Inc. and Wouter W. Latour, M.D.</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>S-4/A</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>333-222009</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.25</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>December 29, 2017</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.17</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102448.htm>Industrial Lease dated October 28, 2013, by and between Vaxart, Inc. and Oyster Point LLC</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>S-4/A</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>333-222009</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.26</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>December 29, 2017</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.18</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102449.htm>Lease Agreement dated April 17, 2015, by and between Vaxart, Inc. and CRP Edgewater, LLC</a></font></p></td> <td width=13% style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>S-4/A</font></p></td> <td width=11% style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>333-222009</font></p></td> <td width=8% style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.27</font></p></td> <td width=17% style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>December 29, 2017</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.19</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102465.htm>Loan and Security Agreement dated December 22, 2016, by and between Vaxart, Inc. and Oxford Finance LLC</a></font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>S-4/A</font></p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>333-222009</font></p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.28</font></p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>December 29, 2017</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.20</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; BACKGROUND:white; COLOR:black"><a href=http://www.sec.gov/Archives/edgar/data/72444/000119312518049470/d536843dex101.htm>Second Amendment to the Loan Agreement, dated February 13, 2018, between Vaxart, Inc. and Oxford Finance LLC.</a></font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.1</font></p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>February 20, 2018</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.21#</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext"><a href=http://www.sec.gov/Archives/edgar/data/72444/000151316218000154/exhibit10_1.htm>Severance Benefit Plan and Form of Severance Benefit Plan Participation Notice.</a></font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.1</font></p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>June 6, 2018</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.22</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:black"><a href=http://www.sec.gov/Archives/edgar/data/72444/000143774918002182/ex_104828.htm>Settlement Agreement by and among Vaxart, Inc., Digirad Corporation, East Hill Management Company, LLC, and Aviragen Therapeutics, Inc.</a></font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>8-K</font></p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>001-35285</font></p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.1</font></p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>February 9, 2018</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.23</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:black"><a href=http://www.sec.gov/Archives/edgar/data/72444/000151316218000319/exhibit1_2.htm>Form of Sales Agreement dated December 19, 2018 by and between Vaxart, Inc. and B. Riley FBR, Inc.</a></font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>S-3</font></p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>333-228910</font></p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>1.2</font></p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>December 02, 2018</font></p></td></tr> <tr> <td align=center> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>10.24</font></p></td> <td><font style='FONT-SIZE:9pt; TEXT-DECORATION:none; FONT-FAMILY:"Times New Roman",serif; COLOR:black; text-underline:none'><font style="TEXT-DECORATION:none; COLOR:black; text-underline:none">&nbsp;<a href=http://www.sec.gov/Archives/edgar/data/72444/000119312518049470/d536843dex102.htm>Amended and Restated Warrant issued to Oxford Finance LLC, dated February 13, 2018</a></font></font></td> <td> <p align=center><font style=FONT-SIZE:10pt>8-K</font></p></td> <td> <p align=center><font style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman",serif'>001-35285</font></p></td> <td> <p align=center><font style=FONT-SIZE:10pt>10.2</font></p></td> <td> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>February 20, 2018</font></p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>21.1*</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9pt><a href=exhibit21_1.htm>Subsidiaries of the Registrant</a></font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>23.1*</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9pt><a href=exhibit23_1.htm>Consent of Independent Registered Public Accounting Firm</a></font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>24.1*</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9pt><a href=#SIGNTU>Power of Attorney. Reference is made to the signature page hereto</a></font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>31.1*</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><a href=exhibit31_1.htm><font style=FONT-SIZE:9pt>Certifications of Principal Executive and Financial Officer pursuant to Exchange Act Rule, 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></a></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>136</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a></p> <div style=page:WordSection4> <table width=80% bordercolor=transparent style="WIDTH:80%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=7% style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=bottom> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=50% colspan=4 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:50.36%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Incorporated by Reference</font></b></p></td></tr> <tr> <td width=7% nowrap style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Exhibit<br>Number</font></b></p></td> <td width=41% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:41.82%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:9pt>Description of Document</font></b></p></td> <td width=13% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.48%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Schedule/Form</font></b></p></td> <td width=11% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.6%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>File<br>Number</font></b></p></td> <td width=8% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8.14%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Exhibit</font></b></p></td> <td width=17% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:17.14%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:9pt>Filing Date</font></b></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <div style=page:WordSection4> <table width=80% bordercolor=transparent style="WIDTH:80%; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>32.1*</font><font style=FONT-SIZE:10pt>&#167;</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9pt><a href=exhibit32_1.htm>Certification of Principal Executive and Financial Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 </a></font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:9pt>101 *</font></p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:9pt>The following financial information from the Company&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2018, formatted in Extensible Business Reporting Language (XBRL): (i) the Consolidated Balance Sheets as of December&nbsp;31, 2018 and 2017, (ii) the Consolidated Statements of Operations and Comprehensive Loss for the years ended December&nbsp;31, 2018 and 2017, (iii) the Consolidated Statements of Stockholders&#146; Equity (Deficit) for the two years ended December&nbsp;31, 2018, (iv) the Consolidated Statements of Cash Flows for the years ended December&nbsp;31, 2018 and 2017, and (v) Notes to the Consolidated Financial Statements</font></p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr> <tr> <td width=7% nowrap style="WIDTH:7.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=41% style="WIDTH:41.82%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=13% nowrap style="WIDTH:13.48%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=11% nowrap style="WIDTH:11.6%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=8% nowrap style="WIDTH:8.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=17% nowrap style="WIDTH:17.14%; PADDING-BOTTOM:2.9pt; PADDING-TOP:2.9pt; PADDING-LEFT:2.9pt; PADDING-RIGHT:2.9pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection4'><font style="FONT-SIZE:10pt; COLOR:black">_________</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><b><font style=FONT-SIZE:10pt>*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><font style=FONT-SIZE:9pt>Filed herewith</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><b><font style=FONT-SIZE:10pt>#&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><font style=FONT-SIZE:9pt>Management contract or compensation plan or arrangement</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><b><font style=FONT-SIZE:10pt>+&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><font style=FONT-SIZE:9pt>Confidential portions of this exhibit have been omitted and filed separately with the Commission pursuant to confidential treatment granted under Rule 24b-2 promulgated under the Exchange Act</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'><font style="FONT-SIZE:10pt; COLOR:black">&#167;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style=FONT-SIZE:9pt>In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release Nos. 33-8238 and 34-47986, Final Rule: Management&#146;s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certification furnished in Exhibit 32.1 hereto is deemed to accompany this Annual Report on Form 10-K and will not be deemed &#147;filed&#148; for purposes of Section 18 of the Exchange Act. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><a name=ITEM16><b><font style=FONT-SIZE:10pt>Item&nbsp;16</font></b><b><font style=FONT-SIZE:10pt>. Form 10-K Summary</font></b></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>None.</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>137</font></p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection4' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; page:WordSection4'><a href=#toc><strong><font color=#0066cc>Table of Contents</font></strong></a><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'></p></font></b> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in; page:WordSection4' align=center><b><font style=FONT-SIZE:10pt><a name=SIGNTU>SIGNATURES</a></font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><font style=FONT-SIZE:10pt>Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <div style=page:WordSection4> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=30% style="WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=50% style="WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in'><font style=FONT-SIZE:10pt>VAXART, INC.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=15% style="WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>By:</font></p></td> <td width=50% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>/s/ WOUTER W. LATOUR, M.D.</font></p></td> <td width=15% style="WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Date: February&nbsp;6, 2019</font></p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=50% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:50%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Wouter W. Latour, M.D.</font></p></td> <td width=15% style="WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="WIDTH:30%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="WIDTH:5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=50% style="WIDTH:50%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><i><font style="FONT-SIZE:10pt; COLOR:black">P</font></i><i><font style=FONT-SIZE:10pt>resident and <font style=COLOR:black>Chief Executive Officer</font></font></i></p></td> <td width=15% style="WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:8pt 0in 0pt; page:WordSection4' align=center><b><font style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">POWER OF ATTORNEY</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt; page:WordSection4'><font style="FONT-SIZE:10pt; COLOR:black">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Wouter W. Latour, M.D. and Margaret A. Echerd, and each of them, as his or her attorneys-in-fact, with the power of substitution, for him or her in any and all capacities, to sign any amendments to this report, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorneys-in-fact, and each of them, or his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'><font style=FONT-SIZE:10pt>Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <div style=page:WordSection4 align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>SIGNATURE</font></b></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:45.62%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>TITLE</font></b></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:18.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><font style=FONT-SIZE:10pt>DATE</font></b></p></td></tr> <tr style=HEIGHT:33.3pt> <td width=30% style="BORDER-TOP:0px; HEIGHT:33.3pt; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>/s/ WOUTER W. LATOUR, M.D.</font></p></td> <td width=2% style="HEIGHT:33.3pt; WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="BORDER-TOP:0px; HEIGHT:33.3pt; BORDER-RIGHT:0px; WIDTH:45.62%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="HEIGHT:33.3pt; WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:33.3pt; BORDER-RIGHT:0px; WIDTH:18.88%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>Wouter W. Latour, M.D.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">President,&nbsp;Chief&nbsp;</font><font style=FONT-SIZE:10pt>Executive&nbsp;<font style=COLOR:black>Officer</font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;and Director</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt><em>(Principal&nbsp;Executive&nbsp;Officer and</em></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt><em>&nbsp;Principal Financial Officer)</em></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>February&nbsp;6, 2019</font></p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>/s/ MARGARET A. ECHERD</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>Margaret A. Echerd</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>Vice President, Corporate Controller</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt><em>(<font style=COLOR:black>Principal&nbsp;Accounting&nbsp;Officer</font>)</em></font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>February&nbsp;6, 2019</font></p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:12pt 0in 0pt' align=center><font style=FONT-SIZE:10pt>/s/ RICHARD J. MARKHAM</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>Richard J. Markham</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>Chairman of the Board</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>February&nbsp;6, 2019</font></p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>/s/ GEOFFREY F. COX</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 6pt' align=center><font style=FONT-SIZE:10pt>Geoffrey F. Cox, Ph.D.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 6pt' align=center><font style=FONT-SIZE:10pt>Director</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 6pt' align=center><font style=FONT-SIZE:10pt>February&nbsp;6, 2019</font></p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>/s/ MICHAEL J. FINNEY</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 6pt' align=center><font style=FONT-SIZE:10pt>Michael J. Finney, Ph.D.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>Director</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>February&nbsp;6, 2019</font></p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>/s/ JOHN P. RICHARD</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 6pt' align=center><font style=FONT-SIZE:10pt>John P. Richard</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>Director</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>February&nbsp;6, 2019</font></p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>/s/ ANNE M. VANLENT</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=30% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:30.68%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>Anne M. VanLent</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=45% style="WIDTH:45.62%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>Director</font></p></td> <td width=2% style="WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=18% style="WIDTH:18.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style=FONT-SIZE:10pt>February&nbsp;6, 2019</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection4'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection4' align=center><font style=FONT-SIZE:10pt>138</font></p><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all></font> <div style=page:WordSection5> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: CC6E0F04 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>exhibit21_1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<HTML>
<head><title>Exhibit 21.1</title> </head> <body lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><b><font style=FONT-SIZE:10pt>Exhibit 21.1</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u><font style=FONT-SIZE:10pt>SUBSIDIARIES OF THE REGISTRANT</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=center> <table bordercolor=transparent style=BORDER-COLLAPSE:collapse cellpadding=0 cellspacing=0> <tr> <td width=379 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.95in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Name</font></p></td> <td width=24 style="WIDTH:0.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Jurisdiction</font></p></td></tr> <tr> <td width=379 style="BORDER-LEFT-WIDTH:0px; BORDER-RIGHT-WIDTH:0px; WIDTH:3.95in; BORDER-BOTTOM-WIDTH:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; BORDER-TOP-WIDTH:0px" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=24 style="WIDTH:0.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=108 style="BORDER-LEFT-WIDTH:0px; BORDER-RIGHT-WIDTH:0px; WIDTH:81pt; BORDER-BOTTOM-WIDTH:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt; BORDER-TOP-WIDTH:0px" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr> <td width=379 style="WIDTH:3.95in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Vaxart Biosciences, Inc.</font></p></td> <td width=24 style="WIDTH:0.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=108 style="WIDTH:81pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Delaware</font></p></td></tr> <tr> <td width=379 style="WIDTH:3.95in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Biota Holdings Pty, Ltd.</font></p></td> <td width=24 style="WIDTH:0.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=108 style="WIDTH:81pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Australia</font></p></td></tr> <tr> <td width=379 style="WIDTH:3.95in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Biota Scientific Management Pty, Ltd.</font></p></td> <td width=24 style="WIDTH:0.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=108 style="WIDTH:81pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Australia</font></p></td></tr> <tr> <td width=379 style="WIDTH:3.95in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Biota Europe Limited</font></p></td> <td width=24 style="WIDTH:0.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=108 style="WIDTH:81pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>United Kingdom</font></p></td></tr> <tr> <td width=379 style="WIDTH:3.95in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>Anaconda Pharma, S.A.S.</font></p></td> <td width=24 style="WIDTH:0.25in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=108 style="WIDTH:81pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:10pt>France</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: DB449290 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>exhibit23_1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<head><title>Exhibit 23.1</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; MARGIN-TOP:0px; COLOR:#000000"> <p style="FONT-SIZE:12pt; FONT-FAMILY:'Arial'; MARGIN:0px; LINE-HEIGHT:12pt">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:26px; FONT-FAMILY:'Arial'; MARGIN-TOP:0px; LINE-HEIGHT:12pt" align=right><b>Exhibit 23.1</b></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:26px; FONT-FAMILY:'Arial'; MARGIN-TOP:0px; LINE-HEIGHT:12pt" align=center><b>Consent of Independent Registered Public Accounting Firm </b></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:13px; FONT-FAMILY:'Arial'; MARGIN-TOP:0px; LINE-HEIGHT:12pt">The Board of Directors<br>Vaxart, Inc.:</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:13px; FONT-FAMILY:'Arial'; MARGIN-TOP:0px; LINE-HEIGHT:12pt">We consent to the incorporation by reference in the registration statements (No. 333-228910) on Form S-3 and (No. 333-225475, 333-215141, 333-143238) on Form S-8 of Vaxart, Inc. of our report dated February 6, 2019, with respect to the consolidated balance sheets of Vaxart, Inc. as of December&nbsp;31, 2018 and 2017, the related consolidated statements of operations and comprehensive loss, stockholders<font style="FONT-FAMILY:Arial Unicode MS,Arial">&#146;</font> equity (deficit), and cash flows for each of the years in the two-year period ended December&nbsp;31, 2018, and the related notes (collectively, the consolidated financial statements), which report appears in the December&nbsp;31, 2018 annual report on Form 10-K of Vaxart, Inc.</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:13px; FONT-FAMILY:'Arial'; MARGIN-TOP:0px; LINE-HEIGHT:12pt">Our report dated February 6, 2019 contains an explanatory paragraph that states that the Company has experienced losses and negative cash flows from operations since its inception, has an accumulated deficit, and has debt obligations, which raise substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="MARGIN-BOTTOM:12px; MARGIN-TOP:0px; LINE-HEIGHT:12pt" align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:16px; FONT-FAMILY:'Arial'; MARGIN-TOP:13px; LINE-HEIGHT:12pt"><i>/s/ KPMG LLP</i></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:13px; FONT-FAMILY:'Arial'; MARGIN-TOP:13px; LINE-HEIGHT:12pt">San Francisco, California<br>February 6, 2019</p> <p style="MARGIN-BOTTOM:7px; MARGIN-TOP:0px; LINE-HEIGHT:12pt" align=justify><br></p> <p style="MARGIN-BOTTOM:7px; MARGIN-TOP:0px; LINE-HEIGHT:12pt" align=justify><br><br></p></body>
<!-- EDGAR Validation Code: 50B22B4E -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>exhibit31_1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<head><title>Exhibit 31.1</title> </head> <body vlink=purple link=blue lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; FONT-WEIGHT:bold; COLOR:black; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'><a name=Exhibit_Index><font style=FONT-SIZE:10pt>Exhibit 31.1</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0.25in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">CERTIFICATION </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:12pt 0in 0pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>I, Wouter W. Latour, M.D., certify that:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:12pt 0in 0pt 29pt; PADDING-RIGHT:0px; TEXT-INDENT:-29pt'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt><font style='FONT-FAMILY:"Times New Roman","serif"'>1.<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style='FONT-FAMILY:"Times New Roman","serif"'>I have reviewed this Annual Report on Form 10-K of Vaxart, Inc.;</font></font></font></font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:6pt 0in 0pt 29pt; TEXT-INDENT:-29pt'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt><font style='FONT-FAMILY:"Times New Roman","serif"'>2.<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style='FONT-FAMILY:"Times New Roman","serif"'>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></font></font></font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:6pt 0in 0pt 29pt; TEXT-INDENT:-29pt'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt><font style='FONT-FAMILY:"Times New Roman","serif"'>3.<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style='FONT-FAMILY:"Times New Roman","serif"'>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></font></font></font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:6pt 0in 0pt 29pt; TEXT-INDENT:-29pt'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt><font style='FONT-FAMILY:"Times New Roman","serif"'>4.<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style='FONT-FAMILY:"Times New Roman","serif"'>I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></font></font></font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:6pt 0in 0pt 49.5pt; TEXT-INDENT:-26.5pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:6pt 0in 0pt 49.5pt; TEXT-INDENT:-26.5pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:6pt 0in 0pt 49.5pt; TEXT-INDENT:-26.5pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:6pt 0in 0pt 49.5pt; TEXT-INDENT:-26.5pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:6pt 0in 0pt 29pt; TEXT-INDENT:-29pt'><font style=FONT-SIZE:10pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:11pt><font style=FONT-SIZE:10pt><font style='FONT-FAMILY:"Times New Roman","serif"'>5.<font style='FONT-FAMILY:"Times New Roman"; FONT-VARIANT:normal; FONT-WEIGHT:normal; FONT-STYLE:normal; LINE-HEIGHT:normal'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><font style='FONT-FAMILY:"Times New Roman","serif"'>I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions):</font></font></font></font></font></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:4pt 0in 0pt 49.5pt; TEXT-INDENT:-26.5pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:4pt 0in 0pt 49.5pt; TEXT-INDENT:-26.5pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt 24.5pt; TEXT-INDENT:-24.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt 24.5pt; TEXT-INDENT:-24.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt 24.5pt; TEXT-INDENT:-24.5pt'>&nbsp;</p> <table width=600 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:6.25in; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr style=PAGE-BREAK-INSIDE:avoid> <td width=47% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:47.04%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Date: February 6, 2019</font></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.22%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.16%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>By:</font></p></td> <td width=44% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:44.6%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>&nbsp;/s/ WOUTER W. LATOUR, M.D.</font></p></td></tr> <tr style="HEIGHT:14.5pt; PAGE-BREAK-INSIDE:avoid"> <td width=47% style="BORDER-TOP:0px; HEIGHT:14.5pt; BORDER-RIGHT:0px; WIDTH:47.04%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="BORDER-TOP:0px; HEIGHT:14.5pt; BORDER-RIGHT:0px; WIDTH:5.22%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:14.5pt; BORDER-RIGHT:0px; WIDTH:3.16%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44% style="BORDER-TOP:0px; HEIGHT:14.5pt; BORDER-RIGHT:0px; WIDTH:44.6%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Wouter W. Latour, M.D.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>President and Chief Executive Officer </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(Principal Executive Officer and </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Principal Financial Officer)</font></b></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></div></a></body>
<!-- EDGAR Validation Code: 63BFDC14 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>exhibit32_1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<head><title>Exhibit 32.1</title> </head> <body vlink=purple link=blue lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><b><font style="FONT-SIZE:10pt; COLOR:black">Exhibit 32.1</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0.25in 0in 0pt' align=center><b><font style="FONT-SIZE:10pt; COLOR:black">CERTIFICATION </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:12pt 0in 0pt 23.5pt; PADDING-RIGHT:0px; TEXT-INDENT:24pt'><font style='FONT-FAMILY:"Times New Roman","serif"'>Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), and Section&nbsp;1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167; 1350), Wouter W. Latour, M.D., President and&nbsp;Chief Executive Officer of Vaxart, Inc. (the &#147;Company&#148;), hereby certifies that, to his knowledge:</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:12pt 0in 0pt 49.5pt; TEXT-INDENT:-26.5pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s Annual Report on Form 10-K for the period ended December&nbsp;31, 2018, to which this Certification is attached as Exhibit 32.1 (the &#147;Report&#148;), fully complies with the requirements of Section&nbsp;13(a) or Section&nbsp;15(d) of the Exchange Act; and</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:justify; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:12pt 0in 0pt 49.5pt; TEXT-INDENT:-26.5pt'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Report and results of operations of the Company for the period covered by the Report.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt 24.5pt; TEXT-INDENT:-24.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt 24.5pt; TEXT-INDENT:-24.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt 24.5pt; TEXT-INDENT:-24.5pt'>&nbsp;</p> <table width=600 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:6.25in; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr style=PAGE-BREAK-INSIDE:avoid> <td width=47% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:47.44%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; PADDING-LEFT:0px; MARGIN:0in 0in 0pt 0.4in'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Date: February 6, 2019</font></p></td> <td width=5% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:5.26%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:3.16%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>By:</font></p></td> <td width=44% style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:44.14%; BACKGROUND:white; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>&nbsp;/s/ WOUTER W. LATOUR, M.D.</font></p></td></tr> <tr style="HEIGHT:14.5pt; PAGE-BREAK-INSIDE:avoid"> <td width=47% style="BORDER-TOP:0px; HEIGHT:14.5pt; BORDER-RIGHT:0px; WIDTH:47.44%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=5% style="BORDER-TOP:0px; HEIGHT:14.5pt; BORDER-RIGHT:0px; WIDTH:5.26%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:14.5pt; BORDER-RIGHT:0px; WIDTH:3.16%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt"> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=44% style="BORDER-TOP:0px; HEIGHT:14.5pt; BORDER-RIGHT:0px; WIDTH:44.14%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0.75pt; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.75pt" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Wouter W. Latour, M.D.</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt'><b><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>President and&nbsp;Chief Executive Officer</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><b><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(Principal Executive Officer and </font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt'><b><font style='FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Principal Financial Officer)</font></b></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:12pt 0in 0pt 23.5pt; PADDING-RIGHT:0px; TEXT-INDENT:24pt'><font style="FONT-SIZE:10pt; COLOR:black">A signed original of this written statement required by Section&nbsp;906 of 18 U.S.C. &#167; 1350 has been provided to Vaxart, Inc. and will be retained by Vaxart, Inc. and furnished to the Securities and Exchange Commission or its staff upon request. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PADDING-BOTTOM:0px; TEXT-ALIGN:justify; PADDING-TOP:0px; PADDING-LEFT:0px; TEXT-JUSTIFY:inter-ideograph; MARGIN:12pt 0in 0pt 23.5pt; PADDING-RIGHT:0px; TEXT-INDENT:24pt'><font style="FONT-SIZE:10pt; COLOR:black">This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:12pt 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:6pt 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: 2D8D1E8F -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>j1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" &' V<# 2(  A$! Q$!_\0
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M6@#RS^P-1_Z!FJ?^ 4O_ ,31_8&H_P#0,U3_ , I?_B:]3_X;S^+/_0WW?\
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M^T]^V/\ \%,/BU/X4^'.HV2#3[=KK4]8OXBNGZ5$ 2&E<#.6Q@*.2:7X=_\
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MB7P9#X1^-GPC\>^'?'!U""R\1Z')--I\-U91O)+:R IO\TA"%P,9Q0!^>?\
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M9W@LPKP/CE70^C*01GGGFJ?_  WG\6?^AON_^_:T >6?V!J/_0,U3_P"E_\
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MXC\6W36UI=ZPA%E!M0NQDV MC"GH* /!O[ U'_H&:I_X!2__ !-']@:C_P!
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MY]=TJVAMS$3*T\KP0A689@B10WE*0*^@_P#B&$^ 7_/;4_\ OG_Z]'_$,)\
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MF<ECQDU\F#@5^I>E_P#!LS\"M$U"*[M+O5H+F!M\<B@90^HYKI?^(?WX9_\
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M^SO_ - SQI_X4+__ !-'_#BW]G?_ *!GC3_PH7_^)IB/Q9HK]IO^'%O[._\
MT#/&G_A0O_\ $T?\.+?V=_\ H&>-/_"A?_XF@#\MOV!OVG/"_P"Q[^USHOCS
MQ?J5KI6DZ=HFK6\<US%YL3W,MN%AC9>X9N,&L?\ 8\_X+D^(?B5^W=X2UKXL
MZ_X=\'?#[P;8:R^F66A:1%I]A;WD]K*L<WE1* 9&<I\QK]4?$G_! #]F7QC9
M+;ZIH'BZ]@5MX23Q Y /K]VL+_B&U_9&_P"A,\2?^#Z3_P")H ^!/@5^WO\
M!SXL_#SX"2_$_P"+6N6GCWPEX5\06EYJ+3RB5KJ:[E>WMKJZ5A*D+1E<;&!&
M<#%>QZE_P5F^#MW^V_XDU31/B+X*B\$>+? WA[3M:2\L]0M9M0GLWE\_R+Z.
M59894!'$K,9>,YKZ8_XAM?V1O^A,\2?^#Z3_ .)H_P"(;7]D;_H3/$G_ (/I
M/_B: /D[X)_\%7O@!\,O#?CO3OA[XH\-:1>:;X_O?$L.I>.M-OYU\0V4D+J"
M([26,SL&.P13;P5.<9K\U_V$/#GP:^/?_!0<ZA\=O$]CX2^&$NHWFMZB]M T
M,5]^\:1+2),YC20G Y^5>*_=G_B&U_9&_P"A,\2?^#Z3_P")H_XAM?V1O^A,
M\2?^#Z3_ .)H _,W]L/]H6#]I;]I?6-<TCQ)X5U;PAI]E:Z3X9TCP\"+/PWI
MT"E8;?']\K@L1U(KSBOV1\+_ /!OI^S!X)29=)\.^+;$7!!D$6ON-^.F?E]Z
MU?\ AQ;^SO\ ] SQI_X4+_\ Q- 'XLT5^TW_  XM_9W_ .@9XT_\*%__ (FC
M_AQ;^SO_ - SQI_X4+__ !- 'XLT5^TW_#BW]G?_ *!GC3_PH7_^)H_X<6_L
M[_\ 0,\:?^%"_P#\30!^76N_\H]/"O\ V434?_2"&O'J_<F[_P"".GP)N_@]
M8>#FTWQ;_8UAK,VM18UU_-^T2Q+$V6V\KM48%<Y_PXM_9W_Z!GC3_P *%_\
MXFDG<;36Y^+-%?M-_P .+?V=_P#H&>-/_"A?_P")H_X<6_L[_P#0,\:?^%"_
M_P 33$?BS17[3?\ #BW]G?\ Z!GC3_PH7_\ B:/^'%O[._\ T#/&G_A0O_\
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M\;D\2ZW\4K/X4>+?"EQ;ZIX:U#4='&HZ;<3)*OF1S*00I\LL5)[XQS7[R?\
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M_P! SQI_X4+_ /Q-'_#BW]G?_H&>-/\ PH7_ /B:8C\6:]-_8H^.7AG]FO\
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M4_M-?$OQ+XF/Q"\%ZAX;M(/!VBZC*\EAJ4T1B/DQQ,2B?=8GCDYSUJU\$O\
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M%9O@[XLL]:@T#5M<EU*STK5+^R>]T6:SLM0:QW+.L4[C8[(XY [8/>N/\?\
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M #^Z?_X,!_\ %5^=?VJ7_GK)_P!]FC[5+_SUD_[[-'_$8ZO_ $"K_P "_P"
M'_$$Z/\ T%O_ , 7_P D?HI_PAW@/_G]T_\ \& _^*H_X0[P'_S^Z?\ ^# ?
M_%5^=?VJ7_GK)_WV:/M4O_/63_OLT?\ $8ZO_0*O_ O^ '_$$Z/_ $%O_P
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M_A#O ?\ S^Z?_P"# ?\ Q5?G7]JE_P">LG_?9H^U2_\ /63_ +[-'_$8ZO\
MT"K_ ,"_X ?\03H_]!;_ / %_P#)'Z*?\(=X#_Y_=/\ _!@/_BJ/^$.\!_\
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M?\:#9ZWC_C\LO^_1_P : /C'QU^Q]XY\8_$+Q#J]AI\,MCJFHRW-NYF4%D.
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M .1#_B,6=_R4_P#P%_\ R1\/_P###7Q$_P"@9!_W_3_&C_AAKXB?] R#_O\
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M_P#D0_XC'G?\E/\ \!?_ ,D?#W_##7Q$_P"@9!_W_3_&C_AAKXB?] R#_O\
MI_C7W#]BUO\ Y_++_OT?\:/L6M_\_EE_WZ/^-'_$),G_ )ZGWK_Y$/\ B,>=
M_P E/_P%_P#R1\/?\,-?$3_H&0?]_P!/\:/^&&OB)_T#(/\ O^G^-?</V+6_
M^?RR_P"_1_QH^Q:W_P _EE_WZ/\ C1_Q"3)_YZGWK_Y$/^(QYW_)3_\  7_\
MD?#W_##7Q$_Z!D'_ '_3_&C_ (8:^(G_ $#(/^_Z?XU]P_8M;_Y_++_OT?\
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M+6_^?RR_[]'_ !H^Q:W_ ,_EE_WZ/^- &S16-]BUO_G\LO\ OT?\:/L>M_\
M/W9?]^C_ (T )X+_ -3J7_80G_\ 0JVJX_P?9ZR8=0VW=G_Q_P V<Q'KGZUK
M_8M;_P"?RR_[]'_&@#9HK&^Q:W_S^67_ 'Z/^-'V+6_^?RR_[]'_ !H V:*Q
MOL6M_P#/Y9?]^C_C1]BUO_G\LO\ OT?\: -FBL;[%K?_ #^67_?H_P"-'V+6
M_P#G\LO^_1_QH V:*QOL6M_\_EE_WZ/^-'V+6_\ G\LO^_1_QH V:*QOL6M_
M\_EE_P!^C_C1]BUO_G\LO^_1_P : -FBL;[%K?\ S^67_?H_XT?8M;_Y_++_
M +]'_&@#9HK&^Q:W_P _EE_WZ/\ C1]BUO\ Y_++_OT?\: -FL+XG_\ )-?$
M/_8,N?\ T4U2?8M;_P"?RR_[]'_&L3XF6FM#X;>(<W=E_P @RY_Y9'_GDWO0
M!Q/_  3P_P"3.O!?_7O+_P"CY**;_P $ZPP_8V\$[L%OLTN2.A_?R44 <W_P
M4K_Y$WX3?]E6\,_^EE?2%?-__!2O_D3?A-_V5;PS_P"EE?2% 'DO[;?[1FJ?
MLK_L]ZEXOT/PW_PENKV]Q;6EGI/VG[-]LDFE6,+OP<?>]*X[X4?\%%_"_P 1
M[^\O+G[-I'A:Q\+6?B*;5)IR3"\TDD3V[1A=P9'C(]3Z5Z5^TM\#O^&@OAU!
MH/VXZ=Y.JV6I>:%W9^SSK+MQ[[<?C7@.H_\ !*&P@^,WQ3\4Z1XHN=.M?B U
MAJ%AIGD*T&B:C;,2TB#H8I.,IT&210![+<_MU?":S\/VVIR^--/2UO-2_LB'
M,$_FO=[#((O*V>8&* L,K@CD&KEY^V7\,=/\9R>'YO%^G1ZM"_E/"4EVB38)
M-F_;LW[2#MW9]LUY[HG[#>H:G\;['XD^(=:L3XH?Q%!KVHP6$+"R(@L'L88H
MM_S_ '&#$MSG-1R_L&W5UXE@TN;6[23P#:^,4\<0VQB;^T5O$Y%L7^Z8"Q8D
MGY^<=* .P^(G[9_A+2/"6D7GAWQ#X8U"\U^VM]2T]+^[DMH+FQDN(X#,)!&V
M/FD4*"!N8@<<D:V@?MF?#'Q1J$]M8>+K"XEMM6&AR8CE"B^,AB$ 8H%+[P5X
M)Y%>2Z9_P33AT[PYXTT__A(W>'7]9TZYT=&A&W0=.LIUFCLH^^#M.3W)!K>N
MOV&[K3_@=8^'-*UV!-7T;QF_C*RN9X28))3>/<B"0#G80^TD<\<4 >@ZC^U[
M\-M*UV+2YO%EA_:4VHW&DQVL:223/=6Y03QA54GY"Z;CT&X<UR'Q2_;A\._
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ME_PHY<;VG_Y,%\M[T_OB,_X63XA_Z#>I_P#@0U'_  LGQ#_T&]3_ / AJ?\
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M.EFD/J=[?:YK\O+UO^EM;_,^$\1/]7O['G]=Y;_8Y.7GYNEK=.]]+>=CZMT
M8T.S_P"N"?\ H(JW530#G0K/_K@G_H(JW7]+'\E!1110 4444 %%%% !1110
M 4444 %%%% !1110!B>*_P#D*Z'_ -?O_M-JVZQ/%?\ R%=#_P"OW_VFU;=
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M_;-:_P"?.S_[_'_"@WFM8_X\[/\ [_?_ %JV*0]* .3\%W>M?\([!BTM"!N
M)F]S[5J_;-:_Y\[/_O\ '_"OB'XC?MG_ !)\$_$KQ'HVE:UI]OINE:C);6T;
MZ;'(R(,$98\GJ:Q_^&]OBQ_T,&F?^"F*OS;$>*654:TZ,J=2\6T]([IV_G/U
MC">#F=XBA#$0J4K3BI*\I7LTFK^YYGWM]LUK_GSL_P#O\?\ "C[9K7_/G9_]
M_C_A7P3_ ,-[?%C_ *&#3/\ P4Q4?\-[?%C_ *&#3/\ P4Q5C_Q%C*/^?=3[
MH?\ R9T?\03SW_G[2_\  I__ "!][?;-:_Y\[/\ [_'_  H^V:U_SYV?_?X_
MX5\$_P##>WQ8_P"A@TS_ ,%,5'_#>WQ8_P"A@TS_ ,%,5'_$6,H_Y]U/NA_\
MF'_$$\]_Y^TO_ I__('WM]LUK_GSL_\ O\?\*/MFM?\ /G9_]_C_ (5\$_\
M#>WQ8_Z&#3/_  4Q4?\ #>WQ8_Z&#3/_  4Q4?\ $6,H_P"?=3[H?_)A_P 0
M3SW_ )^TO_ I_P#R!][?;-:_Y\[/_O\ '_"C[9K7_/G9_P#?X_X5\$_\-[?%
MC_H8-,_\%,5'_#>WQ8_Z&#3/_!3%1_Q%C*/^?=3[H?\ R8?\03SW_G[2_P#
MI_\ R!][?;-:_P"?.S_[_'_"C[9K7_/G9_\ ?X_X5\$_\-[?%C_H8-,_\%,5
M'_#>WQ8_Z&#3/_!3%1_Q%C*/^?=3[H?_ "8?\03SW_G[2_\  I__ "!][?;-
M:_Y\[/\ [_'_  H^V:U_SYV?_?X_X5\$_P##>WQ8_P"A@TS_ ,%,5'_#>WQ8
M_P"A@TS_ ,%,5'_$6,H_Y]U/NA_\F'_$$\]_Y^TO_ I__('WM]LUK_GSL_\
MO\?\*/MFM?\ /G9_]_C_ (5\$_\ #>WQ8_Z&#3/_  4Q4?\ #>WQ8_Z&#3/_
M  4Q4?\ $6,H_P"?=3[H?_)A_P 03SW_ )^TO_ I_P#R!][?;-:_Y\[/_O\
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MTXF*;>F-*B&#M(_D35O_ (;V^+'_ $,&F?\ @IBH_P"(L91_S[J?=#_Y,/\
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M^%<W_$(\7_T$1^YG9_Q'+!_] LO_  )?Y'YJX]F_(T8]F_(U^E7_  J[1O\
MH2-'_P"_2?X4?\*NT;_H2-'_ ._2?X4?\0CQ?_01'[F'_$<L'_T"R_\  E_D
M?FKCV;\C1CV;\C7Z5?\ "KM&_P"A(T?_ +])_A1_PJ[1O^A(T?\ [])_A1_Q
M"/%_]!$?N8?\1RP?_0++_P "7^1^:N/9OR-&/9OR-?I5_P *NT;_ *$C1_\
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MI5_PJ[1O^A(T?_OTG^%'_"KM&_Z$C1_^_2?X4?\ $(\7_P!!$?N8?\1RP?\
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MB_VWJO\ T"__ "**/[;U7_H%_P#D44 ;5%8O]MZK_P! O_R**/[;U7_H%_\
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M^$/&UOJNE6,%P\LEG!+I+P321*S]!>,KL,] 3[5]W4 %(>E+2'I0!\6>,O\
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M[?!_SWA_[^"C[?!_SWA_[^"C_7;//^@N7X?Y!_Q#OAW_ * H_P#DW^9]'?\
M#S?QW_T+_A/_ +ZN/_BJ/^'F_CO_ *%_PG_WU<?_ !5?./V^#_GO#_W\%'V^
M#_GO#_W\%'^NV>?]!<OP_P @_P"(=\._] 4?_)O\SZ._X>;^._\ H7_"?_?5
MQ_\ %4?\/-_'?_0O^$_^^KC_ .*KYQ^WP?\ />'_ +^"C[?!_P ]X?\ OX*/
M]=L\_P"@N7X?Y!_Q#OAW_H"C_P"3?YGT=_P\W\=_]"_X3_[ZN/\ XJC_ (>;
M^._^A?\ "?\ WU<?_%5\X_;X/^>\/_?P4?;X/^>\/_?P4?Z[9Y_T%R_#_(/^
M(=\._P#0%'_R;_,^CC_P4W\=_P#0O^$_^^KC_P"*KW_X ?M2Z=^T+X#O(I5B
ML/$5I QNK(-PPQ]^//)7]17YY?VA!_SWA_[^"O<?V0?V>=<^(6M?\)0ES=:/
MHFE;F%W$2KWC <QIZKZGI7T_"/&.>5<RA1<W74M'%VT75WMI;STZ'R''' 7#
ME#*:F(4%AY1U4E?5](V;=[^6O4^]?#__ " K+_K@G_H(JY5303NT.S_ZX)_Z
M"*MU_1!_+(4444 %%%% !1110 4444 %%%% !1110 4444 8GBO_ )"NA_\
M7[_[3:MNL3Q7_P A70_^OW_VFU;= !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 8L'_ "4&X_Z\(_\ T-JVJQ8/^2@W'_7A'_Z&U;5 !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 8O@O_ %.I?]A"?_T*MJL7P7_J
M=2_["$__ *%6U0 4444 %%%% !1110 4444 %%%% !1110 4444 %87Q/_Y)
MKXA_[!ES_P"BFK=K"^)__)-?$/\ V#+G_P!%-0!YE_P3P_Y,Z\%_]>\O_H^2
MBC_@GA_R9UX+_P"O>7_T?)10!RO_  4UN/LO@3X52;&?9\5?#)VKU/\ I?:O
M?)/%ACD9?L%Z<'&0G6O!_P#@I4?^*-^$W_95O#/_ *5U](4 8O\ PEY_Z!][
M_P!\4?\ "7G_ *!][_WQ47Q*^*/A[X.^$IM=\4:M9Z)H]NZ1R7=T^V-&=@JC
M/J20!]:Y9/VO_AE)X._M]?&FB'2#J!TK[0)CC[4!DPXQNW8.>E '7?\ "7G_
M *!][_WQ1_PEY_Z!][_WQ61HO[07@KQ#X?US5++Q+I4^G^&81<:K,LORZ?&8
M_-#29Y4&,;N>U1?#/]H#PY\6O$5_INC37$LUC;07RR/%MBN[:8$Q3Q-GYD;!
MP>.G2@#<_P"$O/\ T#[W_OBC_A+S_P! ^]_[XK:HH Q?^$O/_0/O?^^*@?6X
M)-02[;1YS=1H8UF,(WJIY(!ZXKH:* ,7_A+S_P! ^]_[XH_X2\_] ^]_[XK:
MHH Q?^$O/_0/O?\ OBC_ (2\_P#0/O?^^*VJ* ,7_A+S_P! ^]_[XH_X2\_]
M ^]_[XK:HH Q?^$O/_0/O?\ OBC_ (2\_P#0/O?^^*VJ* ,7_A+S_P! ^]_[
MXH/B\X_Y!][_ -\5M4AZ4 >5:)\/_"&N67VR^\#Z;>7ER[/-/+IT;O,V?O,Q
M&2:N?\*J\#?]$^T?_P %<7_Q->8ZC_P4$T/X<:WJ/A^;1=0N)]&NGM9)4<!7
M8'.1Q[U'_P /./#_ /T+^I_]_5_PKX:OQ)PO"K*%64.9-I^YU3U^SW/T/#\)
M\83HPG1A4Y6DU[_1K3[78]2_X55X&_Z)]H__ (*XO_B:/^%5>!O^B?:/_P""
MN+_XFO+?^'G'A_\ Z%_4_P#OZO\ A1_P\X\/_P#0OZG_ -_5_P *R_UHX4_F
MI_\ @'_VIM_J?QI_S[J_^!__ &QZE_PJKP-_T3[1_P#P5Q?_ !-'_"JO W_1
M/M'_ /!7%_\ $UY;_P /./#_ /T+^I_]_5_PH_X><>'_ /H7]3_[^K_A1_K1
MPI_-3_\  /\ [4/]3^-/^?=7_P #_P#MCU+_ (55X&_Z)]H__@KB_P#B:/\
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M&.@ X KKJI>(S_Q(;O\ ZY-_*MJ.#P]%\U&"B_))?D85\=B:ZY:]24EYMO\
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M_P#0/O?^^*VJ* ,7_A+S_P! ^]_[XH_X2\_] ^]_[XK:HH Q?^$O/_0/O?\
MOBC_ (2\_P#0/O?^^*VJ* ,7_A+S_P! ^]_[XH_X2\_] ^]_[XK:HH Q?^$O
M/_0/O?\ OBC_ (2\_P#0/O?^^*VJ* ..A\5$>.[AOL%Y_P >*#&W_;:M?_A+
MS_T#[W_OBB _\7 N/^O"/_T-JVJ ,7_A+S_T#[W_ +XH_P"$O/\ T#[W_OBM
MJB@#%_X2\_\ 0/O?^^*/^$O/_0/O?^^*VJ* ,7_A+S_T#[W_ +XH_P"$O/\
MT#[W_OBMJB@#%_X2\_\ 0/O?^^*/^$O/_0/O?^^*VJ* ,7_A+S_T#[W_ +XH
M_P"$O/\ T#[W_OBMJB@#%_X2\_\ 0/O?^^*/^$O/_0/O?^^*VJ* ,7_A+S_T
M#[W_ +XH_P"$O/\ T#[W_OBMJB@#%_X2\_\ 0/O?^^*!XO)_YA][_P!\5M44
M <=X0\5F.'4/] O#F_F/"=.:U_\ A+S_ - ^]_[XH\%G,6I?]A"?_P!"K:H
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M]%'_  GNB_\ 04LO^_HH UZ*R/\ A/=%_P"@I9?]_11_PGNB_P#04LO^_HH
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M^_HH_P"$]T7_ *"EE_W]% &O161_PGNB_P#04LO^_HH_X3W1?^@I9?\ ?T4
M,@_Y*#<?]>$?_H;5M5R</C#2E\:S7']H6GDM9H@?S!@L'8XSZUJ_\)[HO_04
MLO\ OZ* ->BLC_A/=%_Z"EE_W]%'_">Z+_T%++_OZ* ->BLC_A/=%_Z"EE_W
M]%'_  GNB_\ 04LO^_HH UZ*R/\ A/=%_P"@I9?]_11_PGNB_P#04LO^_HH
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M_P !?^1YI_PIW7O^?9?^^J#\*-;L5,TENH2,%F.[H*]+_P"%T^#O^AK\-_\
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M?\*=U[_GV7_OJO<:*9)X=_PIW7O^?9?^^J/^%.Z]_P ^R_\ ?5>XT4 >'?\
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M / U_F>)_P!E6O\ S[6__?I?\*/[*M?^?:W_ ._2_P"%>V?\,%_$?_H&6_\
MW_7_ !H_X8+^(_\ T#+?_O\ K_C1_JMFO_0+/_P!_P"0?ZZ9+_T&4_\ P-?Y
MGB?]E6O_ #[6_P#WZ7_"OH/]D7]JC4/ <P\(:FESJ6BZCF*U$8+RV3D=AW3U
M':L@_L&?$C'_ "#+?_O^O^-?1G[-?[(]K\"_!UUJNJB*\\475NV^3&Y+-2/N
M)_4U]7P9PUG=/,X5:4)44OBE)65NJMUOV^?0^*X^XNX=K9/4HUIQKN7PQC)-
MJ725U?EMW^6MSW'01MT.S'_3!/\ T$5;JGX?_P"0%9_]<$_]!%7*_H\_E$**
M** "BBB@ HHHH **** "BBB@ HHHH **** ,3Q7_ ,A70_\ K]_]IM6W6)XK
M_P"0KH?_ %^_^TVK;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#%@_P"2@W'_ %X1_P#H;5M5BP?\E!N/^O"/_P!#:MJ@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** ,7P7_ *G4O^PA/_Z%6U6+X+_U.I?]A"?_
M -"K:H **** "BBB@ HHHH **** "BBB@ HHHH **** "L+XG_\ )-?$/_8,
MN?\ T4U;M87Q/_Y)KXA_[!ES_P"BFH \R_X)X?\ )G7@O_KWE_\ 1\E%'_!/
M#_DSKP7_ ->\O_H^2B@#$_X*1>"_%7BSX2^#KOPAX;N/%FI^%_'>B:_+ID%P
ML$EQ;VUSOEVNW (7UJD?VROBJ#_R;EXN_P#!Y:?X5])44 ?,FK_M9?$KQ!I<
M]E?_ +-'B:^LKI#'-;W&KV<D4RGJK*RD$'T-8^D_'+Q7H$*1V/[)E]91QJZ(
ML%WIT817 #@ (,!@!D=\#-?6=% 'RQ:_M(^.K'6+74(?V6M:AO[&U^PVURFH
MV"S6]OD'R4<+E8\@':#CCI4'B'X_^,?%VK07^J_LI:GJ=]:KMAN;N]T^:6$9
MSA69"0,\\&OJZB@#Y,B^./BN"\O+A/V3+Y+C46WW<JW>G![IMP;,AV98[E!Y
MSR >U6M3_:.\<ZUJTE_>?LL:Q=WTMN+22XFU"PDE>$-O$98KDH&).W.,G-?5
M-% 'R1=?&7Q+?/?--^R/=3-JAS>E[G3F-V>/]9E/GZ#[V>@JWX6_:%\:>!H3
M'HO[*FJZ/&5*%+&_L+<$$Y(PB#@GGZU]644 ?("?%'7([&:U7]CYEMKAQ++"
M)=,V2N"2&9?+P3DDY/J:OV7QX\7:=IJV5O\ LGZC!9J$58([S3UC4(P90%"8
MX8 CT(!KZPHH ^2I/C9XIF.H%_V2KQCJQ!OB;K3C]M(.1YOR?/SS\V:O^'?V
ME?'GA /_ &3^RWK>E^:J(_V34K&#>J A0=JC(4$X],U]344 ?-G_  V7\5?^
MC<O%W_@\M/\ "C_ALOXJ_P#1N7B[_P 'EI_A7TG10!\V?\-E_%7_ *-R\7?^
M#RT_PH_X;+^*O_1N7B[_ ,'EI_A7TG10!\V?\-E_%7_HW+Q=_P"#RT_PH_X;
M*^*O_1N7B[_P>6G^%?2=% 'R_P"'OVN_BMI>DQ0G]G'Q<"N<_P#$\M/4^U7?
M^&R_BK_T;EXN_P#!Y:?X5])T4 ?-G_#9?Q5_Z-R\7?\ @\M/\*/^&R_BK_T;
MEXN_\'EI_A7TG10!\V?\-E_%7_HW+Q=_X/+3_"C_ (;+^*O_ $;EXN_\'EI_
MA7TG10!\V?\ #9?Q5_Z-R\7?^#RT_P */^&R_BK_ -&Y>+O_  >6G^%?2=%
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M_P"C<O%W_@\M/\*/^&R_BK_T;EXN_P#!Y:?X5])T4 ?-G_#9?Q5_Z-R\7?\
M@\M/\*/^&R_BK_T;EXN_\'EI_A7TG10!\NZS^UO\5M0O-/<?LY>+O]&N/,/_
M !/+3IM8>GN*O_\ #9?Q5_Z-R\7?^#RT_P *^DZ* /FS_ALOXJ_]&Y>+O_!Y
M:?X4?\-E_%7_ *-R\7?^#RT_PKZ3HH ^;/\ ALOXJ_\ 1N7B[_P>6G^%'_#9
M?Q5_Z-R\7?\ @\M/\*^DZ* /FS_ALOXJ_P#1N7B[_P 'EI_A1_PV7\5?^C<O
M%W_@\M/\*^DZ* /FS_ALOXJ_]&Y>+O\ P>6G^%'_  V7\5?^C<O%W_@\M/\
M"OI.B@#YL_X;+^*O_1N7B[_P>6G^%'_#9?Q5_P"C<O%W_@\M/\*^DZ* /FS_
M (;+^*O_ $;EXN_\'EI_A1_PV7\5?^C<O%W_ (/+3_"OI.B@#YL_X;+^*O\
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M_P#1N7B[_P 'EI_A1_PV7\5?^C<O%W_@\M/\*^DZ* /FS_ALOXJ_]&Y>+O\
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M,D;7%Z!CS]RL&#X[J10!\ZV'_!4Y8]?G\4?V1X@U/POKNAZ,="\-VUDIU/\
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MT-/+"TZG80/W?EHS%N@Q0!5\'>!/%?PI_:,^)TMWX'N_%5AX^U:#4=-UN&>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9/ <WQ2U+5K_ ,0:KK6O7>BW&DFWO]9$YLK&XVB011]44X&#44?[''AWP/\
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MS&5O)! VLTC$X!YS7R/\)FU[7/%-MXC^*7PS\>'3];7Q<TNEG29;Z2PN)KZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%<5\=OV@O"O[-_@B?Q!XLOY+.QA1F1(;>2YN+DJ
M,E(HHP7D?T502?2OG,_\%Q_@4/X?BE_X;O6__D:@#ZUOO#]EJ>IV5Y<6L,UU
MIS.UK*Z9: LNUBI[9'%7*^/O^'X_P)_N_%'_ ,-WK?\ \C4?\/Q_@3_=^*/_
M (;O6_\ Y&H ^P:*^/O^'X_P)_N_%'_PW>M__(U'_#\?X$_W?BC_ .&[UO\
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M_P#\/Q_@3_=^*/\ X;O6_P#Y&H_X?C_ G^[\4?\ PW>M_P#R-0!]@T5\??\
M#\?X$_W?BC_X;O6__D:C_A^/\"?[OQ1_\-WK?_R-0!]@T5\??\/Q_@3_ '?B
MC_X;O6__ )&H_P"'X_P)_N_%'_PW>M__ "-0!]@T5\??\/Q_@3_=^*/_ (;O
M6_\ Y&H_X?C_  )_N_%'_P -WK?_ ,C4 ?8-%?'W_#\?X$_W?BC_ .&[UO\
M^1J/^'X_P)_N_%'_ ,-WK?\ \C4 ?8-%?'W_  _'^!/]WXH_^&[UO_Y&H_X?
MC_ G^[\4?_#=ZW_\C4 ?8-%?'W_#\?X$_P!WXH_^&[UO_P"1J/\ A^/\"?[O
MQ1_\-WK?_P C4 ?8-%?'W_#\?X$_W?BC_P"&[UO_ .1J/^'X_P "?[OQ1_\
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M_P"'X_P)_N_%'_PW>M__ "-1_P /Q_@3_=^*/_AN];_^1J /L&BOC[_A^/\
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M6_\ Y&H ^P:*^/O^'X_P)_N_%'_PW>M__(U'_#\?X$_W?BC_ .&[UO\ ^1J
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M^M_C5:B@"S_;-Y_S]7/_ '];_&C^V;S_ )^KG_OZW^-5J* +/]LWG_/U<_\
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M-Y_S]7/_ '];_&C^V;S_ )^KG_OZW^-5J* +/]LWG_/U<_\ ?UO\:/[9O/\
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MH?#O_0-C_P"^V_QKI:* .:_X5#X=_P"@;'_WVW^-'_"H?#O_ $#8_P#OMO\
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MG_Y^+G_O\W^-'NA[Q^X?V;X;_P#/[HG_ ('#_P"*H^S?#?\ Y_=$_P# X?\
MQ5?AY]KG_P"?BY_[_-_C1]KG_P"?BY_[_-_C1[H>\?N']F^&_P#S^Z)_X'#_
M .*H^S?#?_G]T3_P.'_Q5?AY]KG_ .?BY_[_ #?XT?:Y_P#GXN?^_P W^-'N
MA[Q^X?V;X;_\_NB?^!P_^*H^S?#?_G]T3_P.'_Q5?AY]KG_Y^+G_ +_-_C1]
MKG_Y^+G_ +_-_C1[H>\?N']F^&__ #^Z)_X'#_XJC[-\-_\ G]T3_P #A_\
M%5^'GVN?_GXN?^_S?XT?:Y_^?BY_[_-_C1[H>\?ME?1?#Q?$=DJW^C>6R/N'
MVX8)[?Q5H_9OAO\ \_NB?^!P_P#BJ_#S[7/_ ,_%S_W^;_&C[7/_ ,_%S_W^
M;_&CW0]X_</[-\-_^?W1/_ X?_%4?9OAO_S^Z)_X'#_XJOP\^US_ //Q<_\
M?YO\:/M<_P#S\7/_ '^;_&CW0]X_</[-\-_^?W1/_ X?_%4?9OAO_P _NB?^
M!P_^*K\//M<__/Q<_P#?YO\ &C[7/_S\7/\ W^;_ !H]T/>/W#^S?#?_ )_=
M$_\  X?_ !5'V;X;_P#/[HG_ ('#_P"*K\//M<__ #\7/_?YO\:/M<__ #\7
M/_?YO\:/=#WC]P_LWPW_ .?W1/\ P.'_ ,51]F^&_P#S^Z)_X'#_ .*K\//M
M<_\ S\7/_?YO\:/M<_\ S\7/_?YO\:/=#WC]P_LWPW_Y_=$_\#A_\51]F^&_
M_/[HG_@</_BJ_#S[7/\ \_%S_P!_F_QH^US_ //Q<_\ ?YO\:/=#WC]P_LWP
MW_Y_=$_\#A_\51]F^&__ #^Z)_X'#_XJOP\^US_\_%S_ -_F_P :/M<__/Q<
M_P#?YO\ &CW0]X_</[-\-_\ G]T3_P #A_\ %4?9OAO_ ,_NB?\ @</_ (JO
MP\^US_\ /Q<_]_F_QH^US_\ /Q<_]_F_QH]T/>/W#^S?#?\ Y_=$_P# X?\
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M$/D_Z#&L?]_E_P#B: -JBL7_ (0^3_H,:Q_W^7_XFC_A#Y/^@QK'_?Y?_B:
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MZ^.O^^D_PH_X?%^ O^?7QU_WTG^%*WDOO_X(_F_Z^1\Y?\.E/C?_ - #2O\
MP:P_XT?\.E/C?_T -*_\&L/^-?1O_#XOP%_SZ^.O^^D_PH_X?%^ O^?7QU_W
MTG^%%O)??_P0^;_KY'SE_P .E/C?_P! #2O_  :P_P"-'_#I3XW_ /0 TK_P
M:P_XU]&_\/B_ 7_/KXZ_[Z3_  H_X?%^ O\ GU\=?]])_A1;R7W_ /!#YO\
MKY'SE_PZ4^-__0 TK_P:P_XT?\.E/C?_ - #2O\ P:P_XU]&_P##XOP%_P ^
MOCK_ +Z3_"C_ (?%^ O^?7QU_P!])_A1;R7W_P#!#YO^OD?.7_#I3XW_ /0
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M #Z^.O\ OI/\*/\ A\7X"_Y]?'7_ 'TG^%%O)??_ ,$/F_Z^1\Y?\.E/C?\
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M_C7T;_P^+\!?\^OCK_OI/\*/^'Q?@+_GU\=?]])_A1;R7W_\$/F_Z^1\Y?\
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M  :P_P"-'_#I3XW_ /0 TK_P:P_XU]&_\/B_ 7_/KXZ_[Z3_  H_X?%^ O\
MGU\=?]])_A1;R7W_ /!#YO\ KY'SE_PZ4^-__0 TK_P:P_XT?\.E/C?_ - #
M2O\ P:P_XU]&_P##XOP%_P ^OCK_ +Z3_"C_ (?%^ O^?7QU_P!])_A1;R7W
M_P#!#YO^OD?-@_X)1_&IK]K;^P=+\Y8Q*1_:D6-I) YSZ@U-_P .E/C?_P!
M#2O_  :P_P"-?0*?\%>O JZ_)=_9?&VQ[=8ARN[(8GTZ<U<_X?%^ O\ GU\=
M?]])_A1;R7W_ /!#YO[O^ ?.7_#I3XW_ /0 TK_P:P_XT?\ #I3XW_\ 0 TK
M_P &L/\ C7T;_P /B_ 7_/KXZ_[Z3_"C_A\7X"_Y]?'7_?2?X46\E]__  0^
M;_KY'SE_PZ4^-_\ T -*_P#!K#_C1_PZ4^-__0 TK_P:P_XU]&_\/B_ 7_/K
MXZ_[Z3_"C_A\7X"_Y]?'7_?2?X46\E]__!#YO^OD?.7_  Z4^-__ $ -*_\
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M_P#P0^;_ *^1\Y?\.E/C?_T -*_\&L/^-'_#I3XW_P#0 TK_ ,&L/^-?1O\
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ME?\ @UA_QKZ-_P"'Q?@+_GU\=?\ ?2?X4?\ #XOP%_SZ^.O^^D_PHMY+[_\
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M1_\ Q%'_  Y3^%?_ $$_%O\ X&1__$4<J[A=]C\M:*_4K_ARG\*_^@GXM_\
M R/_ .(H_P"'*?PK_P"@GXM_\#(__B*.5=PN^Q^6M%?J5_PY3^%?_03\6_\
M@9'_ /$4?\.4_A7_ -!/Q;_X&1__ !%'*NX7?8_+6BOU*_X<I_"O_H)^+?\
MP,C_ /B*/^'*?PK_ .@GXM_\#(__ (BCE7<+OL?EK17ZE?\ #E/X5_\ 03\6
M_P#@9'_\11_PY3^%?_03\6_^!D?_ ,11RKN%WV/RUHK]2O\ ARG\*_\ H)^+
M?_ R/_XBJ/B;_@C/\+M%T2:YCU+Q87C*X!NT(Y8#IL]Z.5=PN^Q^8=%?J5_P
MY3^%?_03\6_^!D?_ ,11_P .4_A7_P!!/Q;_ .!D?_Q%'*NX7?8_+6BOU*_X
M<I_"O_H)^+?_  ,C_P#B*/\ ARG\*_\ H)^+?_ R/_XBCE7<+OL?EK17ZE?\
M.4_A7_T$_%O_ (&1_P#Q%'_#E/X5_P#03\6_^!D?_P 11RKN%WV/RUHK]2O^
M'*?PK_Z"?BW_ ,#(_P#XBC_ARG\*_P#H)^+?_ R/_P"(HY5W"[['Y:T5^I7_
M  Y3^%?_ $$_%O\ X&1__$4?\.4_A7_T$_%O_@9'_P#$4<J[A=]C\M:*_4K_
M (<I_"O_ *"?BW_P,C_^(H_X<I_"O_H)^+?_  ,C_P#B*.5=PN^Q^6M%?J5_
MPY3^%?\ T$_%O_@9'_\ $4?\.4_A7_T$_%O_ (&1_P#Q%'*NX7?8_+6BOU*_
MX<I_"O\ Z"?BW_P,C_\ B*/^'*?PK_Z"?BW_ ,#(_P#XBCE7<+OL?EK17Z>W
M7_!&7X70:U;6PU+Q;MF5F/\ I4?;WV5=_P"'*?PK_P"@GXM_\#(__B*.5=PN
M^Q^6M%?J5_PY3^%?_03\6_\ @9'_ /$4?\.4_A7_ -!/Q;_X&1__ !%'*NX7
M?8_+6BOU*_X<I_"O_H)^+?\ P,C_ /B*/^'*?PK_ .@GXM_\#(__ (BCE7<+
MOL?EK17ZE?\ #E/X5_\ 03\6_P#@9'_\11_PY3^%?_03\6_^!D?_ ,11RKN%
MWV/RUHK]2O\ ARG\*_\ H)^+?_ R/_XBC_ARG\*_^@GXM_\  R/_ .(HY5W"
M[['Y:T5^I7_#E/X5_P#03\6_^!D?_P 11_PY3^%?_03\6_\ @9'_ /$4<J[A
M=]C\M:*_4K_ARG\*_P#H)^+?_ R/_P"(H_X<I_"O_H)^+?\ P,C_ /B*.5=P
MN^Q^6M%?J5_PY3^%?_03\6_^!D?_ ,11_P .4_A7_P!!/Q;_ .!D?_Q%'*NX
M7?8_+6BOU*_X<I_"O_H)^+?_  ,C_P#B*/\ ARG\*_\ H)^+?_ R/_XBCE7<
M+OL?EK17Z>1_\$9_A<WB62S_ +2\6>6ELLP/VJ/.2S#KL]JO?\.4_A7_ -!/
MQ;_X&1__ !%'*NX7?8_+6BOU*_X<I_"O_H)^+?\ P,C_ /B*/^'*?PK_ .@G
MXM_\#(__ (BCE7<+OL?EK17ZE?\ #E/X5_\ 03\6_P#@9'_\11_PY3^%?_03
M\6_^!D?_ ,11RKN%WV/RUHK]2O\ ARG\*_\ H)^+?_ R/_XBC_ARG\*_^@GX
MM_\  R/_ .(HY5W"[['Y:T5^I7_#E/X5_P#03\6_^!D?_P 11_PY3^%?_03\
M6_\ @9'_ /$4<J[A=]C\M:*_4K_ARG\*_P#H)^+?_ R/_P"(H_X<I_"O_H)^
M+?\ P,C_ /B*.5=PN^Q^6M%?J5_PY3^%?_03\6_^!D?_ ,11_P .4_A7_P!!
M/Q;_ .!D?_Q%'*NX7?8_+6BOU*_X<I_"O_H)^+?_  ,C_P#B*/\ ARG\*_\
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M(H_X<I_"O_H)^+?_  ,C_P#B*.5=PN^Q^6M%?J5_PY3^%?\ T$_%O_@9'_\
M$4?\.4_A7_T$_%O_ (&1_P#Q%'*NX7?8_+6BOU*_X<I_"O\ Z"?BW_P,C_\
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M_P"&2OC'_P!'&:Y_X3-M_P#'*** #_ADKXQ_]'&:Y_X3-M_\<I#^R3\8R/\
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M'/Q@GOHK@_M&:YYD((7_ (IFV[_]M*L?\,E?&/\ Z.,US_PF;;_XY110 ?\
M#)7QC_Z.,US_ ,)FV_\ CE'_  R5\8_^CC-<_P#"9MO_ (Y110 ?\,E?&/\
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MOC'_ -'&:Y_X3-M_\<H_X9*^,?\ T<9KG_A,VW_QRBB@ _X9*^,?_1QFN?\
MA,VW_P <H_X9*^,?_1QFN?\ A,VW_P <HHH /^&2OC'_ -'&:Y_X3-M_\<H_
MX9*^,?\ T<9KG_A,VW_QRBB@ _X9*^,?_1QFN?\ A,VW_P <H_X9*^,?_1QF
MN?\ A,VW_P <HHH /^&2OC'_ -'&:Y_X3-M_\<H_X9*^,?\ T<9KG_A,VW_Q
MRBB@ _X9*^,?_1QFN?\ A,VW_P <H_X9*^,?_1QFN?\ A,VW_P <HHH /^&2
MOC'_ -'&:Y_X3-M_\<H_X9*^,?\ T<9KG_A,VW_QRBB@ _X9*^,?_1QFN?\
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:"?5DT2W\G[9,@22X)8L6*C(&23Q1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>j2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" &U W$# 2(  A$! Q$!_\0
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M^B@#X _XA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ **
M/@#_ (A<?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _X
MA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<
M?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\
MHAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?
M^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\ HAG_ )>?
MB'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?^7GXA_\
MDZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\ HAG_ )>?B'_Y.H_X
MA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?^7GXA_\ DZC_ (A<
M?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\
MHAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?
M^7GXA_\ DZOO^B@#X _XA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?
MB'_Y.K[_ ** /@#_ (A<?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\
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MJG?5"/@#_B%Q_83_ .B&?^7GXA_^3J/^(7']A/\ Z(9_Y>?B'_Y.K[_HI@?
M'_$+C^PG_P!$,_\ +S\0_P#R=1_Q"X_L)_\ 1#/_ "\_$/\ \G5]_P!% 'P!
M_P 0N/["?_1#/_+S\0__ "=1_P 0N/["?_1#/_+S\0__ "=7W_10!\ ?\0N/
M["?_ $0S_P O/Q#_ /)U'_$+C^PG_P!$,_\ +S\0_P#R=7W_ $4 ? '_ !"X
M_L)_]$,_\O/Q#_\ )U'_ !"X_L)_]$,_\O/Q#_\ )U??]% 'P!_Q"X_L)_\
M1#/_ "\_$/\ \G4?\0N/["?_ $0S_P O/Q#_ /)U??\ 10!\ ?\ $+C^PG_T
M0S_R\_$/_P G4?\ $+C^PG_T0S_R\_$/_P G5]_T4 ? '_$+C^PG_P!$,_\
M+S\0_P#R=1_Q"X_L)_\ 1#/_ "\_$/\ \G5]_P!% 'P!_P 0N/["?_1#/_+S
M\0__ "=1_P 0N/["?_1#/_+S\0__ "=7W_10!\ ?\0N/["?_ $0S_P O/Q#_
M /)U'_$+C^PG_P!$,_\ +S\0_P#R=7W_ $4 ? '_ !"X_L)_]$,_\O/Q#_\
M)U'_ !"X_L)_]$,_\O/Q#_\ )U??]% 'P!_Q"X_L)_\ 1#/_ "\_$/\ \G4?
M\0N/["?_ $0S_P O/Q#_ /)U??\ 10!\ ?\ $+C^PG_T0S_R\_$/_P G4?\
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M_P"I#J=??]? '_!KC_R@H^!G_<?_ /4AU.OO^@ HHHH **** "BBB@ HHHH
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M]KVR_P#+GK2^:?H)EPP_&MK1OVA;6RNDL_%>G7'ABZ<[4GD;SK&8^TR\+]&
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M_!KC_P H*/@9_P!Q_P#]2'4Z^_Z "BBB@ HHHH **** "BBB@ HHHH ****
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M^&;=1_Z*7\0__ ^/_P"(I_6<1_SY?WQ_S#E7<]2HKRW_ (9MU'_HI?Q#_P#
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M_/7KIH":/EOQ;\2]3N/%_P 0X]!\8>.KGXI:?XPDM/#FA6UU=7&G/;J8,)+
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M% !1110 4444 %%%% !1110 4444 %%%% !7P!_P7T_YLK_[.J\#?^WU??\
M7P!_P7T_YLK_ .SJO W_ +?4 ??]%%% 'P!_P:X_\H*/@9_W'_\ U(=3K[_K
MX _X-<?^4%'P,_[C_P#ZD.IU]_T %%%% !1110 4444 %%%% !1110 4444
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MO.B;K+&V>,9V]*UJY8.]V4RIKF@V/B;37LM1M+>^LY&5GAG0/&Q5@RD@]<$
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MHH ^ /\ @UQ_Y04? S_N/_\ J0ZG7W_7P!_P:X_\H*/@9_W'_P#U(=3K[_H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS7NP3YTNR\^O_#>;^_7/H3T445N(**** "BBB@ HHHH **** "BBB@ HHHH
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MD'H7@8$?A6I9?MF?&#PH$7Q#\,-&\10J/WESX:UAHY#[B&<9/T!S6L.*</\
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M(GS+A%VE1(3M<YP 01Z]\%#(WPGT,SJB2FV'F!"2H;)S@GMFOD[]MNXT#0]
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MDEA%PB+("SQGHX ZJ?7I5BFFGL*47'1JP4444R0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O-/%7_ "4>Z_WT_P#14=>EUYIXJ_Y*/=?[Z?\
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M*?# 3C JW% !C@YKIC \^I6(X+4;EW#Y>^.M>9^"/CXUMX3^)-QXLCM+6_\
MAE?W<=^+9&2.:T6+S[:90Q)S)"RCKC>#BO68K<G&1Q7B/QX_9K\0^/\ XV6%
MWHZV8\(^+X+.Q\:K)<".40V-S]H@:-/^6AD!:%O13FN+,?K%.,:F&5VKJW>Z
MLG\I<MWTCS,]7A_ZA7J3P^824(M*2DW:W*TY)/O*GSJ*^U/D2,JP^,WQ(\0^
M,O#/AYK_ , >$=3U#P=%XFU%M6L9IHTFEGV"WC N(\;4*YR220>E=[!\4-1T
M#XV>'_".MWOAXPWWA:;5[J^CS;)-=1W$46(M\A C*N3M)8\#YJYKX\? _4_$
MO[2%MXJ;X8^'_B9H0\,_V2+74;ZS@-G<_:C+O5;A&!!0XRO/.*V=5_9WB^*G
MQJ\*Z_XI\$^'I- TWPC-ILFEWPM]033;QKF)TC1=I1@L:,-Z@ =.]>=2AC82
MG"/,Y*44F^:SC=7?P\NV[C=[W/?Q-;**M.E5GR0A*G-M1]FY1FU)I)<_M&T[
M)*:2VLV8?BS]I;5M)\-?$?4+"'1;M/"/BS3="L7&Z2.>"X-KO=RKX9QY[X*D
M#@9!YSL:C\0_&WQ(^*_BS0/ :^%M-TOP+<I8:AJ6N03W1U"]:-93;Q1Q.GEI
M&C+ND8L=S8"G!KG=:_9*U?3? 7Q,T/P[HFBZ99>(?&.EZSHUG:O%;6ZVD!LS
M*=J@+&V892%QDGZUU#^!_'/P5^+WCC5/"GAO3?&?A[Q]?IK!ADUA-,NM(O1"
MD,FXR(RR0.$5AM^=2",'BB/U[F7MU)0O[W*FWO5VLN:WP7LKVM?1L<WDWLY?
M4G3=6WN<[BDWRX:_-S2Y$]:UE)VYN9*\E$M^#_B7KVK?'J_\(:M8:99+8>%;
M+6IEMI&F*74T\D4D8D. T0"#:=H/KZ5RK?$SQUXR^-GCCP_H^O\ P]\/Z;X1
MO;2SBCU>PFN+N]\ZW29F!6XC'!8J %/:KVI^&?B3X._:#N/&5IX+TOQ6NK^$
M[+2;Q++7H;".VNXIY99 GVA=SQ_. "0#QSCI7.WGP3UW2_CYXT\4WWP:\-^.
M5\17=A?:;>W6K6"7&E&*UC1XQYR%@5D4D,I . 12KU<2XQ@U/2H[^[->[:7+
MK&+OKR[=;)V*P6'P"J5*JE27-0AR^_1:]HI4U/W:DTD[<_QV;5W&[1[P]J<8
M.-V.<<#/>H)+<CC'%:KP,ZAF4J[#+#.<''(SWJO+!U!%?22@?G\*QD36X(.!
MTJK-;[<@\@UL36V.@XJI/ &SQ7/.!VTJQBSV^!CJ#5"YMBI..E;D]OC.1D&J
M-S!U&.#7+.!Z5&J<1\4OAGI/Q:\#:EX>URV^TZ;J46R0#AXF'*R(?X71L,K#
MH170?L*?M&:O>7][\)/B!>"?QYX2MQ+8:@_RCQ/I8.V.[7/65>$E'4,-W<XG
MN(-I(P:\M_:)\ ZQJ%CI/B_P@5B\>^ ;DZKHK]!> #]]9/ZQS1Y4CUQ7FU*E
M3"5EC:"NUI)+[4>J]5O'SNMI,^AP]&AF>%EDV,DE&;O";_Y=U+64K](2TC4_
MNVEJX1/IK]HGX&O\6M&L[_2;F/3/%N@.9])OBN5R1\T$GK%(.".W![<^6_#[
MQX?&-O=VM[:2:3X@TB3[/JFFRG]Y:2^H_O1MU5AP17LW[/?QQT?]H[X/:'XR
MT-F%EK$ =X7/[VSF4[98)!V='#*1ZCTK!^/G[.R_$BZA\1>'[M-#\:Z;'LMK
MW;F*\CZ_9[A1]^,^O5>H]*^FQ%!5HK&X1\RDD[+[2MHUYV^]:/I;\3Q6%K86
MO/"8J+C.#<9)[IIV:?HSAO$6A2:K&LULQ%[;H_D*TC+"[, /W@'4#'X5D1;W
MEEC:.59()#$VZ-E#, ,E<_>7GJ*^6O\ @H/\0/BMK5GH>C^&$UOPOJ>E";_A
M(=*LK@P73O\ +Y<T;@@RVQ7=@H3@GD=#7QSJ5U\4];N0;W5?&%S,F0#/J<S,
MN1@CE^XKX#-.)ZM#$RHX?!U*EK:I.ST]'JMG?JK'[!PCX48'-\KIYGB\YPV&
MY[^Y.2YXV;7O)RC9NUUY-/J?K-?:8LV'<M V1F085F _A)/;VJ@ER5PLIC#%
M=Y>-MT6-V!\W3/M7X\:UJVLVU_+;WNIZF\\+;9%:]D?:1V^]U%?6?_!-OX[W
M0TQ_!U]*;BTMKAIH1*=^%D.XCGL&!/XUY^2\91S''?49473E9[N^JU::LK:)
M_<>]Q]X#5>&^'WG]'&K$03A=1ARKEGHI*7/*ZNXI::IWN?J]\*I)8OA'ICPH
M))EM6,:'@,V6P/Q-? /QTM?%G@ZYTOP3X9\/WFL^*]7CU:[UVZGM[BS&K:MJ
M\'EM<6UX/W:BT4B-_-*$(@10V0*_03X/ #X::1M)(,)/_CQI/C');I\,M92[
MMDNK6ZMS;S(^X(JR$(7;:"P50VXE03A>.:_3,?E"QM"G>;BXI?G%^E[Q5FT[
M:Z--I_RUG.0K,9TFIN+A)-=5I*,MMKWBK-IV5U9IM/X1O_V9M3TGX;>$-)U:
M[M;[Q#HG_"/:5IVHZ7#);3V^G&TDBGFMMO\ JHESC<<E!#EL'&:_QV\2B]LM
M$T?PM9^&/$OC>T\46D-O/K6HQ/?+J=O;)*UNENR"*9V27<TSLH+SY.XX6O>O
MC%\#V_:#T6T\,^%?&M_HMOHEFEMK3PVUQ;+:702-X[LA=KFX5.1#*Q0K(A/3
M#:DG[)&A^/8=-U33HEG\1Z%ILD5MXF:);-]2NQ%Y"R%XOWOE.F\.%8*V%.&P
M*\.7#<82J1I1:4K=;MI.3:5]FN:RD_32R/E<5P7"%?$\JDG4:;;?,Y+FG-V<
MG=2]]VG+79:637YC_LL>&]=T70OB'H*)KC>*6UU?#4*_+'=0WT6HZA=2"/</
M+AF:)+8KL;:!/D'#5^KO[#/C>X\9?":X:^C@@U*.\,MS#!87-K% \B*Y0&?F
M1PV[>ZDJ6SBOG_X>?L)CX1?$9F\:>*;"YL[9([N&74PQ667;'YL\<\G&] &B
M X<H%W97BOL3X4WLE[X7(6P@T_3;:XDM]+CBB:$-9H=L3;&Y7(''J #WJN&\
MEJT*_P!:E%T]'%Q=FWK=/W79.[;ZWYGL>Q@\JQF)SROQ)6IN@ZS;G!V?-*3Y
MG.\9<J;J.<_M.TVG9IGD_P ?O^2FW/\ UPB_D:XRNH_:-U8V'Q5N8Q:7MQ_H
M*S[HH]R_*/N9S]]L\#O7"3:]=>5*8-(OI72&*9%9DC$A<\QY)X9!R<\>A-;X
MR:5>?JS[2.QIT5G2W>HBY8>38PPK=HBM),29H2.6  ^5]W !R*Y[Q%K\VGW5
MEIWF:AKVMZA]IM[?2K*(1O>[CA=Z#E54<>9D#J:Y)U5%7921K>-OB!8>!].D
MDF8W-[E4@LH3NN+B1L[%"CGDCKCL:=^SK^SOXQ^+=R_B;5[F7P[9ZP)=U];2
ME;UH5!1+:.)TQ'%DLQ8Y+8!P.#7IG[/O[&%OX:O[7Q/XW6TU?Q-$L#V5N@8V
M^AB,';&AS^\89&7;/(X]:]^KT\%DTZS5;%:);1Z^K?Z+_-$2J):1,;P1\/=&
M^'>F&UT>PMK-7"F:1(P);I@,;Y& R[GNQYY-;-%%?40A&*48JR1DV%%%%4(*
M*** "BBB@ HHHH **** "N1^/?Q9L_@3\%O%'C"^"M;^'=.FO=A./.=5.R,>
M[/M4>[5UU><_M*? 7_AHSPUH6@W=_%;:!;:Y::GK%H\'FC5[>W8R"T/( 1Y!
M&6)!R%(QS7)CY5UAY_5E>=GR^O1OR6[\CU,DA@Y8^BLPERT>9.=KWY4[M*W5
MK1>;5[+4^=/V%8D_9U_:!MO!]WKUKK$OQ7\,Q^)[QX[U;G9X@A;.H(,,=H=)
MHV Z8A/I5/\ :G^.GQ&^/'[('QE\0:-I/A&/X;VEOJNB107,LZZO>0VY:":]
M60'RE =7*Q%<LJ_?!(%>X_$+]A[PE>Z]X/USP1H_AGP%XA\(Z[!JJ7NF:-#
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MBI6;;INSY59IK2YKZW^VKK'@[X2_%RYU32M-;QK\.]>;1-/TZ+>L6J-<F/\
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M_:)^)'BK]C/XKV[3Z'X?\7_#G7XM&UB]TQKF.*[A+6TL<UH=^^)V$T897+
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M )*/=?[Z?^BHZ]+KS3Q5_P E'NO]]/\ T5'0!VV@_P"J'TKX5_X+Y]/V*O\
MLZKP-_[?5]U:#_JA]*^%?^"^?3]BK_LZKP-_[?4 ??\ 1110!^?_ /P:Z?\
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M?FY^WOXY/['HO/ @;0->\7:C;B2VU>U 2;3[=B1ON(>0LY'W<'!SN]*^OO\
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MTL11;HQG)*--T[\L4W9.3<HS?63B[*R27Z$^#?'GB"+P[8I#<ZG';2/Y-O\
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MC*US4];\0V\4=_?-J26LD5U EQ(S*EPC9$@!S@J>5/4&KI\;>*=[!=:ORH<
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MPK\4?&/]K;P7/X^\-^-]$\ ^'-4GG_X1K2VT!-2>ZMHY'C2>[E=PP,I7=LC
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MX3_8+OO#>IZ1>6&O30ZXJ6,RA929KFZ:+C./F5U(]F%97[)GQ'UZ#]GCPO\
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M[K_?3_T5'7I=>:>*O^2CW7^^G_HJ.@#MM!_U0^E?"O\ P7SZ?L5?]G5>!O\
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M/Q?XCU7X?WWPZ\/W^G^$ETFVT>TO#"US>3P"YD-S=RM;V^XJ\48$6$C3<QH
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M;8FX\6^)]'T,8RL,\X-Q)_NQ+EV_!:]"NOER02#CKC./>OR!^-_[ _Q \/\
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M-;\*Q:UI-O\ :M*@TV>PN[.251<Q-%"7#H\3H^PJ1M.X ]\_9#_:Q\*?MJ_
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MY=JD/Q?+^I^A^&TO]OQ%/^:A5_\ )4I_E%G56W\-:=J?G'K67;$X&<<UJ6A
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MTDM=-/4M7G[(D>HZQXF:+Q[XZTO1/&&H2ZCJFCZ?-;6\$SRJJ2(LPA\]%94
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M923TGC/_ ()=:3KOPW^-WA72O%$^B:1\7M&T71+6,6 G_P"$>@TRR2TC"DR
MS[DC!^8KCID]: ,GXL_\%J?A+\(/VKV^%>H?:9YK'7++PSJNKQZKI:1Z;J5W
MY0A@^Q272W\Z[IX%>6"VDC0N<M\C[?K^OE#_ (=KZOX5_:HU_P =^$?'OA_1
M_#7C+Q'#XIUW1=2\"66K:B+U8X(YOL6HR.'MHYUMXRRO%,49I&C9"PV_5] !
M1110 4444 %%%% !1110 5YIXJ_Y*/=?[Z?^BHZ]+KS3Q5_R4>Z_WT_]%1T
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MFTVH)[R:6KMV7X'L]%<U\&?!FI_#KX3^'-!UG6KCQ%JND:?#:7>IS B2^D1
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ML+Y*"W "@[BP!^RM%?D9^SI\:OBOJW[.?Q.U(?M9?!^:TU[PII=Y:WLOQ/\
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ME",7-MQ5KO6Z[2O?G2Z<U[>ECX6=#"5*=55:2<YRYE)-KE?7E2LHW\K'PO\
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M;P9#\0;/2/ALL>H>#]/GL;.&VEUB[B"F.[EG;>RO*I.[!## !!IR?&#XA_M
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M2T7X3^%?#>@ZAI6G>&?#^GZ7JKM)>V=MIT,5O>.P 9I$50KD@ $L#D"N@HH
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M?DE'+=L8%?77_!.C]I+2(?@U=:7K%[+;7UE>"/3;-P/.U**0,T9MH%&26*R
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M /S_ /\ @UT_Y03? S_N/_\ J0ZE7W!XH_X]G^E?#_\ P:Z?\H)O@9_W'_\
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MXQ001K&@)[MM49/<Y/>NDHH **** "BBB@ HHHH **** "BBB@ HHHH X?\
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M>QXW^UK8MXZTWP5X#C),OQ \5Z?ID@ R?LT<HN+@_0)%^M?=P 4    5\;?
MO0C\:OV_Y+QE,NC?!S1>#U0ZKJ (Q]4ME;Z%Z^R:OAFFY2KXM_:DHKTAH_\
MR=S7R,/$3$*E3P66+>$'4DNTJS37WTHTG\PHHHKZH_,PHHHH **** /&_P!K
M3]I'X#_ ,:''\:_%7PX\.'5O.;24\4SVR&Y\O9YIA$W7;OCW%>FY<]17=?#\
M>"_B)\.+'5/#4'A[5?"GB6R@N;6>RABDLM1MC&ODL-HVNFS;MZC&,<5\-?\
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M+B9VEDDCA57=SU8D#))[GO5RBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOA;4$\*_$[0(RNF:RJ9BNX^IM+M!_K8&Z8/*DY'<'YC.<JJ>T^NX-7G]J/\
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M$WA;3/&NAW.EZSIUCJNFWB[)[6[@6:&9?1D8$$?45\U^+?\ @FA9^$[N:_\
MA#XQUGX;7$A+MI##^TM"F;T-M*<Q ^L; #L*^HZ*\['93A,99XB%VMFKJ2])
M*S7R9[^2\3YGE/,L#5<8R^*+2E"7^*$DX2\KIVZ'Q%KUW\:_@LY3Q?\ #'_A
M+M.CX.K^"+C[46 _B:SEVRK]%+51\._MH?#G6M06QNO$4?A[5 =K6&O6\FEW
M*'T*S!1UXX-?==8OC3X;>'?B/8&U\0Z#HVNVS#'EW]E'<K^3@UX57AS$T_\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>:>*O\
MDH]U_OI_Z*CKTNO-/%7_ "4>Z_WT_P#14= ';:#_ *H?2OA7_@OGT_8J_P"S
MJO W_M]7W5H/^J'TKX5_X+Y]/V*O^SJO W_M]0!]_P!%%% 'Y_\ _!KI_P H
M)O@9_P!Q_P#]2'4J^X/%'_'L_P!*^'_^#73_ )03? S_ +C_ /ZD.I5]P>)P
M6MG ':@#F?A7_P CM=?]>\G_ *%%7HU>=_"Q"OC.Z)'6"3_T**O1* "BBB@
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M\B@#U;[1'_ST3_OH4?:(_P#GHG_?0KRG_A64?_/)/^^11_PK*/\ YY)_WR*
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MU$E  X&[".<<;G;UKYE^&G[)/Q'^+_Q#L_"NF>#/$L.HWDX@F:ZTV:WBLE+
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M41)/<B-SGV$!]:\+_8'N+/X>WWCKXV^((1-X>^"FA3:S&CC*7>IR*T=E /\
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M9I/MT)=>U;4_&/C;6?$NOZMJ&O>(O$$XN+_4;V3S)[A@H502  %50%
M%=;I/[2'Q(\/3>%&TWQWX@L8_ R3IX?B1XV72?/C,<IB+*2,H2N"2 .@%<;1
M6L,RQ4*LJT:DE*6[N[O5/5^J3]5<YZO#^65<-#!U,/!TX?#%Q3C'1K16LM&T
M^Z;6S*^GV)L4E+SSW4]S-)<W$\[EY;B61B[R.QZLS$DGU-;US\0_$LOPPN?!
M,7B'5+;PA?7T>I7>D1NOV:YN$*E9&!!((*+]TC.T9SBLFBL88JM&;JQFU)WN
M[ZN^]_7J=57+<)4HPP]2G%P@XN*:5DXZQ:[.+6C6QI^.?'GB+XG:SI5[XCU[
M4M;;0=,CT;3([EU*:?:(<K%& !P/?)X'-/U;XA^)=:^'6G^#IO$6JGPAINH_
MVM#H^]?LJW6UE\W&-P.';@''S$XR:R:*MX[$.;J.;NURMW=VK6L^ZMT,EDV
M5*-!48J$9<Z7*K*5V^9+H[MNZUU?<T]/\=^(="\$^(_#NDZ[J6D:/XOMEL]:
MM[5U5=1@4DB-\@G;\S#C!PQ'0UE1H(HU0=%&!3J*RG7J2A&G*3<8WLNBOJ[=
MKLZ:6#H4ZLZ]."4YVYFE9RLK*[ZV6BOTT-GX??$?Q!\)?%EOK_A;6+W0-=LU
MD2WOK0J)H Z%&QN!'*L1R.]<_I]D;"V*---<2.[222RMN>5V8LS,>Y)))^M3
MT4.O4]G['F?+>]NE]KV[V!8.@L0\4H+VC7*Y65W%-M*^]DVVET;?<W?AY\4_
M%'P?UY]6\(>(=5\,:N\#6WVW3Y1',(V(++D@@@E0<$=0*Z+Q'^V#\:O&&A76
MEZK\8?'U_IUZGEW%O+>)LF7.2IPG0XK@**[,+F^.PU-TL/6E&+Z)M+[CR\QX
M6R?'UUBL;A:=2HK)2E"+DK:K5J^G0N^,_%FN?$SX@:KXK\4ZWJ7B/Q'K7EBZ
MO[YPTKK&@2-!@ !548   J]X,^*'BCX9PZNOA?Q#J?AU]>L7TR_DLV4&ZMG^
M]$P8$$'Z9'8BL2BL'CL1[?ZSSOGO?FN[W]=SL63X%8/^S_8Q]C:W)RKEMVY=
MK?D7;'Q?K^C_  JU3P18:]JEAX6UYK=]5T^%P(M1\A@T0DR,D*R@\$9P,YJQ
MX'\<ZS\,O%ECKWAW4KG1M;TMS)9WMN1YMNY4J67((^ZQ'((P36514O%UWR>^
M_<^'7;6^G;773J6LLP:]JE2C^]^/1>_IR^]_-[ONZWTTV&+Y\MS=W-W=W.H7
MVH7,MY=75PVZ6YFE<O)(Q[EF))^M7_#OB74_!VNVNJZ+J>HZ-JMB_F6U[8W#
MV]Q;MZJZD$?UJG16;KU/:>UYGS7O?K?O?N;+!T%0^J\B]G;EY;*W+:UK;6MI
M8]%\:_MI?'+XA^&Y=&U;XS>/IM)G0Q2P0745J\J$8*M+$BR,".#EN:\Y\%!O
MAU=6%QHCOIUSI<Z75K-$<20S(P=9 3_$& .3W%+179C,VQN*L\35E.VUVW8\
MO*^&,HRU267X:G2Y]^6*5_6R+'B/7M5\;^+M9\0:_JM[KNN:_<FZO[V[8-+<
M/M"C.   %4     "MK6OC'XS\2^,/#6NZEXLUJ_U#P9;16F@R32*3I,<3J\8
MB.,_*RJ06R?E':N=HK'Z]B.:<O:.\_BU>NM]>^NOJ=2R; *%*G[&/+2NH+E5
MHIKE:CV36C2T:TV+>I>)=8\0>-=2\2ZKK&H:IXBU>^_M*ZU&=QY\D_&'RH !
M&U<8 Q@4[QUXMUSXJ_$/4_%?BO7-3\2^(=5CCAGO;^0/)Y4:[4C&  %49X [
MD]235*BE/&XB2FI3;YW>6N[75]V.EE&!INE*G1BG23C!I*\$[74>R=EHM-%V
M-/QUX[\0_%'7M-U'Q+K^IZY-HNF1Z/IJW3J4L+2,Y6%  . ?7)]ZS**,$] 3
M6=>O4JRYZLG)]WJ]-$=&$P5#"T_8X:"A&[=HJRNW=Z+35ZA12[6]#^56],\.
MZAK4BI96-W=NW188FD)_ "LHIMV6IT3FH+FD[+S*=%>A>%?V2_B?XVE5-+\
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M_P#]2'4Z^_Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 1C\IJG?2%$.*NGD$>M5KB'>I'<T <YJ]X
MT8."1UKF]3UVXC!"ROCTR<5U^H:7YH.1FL.^\,&3.%Z^U-,31P/B"2WU;(O+
M*RO0>/\ 2+=)1_X\#7GWBCX-^!?$+,;[P/X2NRW4R:3 3_Z#7M%WX,:0D[36
M5>> 6<GY":YZN&HU=*L%+U2?YG;A<QQ6&=\/5E#_  R:_)H^<-?_ &1/A3J0
M82?#_0HB>\"R0X^FQ@*XS6OV!_A+>%F7PS=6['_GCJ4X _ L:^L+OX<,_P#
M?RK,N_ADS@_(<5YE7AO*:G\3"TW_ -N1_P CZ+"^('$^'_@YC7CZ5JG_ ,D?
M'&K?\$Z/AK,#Y*>([4GILOE8#_OI#7-:E_P3:\&,Y,.N>)8 .Q\E_P#V45]O
M3_"MFSA#6?<_"9SGY":X*G!&0S^+"P^2M^5CW*'C%QK1^#,JK]6I?^E)GPI?
M_P#!-K1AG[/XIU-/3S+-&_DPK'O?^"< 7)@\7 @]!)IQ'\I*^])?A$Y8_NS^
M502?!UR"/*)KBGX=</2_YAK>DIK_ -N/7H^/G'E/;'M^M.D_SIGY_77_  3L
MU2,'RO%&FN1_?M)%_D36=<_\$_O$43$1:[HDN#QD2ID>OW:_0:Z^#;XQY;#-
M4IO@[)NSY9Q7+/PPX?>U)K_M^7ZMGI4OI&\=0^+$QEZTJ?Z11^>\_P"P?XNC
MW"._T&0@\9GD7/\ XY5*?]B'QK"6 ;1I-O\ =NR,_FHK]#F^#<AR?+8'UIG_
M  IF4D_)DGVKGEX59$]E-?\ ;W^:9WT_I,\:Q^*5*7K3_P I(_.N7]C'QRF-
MMMILF?2\48_.J\O['WCN-B!IUFP'<7L6#^M?HTWP6E!_U9&?:J\_P8D P(S@
M>U82\)<D>TJB_P"WH_\ R)V0^E%Q@MZ=!_\ ;D_TJ(_.63]D[QW&2#I$1QQQ
M=Q8/_CU0#]EOQS_T!''_ &\1?_%5^BD_P;EW$"-A^%1?\*>F&?W1)%9OPBR?
MI4J??'_Y Z(_2GXL6]##O_MRI_\ +3\ZS^S/XY!(/A^XR/\ IK'_ /%4U_V:
M_'*8_P"*=NVSZ21G_P!FK]%/^%/S_P#/(_\ ?-'_  I^?_GD?^^:S?A!E/\
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M_P##AZ1_\D4 >_T5X!_P]B_98_Z.6_9__P##AZ1_\D4?\/8OV6/^CEOV?_\
MPX>D?_)% 'O]%> ?\/8OV6/^CEOV?_\ PX>D?_)%'_#V+]EC_HY;]G__ ,.'
MI'_R10![_17@'_#V+]EC_HY;]G__ ,.'I'_R11_P]B_98_Z.6_9__P##AZ1_
M\D4 >_T5X!_P]B_98_Z.6_9__P##AZ1_\D4?\/8OV6/^CEOV?_\ PX>D?_)%
M 'O]%> ?\/8OV6/^CEOV?_\ PX>D?_)%'_#V+]EC_HY;]G__ ,.'I'_R10![
M_17@'_#V+]EC_HY;]G__ ,.'I'_R11_P]B_98_Z.6_9__P##AZ1_\D4 >_T5
MX!_P]B_98_Z.6_9__P##AZ1_\D4?\/8OV6/^CEOV?_\ PX>D?_)% 'O]%> ?
M\/8OV6/^CEOV?_\ PX>D?_)%'_#V+]EC_HY;]G__ ,.'I'_R10![_17@'_#V
M+]EC_HY;]G__ ,.'I'_R11_P]B_98_Z.6_9__P##AZ1_\D4 >_T5X!_P]B_9
M8_Z.6_9__P##AZ1_\D4?\/8OV6/^CEOV?_\ PX>D?_)% 'O]%> ?\/8OV6/^
MCEOV?_\ PX>D?_)%'_#V+]EC_HY;]G__ ,.'I'_R10![_17@'_#V+]EC_HY;
M]G__ ,.'I'_R11_P]B_98_Z.6_9__P##AZ1_\D4 >_TC*&'-> _\/8OV6/\
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MI'_R11_P]6_96_Z.4_9__P##AZ1_\D4 =O\ \*OA_P">:T?\*OA_YYK7$?\
M#U;]E;_HY3]G_P#\.'I'_P D4?\ #U;]E;_HY3]G_P#\.'I'_P D4 =O_P *
MOA_YYK1_PJ^'_GFM<1_P]6_96_Z.4_9__P##AZ1_\D4?\/5OV5O^CE/V?_\
MPX>D?_)% ';CX80C/[M>:FB^&<(((C&?I7!_\/5_V5QT_:5_9_'_ '4/2/\
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M /\ #AZ1_P#)% 'OX '2BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^BO /^'L7[+'_ $<M^S__ .'#TC_Y(H_X>Q?LL?\
M1RW[/_\ X</2/_DB@#W^O@#_ (+Z?\V5_P#9U7@;_P!OJ^@/^'L7[+'_ $<M
M^S__ .'#TC_Y(KXP_P""Q/[;OP7_ &E/%7[&6A?#GXO?"_Q_K=I^T_X(OY]/
M\-^*K'5;N&W5[M&F:*"5W6,/)&I<C ,BC.6&0#]3J*** / [K_@E/^R[>W,D
M\_[-OP#FFF8O)(_P^TEF=B<DDFWR23WIG_#IW]EC_HVG]G__ ,-YI'_R/110
M ?\ #IW]EC_HVG]G_P#\-YI'_P CT?\ #IW]EC_HVG]G_P#\-YI'_P CT44
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MI'_R/1_PZ=_98_Z-I_9__P##>:1_\CT44 '_  Z=_98_Z-I_9_\ _#>:1_\
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M_P##>:1_\CT44 '_  Z=_98_Z-I_9_\ _#>:1_\ (]'_  Z=_98_Z-I_9_\
M_#>:1_\ (]%% !_PZ=_98_Z-I_9__P##>:1_\CT?\.G?V6/^C:?V?_\ PWFD
M?_(]%% !_P .G?V6/^C:?V?_ /PWFD?_ "/1_P .G?V6/^C:?V?_ /PWFD?_
M "/110 ?\.G?V6/^C:?V?_\ PWFD?_(]'_#IW]EC_HVG]G__ ,-YI'_R/110
M ?\ #IW]EC_HVG]G_P#\-YI'_P CT?\ #IW]EC_HVG]G_P#\-YI'_P CT44
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MI'_R/1_PZ=_98_Z-I_9__P##>:1_\CT44 '_  Z=_98_Z-I_9_\ _#>:1_\
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M_P##>:1_\CT44 '_  Z=_98_Z-I_9_\ _#>:1_\ (]'_  Z=_98_Z-I_9_\
M_#>:1_\ (]%% !_PZ=_98_Z-I_9__P##>:1_\CT?\.G?V6/^C:?V?_\ PWFD
M?_(]%% !_P .G?V6/^C:?V?_ /PWFD?_ "/1_P .G?V6/^C:?V?_ /PWFD?_
M "/110 ?\.G?V6/^C:?V?_\ PWFD?_(]'_#IW]EC_HVG]G__ ,-YI'_R/110
M ?\ #IW]EC_HVG]G_P#\-YI'_P CT?\ #IW]EC_HVG]G_P#\-YI'_P CT44
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MI'_R/1_PZ=_98_Z-I_9__P##>:1_\CT44 '_  Z=_98_Z-I_9_\ _#>:1_\
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M_P##>:1_\CT44 '_  Z=_98_Z-I_9_\ _#>:1_\ (]'_  Z=_98_Z-I_9_\
M_#>:1_\ (]%% !_PZ=_98_Z-I_9__P##>:1_\CT?\.G?V6/^C:?V?_\ PWFD
M?_(]%% !_P .G?V6/^C:?V?_ /PWFD?_ "/1_P .G?V6/^C:?V?_ /PWFD?_
M "/110 ?\.G?V6/^C:?V?_\ PWFD?_(]:7@[_@F?^SA\._%FFZ_X?_9^^".A
K:[HUS'>Z?J.G^!M+M;NQGC8-'-%*D >.16 (92"" 0<T44 >VT444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>j3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" '3 JX# 2(  A$! Q$!_\0
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M^B@#X _XA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ **
M/@#_ (A<?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _X
MA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<
M?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\
MHAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?
M^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\ HAG_ )>?
MB'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?^7GXA_\
MDZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\ HAG_ )>?B'_Y.H_X
MA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?^7GXA_\ DZC_ (A<
M?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\
MHAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?
M^7GXA_\ DZOO^B@#X _XA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?
MB'_Y.K[_ ** /@#_ (A<?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\
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M^B@#X _XA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ **
M/@#_ (A<?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _X
MA<?V$_\ HAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<
M?V$_^B&?^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\
MHAG_ )>?B'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?
M^7GXA_\ DZC_ (A<?V$_^B&?^7GXA_\ DZOO^B@#X _XA<?V$_\ HAG_ )>?
MB'_Y.H_XA<?V$_\ HAG_ )>?B'_Y.K[_ ** /@#_ (A<?V$_^B&?^7GXA_\
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M^R5>*/\ TT75'_!)W_E%E^S3_P!DJ\+_ /IHM: /G_\ X-<?^4%'P,_[C_\
MZD.IU]_U\ ?\&N/_ "@H^!G_ ''_ /U(=3K[_H **** "BBB@ HHHH ****
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M0"02* /0J*\@\+_M9>'?#OP&T7Q?XS\4^'775[N>SM[C1K:ZDAU"5)I4$5O
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M1X0^/ NV\+:G-J*62I([O8W%LDD;YV2QM*BB6-L'#IN4XZT =K1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@'
M_!6+_E%E^TM_V2KQ1_Z:+JC_ ()._P#*++]FG_LE7A?_ --%K1_P5B_Y19?M
M+?\ 9*O%'_IHNJ/^"3O_ "BR_9I_[)5X7_\ 31:T ?/_ /P:X_\ *"CX&?\
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M]F+6[/Q3\6?#?B?1OC%KN@>/?$5SJMHGA;4[--)U*VNECS%.)2K0R1[2K%B
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M_+GY<5J:?^R9X$T[5O&ERND22VWQ!\TZ[ITUW++IUZ\P'G2?9V8QK))M&YE
M)QF@#S/^WO'O[/'[0/@GPQJ_CV^\>Z?\0-+U9[C[?I]M;S:7>6=NDXG@\A%V
MV[9*&-]Y4LGS')KR;X;_ !1^-.O_  U^ OB27XI+)??%^Y.C7UO+H-LUKIT1
MMI[A;B%0 QN0MNPW.S1L7'R +@_3OPL_8\\"?"#7Y-5TNPU*ZU(V!TJ&YU/5
M;G49;*S)!-O"9G8Q1G R%P3M&2<"M71/V:O!GASPYX)TFSTCR;#X=S_:= B%
MQ*?L,GE20YR6R_R2R##YZYZ@4 > Z3\>_$/@SPK\3/"7BCXA:V;SPAXOLM T
MC7+31(+O7-7CN[>&>.T2!$\I[D[W42"/  W%?E)KE]%_:Z^(?A[P+XY\,C4-
M;36K+QGH?A?1=8\5Z5!!J>FPZH(OWMS!%B*5HMSF,X4/N3</7Z8\8?LD> _'
M*Z\U]I$RW/B/5;;7;JZ@O)H+B._MHUC@N8I$8-%(BJ "A'?.<G-*R_8F^&MG
MX+\4: _A][S3_&CQ3:T;N^N+B>_FB'[N=I7<R"52 0ZL&! (/ H \:_; ^&?
MB_P5X!^&VER?$&_\2:G=_%'1#I.IZQIUL9]-9A,#O$*QI, V64%5(R%)(&:]
M(_9B\5>*]*^.GQ/^'WB/Q-=^,+3PDNEWVFZE>VT$%[Y=Y%*SPR>2B(P5XCM8
M*#M8 YQFNE\/_L@>!M TRRMFL]5U-K#6[;Q%%<:EJUU>W O;=2L,ADDD+$(I
MP$^[Z@FNPT3X9:)X=\?Z[XHL[,1:WXEBMH-1N/,8^>EN'$(VDX&T2/T SGG-
M 'Q7_P %"?$.C?'7X\>(?"5ZNONWPU\*M<Z)-I>CW>H"W\2716:VD=H(W$;0
MQ01D!L$BY/8'/H%A^U%X@_:@@^!^A>&->NO!:?$G0K[6M;U2WMHGOH'LEBCE
MLK?SE>-9/M$C;F*,0D1P.<CZ1\!_"K0?AI?>(+K1K$6ESXHU-]8U.4R-(]U<
MNB(7)8G VHH"C  ' %<1K/[$GPYUCP[;::NCW=@FGZQ=:]87%CJ-Q:W6FWET
MS-</!*CAXU<LV44A.?NT >?>,/BEXK^!GQ[T#1]6UH>+8=)^'6O:Y>3'38+>
MYU.:UN(#$?D&4;RV*$(0K-\VT< >5W$/CCQ1J/[+?C;Q3X\/B1?&GB:VU6?2
MUL;>&UTZ6;3KB2-;1T4.(T1BC"0N6.&R.E?6'A#]F;P7X&U30[W3])<7?A[2
M[G1[.:>[FN'%M<2K-.KF1F,A>10Q9\G.><&N8\#_ + _PN^'GB#1]2TS0;M;
MCPW=F\T5)]4NIX=&8[LI;1O(4BC.\Y10 >!T P 4_P!K[XAR:)JWAOP_I_BW
MQMH^KZNES/'I7A#1H-0U;4(XPF9=TR.D,,98!B0-QD49'0^*^ ?VE_B?\9/#
MGP$TN'Q/_P ([JWC/4O$6D:]?-I4)GG33_,02"%MR13D1YP,HKL<A@ *^H/B
MU^SCX5^-.MZ3JFM6VH1:MHB30VE]I^H3V%TD,P F@,D+JS1.%7<I.. >#5/P
M5^R;X ^'0\)KHN@1V">![B]N=$5+B4K9/>;OM!&6.[?N;ALXSQB@#Y[N/VC_
M (B>%O 'B#P8?$\5[XCM_BE9_#W3_%-W8Q>=!:7,<,_VB6) L33I&[QJ=H5G
M*$KU%;_[-GAC6? __!0GXGZ;K?BBY\73V_@_1?(O[NVA@N_),]UA)O*54=PV
MX[@BY!''&3[)XO\ V5_ /BSPMXMTO4]#2:R\9ZBNL:K_ *1*DDEXBQJD\;A@
MT4B^3&5*%<%<^M9WPB_9P\&_!3Q)J6L^'].NH]9UJ".WU'4+N^FO+K4%1F9#
M+)*S%F!8@$\@8'0 4"N<#X1\'Z3XS_X*-?%F#5])TW5K<^#]!4I>6L<ZX:2]
M!7# \$=1WKQ'P5\9]:^!_AO6_ WP]?5SX9U7XN7WAK0IM*MHK^YTNPCLA=7,
M%BDS"([9EEC0L2J9<X8KBOIOXJ?L<_#_ .+OCRX\4:[I^L'6+VTBL+FXL-;O
M+ 7$$18I'(L$B!@"[=?6NBU+]F+X?^)OA)IO@H^'+*R\-:-*EQIUM8L]H^G3
M(2RS0R1D.DH)8[PVXEFR3DY N?+GQF\4^/\ 5_@'?Z?XRL?$JZ5I?Q'\*#P]
MJ7B"TM[34]0MWU&U:1)H[<F,M%(&4. NY6&1D'/3_$GX_>//"\OQVU[1[U#;
M?"OQGI-W+:06$.^[T@65K)?0,0NYSY<DL@8G<"@ ('%>\6O[)G@U?"<VC7L.
MM:U;7&J6NLRRZIK%U>7$EU;2)) _F22%@%:-3M&%..0<FM_3_@CX7TF[\8SQ
M:7&7\?2"770\CNE^WV=;?D$D*/*55PN!QZ\T#/F+XQ?ME>,;<?$/Q'X1O9+W
MPXGB'1/ GAEK6RBND^USLK7MZH8@2LOG)$BLP3?'@]347BGXW?%SX7_ _P"-
M&HS+XUATGP[X935/#FM^*M.LK?48K[,@F@*P9CEC $;JQ0$;F4YP#7OFE?LI
M_#KPQ\ C\+K7PW;GP2P8?V:TTCDLTOF[_,+>8'$F&#AMRD#!&!5:V_9*\&1>
M"_$>@7Z^(=<T[Q;:+8:DFK:[=WSR6ZYVQ(TDA,8&3]W!/<F@#R#XMR_%GX3>
M#O#.IZMXZ\;ZUX5O8I]4\4ZUX;T>RDU'193#$T*16QB8_8%Q*6PLDHXRV#7U
M)X!\06OBOP-HVJ66I)K-GJ-C#<P7Z($6]1XU99@HX <'=@=,UPWQ)_9O\*_&
M:YLDU@Z[ MK9/INW3]9NK!+BU;&Z"58G42(<?Q<]>>37H?ASP[8^$/#]CI.E
MVL-CINF6\=K:V\2[8X(D4*B*.P"@ ?2@"Y1110 4444 %%%% !1110 5E>*M
M9GT=M,$#P(+N_CMY/,@EERC!LA?+!VMP/F?Y1W[5JUSOQ"N%@DT -)''YFKP
M*-TT\>XX?@>4#N/^R^$/?H* .BICW44=PD+2QK+("40L S =<#OBGU\3_MZ>
M ?$'CC]N'P/>>$+B:'QEX.\$ZEXCT%%8A;NYM[RVW6K@'E+B)I(3G_GH#VH
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MB[@*X'FH"I)'(SMH ]]N]?L+"X\F>]M()?[DDRJWY$U;KXH_:#^#(^#/QO\
MBG\7?&?PA\+?$SP;<FPU%;Z2Z@DU31+:UM52=T@FCPP4J7PL@)"]"<5[]^U=
M\5G\.?L5>.?&/A^X=77PK<W^G7"Y5DWVY,<@[@C<&'IB@#T?POXRTGQMX=AU
MC2-1L]1TJ??Y=W!('A?8Q5B&'! 96&?8UH13)/$LD;*Z. RLIR&'J#7R-^T_
MKOASX$?L-_#?X;#4K/P[IGC8:9X7DN9)/*2"P\M9+^4MVS;I*N>I:8=S7-?
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M(_C=\:-#U3P[<V-MH'B:PC\.>.8YFV23Z;#>17<9C'\3G;-$0?X9L=,T 6?
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M7'-?'C]E75_C7\9_&5TT]O9>'_%7PRN/!ZW0DS-!=2W+ONV=T",#G//2N?\
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M%Y$&*]<_X*1?MSZO^V#\0;?X*_":.XU;2;B\6WNY[3YFUR=6R$0CI;H1N+'
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M)IGE=HPSH Y/R'"CZFJIX@\06/A30KW5-3NH+'3M.@>YN;B9@D<$:*69V)Z
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M5>%__31:T ?/_P#P:X_\H*/@9_W'_P#U(=3K[_KX _X-<?\ E!1\#/\ N/\
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M#X&&Y/F]![Q_..W>MX$$ @@@USWQ MFN9-!VP//Y>K0N=MG'<^6 '^8[R/+
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M]O(AD0$G ?.,G&,FO0-#T6U\-Z+::=91>19V$*6\$>XML1%"J,DDG  Y))H
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M._\ *++]FG_LE7A?_P!-%K0!\_\ _!KC_P H*/@9_P!Q_P#]2'4Z^_Z^ /\
M@UQ_Y04? S_N/_\ J0ZG7W_0 4444 %%%% !1110 444,< ]J (+V<0H2>,5
MY1\:OB=:^#M O;^[E*6UG&7?!^9O11ZL3@"O0/%FH_9+5R" 0*_/K_@I;\1K
MGQ!)9^%;/4M1TX1$7UW+:2!6;(.Q3D$$!<G!'5@?2O1RK 2QF)C16V[]%O\
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M>./*EVK]/^?IFF06,5O"L<,4<,29PD:A%&3DX XY))^IH!,\H_;)\:ZA\/\
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M:\33OHWC>VU6ZATZ/1VFFU;[+ &>)G)#6TL+9!0J2S97C%>8_$+QKXU\,_\
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M:T?\%8O^467[2W_9*O%'_IHNJ/\ @D[_ ,HLOV:?^R5>%_\ TT6M 'S_ /\
M!KC_ ,H*/@9_W'__ %(=3K[_ *^ /^#7'_E!1\#/^X__ .I#J=??] !1110
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M17XE_$;X":AX?\<Z%\+O"D6GKXE\4VEXVEIXCO6DCN)-#@!3?-:M;%?M$T;
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MX7_]-%K1_P %8O\ E%E^TM_V2KQ1_P"FBZH_X)._\HLOV:?^R5>%_P#TT6M
M'S__ ,&N/_*"CX&?]Q__ -2'4Z^_Z^ /^#7'_E!1\#/^X_\ ^I#J=??] !11
M10 4444 %%%% !01D$8S110!A>*=-%Y:N, DBL;X7:H;&]NM+E)&3YL.?889
M?R /_?5=?>P":,@C@UP?BW29M*U&*^MBR2P.'! ]/\X]P2.] &1^U9\ )OC-
M\,M1L-/,8OGVSPJYPK2(<@9]^GXU^>/BSX+>+/"FIW$%_P"%];CD@R&5;-WR
M1Z$#!^H.*_5CPSXBA\2Z6EQ'A7'RR1YR8V]/ZCU%6[VQBU"U>&50R.,$5[^4
M\0U\#!TXI23UUZ,^!XM\/L'GM:&)J3<)Q5FU9W6KZ^KU/Q2G\#:C+J%XOB32
M5M)C+NBL;A%=K6,@; W4;B/F/IG':M[P!=P>!]=AB-I ^D7\JQWL*1*"RL=I
M=3CAP#G(ZXP:^VOVO/V&=:\8Z[+KWA..WO);A56XM68)(Q48#*3P>."/:O'O
M"?\ P3[\?ZVH?4]-CTBUA<,[2N&D< YPJC/YFOLJ&<Y?5P+=9J[7O+JWZ>NW
M;0_$\=P5Q!A,]C' QGRP:4)?94$]$WM:WQ+J[Z.YXW\0?ACJ?PVD(@U32-0T
M;S2EF;J9H;LKG[NT*V\*/XA7U?\ \$YM*\%^;>2Q^)-/U#Q5<1*)[.*.2$P0
M@YP@D +C/)8#L.E?-O[07@2\\+_%/4+&[=W%C%$D188!0H#D?4DUD?"6VU72
M_BCX:O\ 1WEBOX-3@\EH\AN7 8>X*D@^Q-5+!U,7E:52L[N-^ENZ3TOZNYST
M<ZPV3\53EAL&N6,W&UY.2UY7*.MEY*STTTW7Z[P;/*41XV#I7-_$KQ./"^CS
MW<I<06L+SR!>I"J6('O@5J^&I6FL=S @$\4GBGPQ;>+='GLKI28IXVC;W!&"
M/RK\PBTI>]L?U944G3?)OT/RE^)_[0?B[XN>*I]5U'6-1B224M:6L4[Q16:9
M^5452 "!C)ZD]Z^F_P#@G3^U7XE\5:WJ'@[Q'>7>L_9;-KW3[F4[Y]J$!X68
M\M]Y=I/.<C-</\6O^"<OCCP_XG=?#UI;ZUI32$Q.DJQRHN>%96(Y XR,BO:_
MV3_V6)OV<["_\3^)_LR:K=1+ EO$0YA3.?+#="S,!G'  %?H6<8[*ZF7<E+E
M;LN5+=/\UY]S^<>#,CXKH<2^UQ3FHIOG<K\LE9]=GKM;;?9'SQ^S#_P52^,7
M_!1;2_'_ (>C_9LUKX;MX:O+NWLM1\4ZN;:POKB(C[-:RIY(G!<\R21(Z(%&
M"Q.*]A\._ K]I+QK\"].LK[XH_#OX4>-VU.2>_O_  GX6.N6PT_RQY=M&+]Q
MB97R6F*X(QA0:]X\/V-SXAU>74KTEIISN ZB->RCV%=/=D6^F784?,L#XQV^
M0U^<G])L_/#Q1\,?$5M^TFWCV;XL?$MHWCV'0H+NWM-&O#Y1B>5X4BW;G.9,
M!\*Y&,  5?\ V?\ ]@CX<^)=+UKP5J>K_%#Q#HWC "\U1]3\=:G/>[X&WQB*
M?S0\"[C\RQD!A@'( KL?%.G'6/"Z31D&2%=R^OO6?\ /B"OA#XGP74V3;M"\
M4O\ TSS@9J[&29[#J'_!-'X2:S;?#V.2R\9*?A?&L7A^2+QEJL<D2+,9\3L)
M\W'[PG/F[B1\OW0!6O:?L*:)I/Q(\=^+-'\?_&/1]9\?6EW;721^,[NZL-+D
MN&#&YLK.X,D%O-&1^[*)M09&W%>H^'M:BU6SCEBD62-P&!7G(K:CE"J".<U!
MHF?.VH_LR_';X:?!/3=!^''[0$VM^)K#59;V;5_B5X>@UDZA:N@5;-C:?9BB
MHPWB1<N2Q!XQ76K\7_C%X0^.JZ%K'PIT_6OAT-+6YD\:Z'KR-/#<1VN^:-]+
MD43'?,&2(1/(2"N><X]CM4,KY ''3_&K8 C! /S"@H\>_9I_;B^'7[6'A>;4
M_"VJ:C8SVNH_V1=:9XATNXT34K2]\OS!;-;721N9"GS80-D9YX->M)($+9ZK
MP:\R_:K_ &7_ (>?MA?#Y?"WQ(\,67B?2;>X6\M#*[PW6FW*@A;FVGC*RP3+
MDX>-@<$CH2*\\N/#OQ@^ ?Q0NM9T7Q!9>/?@U8^'RB>"YK MXIT^XM;8+"EA
M>EPMV;AE&];LA@S9#\XH$V?2]N0R[B<_CQ3@ZH. !7E_[*W[4_A?]KKX26WB
MSPFNLVMMY\ME>Z=K&GRZ?J6DW<1 FMKB"0!DDC9@&QE3D$,00:]&W$]S0"9X
MG^W#<)9?#:_DD@2ZMI8X$EB;@.//4=1T.#U[5Y5^S9\'_!_A_P",>BW5I::A
M<7+W3&,7<P>.!@A(8  9/IGI7KW[:=FMS\';YGSM$MNG'4YF6O._@$F?BOHA
MP1MNGZ_]<VKT,/BJU.C*%.32END]SY_,,JP>)QM.OB*493A;E;5VM>A]8D#:
M< ']*A68'*D].W:H9KX00,Q) 451M]46:0D'@UP6/H$];&S"VWC.0/?FG-@'
M!.0:J6USGD'%767<H/!SUI BM*,'/.::?F7([5-,A*=,@?K5=7 ;'<=J 8R1
ML8YQ7B_B+41/XY\20,V2EU@>WR+7LEU(%&/2OF[QSXC-E\5/$A9P%:XQ^ 5:
MJ)$G8U;KXC7]E$]H9U,:C!D*_.!Z9KN?@S90^,?"FI6U];JSBX$HR.=K*-I^
MO!KQ[PY:MXFU9I&'^C0D,Y[$]E_K7MOP,=6UK5D7HD,61TYRU$D$30@\ MHS
M[K>1PH_A/-7QJ[Z=#MD;)%=)=!4C);.*\]\?W[RR);6BF2YN'$<:+U9CP!4W
M*Y2'4M=O?%>JKING+YMS+U)/RQKW9CV%=SX'^'5GX,A,@S=:A(/WMRX^8^R_
MW5]J/ASX%C\$Z*$<K+?W&'N9N[-_='^R.U=#04%%%% !1110 4444 (RAU*L
M RL,$$9!KC/%?@1],9K[2@P"_-) .< =U]O;\O0]I10!R/A+Q4M]$JLV&':N
MJ@F$J @UQ?CCPXV@:B-4LT(@D8"9%Z(Q/4#T)_7Z\;?AG65OK6-@V2P]: -V
MBA3D9HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#P#_@K%_RBR_:6_P"R5>*/_31=4?\ !)W_ )19?LT_]DJ\+_\ IHM:
M/^"L7_*++]I;_LE7BC_TT75'_!)W_E%E^S3_ -DJ\+_^FBUH ^?_ /@UQ_Y0
M4? S_N/_ /J0ZG7W_7P!_P &N/\ R@H^!G_<?_\ 4AU.OO\ H **** "BBB@
M HHHH ****  @$8-9VKZ6MW$P*YS6C2,H88- 'G;17?@G5C=6PW1-PZ'[K#T
M/^>/S![;P_XEM?$EKYENXWK_ *R,_?C/H1_7H:;J>CI=QL"H)-<?JGA:YTB[
M^TV,DD$JDD%#C_/X\4 >@T$!A@C(-<9I?Q.EL\1:I;-E1S+$,=NZ_P"'Y5T6
MG>+=-U4#R+VW9C_"6VN/P/- 'G7QY_8^\*?'QTN;Y;C3]2B78MW:D!F7^ZP/
M# ?I6%\#_P!@SPO\&M;CU-KN\UF^@_U+7"JB0^X4=\=S7N8.0".0:"<<G@"N
MV.8XF-'V"F^7L>%5X9RNIC%F$Z$757VK:W[]K^>XV*)88PB*%5>@%.K,U?QI
MI.@J3=ZA:0D?PF0%S[;1S7,ZI\7VO@8M%LY)V;@3SJ40?1>I_'%<5SW3K-?\
M16GAJQ:XNY0B]%4<M(?11W-<'))>^/M56ZND,-M%_J(,Y"#U/JQI=,\)7NMW
MXN]2GDN9SW?HH]%'0#Z5V.GZ.EC$JA1Q0!6L;!--LRQ4*$&:S-+U ZK*V3E)
M"01Z@\8JWXWU(6&C2!2 TGRC\:SO!$!>%2>0".:"6?)OB-#X8EO[(,6^P74\
M/U"R$#]*\RCN'TOQ/<W5NK20%09% S\I/_UJ])^,EXL'C_Q'&V%7^T+D$?\
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M/_CPKUWP=^W[\3;-5:3Q7<W@]+FWCD!_3-+F0*DGT/UFE^+M[",L+4?\!/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X!_P5B_Y19?M+?\
M9*O%'_IHNJ/^"3O_ "BR_9I_[)5X7_\ 31:T?\%8O^467[2W_9*O%'_IHNJ/
M^"3O_*++]FG_ +)5X7_]-%K0!\__ /!KC_R@H^!G_<?_ /4AU.OO^O@#_@UQ
M_P"4%'P,_P"X_P#^I#J=??\ 0 4444 %%%% !1110 4444 %%%% !1110 44
M44 9_B.Z,=JL2YW3'!^G>JVD6F#N(X%)J1-WJ3=U3Y16A:0B.,<9.*!$R#&
M!4A. 334! )[&DD< >M QDSA4.37&?$/5S#9>4I^:4XKJ=1N1'&W/2O,O%>H
MMJ>IN0<HG H)DQ?#K)8Q374F $'&:H>!O#K_ !;\>OJ%VI?1-$E!"D96ZG'(
M7GJJ\$^^!ZUGZ[<7>NW=GX>THC[;?-M+=HEZLY]E'->S^%/"UKX*\.6FF62E
M8+5-N3]Z1NK,?4DY)^M,25SRG]O7P>?$_P"SIJ=S&@:XT*:+4$XYVJVU\?\
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M*.2,ML4=NXKS'X5PW6EZD\!4+"TA* G+-DYS]*]'UGXL^#_#-PNDZUKB6UZ
M!(BPO(MOGH'8# /MSBO0IT*E27+3BY>BN?.UL=AL-153$U(P5[7DTE?M=GGO
MQ&^!=[\5K]-5TB:S:_,<<-Q!<2B(G8-H96/!XQP<5V'@'X5#X4>"KC3Y)X+F
M]U.9;BZ\DEHXMJ[54'N1DDGWKI;?28[!XC;NDUK<()8IXVWI,IY# CJ*MSP
M0J< D''/I735S7$SPRP<W[J\M?Z1Y>$X2RRAF<LYI0_>SOK?2[W:7=KS(_@!
M<'P]\4;4.Q2*Y+PL>@^93_4"O;_%-U)9QED?()Z=0:\6\#693QSH[A=W^F*"
M/7K7K_B(>?$5 )5!FO(J+4^PPVD6C+:[6XMBQ W#J/2N4\37)DRBDX'7T%7(
MK]X]8DMV/RE:RO$\_DV3OD MQ46.A/0Y7P?X1?XD_$N'0XI#$T\A?S-H;RMB
M%\_F /QKV?X7>)YQ#/IUZABO+1V@FC)Y1U."/\]C7$?L668U;XRZY>%2RV-J
MP#=0"SJOYX5J]2^+WA-/#_BV/Q':AE%TJPWB+P PX63ZD?*?H*3U=BEHKGG_
M ,2A_8OB6SO\E5M;F.<D=@K D_E7TE#*L\*2(0R. P/J#7S]\1+1=<T8R*=Q
M9?QZ5ZK\#?%!\5?#73W<K]HLU^R3 'HR?*#^*X/XTFBX,Y?XX:A,UI,L;L%P
M>AXKX7_:&TR_NY9PB%@V:_2;6O FF>((V6Z@:0/U^<@UQ6M_LB>"?$,A:ZL;
MI\]0+E@*SDFSJI5(QW/R(T[X*:QX^\:V>GV]I/>W=Y,L<%M"I9I6)X'T]Z]N
M_:^_X)-^*O!7P3TWQ9ILZ:SJFFPD:OIUM'DVT74/&>K[>=W'N.!7Z0?#;]G;
MP;\);UKO0]$M;6]<%3<MF28 ]@S9('TQ7SUH'_!4![Z'X[6&J>%;6RU[X::U
M)I7AFQ%XSKXM22\?3;1L[/W;27Z-"ZJ'V!D/.<5"I]S:IB]E%:'XWZW\,M6F
M9E2UE;'HN:L>'O#_ (ZTB(PVVH:K96Y_@65L5^MOAJY^!_Q9^%>G>+?%G@R/
M0_$%WI7AS4=9M-(\Q[>WN-;E\BW2)QM$B^?N!;:N% 8CG%<^MU^S19:/XDU@
M^!/B%>Z/HFI1Z/IM]_9-U);>+[Y[AK9;72B#_I<GGHR8  ^4MG8"U$8RCK%V
M!UJ4E:2/S#MOA9XCU&Z6:ZFFO)3_ !RL6/ZUW/@_X/7BRH;L$J#]U1UK]$/"
MM]^S3\1/%7@O0-(\">-6\0>+YKN"73(M,N4NO#C6LRP7']HH6_T?RYG5#][[
MP;[AW4RSUSX,"_UK3_#_ ,/->M/$GAKQ#H6G75CXKL[BS%S9ZCJT=A]L@!?+
MIGSMN[!W(-RX(RO9O=FD,32CLF>6_L??L4:]\<H=2NK2Z?PYIMO:26\.I&'S
M#YY7"JBGK@\D]A[U\9_M/?L5>.OV</B#<:'XATZ7S'+26UW$"\%\F3\Z-WSW
M'45_0!HNB6?AS3(;+3[6"RL[==L<,*!$0>@ K,\?_#'P_P#%31Q8>(M(L=7M
M%;<J7$0;RSZJ>JGZ4_9Z&4L6Y2N]C^=CP5\-?$NG>);!X1>6:_:8LE&*<;QZ
M5_0Q\0)@/!UE S$-,T9Z9^Z-W\P!^-<))_P3\^$SW23#PM$CHP8;;B0 $'(_
MBKKO&\XU+Q-;64>#'9(%(!S\QP2#] %_,U4$UN95JD96<39\'0>78(#D$ 5T
M &!BL[1+80VR@#''I6C5F 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% '@'_  5B_P"467[2W_9*O%'_ *:+JC_@D[_RBR_9
MI_[)5X7_ /31:T?\%8O^467[2W_9*O%'_IHNJ/\ @D[_ ,HLOV:?^R5>%_\
MTT6M 'S_ /\ !KC_ ,H*/@9_W'__ %(=3K[_ *^ /^#7'_E!1\#/^X__ .I#
MJ=??] !1110 4444 %%%% !1110 4444 %%%% !3+F<6\+.>2.GN:>3@9JK=
MH93ELX'0>E %&RBW3<]2<UJ*   !BJ5@O[]\GH:O8XSZF@28$DX]JBGDVJ>M
M/<[5SP*S]1O!!&S,P 7GZ4#,?Q?JQMK4HI.^3@8_G7FOB;68M&A:1V *C\ZZ
MOQ'?Y26ZE.U0/E![+_\ 7K ^%/@IOB1XF;6+V,G2;&3]RC#BXD!X^JCJ?4X'
MK31F]SJ_@7\/I-#L)=;U&,C5-54%58<V\/54]B>I_ =J[Z3M3J;)VH;+2L-K
M\K_B;H$OPM_:$\4Z,21':ZG*$/3*,Q=#_P!\L*_5"OS[_P""F_@Q?"'[1-AK
M<:,D7B33TD=L?*983Y;#Z[2AIQ9%1:&#X3\9/I<\,TDA*J1GW%?1WPAU.W\4
M^3+$V\ 9:OD.>Y\W2;?80"^":]\_9^\>6'@#2XS=R,TTXQ% O,DGO[+[FM7'
M0Y5.TK,^I;:+R+>)< 8YK1M'^4"O(K?X\7=\5:*SM8HR<+N+,<#\JZ#0OC-&
MUVD=];>6C_\ +:+)5/<@]OI6;@S:-6.QZ/"_.#6O'C8N.F*Y;2_$=CJ]N);>
M\MIDSC(D .?<'D5T]O(LD*E2"".QR*EHVBUT',2!P,FF1O(6^8 "I**0V@KB
M/VD]?/AKX$^*KM2%9-/D1?4LXV ?FU=O7AW[5OC!/$4,?A>U821(XFOB#P2.
M4C^H/S'\*TIQO)&.)GRTVSY+^&>I3MXPMA-&^R%AR5QQBN5^(_P#\2W'CR[G
MM]+OM2MM3N'F2XA3S$<,Q/)'0C/0]*]NL?!*6%X9<!6!X/>NHT:[D2-8HY&5
M<XP#@5[V79M5P,W.DD[JVI^>\2<(8;/,/"ABI./+*Z:M\U9]_P #'\!^$;GP
M1\,=!T.X8RW6GQ,92#N$99BVS([#.*UKFS8PH0I(+9KP_P".7[2?B_PO\2KW
M2M"OFTBRTR00J$B5FN& !+.6!R"3TZ8KUOX1_$.[^*_PGM-7OH(K/4UG>UN&
MBCVQS,F/G5>V01G'0@U6897B:=)8ZK:TW?3I?4CA[BG*\1BY9#@^;FH+EU6C
M4+1=G?IINE?<ZCP-;01^.+229U@BAW2[V(500N!R?<UZ#<ZUI]]<[8KVTD9D
M(($@Y.>E>5WFJ%)#$YVGHN!P3BLO4MYD*;697R?]T^M>(XW/N85.5'>:_;+!
M=.ZC#DXZUPWC[Q +?364$97D"J?AWXD3:7=O8ZD2]H&$:ROR8B>ASW7M[5S?
MQ8U<:=(P+ *6ZU#1M"=U='OG[ NA/8>!->UF=0!?WOEJYZLL:\GZ;F8?A7K&
MK"+Q!:7,$X#17*E&'H#T_*N5^#>C'P)\$O#FD,<7#VJW5QCJ&E)DQ_X]C\*Z
M&"X!/)YJ4NIK*70\SO;.;2;BYTZY.YX3MSV<=B/J*D^#/BX> O'KV5PWEZ=K
M1";B<+',/ND^@/W?RKJ/B'H!U:S6\@7-S:C# =73T^HZUY]J>F)K]@ZX&\>G
M!!H:%&5CZ2HKSKX(_%1M=@71-6DVZO:+B.1C_P ?D8[_ .\.X_'UKT6H:.A.
MX5X+9_\ !._P1;_%SPQXSDN]<GU+PMXCUGQ+#"TZBWNY]2E,SQS*%_>1P3$2
MP@GY' ;)-?/W_!1]]!OO^"A_PHLO&7B7P9H'A4>$[VX$?BN^OK:RN[D:G8KM
MMOL]Q IO/++[3)O 4GY2,UP?Q/\ V]/B!K7B'XK:)I_C;1O%\5C:>/=-OO!<
M/A[RYO"]IIEO<O87\MPA$DGF.D,)R0DGG@)\Z,:0SZ=U7_@F'X?N[SPPEEXZ
M\?:/H^@V&@V-[I5G<6PM=?\ [%NOM-@]R7A:0%7+!Q$Z"0$!A\HJ63_@FII?
M_"(ZCX?A^(OQ MM#MM:B\1>$K1)++'@>^CNGNEELV-N6D7S)'7R[DS+Y3%,8
MKY(FU/XB>*?C)XL\.?\ "W]3;6#\3O!=UH>CWFCQ2IX8LKC2K1S=PQ@AI(=[
M2Q!7/E^9$68%BX.QX^_;^^/6@^*OAMX>B\5^!-"EC2]6ZUCQ)&FEVWCJZM==
MN-.:V2,02E9#!#%*T=LT;[KD%24&* /I>?\ X)>^'M0F\(&]\<^.;Y/#VN-X
MHU(R&Q$_B'5FN!<&\DG6W$MLQ=51EM'A5H56,@J#FI\"O^"37@GX$7^M7%EX
MC\3ZD^L7&DR_Z3'8Q-"FFZF=1MU9X+>-YW,I*R33M)*ZXR^1FO&O$_QQ\5?
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M_P#9*O"__IHM:/\ @K%_RBR_:6_[)5XH_P#31=4?\$G?^467[-/_ &2KPO\
M^FBUH ^?_P#@UQ_Y04? S_N/_P#J0ZG7W_7P!_P:X_\ *"CX&?\ <?\ _4AU
M.OO^@ HHHH **** "BBB@ HHHH **** "BBB@ I-PR1TQ2TQOO'B@!_!&>#4
M31 G)%2@8&*BG? )% %34KE;>(DD#%<_X6T\^(/$DE_*";>Q8K$#R&D[G\!^
MIJUXJNG%OY<0+2RD(@]2>!6YHFEIHNEPVR$D1KRW=FZD_B:">I:HHHH*"FR=
MJ=39.U #:H>*H8KGPQJ4<X!@DM95D!Z;2AS^E7ZY7XY:^GA?X+^+=1D<(MIH
M]U(">F[RFP/Q.!30FSX3_9J\"6?Q'\(PV=PA,GD,BOWVG('Z4SX+_#N?PA"F
MFYFA%N[QMD8(=&VG/X#-=C^Q%IXM+:$<!8XD3I_LULMK$E_\2-:,BA6DU!U&
M!C!4L/Y 5T0D>95@K)G2>'=&N(V57=YCCJ>HKR7]IW5;3PC8V\]O>.+BWO8Y
MRD9+'"GD,>F#FNL^,'Q)N_#$5KIEG(8[S522TBG#10KU(]R>/SKA?%7@X>,_
M#TEH(V)"??QDDUM375G'B)+X4M=#:^$_QSM/$-X\TB.P< %0<#;C@8]:]ALO
M&MK,K@$VB&-5A\S&P>N2.F3ZU\B_#O1I/!VM2V]TCJL; 9S@'WKW;2;D_P!F
M>;$?/3;E@QR0*<H(FG7DM#UNZNU2RDE5O,13M#*<A@._YYJM#N?4+6Y!(#1L
M<?UKC_ _B\^&;F&WG83:/=N "6&;9CW!/\.>H_&O0]4A6'Q/!;*I\M;0DA1G
M)+>W;BLVK'3":FKE1=0CU,&(2AF]!VK-CU V.FKYC+&6<YY[UOV>A0K<AXP5
M+'G*$?TK)318M6BN%D*[8KB0#/ QFDFBFF<OKRHES%<KEBDHQ[?Y%2Z=*+^6
M2,'.URI],UJ:EH$7V"XB&=J@\A2?I2Z'9JPBD2(D2#<6.!DX_.DV7".IC_8I
M))99"2$^ZRG^ CK6=-,JW)@E?:D'S^8[ !E_Q%=1XIFM/#MO+/J-S!:P.NY
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MK9Q76N)I5]=HK&VO(GC>%CU1B1MR#QUQ7YQ_M!?\%BM _9?O[SP_+HUQ(;:
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M2:\UM\^Q\G_##X!^'O#?B6SU'X9>$KB\UN)"BZLLIALU4GEF<\$8X.T5]"?
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M:^'5[)JVO.?AWK^IZ]%%OB$>K&]OGU#[/<C9\\,-X8IHP,$/ AR><^<^%?\
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MQ_\ ]2'4Z^_Z^ /^#7'_ )04? S_ +C_ /ZD.IU]_P! !1110 4444 %%%%
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M=%<Y<?$VRMV*M;7I(]%3^K5&/BI8G_EUOORC_P#BZ .GHKF?^%J6/_/K??\
MD+_XNC_A:EC_ ,^M]_Y"_P#BZ .FHKF?^%J6/_/K??\ D+_XNC_A:EC_ ,^M
M]_Y"_P#BZ .FHKF?^%J6/_/K??\ D+_XNC_A:EC_ ,^M]_Y"_P#BZ +7C#X;
MZ'X^CC75]-M;TQ'*,Z NGT/6N$NOV*?AY>2[GTB?[V[:+N0+[\ ]Z['_ (6I
M8_\ /K??^0O_ (NC_A:EC_SZWW_D+_XNFI-;,EP3W0> ?@YX8^&-BEOH>BV%
M@B$L&2(%\GJ=QYKIJYG_ (6I8_\ /K??^0O_ (NC_A:EC_SZWW_D+_XNAN^X
MTK:(Z:BN9_X6I8_\^M]_Y"_^+H_X6I8_\^M]_P"0O_BZ0SIJ_)/]FKX]P?"_
MX9^#?&'PRU_Q%XZ^,5O9>+M2^('AE=<O-6M[JUM8[^2!M0@>206DRW,=DD(0
M1NXED50P)Q^HW_"U+'_GUOO_ "%_\75:P\=:+I4LSVNE2VSW#;I6BBA0RGU8
MAN3R>OK0!\'? +]L'X^_'OPCX-T6U^*'PP_M'QIXLETY?$NA6EOK[:9:#1+B
M_:&:&,QP).LT2JJLVX(V) 6Z\W\1/VZ/'GQWT/P+IGB/QIX;\$2ZE;>!K\>&
M8](D^V>.9[S58C>3VDID$D,4!MR-J!PHWB4X937Z*VGCO1=/0+;Z5+ JNT@$
M<4*@.W5N&ZGN>]*?'NC%XG.ES%H%*1GRH<Q@D$@?-P,@=/04 ?&MS\6/BYX^
MTSPEJFH^*[22Z\8_$/Q3H&A16.A&&3PW;V-EKT-N_$G^DS,UK Q,@V9X502#
M7FOP>_;$\>>!?V<O"FN2_$;3/%NL-\+-%;4_&NH:<94T"6YUJ.SO)[J&.39(
M]A&[M)OPY>(F0@;A7Z+CXCZ6NS&GW(\MBZ_)%\K'.2/GX)R>?<U'%XZT6&%X
MTTJ5(Y0RNJQ0A6#$E@1NY!))/KF@#YO_ &H_B=JK_P#!/+P]JUO\3&\7>'[_
M %W3++Q?X\\,PBR9]!;41%J%Y";9G$(6$,CRPD[%$CKMP"/$/CE^V-<?L_:I
MX/\ "'[-?C7P9%X!O_[0U;_A(O%?BHWFD7U]!-;1MHUM>7AEW(5E,I2!VDR[
M>7]UEK] H/B)I5K9+:Q:=<16R+L$2I"J!?3:'QCVJ'_A,M!-E!;'1V-M:L'A
MB\B#9$PZ%1NP",GD>M 'QK^SG?:E)_P4#T>.>?46A/C/XDAT:60Q8 T38,'C
M:"6V^F3C'-?9OQ6B,O\ 9N 2 [_^RU-;_$#2S.'2PG23+'=LB!R<9.=W? SZ
MXIVM7T7B46QCCD7RR?O%3UQZ$^E %_PRI6T3/85L51TFV,$"J>HJ]0 4444
M%%%% !1110!X!_P5B_Y19?M+?]DJ\4?^FBZH_P""3O\ RBR_9I_[)5X7_P#3
M1:T?\%8O^467[2W_ &2KQ1_Z:+JC_@D[_P HLOV:?^R5>%__ $T6M 'S_P#\
M&N/_ "@H^!G_ ''_ /U(=3K[_KX _P"#7'_E!1\#/^X__P"I#J=??] !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >"?MWZ
MBVH>'_#?AZ/!_M*_^U3#OLA7@?BSC\JRO _AH6VG0(5  45)\=RWBWX_F(L7
MAT6SB@4#HKN?,;\<%?RKK?#.E"-8P!Z"JV1F]SH/"^CBUA0J,8KLK)BUN,CY
ML50TJS"V@!QQ6G!'Y:@CM4EH\5_;._9F_P"%]>$K'5-,\J+Q1X9,D]BS?*+B
M-E^> GMG (/0,/<U\*?L\:5:V%D+ZZW3SESY@7!.<]R?QK]4T(60@9"GUK\S
M/C]X$O/V8/VEM8TB6,QZ!K4SZEI,FTB-XI&):,?[2,2I_#UKHH3^R>=CJ6TU
M\SU:T^)MGJ>HVFC0136CW>5\[@*0!D+^-=9;;M,C 6YD:)N&7T/J*\1TF^MM
M7T^.99&P&W#8?G4]CGM7H?A#XGV<=HT6KB=W"XBN(0N]3_M(V WYBM7&VQR4
MYWTD<C^T?ILG]L>']7A):6"Z^R,6&3M8;AC\1^M5_$E^XSYDX!( *GO[U<\3
M^(1K>I32WMP;B%+DS6D?E[1$ NU<@=QDGZGO7*^([UKQFC6-V+=&Z$D_2M(G
M/4M=M'9>!_$CZM\-EMHY-I626)L]E)Z8KSS5=6O_  ]\9[>^O97N(-3M5LF<
MG(#1\*"?=>A/]VI?"FM77A7Q1+H5W;36\5S:QW4$SJ=LJMGYQ_P($5%XM4ZO
MIMP6 6XB;) ZY!SD4TA-NR.BU&^*02V\S,()?NNHRH&:ZJ#X_:CI%J&NX8-8
M@>/RA,Z!9X2%P&WKR<<'FJ6B>!]3@\/P_P!H6[2VTELEREY"#)#Y;+G+=U('
M7/3%:%IX'A:Q*Q[)8I!N#*<BI;74TA":VT.QTUK'Q +&_M9WD-Q;@M<HWS2X
M'._^]SZU/X>U!-0N+EY84D6"=84(7&[@DD_IT]:\HM=3U#X:WSPVB/)939#P
ML?E4D_>7TKTC0EET?P/IUQ,"C:C?I(0>P;./Y5G*)TTY79T6KZC;_P!J"R*J
M85A+D*NTH22,^YX-<KX9LYSYUA*VYH6PKJ.)5[-^74>M7M?T^XCUVRO(V#QX
M:&7UP3E3^!R/QK>T#PGY4WGJN-QW<]#6;=D=$$VRQX?\-I;6XPIP??J:[_PU
MX0;2O#CSNI#71#+QSM Z_C6C\.?AG+JT27E_&8+93\D/>7W/M77^);$-!M
M &  , 5C)G9&.AX1\1](>XL)C&I\R+]XGU'(KZ/\'ZV/$?A33=0!R;RVCE/U
M*@G]:\<\5:.#(P(!W9%=_P#L_P!VTOPX@MG.6TZ:2V]\!LK^C"AE1W.UHHHJ
M2PHHHH ",C%5+O3EN." :MT4 8LWA:&5CE%(/M40\'P#^!3GVK?J.]7=9S#
M.4/&TMGCT'7Z4 8I\(0 X,:\>U)_PB,'_/-?RJ3X:VZVGP^T6)84MUCLXE$2
MVLEJL>%' BD)= /[K$D=":VZ ,#_ (1&#_GFOY4?\(C!_P \U_*M^B@# _X1
M&#_GFOY4?\(C!_SS7\JWZ* ,#_A$8/\ GFOY4?\ "(P?\\U_*M^B@# _X1&#
M_GFOY4?\(C!_SS7\JWZ* ,#_ (1&#_GFOY4?\(C!_P \U_*M^B@# _X1&#_G
MFOY4?\(C!_SS7\JWZ* ,#_A$8/\ GFOY4?\ "(P?\\U_*M^B@# _X1&#_GFO
MY4?\(C!_SS7\JWZ* ,#_ (1&#_GFOY4?\(C!_P \U_*M^B@##3PG G1%_*KE
MIHT=O@JH K0HH 1$""EHHH **** "BBB@ HHHH \ _X*Q?\ *++]I;_LE7BC
M_P!-%U1_P2=_Y19?LT_]DJ\+_P#IHM:/^"L7_*++]I;_ +)5XH_]-%U1_P $
MG?\ E%E^S3_V2KPO_P"FBUH ^?\ _@UQ_P"4%'P,_P"X_P#^I#J=??\ 7P!_
MP:X_\H*/@9_W'_\ U(=3K[_H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBFS/Y<3M_=!- 'SWIUN-9\?Z[?G+?:=1E(/^RK;1
M^BUZ+X?L0'CR#Q7#_#BUW6ZNW+2,SGZEB:])T*##J3@8ILS1TEM$%A48Z4Z:
M7RU!QBE0;57KC%0WI.5P.:18*Y?YL@XK@_VD/V;]"_:;\ -H^KKY-W;,9;"^
M109;.7'WAZJ> R]Q[@&N[MER>A.?RJRB#.1D8IIVU02BFK,_,OQ;\!?&'[./
MB!K'6K65K/?MAOXP7MKA<\%6['_9."*U=*TF37;=FB(1VZ]SCVK]&]2TNVUF
MSDMKNWANK>48>.5 Z-]0>#7FWB_]E/PMJ.DZ@VC:?#HNJSQ.;>>$L(HI<':Q
MCSM(SC(QTKHC7Z,\ZI@=;Q>A\=:3\-K@7 60RS G^(UIR>";;3'5[MEB1?F8
M DG\/>MF'2?''A76)=-\16E[%>1N5_=6F(Y!ZHZC#*?8UT6HZ((]-2YU&VNK
M.(L%$EQ T:LV.@)')K3G.6-)=C@]5\5PZE;^7;V\AAC'EC<#C Z8K!@\(3WJ
M2,L+2/-)M0 =<]!BO6]+^&,>N1H\*KY1^8.QP*ZC0_ D&@7"2E%DFB'RG&0G
MO2]HD4J#D[L@TE6^'-KH"QJC"R6*&Y1AN29=N'5AW!&16SX@_96N_#NKRR^%
M?*NM"NV\Q+%I DEGNYPA/#)Z G(''-9_B:R>\@<%3@<^U>^_#N4WG@G2)#DL
M;6,,3R<A=I_45E*36IV0IIZ,\6T?]DN[\3Z@LFK[=.M%^\ 1)*_L .!]375:
MG^S/<7^F+9_VC:&"(@QDQ,K)M/&.>U>NA .3R:6LW49O'#P2V/(+3]G*Y/[J
MZU&T,0^4F.)BQ'X\5W7AOX8:-X>,;+"US(@&&G;?SZXZ5T$PQV&*BC8^8/0T
MG)LTC"*V++CYL#&*SM:M_-C((R16EC&..M5=27,1X&34E,X'Q'I/F!OE%7/@
MB&L[O6K4C"%XYU^I4@_^@BK^K6VY"2 <U5^&L7D>+[X#.'ME/Y-_]>G<E;G=
MT444BPHHHH **^4/VDO^"P?PQ_9\\:7WAN"WUKQ7K6F2M;WB:=&B06TJG#1M
M)(1E@<@[0P!!&<UF?L\?\%H?AK\</'EEX<U'3=9\(7VIRK!:S7QCEM9)&.%1
MG4Y0DX ++C)ZBOFY<7Y-'$_5'B8\][6OI?M?:_S/T&GX5<73R_\ M2. J>QM
MS7LK\MKW4;\S5M;J.VI]A5%?<V4P(!&QNQ/;VY_+FI:BOL?8ILD ;&[D=O;G
M\J^D/SXQOA8%7X;Z$$5%06,6 B3(H&T=%F_>@>TGS>O-4_BWX2\0>+_#\4/A
MWQ?>>#;N"7S9+NVT^VO6F0*?W96=64#)!R,'BK?PKD67X;:$R.DB-8Q$,DLT
MJL-@Y#S 2L/=QN/?FMRXC,MO(@P"RD#\J /C?X<?%WXJ1_\ !.K7OC'JOQ&G
MUC69_!U]J-G9-H=C!;V%U&7V2J8XPSX\O&UR5.XY'2O4?VN?CCXC^%/["=YX
MUT;4X--\01V&FR_;Y;>.6. S36Z2R%'&PX61S@C K-\-_LH>)=,_X)GW7P@F
MN-*'BF?PQ>:.)5E<V8FE\W:=^W=M^<9.W/7BL3Q]\'/C-\>?V7M:^'OB7P[X
M!T)Q:Z;%I]Q8Z[/>I<FWNH'D$JO;IL!CC.,;LDX/'- %W]F3XY^*O&GQ\\3^
M$]/\?:/\6?"5IH":A#XIMM/@BCTG46E*"QD>V(AFS'B7"X=1P>"#69\"_CMX
MCOOVO-,\&:;\5M-^,&D3:1>W?BC[-IUI GA>XB>-8-DEOT\UV=/)<NRA-Q/.
M3Z#9_L]:Y\+/VEM8\5^ HM!T_P .>*_#KV^JZ5*SP6XU>!O]#NUCC7&&1FCE
M(P2J(>2*YCPQ\"OB!\0OVC_ WC7Q1X8\"^!H_ ZWKW$NA:A)>76O/<0&'RF)
MABVVX)\S#EF+(O QF@"/]L#XY:[X&^/_ (0\+7/CI_A3X,UW2YYD\3?V7#=1
MW6J+*JQV,DTZM# OEDR?, 7/RAAT/7/\88OA[\9=+TCQ+XTOKMM/^']UXAU$
MQ:;!#I5U%;SP++?EP6D23#\1+E-K,<Y J]^T?8?$7Q"+G1M \%_#[QIX6U>P
M,%Q!K^HRVS13DD9D00R++#C:<#:P(/L1X/JW[)?B+]F;X1+JMUJ::Y8>"/@M
MJWA.XFMK=KJ[FNY)HIU,4#@AX56-E 8YPJ@CK0![!\/_ -N>Q\>?$'3= ?P'
MX]T1=9T2?Q)87VHVUK%!<:?$%S-A9VD4DR1#8R!P94W!0<U!\+/^"A'A;XJZ
MIX,$/ASQMI&B_$#]QH6MZEIRP6-[="-I#; ARX?:CX8H(W*$*S<9\!_8VOX/
M#OQ&\+^'(_\ A%/&>K^*_!\^F0ZMHOB^]UV3PM;10))Y,T<ZE;:"238ORL&+
MJHP0HQ[5H7[*'B?3O@?^SOX<EGTHZA\*]1TV[U@B=S'(EO92P.(3MRQW.N,A
M<C/3I0!V.L?M>6?A;XD:9HFM>#?'&B:5K6KKH-AX@O+*)-/NKUR1''@2F=5D
M*D)(T01CCG!!-/\ 8W\>:UXYU'XPIK&I76HKH?Q&U+2[ 3$'[):QP6K)"F!P
MJEV('^T:\4U+]AGXC^)_B?H>J:S#H&J7^B>/8O$LWB>Z\07DUQ>Z>EVTL=K#
M9%/)MS'$P3 )4^6,'+$CWW]F[X.:W\&F^*,U\;"YE\6^--0\1Z<D,K8\B:&W
M2-)"5^5]T39QD $<F@#R[XA_M;^+/#W[85NEI-:?\*FT/6[#P1K685+OJM]"
M\J3"4C*K"[6D3+D#,_/MZE\4?VLM.^'WQ&G\*:9X7\7^-=:TVSBU+5H- LXY
M_P"R+61F6.24R2)N9MCE8H]\C!20O3/B"_\ !+=O&/[-WB#3_$GB?Q%'\1/%
M;7>M7TEGK]XNBIJ\TIGCD%KN$;I'((ADIDB//7&.LT?X5?&?X8?%75?&NAZ9
MX'U[5/B!H&DVGB"UO]5GMH]*U.RBDC,T3K"QFMV$K$KA'RON: -SX9_M;^(/
M'O[4WCSP+/X(U^TT+P]#8O::MY,*BV$T$TAEN TV[;(8U\L*FX<[PM6/V8?V
MK=%\<:%\-]"EU/Q)K6I>-O#<^O:=K&JV$%HVI)#*J2HZ0L4291(C;5&W;SG/
M%3>&_A-XY\%_M7>*?$T-MX>U+PS\0-*TV#4I_M<D%SI5Q9PSH?+B*,)4D,BX
MRZE<'.>_F>H?L4?$/P[^Q=\)]"\*:EX?T_XL?"Y=EI?2S2?8BDT4MO=1[PFX
MJT4NX?+]Z-/0&@#TZ/\ ;:M->\(#7/#'@'X@^+M-,]\@GTVQ@$316D[P/,KR
MS(K!GC8HBDNRC.T BN:\8?MXWDGQ0^$5OX.\'ZYXL\)_$K2;K51>6L4*S2*L
M2.B1B69-K1[LRAQP& 7)R*Y[XD?L1^)K!/!?A_0+32?$O@;P[X3&@QZ1?Z]>
M:5#9ZB'!.I2+;J?M.]<@HQ!!SC[Q(F\&_LG?$+X/>!OV?YM%A\-:UKGPHLKW
M2]5LI[Z2VM[N*ZA$9DAE\MCE"BMM9>02,YH ]&^(G[;OA[X>Z[XAB&@>+-9T
M7P7(L7B;7-.LTEL-"<HLA60EQ)(41U>00H_EJP+8Z5K2_M4:???&*Y\':%X=
M\2>)Y-*-G_;&I:;' UGI'VN/S(#(7E5W#1D.3$CA5()[@>'^-_V$]2L_BGX]
MO8O /@SXA:5X\U5M7CGU7Q!=Z;)ISRQHDT$\4:.DT(*%E*X8ARI' -=-\;/V
M9/%_C?XT:)J?A?P]X9\)W>BW.GK;>,=/UJ>"\73H61I[*>S6/9<!@'C19'*A
M7S\IR" ?3=%%% !1110 4444 %%%% !1110!X!_P5B_Y19?M+?\ 9*O%'_IH
MNJ/^"3O_ "BR_9I_[)5X7_\ 31:T?\%8O^467[2W_9*O%'_IHNJ/^"3O_*++
M]FG_ +)5X7_]-%K0!\__ /!KC_R@H^!G_<?_ /4AU.OO^O@#_@UQ_P"4%'P,
M_P"X_P#^I#J=??\ 0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'%4O 417Q7>-C@6X'_CU:>HK^[/M4'@>+&KWSGKL0?SHN3;4Z:BBB@H****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 ??]%? '_#@O_J]3]O_ /\ #O?_ ')1_P ."_\ J]3]O_\ \.]_]R4 ??\
M17P!_P ."_\ J]3]O_\ \.]_]R4?\."_^KU/V_\ _P .]_\ <E 'W_17P!_P
MX+_ZO4_;_P#_  [W_P!R4?\ #@O_ *O4_;__ /#O?_<E 'W_ $5\ ?\ #@O_
M *O4_;__ /#O?_<E'_#@O_J]3]O_ /\ #O?_ ')0!]_T5\ ?\."_^KU/V_\
M_P .]_\ <E'_  X+_P"KU/V__P#P[W_W)0!]_P!%? '_  X+_P"KU/V__P#P
M[W_W)1_PX+_ZO4_;_P#_  [W_P!R4 ??]%? '_#@O_J]3]O_ /\ #O?_ ')1
M_P ."_\ J]3]O_\ \.]_]R4 ??\ 17P!_P ."_\ J]3]O_\ \.]_]R4?\."_
M^KU/V_\ _P .]_\ <E 'W_17P!_PX+_ZO4_;_P#_  [W_P!R4?\ #@O_ *O4
M_;__ /#O?_<E 'W_ $5\ ?\ #@O_ *O4_;__ /#O?_<E'_#@O_J]3]O_ /\
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M_P!%? '_  X+_P"KU/V__P#P[W_W)1_PX+_ZO4_;_P#_  [W_P!R4 ??]%?
M'_#@O_J]3]O_ /\ #O?_ ')1_P ."_\ J]3]O_\ \.]_]R4 ??\ 17P!_P .
M"_\ J]3]O_\ \.]_]R4?\."_^KU/V_\ _P .]_\ <E 'W_17P!_PX+_ZO4_;
M_P#_  [W_P!R4?\ #@O_ *O4_;__ /#O?_<E 'W_ $5\ ?\ #@O_ *O4_;__
M /#O?_<E'_#@O_J]3]O_ /\ #O?_ ')0!]_T5\ ?\."_^KU/V_\ _P .]_\
M<E'_  X+_P"KU/V__P#P[W_W)0!]_P!%? '_  X+_P"KU/V__P#P[W_W)1_P
MX+_ZO4_;_P#_  [W_P!R4 ??]%? '_#@O_J]3]O_ /\ #O?_ ')1_P ."_\
MJ]3]O_\ \.]_]R4 ??\ 17P!_P ."_\ J]3]O_\ \.]_]R4?\."_^KU/V_\
M_P .]_\ <E 'W_17P!_PX+_ZO4_;_P#_  [W_P!R4?\ #@O_ *O4_;__ /#O
M?_<E 'W_ $5\ ?\ #@O_ *O4_;__ /#O?_<E'_#@O_J]3]O_ /\ #O?_ ')0
M!]_T5\ ?\."_^KU/V_\ _P .]_\ <E'_  X+_P"KU/V__P#P[W_W)0!] ?\
M!6+_ )19?M+?]DJ\4?\ IHNJ/^"3O_*++]FG_LE7A?\ ]-%K7S?XL_X-W]*\
M>^%=3T+7?VPOV[]:T36K26PU#3[_ .*R7-I?V\J%)898GLRDD;HS*R,"&!((
M(-?</P ^#&D_LW_ ?P3\.] EOI]"\!:!8^'-.DO9%DN9+:SMX[>)I6555I"D
M:EB%4$YP .* .NHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>j4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" &" U # 2(  A$! Q$!_\0
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MT\]MNZ",7*<::U<G9>;[>OEO]S/H^BOS[\'?\'&GPL^+_P (O#OB[X9_!_\
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MO?6SM K^7%@ ?.[QB$"7]PJ*QA#DC04=Z45!>:M9W]=]+-/KO?:53FG7F_\
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MO(X89GB\NZBBD.([B%MP4J=^ <@@>OUF:!1110 4444 %%%% !1110 4444
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M\OAO28-"TN?7_"MCJL]A80;O)M8Y+B)W6)"[D(#@%V/4DGX!_P"#CS_@GM\
MO@=_P1C^,OBGP3\#O@_X/\3Z7_8GV/5]$\&Z=I]_:>9KNGQ2>7/#"LB;HW=#
MM(RKL#P2*_5ZO@#_ (.CO^4%'QS_ .X!_P"I#IE$YRDW*3NV$(J*48JR1X!_
MP94_\HLO'W_95=1_]-&CU^OU?D#_ ,&5/_*++Q]_V574?_31H]?K]4E!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 >0?MJ_MZ_";_@G=\+-/\;?&/Q7_P (?X8U358]$M;S^S+S4/-O)(9IDB\N
MUBED&8[>9MQ4*-F"<D _+_\ Q%&_L)_]%S_\LSQ#_P#(-> ?\'JW_*++P#_V
M573O_31K%>I5]'P_P_\ VG[3]YR<ENE[WOYKL<>+Q?L+:7N=;_Q%&_L)_P#1
M<_\ RS/$/_R#1_Q%&_L)_P#1<_\ RS/$/_R#7)45]'_Q#_\ ZB/_ "3_ .V.
M/^UO[GX_\ ZW_B*-_83_ .BY_P#EF>(?_D&OH#]AC_@J/\"?^"E'_"4_\*4\
M=?\ ":?\(7]D_MG_ (DNH:=]C^U>?Y'_ !]P1;]WV>;[F[&SG&5S\I5X/_P:
MN?\ )]?_  4,_P"Q\L/_ $X>(:\'/^&_[-IPG[3FYG;:WZLZL)C?;-KEM;S/
MVDHHHKY<[CYC\"?\%?O@?\5K74KGPA<_%7QC8Z1J,^DW=[X>^$7B[5[.&[@;
M;+#Y]MICQET.,@,>H/0BNK^''_!1WX/?$OXJ6?@:/Q)JOA;QIJD:RZ9H7C3P
MUJO@_4=:4E^;*#5;:V>\V^6^[[.)-F/FQD9^4_\ @V'_ .3&_B3_ -E@\3_^
MC8:?_P '+NO>'?'_ .PDGPCTE[;6_CQXXU_2)/AIX>L)%DUXZA%?(S7UNBD2
M0QQ6Z70>Y^6- S*S#=@Y0J/V="4E=U%2;2WO4C%M1OVYM$]TM6MU<(*=2K!/
ME495%=[)0E)7EY66KZ7ND[6?VQ^TA^U7\/OV1_!=KK_Q#\36GAZQU&]BTS3H
MC%+=7VKWDK!8[6SM(%>XNIV/2*"-W(!.W )'&_#[_@I%\(?B%\6])\!C7/$7
MA7QCXAADGT;2?&?A#6?"%SK@C*B1;(:K:6WVMTW*62#>ZJ=Q  )KXL_;':]^
M#'_!<?\ 8F\5?%G4(8O!T7@[5/#EIK5Y<B+2K?Q3+;.K9:3Y4EG4QK'N(9SM
M )*$5T'_  <FZI!XH^$7P*\!^%YX9_C5K_Q6T2_\#V5JIEU2%[:1VN+V)4^=
M(848>9+PJAADC(K>$??I)NZG4Y-.G[SV=_N_>6LO=:77F,)3?).25G&GSZ_X
M.>UO6\+W^)/32S_2>BA<A0"03WP,"BI+3"BBB@84444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'SA_P5 _X)?^ /^"LOP"T?X<_$;5_&&BZ)
MHOB"'Q)!/X;NK:VNWN(K:YMU1FG@F0QE+J0D! <A?F !!^:O^(:/P=_T=1^V
MU_X<N#_Y"K[E^.G[6/PL_9?_ +*_X69\2_A_\._[<\W^S?\ A)_$-GI']H>5
ML\WR?M$B>9L\V/=MSM\Q,XW#/G__  ]B_98_Z.6_9_\ _#AZ1_\ )%:TZU2G
M?DDU?L[$RBGNCY:_XAH_!W_1U'[;7_ARX/\ Y"H_XAH_!W_1U'[;7_ARX/\
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M--6BNO$7AF&2'[3+:PZE;10^;;!S!#%+A9!%.$(C&V->&_X*.?\ !/3X&_\
M!.7_ ((Y_ ']I'X#ZKK'@CXW7TNA3VWBW2_%EW)=ZW+=:?*]VJJ)C"H!WDB!
M$ 5"C95F!Z*S5*51SOR0E3A?JW42:=KVM9J_O>EU9OGIMU%",?BG&<DNEH-I
MIO>[:>G+I^"_I#KX _X.CO\ E!1\<_\ N ?^I#IE<G^TW_P6<_:%_9<T+X1V
M>@_L9?%#X[77C'X<Z/XIUS6O#?VZ&TTS4[D2K<6#)!IMRBR(8ED(+JP$ZC8
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M<Z].DD[[JVDKII)1?V9-R5F]-&GNC:%U3J3TLEK?X;-I-R76*3U2U['Z@?\
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M[??P)\"_&O\ X1;]D"\^&7BS[?\ \2;^TO$>@:\_V>XN;+_7^5?P18N(-_\
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MD#_P;B?\I3?^"G'_ &55/_3OXDK]?J_('_@W$_Y2F_\ !3C_ +*JG_IW\24
M?K]1110 4444 %%%% !1110 4444 > ?\%8O^467[2W_ &2KQ1_Z:+JOG_\
MX-<?^4%'P,_[C_\ ZD.IU] ?\%8O^467[2W_ &2KQ1_Z:+JOG_\ X-<?^4%'
MP,_[C_\ ZD.IT ??]%%% !7Y _L;_P#*Y)^UC_V2JQ_])?"E?K]7Y _L;_\
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MSP?\,"?MV?\ 1HO_ )E/P]_\>KZ]_P"#9?\ X)U_';]AWXD_M-^(?C7\/?\
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M>3A::@YI.[OK);2?*E=>5DEII=/?=E%%%<IUA1110 5\ ?\ !T=_R@H^.?\
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M4 %%%% '@'_!6+_E%E^TM_V2KQ1_Z:+JOG__ (-<?^4%'P,_[C__ *D.IU]
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MU;PGKEC:ZSK:65II=[9^'Q"DQA>TN$G;9?2;=X 1@& W!67^B.OQ%_X*,?\
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M4M!8:3:7FJW>J26=NI)2$3W4LLQCC!V(C.1'&J(@5$51V%%% !1110 4444
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M*^L;J(DQW,$J!XY%SV96!'L:^$/^#H[_ )04?'/_ +@'_J0Z96)^V1_P;(?
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M2OO#_@Z._P"4%'QS_P"X!_ZD.F5^'<1_\C*MZGT^#_@Q]#^;/]A'_DD6I?\
M88E_]$P5[77BG["/_)(M2_[#$O\ Z)@KVNO]#?"7_DC\O_Z]K\V?"9K_ +W4
M]3Q3]N[_ ))%IO\ V&(O_1,]?TF?\&N/_*"CX&?]Q_\ ]2'4Z_FS_;N_Y)%I
MO_88B_\ 1,]?TF?\&N/_ "@H^!G_ ''_ /U(=3K^2?I#_P#)83_Z]T_R9]3D
M'^Z+U9]_T445^&GMA1110 4444 %%%% !17RA^UY<_MRS_&6=/@)9?LGVOP]
MAM(4AE\?WGB"?6;RXP6FD9+*)(8(P2$6,-*2(S(7'F>5'\0?\$O_ /@J!_P4
M/_X*R_ +6/B-\.='_8PT71-%\03>&YX/$EKXEMKM[B*VMKAG58)YD,92ZC )
M<'(;Y0 "0#]CJ*** ./^/WP!\&_M2_!KQ#\/?B%X>T_Q5X-\56ALM3TR\4F.
MX3(96#*0\<B.JNDB%9(Y$1T9756'X(_M+?\ !&;]FSX?_P#!RW^SU^S]I'PW
M^Q_"+QS\/[O6];T'_A(-4D^VWB0>('67[2UR;E,-8VIVI*J_NNGS-N_H>K\@
M?VR/^5R3]D[_ +)5??\ I+XKH _0_P#8A_X)O?!+_@G#X5US1O@MX!T_P59^
M)KM+W5)$N[F^N[YXTV1K)<74DLQCC!<I'O\ +0RRLJAI'+>WT44 %%%% !11
M10 4444 %%%% !7Y _\ !N)_RE-_X*<?]E53_P!._B2OU^K\@?\ @W$_Y2F_
M\%./^RJI_P"G?Q)0!^OU%%% !1110 4444 %%<!\=/VL?A9^R_\ V5_PLSXE
M_#_X=_VYYO\ 9O\ PD_B&STC^T/*V>;Y/VB1/,V>;'NVYV^8F<;AGS__ (>Q
M?LL?]'+?L_\ _AP](_\ DB@#X _X,J?^467C[_LJNH_^FC1Z_7ZOPQ_X-%/V
MW?@O^S7_ ,$V_&^A?$;XO?"_P!K=W\2K^_@T_P 2>*K'2KN:W;2]*19EBGE1
MVC+QR*' P3&PSE3C];_A;_P4)^ 7QQ\=V'A;P3\<?@_XP\3ZIYGV/2-$\9:=
MJ%_=^7&TLGEP0S-(^V-'<[0<*C$\ F@#U^BBB@ HHHH **** "BBB@ HHHH
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M\3_-GSC_ ,% ?^92_P"WS_VA7]=__!)W_E%E^S3_ -DJ\+_^FBUK^1#_ (*
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ME;B])335FFM5^!Y]?-,+1FZ=25FO)_Y']C]%?QV_%O\ :A_:G^%OP]U#7O\
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M37[A_P#!6+_E%E^TM_V2KQ1_Z:+JOQI_X*5_\I3?^">W_95;;_T[Z%7[+?\
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M\E_8%_Y,4^"O_8AZ'_Z;X*]:K^@\%_N]/_"OR/DJGQOU/SQ_X.6_^3%/"?\
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M?49SM;IGI7]&G_!/;_@X\_8Q^!W[ OP.\$^*?C+_ &7XG\'_  _T'1-7L_\
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MV?\ _P -YI'_ ,CT ?/_ /Q%&_L)_P#1<_\ RS/$/_R#1_Q%&_L)_P#1<_\
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M^%O@SPE?:9K&M_V+J)^QW$EGK<:)]G$'GOE[NW&4C8#S,D@*Q'UI_P %ZO\
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M*W_"->-_#7]K_P!I:;_PC.L7GV;S]8OKF+][;VDD3;H9HV^5SC=@X(('Z?\
M_#IW]EC_ *-I_9__ /#>:1_\CT?\.G?V6/\ HVG]G_\ \-YI'_R/7YWQGQAC
M.)<R>:8^,8S:4;034;1VTE*3O\ST,'A(8:G[*#;7F?/_ /Q%&_L)_P#1<_\
MRS/$/_R#1_Q%&_L)_P#1<_\ RS/$/_R#7T!_PZ=_98_Z-I_9_P#_  WFD?\
MR/1_PZ=_98_Z-I_9_P#_  WFD?\ R/7RAU'S_P#\11O["?\ T7/_ ,LSQ#_\
M@T?\11O["?\ T7/_ ,LSQ#_\@U] ?\.G?V6/^C:?V?\ _P -YI'_ ,CT?\.G
M?V6/^C:?V?\ _P -YI'_ ,CT ?/_ /Q%&_L)_P#1<_\ RS/$/_R#1_Q%&_L)
M_P#1<_\ RS/$/_R#7T!_PZ=_98_Z-I_9_P#_  WFD?\ R/1_PZ=_98_Z-I_9
M_P#_  WFD?\ R/0!\_\ _$4;^PG_ -%S_P#+,\0__(-?G!_P= ?\%F/V;/\
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M/_R#7T!_PZ=_98_Z-I_9_P#_  WFD?\ R/1_PZ=_98_Z-I_9_P#_  WFD?\
MR/7QAV'S_P#\11O["?\ T7/_ ,LSQ#_\@T?\11O["?\ T7/_ ,LSQ#_\@U]
M?\.G?V6/^C:?V?\ _P -YI'_ ,CT?\.G?V6/^C:?V?\ _P -YI'_ ,CT ?/_
M /Q%&_L)_P#1<_\ RS/$/_R#1_Q%&_L)_P#1<_\ RS/$/_R#7T!_PZ=_98_Z
M-I_9_P#_  WFD?\ R/1_PZ=_98_Z-I_9_P#_  WFD?\ R/0!\_\ _$4;^PG_
M -%S_P#+,\0__(-?('_!>K_@O5^R=^VC_P $GOBM\,_AG\5O^$E\;^)?[(_L
MW3?^$9UBS^T^1K%C<R_O;BTCB7;##(WS.,[<#)(!_3__ (=._LL?]&T_L_\
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MV\"$+\[@/('*)\[A"H*D[A\"_'7XJ_#[_@KS_P %D?BQ^R/\<O$WB#PYX!\
M:-%;>$?"5AJKZ3'XNU9X$GN+^>1"#<3VRO');6[;H]L;R&-\.#X;_P $N_\
M@F%XF_91_P""V^H_LS^*?%&N?$CX(_"F)?C!X=LQ=*NGZ?JC8M].N;V':0ER
MJRS?NT9 [Q1S8*KMK*E"6(C!7Y%43E%[WC%MR]).$92BO\-W%M\NE2<:$I-K
MF=-I26VK2Y>]X\SC&3TM[UD[+F^A_@'^U]/_ ,'+_P"R!!I7P^_:%\<?LO\
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M\M_V@_\ @[H^!OQ"^%*Z3\*]>\1^"/%6NZW+HLVN^)O#$ER/#6GK$7?6(+6
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M[/NN?$OXEZY%HGAK1$P ,/<ZA.P/EVMO'D&6>0@A5'H6)559A^*7[9EUI/\
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M ()0Z#J,?PVT?4-3\1ZN76\\4^(6M[S7)8&*'[*)XX8EC@!1#Y<:*&959MS
M$?1&C?!+P=X=^*VM>.]/\+:!9>-/$=I!8:IKD%C''J&H009\J*68#>ZIG@$G
M@*.BC'445I.I*33D]E9>2V,XP44TEOJ_OO\ F%%%%04%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/I7)Z%_P5%_9F\4:W9Z9IG[17P*U'4M1G2UM+2U\>Z5-/=2NP5(T19RS.S$
M* 220!0DVU%;L&TDWT1[K16)\1_B9X;^#O@K4/$OB[Q!H?A7PYI*"2]U76+Z
M*QLK-2P4-)-*RH@+,HRQ') [U1\)_''P5X]^%8\=Z%XP\+:UX(:VEO!XAL-5
M@N=*,$182R_:48Q;$*/N;=A=C9(P:ER23?;?R]2DG=+OMYG4T$!@00"#U%>;
MZ!^V5\(/%GP>U3XAZ5\5OAMJ?@#1)3!J/B:U\364VCV$@* I-=K(88V!DCX9
M@?G7U&><\3?\%*OV<_!<6F/K/Q^^">DIK=DFIZ<U[XXTRW%_:.S*EQ$7G'F1
M,R. ZY4E& /!HDOLR_JZNOO6OH).^J_JV_W-H]3^'_P]T'X3^#-.\.>%]%TO
MP]X?TB$066G:=:I;6MI&"3M2- %49)/ ZDFMBL_PEXNTGQ_X6TW7=!U33M;T
M36+:.]L-0L+E+FUOH)%#QRQ2H2KQLI#*RD@@@@D5H5<DTVI;B335T%%%%2,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-,U/]L;0?V7-%OIC?V_QT^(;'6-2$=M*I%QI0='"O*Z"-#!)'\F[SC_#J_\
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04 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>j5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" %2 T0# 2(  A$! Q$!_\0
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MZ!<W DNOA]H-GXML?%]I!(6"Q'4+FU.EF6'*EW5F60*P0 L-O[U?!3XMZ/\
M'WX.^%/'/AZ26;0?&6D6NMZ>\BA7:WN(5FC+ $X.UQD9/-;JE)P=2VB=GY.U
M_3OJKK1ZZ&+J14U"^K5UZ7M_EH[/5'345_//^T#^P)\0_AW^WUX_\4_ME_LK
M_&/]LWPAXTUN5/"OBWP!XEU&^D\,:6AGG2V@TFRDCDC0M<1(8[B2")#'(8C)
MRS_5_P#P;;?%OX>Z+X?^+W@OX;_';QSXIT/0IIM1TGX1>/\ PU)I?B#X7PI<
MW,9@\\W4R7,1Q&)%@(6-]K.L4DS*V%*HI475GI:/,TM;62;36DDU?7W7&ZU=
MFF]:\'"IRK5<RBGM>[LFGJK775I[63>A^M-%?"'_  0!_P""H/C_ /X*J_LB
M>,/'_P 0]'\'Z-K/A[QA=>'[>'P[:W-O;/;Q6EI,K.L\\S&0M.X)# 8"\ Y)
M_,G]MG_@J/\ $#_@JQ_P;G_&OQA\0]'\':-J?A?XGZ7H%K%X=M+FW@D@1[:4
M,XGGF8R;I6&0P& ..Y,2Y46U:[2A)_X:DHQ3]?>6AI1I<]W>UG*/SBINW_DC
MU/Z):*_&;Q;_ ,%(?VX/^"=?_!/'X7?&K7?A9^SWJ7P'T?1?#MG<>'[76=3F
M\8VVGR6L,$<\UU\MDC2OL.8HIC%]HC4HX1W&C_P5Y_:U\&_%7]K'_@FWXPL_
MASX7\8:=\4_$-CJ^AZEXAFU6VU'P['<W>CR1RP)9WL$)F E1B+F.=-T2C:5W
M!NQX>^)C0B[WJ*F^Z;3:NN[2VNEOJ<=*MS4?:R5KTW475-+?7R=M;=;I,_8B
MBOQ)_;<_X.F_$/@S]M#Q]\,OAI?_  +^'.@_#34)M&N];^*FG>)=3?Q'>12&
M*;[+#HEO(;=(Y$D7]_GS%V,"I)0==\(/^#LGP]J__!.'X@_%3Q+X'T_4/B+\
M.-=T_P ,'1]$U&:#2?%%Q>)*T%[;27$7GVUNZVMW)Y4L;R(L*@EF8[>*G54Z
M'UB.JLGYM-J*^]M63UUO:U[=4Z4H5?8RWO;T=KN_HD[O:ZM>]D_V(HK\Y?A7
M^T;_ ,%*=!'P_P#%WC7X*_LZ^//!7B8V\NM^'/ VLWFF>*M!MIH?,,KR:E<B
MR=X20&BB>4R,-JLJGS5^.O\ @IW\3?VLYO\ @Y"^"/A'PWKWPM%VMC/K/PWT
M/5;W6?\ A&4@,.J1?:M7MXVR-1\L7*&2V7&T0KG&X5NZ<E7A0DM9-KT:5WIU
MTVMH[/71VR4DZ,ZT7=1CS>33=EKT7?JKK35'[OT5^(?[7/\ P<F_&SX*?MA>
M-?A3,W[-GP6N_AY+;Z3<GXE:7XMU&3Q-<E2SW]DVE6[K!92*8WC6XPWER(_F
M-N8)^BO_  2'_;A\;?MX_LN3^)OB%H?P[T;Q7HVJR:1>R>!_&>G>)]%U!EBB
ME$T4EE<W(MB1* ;>:5I% 5B2'&%2C[2#JP=XVO?NG977WK3=7U2UL5'[.:IS
M5GM;SM?]'KMYZJ_U/17Y2?\ !PU\;-9^-G[3O[-7[&ND:K=Z-H/QWU^*Z\;S
MVDOE7-SI$5PBBU5L\))MG9ACDPQCD;E;Z_\ VS_V9_C9\0_ GA'X=? 3XD>$
M_@)\/[33IK'7-6M-#:_UZQMXHXX[6TTN(LEO AC\U6F)$D6V)HN0:P=7_9WB
M4M.:45_VZO>;[)-V6[=G9;7N:4:JI-Z\JD_^WF^5+NVE?=)75WJ[?3E%?AG_
M ,&R/QFU7X#?\$:OVLOB%:O)JVM^#M?U[Q!$][*9'O+BVT:&<&5SDL6= 6)S
MG)KQ7]GS_@F_X'_:F_X(*?$?]LOQSJWCC6_VFBNL^,K/QX_B.\CU#3;G3)RM
MO'$J2"+8!: !F0R)YA",@2,)I7?LG-R^&%.%23Z^^DTDNMO>O=K9=796J,KQ
M@_BE4G37:\+W;?1;6LGOY:_T;45^9'[('BS]JG_@I]_P2=^ .K^%/C'X>^%;
M^)=!OK?QWXP&C/J?BB[:VG>T@^PJS+!$\Z1RM-.S"2-RCQ8.17F/_!F;//=?
ML0?&*6ZN;F]N9/B9<M+<7$ADFG<V-H6=V/+,QR23R22:Z'0:KUJ#=O9IOU]]
M0^2=VU=WTVLTSEA54Z%.O':32]&XRE;S:Y=;::[[H_86BN'_ &E_B]=_ ']G
MWQEXVL=%@\17GA;2;C4HM.GUFTT6"Z:-"P66]NW2WMHN,O-(VU$#-AB I_#C
MXQ?\'57Q[_9F\0>'+WQ/)^QWXY@U*ZBGU'P5X$U;6-5UO3;*0R'9)K$+SZ.)
ME"!6,,L[!G4^3@G;S0DI5516[M^+:7Y.]KV2N[:7Z'3ER<]N_P"%K^FZM>UV
M]+ZV_?\ HK\O_P!O?_@L9\?O@]_P58^%W[.OP8^'WPW\7CXJ>#HM7L3XBFNK
M.>PO)A>XN)KB*4I]DMTMUFDB6$RR)'(B.'="(_@O_P %8_VGO@A_P5P\"_LO
M?M,^#O@A=-\2]#DU71];^&\NI1Q6FU+IPT@OG9I%S9RQE-D9!96#.!M.D(\S
M2>EW)*^FL.;F7RY7KMY[VRJ248N>Z48R=ND96:?IKZ^1^HE%?E)^R?\ \%=/
MVN/^"J/Q.^('B']FOX=? 72O@M\/==711+\0]0U6/6?$K(S/)]GDM 8[=W@\
MIMLL++$TZ_/-A@OF7_!GO<:C=WO[7$NKZ8^BZM+XYM7O=/:43-83DWQDA+@
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M\)M+DUGX9K\(527X?:WH%PWVSPQ<11;8GRY+3H66-Y SK([(&$J/\X\BU/\
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MP$5/4O\ @G1_P1DT[]C#XW?$#XQ>/OB9XF^-WQQ^)\$ECKOBO4[2/2[9;1Y
MY@MK*)G6%2(X%(\QE5;>-8EA3*'[7HJ()1CRK^5QUU?*]&DW=I-*UETTVT+J
M2<VW+JU)VTNUJF[;N^OKKN?EU^SQ_P &]7Q/_8OOO%OA?X+?MC^-?A[\&/&V
ML-J&I^%4\$:;J&JB*2-8IU@U29R8)VB7:L\5NI7;&Q1V0$X_@W_@V!B\%_\
M!+CXC?LSP?&^:>#QYXUMO%T?B*7PB#)8+"L"BV:W%Z!*Q$/,@D3EON<<_J[1
M2<4XN+UNHK75M1<913>[LXJVO=;-WIU)<W-YM^5Y)INVVJD[_P# 5ORV^(/_
M  ;O?$[XU?"/PK\&?'7[97CSQ+^SIX7DL0G@O_A#-.M=3N(+6/$<#ZM&_F.B
MO\R"6*14"QC:S1HX\0_;Q^$WB_\ :Y_X*G?L=?#CX0_L\_&GPE\/OV6O%RV5
M[XB\0>%Y].\,MIUE=6#+)97KLZS0B"P<([E6E)C"ARV:_;BBMZ5:<:\*][\L
MN>W\TTK)R>[LKK5]7:QC*G%TI4UI>/(G_+%[I+97_0_/'XC?\$-?%_P]_:_\
M=?&+]F']H_Q!^SKJWQ59KCQCI+>$K+Q5I>IW1<.)X8+J1%A8N9G)82,&GD"-
M&C%#U]Q_P0_\,_%G_@G[K?P-^-7Q6^+7QGO_ !-?1ZS?^+]=UV:2_L;^,?NY
M-.AF>:*SA7+@0@.")'#,_&/M^BN9TH^R]BU[MDEY).Z2>ZL[-6:M96V1LZDG
M5]M?WKW?F[6NULVUHV[WUONS\XO!/_!&;]I.ZL_!'ACQ]^WY\5-<^&G@QH0-
M'\*>&+?P?K-_#! T4,,NL6UR]TZ?=\SS?,,@!.5DVR+U?_!1W_@BWKG[8G[8
M_P +OCW\-/C?J?P5^)OPOTJ31[74'\-0^)H9X=TIC817$T:AP+FY5C)YH<2+
MPI7+?>5?DO\ \%EO^#@KXD_\$M_^"DO@GX;Z3X#\,^,OAM?>&[?Q)XA5;.Z?
MQ EOY]VMTUM*LXA41PV_F?O(6'RON90=RW4J\U6GSNTG)M/;WN5WDWO\*=V[
MV04Z;5.HX+W5&S73ENM$MMVM%Y=D=O\ 'C_@@_\ &'XL:C=_9/VQ?$>JZ)X@
MBM;S7?#_ ,2?A]IOQ&T5M6B\S?=Z=9ZI*\.FPL9&*P1*QC!*B0H$1/<_^"17
M_!'_ ,*?\$F_ 7BZWTKQ+?\ C#Q;\0[]-2\2:LVFV^D6$LL9E\N.ST^W'E6D
M"B5\1JSX+$ A B)XI_P6A_X+B:U^Q=^P3\(OC?\  1? 7CC2/BCKL-E;W.N6
MUS=6K6DEI<3958+B%DF5X@C*S':0ZE0PX]F_:4_X+V?LI?L;?%_4/A[\4/BH
MOACQOHT-M+J&G#PSK%X+?SX(YX_WMO:R1-F.1&^5SC.#@@BM8MTU./POF<&M
MG=*,FO17CHM-$NB,9153V<OB3CSIZM6ORW?G=[O77>[/(/\ @O%^Q?XU\1?$
M_P" G[4'PM\-ZQXR\;?L\^)(+K4_#FDP-<:AKNBR3QM.EM$OS2S(5;$:\LLT
MAYV@']$?#FO0>-/"ECJ=M%?VUMJMJES%'?64MG=1+(@8++!,JR1. <,DBJRG
M((!!%?-/['__  6F_9N_;_\ B#JOA#X,?$";QYXKTC2)M;ETN+0-2TZ1[:)X
MXV*R7MO!#DR2Q* 7!R^>@)'P]^VM_P %F_VTOV&_#$GC_P"(W@7]D_X>:--J
M4!TWX4:KXNNM3^(^KV#7,4#/;/9S-:39+.?-6,B, EHV*[6P4%&G]5FK1FW)
M7NE[]HM+O=QO:-VGS-[JVDE[27MXZN*47WM&\DWVLG:[LK.*Z:_7'_!(?_@C
MY8_\$N?V;?'_ ,-M3\:Q?$_3?'^NW&KW<DNA?V4B13VT5N]LT?VB?>"L9RVY
M<[\8XR?GEO\ @VU\;>#?A-XH^"G@']KGQQX2_9D\7ZG]LO\ P!-X1L=2U!+>
M1XGN;6'5WD66))&C. L00!SYB3%I#)T__!0K_@MG\4?@?+^S#X$^&OPIT70?
MBY^TU;6EQ;Q?$JYGL]+\(22O;(UI=)%Y4LLRM.RLJNCH53]U(\@BK2_8&_X*
MN_''Q%_P5"\8_LF?M#>#_A?+XXT/0T\0VOB+X:7%Z^CPPF&"7R;B*\9IE8B=
M0'.S#;5\ME=9*V5-U:C;6MI0Z6DJ25X]I<EKZWV;5[ZDZ[2Y[[M5/.+J/27>
M+DWTMNKV2T^YOV=OV>/"W[*WP#\+_#7P38?V7X6\'Z;'I>G0%M[B-!R[MQND
M=BSNW\3,Q[U\Y_\ !&3_ ()._P##HOX&^,/!?_"??\+"_P"$L\2R>(OMG]A_
MV3]EWP0Q>3L^T3[\>5G=N'WL;>,GM/\ @J__ ,%#+7_@EY^Q1XC^+USX5OO&
M<FCW%K96VEV]Q]E26:XF6)&EFV/Y40)R6V-D[5 RP-?"'P__ ."JG[>WBC]F
M'2OCGX;\'_LC?'WP3;RV+Z[X.^%&H:UJ?C"R6X6-WM&"23PQ7<2RIYBJLS1Y
M+>6R@D3"NYU:M6^KM&;_ ,34DG\[-M+U>M@]ER4X44M'K&/5\J<=/DVDKZ_+
M3]&/^"@_[%FA_P#!0[]CSQM\'O$6J:GHFF^,;6.+[?8$&:SFBF2>&3:>)%66
M)"R$C<H(RI(8?GC\0/\ @V+^(7QK_8FT;X&^-_VOM;U;PCX$GM)_!.G:=\-M
M,TG2]%>(2K*]U#%-Y]](\<KA'>Y0H[R.WFER!]U_&#_@J+\*/V7OV5_ WQ;^
M,=YXC^$NA>.OLL$%AK_AV_;5-/O)X&F^QW-M!#))%*@CD#;E"@I][D9ZO]L;
M]O/X3_L _"73_'7Q<\5_\(EX5U348M)MKW^S+R_\VYECDE2/R[6*6092*0[B
MH4;<$@D S*E[-R7>44]=.>+7+Y<RNK6ULUT:*A4E-0Y>TG'37E:]Y][::]--
M3Y]UK_@CO?\ BK_@J+\%/VG-4^)]O-J7PE\')X7NM#@\,F&+7)1:WL#W2S&[
M8VZEKPN(BDN!'MWG.X;7[0G_  28'QX_X*W_  B_:F/CX:6/A7H3Z*?"_P#8
M?G_VIN%]^\^U_:%\K_C]^[Y+_P"KZ_-\OB7[4/\ P7M'[(?_  6(T_X0>/-1
M^'OA?X"GP)_PEE]XDO[2\_MA93;3RQQ1%9BLA=HT584MVE<MM7+$5]4?L2_\
M%:?V=O\ @HMKFKZ5\'/B=I/B[6-#A%S>:<]G=Z9?+"2%,R07<44DD2LRJTD:
MLJLZ!B"R@ZQE*HXU%JXN<EILW*:FVO.3GH]+/2RM;!RBHRIO:480?9Q48RBD
M^MDXZK7NV?+GA/\ X(#>/OV5?BUX]OOV8/VJ?$WP%^'OQ(O5U#5_"'_"&6/B
M-+>?,@<V=S<RJ;8;'VJ5C,BA4W/)L0+ZO_P1R_X(X0?\$BU^+$%M\2M4^(UM
M\2]:AU6*74M+%K>V"1>> DTPFD%S*PF!:4)$&92=@W8#_P!@'_@I-J?[0OQV
M_:;T?QOX^^!MUX8^!^KFW1_#=GKFF77AVT2:^61M8N-4BCM6=8[4$R6CM$IC
MF)8*4)3P/_P<5?L6?$3XLP>"M,^/7AM=;N;N2RCDO=.U"PTUI$W9_P!/GMTM
M-IVD*_G;')4*6++F*%THPIZN4(V6[<'RR2ZNRM&W1;+1ZZ8F-ZDY5?L2;;V7
M,DTWVO:3O?5[O9'VK7QU_P $]O\ @DS_ ,,'_MD?M&?%O_A/_P#A*O\ A?\
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M M++5--U*\ETTZ;'JMM?W-Q++$T FE*#9<-'Q(2<9XS@?(_AW_@W1^)?P?\
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M)!NVBU\#O^"!?A7P3\2OVMM0\<^,G\>>%OVL+R2YU#1(M'.ER:"K75U<@1W
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M'AKQII,7]JVVH3:MJ-RI99=*NWC LY[)-C2*5:-P8U;):;]E7]JK]N_]FO\
MX+O?!']F[]I'XW>#_'^B>/\ P_J/B2[M/#>AZ?':36ZZ?JY@1IQIMK<)(MSI
M^\A." H+$,RCNQ=*-*M.G%W2;5_1G%AJKJ4HSDK-K^OEVOKW/VNHHHKG-PHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *_)S]L3]EWQK\1?\ @Z5^ 7C0_#KQ3KOPPL_
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MUUB];I'N\M=^W?CG'3-+116):5E8****!A1110 4444 %%%% !1110 4444
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M]?J_(']LC_E<D_9._P"R57W_ *2^*Z /U^HHHH **** "BBB@ HHHH ****
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M\F,WE:<BMYMO':C9'!,KK,OE*ZF,X5/5OA3_ ,$_OA;\'_B;9>-++2O$FO\
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M/V@/V-9_AEHWC#X>^#;_ .)6OZ5H'G>+]5:PM-4A:Z2:>PA"*SW%Q<0PR1K
MFUG#/\RXS7D/P:^%&E_\$ZOV[_A-X2O_ (4_LT37OQG@U?3-+\4?#/X7Q^"=
M3\/R65I]KECN%:[O'N;:>-0NY)8O+=$#+)Y@*?:WQM^!7A+]HWX>W?A7QMH=
MIK^AW;I*892\<EO,C;HKB"5"LD$\;@/'-$R21N R,K $<O\ !O\ 8O\  'P+
M\72>(=(M?$^K^(6MFLH=6\4^+=7\4ZA8V[LK20VUQJ=S<26T4C)&TB0LBR&*
M,N&*(0J/N2E+NW\URI)>2O=Z=]GJF5O?BH]E]SNW?SZ:/>UKK1K8_:)^$6O_
M !M\"QZ#H/Q%\5?#+S[@F_U3PW!9/J<UL894:"&2[@GC@8N\;>:L9D41D(4+
M;U^6/^#?2T;3_P!A/7[9[O4;]K;XF>,(?M-_=RWEU/MUJY7?+-*S22R'&6=V
M+,<DDDDU]D?#GX?6'PL\&V>@Z9<:Y=6-CO\ +EU?6;S6+UMSLYWW5Y++/)RQ
MQOD;:,*,* !A_ ']G'P9^R[X)NO#G@31O["T:]U6]UJ:W^USW6^[O)VN+B7=
M,[L-\KLVT':N<* ,"BFE"K*:V<7'SNY4VODE%^C>BU;"J^>$8_RR3^7+-/YW
MDODM]$=O1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /F#_@IS^T?X5_9S_X9Z_X2GX8^'_B;_P )Y\:O
M#G@_2/[5,(_X134;O[3Y&M6_F03?Z1;>6VS9Y;_O#B5.<_3]?*'_  5>^-/@
MWX/Z=^SM:^,_AKI_Q(B\;?'7PGX<T9KC4#8R>%=4DGEGM=9A=8W=I+=[?!B4
MQB6.62-W\MW1_J^@ HHHH **** "BBB@ HHHH **** "OC#_ (*(_P#!5+4_
MV0OB._@KP[X1MM2UF33;>_35-4>>.TA9Y7#(( B&X7RTQYD<P4.Q4Y:)TK[/
MK@/C5^RQ\.OVBK62/QIX/T379Y(4MQ>2P>7?11))YBQQW,>V:-=Y8X1P#N8'
M(9@?"XBPF98G!2I9565*J_M-7TUNMG:_=)M=-3['@7,\AP&;0Q/$>%EB,.EK
M"+L[W5G:\>9+7W6TGUT.2_87_;4T[]MSX7WFO6F@ZEX=O=*O#97MK-NGMU?&
MY##<[$27*%2R@!T)^90K1N_ME9OA'P;H_P /_#UOI&@Z5INB:3:;O(LK"V2V
MMX=S%VVQH JY9F8X')8GJ:TJ[\MI8FGA84\944ZB7O22Y4WWMT_#O9;+Q<^Q
M. Q&85JV5T71H2DW"#DYN,>SD]7\[M;-RM=E%%%=QY 4444 %%%% !1110 4
M444 %%%% !1110!YCXU_8G^#/Q)^*\'CSQ'\(_ACK_CFUE@GA\1:EX6L;K5H
MI(-ODNMU)$90T>U=A#97:,8P*?\ &+]B_P"#O[1'BVS\0?$#X3?#3QUKVG0+
M:VFI>(?#%CJ=W:Q*[.L:2SQ,ZH'=F"@@ L3U)KTNBB.EK='=>3[KS&W>]^JL
M_3MZ JA%    X ' %?D#^V1_RN2?LG?]DJOO_27Q77Z_5^0/[9'_ "N2?LG?
M]DJOO_27Q702D?K]1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#Y _X*[_$3P)\/?\ AF#_ (3KX<_\+$_M
MS]H#PII'A[_B?W&D?\(SK$OVO[-J_P"Y!^U?9]K_ .C28CD\SYB-HKZ_KY0_
MX*O>._A?X$T[]G9_B5X&U#QU>:M\=?">E^"XK?4I;"/1/$$T\JV^IS/&ZEX[
M>#[4XA99$ED\N-E56,L?U?0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5RWQ:^.?@GX!:%9ZIX[\8^%?!6F:A>1Z
M=:W>O:M;Z;!<W4@8I CS.JM*P1B$!+$*<#@UU-?AQ_P=,:QX5^%/[4_@KQG\
M7_"7C/Q9X)?P!/8?#V?1[O;:>'O%D>IQ3SW-S%YD6X/:>2H+.RG9CRGQNCCV
MD55IPF[1D[-]DDWIYNW+&]ES-:E^SE*G4E!7E&-TN[NE]ROS2_NIG[=Z%XAT
M_P 4:?\ :],OK/4;02RP>=:S+-'YD4C12)N4D;DD1T8=596!P015ROA#_@WX
M\3+\5?V6OB/\2='T3Q%X9^'WQ5^)^N^*_!6DZU/YMU:Z9.\2NYP[A!+=I=R[
M S*ID8*SKAV^Y->UZR\+:%>ZGJ5U!8Z=IL#W5U<S.$CMXD4L[L3P%5022>@%
M:U8^RBG5]U\L6[_9;BFT_P#"VT_3H94I>T;5/5<S2MU2DTFO6UUZ]2W17\[/
M_!;S_@I-X._X*(_L[^$O'.E_%#P?;^&](^+>FV?A/P1;>([8:LVEP)=K=:_J
MEDLOFQ&6546%947R(,,</<,![/\ LM^'? 7_  5-U#_@HO\ $[XI1^%/BG<>
M$[[4-"\"ZS<2P:DGA;1[2VOY+.32;D%DMD8@2B:WV%W5G+,6)K"=7DH3KS32
M@I2:ZVBJ;7S?M%H[6Y7=J2<5LJ=ZT**>LG%)].:3J)_)*FW=7NVK+E?,?M_7
MY _MD?\ *Y)^R=_V2J^_])?%=<3^R)_P=!>"OV(/V!/@!HO[0ND_&+QI\0_%
M/@U]<.L:9:V6H?;;)=6U&PMY)YKF\AD>=DL-S$JV05)=F+8\E^ __!4#P!_P
M5E_X.I_V9?B-\.='\8:+HFB^"M4\-SP>)+6VMKM[B+3?$5PSJL$\R&,I=1@$
MN#D-\H !/9B:#HU94F[\K:^XY</6]K3C42M?^OGZ[/=']!U%%%8&P4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MRA_P5>UGX1Z7IW[.T'Q9TGQAJ4NI?'7PG;^";CP\\2R:7XE$\LME/<B21$:S
M*1W$,PVR-Y<Y*() DD?U?7R!_P %=_\ A5G_ !C!_P +2_X6!_R<!X4_X1'_
M (17['_R,/\ I?V+[?\ :?\ F'_ZWS?)_??<V=Z^OZ "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OP:_X.K?CC8?
M!;]J4:=KDNH6TOQ-^$L7A'P[J4<IDM= \WQ DFL37$"GS"LME''&&5)&)7"K
MD;E_>6OQ;_X.5])\ ?#W]H5_%/Q)T7P_K<WC'X7IHWPY^WVB:E+!XETS6X[_
M .S+;;9'5+R*=(&FV>5M#1RMMDP>:LTJU%RMRJ4KIJZ:]G-.-NO-?E2^TVHK
M5G12DU2J\N]HM;:-5(/FUT2C;F;>B2;>ESW3_@UZ\:> _&'[*/QC7X46FKZ9
M\*=/^*VHV_A*PU&>2:>SL?L&GM@F1F<;Y&DEVLS%?-P22#7Z85\$?\&[WC34
MOB;^QWXV\42?#K3O@]X9U_XBZQ-X=\"6=UYJ>$H(Q!!<V9CV1_9R+^&]<P>5
M%L,APBJ1G[WKTL3?W$_Y*>[3?\..[6E^]NIYV&22FE_//_TN7?7[]3RW]K3]
MBOX9?MS^!=(\,_%/PS_PE.B:#K,'B"QMO[1N['R+Z!9%BFWVTL;-M65QM8E3
MNY!P,<9\;_\ @E;\"OVA?'WB;Q/XC\'ZC#K'CBPBTSQ.VA>)]6\/P>*K>/>$
MCU*"PNH(;["NR9N4D)3"$[0%'T+17*E;;S?S:2;^:23\DET.IR;W[)?)-M+T
M3;:[-M]3,\%>"=&^&WA'3?#_ (=TG3=!T'1K9+.PT[3[9+:TLH44*D442 *B
M*  %4  "OR4_;(_Y7)/V3O\ LE5]_P"DOBNOU^K\@?VR/^5R3]D[_LE5]_Z2
M^*ZJ4FW=DQBDK(_7ZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#Y0_X*O:-\(]4T[]G:?XLZMXPTV73?CK
MX3N/!-OX>2)I-4\2F>6*R@N3)&Z+9A)+B:8[HV\N A',A2.3ZOKY@_X*<^#?
M@UXQ_P"&>O\ A<?BSQ!X3_LKXU>'-1\#_P!E0M)_;/BB/[3_ &?87&VWGVV\
MN9M['R@-HS-'W^GZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?V'Y7]I?\(QXAL]7_L_S=_E>=]GD?R]_E2;=V-WEOC.TX[^I*"BBB@ HHHH
M**** "BBB@ HHHH **** /'/V[OVH;S]D/\ 9VU+QAIV@7/B#4%FCLK9!&S6
MEE++N"3W3*05@5@!Q@N[QQ@KOWK\S?L"_P#!73Q?^TK^T+I7@+Q7X6\-Q_\
M"0^=]EOM):>V^Q>3;3SOOCD:7S=_EJHPT>WDG=D ?>>LZ-9^(]'N].U&TMK_
M $^_A>WN;:XB66&XB=2KQNC AE92000002#7-^ _@%X$^%>L2ZCX7\%>$O#>
MH30FWDN=+T>WLYGB+*QC+QHI*EE4X)QE0>PKY3,LJS>MFE'%87%\E&-N:'*G
MS6>NO]Y:7^SNM3])R#B3AC#<.XK+LQRWVN+J<W)6YVN1M)0=NG)+WK+2>TM#
MK:***^K/S8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKXG_X*9?\ !3+Q?^QO
M\7M"\*>%-"\-WOVW1UU:ZNM62>;=YD\L21HD<D>W;Y#$L6;=Y@ "[26](_X)
MK?MNZQ^VO\+]8O\ 7O#G]C:MX?O%M9[RSB==+U#>&=1"79F$L:[1)&6; >)]
MV)-B?,X?B[+:V:RR:$G[:-]+.UTKM7\E\M/2_P"@XWPQS["\.4^*:M./U6=K
M/F7,E)\J;CO9NVUWJKI:V](_:Y_:#_X98_9Z\0^/?[(_M[^P?LW^@_:OLOG^
M=<Q0?ZS8^W'F[ONG.W'&<CXY_8?_ ."PGC;X_?M)Z!X+\6^&_#::;XB\VVBG
MT2RO!<6LXC:1'93)-NB^0JW"A WF,ZI&V?T%UG1K/Q'H]WIVHVEM?Z??PO;W
M-M<1++#<1.I5XW1@0RLI((((()!KF_ ?P"\"?"O6)=1\+^"O"7AO4)H3;R7.
MEZ/;V<SQ%E8QEXT4E2RJ<$XRH/85GFV59O7S&AB,'BO9T86YH<M^;6[U\U9;
MZ6NM6;<,\1\,8+(L7@<TRYU\55YO9U>=KD3BE&RU2<97E=)\U^66B1UM%%%?
M5'YP%%%% !7$_M'?&7_AGOX&^)O&G]B:EXB_X1VS-U]@L5S+-R%R3@[(ESOD
MDP=D:NVUMN#VU5M9T:S\1Z/=Z=J-I;7^GW\+V]S;7$2RPW$3J5>-T8$,K*2"
M""""0:PQ4*DZ,XT9<LFFD[7L[:.W6SUL=F7U:%/%4ZF*ASTU*+E&[7-%-7C=
M:JZNKK5;GYX_L:_\%DO'?QM_:)\/>#_%'@[1+S3_ !)-]BC?P[:7"W=G*V")
MW62:0- BAC)C:43=)D["C?HO7$^$?V:?AQ\/_$-OJ^@_#_P3HFK6F[R+VPT.
MUMKB'<I1MLB(&7*LRG!Y#$=#7;5X?#.79G@\-*EFF(]M)NZ=K65EIYZW/L/$
M'/<@S7'PQ'#V"^J4U%*4;WO*[UMJEI9:;V"BBBOHSX,**** "BBB@ HHHH ^
M4/\ @J]\%O!OQ@T[]G:Z\9_$K3_AO%X)^.OA/Q'HRW&GF^D\5:I'/+!:Z-"B
MR(ZR7#W&3*HD$4<4DCIY:.Z?5]?*'_!5[]GG2OV@M._9V?4?B%X/\ WG@7XZ
M^$_%NF1>(;M+6/Q3<6L\JMI-L[,";R6"6=X457,DD CPJNTL?U?0 4444 %%
M%% 'P9_P4(_X*W^)/V9OCW<^!/!?AW1+J?0H8FU6\UJ*65)I9HHYHU@6*5"%
M6-UW,Y)9F("J$W/](?L(_M0WG[7G[.VF^,-1T"Y\/Z@TTEE<H8V6TO98MH>>
MU9B2T#,2.<E'22,EMF]NV\>? +P)\5-8BU'Q1X*\)>)-0AA%O'<ZIH]O>3)$
M&9A&'D1B%#,QP#C+$]S72:-HUGX<T>TT[3K2VL-/L(4M[:VMXEBAMXD4*D:(
MH 554       5\KEV59O2S2MB\5BN>C*_+3Y;6UTU\EII\6[/T?/>(^&,1P[
MA<MR_+G2Q<.7GK.;?,TGS:=5*3ND_@2LKEFBBBOJC\X"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *_"O\ :,\1>,OV^/VNOC3=^+?^"DEG^QU!
M\-O'6H^"=#\ Q:R-%E?3[01>7J$@_M*P:<W#.[B1EE 'RK)M 1/W4K^7OXB?
M!?X)_P#!1/\ X+'>+_@[\4=4\9Z1X_\ $7[0'B:SO?$UHTDUY<^'TM9(M.L+
M>20RPH(KJS\O,D!\M)H@A*"01X)<V)47K[KLKVUYZ:NEU:3=U_+S-:V3W<E#
M"3J-VM)7=NG+-V?9-Q6W5)/1MK]I_P#@@W^T7XQ^/'[+/C72?&'Q$L_C&WPM
M\>:EX)T?X@VL02/QIIUK';M!>[E++(V)2AD5Y-_E[C)*29&^W:_.[_@V@ATC
M0OV'?&_AWP3JVM>(OA%X5^)6N:9\/-8U>Q6SOM4T<-#)YLB@*6/VJ2Z7>R1L
MVWF./_5K^B-=^)=W"6]X0=VK-MPBVVNC;=VNC;1QTHN+G!JW+.:M>]K3DDD^
MRM9>045^*/\ P58_9=\5?!7_ (*7?L2>*?&WQB\=?%3Q!XO^,&%@U'R;#0]!
MM([NW:W@L=.@ CA<121I+,Q>2=H0Y*YV!_P2^$OAS_@H#X^_X*4>+OCMH>D>
M,O$WP[U74O#'A2?6H4GN?!&FV5O?O:_V<[_\>?S 2^9"$9G5G+,6)K@==+#S
MQ$MH*;:ZV@J>W=OVJ5ME9ZO2_4J3=:-%?:<$GYR=1:]E:DVGN[I.*UM^IG[:
MO[!7PF_X*)?"S3_!/QC\*?\ "8>&-+U6/6[6S_M.\T_RKR.&:%)?,M98I#B.
MXF7:6*G?DC(!'R__ ,0N/["?_1#/_+S\0_\ R=7E7[(G_!:RS_8@_P""!?P
M^./[0L/Q"\:7OBF^?PH;O3$@U#5;V19=1-O<SM<SPAPUO8?,Y=G+%20Q+,.5
M_P"(U;]EC_H0?V@/_!'I'_RSKNQ-!T:LJ3=^5M?<<F'K>UIQJ)6O_7S]=GNC
M[_\ V&/^"7'P)_X)K_\ "4_\*4\"_P#"%_\ ":?9/[9_XG6H:E]L^R^?Y'_'
MW/+LV_:)ON;<[^<X7'O]?('_  2D_P""U?PL_P""P?\ PGO_  K/0/B!H?\
MPKO^S_[2_P"$GL;.U\_[;]J\KR?L]S/NQ]DDW;MN-R8W9./K^L#8**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9EC</>3SW<$4,3;!)(X7>&*@_5] !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?,'_!3G]BKQ5^VC_P ,]?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?('_  5W_P"%J?\ &,'_  JW_A8'_)P'A3_A+O\ A%?M
MG_(O?Z7]M^W_ &;_ )A_^J\WSOW/W-_:OK^OD#_@KO\ \+4_XQ@_X5;_ ,+
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>XK;J:=2-2*G!II]5JBZ]"I1FZ5:+C);IJS7JF%%%%69!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A'Q6_;?U'P
M)\=[OX?^&_@5\>/B3J&G:<NHWFK:%HEE8:#"&*XA34=6O+*VN)L.I*6SRE<L
M#AD=5]WK\\/^"H7[>WQ@F^--M\!_A+X'^,/@C2=30KXL^,]K\+]>\1V/A^W:
M+>8-)@LK64W=VX*KY^1%"20"7R\.4Y2YE&.[O9;=.KZ);OOHEJTGI%+E<I;*
MVNKMJMDMV]DOF]$SZH_82_;U^'W_  43^"+>.OAY<:JMG9:A+H^JZ;JMF;/4
MM#U")4:6SN8\LHE02)DQNZ'=\KM7YT?MD?\ *Y)^R=_V2J^_])?%=5]"_8 _
M:A^&_A31-"_X)Z_%?3OA)\(=-L0GB.'XL^"[[2O$WB7Q*TTLEUJDPU30&FF6
M2W>RC$D>V(&!D5%V'/SO\!_AI^TO\*_^#J?]F73OVJ?B'X/^)7Q"F\%:I<:?
MJ?ANVC@M(-+.F^(EB@94L[0&03K=,3Y;'$B_.<;5ZJL4FDNROZV5[=;7ORWU
MM:^IA3DVFWW=N]KNU[:7M:]M+WMH?T'4445D6%%%9O\ PF6C_P#"7_\ "/?V
MKIO]O_8_[1_LW[2GVS[-O\OS_*SO\K?\N_&W=QG-3*<8VYG:YI"E.=^1-V5W
M;HN_H:5%%%49A1110 4444 %%%% !1110 4444 %%%% !1110 445YO^UYX<
M\<^+OV;/%VF_#:__ +-\:W=F%TZ<3B"3_6(94CD(Q'*\0D1'RNUW4[TQO7GQ
M==T:$ZT8N3BF^5;NRO9>;V7F=N6X2.*Q=+"SJ1IJ<HQ<Y.T8J32YI/I&-[M]
MD>D45^5/[!G[*/[37@O]J&T\026OB3PUI+>),>+[O5=15(M82)F:X,D;,S7G
MF++*L<ZI(GF2[ED4AG7]5J\/AC/JV:X:5>OAIT&G:TNJ[JZ3?GI9/2[/L/$+
M@S"\-XZ&$PF/IXN,HJ3E3:]U]8R2E))]5[UVM6E=!17Y9?MF_LU?M3>*OVS+
MG4])/BW5H+C4K^7PCJ6DZMY%II%HT:YC5P\:V3&#9$YD\OSW1\-,3N;]%_V;
M=%\4>'/@!X,L/&MU]L\66>CVT6J2DEY#.(U#+(YDD\R5?NO*'(D<,X"A@HRR
M3B.MC\97PM3"SI*FVE*2TEMY;N]TDVK6=]3HXMX%PF2Y5@\QH9C1Q$JZ3=.F
M[RA=/?5MI-<K;47S7CRZ,[:BBBOJ3\Z"BN2^//A?Q)XW^"_BC1O"&K6VA>)=
M4TV:UT_4)_-"6LKH5#AHF5XVP3MD7)C;:^U]NQOS$_9U_9>_:QT7]J%+Z9?&
MVEW,.L:3+XEU34=9::SOX$92C3,+I!J,44096BBD8JN8R4+ 5\IG_$F(R[$T
M:%+"3K*H[<T=EOIL]>NME:[OHS])X*X#P6>X#%8S$9G1PLJ"NH5'9RVU5VM-
M;72D^;EBTN9,_6BBBBOJS\V"BBOE3_@JK\&/C-\;OAQX>TKX475R^GR374/B
M'3;74X]/FU"*2(+'N>1D#P!?/5XS)AC+&2C[<IYN<8^I@L'/%4J4JLHK2$5>
M3U2T^^[T>B>C/?X7R:CFV:4<OQ&)AAX3;3J5':$4DW=O1:VLKM)MI-I:GU71
M7P9_P1K^"OQM^%DFJ3>-8];T/X=S::T6F:)J\Q69+O[46\R*V?+VR@?:"X(C
M\PS1MMD&&3[8^)=CKNJ?#CQ!:^%[VVTWQ+<Z;<1:3=W"AH;6[:)A#(X*N"JR
M%204;@'Y3T/)D><U,PR^..J4)4VTWR/?3M>UT^C:5_0]+B_A:ADN>3R>AC*=
M>,6E[2+]W7?FMS6<?M).5MKMZ&W17Y+_ +.O[+W[6.B_M0I?3+XVTNYAUC29
M?$NJ:CK+36=_ C*4:9A=(-1BBB#*T44C%5S&2A8"OUHKFX9X@K9K2G4K8:=#
ME=K36^KVNEM;731Z7=CT/$#@G"\-XBC0PN84L7[2*DW3:?+HG9V<E9WO%WO*
M/O65[!1117TQ^?!116;X1\9:/\0/#UOJ^@ZKINMZ3=[O(O;"Y2YMYMK%&VR(
M2K8964X/!4CJ*ESCS*-]7T]-_P U]Y:I3<'42?*FDWT3=[*_=V=N]GV-*BJV
MLQ7D^CW<>G3VUKJ#PNMM-<0-/##*5.QGC5T+J&P2H=20" RYR/R.\&_LJ_MA
M6O[1NE77F>-K'Q9'9P_\3_4=?%W9V]D+H'RIKGS)(Y(EE_>-:?O&906\E@>?
MF.).(Z^5SHQI86=?VC:;@K\MK;Z/5WT3LG9Z[GZ%P'P)A.(J>*GB<QHX1T4F
ME5=N>_-M=K16]YKF:NO=U5_UZHJMHT5Y!H]I'J,]M=:@D*+<S6\#00S2A1O9
M(V=RBELD*78@$ LV,FS7U$7=7M8_/)I)M)W\_P#A]0HHHIDA1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%?EE^V;^S5^U-XJ_;,N=3TD^+=6@N
M-2OY?".I:3JWD6FD6C1KF-7#QK9,8-D3F3R_/='PTQ.YOT%_9#\.>.?"/[-G
MA'3?B3?_ -I>-;2S*ZC.9Q/)_K',222 8DE2(QH[Y;<Z,=[YWM\IDO$M;'XZ
MO@ZF$J4E3;M.2]V5K>6[O=)-KEUOJ?I/%G .$R;*,)FE#,J.(E72;IP=YPNI
M.]KMN,7'E;:BU/W>71L](HHHKZL_-@HHHH **** /E#_ (*O?M>^,_V2]._9
MV@\&3Z?:2_%;XZ^$_ &LW%Q:BXDBTN\GEENEA#'8DDB6WDEV5BL<TA3;)LD3
M?_X*9?L>>*/VSOA#H6@^%M:TW3;G2M86_F@U*0Q6=PGD2QARR0R2^:A?"@%4
M*R2;@Q";:'_!3G]M;Q5^Q=_PSU_PBVG^'[__ (6S\:O#GPXU?^U8)I?LVG:C
M]I\^6W\N6/;<+Y*[&?>@R<HW&/I^N#-,MHYAA9X/$7Y)JSL[/ON>UP[G^+R3
M,J.:X%I5:3O&Z35[-:I^ORW6I\8?\$R/^"<WCO\ 8P^(_B36_%'BC1+K3]7T
MU+*/3-(GN)H;B42AQ/+YB1@-&JLJ85B1<2<I@A_L^BBL,DR7#95A(X+")J";
M>K;>KNSKXMXLS#B3,IYKF;3JR23Y8J*M%66B_-W?RL@HHHKUCYH**** "BBL
MWPCXRT?X@>'K?5]!U73=;TF[W>1>V%RES;S;6*-MD0E6PRLIP>"I'45+G'F4
M;ZOIZ;_FOO+5*;@ZB3Y4TF^B;O97[NSMWL^QI44451 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 445\Y_&O_ (*5>&?AE^TS)\&_"W@O
MX@?%WXEZ?H3^)-9T3P=%IQ;P_8;HUCDNIK^\M(%>4R#RX4D>5@,E K(6F4TF
MD^M_P3;^Y)M]DKE1BW>W]7=E][:2[MI+5GT97Y _MD?\KDG[)W_9*K[_ -)?
M%=?I1^Q=^VAX"_;Y^ >F?$;X=:A=WNAW\DEK/!>VKVE]I5W$0)[.YA;F.:)C
MA@"5/#*S*RL?S7_;(_Y7)/V3O^R57W_I+XKK2<'%VE_7]=#.,E)77]6W7JGH
MUT9^OU%%%245M9L9=4T>[M8+VYTV>YA>*.[MUC::U9E($B"170LI.0'1ER!E
M2,@_DO\ #_\ X(M_&W3OC1;6TFH:)X<T_29H+N/Q59ZD9$5E>-MUK&NVX\^/
M<Q7>D2EH3^\7*L?UQHKY?B/A# 9W.C/&\W[IMKE=KWM=/[EJK/3<_1.!?$_.
M>$J6)I92H6Q"2ESQYFN6]FM5JN9Z2YHZ_"%%%%?4'YV%>7?M@?M6:%^QS\%[
MKQ?K=O<W[M,MCIMC!E7U"[='9(B^"(UVQNS.P.%1L!FVHWJ-<E\:O@5X2_:*
M\#2>&_&FB6VNZ-),EP(96>-XI4/RR1R1E7C;!9<HP)5F4Y5F!X<RABI86I'
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MQ7KNFZW>V-Y<S6ZV$1%O8022%Q LC*CRY<R2%W4$&8H,JBD_*9;GV88C-:V
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M>*[?PQ_9O]K:OI'D>;9WESY_F_VK/NQ]DV[-@SYF=PVX/]'U<?\ &O\ 9[\
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M:ER,D1J,X48["@#^<'XR?L/_ +4_PD_X+)?";]DC_AOS]H#4/^%H>%9_$_\
MPE?]K:O%_9GE1:K)Y'V/^U6\W/\ 9F-_GICS_NG9\WV!_P 0XG[4_P#TDY_:
M _[\ZO\ _+ROU.UG]GOP!XC^,ND_$;4? W@^_P#B%H%HUAIGB>XT:VEUG3K=
MA*&AANV0S1QD3S@HK@$32<?.V>PH _G!_P""U?[#_P"U/_P1\_98T#XF?\-^
M?M ?$3^W/%=OX8_LW^UM7TCR/-L[RY\_S?[5GW8^R;=FP9\S.X;<'[ _XAQ/
MVI_^DG/[0'_?G5__ )>5^IWQK_9[\ ?M*>%;?0OB-X&\'^/]$M+M;^#3_$FC
M6VJVD-PJ.BS+%.CHL@2210X&0)&&<,<]A0!^0/\ Q#B?M3_]).?V@/\ OSJ_
M_P O*^/_ /@BI^P_^U/_ ,%@_P!EC7_B9_PWY^T!\._[#\5W'AC^S?[6U?5_
M/\JSL[GS_-_M6#;G[7MV;#CR\[CNP/Z/JX_X*?L]^ /V:_"MQH7PY\#>#_ &
MB7=VU_/I_AO1K;2K2:X9$1IFB@1$:0I'&I<C)$:C.%& #\L?^(<3]J?_ *2<
M_M ?]^=7_P#EY7Q_\9/V'_VI_A)_P62^$W[)'_#?G[0&H?\ "T/"L_B?_A*_
M[6U>+^S/*BU63R/L?]JMYN?[,QO\],>?]T[/F_H^KC]9_9[\ >(_C+I/Q&U'
MP-X/O_B%H%HUAIGB>XT:VEUG3K=A*&AANV0S1QD3S@HK@$32<?.V0#\L?^(<
M3]J?_I)S^T!_WYU?_P"7E?/_ /P5'_X)6?M3_P#!-?\ 83\=?&O_ (>(?M >
M-/\ A"_L'_$F^VZOIWVS[5J%M9?Z_P#M>79M^T;_ /5MG9MXSN'[_5S_ ,4O
MA/X5^./@2_\ "WC;PSX?\8>&-4\O[9I&MZ=#J%A=^7(LL?F03*T;[9$1QN!P
MR*1R : /QA_9._X(<?M3_M0?LL?#3XF?\/)/V@-#_P"%B>%=+\3_ -F[]7NO
M[/\ MMG%<^1YO]M)YFSS=N_8N[;G:N<#T#_B'$_:G_Z2<_M ?]^=7_\ EY7Z
MW>$_">E> O"NF:%H6F:?HNB:+:16&GZ?86Z6UI86\2!(H8HD 2.-$555% "@
M   "M"@#^<'_ ()Q?L/_ +4__!0/]J?]ISX9_P##?G[0'A'_ (9Q\5KX8_M+
M^UM7O_\ A(<WFI6WG^5_:L7V?_D'[MF^7_78W?+EOL#_ (AQ/VI_^DG/[0'_
M 'YU?_Y>5^IWPX_9[\ ?!SQ5XGUWPAX&\'^%=;\;7?V_Q%J&CZ-;6-WK]QOE
M?SKN6)%>XDWS3-OD+',LASECGL* /YP?^"CO[#_[4_\ P3\_:G_9C^&?_#?G
M[0'B[_AH[Q6WAC^TO[6U>P_X1[%YIMMY_E?VK+]H_P"0ANV;XO\ 4XW?-E?L
M#_B'$_:G_P"DG/[0'_?G5_\ Y>5^IWQ'_9[\ ?&/Q5X8UWQ?X&\'^*M;\$W?
MV_P[J&L:-;7UWH%QOB?SK265&>WDWPPMOC*G,49SE1CL* /Q!_:Q_P""''[4
M_P"R_P#LL?$OXF?\/)/V@-<_X5WX5U3Q/_9N_5[7^T/L5G+<^1YO]M/Y>_RM
MN_8VW=G:V,'S_P#X)<?\$K/VI_\ @I1^PGX%^-?_  \0_: \%_\ ":?;_P#B
M3?;=7U'[']EU"YLO]?\ VO%OW?9]_P#JUQOV\XW'][O%GA/2O'OA74]"UW3-
M/UK1-:M);#4-/O[=+FTO[>5"DL,L3@I)&Z,RLC A@2""#6?\+?A/X5^!W@2P
M\+>"?#/A_P '^&-+\S['I&B:=#I]A:>9(TLGEP0JL:;I'=SM RSL3R2: /RA
M_P"(<3]J?_I)S^T!_P!^=7_^7E?'_P#P3B_8?_:G_P""@?[4_P"TY\,_^&_/
MV@/"/_#./BM?#']I?VMJ]_\ \)#F\U*V\_RO[5B^S_\ (/W;-\O^NQN^7+?T
M?5Q_PX_9[\ ?!SQ5XGUWPAX&\'^%=;\;7?V_Q%J&CZ-;6-WK]QOE?SKN6)%>
MXDWS3-OD+',LASECD _+'_B'$_:G_P"DG/[0'_?G5_\ Y>5\?_\ !1W]A_\
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MW^U9]V/LFW9L&?,SN&W!^P/^(<3]J?\ Z2<_M ?]^=7_ /EY7ZG?&O\ 9[\
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M(@L,UVJ":2,"" !&<@"&/CY%P ?EC_Q#B?M3_P#23G]H#_OSJ_\ \O*^/_\
M@M7^P_\ M3_\$?/V6- ^)G_#?G[0'Q$_MSQ7;^&/[-_M;5](\CS;.\N?/\W^
MU9]V/LFW9L&?,SN&W!_H^KC_ (U_L]^ /VE/"MOH7Q&\#>#_ !_HEI=K?P:?
MXDT:VU6TAN%1T698IT=%D"22*' R!(PSACD _+'_ (AQ/VI_^DG/[0'_ 'YU
M?_Y>4?\ $.)^U/\ ]).?V@/^_.K_ /R\K]?J* /YP?\ @BI^P_\ M3_\%@_V
M6-?^)G_#?G[0'P[_ +#\5W'AC^S?[6U?5_/\JSL[GS_-_M6#;G[7MV;#CR\[
MCNP/L#_B'$_:G_Z2<_M ?]^=7_\ EY7ZG?!3]GOP!^S7X5N-"^'/@;P?X T2
M[NVOY]/\-Z-;:5:37#(B-,T4"(C2%(XU+D9(C49PHQV% '\X/QD_8?\ VI_A
M)_P62^$W[)'_  WY^T!J'_"T/"L_B?\ X2O^UM7B_LSRHM5D\C['_:K>;G^S
M,;_/3'G_ '3L^;[ _P"(<3]J?_I)S^T!_P!^=7_^7E?J=K/[/?@#Q'\9=)^(
MVH^!O!]_\0M M&L-,\3W&C6TNLZ=;L)0T,-VR&:.,B><%%< B:3CYVSV% 'X
M _\ !4?_ ()6?M3_ /!-?]A/QU\:_P#AXA^T!XT_X0O[!_Q)OMNKZ=]L^U:A
M;67^O_M>79M^T;_]6V=FWC.X>@?LG?\ !#C]J?\ :@_98^&GQ,_X>2?M :'_
M ,+$\*Z7XG_LW?J]U_9_VVSBN?(\W^VD\S9YNW?L7=MSM7.!^SWQ2^$_A7XX
M^!+_ ,+>-O#/A_QAX8U3R_MFD:WIT.H6%WY<BRQ^9!,K1OMD1'&X'#(I'(!K
M0\)^$]*\!>%=,T+0M,T_1=$T6TBL-/T^PMTMK2PMXD"10Q1( D<:(JJJ* %
M   % 'Y(_P#$.)^U/_TDY_: _P"_.K__ "\KX_\ ^"*G[#_[4_\ P6#_ &6-
M?^)G_#?G[0'P[_L/Q7<>&/[-_M;5]7\_RK.SN?/\W^U8-N?M>W9L./+SN.[
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M^?M ?$3^W/%=OX8_LW^UM7TCR/-L[RY\_P W^U9]V/LFW9L&?,SN&W!^P/\
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MD9(C49PHQV% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7M$HY2FKN<-8-.S[M-V^4HVFNJCSZ/DO+]*;7]I#P7>_M%WOPFBUK=\0-/\
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K 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>j6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" 'J I4# 2(  A$! Q$!_\0
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M&>: /2**1"#QC!%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFOT/-?'_ /P<4_LB_#;XI7GA'4/BE'<7FG70L;R_L-(O+W2;27=M*O>11M
M#P3OPO<BO)_^"O'AH_M<?MI?L&67@3XB7WA>U\7ZQXEN+/Q7X<FAFN%L3HR2
MRM:RLKH'FMP\:2;6"F4, 2!7R_\ \$X_AK^U;=?\$G_"?AKP-\*/V5-6^#/B
MWPT;B_?5=4F276%E0M//?D-C[0"&+DD&-DPI0( /5/\ @F-_P22/[2O_  3T
M^"MIXB^-$L&M_ KQ-KU[X-\1_#/Q!;:C;6S7,B[%\]TD5Q"ZLIB/RE2T;#!P
M*Y5KY#C+KWO^1]!_L.^(_'/[+'_!4+X@?LTZM\1O%7Q3\#CP%8?$#P_J7BJY
MCO-:T5GO#93V<UQ&D8F5W'FIN4%1@#.2:^_ER,'UKYR_8N_X)T:-^R9X]\8>
M/=8\7^*/BE\5/'XMX=;\6^(_(6ZDMK<8@M8(H42*W@3KL1?F;YB20,?1X/)%
M2WH1U84444R@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!'Z5\,?M>_P#!#3PQ^U?^UWK'QGM_BQ\6?AUXLUK2[;2+AO"NJ+8J
M;>% H3<%W$$J&()(R,^@'W1Z\4@/)!J6MA7TMW/S_P#A#_P;N?"GPI\;?#'C
M[X@>//B]\:M9\&7:W^BVWC;Q$U_I]E.I#+)Y!&"59$;!(4E%W!@,5]C?M-?
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M** "BBB@ HHHH **** "BBB@ HHHHN 449HH ****+@%%!..M% !10#GI10
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^>OVY?
M^"H_P._X)R)H8^+WC>W\,7/B3S#IUJ+.>ZN+I(R [A(D8A5+*,M@$D 9-?0M
M?,/_  4(_P""0_P/_P""GESX=NOBQX=O]2U'PLLL6G7MAJ4]C/%%(07C)C8!
MD)53@@X(XQDT >(S?\'1_P"Q9'$[CXJ73E5+!5\/7^6XS@9BQD].2!FOR%_:
MM_X._P#]HGQI\?-3OOA6?#7@SP!;W)CT_3;K1X+^XO(%8[7N)95+!W R1'M
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MS_@N9^R[X5^ '_!)2?P=\*O ^F>&M%MO&?ARXCTG0-,$<>_^UK8O*8XUY8@
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M:WXKUJQM/#$EO)&99[Z6ZB:WCBMW0E2 V"JYV=A*[![7/ISPC^WMX_\ V?\
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MM&.M-K175B&U?06BBB@84444 %%%% !1110 4444 >&_M%?\$Z/A#^U9\<O
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MZ?\ ^4(7Q=_Z^-$_].]I5-ZZB2,O_@U%_P"4-7@__L8-;_\ 2Z2OTAK\WO\
M@U%_Y0U>#_\ L8-;_P#2Z2OTAI#"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@C(P:**
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M *725^D-?F]_P:B_\H:O!_\ V,&M_P#I=)7Z0T %%%% !1110 4444 %%%%
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M#P7\3O#>HV^E2P2?:I-+TG3TTZXB4E=PAFGNY9F '5"3T%?T61Q+%@* H'
MZ#V ["G $L. ,?C33LK+^M;@W_7RL?)W_!%#]FN]_9K_ ."=O@>#6TD'BWQJ
M)_&GB)F!5I+_ %.3[4^X'D,J-&A!Y!0],XKY%\5_\%!_AO\ \$[?^"Y7[0FM
M?%&?Q+INF>*/"N@6NFSZ?X>O=36>2/S&<?Z/&^W .<G /N17ZV#H#Z4IQDGH
M:3?O<PD]&F?E5H7Q/OO^"V/_  4H^$_CKX?>'?%WA_X._L]6VJ7[>)=?TF73
M1KNJWUO]GBAMHI0LA6- 69B!CC(&1GSG_@G]_P %)?!G_!)K]C/Q;\ OC1X>
M\7Z'\6/ VKZT;30DT"YNU\6I=W$L]M+:2Q(T<BR^8JDE@ "23CFOV9 "Y.#S
MZDFHWLXI)ED:-&DCSL<C+)D8.#U&1Z4.UK#3ZL_GVT']G7P1^RW^SI^SWX<_
M:8\-_%KX*ZY=Z+J^KZ+\5O!>H7-M=^&9[S4I[M=%ND@C<@+',DAW8P25R!S5
M3XB:#\<?VR?V"?$^JQ>+OBS\;/A+\#/BWHGB3PYXK72CHWBS6M'MX&6_EM%9
M-TDEHQ5HY65CDR,257"_T*3VD=W$4E19(V&&5QD,/<'@_C3UA5%P 5'0 $C'
MM[?A3;3Z?U>X7/PU^#]G\"OVL?VW/@)I7PR\>?M??M$ZMH'B&+Q7=2^(_$9M
M](\"K;%'%S>"ZL$#LQ#1^2CAB!M# R*#^YJC*@X(P.E06MA#:%C%&D9<[VV*
M%#$]SCJ?<\U/D[>.N*<G<BVHM%%%(H**** #<.>V*"<=:^)_^"H7_!4+QE^R
M3\6OAI\)/@[\-D^*OQB^*)N;C3],N+HVUE8V=L!YL\[J00!N)Z@ (YR2 #Y:
MW[7?_!2['_)L?P2_\*JX_P#BZ2U5T#T=C]*J*YWX3:KXBUOX7^';WQ=IMGH_
MBF[TVWFU>QM)C+!9W;1J9HD<\LBN6 )Y(%=%3L 4444 %%%% !7YY?\ !T__
M ,H0OB[_ -?&B?\ IWM*_0VOSR_X.G_^4(7Q=_Z^-$_].]I0!E_\&HO_ "AJ
M\'_]C!K?_I=)7Z0U^;W_  :B_P#*&KP?_P!C!K?_ *725^D- !1110 4444
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M!I4GDCFOEG_@HE_P2S\,?\%#-7\-ZAK/B#6_#]_X:BFMX9+(12)+'(59E99
M1G*@@C!ZCI7U/NQSCK2=2< YS77@,PQ&"K+$8:3C);/0Z,+BZN&J*K1=I+J?
MF'-_P;*>!9XGBD^)'BN6.52KH;.UPZD8(/R=P<5^)O[?'[*>I?\ !)#]I?XH
M?!.[3Q%K1\2Q077P]O;>*/;?QW$FS=(-N2VW,9$>,2+CD#G^N[H>?QKS+XR?
ML;?"K]H7XA>&?%?CGX?^%O%7B3P;()=$U+4K%)[C3'#B0&)F&5PX##T(!ZUZ
M^)XMS:O.-6K6;E%-)V6S5FM$=];/L=5DISG=I-)Z;/<_+[]BK_@UET+P9^S5
MX5'BCQYK^F^*]3LH[_6K:UM;=X8+J1 S1JSJ6(3A<GGBO<_A9_P;E^ OAU\2
M=!\03^//%>IKH5_!J"VI@MX5G>*19%5F5 P!*C.""1QFOT;QTQU%'&,X /UJ
MZ/&.;TZ"PM.M:"5K66WW%4^(<?"E[&-2T;6M9!#&(HE09PHQ22YP?J/YBGTA
MSGIFOFF>/?J?D!_P1%_X)T? ?]K+X<?'CQ)\2OA+X$\<>((/C9XIL4U'5]+C
MNKA($E@98@S#(4,[D#L6/J:\Q_:<_9Y\"_LQ?&W_ (*.^%/AWX3T/P;X;M?V
M?[">/3=)MA;VT<DD5P9'"+P"Q )/<BOW!TG0K+0XI4L;.ULDGE::18(EC#R-
M]YR% RQQR3R:AN_"FFWTUW)-IMA-)J$0@NF>W1FN8QG".2/F49/!R.3Q2N]%
MV5OP'S.[?=W_ !N?C_\ LB?M+^"_^":/[<>L>*OCC?R>$_"'QO\ A'X&E\(>
M*KVUE?34-AI*0W6G&9%;RY&DQ+LZ$8)Y(KYU^(7QJ\/?M%?L1?\ !2CQOX;T
MJ\T;PWXE\?\ AJZM(+RT:TEDB+0K]H>)@&3SR#-A@"1*">37ZK?M6?L5_'77
M/VCYO'GP@^)WA*RT'5=&@TG4/!/C?0GU?1()(2WEWEHJ2(8)0K%6 R& &3QB
MM_\ X)Q_\$Y)?V./!7CVX\<>)[?XE^/_ (L:^WB/Q9J\FG):V=Q-L"1006V2
ML<$2@A%)) ..  !5TTWY/\TR5+E:?I^5CP'_ (+8Z9:Z1X6_8RMK>&.&"U^,
MOAN&!%4 1J()555]   ,"O>O^"WHQ_P2)_:)SG_D2-1_]%FOI[4=$L]5$'VJ
MRM;H6L@EA\V)7\EQT9<C@CU&"*EU'3K?5[*6UN[>&YMIUV212H'21>X*G@CV
M-*3NFN[O^7^01T:?8_,']G;_ (.&?V6_@I^P=\.=%L?B!)XR\>>'?!VF:>OA
M71-'OI]0N[Z*SCC-LF80F1*-I.X@#)&>*^1?A;\"_%?_  3X\+_LA_'KXS^&
M=4TCPL/B/XE\6>,XA:O='P=_:\>VRGN45<H%!3>2,H5QU !_>'3OA7X8TFY6
MXM/#>@VLZ?=DAT^)'7Z$+D5K:IH]IKFGRVE[;6]Y:3J4E@GC$D<B]PRMD$>Q
MJN?WN8E))<I^/G[;W[1/P]_X*-?\%)OA5=?!_2YOC1X:^#?@OQ5J?C^\\.J[
MV][8WNES0Q:2ER%VO<3,Y*Q@D@R9 R"!\W?#S]H_1OV8OAI\*M1_9H_:7\1>
M/K?4M?T[3H/V>O&^F)K6H:<QN8Q/91KL#6K6ZE_WV!@+E6!YK^@;PIX"T/P+
M:O!H>BZ5HT,AW-'8VD=NCGU(0 $_6JNG?"CPOI.O/JUKX:T&VU20EFO(M/B2
MX8GJ3(%W9_&IBTK%N1^%_P )[2R_9;_;'_:C\-?%[]J_XF_LMZ_J7CV_\9V4
M%K!;1:7XLTVY"217L$TT#F:4 ;&C0\855!;>!]^_\&[OP\T#P;^P??ZGX5'Q
M.?P]XT\7:EK]E<>.H+>WU*^64QHURD<*($AE>)I%!7)+,02I!K[7\5_#3PYX
M[G@DUSP_HNLR6V?*:^LHK@Q<Y^4N#C)YXK8M;2*QMTBABCABB 5$10JJ .
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M-H-I)%>W^H7$X@%A>6D:$LD>\!EN  N%.TDX!F+MK;^KK\R[=/3]3]V?V?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML_\ >J\(>5[L_7#QY\?_  /\,;-KCQ%XM\.Z+"H)+7E_%"!CK]YA7S_\3/\
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M_ PSEYR?Z:GXW30_\%#/VI9MDC^+M!M)OF$:Q6_A^)1UR&.).GJY^E:.D?\
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MKYGBZW\6I)_-D:6J)QM4 #C P/IBGQQB/[H"CT Q3J*\VYQML****0@HHHH
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M/]E/X=?$6>S73[KQGX>L]7GMD!"022PJSJN23M#[L9).,=37IXZD45+\SO\
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M\['Z@;@0<\T$[>P!K\B/$'_!SEJ6HN!H?PLT6,9P//\ $?VDY^D<2_E6$?\
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M:11V20'YPR1WDS%2FX!8TR6*\@9(_>6BBO.E)R;;=VSDE)MW84444""BBB@
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M^_\ @G!_P2H\'?L)>'XM5N##XC^(5[#MOM:EBPL (!:&V0D^7'D<DDN^,L<
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M\+]#96X5K;0-3OV7TY60 _B*_7O1/AYH/AW:-/T72K$*,#R+2./'Y 5L"V3
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MO;C_ ,?,E?J-MXQ2 8P".M85/$+/I:*M;TC%?H93XKS.6GM+>B7^1^>N@?\
M!M_\&K%8S?\ BCXAZDR_>!OK:%&_!+?(_ UV_AK_ ((#_LXZ$X-SX<US5@.H
MN]>NL-_W[9*^U ><9HV@<CBO.J<89U/?$S^3:_(Y)\09C+>M+Y.WY'S%HO\
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M^#MS??#SX/SVNN^-BS6=]JZ+Y]IHSD@&.,#B:XR<;02J'[V2 I\]_P""</\
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MH*N0!2T45YQQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5NVFK^;9X.-XBQN(7(Y<L>T=%^!T*0+&H"JJ@<8 P!3U4@YSQ7.?\+D\(?\
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ML\Z7$&XDQG,95@I"D,21D C^GZ@ HHHH **** "BBB@ HHHH **** "BBB@
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MD[G_ *+\_P#X(C_\=K]]Z* /P(_X@D[G_HOS_P#@B/\ \=H_X@D[G_HOS_\
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M5'[/4?W_ (D?%B3_ +;6(_\ :%6X/^#+3]G"+[WCWXLR?]OEFO\ *WK]AZ*
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MP69F."0, FOT(HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1110 4444 1S[C$X3AB#C\J_GK_X-V]8LO!/[$G[?5MXADCM;[1;74)M5BN
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MT/5_$>N7UQHYM[#3;.2[NI@FJVKL5CC5F("JQ.!P 3P :N<KO38SBK'X;_\
M!,W]CC_@HY\7OV3-)US]G?QIXNT;X7W%]>1V=K8^/(-*A6X29EG(@:92I,@8
MDXY//.:]_P#^'=7_  6-_P"BD_$'_P .G;?_ "17Z:_\&Q?PQ\2_"#_@DEX4
MT/Q9H&L^&M9@US6))+'5+*6SN45[V1E8QR , 0002.17Z#5)1_.)_P .ZO\
M@L;_ -%)^(/_ (=.V_\ DBC_ (=U?\%C?^BD_$'_ ,.G;?\ R17]'=% '\XG
M_#NK_@L;_P!%)^(/_AT[;_Y(H_X=U?\ !8W_ **3\0?_  Z=M_\ )%?T=T4
M?SB?\.ZO^"QO_12?B#_X=.V_^2*/^'=7_!8W_HI/Q!_\.G;?_)%?T=T4 ?SB
M?\.ZO^"QO_12?B#_ .'3MO\ Y(H_X=U?\%C?^BD_$'_PZ=M_\D5_1W10!_.)
M_P .ZO\ @L;_ -%)^(/_ (=.V_\ DBC_ (=U?\%C?^BD_$'_ ,.G;?\ R17]
M'=% '\XG_#NK_@L;_P!%)^(/_AT[;_Y(H_X=U?\ !8W_ **3\0?_  Z=M_\
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M/^'=7_!8W_HI/Q!_\.G;?_)%'_#NK_@L;_T4GX@_^'3MO_DBOZ.Z* /YQ/\
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M_H[HH _G$_X=U?\ !8W_ **3\0?_  Z=M_\ )%'_  [J_P""QO\ T4GX@_\
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M^VKT/Y6?+\_^UV].,Y\S]<=Z_;Q5(/M4O5)[7$U:379CJ***!A1110 4444
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MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %#' S101D8-
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M!_$^KW4E[XJ\-A_"^O3.2SSW5HJ!96)Y+20/ ['NS-1&-[^025K/N?;%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y_^U?S^R[\1\<_
M\4OJ?_I)+7XK?\&3'_'C^T'C_G\TW^4]?N#\:/!=Q\2?@]XK\.VLT5O=:]I%
MWIT,L@)2-YH'C5F Y(!8$X["O@3_ (-^_P#@C'XW_P""1\'Q.3QAXK\-^)SX
MWGM);4Z5#,GD"$2;M_F ==XP!GIUI4W:4GW02UBEYGPK_P 'F9Q^TA^SG_UP
MN_\ TJBKEO\ @X5^&NE?&3_@X!_9>\(Z];I>:'XGTSPKI>HP/]VXMIM8FCE0
M^S(S#@YP:^_O^"\W_!$?QS_P5;^*WPLU[PEXN\,>&K;P)%,ETFJ0S2/.7FCD
M!3RQC "D8)&3W[B+_@H5_P $//'7[8'_  5=^!_Q\T;QAX9TOP_\+1H2WNG7
M<$S7=W]@U![J385&T;U8*,D8/)XJJ=ER*71E3=^9KJCX0_X//O@7X/\ A1XA
M_9TN?"_AG1/#\UWIVLZ7(;&T2W5[>W:R,"$( "(S-(1GIO->I?\ !UG^QS\-
M_P!G/_@DA\$(O!_A'0]!E\)>+;+0[*>TM$CF%K+IEZ\R,X&Y_,DMXG8DDEE!
M/-?5?_!P=_P11\;_ /!7J_\ A/)X/\6^&O"Z^ !JGVL:K#-(;DW1M-FSRP<;
M?L[Y!QG<,'K7HG_!=K_@EEXK_P""JO[&'A/X:>$_$>A^&]3T#Q3::Y-=:G%*
M\,D45E>6[(OE@D,6N%.2,84CKBH2?L_._P"HXOWE?:S/P[_X+@^-=?\ $_[/
MG_!/CPK,LVK:+#\(-)O;>PEG,45W<S);PNI?< #Y<,2;B05!/(!->^_\%/?V
M8_VF_P!NG]G[PAX&M_V"?#/PGNO!UY%%H.K:5XBTR*>VA",K62?Z0H=)!@E2
M2245@,C-??O[;/\ P;U:=^VU_P $U_@C\+M3\46V@_%+X(>&[+1](\36UL\M
MI*T=M#%<121%E8PRF%6!!#(RJPR-RM\NZA_P;A_MB?M6W7@SPG^T!^T_9ZO\
M,O!<BFT@L)[J^OO+4;3M65(U$QCRBRR-(4#'@C@Z-ZOUN0G9+TL?JY_P3(T'
MXA^$_P!@;X3Z1\4["YTSQ[H_ANVT_5[:XECEFBEAW1*'>-F5F,:1DD,<DY))
MS7X__P#!S%CQ)_P6L_91TC43YVDK]DQ%(<1C?J2;^3Z[5_(5^ZGPC^%.B? S
MX7>'_!WARU-GH7AG3X-,L8BYD98HD"KN9CN9B!DL222222237X\_\'??[.&K
M:?X7^#/[1.BI(1\+-<6PU1H5Q)%#/-%)#*23R!-$$QCK+UQ0Y+VL9>803]FX
MK=HS_P#@]<\;:WI7[+WPAT.VEN(-"U/Q+<37@3(2>6*W/E*QS@XW,P![C/:O
M3/VP_P!A'X':+_P;.A+'PMX:BM?#O@&Q\2Z;JRP)]HAU*5(I'G$V-Q>225U(
M).0VW' %?4G[:G['7@'_ (+M_P#!-S0;.74SIT?BC3[7Q+X;UJWC6=])NVBR
MK%2?F7YGCD0$$C<,@@&OSF\+?\&Q_P"U;XT^ DOP=^(/[35LWPB\/I-+X?\
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M$O$_AZ[-_P"']<AA\];21DV21RQ;E\R%UQE0P(9$8'*X/YQ^)?\ @@)^WO\
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>j7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" '> J # 2(  A$! Q$!_\0
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M!)/"\8"M&LA:/(R"R-@G!Q]/TVA!1112 **** "BBB@ HHHH **** "BBB@
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M;BQ086RB@4%(K? &4&<X'. !2O=6&GK<WO\ @D#>>&;[_@ES\ I?"/V<:&?
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ML,,G!!'-=6>>,9!JGKVEKK>C7ED[M&EY"\!8#)4,I7('?KFH:TL4GK<^!_\
M@UZ /_!%#X3 X&9]9_\ 3O>5X"WC_2_ ?_!33_@HYXETGXA/\*/!NE^!] M?
M$'C&SLS=KH>LFW,8G2$$"6Z5"Z@#YO,(')X/I'P._P"#?3XD?LX?"S3_  'X
M*_;7^-_A?P5IAF^S:7I6GV=LMN)97EDV."60L[NV1T+$U[KX4_X(D?!OP?\
M\$_O'?[/5L?$=QHGQ++W?B7Q#>7WVC7=8OV=)!?33LN&E62.,@%=H"X(.YB7
M+N":O9]3\DOVF]%\+_ 3]F?P#\5_@E\+/VKO"GB[0M?T.:7XQ>+]7ET^#Q(L
M]S''*\UK->R23)<ER0@@55##G9D'[GB_:AF_X),_\% ?VKM+\5W]U=> O&W@
MN7XU^#8;NYDDB2[MT,.HV$.2=I><QN$7 "E2  :Z/XQ?\$"_&_[4GP3T_P "
M_%C]K;XI>--'\+_99/#,$6A:=IT&G3V\B^7<721+NOI!$&0&9\J7+9)Z^=?\
M%5?!W@7_ (*E_P#!0OX"_L_>'K#7]>\8_"'Q0=3^(NJ?V5/;V.DZ"+:.:>VE
MF=1'(+MQ;HJHS DX/I5I]//\"?4^N_\ @BE\'?%7PJ_X)Z^#M1\?7M_?^/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%,DE6%&9F"JHR23@ >M00:O:76GK>175O)9LAD$Z2 QE1U.X'&!@\]
M*+@6J*KZ?J=OJMHL]K/#<P/G;)$X=&[<$<'FF6&LV>KK(;2[MKH0ML?R9!)L
M;T.#P?8T 6Z*JVVL6E[>S6\-U;37%L0)8DD5GB_W@.1^-#ZQ:)J26;75L+QU
MWK 91YI7N0N<D>] %JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
MJHJL2!R<9IU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\5_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X5_X+$_\ !2;XS?L'
M:CX0T[X6?L\:]\;[/Q587LFIW6GF["Z,T9B5%;R8)1\XD<C<5/R'&>:^2O\
M@RKN))_V*?B[OC,?_%<!CUZFSB)'/I7W[_P45_X*S? O_@FR=$TKXO\ B>^\
M/7OC.SNY-)2#1[N_$ZP[%<DP1L%P94&&QG/L:^!?^#*ZZCN?V*?BZ4).?'(?
MD8X-G$0: /V<HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M72%9<^-P_/HUG$<?A0TUHR4[H_9ZBBBD,**** "BBB@ HHHH **** "BBB@
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MU>GIN>3#@/-,PP^)S;*Z7-A:4I^]S+2,==F[_#;H?>E% .0#ZT5[A\&%%%%
M!1110 TDG.>*I:SK5KH&DW5]>SQVUK9Q---*[;4C5026)[  $YJ74KV+3;&:
MYGD2*"!"[NQP% &23Z#BOS,^%7[=T/[9?[7'CKX=^)M2U"U^'7Q.0:1I M[C
M[.]J("VS:W.#<KO##J<H.*\K,<TI85PIR^*;LO6VE_GH?5\-<)8O-Z=?$T4_
M9X>*E-I7:C=7MW=KNWD1_LE_\%.KKQG_ ,%&M<N-7O98?!OC^1='TV*5L)9>
M4S"T?!Z&3<X8]VE&> ,?IZAWID $'FOCRV_X(@_!>UGCFA;Q=%+$P>.1-88,
MC Y!!V\$$ @U]>Z=9_8+"& R2S^2@3S)""[X&,G'4G%<N0X?'4:<X8YIMMM-
M.^^Z/9\0\RX=QU>A6R"$H*,%"2DDM8I)25F]6M'Z%K ]!0 !P!@445[Y^=A1
M110 4444 %%%% !1110 8ZGUKPC_ (*8_L[R?M6?L(?$_P !0ZWIOAVXUW0Y
M?)U'4G"V%M)$5G4W)/ MR8P)">B%S@]*]WSU]J\$_P""GG[.OB/]K+]@?XI?
M#SPG-;)XB\3Z'+;V$5Q*8H+V165_LTC@C:DP0Q,<C D)/&:4KVT''<_(OQ5\
M2OC;^U7=?$7PKKWPX^&7P\T+]MB7P[H&G>,KSQS87?AR*'3+)89WTQ8SONY9
M0FZ",8*G ))&:_>#PWHZ^'O#]C81O+*EA;QVZM(<LP10H)/<D#)]Z_*C]JGX
MA>/_ -OG]C>+]G'P[^Q%\0_A[XGOXK73H-0U^STVT\)^ 6CDC9KVTNXI69_)
M5"8Q#&C-P!U(/ZL>'=.ET;0K&TGN9+R>V@2*2=_OSLJ@%S[L1GZFJ2T)=R]3
M+B'SX)$S@.I7/IQ3Z*EJXTSX7_9R_P""(7ACX3_\$S/B+^S+XI\5WOBKP_\
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MY)!0]<=L9K\@/C!\=O'-G\7?%D,/C;Q?!'!K5ZD:)K-RJHJSN   _  &  ,
M5UYIQ/0PE*G7@N>,VTFGV/%X/\)LQSK&8C 8B?U>I046U*+;]Z]NJMM^)^R'
M[?W[+^H_M?\ [/=UX.TG5++2+NXO;>Z%Q<Q-+&!&^XC"\Y/2OF;]CK_@COXJ
M_9K_ &D/#'C;4?%^AZE9Z%+*\EM;V<J22[X7C&"QP,%\G/85]7_L+:M=Z_\
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M4 %%%% !1110 4444 %%%% !1110 449HH **** "BBB@ HHHH ***"0.IH
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M $DX'<FF?##]E3X;_!CQ&=7\*>#?#N@:FT30-=6-G'#*T;$$H64 D$JI(Z9
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MDP0Q%@1@2$Y%>^EN,CFOA/\ X*W_ !*_:G^ WC7P%XF^#OBGPW8_"_5]2L]
M\4QS>#'U[4O#CSS%%U0(DR--; O&LBKM:(#<-X)"K?0:/A?QKX>^*?[5MQ^T
M;\+-#_8\^)G@J_\ CFOA/3='DU_1(K#PSX'.F64=O<WAO5)C80L&:#[."T@P
M0!DBOW%\-:9)HF@6-G-</=2V=O' \TGWIF50I<^[$9_&OCNW_9Q_;G$R-)^T
MW\'I(U(+ ?"AP6&>1G^T.,CO7V=;+(D$8E97E"@.P&T,<<G';)IWTL2U?Y$M
M%%% PHHHH **** /FS]O[_@J9\#_ /@G='I.F?%SQD?"M[XOL[J32D_LZZN_
MM(B"JYS"C;<&1!SC.:_/;_@RPNTN?V*?B[L;=_Q7(;TX-G$0?QK]-_VLOV&O
M@]^UW8V]]\3_ (;^$O'=YX>L[A--EUFP2Z:R5P&<(6'RABB$XZE1Z5^9/_!E
MA D/[%7Q>V(%_P"*YV\>@LXL"@#]FZ*** "BBB@ HHHH **** "BBB@ HHHH
M ***,T %%!..M% 'G?[2'[3/A7]E7P"GB7Q=<75MI;W268:"W:=O,?.T;5YQ
MP>:\V^!O_!47X4?M#?%'3?"'AK4=5GUG5O,^SI-ITD,;;$+MEB,#Y5/7J:P/
M^"N_P4\5?';]EZ#1?"&BW>O:JFLVMP;:W*!O+7?N;YF P,COWKY!_P"";'[#
MWQ9^$7[9_A#Q#XD\#:MH^BV/VK[1=S/"R1;K>15SM<GEB!P#UKY/,<TQ]+,J
M>'HT[TW:[LW:[UU6A^Q<,<(\-8SA;$YGCL3R8J'/RPYXJ]HWC[K5W=]C]:@<
MC-%(GW12U]9<_'0HHHH **** "FRQF12 <$TZB@$S\R/^"B_['_[0GQ"\8G0
MM$U7QA\2?"-S*=3:.Y:PM;6RE+OY<* %&;8AZMQR.I!KB/@3^SS^T;^SK\'/
M&[W^L>,OAIH/AO2KG7;*.V>QN;6ZN$4L\3Y+NA8!2"O'#9YQG]:R 3R.M>4?
MMSJ#^QY\2QQ_R+=]_P"B'KY+%<-48U9XU5)7L].;3;;OY[G[%E'BICY8*AD$
ML/1]FY15^17;NM;?#=K2_+L?/W[/_P"S-\7_ (U?!/PMXME_:.\;Z?)XATRW
MOVMTTRR=83)&&*ABG(&<<UW_ (6_8I^*FA>)]/O;K]HWQOJ-K9W,<\MI)I5D
M$ND5@6B8A,@, 02.0#ZUWW[!A(_8T^&>>_ARQ_\ 1"5ZY@$9& *]3"9;1=*$
MWS7:3^*7EYGR><\58^.+KT(JFHJ4E94J6UVK7Y+_ *BQJ44 G)I:**]D^)"B
MBB@ HHHH **** "BBB@ HHHH **** "BBHKI'>VE6-Q'(RD(V,[3C@X[X- $
MOMCBBOSNN_V!/V^9;N5X?VX?#T43.2B'X761V+G@?ZSG XS4?_# /[?W_1\G
MAW_PUME_\<H _11DR<YQ7R?^TU$O_#S+]GP!01]DUO/'_3N*\;_X8!_;^_Z/
ME\._^&MLO_CE>0_%/]DS]K3P]^U+\-_#WB#]J31M=^(6N0W[^&O$Z>!+:WB\
M.I'$#<*UL'VSF9/ERQ&T\C->5G"_<Q_QP_\ 2D?6\&?[Y5U_Y<UO_34C]<40
M*.  /I3L#T%?G4/V ?V_CT_;D\._^&MLO_CE'_# '[?W_1\GAW_PUME_\<KU
M3Y.Y^BM%?G5_PP!^W]_T?)X=_P##6V7_ ,<K[8_9F\$^-_AS\"?#NB?$?QC!
MX_\ &VGP-'JOB"#3DTZ/4W,CLKB!"5CPA1< \E<]Z!'>T444 ,:,2@@C*D8K
MS&]_8P^%&IWTMS<?#OP;-/<.TDLCZ3 S2.QR6)*\DDDD]R<UZB<G@4W'<\"L
M:E"G4TG%.W?4Z<-C,1AVW0FX7WLVOR.(A\.>%OV;/AGJT^AZ#9Z-I.GQ2W\M
MII=F$$K!,DK&@^9V"@< D\"OQGN?B/\ %ZX_:V'Q?/A/Q9_;JZN-16/^R[C:
M(0=HMON_<\G]W^O7FOW.D56X(!Q31:Q8_P!6AQ["O%S?)'C?9J%1P4'=)+K_
M , ^[X*X]AD+Q,JV&5>5=<LG*37NO=;/?KZ(_.:[M?%_[1?[0GQZ@^&YAT[6
MO&?A3P^L<FIL]J]G;S1R&7(VEA*$)7! P6/(Q7*?LN_\$K?CO^S/\=?#WC+3
M;WP=G2;A1<PKJ$P%S;-\LL7^J[H3C/0A3Q@&OI7]G=0O_!4CXY#  &B:+T_W
M9*^LBH.3@$BN+#9'0Q,EB*S?-"<K.]DGS/9'T&;<?X_*:;RW!0@J5:C2YE*/
M,VG2BK-]DMMNXL1)C4GJ0,TM%%?6GXXV%%%% @HHHH **** "BBB@ (SC/:O
M/_VH/VE/"W[('P&\2_$GQM<7=IX7\)VOVS4);:W:XF6/>J#:B\L<L.!7H%>(
M_P#!1ZY\ 6O["_Q3?XJW6KVOP['AZY&O'2I"E]+;%<-% 1R9)"1&H[EP,C.:
MF3T'%'L>CZK#KNDVM];EVM[R%)XRRE25=0PR#T."..U6P,<"OP1^'UOX.^$_
MPZ\6:CXE\&_MO_#;PK\(]9T'3];TR#XT75Q<^&=&U*TDGM]2GLX9 L<486!9
M($):-9B2!L(K]Y-(N(;G3+:2"87%N\2M%+OW^8I (;/?(P<]ZJQ*OU+5%%%
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M+^%OBGP-9WBR:SI.G^"5L[J_M\',<<P'R,3@YSQBON49P,]:**^K/Q\****
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M)7_5]#U'RU_P957+7'[%7Q=+1&,'QNK?B;.(D=.U '[/T444 %%%% !1110
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M445[!\4%%%% !1110 4444 %%%% !1110 4444 %%%% !2,Q49P32T,,C!%
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M***^K/QT**** "BBB@#-\4>(+3PEH%]JFH7$5I9:? ]Q/-(P58T1268D\
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MU/G>(>(,5G6.EF&-M[25KM)*]E;9=;#Z***[CQ HHHH **** "BBB@ HHHH
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M5L^O7J?1<=\;4>(ZE"K'"JC*E'DTE>\5\*V5K:V]1U%%%>Z? A1110 4444
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MP?\ 0H_%[_P5V?\ \DT ?KS17Y#?\1G_ .S!_P!"C\7O_!79_P#R31_Q&?\
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M_P %=G_\DT ?KG=DK&S#@A3C\J_%?XH?\%1?COX?^)GB6QM/'MU#:V&JW=M
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M_0G>%O\ P4P?_$4?\*-\$?\ 0G>%O_!3!_\ $5U5% '*_P#"C?!'_0G>%O\
MP4P?_$4?\*-\$?\ 0G>%O_!3!_\ $5U5% '*_P#"C?!'_0G>%O\ P4P?_$4?
M\*-\$?\ 0G>%O_!3!_\ $5U50M>11W*P-+&)G!94+ ,P'4@=2/>@#F_^%&^"
M/^A.\+?^"F#_ .(H_P"%&^"/^A.\+?\ @I@_^(KHY+V*&=(FEC623)5"X#,!
MU('4X_2G6EW%?VZRPR1S1.,JZ,&5OH1UH YK_A1O@C_H3O"W_@I@_P#B*^3/
M^"Z/[.>F^)/^"2WQPL/"/@.QO_$=SH2)8V^D:(DM]*_VF$XB6)-Y. 3A03@&
MOM>XNXK4QB62./S&")N8+N8] /4GT%34 ?#G_!!_]G#3O#?_  2/^"%AXO\
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MW=N* .6_X4;X(_Z$[PM_X*8/_B*/^%&^"/\ H3O"W_@I@_\ B*ZK-% '*_\
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MT7]FSP-\.M8\*?"3R+/4=9\9:K=6K>(]4EMDNOL%E' A\H)%(@::8[=[@!2
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M_P!E9XOAG\7O $6A:!XW,D?CGPXVBC4A)I<9VP_O',@79ANFW>O7/$_[!/\
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M%WNF^.+WP1<>*O$&L7.LWEMX1T"WT?1M(64@165LL4<;3)"BA1-*/,;G.
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M,XM>\/>)I=2L=3C-Y#;1M:LT$,BK^\<,7"LKQD8(()]F_9R_X*3?&GP)XO\
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M\%+OC=\7?BG\2]/_ &?O@AH'CWPK\'KA=.US5-=\4MI4VN:D((YY]/TR)()
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M5RWQ1^"G@[XX:/#I_C3PIX:\76%O)YT5MK.F07\,3XQO5958 XXR.<5\'?\
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M .(HW]E3_G\^)_\ X0VH?_$4?\11O[*G_/Y\3_\ PAM0_P#B* /T4HK\Z_\
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M\11_Q%&_LJ?\_GQ/_P#"&U#_ .(H _12BOSK_P"(HW]E3_G\^)__ (0VH?\
MQ%'_ !%&_LJ?\_GQ/_\ "&U#_P"(H _12BOSK_XBC?V5/^?SXG_^$-J'_P 1
M7.?%W_@YU_9A\0?"?Q18:9J7Q.@U*^TF[@M9/^$+U"+RY6A=4._9\N&(.<C'
M7(Q0!^FRL'4,I!!&<]C2U\4_\&[?B6_\7_\ !&'X$:AJ5]>ZE>S:5>))<74K
MRROLU&[106<[B % &3T  XQ7VM0 4444 %%%% !1110 4444 %%%% !1110
M4444 %-E0R1LH.,C&:=10!\<?\$8O^"?&O\ [!?['-SX%^(,/AG4_$$WBK5]
M8$MA_I,7V>XN2T(+NBG<4 )&,#=C)P:^M/\ A"=%_P"@1I?_ ("Q_P"%:=%
M&9_PA.B_] C2_P#P%C_PH_X0G1?^@1I?_@+'_A6G10!F?\(3HO\ T"-+_P#
M6/\ PH_X0G1?^@1I?_@+'_A6G10!F?\ "$Z+_P! C2__  %C_P */^$)T7_H
M$:7_ . L?^%:=% &9_PA.B_] C2__ 6/_"C_ (0G1?\ H$:7_P" L?\ A6G1
M0!F?\(3HO_0(TO\ \!8_\*/^$)T7_H$:7_X"Q_X5IT4 9G_"$Z+_ - C2_\
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M7\J/L\?]Q?RI]% #/L\?]Q?RH^SQ_P!Q?RI]% #/L\?]Q?RH^SQ_W%_*GT4
M,^SQ_P!Q?RH^SQ_W%_*GT4 ,^SQ_W%_*C[/'_<7\J?10 S[/'_<7\J/L\?\
M<7\J?10 S[/'_<7\JY_XJ^#9/'OPO\2:';-!!<ZUI=S8122 [(VEB:,,<<X!
M8$XYQ71T4 ?.7_!);]DKQ%^PI_P3K^%WPG\67>F7WB/P=I\UO?3:<[R6K227
M4T^$9U5B%$H&2HR03C&*^C:** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0\8[8KP#]E3_@H5X4_:
MU_:*^-?PVT+2->T_5_@=K$.C:O<WJ1"WO99!(0T!5RQ4>6WW@IY'%>_G##Z5
M^)OP!_:^?]@KXT_\%6/BU!8Q:G?>#_$UC/86LI(BFNY#<PP!\<E!)(A8 @E0
MP!!(-$4M6%G;0_;+@C@C)KS3]K3]K?X??L/? [6/B-\3/$%MX<\+:(H\R>0%
MY;B5CA((8U^:25SP%4$GDG !(_,OXG?L\_MG_"__ ()HZM^T9!^UAXPOOBO%
MX4F\7ZKX6FTVR/AJ&R>V:>2VMHO)W1W$$+%DE!P9(@-H!S7G'Q \?:K^WE^T
M;_P2R\$_%;43XFT#Q9X3/C[78KU1LU_5HM/$L;S*H"/\\9.W !$L@QAL4^76
MP+:Y]2M_P</7,GAI_%\'[(G[5,_PU0>?_P ),/"Z"(VW_/P(2^[R\<[LXQWK
M[5_9(_:Y\ _MR? ?1?B1\-M=BU[PQKB'RY0ICFMI5P)()HS\T<R$X9#R#@@D
M$$\)^W?_ ,%'/"/_  3ZLO##^*?"'Q.\5IXJ:YCME\'>&Y-9-MY B+>>$8",
M-YJA<YW;6QT->-_\$-_C;^SE\5/!_P 6[/\ 9W\'>-_ ]E8>+Y+_ ,4:9XDM
M'M)8M3NT+.(H7FD\I (MOE@(%V@;>]"$^_<^[****0PHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*\N19VDLK D1
M(6('4X&:E).1577/^0-=_P#7%_\ T$U,F[:#1XA_P3H_;]\+_P#!2G]FRW^)
M_A#2==T71KG4KO3%MM62-;D26\GENQ$;,N">1SG'4"O>20.O%?@G_P $]_VX
M/%O["W_!MQHVJ_#N*S?XD>//BA=^"O"TEW&)+>UOKV]8"9U/!"1QR$ @C=MR
M",@^H?\ !4_X,_M>?\$Q/V#+OXL>&OVN_'WC75[5K.U\9VFKZ?9-;Q&>XB0W
M.E_N=UN$E*J48L&C=CD$!3;CV$UK8_6[XZ_&?0?V=O@SXJ\>>*+HV?A[P?I=
MQJ^H2C&Y88(S(VT$@%B%P!GDD#O7B_\ P3&_X*@> _\ @JA\&-7\9>"-/U_0
MQX?U5](U'2M;ACBOK63RTD1V5&8;'1P5.><,,<5\?_\ !PQ^TQ9:S^RY\$_V
M>[WQ7IOAS4?VC=:TVUU_5]0O8[2#2]$@:":]N97; 4,YC S@-B0#D8KB?V?/
MVD_A)^QS_P ' <&B_#'QYX1\1_"[]I_PG9Z<]OH6KP7MOI7B'34$-N'\MB$,
MT*;03@N\YZD<$8N[3^0/9-'[&4444@"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@!.Y]J_(G3O^"9/B#QSJ7_  4DT[XK+!\-
M/ 7QMUBUN_#GBK5KJ".QVPM-)%=,Q?Y(TF,.[?M)#$=:_7<GD#'6N6^-'P<\
M-_M!_"GQ#X'\7Z7!K7ACQ582Z;J5E-D)<02*59<@Y!YR",$$ @@@&B^X)V/Q
MY_:6_:6_;3T+_@D)XS^&'B3X(>&M&L_#O@&?3]9^*Z^,K2YT+4]$BM-AN+.&
M/,LEQ<P (@Z;I@Q"C@>GQ?\ !-3Q;^V-_P $?/V.O&7POURV\%?'SX(^%-&U
MWP;J-ZI6WF9K.#SK*Y(!(BE")R00"N""K-7?V/\ P;?^$;KP[IW@?Q%\>_VA
MO%7P4T>:-[/X=:AXD3^R!%&P:.VD9(P[P*1@("I  P00#7Z(>&?#EAX-\.V&
MCZ59V^G:7I5O':6=K @2*VAC4(D:*. JJ  !T Q3OH^]T*]OQ_0_-N'_ (*F
M?MR:'H7_  CFI?L':S?^/8L0'4;'Q=;#P[/(!CSA)AMJ$\[3(<#C=WKTW_@B
MA^P=\5_V4+3XR^/OC7=^&$^(GQY\6-XMU/1]!+RV>B,PD)A$K$[SF1N%+!0H
M =\DU]T4 \#WI)_B/I8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "J^JQ-/I=S&@W.\3*H'<X/%6**35T-/J
M?B1\*/\ @EAX[L?^#?C3OAQX]O=$^#?Q8\(_$>7QCX2E\4:C;VUI_:4=VSVD
M4DN\H//1I$7DD,RG! (/-_\ !<W]K+]K?XW_ /!,36]!^(_[/FF_!GP]I]_I
M<7BW6;KQ3;:B->N/ML2PVVF00DMM>;9(S2,0J1E<DG)_87]L_P#8Y\#?MZ?L
M[Z[\,?B)IT^H^&M>$;/]GF,%S:S1N)(IX9 "4D1P"#@CJ"""0?E3P+_P0"\-
M3^/O"6I?%;XW_'+XZ^'? 5Y'?^'_  MXRUN.YTBVFBSY4DT:Q@W#(, %B >0
M002#2??8&^IP'P9_X)T:]^VE_P %6O&/Q1^/_P ,+2Y^%WPX\%:=X+^'VE^(
M8+>_M-8<KONK_P EBX&'\W;N4'$R' 936A_P6-_X(K>%O'/[(BZ[^S;\+/!G
MA#XT_#K7+'Q3X;D\-:/:Z7=:A+;RC=;F1!&"-K&0!FQNB7N<U^EX^4^U .?K
M1*6MT3%]SD/@'XPU_P ?_!3PIK?BOP_=>%?$VJ:5;W&JZ/.RM)IMTT8,T)*D
MJ=K[AD$@C![UV%%%#8)6"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>j8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" 'H I4# 2(  A$! Q$!_\0
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MUI^UKX%_8@^ ^M_$KXD:N=#\)Z L8N;A8'N)&>1Q'%&B("S.[LJ@=,GD@9(
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MXP\/3>$XK:RTK^R]"T#2IE9)K:VAWLQWHS+N8@@/(3DN30O(5T>!_P#!-O\
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M6;/P3X<^!?CFQ\8N]]:M>3ZV86=IB[(R?OI7<L7(('0*  ![%_P5^_8!U/\
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M&>L:?/%I'AG44M+V5IXF$<$-RR,UO;CRY6=4&78QD],C2_9I_:2^)7_!-O\
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MQI\>SS>'_$>H0_9]4U2*V(:#5QN&/,,Q#'(*EED4Y!-*PUION>=:7\?(-5^
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M"F7QU^'*_%_QW\(_@A^SA>6WAQ-+\%7JZ?K'B2]/F*T\]V49@FZ"0X (QY8
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M"@6R&GJ?:7[!'P3D^ G[+WA;19/&/C;QP;BSBO\ ^T/%.HB^O8Q+#&?(5PB
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M_8!_X+W>&?V?H_C#\2?B?\+/B?\ #^Z\2K9>-=3&J7>D7<+3@&.<JI (M2.
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MB?<FNXLM/@TVTCM[:"&W@A4)''$H1(U'0  8 'H.!5FB@ HHHH **** "@#
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MVF0201R;TWRMM*E@6)!)!8D$EI6W*\ST#_@W1^%&K^$-.^/OBW1/ WBCX7_
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M1XR^'7CRZL/%MV-4C2+Q'')9)-]KWW228D9Y(PT:X"^6NW"D**41278_8?\
MX+!_\HK?VA_^R?:S_P"D<E?EC_P8[_\ )*OVA?\ L+:+_P"B;NO)_P!L3]E7
M_@K'X:_93^(FH_$WXJ6&H_#NP\.WL_B2T76M.D:XT]86-Q&%2 ,Q,888!!/0
M'->G_P#!CVEQ_P (%^T2[,#:-J&A!%R,AQ%?;C^(*C_)J1'[S4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5^=?_!P?^T'^SY\ _!?P7E^/WPGU#XJV>I^,5_L2"TN?L[:5-&B
MF6=CO7S$VL@\DG;)WQ@&OT4K\J?^#HK]A+XL_MQ^ /@/;?"KP9?>,;GPWXPE
MEU..UEC1K**6.,+*^]E C!C8%LX7C.,T ?JJI)SFEHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *:_?K_2G4U@3VI-C1^;'P=_9^_9H_X.)?A#??%W
MQC\'9/#WB/1O$-WX:&K6VHFTUEFLBBB0W5L5+K\P"A]Q4# XQ7EO_!-G_@D[
M^Q=_P4&\!ZMX[T_PA\6/$FE^#?%5[X:;3?'?BJYO8#=6@C+NL*3%&C(D &XY
M/S BO(O^"+__  5D\.?\$UOV8?%'PY^(/PD^/]WKLGCG6-7671O!,UU:M!-(
M@0AV9#GY&XQCI@G-4O\ @BA_P5V\+_\ !/C]F[QMX3\=?"/]H2XU3Q%X_P!7
M\3VQTOP/-<1"UNA"(@S,ZD2?NVR,$#CDU:0-M,_2?_@EO^V7X>_:%\3?&KX8
M^%/ASI?PY\/_ +/'BQ_!=E;:=*AM;V-#(!*D21HL(_=YVC<26R23G/UX5*\@
MU^6/_!MOK=]\0?BI^V)XYE\,^*O#.C^/OB7_ &[I$6OZ9)I]U);3"=U)1AU
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M\@ \U]>_LM?LG?#W]BWX.:?X!^&7AC3_  IX6TTL\=I:@EI9&QOEE=B7DD;
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MK+3(JM;0[Y4_? 1J1R1C.<#!K]%*_$W_ (/.^?AG^S7D9'_"9W8.>G^J@XH
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MZ4VO221BZ;4$D6(I$\F2H4$YV8Z\9K[B4AE!( )'2OAC]EG_ ((UI^SC\>M
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MX)_L0V]F_P 6/B7X5\#RZBI>TMK^[_TJY4'!9($#2,H/&X*0#WH ]FHKR_\
M9C_;-^%7[9OA.?7/A7X]\-^.=,M&$=S)I=VLKVK$9"RQG#QDC)PZ@G!]*]0H
M **** "BBB@!DD@CC+-]U02>_%?FYJO_  =<?L>Z/J5S9S^)O&HFM)FADQX6
MN2 RD@X..1D?E7Z3$9&*Y!O@%X%>0LW@OPFS-R2='MR2>Y)V=: /@'_B+-_8
MX_Z&?QO_ .$K<_X4?\19O[''_0S^-_\ PE;G_"OO[_AGWP%_T)'A'_P3V_\
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M@048!@1R* /+O^"P?_**W]H?_LGVL_\ I')7Y8_\&.__ "2K]H7_ +"VB_\
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M$-U;3QW%O.@DCDC(9)%(!!!Z$8((QUJYN&,YXKM33U1X4HM.S"BBBF(****
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MLX?&?5OB]\2;-+&T\9ZKIDEIX=\":=]HMV6."*2/,?"^2&W#:I !R[EOL?\
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M&,\,([XD_B"!^'-?JQ_P6"_Y16_M#_\ 9/M9_P#2.2ORP_X,=_\ DE7[0O\
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M[V:L[,_*7_@KK^V=X<^,/CC2_!NGV&K0W_P^\1E[Z69$$4X12I\LAB3DMQN
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MEB=U,K1GDDDD("6))Q^A!!Z'O7RO_P $N_B1^RG\1O!_BV;]E>T\&VNBVU[
MNOCP]H<NEQM<%&,1D5XHRYV;L$9 &>17U75-B"BBBD 4452UB\ET[2[JXAMI
MKV:&-WCMXB \S $A%)( )( R2 ">H% %VBOQ>\27_P#P4S^-W@7XL?%SQ?\
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M4) R P)'<5A?\&/6GQCX>?M$78+>9)J.AQ$$_+A8KTC'OEC^E?JK_P %@_\
ME%;^T/\ ]D^UG_TCDK\L?^#'?_DE7[0O_86T7_T3=TA'[NT444 %%>(_M[Z=
M\>=3^ YB_9TU#P1IWQ$_M& ^=XJC>33_ +)A_.&$4G>3LP<8Z]*^)O\ A#?^
M"MW_ $-W[+'_ ("77_QJ@#]1ZYCXQ^(+#PQ\)_$M_J5]::=8VNF7#SW%S,L4
M,*^6PRS,0 ,]R17YO_\ "&_\%;O^AN_98_\  2Z_^-5\T?\ !5C]@+_@IO\
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M?A5#<6\C12QMKT(9&4X((SD$$8IG_#[+]D<<']HKX3?CX@@_QKYS_P""^W[
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M<-.U*[\+:Q;ZK;Z3?2Z==-%G$<\1PZ<]>H.1P000<5Y=_P %$?VQ+;]C_P"
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M2E\7?$?XF?!"^\5^./CUX"^/^D^(+B.3P]K?A31(M+MK2)%99HG6/K)O(R&
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MKYN.*S+Z][-P7LK[VZ'ZA6RKA5<.+$TZ[^N65XWTO?7H8/\ P734)X7^%H&
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M #5-/^,6@> M.NM*UG1O"^H1ZI<V)EE$JW<4,+,7# ;'"Y8".,X(!( /D/\
MX( _LS_L$?&KQ;9>&_CEXEOO%'Q5\0WT0T72-4BN=(T%&&0MJDR2 7$TK$<2
M[%)"J@))S_3]X-\%Z1\.?">FZ!H&FV.C:)H]LEI8V-G"L-O:0HH541% "J
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M0TKP#^V%^T7X1TW5]1EU>]MM+N[6WBNKN4*))W"IR[!%!)Y.!Z4T[ WV/T]
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M_P!&6ZE_X)M<_P#C5;'GG[V45^"?_$45^V1_T9;J7_@FUS_XU1_Q%%?MD?\
M1ENI?^";7/\ XU0!^]E%?@G_ ,117[9'_1ENI?\ @FUS_P"-4?\ $45^V1_T
M9;J7_@FUS_XU0!^XOQ5^'4'Q:^'>K^&[J]U'3K76;=K6:>QE$5PB,,,$8@[2
M1D9QD \8."/F7X:?\$:_AK\*?'FD^(M$U?QC9ZGHERMS;2"_3AE/1OW?*D$J
M0>H)'>OS4/\ P="_MC@_\F7:EC_L#:Y_\:KB?!G_  >)?M#?$/QC-X>T#]F_
MPUKNO6_F&73-._M.YO(]AP^Z) 7&T\'*\'@XKFK8*C5DIU8IM;-]#U<#G6.P
M=*=##5'&,]));/U/Z((P5X]!3J_!/_B**_;(_P"C+=2_\$VN?_&J/^(HK]LC
M_HRW4O\ P3:Y_P#&JZ3RC][*_.W_ (.#/VS_ (5?L?>"/@U/\4O@GI'QHAUW
MQB$TRWOY(XUT62)%+W*%T?=)B10$("MSN.  ?B7_ (BBOVR/^C+=2_\ !-KG
M_P :KY$_X*R?\%#_ -J'_@K+X?\ A_I_B7]ESQ?X43X?:O+JUN^F^'M7F:[=
MT12C^9%@ ; <CGF@#^J91@4M?@G_ ,11'[9'_1EVI?\ @FUS_P"-4?\ $45^
MV1_T9;J7_@FUS_XU0!^]E! /45^"?_$45^V1_P!&6ZE_X)M<_P#C5'_$45^V
M1_T9;J7_ ()M<_\ C5 'O7[=O_!H=\'/VL/CCJ_COP=XUU_X6W/B.[>_U33+
M6PBU#3WGD8M))"C.C0[F).T,5!)P , ?B]_P4&^)?A3]@&\^+O[)_P '-+%S
MH+:G!I/CGQEKL*RZWXGNK"=91%"%_=V=I%<*V(T#/(5W,Y!"C])_^(HC]LC_
M *,NU+_P3:Y_\:K\J_\ @K%\0O''[5WQPU'XR^*?V>->^"E]XCE5=;G^P:A#
MINJ7I&%ES<Q@1S.JG(5L,5+8R6) /)?VBOVYOB5^U-\-_AUX0\7^('N_#'PL
MT.+P_P"'M+@006MM!'D"1D7AYB-JF0@L0BCC'/O'_!O9XF^*6@?\%9?A%#\+
MI-5-UJ&MPP:]!;%_LT^C[@;W[2!\OE+#O;+#A@A7YL54_P""87C'7_V<$U7Q
ME#^R')^T1!XBM7TZTN]:T*_U'2;:'<!*(8XH6B>3>NTR$EEP0N"23]\_L^_\
M%QOCG^R?I]S:?#/_ ()UZ!X#M[W'V@:)X0U:S:XYR-[) &< ^I.* /Z-" >H
MHK\$_P#B**_;(_Z,MU+_ ,$VN?\ QJC_ (BBOVR/^C+=2_\ !-KG_P :H _>
MRBOP3_XBBOVR/^C+=2_\$VN?_&J/^(HK]LC_ *,MU+_P3:Y_\:H _>RCZ<5^
M"?\ Q%%?MD?]&6ZE_P"";7/_ (U1_P 10_[9'_1EVI?^";7/_C5 '[R74'GV
MSQYQYBE<^F:_.WQ9_P $$X/$7BC4]1_X6/>1'4;N6Z*#2D(3>Y?'W^<$XSZ5
M\L_!S_@XX_:Q^)WB>2PUC]EP>#K=86E%W?:'KC)(P( 0?NQ@D$G)(X!ZG /J
M!_X+A_M%MC'PDT(8]/#^N?\ Q->'FU/!5FJ6+BW;;1_FC]!X.J<0X&,L5DM1
M0YM&[Q3=O*0[P1^QQHOPN_X*0^#?A/K<_P#PE.B/X>G2[,\/DB[6074FTJ#P
M <=#VK[B3_@E;\!EE1U^'^FDJ0W^NFZ_]]5^1_BC_@K+X@D_;ATWQSJ-EX0L
M/BII\<>E0>&9(+Z,RF5&$:F!A]H,KK-E0!SE, @\_1B_\%O_ -HI0 /A'H>!
M_P!2_KG_ ,17C96L%2YU.&EW:\;Z:6L['V_%<>(L9+#U*&(][V:4[5$DY:WN
MDTC]:;>!+>!8XP%2-0H Z  8 J3.%X.:_$SXV_\ !Q;^U7\+-5M+;1OV98O&
MD=S$7DEL="UY!;'=@*V8R"3UX.?4#C/$G_@Z$_;&)_Y,NU(>_P#8VN?_ !JO
ML:-15(*<=OZZ'XEC<)4PU9T:WQ)ZZW_$_>RBOP3_ .(HK]LC_HRW4O\ P3:Y
M_P#&J/\ B**_;(_Z,MU+_P $VN?_ !JM#D/WLHK\$_\ B**_;(_Z,MU+_P $
MVN?_ !JC_B**_;(_Z,MU+_P3:Y_\:H _>RC\*_!/_B**_;(_Z,MU+_P3:Y_\
M:H_XBBOVR/\ HRW4O_!-KG_QJ@#]["<=:.G05^ GB7_@ZN_:V\&>'[S5=8_9
M ?2-,T^,SW5[>Z9K-O;VT8'+N[H%51ZD@"L;X9?\'=7[3/QDL;JX\(_LN:3X
MMMK)Q%<RZ)!JM\EN[ E5=HE8*2 3@D$CF@#^A2BOP3_XBBOVR/\ HRW4O_!-
MKG_QJC_B**_;(_Z,MU+_ ,$VN?\ QJ@#][**_!/_ (BBOVR/^C+=2_\ !-KG
M_P :H_XBBOVR/^C+=2_\$VN?_&J /WLHK\$_^(HK]LC_ *,MU+_P3:Y_\:H_
MXBBOVR/^C+=2_P#!-KG_ ,:H _>RBOG3_@EI^U?XW_;:_8L\,?$?XA^!I?AS
MXLUFXOHKO0)(+B%K18;N6&,[9P)!O1%?D8.[(XQ7T70 4444 %%%% !1110
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M_A;P+X6M+3Q3XXLX(6B>Z@B NW@2:3SKM8B&#R*,95LD 9K[$\6?\%J_V?\
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MX4\9/HNI>'$\5:5;:LFEZAL^UV*S1B18Y=A*APK+D G!R,\4-6!+2YV=%%%
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M<LSKY<*J6.X!B1&^!D<^Z9Z>],84444 %%%(6QD=Z $W^YI.4]>:_'7X3?\
M!6/4_P!F?_@M%^UYX*\4_P#"WOBBCWFCP^"?!'AFPGUF:#;;%[IX8=PCMXQY
MD19BR@EE R>GV]^Q!_P5R^&W[>GCKQEX$TS2/'7@+XC^!K?[3K?A3Q=I!T[5
M;6 D*)E4,RNH)3HP(\Q#C!!(UI=%.-G8^KZ*_.+_ ()V_P#!17X-?LZ?\$M_
M$/Q=\1_&+XE^,? VB^*[^RDUWQ[;AM<GNLQA;&"*)Y#( <"-0<G+D@ $BYXI
M_P"#C_X6_"KP5'XK^(OPG_:&^&OA+4X&GT/6=?\ !AAM->(!98H660A9'7YE
M$A4$=P>"$GZ($=.<8I00>G-?D5_P5,_X*BI\'/VT_P!A#XF6/BOQMH/PA\>:
M;J.O:MI-DDSRZS;S6UL]K%+9PEC-,6F150 X9\ XYKZ.^&7_  7H^&_B+]H7
MPA\-_''PZ^-/P9UGXASK;>%[GQUX9_LVRUN5B%2-)%D<J[$H & &74$@D46>
MW436E^A]ST4;AZBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX>?M$?M(?M2ZS9:Q8WNJW4]U-=^$O#UJ) #+<)#;1VXF=VC2-02P+,<#'/\
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MYJ /UEHK\G/^%??\%@?^A[_9K_\  7_[FI/^%?\ _!8#_H>_V:__  %_^YJ
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MN'_0-_9,_P"_M]_\51_:?_!7#_H&_LF?]_;[_P"*H _42BOR[_M/_@KA_P!
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M_;+T3_@H-^R1X.^,'AO3=2T;2/&,$LL5C?[#<6K13R0.C%"5.'C;!!Y&#QG
M_*C_ (*>WW_!2Z7_ ()]?%U?BI8_LUQ_#D^'+D>(3HDEV=1%I@;S!O.WS,=,
M\5]C?\&R/F'_ ((D?!0RA ?)U0#;G[O]JW>.O?% 'WO1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %?+/[?G_!*KP9_P4)^-'P/\;>*-=\0:/?\
MP,\0G7]-@TXQ"+46,MM,8IMZDA=]I$<K@XWCN"/J:B@ HHHH **** "BBB@
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M-/AEO"=/?D0)N5XA<21E2Y&0<@$8"C=L&]/0_8*BBBD(**** "BBB@ HHHH
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M\'?VQO%GBO0_A?X\T;QKJ/@@VXUD:<)'BM1.',1$I41R!A&^#&S#CJ*^'?\
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MSFL+_@GK^QAI/_!/7]C[P7\']$U>^U[3O!L$L2ZA>QK%-=M+/).[E5X4;I6
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MG7/_  ;C7.IZ&N@7W[87[65YX1"B+^QG\6CRFCX_=EMG*X&,$8KZ0_X)]_\
M!'_X$_\ !-%+VZ^&7A22/Q+J<1@O_$FJW!OM6O8V8,R-,W"(656*QJJD@$@D
M#'U#12N,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH  <C-</\ M&_ _3?VE?@'XS^'FLW-[9Z3XWT:[T.\FM"JW$,5
MQ$T3O&6!4. Q()!&>H/2NX P,"BDU<:9\7:=^QYHW_!+?_@D=XF^&?@+P/K/
MQYT;PQIU],/"VK31F[\2P7-PTMU;$QQ%21')*541DML50,D&ORF^#6N?L&Z3
M\%;P#]H?]IWX!:5J),GB3X+6_B&]1H+EF)DLDB6WWRJQ.T$'+ C<0<@?T4E0
M>M9-YX$T6_U,7MQI&ES7@P?/DM8VES_O$9_6J3U=^HTU:Q^%G_!&/_@C2/VO
M/V7OVFDUO2?B%\#/@]\</$]A_P (QID3"#5;G1;":YFBC<W"NQA8S0 N1^\,
M+8)4DG]K/V9/V=/#7[)G[/\ X0^&OA"V>U\-^"M,BTNQ60AI75!S)(0 #([%
MG8X&6=CCFN\" 'CC P *=@9SWH;)ZW/$/^"@'["'@O\ X*/?LOZY\*?'HO8M
M$UB2&XCN[%D6[T^XBD#I-"SJRAA@KRI!5V'0FN@_8Z_9HM_V.OV:O"7PSL?$
M>O\ BO3?!MD-.LM0UJ1)+Y[=6)BC=HU52(T*QJ0H.U%!R1D^G@8&!12&V%%%
M% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
AHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>j9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" &G ^$# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)B_M>^(OV\?V1=$^*^O^%K;PA;^+KN\N-$L8YWEDDTM)WCM9Y"P&'E1-^!P
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MXI']J'X/6>CGP)X>B\1:/XA\#W%S?>'?$S33K;1::D]Q&AAO#-(@VN22NYL
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M\U?X-^5XI\(?LY1>.+S56NI4UYK7^T!_Q))(LF!%68@M( 2K!B20*VOV4?\
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M (-OOCEXQ_:,_P""2/P^\6^/?$VK^+O$M_>ZJEQJ>IW+7%U,J7\Z(&=CD[5
M ST % 'W=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\&_%?]E+Q'
M\3O^"Z]KXIU3PEJ5]\+-4^!=]X2U+5FB!L6N)]0):T9LYWM"Q.,=.<U\R_\
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M&_;A\ _M,?\ !;SX.?%?PKH_PYUCX0?"6T\.VLGAW1O'MC#8ZWXL\16U['=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*\^_:E^&W@KXP_LY>-_#'Q(:%? &LZ-<V_B!IKMK2-++83,S3*08P%!)8$$
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M[GI7Z9_\&J(0?\$3_AIM)R=0UG=['^T9_P"F*^1_^#@2Q_X)^#X<?M!2Q?\
M"&']JK82?W^H_P!H_P!I[X=WR[O(W^5GC&W'O7UU_P &J80?\$3_ (9;<9.H
M:P6QZ_VE<?TQ0!^BU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,?I0!^B]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLT^./'7C^WAN?!WA329M3U6"6W6X6YBC4MY0C8;79VVJH/!9AG'6O2*^:O\
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M]:?,_4A#E12U';Y\I<C# <CKS4E>XF?%-!1113$%%%% !1110 4444 %%%%
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M3)_X*U>&/@LWQ)\6?$KX._M :/K.N:%8^)KHWFH>$-3L2)YDCG/WK>1)"-H
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M'.>]?"?_  6N_:E/@+X867P[TF[>+5?%?[V^,;D/#9HPR,CD;V 'N%>O8O\
M@F;^U&O[3/[-FFSWMQYWB'0 NFZMN;+M*B@"4^SKAL^NX=J\FGFU&6-E@D_>
M23/JZ_".-I9+3SN2_=RDX^:[/T;T/H^BD1@0,=J7->L?*!1110 44$@=>*,T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMR/3Y'*@8Z@,:D^,/_!._P"'NH_#/6;;P?\ #_P/9>(Y[5H]/N+JQ188)6&
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M8:'XMN/%JZ'J4]I& L(O89' :54"@E <XR68DFO3/V$/V-?B[\0_VS6_:/\
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MF&\J._EM[9[R[NO+L99%#.50L HR3@9P!W)K\?\ XY_"[]H;XF_M4WGQ,MO
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MUU?0]C3&T8I:2/&WBEKV3Y(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KRG]MGQK\1OAU^RIXZUSX1^'K;Q5\2=-TMY?#VDW";XKZZR J,-Z9&
M"3C>N<=:]6KPG_@IG^TOJW['/[ GQ:^)V@0VUQKO@WP[<WVG)<+OB%SM"Q,Z
M]U5V5B.X&.])L:W/QPF\$?MQ_M-ZE->?M,?!S]IOXAZ=.YW>$/!WC+2O!_AP
MH3CRY$MRTTR[>/F<$YY)ZU]V_P#!*.*Z^%OQ4L_".C_L 7?[-WA^XLYWN/%L
MNJZ=>S;D0%8I71?M$ID(QEG(!YQBOF#]H?X=?M<_ SP3^S_H5]^UKXLUV/\
M:XUK3O"WB.6;28+:[\(S7:1W3RZ5+&0T6(EFAP<#!! !(V^]?LH?"7Q9_P $
MO_\ @KQX/^"&G?%SXC_$OX7?&'P/J6N)8>-=3.J7FB:C8/'F6&<@$)(C,"H
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M@TZM[G&%%%% !1110 4&BB@!@'0@9K@_VEK_ ,*Z=\!_%4OCA?,\*+ILQU-
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M_:%_;\UOQK(4AN+WP+:K?KT6*XCD195'H-P)'L17<?LI_P#!3!?C+^W)XO\
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M]H66WD>*0^$;B(LO!VNR(P^A4L#[&E+8<=S\FOASJ<W_  4&^/GPS^'>E?\
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MQL\T5!4[V4K:J]M/FTCK:***]4^7"BBB@ HHHH **** "BBB@ HHHH *\/\
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MVEGN+L1@B-'FF=Y"B D*F[:N> *]DHH _E<_X+^? /Q^G[9W[0OBDZ-\$?\
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MP6*_;&\=^"/C39>!/#>M:CX;TFUT^.^GGLI#!<7DDCL /,'S!%"]%QDDYS@
M=Q_P1@_:U\9?&9_$_A/Q7J-WKT6APP75G?W+%YHU=F4Q.YY894$%LG&X9(Q7
MSN"SG!T<7_9=&#5MK+3S/T3.>"\ZQ>3?ZV8VJIJ=F[OWK-V3[?(^^, CGM7@
M/[67_!/#X=?M8:O!K7B*"]T_6;.+R?MUA<"&22($D(^5*L!DX)&1D@''%?0
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M:M=.Y?ZN <BO,/VM?@#??M-?!C4/!MIXCG\,QZJR+=7,5L)GEA!RT6"P #8
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MGQ3K6O:IJ]O=WZB.Y5+>%;M8C'&2@+DMN8,   "0#^L8$'IS17Q)_P $+?\
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MW\ _$GP]KUW8_P!JVFBZG;7\MD9C#]L2*57:+> 2FX*5W $C.<'% 'N?P_\
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M**ONW<\X_P"";G_!-1?VHM/M?&WB/4)K'PU8Z@42P2W(?5!$03^\)P(RV5.
M2=K#([?KC9VJ6=M'%&H6.)0J@# 4 8 K\\OAE_P6T\%>&O%-CX=M/A_<>'_!
M$,BVMM=03H&M8LX#FW5<!0.2JL2!G@GBOOSP?XTTCQ[HRZAHNJ6&K6;';YUI
M.DT8; .TE20" 1P>1GM7Z#PO1P%*@X8.2DU\375G\[^*6,X@Q>/CBLZI2IPE
M=TXNUDNVG7:YKD9&>OI7D'[<'BWQ?X1_9VU\^!-&U'6O%&H)]BLH[)09+8R
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M]A#]I!_!?[1EA9:]X?\ #GB31O&NK1PZA!=Z1;R&"69]JRPG9\@5B"4 "D<
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MN>+-;L="TN)@AGN9 H9CT51U9CV R?:N7%4J-2DX5TG%[WV/1RK%8S#XJ%;
M2:JIZ<M[W\O\C\@_^"@O[.2?L/>,=)\(>&K[6?[,US3OME[J$LNR74G61E\H
ME0%V(-IV#C+Y.>,>R?\ !$SXB^(?&GCGQ/X)U=Y]=\'QZ<MX8;X&XALIO,"J
MJ[L@!U+';T)3( Y-?95Y#\%/^"D/@=HO,T?QKIVF2]8W:.XLG(Z\;9(\CZ9
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MB2WMM5FNTM@Q9,;M^U@R$$@@X)QG(S7-@,RQ&98JGB,.[0C=-.^O?I8]'/\
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MZ^([SX2VWBFQ\ WEY)/I-GXA6$7UE$S$B)FB9E8*. W!( R,Y)_KX_X+F?\
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M>2",]Z[<B_LA8J<<"K32L]^G8\?CS_7&658>KGT^:C)WCMHVKJ]K=#U,GH,
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M\_&B?#MOV5?VL-%T;XU>#-?M+;PEKEI-XG\-7$ @OY[9)$EEMRLA !DCX!)
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M!,(.[RV# Y .#G.,C/%>-?\ @LI\2M6U#5(/#EAX>\/:%>)+#:6\=JS7%LC
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MC;XC+X@T*;3;32+ZQMUBM-.4N-LC"8.,# *L"!\K >J_#_X^:7_P4V_X+K^
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MP):7%N/"/B76M,UO5[0VL;37,]@TIMV64C>H43RC:"%._)!(!'4_M+^/9_\
M@H+^WQXH\0>"O#]Y87WQ:\5-/I6C7>H1RS)<7<H"0F=@B$F1L G: " 3QFOK
M#_@C5_P1"\*?\%>_V</BQ?:+\1=3\/?%KP((4L-%N;&,:5,9PS6\LLX+2%',
M,T;!4!1MK98':?AWX_\ P(\7?L@?M ^(_ 7BRVDT3QEX(U)K*\2";=Y,\; K
M)%(O53\K*XQD%2#S0!_69_P;R?\ !,_Q3_P2_P#V!U\(^.KBW;QGXIUN?Q'J
MMG;3B>#2WDBAA2W5Q\KLL<*EF7(W,0"0 3]XU^;G_!K9^V!\2/VQ/^"9,>H_
M$N]U'7-3\)^(;KP_8:W?,9+G5;2**&1&D=N9'1I7BWDDD1C))!)_2.@ (!ZU
MX)\2?^"<O[._BSXQ2?%CQ1\)?AW>^,M//VZ;7[S286E#1C=Y\I(VNZ@9WL"1
M@'/ KWNL7XA^"K/XE> M<\.:CYGV#7["XTVYV'#>5-$T;8/8[6//K0!^,OQ%
M_P"#T_X8^%?VC)M!T7X4^(O$'PYLKTVDGB1-3C@N[E%<J;F&T*$%,#<JO(K,
M,9VDX'[&_!WXLZ#\=_A3X<\:>%K^/5/#GBO3X-5TR[0$+<6\R"1&P1D$AAD$
M9!R#R#7\PGQ%_P"#0G]J;0OVA[GPUX<MO"FM>!Y+UDL_%LVM0P0I:EOEDFMR
M?/$@3&Y$C8$Y"DCFOZ4OV+_V;+/]CK]E'X>_"W3[Z74[;P'H=KHXO)%VM=M$
M@5Y=N> S;B!DX! R<4 >H  =!1110 $9&#7Q?_P7I_X*$>)?^":'_!.OQ#\1
M/!EI;7'BZ]U"UT'29[F+S8-/FN"^;ET/#;$C<J#\I<H"",@_:%>9?M=?LD^!
M_P!N/]GSQ%\,OB)I9U;PKXDA$=Q&LABF@=6#QS1.!E)$<*RM@X(P002" ?Q_
M_$G_ (*2?M/?\%*[32O@[XQ^)&L^/;7QGXCLC8:9J*VZ1C46<PP%'5%\I<S$
M8!"@')'&1]E_\$A_^#:_]I6+]OCP)XF^)W@NY^&_@SX>:];:Y?W]Y?6[RWS6
MLHE2"V6)W9R[HHW\*JDG)( /ZE?\$_\ _@UC^ W[!W[26F_%"/7O&7CW6_#L
MYNM"MM<:W6UTR?D+.5BC4RR)G*EB%! 8+D C]. ,# H ***1L8&<XH 8X# Y
MP17S'_P4N_9L\$^.OV<?&?BG4?#^GR>(]&TF6>TU)8@EU&T:[E&\<D<8P<C!
M(K\M_P!OWXM?\%1_V<_C%XNUB'QUX>\/?#G4?$E['X76270Y9FL3.YMU$>QI
MCB'83N!([G->4_#K]I#_ (*-_M$Z;KD7B+XA:#XB^'NDPB3Q7;+_ &/;SG3C
M_K65!&DS KN&8QD'C@D9\?,ZV%G3GAZC3DTVD_3<^QX8R[-*6(HYGAXRC34X
MIR5TMUHVN^Q]_?\ !/S_ ()/+XW'@WXF>(_$,%QHDJP:O;:7;V[*\KC$B+([
M,1M#8)"CG&,@$U^G4:"-5 7&T8Q7\]_@S]JC]L'X+:PFD7OQ:N?"/@(VL=UX
M5TS3M,TNZF;3W+>2S2/"[)A5(VOESWQQGN?@%\?O^"A?[0?[3?A^S^'OQ6B\
M8>"M-U"RNO$EOJ-GH]C<6MB;E5F&6B0R QA\&/Y@>, X)\?(<9EN'DL%AW:;
M2;\W8^U\0,EXFS&E//LP?-1BVHZI6C?33[C]W1T%##(Q2)]T4M?8'XR1F'/7
MI_*AHP4(Z!ABI**30[GYV?'W_@A[)XY^+]_K?A;Q=:Z+HVL7374]I=6;S26C
M.2SB-E8!E))(#8QG&2!7V?\ LT_ #2?V9?@[H_@W1I)9[32HV#32X\RXD<EG
MD;'=F).!P./2O0"#TS@TO4X&:\O!Y/A,-5E6HQLY;L^FSCC+-\TPE+!8ZLY0
MI[)V[6U[Z=Q]-D4%<$#!IU%>J?,7/R$_X+5^!;3P9^U'I<^GZ1;:;;:MI7VI
MYH(%B6[N/-<.[$#YG V DY/(KX]GN)KI][M+/)PHR2S,>@ SR?3%?O\ ?'/]
MFWP7^TAX=ATSQGH5KK5K;,9(?,RLD+8P2CJ0RG''!&:\^\#?\$S_ (+_  Z\
M6V>MZ;X+LDU'3R'MWFEDF6-P<APKL5+ \@D$@\C!K\XS;@JMBL7*M3FE"33:
MZKOH?TIP=XX83*<EIX#$4)2JTTTI73]-6[HX/_@F;^P#=?LFZ?>^(=0UUM1O
M?%6GVQEL_L0A%D5W.5W%BQ.6QC@<9Q7UR '4XSQ4$4T60B.A*#  ;G\JG"$@
MG/6ON\#@J6%HQHTM$C\"SW.L7FN-GCL;+FG-_P##?<@)"\'->(?\% ?VEA^R
M]^S;K6NV[ ZW>+]@TE -S&YD!"G'<( SGV7WKV\ \8/.*JZAI5OJT02YABN%
M7D*ZA@#ZC-:8FG*I2E"#LVK)]CERZO2HXFG6KPYXQ:;6U[/;YGY7_P#!'3]J
M:7P5X[U_X?Z[=.+3Q.DFH6,D[D;;Q5)E4YZ&1!N^J'N:T?@9XC\8P?\ !.?Q
MGH?@/2[K5-?\2>*K^P)MY8T>T@<CS)2688^0%1@YRX/:O7?VQ_\ @G)\&/A=
MX-\8_$W6Y?$T4BF74&AAU5HTDG<G;$@QQN<@ #IGT%?,?_!,7]FGX<?M:ZEK
M_A_Q3<:_8^(=/Q>VBV.IO MQ;G"MQCED?&3U(<>E?GL*6,PU6GE]5IRM))WL
M[.WEN?T+B*^39GA\1Q'A(2A",J;G%PO'FC?:S5UJK_\ !/8/^"27PS^+O[.'
MQ@O=*\0>"=:LO!_B>+]]<LT3Q6=Q&"4D^5R<,"4) _N\<5^E"D,#T-<3\ _@
M=HW[.WPOT[PIH+W\NFZ;O\I[RX:>8[G+'+GJ,D\   =!7:G)&.G]*^VRC+_J
M>'5"[=M=7>Q^)\7<0?VSF4\<X*+E9:*U[:)M7>MO,DHH&>]%>H?,A1110 44
M44 1L0H)/ '-?FQ_P4'_ ."C&H?#G]MCPKIWAZ]D;1?AY<A]7CA<E;Z250)8
MFP<'9">,CAF/<5^DS*)$(R06XXKYO\0?\$H_@KXHU^]U2_\ #-Q=7VHSO<W$
MSZE<EI9')9F)W\DDDUXV<8?%UJ48822B[IMOLM3[#@S,,GP>+G6SBFYPY6E%
M+J]+OT/?/!WBRQ\<^%-.UK39TNM/U2WCNK>9#\LB.H92/J"*\]^*_P"U[X7^
M$/QR\%^ ]2F(U3QFTJP,&&VVV+\F_N/,;*KZD5Y3XR_:D\%_L*?%7X:?!G1[
M3R=(U+?'.\MP\ITJ.1F6W^9B20TQ*X)PJ^@Q7R/^U/\ L=_M%?M _M'ZQXY3
MPC- ?M:G2"NIVP:UMXF_<8_><'@.<?Q,:Y<PS>I2IVP\>>::32U2VN>GP]PA
MAL5B7+,:OL*,HRE"4K+FW4;7^]_\$_61'W(" "#3^3R>0*X[X%:OXDUGX3Z#
M<>+],_L?Q*]HBZC:"1)5CF PQ#(2I!(R,'@'!Y%=@,G@<U[]*7-%2M:Z^9\#
M7I>SJ2IW3LVKK9^A\L_\%L/COX[_ &9_^"6_QC\;?#8W$/B_1=%!M+N!=TNG
M))-'%-=(,?>BA>20'HI7<> :_DG_ &,/VR_B_P# G]L7PEXW\#>*O$USXWN-
M;@&TWLMP^N-+*%:WG5B?.6;<5(;));(P0"/[==7TRUU[2[FPOK6"]L[R)H9[
M>>,213QL"K(RMD,K D$'@@X[U^?G[1/[#G['W_!&#X;>-_VI]*^".A0:_P""
M;<7ME';O+)Y=W*XAA2UCE=HK8O)*HWJ@* DJ !@Z&1Z5_P %U/@=\1/VF?\
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M:U67X>7>J:;XC\/I'+JWA[6(5AO[1'P!*NUF26$M\N]6.#@,%+ $ ^M:***
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MIOF;5M;)O^D>=_L:_LQ^"/VK_P!F.Q\/^(_$MUH,M[XQU.;38K%H4EU-E0,
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MF39W6S-5:,H.#5TF?K/&G ^"X7E@\53KJNIV;CIJE9O;H]C\2/AA^TEX_P#
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MXVJ%Z=\GOFOO_P" 7ASQ-X6^$'A_3?&-U97OB.QM$M[VXLV=H9W4;=X+ '+
M G(ZDXKM.0.%Y'O2X .0>3UKS,'E5##595:5[RWN[W/ILYXLQ^9X6CA,4TX4
ME:-DE9;6NAP0#M2T45Z9\R?+7_!:?]H[QK^R7_P3 ^+_ ,0/AZ)4\6Z#HZ_8
MKE(Q(VG^;/'"]T%P03%'(\@)! * D$ U_'LGQ\^)_P :/$MQHNH^.O''B"7Q
MU=PVFHVUQJUQ=G5G>9"HD1W(E;S-I4$$A@",'%?W.^)/#6G^,O#]]I.K65KJ
M>E:G!):7EI<Q"6"ZB=2KQNK##*RD@@Y!!(K\R?VO_P#@G+^R;_P1-^"GCO\
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MM>4X"EA,-&C2O;>[ZW[G\/\ %_$6+SK,ZF.QEN9NUD]$EI9'"_M-ZS\0- ^
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M HHHH *"<#)HH89&* *>IWL.FV$UQ<2+'#$A=V8@  #)/L.*_/;]F_\ 9I^
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M_0]K/,EQCX5CCL[Q<O:S:E3A)O9:/?JT[GWU1117VY^)!1110 4444 %%%%
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M9FO;LVTEPS%'7Y!N$R@9Z8/M7Z)Y..!B@#\#_P#B%L_;#_Z/)N?_  :ZS_\
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M>NZ^7U'"35G;JCXI\1_\&SO[6?CO5I=8T[]J;2/"]KJ86=-.T:?5K*TMP5&
ML:,!G&,DC)/)-43_ ,&MW[80Y/[9%US_ -176O\ XY7[QZ-9MI^D6MLY#-;P
MI$6'0[5 S^E620& )&3712I1IQ4(*R6B2['EXO%U<56E7KMRE)W;?5GX)?\
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MYZ5^B@8'I0!^!_\ Q"V?MA_]'DW/_@UUG_XY1_Q"V?MA_P#1Y-S_ .#76?\
MXY7[XT4 ?@=_Q"V?MA_]'DW/_@UUG_XY67XP_P"#3K]JGX@^';G1O$/[65IK
MFD78 GLM0O-7N;:;!##<CN5." >1U -?T"9&,=!TH8X&3G\* /X\_P!DK_@A
MQXR_:>_X*7_$S]G#1_'OA[1/$GPJ-[)/KDUM.UK=M:7,4),2K\ZDM(&!/0#U
MQ7Z.#_@UK_;#'3]LFY_\&NL__'*^W?V'_P#@B_XJ_93_ ."P?QG_ &E-2\:^
M'M5T+XGC4Q::-;6LR7=E]JNX9UWNWR':(R#CJ2,<5^B@Z"@#\#O^(6S]L/\
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M#O\ B%L_;#_Z/)N?_!KK/_QRC_B%L_;#_P"CR;G_ ,&NL_\ QROWQ!R :,T
M?@<O_!KA^V"#D_MD71'_ &%=:_\ CE>R:=_P0C^,_P ,OA6C:W\2/"_BN\T'
M3WEN=0U&[O[BYO"BEV)>168 G( )(48'U_8H$D@$@@UE>-M!;Q/X,U?3(I%B
MEU&SFM5=@2J%T*AB!S@$YKAQ^74,9!4\0KI:VN>_P_Q-C\FK/$8"?+)JU[)Z
M?,_FV_X)E_LM_&__ (++^'?&WB_X=>/_  G\.=%\*ZG!I<FGZS8OJ$LDCP"0
MNLB1CY?9N0>^,5[[XB_X-BOVP-?U>6[7]KJTTT2XQ;:?=:M:VL(  "I'&X5!
M@=  /:ON;_@@=_P2!\3?\$@O@_X^\,^)O%^A>,)_&&LP:G!-IEM+ MNL<'E%
M6$G))/.1VK[ZQU.00:>#R[#X7^#!1=M^K]0SCB?,LT?^VU7-7ND]EZ(_!+_B
M%L_;#_Z/)N?_  :ZS_\ '*/^(6S]L/\ Z/)N?_!KK/\ \<K]\00>G-%=IX!\
M[?\ !+7]E#QK^Q+^Q9X8^'/Q"\:M\0_%6BS7<EUKAEGF-TLMS)*@W3$R':CJ
MO)P-OIBOHFBB@ HHHH **** "BBB@ HHHH ,=#Z5\F?\%T/#VH^+?^"1OQ[T
MW2+"^U/4KWPO+%;VMG \\\[&2/Y51 68D9X /%?6=<)^TE\(KSX\_ [Q+X/T
M[Q9X@\"ZAKMF;>VU_0Y1%J.DR9#+-"QX# @<<9!(R,YI,<=S\:?^"@O_  5E
M\'?M*_L1?"OX>^%_A9\?DUSP9XH\*:M>?:O 5U# L&FS1-<;&!)+!48*,#)P
M,C-?HG^Q_P#\%F_AS^VK\;K3P%X;\#?&O0=4O+:>Z6[\2>#)M+T]5B3<P:9V
M(#$< $<GBO*+/4OV_OV#=J:A9^"?VPO 5F<&XLF3PQXSCA!^\48FVN&"]@2S
M$=>:]H_8U_X*]?"_]K[XH-\.&L/&OPU^+EO;/=W'@CQKHDVEZJD2 EWC)!BF
M0 $Y1R<<X IB/JT'(S1110 4444 %%%% !1110 CG QZU^5/[2G[-MM^W%_P
M<">(_AMXJ\:_%#0O"6C?!VPUVVLO"_BN[T9/M?\ :,D)=A"VTY1B.1DX'/ K
M]57[5^3/[37[:?@7]@'_ (.(O$?C?XER>(M/\-ZQ\&+#1[6[T_0KO4Q)=?VE
M)+L(MXW(PB,<G ' .,C+BM0Z,N_%OX6^,?\ @B#^U_\  S7?!WQ6^)?C?X(_
M&'Q=;^ O%'A7QKKDFMMI=U=@BUO;.>3YX]K*=R@\[<$D-\MCX3_ 74O^"SG[
M6/[3&N^/OB1\3_#7A#X3^+Y_AYX&TCPEXCN=%BTF:UB7S]2<0L!-<-(RD>9N
M4#(((QC+^,W[1,O_  70_:Y^ 'A7X2>#?'D?P>^%'C*W^(/B[QOK^ASZ18SR
M68)MK&U$ZAY)'=B#P"-P.,*34_[.W[8OA+_@C7^UO^U5X+^.">(?#>E>/?&M
MU\2O!6JPZ-=7UKXHM[V)3+:6[PHP-S'(BIY9QDD\@#--?C_PQ70^E?\ @AK^
MTAXS_:%_8MOM/^(FKR>(O&WPN\7ZQX"U76)5VRZNVGW!2.X?U=HV0,>I*DGD
MFOLH?>-?$7_! WX-^+/AM^Q1J_B;QKHFH>&=>^+WC?7/B VD7Z&.[TV"_N2T
M$<JD91S$J,5/(W@'!R!]NC[QI-$@X!(S7XV?\$K/^";/A_\ X*&?"GXI>.O'
MOQ-^/=OK]K\4?$FBV[:-\0K^PM[>W@NL1!(@Q4%0Q'3&,#&!7[)MU%?BO_P2
M7_X*\_!C_@G_ /"GXJ^ _B7<^-M.\43?%;Q-JL5I9>$=2OEF@FNP(BLD4+(2
MVTX&X=O6DMV![?\ L1Q^/OAA^V'\<?V'/B-\3_''CKPM/X+C\4^"/%]QJ)C\
M3Z=IERYM9K9[L#<9HG.4E/(*$@ ,%7Y\_;__ ."=*> _VF?A1^SU\%OCQ^U#
M>?%SXESG5-0O=5^)E]=67A+P_ Q^TW\T2[2[OM:.)2P!8'O@'Z;_ ."96@^,
M/VTO^"F7Q4_:XUWP1XE^'O@2]\,6O@#P%8>(;0V>J:M9Q3"XFOY(&YC1I!A0
M<Y#XR=I-:O\ P2R\-W'QT_X*6?MA_'/7;6\^WV/BF+X8^'3<P&-;?2]-A1I#
M%N&2LLS*Q(X)7KR::L/HS[R^'G@]?A_X!T/0$O\ 4=370[""P6\OYC/=W8BC
M5/-E<\O(V,LQY))/>OC?_@XW\9ZU\/O^".OQ>U?0-7U30M5M4TP07VG7<EI<
MP[M3M5;;*A#+E21P1D$@Y!(K[C P,"O@_P#X.5M.N=8_X(O_ !CMK.UN;RY=
M-+VQ01-+(W_$UM"<*HR< $\#IS2;!'%^)O\ @@SIZ_!B/7/A7\=_VC/!/Q)C
MTU+_ $?49_']YJ%FMYY0=$GMY25DA9^&'!P<\XP>>^!/Q&^/W_!:#_@F?\$Y
M-'\9#X<3WOB2XT3XQ:QHUVVG:Q<6MA))!,NGO&A$;W#JC,05VAB%)&5.UJO_
M  <8_!Y_@ZND_"SP_P#%;XG?$=-+2TTCP_IW@?4HWNKSR@B!Y)851(P^"S9)
M !(!X%>%Z_\ M _$#_@WZ_X(W?"OP(VFB7XZ_%;5+^]NKI[&74-.\)2W<_GW
M5U.D*N93;)-&HC4-N<,<,JD%N]PZ(]3^&'@<?\$_?^"V?PQ^#'P=^('C[Q3X
M4\=>#]5U;Q[X0\0^(9]>A\/"",&QU%99V=[=YI?W97=A@0<89<?#OBK]H70[
MS]FCXN^/?B;^T+\7?"G[>'A_Q;?6>C>$K'Q!=P'3[U+L)8:;::6G^CS6<D90
M,Q4C#,2>,-]=_P#!)KX^_LX>&T\4^!?A=X]\>^/_ -IWXR65_<ZMX]\3>$]2
MLKG6=16TEE4^?/"([>VB9<I%NP,#.3C'S_\ !#XO_LU?!W_@D-XK^ 7Q9^%N
MNM^TS+!J.GZSX7N_"EU=^)_$?B*623[-?VUT(F,@+F)DE60!%7 R,;G=I=PM
MJ?N%\ M5\3:]\"O!=]XSM%L/&%YH5C-KMLJA5M[YK>-KA !P-LI<8!(&,9KL
M:\*_X)G^!/'GPQ_X)_?![P_\3I;F;Q[HWA6QMM:-S+YLZ3K$!Y<CY^9T7:K$
MDY92<GK7NM)DH_-3_@MSX*N/C9^W?^Q9\,[GQ1XV\.>&/'VO^(;76E\-Z[<:
M1<74<6GPRH#)"P)PZ@C(. 6 QDUY_P#\%"/V'O%?_!'GX%S_ +1_P$^,?QAO
M)/AO=6UWXF\(>,/%4^NZ/XDTM[B.*:/9/S'*!("'!) !Q@@&NO\ ^"Z'QKT/
M]F?]OS]B'XC^*EU>+PGX/\0>([G5;JPTV>_DM8WL(8E)CA5G.7=1@ GJ>@-<
M+_P44_X*4:=_P6&_9UOOV</V9O"7Q"\7:W\4+NUTW6?$.H>%[S2]%\+Z<EQ'
M+/<3S7")SMCP% YR>2<*9C>R*6^NQZ1^T]XOU/\ X*:?\%+_ (:? 2#Q9XQ\
M'_"*S^&:_%#Q+;^'=5ETJ^\1O=3K#9VDES"1(L* [V",-Q)'4 CJO^"8NL>)
MOV7/^"A/QU_9<U/QAXH\<^"O"NCZ7XU\$W?B*^>_U+2K*\+13V#W#Y>6-)@/
M++$D#/J:X3]H^[T[_@E3_P %7OAE\8_%EMK:_!CQ'\*H_A=J/B.VL);N#PY?
M6=R)K9[I8E9DCF0;0VT@,&[ UU?_  3'U^7]L_\ X*=_'[]IK0M-UFT^%FI:
M!I/@'PAJ.H64MDWB-;5FFNKR&.558P"4A58@;@3P""!32#N?HH#D TC\J1ZT
MHQCCI2/]TT@1^27A']CG3?\ @H5_P6>_;"T+QOX\^+VF:/\ #]O"YT6R\-^-
M;W2;:V^TZ;NF'EQ-M^8QJ> ,$L>22:ZOX<:'XY_X)"_\%3/A)\*H?B;X]^)?
MP*_:(M]1L=.L/&6IMJNH^%-8LXA,##<N [0R(0NT\#<2<D G@?!__!1#X:?\
M$Y_^"VG[9M]\4Y_%&E6GC1O"RZ1-8>&[[4X[HV^F8F^:WC<#:94'.,DG'0UV
MG@?XEZM_P64_X*M?!CXD^#_!GC3P]\!_V=+?4=3'B3Q'I$NE-XGU>\A$*0VD
M4H#O'&H5BQ QA@0,KEIW] [G-?\ !7O]A7P5^QK\"_$GQ&MOC'^U5JOC_P <
M:T-*\'>%K#XG7<$&JZW?RMY%M%$JY6%"68JI&$CV@@D5]U?\$N_V4/%?[&7[
M%WA+P5X[\;^(OB%XUCC:_P!=U;6-1EOY1=S8>2"*21BWDQ'"("3D*6XS@?/'
M[2>@W7[4G_!P)\#_  =J%I>2^$/@7X(U#XA-NB;[+/J]S,+.WRV-I>)0)!SD
M'/%?H<!R#[5*=EZ@U8\]_:OO[C2?V7/B7=6LTUM=6WA75)89HG*21.MI*596
M'(((!!'(/-?F'_P2\_X(^>%_VQ/^":_PK^)&N_&']H_2?''C'0!>W.HZ9\1[
M^-;>X\R10Z1.60 ;5.T@@\_6OTY_:ZB>?]E+XH1QJ\DC^$]5"JH+,Q-G+@ #
MJ2>PK\M_^"3O_!=+X%?LI?\ !-'X1_#GQ$/B3>^//"F@"QN]#TOP1J5U/+<"
M61A%$XB$3$AEYW@<\GTI;$]4=U^R9\8/VH_C=^R5^TK^SGH_CS2=1_:!^"/B
M>+PCIWCS5',#W6E7)5X[YRJ-F[6W$H4D$[O++$L"QY3]KS]FX_\ !);XK?LU
MZE\)OB_\7?$/Q>\>^.].\.:OX?U_Q1=:W#X]T^5@-0N9K65BD7E##"2,*(]X
M'4 B3X ?'OQQ_P $X/V-OVGOVR_B5\.=:TWQM\>O%\>I>&/ LT+F^MX AM]-
MBNPH+1D@O))D A$X 9@*X#_@F#^WQ^SW;?M V/Q?^-OQ!\9_$O\ :@^(3P:3
M%<'P'JT.C^#(KAPB:9IJM!LAC4N%><D%OFY +%GU*3U.G_;C^)/@?Q;_ ,%9
M?BWX2_:V^,WC_P"$/PW\.^&-/OOA99:3XBN]!TW4D>(_;;T2VW,]W'."JQON
M/4;6  K[!_X()_%/XB_&3_@G%X;UKXBZGKNOS/JFH0>'-;UJ+RM1UW0DG*V%
MW<#J9'C_ (F&6"J3DG)^3?#/Q3^$'[#G_!3[]J?5/VN?#LD.I_$'4HK[P/XH
MUWP[/K.EZIX>%N%&FVCK%*L<D9&UH@%+$8.2!GZ"_P"#>'X=Z[X*_9E^)&H#
MP]K_ (.^&7BSXBZKK?PU\/ZS%)!<Z7H$IC,($+_-%&[AV5#C .0,$$JP-'Z!
M5\+?\''_ (RUOP%_P2 ^*.J:!K&K:#J<,NDI%>Z;=R6ES"'U.U5MLD9#+E20
M<'D$CH:^Z:^"O^#EW3KG5/\ @C5\5H;6VNKR=I=(81V\32R,!JEJ3A5!)P 3
MQT%)6NK@MSCO'O\ P0?L](^#4OB#X1?'?]HKP5\2[/3AJ&B7]UX_N]2L6NUB
MWI'<6\Q*O"S#:PXP#GG&#XI/_P %)?B9_P %$_V'?V0? =MXEU/X?^-_VAO&
M-]X3\<Z]H+_9+V"UT<2?VB;5U_U,EP%0AEX7<P&!7LWB_P#X.+_A'J?P9FT;
MX0>'/BM\3_B;+I@L]%T'3_ ^I1>?>M&$C,LDL2JD2N068$D ' -?/<G[#_CG
M_@EW^Q5^Q9\3O$VA:OX@U+X%>-M2\1_$>PT6!KZYTRUUU9!=3*D8)D%J&C5M
MN1G<02.::N-(^@/AGX%U'_@E7_P5O^$WPJ\+^-/'GB+X0_M!Z!JP.B>)];N-
M:;0M7TV)9A<6\\[-(B31L0Z9P6.>@ 'Z7@@].:_,3PM\<]"_X*P?\%E_@MXU
M^$W]L:]\+?V=_#^LWNL^*I--GLM/N]3U*%((;&!ID1I)$0;WPN  02".?TZ
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M +67B+]M?_@F[\-_'GC"5)_%T]O<:5K<Z($6ZN[.YEM9)L 8!D,0<@  %B,
M<5]45\B?\$,?V:/$_P"R;_P3 ^&?A3QI92Z7XLN(KO6]5L)?OV$U]=S77D,.
MSHLJJP[,&':OKNF]R3&\>S/;^!]9D1G21+"=E920RD1G!!['/>OQY_X(U?\
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MX,?L1^,'\6^'M)U?Q)\1;B%H+OQIXKU276=>N4<8<&>4XC##@K&J@CJ#7TX
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M2#/"".Q<9%+_ &E;?\_$'_?8H =- DT921%=&&"K $'Z@]:(HEMXPB (B@
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M#*1[@U,!@8%% $<4"01*D:JB*,!5 51[ =JDHHH 1E##!J-+2-""L:(1T(4
MU+10 5#%:16[NZ1QHTARY50"Q]21U_&IJ* "BBB@!DD2RKAE##W (HBA2+(5
M57/H *?10 UXU<8901G/(S3@,# HHH *C-M&YRR(Q]2HS4E% ";   . .U1_
M8XF&#%'_ -\BI:* (_)0)L"KM(P1@8-,M;"&QA\J"..&/J%1 J^_ J>B@ H(
MR,444 1?98MV[RH]W^Z,U+@9SCFBB@"'['%]H,WEQ^>1MW[1NQZ9ZXJ:BB@
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MP+HC'H-R@U)11<",01H<JBJW3( !J,:? MV9Q#$)R,&38-V/3.,XJQ01D8-
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M+10!\HZE_P $1?V7]9U.YO+OX66\MS>3-/*_]NZH-[L2S' N<#)).!@"H?\
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MP0*=F+S*'_#C+]E;_HD]O_X/M4_^2:/^'&7[*W_1)[?_ ,'VJ?\ R37UI12
M^2_^'&7[*W_1)[?_ ,'VJ?\ R31_PXR_96_Z)/;_ /@^U3_Y)KZTHH ^2_\
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MS!DF3(:-F+;6W=015./XCZGU4/\ @FI\2CT_;$_:)_[YT+_Y7USGC/\ 8O\
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MAS_Y H_X=T_&K_H]/XW?^"#PY_\ (%?7]%(#Y _X=T_&K_H]/XW?^"#PY_\
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M*MIXK\06\UUIND3:7X92]OXH0#+)%$;'<ZH",D @=ZZ3_AW3\:^_[:?QM_\
M!!X<_P#D"OS\\7_M>_&7]J[]M3]@3XG^!/#?@F;XL?$OX8^(72'49)X-"TAI
M2!-=2!2TKQQ1HS>6K;F;"@C.:^Z?^"?_ .V=\;-;_;8^)_[/'QZL/ %]XL\#
MZ%8^*M+\1^$(Y[:RU:PNI6BVR6\S.T<BN .&(.&XQ@D<;"-O_AW3\:O^CT_C
M=_X(/#G_ ,@4?\.Z?C5_T>G\;O\ P0>'/_D"OK^BD!\@?\.Z?C5_T>G\;O\
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MO'.J?%#1?BGX TW2[R!_#;26:*RZ:ABP8U1 82S(JEB&&5R:^FM<\0?M;_\
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M2\/S>&[W[3%)_:*6M@T4QV*Q=-KD##A<]1D<U\F?\.R_C<G[.$FAKX+8ZO\
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M -&0_M9?^$PW_P 31_Q$A>)?^C(?VLO_  F&_P#B:_4&B@#\OO\ B)"\2_\
M1D/[67_A,-_\31_Q$A>)?^C(?VLO_"8;_P")K]0:* /R^_XB0O$O_1D/[67_
M (3#?_$T?\1(7B7_ *,A_:R_\)AO_B:_4&B@#\OO^(D+Q+_T9#^UE_X3#?\
MQ-'_ !$A>)?^C(?VLO\ PF&_^)K]0:* /R^_XB0O$O\ T9#^UE_X3#?_ !-'
M_$2%XE_Z,A_:R_\ "8;_ .)K]0:* /R^_P"(D+Q+_P!&0_M9?^$PW_Q-'_$2
M%XE_Z,A_:R_\)AO_ (FOU!HH _+[_B)"\2_]&0_M9?\ A,-_\31_Q$A>)?\
MHR']K+_PF&_^)K]0:* /R^_XB0O$O_1D/[67_A,-_P#$U\>?\%9?^"JVJ_MZ
M^)OV9?#>H_L]?&KX0QZ/\9-#U-=3\9Z0;*SO"&>/R(V(&9"'W8_NHQ[5_0)7
MQ;_P63_X)^>-?V_-%^!5MX,N]$M'^'/Q2TKQ?JO]I3O$'L8%D67R]JMND&\$
M*< \\B@#[2HH!R,T4 ?GY_P="%Q_P1/^+VP*PW:7NR2,#^TK;I[_ %KPW]GC
MXD?\%4+;X!^!X_#OP[_9DG\/Q^'[!=,ENM0NEN)+46T8A:0"YP'*;20 !G/
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M /!6K_HFW[+/_@QNO_DFC_A9_P#P5J_Z)M^RS_X,;K_Y)K]0Z* /R\_X6?\
M\%:O^B;?LL_^#&Z_^2:/^%G_ /!6K_HFW[+/_@QNO_DFOU#HH _+S_A9_P#P
M5J_Z)M^RS_X,;K_Y)H_X6?\ \%:O^B;?LL_^#&Z_^2:_4.B@#\O/^%G_ /!6
MK_HFW[+/_@QNO_DFC_A9_P#P5J_Z)M^RS_X,;K_Y)K]0Z* /R\_X6?\ \%:O
M^B;?LL_^#&Z_^2:/^%G_ /!6K_HFW[+/_@QNO_DFOU#HH _+S_A9_P#P5J_Z
M)M^RS_X,;K_Y)H_X6?\ \%:O^B;?LL_^#&Z_^2:_4.B@#\O/^%G_ /!6K_HF
MW[+/_@QNO_DFC_A9_P#P5J_Z)M^RS_X,;K_Y)K]0Z* /R\_X6?\ \%:O^B;?
MLL_^#&Z_^2:/^%G_ /!6K_HFW[+/_@QNO_DFOU#HH _+S_A9_P#P5J_Z)M^R
MS_X,;K_Y)H_X6?\ \%:O^B;?LL_^#&Z_^2:_4.B@#\O/^%G_ /!6K_HFW[+/
M_@QNO_DFC_A9_P#P5J_Z)M^RS_X,;K_Y)K]0Z* /R\_X6?\ \%:O^B;?LL_^
M#&Z_^2:/^%G_ /!6K_HFW[+/_@QNO_DFOU#HH _+S_A9_P#P5J_Z)M^RS_X,
M;K_Y)H_X6?\ \%:O^B;?LL_^#&Z_^2:_4.B@#\O/^%G_ /!6K_HFW[+/_@QN
MO_DFC_A9_P#P5J_Z)M^RS_X,;K_Y)K]0Z* /R\_X6?\ \%:O^B;?LL_^#&Z_
M^2:/^%G_ /!6K_HFW[+/_@QNO_DFOU#HH _+S_A9_P#P5J_Z)M^RS_X,;K_Y
M)H_X6?\ \%:O^B;?LL_^#&Z_^2:_4.B@#\O/^%G_ /!6K_HFW[+/_@QNO_DF
MC_A9_P#P5J_Z)M^RS_X,;K_Y)K]0Z* /R\_X6?\ \%:O^B;?LL_^#&Z_^2:/
M^%G_ /!6K_HFW[+/_@QNO_DFOU#HH _ 7_@HMXN_;,\1?M7_ +&Z?M.^%OA!
MX?T"+XQ:2=%D\(74TL\MU]HA#B4/*X"!.00!SWK]^J^<OV\O^"=&@_MX^-?@
MOK>L^(=5T*7X,>,[;QC:16<*2+J4D.#Y$A;[JDJAW#) !&.<CZ-H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H[ES';NPZ
MJI(S["I*CO/^/.;_ '#_ "I-V0T?,'_!+G]OZ]_;C_8I'Q9\8V&@^#O+UC5M
M/N%ANBMG;PV=W) )6DE/&0F220 3Z5[=X&_:$\ ?$Q+1_#?CCP?XA34)I+>U
M.FZS;78N944,Z(8W.YE4@D#) ()P#7X-_L_:;:_%7_@GI^Q[\*?%EW/;?"GX
MF_M >(;#Q?$LYMH=32&\NI;6RE=2"(YI<@KD9*C'(%?4_P"TC^Q'\'_V2?\
M@O!^QS-\*_#6@^!=5\4VWB--3TC1HQ;6CK!ICI!=_9UPJ.2[H7"@N$&22N:K
M0?<]GU7_ (*@?';]L/X^^./!?[)7PS\$:]X8^&NIOHFN_$#QWJ<]MHUQJ$9'
MFVUG#;#S)BAR"^<=#@ J6[/]C3_@HM\5M4_;!NOV>OVB_AOH?@?XE3Z(_B3P
M]J_AB_EOO#_B>RC<)-Y32CS(I48Y*,22 <XXW>0_\&W'BP:?_P $\/&_PNL;
MO3].^,/PX\7^(;'7].OU;S;/4);N9X)[B,?.T390;AG(C8 Y%)X%_:M_:O\
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MCG/>FF.Y\D?M8_\ !%SX*?M:?&1OB1=VWB[P'\1YD$-SXG\$>(+C0M1OD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>j10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" '/ I0# 2(  A$! Q$!_\0
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MP*+)OE0E9JZ/MC]CO_@O)^SY^VC\<8OAIH6I^+/"WCN[C,EEHWBO0IM*N+\
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MH^C:O:7NE>*?^$ON=.N-%NDD 18)[AMB&0?N]O\ $", $ C]CO@M)JLOP?\
M";:[<V=[K;:-:'4+BTF$T$]QY">:\;C[Z,^XAAP00>]#).IHHHI %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV_9^^#?QLF\=Z-IUI+%IOASXK:&(K0^$KV! %GF8L2B. "0 P Y!&,C]6=H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBCPY8S2-IMPZ(7BN%C8D*Z@=CR23QWR?^">?[$?P[_X+)?&G]H3XT?'W0_\
MA8)_X2F[\(>&K"_N)A;:!8VY,9\A%8;'W#.X<CKUI"/V!MKJ+4((Y8726*4;
MDD1MRL,9!!'!!'<585=M?DE_P2C_ &SO"G_!,W1/VB_A1\6O'=SIGPX^!'C)
M-.T#5=5$]Z]K9W2[HK<F-&<A2<# ( ';-?1O_$2+^Q+R!\>] /\ W"=3_P#D
M:AKJMAZ['W#17@7['?\ P4Y^!?[?VLZW8_!_X@Z;XUN_#L44VI1VUG=6YM4E
M+!"?/B0$,48?+GD<XXS[[0(**** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAY2_+/"FV0S!PYY\PX_C(''WXK!AD4$BT444 %%%% !1110 4444 %?R>_\
M!<S]C=_%G_!2WXX^)Q\8O@II8DU66[_L:^\4O#JB;8@?*:'R2!(<8"[CDD#/
M-?UA5_.C_P %C/V*OV%_%O[7?QJ\4>,OVH_$?AWXLRRW5W/X6BT1Y8(;]8,Q
MVWFBW((9@@SOXW'D4 2_\&1D>SXZ_'GE3MT?2AQW_?7/(]OPK^BFOYV?^#)"
M*)/CM\?!&Y<+I.EA>.J^=<X/X_2OZ)J "BBB@ HHH) Z\4 %%)N'K2@Y&10
M4444 % .1D4C-M%?E-+_ ,%F_P!K#XR?M@_'+X:? W]FKP=\1M/^"OB.30KW
M4+GQ:FG2LIDE6%V69D!9Q"Y(0D#'..*2=W8#]6J*_+30_P#@OM\4?V6_COX4
M\'_M@_LY:A\$-#\<7BZ=I7C#3M:CU?2([@D "9D!54&Y2Q$A902Q0J"1]#_\
M%3?^"K</_!/MO /A/PGX&U+XK?%[XL7CV7A+PK87 MUNBA4-/-,5;9&ID09
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M6*2TC=E81SL[2! ZH#\Z%2"HK^A?]DCQWJ_Q0_98^&GB?7D=-<\0^%M,U+4
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M*[5**^8]G/(P<\@&)_P9+V2V?QU^/RKDB/2]+C&2.@FN>3[_ )5_1%7\[/\
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M=V6@0>+;<6FN>)+JY5U9S;]8XQN4Y.5 0@,68A?U=5MN.#S2:LD)WN.HHHI
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %,>,,FTX*G@@T^J][>)86DL\QVQPJ7<XSA0"2<?04 <*_P"RC\+7
M<LWPU\ LS$G)\/6A)/<D^7U-+_PR?\*_^B9^ /\ PG;/_P"-U\I7/_!RS^Q)
M9W,D4OQOL$EB<HZG0-5RI!P1_P >OJ*3_B)E_8A_Z+EI_P#X(-6_^1: /M#P
M5\-?#GPVL)K;PWH&B^'[:X?S9H=-L8K2.5\ !F6-0"< #)R<<5OUXS^QI^WW
M\)/^"@G@O5/$7PA\70^,-%T6]&GWMS'97-J(9]@?R]L\:,?E93D CG&<U[-0
M 4444 >)_MW?MY_#S_@G9\!=1^(/Q&U,6FFVF(K6RA9&OM5G/W8+>-F&^0_4
M #)) !-=7HO[1OAJ[_9PL?BIJ=V- \)W6@Q>(YI[\A#96KP";,A!(!5#S@D9
MX!/6OSC_ .#@/_@E[X$\7? 3XX_M#>+=4\3^+O%.F>&E@\,:7J-^QTCPF415
M>2U@4@>9(P+%F)&3D#/-2_\ !7#Q5>>'/^#;CPU!9RM"NM>'O"NF7&"5W03&
MU21,#LRDC'<&DU[I2CMYGHGA3_@Y2^"FO:_HMWJ7@CXT^%_AMXGU(:5I'Q#U
MCPHUMX:OYR^T$3;RX0G^(IGU P<?3O[<G_!0WX:_\$^O@Q:^-?'NHWTUGJMQ
M'9:1I^D6WV[4-<N9!E(;:)2-[, 3DD*!R2!7AO\ P4J^"6@1_P#!!SQSX7CL
M;6/2_#WPW22PC$8"V\EM:(\3J.Q#*&!!SGG.:^+/A1XIO/VB/VSO^"9^F^*)
M1J%G9> +S71%.3()+RVMXUBE(/!91&IR<XYJDKZ+H);<Q^@'[%/_  6-^'?[
M8WQJU#X9S^%OB/\ "KXFV-I]O7PQX[T7^RKZ\ML9\V$!F5P!@D9! YP1S6%^
MU5_P7*^&W[-GQUUCX;Z+X(^+'Q=\6^%[87GB.V\">'_[4C\/0XR3<N715('.
M!G ZD'BO'O\ @LP1\._^"F_[%7C/2UC@UVY\4W6BSS+Q)-:/"6:-B.J$\X/%
M6/\ @V[L8?$7@+]H#QK>+'/K_B?XG:HE[<D;I95AE:-%+'D@ #C@4*S5]K#M
M:U];GVI^Q=^VO\/_ -OWX'V'Q!^&^JRZCH=X[02Q7$)@N["=#AX)XB<I(IX(
MR1Z$BM;]L/G]D?XICT\(ZM_Z135^,MK^W_KG_!(;QW^W5K_@GP_HVOV&@_$/
M3WL])OI)(;.)KI,2L/+.0<DG ."37SY\4O\ @\N^+?Q2^&/B/PQ=?!_X=6MM
MXDTNZTN6:*]O3)"D\31,Z@M@D!B1GC(YH:[=16=[=CTC_@R;_P"2\_M!_P#8
M/TW_ -'7-?T.U_.S_P &25^;OX[?'PLH4R:3I<A [$S7/ _^O7]$U(04444
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M1B224"H>>GF$#"@ ?IBS8Z<YH8-"T444""BBB@ HHHH **** "BBB@ HHHH
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MX)Q?LI6OB;P?X8MO&'C_ ,6Z[:>%O"^EW)86\U]<EBID"D,RA8W.T,I9MHR
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MU;_X-KW32_A!\==#N!Y>L:1\4=6^VPL?WD>^5F0GORO.3VH2TO8F^GW'K?\
MP1M_;J\=_M4>"/'O@CXN1:4GQ<^#FOOX>\0W&GQ>3;:GQNBNECQA"ZX) P,G
M@"OHS]L/_DT?XI_]BCJW_I%-7XM^(_V4_BA^WK\3/V\]%^!FK1:5K^H?$'3%
MMKX:M)IL3>2@,H$\8SG'&!U/!K\<?VLM7^.O[*'QR\6?"WQQ\2/%TVN^&;AM
M-U2*V\47=U:.VT;E#%P'4@XY&#R,4Y+\0M9V1^KO_!DW_P EY_:#_P"P?IO_
M *.N:_H=K^=3_@R)D+?'3X\Y/)T;2C[D^=<_YYK^BNI$%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !112/\ =- '@?Q=_;33P'XT
MFTC3-)3419/LN)I9C&"W<* .<>I/7M7JGPI^)=E\5O!EMK-FCQ)-E7B<@M$X
MX*G'!QZUXO\ &;]C#4O&/CRZU70]0L88-1?S)HKG<K1L>I4@'(/7!P?>O8?@
MS\+X?A%X&MM(CG-RZ$R2R$8WN>20.P]J]_,(9;]3@\.[SZK\SDI.KSOGV.PH
MI P/UI:\ ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH *#C'/2B@]#0
MPGY1QDBO$?VG/VG;WX1ZQ;Z1I%M:SW\T0GEEN 2D:$D   @DD@GDX ]<U[><
M%!D?2O)OV@OV8;;XUWEM?07YTW4;9/),AC\V.9,Y 89!R"3R#W.<UZ&42PJQ
M,7BU>'4QKJ;A:&X[]F3]H"?XV:9>1:A;0VNI:=M+^23Y<JMD!@"<@Y!!!]0>
M^!ZR,8XZ5YS\ _@+9_ _1KF-+I[Z^OF4SSE @.,X55'0#)Y)))/T ]% P>O
MK/,98=XB3PVD+Z%4>?D7/N+1117&:!1103@9H **;O\ <T;O0T .HI@DSWIP
M8&BX"T444 %%%% !1110 4444 %%%% !1110 5#=0M/;R(KF-G4@,.JG'6IJ
M*30'PW-_P3&^.S?LB:C\/A^V%\1D\9WWBH:[#XV&G#[?:V0BV?V:J"?F(M\^
M=PY[8KR3_AR#^U3_ -)%/C'_ ."?_P"ZZ_0WXZ_'7PC^S3\)];\<^.]>L/#7
MA3PY ;J_U&[?;% @( & ,LS$A55069BH )(%?$/P(_X.6?@'^T==?$I_#6A_
M$Z33/AAX1NO&E[?7.BQ0+J5C;R(C?94,^]V8R#:'5 <')&*$]QM/=GT5_P $
M\?V2/B+^R%\.M;T;XC_'+Q5\==3U/41=VVJ:[:_9Y=/B\M4\A!YDF5+!FSD<
MMT[U]# 8&!7EG['W[8?P^_;K^!&C_$?X::[%K_AC5]R+)L,4UK,N-\$T;?-'
M*A(RI[$$$J03ZGN&,]J;[""BBB@ H(R,&BB@#YW^-?\ P3_TWXT?MV_";XYW
M'B6_L+_X466H6=OI,=JCV^H"\0*S/(3N0KC( !!SS53_ (*._P#!-?PM_P %
M&OAMHNFZMKFN^#?%'A'44U?PSXHT20)J&AW:\!TSPRD<%21G@@@@$?2(7/4G
MBE/< =J5M+#NSXH_8_\ ^"/T_P $OVHV^-?Q7^,?C#X]?$VTL3IFD:AK=C!8
M6NBVY #"&VA)4.W=@1GKC)S6!\?_ /@B7J6O?M(>+OB;\$OCUX\^ &L?$6/9
MXKLM&L(-0L=7DQ@SK'*1Y,I'\:DD'D8K[V3[HH[G\*;?41X-_P $]O\ @G]X
M/_X)R_ E/!/A2[U769[R[DU+6-:U602W^LWDAR\\K 8R3G ' '&3R3_*'_P7
M^P/^"PGQWYS_ ,5$W)&/^6:5_9M7\<__  7R\$:W??\ !7#X[7</A[5)[5M>
M=Q<+:3&,KY298,!M(X//3\J;8'W9_P &0?\ R7+X\?\ 8&TG_P!'75?T65_.
MI_P9$H5^.?QYR",:-I0[CGSKGBOZ*Z0!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ! /453U_4O['T6[O-I?[+$TNT=6V@G
M'Z5<J.>);B)D9597!4@C(([CZ4XM*2;$]CXNG_;%\9CQ>=06]462R$BP\I/*
M\O/W<XSG'?.:^QO#NJ#7-#M+P*R"ZB63!ZKD XKRR3]B[P=+XN_M4I>^29/-
M-EYH^SELYZ8W8SVSBO6[>-;6-8T0*B * . !CIBO<SK%X*O&FL)#E:6IS8>G
M.#?.[W>A/1117A'4%%%% !1110 4444 %%%% !1110 4444 %(_W32TA8"DP
M$8C!'0BO'/VC_P!I]O@QJ=OI>GV,5]J4\?GN9G*Q01Y(&<<DD@\ C &3UKV(
MD-G&<FO'?VCOV8&^-.J6^J:=?0V.I01_9W$ZDQ3)DD$D'(()/(SG..,5Z.5?
M5OK,?K?P=3&OS\G[O<UOV=/V@8_CEI-T9K-;+4K KYT:.6C96SAE)&>H(P<D
M>O->GD9X->7_ +.7[/Z? [2;HSW:WNI:@5,LB(51%7.%7/)Y).3C/H,5Z:TB
MHX4LH)Z#/)J,P5#V\OJOP7T*I.7*N<?10#D9%%<1H,*GD5R?QN^*$'P9^%FN
M>)[FWENH-%M7N6AC(#2[1D*,\#)[]JZ[C;[5Y#^W58S:C^R?XXAMXI)II=+F
MVHBEF;Y>P')XKGQ,Y0I2E'=)M'?E5"%;&4J57X922?HVD?"LO_!?O7V9C%\.
M=."%CL#:L^[';($77'I75>+_ /@L7XC\8?LDZKXJ\/:!:Z#XELM4BTYQ*YNH
M(PXSO7A2QQQAA@>]?F8LJHJ@LH*C!!."#WXS7T/\(OA/XC^)'["WC!] T;4-
M7>VU^WF9+6!I'9%7#%5 R^TGHN2*_*<)Q#FE><X.3>CM9=3^R,]\,>$L!1H8
MA4TO?C>\KIIM7OJ="O\ P64^.R,K#6]#;GOI:XZ?[W_UZ_5']B_XTZA^T+^S
MCX7\7:K;P6NI:M:"2=(L^7NSC(SR <9QDXSUK\.$_9[\?.0J^!O&//0#1;G_
M .(_K7[6?\$ZO 6L?#/]D7P9H^NV,FGZE:V*^;!)@/$22<-CH<'IU'>O<X1Q
MF/JUI1Q3=DM+][^9^>^-F3<-X/ 4)Y-&$9N6O*U=JWD>Z4445^A'\U!1110
M4444 %%%% !1110 4444 %%%% 'YN?\ !SIH,]Q^PKX0U[4-(O=?^'_A#XBZ
M+K/CG3;52[7.C1RLLH8#JF]DSG@9!R ,CP[X8?\ !1+]F]?^"XFL_$NP^)GP
M[L/A(G[/]M8V]X;R&VLXBFI;C8K"<$3*G_+N%W@<;:^^_P#@JU^W;X?_ .">
M_P"R)JOC#7O"<WCZ;6;N#P]I7A>,*3X@O+HE$MFRKC85#ELJV54@ D@'\EOV
MW?V=?A5X/^+'P#\!_#7]ACX:W_[3WQBT8^)M8\*:QJU['H_AB-$+/')##=16
MY!,<QRVU56(Y4E@ HHM]O(^R/^#;>32_'&D_M+_$/P+HMSX?^$'Q!^)]S?>"
MK1[8V\4D"1[)IXHNB([E!M  4H5P"A _3A^M?'O_  1D_;43]K/]G#5_#^J?
M#C3OA!XU^#^LR>#O$?@[3D5+'2)X0"AME48$+J3@ L 5;#,,,?L$'//UH9+W
MN/HHHIB"BBB@ HHHH **** "OY]?^"OW_!.#_@H3X^_:A^,_C?P1XP\:6OP:
MG:ZO[:S@^))M+4:<D&94%I]H7"E5?,>SD<8YK^@HC(Q7\]G_  6!_P""*G[:
M'Q:_:F^-'Q2\)^,8;7X87;W6KP61\;7-N5LHX-TB?9@-HRJN-G0YQWH S/\
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M%!('7BDW#UH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI>HHHKZ4_+0HHHH **** "BD;\?PKX&_X*I_\$%O"G_!53XX:%XWU[XG>/\
MP3=:%HJ:+'::$T(@F19Y9O-;>"=Y,I''&%'O0!]]4PQY'(R/0U^-?_$&E\./
M^C@OC/\ ]]6O_P 31_Q!I?#C_HX+XS_]]6O_ ,31<#]E-G P ..U/K\:/^(-
M+X<?]'!?&?\ [ZM?_B:/^(-/X< 8/[0/QG/_  *U_P#B:+@?LOFBOCK_ (),
M?\$@/#O_  2;TGQG9Z!X]\9>.4\9S6LTSZ\8B;0P"0 1[%'WO,).<]!7V+0
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MZ?--[,Y*]*I*:<79+<].0[D!Q@TM(/NCO2UX)UA1110 4444 %%%% !1110
M4444 %%%% !1110 C$*!QS7S7^T[^T_XA\$^.WT'0Y(;%+-5:69HA(\K, <
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M_+L<M:%5SCR.RZGLZX9012TB].WX4M>"=04444 %%%% !1110 4444 %%%%
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M[66Y@E>4,%B9(T=CN ;^''')%?D;^VI^T;^RC\<=.T6#]G#6_#NKWMC+)+K
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M"GG']M-_\9KXS\'_  G\3Q>%/%.HR>'M:MK"QTX^=/-:2Q)'EACEE&?PSZG
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M?L&?%G0?VKO!FM:OX-U#2-'T>\-[<W=VT:QA C# VDDL20  .>IX%>Q?"/\
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MUB.[M+NW8D+-$UM+N4X['VZ8!J(\0K$5?JOL4I2T;:U3>EV^YI6\,/[,R_\
MMB..G*E3M-03T:3NDE>UK;'B0^Z:_4[_ ((%8/P4\9DY.=;'_HB*N\;_ ((I
M_ \8_P")?K84CI_;$_\ \5S7O'[-G[+_ (/_ &5?!DN@>#;%[*TN;AKF=Y)6
MFEFD('S,S')P H'8  >M>GP]PQB<%BU7J--:[/74^9\3?%W*^(,E>782G)2;
M3NTDM/F>FCH,=****_0#^; HHHH **** &D';_.OEG]O6_U5=?TFW=IDT@PE
MD SY;RYYSV) ['H*^I>G?I5+7?#VG^);(V^H6=M>P-SY<\0D7/K@CK7H95CE
M@\3&NXJ5NAC7I.<>6]CYW_8&OM4D76H7,S:/$%,>_)19<\A2>F1V'%=UXP_;
M'\*>#_%<NE2_;KHP/Y<]Q;Q!HHF[C).6QZ@$?6O3--T&QT;3Q:6-K!96H!"I
M"@15^@'%?(?Q#_9*\8P>/+Q-/T\:A97<[/%<I*BH Q)^?)R",^GTS7M85X+,
M<94JXI\B:NEL<\E4I4U&&OF>_?'GPA)\<_@RR:#<1W#S%+NV(.%N  ?ESV)!
M[]QCBO#_ -GW]F_Q7#\3]/U#4M+N=)L]+F\YY)\*9" 0%49R<D]>F*^F/A#X
M(D^'OP[TO2)I1--9Q!7<?=W=2![#I72#WK@HYU5PM*IA:#3A)O5K6QK+#QFU
M.6Z'ITH; '7 I:1S@?6O$.D^,_\ @MIX.U3Q7^R;!)IFGWFH&PU:"XN$@C,C
M11!)5+D 9P"RC(]?2OR%U#2+W2E#7=E=VRL2 9H6C#'N 2,&OZ0)X([F/9(J
MN#V(S7YS?\%][**T\)_#_P J&.+=>7&2H S\BU\#QADD:M.6.YK.*6EM]>Y_
M1G@AX@U<'B*?#RI)QJR?O7LUIVMKMW.C_P"":O[=GPJ^#/[)OACPWXG\9:5I
M6L6?G"6"<MF(M.[+G P,@@]>E?=NC:Q:Z]IMO>V4\=U:W4:R12QN&252,A@1
MP01SD=1^%?S?'H:_>O\ 8%/_ !A]\/B1G&A6@'T\E:VX2SRIBXO#U(I**235
M_0X/&OP^PV25EF5"HY.M*3:=M&]=+6T/8CGH><4*HSQU%?.?QX_X*@?"G]G7
MXB7/A77]7O7UFR56N([2QDG6W+#(5F48#8(..2 1ZU#\$/\ @J?\)/CW\1]/
M\+:+K%[%J^J%EM4N[*6W2=@"=@9AC=@$@'&<<5]2\RPJG[)U%S7M:ZO<_(5P
MMFSPWUQ8>7L[7YN5VMWOV/I:BF))N8'/![4_(SCO7<F>"T%%%%,04$9&#110
M C  8QQ7SY^W)\.]:\4:?H^HZ;;W%];:>94GBA4LR%]I#[1R0,8R.F>U?0;X
M.,G%-(Y'&<5U9?C986O&O!7:>SV,ZM/GBX]SYB_8A^&NNZ1XIOM9O+.[T_36
MMOLX$Z-$;AMRD$*>2  >>F3@&O9OBS\"= ^,L$']JQ3I<6N1%<6\@25%/)7.
M"",]B#BJ_P"TQXIU'P7\'=7OM)+I>1JJ"1.L*LP5GZ<$ DY[=:^4O@G\4?$/
MA_XG:;+;7]_=F[N%2X@>9I!<J3A@03@G&3G&1CZU]+2PN*S-U,RIR4''9+_,
MY)5(44J33=S["^%WPFT;X1Z*]CH]NZ)*P>:65B\LS=BQ/H.P  ].:^8?VNOB
M!KL_Q>O-->\O+6QL GV>*.0QJP(!+X!Y.<C/;''>LC7_ -J[QK>>+Y=0AU>:
MTA24^59J@\A4!X5E(^8XX)//7I7T_9^!?#WQY\&:)K.OZ):W-Q<6J39;<KIN
M4$C<I!(R3P>.]7"A5RFO'%XZ*GS)];NY+E'$1Y*>EC"_8W\8ZMXS^%K'59)K
MC['<&&">4EGD3:#@D\G!.,GG\J]>"8_"J6AZ#9>&=*ALM.M8;.T@&U(HE"JH
M]A5YF X.>:^5QE:-6M*I!63=TNQW4XN,5%N]C)\9D_\ "*WX )!@?_T$U_.Y
MX[X\<ZV0?^8A<?\ HUJ_H$^/WQ&B^$GP?\0^(I[22^ATJRDG:!& :8!2=N3T
M!]?2OPQ\<_&7P5XWUS4M17X7V.GSZE+),3;Z[=JD;,2<[.5X)S@#&>P%?FG'
M7LY1IQ<DFM;:ZG].?1WEB*5;$U84G.+23:MH_FSS(@$<@'ZU=A\07\&@RZ7'
M>W4>F3R":6T61O)D<# <IG:2!QD\UZ-\&_@!H?Q<^'VN:E-XZT'PUKFFOBVT
MW59(X(]0R,@+*S@KCH3LZ^@J7P?^QMXU^(5S+!H8\+ZK+"H,B6_B*R=E'J<2
M=,]Z_/*> Q-HNFF^;:W8_I;$<2Y-[2=+%2473:OS*VMD]&UK\CR=5"G@ 9ZX
M%36A'VJ+.=I=?YBOHGXM_L&6O[//P5T_Q3XT\801:M?RK"=%TFWCO98W.3M\
MWS0G"C).,9XR15+P?\5/V=_#4NG37?PR\;:M<6+(\CW&LJ$N64@DL@?;@G^$
M8!''2NREE-2E62Q,U%Z/5ZM?*YX^+XSP^*P4Y971G6B[QO%)*]O[UKKS5S]J
M?A 0?AEH( P!91#_ ,<%=& >3U'I7$?L^?%+1?C/\(= \2>'XIH-(U2T26WB
MD38T2E1\I'J,8_"NW'3GD&OW/#V=*+B[JRL?YYX^$HXFI&<6G=W3W3OL/HHH
MK<Y HHHH **** "BBB@ HHHH *9+((T9F8*JC))Z >M/J.:!+B)HW *."I'J
M.] 'CLG_  41_9_CE9'^.7P@1T8J5;QCIP93G!!'G9!!XH/_  45_9]88_X7
MK\'A_P!SEIW_ ,>K\J?^"_'_  21_9A_90_9>\*ZAX0^%GAOP-=>._'^E>'-
M8\6_:KR9O#=E<2,\]TJR3-&&Q'MRRD ,V #@C[!\+?\ !M_^Q-8_!2'0T^$N
MC:K8RV(!UZ?5KJ34+A2F1<BZ648)!W90!/08XI=+C:6GF?9GPH^.?@GX[Z/<
M7_@?QCX7\96%G+]GN+G0]5@U&*"3:&".T+,%;:0<$@X(.,&NNV]1V-?ES_P;
M,>%/"_PB\*?M)_#SP')8ZWX$\"?$ZYL-#\20(#+K</E+\LLJ_),T(55$BX#!
M@0,$5^HRG))]:&^PF]1:***8!1110 4444 %?EO_ ,%Z/^":WPATC]D;]H7X
M\W/AHZU\3M3T!8H=4U.=KI=)5'10+6)ODA./X@"WH0.*_4?!_G7S+_P6#_9^
M\6_M4?\ !./XI^ ? NEC6?%?B/2C;:=9M<Q6PGDWJ<>9*RHO /+,![U,KV+I
MOWCP7]LK]MSXA_\ !/\ _P"")GP^^(GPQT;3->\56NDZ+:1VFH6$]["T<D2A
MB8X71R0!UW8'>OQW^+'_  =R?M3^-O!OB/PCKGA/X36$6N6%QI5X@T*^BN(8
MYHFC? :[^5@K$C((!P<&OZ5_V4O ^I_#3]FGP!X>UNV%GJ^BZ!9V-[ '6013
M1PJKKN4E3@@C()!]37\B'_!?I2O_  6"^.XY'_%1.>3N_P"6:5JVFR5M8_0_
M_@R1O&N?CM\>RV,R:3I<AQG&3-<Y[_XU_1-7\Z/_  9!_P#)=?CS_P!@72?_
M $==5_1=4"&GH,]:YWXC?#[3_B;X1N='U$2?9[D##H<-$P.0P/J"._&.*V-5
MU2#1=-GO+F18;>V1I))&Z(H!)/T &:\<T;]N/PQK'BQ-.:UU&"UED$4=[*JB
M,G.,D Y )[]NX YKKP>%Q%1NI0BWRZW70SJ3BM)Z7/&/CA^RMJOPALFU*"YC
MU/1TP'F.(I(6)P 5SR#GJ"?< 5Y]X.T:W\2>*-.TZYG>RCO;A8#.D?F,A8@
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MI#!3PW7Y1VXK];?@%_P2X^$OP1\>:;XNTC1KUM7TY2]J]U?23I [+@N%8XW
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M3)LDI9="4*;;YFG=GY5QSQ]C.)ZU.OBX*+@FDE?J24445[A\(%%%% !1110
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M_E_QH_M^P_Y_;3_O\O\ C0!;HJI_;]A_S^VG_?Y?\:/[?L/^?VT_[_+_ (T
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M_*_PA_X(-VNE?%WP%XF^+/QU^*OQTTWX5.LOA+0?$K01V&G2IQ'+*(US<.@
M 9R#P <CBE%?=N4G:UMS[O\ !EE)I?A#2[64'S;>TBB<<]0@!'/O7R#_ ,'
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M#3)(Y#)L<7#1B,JV1@[L'/&: ."_X@WOVJ_^BL?"O_P<ZI_\BT?\0;W[5?\
MT5CX5_\ @YU3_P"1:_I@HH _F?\ ^(-[]JO_ **Q\*__  <ZI_\ (M'_ !!O
M?M5_]%8^%?\ X.=4_P#D6OZ8** /YG_^(-[]JO\ Z*Q\*_\ P<ZI_P#(M'_$
M&]^U7_T5CX5_^#G5/_D6OZ8** /YG_\ B#>_:K_Z*Q\*_P#P<ZI_\BT?\0;W
M[5?_ $5CX5_^#G5/_D6OZ8** /YG_P#B#>_:K_Z*Q\*__!SJG_R+1_Q!O?M5
M_P#16/A7_P"#G5/_ )%K^F"B@#^9_P#X@WOVJ_\ HK'PK_\ !SJG_P BT?\
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M[,/COXE3Z7)K47@?1;C67L$G$#7@A0OY8<A@I(&,X/7IVKTL_<KYJ_X+%_\
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M7#6@?/R%PJAR".NT9]*XW_@K2Q'_  3*^/(&/^1&U;_TEDK\Z?\ @E[\;/\
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M(=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>9MDWA"N&.3G-?K7@>@HI*3V!O<:@P"*=114JX@HHHI@%%%% !1110 4444
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)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>j11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" ', K$# 2(  A$! Q$!_\0
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M !1110 4444 %%%(<$XR<T +3'D" YX ')/  K\[O^"U?_!>:'_@E5XR\+^
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M@C:9B\/E%VD6>9B2)0"T2<8&#^B048X K6H_>E;JV1%W2\C^?7]@/X>^)?\
M@@5_P<&P?"+QEXTN_&/@[]H;28U7Q'=VWV+^T[V=Y'@GD0NX$JWBS0$[R2+C
M=D9Q7]!$>2"" ![5\L_\%&O^"0OPJ_X*<:_X$UGQY=^+]%UWX<74EUHNJ>&[
M^*RNXB[1N59I(I05#Q(RX (8$@\G/U#9PM;VT<;222E$"EWQN<@8). !D]>,
M<U"=XJ^Z!K6Y8HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !00#U%%% '@7[;?\
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M03_I77 JD/\ @]$_:;/_ #)7P>_\%M]_\E5 S^GVBOD__@BG^W)XI_X*-_\
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MHH **** "BBB@ HHS1D9QWH ** P;I1F@ HHHH **** "BBB@ HHHH ****
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MG!(XXK1TW2[;1K"*TL[>"TM+=0D4,,8CCC4= J@8 'H*%+KUM8'UMU/&Y/\
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M .1FBD,**** "BBB@ K\+?\ @^$_Y(;^S_\ ]AW5_P#TGMJ_=*OPM_X/A/\
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M444 %(>HXS2T4 9FK>$M)U^99;_3-.OI47:KW%LDI4=< L"0,\XK\I_V\?\
M@NOJ'PB_;/\ %/P-^ '[+TOQR\3?#^ 3>)KNV@80V3>6KNBQPP2,5C#*K2,R
M@OE0#C)_6AAG@<5^.O\ P3E_:&\$_L,_\%W_ -KGX3_$^9/#?BSXV^*['5_!
M]]=0/Y6MQ3F:2.U5P" 6-RNW<0K,KKD$ &4_>LNWXC6USP=/^#G;XWZI\ 9?
MBE8_L2Z%-\.X9WMI?$J?:9]+@D1MK*\RV^U"&(!W$ ' [U^L?_!(']HOQ[^U
MI^PWX7^)'Q$\)>&O!.J^,)KC4M.TS0F1K1=-=R;60%9'R[QD%B2K9SE5.0/S
MA_X(V_MJ?!?]@_PA^UU^SK\>O%/ASP?9>#_'NMW=OI&N.(TU;2;A3$\,"-Q.
MY$8/E*"S"9" 021])_\ !J5XBU'Q!_P2?M!-]M'A^S\8ZU;^&EN<EDTWSPZ(
M">H65YAQP"".U:+8B2::]3]+0<@&BD0@J,4M24%%%% !1110 5^%O_!\)_R0
MW]G_ /[#NK_^D]M7[I5^%O\ P?"?\D-_9_\ ^P[J_P#Z3VU 'U__ ,&J?_*$
M+X5_]?VM_P#IVNZ_1.OSL_X-4_\ E"%\*_\ K^UO_P!.UW7Z)T %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %& ,GUHHH \"_;A_X*7?!G_@G'IGA^_\ C'XJNO"5AXGEF@TZY71;Z_AF
MDC"LZ%K:&0(V&! ;!8!B 0#C\R/"?_!P#^QQ^TW^VCXM\2?'&'P+;Z9\)=<L
M[GX0>,8?#.KRZO>Q .\LLC1Q,Z".0(1'(JJ2Q.TD9K]?OCA^SOX"_:5\)0Z!
M\0_!OAOQOHD-RMW'8:WI\5];I,H*K*$D4@. S#(Y^8CO7XV_MZV_["?_  1J
M_:;\96$GP8MOCK\4/BM/::C;?#N/0]/GL/"$(1E1;<FW)MEFSN\H"5V*JQ"J
M02HM)ZC:TT&_\%!/VU?^"2?[<WB2_P#B%XWU4>)O']GIS+%/I^D>(M+FUAXT
M_<Q3F**))#D*@:0@A>-P &/M[_@W._:4U;]JK_@EWX4\2:CX,\*> [*TU*^T
MG1](\-V$EEID-C;R[(S$DCNS'=O#.6)9E8DY)K\T[+_@J[^S1\)/$NER?&;_
M ()E6_PO\-7TRK_;$OA*UD,"D\.(I[. 28R#@.#CH"< _NQ^S'XU\!?$7X">
M$M>^%KZ(_P /=7TZ.ZT'^R+9+>R6V<94)$H41X)(*;058," 015)63(D]D>@
M4449QUI%!16'X_\ B-X?^%7AN76O$^N:/X=T>W=4EO=3O([2WC9R%4%Y"%!8
MD  G))P*UX9EGC616#(X#*1R"#SG\J ):*Y37?CAX+\+ZM/8ZGXP\+Z=?6Q"
MS6UUJL$,L1(SAE9@02"#@CI4WA?XP>$O&VI_8=&\4^'-7O=AD\BRU*&XDVC&
M6VHQ.!D<XP,T =+7X6_\'PG_ "0W]G__ +#NK_\ I/;5^Z1/('K7X6_\'PG_
M "0W]G__ +#NK_\ I/;4 ?7_ /P:I_\ *$+X5_\ 7]K?_IVNZ_1.OSL_X-4_
M^4(7PK_Z_M;_ /3M=U^B= !1110 4444 %%%% !1110 4444 %%%% !1110
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MO_T[7=?HG7YT?\&IH/\ PY%^%Q;/_(0US&?^PK=5^B] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !36_
MBIU(P)% 'X:?\'!'[,6J?ME?\%VOV7_AMHOC?5/ASJGB;PC=QV_B/3HWDNM,
M:.6]EWHJ2Q,2P0KQ(O#'D]#TY_X-2/BV6Y_;T^+)_P"X9>__ "UKL_\ @KSX
M,^+_ ,)/^"P_P>_:-T+X#^._BSX ^%/AIK59?"5U#)=FXF>[$R2VY5Y2J),K
M JJJ>!N')'L?P(_X.<?V6OBGX@&@^+]<\3_!?Q1$56?2O'NCRZ:87()*M,N^
M),#!S(R#D>M3!>ZDASO>Y\T_\0HWQ:_Z/T^+/_@LO?\ Y:U^DO\ P32_8PUS
M]@;]E73/AQXA^)6M_%?4M/OKN[;Q!JL,D5S.LTI=8RKS3, @.!\YSZ#I7K7P
MN^,OA'XW^&DUGP9XH\/>+-)EQMO-'U"*]@.1G&^-B <=LYKI ZCIC-4*PX'(
MR*"<#)HHH _-+_@Z._9$^)G[9?["O@SPS\+/!VK>-M>T_P >6>IW%EI^SS(;
M9+.\1I3O91@/(@X.<L.,9(^_/%GPRM/BC\"]3\&ZR)X['Q%H,NC7PC;9(D<U
MN89-I'1@K-@CH:[!E!Y('% 4 = :E;./<&]4^Q^'G[$$_P"VA_P0-;Q1\'[S
MX :]^TA\*+C5+C5/"^N^&+[]_;M)QAQLD9%<JC-'(BE'+E6<$9]1_P"">?[!
MW[0O[:G_  5&3]L3]J3PM:_#=/"5@VF^ _ ZW FN+$%)$5Y "=JHLTS$MM>2
M63=M15 /ZY$ @8 )I"H/& 2*J,K6ON)N^VEQ5& ,_A7X7?\ !\)_R0W]G_\
M[#NK_P#I/;5^Z5?A;_P?"?\ )#?V?_\ L.ZO_P"D]M0-'U__ ,&J?_*$+X5_
M]?VM_P#IVNZ_1.OSL_X-4_\ E"%\*_\ K^UO_P!.UW7Z)T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME?LMZMK.IZ3\.O%,=UK^LQV,P1[HJTH8X(*[UAMI%1B#M,[G!Z'A?^"\7_!
MKX'_ +%7[ UW\:_@1I&K?#GQM\);NPO!<VNLW,_]H1-=10[V,SLRSH\B2+(A
M4_*P(.1A1:MS/J-QN^5>I^ZP& !UHKRG]A[XMZA\??V-OA5XWU<@ZKXL\)Z9
MJEZP 4-/-:QO(0!T!=B<#IG%>K'..*J2L[,F+NKA1112&%%%% !1110 5^%O
M_!\)_P D-_9__P"P[J__ *3VU?NE7X6_\'PG_)#?V?\ _L.ZO_Z3VU 'U_\
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M"W_@^$_Y(;^S_P#]AW5__2>VK]T0V<>]?A=_P?"?\D-_9_\ ^P[J_P#Z3VU
M'U__ ,&J?_*$+X5_]?VM_P#IVNZ_1.OSL_X-4_\ E"%\*_\ K^UO_P!.UW7Z
M)T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%!Q@YZ4 -.T#)X]Z^=/VW_^"9_[.W[:WAB]N_C'\//"
M.IBUA>237I0-/O[)-N"_VV,I(H YPSE> 2.!7S__ ,%?_P!N[]J[X,_&WPG\
M*/V6O@Q!X[USQ1HIU6\\2WEM+/9:)_I#PB-B6CMXVPF[=+(<@X"'&:^8?"O_
M  ;R_M.?\%"=6@UW]M;]I37[K3)7$Y\&^%;D-;QG.=A(1+2$@#'[N&3.3A\\
MF4KZE/0^.OVL=4^&'_!''X@7L_[&'[;WBJXUQKDD?#NWM6\2:9<R[QB)KF)?
ML9.2P >-I!TW9.3^Y'_!&W]I;XO?M;?L&^%?&WQP\+'PCX^U&>YBGM/[*FTL
MSP1R%8;@P2DLID0!LC"D\J ,"KW[%/\ P1__ &=O^"?MC;-\-?AGH-AK4"!6
MUZ_C_M#6)3C!;[3-N=,Y.1'M7G@ <5],*G.>:I/2S(:OJ.KGOBL=?'PO\2'P
MHMN_B@:7='1UN,")KSRF\@/NXV^9MSGC&:Z&BDU<:/Y@_P#@N)_P2C^+/P _
M9?T/]H?]H_XM7?Q$^-OC/QE8Z+)869!TC0+)[:ZF,$1*KDJ\2 ")8XU^8 .6
MWU_19\;?B;-\%/V.O%OC*VC,D_A/P=>:S$HQEFM[)Y0.>.2@'-?FU_P>5?\
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M]TZ[(9 .%D$4<991]UF*GD&OFK_AG#_@L%MR?CO\$"!S_P @^VX_\IU?<_\
MP2K\2_%'Q-^RC"?C)\0O!'Q-^(-AK-_8ZEK/A2:&73E,4Q5;?,,<:"6(?(X"
M@A@022#6E[W9FUHD?2R?=%+0.@HJ2@JAX@U4Z)H5[?"&>X:T@DF$42%Y)-JE
MMJJ!DDXP .2>*OD\@>M<[\5=9UKPY\,?$FH>&],@UGQ%8:7<W&EV$TACCOKI
M(F:&%F )57<*I(R0#G!J9;#CN?SX_P#!'/X;_P#!0ZS7XU:O\'?A_P"$OAS)
MX^\72:UK?B#XG6%S97EU/\[BU@@D4L54S,Q?R2NY\;\C ^V_^"9__!:7XQR_
MMQZE^RK^UQX(TGPG\61;2WF@ZQHZB.QUQ(XWFV%0[(?,B1VCEC8*Q1D9588/
MI?\ P1V_X+Q^$/\ @HI\-?$,'Q"N/"?PK^*GA34Y[74O#-WJ(MC]F3E9X_M!
M5GP0Z2 <HR'( 8$_(OQ)^+'A_P#X*D?\'1_P>O/A!=6WBGPM\!]!D_X2;Q'8
M'S+%C&;IV"3*-KJ)+F*%6!(9B^TD FM(_$H]+"D])/J=OK'_  >C?L_:+J]U
M92?#3XN-):3/"Q6&PVDJQ7(_TC.,BOS?_P"#AS_@N?\ #C_@KW\._AEHW@7P
MMXS\.W'@G4KV\NWUN.W5)DGBA10GE2N<@QDG('!'6OUAU3_@T%_9&UK4KB[F
M/Q1\Z[E:9]OB1 NYB6.,P=,FOS"_X.5?^"+/P8_X)3?#+X4ZM\+!XN-WXQU3
M4+/4/[9U1;Q?+ABA9-@$:;3F1LGG(QTJ1)GZY_\ !JBX?_@B+\+0 1MO];!^
MO]K75?HM7YU?\&J,83_@B)\+<9^:_P!;)_\ !K=5^BM PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBF2L% ). * ';AS
MSD4G(7H17R_^TK_P5>^&/[-WC2?P[.^I^(]:LFV7<&E1(ZVC<?*[LRKN]5!)
M'0XZ5VO[*/[=W@#]KVUN$\+WUQ!JMD@DN=,OD$5W&A.-X&2&7)QN4D \<9%>
M=3S;!SKO#QJ)R[7U_P"'/H*_"><4<$LQJX:<:+U4G%VMW]'WV/;:8YY/H!3Q
MT%%>B?/IGPE_P4\_X)C:S^T;XO3QYX#-K)XA:!;?4=.N)!$+Y4&$DC<\"0+\
MI#8! 7D8Y^9?@3_P1O\ BK\0/&]M!XMTZ+PCX>CE!O+B2ZBEN)(P>5B2,M\Q
M'&6( Z\XP?V%.,#U]J#R 1@"OE<7PC@,1B?K4T[MW:3T;/U/)O&'B'+<J64X
M><>5*T6U>45V6MM.ET[&3X-\)6/@7PIINBZ="MO8:5;1VEO$O2.-%"J/P %:
M_"CU% !X[4BX*D'I7U$8J*2CHD?ETYRG)REJWJWW8ZBBBJ)"BBB@ HHHH **
M** $. >U&[GH<4QF50"3@>M4;7Q-IUY?26L5]:R7,?WHEF5G7ZC.14RFENRH
M4Y23<4W;?R-+-%,C.3GU%/JB0HHHH **** &G/3@D=JX[XL_'OP?\#=*2^\7
M>(M)\/VTQVQM=W"H93Z*O5NO8&NOD8K&Q'  K\&?VV?C-K/QQ_:;\7:KK$\T
MAL]2N-/LX'8E;."*5D1%';ID^I)/>OF^),^_LR@JD8\TI.R[?,_2/#+@!\59
MA/#3J>SITU>36KU>B7KKJ?MA\(OVB?!'QZM)I_!_B?1]?2W(\U;6<-)%GIN3
M[RY]P,UV\9RQ).37\_/[.'QCUGX"?&OP]XGT.XG@N[*\C65$8@74+.!)"P'5
M64D8(.#@CD"OZ ;.;S[=),8,B@X_"IX9X@_M2C*4H\LHNS[&WB?X>?ZJXVG2
MIU7.G43<6U9JUKIV]5J6****^F/S$**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *:W7..*=2'AP?6@#\F_^#A3]ICXW^-OVF/@7^R5\!O$
M]SX&\1_&7S[_ %?7;:Y>UGALT9D""9!OCC"QW$DGEX=A&B@@$@_+WQL^ /[1
MW_!M5\6/AC\7I/V@?$?Q@^#WB77[70?&VG:P;@10B0%G;R9)IA]Q96CE0JX:
M,!@0Q!^I_P!OO4K;1_\ @Z%_9"N;RZM[2!/!&L;I)I!&B_N]1 !).!DG'UJO
M_P '>'C31?$7_!)9+:QU?2[V8^-M*.RWNXY7QLN<G .<<]:F+:BFNK'+65GM
M8^<?C;^VY^U?_P '&OQ@\0?#;]F2WOOA?^SCIMZVG:IXRN&DLFU:('#-/.OS
MD.O*VD'S;67S6P?E_6K_ ()=?\$^-(_X)@_L=^'_ (2:-K^I>*(=)FN+RYU*
M\A2%KFXGD,DI6-,[(]QPJDL0.K$\UT?[(NB?#?\ 9U_9E\#>#/"=WX9T/0-"
MT6U@MK2&\A0+^Z4L[8.6=F+,S'EF))Y)->MZ5K-GKEHMS8W5M>P,2!-!*)$8
M@X(!7@X-:/31$7O9LNCH****DH*0H#U&:6B@#XZ_:W_X(*?LJ_ML?$JX\8^.
M?A98-XHOI#+>ZEI-Y<:7+J+GJ\X@=4D<]W92Q[DU[+^Q]^P7\(OV!_ 4_AKX
M1^!-&\&:;>R++>-:AY;F_=00KSSR,TLI ) WL0H)  !Q7L!..M%"T0GY@% Z
M5^%O_!\)_P D-_9__P"P[J__ *3VU?NE7X6_\'PG_)#?V?\ _L.ZO_Z3VU S
MZ_\ ^#5/_E"%\*_^O[6__3M=U^B=?G9_P:I_\H0OA7_U_:W_ .G:[K]$Z "B
MBB@ HHHH **** "BBB@ )QUHK,\7>*]-\!>%-3US6;V#3=(T:TEO;V[G;;%;
M01H7>1CV"JI)/H*_G'_;4_X/,?BSKOQCU&V^!GA;PCX>\":?<-%977B"QDOM
M2U6-3@2R*)$2%7QD1@%E! +DYH _I+HK\M/^"!/_  <2P?\ !5+Q!J'PW^(6
MA:5X3^+&EV3:C:-IK.-.\06R$"4Q)(S/%-'D$QEF!4EE( 8#]2Z "BBB@ HH
MHH **** "BBB@ HHHH 3 )YY(K!^)UW?Z?\ #S7)]*02ZE#83O:KUW2B-B@_
M%@*WMV<^W-,>,,A!P5;BHG'FBUW1=*:A-3:O9IV/YR;^]N-2OY[J[DFEN[B5
MI9WD)+O(Q)8L3R3DDY/.:]G_ ."<FM:MH7[;'P]?1WF6>XU$07 3.'MF1O-#
M?[(3)YX&,]A7WA^TY_P12\-?&/Q]>^(_"OB*3P=<:I,UQ>6ALA=6K2,<L\:A
MT9,DDD D9)P!7QG^V=\![?\ 8#\6:=X0\/:]J&H>(=7TPW.JZN$^S,L+N46W
MA522BML8L=Q9A@$XR#^)8C(<9EF(^NUE[D97NGJ]?O/[DP'B#DO%66_V'@&U
M7K4W'D<7:/NZMO:RZ6>I^SNG>)].U6=X+6_L[B:+B1(IU9D^H!R/QJ^I.!QP
M*_G9\%^/=<^'7B:VUK0=7U#2M6M)/,CNK>8QR9'<\\@^A!!'!!K]R/V%/V@+
MO]IK]F#PSXMOXTBU.\B>WO@@PC3Q.8W91V#,NX#MFOT3AWBFGF<Y4N1QDM>Z
M:_S/YS\1_"C%<+4J>*]LJM.;Y;VLU*U[6N]'W/8??'-%'UHKZP_) HHHH **
M** "BBB@ HHHH **"< GTI-Y]#0!\+_\%H?VM?$7P4\'^'_!WAB^N-*N_%:S
M37M[;N4GCMXRHV(PY4NS\D8.%.",U^6^B^*]4\-Z]%JNG:GJ%CJ<$GFQWD%P
M\<Z/G[V\?-G/4YY[U^KW_!7O]F2S_:"\%:)?Z=KFAV'B_P /-+]DL;Z^BMCJ
M<,FW?$I=@ ^54J3QG()&<U^='A?]ASXN>,O$T>D6?@#Q$MU(X4R36YBMX\G&
MXS-\@7OG)XZ9K\=XNHX^IF?[M.2TY;;+[NI_9/@UF'#F'X:MBG"$[R]ISV3?
M;5[JUK6/U@_X)E_M+ZI^U#^S%I^KZ[()M>TNXDTR_F"[1</'@K)@< LC(3CC
M.<8Z5]"O(L>2SA0/4XKQO]A+]EU?V2?V>]+\+3W$5YJK.][J5Q%D))<2'+!<
M\E5P%!.,A<X&<5\<_P#!:K]KGQ)HGCVR^&.@ZA=:3IGV!+[5I+9S'+>F1F5(
MBPY" +D@$9SW Q7W]3,I9=E4*^,NY))-=6^Q_/>%X:I\2\55<OR5J-*<Y.+>
MR@GNEV[+T/T>T_Q-I^KRR1VE_974D7#K%,KE#[@'BKOFD 8 (-?SP?#WXE^(
M?A3XMM==\-ZO?:1JUG()8I[>4J<YSAAT<'H0P((X(-?NC^Q]\;Y/VB_V:O"G
MC">)(+S5[/\ TI%!"K.C&.3:#SMWJV/8BN?A[BBGF<I4^3EDM;;Z'I>(WA7B
M>%84L0ZJJ4YNU[6:=KV:N_/4Y[]KS]O;P1^QO8VJ>()[F^UC4%+VFEV2J]Q*
MH/+MD@(F>-S'D\#)S7F/[.?_  61^'GQU\;6WA_4;#4_"&H:A((;-[\H]M<.
M3A4\Q3\C$\#< "<#.3BO@7_@J?<ZM<_MV>.1JQE!CE@2S#9P+;R$\O;_ +))
M8\=\U\];F3#*65U(*E<[@>Q&.<Y].<U\GF7&N-HYA*E32Y(NUK:O7N?KO#/@
M=DN-X=IXO$5).M4@I*2>D;JZ5MFEUOJ?T=JYE4'((8?G7YS_ +?/_!(+Q!\0
MOBEJ?C/X:26$_P#;DQN;_2+F;R&CG;[\D3D;2&/)5L8.<$@X'W5\ KK5+GX(
M>$9-<##69-'M#?;A\WG&%-^??=FNOV' S7Z!F&5X?,L/&&(CIHUW3/YVX=XI
MS'AK,)8C+II25XNZNI*_5?(_,W]B?_@C=XIT7XHZ5XE^)QL-/T[1+A+N'2K>
M=;B2\E0AD\QU^54# ' )+8QP,U^F,*!$"@<#C%.V$8ZXH4'@@=*K*LGPV7TG
M2PZ:3U?5M^9/%G&.9<18I8O,9)N*LDE:*7DM=Q]%%%>J?+!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !2-G'OGBEI >3GH* /A?\ X*G?
M\$#/A5_P5N^*_AOQA\0/%7Q!T'4/#&DG1[:+P_<VD4,D1F>8LXGMY6+;G(R"
M!@#C/-?+W_$%1^S7_P!%&^.'_@QTO_Y!K]5/B/\ M'?#[X-ZK;V'C#QWX-\*
M7UU%Y\%OK&MVUC+-'N*[U65U)7((R!C(([5@?\-V?!#_ *+)\*?_  K;#_X[
M2CIL-L_,D_\ !E+^S4?^:C_''_P8Z7_\@U^B7_!.7_@G_P"$O^"9G[,&F_"C
MP3JOB+6= TR]NKZ*YUN6&6[9[B0R.&:&.-" 3@84''4GK72?\-V?!#_HLGPI
M_P#"ML/_ ([7<> OB3X=^*WAZ/6/"^O:+XETB9VCCOM*O8KRV=E.&421L5)!
M&" >#Q579+1NT444AA1110 4444 %?A;_P 'PG_)#?V?_P#L.ZO_ .D]M7[I
M5^%O_!\)_P D-_9__P"P[J__ *3VU 'U_P#\&J?_ "A"^%?_ %_:W_Z=KNOT
M3K\[/^#5/_E"%\*_^O[6_P#T[7=?HG0 4444 %%%% !2.<*3G%+6=XKTA_$7
MA?4M/CN'M9+^UEMUF3[T)="H<>X)S^% 'X#?\%6?^#O7QEX$^/FN^!/V<M'\
M,KH7A>\DL+CQ5K-LU])JT\3%9&MH0RHD 8, S;V< ,-H(!]I_P""%?\ P=$:
ME^W-\==+^#7QOT/0M$\8^(E:/P[X@T='@L]4N%4M]EGA=F\N5U#%'5MK$!=H
M)!/\\'[3'[/GBC]E7X\>*OA[XTTZYTOQ-X4U&6QO89D*[RK';*F?O1NN'5AP
MRL",@BOHK_@@Q^S'XL_:=_X*J?!ZR\*VEZ\?A;Q#:^)=8OH5/E:98V<JS22.
MPX4-M$:@D;FD51R: /ZSO^"B/P/UG]I7]@WXQ?#_ ,.RF+7O&/@_4])TXEMH
M>XEMG6-">P9B%)]&-?P^^*_"^I>"?$E_HNL6-WI>K:3<R6=Y9W,;136LR,5>
M-U/*LK @@\@BO[ZNH^M?,?[5?_!'']F?]MCQP?$_Q*^$7AG7O$DA4S:I#YMA
M=W6WH)I+=XVEP./WFXX&.!Q0!_/'_P &E/[-'BWXN?\ !5W0?&^E6EY'X7^&
M6G7M]K=^JD0*;BVEMH+8MT+R/(6"]=L3G& :_JXK@_V>OV9?A_\ LG?#JW\(
M_#;P?H'@KP[;N918Z5:+;QO(<9D<@;I'( !=B6( &3@5V\\ZP1L[LJ*HW$L<
M  =22>@Q0!+17Y[?'G_@Z _8]^ /Q5G\(7GC_4O$5[8SFWO;WP]I$VHZ?:.#
MA@9UPL@4YR8?,'!'7BOLG]FO]J+P!^V#\(]/\=?#/Q5I/C#PKJ9*Q7UA*6"2
M#&Z*1" \<BY&8W"L,C(&10!Z!1110 4444 %%%% !1110 4?6BB@!C="1UKX
MB_X*T?L :]^TE'I7C/P5;I?^(M%MS:7>G%PCWUON+@QDD#>K%OE)&0W7( /V
M]P1R20:0H&R#QBO/S++J6.P\L/6V?WW[GN\-<18O(\PAF6":YX=U=-/1IKLT
M?A+\/O\ @G]\8?B1XMCT:U\!>(+"9Y DMQJ5J]I:VXSRS2. "!UPN2>P-?LM
M^RI\!+7]F3X#>'O!=K.;H:1 ?/GV[?M$SL7DDQV!=F..W KT)8P,$!<GOBG=
M,GG->5D?#&&RR4ITFY2>EWV\CZSCKQ0S3BB%.CBXQA3@[J,4]7:UW=_<*6!Q
MTQ0IR<<G->??'C]IOP7^S-X:35_&>M6^DVT[;($(,D]RP_ACC7+,1[#CVKSC
MX%_\%0?A%\?O&$.@Z1KMQI^K73[+:#4[5K7[4W948Y4L>RYW'T->Q4S#"TZJ
MHSJ)2?2ZN?'8;A[,\1A98VAAYRI1WDHMQ5M];=#Z*S134;?D\ =*=FNVYXX4
M49HH **** "BBB@!I VD]:\K_;0^.4W[-_[,GBWQA;('O=*M0MH&7<OGRNL4
M6X=QYCIGVKU3^#Z5Y'^W!^S7<?M=?LT>(/ %IX@/A>ZUJ2TEBU,68NQ;M;W<
M-Q@Q%TW!Q$4/S# ?/.,'FQ4:CHS5+233L_.VAZ&4SP\,;1GBU>FI1<EWC=7_
M  /PQ\;>-M7^)'B:ZUG7]2N]7U6_<R3W-U(9))"23WZ 9X P .  *^G/^"?G
M_!5SPW^PU8ZA8_&+Q;-I'PW>,?8;NXMY[S^S[HD;8D6)7<(ZACC&T%<\9.>1
M^+?_  3#^,WPO\93Z9!X/U'Q':^81;7^E()H)UR<$C(9#C^%NGJ1R<+]KK_@
MA=XD\6_L=W'C+XB^*F\)VGAV[CU&7PS;6*W<^I#<L:)+<"55A^^WW5? .<Y&
M*_'LCP>8X?'^WK1DE"[DW>S2U?J?V=QWG'"^9<.K+\)4ISG5Y8THQ:NI.RCH
MM8VZW/OOP_\ \'$G[(_BNTEN-*^)>HZC;PC+R6WA75I$7ZD6U?!'_!5;_@J#
M^R?^TIXRTOQ=X*^+UE/XCM8!IFH:;=:-J%JT\:L2CJTD 4,I9@0Q&00?X2#X
M9H.B6?A?1[?3M-M8+"PM$$<$$"A(XE Q@8__ %GOFJW@W_@CUX:_X*L?'^P\
M/S>)Y_A_K,=A-=/JMKI2WQO%0IA)$,D?(W$A]Q/8@\8]V'$N&SFJ\NQ%-J,W
M9.^J?1GPM?PNQ_!6&7$N78A3JT5>47'W7%K5;]#E7_:L^%5A?62:G\1?#&G6
MMY*L;70E>Z6!21EV2!7? '. N3T'-?J;^SO_ ,' _P"PS^SQ\%O#O@RP^-<,
M]OH-HMN9CX>U,&=\DO(1Y'!9BS8[9KY%_P"('S23D']H_5/Q\&)_\F4T?\&.
MVC$Y_P"&CM3S_P!B6G_R97U61<-8;+'*=)MR?5GY)Q[XFYCQ3&G3Q45"$'=1
MCU>UW?\ K4]S_;._X*P_\$\_VSHK6[U/XUOHOB.PC,4&K6?A_43+Y?7RY%-O
MB1 22 <$9.",G/E?[.O[8O\ P3N^#OCNTU_Q!^T'/XTFTZ59[6UG\+ZC;6J2
M+RKN@@)<@@'!;;[&L'_B!UT9>/\ AH[4\'_J2T_^3*X?]I#_ (,[_#'[,_P5
MU_QMJ'[06KZA;Z%!YHM4\'QQM=.6"I&&-V=NYF S@XZX.,5U8O*,N]H\;6II
MRCK?TUOV9Y64<7\0K#QR/!8F2IU'RJ*?\SM9/=)M]&?I3%_P<S_L3+&%3XR0
MA1TQX?U/C_R!3O\ B)P_8F)VCXS0$GM_8&IY_P#2>OQU\!?LJ_#[X>^&8=+L
M_">BW,2)MDFO;2.YN)SC[SNZD\]<# '8# K&T3_@E/\ #KXA>-M:\:VMW/H9
M\)6D>L-X=ALEGL]6VSI&ZERX,(7>C%=K!@"!CDUX&&XZP=6I*GRM63:?>R/T
M/,_ 3.,)AJ>(=6,N9Q4DKWCS-*_G9O4_>/0O^"W'[._BS1;+4M*\6:K?Z??C
M=#.N@WL09?[V)(E;'?.,$=,UT?[/'_!6GX"_M1?'^7X7>"_&D^H^.HK.6_;2
MY]'O;1_)CV[W#RQ*A W+T8Y[9K\5!@# P!C P,#'8#Z5]/\ _!&3X;66M_\
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MOP.^*4/C3PM\5?'FE^)HY_M#WHUJXE:Z;.2)E=BLRD]5D# ]P:_K6_X)(?\
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M7?!;6[OPC-\%="\33>&I#IDFJMXFEA;46A/EF8H+=@I<J6P&(&3R:Z;X-_\
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MLLR2L\15J.I);0TZ]SY_ <7<4\=8&.683#JA!_'6]ZVC3]W;5M;)L]#^)O\
MP0L\7VWC*5?!OBG0-0T&:0F!M2:2&Y@4DD*^Q&#D#C<,$^@YKZ^_X)_?\$^=
M+_8J\/7]Q-?+KGBK6E5+Z_$?EQQQJ21#$I)(4$Y))RQP3C  _+;]E[]N'QS^
MS#\0K'5++7-3O]&651J&EW=R\UM=0D_, K$A' R0RX.<9R,@_N5X7U^#Q3X>
ML-3MF+VVH6Z7,1Z$JZA@?;@BO7X3IY5B:DL5A:?+./1N]K]4?&^+F(XNRRA2
MRK-<4JM":TE%*/-RVTEUNM.NII*,#%%%%?H!_/X4444 %%%% !1110 4444
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MN1PE"I64ZD4[0AJ[]G;1?,^>?^"9'_!.1?VIM2E\5>,(KZV\%:9*H@B"F/\
MMN0$[E#=?*4 !BO4G:",''ZZ:1I5OH>GV]I:Q1V]M:HL442+M2-   H X
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M_9:;:H8[:PMTMXESG:J*%4?D!3])T>VT73(+2TMXK:VMHUCBC10J(JC 4 <
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M_ ]E\2_ &N>&]20OIWB#3[C3;I1WBFB:-Q^*L:B:O%H<79H_.S_@TSMX(/\
M@C%X+:(@O+KNLM+@8PWVUQSZ_*J^OIGC%>0?\% W;2/^#KK]E2YT_8;J;P5<
MBZS+M(0)JPR0/]GMWKR3_@D1_P %+]#_ ."#,_Q#_93_ &IK?7_!D7A77[O5
M_"GB :9-=V6J6DH4E4\I2Q1RHE1U!4F5U8HR@'T'_@FIK>N?\%EO^"Y.N?M=
M6WAC6]"^"?PKT*3PUX-N=4M_+;69VCDAW*#P3B>YE8*3Y>Z)222:W33FGT7^
M1-K1DGU/AKQ/_P 'BW[6&D>)-0M8-*^#K0VMS)%&3X?NB2JN0#_Q^<\"OE+_
M (*:_P#!;;XQ?\%8_#'A+2/BC9^";2U\&7=Q>6!T+39K1V>=$1PYDFDR (UP
M!COU[?UW']C?X0S2,[_"KX;.[G<S-X9LB6)Y))\ODYYI3^QC\'F&#\)_AKC_
M +%BQ_\ C=9C1_*C^PI_P<F?M"_\$\?V9M!^$_@+3OAO/X7\.R74MH^K:/<7
M%V3<7$EP^YTN$4@/(V/E&!@<XS7KW_$91^UK_P! GX._^$]=_P#R97])Z_L7
M_!U!A?A/\- /^Q8L1_[2H_X8S^#_ /T2CX:_^$Q9?_&J /YL/^(RC]K7_H$_
M!W_PGKO_ .3*/^(RC]K7_H$_!W_PGKO_ .3*_I/_ .&,_@__ -$H^&O_ (3%
ME_\ &J/^&,_@_P#]$H^&O_A,67_QJ@#^;#_B,H_:U_Z!/P=_\)Z[_P#DRC_B
M,H_:U_Z!/P=_\)Z[_P#DROZ3_P#AC/X/_P#1*/AK_P"$Q9?_ !JC_AC/X/\
M_1*/AK_X3%E_\:H _FP_XC*/VM?^@3\'?_">N_\ Y,I/^(RC]K;_ *!'P<_\
M)^[_ /DROZ4/^&,_@_\ ]$H^&O\ X3%E_P#&J/\ AC/X/_\ 1*/AK_X3%E_\
M:H _B\_:S_;1'[7OCW5/%.K_  L^%7A;Q%K+M->WGA>QOM-6>9B2TQ@^UM )
M"222(QDDD@DDUXC7]V/_  QG\'_^B4?#7_PF++_XU1_PQG\'_P#HE'PU_P#"
M8LO_ (U0!_">%!&<C/I25_<M\0O^">7P(^*7@W4?#VO?!WX;7VD:M"8+F$>'
MK6%F4_W7C171@<$,K!@0""",U_.#_P '0W_!+'X-?\$R?B#\)H/A!H>IZ#;>
M-K75+K4H;K4YKY-T,EL(UC\TLR "1QC)SD>E 'Y4*,G&<4, .A!K^H#_ (-Y
M_P#@BM^S;JO[#WP@^.FM_#FQ\4?$/Q)I+WEQ=:Y/)?VD,HN)H]\=K(3 IVJO
M)0D'D$'FOTQ_X8R^#W_1*/AK_P"$Q9?_ !J@#^+?]A#]M_7_ /@GS\?+'XE>
M$O#7@KQ!XITB)ETR7Q)8RWL6ER,-IGBC26,"7:64,V[:&)4 \U]\?\1E'[6O
M_0)^#O\ X3UW_P#)E?TG_P##&?P?_P"B4?#7_P )BR_^-4?\,9_!_P#Z)1\-
M?_"8LO\ XU0!_-A_Q&4?M:_] GX._P#A/7?_ ,F4?\1E'[6O_0)^#O\ X3UW
M_P#)E?TG_P##&?P?_P"B4?#7_P )BR_^-4?\,9_!_P#Z)1\-?_"8LO\ XU0!
M_-A_Q&4?M:_] GX._P#A/7?_ ,F4?\1E'[6O_0)^#O\ X3UW_P#)E?TG_P##
M&?P?_P"B4?#7_P )BR_^-4?\,9_!_P#Z)1\-?_"8LO\ XU0!_-A_Q&4?M:_]
M GX._P#A/7?_ ,F4?\1E'[6O_0)^#O\ X3UW_P#)E?TG_P##&?P?_P"B4?#7
M_P )BR_^-4?\,9_!_P#Z)1\-?_"8LO\ XU0!_-A_Q&4?M:_] GX._P#A/7?_
M ,F4?\1E'[6O_0)^#O\ X3UW_P#)E?TG_P##&?P?_P"B4?#7_P )BR_^-4?\
M,9_!_P#Z)1\-?_"8LO\ XU0!_-A_Q&4?M:_] GX._P#A/7?_ ,F4?\1E'[6O
M_0)^#O\ X3UW_P#)E?TG_P##&?P?_P"B4?#7_P )BR_^-4?\,9_!_P#Z)1\-
M?_"8LO\ XU0!_-@/^#R7]K;@G2/@Y@?]2]=__)E9_B7_ (.\OVG_ !EIDECJ
M_A;X&:I93</!=>%[B:)OJK79!_&OZ7O^&,_@_P#]$H^&N/\ L6++_P"-4?\
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MW?N^I_-5IG_!X=^U7HUA#:V>A?!>VMK=!''%'X;ND1% P% %WP !C XJ<?\
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M7EBL7-SG)W;?F?S9?\1D_P"UK_T"?@[_ .$]=_\ R91_Q&3_ +6HZ:1\'?\
MPGKO_P"3*_I/_P"&,_@__P!$H^&O_A,67_QJC_AC/X/_ /1*/AK_ .$Q9?\
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M,]^U% 'F?[&OP8U#]G#]D7X7_#W5KNSOM4\#>%-+T&\N;3=Y%Q-:VL<+O'N
M;860D9 .",@&O3*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!N_#7C.+XF1,_@GX@Z+;):+>S MMBFC1(T(9AY>/+5T=H\EU<,/S\_X-Y_\
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ME,PQ69(X^9WS@Y%5%*Z3Z;BEK>2V9^OD9)7)S^-.I%^Z,4M2""BBB@ HHHH
M**** "OSN_X.HS_QI*^*O_7YHO\ Z=;6OT1K\[?^#J3_ )0D_%7_ *_-%_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
$@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>j12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j12.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (F!"4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH)
MQUH **\X^.O[7'PP_9DU'0K3XA^/O"7@JY\42M!I,>M:G%9-J,BE R1;R-[
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MO_@IQ^SUX;^&.A>-=0^-7PRL?"7B:XN+32M8G\0VR66HRP$":.*4MM=HR0&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4$9&*** /SY_X.6?V)
M'_;!_P""8?BB]T>S,_C+X8RIXOT62-3YX-N#]H12.26MS)A>065#C(!'KO\
MP19_:^D_;?\ ^":'PJ\>WERESK,^E#3-78$EOMEHQMY2Q/\ $YC#GW>OI[6]
M*M]>TJYLKN)9[6[B:&:,C(D1@593[$$BOQ__ .",/Q+TK_@EM^VM^UC^RWXJ
MOVT_PGX&DG^)/ANXG)V0Z08%FN H[+'$T1XR20YXQDS!VYEWU&U=)]?T,_\
MX+,RS_\ !3K_ (+0_L_?LEZ<3=>$O DB^-O' C/RQC!=4<D<,MLN ,X)O%'6
MND_X.#O^">/BOX5^,_#7[:/[.]JVE?%3X3,ESXCM;&('^U],B389C&/O^7$6
MCE0 EX7/&8\FU_P;5_#74OVF?B/\??VS_%=M<0ZS\:O$USIOAZ.8 M::3!*"
M55OXD!6& $=/LC=<YKZR_P""R_\ P5"\-_\ !+C]D74O%5_;V>M>+_$&_2O"
MN@2L"=5O&7[SH/F-O$#ND(ZC:F09 :'>,5WW^8XOFDUTV/@#]MG_ (+EWO\
MP5/_ &:_AC\!OV75O5^,/[0EJ(/$L:R-$?!5FN?MD4DI49W".0;QU@!;@NH/
MZ=_\$V?^"?\ X-_X)I?LH^'OACX/MXRM@@N=7U+R]DVM7[JHFNI/=BH '145
M%'"BOP5_8;\"?%+_ (-V?VK/A#\<_C/X=L(_AY^T%IKV'B*2UL%2X\'O<RF9
M877:%@E0"*4QH0/+$L>,QX/]$?QL_:/\,_!K]F7Q)\5+[4+>Y\*>'M G\0M=
MPN'CN+>. S*4/1MX  QU+ =ZTF^6+??^K$)7:2^1^1G_  5^^'U[_P %I/\
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M?#V_^*/C6UDM;32?#EI(8VO9IYXX0S, <1IYF]CV53R.H_#CX7_#+]H7PO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCY+#^+CCG[^YP,=J,[1@=J$]4Q7/GS_@IQ_P3_T+_@IA^QSXG^$^NZ@^C-K
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMM1(IV.5+G[I=5!) SS32UL'2Y]YT4BME0?6EH&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9!R#2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 5M5U!=*TRYNG5FCMHFE8+R2%!)
M]\"OX^_^"@O_  7?_:1_:)_:W\4>(-+^*7C+P5H>EZS<1:#HVB:C+8VVEV\<
MI6+Y8R TNU5+.V26SSC ']A;H)4*L 0>"",@U^*'[<G_  9T^&/VA?VF=<\<
M?#[XFOX(T7Q9J,NIZCHUWIGVM;&69R\OV9U9?D+L2$8 *.,D 8 /JG_@VU_X
M*1>,?^"DO[ #:S\0I!?>,O!.L2>'K[4UB$?]KHL44L4[@<>:5D*O@ $H&ZL:
M_0BO!_\ @G)_P3Y\$?\ !,O]EW2/A;X$%U/86,LE[?ZA=;?M6K7DF/,N)<8
M)"HH4<*B*.<$GWB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH YKXK_%KPQ\#? &I>*?&.OZ3X8\.:/$
M9KW4M2N4MK:V0=V=R /3'4]!7Y7>)?\ @V^\+?M%ZNVI>$_VB?%5M^RYXZ\1
M1_$6;P!8VJSV5Y/*-Y>WN_- 6)T(VDQ,0,'+$!AH?\%5?A;'_P %*?\ @M5\
M$_V7O&VHZO:_"+1O"MUX\UG3+&<VXU^Y5I$BC=N250Q@''(61\$$@C]0OAM\
M*/#WP<^&6C>#?#&EV^D>&?#UA'ING:?#N,5K;1H$2)=Q)("@#DDX[THO3FZO
M8;5G;[S\]_!O[+_PN_X*K_M_>%_B]HOQ]T[Q]\,/@&T,?AWX;Z.J)#H.JQ!H
MS/<\A@N8T* IEO+&'VC!_2H#&,#K7XQ?\%"_V1?"'_!'O_@I)^S/\9O@-92>
M"(_BCXUC\%>,/#EG,_\ 9FK073QJ)!"3D,#([$ [0RQD 8.?V;0%2!N) JK/
ME3_JY,M);=K$E%%%(84444 %%%% !7\]7_!>[_E9B_9B_P"OCPQ_Z=6K^A6O
MYZO^"]W_ "LQ?LQ?]?'AC_TZM0!_0K1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;/:3U!STI<C@U\1?L]_\%EKSX\_&GPWX/D_9I_:,\(Q^(KH6QUG7/##6^G6
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M_8+_ .#BG6?!?@Z36[Z*7X'OJ.IZIK%^]]J.LWTNJ6GG74\KG)=R <# &,
M"O;?V_?B1?\ _!1W]L'3?V/_  1)>/X)TAK?7/C7KEG*8TL=/4B6WT19 >)K
MME02*.1$>006PI+2+77_ #8DO>:>RM^A]8_L5_MO?#S_ (* ?!Q_'OPRU2ZU
MGPQ_:%QIJW4UG):F26%MKE5D )7/(.,$&O7U! 'M7YM?\&M.DV^@?\$VM6L+
M.$6]I9^/_$$$$0Z1HMV55?<  "OTFJYQL]/(E-A1114E!1110 4444 %%%%
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MWP_I[C['ITURW3[3,@C$:A2$!;!#,:V?V<?^"JGQ^\5_#CX4_M :M;_#>V^
M'Q3\>#P58^#;'398]7T&QDNI+&SNQ>>85DD\Z,;XC&JA<E2 0 12=K=?\_Z7
MWC:LO)?Y?TSZ,\6_M1>.OV5_^"N7A_P!XUUR;5_A!^T%I,G_  A4EQ!"C>&]
M?L54SZ>'10S0W$)$B&0EO,8*I(R!]I@<8/-?G-_P<1C^R/"G[+>N63&+7](^
M//APZ:R??)<7 91ST(5<CH<"OT9'.:E+W;^=OR_S%+XO5"T444QA1110 444
M4 %%%% !1110!X)^S7_R>7^TA_V%M!_],MM7O=>"?LU_\GE_M(?]A;0?_3+;
M5[W0 4444 %%%% !1110 4444 %!YZXQ110!^:^LL5_X.FM)&I^8(F^")&C;
M\[/,^W3^?LSQG;MW8[;<]JT?^#DGXI>(#^Q]X0^"G@^Z-MXH_:1\::=X"A*D
MJRVDLF^Z.>@5@(HFSU69OJ.U_P""J7P1\0>!/CU\$/VGO ^@ZMXE\0?!W5I-
M+\0:1IEM)<WFI^']1 M[HQ11J6=X"RS *"2J. .:^AOC9^QY\.OVI_B!\,/&
M_C#1KK5-;^%>IG7O"TXO+BU%C=.(_P!X\2,JR'$:?+(I (Z#)R)7C&ZV_P [
MAM)ONOTL<?\ M$_L_?"+X5?\$S/$OPU\:02:9\'/#G@TZ1J+6UNTDUK8PPA?
M/58U8F12HER%/S#<0>:_+OXS_LW?$SX5_P#!&S7Y=4_;$TKQ3^R='X6DF\-O
M8Z)Y'B7Q+:/&19:.US(V%220)"T8!D WH< $#]P-=\/67B;0+O2M2M+>_P!.
MU"![6ZMKA!)%<1.I5T=3PRLI((/!!([U\4>"O^#=/]E3P'\2M/\ $5KX#U&Z
MM])O_P"U+#0;[7[Z[T&RN=VXNEC)*8<9Y"L"HXP.!B6KMWZCC*R7D<Q^P)_P
M2O\ AY^T%_P2#_9U\&?'/P!!J^K>%?#T=[;&2>>QO],:Y:24HLUNZ2H&CE 9
M-V#G##(X^7/BOXTLOAA8_&#]H;X3^'-$TWX.?L:>'[OP!\'=)BBW:5<^(976
M/5-7V9S*D+R^5YC$F1E=@Q)<G]D_B)X(3XA?#[6O#S7M_I,6LV$]@;O3Y1#=
M6BRQF,R0N0=DBAB5;!P<'M7E_P ._P!@#X9_#K]B>V_9]M]"%_\ #2/1I-$N
M;&]E,DE_%+N,TDL@P3+([N[.,'<Q(QQBY2NW((:))GR%^PO\>_CG\$OV_/AS
M\)OB=\5W^,FA?&3X7GQ[#=7FD6NGW?AV^C>(201?9U4/:N)#MW@L"H&>#FU\
M?&1O^#FOX!C36_TU?A9KAU@(?F%J7D\C?CMYH;&>,@U[[^Q7_P $E/A=^PQ\
M2+WQCX=N?&7B7Q5/I4?AZSU3Q3KLVK3Z/I,1!BT^U,G^J@7:O !)"J"3@5YA
M_P $X/@)XH^,?[=_QN_:I\=Z)JWA_P#X261? WP]TO58'M[RU\/6+D-=O#(H
M>/[7<*TJ!PK!68D8922_O*W1._X_YB?POSL?>=%%%( HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ^<_V!/\ D:_CM_V4W5?_ $&&OHROG/\ 8$_Y&OX[
M?]E-U7_T&&OHR@ HHHH **** "BBB@ HHHH **** $'&,]:^+OV]OVG/'?B;
M]M7X-?LW?"/Q"WAKQ)XH=_&7CC6X(89KC0O#-I(%98UE1T$MW-^Y5BK;0K<#
M<&'V@_ )YXK\X?V3IY/$'_!R+^UI-J)9[K0? 7AC3M)##)CLY((9Y57V,QSU
MZDTHOWDAI:,E^+/[37Q\_;D_;4^)'P]^"'Q&\,?!CX6?!3R-+\3>,[[2(M4O
M-2UN5/,-I LS")8XT:,,2,Y)Y)( L>%O^"@WQ[_8C_8,^.GB[]ICPKIFI^(/
MA!<_9_#'B+2PEOIOQ%BF^6TEBC5F:(F0HKY &)%P,@@?)O\ P3P_X)7^"/VX
M/VZ_VP-*^-E]XEU72_!_Q'NKFQ\%P:W<Z=:+)>()/[1D6WD21W:)8T4D[0%X
MR<8\;_:1\->(/@=^QI^W?^S=I/B+7?&GPO\ @)XK\):WX<FU.Y-W<:+:W-U%
M=75GYN"2L0!X)&#'(V 6:B+O%7W:'9<S71,^N/BE^T+^W!^PW^RKX9_:G^(/
MCSP?X\\)R?8-5\;_  WM?#D=B=!TR\DC&+.Z#>8\T(E0,') .3\P!(]%_:?_
M &H?C#^V%^WM'\)/@E\6D^$GA/P_\)8OBD=>MM&M[^Y\0/=2M':P,MRK+';!
M?+9BH#'<PR" *ZK_ (+7?$K0W_X-_P#XBZTMW:OIFO\ @O34TY]^5N3<2VHA
M"9Y).X$=\ GC!-6['_@D+X!_:Z_9H^!FN>+KOQWX'^('ACX:Z9X6O]7\,:W+
MH]_>:>^GQ+<Z==%!B2%F+@J0",L 0"1522N_+^O\B(N]GW_X!P<__!67XB_$
M+_@CY\,?%7AZTTZ3]HWXX7)\$^%K.SB'D3:N)Y()]16-\A;>"**2X.[*KA0Q
MP<U]_>!O NN:'\#-,\.:SXLU35O$=MHR6%[XD\J&*\N;D0A'O0BIY2N7S(%V
M;0<#:0,5^-?B+XX)^S]HWC#]HOX7>%])N/AK\!C;_!']G_2+UW?2YKZYN4MM
M2UN1@P=U+AHP^0SA'4D9+5]W_L5_M5_&OP_^WMXM_9T^.-]X*\7:O8>#;7QO
MHWBCPWITNEQW$$D_V:>TFMG>0!HY<[75AN4 D9.%&N;;K_7_  1--?+^O^ :
M'_!)']K_ ,8_%ZS^)GP>^+6HPZE\9/@)X@;0M;OEA6!M?L)<R:?JFQ%5%\^$
M,&"@#=&3A0P%?9&>1@8Q7YS_  D0>'?^#GKXJV^F*$MO$/P5T^_U@*.&N8;Z
M&&%F]Q%P#Z&OT97D"DW=)]_^&&U9M"T444#"BBB@#P;X1_\ *1CXW?\ 8G^#
M_P#T?KU>\UX-\(_^4C'QN_[$_P '_P#H_7J]YH **** "BBB@ HHHH ****
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M_'7Z#+P,>E10P+;HL:*J(H 50 % ]..E2\%@10^GD M%%%,84444 >#?"/\
MY2,?&[_L3_!__H_7J]YKP;X1_P#*1CXW?]B?X/\ _1^O5[S0 4444 %%%% !
M1110 4444 %%%% !1110 4 !>E%% !1110 4444 %%%% !05R,=*** "BBB@
M HHHH **** "BBB@ I N,]\T9Y&.AKQ;_@H=^UY'^P?^QGX_^+,VCR:^W@[3
MA<6^G+*(1>7$DT<$$;/@[%:69 S $A=Q ) !38)7=CJ/BU^RG\,OCUJ]M?\
MCCX?^#O%]]9Q>1!<:QI$%[+#'G<55I%) SS@8YYKE/\ AVS^SV6_Y(C\*O\
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M%M!_],MM7O= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M10 4444 %%%% '@WPC_Y2,?&[_L3_!__ */UZO>:\&^$?_*1CXW?]B?X/_\
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M"M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '@G[-?_)Y?[2'_ &%M!_\ 3+;5[W7@G[-?_)Y?[2'_ &%M!_\
M3+;5[W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'SG^P)_P C7\=O^RFZK_Z#
M#7T97SG^P)_R-?QV_P"RFZK_ .@PU]&4 %%%% !1110 4444 %%%% !1110
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MZM0!_0K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!X)^S7_R>7^TA_P!A;0?_ $RVU>]UX)^S7_R>7^TA_P!A
M;0?_ $RVU>]T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\Y_L"?\ (U_';_LI
MNJ_^@PU]&5\Y_L"?\C7\=O\ LINJ_P#H,-?1E !1110 4444 %%%% !1110
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MQGE@B DD# '>K/Q@^-GA+]G[P#?>*O''B31/"7AO30#=:EJUXEI:P9.!N=R
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M#KF@#^Q7X'?'OP7^TO\ #73_ !CX!\3:1XL\,:J,VVHZ=.)89,=1D<JPSRK
M,.X%=A7X<_\ !D]IOCN#]G?XNW-^MZOP[GURV&D^;D1/?B+_ $HQ9ZC9Y 8C
MC( /(K]QJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \$_9K_Y
M/+_:0_["V@_^F6VKWNO!/V:_^3R_VD/^PMH/_IEMJ][H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4W5?_08:^C* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /!OA'_RD8^-W_8G^#_\ T?KU>\UX-\(_^4C'QN_[$_P?
M_P"C]>KWF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH XCXZ?LW> ?VFO!D_A[XA>#_#
M_C#1IU*M;:K9)<*F>I0L-R'W4@^]?G#^U%_P:S?#7Q)X?\2)\ O'OC?X#3^)
M[*:RU+2;"_N+[0-5CE4H\<]O(^XH4.W ?&.U?JDYQ$22 >M?@7_P3,_X(\P?
M\%4_%'Q3^,6O_&;XT>$_AK>^-=4T[PSH&D^)F.HF*&<AY9[AE*(-QPL:Q9P,
MD@8RDKM_>/I=GT?^R!XY_;V_X)J>.OAG\'/B/\./#'QE^#K7=EX8L?%_A:*1
M;GP]8KMAB>XCC4,%1 &9I(R %P9,\G]948.2 >G45_/E^WE_P12LOV)_VT?@
M+HQ^//QUU+X:?&;7IO"SG_A(F76M!OO+5K>99 /+FB9FPPV(P X)S7W3_P $
M>=?^*?[+/[;WQL_9/^(_Q'UCXMZ7X%TK3O%GA'Q'K$DDNII871V/:SN[,S!&
M,>T%CM(?!VE56]]7U(>FQ^DVP>](8PR[3G%.HJ2B"TL8;"%(H(HX84SM1%"J
MO))P!P.2:2XT^"[*&:*.7RF#KO4,$8=" >A'J*L44 -V#'.?SJ&/38(9Y)EB
MC2:4 /(% =P!@ GJ<>^:L44     ':OYZO\ @O=_RLQ?LQ?]?'AC_P!.K5_0
MK7\]7_!>[_E9B_9B_P"OCPQ_Z=6H _H5HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \$_9K_Y/+_:0_["V@_^
MF6VKWNO!/V:_^3R_VD/^PMH/_IEMJ][H **** "O,OVR_A#JOQ__ &2OB7X'
MT.\2PUCQ;X9U#2;*=V*(DTUN\:;B.BEF )YX)KTVB@#^%3XB?L8_%CX7_'"X
M^'.M?#KQC9^-X;HVBZ.NDSR7-PX8J/)55/FJQ&59,JPP02#7]='_  0A_9$\
M9?L1_P#!,3X;^!/'KO%XGMX9]0N[%GW_ -E?:93*MKGIE 1N X#,P&<9/U\;
M*%Y0YBCWCHVT;A^/:I  H  P!T% "T444 %%%% !1110 4444 %%%% 'Q)_P
M5$_X(*? W_@JKK]CXB\8VNL>&_&UA"MH/$6A3K%=W%NN2L4R.K1RA2?E++N4
M$@''%=?_ ,$PO^"/'P=_X)1>#]3M/ASIM_=:_KX5-7\0:K.)]0U!$)*1Y "1
MQJ3G9&J@GDY(!'U910 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'SG^P)_R-?QV_[*;JO_ *##7T97SG^P)_R-?QV_[*;JO_H,-?1E !2.X'!S
MGV!-+7\Z/_!RU/\ $[]H/_@N%\,?@EX5^(.M>%['Q'X?TJTT^'^TKF#3[.ZN
MKFZ5YW2$Y)81H"0I)"@=J /Z+-_U_P"^31O^O_?)K^=__B$B_:U_Z.9\-?\
M@WUG_P"-T?\ $)%^UK_T<SX:_P#!OK/_ ,;H _H@W_7_ +Y-&_Z_]\FOYW_^
M(2+]K7_HYGPU_P"#?6?_ (W1_P 0D7[6O_1S/AK_ ,&^L_\ QN@#^B#?]?\
MODT;_K_WR:_G?_XA(OVM?^CF?#7_ (-]9_\ C='_ !"1?M:_]',^&O\ P;ZS
M_P#&Z /Z(-_U_P"^31O^O_?)K^=__B$B_:U_Z.9\-?\ @WUG_P"-U\B?\%6O
M^"9O[1'_  1CLOA[KOBGXYW'B&3QC?7,5@V@ZUJ22V<EJ(7+L9=F,^<N"N3D
M'IQ0!_6Z#D9%%<%^RWXDOO&7[,WP[UC5+F2\U/5?#.F7EW<2'+SRR6D3NY]R
MQ)^IKO: "BBB@ HHHH **** "BBB@ HHHH **** /!OA'_RD8^-W_8G^#_\
MT?KU>\UX-\(_^4C'QN_[$_P?_P"C]>KWF@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6_@G\,/%NL?#SPMX+@@2^NM'?[+J.KW<D:RLS3@;TC0$*JQE<_,6)R /9_\
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M017\).EVNF2^*8(;V\N(=(-R%FN8H0\JP[N75"0"VWD D#. 2.M?T1_LX?\
M!VY^S!^S!\ O!?PY\._#GXNG0_ ^BVNB633161EDBMXEB5W(GP7;;N)'&2<<
M4 ?N+17XW?\ $:G^SS_T3KXK_P#?FR_^/T?\1J?[//\ T3KXK_\ ?FR_^/T
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M"M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '@G[-?_)Y?[2'_ &%M!_\ 3+;5[W7@G[-?_)Y?[2'_ &%M!_\
M3+;5[W0 4444 %<=^T!\&],_:)^!WB_P'K331Z3XQTBYT>Z>$@211SQ-&77/
M&Y=V1GC(%=C10!_*?\0O^#13]K30?CC/X?T'3/"'B#PG)=%+;Q4=>@M;40%L
M+)- Y^T(X7!94C?!R%+<&OZ+_P#@F'^PGIG_  3?_8J\%_"?3K]M6GT"W:74
M=0*E1?7DS&2:15/W4W':HX(55SDY)^@:* "BBB@ HHHH **** "BBB@ HHHH
M _,3_@M)_P &UO@__@J?\3(_B1X>\7S?#GXCM;16FHW,EA]OL-8BC&V,R1!T
M=)54!?,5B"H *$X([[_@BG_P02\%?\$@M/UO6X_$EUX[^(WB:V6RO];ELQ96
M]M;!P_V>W@#.45F"EF9V9BB_='%??M% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 ?.?[ G_(U_';_ +*;JO\ Z##7T97SG^P)_P C7\=O^RFZ
MK_Z##7T90 5_/K_P62_Y6N?V>/\ KU\-_P#I9>U_057\^O\ P62_Y6N?V>/^
MO7PW_P"EE[0!_051110 4444 %%%% !7X3_\'O\ _P DQ_9T_P"POK?_ *)L
MJ_=BOPG_ .#W_P#Y)C^SI_V%];_]$V5 '['?L9_\FA?"O_L4-(_](H:]*KS7
M]C/_ )-"^%?_ &*&D?\ I%#7I5 !1110 4444 %%%% !1110 4444 %%%% '
M@WPC_P"4C'QN_P"Q/\'_ /H_7J]Y/2O!OA'_ ,I&/C=_V)_@_P#]'Z]7O)Z4
M ?S>_P#!#;]G#P!^TQ_P7M_:FT;XA>#/#?C72;6]\2W<-IK.GQWD,4PUT*)%
M60$!MK,,@9P2.]?MS_PZ,_9>_P"C?_A%_P"$O:?_ !%?CW_P;B?\K"?[5O\
MUU\3?^G]:_H-H ^=O^'1G[+W_1O_ ,(O_"7M/_B*/^'1G[+W_1O_ ,(O_"7M
M/_B*^B:* /G;_AT9^R]_T;_\(O\ PE[3_P"(H_X=&?LO?]&__"+_ ,)>T_\
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M7[,7_7QX8_\ 3JU?T*U_/5_P7N_Y68OV8O\ KX\,?^G5J /Z%:*** "BBB@
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MTR+Q?X!EF6[TQ"ZQ^;=".(PN%!WL5W# ),@[?MMG'4]:I[(ABT444AA1110
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M"101@]7>1E7/0 DG@&OPR^'G_![1XQG^.,!\4_!WPQ#\.+BZ"/'IU]<'6+2
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M%% !1110!X-\(_\ E(Q\;O\ L3_!_P#Z/UZO>3TKP;X1_P#*1CXW?]B?X/\
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MS5__ (W7ZI_MF_\ !;_]F+_@G_\ $>'P;\2OB+:Z?XJV(]QI>GZ=<ZG<6".
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MXC_M[?'V\^#?QJ33-6\0WUC-J6A^(+&RCLFF\D*9;::*/"$[3N5E4'A@V>,
M'[6U^&/_  >QW/CX? _X-PZ<NI?\*Z;5;U]8-N'-O]O"1"U$Y'R@A#+Y>>I,
MF,FOW.KF/BY\'?"OQ\^'FI>$O&GA_2?%/AK6(Q%>Z;J=LMS;7*Y!PR,"#@@'
M/4'D4 ?QL?\ !$*Z\:P?\%7/@8_@1=3?6_\ A*K19A:!F/V(N!=^9M_Y8^09
M-Y/ 7)-?VG5X1^RC_P $S/@/^Q!K=]JGPM^&/A;PAJNI(8KB_M+;==O&3GRQ
M*Y+!,_P@@>U>[T %%%% !1110!X)^S7_ ,GE_M(?]A;0?_3+;5[W7@G[-?\
MR>7^TA_V%M!_],MM7O= &1KWCG1O"]TD.I:KIVGRR+N5+FZCA9ER1D!B,C(Q
MFJ7_  M[PK_T,FA?^#&'_P"*K^8/]N/]F7QG_P %._\ @Y-^)7P;M?'][X;N
M=5UF[MK*_NS-=06$%I8F98EB5U(7;'M ! !.>>_T+_Q!=?%+_HY32_\ P0WG
M_P D4 ?OO_PM[PK_ -#)H7_@QA_^*H_X6]X5_P"ADT+_ ,&,/_Q5?@1_Q!=?
M%+_HY32__!#>?_)%'_$%U\4O^CE-+_\ !#>?_)% '[[_ /"WO"O_ $,FA?\
M@QA_^*H_X6]X5_Z&30O_  8P_P#Q5?@1_P 077Q2_P"CE-+_ /!#>?\ R11_
MQ!=?%+_HY32__!#>?_)% '[[_P#"WO"O_0R:%_X,8?\ XJC_ (6]X5_Z&30O
M_!C#_P#%5^!'_$%U\4O^CE-+_P#!#>?_ "11_P 077Q2_P"CE-+_ /!#>?\
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M8@@;W!;!*@@$T ?JG_P_J_8Z_P"CAOAU_P"!Q_\ B:/^']7['7_1PWPZ_P#
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M .#008_X(\V(]/&&K#]8: /U%HHHH ***CN+B.T@>65TCC099G8*JCU)/04
M24$9X(K(\)^.=&\>Z<UWHFJZ;JUM&YB:6RNH[A%8=5+(Q (],YK\^/\ @Y=_
MX*C>,O\ @FK^Q3IC_#IC8>-?B%J[:)::NT:O_8\"0^;/-&&!'G$%$0D$+N=N
MJB@#]&+;3X+,NT,$,1E.YRB!2Y]3CJ:FK^1W_@EU_P %^/VD/@=^V=X1G\2_
M$GQ9\1/"WB75[;3-<T;7]0DOHIXKB=(VEBWDF.9"P964C.W:<@D5_0%_P<&_
MML>,OV%_^"7'C'QQ\/9I-/\ %%_<6>C66HA-S:2+J4(]P,\!U0L$)X5V0\X
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M3&S<F-T*NN<D!L$DC)^KZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-+_Q#KWP1A_M;4YC/<RV-QHE@DKD<G9!.B GKPHR>3S0!]%?\$D_^#M#Q?\
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M_P"(7B.YM[BZM]#OO$NH20P@&658="N96503@DA"![D5\&_M+_\ !<_]IO\
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MW#(RG\:_I+,BCJ0!]:_DX\9?\$._^"B/Q#;X?OK'PSUF^?X7Z=!I/AEGU;2
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M1+\([%CX7\."\%W=:AK%XPL;66X$9V);127*R, Y9M@7 !)JO^S[_P $OO\
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M _._E3Z$5^X7[''_  >:^)?A-\/?#'A;XC?!_2M=M=!MH;"74]"U-K2>6")
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MK_\ @GC_ ,%BO@?_ ,%,FU#3_AYXCN8?%>C1F;4/#>L6;6&JVT8(!D\EB0Z
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M"N"^,/[+OPU_:&GLI?'G@#P;XSETT@VLFM:/;WSVW.<(TJ$J"3G X/I7@/\
MP4T_X+)?#7_@E?JO@ZR\>Z-XSUBY\;^<-.30=/CNV+1%0RL&D0Y)9<  YKYQ
ML?\ @[._9ZM[^#^W/!_QJ\,::\@6;4-1\)$6]LN?O-Y<S-@#G 4GT!I)W&U8
M^8_@%^R+X[\#_P#!W!K_ (LL_AEXJT?X:PW-TEEK$/AZ>WT..(:&D:B.98Q
M%W_* "!NXZY%?O+7C9_;I^'.M?L<ZE\=?#6N+XO^'NGZ+<ZZ+S1HS=27$,"L
MTB)&,-YJE64QG#!@00",5\0C_@[!_9R'_,#^+V/^Q-E_^.4P6Q^H5%?+?_!-
M+_@K3\,?^"J.B^*M1^&D?B06OA"YAM;Y]5TW['EY59E"?.V[ 4YZ$9''.:^I
M*;33$%%%%( HHHH **,UF>+O$4/@[PMJ>K7*2/;Z7:RW<JQ@%V2-"Y !."<
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M'X$>$/@_:ZEK?P-^ NK_ /"6^*_%4ME);V=[<JZ$01[P"1B)(D(&6:>1@-J
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M(9D(P02JJ?O"OD7_ ((XR>)/^"F7_!7/XN?MHW_A_5?#_P ,[311X+^'ZZA
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MFUCXW1:MXBN?"SQ:H@%Z\27UWI\\]G&]RHXG5HXQN#YW%F)Y))\A_P""R/\
MP75^%_[17[*7B/X$_LW:U<?%_P"*OQAMSX7M;3P]:2W$-I:W)$=Q([[<$M$S
MQJ <@R[C@*37H/Q7^-7C+_@WC_X)=?LV:3:>%+/Q3X9\/7]GHGQ$O5\V5]$C
MN2]Q=7$0C^\%F>95)X.$&/F&*BFD_E8)6=DM]3YF_P"#AG_@H%X2_;)U#PC^
MR]H_@[6?!3GX@6]D_P 0/&^GG1O#NE&TD>*22RF8$R(P8 R#:!&,;3N!'K/_
M  =!^*-7T7X%_LQ_#[3M&U_XB6.M^-[.\O\ 3],@:>YUZ*QCB"QAU5@'F\U@
M"<C+9P0IK5_X+\?\%*_V;/VA/^"7'B#P=X=\4^&/BKXP^):VMOX-T71)!?7X
MO3*C1W(1/GA\H9))P23LP2Y!ZKXL?\%!?'O_  1E_9>_8YT?XB^#4U'P3J>E
M67A_Q_XBF::2X\)RI;P*BE5!7Y0Y!+'GR6"Y.*<5[MGNFA-ZW79Z'/Z[_P %
MP_BK^Q_\0/"S?M.?LDWOPD^%WBR\33K+Q-9:C;ZJNE.Q&P70BWJ#MQE248@,
M5!VD5^J^CZK;:YI-I?V-Q#=V5]$D\$T+AXYHV4,KJ1P5((((X(-?D?\ \'#?
M_!17X/?M3?L!GX)?"SQ/H7Q8^)/QDU'3+7P]I/AZ8:C+&%NXIOM+^7GRP!&0
MN<$DGL"1^G?[*GPRO_@M^S)\._!^JS)/JGA;PUIVDW;JVY6E@MHXGVGN-RG!
M],4WK%M]Q.R:]#T&BBBI&>#?"/\ Y2,?&[_L3_!__H_7J]YKP;X1_P#*1CXW
M?]B?X/\ _1^O5[S0 4,,C%%!Z&@#\C/^"]>4_P""K/[!;*2#_P )LW(Z_P"O
M@K]6?'OP_P!"^*/A.^T'Q)I&FZ[HFIQ-!=V-_;I<6]PC @JR,"""">U?D5_P
M<;?$C0?A!_P4<_8B\3^)M3M=&T#0?%<M]J%[<-MBM8(YX"\C>@ YS7U3\6_^
M#CC]CSX6>";[6(_C'H/B6>UC9HM.T59+N[NW RJ(JKC+' R2 ,Y) J8_!\V5
M-/G^2/GW_@@GHW_#+G_!13]LC]F;1[BX;X;^ ]:L]:\/:?,_G1Z>MXC&6)2Q
M)"E3&,9YVDGDDGU/_@X&_;4UK]EOX#>%?A?\*+6V'QI^/6J#PQX;%O;QO/90
MN52XN5&WJ!(D:D#(:0'G;7(?\&[7P<\9?$OQ7\=?VL_'FCW7AK4?VBM>6?1=
M+NHRD\&E6S2+"[ \@L3@<881AAP17,^"8S^VI_P=4>+)-7D%SHG[,/@6"+3(
M,9A%_=1PLTF#T<&\;D?\^Z=Q5\K?+%]M24TN:2^1]Z_\$ZOV$/!__!.C]E;P
MY\-?"%I$JZ?$)]5OR/W^LW[J//NI6/+,[#C/ 4*HP !7NM(@PH%+0W<459!1
M112&%%%% !W%<G\>?^2(>,?^P)>?^B'KK.XKD_CSQ\$/&)/_ $!+S_T0]9U/
MA94/B1^<O_!HBQ/_  2,L@23CQ;JW\K>O.O^#HOX.Z1^S!#\%/VL/ ]C;>'_
M (H>!O'UAITVH6,:POJ=K)'-,$GQ@2;3 R98$E)W4DK@#@_^#:'_ (*G_L\_
MLB?\$SK/PG\2?BSX3\(^)$\2:G=MIU_<E9Q$_D;'P!T;#8]<'TJ/_@I-^USH
M?_!PC^U=\&?V;O@&-3\6_#GP_P")HO%7C[Q4EG)%IUE#"I3:CN!DK#). 3P\
MD\:KD@XV:]Y6\B(NR=]M3],OCC^QU\);']H^Q_:S\2:5XAU3QI\-O"]Q'8K!
M+)=1PVPAE=A!9C*FX(D<*5PQ)49X!'YE> _VO="_X*K_ /!QG\&M?TG1-1^#
MD'PAT.ZF5?&D(TGQ)XQ,L<VRVBMCU4"8X0LQ\H3,"<@#[6_:Q_X*ZZC^PS_P
M5 \"_"SXF:)H?A3X&^/-#>73?'-W)*D<6I('S;2M_JXU!"*2>GFH<XSCY2_X
M*\?'[X=_\%!_^"EG[(?@'X"W^F^.OBIX-\:PZ_J_B#P\PN(O#VDQO'*Z37$?
MR_\ +,R[23L$?8R %4[<Z?0<D^5I[E#]JG]H+XGV'_!QGXRU;X8? KQ!\:O$
M?@3X>VWAS2K,SII^EZ=).RSS74]Q.HCP58( '4DY )((KZF_X)X_\%D;SXU_
MM>:A^S[\<?@[=? ?XW06;:AI5C)(ES8Z[ %9F\B91@L$5F!5G1Q'( P9"IT;
M'_@M'I_P>_X*@?$?X#?'6Q\._"O1K.TM]0\!^(K^Y>*#Q/ PS)OE<"-'!.
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M8XKI@,=!110 4444 >"?LU_\GE_M(?\ 86T'_P!,MM7O=>"?LU_\GE_M(?\
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MU:X0QR7FDZ-#;3LI.2-ZKD Y.<'FO7:** "BBB@#P;X1_P#*1CXW?]B?X/\
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MM.\.:U>^'KZX:UFMHX[VSE,5S&IE1=X2167>N5)!P3BORU_X(^?M$Z+^S_\
MLO\ [<'Q=U>UC\!^)-.\5:GXGU[X9QV[V\G@5T@E\B+! 5S<;<AXT53Y8 !
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M\8^)I=(9M#\%P7DL"Q/*SKY<UQ.9XPD:@JOFDDDJ4KZ&_P""PG[97BS]CO\
M8JL]>\!R:3%\0?&'B'2/"WA_^T+<7%L+N]N%7+H>JA Y]NO7%>=_\'+-C!:_
M\$<?BE)%#%&]SJWAV65D4*97_MO3U#,1U.U5&3DX4#H *E_X++_#GX!?&RP_
M9\\#_'GQ-XL\.V'B/QC$-!72I3;VE_?)$F(;J8<PHP8*&!# N<$'D).Z^:!I
M*WS-K]C3P;^V3#\==*OOB?\ %SX ^+_ -H)EU?3O#&C2PZB6,3",+)MVH5D*
M$YQD CO7V\.!CI7X_P#[0/[(_P //^"7'_!7#]DJ']G"QG\ ZC\4]9NM#\8>
M$M+OYY[/6='CB4M>S0.[E3$6DQ(1@E2V048G]@,G QZ53=TF2]'9]A:***0S
MP;X1_P#*1CXW?]B?X/\ _1^O5[S7@WPC_P"4C'QN_P"Q/\'_ /H_7J]YH **
M** /S0_X+'_\%L/$'[+&JW_P\^#/A37->\8Z!J6DKXM\3S:47T/P?;W=S$J1
M.\@V2W,ZMM50"%5RV2PP/T!^)WQ=\/\ P1^$&L>-_%VIV^C^'?#FFOJ>IWLQ
MVQV\,:;W<_0#H.IP.N*^.?\ @XIT^&R_X)F:^\,,43W'BOP])(RH%,C?VG;#
M<V.IP ,GG  ["O/O^"UNA_''XU_$[X2>!/#OP*\5_%KX#Z=Y/B7QE::'K%I8
MR>)+J&1OLVES-.X*VZND<L@ /F!E&1M.96L?.XVE<ZG_ ((V?\%1/'O_  46
M_:$^/H\3:,?#'A#PU>Z9-X0TJYLU@OH-.N8))(IIVP&9YD6.7#?=$F!P,GKO
M#G_!1'4-/_;$_:DUCQ5K\.F_ ;]G/0]*T^[C@TX74LFK2PM>7DZM&AG<QQ-%
M#Y0)4-SC))'R/_P2X_:_\::-_P %6?VJ=3\4_ /Q-X!\/ZB-+OO%$USK-B\'
MP^@L=&=HA<*AQ(LJ1#9Y7" @'@''V/\ \$0OAU-?_L&0_$#Q%I\2Z_\ '_7]
M3^)FKPS*)5_XF5RTMLF3U5;1;8 8 '85HXI6MV7]?F0GW[GG_P#P2I_X*F?$
M;]O[]N_XW^'_ !-X+U/X=>!?"F@:)JGA;1-9LE@U<V]WY[+>7)^\#/&(W$>2
MJ+M R22>6^-W[5W[3O[17_!1'XR?#GX&>/O@]X$\'_!V'2+"_N?&.DM<O=ZA
M>0-.T<<B\G"E.#P"".N:[/\ 9*0/_P '!?[7ZL3M/@SP:#SV^S35Y;\"?^"9
M?[$G[??QQ_:7\2ZE#KOQ"\41>,;RQ\5P>)+Z:S/A:[0NDCVJ1N@6,;6"3.#\
ML0 . <PDM/ZZE]7\OR1^@/['&@_%7PU\"M.M?C/X@\(^)_'BS3O<W_AJS>TT
M^6%I"80B. 0P0@$XP2,Y/6O5LU^<_P#P;2_$'Q#XP_8G\9Z-J7B'5_%WA;P+
M\0M7\.>#M9U&1I9;_1X#$86$C$ET5VD4$$@!=HX4 ?HOW_&JDNOH0KIM/N+1
M112*"BBB@#YL_P""E_\ P5#^&?\ P2Z^!%[XP\=ZC!/JDD3KHGAZ"<+J&O7
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M=0\371O9YAJ$]O"887"2.R1;8R1B-5!ZD$\UZ,<C. <U\[?\$QOB5\2OCO\
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M_@J9\"?VYO&&I>'OAGX\M=>\0Z3:+?W&ESV-UI]Y]F?&V=(KF.-GC.Y?F4$
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MP3\6O@O_ ,$T_BG\,=7U&Y^%WQ \6>)O$FHZ)J]A>PW4NF+=S;[6Z5X78 \
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M[X.7/@+XF>%=/\5^%[DJXMKDLCV\B@A)894(DAD4$@21LK#)P>37YF_LV_\
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M/;<X@::%9"@SS@%B.><5W?49'-4]"T*S\,:)9Z;IUK!8V%A"EO;V\"!(X(T
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MPUO5M:N-8U'4=$TQS_9.ARSSL[!+BX51Y0*[88V8 EB:_2[]GC]F[P-^R?\
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MX;_P7X=EGMM7^,'B72? <=Q"A=K:.^N5$KX';RXV4]!AB.,YKZ^^ _P<T?\
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MMK.QMDM[>W7).U(T 51DDX  K12T?GMY;?Y?B2U?^O4U****0PHHHH ****
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M0OP4TO2/A78_#BST.;5[/4;O5KE;Q;N:ZS:LZ+;QD>5&'8.1@[1R!HG=)/\
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MGM/B9';^(/BYK.JZW=:S?V_A'2I0;+2!+<.QBAN9R8EC7:2B2'+8./UA4!0
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MU+2VOH5F-IJ$'D75OD9V2)D[7'<9./6@#5HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ H]\<T44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %-D0.,$L/H2*=10 S[.OK)
M_P!]M_C3@NW '6EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N%^,7A'Q]XHET\^"
M?&NC^$5AW_:Q?>'?[6^U$XV%3]HA\O;AO[V<CICGNJ* /F'X6?L<_%[X/7?B
MF?1_C3X=,OB_6KC7KW[1X $@6YF"AMF+X80;5."2>O/-?3%G'-%:1)/(LTZH
M!)(J; [8Y(7)P"><9./4U-10 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
I%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>j13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" 'H XH# 2(  A$! Q$!_\0
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M=%<S\*/BYX8^.GP^TKQ9X-U[3/$OAK6H1<6.HZ?.L]O<H>ZLIQD$$$'!!!!
M((K*_:*_:-\%?LG_  :USQ_\0=?M/#7A/P]#YU[?W&65 2%55506=V8@!5!)
M)P!0!W=%8GP]\>:7\4/ FC^)=$N3>:-K]E#J%E/L*>=#*@=&VL 1E6!P1D5P
MGQ4_;3^&?P7_ &@_ ?PL\1>*+2Q\??$HRCP]HXCDEGO5B4L[G8I$:85@&<@$
MJP!)!%.P'JU% (/0T$@=32 **\M_:=_;(^''[&^AZ!J/Q%\3VGAZ#Q3K$&@Z
M0LB/++?WDS!4BC1 6/7);&%')(&*]+FN8[6W>661(XXU+N[$*% &<DGH .<G
MI1<">BOBS6O^#AG]CGP_\59?!US\;O#HU6"[-E),EM<R6*3!MI!N5B,. W&X
M,5[YQS7V$GBK39/#2ZTNHV+:.UM]M%\)T^S&#;O\WS,[=FSYMV<8YSCF@#1H
MKX?\0_\ !QM^QEX9\<R>'[GXX:$]U!,8)+B"QO)[-6!P?WZ0E" ?X@2.^2.:
M^Q_ WCS1?B=X1TWQ!X=U6PUO1-7@2ZLK^RG6>WNHF&5='4D$$=P: -FBO%_V
MJ?V__A-^Q/KG@ZP^)_BN'PM-X^O6T[1&GM)Y8;N<&-2ADC1E0@R)]\@8).<
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MQ+=/-@E59$!]2N"<@$X- 'MM%%% !1110 4444 %%%% !1110 4444 %%%%
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M%'[$<O[;/_!,3QG;:1;O+XP\ %?%^@/$N9O/M06EC0]<R0&10/[VP]A7JO\
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M"\?PZ_94US4M0M_@]\,_#P\9^*=/MI3$-6GY;8Q&#R'MX@>2HDE*X)S74?\
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M*D@QP3',.1U!M,=#7ZJ_\%!/VL-/_8?_ &,OB+\4]1>/;X0T:6YM4<@"XNV
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M^#\?CQ@D_AS6=+AMXM7T6=74Y-N#%<%& *M&< @@C! (XC_@OE\7/B9^PO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M L6P,?75%.X!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_LT_'S2?A)X*^&WC;XU?%74M,;7;GP]X8$*G1].#%!<W4TK!(@[C:JG)8XZ
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *">,CFBD<X4T
M?&W_  47_P""M_PW_8V^*7A+X/7WA7Q-\4_B%\2=L">$O#UDM[/'8ROY3SW*
MYR(RI<A0I+!')P 37GNJ?\$K/@/_ ,$B]'\;?M _!SX'^)/'/Q!TBQE&EZ!8
MZE<WTL,<SXFBL8G+B$;'?[JLP4%5P"0>2_8TFT;PM_P<A?M66GC-K1/&OB#P
MWH%UX*>["K--I*6P6Z2U).<"4*7"\G:3T!K]-@.1G/':DGH-[GYV?\&\5_\
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MR\JV1U%?M@HP*_ 70#G_ (/7;GZ2_P#J/&OW[I %%%% !1110 4444 %%%%
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M>_W?:Y[)976U>4M\Q8PB/!/)7:223D@'V+1110 4444 %%%% !1110 4444
M%%%% !1110!X3\=_^3Y/@+_UZ>)/_2:UKW:O"?CO_P GR? 7_KT\2?\ I-:U
M[M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %))]T]*6@C((H _-_\ X+)_!G]D7]J_QOI-A\2_CKH'P8^-
M7P] DT7Q!8^(8+#6M'64!U21&8&2-@0P4E2-Q*L 3GXP;X/GQI:/X;\7_P#!
M7ZWO?!$@-O-!9ZQ#%?74'38TINL@E>"26'<@]*^Q?^"F_P#P;:?#G_@H7^T!
MJ'Q@LO%^N^$?B3>I )3=6L&K:+=F&)8HQ+:2*&V[54$+(,]< \U\O:G_ ,$U
MO%7[%]R[_%+]@[X&?M ^#+/(?Q#\,/-L-86(#F673KB0EG &2L7&?XAV213W
MT/O[_@CS\.OV5OV>/A/J7P[_ &;/&WA;QI/9E=3\1W]GK$6IZKJ4SDJ+F[DC
M]2"J@ *HR  2<]A_P4Z_X*I?##_@ES\#;[Q1XVU6TN?$,]N[:%X9@N%&HZ[/
M@A41.62/=]Z4C:HSU. ?&?\ @BS\8?V,?BSKWC5OV9?!-I\/O&EA;PP>+-%G
MT:73M4M(Q(P1)0S-&P60,,QNP!X.*ZG_ (+1?LL?#O5OV)OV@?BO>>$-%O?B
M+9_"[5=(M==N8!-=6=LL$SA(2Q(C.YV)90&(."2.*IB6YZ=XL_X*,>%/A'_P
M3=T_]I'QQ:W&C>'IO"UEXDN-/MG%S<![J.-H[6(D*'=I)%0$A02<G !Q\XWW
M_!;CXE?!+0_!WCGXU_LS>)OAM\'/'-[;65KXEBU^WU*\T8W3!;9]0LU56@5\
MJ3AF*DX(S@'Z%_86\'^%_''_  2S^#%CXRTO0M8\-CX?Z-<7MOK-M%<601+&
M)]\BR@IA,9R1@8SQBOC3X]?$36O^#@_XLV/PE^%=O-I_[*?@/7[:^\9^/VA,
M:>+KJSE#IINEAAAXED +2X(RH(( 4.)>\Q=+GT]^UE_P4ZU_X;_M46'P+^#/
MPLOOC)\4CH@\3:O;C5XM)TO0-.9]D;SW+J^)9&QLC"'(922 15K]EW_@K;X1
M^-/[-7Q1\=>-O#^L_"O6?@;<W5EX_P##VKLDMSHDL$0E)1D.V:.1"#&P W'@
M#IGQW]@2W6#_ (+X?MKK> K?1Z1X42P$F"RV8L$&%)YV;@O3C/7G%?&?_!3C
MSSXG_P""IYT7SA9GP]X(-_Y ^7S?-C\_.._D8SGG'7C%%BFK?@?9/AW_ (+G
M^,_#_A_P/\1?B=^SCXJ^'7P&^(FHV]CIGC"?6[>ZN],6Y<):3W]DJAK>*4E?
MF#L0&!(S@']&HY5F4,I!5@"".01V-?G7_P %XUTI?^#>SQX (!:+X8T/["%
MVAOM-GY6WMTZ8_"N&_X*>_MT?MH?LH1?!W2_V>/A"_Q&TG5?!5K=Z]=OX;NM
M3>UOP IB+0R*$)4!MIR<DG-)BOHCY3\/_P#*Z[<_27_U'S7[]KW^M?RJVC_\
M% [/_@IC)^U:G[-7BS_A9$FY3;'P?>'3,&S^R']UNWY\OG._[W/M7[(_\$2/
MVWOVO_VL?B3X[L/VEOA+_P *WT;1]-MKC1)SX>N=+^V7#RLLB;IG8/M0*<
MC.2>10(_1JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#P+XY?\G\? /\ [!WB;_TGM*]]KP+XY?\ )_'P#_[!WB;_ -)[2O?: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *\+U3_E)?H7_ &3+4?\ TZV->Z5X7JG_ "DOT+_LF6H_^G6Q
MH ]THHHH **** /"/BA_P3(_9\^-/QFB^(?BSX._#_7_ !I$Z2G5KS2(I;B5
MTP5=R1B1EP,%@2/6O<;>%+6!(HT6..,!550 J@#   Z  8P*FHH **** "BB
MB@ HHHH *** <]* "BBB@ HHHH **** /"?CO_R?)\!?^O3Q)_Z36M>[5X3\
M=_\ D^3X"_\ 7IXD_P#2:UKW:@ HHH(R,4 >:_M2_M9_#K]BOX37?CCXH>*]
M,\(>&K1A";N[8YFE8$K%$B@O)(P!(5 3@$\ $UY[^PY_P58^!'_!1=M3@^$O
MCRQ\0ZGHR"6]TR6*2TOH(MV!+Y4JJS1Y(&Y<@$@$@D _F?\ \'HW[/WQ$^(_
MP+^$_C#P_9:GJW@CP??WL6NVUI&\JV<\Z1B"ZD51P@"2)N(P"X!(W5^?O_!J
M5^SC\2O'_P#P54\)^-?#%CJMEX0\%VUY-XCU7RG2S-O+;O$MJS8VN\DC+A!D
MC:6P N: /ZOJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ I'^Z:6D?[IH _';_@L=_P<N>)OV%/VP=5^!'@/P9X7M-<TR.U-
MUXN\5W<TNG6@G@28.+6W =PH?J7R2,;2#7RB/VR?@K^V!=Q7_P"UA_P4"\<>
M*+"9A++X-\ >'+_0-#3H3$TBP;I5[9"*Q SO.<U^D'_!3'_@ICHOP)_:PT[X
M/_#;]FX_M&?&;4-+76]7M+2Q@QI-EG;&\TS1.Q9@. 2 HVY.6 KYQO/^"NWB
MW]LKQUI?PT_98_9#\(WGQ7T.RFNOB%I_C?2;:SM_!LT<S0FT9SY*NQ=20Y89
M#* F0V!; ?4O_!%#XF?L0:S+XI\,_LD6NEQZEI=E;S^(+E=-O([^ZA+LL337
M-TN^;Y]QP6."2<#-?6O[7_[/</[6O[+GQ"^&4^JR:)#X\T*[T)]1C@$[60GB
M:,R",L Y7.<%AGID5\K?\$7/V\+G]J75?BAX$\>?"#0/@Q\;OA->V]AXJTG2
M;:**WNXI@[0SQLN6*':QP692&5E8AAB7_@LI_P %C[3_ ()X> -9\,^"/#FL
M>.?C/+X>GUVQTRUTV6XL="LD#AM3OI0 JP1E'.T-N8I@[0<T-#2U.\_:;_X)
MC7WQ_P#^"8&E?LTZ7\3M5\(6EGHNFZ!>>(;72UGGU&TM$1'C:$RJ%6;RUW .
M<#(R03GPSX2?\$6OVBO@9X'T#PKX6_;G\8Z-X6\-P1VEEIEI\/\ 3XH88$(^
M1<3\9&<DY))).22:]L\??\%''_9V_P""/.E_M'>,K:WU361X&T[7)+*V4V\6
MHZE=P0B.%!DE$>>51P257)YQS\Y>,OV\?VPOV&? /PQ^,OQWC^$NO?"GQOJE
MA8>*=!\/:7<V>J>!4OV5;:19Y)F6X"%D60%1AC@9!W!M.X)W1[_^UC_P2_\
M$OQ,_:>TCXY?![XO:E\'?BW!H2^&=9U#^Q8-8T[Q+8*VY$N;65E7S$?E7!)
M !' (TOV5_\ @DIX0^!G[-'Q-\ ^-/$&L_%;5_C=<75YX_\ $FKHL-WK\MQ%
MY3!50D0QHG$:@MM.3D\8X']H[]LWXY?'3_@H7J7[.W[.E[X$\,2^!/#EOXC\
M9^+O$^F3:G%:M<D?9;*W@CDC!=T*N69N 3C!!!R?@+_P5Z\2_#O]FO\ :1N/
MV@-%T*R^)_[+<K)K\/AXNECXA@D@$MC<VZR$L@N"0F"3@GMR 7TL&M[&3X7_
M ."$WC77M,\#?#[XG?M)^*_B3\ _AQJ,&HZ5X+GT&WM+C4!;N&M;:_OD<O<0
MPD+A2H!"XPO&/T=AC6&-54!50   8 '85^5WC+]OK]LK]D+]G[P5^T=\8X?A
M%J?PFUN[L9?%7A#1=+NK?5_"6G7SHD,Z73RLL\D?F(74J!U )&2/U,TW4(=6
MT^"ZMW66WN8UEB<'*NK $$>Q!!H8BS1103@9-( HH!SR** "BBB@ HHHH **
M** "BB@G S0 $@=>])N!R*\D_;M_:9_X8U_8Y^)?Q4%@-4D\">'[K5X;,L56
MZEC0F.-CU"ER@)'(&<<U^=>K^*OVR/@7_P $^+;]K_7/CU:>(=6M])@\;:U\
M-)= M(O#3:-($E:TMID7[0DXMV!$A<C=D$'@D2Z@?KAD9QWHKX=_;E_:T\0_
M%/P5^RMH7PJU_4/#>I_M"^+])NWO+)T^U6^@Q6K:C?8)! S"BQ[L'E\#DBOG
MC_@KC_P5N^./@CXR^&_"/PG\$>)_!7P^T7XD:1X4\3_$'4K:.*/6+F:8$V&G
MI)GS(B@<23!20!@;,@D47=(5]#]:: 0>G->??M._M(>%/V1?@1XG^(WC?4DT
MOPSX4LGO;N4C<[@<+%&O5Y'<JJJ.2S 5\/?\$-_VZOC9^V5^T5^T?'\8[>?P
M\FAWFC7?A_PHT4:_\(U97EM)/%$Q4;VE:$PL^\DAB1A?N@*MI<_2*BBB@044
M44 >!?'+_D_CX!_]@[Q-_P"D]I7OM>!?'+_D_CX!_P#8.\3?^D]I7OM !111
M0 4444 %%%% !1110 44A;&?:O@KXZ_\%.?C'\2?VV/%?P-_9A^&/A7QSK'P
MRM(;GQKXA\6ZO+IVCZ9-.I:&RC,(+O,P!YP0"&X !- 'WMN'J**^8O\ @GA_
MP4/7]LOX?^.(?%GAB7X=_$KX2ZK)H7CGPY/=+<)I=RB%UEBF  DMY4#,C>@/
M4 $^9_"#_@L_X6\/?\$Z+7]H7XRWFC^%=+\5ZMJL?A#2].61[[Q!:17<T5E%
M!"Q9YKF:.-6(4!1OR=J@D 'W2"#T-&1C/:OEO_@D#^WYJG_!2W]BZP^+&K>'
M+3PM/JFLZE8Q:?;R/((8+>Y:*,NS'/F%0"V,#=G  KRW_@HM_P %L=,_8]_;
M7^#OP)\*:/8^*_%WCOQ#86/B1YI)%A\,V5V^R$L4_P"7B7YG1&(&R,D@A@:=
MN@'WM12+W^M+2 **** "BBB@ HHHH **** "BBB@ HHHH *\+U3_ )27Z%_V
M3+4?_3K8U[I7A>J?\I+]"_[)EJ/_ *=;&@#W2BBB@ HHHH **** "BBB@ H)
M Z\4C/QP>:^ _P#@MK_P4H^*7[)7PK\2^&/@G\-_$7B3QO!X4O/$NH^*GME7
M0_!NG1))ONGE<[9+D!',</<@$AA\I:&D??NX>HI-P]:^!?BS_P %%/&'[-/_
M  0P\#?&,2)XH^*'BCPKH5GI;WJ*4O\ 6M12&**65%V@J))#(P& 0I P*\M^
M,7CS]IW_ ()-:E\&_B5\1?C?<?&?P/XX\2V'A;XA:)J.AVEC'H,M^=J76FO
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MV?%.Z^$"?LQ^/KKP=H>A>"[?3O$-M'XB331+J"D?,593O(3:-P],5[S\'/\
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M>SY<-G(X.:\=_9R_X)-_LY_LD_$V7QG\.OA)X6\,>)VC>*+4($EEELT<$,L
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M>VC\R>[N""/*MT! WG@L0 ">*_.GX^_\$R_CHNE_&KX.6>G^"%^"?Q=^*/\
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M 4444 %%%% !7A>J?\I+]"_[)EJ/_IUL:]TKPO5/^4E^A?\ 9,M1_P#3K8T
M>Z4444 %5=6TR#6],N+.ZB2>UNXFAFB<961&!5E/L02*M44 ?SV_'O\ X,I?
M$FM_M#W]U\//BSX8TOX::A>F>*'5[.X?5M+A=LF%5C7RYM@)"L7CR ,@')K]
MNOV)?V1/#'["7[+G@[X4^#_M$FA^#[(6R7%QCS[V4L7EGDQQODD9F(' S@<
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M1?A+X=_&?X6:#\/[OXI>#I?'7@VZT;76U))+2-HO-M+M612ERB3QL2I*G)
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MD_\ 2:UKW:O"?CO_ ,GR? 7_ *]/$G_I-:U[M0 4444 %%%% !1110 4444
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MPQXAB5+F-)6AEB='$D<L4BG='(CJK*PY! ZC(H&K=3XL\9_&W]KSX_?M,O\
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M !6+\0_!.G_$OP'K7AS5HO.TOQ!83Z;>1\?/#-&T;CGU5B*VJ",C% 'YL_\
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M>"/BM\4OB1XLN_&FME;=VTW2+BX"H+:U)VL42, %B.3P,A03SGA?_@@!\-?
M7_!6SP]\2]!^$_P^TSX.Z#X,"V]A"2)+?Q)'?+-#>+"?XDC  ?. 0.,U^EQP
MN!SB@J ,XIIV&WN?,'_!5+X,?$O]J'X"Z3\*/A]&]EI?Q'UNWTGQMKJW:02:
M)X>^9[TQ@D,\LR*(%"@X$K$@#)KQ?]J;]D+XI_LV?MJ>#/B_\!?AIH7Q$T'3
M?AC<?"^3PF=9@T:31HQ,DUI<PO,-C0@HJ.@.[&2 :_0;9Z\_@*-G(.>E):;"
M/RJ_:G^$?B3_ ()S?\&\&E? :XFL]?\ BG\0((_ >F6FG9:*[U75[N226&$$
M;FCB228;L#"QY( K]%_V6?@Q%^SE^S5\/_ $#K)'X*\.V&B!QG;(;>WCB+#/
M8E2?QJ?QY^SQX/\ B=\3?!_C'Q!HD.J^(/ ,MQ/H$\\CLFFS3Q^7),D6[89=
MF5#LI90S!2-QSVZ@@D9QBBXVQU%&1G'>B@04444 %%%% !1110 4444 %%%%
M !7A>J?\I+]"_P"R9:C_ .G6QKW2O"]4_P"4E^A?]DRU'_TZV- 'NE%%% !1
M110 4444 %%%% ".2!Q7YX?\$[/A?%^R-^VE^TC^S5XFL8Y/!7Q'U&?XD^"(
MKF,_9-5T_4,QZI9+D;2;>8HK(.0DB'&#Q^B!&1BJTNGP3W<4\D,3SP@B.4H"
M\8.,@$\@' X'7% 'YRW/_!OQJD'@6\^%.E?M+?%72_V<]0O6FE^'B0P.T=F\
MA=].COR?.6T;)79M/!ZD\U]$_MB?\$R?"W[67PI^$G@>+5;SP?X2^$GB?2?$
M-EIFG6Z/!>1Z=@0V;AND>T8R.0.E?35% #(T(Y->!6_[%MUK7_!1"?XZ^)O$
MJ:U;:+X8'AOP?H'V,QQ>'?-<27MV9"Y$D\Q5$W!5VQJ%YY-?0%! /44 ?GIX
MW_X(<ZIXO^(>N:$/C!?6G[/?BCQ\OQ*U/P$FAQ&\EU3SEN7A34#)N6TDN5$I
M3RRP/ 8=:T/VNM#?]NC_ (*V?!CX8V,4EUX1_9ZS\2_&%T(BUO'J;H8=*L2W
MW?.(:2?:>0BJ<<U]]D ]15:WTV"VNIIXH88Y;A@971 K2D# +'J2!QST'%-.
MWR&W<L!3MQ2T CH.U%(04444 >$_'?\ Y/D^ O\ UZ>)/_2:UKW:O"?CO_R?
M)\!?^O3Q)_Z36M>[4 %%%% !1110 4444 %%%% ".,XY(QS7P!^TIILW[%'_
M  6;^''QG>&=/ 'QVT0?#7Q7>*A\C2M4AD\[2IYF'"K,2\&YN VT9K]  <C-
M5K_3[?4X/*N8(;B/(;9*@<9!R#@C&01G/8T+>X'B?[?_ .Q+IW[?/P/L?!&J
M:[?^'K>Q\1:9XA6ZM($ED9[*Y2=8RK' #E<$]1G.#TJ3]OC]A'PI_P %!OV?
M)/ ?BF[U;2)+6]M]7T76]*F$.HZ#J-N2T%W Y& Z$G@C!!(X."/<<#T%%.X'
MQ5^S)_P2/U?P%^T_H7Q?^,GQK\8?'GQGX*TZ33/"G]KV$%A8Z LBA);A((B0
M]RZ#!E)!.2<9P1R?Q6_X(?:Q+\2/B/??"']H3XA?!3P=\8+Q]0\6^%]'LX+F
MUGN90%N)[.1R&M))E&&*9ZXQ@ #] :*0'FO[,/[,'A?]CK]G+PY\,OA_9+I>
M@>$[ 65@)OWK.V"3-*1@N[N2S'@DDXP,5X'\-O\ @D1H-K^P3\3/@YX[\2WG
MB[7?C3=:AJGC7Q9%;BVNM2O[J3>DZ(S/L6 )"L:%F 6( YR<_8PS@9ZT' R:
M=QIGQ9^R5_P3R\0?LN_&F\^-GQL^,D?Q+\2>$?!(\&Z/?_V)'HMGHFB0N)Y9
M)5623S+ARBL\I(&%P%&:P?\ @BO\,-3\<ZQ\;_VF/$%G/9WO[1?BHW_A^&YC
M*30>'+,-!II8-R/-0O+C ^5HSBONJXM8KR!XYHTECD!5T=0RL".00>H]C1!;
M)9QK'$BQQ1@*B*,*H P  .@ XP*38B>BBB@ HHHH **** "BBB@ I&!(P*6B
M@#\D?C9\:OAY_P $Z_\ @O/X_P#B=^T?HMS9>%_B/X9TFQ^''CF[TQ[W3=":
MW0K>6>]5;[/([D-N R >2 QKZTO_ /@NO^Q[::*UW+^T+\-983'N,2:D)96&
M.1Y:@L3VQCVQ5G]KK_@IY^R/\*_&6L_##XS_ !%\ 6^KZ>L?]HZ%KUF]T(Q)
M&'0LAB9#E&4\=CVKYLLOVNO^"3^F:NM_;W/[-L5XK"195\+1AE;.01_H_!S]
M*270"K_P1X\4^%_VG/\ @JI^T-\;_@QX2U'PS\#=>T#2]%34GTQ].LO%^LQ2
MRO->V\3 <*A"D@ D\D N17ZG 8&*\!_8U_X*!_L__M>3:AX<^"7COPKXH'A:
MUCFN;#1H7BCT^%V*H=A1%"D@C []J]^JFP/G/_@J?^PF/^"C?[$_BSX6PZR/
M#VJZGY%]I&HNADBM+VWE$L)E4<M&67:P&2 Q(!( KX]_:#_9H_;=_P""D_P+
MT/X"_%KPE\*?AQX*FO;)_&WC72]?.IW'B&WM)HY0ME9! T#RO&C'S" .@*C*
MG]3J*$P/S]_:!_8_^.?[+G_!0#4/C_\ LZ^'_"WQ L?'?ABT\,^,/!NMZS_9
M$DDMD MI?P7+*4W+&J1LK#. 2 =V1E_ S_@D3XO^,/[-'[2S?M!:CH,7Q3_:
MH<G5AH3/<6/A>VAA$>GVT3-CS#;L Y(X8]SR3^BV!G/>BBX[ZGY1^.?V-?VT
M_P!M?]G?P;^S3\8=$^&GAWX:Z9=V,'C'QYI6NM=WOBO3+&1'CB@LPBM#+-Y:
M!V<@9R0 ,@_I9/\  ;P1=.KW'A#PQ=2JB1>;/I<$LC*JA5!9E).%4#D] !78
M447$?S\>!=!L?#/_  >C2V.FV-GIUE"LOEV]K D,2?\ %/D\*H '// Y/-?T
M#U^ ?A__ )77;GZ2_P#J/FOW[7O]:0"T444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 >!?'+_D_CX!_]@[Q-_Z3VE>^UX%\<O\ D_CX
M!_\ 8.\3?^D]I7OM !1110 4@8MTI:_E(_X./?\ @J#\:OB/_P %+?B%X @\
M8>)_"7@KX:ZI_9&D:-IE[+91.8T4M>2;"#))*Q+!F)PI4# !) /ZMQGOBBOR
M>_X-+_V]?B7^V=^QSXST?XDZQJ?BJY^'>LPV&FZY?N9;F>VE@#BWEE/,C1%2
M0S$MM=020!7ZPT %%%% !1110 4444 %%%%  !@8%%%% !1110 4444 %%%%
M !1110 4444 %%%% !7A>J?\I+]"_P"R9:C_ .G6QKW2O"]4_P"4E^A?]DRU
M'_TZV- 'NE%%% !1110 4444 %%%% !1110 4444 %%%% !1110   =!1110
M 4444 >$_'?_ )/D^ O_ %Z>)/\ TFM:]VKPGX[_ /)\GP%_Z]/$G_I-:U[M
M0 444$X!- !17RU_P51_X*P_#?\ X),?!*Q\7>.XM4U>^UZ[-EHVB:6$-WJ,
MJH68Y=@J1H -SDG!90 20*\+_P""3'_!R!\*/^"IWQ;F^'<'A[7? 'CQK:6\
MT^QU*:*XM]6CC&Z1894P?,5/G*,H)56()P: /T9HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "@]#12/]TT ?GS_ ,%F/^"4
M&@_\%%-)T_QC\-8O L?[0WPOU"VN].N-16":VU&))$9[#4HRKAXBGS+YJ-M/
M &US7T+X!_X)V?!34?!&CS^(O@!\%M.\0S6<+ZG:VOA:PFM[>Y* RI&YA^9
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M** "BBB@ HHHH **** / OCE_P G\? /_L'>)O\ TGM*]]KP+XY?\G\? /\
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M?"/POJFL:SH?A,7?V:[U,QFZE\S19)FWF-54X+D<*. *_I@I#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P+XY?\G\? /\ [!WB
M;_TGM*]]KP+XY?\ )_'P#_[!WB;_ -)[2O?: "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\+U3_E)
M?H7_ &3+4?\ TZV->Z5X7JG_ "DOT+_LF6H_^G6QH ]THHHH **** "BBB@
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MOMVL7;Q/"B+$C,R1J)&9F<#.T  Y) !_1D#D9HH'044 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !2/TI:#G''6@#\YOVG/VXOV
MA?V@_P#@I]-^SM^S:/"&@Z1\,;2PUGXC^*M>@:X,*W#"1+*W09 =XAC.TDEF
M^9 ISPW[;7[57[0O[<G_  54O/V5_P!G/X@VWPET/X<Z%'KOCCQBFGQWUVLL
MA0K;1J_  $D:A1@EBY+;5P<CX]?%3QI_P1P_X*V_&#XP:A\)O'_Q,^$O[0VC
MZ9(+_P )6)O[K1M4L(#%Y$L0Y5)!SN) ^8$9(8"3_@DO::M^Q_\ "#]I_P#;
M<_:(\.ZSX%G^+6M-XB&F3VCSZII6B0LYMT:(?.K,TV-A .(T) !P%#9-E-:G
MK_\ P2/_ &MOC6G[3/Q@_9C_ &A]6TKQ;X^^$D%EJND^*[&U6U'B;2KH';+)
M&ORB13LSA00693DKD_H*#@#-?E]_P1<O/&W[;7[?'Q[_ &N]?\'ZUX(\#^-[
M#3_"G@6SU> P7=]86I):Y9#SAB%.?NDR,%)"YK]0L#T%4]B.K$*@]:Y7P[\#
M?!7A'QA=>(M)\'^%M,\07N?M.I6FDP07D^>N^9$#MGW)S75T4AG.^/OA;X8^
M+&D)IWBKPYH/B73XY/-2UU;3XKR%7 P&"2J5! .,@9K3T+P_8>%](M]/TVQL
M].T^S01V]M;0K%# HZ*JJ % ]  !5^B@#D] ^!O@KPIXRN/$FE>#O"VF>(;S
M/VC5+728(;V?/7=,JAVSWR3FNK('4BEHH _ 30#G_@]<N?I+_P"H\:_?NOP#
M\/\ _*Z[<_27_P!1\U^_:]_K0 M%%% !1110!\M_\%@?^"D=E_P2N_8DUWXI
M2:0OB#5Q=0:3HFFNYCBN[Z;<4$K#D1JB.[8Y(3 ()!'XW?\ !/?_ (.]_C'X
MP_:Y\+^'OC)HG@F_\!^+=5ATN>71]/EL[O1C,XC29&,K"1$=E+*P)*[B#G K
M]J_^"I'_  3M\.?\%0OV/=>^%7B+4)]&:]FBO]+U6&(2OI=]"3Y4VPD;UPSH
MRY!*NP!!P1^2/_!/?_@SO\5_!O\ :R\/>,/C#X]\):SX/\':G%J=OIFA).\^
MM20N'B64RH@BCWA2P&XD J,9R #]]T<,H(.X$<'UI:1.!C&/:EH **** "BB
MB@ HHHH **** "BBB@ HHHH \"^.7_)_'P#_ .P=XF_])[2O?:\"^.7_ "?Q
M\ _^P=XF_P#2>TKWV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O"]4_Y27Z%_P!DRU'_ -.MC7NE
M>%ZI_P I+]"_[)EJ/_IUL: /=**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /"?CO_ ,GR? 7_ *]/$G_I-:U[M7A/QW_Y/D^ O_7I
MXD_])K6O=J "BBB@ HP/0444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 444$9!% 'BW[7?\ P4!^#/["WA<ZM\5?B)X<
M\(1LI:&VN;D/>WA Z0VR9ED/^ZI]R!7YE?M*_P#!S'XX^,9T/0/V=/@)KE_I
M/C[7[?PEH?CCQ[;26.BW>H7)/DHD.W:X(4OAI =HR5!XKUO_ (*5_P#! GQ)
M^T+^V=>?M(_";Q[X8L_B3/;P1/H'CKPY;ZUH,_D1)&@3>C&(D(,DH_+$@K7R
ME_P46_:R_:A\'VOP#L/VC_V<SX7\/?!GXEZ3XMO?&7@0MJ.BW5C9I(D@%M'O
M,!VR!@&=0 "-H) HB4]M#]'?^"7O['7[2GP7\<^+/'G[1_QM@^(FO>*[&"SM
M/#FE6[0:-X9"2,[>0/D0ELA<B-20HR6K[3'05X'^Q)_P4S^"/_!1+0[V]^$7
MCO3_ !5)I<<<M_9"*6VO=/5R0IEAE564$@C.",C&<U[X"#TYIMLD*3</6E)P
M":^ ?$'_  6MAU[_ (++>"OV8/ ^AV.M>'[@:A:>*?$TOFE;;4;:R>Z-E:LI
M".\8$8E)W8,FT $$D2; ^_B0.IH!!Z&OB/\ :J_X*$_%O5_VW)/V=_V;_!G@
MGQ+XW\.:!'XE\7:WXPOI[?1]!MY6"V]N$@'F2W$N588.%5@2#R5@_9Q_X+ "
M]_9K^.7B#XW>%8?AY\0/V;)IK?QSH>GW?VVWE A$MO<6;]6CN 0$#9(/!)SF
METN!]Q;AZTM?F%=?\%;/VG_@#\,/!7QP^-?P7^'GA[]G_P 7WMI'?C1M:N+C
MQ+X0L[QPEK=W:N!%*I,D9=8P"H;D C%?IM:7D=];QS0L)(94#HPY# @$$>Q!
MIM ?@5X?_P"5UVY^DO\ ZCYK]^U[_6OP$T'(_P"#URY'J)?_ %'S7[^4@"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P+XY?\G\?
M /\ [!WB;_TGM*]]KP+XY?\ )_'P#_[!WB;_ -)[2O?: "BBB@ HHKX&_P""
ME?\ P<5_ /\ X)C_ !97P%XF/B7Q=XTA2.;4-,\/6T<K:4DBAD,TDKH@9E(8
M("6 () !% 'WS17B/[!7[?\ \-/^"D/P)A^(/PNUB74M(-PUE>07$!M[O3+I
M55F@FC;HX5E.02I!!!(KVZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "O"]4_Y27Z%_V3+4?_ $ZV->Z5X7JG_*2_0O\
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MBCQYX&^(:W5O-8ZO?RW[Z5-'!).MU"\I9D ,9#J"%*L21D U^_\ _P %!O\
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M5M#"$669.L<DA+?(<,%520"<#]5:** "BBB@ HHHH **** "BBOSK_X+Z?\
M!=*+_@D'X*\,:3X;\.V'BOXD^-EEGT^UU"1TL-.M8B%:YF"$.^YSM5%9<E7)
M(  (!^BE%?D+_P $%/\ @Y1UO_@IA\>;KX2_%#PIX?\ #OB^>PEU+1M2T1I8
M[341$09('BE9V20*VX,K$$(PP#@G]>J "BBB@ HHHH **** "BBB@ HHHH *
M*** "O"]4_Y27Z%_V3+4?_3K8U[I7A>J?\I+]"_[)EJ/_IUL: /=**** "LC
MQK)J,/@_5GTA%?5DLIC9*V"K3[#Y8/L7QUK7HH _@T^..N^+=>^,_BB^\=SZ
MI+XTFU2XDUF34&<W?VOS#YF_?\P8/D8/3&!BO["/^"">O_$#Q+_P26^#-[\2
MFU"7Q)+HY$<M^6^US60E<6CR;OF), CP3R5VGO7J7Q(_X)I_L_?&#XM+X\\4
M_!KX<Z_XQ$JS-JM]H<$UQ-(,8>0E<2,,#E@3[U[7!;):01QQHL<<8"HB *J@
M#   Z #C H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH \)^._\ R?)\
M!?\ KT\2?^DUK7NU>$_'?_D^3X"_]>GB3_TFM:]VH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D?.TXZTM
M% 'Y-_ME_%+Q+_P10_X*L^+/VB+_ ,'>(/&'P!^/VEV%AXOO=%MS<7/A34K)
M!%%.R="CQG@$J&RX!!4 ^I>,/^#H?]B_P]X!;7[+XC7FO:BT):'1[#0+PZE*
MV,B(;XU123QDN #WK[:_:0\83_#W]G[QOK]M9Z-J%QHF@WM_%:ZO.MO87#10
M.X2>1_E2(E0&8\ 9-?C5^R%^T?\ M,?M.>%8?BQ\-/\ @G3^SPEE<DW.GZY,
M+72Y=1P<B:U,NQW4D9611@]03UH5GIV ^G?^"('@;XC_ +3'[2_QL_;%^)?A
M6^\"+\8DLM'\%^'K\%;NST6T!"2N" 1YAV') W$.P&TJ3^F%?C!\-O\ @X7_
M &MKO6?B%/XB_9"L;RQ^#\\:>.-*TG7)(-<T6)T+B<6\H=I(S&KN'5"A"D[@
M.:_5_P#9A_:-\,_M=?L_>$OB5X.N9;OPSXRTZ/4;*21=DB*V0R.,\.C!D8 D
M!E."1S3>UP/0****0!103CK10 4444 ?@'X?_P"5UVY^DO\ ZCYK]^U[_6OP
M$\/_ /*Z[<_27_U'S7[]KW^M "T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 >!?'+_D_CX!_]@[Q-_P"D]I7OM>!?'+_D_CX!_P#8
M.\3?^D]I7OM !1110 4444 %%%% !1110 4444 %%%% !7YH_P#!PK_P0KU'
M_@KAX8\*>)/!/B#3= ^(W@:":SMXM4#BQU:TE8.86=<M$Z."RL%8$,P('!'Z
M744 ?C)_P;]?\&VOC3_@G?\ M&3?&+XP:]X>N?$>GV$^G:+HFC2O=16S3;5>
MYEG95!8(&545<#>23P!7[-T44 %%%% !1110 4444 %%%>0_MP_MF^#O^"?_
M .S+XG^*?CN>=-!\-P!_(MP&N;^9R%BMX5) +NY &2 !DD@ F@#UZBOQ#_9$
M_P"#S#PK\:/VE=,\)_$#X5S>!/"'B*^2QLM=MM:^W/IK.P5&NHS$F4)(W,AR
MH.=K 5^W2L) &4@@CCG((H =1110 5X7JG_*2_0O^R9:C_Z=;&O=*\+U3_E)
M?H7_ &3+4?\ TZV- 'NE%% .>E !1110 4444 %%%% !10"#TYHH **** "B
MBB@ HHHH **** "BBB@#PGX[_P#)\GP%_P"O3Q)_Z36M>[5X3\=_^3Y/@+_U
MZ>)/_2:UKY5_X+X_\%Q]?_X)!WOPTTGPIX!TWQMKGQ!-Y*3J%U+%#;1VYA4(
MJ1#<\CO,.X "]"3P ?I!17X'K_P=(_MA, P_8VO2" 01HNMD$>OW*3_B*2_;
M#_Z,UOO_  2ZW_\ $4 ?OC17X'?\127[8?\ T9K??^"76_\ XBE3_@Z/_;%D
M<*O[&E\S'H!HFMDG\-E '[X45^"$O_!T;^V+%@/^QG?J3R =$UL9_P#'*;_Q
M%)?MA_\ 1FM]_P""76__ (B@#]\:*_&3_@FG_P '-'Q3_:Q_X*(>$/@5\3?@
M?IW@"X\5">,N)+RVOK&1;:2XC=X;@9*,L>.QPP()'!_9N@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ H)P,T4C_=- 'F7[9OP(?]J3]D
MCXE?#:*^_LR;QWX:U#0H[LYQ;-<6[Q*YQS@%@3CMFOS6_9K_ ."N?Q9_X)P_
M 7PM\%/C)^R3\;M6\5?#O3XO#MEJW@G1_P"U-%\006RB&&>*48"ET53CGDY(
M!R!]#_MI_L%_M>_&S]HK6O$GPJ_:\_X57X(OHX%L?#G_  B<%_\ 862)5D/F
MLV6WN&;GINQ7E?\ PZQ_X*!;?^4@!_\ "#MO_BJ!G"?#C5OVEO#L'[2G[6&M
M_L_Z]_PFGQOL-+\%>!_AK:$2ZG:6<23QI>ZECB-09%9MV"!D$*,$_<__  1_
M_91\0?L1?\$W/A1\,?%;0'Q-X<TEO[22&3S8H)YIY)VB5N^PR;<C@E21Q6#_
M ,$YOV1OVC_V;/%WB:\^./[1Q^.&FZI9PPZ79GP]%I?]ES*[%Y=R$E]RD+@]
M,9KZV  &*;>ED(S_ !%XCL/!_A^]U75KZTTS3-.A>ZN[NZE6&"VB0%F=W8A5
M50"220 !DD5\V?!C_@M#^RY^T%\7K3P)X1^,WA75O$^HRF"QMCYUNFH2 D%(
M)I$6.5B1@!&);MFO1_VVOV1="_;L_9G\3?"OQ/JFNZ1X?\5I'#?3Z1<""Z:-
M)5DV!BI&UBH# CD9'0U^=/\ P6KT'X?_ !6TWX1?L7?!#PEHNI?%ZVUO2M2L
M!I5JB+\.-+M)%>2]GF09A+QC;M)!8.S'DIE)]!I'Z$?M<?\ !0GX,_L*6FES
M?%?X@:+X-?7&9=/M[GS)KJ\V_>9(8E>0H.A;;M!(!.2!77? C]ICP#^T[\*+
M7QS\/_%FB^*O"5XKLFIV-P&@79]]7S@QLO=7 ([@5\)_LC>&[/XW?\'!G[46
MO>*8+;6K[X4>%?#OA?PZ;M!*NG6]S;"YG>)6&$:20N21SAV&<$BOD_\ :]\4
MW?[&.@_\%0O!/P]*>'/#;Z?X=UVRLK+]S#IMSK!2TOFB"C$>]26PN ">,8&'
MRCMJ?I_\)/\ @L5^S)\=OCA!\.O"7QC\):UXONYWM+2SB>58[Z5 2T<$[H(9
MF&#Q&[$]LU],#[QK\L_^"QW[*'@?X(_\$ UG\)^'](T'4_@YIFA:[X7O[2W2
M.ZTR]BN;4&>.4#<'<NY8Y^8DDY-'QP_X.L?@/^RC\2+KX?\ C;PU\3;SQ5X?
MM++^TI]+TVTDM))IK2&<F-GN$8@"4#E1R#QC%%NQ*/E#P_\ \KKMS])?_4?-
M?OY7\T_[ '[9WA;]OC_@Z\T/XK^#K36;'PYXI%W]DAU2%(KM/+T22%MZH[*,
MLA(PQXQ^']+%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH \"^.7_)_'P#_[!WB;_P!)[2O?:\"^.7_)_'P#_P"P=XF_])[2O?:
M"BBB@ HHHH **** "BBB@ HHHH **** "OQ;_P"#M'_@JS\5_P!BZV^'WPO^
M%NN:CX*F\;V-QJVK:_8.8KQH8Y!$EM#*.8LG<SLN&(* $#.?VDKYB_X*;_\
M!)[X3_\ !5OX6Z?X<^)-EJ,%]H4LDVC:YIDPAU#2GD #A2P*NC +E'4@E5.
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MVLM=^-=EI?@GXD?M4B.*STB"Z%]'X3L[.%5TV*:1?E>1)0'<ID>G)P/T[$8
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MG3P=\3?"CSMH'C73(M3M%G7;+$'',;@='5@RD>JFO0Z "BBB@#P+XY?\G\?
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M-$D)Z$N3@ T ?1'_  :^_P#*$_X1?[VI_P#IQN*_0&OS^_X-??\ E"?\(O\
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M%X/VT+S_ (*I?%#X"?L\^"?"7B5?!5Y)!9:<-%:\OYH(8HS+.[M.@/S/G
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MY0%(]Q7+?M6_\&F-G^UK\=]8^(-Y\;-=\.W7B"&S\W3H-+66.U:&TAMR%8R
MD$Q9R0.M6T(\/T#4[5?^#TVYNC<V_P!GQ+^]\T;/^1?(^]TZ\5^^8\7Z2?\
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MZ+9_VC\=]174#"GVH6^@(81+M&X(6DR5SG!/)&,X- 'X0_L_$?\ "^?!!)
MUZQ)SP!_I,=?W>-XMTH'G4]/'_;PG^-?A8G_  9">'HR&'QZUL$'@CP_%D?^
M1*M?\03^E_\ 1PWB;_P2I_\ ': /W(_X2S2O^@KI_P#X$)_C7,?&;X[:'\&?
M@_XK\875S;WUMX4T>\UB6V@N4\VX6W@>9D3)^\P0@9[D5^+W_$$_I?\ T<-X
MF_\ !*G_ ,=I&_X,G])="K?M"^)64CD'1$((]"/-H ^/O^"IO_!S'IG_  5+
M_9=U?X7^)O@/:Z+:R7L>I:/JT'BEI;K2KJ(L(Y=AM@K@HSJRY (<X((!'YF_
M GXM7'P$^,GACQI9Z7I&M7GA74X-4@LM4B::RN9(G#JLJJRLR;@#@,,XZU^]
M1_X,@?#IY_X7UK7/_4OQ?_'*\:_:+_X,J?BOX;U1Y/A=\3_!OBG3A"&$6O1S
M:7="0 97,:RH03G!)&.A'>@!_P /_P#@]K^+6EV4<?B?X+_#_6YU7YI=/U.[
MTX,<]=K^<!QV!Z_E76G_ (/B/$0_YMXT7_PK9?\ Y%KXD^+7_!KO^VA\*M[Q
M_"ZW\40*VSS=!URSNMW!.0C2))CC'*]:^3/B!^Q%\7?A9\==,^%_B#X;^+]+
M^(NMK$VG^')=-D_M*]\TL(S%" 6?<48# .=IH _77Q7_ ,'O/Q!O-*NH]$^
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MMQ?L?^ ?BQ;6\7AN/QMIWVYM,NKQ));*19'BD3<,;@'C;!P"1@X!R*_(T_\
M!D%X<R<?'G6\9XSH$7_QRK$7_!DYI%O&L<?[0GB1(UZ*NB( /H!+0!^J'QO\
M3:;)^WI\!I%U"Q*)IWB7<1<(0O\ H]IC//%>]?\ "7:3_P!!/3__  )3_&OY
M]O'?_!H5I?@_]H+X?>"O^%[>(9QXTMM4G-T=(4-:FSBA< #S>0_FX/(QMKT'
M_B">TO\ Z.'\2_\ @E3_ ..T ?$_[:'P:\9_M(_\%G?VV?#'PYN'F\0ZAH^J
MW$5M;3A7U6WA-G+/;(1]]I(D<!<_,>.2:_,BSN=2\!^*H+B/[9I6L:/=+*A(
M:&>TGB8$'LR.K 'L01ZU_07'_P &2FBPS^<G[0/B%9N[C0D#'\?-S7EO[2W_
M  92>/=&TRRN?A3\6_#_ (FOI)2M[;>);:330J]G26(2Y(YRI49Z@]J ,GX3
M?\'L7Q6\/1Q0^,O@WX%\1116T<2R:;J=UIT\DB@!I)#)YRG=@G 5<$]2.*^B
M_!/_  >T_"B^,G_"1?!GX@:;A4,?V#4+.\#-QO!WF(@#)P><@<@$U^;7QB_X
M-5/VROA1"TMGX$T3QI$+CR = UZWE9AVDV3&)@A]2,CN .:^4?VH?^"<OQR_
M8KT>WU+XJ_##Q7X&TV[OCIUO>ZE:[+:YN A<I'(I*N=JL<J2" >>* /VL^('
M_![SX:MP5\*_ 76[TBY(#:KXBBM08.,-B.*3#GGY<D#U/2OC+_@KA_P<_P#C
M7_@II^SG<_"O1O %K\-O"^J7<<^JS1:W)?7>I11MN2W8B.)5C+!68$-N*@<
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M_;2\*7^MQ0_##3]9M]'R8[FP\16#IJ:Y S KRK(3@YPZJ<#&,\$ _3/X8?\
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MK]D+3+.^^)WPM\;^!=/OV5+>[UC2I;>WE=@2$$A&W?A6.W.X '(XKT+X>?\
M!%O]JOXL^#O#WB#PY\"O'VK:%XJB2XTR^AL1Y%S$X#)*6) 2-@00[X4@Y!Q0
M!YBW[<_QM9BQ^,7Q3+'N?%=_G_T;3?\ AN7XV?\ 18_BG_X5=_\ _':^R/@U
M_P &JO[97Q::^^V> ]$\$K92B$-XBUV"(7!S@M&(#*2HZY( (Z9K[@^'G_!D
M0TWANVD\5_'<1:O)&K3Q:5H&ZVB?;\RJ\D@9P#P"57(YP.E '5?\&;?[4OCC
MXKV/QQTSQUX^\0>)+#3'TRZL(]=U>6[-L\@G60QM,Q(#!$! .. <#O\ N-_P
MEFE?]!73_P#P(3_&OPRMO^#)/1++=Y'Q_P#$$.[&=FA1KG\I.:E_X@G]+_Z.
M&\3?^"5/_CM 'ZJ?'/Q+IK_MO_ >1=0L6C2T\2;F%PF!_HUICO7Y#?\ !XL^
MF>+?VG_V4K622TU"RN)=0@N8UE#*T;7=@&5B#P""1U%8WC[_ (-!M+\'_'?X
M?^#O^%[^(IQXSAU24W1TA UK]DBA< #S>=WF$>V*[F?_ (,E=%O&5I?V@/$$
MI7H7T)&(^A\WB@#@OB__ ,&:8\1?'A[_ ,"_'#PKH_PTU*X%RMOJ<#S:MI<3
MD,84V'RYBH)"LS(2 ,C.2?UFN_B-\$/^"%G_  3<TRVO=::'P%\,=.2QME1T
MN-1U>YD<G:JJ1NFFF=F[*NXDD*"1^;8_X,GM+[?M#>)1_P!P5/\ X[7!_M-?
M\&87B'PK\$M=U3X>?%V^\:^,=-@^T:?H>I6*6<&I,I!:(2F0A'9=P4MA2V 2
M 20 ?7?[ O\ P=D?!;]M+]I'3?AQK/A/Q'\-;KQ)<BST+4M4N8;BTNYV($<$
MK1\PO(3@$@KG + D5^<G_!XM\(O'<?[=^@_$&]:YU/X;:KH%MI>B74,WGVNG
MW$6XW%N<'$;LS>9@XW Y&<''RW\-/^#??]I[6M/\::YXS^'6N_#3PM\/M!U#
M7M3U?781 DBVEO),(;=0<S22% H*94 DE@  ?<O^")__  ;V67_!7C]F'7O'
MFJ?%36/"+:/K\FC"QBT];N.4)#%()"6<8)\S&,=O>@#W7_@RU^%7C;0OCE\4
MOB!<>?I7PRNM"31C/<RB*WU/41<1R((U8_.T48ERP!"^9MSEB*_=3XF_LP_
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M_;[^.'@7]O'Q5^R-^T_-HNO^.])T;_A(_"7C/3+<6D7BO3PP4EXE 02 ;CD
M$&.12"5#&O\ \%M/^"RWBO\ 96TGQI\*_@9X*\2>+?BUI'AJ37M:UN*R(TGP
M+IQB9OMLLKC8\H0$JA(7.W))^0C8)'Z4J,@XSD]_6EV#TKP'_@EO\3=>^,O_
M  3F^"?BSQ1JEUKOB/Q%X.TZ_P!2U"XV^;>3R0*SR-M &6))X 'TKX"_X.*O
M^"RWQ"_9PG?X7_ &[N[+Q'X6;3M7\?>*K)(YE\,6US<K#:V1\Q6037#LI((+
M"/&!@D@>]A+57/U[V#&*6L#X8ZG<:S\-O#U[=R-/=7FFV\\TA !=VB5F) [D
MDGBM^F!X%\<@!^WS\!#W.G>)O_2>TKWVO OCE_R?Q\ _^P=XF_\ 2>TKWV@
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M>I?\$C_V:->\ :GXQLO&LVL:_)K*WEM8/9K$&ACC\LJSL208\Y&.N,>ORO\
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MVS\Z_P!@;_E8?_;2_P"Q;\+_ /HIJ_2:OFGX _\ !/P_!'_@HC\:OCP/$_\
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M)46_[#OC?QQ\2/&'CO6/B[\:_B2Z?\)!XOU.!;9C F"EK!"I*Q1 A3@'G:@
M 4"A/0.Y]>JVX4M &!BBD(\)^.__ "?)\!?^O3Q)_P"DUK7NU>$_'?\ Y/D^
M O\ UZ>)/_2:UKW:@!I7"D>E?E?\&Q_QUO?%SMCX.V?_ *%85^I^,KG-?G3^
MUY_P18^)_P 8/^"B7B']H?X4_M&ZC\&_$/B+0;7P_/#:>'(K]_L\*1AE+R2;
M2'>-&^X"" ,TTQO:Q[9_P6[^)>@_"O\ X)0?'C4-?N+:WM+SPA?:9 LS >?=
M7,1A@C4$Y+&1UX'/!/8URW_!&RXE_9F_X(>_!_4_&$;Z?'X;\$2:W>+/\C1V
MY,UTI.>F8F0C/J*\='_!OIXM_:*\>>'K_P#:A_:>^(7QY\+>'+Q;^#PE)81:
M3I5S,GW6F6)R&&,@@*&()&\ FOMO]L?]F(_M/_L<^.OA/I6K)X/3QAX?FT"W
MOK>V\Q-,BD3RP5B5E!"IP " !Z=*FV@)[7/B'_@VR^#^I_$CX3_$7]JWQW%)
M<_$+]HOQ%=7\-S<)F6ST>&4QV\"$\K&S(Q !P52+ PHK].@OR_6O,/V-/V<;
M7]D#]E/X??"ZSO?[3MO >AVNC+>&+R3=F&,*9=F3M+$$XR<9ZFO4"<#-.37R
M$F^H4444 %%%% 'YK_\ !V+G_AS1XQ([>(-$_P#2Z.OT$^$7/PD\+ 8_Y!%I
M_P"B4KPS_@K-_P $^3_P4[_8RUKX1CQ2?!W]KZA97PU,67VPQ&VG67;Y>],[
MMN,[ACKSTKY>E_X(T_M;ZUX>CT'4_P#@H!X^AT$0"U>/3?"EM:7 B"[0JRQR
MJXXXSNS2O<I]#C_V)/&6D^(O^#DC]L?X@V>H6L'@GP3X*T_1=;U4RA;."[06
MID#R9V@I]FG!R>/+;.,&OH7_ (*'?L"Z=_P6?^!6FZEX(_:&\;>&/".J:+<0
M6"^$=2CD\/\ B%G?B6[5>;B,%"A4.HP6'7(KTW]@G_@EI\,/^"?7[-6I_#7P
MU:76NVWBAIIO$^JZNPFOO$DTR%)'N& Y!4E0HX4>I))^5/"/_!#CX]_LS^"-
M=^&?P+_:XUGP'\%M9NII;;1+[PQ!J.J:!%.Y:6*TO"ZL@.6Y 4@DD88EB[:)
M=A+>_<\*_97OO!__  4@_P""%^I_ WXR>-?"7P$T[X>>/D^'TNKZ(MO96&LS
MV+I-$L22D(9)GRS;<%FC+8Y(KI?^"J?_  0Z^$'["_[!?BCXU_!W4O&7@#XO
M_":SBUJR\71^([J6^U21)8T=+EG<AS("0  ,'"@%25/U7/\ \$"_@NW_  3*
MD_9D236ET62[&M_\)&9 VJ_VT.?[2W8V[\_+L&!Y9*YYS7EGB7_@B'\>?VE_
M".@?#OX^?M::O\0/@UHMQ!)>:!IOAB'2K[Q%% P:**\NU<NXRJ9)R21GEL,&
M_(:??8^V_P!@KXTZM^T?^Q-\)O'WB"%;?7/&'A/3=6OT52J^?-;1NY [ L20
M.P(KUX#' K-\+^%[#P3X;T[1M*M(;#2M)M8[.SMH5VQ6T,:!$C4#H%4  =@*
MT@<]*3M?0A7ZA1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **"0.II/RQ0 M%%)\WM0 M%%% !1110 $ ]111
M2;CS[4 +12!@3CFEH **** "BBB@#P+XY?\ )_'P#_[!WB;_ -)[2O?:\"^.
M7_)_'P#_ .P=XF_])[2O?: "@C/4444 %%%% !1110 4444 %%%% !1110 4
M444 %! /4444 %%%% !1110 4444 %%%% !1110  8&!10,X&>M% !7A>J?\
MI+]"_P"R9:C_ .G6QKW2O"]4_P"4E^A?]DRU'_TZV- 'NE%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'A/QW_ .3Y/@+_ ->GB3_T
MFM:]VKPGX[_\GR? 7_KT\2?^DUK7NU !0!CH**"<#)H *",]103CK1GC(YH
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M$$46T$S0HHHI"/ OCE_R?Q\ _P#L'>)O_2>TKWVO OCE_P G\? /_L'>)O\
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MPTB;P[=Z_P#$R72+8/K6OW%Y&]Y-:PW##$*O/-()'P6*@#D9!\9\,#Q5<_\
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MB.]MGBG>WN].NDSY=S;S(0\4JY.&4]"0002*\.\!_P#!#GX'>!?!WQ"T]_\
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M;Z[J(A T^&\N(_-6T27/SS)'M9U PF]02"<5ZE0V 4444@"BB@G S0!\Y?\
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M]E6QU#X>6VF2_$#QWXGTSP3X<GU)=UCI]Y?S>4MS,H^\L:AF"G()"@@C(*]
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MQBN&1<YP"ZD@9YP.]-\-?#+PWX*O)+C1O#VAZ3<RIL>2RL(K=W7(.TE%!(R
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M-6]WK.F6UV[/=6-IJ+.&2&4NXRR$J&8<Y)(-6ZGRS\'_ (@^/_VF_P#@K?\
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M=M=W&CZEI*-K][;3&"^N=5D=;B:^64#(F%R-ZL0<;%&"!BO7?CI^P_\ #/\
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MP+U#XA^.M;^!_P#PV)XGU3Q'XXUS1[R+2KSP_8V>F!] \.PW<BE;:-(MNY<
MM(9 ,'(/["^.?A_H?Q/\.S:/XCT?3M<TFX9'EL[^W6XMY2C!E+(P*G# $9'!
M -5OB3\)?"WQE\)R:#XM\.Z)XET69E=['4[*.ZMV93E3L<$9'8XR*:8NECYJ
M_P"")/Q^\8_M*?L :#XB\;:U<>*-1M=9U?2;'7YX1%+X@L+6_F@M;U]H"LTD
M2*2R@!B-P'-?7-4M%T6Q\,Z/;:?IMI;6%A9QB&WMK:)8HH$48"JJX"@ 8P,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%4=>T&V\2Z-=Z=?1M-9WL303('*%T8$,,J01D'J"#[
MT >(_','_AO?X"$ [?[/\3<]O^/>TKWRO';C]@WX3WNLV>H3^$DGO].61+6Y
MDU&[>:V60 .$8RY4, H.",@ '.*]$^'_ ,.M'^%V@KI>AVCV=B)&E\MIY)CN
M;&3ND9FYP.,XH WJ*** "BBB@ P/04444 %%%% !1110 4444 %%%%   !T%
M%%%  !CH**** "BBB@ HHHH **** "BBB@ HHHH *\+U3_E)?H7_ &3+4?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
24444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>j14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j14.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" )_ P\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZJRL5)!PP/>@#KZ*\U^ /Q1;Q1\!K7Q/KOC'P1XFC62]:?7O#I,.CR1174R
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M$'A#]G_PIK/PF\'&^L_!7Q(T+QSXG\+>&]-C6]\4V5I>QS7"0Q(%$MR#'%,
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M."4.*^B*** "BBB@ HHHH **** "BBB@ HHHH **** "BC-% !110&!. >:
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MES/:200LJRN]PJ&- A9 VYA@NOJ*]5KY/^-1)_X+#?!  X_XM_XF_P#2G3J
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M,'P-TA5AL/V@G7Q9\-4<%;>#5KETMM4M\J3)@.\=R[?=12Y&,&@#[W_9^_:
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M6;?2)4B\BRNOMIB:1&51)\R<$,S#TQ7R1XG^._Q:;P;^U1XH3XN>,K=O@O\
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M<H_X8$\4_P#1:O&?_?A?_CE 'T7I6CVFAZ?#9V-K;V5K;KB&&",1QQKZ!0
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M5XS_ ._"_P#QR@#Z7F<1Q,Q. !G/I6'X*^(.B?$.RFNM"U.SU2WMY6@DDMI
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M(M1^#'[4>NZ3J7BG5/%DMSX8M;M;N]3;)$INKA/+'S-\H*D]>K&@#Z0HHHH
M**** "BBB@ HHHH **** "BBB@"AXE)_X1K4,?\ /M)_Z :^;$O(=._9A^$<
MT\L<,4>NVI=W<*JCS)>23TKZ2\1G_BG=0_Z]I/\ T$U\@_%_P_9^*OV(/AKI
MVH0+<65YJ]O%/$2<2*9I,@X(X_&O/S3'T\#A*N,JIN,$Y-+>R5W8J$7*2BNI
M]9#XE>'2.-?T;_P-B_\ BJ#\2?#W_0?T;_P-B_\ BJ^31^PU\* N!X+T[/\
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M_P!7<5W7WO\ R/K#_A9/A[_H/Z-_X&Q?_%4'XD^'<<Z_HV/^OV+_ .*KY/\
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MVV_Z_P#7W+7N0SN&:#22L[#J***!!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 (_P!TUY99?\GIZA_V)=G_ .EUW7J;_=->
M667_ ">GJ'_8EV?_ *77= 'JE%%% !1110 4444 %&X>HKR']NCXQZU^SS^R
M#\1/'GA\VK:OX/T.YU>VBN8]T4S0QE]C@<@-C&1R,UX?X_\ VWOB)\"OV+?
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MRH8@N$;&<&OK49WG'3/]: )**** "BBB@ HHHH **** "BBB@ HHHH ****
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MVLOV>=0\50^'6\->(M)U/5?#][IUY+YL$6H:?<R6LVR10/,A,L1PR]1QU!H
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M44 %%%% !1110 4444 %?+G[('_)[7Q[_P"OJU_]#GKZCKY<_9 _Y/:^/?\
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M=)_PP-\&?^B>>&__  '_ /KTO_# _P &?^B=^&O_  '_ /KT?\23X7_H8O\
M\!7^8?ZRS_D7WG,#Q?I()_XFNG8_Z^4_QKFOA9J]KJG_  4,T<VES;W0C^'N
MI[C%(K[?^)EI_!P>*]+_ .&"/@UM&/AYX;)_Z]S_ (UO?##]E_X>?!CQ)+K'
MA7PEHVAZG-;-:/<VL.V1H6=7://7:61#CU45^C^%OT9</P?GU/.X8QU'!25F
MDD[JW<XL=G,L32]DXI;'HM%)O7U%'F+ZBOZLYEW/%N+12>8OJ*/,7U%',NX7
M%HI/,7U%'F+ZBCF7<+BT4GF+ZBCS%]11S+N%Q:*3S%]12>8HZL*.9=PN.HI
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M ,57K>?<T9]S7E?\1>XQ_P"AA5_\"9I_9N&_D7W'DG_#$7@7_GEKG_@XN/\
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M2QM_A?XK;PREW;:DM]#J@%M#/YZLJJ%!\W&WYL8ZFN4_9#_Y/9^/?_7U:_\
MH<]4O^"<7[//C[X+_$_X]^(/&'AS1?#MA\3_ !D/$VE6UGJ?VN:%#:0P-'*H
MB15(,6X,K-G=T&.;G[(6?^&V/CWGK]JM?_0YZF6S)?0P/V/O^2'6/_7W=_\
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MG:)?QV=TUS!YMM;1P%D=D0L&V;ONC&<<XR?5: "BBB@ HHHH **** "BBB@
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M7U+P[IUS-X;U)Y;BVCD=AKVH#<Q0$\"; YK1_P"'5WP2_P"A:U3_ ,*#4?\
MX]7E?AC]EE[SP[8S'XG_ !JC\VWC?9'XXOE1<J#A5#\ =JOC]DYB.?BG\;A_
MW/=__P#%U_*^,^DKX;4:\Z-6F^:+:?[I/5/7\3V8Y)C'JE^)Z+_PZM^"?_0M
M:I_X4&H?_'J/^'5OP3_Z%K5/_"@U#_X]7G?_  R:_P#T5/XW?^%U?_\ Q='_
M  R:_P#T5/XW?^%U?_\ Q=<__$SWAE_S[?\ X*17]B8WLOO/1/\ AU;\$_\
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MM0N[E(?L=W'J"3O#Y#+(SMM$#A]ZK@D8SS7K- !1110 4444 %%%% !1110
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MU#6-*%O8:^MO_K5A<,SQR*/FV3I$S*=RA@0: /<J0,#T.:\9\;?MH^&OAO\
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MPBT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+,/^AE#_ , ?^9?^LR_Y]O[U_D=#S[4<^U<]_P .N?!__0]_&#_PKY_\*/\
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M?074@ Z>@KV^O#?^"=?_ ":YI7_7]?\ _I7+7N(8'H<T&M3XF+11100%%%%
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MK_[0?[4VA_LWW6CV^JZ/XTUZ[UI)Y8+;PYH%SJ\R)#L#R2) K%$S*@W-@$G
MZ5Y#I&?^&_\ X;X_Z%77_P#T?IU>L?MF#Q+>_LZ^(=(\(17W_"2>*Q!X<L[N
MT3,FE"^N$M7O_86L<SSG_KC[U_L3]&__ )-WEWI+_P!+D?G>:_[W4]5^2*FC
M_MJ^#?$G[/7A?XGZ?'KEUX5\6Z4^N6!&G2K>/9+:O<B7[,1YIWJB*JA2S/-$
M /F%<_\ #[_@HMX*^(\_B:TM?#OQ,LM5\*6]G=7>F:AX0OK6^G2[>=(/(A=
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MG'T0ZBC</6D#@^U>.L/5_E9O="T4;AZBD+ =Z:P]3^5D\Z.$T?\ Y2 ?#?\
M[%37O_1^G5]6LI/4"OE'1B/^'@/PW'_4J:__ .C].KZPW ]#7^POT<$UX>9<
MGVG_ .ER/SW-G_ME3U7Y(9L)S@=/UH*$CD5)17[B>>,"D<XI-AQTJ2B@"/R\
M+D#\*4*?2GT4 (JD')I:** "BBB@ HHHH **** "BBB@ HHHH 0_>%?+O[('
M_)[7Q[_Z^K7_ -#GKZB/WA7R[^R"P'[;7Q[S_P _5K_Z'/00^AU__!.T%OV6
MM+ '_+_?_P#I7+7N*C# 8Q7AW_!.DC_AES2C_P!/]_\ ^E<M>Y?\M*F&QM4^
M)CJ***H@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@!'^Z:\LLO^3T]0_P"Q+L__ $NNZ]3?[IKRRR_Y/3U#_L2[/_TNNZ /
M5**** .9^)]YJ]AX,NY="NM'L]54H()=39EM =ZY#E>0",J".<D5XGI7_!2;
MP#:?&R+X<:MJ=G<^*0'>5]"=M4L[=$B$CO,\0;[.,[E59#N8ITY%<3_P4/\
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M-6W_ *-EKZQ\2,/^$<U 9_Y=I?\ T$U\F_$'YOV./A7C_H-6W_HV2OEN-?\
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M5=SD+D\D5-\:/CMX0_9Z^%^H^-?&NO6'A[PII2H]WJ-R6\F(.ZQIT!)W.ZJ
M <EJ .O#@C(((HWC.,UXWXS_ &Y/AM\/-3T:TUG6[C3I/$6OZ?X:THSV,Z)J
M5_?0QS6\4;%0#NCD5B3C!5P>5(KIO&7[1?@_P#\:O!_P^U35TM?%WCQ;J71-
M/,3EKU+:(R3L&QM 1!R,Y^9>.<T =_1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 0ZC_ ,>,W_7-OY5\(_!G_E'A\7O^PG<_^CEK[NU'_CQF_P"N
M;?RKX1^#/_*/#XO?]A.Y_P#1RUS8W_=JGHR8_$CVOP=_R*.E?]>D7_H(K4;M
M]:R_!W_(HZ5_UZ1?^@BM1NWUK_"3B!_\*=?_ !R_-GZA0_AQ]$)_%_GUKRC]
MJ[K\-/\ L?M'_P#1C5ZO_%_GUKRC]JYN?AH.Q\?:/_Z,>OT/P*_Y+K+O^OB.
M/-O]UJ>A]DK]W\*='WIBN A)(QBN+\#_ +1/@SXG?"\>,O#FOV6N>&9+J6RB
MO[-B\4T\=RUJ\:' W,)U:/C@L."1S7^T#W/SZ/PG<!@>A%+7A7@W_@H_\$_'
MGQ/3PAI7CVQN?$,AN1';FTN8XY!;QO).RS-$(F5$1V+!RI"Y!/%=?\&/VJ_A
M_P#M!:YK.E^$?$MKJVJ>']C7]D8)K:YME<L$<QRJCE&*L P!4E2 >*8CT:@G
M'6N'\'_M%^"O'OQ;\2^ ]*\06=WXQ\'PP7.KZ5L>.XM(IBZQR890&1BCC<A8
M C!(R,X_Q#_:]^'_ ,./'VL>$K_7A-XLT/P\_BF[T:SM9KJ\33D,@\X(BD'<
M8I%5<[F*X .10!Z?O7U%*"#T->??##]H_P '_&/QSXU\/>'-774=7^'UW#8Z
M_;B%T:PGEB\U(VW*,DQX;C(PP()S4WP'_:%\(?M)^&M1UGP7J\6M:9I6JW6B
M7$Z1O&$N[9]DT>& ;*/E3D#D&@#NZ*** "BBB@ HHHH **** "BBB@ HHHH
M**** "OES]D#_D]KX]_]?5M_Z'/7U'7RY^R!_P GM?'O_KZM?_0YZ"6=A_P3
MJ_Y->TO_ *_K_P#]*Y:]Q_Y:5X=_P3J('[+>ED_\_P#?_P#I7+7?>&?V@?!?
MC'QK)X>TOQ#87FL1M.OV="V9# XCG",1M<QNP5MI.TG!Q4PV-9KWF=K12!@3
M@')I:H@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#>'+?Q-J%_>16]]:2ZNFED61#&4I*T;C<VU4QMSMD9@05%?'W_!%?0_$]_\
ML1?#_P (^)O!]QX6M[/QEXFU<V\SF5;BWM]7N)(PPVIY;"ZN49 0=ZVN\<,
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M==UZF_W37EEE_P GIZA_V)=G_P"EUW0!ZI1110 4444 %%%% !12!P>A%+0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"'4?\
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M'6M*C$UW8Z?J44\\,98J)"JL24+ C<,KD8S6E;_&CPG-\69O ::_IG_"9P6
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M US_ .BS7OWP% ;X'>$01G_B3VO'_;):\!_:;(_X9Z\:#UT:Y_\ 19KW_P"
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M%O:J_P !OVI/AU^U)H-[JGPY\:^&_&NG:=.+:ZN='OX[N."4C(1F0D!L<X-
M'9>)O^1<U#_KVD_]!-?+6O\ _)JOP@_[&"T_]'25]1^)'!\-Z@<_\NTG_H!K
MY;U]@/V5OA#CI_;]I_Z/DHEL73^(^LQT%%137<5K"9)'6-%ZEC@"BWO(KN(/
M%(DJ-T*D$4$$M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M81*0PR"/+'!H\'?#CP_\.H98?#^A:/H4-PX>6/3[*.U65@H4,P10&(4!03T
M K./0J6YOT4458@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "OES]D#_D]KX]_]?5K_ .ASU]1U\N?L@?\ )[7Q[_Z^K7_T
M.>@EG7?\$[?^37-*_P"O^_\ _2N6OC[]CJ^U=8_V.;Z*6ZD\>ZYJOBC_ (3V
M23/VJ56MYWOQ<C&3LU(6:X?[C$ 8S7V#_P $[06_9;TH#_G_ +__ -*Y:]5T
M?X:^'O#OB2ZUBP\/Z+8ZM>[OM-[;V44=S<;FW-OD50S9;YCDG)YZU,-C6;]Y
MFY'C><=:DIJ)M/3MBG51 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% "/]TUY99?\GIZA_V)=G_Z77=>IO\ =->667_)Z>H?
M]B79_P#I==T >J4444 %%%% !1110 4444 %%%% !1110!1\2C'AS4.Y-M)_
MZ :^6M?('[*WP@/8Z_:?^CI*^I?$I_XIS4/7[-)_Z :^8;W2WU7]ESX01HZJ
M1K]KR?\ KK(?Z4I7MH53=I:GU8.@HH48 %%,D**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @OC_H$OO&W\J^$O@UQ_
MP3P^+^?^@G=?^CEK[MU 8L91Z(W\J^&?@'I<FL?L!_%RW1E5Y-2NR">G$BG^
ME"^ 2?O(^T?A[QX"T4?].4/_ * M;;=16+X C,7@;1E)RRV4.?\ O@5L@EF&
M. *GL4QU%%%4(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@!#]X5\N_L@D#]MKX]D_\ /U:_^ASU]1'[PKY;_9%S_P -K_'S
M'_/U:_\ H<]!+Z'9?\$Z"#^RYI9&?^/^_P#_ $KEKW//.*\7_8'T:30/V:M(
MAE=)&:ZO9<KG&&N9& Y] <5[.K9^M3#8TJ/5BT4451(4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% "/]TUY99?\ )Z>H?]B7
M9_\ I==UZF_W37EEE_R>GJ'_ &)=G_Z77= 'JE%%% !1110 4444 %%%% !1
M110 4444 4?$F?\ A&]0S_S[2?\ H!KYDNM3;2/V7O@_($\S&OVO4X_Y:RC^
MM?3GB7_D7-0_Z]I/_0#7RSX@S_PRK\(./^9@M/\ T=)1>RN5"-W8^LU.0#10
M.@HH)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** (=1_P"/&;_KFW\J^&OV?]4;1OV!?BU<JGF;-1NQC.,YD"_UK[EU
M'_CQF_ZYM_*OA'X,?\H\?B__ -A*Z_\ 1R4]H,2^)'VS\/G,G@?1G(^]90G_
M ,<%;8&!BL3X=''@+1,_\^4/_H K9&0W)J8[%2W'4444Q!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (?O"OEO]D3/_  VQ
M\>\=?M5K_P"ASU]2'[PKY<_9#R?VV?CWQ_R]6O\ Z'/02^AW_P"P;K+:]^S5
MH\Y3RMMS>18SG[MS(N?TKV./O7AO_!.O/_#+NE8Z_;[_ /\ 2N6O= ,< 4&D
MUJT%%%%!(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% "/]TUY99?\GIZA_V)=G_Z77=>IO\ =->667_)Z>H?]B79_P#I==T
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MA9#A)+-HYV\IS_SS>18U8'@]#UP<?_@F1KVO7/B3X^:+>0M%X3\,_$C4-/\
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M4 %%%% !1110 5\N?L@?\GM?'O\ Z^K7_P!#GKZCKY<_9 _Y/:^/?_7U:_\
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MDLQ)+,Q/)9B23U)K='044$!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% $.H_\ 'C-_US;^5?"/P9_Y1X?%[_L)W/\
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MP13G)ZTZBBJ("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M =+.'_T!:U3G(QFH\ABT444P"BB@G R: "BF^8,>_I0) 3B@!U%%% !1110
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M?BW_ ,!K?_XFNYE^'6FS?$R'Q6XE.JP:<VEJ=YV>2TBR'Y>F=P'/I71;AZT
M>2?\,[>+_P#HK?BW_P !K?\ ^)H_X9V\7_\ 16_%O_@-;_\ Q->N44 >1_\
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M(_\ AG;Q?_T5OQ;_ . UO_\ $T?\,[>+_P#HK?BW_P !K?\ ^)KURB@#R/\
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M(TC\GMN8UT5 'D?_  SMXO\ ^BM^+?\ P&M__B:/^&=O%_\ T5OQ;_X#6_\
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M ,!K?_XFC_AG;Q?_ -%;\6_^ UO_ /$UZY10!Y'_ ,,[>+_^BM^+?_ :W_\
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M* "BBB@ I'R4('6EH)P,T ?&?PD_X*;:A:_LW_M0?$7XAZ7I-M9_L[^,M?T
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MG1H)V(BDO+N8(K/CDI'&))6 P6$9 ()R/6Z\/_;P_9TOOVB?AGX:&D"*37/
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M.*DHH **** "BBB@ HHHH *8(V7OFGT4 1K"0V2:!$0>!4E% !1110 4444
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MC'-/C4KUIU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2/\
M=/.*6@C(Q0!7EMEG3;(B.I[,,U&VD0;<"WA_[X'^%6O+]Z7:3W-3**>Z%8KQ
M6B0* B(H] N*?Y.3TYJ79@Y!H*DG.<4[#LK60SR<]11Y1_Q]ZDHI@1B$\9-#
MQDCL:DHH JW&GP7F&FBCDV]-Z@XJ%M"LP ?LT)_X *O>7[T%,G)-9NE!N\HF
MD:LXI),AAMUMD58T5%4< <"G"/L,<^U2[!C&* N"#Z5:5B&QGE8;..:/(/KQ
M4E%,1%Y)&2 OL*41'&":DHH C\HGLO%'E''1<U)10!''&5;/Y5)110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>j15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j15.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" *K T8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH AN+F.TMY)976.*,%G9B%5 !DDGL
M *\?^%/[9%K\>O <WBSP/X&\=>*/",TR+H^LP)I]K;^)(#(8WN[-+B[BF:W0
MJQ$DL<8F10\ F1T9N+_X+*>&O%/B_P#X)3_M!:7X-CGN-?OO ^IQ100QF26Y
MA,#?:(40 EGDM_-15 +,S@#DBNP_X)T>)_#?B_\ 8!^">H>#W@;PQ/X&T9=-
M6%@5@A2RA18B ?E:/;L9>JLC*0""* /1_A/\1K'XQ_"WPSXOTRWU*UTWQ5I5
MKJ]I#J%LUK=PQ7$*RHDT3?-'(%<!D;E6!!Y%='7S3_P4T_:4U#]FS]E>QUGP
MU?)I*>(O&6@>%;W7H%C9/#MIJ.KV]I>7^6!17CCDE",X*K,\;,K %6X_5]1\
M3_LJ?\%1_@YX$\+ZCXZ\4?#SXS>$_$+ZYIFLZW=ZW#X8N=&6P>#54N+MIKB-
M9A>+:R1>:L3/)#)M\PL7 /L:BOS>\::%XL^.?[:W[=WA2_\ BS\6M&T/P;X,
M\*:KX8MM#\2SZ6GAN\FTS57:>V-OL9?WD".R,S),3B9956,)8_9Y\7>-[W6O
MV OB?J'Q,\?ZKK?QYT,6_CG3[O5-VAZR)_!UUJZ.FGJJVMK)#=V<926VCBD9
M7D65I0QH _1FBOE/X_VNL^+/^"G'PU\%MXQ\9Z3X1\4_#'Q7=:GI6DZO)I\4
M\MMJ.@1QRJ\162*4)=3J)HW65 YV.A)-?*MUXE\=> /^"=UC\11\5_BEJWBK
MX-_&]O!>DW-]XDN&CUG2HO'O]B-!JL:%4U%I;)PK27 =U:-&1HV+EP#]5J*^
M4/V\_P!HK6_!G[5W[/7PGL2]IIOQ8N==FN)QKESH:W]SIMK!-;:<U[;P2RPB
M7SI9P(VB:5K!8B[1R2Q2;O[-/P5^(_P=^"OQ/\,>,OB)J6M)<ZE?:AX5F359
MM5U7PGID\"M'8/J-U");MXI5F9)IU>4)(BLS!$- 'TE17R7_ ,$I/AUKM_\
MLI_"?XO>(_B1\2O&GB'X@?"GPQ)J>F:OK)NM*%Q]@CF-W# X)CNI?-VRRB3]
M\5#."^6K@/V)M3UC]M3]DS]G?]HJS^.6L:!XBUO5K;6_%X^VW%QH&MK<M+9W
M/AJ/3WN4M+81W;P6T$PB>X5[16)EFGEE< ^S-=\;:KI?Q0T#0K?PIK&I:1J]
MK=W%YK\$ULMGHTD)A\J&9'E69FF\R3:8HW"F([MH.X=/7S=\8/&&N:)_P5'^
M!>AVNNZQ#X?\1>!O&=UJ&DI=,MC<SVEQX?%O,\8P&D074X5FR0)&QC)KPW_@
MIM\1;_5K#]IL^$/'OC/4/$WPK^$O]LQ:=X=\0W?ARS^'-\D%_>QW=W<6URK7
MMW>QQPO%:O;R)''IP$K0QWP:4 ^H/V]/VQ-,_8&_95\5_%G6_#?B/Q3H_A&!
M9[RST3[/]I5&=8Q(?/EB7RU=DW%2SA22$;!%>QU^?/\ P5Q\<:C\3?\ @W1\
M?^)-8E2XU;Q!\-M,U*^D1%C62>86DCL%7 4%V)P!@=!7Z#4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 45Y?^UE^V!X _8>^$=UX]^)VK:CH/A"PECBN]
M3M]#O]4CLB[!$:86<,K1(SLJAW"KN=5SD@'6UK]H7PQX;^ MQ\3+Z76[?P?:
M:4=;FF;0;_[;%:!-YD:Q$/VL$)\Q3RMX )*C!H [JBN8^$?Q7T7XY_#'0_&'
MAN74)]!\1VJ7VGRWNFW.FSS0.,HY@N8XYD####>BDJ01D$$]/0 4444 %%%1
MW%PEM \DC+''&"S,QPJ@=23VH DHHKS;XS_M2^$O@-XGT?1=>C\87FJ:_;7-
MY9VOA_P?K'B*0PV[0I+)(-/MI_*4-/$ 9=H8OA=V&P >DT5\[_L_?\%2?@Q^
MU-IGA?4O >K>--=T/QI=/9:-K9\ >(;31KV9'E1D%_/9):H0\,B?/*H+IL&6
M(4_1% !17G'C3]JCP9X!_:+\&?"C4[Z_@\;^/K.\U#1+3^R[DV]Y!9ION7%U
MY?V<-&"FZ/S/,'FQG9M8-7H%W="RM99W$KK"A=A'&TC$ 9^55!+'T !)Z $T
M 3T5P?[.?[1GA3]JOX66_C3P7=WU]X?NKR]T^.2\TVXTZX$]I=2VEPCV]PB3
M1LDT$BE9$5OEZ5WE !11D9QGFC..M !17COP*_;L^&G[27QG\<?#WPCJGB"Z
M\9?#8P+XET[4/"NK:2VDF<%H [W=M%&3*BEX]K-YB#>NY/FKH-(_:;\(ZW^T
M5J_PIMI]>D\;:%I=OK5];MX=U%+*"SN&D2"7[<T M&$C0SJJK,69H)E +1.%
M /0J*** "BBB@ HKE/@U\7-,^.OP]L_%&C6FO6.FW\MQ#'#K>C76CWRF"XD@
M8O:W4<<\0+QL5\Q%+*58## UU= !1110 4444 %%%% !UX->%^ O^"<WPG^$
M^JWUQX0TKQ1X-L]1OQJ4NC^'O&>MZ3H:S[PS,FFV]VEG&)&&9%CA59,G>&R<
M^Z44 <E\0O@9X.^*_P (+_X?>(O#&BZOX'U.P&EW&ASVJ&Q>V"A5B$8 550*
MNW;@H54K@J",_P"%_P"S=X3^$>L+J6EV^MWNK)8)I<>HZYK^H:[?16JE6,*7
M%]--*JNR(SA6'F,B,^YE4CO:* /'3^PE\,S\0/BAXJ72M>AU_P",VGP:5XNO
M(O%.JQMJ5M!&\<*(JW(6U\N.215:W$;*)'P1N;,.C?L ?"WP[I_PDM+'1]?M
MK7X%J$\$1)XJU<)HRBV>U"D?:<7 %L[P 7'F 1.R#",5/M%% 'G?B/\ 9=\&
M^+/V@=%^*-]::TWC;P[IESHVGWD7B#48+>WM+EHVGB^RI.MLPD:&%F9HRQ:&
M(YRBD<+>?\$RO@YJ7P/U7X<7&A^)I?!^M^)&\77MDWC37/,FU0W@OC<^?]L\
MY2;L"<JKA#*-^W=S7OU% 'E7[4O[%WPP_;5^#2?#_P"*7A*T\9>%XIX;N""\
MGG6XM;B($1SQ7,;K<13!693+'(KLKNI8J[ V_AK^R9X"^#WP5OOA]X8TF]T;
MPWJ@F^W&#6+T:E>R3*%DGEOS*;R2X90J^>TQE 1 ' 50/2J* .,^ ?P'\-?L
MR?"#0_ ?@VUU&P\+>&;5+'2[.\U6[U-[*WC4+' DMU+++Y:(%54+E450J@*
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MKWM[#I]I+<7$L<%O"ADDD=@J1J!DLQ/  '))X H L44V.02(&4AE89!'>G4
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MFU:&-(GG$-Q.D-TL\4D:QM&J_3O_  3^_89\.?\ !.7]F/0_A)X.\0>+-?\
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MZ#)JMEJ__%/6VGMI-Q+"&2QEA>T"1?:VC24,Q# E0X!]6_\ !.+X@:U\6?\
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MWPU?W^G:/'>:'<6-NUS<PPO%#ON)$3YW7:#N;:@+4 >Z_%K]N7X8_!'XNQ>
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M(?\ X[1_PE'[6_\ T+7@C_P(A_\ CM?5]% 'RA_PE'[6_P#T+7@C_P "(?\
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M7UA10!\G_P#"4?M<?]"UX)_\"(?_ ([1_P )/^UO_P!"SX(_\"(?_CM?6%%
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M'_19O#7_ (0D?_R51Y/[0'_19O#7_A"1_P#R57H.3Z49/I7^?/\ Q-7XE_\
M0='_ ,$T?_E9]5_J_@?Y7_X$_P#,\^\G]H#_ *+-X:_\(2/_ .2J/)_: _Z+
M-X:_\(2/_P"2J]!R?2C)]*/^)J_$O_H.C_X)H_\ RL/]7L#_ "O_ ,"?^9Y]
MY/[0'_19O#7_ (0D?_R51Y/[0'_19O#7_A"1_P#R57H.3Z49/I1_Q-7XE?\
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MMN\FVEN[.*X>--Q+;%:0@9). ,DF@#T>BOE/]@C]N3Q7\=/C7\5OAA\2=/\
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M3_\ @B\LT#*LJQRA21D#.ML.GXU]2_M3_P#)LGQ&_P"Q7U/_ -)):^5=./\
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MR>2)98_-:)PI<JPH ^S**!GOUHH **** "BBB@ HHHH **** "BBB@ HHHH
M*^2OV^O^3L?V<_\ L8&_]*;&OK6ODK]OK/\ PUA^SGCK_P ) W_I38U429;#
M_P!I:\\<-^VW:VG@CQ1IWA2\;P.DL]S=Z.NIK*@OY1L"&1-IR5.[)Z8QSD1^
M3^T!_P!%F\-?^$)'_P#)5;/Q?&/V_P"$<?\ )/E_].3UU'.<&O\ /WZ0GCMQ
MGPOQ=4RK)<4J=&,(-)TZ<G=J[UE%O\3ZC*,HPV(H>TJQ;=^[7Y'GWD_M ?\
M19O#7_A"1_\ R51Y/[0'_19O#7_A"1__ "57H.3Z49/I7X7_ ,35^)?_ $'1
M_P#!-'_Y6>I_J]@?Y7_X$_\ ,\^\G]H#_HLWAK_PA(__ )*H\G]H#_HLWAK_
M ,(2/_Y*KT')]*,GTH_XFK\2_P#H.C_X)H__ "L/]7L#_*__  )_YGGWD_M
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MI,COL*F.,J48%<U]/4 >:_LJ_P#)-=2_[&?7O_3M=44?LJ_\DUU+_L9]>_\
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M!\2?_ O2O_DJC_A;WQ*_Z(!\2?\ P+TK_P"2J]=?1M\1?^A=+_P*'_R1Y_\
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M_P D']N8+^?\&>FX_P!FC'^S7F7_  M[XE?]$ ^)/_@7I7_R51_PM[XE?]$
M^)/_ (%Z5_\ )5'_ !+;XB_]"Z7_ (%#_P"2#^W,%_/^#/3<?[-&/]FO,O\
MA;WQ*_Z(!\2?_ O2O_DJC_A;WQ*_Z(!\2?\ P+TK_P"2J/\ B6WQ%_Z%TO\
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MZ[)J5U9-9:/;V4L<N;:),;T)#*QR0PV[=KM]5T44 >:_LJ_\DUU+_L9]>_\
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M2YOV?=;O3I_B#78H[;^VKA[-(4-MM9C=6D@E\]G.S;/90?*65@GTAC P***
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M(=3GCRM-)6U3OOY'U/%WB)'.L#]45'D]Y.][[?)&W@9SCFC QC'%0?VI;?\
M/Q!_W\7_ !H_M2V_Y^(/^_B_XU^V\R/S&Y/CMCBC QC'%0?VI;?\_$'_ '\7
M_&C^U+;_ )^(/^_B_P"-',@N3T8'H*@_M2V_Y^(/^_B_XT?VI;?\_$'_ '\7
M_&CF07)Z,=\<U!_:EM_S\0?]_%_QJ2"XCN$W1NKKZ@YIIA<?@>@HP/0444 &
M!Z"@#' %%% !1110 4444 %%%% !1110 4444 %%%% !1110!P7[4V?^&9?B
M/GI_PB^I_P#I)+7RG:$+_P $4').!Y<O_I[:OJW]J?\ Y-D^(W_8KZG_ .DD
MM?,_@"-)O^".L"R*K*8Y\@C@_P#$X>HJT_:4W3[Z%4I\E13['S$GQP\%[0#X
MM\,\?]1.#_XJN!_:@^*WA?Q#\#]:L]/\1Z%?7<SVPC@@OXI)'Q<1$X522> 3
M]!7Z]I\&_A^%&/#'A'G_ *A]O_\ $T+\'? *\CPQX2 _[!]O_P#$U_,.6?1J
MPN$Q]+'1QDFX34DN5:M-.VY^X2\8H.FX?5NEOB_X!V,'," \_*/Y4\ #H*1
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MV[[69^8G_"[_  7_ -#=X9_\&<'_ ,51_P +O\%_]#=X9_\ !G!_\57Z>?\
M"G? '_0L>$?_  7V_P#\31_PIWP!_P!"QX1_\%]O_P#$U\2OHL8+_H.E_P"
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MGQ&_[%?4_P#TDEKY4L(UE_X(I[6&Y61P0>X_MQJ^J_VI_P#DV3XC?]BOJ?\
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M3>+_ /H:5_\ P;/_ ##^SL+_ ,^U]R/'O^& /@K_ -$V\+?^ O\ ]>C_ (8
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M+PC_ (1+XPY''_"U=>_]"AJA_P ,)?&+O^TGJ8_[D?3?\:]0_8\_9@N/V5_
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M]')ZG_X0^F_XU4/H4\7*2;QN&^^K_P#*@?$]#_GW+\/\R]_P3-S_ ,7P]/\
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M%]EHHH \U_95_P"2:ZE_V,^O?^G:ZHH_95_Y)KJ7_8SZ]_Z=KJB@#TJBBB@
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M3PI;_#[Q)X7L?$.AZ./",VD7DFNZZE_J-K8M]GOENTBBG\RZ^2-K61<)DO\
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MB:YHU]J>H66H-;BU5$5+K4(V&RX<XM>582LJ &A^TK^W1XM^'/\ P4:_9_\
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M_3M=44?LJ_\ )-=2_P"QGU[_ -.UU10!Z51110 4444 %%%% !1110 4444
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MB$E*5DTE9:*VSN/HHHKWCR0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@#F-=D5_VS_"^TAO^*/U3H?^GRPKQ?X$_P#(_P#Q=_['K4/_ &2O1/#7P?\
M"_PC_;(T&+PQH.EZ%'>^$=2>=;.!8A,RW=B%+8ZX!/YUYW\"?^1_^+O_ &/6
MH?\ LE?S+]+;_D@*O_7RG^9[&0_[VO1GHY^\*Y;_ ()C_P#(.^-O_94]5_\
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M@#S7]E7_ ))KJ7_8SZ]_Z=KJBC]E7_DFNI?]C/KW_IVNJ* /2J*** "BBB@
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MGU?5]7N655:>ZNIV:2638B("3A4C15"JJJ/0* "BBB@ HHHH **** "BBB@
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M/[@I:184444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M97[,^M6=EXI^*Z3WEK;N?&UT<22JI(^SVPSR?45JZ^3_ ,-G>%\\$>#]4_\
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M2_\ H)6'_?\ 3_&C_A*M+_Z"5A_W_3_&OR._X9H\ ?\ 0HZ%_P" RT?\,T>
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M:Y:1V[7&Z[L3E-DCY QSG&,CK7"? G_D?_B[_P!CUJ'_ +)7M.OG_C-'PO\
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M[7%_%X6^(WA63PS\,+?QKX6\':_KCZYI'B;[-<3V\NM)<?:IS;R2W-Q:P30
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M$S_@F/X[^,'@N]\.^)?C]KFIZ)J!C-S;?\(KI\/FA)%D4;DVL/G13P1TK[%
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MAGPWJB6]KX4@T6PT:.[?58W@>%+B;$THMU=T<8,9@8$[V4?9H&. * "BBB@
MHHHH **** "BBB@#RSQ!_P GH>%_^Q/U3_TLL*K?LL_\C+\6?^QVNO\ TGMJ
ML^(/^3T/"_\ V)^J?^EEA5;]EG_D9?BS_P!CM=?^D]M5,74]<HHHJ1A1110
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^2OV^_\
MD[#]G/\ [&!O_2FQKZUKY+_;]_Y.Q_9S_P"Q@;_TJL:J),]CUV+_ )/EG_[$
M6/\ ].#UZO7E$1_XSDG_ .Q%C_\ 3@]>KU-QQV"BBB@84444 %%%% !1110
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M'%#<RO<KY:JYF8LSLH"#_;!GYRCY6_X* ?L)W\/A+PW)IOQZ_:)TOQSXIO\
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M$UB1_".I& Z=I<E@(E^UV.X,'GFW$G&""N,'KGB+]B+_ )&7XT_]E!U#_P!
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MG+;^>?;_ !'W)'^Q3\:'16_X:(CPPS_R(5E_\=IW_#$WQG_Z.(3_ ,(*R_\
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MAKX+_P#1)/AO_P"$Y9__ !NO4]WT_.C=]/SHN'(NQY9_PPU\%_\ HDGPW_\
M"<L__C=)_P ,-_!?_HDGPV_\)RS_ /C=>J;OI^=&[Z4KAR+L<W\-OA+X6^#^
MD36'A/PWH7AFQN9C<2V^EV$5G%+(552[+&J@MM51DC.% [5TM(!MY)YH+8 Q
MSFFVWN-*PM%%%,84444 %%%% !1110 4444 %%%% !1110 4444 >:_LJ_\
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#@_VI_P#DV3XC?]BOJ?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "ODO\ ;\_Y.R_9S_[&!O\
MTJL:^M*^2_V_,_\ #6/[.>.O_"0-_P"E5C51)EL2?M)ZKXYA_;;M;3P/XAT?
MPW>MX'26XN-0T@ZDDD8OY!M""6/:=Q4[LGH1CG(B^U?M"_\ 15/!'_A$-_\
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M[1Z64UZ='$*I4=E9GNX)! P17*_\$R?^/#XV_P#94]5_])K*N5_X7KX]SS\
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M)>3&YTZ:.]MXVM$ CD-A_JG=2BRYWL5VM]RT44 %%%% !1110 4444 %%%%
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MX>?\H>+;_KG/_P"GAZ^E?VIO^39?B/\ ]BOJ?_I)+7S5\//^4/%M_P!<Y_\
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MY)KJ7_8SZ]_Z=KJB@#TJBBB@ HHHH **** "BBB@ HHHH ***#GM0!Y7K_\
MR>?X7_[$_5/_ $LL*^?/!?C?XMQ_%/XJIX(UCP#IFEQ^,KU)$UG1;J[G:55C
M3<KQ7,:A=B)P5)SN.<$ ?0>O_P#)Y_A?/_0GZI_Z66%>+_ K/_"?_%W''_%=
M:A_[)7XG](#C;->%>$:F;9--0K*4$FXJ2LW9Z--:GH97A:>(Q"IU-K='8O\
M_"<_M'?]#1\'_P#PE[__ .3J/^$Y_:._Z&CX/_\ A+W_ /\ )U=QR>AHP?6O
MX#_XFS\1O^@J'_@JG_\ (GU/^KV#[/[W_F</_P )U^T<?^9I^$&1_P!2O?\
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MW>7<E];QK(D<3&.VBNK"6&61Y5?<K;48;68 ^LJ*^8O@5_P4"D\=_M:?M+>
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M0,^T**^6/^"Q?A/Q3XR_8BN]/\#>-/$GP^\9ZGXM\*Z/I&O:)JES83:?+?\
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MT4 4= TDZ!H-E8_:;R]^Q0)!]HNI/,GGVJ%WR-@;G;&6.!DDFKU%% !1110
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M\ ?%?QSHGAG]H7XF0:EK&EZ?,_BF]=8[J[CA9E\PC< S XR#S[5]_P"O _\
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M[>.TMH[>4;7C6)0C@*%P1C!&T <]@!5RB@#./A?36GMY3I]B9;0!8'^SKNA
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MY(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!P?[4__ ";)\1O^Q7U/_P!)):^:?AV?^-/%O[1S_P#IX>OI7]J<8_9C
M^(P'_0KZG_Z225\Q^#=2CTK_ ((VQ3S;O+CCFW8Y/.LN/ZU2)LV[(^V(_N"E
MIL)W1J<=J=4E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5\E_M^_P#)V/[.?_8P-_Z56-?6E?)?[?F?^&L?
MV<\=?^$@;_TJL:J),MCUR+/_  W)/S_S(L?_ *<'KU<>F,5\S_'+]H?3_@'^
MVA#<WV@^+O$!O?!<<2P:!I3ZA-'_ *=(=[HI!"?+C=TR0.]6S_P4ET'C'PU^
M-W'_ %)EQ_C7CXW/<NPM3V6*Q$(2[2E%/[FT7"$GLG]Q]&G'<<T?+Z5\Y_\
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MVN$)V_GA^9^D^%7_ "/(^C*M?0O_  1J_P"24_%'_LHFH?\ I+95\]5]"?\
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MD4<4:*"[L7D1<*IQN&<#FO$O@3_RD>\1_P#9.[+_ -.-Q6#_ ,%V?$%AH/\
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M/X1^(WCK4O#OA[5)M<OM&>:*^N+&QN+C3K2:%U26V>]5#:K<HS - 91*O)*
M*V,S3/VN_A]K/[4>I?!:+7+B+XF:7HJ>(Y=&N=+N[8S:<TBQ"Z@GDB6"XC$C
M!"89'VL&4X*L!\X?L+^-;SX=_M#>!_A=\._$UGXY^ ]Q\*8?$%HZV-LEQX3N
MDN+>*UC:>VCC5H[V*2X<).KSF2SG8NPW >;?\%$/#-]IG[=WC3XS>!Q;ZA\1
MOV=O W@WQ5'I\,B-<ZKHIU#Q7'K>G;2<YEL'+H,9\Z*V(YVT ?;/QH_:V\ _
ML_?$3P+X1\4ZS=6OB?XF7=Q9>&=+L]*O-2NM5DMXA+.5CMHI&5(HR'>1PJ(O
M+, ":SO#G[:G@7Q#\4O!W@EI/$VD^*O'EEJ>I:-INK^'+_39;BWT^<0W,C>?
M"H3:S(55B&=)8W4%'5C\3_M(>,=&^)?_  5,_8@^(AU>#38_'5_XP?1;F1HX
M;B#1AX7NDLI@LH('FR3/.N],YN41E)0+7SW\!/VQ/&WC/PM^R[\0D\1M\2OB
M_8> OCI?6$=Y<)<7FKWT&I0-86YCCQPZVT:)'&JJ$0*BA5  !^O3_M)^$(OV
ME;;X1-?W:^.[KPY-XKCLCI]PL+Z=#<PVSRBX*"%F$MQ&NQ7+C=DJ!@GOJ_+7
M_@GQ\:?!7Q7_ ."E_P $?$^@_$N\\?7WC#]GW5IM7N+[7GU*2/6Y-2T*XNH-
MCLPLY<)(S640CCA$9VPQ@MN_4J@ HHHH **** "BBB@ HHHH **** "BBB@
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MMKJVM[FW;&8I8U=#@Y'RD8X-&GZ3:Z1:+;VEM;VMNN<10QA$&3D\  <FK5%
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MI)]C[4BYB4>PJ"STVWTY9!;V\, D<R-Y:!=['JQQU)]>M3Q ! !3J!A1110
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M_$SQ3\1_$WA6W\&>"EU+PG'9RWDDGB2Y$+K<J[Q["+,DD"-MV0N#C&>W4?\
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MB]_T*7P^_P#"GN__ )!KTNB@#S3_ (2/XO?]"E\/O_"GN_\ Y!H_X2/XO?\
M0I?#[_PI[O\ ^0:]+HH \T_X2/XO?]"E\/O_  I[O_Y!H_X2/XO?]"E\/O\
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M*>[_ /D&C_A(_B]_T*7P^_\ "GN__D&O2Z* /-/^$C^+W_0I?#[_ ,*>[_\
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MO_"GN_\ Y!I_[0OPIU/XJS> VTV2SC'ACQ=9:[=_:'9=\$*RAE3"ME\NN <
M\\BO2* /-/\ A(_B]_T*7P^_\*>[_P#D&C_A(_B]_P!"E\/O_"GN_P#Y!KTN
MB@#S3_A(_B]_T*7P^_\ "GN__D&C_A(_B]_T*7P^_P#"GN__ )!KTNB@#S3_
M (2/XO?]"E\/O_"GN_\ Y!KFOBY\<OB;\%OAQJWBC5?!O@J;3]'B$TZ6OB2Y
M>9E+*ORAK-03EAU(XKW"O/\ ]J'X8ZC\9O@%XF\+Z3):Q:CK%LL,#W+LD*L)
M$;YBH8@84] : *@\1_%X]?"7P^'_ ',]W_\ (-'_  D?Q>_Z%+X??^%/=_\
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M7^-'A?0_AE9^,KO6+:'PWJ$-M/:7A5R;L7)1;=(T WR22M)&J1JI=W=552Q
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MCI?P_P#"FFZ#HFG6>D:+HUM'96%E9PK#;V<$:A(XD10%5%50H4#   K4HHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%&: "OF;]H_P#;*\6?!G]O3X'?!S3M#\/WUC\;K;Q!
M/;ZM<W$RRZ.=)M(+B17A52)O-\\*I#IMP<AN_P!,YK\\_P#@I[X-U'Q__P %
MA_V%-)TGQ?X@\#:A<67Q#:/6-$AL9;VVVZ7I[%46]MKF AP"IWQ,=K':5;#
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M['PJ^)^B?&GX<Z-XL\-7ZZGH6O6J7=G<!&C9T8=&1@&1U.59' 965E8!@0/
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MT%_;::FGK-"+*TG&8E9@"&G;G<3[]JO_ +5O[8LG[)/C_P"&L.N^%YKWP/\
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M&>%;?P/Y#VW_  CT>DVZZ3Y+.6:/[,%\K8S,6*[<$DDC)J;3?@OX/T?X:?\
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MD=Y9'(R[N['DUUM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1@#H!110 8]J*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>j16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j16.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" +_!6@# 2(  A$! Q$!_\0
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M=56)",+B-LLQ"CCGD5ZS10!\N?\ !+G_ (*@:1_P5"\%>/\ 6](\$^)_ @\
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M=\*_"&B7FJZ_\-OVD?#6CZ?"T]SJ.K_"[4[*S@ ' :61 H9FPB@GYG95')%
M'V_17Q2G_!<[P#(BLOP:_:L96&01\(-7((]?]72_\/S/ 7_1&?VK?_#0:O\
M_&Z /M6BOBK_ (?F> O^B,_M6_\ AH-7_P#C='_#\SP%_P!$9_:M_P##0:O_
M /&Z /M6BOBK_A^9X"_Z(S^U;_X:#5__ (W1_P /S/ 7_1&?VK?_  T&K_\
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MX"_Z(S^U;_X:#5__ (W1_P /S/ 7_1&?VK?_  T&K_\ QN@#[5HKXJ_X?F>
MO^B,_M6_^&@U?_XW1_P_,\!?]$9_:M_\-!J__P ;H ^U:*^*O^'YG@+_ *(S
M^U;_ .&@U?\ ^-T?\/S/ 7_1&?VK?_#0:O\ _&Z /M6BOBK_ (?F> O^B,_M
M6_\ AH-7_P#C='_#\SP%_P!$9_:M_P##0:O_ /&Z /M6BOBK_A^9X"_Z(S^U
M;_X:#5__ (W1_P /S/ 7_1&?VK?_  T&K_\ QN@#[5HKXJ_X?F> O^B,_M6_
M^&@U?_XW1_P_,\!?]$9_:M_\-!J__P ;H ^U:*^*O^'YG@+_ *(S^U;_ .&@
MU?\ ^-T?\/S/ 7_1&?VK?_#0:O\ _&Z /M6BOBK_ (?F> O^B,_M6_\ AH-7
M_P#C='_#\SP%_P!$9_:M_P##0:O_ /&Z /M6BOBK_A^9X"_Z(S^U;_X:#5__
M (W1_P /S/ 7_1&?VK?_  T&K_\ QN@#[5HKXJ_X?F> O^B,_M6_^&@U?_XW
M1_P_,\!?]$9_:M_\-!J__P ;H ^U:*^*O^'YG@+_ *(S^U;_ .&@U?\ ^-T?
M\/S/ 7_1&?VK?_#0:O\ _&Z /M6BOBK_ (?F> O^B,_M6_\ AH-7_P#C='_#
M\SP%_P!$9_:M_P##0:O_ /&Z /M6BOBK_A^9X"_Z(S^U;_X:#5__ (W1_P /
MS/ 7_1&?VK?_  T&K_\ QN@#[5HKXJ_X?F> O^B,_M6_^&@U?_XW1_P_,\!?
M]$9_:M_\-!J__P ;H ^U:*^*O^'YG@+_ *(S^U;_ .&@U?\ ^-U;\*_\%POA
M=KOC[PSH&J^!/C[X,/BS5[;0K'4O$_PWU+2=-%Y<.(X(GN)4"J7<A1GN: /L
MJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!'<1H68A549)/  K$\$_$WPU\2X]0?PWXAT/Q FE7)LKTZ;?Q78
MLYPJN89/+8[) KJVUL'# XP17G7[97["'PT_;]\%:/X9^*FCZAXA\.:/J U-
M=-AU:ZT^"[E$;(!/]GDC:6,!R=C-M) )!Q7P+_P:7>'[+PE^S#^T/I6FV\=I
MIVF?&S6;2U@3.V&*.TL41!GL% 'X4 ?JW222+#&SNRHB#+,3@ >II:_-O_@X
M8^)^O>,-3_9L_9HT36=1\/6?[3'CQ-&\2WUA<FWN7T*V: 7ULC#D"074>>Q"
M%3D.10!]W?#O]I?X<?%_Q)?:-X2^('@CQ1K&F9^V6.D:Y:WUS:8QGS(XG9DQ
MD?> ZBNVK\M_^"T'_!-'X6_LB_\ !/;4?C%\ O!/AKX0?%3]G_[)XA\-Z_X9
ML4T^[DBBGCCN+>ZDC >ZCD@DFW"8N6;[Q(9PTG_!9W_@I#XJO/\ @BK\*/%'
MPZO)O"OC#]J:;PYH6GWEI<M'/H2:K:_;)VC<?,"$C: L"&7SMP(8 T ?H9H7
M[3?PV\4_$>X\':9\0O ^I>+K0E9]#M==M9M2A(SD-;JYD4C!ZKV-=Q7YM?MX
M?\$0O@1\(?\ @EQXN@^&?@/0_!WQ"^$OA>X\2^%_&VF6ZVGB5-4TZW-REQ)?
MQ[9W>5X<,68@;\@#:N/I+_@C[^USJ?[=?_!-'X0?%+6RCZ]XCT4PZK(@ 6XO
M;2>6SN)0!PH>:WD?:.F[':@#Z3HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_HE/_ES:Q_\ )=?7]%,R/D#_ (<*_LG?]$I_\N;6/_DNC_APK^R=_P!$I_\
M+FUC_P"2Z^OZ* /D#_APK^R=_P!$I_\ +FUC_P"2Z/\ APK^R=_T2G_RYM8_
M^2Z^OZ* /D#_ (<*_LG?]$I_\N;6/_DNC_APK^R=_P!$I_\ +FUC_P"2Z^OZ
M* /D#_APK^R=_P!$I_\ +FUC_P"2Z/\ APK^R=_T2G_RYM8_^2Z^OZ* /D#_
M (<*_LG?]$I_\N;6/_DNC_APK^R=_P!$I_\ +FUC_P"2Z^OZ* /D#_APK^R=
M_P!$I_\ +FUC_P"2Z/\ APK^R=_T2G_RYM8_^2Z^OZ* /D#_ (<*_LG?]$I_
M\N;6/_DNC_APK^R=_P!$I_\ +FUC_P"2Z^OZ* /D#_APK^R=_P!$I_\ +FUC
M_P"2Z/\ APK^R=_T2G_RYM8_^2Z^OZ* /D#_ (<*_LG?]$I_\N;6/_DNC_AP
MK^R=_P!$I_\ +FUC_P"2Z^OZ* /D#_APK^R=_P!$I_\ +FUC_P"2Z/\ APK^
MR=_T2G_RYM8_^2Z^OZ* /D#_ (<*_LG?]$I_\N;6/_DNC_APK^R=_P!$I_\
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M4 ?('_#A7]D[_HE/_ES:Q_\ )='_  X5_9._Z)3_ .7-K'_R77U_10!\@?\
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M9O&WB3P5\/M%USX?_#S4;O3=1GN]::VU35FL\B[DM(A$T>V,A@N]P9-AQC(
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M444 %%%% !1110 4444 %%%% !1110 4444 %?'G_!9__DC_ ,&?^RV^#/\
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M_P#@NW_RBD^+/_7'3?\ TZV= 'U;H'_("LO^N"?^@BK=5- _Y 5E_P!<$_\
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MB1\*+?3=2^,^A^-/@AXK^(7CWQIJ]]<>&O$UGHHU"W>VG7;8(M\3BP^S#:K
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MVIO*MYXDU'Q-I=W:Z8%A=U+Q0N9&W.JH-HX+@] :RO\ @L_^QG\5?VO?A_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M--G0!]GT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !114=W ;JUEB#O&9$*[E.&7(QD>] 'F7[:7P,\2_M*_LQ^+? WA+QM/
M\/->\1VHM8->BL4OC9J74R PN0LBO&'C*DXPYK\ZO@K_ ,$ ?VGOV=/AS8>$
M/!/[>OCCP]X9TO?]CTZW\,(8+0,Q8I&&N3L3))"C"C/ %=]??\&]VM7E]/./
MVU?VM(A/(TFQ/%Y"IEB=HXZ#.!47_$/+K7_1['[6_P#X6!_PH ^H/^"=7[)G
MQ:_90\)^)K'XL?'G7?CO?:Q>13Z?>:EIB6+:5$J%6B4*[[@S$-GCI7A__!7'
M]ECXB:)^TY\#_P!JWX.>%;GQWXT^"<]UI^O^%[298[WQ%H-W&T<Z6X;AYXA)
M*RIU8OP"0 ?=O^">O[!UY^PEX5\2:9>?&'XI?%]O$-Y%=K=>-M5_M"?3@D93
MRX3_  HV=Q'<BOH>@#\KOB8GQ#_X+G?M7?!&TN?@M\2_A-\!?@SXCC\;^(+[
MQ[IW]D7WB+4X%(M;*VMB2[1JQ?>_W2&8<$*&^M_VS_VL/C+\"?VF/@SX3^'G
MP6O_ (C>#?'6HFU\6>(H7E$?A&$30()G"*5(V22/\Q _=5]-44 ?)_\ P6ZU
M[XIZ9_P32^)&F_!GPUXC\4?$'Q3:IH%C;Z);M/=V\5RXCN)U Y4+"9/F[$@Y
MSBNX_P""8O[)EE^P]^P1\+?AE:68LKCP[H4']I*5 =[^5?.NW;'!8SO)S7O%
M% 'B'[;O[9MU^Q;X7T#6D^%7Q2^*-AJUZ]I>)X'T8ZK=:0HC+K-+""#Y;,-F
M1T)%?$.C>!OBA_P5G_X*T_!'XS7_ ,(/'GP:^#G[/-K?W5I=>-;0:;K7B?4+
MI JQQVFXR1PH5C;>V58*XR2P _4VB@ KY'_X+M_\HI/BS_UQTW_TZV=?7%?(
M_P#P7;_Y12?%G_KCIO\ Z=;.@#ZMT#_D!67_ %P3_P!!%6ZJ:!_R K+_ *X)
M_P"@BK= !1110!\_?LKK_P (U^U9^T)H).U)-<T[78%]$NM/C#G\989*ROV]
MOV)1^T7XB\(>,-)T'P_XAU[PC)+#<:5JEU+8Q:W92KAH#<Q O&R,=RY#+RP(
MPQK5\-J/"_\ P4Y\46X(4>+OA]97^/[[65])#GZXN1^%?0-?:8W-\3EV9T<Q
MPDK2=*GWUO24)IV:>K4E=--;IIZGAT,'2Q.%GAJRNE.7R]]R6^FEUY=]#XJ\
M!V7CS]F/XCBSTOPAX*L_B'\89(X-+\.V=Z\>A>&-+TNV"^9-,J*\TI$@X1%W
M$@9 7->_?LR_'O6_BIJ/B[PUXOT2ST'QKX$O8;75(;&X-Q8W,<\7FP7$#L V
MUTS\K#<I4]>*U/C]^S?I/Q^BT6XN-2UOP]KWAFX>YTC6M'N?L][8-(FR158@
MJR.N R,"#@>E2? ']G71OV>](U2.PO-7UG5O$%W]OU?6-6N3<WVIS[0H:1\
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M_P#E%)\6?^N.F_\ IULZ /JW0/\ D!67_7!/_015NJF@?\@*R_ZX)_Z"*MT
M%%%% 'S'^UCXZL?@-^V/\,?'6IM(FEGPSXCL;]HUR_EP017BJ!W9C&P ]:F\
M&?M@?$73=9\":GX]\!Z'H7@OXF7T&G:3/I^K-=7^ESW*E[5+M"BHWF@ $QD[
M&.#GK5K_ (*!>'++4M;^"]YJ-M%=::OCJ'2K^*5<I-:WUG=6TD;>S,\8K1^&
MO[ .B> O&'AZ^OO%_C;Q3H_@N3SO#6B:Q?K-9:,X4HCJ H:5HU)"&0ML'3D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ,%2?V_O&_[&?[0?[+GA;PG:Z!<:;\9?'?\ PC>NMJ-M)-+%:XAY@*R*$?\
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M* "BBB@ HHHH *^(/^")7_-W7_9ROC+_ -LZ^WZ^(/\ @B5_S=U_V<KXR_\
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M)[LZ.8Q;) JF1IB_RA N[=QC/% 'CWQ+_P""RGB'X+?\&^?AW]J75-*TN_\
MB#KWAFP6UL_+*V,^KW,@MA*R!@1"'WS-&K E4*!AD$?$_P ??^"@WB#]F/\
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MW_TZV=?7%?(__!=O_E%)\6?^N.F_^G6SH ^K= _Y 5E_UP3_ -!%6ZJ:!_R
MK+_K@G_H(JW0 4444 > ?\%+T-C^R\^M@[3X5\0Z-KA;^XMOJ$#L?IMR/H:]
M_!R 1R#7D/[?GA8^,_V*OBAIX3>7\.W<P'KY49E_]DKF/A=_P4H^#?B+P%8S
MW?Q"T&"^M-&BO[Y)I&CP1$AE520!(ZL<%4+-GC%?6T\NQ>.R6E]4I2J.G4J)
M\L7*RE&ERWLG:[4CQY8FC0QT_;34>:,;7:5[.5]_5'T+17FGP,_:W\#_ +1&
MKW^F^'+^_35M-A2ZFT_4]-N--O/(<X6=8IT1FB)X#J"O(YY%>EU\YC,%B,)5
M='$P<)+I)-/75:/N>G1KTZT.>E)27=.Z"BBBN4U.?^(OPF\+_%[28K#Q5X>T
M;Q%9P2>;%#J-G'<I$_\ >4.#@XXR.W%:^CZ-9^'M*M[#3[2VL;&TC$4%O;Q+
M%%"@& JJH 4 =@,59HK66(JNFJ3DW%:I7=DWO9;$*G%2<TM7UZA111618444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7QY_P6?_ .2/_!G_ ++;X,_].:5]AU\>
M?\%G_P#DC_P9_P"RV^#/_3FE %__ (+I_!/Q9^T;_P $G?C+X*\#:%?>)O%>
MOZ9:Q:?IEFH:>[=;ZVD95!(!(1&/7H#4'[3OP-\7>,/^"(/B/X=Z9H-_>^-K
MOX4)HL.CQJ#<R7HT](S !G&_>"O7K7UW10!^9'Q/_P""5?CC]K/_ (-_/A#\
M(Q$G@_XO_#S1]&UK2;;5 $2VU:Q0_P"C3D!MJNK.F1P&*DY (K&_:/\ VQ?V
MMOVR?V1O$'P,TO\ 9&^('@WXH>-]&/AO6O$NL:E91^%=,6=/)NKJ*Y5B9D*&
M0JBJ6&X?>P ?U0HH \B_8(_95MOV(/V-?AQ\)[6^;4U\#:)#ITMX5VBZG +3
M2 8&%:5G(!Y (SD\U\U?\')/[-GCO]K'_@E9XH\%_#CPQJ?B_P 4WFM:5<0:
M;8*&GDCBNT>1@"0,*H)//2OO*B@#\\/^"ZG[+?Q"_:-_8@^#'AWP-X3U;Q-K
M?A_Q_P"'-3U&SLT5I;2V@1Q-*V2/E0D9^M7O^"SW[,?C_P"/W[4O[&>L^#?"
MNJ>(=+\ _$K^UO$-S:(K)I-IB#]]+DC"_*W3/2OT!HH _/;_ (*-?LO?$'XK
M?\%G_P!BGQ_X<\*:KJ_@WX?2Z\?$>K0(IM]($UNBQ>:2<C<00, ]*;_P6G_9
M>^(/[0'[6_[%NN>"_"FJ^(M)\ ?$235/$5U:(K1Z1:DVF)I<D87Y'Z9^Z:_0
MNB@#\\O^"CO[)OQ;^#W_  40^'_[7OP.\(P_$S4]#\/2^#?&W@D7L=G>:QI;
MR-(D]G))\AGC9R2K'D1H .6KV+]C[]OOX@_M0_%V/1-3_9<^+GPH\/P6DTUY
MX@\7BTLX8IEV^7!%$KM),7)/S*-HV\]:^JZ* /S6_P""AW[2GC3XT:7\0/@]
M\0OV"?B-\5=,DGNK/PSJVFM9:CI.H(05MKS[065[&0G:Q_C0#KVKT#_@G%\$
M/C5_P3'_ ."+/A+PQ?\ A67XH_%CP;8372^%;?6(H6*S7KRBPBNGS'NA@DP.
M2I9"JDC::^Z:* /QJ^-GP2\>_P#!5']N_P" WCCPC^RGX]_9R\3_  X\7VWB
M'Q=\0O$T-KIDUW80L&>S00L7O9)",!B#@<$A&;'[*T44 %%%% !1110 4444
M >>_M5?M1^#/V+O@'X@^)GQ"U*?2?"'AA8&O[J&UDNI(_.N([>(+'&&=RTLT
M:X4'[U=/J_Q(T'PW-HD&K:QINC7?B286VEVNH7*6MQ?SE"_DQ(Y#/*%!)106
M !XXKR__ (**_L86'_!0C]C+QQ\(M0UFY\.#Q9;0FUU:WA$TFF7=O<Q75M/L
M)7>JSP1EE#*67<H9<Y'Y8_MI?L<_\%-_$/QH^ $FI>-O@O\ $2?PCXO%WH&N
M:;HEY#'HMT+26/[=JZI:;8[<H64E-_SNN% H _;FBOS _P"%-?\ !7#_ **S
M^R!_X!ZE_P#*ZOM+]@3PY\?_  O\#)K;]I'7_A[XC^(9U29X[OP;'-'IPL2D
M?E(1+#$WFAQ*3\N,%>3V /;:*** "BBB@ HHHH **** "OB#_@B5_P W=?\
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M'PS^TG\'/$O@'QGI<.L^%O%MA+INI6<G EBD7!P>JL#AE8<JR@CD"OS>MO\
M@@3\?OAI GA;X<?MW_&/PM\,K9?(LM&NK;[9>Z=; _)#%<B9-H4<#:JC ' H
M ]1_X(D6^L_ CXA_M'?LZ2^*=;\;>#?@1XJLK/PGJFJS_:;JUL;ZR6Y&G22_
MQ&V;*]@ PX4?*OWY7A/_  3U_P""?7@O_@G)\#9/!OA*YU?6KW5;Z35]?\0:
MQ/\ :-4\1:A*!YEU<28^9C@ #HH'<Y)]VH **** "BBB@ HHHH *^1_^"[?_
M "BD^+/_ %QTW_TZV=?7%?(__!=O_E%)\6?^N.F_^G6SH ^K= _Y 5E_UP3_
M -!%6ZJ:!_R K+_K@G_H(JW0 4444 <O\</#L7B_X*^,-)GNUL(=4T2]M)+D
MC(MUD@=#)_P$'/X5^6NE?%?QI\:?V2_@AX:/@GP1H>A^%]9TM[#Q'/J\%\YG
M1WC@\ZQC'G6\,TVU)'.<;LD'BOU$^/\ JT6A? KQI>37L.G1VVAWLANI5WI;
MX@?YRO.X \XP<]*_##]GK7+GP$/ /B+5?!^OSZ#X0\66\]SJ<.E6JV\K+,)9
M;=I1$LT\A1/EB>8@$< < ?O7A%EGUK+\35LFZ=2$HWO\7)43Y;2BG)W2M+F7
M]U]?S[C'%>RQ-*%VE*,D[6VYHO71M+=Z6?F?KY\*/A5\1_B%^TKI_P 2OB+I
M'ACPFWAO1+C1-.TS1]1?49+PSR1O)--.T<8$8\L;(PI(+$DYXK?N/V^/A3:_
M%,^$)/%,:ZFM\-+:Y^R3_P!G+>$X^S&[V>0)<\;2_7Y?O<5X9X[^*\/QO^-?
MQ#;7/C7K/PIT3PAIUC?>%K?3M0BT]-0MI[-+@ZE*)!FZ0R,T?E=!Y>,;C7$_
MLV?!OXS_ !D_8-\+_#6^\)^$M,\,^*%BU&?Q/<7S"[@MGN1=%S9^7N-V<?*^
M[;\RG-?/U.'*%>E'%9M-4U%4XJ,7[-4XSC*=TZBE[5Q6KA%N3E)J^U_1CF=2
MG-TL)%R;<FVUS.3BU&S46N6^RDTDDKVW/I?XJ?MT:?X \=Z]HFC^"O&OC:/P
M<B/XDOM#M(Y;?1=R>9L;>ZF601D.4C#, 1FO7O ?CC2OB9X+TKQ#H=Y'?Z1K
M5K'>6=PF=LL;J&4X/(.#R#R#P:\(\9?LG?$3PYXY\8W?PS\>Z-X>T7XANL^K
MV^K:2U]<6%SY*PO<VCK(HW.BJ2L@*AAN'I7LWP5^%&G? OX3>'O!^D--)IWA
MRQCL8'E.9) @P7;'&6.2<<<U\=G%'*(X.E+!2O4]V^LKVY??YTTDFIZ14&TX
M[[)OVL%/&.O-5U:.O:V^EK.[3CJ[VUV[+IZ***^6/6"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OCS_@L_\ \D?^#/\ V6WP9_Z<TK[#KX\_X+/_ /)'
M_@S_ -EM\&?^G-* /L.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *^0_P#@KM^V1\0_V<? _P ./ ?P9@T5OC)\<_%,7A/P
MS>:PN^PT1?+::ZU"5,$R"&)>%P1EPQ#A=C_7E?+/_!5K]@SQ-^VU\)O".H?#
M?Q7:>!?C#\*/$EOXM\$ZW>1F2RBO(U9'M[E0KDV\L;L& 5N53*LNY6 /EB7_
M ((V?MOZ+ ?$NF?\%$?%MYXUC7SUT^^\)*-"EE&UA$8S<NBIO!!<6YRIQY8&
M0?J?_@D-^V?XQ_;/_9AUB?XE:3INC?%+X9>+=4^'WC2#3FS9/JNGN@DEAY.$
M=)(FQG&6./EQ7RV/CY_P5HUF4^&4^!?[..D7,D:V_P#PE\NN&2PC;.UK@6ZW
MK3=!OVF$XW#Y6P4KZ_\ ^"7G[#%Y^P)^S++X9U_Q._C7QWXLUV^\8>,]?,0B
M35]:OG#W,J)@;4&U$&0"0F<+G: #Z+HHHH **** "BBB@ HHHH *^(/^")7_
M #=U_P!G*^,O_;.OM^OB#_@B5_S=U_V<KXR_]LZ /M^BBB@ HHHH *^%_P#@
MJ!J,'@+XE7?BOQ[X+U#QWX%T_P )^5X:M)$FET6RUQKAA(]ZL1!4F%H]KMP5
M1U4AN1]T55UW0K+Q1HMWINI6EM?Z=?PO;W-M<1B2*XC8%61U/#*02"#P0:PQ
M-'VD'%.WX_@?3<)<01R;,H8VI3<X[22DX2L[7Y9K6+:TNMTVNI\*_P#!/SQO
M\4O@%+\./#7BRXCO/!?Q(U/4K/P]I-Y:26^J:-;PVYN8KA!)(\GV9MLB^5*2
MT:F([OFVCLY/VUOBO)\%+CXXP:/X$;X307#S#17-PNOR::ER8#<>=O\ ($Y(
M+^24QCY=VZO4]"_9\^"'[#MO?>.H].TGP?%:6_V9]3U#49YQ:1,V?)@\^1_+
M#'@1Q ;N  >E<'\(/V</@%^TGJU_KO@WQ#JVO^&[;5O[1OO"=OK=RFA0WY?S
M!++ISXV%G!8*P$;$'"D#%<,*56$524M>BOZ6Z7:6NGGY'Z5C,\R3,<56SJO@
MY.DW%3J>Q2C+WIN<+1J<L*DHRIQ53F<FXN3LYL^J(I5FB5U)*N PR".#3J**
M]4_$&%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^,/VU/^
M4Q?[$?\ UZ>/_P#TTV=?9]?&'[:G_*8O]B/_ *]/'_\ Z:;.@#[/HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#B_VA
M?VA_!O[*GPCU7QYX_P!;A\.>$M#\HW^HRQ22QVHDE2)&81JS8WNH) P,Y. "
M:L_![XZ^"OVA/!UOXA\">+/#OC'0[I0T5]HVH17L#9[;HV(!]CR*U/'MCH.I
M^#=2@\40Z1<>'G@;^T$U18VLVAQEO-$GR;,==W%?A)_P4#U7]B7X+?&"YNOV
M3?'?Q2\+?M"73,+72?@'YNI6&H7 R-MQ;!A:>7D@,L+CY<G8U '[Y5\1?\%7
M_P!N3XA_#+XM?![]GGX&W6C:?\9?CMJ$Z0ZQJ5L;N#PKI-M&9+K4#!]V1PJM
ML#_*=C\$@8^5_P!EK_@H[_P48_9C^!&G^+/V@OV:+WXG^$H\BZN]!>VL_%UI
M"HR9YM/A+*_&3@1QGCG;G-=7\4?%X\8?\'//[+?BJY@O;#1O&/P7OIM%M[Z/
MRIX;ATOYY(W&2!*(G0,H)P1^- '52_'#X^?\$D?VNOA%X:^-7QBA^.GP:^..
MKGPM%X@U+08-'U/PIKCKNMU)A8I);S'*@,<KANFW+?IA7Y>?\'4:RZE^S!\!
M]*TY@OB+5OC/H,&CXY<7&RXVLH[X)'YBOU#H ^%O^"Z_[2?Q?^ 7P\^!ND?!
M;Q?8>"/%?Q3^*>F^"I-4O--BU"&&&ZMKLY:.16X$B1M\N#\N,\FK'[)O[+'[
M;_P]_:#\.ZQ\6/VE_ WCSX?63S'5M"L/!T5A<7ZM!(L8695!3;*8W//(0CO7
MJ_\ P4A_X)S:'_P4A^'/A#0M6\8>,/ M[X%\2P>*]&UCPW/'!?6E]##-%$ZL
MZMC;YQ88P<J.:^3_ (3_ !R^.?\ P3*_X*B_"W]G[XI?%.\^.?PM^/%G?GPM
MK^MV<4&O^'[^UC\QH)Y(@!/&_P J@MSF4$;0A# 'L?\ P5N_;K\=_!'Q=\(_
M@=\%)]%MOC7\>M8?3],U'4X/M-MX9TZ!0]WJ+P]'95("*WRDA^NW!\@\1_&K
MX_\ _!'O]I;X1VOQF^-,?QX^"OQDUQ?"E[J^I^'8=&U+P?JTJYMI5:!F22UD
M8$%7Y4 XY&6I?MH,-(_X.@_V3[K4V TZ^\ :U:Z?N^5?M(%X6 )ZMADX'/(J
MS_P=9O\ :_V#OAIIUJX&M:C\6] CTU0?G,NVYY ZG&1T]10!^G5?(_\ P7;_
M .44GQ9_ZXZ;_P"G6SKW7]H"P^*-Q\'O)^%=_P""K/QRLD 6?Q3!<3::8P1Y
MVY8")-Q&=N#C/6OSS_X*QZ'^U[:?\$^_B')\2]>_9^O/!"QV/]IP^'=.U2+4
MW']H6WE^2TSF,'S=A.X?=#8YQ0!^HF@?\@*R_P"N"?\ H(JW530/^0%9?]<$
M_P#015N@ HHHH R_&_@W3OB+X-U70-7@%SI>M6DME=Q9(\R*1"C#(Z'!/(Z5
M^<GP'_X)D7?Q2UOXA_#J\^*GB6R\"^ ?'1E.C)8Q-/J&^RA9+@W&X;)"CLG"
M$ IN !;C]+Z^?O@)GP_^WI\=],.%CU2TT'6(5Z=;:6&1OQ:,?E7W/"6?X_+\
M'C5@ZG*U",UI&5I*I"-US)V?+-ZJS\]$>#G&78?$5J#KQO=N+U:T<9.SLU=7
M2TV/3M7_ &=? ?B33=$M-5\'^&]8B\.6\=KIIU#3XKI[.)  JHSJ2  !^(S7
M9(@C0*H"JHP !@ 5YQ\=?VJ_"G[/NIZ7INKC6M4UW6D>6STC1=-EU&_FB3[\
MWE1 D1KD LV!DXY/%=#\(/C%X>^.W@*S\2^&+]=0TJ\+(&*-%)#(C%7BD1@&
M21&!#*P!!%?-XG"YB\+#%5XS=)M\LG?ENV[V;TU:?JT^S/3I5L,JLJ--KGZI
M6OIW]+KTNNYT]%>(_'#]NOP1\._A/XZUGPYK_ASQ9K_@NQDN9=(M=2C:7>&"
M#?M)(178;F'W1GI7,^$/BO\ %CX0?&[X>:!\1-<\'^+=,^*'VFVMSHNG/92Z
M+=PVSW.%)D?S[<HC+O(5@VT]&Q790X9QM2A*M-*%N:T974I<D>>7*K?9@U+5
MI.]HW>AC4S2A&HH)\VUVK-+F?*KZ]7II>W6R/I2BBBOGCT0HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KX\_X+/\ _)'_ (,_]EM\&?\ IS2OL.OCS_@L
M_P#\D?\ @S_V6WP9_P"G-* /L.BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *8]Q''-'&TB+)+G8I8!GQUP.^*?7A'[?'_!.
MSX?_ /!1?X>:/H7CBX\5:3=^&;\ZIH.M^&]8ETO5-$NS&T?GPR+E"VQF&)$<
M<],\T >[T5^,W[77[37[1_\ P04LC=77[4?PH_:#\&6J>9'X,^)ER+'QX8L9
MQ;30%I;ICQF6;(&X )SFO8_V0/\ @Z9^!?QPT?PVOQ3\/>-_@'J?BI VEW'B
M/3I;C0=5.0,VNH1Q@.@/!>2.)1ZT ?3?_!1#_@I-9_L0ZCX#\'>'?!VI?%+X
MR?%B_?3_  ;X*T^\2R?4C%M:XN+BY=72UMHD;<TK*W0\;5=T\[^$'_!5'X@>
M /VK_!OP:_:9^#UE\(=?^)\<O_"%>(-&\1KKN@Z[=1_-)I[R>5&UO<JI0 -N
M$C, ,;D#>&ZS?3>-?^#NO1[;6$8V_@[X)22Z$LIW(KRSN))8P>%8BXG0D<D(
M0>!47_!VU+)X9_8S^"'BK3$*>*/#?QGT2?2)HSMG$OV2_?RT8<KEXHVX[QJ>
MU 'ZK5\Y_P#!5;]ON3_@F;^Q=K_Q=B\'GQW+HE[862:-_:O]F?:3=74=N#Y_
MDS;=IDW8V'.,9&<U]&5\K_\ !9G]AGQ7_P %&/V"/$7PK\%ZKX>T7Q!J^I:;
M>P7>M/,EG&+6\BN&#&)'?)$9  7J>HZT >/^ ?\ @I_^V5XE\=:)INL?\$]]
M>T#2=0OX+:]U-OBMIUPNG0/(JR7!C6T!<1J2VT$$[<9&:^P?VN?VJ_!O[$7[
M.7BOXI^/[^73_"OA"T^U7;Q1^;-,S.L<4,2<;I))72-02!N<9(&2/B=_^"K'
M[0G["G[17P[\$?M@?#/X;V/A/XJ:K%H&B_$/X;:C>SZ-9ZE(/DMKJVNU\]-[
M$?.2H"AV D".4X[_ (.NKF75_P!F3]G_ ,+W2./#7BOXTZ)9ZTYR8I8?)NL0
MR*/O*V6?'K"/:@#M-<_X+'?'[X._"33/C5\3_P!D^Y\*_ /4?LUS>WUEXQCU
M#Q/X:TZ=E":A=Z<+=<J0Z,T*N'B!;<3MY_0?P+XWTCXF^"-&\2:!?V^JZ#XA
ML8-2TV]@;=%>6TT:R12H>ZLC*P/H:\L_X*/>'K#Q1_P3S^.NFZFD1TZ[^'VN
MQ3[TW*B_V=/\V/5>HQR"!CFOGO\ X-H/%6I^,/\ @B%\"KK5FGDN+>RU*QB>
M5R[-;V^K7L$ &>0JQ1HH'8*,<8H ^[*^(/\ @B5_S=U_V<KXR_\ ;.C_ (>X
M?$S_ *,C_:@_\!-)_P#DRL/_ (-^_%]U\0?AM^TSK]]H>J^&+W6_V@O%-_/H
M^IA%O=*DEBL':VG",RB6,L4;:Q&Y3@D<T ??=%%% !1110 5Y-\;_P!JE?A?
MX_LO!WA_PAXB\?\ C&[L3JLFF:288ELK/>8Q---,Z(@9PRJN26*G@=:]9KQG
MXT?LV>)M;^+\7Q!^'GC*V\'^*9=*71-2CO\ 2QJ5AJ=JDC21;H]Z,DL;NY#J
MW(.TC%8UW/E]S]+_ "OH>]P[#+Y8MK,6E'E?+S<Z@Y=%-P3FH[_#K>UVE=KA
MOB=K5U^V?\,?!WC?P%HKW^N?#'Q?]MOO"'B'%C,]W;QR0S6<I.Y(KB,3+)&Y
MW*#M.>>.B_9]^'_C;Q5^TQXF^*?C#PI:^ %O]!MO#MIHJZC#?W5V(IWF:[N9
M("8MPW"- "Q"@Y(X![O]FSX!C]G[P7J-G<:W=^)==\0ZK/KNMZM/"EN=0O9@
M@>18D^6) L:*J D (.3UKT*LZ=!NTY[[M>>W]:V/9S/B6G1A6RW+HQE1]Z,)
MOGYU"4E.45=J+BY*Z<Z?/;=K9%%%>;_M4?'.\^ 7PPAU+2M+AUC7M9U6ST'2
M+6>8P6SWEW,L,1FD )2-2VYB!G QQG(Z)S48N3V1\I@,#6QN)AA,.KSFTEJD
MKONWHEW;T1Z117A'PN^-?Q(\*?'[2OA]\4;;P3=W7BC2;K5='U+PPMS#$C6S
M1">":*=G8<3*5D#8.""N:]WJ:=135UT-\TRJK@:D85&I*:YHRB[QE&[5T_5-
M.Z333T"BBBM#S HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KXP_;4_P"4
MQ?[$?_7IX_\ _339U]GU\8?MJ?\ *8O]B/\ Z]/'_P#Z:;.@#[/HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XP_X+
MU?&+X;_#7_@FQ\1+;XB:;8^+M-NX+)Y?"G_"1C1;S6XOM\"D1RJKRJJGYB40
M\*1D9R.[_95\,_LJ?L:>#(])^%MQ\&? ]G/&OG?V=JMBEQ<\?\M9BYDE(]78
MUXW_ ,%4_P!D']DO_@IS\+_&5S\1O&/A/2==^$I31=1\70ZHOVCP.SW".T$R
MF01*TA4KB521O.,&O"HOV./^"021*K3? AV4 %CXXN<GW_X^Z /N+]C3_@HI
MX>_;8_: ^-WA'PG;66H>'_@_J>GZ7%XET_44O;'7)KBV::58RJ[0T+*4;#."
M3U'(KF_^"HG_  3GU;]M.U^'WC3X>^*[;P!\:O@WJYUOP=KUQ:"YM2SJ%FL[
MI!\S6\R@!L9(QT()!ZK_ ()Q67[-?A7X/7WAO]F.X^'[^$-%O,W\/A:\2[2.
MYD7.Z>0,SO(RJ.9&+;5 S@"OH6@#\^OA5_P3L_:!_:B_; ^'WQ<_:R\6?#6Y
ML_@Z\EYX/\&^!+.Z333J3J%.H74ETS.SJ I502 P!&W!#>U?MH?LX_'SXO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX\_X+/_\
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MWP9_Z<TK[#KX\_X+/_\ )'_@S_V6WP9_Z<TH ^PZ*** "BBB@ HHHH ****
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M3_[:_LW[=9_VCL\W[+YR^?L_O;,[L>^*39482E?E5[%RBBBF2%%%% !1110
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M8'TVRM[,VUK<REE$;3W0CEE<1EM@VJQ)%?I70 4444 %%%% !1110 5\C_\
M!=O_ )12?%G_ *XZ;_Z=;.OKBOD?_@NW_P HI/BS_P!<=-_].MG0!]6Z!_R
MK+_K@G_H(JW530/^0%9?]<$_]!%6Z "BBB@!EQ<1VEO)-*Z111*7=V.%4 9)
M)[ "OR6_X*)>"OA3^WE\8?$'C+X<?%?2;KQ3H?AV6:YT.:SGQJHLX9)<VTI
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&>ZF2"/=\.?$"*69@HR39@ 9(Y. *^OD<2(&&2&&1VH 6BBB@ HHHH ****
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M\7RRB[<THZQDDT[Q?JK/J%%%%;'@A1110 4444 %%%% !1110 4444 %%%%
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M."1S7Z-Z3]K_ +*M?M_V?[=Y2?:/(W>5YFT;MF[G;G.,\XK\E_CI\6_VMO\
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MO[+O_!3+X6_M=?$"Y\+^%+W5HM9@@DN8X=0L_LXNHT*AFC(8@GY@=IPV 3C
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MT)I-69XCK_\ P3S^%UWJLNI^'M(U#X?:S*<_;_!^I3Z)(#[I RPM_P "C/\
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M%DCD'J&4D$?2K%>%*+3LUJ=Z=U=!1112&%%%% !1110 4444 %%%% !1110
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M?.^Q0_:1&+C8OF^7G9NQSC/.,UX+^PPP\%ZW\6_A^X,;^$?&=U>6L9Z_8]1
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MVGV@9EN(E7>L,;(\@+@'( /W+/.EK \LKI'%&I9W8@*H R22>@ K\6_VG?\
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M9]?LFBBBNL^#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KF/'?P4\&_%)&7Q-X2\,^(@^ ?[3TR"[S@8'^L
M4]*Z>BM:->I2DITI.+75.S^]$3IQFN6:NO,\%O\ _@FA\'1=/=:)X=O_  ;?
MN21=>&M9O=)=">I"PRK'Z=5.*B'[''C;PE@^$/C_ /$[3P,?NM?2R\0Q8';,
M\(DP1W\S=[^GO]%>VN*<U:M5K.HNU1*HONJ*2.%Y3A-X0Y?\-X_^DM'@'_"-
M_M-^#!LL_%'P@\<PH/O:II%[HMS)S_>@DFC''^QUQTY-'_#1GQJ\(@_\)%\
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M44 %%%% !1110 4444 %?'G_  6?_P"2/_!G_LMO@S_TYI7V'7QY_P %G_\
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MX'_LF_M3_$']L_XR_"P_MM_$6VM_A?::)/%?OX>M)VO_ .T+>29@T;/A-A3
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M\2[O]K)?#EQK-W?VS6$'PRT:XCB%M>36P(=@"=PBW=.,XH _3*BOCW_AC/\
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M_P#A"?$_[--IL^//BA->_MOPQK=QYVK#[+]IDM?)OTV6I^3RTDWR+AMSMD8
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M621\AB:\JU65::5Y-MV5E=N^B6R\CZ_HKY _X1S]OO\ Z'+]C_\ \(WQ'_\
M+2C_ (1S]OO_ *'+]C__ ,(WQ'_\M*9B?7]?&'[:G_*8O]B/_KT\?_\ IILZ
MT/\ A'/V^_\ H<OV/_\ PC?$?_RTKPSQ1IO[06G_ /!9/]C\_'#6O@YJ\+V7
MCC^QQX&T;4M.:(_V5;^=]H^V74^\$>5LV;<8?.<C !^F5%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7SE_P4
M<_X)T:/_ ,% /!'AAHO$VL?#_P"(?P[U9->\&^+])4/=Z%>J "3&2!+"X #Q
MDC< .1BOHVB@#XA^ 7_!*7QWJ7[6'A;XT?M'?&R7XV>*_AU;2V_@S3;+P[%H
M&C:#),H6:\,"22>;<NHQO)4#C@X7;W7[;?\ P3@U/]L#]J'X)?$>R^*WB?P+
M:_"#4CJ%QH>G1.]KXF!G@E\J<B9 !B$KRK\2-QZ_4E% 'SO_ ,%&O^">&C?\
M%!?AQX=M6\2ZSX!\=> M7C\0>#O%VD*K7OA^_08WA&($L3C >,D!@!R" :\F
M^!O_  2F^(7B#]J;P?\ %[]I+XXR?&O7OAG'+_PAND6'AN+0-&T>XD0(]])"
MDDGG7..%8X"X!&2!C[AHH ^>?^"C/_!/+1/^"A'PRT&PF\1:SX%\;>!M7C\0
M^#_%VD -?>'=0C&!(JL0)(V'#QD@, .00"/(_@I_P2F^(?BC]J+P9\6?VE/C
M@?C9K/PO$C^#-'L/#46@:/I-U(@5[^6%))//N<#Y6. A (R<8^XJ* "BBJ7B
M6XO[3PYJ$NEV\-WJ<5M(]I!*^R.:8(2B,W8%L GL#0 [Q!IK:SH%]9HRH]W;
MR0ACT4LI&?UKR/\ X)W?LQ:C^Q?^Q!\,OA5JVIV6LZEX$T.'2;B^M$9(+ETS
MET#?, <]^:^4/B;%_P %(/!'P;UCXDMXQ_9Q_M;0[&759/A]:^'KV:":*-3(
MUN-1>8.9MBD A50L>H&#7T;_ ,$U?^"@VC?\% _V!O"?QO:RC\,VVK65Q)JU
MK)+OBTV>UD>*Y <@$QJT;,&(!VXS0!]$UX?^QA^RIJ?[,/B/XV7NHZK8ZFGQ
M2^)%_P"-[-;9'4V4%Q:6<"P2;NK@VS$E>,,/>OC/X*?MB?MD?\%._"/BKXO_
M   U'X3?#_X4:7J5Y8>"M)\4:+/J%]XZ6U=HVGGG251:Q22*578,@@Y) W'Z
MF_X)A_\ !173?^"@G['D?Q%U'38O!_B#P_=W>B^,M&EG#CP_J5F<7,98\[-N
MV12>=KC/(- 'TM7AGA+]E#4_#O\ P46\9_&J35;&32/$_@;2_"D6G*CBYAFM
M+RZN&E9ONE&%PH '.5-?''P6_;&_;#_X*@^'?%WQ7_9[U3X2_#_X3Z-JUYIO
M@W3_ !3H\^HWOCH6KE'GGG251:PR.I5=@R.<DXW5]5?\$L/^"@$'_!1C]EF+
MQA=Z,OA;QEH&J77AKQ?X?\T2G1-6M7VSP@YR4(*NI/.UP#R#0!](5X1^T3^R
M5JGQH_;#^ /Q*M-6L++3_@_>:U<WMG-&[37XOM.:T01D< JS;CNZCIS7N]%
M!7@O_!2+]D35/VW?V:1X%T?5[#1+P>(=&UG[3>1N\6RQU""Z=,+SN98BH[9(
MS7O5?)G[1'PW_;/^('QJUV3X;_$SX*_#OX?6AA_L6+4/#%UK6JW^(U,OVIC+
M''$IDW ",$[<'.: /K.N*_:2^%US\;_V>/'?@NSNH+&[\6^'[_1H;B92T<#W
M%O)$KL!R5!<$XYP*^6_^"/?_  41^(7[8.K_ !F^''Q>T/PYIOQ.^ _B8^'-
M8OO#QE_LK6 ?,"3Q+(2T9S$V5+'@J<+R!SGQ\_;B^-O[4/[??BK]G;]F74/
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MJMCJB?%3XC7WC6S6V1U-E!/:VD"P2;NK@VS$D<885[G110!XAX<_97U/1?\
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M*WQ,U#]FS7_A?\./A#\,M>F\,:;K?B;19]7N?'&H6_%PZ!)$6"T#%0K*"Y#
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MG]M*S_9I_9M\(>$?&/Q;MM%_X27Q/JWBV^FMO#G@ZP;"PBX^S@SRSR,\3"-
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M'OASQ-\2M/GO/ OBWP+>W4WAWQ#/; M<V+)> 3P7"(48!LABX4'+)N /8?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /A'5_\ @MEK^E:O=VB_L<_M>W2VL\D(FA\%(T4P5BN]#YW*MC(/<$5]
M$_L6?M<WW[8'@?5M:OOA5\4?A/)I=]]B73_'&DC3;N\'EJ_G1(';='\VW.>J
MD5[+7-_&6'Q/<_"/Q1'X*DL8O&$FE7*Z(]X<6Z7IB80-)P?D$FTG@\=C0!\0
M_P#!3?\ ;<\7_'GQ[K'[(O[-5M#KWQ<\3Z:UMXQ\2N2=(^&>EW"E))[F50?]
M+>-B(XA\P+!NNT'K/'O[%VF_\$^/^"%7Q"^$7P_FGO#X2^&VMQ17LJ!)=0O)
M+2>2:X95^Z9)7=MHS@$#)QFOC7_@GU^P]_P4>_X)T_#KQ#HOA3PS^S%K^J>,
M-;N/$&O>(-=U?4)]5UB[F.2TTB! P7G:-O&YO4U^H_[*MG\4O&W[,]G9_M!:
M3X(@\>:DMW;:W8^&I)9M(D@:1UC5#+\YW0%=P/<MVH \(_X-X/L?_#EO]G_[
M"!Y']@2[NG^M^V7'F]/^FF^OB7_@G*=4;X*?\%6%\-_\>G_"6>(SI>/^?O['
M>^=T_P"V72O;/@C^RE^V;_P3 \$^)?@S\!O#OPK^)'PLO-2O;[P1KOB37I=-
MO/!4=V[2FWNK<1M]ICBE=F7RSELG( .U?J/_ ()=_P#!.33O^"?/['2_#O5-
M1A\8>(_$MY=ZWXSUF2':NO:E>'_2'*GGR]NV-0>2J GDF@#SW_@W ^R?\.3?
M@']B&(3I-YNZ?ZS^TKOS/_(FZO&_^#?4R?\ #8G[?0L\?\(Z/BX?LF.GVG-U
M]HZ<?\\J?\%?V2OVQO\ @EUX7\6_"'X >&_A7\1OA5JNK7NI>"M7\1Z])IMY
MX)6[9I&M[FW$;?:8HI&++Y9RV3D#.!]3_P#!*+_@GQ'_ ,$X?V58O"%]K,?B
MGQKXAU2Z\2^,-?$7E_VSJUTP::4# .Q0%1<\X3) )- 'TO1110 5\R_\%!?A
M9^U1\1H[0?LZ_%#X<_#^%;"6*]C\1Z ]_//<$G9)%,-RQ@+@8:-^>?:OIJOC
MCX\?&']M[X>_&OQ+9^!/@U\'/B)X"N;E3X=U";Q?+H]]:0F-<B\BDC8.PDW?
MZH_=QWS@ \>_X-[_ (E^'/#%S\:_@IK/@F_\'?M ?#_Q -0^)=Y>:L=7D\7W
MEUN9=56Z*(623!(BV@1JZXSN)K%_X(%B<?MZ_P#!0<:GDZY_PM*'S\_\\,WO
MD=>?N[J]B_X),?\ !.#XA?LS_%KXQ?'#XW:_X>USXT?'2^M[C5;;0%?^R]#M
M+=2L%I"[@.^U2JEB.D:#YB"QYWX^?L4?'+]E#_@H'XL_:(_9GT3P5XT@^*ND
MV]AXZ\#Z]JC:1]KO+;B#4+:Y",@?9\KJ^,Y8Y.[Y0#S[XSF0?\'8/P=_LO E
M/PAU'^V?4V^ZZ\KI_P!-?+ZT_P#X(1M<G_@I!_P4/&JD'7/^%D6/G=<_9\7_
M )'7_8S7LO\ P3F_8&^)7A;]JWXE?M+_ +05SX7F^+_Q$LX-"TS1M D:XT[P
M;HL)#+9QSNJM+)(RHTC8QE>"=QKG/VB_V*/C?^S!_P %!?$7[1W[,^C>#/&+
M?$S1H-*\>>!]>U,Z0NH7%MQ;ZA;7(1E$H3",KXSR<G<=H!Y[^T67'_!U=^SX
M-,R)C\+-7_M?'>WVWOEYQ_TTV=>^*_4"OB#_ ()X_L$?$W2?VOOB'^T[^T+-
MX5/Q:\<:;#X=T70M E:ZT_P;HL3!Q;).ZJTLLCA6=@,9!P<,0/M^@ HHHH ^
M6O\ @KY_P4)C_P""=/[(-_XDTJ"/5OB+XINH_#?@;1@ \FJZQ<G9" A^\D?,
MC=B%"]6%:_\ P2N_8?'[!O[(FC>&=5NO[8\?>()7\2>.-:D.^?6M<N\274SO
MU<*W[M2?X8UZ9KQS]K7_ ()Q?$+]K/\ X++_  *^*NN/H,WP.^"^DSWMO8R7
MKF]GUMS*5D^S[-A566U;>6SB,C%?>- 'Y9?\&PYD^S?M<C4,_P!OCXU:K_:&
M[[V?X??'WL4>$#<?\1;WBT::3]E_X4Q;_P!K8Z;O-B\O/OC9U]J[WQY^QI^T
M'^PE^W+\3OB[^S/X=\"_$/P=\</L]]XH\$Z]K+:++IFL1#:=0MI]C(R2@NTB
M-AMSG'&,=_\ \$O?^"?'CKX'?&/XK_'KXX:GX>U?XX?&>X@2\@T0R2:;X8TR
M 8@TZWD<!GQA"[$ $Q)C."S '@?_  ;1_:/^$W_;1&J _P!OCXTZA]NSUQ\^
MSKSC[U/L7F'_  =NWPTPGR3\%$_MC'3_ %X\K/O]SKVKOOB;^QG\?_V(?V[_
M (D?&G]F?P]X&^('ACXW0V\_B[P1KVL-HKV6KPC:-1M9]C(5D4N9$;!+.Q&>
M,=Y_P3(_8!\??"'XX?%3]H#XZ:AX=U+XW?&&2"WFM-#>273?"NDVXQ!I\$D@
M#2'A"[D8)C3&<$D ^T**** /SD_X.NO^4(WQ,_[">A_^G2VK]"/!/_(F:1_U
MY0_^BUK\Z/\ @N1^RA^UO_P40^%OCGX*> _"7P=C^%FNSZ9<6.OZEXBNK;6B
MUNT%S('@$+1*//1T&"<H >IKZN_82UW]H?4]!UFT^/?A#X9^%'TY+2'0CX1U
MFYU'[8H603F?SHTV$;8MNW.=S9Q@9 /F[_@ZD_Y0;_&#_KYT+_T]V-?<WPR\
MW_A3'A[R?]=_8MML_P![R%Q^M? G_!</]EO]K7_@H-\)/'WP1^'_ (1^#R_"
MSQ,=,EM=?U3Q%=6VLA[>:VNY T A:(#SXF0<G*8/4\?3O[ .I?M$MX9U33/C
MUX0^&7A:/1[:QM= ?PEK-SJ)O0J2+.;CSHTV$;8=NW.=[YQ@4 ?)'_!J-N'[
M!'Q-^U _VP/B_P"(/[4SU^T>79Y]\8QU[YJ#]D)IS_P= ?M6#22/L/\ PK;2
M/MV<;?MF;/RLX[[?,Z^]=*O[&/[1W_!-K]JOXK>+?V9_"WP]^)7PS^->ICQ%
MJ'A+7=:;0[GPUK##$T\$@C9)+>3)8KPPX 'R@GV#_@E/_P $^_%?[*,WQ-^)
M?Q9U?0_$7QR^..M+K?BJ[TB-A8:=%&I2VTZV9P':&%2PW, 22.NT$@'@/_!J
MFTA_8L^,?VXJ=<_X71XA_M/^]YWE6>??&<XSWS3?V8&?_B*C_:,&FD?8/^%4
MZ5_:6>GVCS+'9T_BVYZ]MU=)??L9?M%_\$Z?VOOBIXY_9F\,?#_XD?#CXWWZ
M:]K'A#7M9.AS^'=9QMENK>41LCP2Y+,G##@ ?*"?6?\ @E;_ ,$_/%W[,.N_
M%+XK_%_5=!U_XY?''5X]4\1SZ.C?V?I%M"A2UTZV9P':.)"06(!8XZ[0Q /L
M&BBB@ K\Q?\ @ZR_Y,,^'?\ V530?YS5^G5?EM_P6=_8[_;(_P""BEH_@'PU
MX.^"EG\/?#?BZS\1:%JUUXENXM4O4M@Q19XO)9$W%VSM)Q@4 ?I+\9+N[L/A
M#XKGL 6OH-'NY+<9QF00.5_\>Q7XP?\ !N?^RY\;/VFO^"8-M-I?QXU[X+^%
M+/Q%JJZ7;>$=+LY]1U&\,X::YOI[J.3,8?")!$(\JA+.=V!^KG[&GB7X[^+?
M".M-\?/"7PZ\*ZPETJ:;!X2U:XU*WN+<I\S2M,B%7W9& ""*^,O@K^QS^U9_
MP2D^(_Q$\-?L_>%_AI\6/@GX[\03^(]!TS7_ !!+HE[X(N+@DS0$B-UFM@=N
M GSX3L2<@&U_P2__ &W_ (L_&SP+^T]\$/BUJ&G^(?BS^SY=76C)XCLK86J>
M(K:6WF^S7#Q*-J2YCRVW (=>,@DU/^#4#R?^'.'A7;N^U_\ "1ZU]NW=?/\
MMC[OTVU[A_P2E_X)[>(?V--!^(WC'XDZ]IGBGXR_&WQ WB7QC>Z9$T>G6SX8
M0V5JK?,8H5=P&8 L6Y& *\#^&7['G[5/_!+#XD_$S0OV=/"GPR^*/P>^(_B&
M?Q/HNF^(->DT:[\#WESS/$0$99[7<$VA#OP@'!R2 <G_ ,$ZFU#_ (>]?\%)
M!HF18?\ $M*_]A#[%-Z>^[WKOO\ @U-,)_X(\>%]N/M@\2:W]N]?/^VONS^&
MVO<O^"3/_!/?6/V%?A/XNU'QYKUAXM^+_P 6O$,_BSQOK-E&R6LMY+]VV@W
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M8O-4U[_@J#_P3)M/$L*1:?<^++R^NDSN1M30Z2R!@< %)"-IZ_.W'&*^DO\
M@XKL;'4?^"*OQ_CU (UNNAP2IN (\U+ZV>+KW\U4Q[XZ]*W_ /@K]_P3OU?]
MO?X)^%KWP+K%AX:^,'PC\1VWC/P)JUXK&V2_MV#?9IBOS"&;:@)&2K)&V" 5
M/SE^U'\'OVPO^"OOPTT/X'_$[X,^'/V>?AGJ&HVEW\0?$D'CBU\07&OV]K*L
MPM=.MK?#0K++'&VZX)*\ [MA\P ^PO\ @DY?ZCJG_!+K]G2XU92-0F^&OAYI
M222S_P#$M@VLV?XBN"?0DU] UG>#_".F?#_PCI6@Z)8V^F:-HEG%86%G NV*
MUMXD$<<:CLJHH 'H*T: "BBB@#\P/^#E_P#YLW_[+_X?_P#:E?I_7Y#_ /!6
MKX,?MM_MW_$GP%8:)^SCX0M?#7P9^)T/C'0]4_X6)9>;XDM[*618!)"X4V_G
M1E7/+%"<8.*_17]B?XG_ !F^*WPVU._^-WPNT;X3^);?4V@LM+TWQ)%KL5U:
M"*-EN#-&JA&,C2IL(R!&#_%0!\8W'_!./]KK]B_X[_'+XE_L[?$;X/>(;;XM
M>++KQE=^#O%V@7,)GD+$I:I>13<,4++N/EKNP25!)7Z0_P""2?\ P4KL/^"H
M/[,%SXQ;PY<>#/%OA?6;CPQXK\/S3"?^R]2MPC.J/@%XF21&!*@@EDY*%CP'
MQ4_;,_;8TGQ/XR\/^$_V,=)U5+6_NK3PSXKN?BKI,>EWMN)&%O>7%F=MT@*;
M&:$?,3E=R_>&M_P1(_X)J>(/^";'[,GB#3_'7B#3O$_Q,^)'B6Z\8>*[W3U(
MLH[N<(OD0$JC,BA-Q8JN7DDP NV@#YW_ .#60S:C\/?VJ]4U6-5\37_QRUK^
MTR1\^X10-@G&3B22;J>YZ9YB^.8?1_\ @[U^#!TA$#:K\%+D:WLXS&)M7V,V
M.K;HK=<'' 4UW-W^RK\>_P#@F'^VW\6OB/\ L]?"_1?C?\,/CU=QZ]KG@W_A
M);7PUJ?AO7%W"6YMYKG]Q+!.9'=U.'R0!@1CS.M_X)S?L$?$RY_;5^(W[6'[
M1%AX>T;XJ>-["+PYX;\)Z3>#4;;P/HL1'[HW7W9KB4HC,\8"C]X00)3'& >.
M?\$:GEUK_@N?_P %%=0UM%&O6VMZ%9VA8[G%B!>JF">0#%%:\ 8X'H,L_P""
MSH?2?^"Y?_!.F_T=$.N7.NZW:W9'RN;/_05;)') CEN3C&.O/)QZI^TY^QU\
M9/V4O^"DFH_M2?LZ>#-$^)__  L;08O#WQ%\ WFN1:%<ZD]N%%KJ5G=S9@65
M4CCC9) !A3C)E9HV?LR?L5_&+]J[_@H_IO[4W[2'A'0?AQ)\/="DT#X=_#VS
MUF/79=(><$W&I7=W%B!YV626-5C! !4Y!B5G /T&HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4>F.TFFV[,2S-$I)/))P* )Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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MH **** "BBB@ HHHH **** "BBB@ J.ZEDAC!CB,K$XQNQCWJ2B@"I]NN?\
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MR\$;3Q^E-_X6_!_T#K[_ +Y/^%?B_P#MD?\ !<GXB^,/V\/BU\)_"GQ$\,_
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M.OO^^#_A6711S :G_"WX/^@=??\ ?!_PH_X6_!_T#K[_ +X/^%9=%',!J?\
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M^>D?_?0H^U1?\](_^^A7G?V:/^Z*/LT?]T4<P'HGVJ+_ )Z1_P#?0H^U1?\
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M?8XO^>:?E1]CB_YYI^5',!WO]O67_/W;_P#?P4?V]9?\_=O_ -_!7!?8XO\
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M!-8\80ZEXVU1H5U7QI/]M*R!BUO; XAB'H O./4UXV;5'+EP<7\=W+RBM_\
MP)VCZ-OH?:<(X6-+VF;U5?V-E!/9U97Y7YJ"3F_-13T9TOA;PY;:%I=M9VD*
M6]I9QK%#&HP$4# %;0 ' %:<7@>]C0 2VGY-3O\ A"[[_GM:?^/4HI)61M.<
MI2<I.[>K?=F516K_ ,(7??\ /:T_\>H_X0N^_P">UI_X]3)N95%:O_"%WW_/
M:T_\>H_X0N]_Y[6G_CU 7,JBM7_A"[[_ )[6G_CU'_"%WW_/:T_\>H"YE45J
M_P#"%WW_ #VM/_'J/^$+O?\ GM:?^/4!<RJ*U?\ A"[[_GM:?^/4?\(7??\
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M?_\ 0'U'_O@4<K LT56\^_\ ^@/J/_? H\^__P"@/J/_ 'P*.5@6:*K>??\
M_0'U'_O@4>??_P#0'U'_ +X%'*P+-%5O/O\ _H#ZC_WP*//O_P#H#ZC_ -\"
MCE8%FBJWGW__ $!]1_[X%'GW_P#T!]1_[X%'*P+-%5O/O_\ H#ZC_P!\"CS[
M_P#Z ^H_]\"CE8%FBJWGW_\ T!]1_P"^!1Y]_P#] ?4?^^!1RL"S15;S[_\
MZ ^H_P#? H\^_P#^@/J/_? HY6!9HJMY]_\ ] ?4?^^!1Y]__P! ?4?^^!1R
ML"S15;S[_P#Z ^H_]\"CS[__ * ^H_\ ? HY6!9HJMY]_P#] ?4?^^!1Y]__
M - ?4?\ O@4<K LT56\^_P#^@/J/_? H\^__ .@/J/\ WP*.5@6:4=157S[_
M /Z ^H_]\"E%Q?@@_P!CZCQ_L"CE8&O\*>;/7!ZW3?\ H-==IG&FVX](E_D*
MY7X76-U::;JTES:S6IN)V=%D&&(V]:ZO3?\ D'6__7-?Y"J0$U%%%, HHHH
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M[6?QA^%?@GQ#\/\ P)X]^'3>&M)LM:M#HMYX@U%54EQ;G&T  C<W4F@#[O\
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M%7B:WT?4=7TP6U\Z2%EMWCE==RQG/#*0.<T >Q_M'_\ !7?X*?M6^+[CX)>
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M5_8ZKXJ\/:1:I%<7<:PIN8QC!E<'.0<FD7:+>A]=?!#_ (*/_#C]L7X'^/\
MQ#\+-=FN]2\':9<W$]I>VK6]U9R+"S1.T3?PD@8/>OGC]@S_ (+M?"_Q9\%/
MAKI/Q=^(VFI\5?%B2"^$5MLM[20RLL:3%1MC9AC _/%8'P(T?4OVEOVU_BU\
M8/!GPR\1?#[P OPSN?#4D6IZ<=.N=>U%H#L*V^!NV?=#8KXG\4_LZ:]\4?\
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ME\"OA+?>"=<AUCXXZ.VK6LLEQ&O]C[3S%*H!W-[J<5YG_P %>/VN/A[\4_\
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M*^?_ /@I)_P44\'_ /!,7]G@_$GQOI^L:EHPU"'3O)TV-7F\R4D*<,0,<5]
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M%O['7AV3XQ6>J6WCJREGL[J;484ANK^))"(KB1$)56=,$@=Q0!] T444 %!
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MXXH ^B/V=/VH?A[^UOX!;Q1\-/%FC^,O#JW#VAOM-D,D(E3&Y,D#D9%3:?\
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M^#_@W_P6@\%R^%/#.C>'Y==^'NJW>I2V-HL+WTIO$^>5@,NWN?6@#[9HHHH
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MP^#>H_LE0?!:6W\0GP7;^)CXL5!JD@N?MIN//SYO79O_ (>F.*Y#X+_M7/\
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MG_@D[XN\3?L/_%+PG\1/%>AZC\5?BAX@?Q;)JUA:,FFZ3J2,K6IBC;YBD90
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M: /QL^"_[46A^$/^"6I_9!UC3-2T?]H2#Q3_ ,(ROA7^SI/.G+7XG6]# ;3
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M?5*3M_,_Y8__ "3V7;?IKZN'G2P%#^U<4DTFU3B_MS75K^2&\GU=H+=M>D_
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M^+%[XB\)_M4_%^QT_6]>.O:UI2+;K!K,A<L4F;;N8$';UZ5]#?ML_L0?%/\
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MUJE^PWXYTNV_X*1_#Z3P_H>B> ]$\=>!=1U:/3+3Q:VJW6JQEE>"2ZB+E4D
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M[72[_6O">C:C8I<RK$+J!<AF0L1G;WQT% 'TL?\ @IAX*31[;6)K+4[/P_\
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M>6GFW!8*K$]% )(KZ.\3>+=-\%^%+[7-7O(-.TK3+9[R[N9V"QV\2*69V/8
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M_P %8O$%_P#%#X2V5WXF\._!KPK\1/!EGXCMM;UW1)=0L=0O99 LEA]H#+'
MRC."YYS72_MO_P#!3C4OA-^U#HOPET'Q=X<\'7)\)MXIO?$6H:+-J]O>Y.V*
M"&*$\!R"2Y/ (QF@#[AOO"NEZFL*W.FV%PML,1"6W1Q$/1<CC\*?:>'=/L%C
M6"PLX%B8N@CA50C'J1@<$^M?!?BK_@H]\:/&W[-7[/>I^ /#'AI/'?QAUJ;1
M;Y-:CF@M+)(@VZ[5#A]N%#A#R<X]ZVW_ ."C_C3]F/\ :.^+W@SXU+X=30?
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M\4RZ/9V,\$T]]XF@CN%B=BP8+!C=P><GM76?M!_\%4/B#X3_ &V?!'@"ZO=
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M%7/A=_P4R\7Z'XK^)'A?XQ?#$^"O%G@WPW+XQTRQTK4/[236M,3.0K #$ZD
M,N,#DC.*;^Q%_P %.=8_:!_9W\6_%SQMI/@71OA]H>F-K%M=^'/$/]KW*P*I
M=H[F(*#%,JCE?6@#UOX3?\$W_@9\#&NF\)_#'PGH;7^E/HEV;:R53=V;G+Q2
M?WP3USFL/X9?\$F/V=?@UXTTCQ)X7^%7A?1=?T*Y-U8:A;0%;FV<C&%?.=N#
M]WI[5X=^QE_P6FE_::^.^@^'M1T3P3:^'_B%87>H^$I=%\31ZEJ:QP1F3;J%
MLHS;LR#(Z@$X-9-C_P %J?B)XD_9V\6_&'2?@!JDWPU\"RW4&I7<NKH+R_\
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M'XS?M _L\>%=<_M'4/"W[/UG#KFI:W=@A-<U-8!#"D9SEB""[$],@5]L444
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M#_P1[^"WP5L_"&GZ5I_B.[\/^ [TZEH6B:EKES>Z9I]UDD3+!(Q3>"202.*
M/E_QQ_P4B^(EK??%7]G*P\3PVO[0-OX[MM&\*W,RKYDNCWSB2.Z4=#Y,0=2>
MW%?3?_!6'4_$WPS_ ."3OQ6DTG4;JY\0:=X2DAEOP2)I/D"32Y'0D;CQZUYG
M:_\ !./Q!\1/^"[%[^T-XB\.:'I?A#P?X5CTKP_=6\X>ZUJ]?AYITQE3$I(4
MYK[C\8>$-+^('A74=#UNQMM3TC5K=[6\M+A \5Q$ZE61@>H(.* /AW]FF\^
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M3-&=[#15F17432L0N0&&<>AKU_\ :A_X*??![]DG]FGP3\6_$MSKEWX*\?O
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M^DW<8)YQ7H'[4G_!7OX"_LB> _AMXK\4ZSK%SX6^*L!N=$U33HWGA\H#):0
MY&.F "<U^,GQB^$5A^SC^V]^T5\._C]KWQW\%^#_ (A:Q/J<%UX.T[[98>(H
M'<NBS*5)?J "#P1R*]Y^.?PG\,:OX)_X)Q:)X2T3QAJ_@"U\1RQQ1>)-.)N_
MLWVGK<HJ[4!/(! &*R@E*,5U;6OKNOD:5'RN7E?\-G\_N/U@_8/_ &TO!?\
MP4,^#]YXX\%Z7XHTS0[;49-/C_MB-K>:ZV=)47/^K8<@GFOST_;[_:O^/NM?
M\%L;#]GWX<_&B+X4^&-6TB.Z6[O(XY;>V?868DN1DMC'6OU^BT6Q\/O+:Z=9
M6=A:QN52*VA6*-0#@8"@#I7X)?\ !67Q7X*^$O\ P<-:=XO^*G@+7?''PXL-
M"A6_L[/3);I9F:)@N HPV&]#3@XN:OM_P/\ ,'?E?]=3]//@[XKUO]@;]CCQ
MCX\_:(^-=G\5;'0Y3>#7M/C6-8X@,"V01L5>1FP!SUK%_92_X+!> OVM-%\6
M7FF_#CXO^%SX6T*3Q$J:[I;P?VM:*I(:V()$A;' %>(:Q^U3^S#^TU_P2-^*
M&GZ1\)_B!H?P>T748--U+2+/2'AO[2>X.Y;VWB(RPC(#'%>0_P#!"+XR_$^_
M_;#\3?#3P7XG\=_%+]F[3O#\D5KKOC+16T^XTN?RB([>(N,CGC:.#UI<KDYI
M=%I]W7\/7U!M*,7YZ_>MOQOV/>_^";__  7*T/\ X*9_\+%\/+X"\5^ M3T*
MRO)K+4(Q+<6D<,<;'?+(<!)QC/E^M8__  3&_P""@?ASX5_\$ZOB3\7/B%\3
M?&_Q3T#POXI:SGU&^LOL]Y8JS%1"B;SN0'G)->*?\$._BY#^SOJG[3/P!\9>
M&/%6A_$/7]8UC5=/6729#:36XCE.?. P,@C [YXKP[]E3P;JR_\ !N/^T+I\
M^BZL+FY^($.+5K*7S9D,XSA-NYACK@5FYNUTMXQ?WO7_ "*EH[/I)K\/Z9]_
MZ1_P<K?LJZO\88_"IU/Q=::?/:M<0^(KFT:/3)W5-QB4EMY;^'(&,\5ZK_P3
MP_X*]_"/_@I5KGCG3/!>F>,=$O\ P#;&]OH-:C$4D]OS^]C"L3CCHV#R*^%/
M^"JOP&TBT_:O_8!TO2O!=LFBQ16:WMM:Z5^X7YHB1*%7'7D[J]P^$FF:W\+?
M^"UG[:FL>#_#"O?6?P\MY]'MELS#:7ERBDJBD *Q]AUQ6M1*$7)_WU_X#;6W
MGV(A>5O/E_\ )O,[OP;_ ,' WP/U_P".>A>"=<\)?%KP+#XJO38:)KWB'27M
M=,U23?L!C8MN*EN <=Q6'\6_^"_7A#X/?\%&+SX$WOPO^(6H66GJ()M6L;:6
M:ZDN20 8X!]ZWY'[S-?C/^T#\9?'7[1-K\)?'GC#6?C;XQ\0^%O%@G\56>J:
M.ZZ)X7_TE2D%D%4$DJIR/;'6OU1_:U_:7TC]BK_@NO\ #KXU^,?#'BB[^&_C
MGX=VVFV.IZ;I+W;1S.%(WQ@9##<,@X(_"B"7-#F[M/\ \!NM?Z_S<[J,FNR?
MIK9_YGT+^V3_ ,%P_@A^QI\3I/!MWIWCOQUXCTRT2_URU\+V;7@\.V[*&WW3
M9PN >0.G>O0_VD_^"GOP6_9<_9)\-_&C7=6U/4?"/C%(CH<>F!I[O4GD7<(U
M7. PZ')P#7XQ?'SX':I^R%_P5$^+NK_%KQ!\:/ 7PW^,L,M[IGB7P/8&[&JV
MTX$@MYU*G(VMM*<$$5]+?&+P#^S;<_\ !%#X2>%O&%I\<;?X=/KUR/#>OKI7
MFZ[HDH8D32VZKCRF[*0*F,;TW+KI^=FO\KER:511Z:_E=/\ .]C]!_V!_P#@
MHKX3_P""@-UKUIH_@7XF^!;_ ,/0Q7$UMXKL'LGGBDY1XCDA@1SQ7TA_8=OZ
M3?\ ?YO\:_)W_@W(_:*^-7Q-^,_Q,\+:YK7B_P =?!#PW;+%X7\3^)M+:SO9
M61@J1 L V-G5.0,5^MM55CRVMU1E!O6Y4_L.W])O^_S?XT?V';^DW_?YO\:M
MT5E<LJ?V';^DW_?YO\:/[#M_2;_O\W^-6Z*+@5/[#M_2;_O\W^-']AV_I-_W
M^;_&K=%%P*G]AV_I-_W^;_&C^P[?TF_[_-_C5NBBX%3^P[?TF_[_ #?XT?V'
M;^DW_?YO\:MT47 J?V';^DW_ '^;_&C^P[?TF_[_ #?XU;HHN!4_L.W])O\
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M11D<C\Z^-/VU_%UK_P $XO\ @B3\._%7PH^'_A"QUK4;72+6ZOY]"CNX[%9
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MINVYQ3%U#2(XA&MO;K&#N""S^4'UQMQGWKU7[+"20(HB1_LBC[)%_P \H_\
MOD46 \O.N:<95D(!D48#_9SN4>@.,@41:[I\$C/&!&[\LRVY5F^I R?QKU#[
M)%_SRC_[Y%'V2+_GE'_WR*.4#RI;_1X[IKA;:W6X;DRBSQ(??=MS3Y]6TNZE
M226..62/E'>U+,GT)&17J7V2+_GE'_WR*/LD7_/*/_OD46 \KO-2TG42IN8(
M;DI]TRVGF%?H2M..L:80@,<9$7W/]%/[O_=^7C\*]2^R1?\ /*/_ +Y%'V2+
M_GE'_P!\BBP'F/\ PDEG_P ])/\ OT_^%13:GI-RY>6&&9S_ !26>]OS*UZG
M]DB_YY1_]\BC[)%_SRC_ .^11R@>6)JNE1Q-&L42QO\ >1;3"M]0%P:6TU?2
M]/B,=M'';1DY*PVIC!/K@"O2]5N+/1-+N;VY6*.VLXFFE?8#M1023^ !KXC\
M*?\ !Q+^R1XX^(%EX8TKQW=WNKZCJ*Z7!''H-VR/<,^P+O$>T?-W)Q1R@?2!
MU72S<F<Q1F=A@R_93O(]"V,D4JZMI:1&-8HEC8Y*"TPA/J1MP:]2^RP@@>5%
MD_[(JK/J&FVNJ06,L]C'>W*EX;=G1990.I53R0.^.E%@N><2:SILK(SHCM']
MTM;%BGT)''X4JZ[IZ2M(H"R,,,XMR&;V)QD_C47P4_;!\ ?M ?&7Q_X"\-SW
ML_B+X9W,5KKD<^G201122+E1&[ +(,=UKU7[)%_SRC_[Y%%@/*?MFC>4\?V6
MV\N1MS)]B^5CZD;>3[T^YU/2KQ46>&*=8ON"2T+A/IE>/PKU/[+">D49_P"
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M2?\ ?I_\*/\ A)+/_GI)_P!^G_PKT[[)%_SRC_[Y%-FBM[:%Y)%ACCC4LS,
M%4 <DGL*.4#S/_A)+/\ YZ2?]^G_ ,*/^$DL_P#GI)_WZ?\ PKYD^(G_  <8
M?LD?#;XAZKX:NO'%[J-[HMT;.[GTS0KF]M(Y0<,OG1H5.#U(->^?"_\ ;U^&
MWQA_::U#X3Z'/=W'BG3O#UKXG?=9E(&LK@ Q.'/<@C@C(HY0-_\ X22S_P">
MDG_?I_\ "C_A)+/_ )Z2?]^G_P *H?MA_MJ_#K]A;P7H^O\ Q"GO[/3M<U.+
M2+1K+39+UVN)" H*Q@E1D]3Q7DG[6'_!;S]FG]B_XDKX0\;>,77Q(MLEW<6.
MF:7-J$MC&X#+YPB4^62"#AN:.4#VK_A)+/\ YZ2?]^G_ ,*/^$DL_P#GI)_W
MZ?\ PKK_ (6?$+0?C-\.=$\6>'I4O-#\0VD=]93M"8S+$XRI*L 0<=CS6_\
M9(O^>4?_ 'R*.4#S'_A)+/\ YZ2?]^G_ ,*/^$DL_P#GI)_WZ?\ PKT[[)%_
MSRC_ .^11]EASCRHL_[HHY0/,?\ A)+/_GI)_P!^G_PH_P"$DL_^>DG_ 'Z?
M_"O3C:PCDQ1@#_9%(]O"JY\J+)Z?*.:.4#YI_:=_:&M_A'\/)9M.)N=?U-Q9
M:3;&-LS7#\ X]%^\?I7DOPA\)VO@;P[Y,]S+>:K>R&[U*\>-B]W<-RS$XZ9X
M [ 5UVLZJGQ__:DUG7F2.30? 9;1M)3:-DEV1^_F],K]RO2[/3X88@!%'G_=
M%?,QJ?6:\L0_AC>,?1:2E\VK+R2[L_2W0_LW 0RZ.E2:4ZO>[5X0](1=VOYY
M._PH\]CUFTB4 .__ '[;_"G?V]:_WW_[]M_A6O\ ';XV>$OV:?A7JGC7QI?1
MZ1X:T90UW=>09?+!.!\HY//I7E'[-?\ P5._9_\ VN/&T7AKP+XYLM0\07"E
MH+"ZLWLY[D 9_=K(!OX]*Z[GFI.U['H']O6O]]_^_;?X4?V]:_WW_P"_;?X5
MZ.UBB$!H8P3V*C)I18*3@0QY'7Y1Q]?2@5SS?^WK7^^__?MO\*/[>M?[[_\
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ME]-P^;%<]&I]6Q2G]FH[/RE]E_/X7_V[V.[%T/[2RN5)ZU<.G*#ZNG>\X?\
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M,\<>'=4T;QQKG_"-Z-=6B&6.[U#&?L_ ^5\>N*.4#M/^$BL/^?RW_P"^J/\
MA(K#_G\M_P#OJNT\9:KH'P^\*:CKFLFRL-*TJ![J[N)(QLAC499CQT KQG5/
M^"C_ .SQH/P+TGXE:A\1?!^G^"M>F>VT[4KF01)?2(<.D:D;F(/7 HY0.R_X
M2*P_Y_+?_OJC_A(K#_G\M_\ OJG?LV_M,?"W]K[PA<Z_\-?$>@^+M)L[@VL]
MQ8X9890,E&! (.*]$_L2R_Y]+?\ []BCE \Y_P"$BL/^?RW_ .^J/^$BL/\
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MLU>(OA'XL\<Z7\1O"VJ^&O T:2ZY<V@,C:<CG"LZ;=P!/3BO=? /B/P[\3O
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MB_X)<? WQ'^T%X6^*1\#66G^.?!L$-KI>I:?-):/!#""L<16-@K( 2-I!&*
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MOB?7O&4OA^V\A]9UJ42WU^<DEY6'!;)KA?&__!,?X&_$'QA\.==U+P!I)O\
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M>1Z?J$@  ,D DV'H.  * /S^^(_[7NK_ /!6S]O?]G#X3:1XH\5?![X3>)O
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MLZ?LU?$?PYXO\'?#JQTSQ/X5BD@T[4FN9IIXHW4JR$NQW#:2 #P!TK"\2_\
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MG64(0'^48R1D5P9I7E1PE2</BM9>KT7XM'O<+X*GB\VP]&M\',G+_#'WI?\
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M^!'@BT^-GC3X@:!XL\&R:SJFDZGK)O(;2X:$-G;DX5B<@-R*_5<=!7P]X/\
M^"3NF_ +_@HY\+?B+\-=$TO1/ WA;1;NQU?S+N26^N)9%Q'C>3N51QUX%?<(
MX 'I0A3:=@8;@0>]>1_M.6\WAKP]IOBZR5_[0\%:C%JB%!\QA#!9E_%#7KE8
M?C[08_$?AO4+&10T=[:R0D?[RD#]:PQ='VM&5-;M:>3Z/Y.S.W*<8L+C*=>2
MO%-77>+TDOG%M?,^@/"FO0^)_#MEJ%NP>"]@2>,@Y!5E##^=:%>*?L ^*F\1
M_LR^'H99FGN-($NERN1@EH'*U[77MX/$>WH0K+[23^]'Q&;X!X''5L&]?9SE
M'ULVK_,****Z3S@HHHH *9=6L5]:RP31I+#,I1T895U(P01W!%/HH _%;_@H
MY^S+\.= _P"#AG]DKP_8^!?"EIH>L0W#7]A%ID*6UX0'(,B!=K<^HKT/_@I#
M\=O$WP^_X*-_"S]E_P"%<_C#X7^"-3T"]\1:@GP\TRV74=4N<$QI$K[%"@@;
M\'-?=GQG_P""='P\^.O[8'P\^-VN1ZJ?&OPS5UT=H;DI;X8'/F)CYNIK+_;=
M_P""77PT_;P\9>$O%'BAO$&B^+O [.='UW0=0>PO[56.63S%ZJ3S@T ?EY^V
M#^W=^V1^S_\ \$OOA\_BN^\0_#KXJW'Q(_X1FVU74;>!;G6]-=L6\\J(64'!
M ;N3FNX_;KUC]JS]BR/]G'X;^&_VA=7U_P >_&+Q5+'J&O:I90M#:K)&I,2Q
M[<&*/)*CO7VMXZ_X(G_"SXJ_!_2_!OBS7?B!XHM-)\31>*X;S4]<DN+S[7'C
M:-[#B/C[HP*]8_:)_8(\!_M._$_X8^+O$T6HOJ_PEU#^TM",%P8T67:%^<8^
M88'2@#\0](^/W[8GB#XD?M<?#9/VF=>CM?V;]/G\0C4_L,0O-8EC(Q"&QF.(
MDG*CC@5^Y?[ WQ,UCXS?L4_"SQ9X@N3>ZYXA\,V-]?3D &:9X5+-@>IYKS#2
MO^".OP@T?XC?'/Q3##K@U3]H.PDTWQ43>DHT3G+>4,?(?>OH/X)?"+2?@%\(
MO#?@G05G71?"VGPZ99"9]\@BB4*NX]S@=: .HHHHH **** "BBB@ HHHH *_
M"#_@XRTS7=6_X+7_ ++\'ACPEH'CGQ!+9E;'0M:;98:G)YQQ%,V#A3]*_=^O
ME/\ ;A_X(^_"S]O?XU^%?B%XNNO%6F^*_!L!@TJ]T;4FLWMP6W;@0/O9[T >
M&_M5V/[3GPZ_X)802?#?X7:'\-/B.^N)+XAT#X=R1330:;O_ 'TMD64*T[*/
M3->)^.OVA-*_:(_X(@?M*GP1\:/C'J7B#P5:M+JL?BVV2RU_1)412]C)@9\I
MSGYA@^A%?=FE_P#!+K0-)^#\WA!/B/\ %IU;5$U:'57\1R-J-M*JXVI+CA".
MJGBF_"'_ ()'_"7X2?!#XH^!5@UK7K/XR223>++_ %6],]]JCLFW+28&,#IB
M@#\WO%WB7Q]^S+_P2V_8RU!OB!K'C"Z\=^-]#,KZY;PW)L+:7&;>$E<A1V8D
MM[UZ3^VG\2_VF?C?_P %*/C]X ^'?QKO/AK\/OAGX%MO$<L=O9QS7+SF)F$<
M3,,H&8?,0>E?5?AG_@AO\(_#_P $?!?P^GU7QSJ_AOX?^([?Q-H4-_K#3-83
MPG*1J2/]5G^"O8)?V _ 4WQS^)/Q#,6H_P#"0?%30H_#NMG[0?*:UC4JH1<?
M*V">: /Q7_9V_;<_:]UCX6?LO_&WQ3\<KC4]#\?>/AX/?PY#8QQ1W-JLFQI9
MV ^>1B#R>U>U_P#!3K]M[Q-H-[\6/B%\&/CG\:==U#X;^)[2RN;/3=)MU\':
M%NF1'L9I6(>1OO98 \G%?>GA;_@B[\&_"/P'^&/PZM(=?/A_X2^(F\3Z%OOB
MTRW9?>3(V/F7/:N'^(__  ;P? +XCZQXXDED\;Z9I'Q!U$ZQJVBV&NRP:=)>
MEMWV@1#C>&Y&<C- 'S3^VQX<\:_$_P#X+R_LH16GQ/\ &'AJW\4^#GU6:UT^
M1$AMFB5&EC1",$2DG=N!([8KR_QO^W/^TQ^W5\=/VD;GX8ZW\6=(USX-Z[%I
M'@SPSX5T^VETNX,<F)#J+2.K$R!201D &OTE^*W_  1[^&GQA\1?"+7]5U?Q
MJGBKX+6Z6>@Z[;ZLT5^\*D$1S.!^\4X .>HJG\6O^"+WPK^(OQ\U_P")6BZM
MXY^'OBCQ:BKKLOA;6I-/BU=@,>9,B\%\=Z /I/X(Z[KOB;X.^%M0\3Z=+I/B
M.\TNWEU2SDQOM[DQKYJG;QP^>E=161X \&6WP[\%:7H5I-=W-MI-LEM'+=2F
M6:0*,;G<\LQ[DUKT %%%% 'YP?\ !?W_ ()Q_%K]K^3X3_$7X+QZ!J_C7X1Z
MG+>QZ)K:I)9Z@C@9.R0%&8%< ,.<]:_//]N[]MO2_P!J7_@D_JD'A7PW<? ;
MXH^"/B/I^G?$31/#\$=G:ZA?R.(_/W1XW#(W 'H1@Y%?MY^UI^PYI7[6FMZ#
MJ5WXS\?^#[[P_'+%#+X:UAK'SED^\)  0WMGI7BUO_P0$_9XA_9?\3?"Q]%U
MJ?3O&.J1:WJ^KRZB[ZK>WL;%DG:<\[@2>@Q0!\\_M*?$;XN:W^UK^S!^R;X6
M^,?BGPI%K/A=_$WB7Q@/*&K:O%$@"VZ';M#?AR.N:P?^#<[PGJ'@3_@H'^VI
MHVJ^(KGQ;J&F^)+2";6+@*)K\A7P[[?EW8P#CN#7UU\:?^")WPH^/'A#X;66
MN:KXY77?A5$UOH?B6UUEX=92%O\ EF]PHW,H'0'I76?L"?\ !*CX7_\ !.'Q
M!XTU3X>C7VO/'LT4^JR:GJ#7;2R(#\P+<@DDD^I- 'P=_P '&6EZ_K'_  4-
M_8^M_"WA#P_X]\12ZO="QT#7'\O3]3?;_JYFP<+WS@]*Z;_@HK\;/C5^P]_P
M1^O/%ND^#/ _P!^*=_XIM+5[+P<R361624(KE]H!+=\BOM#]N;_@EW\//V_/
M&?@KQ%XNO?$^E:[X EDGT:^T746LYK9WZMN SFN.\0?\$6?AQX\^".N^ /%?
MBOXD^+]!UW4;34Y!K&O/=2VTUL^Y#$S#Y03U ZT@/C7]NSQQ^U9^Q!_P3\^%
M%S%\<[KQ'\7OBMXUT^"35)+.**ST];F(8MD3&/*!()R.2*M_M"?%3]H/X8?M
M3?LY?LA7GQLU]M;^)"7&O^+_ ![;6T4.H7"9)^QV@(*QHI'!'..M?HK^TY^P
M/X#_ &M/!_@/0_%D6HR6/P[U6UUC21;W!C99[=0L9<X^88'([UG_ +9/_!-_
MX<?MN:IX3UCQ/#JNE^*_ LYN-!\0Z/=M9ZEIK$88)(O\)[@\4P/R;^/_ /P4
MI^/?[('PT_;&^#C_ !)UKQ1KOP6;3M0\+>,[F%!J$-M<2KO@G8#:S8; -??O
M_!"K0OC!XS_91T/XL_%SXM:K\0]1^)NE6^H6NG30)%:Z(F2 J;0,L0/F)ZUM
MG_@AI\$;K]GOXC_#^^B\2:F/BS=17GBC7KO4FEUC5)(F#1[IR,@+C@ 8KZ3_
M &<O@+H/[+OP,\+_  ]\+I<IX?\ "-@FG6 N)/,E$29QN;N>>M ':T,2 2!D
MT44 ?D)_P1R^$W@']J7_ (*)?M6>*/C)I&D>+/C3X:\8&PTZ#7H5N)]+TA5(
MB,$;@A4[;E%:'_!PU\#%^'>B?LT^'_@_9Z!X U[6/BO#/87-K81I;6U])'C[
M2\8&UF'4Y'.*^K/VDO\ @BA\(_VBOVF6^,$=[XS\#?$.XB6&ZU;POJ[Z?)>A
M1@>:%X8XXYZUJP_\$AOAK=^$_ ^EZSJWC7Q)+X!\6?\ "9Z??:KJ[W-W)?XQ
MF1VZI@?=&!0!\5?!KX[?&WX!?M-?M;_ _P =_%;4?BK;>#OAJGBW3=4U6SB2
M2VNYD.]%0#;Y0/1<8QBOGKX??L9?&C_@IQ_P2D_9V^.'@*X\.Z_\3/A+K6H7
MB>'=2LXH].UJ+S_NB,#R]X Q@CYL]0>:_8+7?^":GPW\1?M"?$OXF7,6K-XD
M^*WAE/"FMD71$)LU! $:X^5^>M>9>'?^"'OPT^'_ ,'_  9X*\(>+_BAX-TO
MP.MTEC)H_B&2VEF6X;=()2!A^>A(XH _/GQQ_P %O=9L/^":^MR_#GX>Z'\"
M_C7J/Q$MO 7BL:=:1I;:7=R@;[M!C!8KD#.=I'4U[;X4\;?&K]D'_@JE\./A
M+J?QV\5_$CPGXI^&FJ>)+BWUA83/;WD,)(;<B@E=_P RAN@%?2?A[_@@3^SQ
MH?[+'BCX3S:'J^IZ/XOU9=>U+4[S4'EU26_4_)<B?J'7)P1ZUX;\/?\ @C#?
M_LT?\%@/AEXZ\(V?B;Q+\.K?P7J.D>)-<U_6S?7/G2+Y<4.'.[;Y?'RC H ^
M9/AU_P %6OC;<_\ !$'X@_$C4/B1=#Q_8_%8>'],U"8QK.;7[0@,"+CYAM)Z
M#.*^DO\ @J3^U+J,DNK:=X*^+OQDL_B1X)^'T/B.Y\.^"M-@EL=-=XA(EYJ,
MLA&$<Y&T9X[5W]S_ ,&P_P"S%='4HWLO&1LKW5/[8M[+^W)?LNG7)?>SPQ_=
M!/0Y!XXKU/\ :)_X(I?"']H_XKZGXQU&Z\8Z)JWB'08/#>N+H^L26D.MV4*!
M(X[A5X;:H'IG% 'YL?M=?\%2/VDO%O[&'[$.L>#_ (@-X4\;?&:ZFTW6;Z"W
M3RKM_,2)970@C@$M@=37L7[;/C[XZ?LS?'7]G/\ 9ID^,_Q.UV?QQ#J>M>(_
M%&A:?;OKVJ&,Y2VMU<JJHI]P<>M?4>B?\$!_@EI'@CX6>'9+SQG?:7\'-9DU
MOPS'<ZJ7-G([!C&3CF,%00M>K?MT_P#!,/X:?\% M5\)ZMXQ77=-\1^!YFGT
M36M%OWL;^Q+?>"R+S@GM0!PW_!&+QG^T#XB^ 7B73?V@]'UZRUC0-?GL] U#
M6H(H;_6-,ZQ33+&Q7>!P3U-?8=>3_LG?LD:9^R5X=UC3].\2^,?%+ZW=B[GN
MO$6J/?SJP7:%1F^ZN.PKUB@#F_C*,_"#Q6",@Z/=_P#HAZ_FQ_8X_P"">OQ,
M_P""E'[$/PP\%^!?@QX9T+3M"\?7FJZI\4KV[BCNIH%NCNAB55\S@=B3D@8Q
M7],WB'1(/$V@7VFW(8VVH6\EM*%.#L=2IQ^!->8?L3_L7>#?V"/@9;?#WP(F
MH)X?M;R>]07DYGE\R9R[_,>V3Q0!^3W[)GQG_:1_:A_X*Y?%_P"$\'QSUWP]
M\-O@=-%=-96UM&\NIQ6Z*JVP8C*HY!+'.<&O-]:_;)_:C^)?[ 7QC_:ZL/C_
M 'N@7W@?QC/IFD>$(XX!I<=E#<>6\<L97+2MQM!ZC-?KU^SW_P $POAC^S3^
MU1\2/C!X<@U4^+?BE_R&S<W1EMV&02$3'RCBO#O&'_!N!^SOXPUGQ$'3QI8^
M&?%FKC7-6\,6FMRQ:1>708MO:$>Y/0]Z /A+XQS?$G]O/_@KG^RUK'A;QO+\
M,O&/COX.QZEJ>N:?;))-:JREI1 K@@,S=/0&O=O^"1_QL^,7[=OPI_:'^"7C
M_P"+_B2SUWX1>)UL=)\?Z68X+]8T9B!(Q&UQ\OS!NV:^MOCA_P $5/A!\:?B
MIX-\9Q7'BWPCKW@#08_#F@S^']5>R_L^S0855QU..,FK7@'_ ((P?!;X9_LL
M>(?A)HUIXAL= \8ZDNJ^(;V'5)8]3UN8-N)FN%(8ALD$#'!H ^</V!?^"L_Q
M.@_;1U']G3QG!8?'NUT65H(_B3X'B+Q6H!X74DP(4D'0F)CZX->9VO@CPS^T
M3_P=2^+]$^*UA8^(+3PQX*AN/"6F:NJSVR28!,D4;_*6 +'@=J_4_P#9Q_9=
M\ ?LD?#:S\(_#KPMI7A;0;)<)!9PA3(>[._WG8]V8DUXU^V;_P $A_A'^VQ\
M6M'^(>N0Z_X;^(FA(L-IXE\.ZD]AJ*1+G;&77AE&3U'>@#P7_@X$_9Y\!?![
M_@DM\=]9\*>$/#GAS5M?T^W74KG3K&.VEO524;!(4 W =LU\H?\ !.+XV?M%
M_LW_ +>?[*7P^\<_%>;Q9X3^+GP^^W-X?2V2.QT>".#,$<8 &6"A<MU)S7Z#
M7'_!$WX9^(/A+X_\(>)/%'Q*\76?Q(M(K'5;G6/$$ES.L4;;E$1/$9SW S7:
MV'_!+'X7:=\=OA-\1(X-7/B+X,Z$/#WAYC=DQK;>7LQ(N/G;'>@#X$\#?LZ>
M._\ @KA_P1M^./@2RU73K?Q;#\3=4?1R\26UM<&TNPT<$NT8*L."2#[YKB_V
M:/\ @I'XA_8J^&7QD^'OQ3^$'A3P#^U%\,/ ,MYI>N:)IMNEMK^GPJ/+9FC&
M,H2&QC#8Z"OTETW_ ()4?#_PQ^SKKGPU\/ZQXS\-:5KWB:;Q9->Z9JK6]_%>
MRR>8Y24#(0G^'IBN9^&'_!$7X+>!O$WC;Q#K<?B7Q]XI\?:1)H6J:SXEU-[V
M\-DZ[6A1C@*,8Z#M2 _.'X7?M+_M'_#SX4?L:_%'5OVB=>\2+^T+XM@@UWPY
M<1P&%(7=N(2 &" ###H">U?N_7Y"_M#_ /!O)I7P ^*?[.FL? W2_%7B&/P3
MX[M[S5?[7UXSQ:)I2Y9Q#'(0 N_G"C)K]>J8!1110 'H:1/N#Z4IZ&D3[@^E
M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWA;2MHE*)&J_O;DQD*,#AFXZ5]/_ +??['/Q(_;(_;I^!FES@']GWP4\FO\
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M9I[6*20D8)8H"?UK\_?V_?\ @B;X3\0_LX>.[?X1Z5XAMO&7C;Q!;:WJ,?\
MPD=TL.H2_:5>:1U9RI(3...,#&*^]/AGX2C\!?#O0]%C-PR:78PVP,TS32?*
M@!W.Q)8Y[F@#<HHHH **** "BBB@ KF?C3\3+;X+_"'Q/XNO(FFMO#.EW&IR
M1@X,@BC9]N>V<8_&NFKG?B[\.+/XP_"OQ'X4U LMEXDTVXTV9AR566-D)'N,
MY_"@#\UK/]JKXP?"#]E_X0?M/ZUX_P!7UW3OB!XCMTUWPC*B#3H-,OYC'!';
MJ!E)805.[/S<YK[C_P""@7[44W[('[$WQ#^)]A9KJ%]X7T66]L;=Q\LTY 6(
M-[;F7-?%.E?L7?&3XI?LY_!_]FOQ%X-;2/"_PX\1V]SK7BMKZ.2UU+3;*8R6
MX@0?.99!L!!P%P>37T'^TG\'OBK^V_X)_: ^"_B;PSHOACX?ZQH0L?!OB&*Z
M:6XN[AER&EC_ ( C!>10!XW\*OB-\</@#%^S/\1/&WQ,U7Q58_&*YM]*\7Z#
M<VR?9K.YO8S+!+:A0/*6/A2HX(YJM^W_ *[X]^&W_!2;X0I?>./[1\.>*M2F
M72]$6S2)=*14VO\ O -TC-_M=*O_  <^"/Q[^+DG[-G@#X@> [?0=#^"-S%J
M/B?7Y=26:/6KFSB,5L+55&XJ_#,6QCI7-_\ !4B#XA>-?^"@7P?U#0/AY=ZM
M;^ ;B>]B;[='$-8B? =H\_<*'L>M>/G?^[Q7]^'_ *4CZ_@BW]HS;Z4:_P#Z
M:F?8\2>6I4= 3BG55T2]FU+2+:YN+9[.XN(Q));LP8P,1DH2.N.F:M5F=(44
M44 %%%% #+FX2SM)IY,^7;QM*WT523_*OS/\,?M!_M ?M*?LJ_$S]HSPY\1/
M^$8M/"GB"Y7P]X66U1[&;3K*7RYX[C(R\DF"5;M7Z8SP)=V\L,@)CGC:-OHP
M(/\ .OS5T/\ 9*_:'^ /[+WQ-_9Y\)>%M*UK0_&/B*>?0?%,FH+'!I^FW<OF
M7 G3&[S5Y"@ BDRXGWYX/^*+^+OV>].\;16F)M0\/+K*VPY^<P;]GYBOS3\8
M?MM?%?X9?L.^%OVDU^-5EK6I:IXK%MJ7A"1(19M9O<F(V440^99D7DL>:_0/
MX:Z?XV^&'C/PYX#@T#3;OX;Z#X0BA.M&;%S)J$:A?(V?W&&3GWKXJ_:>_P""
M:-S^UEK&B^&?"7P3T[X4:9>^(UU;Q9KEW>+(CPQR[R+.)"0)92,EL*<&AA"U
M]3O(?VB?B/\ MS_M6_%;PMX*\9W_ ,.O"OPK\,V][:-8QJUQJ&IS0^<#,QZQ
M+]W9WS7&_'K_ (*?>(=>_9A^ =U;^+Q\-[[XBW-S#XCUN"P^V76RR8QSI:0@
M',LKCY0.F:[_ %#]F'XE?L?_ +7'Q7\9?#;PHGC;PM\5_#<&G06J7:P3:3J,
M,7E+)+NX,17!)&3QTJAXC_8-\:?L_P#P\_9KUGPAX7TGQ[KWP=O+BXUS2)YQ
M&;G[82UP]NS@@NCL<9QG%+4>G]>G^9)I_P#P4-\,_!_]A+XM?%+PA\2_$OQ6
MN/#LD=K;:=XCMA;W^A7L@\N.*6,@,%9R&^:M#X3_ !1^*/[/7CG]G_4/B!XX
MU/Q?%\;;9[/6M,FB18-*OWC\V*2WP/D11\I7O7%Z7_P3 \7_ +1]C^U)K/C#
M3-.\"O\ &_R?^$>TE)1))82VXS%<W!7Y0Y<#(&>*[OX,? [XL_&#QO\  .P^
M)?A)?#UC\#;.2;4=5^W+.NO7Z1^5"85'/ED?,2V#VQ0%E_7H?;3 JQ![4E*S
M%F)/4TE49A4%\/E4\94@_K4]17O^H[]10F*2T,O_ ()].-,T/QEI:!A'8^)+
MAADY'[SYSBOHVOG#]@\@ZC\0L$'_ (J)O_0*^CZZ<F5L'!+I=?<VCS^,O^1S
M7;Z\K?JX1;_%A1117IGS 4444 %!. 310>AH _,S]B/_ (+,1?#[]F_XL>/_
M -H+Q'=3:7H/Q:O_  5H\MEIIEE1!)M@AV1C)],GFOI'2/\ @JKX/\5:'\0H
M].\*_$"T\4> =#_X2!M#U+1&M[S4+1E)BGA7<=T;$<\@@=J_-P?\$Z?C8?V0
M-=T&3X;ZS+J=Y^TRGBY+,M"6DTC[2&-WRV/+V\XZ^U??_CGX >,=>_X*#_%G
M7[70KD>']>^%@T+3M1+*L$UX2_[D<Y!&1VQS0!?\"?\ !7SP(W[+G@?X@>--
M*\3>&-4\=20V>E:#_9CO?ZS=N"?*LXLDS*,?>R!6O8?\%>O@T_P0^(WCG4K[
M7]!MOA),EOXNTG4=,>'5=$D;&U9(,DG=G(()R*_/?]JC]BWXQ?M;_L,_ +5-
M*^%GC71_&O[->LB'4_"][>1V%WXAMBNR6:PN8I."%&Y22IYQ6SXT_8EE\:?\
M$\OVG]+^%OP"^,?A;QI\08--:8^,]4CO-1\3SI(I8)F5\", C+,,B@#[GU'_
M (*]_"_1OA#HGC6^TGQ_9Z9XNU"'3?#%K+H+B_\ $\LJ;U-I!NW.NWDD[<5T
MOC3_ (*1>"_AM\,O#_B#Q%X?\>Z-J'BO5/[&T?P[/HK?VUJ5UC.R*W#'<,<[
ML@5X1^W;\*?BE\/_ (4_LP?$7X?_  [;X@^(/@M<6SZMX51XX[F6"6Q2WF:$
ML0HFB()!SU%>0_\ !2GP1\8/^"BGP8^'/Q.TCX&_$'P]JGPG\:_:)/"$^LQ6
M&MZSISQ[9+FWFA;$3KGA=V3B@#ZSU?\ X+#?!;PQ^SKXL^)6M:AKNC:5X#U:
M+0O$>G76F.NJ:/>R,%2*6W!)!)(P02"*UO@]_P %/? GQB^)Q\'PZ#X^T'7[
MO2)->TBVUC0VM&UZS106>URQWM@CY3@\BORK_;J^"^@_!K_@D]\==;\.?!CX
MH_#:]\1>,/#=[=3>.=76]O\ Q/<)<KTQ(^T*?DW$\Y!K[>_9RUSXE?ME?MU?
M"KQAKGP;\4_"_P '?"7PE<(U_KLD EU6^NX$C\F 1.VZ%%&[<<9ST'2@#WO_
M ()]?M[G]N#P!+JDW@KQ5X5NX+N[@8WVGM%:2+#</$-DA8[F(4$KV.17T57Q
M[_P2EU_QM\/O#OB3X5>-/AEXL\+7'AC6]2NK77KGR9-*UFWFNY)8WA=7WABK
M\J5&,=:^PJ "BBB@ KY3_P""I/[4OB?X+:-\-_ ?@34$T;QK\8?$T/AVRU0Q
MK*=*A^_/.JMP7"#"YXR:Z[]JO_@G/X+_ &O?'-AX@\1ZYX\TR\T^T^QQQZ)X
MBN=.@9-V[+)$P#-GN>:\$_;6_P"">-[\(?@W\)?$'PNLO$_C;5?@9XN3Q+'I
M=[J+7VI:M;/\EQ%'+,V2X4Y52P!(Q0!T/[ O[4_C70OVYOB[^S1\1_$4WC/5
MO ME:>(] U^:W6&YOM-N>-DX3"^8C@\@<@UZ;_P4:U.3PE\-M,\0WOQX?X#>
M&M)N&_M+4UMH)!>%E(2,M*IVX/.%Y/2OF3X%^ ?BM%\?_P!HO]L9?A=X@M_$
MVM>';?P_X'\!:E)';ZEJ5O:?-OG"LRQO(Y.!N/ KV+XX_M.>)-8_9M^'MQ\1
M_P!EWQ3X]_X32P>X\0^'-.BM=1/ARX5?EBECF8!]Q.-P/% %3_@FI^V=JMU_
MP3JU7XI?%[QG;Z_H'A^^U&2T\7&U6W77-*ADQ#=>6O\ $XR  ,DBN:_X)@?M
M[?%+]LG]LKXM#Q9HESX5^':Z39:IX'TF[@$=XUC(Y47<W\2M*/F"GH*P/V#/
M^"=5Y\9/^"<GB#X>_$3PQK_PA\/>)/&EUXAT7PI;7RR7'AZQ$RR6]L6^9=NY
M2QCY SBN@_9K_89^(/PT_P""H/Q$\77GB_Q]=>&5\+6%EI6H7TMNUKJ4BY!@
M=%4$K%P0 !TZT ?/'C#_ (*+_%S5?VPO&GAC4OBBW@+XE:#X]M-(\*_"M=.A
MFA\1Z(SKFX:4@EC(A9MVX%<=*^B_^"L_QIG_ &?DU'6C^TXWPEUR?1&D\,^%
MS;6\JZI>J<+PZEI=\F$QD#FOA&[_ &"_BG,?&?AKQA\"/&'B7]HN[^)#:[X6
M^,%I<Q_8K6U:=6CN'G,@D2.*(%?(V%3_ #^Y/^"F^MGQ+X%UCX>^(/V9/%?Q
MM\23^&%L](\1V.GVDEE)?218),TCK);;9</N4&@#V#0_VR?$/P4_X)S^&/B/
M\7=+CTWXB7VC0(^B1%?-U+5I5VPVT:+_ !ROM^4?=!/I7SE_P3Y_X*"?&\?L
MC_M,>,/CO'IT?C?X3ZI>;=+@B18-* M_-CMBR_?";E!/7@UV7P5_X).:M\8?
MV,OV>-(^-'B_Q9:_$/X/H-2AGTW4@XANR/D$I<,)6B4A03GD5PG[-7_!.?XB
M6WP__;6\-^(;[Q5=M\3]7O(=!GUJ:)DUE&MU"77R#AF8;#G'':@"I_P33_:I
MU+]H3X@_#^?7?VQ=-\4^.=9C?5-6\$V6DPP:9>QNN[[+:R-&I8Q @%D8DD&N
ME_;B_:4^.7[/O_!7']G?PM:^/-.;X6_%?5Y[%_#\.F(DT*PP[F,DY^9RQ[=!
M7C7@'X&_$[]KKXK_ +(V@+^SYJWP5_X9WU'[?XFUJZCMX+$I##Y(M[)HG+2K
M,1O.X #=SZUUW_!6H_%?Q1_P4V_9X\6>#_@1\0O&OAKX*ZI/J&J:CI[6R0WR
MW$80+!OD!)7J<@4 ?J91570]1?6-%L[N2VGLI+J!)FMYL>9 64$HV.-PS@X[
MBK5 &3X]\60> _ ^L:Y<X^SZ/937DGN(T+$?I7Y4>*_VV_VB_P!EOX/_  G_
M &G/%/CRU\4?#?XC^*HK#Q#X1.G1I#H>FWDYALVMG4!S*I +$G!S7ZI_$CP?
M%\0OA[KF@SD"+6;">R8^@DC9<_K7Y'>,?V>_CW^V#\"/A)^R7JOPHUWP9X<\
M >*H;CQ9XSNY83IM[IEA<&:U>S96+M)+\H*E1C!H _7?Q!'<^(?!UVFF7[:9
M=7MHWV:\\L.;9F3Y9-IX.,@X/I7YW?LH_M.>*+G_ (*6Z!\.O"O[1/\ POOP
MZNCWS^-;![*!7\-W$3;8I!)&!C<^5V<XQ7TSX$_:4^*K_%7XQ:!J?P;U*V\*
M?#RSC?PEJ<=XA?QF1'EHT!.$;(P,X%?*GP'\':M\=_\ @J+\-_B)X0_9E\3_
M  ,TW0-)OSXR\0:K#;6#ZR\T>([(Q0.PGVR9?S&Y^E 'A?[9O_!3SXU>'?VC
MOCCX9?XN2_"SXD>#]4M;;X8?#J+18+N+QG;N1MD>5N7,I)&"1L%?9'[=WQ'\
M2?#K]GWP=XZ\>?M$-^SQ=/X<2.\L8[*WECO-::$/MRZDMA\KL7BOSY_:&_80
M\?ZNO[0OASQ]^S%XV^*7Q=\6^+9-7\!_$C2]2C2*&(L/LQ-PT@>V2 <[%4@X
MK[E_:'\1^)/ /[+/@KX7?%+]G'Q7^T1?IX,A6[U.Q@M;RW_M40A#$_G,K1MG
MK,,],XH YG]MS]MWXW_!W_@AAX0^*5IJ4FC?%'4)M)@O]2@TY;@^1-<%'N?)
M4$#=%MDP <9KV'_@FEKOB7Q_X.UKQJO[3MM\?M!GLC%%!;Z5:VHTRZ5=S!O*
M4.&SQM<"F_LLP^-OV*O^"6G@*U\:?#GQ)X]\0:7'''=^%M+\J^OM-@EE=DB'
MFL%D\A"JGYNW%>/_ /!+#]F;Q[HW[??Q\^/'_"M]4^#WPW\;VL,&D>#KHQQ7
M>KW,:Y>\D@C9HX68C  />@"C_P $@OVGO''[5WQ@DO\ Q3^T];ZQKVEWFHC5
M?A<^BV]I<6D*SO'"Q8J)2J@!LC(-<=\?O^"GVI?$+]O[XL>#-=_:-TG]GWX;
M_#$1:5IZ6FG+<ZIJU^Z;I+F9F1Q';QD@9.%->EZ)IOB/]K/_ (*:_"3QEH?[
M.OB?X2P?#TZC+XF\7:Q;VMK)JD3QF-+&,1,QF1F^?<V,>E>6_&'X)_$/]D;]
MJ']J>VM_V:K[XU:!\?[,7'A[6]/2VD:.X>$Q-97AE8&.%7(<$ _=H ^EOVXO
M&OQ:\!?\$I)O&WPQ^-6EW^O>%M$?6KKQ:=)M[D>([=(RP\M /+C9^/F4<8KU
M[_@EG\:/$/[17_!/#X0^.?%=[_:/B/Q1X<@O]0N=H7SI6SEL#@5\A:Q^S9\4
MOV/O^#?+2_@E!X!U_P")'Q#UGP[-H<NG:'-&PTJ2Y+N-SR, 8XMP7C/2OH+_
M ((BKXO\*_\ !/#P!X(\;_#[Q-\/O$'P_P!,AT2YM]8\K_360$F:(QLV4Y[X
M- 'UQ1110 4444 %%%% !1110!^<_P 2_CM\9OVM_C'^T)=_#/XCW/@#0?@"
M!IVF65O90W$>O:C%$9YS<EP3Y1 V +C'6OL#]AC]I./]KS]DOP+\15@%M-XF
MTQ)[F( A8YU)24#/;>K8]L5\3_$3PC\3OV%/C3^T=HW@_P"$_B[XCZ5\?'_M
M;P[J&CK";73+^:$P30W9=U,<:D[PP#9'%>T?LW^'_B3^P#X%_9V^"F@_#V[\
M:>&[BQ:W\6^)H[I8X_#LIS(S%"<N"[$#'84 ?)O[:/\ P42^(_@W]J/XQ^&-
M6^-4_P (?%GA:]LH_AKX-CTJ&Y3QE!(0 [,P)?S'.TY*[1S7W+^TE\,/B?\
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M K28X%OHK&*YGUK79%WK','!Q;J,#"XSFOTBK\Q/&WP_^+W_  3*_;\^/'Q
M\"?"OQ'\7/"7QYTV+4=.316A$^EZ[&OEB.YWLNVW88.X D<T ?8G_!-?]HCQ
M!^T_^QUX4\4>+HK:+Q<JRZ;KGV==D+WMO(T4K(.RLRYQ[U\@_P#!8/\ :9\=
M?LN>*+ZX^'/[1#)\5]0U"P'AGX6M8VTPU..60*80I&X[QN.\GC%>Q_L<Z/\
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MW[,6NV'AK_@W1\=>%M9N(+;QY;^*+_1M0LKB4+>2ZP^IJ8TP?F,C?*1WP,T
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M3:0<GBOSZ_8-\0V7PC\*?\%"+'XB7EOI?B.'Q3J5_>G4I@KRV$]HXM6!;JC
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M9AMM$7Q'-J%QJ?B:[^PZ1I6FVC7E_J4V,E8XEY( Y)Z 5@^&_P#@H!\,-?\
M@7XK^(<^N2Z+H'@:66#Q FJ6[6MWI$L>,QRPGY@QR-H_BR,5\K_M'^+K;Q/_
M ,%B?V6O'PU2WU/X9:_X?U.TT'4DFS9/J$B;DVL>-[IT[GI7S;^U?:SZPO[=
M_BBSC:Y\ 1>*?#:WEQ&XDM9I;9T-XW&0=BD!SV[T ?I#^S]_P4S^%?[1OQ+L
M_!NDWNN:-XGU72SK>FZ=KVE2Z;-J=B.MQ )!\Z <GN!VK,7_ (*O_""77XX8
M;[7[C07UK_A'_P#A)HM)E?0DO=^SRC=8V@;_ )=WW=W&:^<OVCO&O@[XS?\
M!47]C[3/!M[8:OJX\.ZGJ-[)ICAVBT26S"*S2+P(RQX![U\O_M;_  G^//[(
M'[#^M?L^Z7'\,-4^'6N^,EC\,>)O[8WZUJHN;X3"SBLE'-PC$@R%L #)H _5
M/]K'_@H/\-OV*Y-,'CR\UFTCU9HDAFL]+FNX4,DHB3>Z JF78#DUWWQD^.6@
M? GX47_C37WOET/38!<S-:6CW,VPC.1&@+'CT%?&?_!<QXO#7_!+C3]-U2ZL
M[?5H=3\/12)-.BR,R7,(?&3DX(/2OK'XOZ[I]Q^R=XFNEOK![0>&K@>?YZ&'
M/V9A]_.WK[T 4?V9/VV_AW^UO^SN/BIX.UB27P4#<;[Z]@:U,0@)\TLK\@+@
M]:\[^%'_  5Z^"?Q@^(/A?P[I^KZYI\OCF>6V\-7VIZ//9Z?XADC)#):SN-L
MAX..F1TS7Q3_ ,$BQ+XD_P"#;SQOI^DRQWFI_9?$0\FWD$DJYD<X*@Y!(!ZU
M'^T/\5O 7Q(_8I_84T#P;J&DZEXOU/Q;HC^'[6P=7N85MU(O" O,84 ALXYX
MH ^^?CW_ ,%'O G[-.MW\'B[2/'EAIFEW45I=ZRGAV>73(&D("L9E&-F2 6Z
M"O>--U&#6-.M[NVD6:VNHUFBD7D.C $$>Q!!K\Y/^"[WA+QSJOP@U#QQH'QO
MT33OAYX/FM/^$E^']V($@\0^7,K/:FX3]\LL@( CS@XZ5^@GPNU2#6_AGX<O
M;6S&GVUYIEM/%:_\^R-$K+'_ ,!! _"@#=HHHH **** "BBB@ I'<1H68X51
MDTM-F56A<.0$*D$],#% '@WP>_X*,>!OCM\0K?P_X<T;X@W0NKN>RCU63PU<
MQ:4SPL5<_:2-FW<I /0FO=K^^CTRQGN9B5BMXVD<@$D*!D\=^!7YSV7A[QM_
MP3<_;0^$7AOPS\9)_''PP^+'B&]TV3P1J,%M)=:29=\YN;66,!_*1R0V[(P>
MM?>/ACXZ^#O&_P 0=?\ "6E>(M*U#Q)X75&U;3HI@T]@'^Z9%[ T >:?LQ?\
M%'/A=^U]\7/&7@7P7J.K7'B3P)''+J]M>Z;+9^0LAPA'F ;@?:OGK]K[]M?P
M1HO[7^A:5IH\1>(-3\$S2Z=X@72M*ENH[%Y4#) '7Y7FZ$H.0.:X+_@G)KVG
M3?\ !?K]L<Q7^GNMQIVC)"$N$/FD*,A0#R1WQT[U\_W_ ,-?&7AOP%^TWX\M
MOBQ/IOBWP+\2;S4+'PDPMXX[68[/+GG)'F2M*N G.,<"O*SI/ZG.:^S:7_@+
M4G^"9]3P7*+SFC1F[*IS4_G4C*"^YR3/T\T:_35=)MKJ-942YB615E0I(H(S
MAE/(/J#TJS7!_LO?$/5_BU^SMX+\3:_9'3M<UW28;N_ML8\J9A\PQVR1G\:[
MRN=--71Z$HN+<9+5!1113$%%%% "@%C@5\]>+/\ @J1\&_!WB#5[*XUS5KJP
M\.Z@FE:QK-GI<MQI6E73G"Q37"_*ISP3T'>O?M2CEFTJ\2 D3O;RK&1UW%"!
M^M?D_P#LK_$+P5\._P#@B;\>?#WBZZTZP\2Z?XDUBPU>PNRHNWOI[G-JK(?F
M9F!!7&<4F5%7/U@M]2M[O3([V*>*2SEA%PDRL#&T97<'SZ8YS7S_ *=_P5-^
M#6J:M:QC7-7M]'O]5;0[37KC2Y8](N;X-M,"7!^4G/&>F:T_AYXMMH?V3-'\
M!MJ<$?Q ;X<BY726D(O=OV4J)-OIG S7P#^T-\1O WB3_@WX\(>&]"FL)O$%
MUK5IHMGI<4@-X-82]S*FP?,) <L3Z=Z&QQC<_1?XU_MH^%/@%J^H6NM:9XTN
MX=(@2ZO[W3="FN[.TB89#-*O!P.3CH*WO%G[1FA>&?!.@^(;.R\0^)=,\2QK
M/8/HFG/>%XV7<KL%^X"/6OE_]K[]I_4/'>CZ7^S;X!\5>'-$^(NHZ'9CQGJF
ML7<<%OX<TYHD67F0@27#C<JJ.G4U[[XH^#.J:9^SIX6\"?#+XF)\.;G2;.&V
ML=7ABMKQ[R"./!"K+E6#'YBR\CUHN)K0W/@/^U1X*_:3\&ZOKGA74+FY@\/W
M,EGJMO<VKV]WIT\8R\4L3?,& &?>L/X"_MV?#C]I;QEXQT'PIJ6IS:CX"B2?
M68[W3I;0VR/G:P#C+ X)X[5X!_P1)\:17_A3XQ^%KRTTZ[\2>"O&<UGK_BBT
MD+P^+KAAN-V<\!@/E(!VC':LW_@G]JUC-_P5[_:[$5Y82K/%I"Q*D\;"7"\A
M0#\V.^*$-QM<^@O@;_P4+^%W[0_Q<UOP5X:UZ.ZUK2)_)A4_=U(!<M)#QG8O
M0D]Z]NKR+X2?L/?#WX'_ !=OO'/AO3+BR\1ZK%+%?3F=G6[WON+,IXR#P".@
MKUVA$NW0*AOI!%#N;A5.X_0<U-7(?'?QBG@+X4Z]JKL%-K9R!/4NPVJ![Y(J
M:M54X.I+9*_W&V&PT\16AAZ:O*;45ZMV1J_\$[HI;[X;:SJTB&/^U_$%[*F1
M@E%DVJ?RKZ.KRK]C[P)+\/O@1X7TR<$W,%@DEP3U,CC>Q_6O5:]#*Z4J>#I0
MGORJ_K;7\3YWBC%PQ.;XFM2^%SE;T3LOP2"BBBN\\(**** "BB@]#0!YI^S1
M^UUX#_:ZTGQ%?> ]7;5[;PIK,^@:DQ@>$P7D!Q)'A@,X/<<&O2P<@$<@U_.]
M\,_VBO%_P=_9\U_PCH7B:[\!^%OBI^TKJWA_Q7XGMF\J73;)GYC6;_EB9/N[
M\@CUK[P_9)^)'A3]E']N/XN>'?#7QBUCQI\+_ 7P\@UAX]6\3'6;;1[@.2P\
MXLW+8'&2><4 ?:_@;]N7X6_$C]I[Q+\'-%\66-]\0_"5HE[J>E)G?!&WHWW6
M(XR 21GFO6J_G!T;QAXK_9)^)?PZ_:PT7X7_ !6T[Q9KWC2ZU'XA>(-9TQ$T
M.]T34)1%$D<BR%UC5"K E1^%?T::#K=MXDT.SU&SE2>SOX$N()$.5D1U#*P/
MH010!:HHHH Y/XU? OPC^T7X$E\,>-] T_Q)H$T\5R]E>Q^9$TD3AXVQZJP!
M'N*ZBTM8[&UB@A18X84"(HX"J!@#\JDHH **** "BBB@ KA_V@?VB_"7[,7@
M(^(_&&I&PL'N([2WCCC::XO9Y#A(88URTDC'HH%>0_MF_M+?'WX,_$+3=.^%
M7P*M?B?HES9&:YU&3Q FG&VFW8\K8RG/'.:^6_VX/B#\1?BCXC_8_P#$OQ2\
M#)\.FA^)P75]*^WB^MK4^65MY'F "C<W3(ZT ?=O[.O[7G@?]J)]>MO"VH70
MU;PO<BTUC2;^U>SU#3)",J)87 90PY!Z&D_:4_;!\!?LG6FB-XQU:2WOO$UX
M+#1]-M+=[J_U6?&=D,* LY Y.!Q7Q+^SQXA@\.?\'"?[3&O17L5AX(TSP#HZ
M:]J#RB+3K:_5B2)I"0BRA.N3D"L?]M3Q%8:[_P %Z_V3/$.LWB7_ ,/+[0]0
M7PSJ,4ZOI[ZLP.W;("4+%.@SSVH ^V_#_P"WU\+]=_9_\1?$R37WTOPMX2EF
MM]:;4;:2UNM,FB(#0RPL-ZR9(PN,G(Q5+]G[_@HG\+_VD?B#%X2T34]4TWQ3
M=:<NL6FDZWILVFW=_9'_ )>(4E ,D?3)'3-?GC^T/*NH0_M@ZDS)-X''Q1\,
MM=7 (>S;RWC^UDL/EPO&_P!.]=G_ ,%(;JU\4_\ !8?]EC_A7+K?^)HO"NLS
M73Z2WF-'I#VS>6SE.!$S[=N3SQB@#Z^F_P""K_P37XCS>'(/$E[>K:ZVOANY
MUBVTZ:71[34F.!:R787RUDW<8)Z\5T'QU_X*#_#G]G[XC7'A+5YM?U/Q!8Z<
M=7OK31=(GU%M-M?^>LYC4B-2 2,\D U^5W[*E_H^G_\ !N=XZTHR6T'C<>,K
MNVO+0D)?MK)U)3&A0_,9SP1WP,U]0_M%:'^T%^S!\7O$GQ'\"^$/!GC?PS\0
M? 5E9>+#KFL#3KOPO=VMF5,\A(.^$J6++P210!];:W_P4*^$6B_L\:)\4E\7
MV=_X/\2S1VND7%DK7$VIW$C;5@AB4;WEW9&P#((-:GP1_;,\#_'RS\4MHUQJ
MMG>^"GV:UIVJ:?+8WUAE"ZLT+@-M902",@XK\,_V'/#OBGPO\ _V#=0\707=
MMX#N?C%J]Y(S(8;2,RE_LSG=T1I,[">O:OU:^#UZ=4_X+._&*339(I](M?!.
MDV^KO$ZO%'=AF*1R8Z.$SP>0* /9?V;OV[OAS^U=XW\3>'/!VI:C<ZSX16*3
M4[:[T^:T>%)<^6P\Q1N#8."*SO&__!1#X<>#_B?K?@ZV?Q'XGU_PR(QK$'A_
M1I]372V?[L<S1@A'(YV]<5X)^Q?J]BW_  6=_:E6*[L6$NDZ L:I,A+$0MD
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MH0%5XP."S2$+@T 7_P!DK]B7X:?L->"+SPY\+_#<7AC1;^X%U-:QW$LR%P,
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M9F@W^66&!R5[5]/00):P)%$BQQQJ%15& H P !Z4ZB@ HHHH **** "BBB@
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M:O\ ?I'YOL>M@*WU+#U<UEI[-<L/.I)-1M_@5Y_]NI/='TIX<M!;6*X78",
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M>OP9^'7Q"E\*:W\2?"FF^(+>58)[.6\&ZWD8X5)"/E1B>@8@UL?&']K7X:_
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MIKS,_M\?"[Q'\(O&/BOPMXST'Q!%X-TR;4KR&&8B2)4C+*6C(#A20!NVXYH
MJ>!O^";WP<^'?[-_B;X3Z;X0@7P5XS$@URVFN)9I]5,F-S33,QD<X Y+<=JD
M\<_\$YO@Y\1OV:M#^$>K>#;.?P+X8$?]D62RR))IK1_<>*4-YB,/4-FO*_\
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MF?BY)XX\8>"(=0\077DF]>*[FMX=2,+!HS<11L$F*D#&\&M_P1^V;H?@_P"
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MQ)M?%OCOP@NJZY;PQVTDT=Y-;K>11MN2.=(V"RJ#T#@UV/CO]C?X;?$KXG^
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MA8ZA<-82+%87#1$+#*V,(Y[*<&OUI(R,$9!I-HR#@9'M0!^"FA_LL^+O%/\
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M=*TO0-5CTBXU..QGAC7[39M'$CM$[>A4 ],U^E^P8(P,'VH>-9  RJP'J,T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/$M$12T2HG147"CZ"MRQT:&Q4!5!(JW17HH^>;"BBB@04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4$XHHH ,CUHR#T(HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>j17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" $R K0# 2(  A$! Q$!_\0
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XWP3^T;\/?B5\1=?\
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M&I^Y=%?C7+^TI^V_\%?^"NEI^R+=?M%>#?B!/\2O!AU^S\::K\-+*Q?P4/\
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MIT\\,D!=U,S7.-BQ@J5^8FE%N3C\B7\*EW5S]GJ***D HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KE?CA\$?"G[27PD\0>!/'.B6GB+PEXILWL-3
MTZX+*ES"PY&Y"'1@<%70AE8!E((!'55^+'_!4F[_ &H+;_@I/XD_X6'!^VT?
MV</L!;P%<?LR7,4=W!*(K3SQJ:1H7<%_-P;IT*E6\D,A?:GV92ONNA^K_P"R
M?^R'\.?V&_@M8?#SX5^&+?PEX/TV::X@L8KF>Z;S97+R.\L[O+(Q)ZN[$  #
M   YCX8?\$WO@C\(/%?Q8UK1/A_IAO/CE.UQXZCU&YN-4M/$;,TQ99;:ZDDA
M5&,\N41%0A\$$  ?$G_!$#]IGP-XR^+'C73/AS^VYXW^/WA--*&IQ?#WXGZ3
M,WC+0[DQQ^9*NJW)BDNHD,;H\<$#PQ&1#N#'?+]*_P#!'W_@J3_P]>_9@\0?
M$C_A!?\ A ?["\27?A[^SO[:_M7S_(A@E\[S?(AV[O.QMV'&W.3G T<7KZ:^
MFG_ )3TTVO\ B<EX>_X-MOV(_#'Q$M_%%M\!-"EU.VO#?)#=ZQJEYIQD+%MK
M64MRUJ\63_JFB,>.-N !7N?[97_!-[X)?\% OAWH7A3XN> =/\5Z#X9N!=:5
M;I=W.FOI[^68\1R6DD4BH4P"@;8=JY4E5Q\2^'_^#E3^W?\ @E?\2?VF?^%+
M>5_PKWQO'X-_X1O_ (2_=]OWM;#[3]J^Q#R\?:/]7Y+?<^]SQ?\ B?\ \%U_
MC_\ "K]GAOC=J?[#_B2S^"/V:QU4>(+GXD:=_:HTVZ,>V[?2X;>6:/:)%9D=
MEV@@L5&XK"6ENFGIW14DXRUWU_R9]5?"3_@D=^SW\"_BK\//&_A;P ^F>*/A
M1HDGASPK>MK^IW)TJP<W!:#9+<,DH_TJ?YI5=AOX(VKCL_'7["'PH^)7[67A
M3XY:WX4%]\4O!&GR:5HNM'4KR,6=M(LRO']G246\F1<3#,D;'Y^O QXO^W?_
M ,%>-*_9>\!?!"Y^''A$?&;Q;^T-JMK8^"M#M=8&EQW]M-$LAO7N##-LB19(
M<Y0_ZW)P%8CR']J[]J/4O!W_  7X_9_^'44WQ176/$G@>\U!-)T[XCMI_@JX
MG6#4F"7NF?8':Z?=%@7'FQE<1-Y1\O:UOF;U\_\ -_UYA%>Z[=E]U[?UZ'K&
MF_\ !O9^QCI?QBO?':_ +PC<Z]J$]Q<S17EQ>7>E%YPPD*Z=+,UD@^<E56$"
M,X*!2JD=+HG_  17_9I\/_#_ .&_A6V^'EW_ ,(_\(?$#>*/!]G-XIUF==#U
M!I4F:6,O=EF4R1J_E.6BW;CL^9L\]^PE_P %?=(_:A^$_P :-5^(O@^7X,^,
M?V?=2N[/QQX:O-5&IOI<$$32K=K,(8O,BD6.7:0F#Y9(+ J3S?[./_!5KXS_
M +5G[ T'QL\$?LHZQK=]XDU*6+PMX<'C[3;(W^FQOM;4KRZO(X$M48K($CC2
MX=BH/"-Y@FVGW/\ R_S$VV[O?7_@GTAK7["GPJ\0_MAZ3\?;SPKYWQ:T/1SH
M%EKO]I7B^39'S<Q?9Q*+=O\ 72_,T1;YNO POP=_88^%?P!_:!^(/Q3\(^%O
M[)\>?%1XI/%&I_VE>7']IM&24/DRRM%%@D_ZI$SGG-?$7[!O_!QJ/VJ?V[M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH Y#X[?'_P3^S#\+]3\:_$/Q3HG@[PKHZ;[O4]4NEMX(R>%
M0$\O(Q^58U!=V(5020*\/_8D_P""N7PC_;YMOBG?^"F\3Z;H/PCN(X]7U?Q#
MIG]E6US$\+S"YA21_/6+RXRQ,\43 8.W%?1GBKP3HWCJTM;?7-(TO6;>QO(-
M0MXKZUCN$M[F"020SH'!"R1R*KHX^964$$$9K\]?V6_^":/Q"NO&W_!0/1O'
M&EOX3\.?M&:S/'X8U9;VUNS=6D]G<P&X\N*1WCVF53LE5&/I23W]-/6Z_P""
M4DM/57]-3UCPC_P6L^'OB3PGX)\:WO@3XJ^'/A#\1M<70/#OQ'U6QTZ/0;^>
M266&VD>&.]?4;:"XDB*QRW-G$HWH7,8;-;GQ&_X*Q^%O#7Q!^*&@^$/AQ\5/
MBQ'\%84?QQJ?A*VTLV6@2F)YFMO]-OK:6ZG2*,NZ6D<VW(4_/E!\7>+?^">G
M[0'[1O\ P3$^"W['OB/X57O@]_ VO:;;>)/B =?TFZ\.RZ5ILTS"YL4CNFU"
M2:>-8@D<UE$ TAWE ":]"^'O[(WQL_8*UW]K_P +^$_A+K?Q<\/?'_5+WQ1X
M2UO1]=T:SCTZ[O[66&:SU..^N[66-8I=C"2V2<-&V>'R@N:LGR^=O/:U_77M
MM]Y%)VOUM?RWO^G?_+]#_@A\;/"W[2'PB\.^//!.KP:]X3\5V,>HZ7?PJR+<
MPN,J=K@,C#H58!E(((!!%?E5^QO_ ,KDG[6/_9*K'_TE\*5W?[)G_!&?]K_]
ME#]G'P?X \$?MQVGP^T#0--B3^P+7X1Z1K]OI]U(/-NQ%>W3I/-&UR\SJ9$4
MA7"X&*^)/V:?V5OVE-;_ .#EO]H7P3I'[5O]B?%W1_A_:7>M_$G_ (5EI=S_
M ,)!9F#P^5L_[*:3[-;[5FM5\U&+'['G'[UL$TE)J.Q$6[:G]#U%? '_  [P
M_;L_Z2*_^8$\/?\ QZC_ (=X?MV?])%?_,">'O\ X]4C/O\ HKX _P"'>'[=
MG_217_S GA[_ ./4?\.\/V[/^DBO_F!/#W_QZ@#[_HKX _X=X?MV?])%?_,"
M>'O_ (]1_P .\/V[/^DBO_F!/#W_ ,>H ^_Z*^ /^'>'[=G_ $D5_P#,">'O
M_CU'_#O#]NS_ *2*_P#F!/#W_P >H ^_Z*^ /^'>'[=G_217_P P)X>_^/4?
M\.\/V[/^DBO_ )@3P]_\>H ^_P"BO@#_ (=X?MV?])%?_,">'O\ X]1_P[P_
M;L_Z2*_^8$\/?_'J /O^BO@#_AWA^W9_TD5_\P)X>_\ CU'_  [P_;L_Z2*_
M^8$\/?\ QZ@#[_HK\=?^"#O[0O[7W_!6?]CO7?B'K?[3\7AB]T#Q==>&?)7X
M;:->&Y6*TL[H3,RK"H/^EE-H3I&#DDFOM;_AD#]J?_H\3_S%&D?_ !RO-JXZ
MM&;C'#SDEU3IV?I>HG]Z1Y%;,L1";A'"5))=4Z5GYJ]1/[TGY'UI17P]\??@
MC^U/\#O@3XU\;?\ #6W]J?\ "'Z#?:W]C_X5=I$'VO[-;R3>5YFYMF[9MW;6
MQG.#TJY_P3H\0_'+]K?]C;P=\0M7^-/V34/$'VWS8O\ A$-/DV^3?7%NO*A
M<K$#PHZ]^I\S%<0UJ554(8.K.;5^6+HWLG9N\JL5NTK7OKM:[75DN84L;F']
MG8J^&ER.:=76+2E&-E['VKO[U]8I63UO9/[5HKQ?_A2/Q@_Z+C_Y9ME_\51_
MPI'XP?\ 1<?_ "S;+_XJL?\ 6+'_ /0KK_\ @6&_^:#[+^PL%_T,:/\ X#B/
M_E![117B_P#PI'XP?]%Q_P#+-LO_ (JC_A2/Q@_Z+C_Y9ME_\51_K%C_ /H5
MU_\ P+#?_- ?V%@O^AC1_P# <1_\H/:**\7_ .%(_&#_ *+C_P"6;9?_ !5'
M_"D?C!_T7'_RS;+_ .*H_P!8L?\ ]"NO_P"!8;_YH#^PL%_T,:/_ (#B/_E!
M[117B_\ PI'XP?\ 1<?_ "S;+_XJC_A2/Q@_Z+C_ .6;9?\ Q5'^L6/_ .A7
M7_\  L-_\T!_86"_Z&-'_P !Q'_R@]HHKQ?_ (4C\8/^BX_^6;9?_%4?\*1^
M,'_1<?\ RS;+_P"*H_UBQ_\ T*Z__@6&_P#F@/["P7_0QH_^ XC_ .4'M%%>
M+_\ "D?C!_T7'_RS;+_XJC_A2/Q@_P"BX_\ EFV7_P 51_K%C_\ H5U__ L-
M_P#- ?V%@O\ H8T?_ <1_P#*#VBBO%_^%(_&#_HN/_EFV7_Q5'_"D?C!_P!%
MQ_\ +-LO_BJ/]8L?_P!"NO\ ^!8;_P": _L+!?\ 0QH_^ XC_P"4'M%%>+_\
M*1^,'_1<?_+-LO\ XJC_ (4C\8/^BX_^6;9?_%4?ZQ8__H5U_P#P+#?_ #0'
M]A8+_H8T?_ <1_\ *#VBBO%_^%(_&#_HN/\ Y9ME_P#%4?\ "D?C!_T7'_RS
M;+_XJC_6+'_]"NO_ .!8;_YH#^PL%_T,:/\ X#B/_E![117B_P#PI'XP?]%Q
M_P#+-LO_ (JC_A2/Q@_Z+C_Y9ME_\51_K%C_ /H5U_\ P+#?_- ?V%@O^AC1
M_P# <1_\H/:**\7_ .%(_&#_ *+C_P"6;9?_ !5'_"D?C!_T7'_RS;+_ .*H
M_P!8L?\ ]"NO_P"!8;_YH#^PL%_T,:/_ (#B/_E![117DGAOX/?%33/$6GW.
MH_&/^U-/M[F.6YL_^$3LX/M<2L"\7F*V4W*"NX<C.17K=>QEF/KXJ,I5\-.B
MUTFZ;;\U[.I47WM/R/*S#!4</)1HXB%:_6"J)+R?M(0?W)H****],\\****
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M ,;H_MG#_P M3_P55_\ D _U@PO\E7_P36_^5GUI17R7_P -?_M3_P#1G?\
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MFLX$TR;S$C9)"WER.54 OL)*C[6_X(B>/+OXI?\ !+_X7>)KN&WLO^$@AO\
M4+;3K=BT.BVTNHW3P6$><8CMHBD"C PL0&!C J*_=W]/U*J?%9Z/_+0^K:**
M*DD**** "OR!_8W_ .5R3]K'_LE5C_Z2^%*_7ZOR!_8W_P"5R3]K'_LE5C_Z
M2^%* /U^HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** / /^"L7_*+
M+]I;_LE7BC_TT75?/_\ P:X_\H*/@9_W'_\ U(=3KZ@_X*$_"W7OCC^P+\<?
M!/A:P_M3Q/XP^'^O:)I%GYT<'VN\N=.N(8(O,D98TW2.J[G95&<D@9-?F!_P
M1G_X*/\ BK_@G;_P39^&_P '/&W['7[;^J>)_!_]I_;+K1/A/-/82_:=4O+R
M/RWFFBD.([A =T:X8,!D8) /V>HKX _X?Z?]65_M_P#_ (:'_P"ZZS_%G_!Q
M!I7@+PKJ>NZ[^Q[^W?HNB:+:2W^H:A?_  I2VM+"WB0O+-+*]X$CC1%9F=B
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MJ/\ A]W_ -6A_MQ?^&K_ /NJC_B%O$__ $"_^3T__DP^O4?YOP9]Q45\._\
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MNH0S7E[=22W-U)Y:I&'GD=A'&B A$51-]--_^":)J^J_KK]^OI?R/C_XA_\
M!1;Q=-^V+X7\7>%/$6G7?[-NFZ]H?P_\2QBSB<3:IK5I)<0WRW)7S%2"2YT2
M'"N(S]NGW LBE?=/^">'QE\9?M+^#_&_Q)U_49&\(>*_%5['X"TPVT,:V6A6
MC?9(;G>L:R2&\DAEN@9&<".>(*0 <ZVA_P#!-[X)^&_V2M<^!5EX$LX/A5XD
M%P-1T+[==LMQY[[Y/WYE,ZD,%V%9!Y81%3:J*!ZM\._A]HOPE\ Z)X6\-Z=;
MZ1X?\.6,.FZ;8P B*TMX4$<<:YR<*J@<DGCG-.ZZ+^NOX[>3MT$W_7]=^OIU
MN;-%%%2(*9<0BX@DC)($BE<^F13Z;,',+B,JLA!VEAE0>V1W%# _(+]AGP7\
M?_@_XJ\4ZSXF^ FN+%^Q;X"\1>%/A_;>9(&^*-_>78N$N;(K"!M:UM(8MT:S
M9>X/.\LB_?'_  2D^ 7BS]FC]@+X>>%?'D4-MXW^SW.KZ_;1%&CLKZ^NYKZ>
MW4HS*1')<,F0S [.IZU^/?C?_@L=_P %+_V>?VR?C5X/TSX!Z3\2]6TS6;5K
M^UTCPIK_ (CTS0HC9QK:_919W\B6L=S BW!C9BQDED)"MN4?K5_P1H\6_%+Q
MY_P3G\!:U\9]+\2Z)\2-4EU.YU;3]>M[NWOK+?J=TT,3)=YG5%A,:H)"S",)
M\S=3:;<+^GKK=_U\BIWYG_7]?J?4-%%9WC#Q#_PB7A+5-5^R7U__ &9:2W7V
M:SMWN+FXV(6\N.- 6=VQ@*H))( &:S;MJ)*^AHT5^07P+_;T^/'PR^!?AOXI
M_M;>(_VKO@OHGBKQ3) ]U:>$? \?ACP[;37,@LK6[MY+2?78D*(L32RP(=TB
M_,,B1O2OAO\ M<_&3]OC7_VO?$_A3XNZ[\)?#?P!U>]\+^$M)T+0]%OX=2N+
M&UEFFO=1>_M+F6599-@5+>6W"QKC[Y,A;T3D^F_X?YC46W9=?QW_ ,C],Z_(
M']C?_E<D_:Q_[)58_P#I+X4KO/V3O^#K3]E[QC^SAX.U/XQ?$*U\ _$Z\TV.
M3Q#H=KX9UJ\M[2YQRT4D-M,ACD7;(J^8[*L@5CN4UX'_ ,$D_P!J/P)^VC_P
M=7_M*?$SX9Z[_P )+X(\2_"J'^S=2^Q7%G]I\@>&;:7]U<1QRKMFAD7YD&=N
M1D$$U*+BW%]"$[JY^WU%%%2,**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KP#_@K%_RBR_:6_[)5XH_]-%U7O\ 7@'_  5B_P"467[2W_9*O%'_
M *:+J@#Y_P#^#7'_ )04? S_ +C_ /ZD.IU]_P!? '_!KC_R@H^!G_<?_P#4
MAU.OO^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLSQGXUT;X<>$M2U_P 1
M:MIF@Z#HUL]YJ&I:C=):VEC BEGEEED(2-%4$EF(  R31<#3HKR_X+?MO_!;
M]I'Q1-H?PZ^+WPO\?:U;6[7DNG^'/%5AJMU% K*K2M'!*[! SJ"Q& 6 SR*W
M=?\ VD/AWX5UF_T[5/'O@O3=0TK4++2;VUNM;MH9K.\O<?8[:1&<%)KC(\J-
M@&DR-H:A@=G13+BXCM+>2::1(HHE+N[D*J*!DDD] !WK*^'_ ,1/#_Q9\&:=
MXD\*Z[HWB;P]J\7GV.J:5>QWME>QY(WQ31ED=<@C*DC@T!<V**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH _'+]LW]MG]M?]GS_ (*9?&^R
M_9L^#OPW\:>![W6/#.A7EUKZB!9=;N-,@\LASJ-J7FDCD@C<C*)'!;Y"$EI/
MT)_X)9_M+>/_ -KG]B#PGXY^*6@Z-X7^(-[=:GI^N:5I44D5I8W-GJ5S9M&J
MR2S,"/(YS(WS9QQ@#X(_;0_X)@>+_P#@I?\ \%._C9>?#[]HWQ#^SC)\/XO#
M<>K6&@K=3S>([L6;7%OJ\\<5_;"/RD=8(I<,<VTF""IS]I?\$3+_ $ZX_P""
M8GPMM-,EM;R#0K>]T274+:[:Z@UFXL[^YMI]021BQ9;J6*2X&6.!-C) S517
MN/3J743YK]++\CZIJCXF\/V_BWPY?Z5=R7T-KJ5O):RO97LUE<HCJ5)CGA9)
M8G /#QLKJ<%2" :O45)*9\A^*?\ @CSX=^+/@[1?!WQ+^,?QV^+'PUT/5%U:
M/P?XKUK3[FRO98W=X$N[R&QBU.[CB=PRI/>."8X]^\+BKGQ(_P""17@_Q/X[
M^*&M>$?B%\4OA1:_&NU2W\<:/X2N-+&G:^XB>!KC;>V-S):S/#(4=[1X2VT,
M?GRY^L**=_Z_K<+LY;X(?!/PM^S?\(O#O@/P3I$&@^$_"EC'IVEV$+,ZVT*#
M"C<Y+.QZEF)9B222237Y5?L;_P#*Y)^UC_V2JQ_])?"E?K]7Y _L;_\ *Y)^
MUC_V2JQ_])?"E#=]62E;0_7ZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KP#_ (*Q?\HLOVEO^R5>*/\ TT75>_UX!_P5B_Y19?M+?]DJ
M\4?^FBZH ^?_ /@UQ_Y04? S_N/_ /J0ZG7W_7P!_P &N/\ R@H^!G_<?_\
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ML?\ TE\*4 ?K]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7@'_!6+_E%E^TM_V2KQ1_Z:+JO?Z\ _X*Q?\HLOVEO^R5>*/_31=4 ?/_\
MP:X_\H*/@9_W'_\ U(=3K[_KX _X-<?^4%'P,_[C_P#ZD.IU]_T %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 445X5^T/^W1;_  *_:!\*?"_2OAK\1?B3XR\7
M:)?>(;6T\,OH\*06=G-;PS/+)J-_9H#ON8@%4L3DGL:5QGNM%?.ND?\ !1C3
M=*^*%CX-^('PQ^)_PF\0:[IE[JF@0^)$TBZA\1+91&:ZAMY],O[R%)XXAO\
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M /AWO_N2C_AP7_U>I^W_ /\ AWO_ +DK[_HH ^ /^'!?_5ZG[?\ _P"'>_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTRJFK$IGP!_QM._ZL _\NZC_ (VG?]6 ?^7=7W_12&? '_&T[_JP#_R[J/\
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M10 4444 %%%% !1161\0?&EK\-O 6N>(KZ.XFL= T^?4;A(%#2O'#&TC! Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  ,@ 'M1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% SCG)HH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>j18i.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j18i.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (3 JH# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHRYDD("G(V-U'Z.NFY2H)!(.#Z5_(;^T[_P3#\4^!_\ @NII7[.]S\6M0O\
MQ)XDUO3HH?&IM)A<6)O(5F1A&9S(3$'"\3#.W((Z4HZS2!+W6S^O16PQ')(I
M7;:,U_.#_P ',_PY\;?\$^OV2?V//AI:_$GQ'JVJ>&=+UW3]0URTNKBPDUEE
M>R822*)68XWD ,[$<\\U^J?_  49\2:AHW_!OAXWU2SU"]L]3A^%5K*EY#</
M'.DGV2 [PX.X,2>H.>:;V;!+5+N?=._D9(%#R+%'N=@JCDDG  _&OY\/^"4O
MQ5\4Z[_P:Y?M::W?^)?$%[K5CJ&K"WOY]1FENK?&GZ>0$D9MR@$DX!&"2>I-
M>(?\$8O^"9OQN_X+6?LG>+K?Q#^T1XR\(?#3P/K,L.DZ<&EO_P"T]8E@CDDE
MFS*A,<:>0 6+D;V"!/F)J4;-^6I*=U?;6Q_3^'4J"""#TQSFD2=)5RK!AG&0
M<C/I7\G_ /P1_P# _P"TM^WQ\7?$_P"QYIWQW\6>"?AM8S7.L>*)H;F6ZDMX
MK.3[.\-L2ZN$EED0-$'6-B S E<'US]@S3?BE_P1P_X..=#_ &>[/XD:WXL\
M(ZWK%OI&H1W,TJ6NL6=[:+/#+);EV59XC(AW DAD8 [6((EJO,'LWV/Z923D
M=R*;',DJ$HRN!P<'(!]*_GD_X+,?MN_'/_@J-_P5X@_8T^"OBR_\%^%])U$Z
M#>M:WDME'JEU'$9KZYO)(CO>"!%=5B&03$QP6<8\P_X*(_\ !*_]H7_@WAT#
MPC\=/A=\?_$'B/2DU&#3M5EC26Q-M=.K.BS6S32Q7-K(8V4A\X.T$'((45I=
M]=BFNG4_ILW#)/I1O&X#/0XK\!/^"\?_  45UC]LO_@@C^SC\9_#NH:CX2UG
MQ;XOCAU:+2;V6V\B[ALK^&YB5D8,8O.B9E!).TIGD5^AW_!/+Q'J.I?\&]'@
MS5KK4+ZXU23X374[WLMP[7#2?9)R',A.[<",YSD=:4M$WV$K.WF?=S.%SFFO
M*J*Q<[5 R2> *_ 3_@TE^*/B?QW^S'^UQ<:YXCU_69[#3+#[+)?:A-<-;$VF
MI$E"[$H<A3D>@]!7PE_P1^_9#_:#_P""R.J^-/A3H_QL\0>%/ VB0P>(M=N-
M1O+J^BFN1OAM(O+$@9R=TI +A5"LV"P4&W"SMY7^\29_74"2">M*">XQ7@7_
M  3&_8_U+]@[]AWP%\+=:\0S^*]=\,VCC4M4>YFG2ZN)97E<QF7YQ$I?:BD#
M"J!@<U[Z#V/!J6"=PHHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 (02F#UK^>/_@L!^W)^U'_P2(_X+2:;X]U;Q7X_\4? S4M3
M76M#T";5IXM#U&RDA\N[T[:O[M98F:0H&5BO[E\$8S_0Z>>/6N9^*?P=\)_'
M'P=<>'O&OAK0?%N@W>/.T[6+"*^M93S@F.564D9/.,BEL[C36S/PL_X*I?\
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M\/O^":?[/GPK^'^M^$_#_P %_AGIOAOQ*$&KZ<GAZV>#5 CJZ+.K(?,5756
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M %/1=!M;&[O5=Q(RRRQ(K.&<*Q#$@L >HS3=9_8_^%'B/XT0?$?4/AIX"O\
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M'XJ_\&?>5_99_;$!QQI>GY_\!-3K4_X,=X4.L_M'2[5,BP^'U#=P"VHDCZ9
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M]_T75=OUK-;+N#W=A:***8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYWO =K\=+G_@O;\#=:_:+CU6#XH>+/&WAS7+N#42B7%K;SW41MXC$IQ;A8P
M(< H, @'(I07-*PY*T;G]>08\#%</^T!^TIX!_95\ -XJ^)'C#P_X)\.+<):
M?VCJ]XEK;F9\[(PS'ECAC@9. 3T!KLKN[CL+:6>:2.&"%3(\CL%2-0,DDG@
M $Y/2OY1?^#B3_@ISXA_X*I?'C77\#)?W?P!^"=VFF6=[$"+2^OK@O']ND/&
M3,8I$A')$4;-@%G%%];(<8WU/ZFOA!\8O"_Q^^&^E^,/!6O:9XF\+ZVC2V&I
MZ?,)K:[579"R,." RL,^H-=/7Q'_ ,&X^1_P15^ H_Z@]U_Z7W-?;E5)6=B(
MNX5X+\8?^"H?[.?[/WCN7POXU^-WPR\->(K=MD^G7OB"WCN;9LXQ(F[,9]GP
M:O?\%%=!^*GBO]BCXC:1\$FAB^*.KZ0]AH$LEVEH+:65EC>597^5'2)I&4GH
MRKT-?CE_P3G_ .#2+1?$7[.7CC7OVL9_$WAGXA7EW<K8#3=>MI+?2;9(U;[?
M)*AD29W=G)$C !4Y ))$I[MEI?B?NY\//B3X?^+7A*R\0>%M<T?Q)H.I)YEI
MJ.EWD=W:W*YQE)8R589!'!.#4/Q4^+'AOX(?#S5_%OC#6]-\-^&="@-SJ&IZ
MA.(+:SC! W.[< 9('N2 ,DU^ O\ P9@_%WQ7I'[2_P ;/A?:ZM<ZQ\.K72%U
MF(%B;:&]CNU@2:)22$,\3N2!]X1(3G:*\5_X+3_\%+_VF/\ @JIX ^)R:)X(
MOO!G[-'P?U<VNM2VSL8-6N4OA:PM<W3A1</YI1EMXEQ']Y@Q4.')6MY@EJT?
MTH? +]H_P)^U/\/H_%OPY\5Z)XS\-33R6J:EI5RMQ;M+&0'0,."5)&1VKMP<
MC-?F!_P:)X'_  1OT7_L:]8X_P"VJ5^G]#5F2F! /44444#"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1CP:_FI_X.
MG>/^"\/P:X_YE_P]_P"G>[K^E<\@BOQF_P""Y'_!$+XZ?M\_\%1_A[\6OA[:
M>%)O"'AC2=(L[QM0U<6MR)+:_GGEVQ[#D!)$P<\G(QQRH_'%]A/X6CY?_P"#
MS+18O$/_  4"^ FG3%EBO_#'V=R.H5]1=21[X)KZ0_X.V_V9/ /P7_X)(_#6
MS\+>%-"T.'P;XOL-)T@V5G'"UI;-978>,,HSAC&A8$_,R@G)&:ZO_@X8_P""
M,'QM_P""D_[8GPC\;?#*U\+SZ'X,TE+/4#J>JBTE$@O6F.U2IW#81SZ\5]"?
M\'%G_!/#XC_\%,/V%='^'OPP@T6?Q#9^+;3695U.^%G"+>.WNHV(<J<MNE3C
MC(R<\8):U-+K?]2HOWOE^A\K_LE_LB?#_0_^#2/Q/=-X5T*;4O%'P[UOQ3J%
MZ]HCW-S?1FYDMYVD*[M\7EQA#_"$ '?/RE_P14=F_P"#:_\ ;H7<VT?;2!V!
M_LN'G\<"OUE^#G[ 7Q#\#_\ ! :;]G6^AT8?$IOAQJ?A@1)>[K'[9<)<",>=
MM^X3(N6V\<\'%?*G_!-S_@B+\=/V7_\ @C=^T]\$?%-IX5C\<_%<7']@);:N
M)K1_,LHX5\V4*-GSJ>QXIS?O2_ J#5HW[_Y'%_\ !F%^SAX*\1?LA?%OQIJO
MAO1=6\0:IXG/A^6ZO;*.X<6$=E!)]G!<'".T[EE& WRYR ,?*_\ P;*_LQ^#
M?'__  7'^)\.J^']*U+3OAM8ZW?:):7<"30V4R:E%:Q2*C J62.5PIQ\I((P
M0"/U>_X-N?\ @FK\3_\ @F!^R-XR\%_%.#0[?6M;\62:Q:C2[\7L1MVL[:(%
MF"C#;XGXYXP<\XKQ7_@AI_P1?^-O[ 7_  4T^,7Q5^(5KX7A\)^-M-U.UTUM
M/U875R9)]3@N8P\>P;1Y<;9.>#@=ZT37/Y6_&QC=\K[W_4^-OVQ_ 6C?#?\
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH   .@HHHH
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MR%P1\5_\$@+C3H_^#3/]I<SFW"J?%"S;O^>AT^UV9]\E,?A7Y]?M#V^J1_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#X)NN\G_!/#X"M)GS&^'7AXMGCG^S+?/TJ1GM5%%% !1110 4444 %%%%
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MTD?M:?M:> _V(?@-KWQ)^)&NP:!X6T"+=+*_S2W,ASY=O#&#F2:0_*J#DGT
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MQ^V+^T1JGC33]2_;I\2ZAX+\7W-TLNB7L5\+22SF=B+=X$N/)V!"%*JH7 P
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MR>Z!_P"FVWK\6/\ @^-_Y#_[./\ UPU__P!"T^OVG_X)V?\ */WX%_\ 9/=
M_P#3;;T#/8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KX)_P"#G'_E"+\:_P#KCI?_ *=;.OO:OS%_X.JOVL?AU\,_^"7?
MCKX9ZYXLTNS\?^/H;(Z%H.\R7M\D6H6\LDNQ02D86-_G?:I*E02>* .=^&/_
M  4FT;_@EQ_P;0_!OXAW;VMQXFNO!=II7A7396&=1U.5'\H%>ICC :60_P!V
M,C.2 ?P1^$6L:MX(\ ^-/VG?'%Y/JOC+Q!J5S8>$I[QM\^HZW/F2[U,YZBU2
M0L"!CSY(NFTBM2/XI?$'_@K3XT_9_P#@=I^_3?#/PO\ #5OX>L("Y>WLHT4/
M?ZG-V!;'?&$CC4<DD]M!\'9/^"LW_!2SX>?L_?"I9;/X:>$V7P]I5Q&-R6>E
M6Y+W^J2<8,DI$DF3C<S1+U(KQ\;6]MB(X"';FEY1Z+UD]/1,\K%UO:UE@H>L
MO)=%_P!O/\+GJ_["/_!-63PM_P $(OVG_P!I_P 66+?VEXHT)=!\'BX3+)9K
MJ-L+R\&><R2+Y*L,';%+U#U^\'_!O?\ \H8OV??^Q;/_ *4SUQO_  7(^$V@
M? ;_ (( _%SP5X5T^'2?#7A7PE8Z5IMI$ %@@AN[5$' Y. "2>222>2379?\
M&]__ "AB_9]_[%L_^E,]>ND>HD?9-%%%,84444 %%%% !1110 4444 %%%%
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MQ6\>>LDLA2-1ZL.P)'\6W[7'[5>O?MV_M+>/?BK\0=2G'B#Q3/)>P00H98H
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M'?2K+XB1:':IXF77[!]/N6U!8P+AL1PB J9 Q4QG!7:< Y%*/4;\S]) HSG
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M  35_8*\4_%WP?XY^(VLZOHVH6%K;V&KRV;VK)<721-N\J!')56)!!'(Y&*
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MH **** "BBB@ HHHH *_-O\ X.QO^4*OC[_L,:+_ .E\5?I)7YM_\'8GS_\
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M(N3QP,@_U#^)_$=KX3T.ZU*^E6&TLXS+(Y_A4#/^17\0O_!2+QU8?%/_ (*
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M*I#JMU=>:UY90ROA=RB1 C,0K&W R PQ^V-&!Z"FWIYC3LS^>C6/V:/VR/\
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M5RN,_:'T_5-7^ /CFTT73;76=9NO#]_%8:?<PI-!?7#6T@CAD1R%='<JI5B
M02"0": /FZ7_ (+^?L:Q3,C?M!^ ]R'!*RS,OYB/!'N.*T_ O_!<G]DGXF>-
M-*\.Z)\>O =[K.MW<=C8VQN)(C<32,%CC#.@4%F( R1DD#J:_D\_:2_8/_:
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MHZ5</<1V^I6TEK*\$IBE570J2KCE6 )((Y!P:_GD_P""T/\ P;.?"'_@GO\
ML >/OC#X5\>?$[6=:\/7-E]FL=8NK2:UD%Q?0P-O*0*Y(65B"&!) )SS6QL=
M_P#\$G?^"-/QR\9_![X"?$G2_P!M_P 7>'/#%]I^E:]#X.L;BZ<65MM27[ D
M;7GE$!,QX,17&<H1P?WMK\-O^"4W_!KW\&_B9^S[\!?COJ'Q ^*T'B#5M)TC
MQ?-I]EJ%M;VJ7)2.?RD98?-6,-QD.& Z,#R/W)H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3G/M2TU\,,'
MI2;L"/"_^"AW[1WP<_97_9LOO&'QVM+"\^'MK?VUO<1WFB'6(?/D?;"3 $?)
M#?Q;3MZ\5^>/B;_@M]_P2PUS0[FUO?"G@O4K>9"KVY^$Q)D&",#=:@ ^^1CU
M%>.?\$<OVP?!?[=F@_M*?#_]M/XJZ%XO\)V7BJQ;0=)\?>)8[.)!#+>$FW#R
M1L0I$60IP,)Q7U2/V&O^"48&3;_LV9]_&L7_ ,ET6&W;3L>/?\&BOQBC\?\
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M^9J_DT;%%(7"X).,T@F#="#^-?H[DMC\[L.HIN[WIU,04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F_[5W[6'@/\ 8G^!
M&N_$CXD:[%X?\)^'XPUQ<,K222NQ"I#$B@M)*[$*JJ"23V )'I%?B5_P>O\
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M ,%,/AU^V!X\N/#'ABUUW3]6ALWOA%J,$42S(K*K!2CMEAO!QCID]C4VE?\
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M+8,#G>CA27&,_*RD$X.1@YNWW[1FG-\7+3PU9P175M/,()+L3?+'(<X51C#
M':,Y')QVKEJ\3YO'&4L4^2I.FG=Q36G:5M/-'1B?!W"TXXC+,-*7))*5^9.*
M:UNKNZ>ZUW/T:7XF?%#]N3Q;J4/@O4V\&>!=.F,/VW)2:X(]U^<L1@[5*A00
M"233]2_9U^,'P:TZ3Q!X-^)-QXM:S+-<6,SLXEV$[E579U9@01M^5L\9SQ7P
M(G[7T'PB\87>DIK/B+P]=6S &2V>1(I 5!##RVY!!ZD5>^'G[;&G?!+0;K3_
M  QX\N]'L+ZY>\G@MY9F#S.<NYW D,QY)&,GDY/-7A^(858>VQU*LZLKM3C)
MV7;E6UD>77\+\VI+EP"@J*2M%T[\RZ\TM7?S7X'ZN?LG?M,6O[1_P_>\E@6Q
MUO39!;ZE:Y.(I,<,N>=K#D9Y!!')&3ZOYR\G<!GW%?BOJ'[57_"J[1-;'BC5
M])'B?,WFVKRQ27G\>7"X/5L\@<M[USVH_P#!0^VN<B;Q?XQN0?\ IXF.?S>O
MILJ\2L1]5C&IA95)+1RZ.S]-SY;%>!>-Q&(E4PE11IMZ*S=NZ]+WMY'[CM>Q
M(2&D0$^K 4L=RD_W&5@.ZD$5^#6I?MW:3<DA[KQ->9X^>7.?^^GK[7_X(A_M
M/0_&'QI\0O#UK%>QVVFV=E?J+FY#,C.\R$B,9V@A1\V>=N,<9KZ7(N-,5F&,
MCAIX1PB_M-]OD>!Q7X.XW(\KGF=:LI*-M+6O=I:>\_R/T3HH&<<]:*_0C\;"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  YP<=:_-C_@YZ
M_P"":OC+_@HC^PMI4GPXTR76_'7PWUG^VK32X6 GU.U>%HKB&+. 90/+D5<@
MMY9498@'])Z1@".>U)H:9_.;\0M._::_X.!_VC_V:? OBSX!>-/A1X/^#AB/
MC#6M8L[FUM;B0-;B[G4SQ1A6>.W"Q0+O8-*Q)*@D?NGXZ_8!^!GQ2\77_B#Q
M/\&_AAX@UW5'$EYJ.H^&;*ZNKIP H9Y'C+.< #)). *]=';(SBG!B<>]4Y:6
M)MK<_F^_X/)/V9?AQ^SEK7P"3X?> O!_@A=6@UPWPT+1[?3Q=E&L=GF>4J[]
MNY\9Z;CCJ:_77]@W_@G%^S[XJ_8;^#&J:I\$/A-J.I:GX%T.ZNKJY\*6,LUS
M*^GP,\CNT9+,S$DDDDDDDDFJ/_!7O_@BW\-/^"N-YX"F^(7C3Q5X1;P0+V&P
M&CS6L8NS=& N'\Z-\D&!<!<=3G/%?5_P.^%EG\"_@QX0\#Z=<7-WI_@W1+/0
M[6>YV^=/%;0) COM 7>5C!. !DG  XI#/-A_P3!_9N//_"@O@X/^Y/T__P"-
M5Q/Q_P#^"7OPVU3X7:A9_#7P!X'\$ZO)\SII&C6UA#JB;2IAG$: .""<%L@$
M^A-?5623VQ2$<DD]>E<.88"EC,/+#5E[LOO\FO.YV9?CZV#Q$<30=I1?R\T_
M)]3^<.]_X-U/@3X3OKFR\?WOQW\/:RDS$_V?)IQ@D!.<*LMOP!GJKL".?:N!
M^-'[,7P5_P""+D<'Q6T"W^(>J:CK-I=:3X8M?$I@E&H7(1#+*'BAC6-55D#$
M$G;(0"217].DUC!.1YL,4A7IN4''YU\@_P#!6?\ X(R^ ?\ @KUX?\#Z;XU\
M3^+/#$'@.XO+BT;03;JTYN5A5P_FQN, 0KC '4YS7S2X<QU6U#%XMSH]8\J3
MDNSEV]+'TL.),#1E]8PN$4:O\W,W%/NH]'ZMF=_P3J_8U^%/QK_8(^$/CS6O
MAOX('CCQOX%TS4]7\0VNBV]OJES=7-G')-*;E4$NYG8DDL2>^:\3_:;_ .#=
M?PG\8O$"W!TOPYK5M'Q%)*T^FW*KN)"N;<A9,9/)P?0#-?H/^S1\#=._9@_9
MY\#_  XTB[O;_2_ FA6>@65S>%3<W$-M"L*/)M 7>50$X &2>!7FG['7_!4/
MX+_MX?$/QKX3^&WB>[U3Q)\/)1#KVGWFE76GSV3>;)$?EG1-X62-E)7.TX!Q
MD9]3,.','BW&33C**LI0;B[=M-T>5@>(L9A5+E:G&3NXS2DKOK9[/T/'_P!C
MC_@BKX)_9Y6T?5-.T-K:SSY>F64#-')G&?.FDS)*#@?*3@X .0,'W(_\$P_V
M<"26^ GP=8GDD^#]/)/_ )"K.^%W_!4#X-?&C]LWQ1\ O#'B6\UCXF^#$FDU
MFQATJY-M8B$QB3=<E/)RK2(A <G<=O4$5]"$C:3TS75E>3X; 0<:">N[;NWZ
MMZG+F>;XK'34L0]([)*R7HEHC^?_ /X/$OV3_A=^SK^SI\&;SP!\.O _@F[U
M+Q)>PW4VAZ);:?)<QK:J51VB12R@\X.0#7WO_P $;_\ @GQ\!OB1_P $L/@)
MKWB#X+_"S7-;U7P;8W-[?W_A>RN+F[E:,%GDD>,L[$\Y))KTK_@JK_P2<^'G
M_!9#X=^$M!\6>+_$6B67@O4IKZWF\.S6S-+))$$9)#(D@P  <#!]Z]R_90^
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M JDJMD5';N-'YG?\$58+7]G'_@X UKX6?LO?$7Q3\4?V;WTF:?Q+=3SFZT^
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M&?XC_:6_8$U#_@M3\0/"OQ4^$>E^%/C%81R1ZAXQ^(0A_L'5Y5AA$?EI//)
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M3<3%5()#!21D<U^]8&5 ]:S^S&^XY?$TA:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#Y7_:]_X(K_LR?MW?$U/&?Q-^%FE:
MYXI")'-J<%W<Z?<7B( %6<V\D?FX  !?+   $  5[Y\%/@?X1_9P^&.D>"_
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M@&F?MK_\$D_V>_\ @H;K6G:K\6OAOI?B;6M*B^SVVIQW$]C>K%DD1-+ Z,Z
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M->P4447 YKXN?"'PO\>_AUJWA#QIH&E^)_#&NP&VO],U&W6>VND)!PRL,9!
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M9?VRO^"??P>_X*">!K3P]\7O ^E^,;#39C/8O.TD%U82$ ,89XF66/< ,A6
M; R#@8]FHIA<\0_8M_X)S_!?_@GIX6U#2/@_X#TGP?!K#I)J$\;RW%Y?E,[!
M+/,SR,JY;"EMJEF( ).?;Z**=P"BBBD 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 &.A]*X_X[_'/PO^S5\'_$/CWQKJ@T7PGX6M
M&OM3OC#),+:%2 7V1JSG!(X52?:NPKY$_P""]?\ RAV_:$&.OA&X_P#0TJ9.
MR&E=V.&3_@YM_8C=PO\ PNRT&3C)\/ZJ /\ R6KZ=_94_;;^$_[<?@BX\1?"
M;QYH'CC2;.40W3Z?,?-LW(R%FA<++$2 2 ZC(R1G!K\B?^#9_P#X)4?L[?MD
M_P#!+:#Q1\3?A-X6\8^([CQ-J=C)J5XDBW1A3RMB!T=2 N3@C!&:\*^#GPF3
M_@B+_P '2'A?X9_#F_U*/X;_ !(FL]._LR>=IB;'4XR$@D8G+^1=J&1VRP5!
MDDEB=.751)OHWV/Z0>-WO0< Y/6OR&_:2_X+=?M;_%']M3QM\)_V5_V:X/$U
MEX :5;W6/%UK<VPU-(W,9GA#S6L:1/*&$>7=I -P !($'[#W_!P]\9/VJ?@;
M^T7H^I?"#P[HOQ^^ 6B3:ZVB"2Y33]5CM9_+O;=XF<S0SQ[6 42,&9E&1@YA
M;7*LS]@: !QCM7P5_P $>?\ @M%8_P#!1?\ 8(\9_%[QEI^C^$-3^&]W?)XD
MLK"9WM[6VA@%RDX,A+ -"6')(W1OTZ#%_P"""G_!7'XF_P#!7?P_\2/%7BCP
M'X8\'>#/"M_#I>CW&G37$MQ?W#!I)4<R$KB.(P9( RTO0 8HMK8F^ES]#Z**
M*8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% ";1G.*6BB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>j18ii.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j18ii.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" '! U$# 2(  A$! Q$!_\0
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MD 9/ H!R,B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2_AM_P %VOV//#>AV<6GZ+H&A^$M-L+2-=L=O!#K]S''&!V"HJC'H*Z3_@Y
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M$?BW\3?C?IE_>".:ST2#4K[9(J[REWI[/<1O Z@J)"3@\?*2I/U;_P %V?\
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M:/X)R_$3P[_PM229;<>'$F+7WF-!]H"[0, ^3\_)&!R<5[:TBHH)Q@D#]:_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ H_"BB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *CN+F.TC+RR)$@_B=@H_6I*_-C_@ZT\4ZIX,_X)&Z[?Z1
MJ6H:3?1^(M,"W%E<R6\H!:3(W(P.#W&<'TH _2.WN([J,21.DB-T9"&!_*I*
M_/C_ (-??$FI>+O^",GPTU#5=0O]4OI[W5_,N;RXDN)7QJ5P!EW))&!C&<#H
M,"OT'H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ** 0>AHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ,&4O_DS]!Z*_/C_ (?HZE_T;_\ $G_P'E_^-4?\/T=2_P"C?_B3_P" \O\
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M@_Y_P?\ D'_$)^*/^@9?^#*7_P F?H+17Y\_\/SM3_Z-]^)?_@-+_P#&:/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW_T-WA/_ ,&DO_QFC_AS3^TW_P!#=X3_ /!I+_\ &:_7K'^S1C_9H_U<RO\
MY\0_\!0?V7@_^?4?N/R%_P"'-/[3?_0V^$__  :2_P#QFH-2_P""//[2^E:=
M<74OBWPIY=M&TKXU2;.%!)Q^YZX%?L#D^E9GC8G_ (0S5^/^7*;_ -%M0N&\
MK_Z!X?\ @*!97@_^?4?N/S"_X)/Z?\:?B]^SQJEYX7\8V%KID.LNGE7T8>3>
M8D+$':>"-O&>QKZ@_P"%(?M%Y'_%;^'L_P#7L/\ XBO-/^#>?G]D+7/3_A(7
M_P#2>.OOO R?6O/J\)864W*-2I%/I&327HEL?88'B6MA*$<-2I4[15E>$6_O
M/E#_ (4=^T9_T._A[_P&'_Q%'_"COVC/^AW\/?\ @,/_ (BOK"BH_P!4,/\
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M?@)'XE\=:A\-YM*U#6]<M5CT--1-];WLZ^2_S31; 4B##[V0W;'/@'_!7_\
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MQXHL[CQ%X3T^_D@AMH&CA:2%6*J2<D#/>O9O^(>+P=_T4'Q;_P" EO\ _%4
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M?%O_ ()N7GQB^./AC4?AKK'@2.^@\7Q/IMRD!>R)66YM8RI>2*0 $*F_:Q9
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M/_:N\5?M!'QQ\1_ASIMKX&\5:H_ARVM;Q(E/ABQA4G4RS?-+&P5Y6E)VC)
M4 'Z;^&__!3_ /9_^+WQWT_X:^%_BUX'U[QGJFGIJ=GIMAJ2SR74+P^<I1E&
MQF,7[S8&+A?F*@<U3BQ[?>>^T5\PZW_P65_9@\/?'=OAO>_&_P"'=OXL2[^P
M26S:H/+BN,E3"\X7R%D# J4:0$-P0#Q7MWQF^/?@K]GCX<W?B_QSXL\/^$O#
M%BJF;5-5OH[2T3<0%&]R 2Q(  R22  2<&?,:3V.PHZ\'FOG#]F+_@K1^SO^
MV1X[?PM\.?BYX,\3>)-C21:9!=O%=W*J"6,44J(T@4 D^6&P.3@<U\[? /\
MX+8>'_BS_P %F/B%\$[SQY\.X/ FC:/;:=X6-O=(;K7-=>Y5)[?S2?GE3#+Y
M48&,$G)Z%GL#6_D?HQFBOGG]J7_@JE^S]^Q;X]LO"WQ,^*WA#PIXAOHEG73K
MNZ=KF*-CA9)$C1S&C$'#2;0<'!.":]B\/?%SPMXN^&UOXRTOQ)H>H>$KNS_M
M"'6K>^CDL)+;&[SA,#L,8 )W9P!WH7<+:V.C+ #DXI01QSUK\R_^"G/_  7/
M^%UQ^P/\:;K]GWX[>#KCXK>#;&"?3SIES%<W _TV"*5X$GC,=PH1F!,8D #
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M?"#PMXWT!KE]$\7:5;:Q8&>(Q2F"XB66/<IY5MK#([&NI)QUJFM2([!7#?M
M?LU^ ?VJ_AY<^$OB1X0T'QIX<N6#M8ZK:+<1JXZ2)D91QSAE(8=B*[FBI:*/
M$/V4_P#@F_\  O\ 8AOK^\^%/PP\+>"]0U1?+NKVRMR]W*F0?+\Z0M($R =H
M8*2,XS6'\=/^"2W[-G[2_P 6/^$Y\=_!KP3XE\5LRO-J%U9D/=E<8,RJ0LQP
M ,R!LCCGI7T713NP*FBZ+9^'=*MK#3[6WL;&RB6"WM[>,1101J %157A5
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M?\%]?^";OP,\%_\ !$CQ-?Z#X#\(^'+_ .%^G6-WX=O].T^&VN4<S0PLC2J
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M%=-T/1+&TTO1M'M8[*QL[6,1PVL$:A$C11P%50  .@%:A&1BN$_9IN_&-_\
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M/AB5!^2_UA#GU&I7 K]%:DH**** "BBB@ HHHH **** "BBB@ HHHH ****
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M11#!(B3C4(IX\]7<S$J1E_,! .17S-_P1L^&G[2WQ$_X(B? Q/V</'7P_P#
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MFF]AO4\O_:;_ &0/ ?[7^E>%['QYI4NK6O@_7K;Q+I:I<R0^1?6^[RI#L(W
M;FX.0<YZ@$-_:J_8^\!?MH^"=*\/?$'29M7TK1=8MM=M(TN9+=H[JW8M$^4(
M) )/!X->H,...W%*5STI;;>HKGE?@_\ 8S\ >!OVJ_%'QHTW2)8/B#XPTJ'1
M=4U W+LD]K$R,B",G:"#&IR!GCW.?5% '3G-*2!UXH!R,TQW"F-&&<,=P(Z8
M) _'UI]% !WS7E/[2G[&/P__ &MM8\#W_CG2)M4N?AUK4?B#0V2ZD@%K>)C;
M(0A&X<#@Y'YFO5J0?>-($SY<_:\_X(\_ S]M7XIP>._%>@:QI7CJ&!;1O$7A
MS6+C1]1GA486.26%AO  P"1G&!G  KJ?V8O^"9OP4_9%^$>O^"?!G@738=$\
M7%F\0G4"VH7&OLP*L;J68LTF03P> 22 "23[W122TL%SX4T?_@W'_92TCQ-!
M=?\ "%:W=Z%9WIU&V\+W7B*]E\/VT^20R69DV#!)."3G)!R"0?N'3=,MM&TZ
M"SLX(;6UMHUBBAB0)'$J@ *JC@   8' JU157=K %%%% !11FC- !11FB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/\2WE_8Z!>SZ
M9:17^H0P2/;6TDWDI/(%)5"^#M#, ,X.,YP<5H44F@/YV_VT/^#J/XR:1^V!
M\.;/2/ACXO\ AII/@K7+BT\9^$;F2&ZG\6&.XB5K:.5H,QE0DB;H\Y,H//%;
M_P"UA_P=A?$[XX_ K6?"_P */@7\0_A]X]U5H8],UU6_M!K-A*C,!";;#ED#
M+@@_>SVKZ<_X.(OVX?#G[(_QL^!NF^%?@-X0^,'QTU:^N+[PO/JFG27,FB[9
M85W0)%AY)Y)EC(Y( A)(/%>'67_!4?\ X*7KY<\/[''AQ#Q(C#0G5A[_ .OR
M#^HHA).*]1R5G<_7O]@[Q%XY\6_L9?"W5/B2DZ>/-0\,6%QKHGB$,WVMH59S
M)&  CDD%E &&)&!C%>O$COT%<-^S9XM\3^/OV?/ ^N>--)70O%^KZ%97FM:<
MJE5L;V2%6FA ).-DA88).,=37<YQG-5-ZOH9P^%"T444BPHHHH *_,K_ (.V
M_P#E#MXA_P"QCTO_ -#DK]-:_,K_ (.V_P#E#MXA_P"QCTO_ -#DH Z/_@U9
M_P"4)OPO_P"OW6/_ $Y7%?HE7YV_\&K/_*$WX7_]?NL?^G*XK]$J "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#\@_\ @N?_ ,'&'Q&_X)4?M>6GPZ\*
M_#_P5XGTRXT.WU4W6JS727 DD>0%0(G"[0$'OUKX;\+_ /!P7\0/^"<=Y-K_
M (=\!>#-?G^,L@\0:C'J4URJ:?+GF.'RW!*?.>6R>![UR?\ P>0?\I/=,_[$
M^P_]&35\6?MXH9?!?PD13M9M$4 ^ARO- ']3_P#P3U_X*R^$?VJ?V./ OQ \
M:ZSX8\+^*/$UA]JU#2[224PV<F]AM7?EL8 /)/7K7LX_;B^$X_YGC1<?[Y_P
MK\'?^";'_! 3]H#]JO\ 8B^'_C_PI^U!_P (5H'B;3OM5GH@TVYE%@F]ALW+
M,H/()X ZU[G_ ,0O_P"U#U_X;)/_ (*+O_Y(KYVM'//:2]DZ7+?2_->WG8\2
MLLVYW[/V=NE^:]O.Q^R_PR^/'A'XS7%Y%X8UVQUE]/"-<+ Q)B#[@I/'?:WY
M5V' .,5^+G_!L3+X_P# '[=7[7WPL\<^.M2\=3?"^_L="2]N&<1320W>H0O,
MB,6*!_+!QDD# ).*_:/ )R*];!?6/9+ZUR\_7EO;\=3TL+[?V:^L6YNO+>WX
MZBT445V'2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% "$X!YS1NXZX)KGOB)\4_#WPET--2\1ZM::19/((5EG;:'<YPH]20"<#L">
M@-<.W[<?PH8''C72?S;_  KS\1F>$H2Y*]6,7V;29QUL?AJ4N2K4C%]FTOU/
M6 PZDC%"N"< @U\8?MK?\%"].TO2=!L_AWKD&H7;7Z7EY-;D[4BB8-Y)R!_K
M#P1S\H/J*]F\*_MZ?"[6_#]C>3^+-.L9[F%9);>4L)(&*C*MQU!R/>O(P_%V
M5U<54PJK13@EJVK._9];'G4>(\OG7GAU45XV=VU9W[,]J!P,C)%!/MQ7E>G_
M +:?PMU*_AMH/&FCO-<.(XP7*AF)P!DC R?6O4TE6505(((S7N8;&X?$7="H
MI6WLT['J8?%T:Z;HS4K;V:?Y"YP3G.#7E?[4_P"VO\*_V)O P\1_%/QSH/@S
M2Y&*PM?3_O;IA_#%$N7D.2 =JG!(SC->I.#D9Z"OR)_8\^!.C?\ !4C_ (+;
M_M%?%#XJ6<'BCP]\ M5C\%>"]"OE$]A921%O,N3"WREB5##C!:1B<X&.E*[L
MCIZ7/IW]G?\ X.%?V4?VD/B-:^%-'^*%IINM:G*L.GQ:U8S:;'?LV=HCDD&P
MYQP6*YZ#)XKZE^/O[1G@;]EGX7WWC7XA>*-(\)>%]- \_4-0F$<8)R0J@99V
M(!(506.#@'!KY%_X*F_#S]D/]I/X/^)_@Y\2O&WPH\"^*HH%-A=37%I::IX<
MNMH>&= 2K+P1QP&5B.^:LK_P3(^'/[<'P'_9ID\0_%#5?BKX4^"92\MIXI8)
M]-\:S0Q+"LMX ")"IC!R#G.\$G<<NUU<.NI[!^R)_P %6/V?_P!NKQ)=Z)\+
M_B9H/B;7+*+SY=-"RVMWY7&)%BE56=,$'*Y !&<5]# [<9[U^'_C;]J[X9_\
M%!_^"ZW[,%K\'O#T_P ,]4^&HU"_UO7]=TP>'9O$=D4\N/3[6%@'N!Q(%/ (
MF<@83G]OW( )[ Y-.RY4R7O8\<_:;_;^^#W['7C'P;X?^)?CK2?">K_$&[:S
MT*WNA(S7TBR11MRBD(H::,;G(7YCSP<>R;P0".AK\+OVKOV3M1_X+M_MO_M@
M:_80R7WASX%^#V^'7@!T4LL_B6&1;V9XV'R[A-%-"2.=EW$?2OMG_@G!_P %
M8-&\=?\ !%.S^//CJYN9-2^&'A^YLO&<3'_2WU#38_+D4ACQ-<8B< X^:Y /
M>E'X>9_TG_7XE2C9V7]?U^A]P>/_ !UI7PP\$ZOXCUV\2PT70;*;4+ZY=2RV
M\$,;22.0HR0J*QP 2<5B_ 'X^^$OVH?@_HGCWP+K,/B#PGXCB:?3M0BC>-+E
M%D>-B%<!AAT8<@=*_*;XO_MM?MO?'W_@FMXT^.%[\,?A9;?"+Q?X5U&ZC\*1
M75R/$EOH=Q9RHM^)#\C2+&XG\O'S("0!D*/K7_@W5_Y0L_ 3ISHUS_Z<+JJ4
M=&WTM^I+>J/M@D#%&1CVKXE_X+'?\%)O'W_!/)/@W'\/O!6F>/=8^)OBT>&1
MI-S(\4MP[P.84B=3A6:78"6!&,\=Z\>US_@HK^UQ^Q-^U+\%]%_:(\'?"C4/
M 7QM\00^&([KP?<7'VGP]J$^?+B8RG$B+UR0=RJ^"" 3,5<N2M^9^G6X>M*"
M#TYK\I_BW_P57_:P^*__  4I^-/[./P#^'?PSU*\^&3V=_'KNOW4]O#%9O:P
MR/'* 2&F>6=53:   V1W'Z7_  SU;7X_A%H>H>.(=-T_Q,-)@N-=BL"S6EM=
M>4&G2(DEC&K[@">2!GO0EI<3WL=02 "<]:,<DYK\?_\ @J=_P<&_!C4+7X2P
M?!WX^"WO=/\ B)I[^*UTJ&\@/]D(S"Y68M$ \73*@DGL#7Z$_L@?\%+?@;^W
MKJ&MVOPA^(6F>-9_#JQR:BEK;7,)M5D)5"?.C3()!'&>E-*ZNA25K'NY8#KQ
MBC=C@]<5\I_\%9O^"CEU_P $\/@UX>N/#7A<^./B/\0M:A\.>$=!,ACBO;V0
MCYI6'S"-003C!Y'( )KPN/\ ;1_;0_9)^,/PQ_X7C\./ GC3P#\2=5@T2_F^
M'UM>W-_X0N9B-C3*00\"DX:0X&%)R,#*0-,^VO@+^U;X!_:<O_%]MX'\16VO
MS^!-9D\/ZXL44B?8+Y%#/"V]1D@,.5R/>O1B1G.1BOPS_P""9/C[]J"?]I;]
MKKP=^SYX;^'<5E%\5M2U;5O%'BZ:<VXE91''9011#YG(C+LQ.%5UX.<5]/\
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MHGI%2[E0C>3B?17@;QOI?Q)\%Z/XBT2[CU#1M?LH=1L+J,$+<6\R+)'( 0"
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MI6%P.'PR:P]-0OO9)7^X^ZP^$HT$U1@HWWLDKB29P,#BOQU\?_$WQ'_P0/\
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M?*[K^M;GXB? N5#XK_X)#;74F31=7VX/WO\ 0XSQZ\<U]2?\%C& _P""H/[
M@)P3X]O,>_[A*_12+P?I41L6CTO3HVTP$696V0&T!&"(^/D!''RXJ:^T*QU.
M[M;BZL[6YN+)]]O)+"KO V,$H2,J2.,C%7*5Y7\[D):6[*Q^3?[&/[2G@O\
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M:_H%_P""1G_!.V+_ ()_?\$^_ /PL\11:5K6NZ/'+>ZK*L8G@6]N)#+,(F<
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M37<5N 998X]YVC>0N3Z#/6I-P]: %HJ+[9%]H\KS4\W&[9D;L>N/2I<C..]
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M@9VYP.E<&89EA\%!5,3+E3=KZ[_(X\9CJ.%BIUY63TO9_H?=_-!.!SBOC_\
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M9\,[[Q=;6VM7FE6SW%Y:!Y9!#)&J*?G6?RB"P*YP&X)JM\8M _:;_P""7O[
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MT C,<=T,HBPQK&TD?D %FWA=H!+CWOXU?\'&W[4'[67PJ\6>-Y_V7? 'B_\
M9AM=1%GJ=OK?A6^U?3DB#H1%<WQE$/G@-&=ZQJJ,T9V@D9_4S_@DQ^QS^R#\
M?_@'\//VBOAA\ / _A75?$5K]M@\ZR6[N-$O(I6BF2)I-RHT<T;A9$5&*[6
M7. 0B^77^NHYRUNMSZ(_X)G^$O$G@3_@GU\%]&\71W,7B+3/!FEVU]#<@K-;
MR+;)^Z<-@AT7:I!Y!4CM7NNW(]S0 5X  %+GK[54G=M]R(*RL%%%%(H****
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MX&!DXR?TK[C\:^ OV0O^4X7Q^_[ *_STVOOWN/QH@DM$*"M>PM%%%66%%%%
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M[Y'?.00>001P0:YZ>*HSG*G"2<H[H]C&</9EA<'2S#$T91HU;\DFG:5M[/\
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MY_TI8IF412DDL3ALLS8(4E3R&K_\&WWA/5OV1+SX>R?$SQ#>^-_$WCRP\?\
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M (-8-=OD_8@^(_A(ZA=ZCX9^'7Q2USP[X9EFE\T#3D6VF5%;H0))I#D<9<@
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M^4)OPO\ ^OW6/_3E<5^B5 !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?S._\ !["[)_P4'^%A4D9^'D?0_P#42OJ_IBK^?7_@[B_8/^-'[5?[
M;_PXUKX:_"_QOXYTG3_ R65S>:+I,UY#!.+^\<Q,R @,%=3@]F![T ?@>)64
MDAF!/4YK^AG_ (('_P#!??\ 9>_87_X)@> OAK\2_'>IZ)XQT.ZU66]LXO#N
MH7B1K/J-Q/$1+#"R',<BG@G!.#@@BOQY_P"'-G[5O_1O/Q<_\)NY_P#B:_HM
M_P"#?S_@F'X-\-?\$LO %E\9_@+X1A^(45WJO]HKXJ\(VSZJ$.HW!A\TSQ&0
MCRBFW)P%VXXQ0!T7_$5K^Q#_ -%0UG_PD=6_^1Z^)/\ @NA_P='>#?B;^R]9
M>"?V5/'FLC7_ !3=20^(-=CTN[TR[TBP5/\ 5V[S(A669V \R,EHUC?&&96'
M[%?\.X/V>?\ HA7P?_\ ".T__P",U\1?\%T?^#>OPI^V_P#LQV+? WP;X#\"
M?$KP9=27]C!IVF6VDV_B&%X\2V<KQ(JAR5C:-W^56# X#E@ ?R[^"OCOXU^'
M/Q'B\8:#XN\2Z1XICF^T#5K34IHKUI,ABQE#;B20"<DY[YK^H;_@DO\ \'%/
M@+X^_L1^%]4^,NO2:7\1]->72=9>WTFXEBU&2';LN@(D*J9(W0LHP X? "E1
M7\[/P4_X)0_'GX\_M>:O\#=#\ :FOQ&\.8DUK3KLK;C1X28AY\[L=J18FB.[
M)!$BD9R*_JJ_X)@?\$>?AW^P'^QMX5^'>LZ#X4\:^)+-9+W7-8N])AG%Y?3%
M6E\LR)O$2;51,X)5 2 20 #3_P"'W'[./_0ZWW_@CO?_ (U7>?LZ?\%'OA'^
MU;X^?PSX'\1W.JZS':O>M"^F7-NHB1E5FW2(J\%UXSDYKM?^&3_A9_T3;P'_
M .""U_\ C=?'?P0\'Z3X$_X+K>,=+T/2]/T;38? \;QVME;I;P(S,A8A$ 4$
MD#)'7 H _02BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "FR L,8!'H>].HH P/ ?PQ\-_"S3;FR\+^'M$\-V=]
M=R7]Q!I=C%9Q3W$A!DG=8U :1R 6<C<V!DG%;]%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "#( SQB@D  'DU!
MJ%]%IMA-<SN(H;=&E=VZ*H&23^ K\#=>_P""NO[;7[:^D_'WXW_!'6?"/A'X
M0_ C4&ACT6[T];FYUB*-LL"Q!WN(\2-\R *V 214W_ :BWL?OU7YE?\ !VW_
M ,H=O$/_ &,>E_\ H<E?37_!*3_@H':_\%#/V#/ GQ7OH['1]4UV"2VU2U68
M+%%>P.8IQ'DYV%P2 >0" :^6O^#LS7;+4/\ @CWXA2WO+6:0>(]+.U)E8_?D
M[ U;5B4[G7?\&K/_ "A-^%__ %^ZQ_Z<KBOT2K\X?^#6;7['3_\ @BI\,(Y[
MVTAD%YJY*O,JD#^TKCL3FOT-_P"$LTO_ *"5A_X$)_C2&:-%9W_"6:7_ -!*
MP_\  A/\:/\ A+-+_P"@E8?^!"?XT :-%9Q\7:4 2=1L !ZW*?XTB^+]*<9&
MI6! ]+E#_6@#2HK._P"$LTO_ *"5A_X$)_C1_P )9I?_ $$K#_P(3_&@#1HK
M._X2S2_^@E8?^!"?XT'Q;I8&3J-@/^WE/\: -&BLU/&&E2#*ZEIY_P"WE#_(
MTO\ PEFE_P#02L/_  (3_&@#1HK._P"$LTO_ *"5A_X$)_C1_P )9I?_ $$K
M#_P(3_&@#1HK._X2[2O^@E8?^!*?XTB^,-*;.-3T\X]+E#_6@#2HK._X2S2_
M^@E8?^!"?XT?\)9I?_02L/\ P(3_ !H T:",]R*SO^$LTO\ Z"5A_P"!"?XT
MO_"6Z7_T$;#_ ,"$_P : +^WV;\Z4# P*S1XPTEC@:GIY(["Y3_&E_X2S2_^
M@E8?^!"?XT :-,N.;9_]T_RJC_PEFE_]!*P_\"$_QK\N_P#@XG_X+A?$3_@E
M%XE^%-G\-]-\':[;>.+75);]M31YS$UL]J$">6XP")WSG.<#'0Y .'_X)M*#
M_P '87[8V0./!T1_71.:_8VOX\?@G_P7Z^+/P*_X*&_$S]I#2=!\'3^,OBEI
MBZ7J5I/;RFQ@C4VF#$H<,#_HD?4GJU?T1?\ !!+_ (*@>)_^"G/[%.I?$3XA
MQ>&-%UVS\57>BQV^FL88F@BM[617*R,6W%IG!(., >])*PDK'W97P=\._P#E
M/IXV_P"Q%@_FE>Q?\%)/^"F_P[_X)G?LPZG\2/%]XNHB.5;+2M*LID:ZUB\<
M,4@C&<#A69F/"JK'MBOYZ_!O_!T[XZT#_@H5J7QQN_AEX8EM=8TY-'GT2*^E
M5XK96!RLY7F0 =2H!/84QG]4=%>'_L+_ +?WP\_X* _LT>'OB?X*U2./2M<0
MK-9WDJ1W>F7*8$MM,N<!T)'()!!5@2"*]?\ ^$LTO_H)6'_@0G^- &C16=_P
MF&DAL'4]/SZ?:4S_ #H_X2S2_P#H)6'_ ($)_C0!HT5G?\)9I?\ T$K#_P "
M$_QH_P"$LTO_ *"5A_X$)_C0!HT5G?\ "6:7_P!!*P_\"$_QI#XPTE2 =3T\
M'T-RF?YT :5%9W_"6:7_ -!*P_\  A/\:/\ A+-+_P"@E8?^!"?XT :-%9W_
M  EFE_\ 02L/_ A/\:/^$LTO_H)6'_@0G^- &C16:WB_24'S:GIX^MR@_K2_
M\)9IG_02L/\ P(3_ !H T:*SO^$LTO\ Z"5A_P"!"?XT?\)9I?\ T$K#_P "
M$_QH T:*SO\ A+-+_P"@E8?^!"?XT-XPTI.NIZ>OUN4']: -&BL[_A+M*_Z"
M5A_X$I_C1_PEFE_]!*P_\"$_QH T:*SO^$LTO_H)6'_@0G^-'_"6:7_T$K#_
M ,"$_P : -&BLUO%^E(.=2L!];E!_6E_X2[2B,C4M/(]1<I_C0!HT5G?\)9I
M?_02L/\ P(3_ !H_X2S2_P#H)6'_ ($)_C0!HT5G?\)9I?\ T$K#_P "$_QH
M;Q?I2C)U*P ]?M*?XT :-%0VEY#?P++!+'/&W =&#*>?45-0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/_%/1KCQ
M%\,?$6GV@)NK[3+FWA'J[Q,JC\R*_GR_X(L_&CPQ\(/^"+W[=.@>(=7L-/UK
M3[[4_,LIIE2=_/LA;1L%)R09@5XSR*_HM(R0?2O@S]IK_@W _97_ &L/COJ?
MQ$\2^#=4M==URX%UJL6DZO-8V>I2@Y+R1(=H9CRQ7!)R>M2U?F71JQ496:?9
MW/RS_8D_X(U_&;_@H_\ \$8?@5_PK[Q[8?#TZ)KOB&]G%_=7EM]MBN+E%B9?
M(!R/W3')[$8[UX)_P5&_X-_/CY_P3W_9*U#XC_$#XP:%XP\.V>HVME)IEKJ%
M_-)))*6"OMF4)A<'DG//'>OZFOAK\-=!^#O@'1O"WAC2[/1?#^@6D=CI]C:I
MLAM844!44#L /Q]Z^,/^#B[]DKX@_MK_ /!-+6? OPS\/R^)?%-UK=A=QV4<
MT<3-%&SEVW2,%X!'&<UI*?,R(QLC\0_^"9__  ;Q_M!_MZ_L=^&_B?X#^,>@
M^$O#.NS7<5MIESJ.H0RP&&XDA<E85*#<R,>#R#SS7O/_ !"-_M:?]'#>%_\
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M=_"[1]<T.[NM<%W;K''% C"5MA?>=IXP%R<C&:_:S(SCO0!_.;_Q"-_M:?\
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M<0V4,4J9'!VNK#(X..*].H _G-_XA&_VM/\ HX;PO_X-]6_^(H_XA&_VM/\
MHX;PO_X-]6_^(K^C*B@#^3#_ (*H_P#!%K]H/_@E3\"](\=>-/C-:>)-.U?5
METF.VTK5M1,J.T;N'/FA5QA".#FO5/V/_P#@VP_:=_;#_9B\#_%#0OCQHFE:
M/XXTJ+5;2SO-7U/[1;QR#(5]BE<CV)'O7ZI?\'/7[$'Q0_;P_8K\*>%OA3X5
MN/%FNV'BF.^N+:*>*$Q0""53(3(R@@$J,#)YZ5]/?\$EO@QXE_9W_P"";/P8
M\#^,=,DT?Q1X8\+VMAJ=D[H[6TR+\R%E)4D'N"10!^+'_$(W^UI_T<-X7_\
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M0V&D:3'%*\=Q<S/A6E,8++$BAG;&"0NT$$@U^9.L_P#!<#]MS]AF/X0_$O\
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MBU/!VB6NIWG]HHBNA>*)I6:621$ 5ID4+G).>#@U[?\ "_\ X*(_M"_LI?\
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M\/$8U1HQ]D"B#[,4WR)][,^<9^Z.E?G_ /LX?\%EOV[O%_\ P5 \&?LZ^,O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;OQQXRUOP]-);:J_A;2([NUT^:-PDD;RS31!BK?*2FY001G/%? &H_%30_\
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M84444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>j19i.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j19i.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (R P # 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJO[1-KXIU#2_!=G:7&LG3S::3:7"V4!8R2QV$D.\QJJ.<,-[*A(#9!/Z!?\
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M^Q^LF"=OM7\OG_!;G4+?2/\ @Z6\.W5W<06MK:^*?!4LTTTBQQPHJV!9F8D
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MO_$]MH\NGW=A<WB);R6]S(TNRW97!#0H,DX&XCJ14W2&DV?9JD= <TM?-O\
MP29_:N\;?MN_L(^"_B9\0_#MMX4\6^(3>?;=+M[2>UBM_*NY84PDQ,@W)&K<
MDY)R.,5])5;31*=PHHHI#"BBB@ HHKX-_P"#@?\ X*D^-_\ @DY^REX5\>>!
M-#\,Z]J6N>*8M#G@UN.9X$B:UN9MZB)T._="HY)&"?:DW8:5S[RHKYR_X)/?
MM=Z]^WG_ ,$^OAM\6_%&GZ5I6O>,K.>XN[735=;6)H[J:$! [,P!6-2<L>2>
MU?1M4TT]24[A7F?[6'[(7PZ_;@^#.H_#_P"*'AFS\5>%M299'MIV>-X)5SLF
MBE0AXI5R<.K @$CD$@^F45+129^3][_P9P_LE76KM<QZE\7K>!G+BV3Q!;F-
M!G(4%K8O@=.6)QW)YK[X_8A_X)__  G_ ."=OPG;P9\)?"EMX:TFXG^U7DAD
M>XN]2GP%\V>9R7D8 8 )PHX4 <5[1FBJ38F%%%%( QT]J/7BHYY5@B>1V540
M$L6.% '<^@QWK\1_^"P'_!UU<?LQ?M-6GP]_9WM_ WCVUT1&A\2:WJ,<MW9F
M\+@"WM7AE17$8#!W!92S;0?D)*6KL.VES]O,]/>D;(!.3S7+ZC\2M.\&?"&?
MQAXBO+?3=*TO2#K&I73Y$5K"D/FRN>IPJACW/'<U^$OQ1_X.W_CG\<OBUXDM
M?V;?@':>(_!OAE9+E[F_TV_U;4)+-"1]JG2U9$MD8#(4[MO0L3D 6[7825U<
M_H#W#U%%?F[_ ,$*_P#@X(T/_@K?+K/@WQ%X<M? _P 5?#EG_:,MA:W#36&K
MVF\(\UL7^="C,@>-BQ =2&89"_I$,X&>M4U82844$@#FOS9_X+F_\'"V@?\
M!)._TKP3X>\,P^.OBGKME_:*V5Q<FWT_1[4N42:Y*Y=V=D?;$NTD*264;=T-
MZKS*2/TF P,4$ 9)[U_//H7_  =N?M+?L_>-/#MU\=?V>-+TOP?XBVW,'DZ9
MJ.B7MU:DC,MJ]T[QRD @X(P>!E0P(_8OXB_\%0/A3\._^"=Y_:;EU6>]^&LV
MBQ:S9M%&!=WAF98XK58R<"<S,(BI.%8-D@ D5)65WL);I'T:#GI17\Z.J?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX5_#"^CC^,7C6R-Q+J  <^%=.<L@N #P;F0JPB!!"A6<C(0&&[-%)7T/E_\
MX/(_^"@/P^\>>%/!_P"SUX?EL_$/CS0-<3Q!K<\ 64: HMY8H[0N.D\OG;V0
M<JJ)N&6&/-_^"O7PW\8?L5_\&S?[+'PG\2"\T[6=:\0?VEK-FYPUN'2\O$M9
M!V,9N8\J>C1D=JQO^#?S]D;]F/PSXGT[]HG]I[X_?""[\;SW9U70?"FL^,;*
M2XM)RY;[?J2R2EFN2^72)N5.'?+$!?KS_@[7_L']K'_@DYX$^*?P\UW1?&?A
M3PWXSBE?5]'O$O+-X)HI[5W66,E6"W CC.#P3CJ"*<ERQMW:N5!IR\DF>C_\
M$QO@#X<U#_@U:DT"XT^UEL_%?P^\1ZI?AD!\ZX=KQUE;U93''@]1Y:X(P*^1
M/^#(3XEWT?C_ ./?@\R2MIUQ8:7K"H3E(Y4DGA8@9X++(HXZA!GH*]V_X)R?
M\%%OAIX._P"#7'69-1\5:%::WX%\(:YX6N]*EO(TO&OIFN5M(A$3O8S">(J0
M.1NY^5L>.?\ !DE\'KK38OCW\3+R-K?1Q'IV@07+Y6-Y%\ZYG'I\BF D]MXK
M7[<NQD_@2\S^@*BO$_V:O^"C/P,_;&\7W^@?"WXH>$O'.LZ7:&]N[32KOSI;
M> .J&1ACA=[*,^I%>U%B.X-9="CXJ_91_P""$WP!_89_:TU/XZ^$4\4Q>+KN
MWOA</J^KK>64!NF#SW \R/>LA 8;M^ KN"#FOPT_X+=_'K1/^"T7_!:OP9X,
M^!EG'KWV,6?@FWUJT0;=9G2YDEGNU<#FWA$C@2'@I$S@E2*]M_X.9?\ @NYK
M?QK^*VK?LQ_!K7AI?A'2KLZ3XQUN&[6V_MR\W['L1.2%CM(FRLK%@)&# GRU
M._Z1_P""$GP6_8J_X)4> 8_$WB/]H_X#>)_CAXAM!%JNJIXQT^2WT2-L%K*R
M_>9"YP'E^](1QA<+54[Z2[;#EI==6?LCI/AZ#3M'L[1U2Y:T@C@$LB@L^U0,
MDXZG&:_G7_X*9>/->_X. /\ @N3X;_9I\%W\MM\)_ACJ$UGJ%S:8$0-N1_:N
MHD?=9P1]FB)!&0I&!(V?W$_X*.?M+#]E+_@G]\6/B98SJ;CPUX5N[W394(*M
M<O$4MB#W!E>/OR*_)'_@RG_9PCO/#OQI^-VIJ]SJVI7\'A6RN91F3:JB[NSN
M/)WO);9YY,=$5>=WTU$W:/J?MY\&O@]X;^ /PL\/^"O!^DVFA^&/"]C'IVFV
M%LFV.WAC4!0/4GDEB268DDDDFNIQU/K0,]^:*3>MV)*P4444#"BBB@ HHHH
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MAL;>QFNXPP(BDN%+<<8)6-21T*G!'[6T$X&:%NWW$MK'YW_\$]_^#=GX:_\
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M$/\ P5$^) \?C6=6^&WQ$GC2#4-6TNVCN;?6$10J-<V[E0TBJ HD5E)4 -N
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M'#PO_P"#6#_XJD-,ZFBJNDZQ::_I\5Y875O>VDXW13P2"6*0>JLIP1GTJU0
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MIZ^S* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#]H'Q7^U/^R9X,\?>-_A]JWPM\3^)+5I[WPUJ+,UQIY$KHI.]4<!U59 '56
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M 7AOXA^+? VO_%;PCI.C:E;VOC75?#^K7=HD-S)+.D)O'@D&[=(LZJ[DJ6W
M-D\_U6_\$#+;6;K_ ()F^"=:UCXUZO\ 'AO$\D^K6WB#4UE%S9Q.P4V#F5WE
M+02)(K;V)#%@/E"T ?:%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M _\ 8?U;_P!)[>@#] _^#>G_ )0O_L_?]BZW_I5/7V97QG_P;T_\H7_V?O\
ML76_]*IZ^S* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJGK[,H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_@I#X@O_ !;):W_PW^)5^WFS^(_#RJHOY>/GNK9OW<S'NXV2'C+G&*^"9O\
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M-_927$1MY+:3R_\ ED88TG6.0%D,:MD@J1^^Z=:IQTN3?6WD.HHHI#"BBB@
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M90^)?C<7EO82^$O"^I:M%/.P6..6&UDD3)]W51CJ20!R10!_&C_P5AMWM?\
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M\$K/V7/#O['/P'TRSNE2'PY\*M!?4=8N4A,GVBY$32W,^T LY)$K #)P$ '
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MX."OV1/V@OC%9^ _#'QCTB?Q#J=R+.P6\L;NPMK^8G"QQ3S1)&68X"@L-Q(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "H=0_X\Y?\ <;^535#J'_'G+_N-_*L:W\.7H73^)'R1_P $K<E_B& <
M?\3&+_VI7U!\1;;6;WP-JL/AZYM[36Y+9UL9IUW1Q2D?*S#!XS['Z'I7R_\
M\$KN6^(@Z9U&+_VI7UYGCKR:^2X+IJ>1TX7:OS*ZW7O,^LXUFXY[5G9.W*]=
MOAB?'Q^&W[4G)/BK2^/^FL7_ ,:K@_AO\1?V@/BKX\U[PWI/BV ZCX<<I=B9
M84CR'*?*?+YY4]A7WTXQ&QQC KY!_8:7/[7OQ< '!N)/_2EZ^=SCA_ZOC<+0
MIXBK:I)I^^WTN?19/Q#]8P>*K5,-1O2C%Q_=K=R2U.C^$W@+]HG3OB)I,_B7
MQ+I-QH,,X:^B)C<RQ8Y50L2G<>QR,'GVKZ;C(90 !BEVD< 8SQ2@=L_6OO\
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MM3^#_@Z;PO>^*=7U"UU*1]5N[WSXXH8610)Y'"X+L<C!.><\5_3 .@K\,/\
M@^#_ .2"_ '_ +#^K?\ I/;U(T??W_!O#:QV?_!%S]G](QA6T"5SSGEKRX8G
M\R:^T:^,_P#@WI_Y0O\ [/W_ &+K?^E4]?9E !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5^(G_  ><?\@7]EG_ +&W4/\ T&RK
M]=?VI/VL/A[^Q9\(+SQ[\3_%%CX1\*6,L=O)?7*22 RR'"1JD:L[NQS@*I.
M3P 2/P#_ .#G/_@JQ\ _V]])^ 2?"?Q];^+)/!OB*\O=7$>GW=O]CA<6NUSY
MT2;LF-^%R>.G2@#^D*LGQQXSTKX<>#]5\0:]J-II&B:):2WU_?74@C@M((T+
MO(['@*J@DD]A7RK\ ?\ @O+^R=^T_P#%W1/ ?@KXOZ3JOBOQ'/\ 9M,LI-.O
M;7[9-@D1*\L*IO;! !8%CP,D@'\I/^#LC_@M,?&.M7G[+?PSU8G2],F5OB!J
M-I+\MW<(0R:6K#JD;!7FQU<(AQL<$ ^ _P#@NW_P5SU;_@J]^UU=:CIUS>6G
MPM\'/)I_@_3),H&BW8DOI4[33E0Q!Y5!&G523\]:3^R)XBNOV0-5^,M[&UEX
M9M=<M] L-Z$'4IY$D>0H?[D8C )Y!9\#D'&E_P $]/V(_$7_  4!_:BT+X>Z
M$SV=K<;K[7-4*;HM%TV+!N+I^WRH<*IQO=T7JPK]7/\ @N]\,O#WP3_X):Z#
MX3\(:9_9?A;PSXATW3].MA@M%$L-UAI&'61R&=V/+.[GO7R'$7$T<#C<)EU/
M6I6FE;M%;O\ 0^;SK/8X3%8?!PUG5DEZ1ZL^C?\ @WM_X(;?!OPMX;^$O[2E
MIKGCB7XB6&GQZD+)K^ Z;')<V;1N&B$'F%<2N5_><8&2<&OV@ P3UQ7P?_P0
M[^%_B?PS^Q-\%O$ ELCH&O\ @;3)I(Q(WFX-LC1G&W&1G!Y[GTK[OZYP>M>E
MD&*Q-;#/ZW!PG&4EKU2>C7DU8[LFKUZF'_VF#C)-K7JD]&O5#J***]T]8***
M* "BBB@ HHHH **,T9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BC/;O1N'J* "H=0_X\Y?\ <;^535#J'_'G+_N-_*L:W\.7
MH73^)'R1_P $K/\ 6?$/_L(Q?^U*^O">?QKY#_X)6?ZSXA_]A&+_ -J5]>'K
M^-?+\#_\B:EZR_\ 2F?5<<_\CJM_V[_Z3$:WW6':OD+]AG_D\#XN?]?$G_I2
M]?7K?=>OD+]AG_D\#XN?]?$G_I2]8\1?\C/ ?XW_ .DCX>_Y%V/_ ,$?_2T?
M8%%%%?:'R(4444 %%%% !1110 4444 %%%% !1110!Q/[1/P5TS]H[X#^,_A
M_K,DD>E>--%N]$NI$ +Q1W$+1%USQN7=D9XR!7\YWP9^/'[?/_!N/J'B#X26
MOPO_ .%@?#I]1GNM(NI]!N]3TF9FY-Q:7-JRM&)%4,\,ARIR2JDDG^C#]H[X
M<W_Q@_9\\=^$=+O(M.U/Q3X=U#2+2[E+".UFN+:2*.1BOS *S@DKS@<<XK\%
M-+^(7_!4_P#X(ALL6N:5??';X6Z61EW\SQ-:) N1E9TQ?VP _P">@"*0/E(Z
MRM'ZE+8[#_@E+^R-^U+_ ,%3?^"J7AK]K/\ :9\/:EX0\,?#V$3Z!9WNFOI<
M=S*@D^S6UG:R9E6".21IFE?)9@!N8D[?WP4 XSUK\PO^"7O_  =#?"3_ (*$
M?%'P]\-/$'A7Q-\-OBAXBF-I:6$B_P!H:;>SJC,R)<(JLAPC'$L:@8QN)QG]
M/4'<5;>B(75]1U%%%(84444 %%%% !1110 5^&'_  ?!_P#)!?@#_P!A_5O_
M $GMZ_<^OPP_X/@_^2"_ '_L/ZM_Z3V] 'Z!_P#!O3_RA?\ V?O^Q=;_ -*I
MZ^S*^,_^#>G_ )0O_L_?]BZW_I5/7V90 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 <'^T=^S-X"_:Y^%=[X(^)/A;2?&'A74)(Y
M9].U",M&7C;<DBE2&1U/(92".1G!-?S_ '_!TU_P35^!?[#MC^SZWPH^'&B^
M"F\5ZYJ%MJYLI9W-]'&+38C>9(W \Q^F/O'/:OZ!/VD?VA/"O[*'P*\4?$?Q
MOJ0TKPKX/L)-1U"XV[F"*.$1>K2.Q5%4<LS*!R:_E@_X+=_\%>/B9_P56L?
M'CJY^%Z^!/@_X8UW4(/!E_<1R2SZM= 0&<2SDB.1D5(B5B4*A8J68\T ?I%_
MP6OT7]D[_@A+\,M*UWX/?"'P9HO[1OB1)D\&7:&:YE\-I@QRZL4ED=0T88K$
M2N3*01D(^/YRYKB_\7Z[)+,]WJ>JZI<;V=BTUQ=S2-DDGEG=F.<\DD]R:]0_
M;4_;2\=?\% _VC=?^*/Q*U&&^\1:WM BMT:.ULH4&V*VMT)8QQ(,X!)))9B2
MS$G]'O\ @V4_X)@V_C3Q%>?M3_$?34F\%_#ZZ,'@ZQN$^77-:7I.%(^:*V)&
M#T,V/^>3"N;&8NEA:$\17:48IMM]DC'$8B%"E*M5=HQ5W\C[5_X)8?\ !.J#
M_@F9^R+::/K5I$GQ=^(T4&K^,Y2H,NE0XW6ND@]0(P=\H'65B,L$7&?_ ,',
M_P (6^&O_!%33+NZ0IJFL^/M)FG!&#&GV6]V1GZ Y(]2:^L+QO&6H^$?'?Q!
M\/>$;KXB>(O"NG7&L6>A12^4VNWRJ6AM0W)&2,X )(7: 20*_(?_ (+??\%0
M?VJ_VP?V++;PC\9?V7M6^#_@ZW\1V=^FNW&E:E;(;F.*X2.#=<*$RRNYP.3L
MX[U^2<!82KG>9UN*L8M'>-%/I%:7^?\ F?G?"6'GFF/J<08E:.\::?2*Z_/_
M #/WG_X(R_\ *)O]G/\ [)[HW_I''7TQ7X(?\$R_^"P?[:G@7X!?!'X>^'OV
M,]=\4> =,TG2M&LO$"6&I0)J-@J1QK="X93 @:/Y]Y.P=<XK][8R2,D$>QYQ
M7[(?I0ZBBB@ HHHH ***"<#- "9YQS2URGQB\?7/PP^'6J:]:Z3>:Y-IT7F+
M96Q(DFY X(!( !R< D '@U\TG_@IAXD)!'PJUA0/6:7_ .,UX.:<1X'+YJGB
MI--JZM%O\DSV\KX<QV80=3"Q32=G>45K\VC[ R.":08R.!FOC;3_ /@J7J^K
M/*MG\.+R[:$XD$-X\AC/H0L7!X/%=W\"/VXM;^+WQ,T_P_=?#K6-)AO=Y>\:
M1W2W"J6!8-&H )&,YSDC@UP8/C;*<34C2HU&W)V7NR_.QWXS@G-\+3E5KTTE
M%7?O1O;?:]SZ0HIL;9%.KZT^5"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I'.%SZ4M% 'FW[2?[0UM^SCX+M]9NM)U#5TN;I;58K4 %"59LL3P!\I'U
M(%>''_@J_I*JQ/@K70!R3YT=?6LUO'<(5E174]0P!'ZUPO[16E6L7P'\7LEM
M;J1I%U@B, @^4W-?*YYA<T]_$83$J$8J_*XI[+N?2Y)BLK7)0Q>&<Y2DES*;
MCHVNB/ D_P""L&CN R^#-;<#C*SQD5Z=^S'^V79?M*>(]1TVV\/:OI,FGVXN
M#+<8>)@6V[=PZ-SG!ZC/I7,_\$Q+""Z_9J1I(8G8:E<<L@)QE?6OHVVLX;4M
MY44<9;KM 7^5>?PU#.,31HX[$8E.,E=QY4M^EST.)9Y1AJU; X;"N,HMI2<V
M]GV9.IR,U#J'_'G+_N-_*I@,< 5#J'_'G+_N-_*OM*W\.7H?&T_B1\D?\$K/
M]9\0_P#L(Q?^U*^O#U_&OD/_ ()6?ZSXA_\ 81B_]J5]>'K^-?+\#_\ (FI>
MLO\ TIGU7'/_ ".JW_;O_I,1K?=>OD+]AG_D\#XN?]?$G_I2]?7K?=>OD+]A
MG_D\#XN?]?$G_I2]8\1?\C/+_P#&_P#TD?#W_(NQ_P#@C_Z6C[ HHHK[0^1"
MBBB@ HHHH **** "BBB@ HHHH **** .*_:-^)5Y\&OV?/'?C#3[./4;_P *
M>'M0UBVM)-VRZEM[:298VV_-AB@''.#QS7X&:'9_\%4O^"W_ )=R^HW_ ,"_
MA?JF&61#)X6L&B)R"JKNU"Y4CD$EHSQR.*_H*^(_Q T7X4^ ];\4>([Z#2_#
M_AVPGU+4KR8$QVMM#&9)9& !)"HK' !)Q@ GBN6_9F_:Q^&W[8_P\_X2SX7>
M-=!\<>'C+Y+W>F7(E%O+@,8I5/SQ2 %3L=58 @XP120[V2/S_P#^"67_  :Y
M_##_ ()]_%C0/BAXG\8>(_B3\4/#\YO+*[/_ !+M,L9V1D9U@5F>5L.PS+(0
M<YV@\U^HRKM%+SN]J*JY-M;A1112&%%%% !1110 4444 %?AA_P?!_\ )!?@
M#_V']6_])[>OW/K\,/\ @^#_ .2"_ '_ +#^K?\ I/;T ?H'_P &]/\ RA?_
M &?O^Q=;_P!*IZ^S*^,_^#>G_E"_^S]_V+K?^E4]?9E !1110 4444 %%%%
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M*** "BC-% !1110 5Q/[1_\ R0;QC_V![K_T4]=M7$_M'_\ )!?&/_8'NO\
MT4]<&9_[I5_PO\F=F7?[W3_Q1_,\G_X)??\ )L:_]A.X_FM?1J_TKYR_X)??
M\FQK_P!A.X_FM?1J_P!*\KA#_D38;_"CU>+O^1SB?\;_ #%J'4/^/.7_ '&_
ME4U0Z@?]#E_W&_E7O5OX<O0\&G\2/DC_ ()6?ZSXA_\ 81B_]J5]>'K^-?(?
M_!*S_6?$/_L(Q?\ M2OKP]?QKY?@?_D34O67_I3/JN.?^1U6_P"W?_28C6^Z
M]?(7[#/_ ">!\7/^OB3_ -*7KZ];[K5\A?L,_P#)X'Q<_P"OB3_TI>L>(O\
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M"_\ P2[/BK_@E-HO@J/Q+<_#KQ3\2)HO$FIZ];$1RI&Q!@@F9G3]P(0C$;@
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M/-&>>WM7Z3@L%1PE%4,/'EC'9'YQC,96Q565?$2YI2W9C_$+_D1-:_Z\IO\
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M+,_]TJ_X7^3/F\N_WNG_ (H_F>3_ /!+W_DV9/\ L)W'\UKZ.KYQ_P""7O\
MR;,G_83N/YK7T:[$*2".*\KA#_D38;_"CU>+?^1SB?\ '(\D_;>\&W?CO]F;
MQ/9V,;S7,4"W:QH"6<1.)& '<E5/'>OCCQ'^VI>Q?LO^'/ /A])[&[CM#:ZI
M=@$,8PQ"QQ'KEEP6/H<#DFO?/V]?VS$^&6FW'A#PW<J_B.\CVW=PA##38F'3
M_KHP/ _A')ZBO!O@Q^PKX^\6^!K+QKI5Q9:3?),+G3K:\4AY47D2\@A>>0&'
M(YR.,_FG&..Q&*S:5')G*4U#EJ..MHIWT??_ (8_2^#<#A<+E,<1GG+&#J*5
M)2;5Y6M=K^7K^.QRWPW\4^,_V+/B;I&K7NFW=E'J5LD\ME-E5O[5N2I]'4\\
M\JV 1@D'W#X.^+8OVE?^"AB^+-%BF_L;1M/#O*R%21Y)C /H2\C#W"'J*X#P
MGX6^*7[>YN;/4M>TR6S\,3[7DN((XVBD8$841H"V0O<@?I57]EOXU:C^QC\;
MM1T#Q1:/:Z==S+;:JA3+VSKG9.IQEDP2>"05.>PKYK*<14PN(H0JN:P;J*2E
M-:\RZ7N]+GTF;X6GB\/B)TE!X^--QE&#=G&33NDTKM1_/T/T@D&(F&><&OD#
M]AG(_:_^+G?_ $B3_P!*7KZULM0AU;3X[JWECGM[A!)$\;!E=2 001U&.<BO
MDK]ADC_AKWXN8_Y[R?\ I2]?K_$,D\QR]I[S?_I)^.Y!%K+LP3_DC_Z6CZYO
M)FM[2:0(TCQJ6"CJYQT_&ODV\_X*%^/K:[FC'P?UE0CLHWBXW  XYQ"1GZ$C
MT)KZW*AB> 13?+7& JD5[>:X#%XGE^K5W2MO9)W^\\?*L?A,-S?6<.JM]KR:
MM]Q\;+_P4Y\5OKKZ8OPSG.IHNXV@N)C.!@'.SRMV,$'..E;.A_\ !0/Q[J>L
MV=L_PBUH)/,D;%!<;@"P!/S0@9 .>2!ZD53T) ?^"K>IC&0+#&,?].D=?7GD
MK@$* 5]J^.R+#YOC75E4QLDJ=1PMRQU2M^9]CGN(RC!JE&&"C>I3C._/+1RO
MMKT'1-O53@@D9(/:GTQ<EA3Z_2HJR/SEL****8@HHHH **** "BBB@#P_P#X
M*4>&_$'C/_@GU\;M)\*K._B+4? ^L6^GI I:665K.4!$ Y+-RH Y)(Q7Y$?\
M&I_[>G[*W[.7['NL>&O%WB;P7\.OBX=8N+G6+_Q!+'92ZS:G!M_*N9<*4C0%
M3"&!5@S;?GR?W>U&^@TNRGNKN:&VMK9&EEEE<)'$J@DLS'@  $DGIUK^;K_@
MHOI'_!);X^?M$>(-=L?B/\1_!^MWMY)-JLO@31Y9]$O;@D[Y8DGMV0;G.282
M(V/*CDDS'=^8[:'3_$;XO_";]L+_ (.H_@7KG[,<5E?6VF3P2^*];T2V,.GZ
MM- MP]W.F  RBU(B:4#$C="W!/\ 1(IP,G.ZOQ2_X(6?M'?\$YOV:OC]I7@3
MX":AX\U[XJ_$4_V1'KOB71YVNYU"F4P+)L2*",^66(11N*KN)P,?M:ISSZ5;
M5HI$-NX^BBBD4?/W_!4R/QC>?\$Z_C-9_#[0M4\2>,]5\*7NFZ3IVG(7NIYK
MF,V^8U')*B1GXYPM?@I^R%I__!1C_@CK_P $^=3\8Z!\+?#'ASX6Z)J\^O:[
MI_B/2H)=:E#"*&2>>!G%PD"B)!E=K!<M@K\U?T!?\%"-#^+OB#]COQU#\!]:
MMM!^+,=D+CP]<3V\$\<TT<BNT!$ZM$#+&KQAG&%9U.1C(_#3XB?\%H_VN_BI
M^P)XO_9?\??LZ?$KQ%\;_%*7/ANY\2MHD\)EM+B1@Y:TCMPIF5&:)61A&5VO
MU!!F-U>W4I6:5]KFI_P7D_X*;6W_  4A_P""!7P6^(.BZ<?#9\2_$$:;XCT>
M.0O'9WUI979>)6P-T99DE4D9VNH/(->@?\%[?A'H6D_\&S7[,\MM8PPR>&X?
M"SV3*@4QF?27$PR/[Y8L0,9(!/(J]\1/^#?;XF6W_!MSI/PH@L$U'XSZ'XD/
MQ);0XI4+">2-H9=/C<':TRVK#H2&E0J"00:^2/CY^T-^TU_P5=_8X^ O['.E
M_L]^.="\0_#^[M+/6=9O;*YAM[K[' UI;R3>9"JVT:1,SRL[G+*-OH;EK>,>
MZ$GJGTU'_P#!0?QM?_';X[?\$P=$\3&6_P!.O? /A)KB"Y^?SVGU)+>9F!X/
MF1V\><YR,9KZ0_X.JH%^'7_!57]D/QGI,3PZ^)8%,T Q)(+;58)(@".209G'
MXXKJ?^#@+_@DY\1/AA\*/V7OB;\$_#U_XTU']FK1[#0-0L["W:YNV@LFAFM;
MM84^>1!-'+Y@0%@)5., D>0FZ^,__!QI_P %<_@GXQU+X*^*_A9\+_A(+.76
M+C5(IO(C$-S]KG FEBC5Y)I%2)(T4L% 9N Q%QE[RMT;)2:3;['>?M__ /!V
M[\6?V0OVV/BC\+]&^%OPYU72_ ?B.[T6UO+R>\%Q<QPR%0[[) H8XR0  #7Y
MO?\ !7?_ (+N>.O^"P'@SP7HOB_P5X1\*0^";VYO;:31Y;AWN&GC1&#^:[
M! 1C!R:_K0\0?LI?"[Q;KUWJFK?#7P!J>I7TAFN;N[\/6D\]PYZN[M&69CZD
MDFOQ(_X///@?X*^$?P/^!<_A3P?X6\,37NNZHEP^DZ3;V33JMO 5#F)5+ $D
M@'(&368(_2'_ (-U;QM0_P""+'P!D8*K+H=Q'A<XPE_<J#]2 #]:^UZ^,?\
M@WIC6/\ X(P?L_A551_PCSG@8Y-W.2?Q/-?9U PHHHH **** "BBB@ HHHH
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MFI^#_P#KU?\ ]&O7CQ_Y*A_]>?\ V\]G_FF/^X__ +8>O4445]F?(F-\0O\
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MW3^R6GQT\+-KNBP*OBK28CY:C ^WQ#DQ$_WAR5)Z'(Z'CC/^"5W^L^(?./\
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M6_\ 2>WK]SZ_##_@^#_Y(+\ ?^P_JW_I/;T ?H'_ ,&]/_*%_P#9^_[%UO\
MTJGK[,KXS_X-Z?\ E"_^S]_V+K?^E4]?9E !1110 4444 %%%% !1110 444
M4 %%%&: $Z XP#2 GTS2@@YQGFOQ%_X.D_C9^T]\./VC/AK;_ _XB^)O"/A>
M;P]*U_:Z'XGATB22]%R^7E7S(W<&(Q!2<KPV #DG*I5A!7F[&E*C.J^6FFWY
M'[<MQ]3UKYO_ ."CG[6UC^SC\(+VV34;?3=4U&UEDDNI) BZ;:*#YMPQ/W<#
M(!/?)[5_+%:?\%'_ -MR]^)TG@V/X_?%Y_$42DM;?\)U($&$WG][Y_EGY3G
M8^G7BO+OCO\ M[?'CXG:5XA\(?$7XE^+/%:WD\<.HC5=5;4I6,#-B(3%F/EA
MCDJK;25!YQ7FYMAZ^*PSP^%J*+E9-]5%[M>=MCU<HG2PN)CB,93<HQOIWDEH
MGY7W.D_X*7?M[7G[9?Q5-MIDMQ!X$\/R-'I-JV5-RW(:ZD7/WW[ _=7 ZEL^
MF_\ !,W_ (-\OCO_ ,%1OA-J_CGP</#OA?PO97 M;'4?$DT]M#K<H8B46_EQ
M2,ZQXPSE0NX[020P7K/^"!__  0HU_\ X*L?%I?$WBN*_P!#^!WA>[ UG4DS
M%-KDRX;^S[1B/O$$>9(.(U/]XJ*_K$^&OPUT#X.> -'\+>%=(L- \.>'[2.Q
MT[3K*(106D*#:J(HZ  ?4G)R22:Z\OR^C@</'"X=6C%67^;[M[LYLSS*MCL3
M+%8AWE+^DEY(_D0_:V_X(U?'3]F[]O\ ^$/P0\8>,_"NK_$#XEQ62>'M3M]3
MNI[2PC:Y>V@6262%9$"/$<!58*NW'H/VD_X(P?\ !(?]L3]B+]K1?%WQD^/T
M7B_P%#HUQ8R>'X?$FI:NE[*P A.RYC5(A&1N#+EN-N,,:\I_X+9#_CIP_8B(
M[QZ3_P"GBZK]O\8&#S79<X+F3XO\)V7CCPOJ&D:E")['5+>2UGCR1NC=2K#(
MY!P3R.17Y _&#_@GGJO[#/Q@\06MM.=3\)>)K3_B173,/.4J3NMY1_?7<N&Q
MA@0>#D#]$?CO_P % =#^!7Q(N_#=YX?UV^N;)(W>:((D3[E#?+N(R,'&0,9R
M.QKY=_;*_:XTK]I<>'?[/TK4=,.C2R._VHH?-W;<!=I/(VGKZBORKCS.,JQ&
M#GAN>]6+5DD[K57UL?MWA74XBRO%)X>#^KUE>5[-.R;B[7NG?3T9\;?L8?M3
M>+O^"67[0VJ0>)?"6H*NH1QVFM:3<L]O<+&K;EFB&?+=ADX8@JP) 8 DU^SW
M[-7[6O@/]KCP*FM^#-:@U*$ "ZM7^2ZLG(^Y+&?F4_F#U!(YKX]_:G_:"^#?
M[8?@==(\8_#[7I;JVC*V6IV[017M@V/O1R;LXSSM8%3W%?$/B/\ 9U^+G[##
MZ9\6O 5WKJ^%KDEK76[6(H\,8?!BO81E0A(QDAHVX((/ ZLGSZC0?U?"3]M3
M2NU9J45UO=:H_0,\R'+>-XK$XV/U',G:*YFO9U6EHEKH]/7_ !'WY^W%\'=*
MUS]K'PMX>TRULM!/B6!1/<Q0@)+*\CJ'901DC '8G/)-?/W[5?[%VL_#>PFT
MWQ?ID4VE7[K'!J=J1Y<KC)0+(?F1OO?*PYYZC)J*S_X*3:=^V9H7AT>(!:^$
M_BOX9E#65S&VRQUM<A@L;,?W4P90P1S@G< QSBNU_P""BO[4$O[6G[%L7A.+
M2[JU\<6>JVD]Q;@!8IA&'#NK$_+U!VM@C) )QFOA\URS*ZN-Q-6I4=*;?-3D
MM(O36+7=,,BPW$^2XK!9?7@XQ3Y*E];>]I.,KZQM;796L[%;P-^T'H'A?X3V
MWA&Z^&_A"_CM--734U*.%(;]@L>P2F38?GX!R,9/UJ?PI^U9K'@[]F:^^']@
M]S!/>7K2?;4< 0VK@%XEP=P8N#R.,,<<UOVGQ1TKQY^SMX&^&WA3P9!JWC8Z
M/:6-_?/8H9;>1(D60(V,[L@YD)  R<GJ-W]J']C:/X"? OPCK$=L;R_M)MGB
M&:)FVR&0@J!Z*IR@/&<@GK7F8NCF\G4Q&$Q'M8TX6E-*RL[75[:VWOT//>*R
M=8B.&Q]!PG4JMQC*3E=QO:33>BD]$NNFAY%\(OVTKC]G[1Q#;? 32?$VH D2
M:G/XAC>:89_A1H#Y:X_A!_/K7-_'S_@HY%\9($T^Z_9XN-"UB1U6"_TZ_9YE
MYY&Q+<"4<_=)Y[$&O;?VJ?@)X \"?L7ZU\6_ U_J-V^GP0RQV5Q=+)$KO*B-
M&_ =67>>"<Y ZYYX3X;?L\WOCG]D'1/BW)K^C:7:ZK:O.]A/O1PZR,GEQL,[
MV8KP, \XZ9-=M:.=8?!?5YT:<Z7+S7CR[=[O6_F>SE];A>K'^V*M"49.K[*[
ME43]I:Z7*I-6MTVZ'V/_ ,$V?C9?_$;X57NB:O+-+J'A:5+=7FSYA@928PV>
M=RE67GG &>:^D6<#D\"ORT^#_@?XM:)X=/BGP/9^)(=.NG*-<:<P;SRAQS'G
M+@$D9*D9S[UU.K_MR_&#PYH=[HFM3O!)=PM!YMYIQMKJ'((W(1M&X9ZD'!KZ
M+(?$.."RZG3S&C432=I6NFEMK^I^6<0>'CQV:5:F5UJ;BY?#S6<>^FO6Y]'_
M +5?[=OA#P;I>N>$[!;G7M8NK6:RF^R;?)M6="I#.3@D9R0N<8P<&OGO]@K]
MLOPY\ ='U/3M5M[J[L=6O5D^WV;+-';D(JD, <G Y.W)P>E<[\!?C_X1^%'P
M]U_3[[PK<7NOZU:7%N-8$B2/'YB,JJ%;E%R<G!))R3G@5YW^PCX\T_\ 9G_9
ML\3^#/%OA2T\3W6OZHUY&OV@+! GE(@;?MW!\J2"HR!CD&O%J<4O%8BGFLL7
M"$XJ5H<K=NT7U;?<^OP7!5##Y1BL#]6G-\U-7YDG/5WE'HE'>SWZGZ>?$+X]
MZ1H'P$U3QSI5U;ZII]O9-<6SQMN29SPJGT^8@'/3G.,5\U_LG_ +1_B-H%]\
M5?B?=6NIW.LS226JZA,%@4*Q4R,&.#R,*I^4 #CICYJ\(_$'Q=?>"]2\#Z"U
M]=:-K4OVF73H(?M#G:0Q*X!( PI., X!K=^!G[/'BG]ID36NG:M8QVFB@(\=
M]>,3;J<D%(L$[<^P&>,YJ<1QI/-<;0DL,ZO+%VAM%U.^N]EWV/,H<$1RC!5U
M/%JE>2O-:R5/HM+6;EVT9)_P2+^ =E\6_%GQIT[QKI4UW9SWL,NEO<$AXD,M
MP-\#9RHP%Z8R-O!&*^@_V5+[5?V7_P!JG5?A/?W<E[H6J*USIC/_  G:75AV
M!90RL.!N0$>_Q=^SE^T1JOACQGJ.N>&GNK#4?"VH/I]V""\,OSNH5R.&1PA.
MTX((..0#7U=\#_']Q^UG^W-HGBN'3WT^#0],#W:%@P5E1EX(Z@R2<=\"MLKS
MJE.OAZ2I>RQ4:B325E*#>M^]CV./,HQKQ6,Q&+:>&G23M?X)QC%1:71O?3>^
MI]UJ"!S0_P!P_2D4CL#0[#8>>U?OB9_,Z/S3_8Z_Y3P?&K_KPN/YV-?I:WW3
M7YI?L=?\IX/C5_UX7'\[&OTM8@#)Z"O+RC^%/_'+\S](\4/]_P +_P!@U#_T
MV@W'V_.@$^G%8EU\2?#]E<O#/KFDPRQ$JZ/=QJR'T()X_&H_^%J>&3C/B#1?
M_ V+_P"*KK>-H)V<U]Z/SU8:LU=0?W,W^.IP32-D\X-847Q.\-RNJ)KVC,SG
M  O(R2>P'-;@;S &7D&M*=>G4OR23MV:9G4I3A\2:]=#YI^-/[8_COX<_$K5
M-&TSX8ZGJEA8.$BO )F6Z!4'>I2,KC)QC)/'.#P.'UC_ (*7^-/#MY;6^H?#
M=[">\;;!'/)-$\QR!A08\L<D#CN<5]F&,<DJI_"OD/\ X*&!1^T!\(0% !OQ
MV_Z>;>OSSB?#9K@Z$L72QDK<R2CRQLN9I;^1^@<+XG*L97A@Z^#BVHR;ES2N
MW&+??K8/^'@/Q*P /A)J;?\ ;.Y_^-U]._"[Q9?>._A_I.KZEI-QH=]?VZRS
M6,QS);,?X3P#[\@'!Y /%;L<*^6A"J<CTJ+4=3M]$L)KJ[FCMK:W0R22R,%1
M% Y))Z #UKZC*LOQ>%;J8O$NHFMFDK?<?,9IF.$Q2C#"X54FGNFVWY:GR_\
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M[;_3<(C(OUD4=Q7?G^)Q%'!3GA$O::)7\VD<F04,-7QL8XQM4TFW\E<_IB^
M'P,\(_LU?![P]X&\"Z)9^'?"GARS2TTZPMEVI%&.<DGEG8DLS,2S,22222?
M/^"LW_!7/P1_P2)^%WAGQ3XU\->+O$\/BO4WTRT@T.")O*=(_,9I9)71$&,
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MRO\ ;L^%,_Q5_9WU>VTZW,^I6&R_@1%^>3RSEE7ODKG [G [UY]>_P#!9O\
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M '[[_P!+JSXC_P"1G@/\;_\ 22^&O^17F/\ @C_Z6C[0UBW-_I-U IVM-$R
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MP_X/@_\ D@OP!_[#^K?^D]O7[GU^&'_!\'_R07X _P#8?U;_ -)[>@#] _\
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M#'#S=XM*5ERO\3]+X!X8GBLPPV)HU8M\R?+JY;[:*UW;N?HG^R81_P ,T^"
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MS^8-;-G_ ,&[GPNC&+CQAX[E/^S-;)_[1-?H128/K7V$<CP"VI+\3X^MXO\
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MA%_P7]_X*-?'S5KK3_ ?COQEXVO[&'[3<VV@^ =.U*:WBW!=[K#9,RIN(&2
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M<)?\%$?A%XU'ASQ;\1/%?A?Q$RQN-*U;P+IMC>E7^X?)ELE?#=CCGMFO1O\
MAZQ_P5L'6P^-_P#X9^'_ .5U ']3%%?RS?\ #U?_ (*V?\^'QO\ _#00_P#R
MNH_X>K_\%;/^?#XW_P#AH(?_ )74 ?U,T$9&*_EF_P"'J_\ P5L_Y\/C?_X:
M"'_Y74?\/5_^"MG_ #X?&_\ \-!#_P#*Z@#^F[XS?"32/CO\+->\'Z^D\FC^
M(;1[*[6&0Q2%&&"58="/7V[U\<#_ (-\/@LARNJ^-@/^PC'_ /&J_%D_\%5O
M^"M8Z6'QOX_ZI!#_ /*ZE_X>K_\ !6O&!8?&_'_9'X?_ )75R5\#0KM.M!2M
MW/HLEXLSC*(RIY9B9TE)W?*[7?<_;#P[_P $!O@MX?\ $%CJ!OO&5T;&XCN%
MBEU) DA1@P#;8PV,@="#CN*^X8HQ'$BC@*,<>@K^6W_AZM_P5K_Y\?C?_P"&
M@A_^5M6=(_X*H_\ !6&;4X$O+7XXPVKR*)9%^#\+,B9Y(']G<G&3BJH82C0B
M_902]$9YMQ#FF<U8/,J\JCCHG)WM>U_^"?T._P#!14G_ (9*\1CTEM/_ $JB
MJ;_@GJQ'[)/A8]1FZ_\ 2F6OQ6\8_P#!1_\ :$\.:9:3_''QM\6K/X;2W<,6
MIMXB^'2:38NQ.8P\ZZ=$R'S I 5P25Q@C(J'P1_P4Q_:!\866I/\"_'WQ7U'
MX=Z?>RVUC_PC?P\CUBSM7X=T$QTZ5BQ9]VUG) << $"OBEB9?ZP/%^SGR>SY
M;\KWYKGZ<^"*O]A?V;];H>T]I[3^+&W+RVM?N?T,*?,7.#D4\# Q7\N&J_\
M!5#_ (*Q0:C.EK:_'&:V5V$3M\'H0S*"<$C^SN"1CBJO_#U;_@K7G'V#XWX'
M_5((?_E=7WL7=7/Q:I3<9.+Z=MC^G'XU\_!_Q3VQI-U_Z):OFW_@D=_R3;Q9
MZ_VG'_Z)2OPGL/\ @J%_P55UF]AL]>TKXX7>B7;"'4(!\(8E,UNQQ(@(TX$$
MJ2,@@C/!%>D_M5?MR_ML_ KX@VMA^S/X9^->D^%+W3XKC4@OPJN+A9;PEAP;
MNQ=P1'L!"D+GL2":^5S#"5IYYA:\8WC&,[OHKVL?699B:4>'\91E)*4I4[+J
M[/4_I)J*Z^6W<?[)_E7\M?\ P]7_ ."MG_/A\;__  T$/_RNIR?\%5?^"M1.
M&L/C?M/7/P?AZ?\ @NKZF<;Q:1\E#='[>_\ !*/_ )'SXA>T=M_Z,GK[9R!D
M^M?S>?M&?MJ_MB_!31/!UU^SMX4^-NCZQK>F+)XM8?"RYN-TX"%$875DZJRL
M9B1& ,,.2,5Y7_P]6_X*U@\6'QO/_='X?_E=7S'!N#JX?*H4ZT7&5Y:/SDSZ
MSCG$TJ^;U*M&2E%J.J\HH_J5?!P>M?-/[1W[#][XG\=_\)Q\/-6_X1OQ2&\R
M9<F.*Y?IO#*/E8C@@@JW< Y)_  ?\%5_^"MF0!8?' _]T@A_^5M>=>$/^#A#
M_@H=X^^(9\(Z%\1?%6M>+?-E@_L2Q\"Z;<ZCYD08RI]G2R,FY K%AMRNULXP
M:]7-<GP^84O98A;:IK1I]TSQ,JS7$Y?6]MAI6;T:>J:ZIK9H_8[X7? [X@2_
MMJ>,K[0[X67Q-U6"2#6KTW2+$(_W.\IA<*?EBY4 ]>G-?;?[*7[&MG^S_-=:
MUJMZ==\5Z@#Y]ZX)6(,<LJ9RQ)/5CR?;I7X8^/?VXOVS/#7[-'A;QCX)\*_&
MVV_:#UBZ:/Q3>#X57#L\($F\M')8FV4,1;$&-<_*>G(/E/\ P]6_X*UG/^@_
M&\?]T@A_^5U?(<*<,*#EB<;S2G&<N7G=TDG9-)]7W/N>-^+:^*=.A0E%0E3@
MI<J5W9?"WO9=%T/Z0/VDOV3/#?[2FF1?VCYEAJUHI6VU"W \U!_=8'ATSS@]
M^1CFOSQ\7?L"Z-HW[5EGX DAT&YU*^EC"ZD=/"H T;29*9Y.%QC/)[U^9W_#
MU;_@K7G'V#XWX'_5((?_ )75ZGX<_;2_;%UK]EO6O''B#PG\;9?VD++44CT>
M]/PLN0WD@QJKB);(6I58S,IWH3D\@D@TN,.%:&)E3Q%&G[\IQ4G&ZO%[MV_,
MVX XTQ^71K898EP@J<W%-Z<W2W^74_3_ ./'_!#K_A:G@^SL],^)%]IES:H#
M)!+IJ264[YX.U2K+@=!N8#TKY,\8?\$=_P!I']F[4I-4\'2C5O()87/AG5WM
M+D@=]C&-B>V 6S[BOA\_\%5_^"M6>+#XWX_[)!#_ /*VC_AZO_P5KP/] ^-_
M/_5((?\ Y6U[\.$LNIP4*$7#SBVGZ]3KR;QLXFP,71JSA7IMN\:D(M.^^J2?
MXGVKH?\ P4Q_:H_9(O(['Q:VL3PQG:(/%NCN2>>TP",P)XSN(]*Z/Q/_ ,%)
M/&'[7-U<>*]0TO1]$NO 5HLVG0VVZ5&N!F5I'+<D%HX_E[ $9))-?GYJ_P#P
M4T_X*M>(+"2UU'0OC#?VLP*R17'P9MI8W4C!!#::000:ZO\ 8N\9_&G1?@U\
M1XOB3\$?C';>)[FT>73A;?#O4HDU=V24>4J16WEQ,'9< !5"GH IKYKBO(\Q
M^I<F&J2J*\=-VM5J?H'#7B%P?F-=U<RRZGAJZ3M.&D6G\2MHDVKVW[7/T,U7
M_@XR\4?V!;0V/PWT2&_$"K-/<:I(T1EP,LJ*@.W.2 6R./K7G>L_\%T?V@O'
M\KQ:%:>&K%W^4+IVCRW4B]LC<[\_4'Z5^7OA7XH?MX_#N[F/AOX+^/M.MVE:
M2)+GX,1ZC)$"2=OFW.GR2$#.!EC@5I_$;_@M_P#\%"_V7_[.M?%WB#Q+\.6U
M!'-C%JWPTTO1S=(A <Q"2P0L%+*#MR!N .,C/T5+*\SG!>VQ'+Y)+\]#PL3Q
MYP%@JLEEN2JI9Z.I-M/SL^8^\O"WC_XF?%+]HB\U_P"*1\0OKFH:,WV=]4LW
MLP8%E0#R8RJJ$!S]T<DDG))-0? /]G?]IKXN>#'G^&\?CU?"8NYTMC:ZXVG6
M;-O.\QAI4!&XG)48)SSD&O%?V,/V]?VOOVI/%]OJ7[0&@_%GQ5X&?1'O?#VI
M6OPMD6"1Y3&ZO'/8V2LZ21 E3N*,=IZX-<-)_P %,O\ @J9X1GDTSPMH/QJT
MOPW8L8=,M4^#\($%LI(B3G3CT0*,DDGN2>:^<P'"U59SB)59RY.6-I;.3ZJ_
MD>]C_&ZE2RJE5P."HJ<G;V<ES0@H[-+3>Z[=3[:'_!*/]K/QD^=2@U(%SR=0
M\6"7\]LCFKMK_P $(OC_ *TZC4+OPI"#WGUB:;^49KX7'_!5C_@K6/\ EP^-
MX_[I!#_\K:/^'J__  5K/6P^-_\ X:"'_P"5M?4KAC"?:E)^K/E)_2 XDVHT
MZ,/\-/\ S;/N#Q1_P2;^)?[&FO:#XMUN30M7T07+07DVE22-]@9T94:0.JDJ
MS';D9P< XSFND_9__P""-7BC]L+5O$'C+5=>C\&^';Z_D&FLUI]IN-00$AI
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M"7A:Q_:":T32_#=Y-<:0T_B)]%432HJR?,LB;\A5X)..O>F!RG_!O3_RA?\
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M10 4W:V.O-.K/\1^*=,\'Z/-J.KZC8:5I]N,RW5Y.D$,8]6=R%'XF@#\U?\
M@[D&W_@C/XC. #_PD^CY_P"_YKC_ /@S4RW_  2FUW)! \?ZCC_P%LZ^^?VH
M?V9OA!_P5&_9SNO!'BZ:T\:^!;V]ANI3HVLE5::!MR8FMWR"#U ;FL[]DK]D
MGX)?\$GO@=+X.\%36?@?PA?:K+J1&M:XSB2ZD2-6(EN'S]V-!M!XQG'-#8[G
MT$ >^":*J:3K=GKVG07EC=VU]:7*AX9X)!+%*O8JRG!'N#5L$'H:!","1Q1A
MAT(I:* "D.[/M2T4 -V'UI5! P:6@D#J: "OY7?^"*#$?\'1\AR>?&/C'_T3
MJ-?U!^-_B?X:^&=I;7'B3Q#H7AZ"[D,4,NIW\5HDSXSL4R, QQS@<XYKY;^
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M&) B(!V"JJCZ"M2F[7T)5[!1110,R/&LNJQ>#]5?0X;:?6X[.9M/CN&V127
M0^6KMV4OM!/89K\$OA+_ ,&Q_B/XR>$_C;\7/VY?B!K.D^,9%N-0L-6TW7[>
MZM;9%B>62]N'=&S&C85808PJ*0,97'[^WEU%96LL\TB0PPJ7=W8*J*!DDD\
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M0\1^(+'PEH-]JNJ7EMI^FZ9;R75W<SR".*VB12SR.QX554$DG@ $U?K\T_\
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M:!H\*"=S(,98 ^R?\&3GPUOM$_8]^+WBFXMY8K+Q!XLM[*UE;A9OLMJ"Y7U
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MDOY,GAHW<&7MXF7YA,MI;.COG(DD;;@*"?EG]IG_ () 6W[$'_!'#X&?M?\
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M)IT\_!]"!(..U?4=$_B9$-@HHHI%!1110 4444 %%%% !1110 4444 %%%%
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MPCX<A,5I:HS2.S,Q9Y9'8EI)'<LS,Q)))]A7HM%).RL#5PHH P,"BF 4444
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MCE_C%\'?#/Q^^%FN^"?&>BV7B'PMXEM'L=2TZ[4M%=0L.5/<$'!# @J0"""
M:_.3X:?\&B_[)7PY^,MKXKDMO'OB&PL;L7<'A[5M92;3"P;<J2!(5EDC!Q\K
M2'(&&+ D']1**$K,;VL0VUNEG;QPQ1I%%$H2-$4*J*!@  <  <8'2IJ,#&,<
M44P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&<*
M,^M*#D9K$^(+%/ .N,I*LMA.01P0?+;D5_*)_P $6/\ @FE\0_\ @LAXS^)F
MG0?'_P 6?#P?#^.SGWNMUJGV[[3)<*!@746S;Y'7+9W=L<J*N[#:5KG]:IQ@
M@GI0,;0 :_F)_:=\&_M;?\&P'[2G@+Q5%\7]3^)WPX\43LGE7%U<MINKK"5,
M]E<VDSN()2C[DDC<D9)5@0RU^^'Q:_X*C?!/]GW]E#PC\9?'WC;3O"G@WQQI
MMMJ.C/<AY;K4!/ LZQ0P1*TLD@1AD*IV]\#FA;76Q+6MCZ'H(R,5\%_ 7_@Y
M:_8Z_:'^)6F^$]'^*+Z7K&L3I;67]MZ-=Z;;SRNP54\^6,1H6+ #>R@GO7LF
MK?\ !6;X"^'OVSH?V?=0\<I8?%JXNX[&+1+C3;N+S9I(!/$JS-$(3OC92I#X
M)( )) +L] /I"D VYR:\1_;8_P""B7P?_P""=OA71=;^,'C"'PEI_B&[>QTY
MVL[BZ>YE1-[ )"CL %P22 !D#.2!7IOPM^)NC_&?X;:#XN\/7$EWH/B?3X-4
MTZXD@>!I[>9!)$Y20!URC X8 C/04+4'YG14444#"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC@/'9)$G/(=67@Y!_HPT31;3PWHMGIUA;Q6=C80);6T$2A8X8T4*J*!T
M]J_GV_X,K_V+CK'C;XG?'S5;/?%H\*>$= ED4G]]+MGO)%SQE8Q;ID=I7'K7
M]"JX*@'O3DK:(B]W<4=!1114%!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% "'! )/ K\]_^"G?_!NC\)_^"I_[2=A\2_&?
MC'Q_X>U*VTN#29[/19K5;>YBA>5D?]["Y5_WK#/(P!P.<_H23CZ4'/89I6!=
M3RS]CK]C[P%^PA^S]H/PR^&VD-I'A?058Q+)(9;BZE=BTD\TAY>1V)))P.@
M   ]3HHIM@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>j19ii.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j19ii.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (6 L8# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA_:,\.W?AZ'XD^,ET0ZE+-IBRV3_ &J&5Y=L);"Y**1@\<CO7P)X-_X.#O\
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M_P")GQ#GNWLHIUL=-TRR0/>ZS>.K,EO"&(4$A68LQ"JJL2> #^+?BC_@]/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_"H/<DX [U]/_P#![SXXLT^%GP#\-K>P?VA/JNJZD]IN4RB)(8(UD(ZA2SL
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MX)_?\%/O#WQH\/?$?3+_ ,!>%I[S[#H=U92OJCPS6,MLHDG!$9??)O)"@8R
M!QC2_P""S/\ P; V?[?OQ^N/C%\)O&=E\/?B%JSQRZS::A#(VGZE/& J7<<D
M7[R"?"KN(5@Q4-A6R6::7+Y*PY/F<O,YW_@])\8^&+/]@+X>Z!?7%G_PEE_X
MUCO-+MR0;C[/%:7*W$BC.0@,D2D],LHZXKI?^"0G[)UC^W+_ ,&N.E_"J]6(
M'Q?I.N6]E)(H9;:]75+F6UEYZ;)TC;Z \UX'XF_X- /B?\<?AC?ZI\4?VD;G
MQ?\ %<FVM=+N]0^V:CIVFV2$F2-I)W,\K'("@"-4^8X8D$?J!_P3#_98MO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %?+_P#P5A_X)A^&_P#@K#^S1:?#7Q-XAU7PO;6&
MMP:W!J&GV\4\\<D4<L>S;)QM99FR00>![U]044FKC3/SH_X):_\ !M;\%?\
M@F)\8D^(UEK/B7X@>.K.*2#3+_61#%;Z0LB%'>&"-0!*R,R[W9B%8A0"23^B
MR?=%!^\*!]XTW*Y-A:***!A1110 4444 %%%% !1110 4444 %%%% !1110
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M<=*_'?\ X+B_\$6/@[X#_9O_ &L?VG-2M]2\4?$WQ-IT=]I[ZA(OV+PX=]I
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M*_<WPO&>4U:T*3RNG[S2W[NW\I^9/Q[_ ."G'[0?ARSTP^%M2^V2S.XN%M]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU@VI?V;!)+F,'EE>9S"I&<LC#M7'?\$Z/^"M?PH_9W_X-T?CA\'/$&O1Z?\
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MIC(P01WZ]QC%=7^WM\%=&UOXO>-=)TZ6X'AZYUV74-%OA'RNRY,T+C/RMM8
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MXO\ X[2_\1"'P8Q_R"/'&?\ L'Q8_P#1M:\'_!!3X#31(_D^+AO4'!UA\_\
MH->5?MO_ /!'/X/_ +/W[*7CCQEH$/B0:SX?TU[JT-QJC2Q!P0 2I7D<GBO3
MJSSF$'-N%DF^O34^$R_"^%F+Q5/"4HXE2G)15W&UY-)7UV/K?]BG_@H%X-_;
MJM_$,OA"TUNU'AMH$N?[1MUA+><'*[=K-G'EG.<8XZU[PA.2":_,#_@VZ0-I
MOQ;X /G:9_Z#<U^GXX)P.M>KE.+GB<)"M4M=WO;;>Q^;>)7#N%R/B/$Y5@K^
MSIN-KN[UC&6OWCJ***](^&"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMS\=KT:E&;IU4U);IZ-"-;HQR0"?>@6Z?W5S]*?16Y%V)L'I7SW_ ,%4N?\
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M'_!1G_@ASX9TGX0/9)>Z1\7M7U*X%[JW]FI]G.EV4.5;^/,@(QV(/O6)KO\
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M /?P5^<__#N[XP?\^-G_ .#9:/\ AW=\8/\ GQL__!LM'^NF<?\ 0MG][_\
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M!-CXO^&?PR_:9M=(^ ?C;4X[W4-$OX[M9YE0@IYT$0\F:10JC<'C$AC0L!@
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M,8P<5\N?\&NN?^%<?ME^WPTC_P#0[BOZ'/\ @I-&H_X)U?'TJH&/AQXA[?\
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ME1GFOEC_ ()2?\D6UW_L,-_Z*CKZG'W17%P'_P B'#?X?U9V<=_\C[%?XO\
M(^(/^"_?_)B:?]C%8_RDJK_P;]_\F17O_8RWG_H$-6O^"_?_ "8FG_8Q6/\
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M,&W>8[=/+&,8ZGKQ7V30 4 8&!110 4>^.:** "BBB@ HHHH **** "BBB@
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M6<;33SS.(XH449+,QX  !)). *L03+/$KJZLK@$$'((QUK\,/VD_^"S7Q/\
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M8,FLZCH5Q*\5G;0@$33K,D;J%09,B@A2FXE>M?T(5\Y_\%<\G_@EU^T'G/\
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MXNARJ'+R+96MKO=6WW')WI: ,# HKV3\O"BBB@ HHHH **** "BBB@ HHHH
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MW.^6!V%2,-N&K-]D2D]/-V/ZCXY%D4,K!E89!!R"*Y[XQ_\ )(_%/_8(N_\
MT0]?DU_P0@_X+1_#[X)?\$:_ ^K_ +0WQ"7P\GA_Q)?>!]+U&^M[N^EO8[>*
M*YAC/D1R,/+AG6,%@!MB49)XKZ#^)G_!R'^Q3KOPX\06-G\=-*FNKS3;F"%/
M["U92[M$P4<VH R2!R0*J4;.P)GX_?\ !F1_RE,\5_\ 8@7W_I995_4/7\N?
M_!FA>Q0_\%4_$L3-AY_ &H",<_-B[LB?R [U_48#D9I#"BBB@ HHHH ****
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MSN:_4FORS_X-R9 -?^+"%OF:WTPX]MUS_C7ZF5["9Z284444 %%%% !1110
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MQ5_Z]-._]#N*_5"OJT?01V"BBBJ*"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I' ) /0TM(WY^U)@?G'^U];77P6_;@D\0RP.UO
M)>6FLP<8$R*$#@'UW1L/;(K[0^)/@G1/VN/@DMC!JTL>CZVL-PEU:[6?"L'
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M"148^SO;SNCYK,LWQ>8\'.OC)N<E62N[;6\D?2B?=%+2+]T4M?K9^2A1110
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MM5:*;P_'IEG*! A1I5198FFN$A26/S9#(K'<Q0#:0KMK;L"6ES^C^N;^,?\
MR2/Q3_V"+O\ ]$/7@G_!(+_@H5#_ ,%.OV#O"'Q5>PM=)UN],NFZ]86S%H;/
M4+=]DHCW$L$<%)%!)(65022"3[W\8_\ DD?BG_L$7?\ Z(>J:L2G<_F<_P"#
M,C_E*9XK_P"Q OO_ $LLJ_J'K^7C_@S(_P"4IGBO_L0+[_TLLJ_J'I#"BBB@
M HHHH **** "BBB@ HHHH **** $V#WKP'_@JR /^"9?[0![CX?ZW_Z0S5[_
M %X!_P %6?\ E&5^T!_V3_6__2&:@#\3O^#'_G]H+X]@_P#0O:7_ .E,U?T7
M[![U_.A_P8_?\G!_'O\ [%[2_P#TIFK^C"@ "A>E>-?\%#O^3&/BS_V*U_\
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M[E15]0:V/Z6-'^'>@:#XQU;Q#8Z%I%GKVO")=3U*"SCCN]0$2A8Q-*!OD"*
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MH **** "BBB@ HHHH **** "BBB@!I!P2.":_-[6VCLO^"C;MK.!"/%*EB_
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M(;VRG_V=V6"DCT8'TKW#1O\ @J'X#\/:3;6-CX5\0VMI:1K%%%%%;JJ*!@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1\7O^Q5O_P#T2U>V5XG_ ,%(O^3"/B]_V*M__P"B6H ^#?\ @W0_Y*A\3_\
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M4SQ7_P!B!??^EEE7]0]?R\?\&9'_ "E,\5_]B!??^EEE7]0] PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O$_^"D7_)A'Q>_[%6__ /1+5[97
MB?\ P4B_Y,(^+W_8JW__ *):@#X-_P"#=#_DJ'Q/_P"P59?^C9*_5ZORA_X-
MT/\ DJ'Q/_[!5E_Z-DK]7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FOD\"G4QB5)/
MXT ?S:_\% /V7=:_X+._\'//B?X*>(_%]_H'A;PI:);12QJ)GTZPMM/BN94M
MHV.P22S2L=QX!<L0=H!Q--_8FU3_ ((%?\'$GP'\)^"?&VK:MX2^(=UI\2SW
M86*>YT^^NGLI[.Z"#9(5=-P8*!GRVP"..E_;Z^#O[9O[,O\ P7C^+_QU^ /P
M=\<:T^H3BUTW6(_"TNJ:?=6\NGVT4A3Y=K8*$9'0@BO"OVG-"_X*/_M>?M4_
M#[XR^-?@-\0+KQS\,6MFT.:V\"RV]O$;>Z:ZBWQ!</B4DG/4<=*(.W+^)4U\
M7IH?U;X Y/:E '4 <U^$O[%G_!1#_@J5X]_:X^&VB?$OX4^(M*^'VK>([*U\
M17<OP\-HEM8O,JS.9MO[L!"QW=NM?NRGW13L0GT%HHHI#,CQQXST_P"'7@O5
M_$&KW*6>DZ%93:A>SL/E@@A0R2.?8(K'\*_"S3O^#AW]MO\ ;QUSQ]XL_9<^
M OAN^^%7P]=FN)M1M'OKZ6-<L [&XB#S-& Y@@1F4'JW!/[NZWI%IXATF[L+
M^UMK^POH6@N;:XB$L-Q&ZE61U;Y65@2""""#@\5^57_!9[_@K3\*?^".?PJU
MGX-_ ;PAX2L?C5X\B+)H_AK28;2TT)[B,1K>W44"J'N63;Y46"S$(S80 /)4
M;'KO_!(K_@NUX?\ ^"AW[$/C_P")WC'18? ^L?!Z*2;QA;6TC368@2W>=;FW
M+?,%=(Y1Y;$LK(1N8$$_GUJ7_!S5^V;\7O!?C7XY?##X$^#V_9Z\!ZJEE?SW
MUM/=7$$;%2!-,EPA+['C+M%$4B,B;L@Y._\ L^_\$S?&?_!-O_@VD_::UOQO
M%<:7\0OBQH2ZKJ&EMS+H]DI2.*"4=IBDLSR#^'S IY4UO?\ !'C2=/N_^#3C
MXW)<Q0&&XT[Q?).'( 9Q;84D]C\J>G054VDV^R%%;+N['ZI_\$V?V\- _P""
MDO['/@_XN>'[.72HO$43Q7NFR2B633+R%VBG@+ #<%=25; +(R-@9P/5?C%Q
M\)/%7.<Z1=_^B'K^9+]A+]L']IK]D_\ X(>^';_]G-?$8U;4/B_JUIJ!TGPW
M'KSFU&EV3@-&\,HC'F'A@JDG(R>E8^O_ /!9C_@J'JNA7UKJ"?$O[!<6\D5S
MN^%5NB^45(?+"Q&!M)YR,=<BKG'4B+.C_P"#,C_E*9XK_P"Q OO_ $LLJ_J'
MK^6G_@S9NIXO^"K^MHF[RI? .I>;\N1Q=69'/;FOZEA]WC-04%%%% !1110
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MG188YDC3<LR;TR^,$Y']*@(#8'>@J,D<^M-O6XDW8^4?^"*__!/&X_X)C?\
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M4 %%%% !1110 4444 %%%% !1110 5X?^W?_ ,%#_A1_P3;^%=CXQ^+?B-M
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M[_RB9_:-_P"R>ZS_ .DDE 'Y#_\ !CI_R-_[1G_7GH/_ *,OZ_H1_"OY[O\
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M_P#*)G]HW_LGNL_^DDE?3-?,W_!9W_E$S^T;_P!D]UG_ -))* /R'_X,<_\
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M6>:PL[CQ%H]IJ<MLER'%NTT"2% >X4MC)P3B@#A_^"CI/_#!_P 6?^Q:O/\
MT U\0?\ !N6-WB'XK_\ 7#3O_0KBN!_X*A?\%8O$/QD\5^)?AOX$NH=.\!6Y
METN_NTC62?7L$K+AB#L@R& VX+ 9)P0H^9OV1_VT?'7[%OC2?6?!MW;BWU Q
M)J=A=0"2VU%$)*HYQN0\OAE((R>HXJ':^K[$MK9G]$*KMSWS2UYA^RS^U+X=
M_:G^!NA>-]*FBLX=6A(GM)IE\RRG0E98FZ9VN#@\9!!P,XKT-O$%@HR;VSP/
M^FR_XU91<HJDGB+3WSMO[(_2=3_6G?V_8?\ /[:?]_E_QH MT54_M^P_Y_;3
M_O\ +_C1_;]A_P _MI_W^7_&@"W15-O$.GJ,M?68 _Z;+_C2)XBT]_NWUDP]
MIU/]: +M%5/[?L/^?VT_[_+_ (T?V_8?\_MI_P!_E_QH MT54_M^P_Y_;3_O
M\O\ C2/XAT]!DWUF!_UV7_&@"Y15*/Q%I[_=OK,_2=3_ %IW]OV'_/[:?]_E
M_P : +=%5/[?L/\ G]M/^_R_XT?V_8?\_MI_W^7_ !H MT53;Q#8*,F^LP/^
MNR_XTB^(;!_NWUFWTF4_UH NT54_M^P_Y_;3_O\ +_C1_;]A_P _MI_W^7_&
M@"W153^W[#_G]M/^_P O^-(WB+3T&3?68'_79?\ &@"Y15)/$6GN,K?63#VG
M4_UIW]OV'_/[:?\ ?Y?\: +=%5/[?L/^?VT_[_+_ (T?V_8?\_MI_P!_E_QH
M MT53;Q%IZ];ZS'_ &V7_&D7Q#I[<K?V;?\ ;93_ %H NT54_M^P_P"?VT_[
M_+_C1_;]A_S^VG_?Y?\ &@"W153^W[#_ )_;3_O\O^-(WB*P09-]9CZS*/ZT
M 7**I1^(M/<96^LV'M.I_K3O[?L/^?VT_P"_R_XT 6Z*J?V_8?\ /[:?]_E_
MQH_M^P_Y_;3_ +_+_C0!;HJFWB'3T&6OK,#_ *[+_C2+XBT]^1?61_[;K_C0
M!=HJI_;]A_S^VG_?Y?\ &C^W[#_G]M/^_P O^- %NBJG]OV'_/[:?]_E_P :
M1O$.GIUOK,?]ME_QH N45%;W4=Y$)(9$E0\!D8,I_$5+0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!\A_P#!>G0;KQ)_P1W_ &@[6SB>
M69?"<UP54$G9$Z2N<>R(Q_"OSC_X(_\ C_2M"_X-./CI/<7D*KI=GXLM+D;@
M3%++;+Y:8]6\V/ [[AUK]P/'G@C2_B3X(UCPYKEG#J.B:]93:=?VLHRES;S(
M8Y(V]F5F!^M?B3XS_P"#/SQ=I6J^)?"/P]_:=UWPS\$O%NHQWU_X8N=/GF9Q
M&V8UE5+A(;EXQ@+(ZJ?E4D$@5-MUW*3V?8^0OV%O^"37QB_X*:?\$-/"^D?"
M^?1+:ZTKXNZOJTO]LZA)8Q-;G3+.WS&RH^\F16!X !4\DYQGC_@T(_;) (.H
M_#,D]?\ BJ)__D>OZ0?V(?V.O"/[!'[,'A+X4>!XKE/#_A.U,*37)5KB]F=S
M)-<2D  R22.[G  &<   "O6N ?<UI.5V9Q5E8_E.U+_@T6_:]\*6-]?2/\,X
MK:PMGN99H_$K@,J*690/(W9P#U 'O7Q]_P $X/\ @G9\3O\ @I_\;-4\!?"V
MYT6'7]*T:77)SJ^H/9P_9HYH86"LJN2V^=.,=,G/%?VI?%HX^%?B;_L%77_H
MEZ_F@_X,M2/^'H?C89Y_X5K?<?\ <2TVI*,+_B$(_;*_Z"/PT_\ "IG_ /D>
MC_B$(_;*_P"@C\-/_"IG_P#D>OZG** /Y8_^(0C]LK_H(_#3_P *F?\ ^1ZR
MO'O_  :<_M>?#OP+K?B'4M1^'!T_0K&?4+H1^)IV<Q11M(^T>0,G:IP"1D]Q
M7]6->>_M;'_C%/XFD\?\4GJG_I'+0!_&M_P39_X)L?%/_@J)\6=:\&_"NZT*
M'6=!TDZQ=-J^I/91& 2QQ$*RHY+;I%XQTR<\5]H?\0@W[97_ $$OAG_X5,__
M ,CUV7_!E*1_P\+^)@[_ /" 2_\ IPLZ_IIH _EC_P"(0C]LK_H(_#3_ ,*F
M?_Y'H_XA"/VRO^@C\-/_  J9_P#Y'K^IRB@#^4?XG_\ !J3^US\)_AIXC\5:
MMJ/PZ.E>&=+N=5O!#XEG>0P01-*X53 ,MM5L D GN*^5/^":O_!,7XK_ /!4
MOXC^(O"_PJNM!AU3PUIBZK>G5]2>RC,)E6(;65');<PX( QSFO[#OVZR!^Q%
M\9"?^A'UO_T@GK\!?^#)$_\ &:GQB]?^$)B_]+X: /,O^(0C]LK_ *"/PT_\
M*F?_ .1Z/^(0C]LK_H(_#3_PJ9__ )'K^IRB@#^6/_B$(_;*_P"@C\-/_"IG
M_P#D>N;^,O\ P:M_M:? WX1>*O&FNZA\.SHGA'2+K6;\0>)9I)3;V\32R!%,
M #-L1L D9.!D5_6!FO$/^"F! _X)T_'DGH/A]KO_ *;YZ /Y$O\ @FC_ ,$N
M/BW_ ,%4?&OB?0?A1=Z!#?\ A.QBO[_^V-3DLD,4DA10A5'W'<#P<8'<U]@?
M\0A'[97_ $$?AI_X5,__ ,CU[#_P9#$_\-/?'(?]2O8?^E;5_1W0!_+'_P 0
MA'[97_01^&G_ (5,_P#\CU\'_M__ +"OC[_@G5^T5>?#/XE3:1/XIL[&WOY6
MTR]:[M_*F0L@#LJDG Y&./>O[C*^:/VG?^"/G[-?[9GQ7G\<?$WX4:'XN\5W
M5O%:2ZC<W5W'(\40VHI$<JKA1QG&?K0!_$YM.>!Q7U?_ ,$P/^"4GQ?_ ."I
MGB'Q7:_"JZ\.1/X%CL[C4UUC59+$.EP\HC"%4?=_J7STQQUS7] W_!2;_@@]
M^R/\%O\ @GO\</%_AGX)>'-'\1^&/ NLZIIE]%>WK/9W,-E+)%*H:<J2KJIP
M01QR#TK\ZO\ @T<\=ZU\//#'[4M_X<TR_P!6U^32= MK&"SMVGD$KRZ@HD(4
M'A =Q)'\..XK#%XA4*$JTDVHIO3\D8UZT:5.562T2;\R?1=&;X>^-M9\/>(%
M&G7EJEQHURS9=;.=3Y;9(Z@,I&1GCFEU*QL_"?@V]LGU"PU&_P!1GB>,6DGF
MK J;B26QC+9Q@=LYKZ.^)'[ _C7X@ZA)J'_"'^,+34IB6EG&DS.)R>27!')S
MW!!/O7/Z%_P31\=V=ZLFH^%_%UU IR8HM&FB#^Q8@G!]@#[U^;QXCPN(7UNH
MJD'HW#E>KCM9V_4^'6=X>M_M,U.+T;ARO5K;6Q\R>-/^#?/]HS_@HE%I'Q)^
M'#^#K'PQ>V9LH?[5UR2SN)WAED5G\M(F 7)P"3DXZ 8KRO\ :6_X-A_VJ/V6
M/V?_ !?\1_%>H> &\->"M+FU?4EL_$4TTY@B4LX1#  S8'0D9]:_?[_@E?-X
MN^& U+P-KWA?7](T5T^V:9+<V$L,%NXPLD62N &&U@,CD-W-=9_P6Z8G_@D1
M^T6#T'@34O\ T2:^XR3-O[0PD<3R.%]T]T?6Y5F"QN'C7Y7&^Z:LT?RP?\$R
MO^"1GQF_X*K-XP'PGN_#<)\%"U_M+^V-6DLL_:/-\O9M1]V/)?.<8XZYKZL_
MXA"/VRO^@C\-/_"IG_\ D>OIK_@QT(^U?M%CG.W03C\;^OZ J]<]$_EC_P"(
M0C]LK_H(_#3_ ,*F?_Y'H_XA"/VRO^@C\-/_  J9_P#Y'K^IRB@#^23]JO\
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M?^S=J?Q0^(M]X*D\+:5=6UI.NF:]+=7!>>41IA&B4$;B,G/ YQ6!_P $X/\
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MAW<_$#QJ_@;X7:3*PL?MMMI4<%S?L?F$$201^;,QV[MJJV I)  )'-_L/_\
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M%7PHNO''Q2\7:5X-\,6CB$W=ZS$S2L"5BBC0&260@$A(U9B 3C )'A'[(_\
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MU\0?$JY5X+S0CIDEW8Y2W-R\,LI0P;UB4ED))!^4C<,#0_:>_;(_9R_X)/\
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MJ7]KOX;?L4?"VY\:_%/Q?I'@SPW;N(OM5Z[%IY2"1%%&@,DLA )"1JS$ G&
M37@O[*W_  6/_91_X*<^*[GX=^#?&NB^*M9F0S+X?US2);9M12/YRT4=U&$F
M*;=VU<LH7<0 ,U^0_P#P=.?'_P .^+_^"R/P?\"?%"YU<_![P!I5AJ.MV6GJ
MSSW$=S<R2W?EJ",RR0PQ1@[ACU')KI_V+?'G["G[:'_!5KX:7^E_#WXG_LJ?
M$SPU+8OX6T2WBM-+T?Q%<POYEOYP5&=)YHRJ;2%69>-Y9AN4%=)OJ.2L?K=^
MUA_P49_9B_X)+VMAIOCKQ#X8^'EQXA)N[;1M(TAGN[L#Y#.UO:1E@GR[?,<
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M&OX8Z#JU]8::^J:_KEW>W<3&WM+8#)6.95RL42@  $D <DU#=MQI7.;\+?\
M!=_]B']K?QSX>^'EG\2-"\9ZOXJU2WT_2])O_">I2Q75Y(X2(#S[01JQ9L;F
M( SU%=M^TE_P58_93_X)A>.K?X<^.O&6@_#;5[FS76(M(L?#UX\7DRNZ"4BT
MMWC!9HW&"0WR@XP03^2__!MO_P $U/"'[;7[:7C;]JVX\!V?@SX6>#/$#1_#
MOPO \C6\5['ADE9I&9I/LT?EG)8AIY"1@1[:\*_X*D_M$>#_ (J_\''?Q$U+
MQM\)=>^/'A/P7'_PCD7@[1Y9HI]0DM; 1%F:%6<)'<O*YVC^$=LU;2NEW$EO
MV/WY_8T_X+ ?LZ_\%!?B-J'A/X0?$6#QAX@TK3VU6ZM%TB_LS%;+(D1DW7$$
M:G#R(, D_-G&,D?3..2:_(G_ (-S?VB_V,/CQ\4O%C_!3X-/\#OC)I^E/;ZI
MHUYJ,]Y+>:=YT9=H)7<JZK*L0=2BNIV\$$FOUVQVHDK;"6Y\[_MT?\%4/@1_
MP3>L]-;XN^/;#PU?:RIDL-,B@EO=0NXP<&18(59Q&""-[ +D$9)XK)_9-_X*
M(?LU?\%9?#U_9> O$?AGXA_V&RW-[HFJZ85N[+DJLYM;I Q7)V^8JE06QD$X
MK\>/^"ZFC^$_V/\ _@X=\!?&7]H+PQ;_ !'^"?B?3()(]&1X;R6-;:T-L0]H
M[C<D5RRS[7 CE!8 DAP'?\$*H?!W[7G_  <-^/\ XQ? #PQ:?#7X,>'-'N'?
M0WF@M)YUGMTMQY=G&YV))<!IRJ9CBPH)!*@J*NKL<E8_6;]JO_@KG^RI_P $
MM_$-IX$\:>,-!\&:O+&+L>']$TB6XEM4DY$LL5K&5AW]1OVLPY (YKW/]EG]
MKGX<?ML_"6T\<_"WQ;I?C#PQ>.81=V;,K02J 6BEC<+)%( 5)1U5@"#C!!/X
M)_\ !!K]GOP)_P %6_\ @K5^U1X]^-GAG2_'XA:ZGM=/U>/S[>%KN]DA5@AX
MS%;Q"-#G* @K@@$>@_\ !JY?W/[.?_!5#]JSX#Z?>3-X3TN2\FM+9W9PLFGZ
MFUK&XS_$89L,3R=J]<"G"-[7WM<<EO;HTC]]:***0@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ I&0-U%+10!^ _QB_Y77/"/_7.V_P#4
M=DK[*_X+K_\ !5O2O^":/Q=^$9\9?L^Z'\2_!_B.X\P>*]1,4KZ#+%<(9XH(
MG@?]^L.R9/WB;B,#[I(^V=0_8E^$>K?M%P?%VY^'/A"?XGVV/*\4/IL9U2/$
M)@&)L;AB(E.OW3CI73_&?X$^#/VBO -[X4\>^%]"\8>&]0P;C3M7LDN[:0CH
MVQP0&&>&&".Q%3%6BEV"3NVS^=[_ (../VWOA5_P6)^.W[.WP_\ V<9_^%A^
M-WN9X&U*TL)[=D-X\"PV9,B*Y*E'D?C;&.<Y+8_HZ\':5/H7A32[*YF,]Q9V
MD4,LF23(ZH S9ZG)!->.?LT?\$R?@!^QSXGFUWX8?"7P5X.UV>,Q-J5E8*;P
M1G[R+*^YU4C@A2 >^:]V5",'-6G[O*)N[N^Q\"_\'!O_  5WD_X)2?LCP7/A
MI+>Y^)WC^:72_#*3J'BT_8@,]](I^^(0Z!5.0TCH""H85^,'_!$[]L']D3]G
M;XJWO[0?[3OCWQ?XY^/6HZC->V4%QH-UJ-OHDA8C[:\Q!$]VXY5ONQ*1@;L%
M?Z0?VC?V%O@Y^V!?Z3=?%+X:^#O']QH22Q:=)K>FQWC62R%2X0N#M#%%) Z[
M1Z5YK_PY*_9&Z_\ #.GPBP/^I<M_\*F.C*;NK'Y ?\'!'CVU^%'_  5._9!_
M;&L;+4]0^%VO:;H6J1W9M65F6TO#>-&5/W)6M;E&"G!)5L9P<8_[?O[2OA#_
M (+<?\'!/[-6B_!2^F\7>$_"!TQK[5$L9HHBD-ZU_>/MD56$<<*JI+ #?D#/
M&?WY\??LJ?#?XJ_!.#X;^)O _AC7/ -I;0VEOH%[I\<UC;Q0J%A5(V!";% "
ME<%1T(KF_P!E_P#X)[_!+]BFZU"X^%/PP\(^!KO5D$-Y=Z98JEU<1AMP1IFR
MY3/.W=C(!QP,5%V:\GH3+5>J/9AT%?G#_P ''O\ P6(O/^"7/[,6GZ-X)FB7
MXL_$L3VNASN@D71;:,*)[\J>"ZF1%C!!!=MQ!"%3^CP& !7C_P"T;^P+\%?V
MO/$.GZM\4/A?X+\>:GI-N;2SN=;TN.[EMHBQ8HA<'"EB3@=SFHDKE1:3/YVO
M^"&?[8W[&?[&?BN?XY_'WQUXO\<?M!:Q<3W,9G\/W>H0>'6D=@\PF(/GWDH)
M+3$D*'VKSN8_I]_P62_X+)>&OV$_B3\"=:\2? '1_B/\/?'UM;:M9^--22-[
MC0P98Y)8X(7@<BX2!HIE'FH6)Q@;21]1_P##DO\ 9&R<?LZ?"+/_ &+D'^%>
MU?%+]FKX??&_X2CP'XP\&^&_$W@Q8HX4T;4=/CN+.)(UVQA(V!"%%X4K@@="
M*MRVT)1_/+_P<1_MF?##_@L7^U9^SEX#_9ON?^%A>,$EFM9-4L[&> @W<L!A
MM2TB*Y$?ER2N2-L8).<E\?TBZ!93:;HMG;32M-/;P)')(<DR,J@%N?4C/XUX
MU^S/_P $T/@'^QOXCGUKX8?";P5X,UJYC,,FH6.GK]LV'J@F?<ZJ>X# 'N#7
MN>".A-"VL#WN?GG_ ,%O/^"SGBS_ ()$>)_A?=1?"Z'Q=X"\:W36^K:\][)&
M=,>.1#) D2KM,K0%WCW. Q1A@A2:_);_ (+_ '[5_P  O^"AWQ[_ &?-*_9(
MTVVU?XDK<E9=1\.Z')I<Q>:2 V5J1LC9YHI!(^0"(\GYN3C^DWXO_!?PE\??
M -_X5\<>&]$\6^&M479=Z9JUFEU:SCJ"4<$9!Y!Z@\@@\UY;^S;_ ,$O_P!G
MS]C_ ,82^(OAI\(O!/A#7Y4:+^TK.P!NXT8894E<LR C@A2 1P<U,>ERF]#\
M9O\ @X*TW5/V'?\ @M/^RO\ M&>++6]OO"]M:Z*NL7T,)=3<Z==LUVBXX\PP
MRK(J\%N<9P<<]^V7^T7X4_X+:?\ !QI^SGI_P8OY/%G@SP.-,EO-62REBB>.
MUNY-1O'VR*K"-8PD>64 OD#.1G^@'XY?L\^!_P!IKX?7/A/XA>%- \9^&KQE
M>73M7LDNK<NN=KA6'RN,G##!&3@\UR'[+W_!/[X*?L5RZC)\*?AGX1\"W&K(
M([RYTRQ6.YN4!R$>4Y<H#R%+8!YQ50E9IOH[H3U6G56/858D\U^?_P#P7,_X
M+%^,_P#@D18_#C6M,^%MOXU\'>+KZ2RU;69;Z2(:1(C1L(=BK@R2PF5D+.H)
MB88.#7Z [!ZFN<^*/PD\,?&_P)J/A?QEX?T;Q3X<U>+RKS3-4LTN[6Y7L&C<
M%3@\@XR" 000#4KN-'\V7_!PW^V;^SE_P4-\0? ?2/V6-)@USXH37S/)>:#H
M+Z7=1BX\L6]BWR1M)<>>2P #",@D,-YS^@_[>O\ P6+TS_@F;^VM\$O!?QQ^
M"&BZO9W.A:9/<?%6=4N[ZU<1&.[DMHQ;EPT%QDLJ3%MLFX#+ '[J_9U_X)9?
MLZ_LE>.CXH^''P>\#>%/$>QHTU.TT\-=0*WWA'(^YHP1P=A&1QTKO_VA_P!E
M7X;_ +6_@8>&OB;X)\-^.=#602QVFL6*7*P2?\](RPW1OCC<I!QQG%4FDK)"
M>]S^?K_@IG^T/X'_ ."P'_!?']G&U_9P=_&%QX:ETQ-6\165G+!%,+>_-Y+)
MN=5<QVT 8F1@!EBH)P,_TB1\+@9R/6O'OV7O^"?OP5_8LDOI/A5\,?"'@:XU
M-!'=W.F6"I<W* Y"/,<R% 0#M+8R <9%>Q ;1ZT.UE'YB>KN?C7_ ,%Y/^"-
MG[4?[>W_  4'\$?$_P"$NI>"W\.> M&LDTBV\0:D!'9ZA'<RS2R"UDADC8,?
M(R6!#; "" !7YE_&OX6_MIV'_!=;P7X=\3^-_#%U^U-/;VIT?78Y+<V$,9LY
MFC#$6XCR(1(#F(\GOP:_K'(([FO,?$/[%_PF\5?M!:?\6-2^'GA*^^)>DJB6
M?B:73HVU.V"(T:A9L;AA&91SP"1TI4Y6:\BF[IGX&?M?:SK/_!+'_@X\^"GQ
MK^-\LPTWQ-X=TB[\1ZW;P&>W:[.BC2M1E38OS".X4RE44$(ZD*,@5T?PE^*N
MC_\ !7;_ (.P_#_Q#^&,LNO?#OX<VT-ZVKFU>**6WL;)D\[#J&4/>3*B%@"0
M0<#M^[G[1W[)OPU_:]\$Q^'/B=X(\-^.=$AE\^&UUBR2Y6WDQC?&Q^:-L<94
M@XXSBJ'[,?[%7PF_8Q\.WNE?"KX?>%O EEJ4@EO!I-BL,EXRC"F63[\FT$@;
MF.,G&,FG&6U^A+7XGJ8X%?BW_P %I_\ @C5^UG^V'_P5"T/XV?"+5_! TCP5
MI^GIX:77]3#?V9=0%I'=;:2"2+'G-OR0<D D<#'[24A7<"">M3;6X[G\GMY\
M+/VV!_P7R7PY+XW\,']K#[&I77Q);?V?Y7]D!@,_9_*S]C^7F+.[WYK]7/V\
MO^"SVD?\$W_^"@/PB\$?'3X'Z!=6UWHFGW5U\5G1+N]MV:$I<RVL:VV\"&YW
MAE23(1]P4;@I_1>3]C/X42_M%K\77^'WA-OB@B>6/%)TZ/\ M0*(?( \[&['
MD_N^OW>.E6_VC/V3OAK^UYX+7PY\3O!'AKQSHT<GFQ6VKV*7(MY.F^-B-T;8
MXRA!QWJN;1+L-VNS\ /^"@?[0'@K_@KU_P '#W[.S?LXJWBD>%I](.L^)+*S
ME@BN5M+]KR:<EE5S';V_R^8P&6.T$@+G^D'&4)]:\A_9@_8%^"_[%D5]_P *
MI^&GA'P+-J:A+NXTRP6.YN5!R$>8YD901G:6(!YQ7L"C;D9Z4-Z*)-[NY^8/
M_!9/_@L!X>_X)K?ML_"72?B)\ M%\4^#M<6WO(OB%=+'<W>C!;DK<K:Q&!F\
MZW!CEPLJEO,& #@G\\/^"X'[5'P]_P""Q_\ P5'_ &;?"?[-DY\<^(M-ECM+
MS7;*RFMT?S+J*=4+2*KE+:..65W(VH';!R&Q_0K\?/V;O 7[4G@&;PK\1O!_
MA[QKX=G<2M8ZQ9)=0K(,@.H8$HX!(#+A@">>37%_LP_\$Y?@7^QCJMYJ'PL^
M%G@WP3J6H1>1<7VGV"B[ECSG89FS)MSSMW8)[' J8Z6\BI/L?BC^WYXUL/\
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MUWX:7O\ 9/\ ::K;B6*:73;TR3VQW?(7:W>-E5B P##H"1S7_!6S]KWX;?\
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M7[_]F^67Q3-X=NM(?6M>M+":U6X2VOS>2LV]%<I!;!@SLH )*@G K[4^/_\
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MATJQAM;:)(+>W18HHT&U8T4 *H'8  #%3'1-=V-N[1_.K\(?C;X7_P""-/\
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M;%^$_CYA9:Q\)["^\6:;8R'EM2MF&GW%NH/7?.;$# Z;CTKWW_@S9_9,OI/
M/Q6_:/\ $R27.M>/M3;0=,NYOFEEAC?S[R;/4B6X=%)SR;=OQ^&_^#JG]F2S
M^%__  5^G;P3=P7&J?&/1['4;_1[&4^?'?2R&V,<B _\MV@CE /5F)QT)_H_
M_P"">?[*-C^Q!^Q3\-?A78I$O_"'Z)!:W;Q]+B\8>9=2^^^=Y6S[THN\>;KL
M$TK\OS/:$&% I:**D HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
..*** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>j20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" %) R<# 2(  A$! Q$!_\0
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M6\'42ZN*WMZ=?1ESI.%5TI?9FH-]%)[)^I^I]%?@-_P:Z?M!?M,:M\._C?\
M$>63PW\3_ MGK%YJGBY-4N]3U'X@^(-3M](!M;?3Y&9H)%?R[>+]^2^,A>BB
MLKPG_P '67Q]^,=I<WOA[7?V,O"&JW]W<KI7@CQ;;^*;;6(561A%!<:H_D:.
MKE #YLMU!&<_,(B=@Z*B49JGN^6,FENN;96W?6UMU9M*Z1"3<93>B4G&_HWO
MV\[];I-V9_0=17CG[ ?[2VM?M>_LF>$OB#XB\/:#X8UG7HIOM-CHGBFQ\3Z<
MK13/%O@O[*22"9'V;L*Q*$E&^923['55:;IS<);HSIU%.*DNH4445F6%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Q+\:O\
M@CI_PN#_ (+)?#K]K;_A8W]G?\(!HRZ3_P (I_8'G?;\17L?F?;/M*^7_P ?
MF=OD-_J^OS<8?_!2?_@B-=_MH_MC_#W]H/X;_&76/@A\7OA_:K8PZO#X?AUV
MVN8$:9H\V\DL0#CSY5;>SHZ-M,?4G[VHI*-HPBM.1N2MHTVVV[[ZW?WVV*E+
MF<I2UYHJ+[.*V5MC\S/ '_!OKXR3_@H]\,?VG?B/^TYK_P 4?'_@D$:NE_X.
MM=/M=6")/%!':1VTZQV$212KN0)-OE$LF092J^M_LB_\$=O^&5_^"IWQH_:8
M_P"%B_V]_P +?MI[?_A'/[ ^R_V3YD]O-G[5]I?SL>1C'E)G=GC&#]L455.7
MLY*4-+<Z7ESVYM/.R].EC.K%5$U/6_+?_MR_+]UW^I\1_P#!,;_@CA_P[C_:
M9_:!^(O_  L;_A,O^%ZZN=5_L_\ L#^SO[$S=W=QY?F_:9?/_P"/K;NV1_ZO
M./FP*7_!(C_@B5IO_!+_ ."7Q5\":SXYB^*FC_%:_-S?)+H!TE(H&@:"2W91
M<SF0,KG+ K].]?=-%0HI0]G;3D4+;^XG=+^M7U9HYR<G.^KESW_O6:OY:-^7
M7<_,;X7_ /! GXN?L86/B/PO^S'^V9XS^#_PP\17#7Q\-:OX&T[Q5-97#ILE
M>"[FDB:($!0/+17&Q2SNP#5Z5\"O^""7P^_9H_X)X_%_X(^$?%.OR>(_C?I%
MQ9^*/'.MQC4+Z\NYH'C\\P*\:^6C22,L6\-\YW2NQ+G[OHHE!2A*G+527*[Z
MMQ[7>MMM+]%V0HOEG&<='%\RMHD^]MK^=NK[L^=/^"4_[ ?_  ['_8D\,?!O
M_A+?^$W_ .$;N+V?^U_[+_LW[1]HNI)\>1YTVW;YFW/F'.,\9P.]_;4_9P_X
M; _9(^(_PL_MG_A'?^%@>'[S0O[3^R?:_L'VB)H_-\G>GF;<YV[USCJ*].HJ
M\4_K"DJVO,K/II:W3R%A_P!RTZ>EG?YWOU\S\^O#_P#P0F_L+_@B'J7[&O\
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M(/#4"7>I7,J0^9<07%M-%%;1B6WB\N'[,XCB'E[F.)!D?"?_ ((2^//V8/\
M@H[X_P#CK\(OVE;OP3H7Q2\2)KGBCPC=> K/51J=N;K[5<6/VN2=?*1W>94D
MBA62-) -SE2S?H_15PFX3ISCHX)QCIHDW=JVUF^C5K:;:$RCS0G"6JFTWW;2
MLG?>Z[[WUWU/SK^$'_! O_A5/QH_; \7_P#"V/M__#5VE:SIGV3_ (1CRO\
MA%O[0DN'W[_M;?:O+\_&-L.[;U7/'8_L?_\ !&/_ (91_P""2/C?]EG_ (63
M_;__  F5EK5I_P )/_PC_P!E^Q_VC$8]WV3[2^_R\YQYR[O5:^XZ*Q5**I.@
ME[K@J=O[B;:7?=MWW\S9UINJJS?O*;J7_OM)-]MDE;;R/S-NO^"'GPK^ _\
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M6;6_A%JFE?%?_A5FI_"2^O-1M+C_ (1A=<^U33M:,C;6N853RVM0<$.&W<@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQFUC48;)+Z\E#&*VA,C#S)GVMMC3+MM. <5\3?\ $4;^PG_T7/\ \LSQ#_\
M(-<M\9/^#B?_ ()Z?'OP'>>&O$OQNU2;2+\!;A-/T+Q9I<TR!@3$9K6UBE,3
MXVO'OV2(2CAE)4Q/FM[N_F.-NO\ 7;\3[A_9W_:]^&7[6.B&^^'?C;0?%(BL
MK34+FTMKC9J&GP7<9DMGN;1]MQ;>;&"R":-"RC(!%>CU^8OP*_X+Z_\ !-O]
MF;1[W3/ ?Q5C\,Z->7#7*:5:>%?$_P#9FG%@-R65JUF8+*)B-YBMDCC9RSE2
M[,Q[O_B*-_83_P"BY_\ EF>(?_D&MIN-_=)3>M_Z_K^NY]_T5\ ?\11O["?_
M $7/_P LSQ#_ /(-'_$4;^PG_P!%S_\ +,\0_P#R#4#/O^BO@#_B*-_83_Z+
MG_Y9GB'_ .0:/^(HW]A/_HN?_EF>(?\ Y!H ^_Z*^ /^(HW]A/\ Z+G_ .69
MXA_^0:/^(HW]A/\ Z+G_ .69XA_^0: /O^BO@#_B*-_83_Z+G_Y9GB'_ .0:
M/^(HW]A/_HN?_EF>(?\ Y!H ^_Z*^ /^(HW]A/\ Z+G_ .69XA_^0:/^(HW]
MA/\ Z+G_ .69XA_^0: /O^BO@#_B*-_83_Z+G_Y9GB'_ .0:/^(HW]A/_HN?
M_EF>(?\ Y!H ^_Z*^ /^(HW]A/\ Z+G_ .69XA_^0:/^(HW]A/\ Z+G_ .69
MXA_^0: /O^BO@#_B*-_83_Z+G_Y9GB'_ .0:/^(HW]A/_HN?_EF>(?\ Y!H
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M? '_ !%&_L)_]%S_ /+,\0__ "#1_P 11O["?_1<_P#RS/$/_P @T ??]%?
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MXE_#/^U/[#_X6)X5U3PQ_:7V;[5_9_VVSEMO/\K>GF;/-W;-Z[MN-RYR//\
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M?POXQTJ&[M],\6:3::S:172JD\<-Q"DR+(%9E#A7 (#, <X)'-?EU_Q"[?\
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MTC_Y(H_X=._LL?\ 1M/[/_\ X;S2/_D>C_AT[^RQ_P!&T_L__P#AO-(_^1Z
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M%^RQ_P!'+?L__P#AP](_^2*/^'L7[+'_ $<M^S__ .'#TC_Y(H_X=._LL?\
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M$I_CO%X \ 7'B3XC>+[+1;25/#^AF\UO6HK75K:2.(B!&FG6%&G95.X(&D(
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M:]VE']X/"_B;3_&OAK3M9TB\M]1TK5[:.]LKJ!P\5S#(@>.1".JLK @]P:_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHE<_0RBBBOH#\?"BBB@ HHHH **** "BBB@ HHHH ^(O^"\'[=VO_P#!._\
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M#319>7YOVK[1N\OR?+^?S-VW;SG'-?F'_P '1O[#/@WQA_P3[^+_ ,:]>O\
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M;6YDG]ZN?U'4445@;!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$93PD^91T>C7YI'CYAE6*P,E#%0Y6]5JG^384445Z9YP4444 %%%?,'[:O\
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M&A_"+0_AOJ7Q%U>RT>?[.VN7S7@TZW^<ADWVS.)5+HX&YAM(D..%_P""1O\
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M10![_7C.I?\ !1O]GG1OB%<>$;SX\?!FT\66FHMI$^BS>-=,CU&&]64Q-:M
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MS].\/_"OC#BB,LPX7PWM?82C>2J4H<LOB7\2<6^]TFCS'X3_ /!(CX;>._\
M@K#\3O@3>:WXXB\(^"_#4.LV-W#>6JZE+,\>F,5D<VYC*9O9>%C4_*G/!W?L
MG\(OAI8?!?X3^%_!VE37=QIGA/2;31K26Z97GDAMX4A1I"JJI<J@)(503G
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M?JI_PZ=_98_Z-I_9_P#_  WFD?\ R/70?"W_ ()[? +X'>.[#Q3X)^!WP?\
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M?_1<_P#RS/$/_P @T?\ $4;^PG_T7/\ \LSQ#_\ (- 'W_17P!_Q%&_L)_\
M1<__ "S/$/\ \@U\@?\ !5O_ (.\O#GPD_X0+_ADG6_A_P#%#^T/[0_X2O\
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MYZ??]%? '_$4;^PG_P!%S_\ +,\0_P#R#1_Q%&_L)_\ 1<__ "S/$/\ \@T
M??\ 17P!_P 11O["?_1<_P#RS/$/_P @T?\ $4;^PG_T7/\ \LSQ#_\ (- '
MW_17P!_Q%&_L)_\ 1<__ "S/$/\ \@UI^'?^#EG]BSQAYW]D?%W4]4^S;?-^
MR> O$D_E;L[=VW3SC.#C/7!J*E2,(\TW9=V=&%PE?$U50PT'.;V44VW97=DK
MMZ*_H?=E?GG_ ,%D?^3ZOV)/^Q\;_P!.&C5V?_$1)^R+_P!%&\3?^&X\3_\
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M[OG@1E\_;>"2&WDD+LT@M8X8W)7Y J1JOJ'_  Z=_98_Z-I_9_\ _#>:1_\
M(]>_T4 > ?\ #IW]EC_HVG]G_P#\-YI'_P CT?\ #IW]EC_HVG]G_P#\-YI'
M_P CU[_10!X!_P .G?V6/^C:?V?_ /PWFD?_ "/1_P .G?V6/^C:?V?_ /PW
MFD?_ "/7O]% '@'_  Z=_98_Z-I_9_\ _#>:1_\ (]'_  Z=_98_Z-I_9_\
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ML?\ 1M/[/_\ X;S2/_D>C_AT[^RQ_P!&T_L__P#AO-(_^1ZC_;\_X*2^!_\
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MF5-S8.%SDXXK2<>63C>^MM.NMM.]^G<SIRYXJ23U5_/OK^I^-/\ PX'\1_\
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M $4QG@'_  Z=_98_Z-I_9_\ _#>:1_\ (]'_  Z=_98_Z-I_9_\ _#>:1_\
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M=_98_P"C:?V?_P#PWFD?_(]'_#IW]EC_ *-I_9__ /#>:1_\CU[_ $4 >7^
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MN>5_:7_",>'K/2/[0\K?Y7G?9XT\S9YLFW=G;YCXQN.2N_HH **** "BBB@
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M3#HMI/HV@VMA+:V!F,YM(VBC4I!YS-)Y0PF]BV,DFNY+!022 !U-?E5^V_\
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M&.[T._N[V&PB62>:*!&=(PTC!06=@JKD]V8@ =R0.]>.?\% /VWO"W_!._\
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MYU#6;V9PEO96D(YEN)9"%1!@<DL5568?D7\;?VK/''[07_!0+6/V<?VK=/\
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M>K&XDKXN_:$_X)__  H_X*"W7PHU[]DWXS>-/$?QP^+FG7#^//&>IZU=:O\
MVAX=>V:*>?7K=V,5F4N8(8(+6*.%?,5D2+%N'A^XOA/\%?V@?^"B?_"II/VF
M/@]X(^"GACX/Z_;>)GT*R\1P^(=0\5ZS9VX2SGC\A3!I]@DDTTAC,T\SM$D9
MVQY>3ZU_9V_9$^&7[)-GXBM_AIX(\/\ @N#Q9JLNMZLFF6PA%[=R'+.WHHY"
MHN$0$A54<5M&DH3<I.^NC3U:26C:M:,VY<R5I623U:=/G]K*=-**LVFFFM%S
M7V3O>4++EDVXW;:2Y6I^'? /_@BA\"/@]XCU_P 5:]X<E^)/Q"\<PPGQCXB\
M47,MZOB>ZCNH[S[1)8LQLX3]HBC94AA58UC5%XW;F_M8?\%QOV<OV(OCQJ7@
M#XE>*]:T2^T*RMKG5]3MO#M]J>F://<@O:65Q+:Q2M'<SPI+-&A7!CA<E@=H
M;ZYK\_/VJ?\ @G5KGQP_X+(^%_%5WIOB/4_@IXY^'S:5\0;.SOXK;3-1N=-O
M#/I]OJ",/,N+>4W!4P1-^\$9$F8?,1X4I2JTZ2LHOFZ622A*6B5DM59)65VO
M1THPA3J3=VTH]=6W*,=6[MZ-W;Z:W6Y\Y?\ !2?_ (*.?LE?\%3?'OA'X/ZM
M\8O#6@?#H^%)?B%I_CW2H7DU^SUN&;_1-.L6>-GLKL1QRR2V[Q?:9Q+!#$J2
M.-WKW_! ;_@E5\8?V&=)\1>,?B-XX@MK?XGVT=]JO@*VMVEM'NW17_M*X$JJ
M;/4&5C'/;P>9"65CO<>4D'Z+> /AAX:^%&DW-AX6\.Z%X:L+R\FU"XMM*L(K
M.&>YF;=+.RQJH:1VY9R-S'DDUN5I0<:/,Z>\D[WZW;>VUTN6-^T(NW,DTJCE
M424]E:WE;S\W>75KF<4^5M,HHHJ"@HHHH **** *VL:S9^'=(N]0U"[MK"PL
M(7N+FYN)5BAMXD4L\CNQ 554$DD@  DU^?G[8G_!;36?#O[)_P 1_'GP;^#'
MQ;US0_"OV".U\>ZOH%O8>';RUO&11J>FPW5U!=:K'&'!18HECE8I^]6-Q)7T
MG_P4^_9J\5_MA_L"?%'X:>"-:M-!\5>+=&:TT^YNQFVD<2(YMYOE;$4RHT+G
M:<+*QP>E?/OPG^"O[0/_  43_P"%32?M,?![P1\%/#'P?U^V\3/H5EXCA\0Z
MAXKUFSMPEG/'Y"F#3[!))II#&9IYG:)(SMCR\F:A*I*4$[6Y=]%9OWG?2]DK
M*,6I7>Z5FM'-4U&;5_B];I+E6S2YF_B:DE9W3V?R<_[)_P )_P!I[XX? ?XB
M_LH?&3QWXG^-7Q&@N)_B%XOO=:N-8DU3PQ):O!=RZY;RMY-FRSQ16]O:QQPK
MY@9$BQ;B2#Z__8__ ."!_P )O@WI/AGQ'\48KCXO_%VP\*CPGJGB+4[J>*PN
M=/-BMC]@CTZ-UM1:QVP,2AXF=LM([&0[A])_ _\ 9Z^#'[$VHW>A^!?#_@SX
M>7OQ,UJYU1K&T,=I-K]_Y;33>4C'=)LC5V$<8VQH&VJJYK+_ ."@?QNMO@[^
MSU-8Q:SXDT7Q3\1-0M_!?A27P^MJ=4?5[\F.W,)N08%V /*[R A8X9& +!5-
MSJ*G3?LXZRM:*[NZ4(=E>3BEI?F;LE+E6<*;G->TEI%6N_Y4[N<^[M%-W;24
M4KOEYG%^W?\ %OQ-^QO^PYXM\6?"WPWX#NM1\!:0L]AI6NZHFA:-;6D  *"0
M 1H$B7"1EHD)"KO08K\@OVIO^"T-M^W!KOAGQ+XN\ ^&=0^ =\L'ARSTKQ%J
MLQT3P+XTE=8VE\9VBV_F36\"^=+:HO[B186;/G!S9<Y^P9^Q=^U1X(_X*H7'
MA_QCX<N?BE/X4\46.J?$LZIX@U2Y\":_=_9H);?7HKJ1?*_M6VAN+=Q9SPLW
M^JDBA0(I@_=J7]F+X:S:EXEO7^'G@9[SQG/#<^()VT&U,NNRPLK0R73;,SO&
MR(5:3<5**1C H]BIJ-:H^92=[._2UWT;4DWRO1QG&,DU).*GG<6Z5-<K2W\G
MMW2:LKK53A)QMRN,W\B?";_@W._9"L?V<_AOX5U_X6^$_'ESX-A2Z7Q0(FT^
M^\0SN?,:>YELW0W,+,<I#,TL:IM49 R?NS2=)M- TJUL+"UM[*QLHD@M[>"-
M8XH(U4*J(JX"JH   & !BK%%:U*CE*3[N_S^5EY;"A!)+NE;^KW>^NX4445F
M6%%%<K\==8\2^'O@EXQU#P9I\6K>,+'1+VXT.QD8(EY?+ [6\1)X :4(N3ZU
ME6JJG3E4:;LF]-].WF:4:;J3C33M=I:[:]S$^)7[7_PI^#?BJ^T#Q5\2? OA
M_P 1:;H\WB&YT>]URVAU./3H8Y));O[*7\XPJD4C%PA&(VYX-? '[0O[:'[2
M/[5G['7B/]J3]G?XL_#/X=_"GP#%=ZSH_AO4M(M=7NO'MC9NK7!U2]DD*Z6S
MK%*(K6%!.HD FEBD?;!Y-^Q-^T?X0_:=_8\7P!^SIH?C30/VSO%L=IH'Q8\<
M7/@^2+7O"%U)=F35[W6-9N;?RRI^SW8MX$E,P8PQQ10F+]S]??#;_@A#\+OA
M7^U)KWC/2=:\2P?#CQ+<VNO:E\+5E">%;WQ!;L2FJ26ZD*P!VN+;;Y0E1'P1
M'$D>TZ$XU+2E:VBDM5=:\R3_ (D''W8WLG*]U;WJ>=.O&W,HWUUB]'RV2Y6_
ML2NW)VNU%)I[*I\L?L3_ /!O'8_M6:1\.OC/^TQ;V.F>*K"ZGU>P\&Z#IUHM
ME<Z?=WMS?BWUM[F"66\F8W>PJ&C$42+&!OW/7ZG_  .^"OA?]DSX":#X'\)V
MFI6OA/P3IHL]/MI)[G4KF*WC!(0%R\LA R%09P,*B@!5%WXX_%O0_@-\'_$G
MC+Q+K5EX=T/PYI\M[=ZE=P27$-HJJ<,8HR))3NP!%'\\A(5?F85^&GQZ_P""
MU/[>/[,/QVM/"'C'2_#]CK6FZ/J&III \%I+-XQT)Y9I$\06D27>X75G;QEF
MTYIHBJ1N9MS;S#%2O"+="DN2+N[=-F[M]7HVV^G-+1*;2I4)656H^:6B;ZO5
M;+HKM+2^O+'5N*?O/[</_!P/X&^*_AGP];Z WQ5\+? ^[U2]T3XA>+=#MHK'
MQ)I.HP&7R- :.2>.;26O?*S]ME"?(Q2-HY%GEM;W[(G_  :U_!R+X OKFN3^
M-?AK\3/%VH7FKP:M\/O'-T+OPOI-X&":%'=2&2"\B6V?RI9VA+3%WPY0@M[=
M\#/^"+/[/OQM;0_C*MW\4M?G^)7A)K3Q?'XDO)85^)$%XHE\_6;*XB#K.C$/
M$(/(6 I%Y8411%/N/X8?#'P]\%?AUHGA'PGI%CH'AKPY9QZ?ING6<?EP6<$:
MA411Z #J>2>22236BPZI*<*B]]Z-^C?,NFETN71/E;BTFYRJ2J\JCC*#]S=?
M^VOKK9OFU:YDI)M<D:>3^SO\!O#W[+OP,\*?#KPE%>P^&O!FF0Z3IJ7=W)=3
MK#$H5=TCDLQP/8#H   !V=%%.I4E.3G-W;U8X0C"*A%62T04445!04444 %%
M%% !7S;\3O\ @I/I>B?'.\^&WP\^&?Q3^-'BG2UNH=5N?">FVZ^'_#]]# LX
ML+_5KR>"T@N75T_=*\DB[AN12RAOI)@2I )!/?TK\LOV<?V7OVR/"GP+^(O[
M)^O^ OAY#X!U^^UM/^%W7?B&&=M4TO5;QIKHC1(T,TVILEW<@-.T$ =!N,@0
M&?*2G*3A#>S:Z)O1)-NZ5KW=]7;2^J-%RJ*E+;F2?5I:MM)6;V2\KZGRY\6=
M:^!'_!;;]A7XA^,OBQXG\::E^T_97LNB^%/ 5MJ$T,W@W5IS_H&FZ1I23&"]
M@N1"GG7LBNTJ+-*SVRQ*L'V!_P $O_\ @@[JW[+OPV\ ^%_BSK7P[\3^%OA?
MXFN/&OA[1M$\-&"YN]9N+94%WJEY+(_VEK7S)X84CC3*Q6\CR-M6&/[$^"'_
M  3F^"G[.WCWP_XM\)_#WP_IWB_PUX6M?!MEKH@#7ZZ;;QK''&S]"^Q54R8W
MLH"EMH"CVRNF')24HT^MEY>Z])).[YFUS-MMJ5M6X\\N>HI5>7VE[*[6NOO+
M6+:23BKN*2235]$I<B^9_P!IC]M'X$_\$@OA9X"\/:Q82^%O#^JSRZ?H.@>%
M=!DNWM;6!#/>W@M;=2PMK:(M//(JE@I+8=FP?D_]M_\ X.%?V4?C1^RJNC^#
M_B/X%\8Z5X]\367@KQ#'K^BWI30],NLM>:E+IMQ'#<7$,<*E5=5,8GEBW$[6
M0^X_\%O_ -E?X@?M%?!WX6:U\*%\1CX@_#GXBZ5K%G)H-S;VNI1V<Q>RO6AE
MN%:%&6"X9]TH* 1DD'&T_1_P!_9#^&O[,&EVD'@CP=H>C7EKIXTR355MEDU:
M_A\UYV%S>,#/<,\\LLSM*[%Y99')+,2<(056$W7U7/:W\R2A)I^4KN+ZZMIZ
M66U2;IRBJ.CY;W[-N:37FK*5M4[)-)/7\D/^"77_  1;\1>'OVX+;XO_  8^
M.>HO\#_AU>/H7@_Q5=9OM6\9Z7$D8NM+DC\J.TO-)^T-/'%>(RD&W8PHR_9Y
MXOVUBA2!2L:*BEBQ"C R223]223]33J*WE5;A&GTCWU>NK;?F]>UVWNVWFH+
MF<^KLODMOZ]$K))(HHHK,H**** "BBA@2I )!/?TI-V5[ ?-OQ._X*3Z7HGQ
MSO/AM\//AG\4_C1XITM;J'5;GPGIMNOA_P /WT,"SBPO]6O)X+2"Y=73]TKR
M2+N&Y%+*&_*GXB>,/@E_P68_8I\=?$#XE>,/'DW[5FC:D^F>#/!6GZG<6MWX
M'UF5@VG:?HVF13>3=Q7'D1F6^D5GD1)I6>V6)5@^F_V<?V7OVR/"GP+^(O[)
M^O\ @+X>0^ =?OM;3_A=UWXAAG;5-+U6\::Z(T2-#--J;)=W(#3M! '0;C($
M!G^SO 7[#?[/G[&.JZ;\2;3PGX,\(:KX'\)6WA-?%FH/';RV>DVR+'&LL\A5
M =JJK3-AV4!2VT!1$**G%2JO1I:K22;NVXK[+6D%S)NSDUHG&>KK.G4:I[QD
M_P#"TM%=_:4DW*R:6BBU=J4/BO\ 8A_X-T)/@!X:U7P)XGU?X?7'P<\5W?AK
MQ/XAT"S\/RSZYK&JZ=;1F6PFU&:9@--%]%]I"+$SO]HFC4VZ9\S]*_ _PG\/
M?!CP[K%KX(\,Z!H9U6^NM9GMK2%;&&_U"X8R2SS-&A.^1\;I"K, !P0H%8?[
M6'[1/AS]E3]G+Q9\0?%-[J%EHGAZQ,CR:=%'->RRR,L4$5NDG[MIY)I(XXQ)
MA"[KN(7)K\/OCE^QU^UI\4/VG3\._$NL>/M7^./AGP]=:WX&\<Z5KM_)I>K>
M'+V>ZD?PQXFDLS!%I\\_V::-+J'R4DDB\KS'5(98;KXF<YN*5KWV\HK1;MM1
MC%V>O+'3FERQEC1P\(Q4V[VMOZVN]DDW*U]%>6O+&\H^B?M%_P#!>/XF_'OX
M?>(?AC>>!M,T_P 3^ =?O&^*>A^!?%Q?5?$WA."=TFF\.7BHRRA$21+PHZ7,
M:12%!#F:2T]T_P""8_\ P22_90_;3_9;\2?%;5OAI\'O%&F?':2&[@TCP[8B
M.S\"6=O$L,6F6ETJQ74%XH3==S1^0TL[/\BJ!N^[O@+^SAX;@^'/POU?Q/\
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MFC=)QO!KEE'FIR9RPPUH):].U]6T]'9Z-)M2M)6E&7+.*\P_8K_X(N_L^_\
M!6SX@^*?VBO$+^-/&_@/Q+I2:'H.LZUXON9/$WB+5H)&6Z\1W/V>8)8NK!(+
M>QQY:1P!F@B!6.OTI_8!_P""=WA'_@G=X&\2Z3X:\3?$3QIJ7C+6'UW7=?\
M&FNMJ^JZK=LBQB220*B9"(JY6,,P4;BQ ([7]F[]D7X;_LAZ)KFG_#CPAHOA
M*W\3:I+K>K#3[=81?WLN-\S!<*N<#"(%C0<(JCBO1ZZ'*,4HTERKE2LMMU)V
MT6G-MHM%%)1245BHN7O5'=WO=[Z+E5]7KR[ZO5MMR;<F4445F:A1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M75Q(TL]S<W5P\D]Q/([%FEFD=VXRW QV-%%4Y-[DI);!1112&%%%% !1110
M5^>__!P!\<?B1\!_"GP-OO"'Q$\:_#?PMKOCI=%U[4O"&@KK&LBZEM)GTO;
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MK=U-^56O^/KY[*^[25S%0TU=_P"E^%U>VU]>B"BBBLRPHHHH **** "BBB@
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M8J,JDIJZ:A9/5:<_-=;;.*7J[6'6;E"$(Z6<KOKKR<MGOT;?3;1]/#_V-_\
M@DEX,_8MU305TCQ[\6?%OASP9=7]]X4\,^)]:@O-(\*7%Z"LLMHL=O',S+$\
ML4?VB6;RDN)]FUII6?ZJHHJW)M)-WL2EJWW_ *_/7U;?4****D84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !10I) SS10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>28
<FILENAME>vxrt-20181231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Feb 06 15:31:57 EST 2019 -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:vxrt="http://www.vaxart.com/20181231" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:compsci="http://compsciresources.com" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="vxrt-20181231.xsd"/>
  <context id="c0_AsOf31Dec2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c1_AsOf31Dec2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c2_From1Jan2018To31Dec2018_GovernmentContractMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c3_From1Jan2017To31Dec2017_GovernmentContractMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c4_From1Jan2018To31Dec2018_RoyaltyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c5_From1Jan2017To31Dec2017_RoyaltyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c6_From1Jan2018To31Dec2018_NonCashRoyaltyRevenueMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vxrt:NonCashRoyaltyRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c7_From1Jan2017To31Dec2017_NonCashRoyaltyRevenueMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vxrt:NonCashRoyaltyRevenueMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c8_From1Jan2018To31Dec2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c9_From1Jan2017To31Dec2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c10_AsOf31Dec2016_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="c11_AsOf31Dec2016_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="c12_AsOf31Dec2016_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="c13_AsOf31Dec2016_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="c14_AsOf31Dec2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="c15_From1Jan2017To31Dec2017_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c16_From1Jan2017To31Dec2017_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c17_From1Jan2017To31Dec2017_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c18_AsOf31Dec2017_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c19_AsOf31Dec2017_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c20_AsOf31Dec2017_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c21_AsOf31Dec2017_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c22_From1Jan2018To31Dec2018_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c23_From1Jan2018To31Dec2018_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c24_From1Jan2018To31Dec2018_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c25_From1Jan2018To31Dec2018_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c26_AsOf31Dec2018_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c27_AsOf31Dec2018_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c28_AsOf31Dec2018_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c29_AsOf4Feb2019">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <instant>2019-02-04</instant>
    </period>
  </context>
  <context id="c30_AsOf30Jun2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <instant>2018-06-30</instant>
    </period>
  </context>
  <context id="c31_From13Feb2018To13Feb2018_ConversionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">vxrt:ConversionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c32_From13Feb2018To13Feb2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c33_AsOf31Dec2018_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c34_AsOf31Dec2018_AviragensStockholderrsAndOptionsholdersMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:AviragensStockholderrsAndOptionsholdersMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c35_AsOf31Dec2018_OxfordFinanceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c36_From1Jan2018To31Dec2018_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c37_From1Jan2018To31Dec2018_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c38_From1Jan2018To31Dec2018_IntellectualPropertyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c39_AsOf1Jan2019_RecognizeLeaseLiabilitiesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">vxrt:RecognizeLeaseLiabilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="c40_AsOf1Jan2019_DerecognizeLeaseLiabilitiesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">vxrt:DerecognizeLeaseLiabilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2019-01-01</instant>
    </period>
  </context>
  <context id="c41_From1Jan2019To1Jan2019_DerecognizeLeaseLiabilitiesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">vxrt:DerecognizeLeaseLiabilitiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2019-01-01</startDate>
      <endDate>2019-01-01</endDate>
    </period>
  </context>
  <context id="c42_From1Jan2018To31Dec2018_LaboratoryEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vxrt:LaboratoryEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c43_From1Jan2018To31Dec2018_OfficeEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c44_From1Jan2018To31Dec2018_LeaseholdImprovementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-02-13</instant>
    </period>
  </context>
  <context id="c46_AsOf31Dec2018_RestatementAdjustmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c47_From13Feb2018To13Feb2018_ScenarioPreviouslyReportedMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c48_From14Feb2018To31Dec2018_RestatementAdjustmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-14</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c49_AsOf31Dec2018_MoneyMarketFundsMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c50_AsOf31Dec2018_MoneyMarketFundsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c51_AsOf31Dec2018_MoneyMarketFundsMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c52_AsOf31Dec2018_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c53_AsOf31Dec2018_CorporateBondsMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c54_AsOf31Dec2018_CorporateBondsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c55_AsOf31Dec2018_CorporateBondsMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c56_AsOf31Dec2018_CorporateBondsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c57_AsOf31Dec2018_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c58_AsOf31Dec2018_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c59_AsOf31Dec2018_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c60_AsOf31Dec2018_FairValueInputsLevel1Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c61_AsOf31Dec2018_FairValueInputsLevel2Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c62_AsOf31Dec2018_FairValueInputsLevel3Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c63_AsOf31Dec2018_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c64_AsOf31Dec2018_FairValueInputsLevel1Member_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c65_AsOf31Dec2018_FairValueInputsLevel2Member_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c66_AsOf31Dec2018_FairValueInputsLevel3Member_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c67_AsOf31Dec2018_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c68_AsOf31Dec2017_MoneyMarketFundsMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c69_AsOf31Dec2017_MoneyMarketFundsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c70_AsOf31Dec2017_MoneyMarketFundsMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c71_AsOf31Dec2017_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c72_AsOf31Dec2017_CorporateBondsMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c73_AsOf31Dec2017_CorporateBondsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c74_AsOf31Dec2017_CorporateBondsMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c75_AsOf31Dec2017_CorporateBondsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c76_AsOf31Dec2017_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c77_AsOf31Dec2017_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c78_AsOf31Dec2017_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c79_AsOf31Dec2017_FairValueInputsLevel1Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c80_AsOf31Dec2017_FairValueInputsLevel2Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c81_AsOf31Dec2017_FairValueInputsLevel3Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c82_AsOf31Dec2017_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c83_AsOf31Dec2017_FairValueInputsLevel1Member_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c84_AsOf31Dec2017_FairValueInputsLevel2Member_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c85_AsOf31Dec2017_FairValueInputsLevel3Member_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c86_AsOf31Dec2017_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c87_From1Jan2018To31Dec2018_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c88_From1Jan2018To31Dec2018_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c89_AsOf31Dec2016_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="c90_AsOf31Dec2016_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="c91_From1Jan2017To31Dec2017_ConvertiblePreferredStockWarrantLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c92_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vxrt:ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c93_From1Apr2018To30Jun2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2018-04-01</startDate>
      <endDate>2018-06-30</endDate>
    </period>
  </context>
  <context id="c94_AsOf31Dec2018_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c95_AsOf31Dec2018_CorporateBondsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c96_AsOf31Dec2018_CashEquivalentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c97_AsOf31Dec2018_ShortTermInvestmentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c98_AsOf31Dec2017_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c99_AsOf31Dec2017_CorporateBondsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vxrt:CorporateBondsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c100_AsOf31Dec2017_CashEquivalentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c101_AsOf31Dec2017_ShortTermInvestmentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c102_AsOf31Dec2018_PurchasedTechnologyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">vxrt:PurchasedTechnologyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c103_AsOf13Feb2018_PurchasedTechnologyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">vxrt:PurchasedTechnologyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-02-13</instant>
    </period>
  </context>
  <context id="c104_AsOf31Dec2017_PurchasedTechnologyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">vxrt:PurchasedTechnologyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c105_AsOf31Dec2018_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c106_AsOf13Feb2018_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-02-13</instant>
    </period>
  </context>
  <context id="c107_AsOf31Dec2017_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c108_AsOf31Dec2018_IntellectualPropertyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c109_AsOf13Feb2018_IntellectualPropertyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-02-13</instant>
    </period>
  </context>
  <context id="c110_AsOf31Dec2017_IntellectualPropertyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c111_AsOf13Feb2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <instant>2018-02-13</instant>
    </period>
  </context>
  <context id="c112_AsOf25May2017_EntityLoanModificationProgramMember_HHSBARDAMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LoanRestructuringModificationNameAxis">us-gaap:EntityLoanModificationProgramMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:HHSBARDAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-05-25</instant>
    </period>
  </context>
  <context id="c113_From25May2017To25May2017_EntityLoanModificationProgramMember_HHSBARDAMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LoanRestructuringModificationNameAxis">us-gaap:EntityLoanModificationProgramMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:HHSBARDAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-05-25</startDate>
      <endDate>2017-05-25</endDate>
    </period>
  </context>
  <context id="c114_From1Jan2018To31Dec2018_EntityLoanModificationProgramMember_HHSBARDAMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LoanRestructuringModificationNameAxis">us-gaap:EntityLoanModificationProgramMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:HHSBARDAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c115_From1Jan2017To31Dec2017_EntityLoanModificationProgramMember_HHSBARDAMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LoanRestructuringModificationNameAxis">us-gaap:EntityLoanModificationProgramMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:HHSBARDAMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c116_From1Jan2018To31Dec2018_RoyaltyMember_RelenzaRecognizedMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:RelenzaRecognizedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c117_From1Jan2018To31Dec2018_RoyaltyMember_AviragenTherapeuticsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:AviragenTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c118_From1Jan2018To31Mar2018_RoyaltyMember_AviragenTherapeuticsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:AviragenTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-03-31</endDate>
    </period>
  </context>
  <context id="c119_From1Jan2018To31Dec2018_RoyaltyMember_InavirRecognizedMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:InavirRecognizedMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c120_From1Jan2018To31Dec2018_RoyaltyMember_JP">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">country:JP</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c121_From1Apr2016To30Apr2016_HCRPMember_RoyaltyArrangementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vxrt:HCRPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:RoyaltyArrangementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-04-01</startDate>
      <endDate>2016-04-30</endDate>
    </period>
  </context>
  <context id="c122_From10Dec2014To10Dec2014_NotePurchaseAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:NotePurchaseAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-12-10</startDate>
      <endDate>2014-12-10</endDate>
    </period>
  </context>
  <context id="c123_From20Nov2015To20Nov2015_SecondNotePurchaseAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:SecondNotePurchaseAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-20</startDate>
      <endDate>2015-11-20</endDate>
    </period>
  </context>
  <context id="c124_AsOf31Dec2018_NotesIssuedIn2014Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">vxrt:NotesIssuedIn2014Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c125_AsOf31Dec2018_NotesIssuedIn2015Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">vxrt:NotesIssuedIn2015Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c126_AsOf31Dec2017_ConvertiblePromissoryNotesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vxrt:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c127_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vxrt:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c128_AsOf13Feb2018_ConvertiblePromissoryNotesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vxrt:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-02-13</instant>
    </period>
  </context>
  <context id="c129_From13Feb2018To13Feb2018_ConvertiblePromissoryNotesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vxrt:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c130_AsOf22Dec2016_LoanAgreementMember_OxfordFinanceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:LoanAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-22</instant>
    </period>
  </context>
  <context id="c131_From22Dec2016To22Dec2016_LoanAgreementMember_OxfordFinanceMember_LondonInterbankOfferedRateLIBORMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:LoanAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-12-22</startDate>
      <endDate>2016-12-22</endDate>
    </period>
  </context>
  <context id="c132_From22Dec2016To22Dec2016_LoanAgreementMember_OxfordFinanceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:LoanAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-12-22</startDate>
      <endDate>2016-12-22</endDate>
    </period>
  </context>
  <context id="c133_AsOf31Dec2018_LoanAgreementMember_OxfordFinanceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:LoanAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c134_AsOf31Dec2018_ConvertiblePreferredStockMember_LoanAgreementMember_OxfordFinanceMember_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:LoanAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c135_From1Jan2018To31Dec2018_LoanAgreementMember_OxfordFinanceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:LoanAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c136_From1Jan2017To31Dec2017_LoanAgreementMember_OxfordFinanceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:LoanAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c137_AsOf31Dec2018_WarrantMember_CommonStockMember_LoanAgreementMember_OxfordFinanceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:LoanAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c138_From1Jan2018To31Dec2018_WarrantMember_CommonStockMember_LoanAgreementMember_OxfordFinanceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">vxrt:LoanAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vxrt:OxfordFinanceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c139_From1Jan2018To31Dec2018_TheFirstLeaseMember_OfficeSpaceInSanFranciscoCaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">vxrt:TheFirstLeaseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">vxrt:OfficeSpaceInSanFranciscoCaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c140_From1Jan2018To31Dec2018_RemainingThreeLeasesMember_OfficeSpaceInSanFranciscoCaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">vxrt:RemainingThreeLeasesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">vxrt:OfficeSpaceInSanFranciscoCaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c141_From1Jan2018To31Dec2018_OfficeSpaceInAlpharettaGeorgiaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">vxrt:OfficeSpaceInAlpharettaGeorgiaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c142_From1Oct2018To31Dec2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2018-10-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c143_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c144_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c145_From31Dec2017To31Dec2017_ConvertiblePreferredStockMember_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-12-31</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c146_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c147_From13Feb2018To13Feb2018_DividendPaidMember_ConvertiblePreferredStockMember_SeriesCPreferredStockMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">us-gaap:DividendPaidMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c148_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c149_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c150_From31Dec2017To31Dec2017_ConvertiblePreferredStockMember_SeriesBPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-12-31</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c151_AsOf13Feb2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-02-13</instant>
    </period>
  </context>
  <context id="c152_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c153_From13Feb2018To13Feb2018_DividendPaidMember_ConvertiblePreferredStockMember_SeriesBPreferredStockMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">us-gaap:DividendPaidMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c154_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c155_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesAPreferredStockMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-02-13</startDate>
      <endDate>2018-02-13</endDate>
    </period>
  </context>
  <context id="c156_AsOf31Dec2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c157_From1Jan2018To31Dec2018_MinimumMember_ConvertiblePreferredStockMember_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c158_AsOf31Dec2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c159_AsOf31Dec2018_ConvertiblePreferredStockMember_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c160_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c161_AsOf31Dec2018_MinimumMember_ConvertiblePreferredStockMember_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c162_AsOf31Dec2018_MinimumMember_ConvertiblePreferredStockMember_SeriesBPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c163_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c164_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesBPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c165_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c166_AsOf31Dec2017_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c167_AsOf31Dec2018_ConvertiblePreferredStockOutstandingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:ConvertiblePreferredStockOutstandingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c168_AsOf31Dec2017_ConvertiblePreferredStockOutstandingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:ConvertiblePreferredStockOutstandingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c169_AsOf31Dec2018_OptionsIssuedAndOutstandingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:OptionsIssuedAndOutstandingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c170_AsOf31Dec2017_OptionsIssuedAndOutstandingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:OptionsIssuedAndOutstandingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c171_AsOf31Dec2018_OptionsAvailableForFutureGrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:OptionsAvailableForFutureGrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c172_AsOf31Dec2017_OptionsAvailableForFutureGrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:OptionsAvailableForFutureGrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c173_AsOf31Dec2018_CumulativeConvertiblePreferredStockDividendsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:CumulativeConvertiblePreferredStockDividendsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c174_AsOf31Dec2017_CumulativeConvertiblePreferredStockDividendsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:CumulativeConvertiblePreferredStockDividendsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c175_AsOf31Dec2018_CommonStockWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:CommonStockWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c176_AsOf31Dec2017_CommonStockWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="vxrt:CommonStockReservedForIssuanceAxis">vxrt:CommonStockWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c177_From1Jan2018To31Dec2018_MaximumMember_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c178_AsOf31Dec2018_RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c179_AsOf31Dec2018_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c180_From1Jan2018To31Dec2018_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c181_From1Jan2017To31Dec2017_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c182_From1Jan2018To31Dec2018_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c183_From1Jan2017To31Dec2017_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c184_From1Jan2018To31Dec2018_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c185_From1Jan2017To31Dec2017_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c186_AsOf31Dec2018_DomesticCountryMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c187_AsOf31Dec2017_DomesticCountryMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c188_AsOf31Dec2018_StateAndLocalJurisdictionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c189_AsOf31Dec2017_StateAndLocalJurisdictionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="c190_AsOf31Dec2018_AU">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:AU</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c191_AsOf31Dec2018_GB">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:GB</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c192_AsOf31Dec2018_FR">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:FR</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-12-31</instant>
    </period>
  </context>
  <context id="c193_From1Jan2018To31Dec2018_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c194_From1Jan2017To31Dec2017_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c195_From1Jan2018To31Dec2018_WarrantMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c196_From1Jan2017To31Dec2017_WarrantMember_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c197_From1Jan2018To31Dec2018_WarrantMember_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c198_From1Jan2017To31Dec2017_WarrantMember_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c199_From1Jan2018To31Dec2018_CumulativeConvertiblePreferredStockDividendsMember_SeriesBAndCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vxrt:CumulativeConvertiblePreferredStockDividendsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vxrt:SeriesBAndCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c200_From1Jan2017To31Dec2017_CumulativeConvertiblePreferredStockDividendsMember_SeriesBAndCPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vxrt:CumulativeConvertiblePreferredStockDividendsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vxrt:SeriesBAndCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c201_From1Jan2018To31Dec2018_ConvertiblePreferredStockOutstandingMember_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vxrt:ConvertiblePreferredStockOutstandingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c202_From1Jan2017To31Dec2017_ConvertiblePreferredStockOutstandingMember_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vxrt:ConvertiblePreferredStockOutstandingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c203_From1Jan2018To31Dec2018_ConvertiblePromissoryNotesRelatedPartyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vxrt:ConvertiblePromissoryNotesRelatedPartyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-12-31</endDate>
    </period>
  </context>
  <context id="c204_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesRelatedPartyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vxrt:ConvertiblePromissoryNotesRelatedPartyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="c205_From1Jan2018To31Mar2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-03-31</endDate>
    </period>
  </context>
  <context id="c206_From1Jul2018To30Sep2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="c207_From1Jan2017To31Mar2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-03-31</endDate>
    </period>
  </context>
  <context id="c208_From1Apr2017To30Jun2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2017-04-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="c209_From1Jul2017To30Sep2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="c210_From1Oct2017To31Dec2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000072444</identifier>
    </entity>
    <period>
      <startDate>2017-10-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="usdPershares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="pure">
    <measure>xbrli:pure</measure>
  </unit>
  <unit id="jpy">
    <measure>iso4217:JPY</measure>
  </unit>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">11506000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1571000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShortTermInvestments unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:ShortTermInvestments unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1415000</us-gaap:ShortTermInvestments>
  <us-gaap:AccountsReceivableNetCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1796000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">630000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1343000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">137000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">14645000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">3753000</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1066000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">730000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">19413000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">40000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:OtherAssetsNoncurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">103000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:Assets unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">35227000</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">4523000</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">962000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1390000</us-gaap:AccountsPayableCurrent>
  <vxrt:SecuredPromissoryNoteClassifiedCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1667000</vxrt:SecuredPromissoryNoteClassifiedCurrent>
  <vxrt:SecuredPromissoryNoteClassifiedCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1528000</vxrt:SecuredPromissoryNoteClassifiedCurrent>
  <us-gaap:DeferredRevenueCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">3328000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1518000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1605000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">7475000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">4523000</us-gaap:LiabilitiesCurrent>
  <vxrt:ConvertibleLongTermNotesPayableRelatedParties unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <vxrt:ConvertibleLongTermNotesPayableRelatedParties unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">35282000</vxrt:ConvertibleLongTermNotesPayableRelatedParties>
  <us-gaap:DeferredRevenueNoncurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">14413000</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredRevenueNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:LongTermNotesPayable unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1944000</us-gaap:LongTermNotesPayable>
  <us-gaap:LongTermNotesPayable unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">3440000</us-gaap:LongTermNotesPayable>
  <us-gaap:OtherLiabilitiesNoncurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">157000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:Liabilities unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">23989000</us-gaap:Liabilities>
  <us-gaap:Liabilities unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">43245000</us-gaap:Liabilities>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1000</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">714000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">108513000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">41259000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">-97989000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">-79982000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">11238000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">-38722000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">35227000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">4523000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf31Dec2018" decimals="2">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Dec2017" decimals="2">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf31Dec2018" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c0_AsOf31Dec2018" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">1221064</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf31Dec2018" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">1221064</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockLiquidationPreferenceValue unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">39956000</us-gaap:PreferredStockLiquidationPreferenceValue>
  <us-gaap:PreferredStockLiquidationPreferenceValue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">39956000</us-gaap:PreferredStockLiquidationPreferenceValue>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf31Dec2018" decimals="2">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Dec2017" decimals="2">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf31Dec2018" decimals="INF">200000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">200000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c0_AsOf31Dec2018" decimals="INF">7141189</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">138492</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf31Dec2018" decimals="INF">7141189</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">138492</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:Revenues unitRef="usd" contextRef="c2_From1Jan2018To31Dec2018_GovernmentContractMember" decimals="-3">1344000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c3_From1Jan2017To31Dec2017_GovernmentContractMember" decimals="-3">5839000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c4_From1Jan2018To31Dec2018_RoyaltyMember" decimals="-3">1340000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c5_From1Jan2017To31Dec2017_RoyaltyMember" xs:nil="true"/>
  <us-gaap:Revenues unitRef="usd" contextRef="c6_From1Jan2018To31Dec2018_NonCashRoyaltyRevenueMember" decimals="-3">1475000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c7_From1Jan2017To31Dec2017_NonCashRoyaltyRevenueMember" xs:nil="true"/>
  <us-gaap:Revenues unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">4159000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">5839000</us-gaap:Revenues>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">17275000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">12355000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">6681000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">3499000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">1600000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
  <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:BusinessExitCosts1 unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">359000</us-gaap:BusinessExitCosts1>
  <us-gaap:BusinessExitCosts1 unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">25915000</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">15854000</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-21756000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-10015000</us-gaap:OperatingIncomeLoss>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">6760000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">58000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">53000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InterestExpense unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">821000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">3036000</us-gaap:InterestExpense>
  <vxrt:NoncashInterestExpenseOnLiability unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">1859000</vxrt:NoncashInterestExpenseOnLiability>
  <vxrt:NoncashInterestExpenseOnLiability unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-11000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">69000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <vxrt:GainlossOnRevaluationOfFinancialInstruments unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-3000</vxrt:GainlossOnRevaluationOfFinancialInstruments>
  <vxrt:GainlossOnRevaluationOfFinancialInstruments unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">3347000</vxrt:GainlossOnRevaluationOfFinancialInstruments>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-266000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">3858000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">433000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-17898000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-9582000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">109000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-18007000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-9582000</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockDividendsIncomeStatementImpact unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">339000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
  <us-gaap:PreferredStockDividendsIncomeStatementImpact unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">2878000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-18346000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-12460000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c8_From1Jan2018To31Dec2018" decimals="2">-2.90</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c9_From1Jan2017To31Dec2017" decimals="2">-91.65</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">6316065</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">135953</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c10_AsOf31Dec2016_PreferredStockMember" decimals="INF">1221064</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c10_AsOf31Dec2016_PreferredStockMember" decimals="-3">1000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c11_AsOf31Dec2016_CommonStockMember" decimals="INF">135658</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c12_AsOf31Dec2016_AdditionalPaidInCapitalMember" decimals="-3">40758000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c13_AsOf31Dec2016_RetainedEarningsMember" decimals="-3">-70400000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c14_AsOf31Dec2016" decimals="-3">-29641000</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c15_From1Jan2017To31Dec2017_CommonStockMember" decimals="INF">2834</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c16_From1Jan2017To31Dec2017_AdditionalPaidInCapitalMember" decimals="-3">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c16_From1Jan2017To31Dec2017_AdditionalPaidInCapitalMember" decimals="-3">477000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">477000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c17_From1Jan2017To31Dec2017_RetainedEarningsMember" decimals="-3">-9582000</us-gaap:NetIncomeLoss>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c18_AsOf31Dec2017_PreferredStockMember" decimals="INF">1221064</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c18_AsOf31Dec2017_PreferredStockMember" decimals="-3">1000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c19_AsOf31Dec2017_CommonStockMember" decimals="INF">138492</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c20_AsOf31Dec2017_AdditionalPaidInCapitalMember" decimals="-3">41259000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c21_AsOf31Dec2017_RetainedEarningsMember" decimals="-3">-79982000</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="shares" contextRef="c22_From1Jan2018To31Dec2018_CommonStockMember" decimals="INF">1571702</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c22_From1Jan2018To31Dec2018_CommonStockMember" decimals="-3">157000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c23_From1Jan2018To31Dec2018_AdditionalPaidInCapitalMember" decimals="-3">35420000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">35577000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <vxrt:StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock unitRef="shares" contextRef="c24_From1Jan2018To31Dec2018_PreferredStockMember" decimals="INF">-1221064</vxrt:StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock>
  <vxrt:StockIssuedDuringPeriodValueConversionOfPreferredStock unitRef="usd" contextRef="c24_From1Jan2018To31Dec2018_PreferredStockMember" decimals="-3">-1000</vxrt:StockIssuedDuringPeriodValueConversionOfPreferredStock>
  <vxrt:StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock unitRef="shares" contextRef="c22_From1Jan2018To31Dec2018_CommonStockMember" decimals="INF">1918543</vxrt:StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock>
  <vxrt:StockIssuedDuringPeriodValueConversionOfPreferredStock unitRef="usd" contextRef="c22_From1Jan2018To31Dec2018_CommonStockMember" decimals="-3">192000</vxrt:StockIssuedDuringPeriodValueConversionOfPreferredStock>
  <vxrt:StockIssuedDuringPeriodValueConversionOfPreferredStock unitRef="usd" contextRef="c23_From1Jan2018To31Dec2018_AdditionalPaidInCapitalMember" decimals="-3">-191000</vxrt:StockIssuedDuringPeriodValueConversionOfPreferredStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c23_From1Jan2018To31Dec2018_AdditionalPaidInCapitalMember" decimals="-3">70000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">70000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c22_From1Jan2018To31Dec2018_CommonStockMember" decimals="INF">3510439</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c22_From1Jan2018To31Dec2018_CommonStockMember" decimals="-3">365000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c23_From1Jan2018To31Dec2018_AdditionalPaidInCapitalMember" decimals="-3">31403000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">31768000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c22_From1Jan2018To31Dec2018_CommonStockMember" decimals="INF">2013</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c23_From1Jan2018To31Dec2018_AdditionalPaidInCapitalMember" decimals="-3">13000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">13000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c23_From1Jan2018To31Dec2018_AdditionalPaidInCapitalMember" decimals="-3">539000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">539000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c25_From1Jan2018To31Dec2018_RetainedEarningsMember" decimals="-3">-18007000</us-gaap:NetIncomeLoss>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c26_AsOf31Dec2018_CommonStockMember" decimals="INF">7141189</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c26_AsOf31Dec2018_CommonStockMember" decimals="-3">714000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c27_AsOf31Dec2018_AdditionalPaidInCapitalMember" decimals="-3">108513000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c28_AsOf31Dec2018_RetainedEarningsMember" decimals="-3">-97989000</us-gaap:StockholdersEquity>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">3203000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">380000</us-gaap:DepreciationAndAmortization>
  <vxrt:ImpairmentofPropertyAndEquipment unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">539000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">477000</us-gaap:ShareBasedCompensation>
  <vxrt:AmortizationOfDiscountOnShorttermInvestments unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <vxrt:AmortizationOfDiscountOnShorttermInvestments unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">24000</vxrt:AmortizationOfDiscountOnShorttermInvestments>
  <vxrt:LossgainOnRevaluationOfFinancialInstruments unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-3000</vxrt:LossgainOnRevaluationOfFinancialInstruments>
  <vxrt:LossgainOnRevaluationOfFinancialInstruments unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">3347000</vxrt:LossgainOnRevaluationOfFinancialInstruments>
  <us-gaap:OtherNoncashExpense unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">448000</us-gaap:OtherNoncashExpense>
  <us-gaap:OtherNoncashExpense unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">2557000</us-gaap:OtherNoncashExpense>
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">18000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">144000</us-gaap:AmortizationOfDebtDiscountPremium>
  <vxrt:NoncashInterestExpenseRelatedToSaleOfFutureRoyalties unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">1859000</vxrt:NoncashInterestExpenseRelatedToSaleOfFutureRoyalties>
  <vxrt:NoncashInterestExpenseRelatedToSaleOfFutureRoyalties unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <vxrt:NoncashRevenueRelatedToSaleOfFutureRoyalties unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">18000</vxrt:NoncashRevenueRelatedToSaleOfFutureRoyalties>
  <vxrt:NoncashRevenueRelatedToSaleOfFutureRoyalties unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-13500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-960000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">873000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-52000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-3784000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-1559000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-6393000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-77000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-14548000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-10040000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">707000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">117000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <vxrt:ProceedsFromSaleOfEquipment unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <vxrt:ProceedsFromSaleOfEquipment unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">70000</vxrt:ProceedsFromSaleOfEquipment>
  <vxrt:CashAcquiredInReverseMerger unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">25525000</vxrt:CashAcquiredInReverseMerger>
  <vxrt:CashAcquiredInReverseMerger unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <vxrt:PaymentsForfractionalsharesinmerger unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">21000</vxrt:PaymentsForfractionalsharesinmerger>
  <vxrt:PaymentsForfractionalsharesinmerger unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:PaymentsToAcquireInvestments unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">573000</us-gaap:PaymentsToAcquireInvestments>
  <us-gaap:PaymentsToAcquireInvestments unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">7351000</us-gaap:PaymentsToAcquireInvestments>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">1988000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">10580000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">26212000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">3182000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:RepaymentsOfNotesPayable unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">1528000</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:RepaymentsOfNotesPayable unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:RepaymentsOfShortTermDebt unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">214000</us-gaap:RepaymentsOfShortTermDebt>
  <us-gaap:RepaymentsOfShortTermDebt unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">13000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">24000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-1729000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">24000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">9935000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-6834000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c14_AsOf31Dec2016" decimals="-3">8405000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InterestPaidNet unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">356000</us-gaap:InterestPaidNet>
  <us-gaap:InterestPaidNet unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">335000</us-gaap:InterestPaidNet>
  <vxrt:StockIssuedDuringPeriodValueUponReverseMerger unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">31768000</vxrt:StockIssuedDuringPeriodValueUponReverseMerger>
  <vxrt:StockIssuedDuringPeriodValueUponReverseMerger unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <vxrt:ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">35577000</vxrt:ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger>
  <vxrt:ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <vxrt:ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">70000</vxrt:ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity>
  <vxrt:ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">52000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
  <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <dei:EntityRegistrantName contextRef="c8_From1Jan2018To31Dec2018">Vaxart, Inc.</dei:EntityRegistrantName>
  <dei:DocumentType contextRef="c8_From1Jan2018To31Dec2018">10-K</dei:DocumentType>
  <dei:CurrentFiscalYearEndDate contextRef="c8_From1Jan2018To31Dec2018">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntitySmallBusiness contextRef="c8_From1Jan2018To31Dec2018">true</dei:EntitySmallBusiness>
  <dei:EntityEmergingGrowthCompany contextRef="c8_From1Jan2018To31Dec2018">false</dei:EntityEmergingGrowthCompany>
  <dei:EntityShellCompany contextRef="c8_From1Jan2018To31Dec2018">false</dei:EntityShellCompany>
  <dei:EntityExTransitionPeriod contextRef="c8_From1Jan2018To31Dec2018">false</dei:EntityExTransitionPeriod>
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c29_AsOf4Feb2019" decimals="INF">7141189</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityPublicFloat unitRef="usd" contextRef="c30_AsOf30Jun2018" decimals="0">12181506</dei:EntityPublicFloat>
  <dei:AmendmentFlag contextRef="c8_From1Jan2018To31Dec2018">false</dei:AmendmentFlag>
  <dei:EntityCentralIndexKey contextRef="c8_From1Jan2018To31Dec2018">0000072444</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="c8_From1Jan2018To31Dec2018">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers contextRef="c8_From1Jan2018To31Dec2018">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory contextRef="c8_From1Jan2018To31Dec2018">Non-accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityWellKnownSeasonedIssuer contextRef="c8_From1Jan2018To31Dec2018">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:DocumentFiscalYearFocus contextRef="c8_From1Jan2018To31Dec2018">2018</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="c8_From1Jan2018To31Dec2018">FY</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentPeriodEndDate contextRef="c8_From1Jan2018To31Dec2018">2018-12-31</dei:DocumentPeriodEndDate>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 12pt&quot;&gt;&lt;a name=&quot;Notes&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;1.&amp;#xa0;&amp;#xa0;Organization and Basis of Presentation&lt;/font&gt;&lt;/b&gt;&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; PAGE-BREAK-AFTER:avoid; FONT-STYLE:italic; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;&lt;font style=&quot;FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;General&amp;#xa0;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Vaxart Biosciences, Inc. was originally incorporated in California in March&amp;#xa0;2004, under the name West Coast Biologicals, Inc. The Company changed its name to Vaxart, Inc. (&amp;#8220;Private Vaxart&amp;#8221;) in July&amp;#xa0;2007, and reincorporated in the state of Delaware. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;On February 13,&amp;#xa0;2018, Private Vaxart &lt;font style=&quot;COLOR:black&quot;&gt;completed a business combination &lt;/font&gt;with &lt;font style=&quot;COLOR:black&quot;&gt;Aviragen Therapeutics, Inc. (&amp;#8220;Aviragen&amp;#8221;)&lt;/font&gt;, &lt;font style=&quot;COLOR:black&quot;&gt;pursuant to which Aviragen merged with Private Vaxart, with Private Vaxart surviving as a wholly-owned subsidiary of Aviragen (the &amp;#8220;Merger&amp;#8221;). Pursuant to the terms of the Merger, Aviragen changed its name to Vaxart, Inc. (together with its subsidiaries, the &amp;#8220;Company&amp;#8221; or &amp;#8220;Vaxart&amp;#8221;) and Private Vaxart changed its name to Vaxart Biosciences, Inc&lt;/font&gt;. All of Private Vaxart&amp;#8217;s convertible promissory notes and convertible preferred stock was converted into common stock, following which each share of common stock was converted into approximately 0.22148 shares of the Company&amp;#8217;s common stock (the &amp;#8220;Conversion&amp;#8221;). Except as otherwise noted in these Financial Statements, all shares, equity securities and per share amounts of Private Vaxart are presented to give retroactive effect to the &lt;font style=&quot;COLOR:black&quot;&gt;Conversion&lt;/font&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;I&lt;font style=&quot;color: black;&quot;&gt;mmediately following the completion of the Merger, the Company effected a reverse stock split at a ratio of one new share for every eleven shares of the Company&amp;#x2019;s common stock outstanding&lt;/font&gt; (the &amp;#x201c;Reverse Stock Split&amp;#x201d;). Except as otherwise noted in these Financial Statements, all share, equity security and per share amounts are presented to give retroactive effect to the &lt;font style=&quot;color: black;&quot;&gt;Reverse &lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;Stock Split&lt;/font&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;Immediately after the &lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Reverse Stock Split &lt;/font&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;there were approximately 7.1&amp;#xa0;million shares of the Company&amp;#x2019;s common stock outstanding. Private Vaxart&amp;#x2019;s stockholders, warrantholders and optionholders owned approximately 51% of the fully-diluted common stock of the Company, with Aviragen&amp;#x2019;s stockholders and optionholders immediately prior to the Merger owning approximately 49% of the fully-diluted common stock of the Company&lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;. The Company also assumed all of Private Vaxart&amp;#x2019;s outstanding stock options and warrants with proportionate adjustments to the number of underlying shares and exercise prices based on an exchange ratio, based on the combined impact of the Conversion and the Reverse Stock Split, of &lt;font style=&quot;color: black;&quot;&gt;approximately 0.0201346 shares of the Company for each share of Private Vaxart.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The Company&amp;#8217;s principal operations are based in South San Francisco, California, and it operates in one&amp;#xa0;reportable segment, which is the discovery and development of oral recombinant protein vaccines, based on its proprietary oral vaccine platform.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; PAGE-BREAK-AFTER:avoid; FONT-STYLE:italic; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;&lt;font style=&quot;FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;Liquidity and Going Concern&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 10pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in; line-height: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Since incorporation, the Company has been involved primarily in performing research and development activities, hiring personnel, and raising capital to support these activities. The Company has experienced losses and negative cash flows from operations since its inception. As of December 31, 2018, the Company had an accumulated deficit of $98.0 million and a loan with an outstanding balance of $3.6 million from Oxford Finance, LLC (&amp;#x201c;Oxford Finance&amp;#x201d;), repayable in monthly installments by January 2021 (see Note 9).&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;The Company expects to incur increasing costs as research and clinical trials are advanced and, therefore, expects to continue to incur losses and negative operating cash flows for the next several years. Absent additional funding or adjustments to currently planned operating activities, and in view of the uncertainties regarding future royalty revenue on sales of Relenza and Inavir, management believes that the Company&amp;#8217;s cash and cash equivalents of $11.5 million held as of December 31, 2018, are sufficient to fund the Company into, but possibly not beyond, the second quarter of 2019.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;The Company reviews its operations and clinical plans on a continuing basis, including its commitments for upcoming clinical trials. The Company plans to finance its operations with royalty revenue on sales of Relenza and Inavir, additional equity or debt financing arrangements, &lt;/font&gt;and potentially with additional funding from government contracts or strategic alliances with partner companies. The availability and amount of such funding is not certain.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;The uncertainties inherent in the Company&amp;#8217;s future operations and in its ability to obtain additional funding raise substantial doubt about its ability to continue as a going concern beyond one year from the date these financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in -0.9pt 0pt 0in&quot;&gt;&lt;a name=&quot;_Hlk510097426&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;While management believes its plan to raise additional funds will alleviate the conditions that raise substantial doubt, these plans are not entirely within its control and cannot be assessed as being probable of occurring.&amp;#xa0;If adequate funds are not available, the Company may be required to reduce operating expenses, delay or reduce the scope of its product development programs, obtain funds through arrangements with others that may require the Company to relinquish rights to certain of its technologies or products that the Company would otherwise seek to develop or commercialize itself, or cease operations&lt;/font&gt;&lt;/a&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:ConversionOfStockSharesIssued1 unitRef="shares" contextRef="c31_From13Feb2018To13Feb2018_ConversionMember" decimals="INF">0.22148</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:StockholdersEquityReverseStockSplit contextRef="c32_From13Feb2018To13Feb2018">the Company effected a reverse stock split at a ratio of one new share for every eleven shares of the Company&amp;#x2019;s common stock outstanding</us-gaap:StockholdersEquityReverseStockSplit>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="-5">7100000</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage unitRef="pure" contextRef="c33_AsOf31Dec2018_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember" decimals="2">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage unitRef="pure" contextRef="c34_AsOf31Dec2018_AviragensStockholderrsAndOptionsholdersMember" decimals="2">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <vxrt:ExchangeRatioNumberOfSharesExchangedPerShare unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">0.0201346</vxrt:ExchangeRatioNumberOfSharesExchangedPerShare>
  <us-gaap:NumberOfReportableSegments unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="0">1</us-gaap:NumberOfReportableSegments>
  <vxrt:LoanAgreementBorrowedAmount unitRef="usd" contextRef="c35_AsOf31Dec2018_OxfordFinanceMember" decimals="-5">3600000</vxrt:LoanAgreementBorrowedAmount>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:24pt 0in 12pt&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;2.&amp;#xa0;&amp;#xa0;Summary of Significant Accounting Policies&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Basis of Presentation&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America &lt;font style=&quot;COLOR:black&quot;&gt;(&amp;#8220;U.S. GAAP&amp;#8221;)&lt;/font&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Basis of Consolidation&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;The consolidated financial statements include the financial statements of Vaxart, Inc. and its subsidiaries. All significant transactions and balances between Vaxart, Inc. and its subsidiaries have been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Use of Estimates&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Actual results and outcomes could differ from these estimates and assumptions&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;Foreign Currencies&lt;/font&gt;&lt;/strong&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;&amp;#xa0;&amp;#x2013;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Foreign exchange gains and losses for assets and liabilities of the Company&amp;#x2019;s &lt;font style=&quot;color: black;&quot;&gt;non-U.S. &lt;/font&gt;subsidiaries for which the functional currency is the U.S. dollar are recorded in &lt;font style=&quot;color: black;&quot;&gt;foreign exchange gain or loss, net&lt;/font&gt; within other income and (expenses) in the Company&amp;#x2019;s statements of operations and comprehensive loss&lt;font style=&quot;color: black;&quot;&gt;. The Company has no subsidiaries &lt;/font&gt;for which the local currency is the functional currency.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company considers all highly liquid debt investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents, which may consist of amounts invested in money market funds, corporate bonds and commercial paper, are stated at fair value. Cash and cash equivalents as of December 31, 2018 and 2017, includes $50,000 of restricted cash.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Short-Term Investments&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company&amp;#8217;s short-term investments have only comprised commercial paper and corporate bonds. The short-term investments are classified as held-to-maturity based on the Company&amp;#8217;s positive intent and ability to hold the securities to maturity. This classification is reevaluated at each balance sheet date. Short-term investments are stated at amortized cost, adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is presented as interest income in the statement of operations and comprehensive loss. The specific identification method is used to determine the realized gain or loss on securities sold or otherwise disposed. When the fair value of a debt security classified as held-to-maturity is less than its amortized cost, the Company assesses whether or not: (i)&amp;#xa0;it has the intent to sell the security or (ii)&amp;#xa0;it is more likely than not that the Company will be required to sell the security before its anticipated recovery. If either of these conditions is met, the Company must recognize an other-than-temporary impairment through earnings for the difference between the debt security&amp;#8217;s amortized cost basis and its fair value. Gains and losses are recognized in earnings when the investments are sold or impaired.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;&lt;b&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Concentration of Credit Risk&lt;/font&gt;&lt;/b&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. The Company places its cash, cash equivalents and short&amp;#x2011;term investments at financial institutions that management believes are of high credit quality. The Company is exposed to credit risk in the event of default by the financial institutions holding the cash and cash equivalents to the extent such amounts are in excess of the federally insured limits. The Company has not experienced any losses on its deposits since inception.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The primary focus of the Company&amp;#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&amp;#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one&amp;#xa0;corporate issuer or sector and establishing a minimum allowable credit rating. The Company generally requires no collateral from its customers.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;Accounts Receivable&lt;/font&gt;&lt;/strong&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;font style=&quot;color: black;&quot;&gt;&amp;#x2013;&lt;/font&gt;&amp;#xa0;Accounts receivable arise from the Company&amp;#x2019;s royalty revenue receivable for sales, &lt;font style=&quot;color: black;&quot;&gt;net of estimated returns,&lt;/font&gt; of &lt;font style=&quot;color: black;&quot;&gt;Inavir and Relenza, and from its &lt;/font&gt;contract with the Department of Health and Human Services, Office of Biomedical Advanced Research and Development Authority (&amp;#x201c;HHS BARDA&amp;#x201d;) (see Note 6), and are reported at amounts expected to be collected in future periods. &lt;a name=&quot;_Hlk521491497&quot;&gt;&lt;/a&gt;An allowance for uncollectible accounts will be recorded based on a combination of historical experience, aging analysis, and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. Account balances will be written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company has provided no allowance for uncollectible accounts as of December 31, 2018 and 2017.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Property and Equipment&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;Property and equipment is carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Depreciation begins at the time the asset is placed in service. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is reflected in other income and (expenses) in the period realized.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The useful lives of the property and equipment are as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 181.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Laboratory equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 322.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;5 years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 181.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Office and computer equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 322.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;3 years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 181.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 322.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Shorter of remaining lease term or estimated useful life&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;a name=&quot;_Hlk513886420&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Intangible Assets&lt;/font&gt;&lt;/b&gt;&lt;/a&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;Intangible assets comprise developed technology, intellectual property and, until it was considered fully impaired (see Note 5), in-process research and development. Intangible assets are carried at cost less accumulated amortization. Amortization is computed using the straight-line method over useful lives ranging from 1.3 to 11.75 years for developed technology and 20&amp;#xa0;years for intellectual property. In-process research and development is considered to be indefinite-lived and is not amortized, but is subject to impairment testing&lt;/font&gt;. The Company assessed its in-process research and development as fully impaired in the year ended December&amp;#xa0;31, 2018 (see Note 5)&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Impairment of Long-Lived Assets&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company reviews its long-lived assets, including &lt;a name=&quot;_Hlk529199618&quot;&gt;property and equipment and intangible assets&lt;/a&gt; with finite lives, for impairment whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate over its remaining life. When indications of impairment are present and the estimated undiscounted future cash flows from the use of these assets is less than the assets&amp;#8217; carrying value, the related assets will be written down to fair value. The Company assessed leasehold improvements and furniture at its leased offices in Alpharetta, Georgia as impaired in the year ended December&amp;#xa0;31, 2018 (see Notes 5 and 10). There have been no other impairments of the Company&amp;#8217;s long-lived assets for the periods presented&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Accrued Clinical and Manufacturing Expenses&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company accrues for estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials, and contract manufacturing activities. The Company records the estimated costs of research and development activities based upon the estimated amount of services provided and includes the costs incurred but not yet invoiced within other accrued liabilities in the balance sheets and within research and development expense in the consolidated statements of operations and comprehensive loss. These costs can be a significant component of the Company&amp;#8217;s research and development expenses&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The &lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Company estimates the amount of services provided through discussions with internal personnel and external service providers as to the progress or stage of completion of the services and the agreed-upon fee to be paid for such services. The Company makes significant judgments and estimates in determining the accrued balance in each reporting period. As actual costs become known, it adjusts its accrued estimates. Although the Company does not expect its estimates to be materially different from amounts actually incurred, its understanding of the status and timing of services performed, the number of subjects enrolled, and the rate of enrollment may vary from its estimates and could result in the Company reporting amounts that are too high or too low in any particular period. The Company&amp;#8217;s accrued expenses are dependent, in part, upon the receipt of timely and accurate reporting from contract research organizations and other third-party service providers. To date, the Company has not experienced any material differences between accrued costs and actual costs incurred&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Convertible Preferred Stock Warrant Liability&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company has issued certain convertible preferred stock warrants. These warrants were recorded within other accrued liabilities in the balance sheets at fair value due to down-round protection features contained in the convertible preferred stock into which the warrants were exercisable. At the end of each reporting period, changes in fair value of the warrants since the prior period were recorded as a component of (loss) gain on revaluation of financial instruments, net within other income and (expenses) in the consolidated statements of operations and comprehensive loss&lt;font style=&quot;COLOR:black&quot;&gt;. In the event that the terms of the warrant change such that liability accounting is no longer required, the fair value on the date of such change is released to equity.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Convertible Promissory Notes Embedded Derivative Liability&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company recorded derivative instruments related to redemption features embedded within the outstanding convertible promissory notes. The embedded derivatives were accounted for as liabilities at their estimated fair value when the convertible promissory notes were issued and were re-measured to fair value as of each balance sheet date, with the related re-measurement adjustment being recognized as a component of (loss) gain on revaluation of &lt;font style=&quot;COLOR:black&quot;&gt;financial instruments&lt;/font&gt; in the consolidated statements of operations and comprehensive loss&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Revenue Recognition&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#8211;&amp;#xa0;The Company recognizes revenue when it transfers control of promised goods or services to its customers, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition, the Company performs the following five steps:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(i)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;identification of the promised goods or services in the contract;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(ii)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(iii)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;measurement of the transaction price, including the constraint on variable consideration;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(iv)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;allocation of the transaction price to the performance obligations based on estimated selling prices; and&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(v)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:normal&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Revenue from royalties earned as a percentage of sales, including milestone payments based on achieving a specified level of sales, where a license is deemed to be the predominant item to which the royalties relate, is recognized as revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied), as required under the sales- and usage-based royalty exception.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;The Company performed research and development work under its cost&amp;#x2011;plus&amp;#x2011;fixed&amp;#x2011;fee contract with HHS BARDA. The Company recognizes revenue under research contracts only when a contract has been executed and the contract price is fixed or determinable. &lt;font style=&quot;COLOR:#212121&quot;&gt;Revenue from the HHS BARDA contract is recognized in the period during which the related costs are incurred and the related services are rendered, provided that the applicable conditions under the contract have been met. Costs of contract revenue are recorded as a component of operating expenses in the consolidated statements of operations&lt;/font&gt; and comprehensive loss&lt;font style=&quot;COLOR:#212121&quot;&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Under the cost reimbursable contract with HHS BARDA, the Company is reimbursed for allowable costs, and recognizes revenue as allowable costs are incurred and the fixed-fee is earned. Reimbursable costs under the contract primarily include direct labor, subcontract costs, materials, equipment, travel, and approved overhead and indirect costs. Fixed fees under cost reimbursable contracts are earned in proportion to the allowable costs incurred in performance of the work relative to total estimated contract costs, with such costs incurred representing a reasonable measurement of the proportional performance of the work completed. Under the HHS BARDA contract, certain activities must be pre-approved in order for their costs to be deemed allowable direct costs. The HHS BARDA contract provides the U.S.&amp;#xa0;government the ability to terminate the contract for convenience or to terminate for default if the Company fails to meet its obligations as set forth in the statement of work. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt -0.9pt 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Payments to the Company under cost reimbursable contracts, such as this contract, are provisional payments subject to adjustment upon annual audit by the government. Management believes that revenue for periods not yet audited has been recorded in amounts that are expected to be realized upon final audit and settlement. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly in the period that the adjustment is known.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Research and Development Costs&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Research and development costs are expensed as incurred. Research and development costs consist primarily of salaries and benefits, stock-based compensation, consultant fees, third-party costs for conducting clinical trials and the manufacture of clinical trial materials, certain facility costs and other costs associated with clinical trials. Payments made to other entities are under agreements that are generally cancelable by the Company. Advance payments for research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related services are performed.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Stock-Based Compensation&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;The Company measures the fair value of all stock-based awards, including stock options, to employees and, since April 1, 2018, to nonemployees, on the grant date and records the fair value of these awards, net of estimated forfeitures, to compensation expense over the service period. Prior to April 1, 2018, the &lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;fair value of awards to nonemployees was measured on the date of performance at the fair value of the consideration received or the fair value of the equity instruments issued, whichever was more reliably measured. The fair value of options is estimated using the Black-Scholes valuation model&lt;font style=&quot;COLOR:black&quot;&gt;. The expected term of each option is estimated by taking the arithmetic average of its original contractual term and its average vesting term.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Net Income (Loss) Per Share Attributable to Common Stockholders&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;Basic net income (loss) per share is computed by dividing net income (loss), as adjusted for dividends on the Series&amp;#xa0;B and Series&amp;#xa0;C convertible preferred stock in the period, by the weighted average number of common shares outstanding during the period, without consideration of potential common shares.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Diluted net income (loss) per common share is computed giving effect to all potential dilutive common shares, comprising common stock issuable upon exercise of stock options and warrants. The Company uses the treasury-stock method to compute diluted income (loss) per share with respect to its stock options and warrants. For purposes of this calculation, options and warrants to purchase common stock are considered to be potential common shares and are only included in the calculation of diluted net income per share when their effect is dilutive. In the event of a net loss, the effects of all potentially dilutive shares are excluded from the diluted net loss per share calculation as their inclusion would be antidilutive.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt -0.9pt 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;In June 2018, the FASB issued ASU 2018-07, &lt;em&gt;Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. &lt;/em&gt;This update simplifies the accounting for share-based payment transactions by changing the guidance for accounting for nonemployee share-based awards so that, instead of revaluing each award at each balance sheet date during the period over which it vests, the value will be fixed on the grant date and expensed over the vesting period in the same way that employee awards are already accounted for. This guidance is effective for annual periods beginning after December 15, 2018, including interim periods within that year, with early adoption permitted for entities that had already adopted Topic 606 (see ASU 2014-09 below). The Company adopted ASU 2018-07 effective April 1, 2018, and since it had no unvested awards granted to nonemployees, its adoption had no effect on the Company&amp;#x2019;s financial condition or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;In May 2017, the FASB issued ASU 2017-09, &lt;i&gt;Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. &lt;/i&gt;This update provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. This guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that year, and must be applied prospectively to an award modified on or after the adoption date. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&amp;#8217;s financial condition or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;In January&amp;#xa0;2017, the FASB&amp;#xa0;issued ASU No.&amp;#xa0;2017-04, &lt;i&gt;Intangibles-Goodwill and Other (Topic&amp;#xa0;350) Simplifying the Test for Goodwill Impairment&lt;/i&gt;&amp;#xa0;(&amp;#8220;ASU&amp;#xa0;2017-04&amp;#8221;), which will simplify the goodwill impairment calculation by eliminating Step 2 from the current goodwill impairment test. The new standard does not change how a goodwill impairment is identified. The standard will be effective January&amp;#xa0;1, 2020, with early adoption permitted, and is to be applied prospectively from the date of adoption. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&amp;#8217;s financial condition or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;In January&amp;#xa0;2017, the FASB&amp;#xa0;issued ASU No.&amp;#xa0;2017-01, &lt;i&gt;Business Combinations (Topic&amp;#xa0;805) Clarifying the Definition of a Business&lt;/i&gt;&amp;#xa0;(&amp;#8220;ASU&amp;#xa0;2017-01&amp;#8221;). The new standard &lt;font style=&quot;COLOR:black&quot;&gt;clarifies the definition of a business to help companies evaluate whether acquisition or disposal transactions should be accounted for as asset groups or as businesses&lt;/font&gt;. The Company adopted this standard when it became effective on January 1, 2018, and it was applied in connection with the Company&amp;#8217;s accounting for the Merger as a business combination.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;In August 2016, the FASB issued Accounting Standards Update (ASU) 2016-15, &lt;i&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments&lt;/i&gt;, which provides additional guidance on the presentation and classification of certain items in the statement of cash flows. The standard is effective for fiscal years beginning after December&amp;#xa0;15, 2017, with early adoption permitted. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&amp;#8217;s financial condition or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;In May&amp;#xa0;2014, the FASB issued ASU&amp;#xa0;2014-09&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;, &lt;i&gt;Revenue from Contracts with Customers (Topic&amp;#xa0;606)&lt;/i&gt;, which supersedes nearly all existing revenue recognition guidance under Topic&amp;#xa0;605, &lt;i&gt;Revenue&lt;/i&gt; &lt;i&gt;Recognition&lt;/i&gt;. The new standard requires a company to recognize revenue when it transfers goods and services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. ASU&amp;#xa0;2014-09 defines a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when (or as) the entity satisfies the performance obligations. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The Company has &lt;font style=&quot;COLOR:#212121&quot;&gt;determined that its HHS BARDA government contract is not within the scope of ASU 2014-09 as the government entity is not a customer under the agreement. &lt;/font&gt;The Company adopted &lt;font style=&quot;COLOR:#212121&quot;&gt;ASU 2014-09&lt;/font&gt; with respect to its royalty revenue using the modified retrospective method on January&amp;#xa0;1, 2018. Under the modified retrospective transition method, the cumulative effect of applying the standard is recognized at the date of initial application for all contracts not completed as of the date of adoption. The adoption of ASU&amp;#xa0;2014-09&amp;#xa0;did not have any effect on the Company&amp;#8217;s financial condition or results of operations and therefore no cumulative effect adjustment was recorded, although the Company has modified its accounting policies to reflect the requirements of this standard and make additional disclosures&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Recent Accounting Pronouncements&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;In February 2016, the FASB issued ASU 2016 02 Leases (Topic 842), which replaces most current lease guidance when it becomes effective. This standard update intends to increase transparency and improve comparability by requiring entities to recognize assets and liabilities on the balance sheet for all leases, with certain exceptions. The new standard states that a lessee will recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statements of operations. The new guidance will be effective for the Company starting in the first quarter of fiscal 2019, with early adoption permitted. The Company plans to adopt the new guidance effective January 1, 2019, using the modified retrospective method, and to use the effective date method of adoption, as permitted by ASU 2018-11, Targeted Improvements, which the FASB issued in July 2018, which reduces the disclosure requirements on transition. The Company has elected the short-term lease recognition exemption for all classes of assets, which means that it will not recognize right-of-use assets or lease liabilities for leases with a duration of one year or less. Further, the Company has elected to use all of the practical expedients available on transition, whereby it has not reassessed under the new standard its prior conclusions about lease identification, lease classification and initial direct costs.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;We expect that this standard will have a material effect on our consolidated financial statements. The most significant effects relate to the recognition of new right-of-use assets and lease liabilities on our consolidated balance sheet. The Company currently expects to recognize lease liabilities of $1,207,000, $766,000 of which is current, and right-of-use assets of $941,000 based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases, to derecognize liabilities of $239,000, $100,000 of which is current, and recognize an increase of $27,000 to accumulated deficit on adoption of the new accounting policy.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;The increase in accumulated deficit arises because the right-of-use asset impairment charge that would have been recorded in the three months ended December 31, 2018, under Topic 842 exceeds the lease loss accrual, net of accretion, that was recorded (see Note 10). This impact aside, the adoption will have no effect on the Company&amp;#x2019;s statements of operations or cash flows, other than on related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The Company has reviewed all other significant newly-issued accounting pronouncements and concluded that they either are not applicable to the Company&amp;#8217;s operations or no material effect is expected on its consolidated financial statements as a result of future adoption.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Basis of Presentation&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America &lt;font style=&quot;COLOR:black&quot;&gt;(&amp;#8220;U.S. GAAP&amp;#8221;)&lt;/font&gt;.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Basis of Consolidation&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;The consolidated financial statements include the financial statements of Vaxart, Inc. and its subsidiaries. All significant transactions and balances between Vaxart, Inc. and its subsidiaries have been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:UseOfEstimates contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Use of Estimates&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Actual results and outcomes could differ from these estimates and assumptions&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;Foreign Currencies&lt;/font&gt;&lt;/strong&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;&amp;#xa0;&amp;#x2013;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Foreign exchange gains and losses for assets and liabilities of the Company&amp;#x2019;s &lt;font style=&quot;color: black;&quot;&gt;non-U.S. &lt;/font&gt;subsidiaries for which the functional currency is the U.S. dollar are recorded in &lt;font style=&quot;color: black;&quot;&gt;foreign exchange gain or loss, net&lt;/font&gt; within other income and (expenses) in the Company&amp;#x2019;s statements of operations and comprehensive loss&lt;font style=&quot;color: black;&quot;&gt;. The Company has no subsidiaries &lt;/font&gt;for which the local currency is the functional currency.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company considers all highly liquid debt investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents, which may consist of amounts invested in money market funds, corporate bonds and commercial paper, are stated at fair value. Cash and cash equivalents as of December 31, 2018 and 2017, includes $50,000 of restricted cash.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:RestrictedCash unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="0">50000</us-gaap:RestrictedCash>
  <us-gaap:RestrictedCash unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">50000</us-gaap:RestrictedCash>
  <us-gaap:InvestmentPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Short-Term Investments&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company&amp;#8217;s short-term investments have only comprised commercial paper and corporate bonds. The short-term investments are classified as held-to-maturity based on the Company&amp;#8217;s positive intent and ability to hold the securities to maturity. This classification is reevaluated at each balance sheet date. Short-term investments are stated at amortized cost, adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is presented as interest income in the statement of operations and comprehensive loss. The specific identification method is used to determine the realized gain or loss on securities sold or otherwise disposed. When the fair value of a debt security classified as held-to-maturity is less than its amortized cost, the Company assesses whether or not: (i)&amp;#xa0;it has the intent to sell the security or (ii)&amp;#xa0;it is more likely than not that the Company will be required to sell the security before its anticipated recovery. If either of these conditions is met, the Company must recognize an other-than-temporary impairment through earnings for the difference between the debt security&amp;#8217;s amortized cost basis and its fair value. Gains and losses are recognized in earnings when the investments are sold or impaired.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;&lt;b&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Concentration of Credit Risk&lt;/font&gt;&lt;/b&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. The Company places its cash, cash equivalents and short&amp;#x2011;term investments at financial institutions that management believes are of high credit quality. The Company is exposed to credit risk in the event of default by the financial institutions holding the cash and cash equivalents to the extent such amounts are in excess of the federally insured limits. The Company has not experienced any losses on its deposits since inception.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The primary focus of the Company&amp;#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&amp;#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one&amp;#xa0;corporate issuer or sector and establishing a minimum allowable credit rating. The Company generally requires no collateral from its customers.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ReceivablesPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;Accounts Receivable&lt;/font&gt;&lt;/strong&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;font style=&quot;color: black;&quot;&gt;&amp;#x2013;&lt;/font&gt;&amp;#xa0;Accounts receivable arise from the Company&amp;#x2019;s royalty revenue receivable for sales, &lt;font style=&quot;color: black;&quot;&gt;net of estimated returns,&lt;/font&gt; of &lt;font style=&quot;color: black;&quot;&gt;Inavir and Relenza, and from its &lt;/font&gt;contract with the Department of Health and Human Services, Office of Biomedical Advanced Research and Development Authority (&amp;#x201c;HHS BARDA&amp;#x201d;) (see Note 6), and are reported at amounts expected to be collected in future periods. &lt;a name=&quot;_Hlk521491497&quot;&gt;&lt;/a&gt;An allowance for uncollectible accounts will be recorded based on a combination of historical experience, aging analysis, and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. Account balances will be written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company has provided no allowance for uncollectible accounts as of December 31, 2018 and 2017.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Property and Equipment&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;Property and equipment is carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Depreciation begins at the time the asset is placed in service. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is reflected in other income and (expenses) in the period realized.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The useful lives of the property and equipment are as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 181.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Laboratory equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 322.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;5 years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 181.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Office and computer equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 322.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;3 years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 181.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 322.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Shorter of remaining lease term or estimated useful life&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;a name=&quot;_Hlk513886420&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Intangible Assets&lt;/font&gt;&lt;/b&gt;&lt;/a&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;Intangible assets comprise developed technology, intellectual property and, until it was considered fully impaired (see Note 5), in-process research and development. Intangible assets are carried at cost less accumulated amortization. Amortization is computed using the straight-line method over useful lives ranging from 1.3 to 11.75 years for developed technology and 20&amp;#xa0;years for intellectual property. In-process research and development is considered to be indefinite-lived and is not amortized, but is subject to impairment testing&lt;/font&gt;. The Company assessed its in-process research and development as fully impaired in the year ended December&amp;#xa0;31, 2018 (see Note 5)&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c36_From1Jan2018To31Dec2018_MinimumMember">P1Y109D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c37_From1Jan2018To31Dec2018_MaximumMember">P11Y9M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c38_From1Jan2018To31Dec2018_IntellectualPropertyMember">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Impairment of Long-Lived Assets&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company reviews its long-lived assets, including &lt;a name=&quot;_Hlk529199618&quot;&gt;property and equipment and intangible assets&lt;/a&gt; with finite lives, for impairment whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate over its remaining life. When indications of impairment are present and the estimated undiscounted future cash flows from the use of these assets is less than the assets&amp;#8217; carrying value, the related assets will be written down to fair value. The Company assessed leasehold improvements and furniture at its leased offices in Alpharetta, Georgia as impaired in the year ended December&amp;#xa0;31, 2018 (see Notes 5 and 10). There have been no other impairments of the Company&amp;#8217;s long-lived assets for the periods presented&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <vxrt:AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Accrued Clinical and Manufacturing Expenses&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company accrues for estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials, and contract manufacturing activities. The Company records the estimated costs of research and development activities based upon the estimated amount of services provided and includes the costs incurred but not yet invoiced within other accrued liabilities in the balance sheets and within research and development expense in the consolidated statements of operations and comprehensive loss. These costs can be a significant component of the Company&amp;#8217;s research and development expenses&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The &lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Company estimates the amount of services provided through discussions with internal personnel and external service providers as to the progress or stage of completion of the services and the agreed-upon fee to be paid for such services. The Company makes significant judgments and estimates in determining the accrued balance in each reporting period. As actual costs become known, it adjusts its accrued estimates. Although the Company does not expect its estimates to be materially different from amounts actually incurred, its understanding of the status and timing of services performed, the number of subjects enrolled, and the rate of enrollment may vary from its estimates and could result in the Company reporting amounts that are too high or too low in any particular period. The Company&amp;#8217;s accrued expenses are dependent, in part, upon the receipt of timely and accurate reporting from contract research organizations and other third-party service providers. To date, the Company has not experienced any material differences between accrued costs and actual costs incurred&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</vxrt:AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock>
  <vxrt:ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Convertible Preferred Stock Warrant Liability&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company has issued certain convertible preferred stock warrants. These warrants were recorded within other accrued liabilities in the balance sheets at fair value due to down-round protection features contained in the convertible preferred stock into which the warrants were exercisable. At the end of each reporting period, changes in fair value of the warrants since the prior period were recorded as a component of (loss) gain on revaluation of financial instruments, net within other income and (expenses) in the consolidated statements of operations and comprehensive loss&lt;font style=&quot;COLOR:black&quot;&gt;. In the event that the terms of the warrant change such that liability accounting is no longer required, the fair value on the date of such change is released to equity.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</vxrt:ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock>
  <us-gaap:DerivativesPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Convertible Promissory Notes Embedded Derivative Liability&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#xa0;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#8211;&lt;/font&gt;&amp;#xa0;The Company recorded derivative instruments related to redemption features embedded within the outstanding convertible promissory notes. The embedded derivatives were accounted for as liabilities at their estimated fair value when the convertible promissory notes were issued and were re-measured to fair value as of each balance sheet date, with the related re-measurement adjustment being recognized as a component of (loss) gain on revaluation of &lt;font style=&quot;COLOR:black&quot;&gt;financial instruments&lt;/font&gt; in the consolidated statements of operations and comprehensive loss&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Revenue Recognition&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;&amp;#8211;&amp;#xa0;The Company recognizes revenue when it transfers control of promised goods or services to its customers, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition, the Company performs the following five steps:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(i)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;identification of the promised goods or services in the contract;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(ii)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(iii)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;measurement of the transaction price, including the constraint on variable consideration;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(iv)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;allocation of the transaction price to the performance obligations based on estimated selling prices; and&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(v)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:normal&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Revenue from royalties earned as a percentage of sales, including milestone payments based on achieving a specified level of sales, where a license is deemed to be the predominant item to which the royalties relate, is recognized as revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied), as required under the sales- and usage-based royalty exception.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;The Company performed research and development work under its cost&amp;#x2011;plus&amp;#x2011;fixed&amp;#x2011;fee contract with HHS BARDA. The Company recognizes revenue under research contracts only when a contract has been executed and the contract price is fixed or determinable. &lt;font style=&quot;COLOR:#212121&quot;&gt;Revenue from the HHS BARDA contract is recognized in the period during which the related costs are incurred and the related services are rendered, provided that the applicable conditions under the contract have been met. Costs of contract revenue are recorded as a component of operating expenses in the consolidated statements of operations&lt;/font&gt; and comprehensive loss&lt;font style=&quot;COLOR:#212121&quot;&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Under the cost reimbursable contract with HHS BARDA, the Company is reimbursed for allowable costs, and recognizes revenue as allowable costs are incurred and the fixed-fee is earned. Reimbursable costs under the contract primarily include direct labor, subcontract costs, materials, equipment, travel, and approved overhead and indirect costs. Fixed fees under cost reimbursable contracts are earned in proportion to the allowable costs incurred in performance of the work relative to total estimated contract costs, with such costs incurred representing a reasonable measurement of the proportional performance of the work completed. Under the HHS BARDA contract, certain activities must be pre-approved in order for their costs to be deemed allowable direct costs. The HHS BARDA contract provides the U.S.&amp;#xa0;government the ability to terminate the contract for convenience or to terminate for default if the Company fails to meet its obligations as set forth in the statement of work. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt -0.9pt 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Payments to the Company under cost reimbursable contracts, such as this contract, are provisional payments subject to adjustment upon annual audit by the government. Management believes that revenue for periods not yet audited has been recorded in amounts that are expected to be realized upon final audit and settlement. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly in the period that the adjustment is known.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Research and Development Costs&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Research and development costs are expensed as incurred. Research and development costs consist primarily of salaries and benefits, stock-based compensation, consultant fees, third-party costs for conducting clinical trials and the manufacture of clinical trial materials, certain facility costs and other costs associated with clinical trials. Payments made to other entities are under agreements that are generally cancelable by the Company. Advance payments for research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related services are performed.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Stock-Based Compensation&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;The Company measures the fair value of all stock-based awards, including stock options, to employees and, since April 1, 2018, to nonemployees, on the grant date and records the fair value of these awards, net of estimated forfeitures, to compensation expense over the service period. Prior to April 1, 2018, the &lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;fair value of awards to nonemployees was measured on the date of performance at the fair value of the consideration received or the fair value of the equity instruments issued, whichever was more reliably measured. The fair value of options is estimated using the Black-Scholes valuation model&lt;font style=&quot;COLOR:black&quot;&gt;. The expected term of each option is estimated by taking the arithmetic average of its original contractual term and its average vesting term.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Net Income (Loss) Per Share Attributable to Common Stockholders&lt;/font&gt;&lt;/b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#8211;&amp;#xa0;Basic net income (loss) per share is computed by dividing net income (loss), as adjusted for dividends on the Series&amp;#xa0;B and Series&amp;#xa0;C convertible preferred stock in the period, by the weighted average number of common shares outstanding during the period, without consideration of potential common shares.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Diluted net income (loss) per common share is computed giving effect to all potential dilutive common shares, comprising common stock issuable upon exercise of stock options and warrants. The Company uses the treasury-stock method to compute diluted income (loss) per share with respect to its stock options and warrants. For purposes of this calculation, options and warrants to purchase common stock are considered to be potential common shares and are only included in the calculation of diluted net income per share when their effect is dilutive. In the event of a net loss, the effects of all potentially dilutive shares are excluded from the diluted net loss per share calculation as their inclusion would be antidilutive.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt -0.9pt 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;In June 2018, the FASB issued ASU 2018-07, &lt;em&gt;Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. &lt;/em&gt;This update simplifies the accounting for share-based payment transactions by changing the guidance for accounting for nonemployee share-based awards so that, instead of revaluing each award at each balance sheet date during the period over which it vests, the value will be fixed on the grant date and expensed over the vesting period in the same way that employee awards are already accounted for. This guidance is effective for annual periods beginning after December 15, 2018, including interim periods within that year, with early adoption permitted for entities that had already adopted Topic 606 (see ASU 2014-09 below). The Company adopted ASU 2018-07 effective April 1, 2018, and since it had no unvested awards granted to nonemployees, its adoption had no effect on the Company&amp;#x2019;s financial condition or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;In May 2017, the FASB issued ASU 2017-09, &lt;i&gt;Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. &lt;/i&gt;This update provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. This guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that year, and must be applied prospectively to an award modified on or after the adoption date. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&amp;#8217;s financial condition or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;In January&amp;#xa0;2017, the FASB&amp;#xa0;issued ASU No.&amp;#xa0;2017-04, &lt;i&gt;Intangibles-Goodwill and Other (Topic&amp;#xa0;350) Simplifying the Test for Goodwill Impairment&lt;/i&gt;&amp;#xa0;(&amp;#8220;ASU&amp;#xa0;2017-04&amp;#8221;), which will simplify the goodwill impairment calculation by eliminating Step 2 from the current goodwill impairment test. The new standard does not change how a goodwill impairment is identified. The standard will be effective January&amp;#xa0;1, 2020, with early adoption permitted, and is to be applied prospectively from the date of adoption. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&amp;#8217;s financial condition or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;In January&amp;#xa0;2017, the FASB&amp;#xa0;issued ASU No.&amp;#xa0;2017-01, &lt;i&gt;Business Combinations (Topic&amp;#xa0;805) Clarifying the Definition of a Business&lt;/i&gt;&amp;#xa0;(&amp;#8220;ASU&amp;#xa0;2017-01&amp;#8221;). The new standard &lt;font style=&quot;COLOR:black&quot;&gt;clarifies the definition of a business to help companies evaluate whether acquisition or disposal transactions should be accounted for as asset groups or as businesses&lt;/font&gt;. The Company adopted this standard when it became effective on January 1, 2018, and it was applied in connection with the Company&amp;#8217;s accounting for the Merger as a business combination.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;In August 2016, the FASB issued Accounting Standards Update (ASU) 2016-15, &lt;i&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments&lt;/i&gt;, which provides additional guidance on the presentation and classification of certain items in the statement of cash flows. The standard is effective for fiscal years beginning after December&amp;#xa0;15, 2017, with early adoption permitted. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&amp;#8217;s financial condition or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;In May&amp;#xa0;2014, the FASB issued ASU&amp;#xa0;2014-09&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;, &lt;i&gt;Revenue from Contracts with Customers (Topic&amp;#xa0;606)&lt;/i&gt;, which supersedes nearly all existing revenue recognition guidance under Topic&amp;#xa0;605, &lt;i&gt;Revenue&lt;/i&gt; &lt;i&gt;Recognition&lt;/i&gt;. The new standard requires a company to recognize revenue when it transfers goods and services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. ASU&amp;#xa0;2014-09 defines a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when (or as) the entity satisfies the performance obligations. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The Company has &lt;font style=&quot;COLOR:#212121&quot;&gt;determined that its HHS BARDA government contract is not within the scope of ASU 2014-09 as the government entity is not a customer under the agreement. &lt;/font&gt;The Company adopted &lt;font style=&quot;COLOR:#212121&quot;&gt;ASU 2014-09&lt;/font&gt; with respect to its royalty revenue using the modified retrospective method on January&amp;#xa0;1, 2018. Under the modified retrospective transition method, the cumulative effect of applying the standard is recognized at the date of initial application for all contracts not completed as of the date of adoption. The adoption of ASU&amp;#xa0;2014-09&amp;#xa0;did not have any effect on the Company&amp;#8217;s financial condition or results of operations and therefore no cumulative effect adjustment was recorded, although the Company has modified its accounting policies to reflect the requirements of this standard and make additional disclosures&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Recent Accounting Pronouncements&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;In February 2016, the FASB issued ASU 2016 02 Leases (Topic 842), which replaces most current lease guidance when it becomes effective. This standard update intends to increase transparency and improve comparability by requiring entities to recognize assets and liabilities on the balance sheet for all leases, with certain exceptions. The new standard states that a lessee will recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statements of operations. The new guidance will be effective for the Company starting in the first quarter of fiscal 2019, with early adoption permitted. The Company plans to adopt the new guidance effective January 1, 2019, using the modified retrospective method, and to use the effective date method of adoption, as permitted by ASU 2018-11, Targeted Improvements, which the FASB issued in July 2018, which reduces the disclosure requirements on transition. The Company has elected the short-term lease recognition exemption for all classes of assets, which means that it will not recognize right-of-use assets or lease liabilities for leases with a duration of one year or less. Further, the Company has elected to use all of the practical expedients available on transition, whereby it has not reassessed under the new standard its prior conclusions about lease identification, lease classification and initial direct costs.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;We expect that this standard will have a material effect on our consolidated financial statements. The most significant effects relate to the recognition of new right-of-use assets and lease liabilities on our consolidated balance sheet. The Company currently expects to recognize lease liabilities of $1,207,000, $766,000 of which is current, and right-of-use assets of $941,000 based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases, to derecognize liabilities of $239,000, $100,000 of which is current, and recognize an increase of $27,000 to accumulated deficit on adoption of the new accounting policy.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;The increase in accumulated deficit arises because the right-of-use asset impairment charge that would have been recorded in the three months ended December 31, 2018, under Topic 842 exceeds the lease loss accrual, net of accretion, that was recorded (see Note 10). This impact aside, the adoption will have no effect on the Company&amp;#x2019;s statements of operations or cash flows, other than on related disclosures.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The Company has reviewed all other significant newly-issued accounting pronouncements and concluded that they either are not applicable to the Company&amp;#8217;s operations or no material effect is expected on its consolidated financial statements as a result of future adoption.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:OperatingLeaseLiability unitRef="usd" contextRef="c39_AsOf1Jan2019_RecognizeLeaseLiabilitiesMember" decimals="0">1207000</us-gaap:OperatingLeaseLiability>
  <us-gaap:OperatingLeaseLiabilityCurrent unitRef="usd" contextRef="c39_AsOf1Jan2019_RecognizeLeaseLiabilitiesMember" decimals="0">766000</us-gaap:OperatingLeaseLiabilityCurrent>
  <us-gaap:OperatingLeaseRightOfUseAsset unitRef="usd" contextRef="c39_AsOf1Jan2019_RecognizeLeaseLiabilitiesMember" decimals="0">941000</us-gaap:OperatingLeaseRightOfUseAsset>
  <us-gaap:OperatingLeaseLiability unitRef="usd" contextRef="c40_AsOf1Jan2019_DerecognizeLeaseLiabilitiesMember" decimals="0">239000</us-gaap:OperatingLeaseLiability>
  <us-gaap:OperatingLeaseLiabilityCurrent unitRef="usd" contextRef="c40_AsOf1Jan2019_DerecognizeLeaseLiabilitiesMember" decimals="0">100000</us-gaap:OperatingLeaseLiabilityCurrent>
  <vxrt:IncreaseDecreaseInAccumulatedDeficit unitRef="usd" contextRef="c41_From1Jan2019To1Jan2019_DerecognizeLeaseLiabilitiesMember" decimals="0">27000</vxrt:IncreaseDecreaseInAccumulatedDeficit>
  <vxrt:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 181.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Laboratory equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 322.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;5 years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 181.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Office and computer equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 322.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;3 years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 181.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 322.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Shorter of remaining lease term or estimated useful life&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</vxrt:ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c42_From1Jan2018To31Dec2018_LaboratoryEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c43_From1Jan2018To31Dec2018_OfficeEquipmentMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="c44_From1Jan2018To31Dec2018_LeaseholdImprovementsMember">Shorter of remaining lease term or estimated useful life</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
  <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;NOTE 3.&amp;#xa0;&amp;#xa0;Business Combination&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;On February&amp;#xa0;13, 2018, the Company acquired Aviragen in a reverse merger (see Note&amp;#xa0;1). On the date of the Merger, &lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Aviragen had in-process research and development as it was conducting a Phase 2 trial, it had previously developed drugs that were licensed to others who brought them to market and it had a workforce that was considered to have the necessary skills, knowledge, and experience to perform a process that, when applied to the in-process research and development, was critical to the ability to convert it into outputs. Based on this evaluation, the Company determined that the Merger should be accounted for as a business combination.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Since the date of the Merger, the results of Aviragen&amp;#8217;s operations have been included in the consolidated financial statements. As a result of the acquisition, the Company eliminated the majority of its debt and acquired a significant cash balance in exchange for equity securities.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The total purchase price for Aviragen is summarized as follows (in thousands):&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;31,789&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;31,789&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;In connection with the Aviragen acquisition, the Company allocated the total purchase consideration to the net assets and liabilities acquired, including identifiable intangible assets, based on their respective fair values at the acquisition date. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The following table summarizes the preliminary allocation of the purchase price to the fair value of the respective assets and liabilities acquired, adjustments made since the acquisition date and the final allocation as of December 31, 2018:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;As of February 13, &lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Adjustments&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;As of December 31, &lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;25,525&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;25,525&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accounts receivable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;14,666&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;14,666&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Prepaid expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;446&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(10)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;436&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Property and equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;170&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;170&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Intangible assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 20pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Developed technology &lt;sup&gt;(1)&lt;/sup&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;22,400&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(300)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;22,100&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;In-process research and development &lt;sup&gt;(2)&lt;/sup&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,600&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,600&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 30pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;64,807&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(310)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;64,497&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accounts payable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(3,379)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;75&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(3,304)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Other current liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(6,351)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(393)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(6,744) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;L&lt;font style=&quot;color: black;&quot;&gt;iability related to sale of future royalties&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(16,300)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;400&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(15,900)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net assets acquired&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;38,777&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(228)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;38,549&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Purchase price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(31,789)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(31,789)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Bargain purchase gain &lt;sup&gt;(3)&lt;/sup&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6,988&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(228)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6,760&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;__________&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.25in; TEXT-INDENT:-0.25in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(1)&amp;#xa0;&amp;#xa0; &lt;font style=&quot;COLOR:black&quot;&gt;Developed technology comprises Inavir and Relenza, both influenza vaccines on which the Company is presently receiving royalty revenue, which, based on valuations prepared by an independent third party based on estimated discounted cash flows based on probability-weighted future development expenditures and revenue streams provided by the Company&amp;#8217;s management, are being amortized on a straight-line basis over the estimated periods of future royalties of 11.75 and 1.3 years, respectively.&lt;/font&gt; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.25in; TEXT-INDENT:-0.25in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(2)&amp;#xa0;&amp;#xa0; In-process research and development (see Note 5) related to teslexivir, or BTA074, a direct-acting antiviral that, at the time of the Merger, was being actively developed as a treatment for genital warts. The &lt;font style=&quot;COLOR:black&quot;&gt;valuation was prepared by an independent third party based on estimated discounted cash flows based on probability-weighted future development expenditures and revenue streams provided by the Company&amp;#8217;s management.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.25in; TEXT-INDENT:-0.25in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;(3)&amp;#xa0;&amp;#xa0; &lt;font style=&quot;COLOR:black&quot;&gt;The bargain purchase gain represents the excess of the fair value of tangible and identified intangible assets, less liabilities, acquired over the purchase price.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;In addition, the Company incurred and expensed costs directly related to the Merger totaling approximately &lt;font style=&quot;color: black;&quot;&gt;$0.5 million and $0.9 million in the years ended &lt;/font&gt;December&amp;#xa0;31&lt;font style=&quot;color: black;&quot;&gt;, 2018 and 2017, respectively, which are included in &lt;/font&gt;general and administrative expenses &lt;font style=&quot;color: black;&quot;&gt;in the consolidated statement of operations and comprehensive loss&lt;/font&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Selected amounts related to Aviragen&amp;#8217;s business included in the Company&amp;#8217;s consolidated statement of operations for the year ended December 31, 2018, are as follows (in thousands):&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; border=&quot;1&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 80.44%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Revenue&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;2,815&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 80.44%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 80.44%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;(3,847)&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;The unaudited pro forma information in the table below summarizes the combined results of operations of Vaxart Biosciences, Inc. with those of Aviragen as though these entities were combined as of January&amp;#xa0;1, 2017. The results of Aviragen&amp;#x2019;s business for the year ended &lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;December &lt;/font&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;31, 2017, are based on information used to prepare its audited consolidated financial statements prepared for the year ended &lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;June 30&lt;/font&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;, 2017, as adjusted by information used to prepare its unaudited condensed consolidated financial statements prepared for the six months ended &lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;December 31&lt;/font&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;, 2017 and 2016. The results of Aviragen&amp;#x2019;s business for the year ended &lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;December &lt;/font&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;31, 2018, are based on the Company&amp;#x2019;s results of operations, with the results increased by Aviragen&amp;#x2019;s activities in the forty-three days prior to the closing of the Merger. The pro forma financial information for both years presented also includes the removal of direct acquisition-related costs, the reduction in interest expense on borrowing converted into equity in the reverse merger, and the actual depreciation and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets had been applied as of January&amp;#xa0;1, 2017. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;This unaudited pro forma information is summarized as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; white-space: nowrap; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December 31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 2.15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 70%; height: 2.15pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 2.15pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2%; height: 2.15pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 2.15pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 12%; white-space: nowrap; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 12.25pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total revenue&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;15,695&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;13,527&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 12.25pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 27pt; text-indent: -9.35pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 12.25pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;(13,162)&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;(29,270)&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;inherit&amp;quot;,&amp;quot;serif&amp;quot;&quot;&gt;The pro forma financial information as presented above is for informational purposes only and is not indicative of the consolidated results of operations of future periods or the results of operations that would have been achieved had the acquisition had taken place on January&amp;#xa0;1, 2017. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-5">500000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-5">900000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;31,789&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;31,789&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock>
  <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">31789000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
  <us-gaap:BusinessCombinationConsiderationTransferred1 unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">31789000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;As of February 13, &lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Adjustments&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;As of December 31, &lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;25,525&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;25,525&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accounts receivable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;14,666&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;14,666&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Prepaid expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;446&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(10)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;436&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Property and equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;170&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;170&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Intangible assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 20pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Developed technology &lt;sup&gt;(1)&lt;/sup&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;22,400&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(300)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;22,100&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;In-process research and development &lt;sup&gt;(2)&lt;/sup&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,600&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,600&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 30pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;64,807&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(310)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;64,497&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accounts payable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(3,379)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;75&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(3,304)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Other current liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(6,351)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(393)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(6,744) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;L&lt;font style=&quot;color: black;&quot;&gt;iability related to sale of future royalties&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(16,300)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;400&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(15,900)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net assets acquired&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;38,777&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(228)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;38,549&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Purchase price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(31,789)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(31,789)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Bargain purchase gain &lt;sup&gt;(3)&lt;/sup&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6,988&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(228)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6,760&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">25525000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">25525000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">14666000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">14666000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">446000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets unitRef="usd" contextRef="c46_AsOf31Dec2018_RestatementAdjustmentMember" decimals="-3">-10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">436000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">170000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">170000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">22400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill unitRef="usd" contextRef="c46_AsOf31Dec2018_RestatementAdjustmentMember" decimals="-3">-300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">22100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">1600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">64807000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets unitRef="usd" contextRef="c46_AsOf31Dec2018_RestatementAdjustmentMember" decimals="-3">-310000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">64497000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">3379000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable unitRef="usd" contextRef="c46_AsOf31Dec2018_RestatementAdjustmentMember" decimals="-3">-75000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">3304000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">6351000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther unitRef="usd" contextRef="c46_AsOf31Dec2018_RestatementAdjustmentMember" decimals="-3">393000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">6744000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
  <vxrt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">16300000</vxrt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties>
  <vxrt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties unitRef="usd" contextRef="c46_AsOf31Dec2018_RestatementAdjustmentMember" decimals="-3">-400000</vxrt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties>
  <vxrt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">15900000</vxrt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet unitRef="usd" contextRef="c45_AsOf13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">38777000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet unitRef="usd" contextRef="c46_AsOf31Dec2018_RestatementAdjustmentMember" decimals="-3">-228000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">38549000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationConsiderationTransferred1 unitRef="usd" contextRef="c47_From13Feb2018To13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">31789000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount unitRef="usd" contextRef="c47_From13Feb2018To13Feb2018_ScenarioPreviouslyReportedMember" decimals="-3">6988000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount unitRef="usd" contextRef="c48_From14Feb2018To31Dec2018_RestatementAdjustmentMember" decimals="-3">-228000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; border=&quot;1&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 80.44%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Revenue&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;2,815&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 80.44%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 80.44%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;(3,847)&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">2815000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-3847000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; white-space: nowrap; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December 31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 2.15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 70%; height: 2.15pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 2.15pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2%; height: 2.15pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 2.15pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 12%; white-space: nowrap; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 12.25pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total revenue&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;15,695&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;13,527&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 12.25pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 27pt; text-indent: -9.35pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 12.25pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;(13,162)&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;(29,270)&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
  <us-gaap:BusinessAcquisitionsProFormaRevenue unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">15695000</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessAcquisitionsProFormaRevenue unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">13527000</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-13162000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-29270000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;NOTE 4.&amp;#xa0;&amp;#xa0;&lt;/font&gt;&lt;/b&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Fair Value of Financial Instruments&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;Fair value accounting is applied for all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). Financial instruments include cash and cash equivalents, short&amp;#x2011;term investments, accounts receivable, accounts payable and accrued liabilities that approximate fair value due to their relatively short maturities. As short&amp;#x2011;term investments are classified as held&amp;#x2011;to&amp;#x2011;maturity, they are recorded at their amortized cost.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance also establishes a three&amp;#x2011;level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows&lt;font style=&quot;COLOR:black&quot;&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.45pt 12pt 0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Level&amp;#xa0;1&amp;#xa0;&amp;#8211;&amp;#xa0;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.45pt 12pt 0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Level&amp;#xa0;2&amp;#xa0;&amp;#8211;&amp;#xa0;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.45pt 12pt 0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Level&amp;#xa0;3&amp;#xa0;&amp;#8211;&amp;#xa0;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The Company&amp;#8217;s money market funds are classified within Level&amp;#xa0;1 of the fair value hierarchy and are valued based on quoted prices in active markets for identical securities. The Company&amp;#8217;s corporate bonds and commercial paper are classified within Level&amp;#xa0;2 of the fair value hierarchy and are valued based on quoted prices for similar assets or prices derived from observable market data. Level&amp;#xa0;3 liabilities consist of convertible promissory notes embedded derivative liabilities and a convertible preferred stock warrant liability as they are valued by using inputs that are unobservable in the market. The determination of the fair values of the convertible promissory notes embedded derivative is discussed in Note&amp;#xa0;8.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The following tables present the Company&amp;#8217;s financial assets and liabilities that are measured at fair value at December 31, 2018 and 2017:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.7%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;1&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;2&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;3&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Total&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;December 31&lt;font style=&quot;color: black;&quot;&gt;, 2018&lt;/font&gt;&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 24.12%;&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Recurring Financial Assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Money Market Funds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Corporate Bonds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Recurring Financial Liabilities:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible promissory notes embedded &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0; derivative liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible preferred stock warrant liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.7%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;1&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;2&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;3&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.62%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Total&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;December 31, 2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 24.12%;&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Recurring Financial Assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Money Market Funds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Corporate Bonds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Recurring Financial Liabilities:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible promissory notes embedded &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0; derivative liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible preferred stock warrant liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The following tables present a reconciliation of all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level&amp;#xa0;3) for the years ended &lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;December 31&lt;font style=&quot;COLOR:black&quot;&gt;, 2018 and 2017:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 9.35pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 9.35pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Convertible&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Preferred Stock&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Warrant Liability&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Convertible Promissory&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Notes Embedded&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Derivative Liability&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.95pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 9.95pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.35pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 9.35pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Total&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.95pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 9.95pt; width: 57%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%; height: 11.1pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Balance at January&amp;#xa0;1, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 10.55pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Issuances&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.9pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%; height: 9.9pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Revaluation loss included in (loss) gain on revaluation &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#xa0;&amp;#xa0; of financial instruments, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 10.55pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Settlements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(70)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(70)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%; height: 11.1pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Balance at December 31, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 10.55pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 22.3pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%; height: 22.3pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Total losses included in other income and (expenses) attributable &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; to liabilities still held as of December 31, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 9.35pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 9.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.6%; height: 9.35pt; white-space: nowrap;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Convertible&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Preferred Stock&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Warrant Liability&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.38%; height: 9.35pt; white-space: nowrap;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Convertible Promissory&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Notes Embedded&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Derivative Liability&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.62%; height: 9.35pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.95pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 9.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.62%; height: 9.95pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.35pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 9.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.62%; height: 9.35pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Total&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.95pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 9.95pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 10.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.22%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12.16%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 10.82%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.8%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Balance at January&amp;#xa0;1, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;134&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.22%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3,280&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3,414&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 10.55pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Issuances&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.22%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.9pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.8%; height: 9.9pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Revaluation gains included in (loss) gain on revaluation &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; of financial instruments, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 10.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(67)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.22%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12.16%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(3,280)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 10.82%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(3,347)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 10.55pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Settlements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.8%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Balance at December 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 10.55pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 10.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.22%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12.16%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 10.82%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 22.3pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.8%; height: 22.3pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Total gains included in other income and (expenses) attributable&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; &amp;#xa0;to liabilities still held as of December&amp;#xa0;31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3,280&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3,347&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.7%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;1&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;2&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;3&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Total&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;December 31&lt;font style=&quot;color: black;&quot;&gt;, 2018&lt;/font&gt;&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 24.12%;&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Recurring Financial Assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Money Market Funds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Corporate Bonds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Recurring Financial Liabilities:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible promissory notes embedded &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0; derivative liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible preferred stock warrant liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.7%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;1&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;2&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Level&amp;#xa0;3&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.62%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Total&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;December 31, 2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 24.12%;&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Recurring Financial Assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Money Market Funds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Corporate Bonds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Recurring Financial Liabilities:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible promissory notes embedded &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0; derivative liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible preferred stock warrant liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c49_AsOf31Dec2018_MoneyMarketFundsMember_FairValueInputsLevel1Member" decimals="-3">15000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c50_AsOf31Dec2018_MoneyMarketFundsMember_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c51_AsOf31Dec2018_MoneyMarketFundsMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c52_AsOf31Dec2018_MoneyMarketFundsMember" decimals="-3">15000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c53_AsOf31Dec2018_CorporateBondsMember_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c54_AsOf31Dec2018_CorporateBondsMember_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c55_AsOf31Dec2018_CorporateBondsMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c56_AsOf31Dec2018_CorporateBondsMember" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c57_AsOf31Dec2018_FairValueInputsLevel1Member" decimals="-3">15000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c58_AsOf31Dec2018_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c59_AsOf31Dec2018_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">15000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c60_AsOf31Dec2018_FairValueInputsLevel1Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c61_AsOf31Dec2018_FairValueInputsLevel2Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c62_AsOf31Dec2018_FairValueInputsLevel3Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c63_AsOf31Dec2018_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c64_AsOf31Dec2018_FairValueInputsLevel1Member_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c65_AsOf31Dec2018_FairValueInputsLevel2Member_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c66_AsOf31Dec2018_FairValueInputsLevel3Member_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c67_AsOf31Dec2018_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c57_AsOf31Dec2018_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c58_AsOf31Dec2018_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c59_AsOf31Dec2018_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c68_AsOf31Dec2017_MoneyMarketFundsMember_FairValueInputsLevel1Member" decimals="-3">1192000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c69_AsOf31Dec2017_MoneyMarketFundsMember_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c70_AsOf31Dec2017_MoneyMarketFundsMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c71_AsOf31Dec2017_MoneyMarketFundsMember" decimals="-3">1192000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c72_AsOf31Dec2017_CorporateBondsMember_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c73_AsOf31Dec2017_CorporateBondsMember_FairValueInputsLevel2Member" decimals="-3">1415000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c74_AsOf31Dec2017_CorporateBondsMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c75_AsOf31Dec2017_CorporateBondsMember" decimals="-3">1415000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c76_AsOf31Dec2017_FairValueInputsLevel1Member" decimals="-3">1192000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c77_AsOf31Dec2017_FairValueInputsLevel2Member" decimals="-3">1415000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c78_AsOf31Dec2017_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">2607000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c79_AsOf31Dec2017_FairValueInputsLevel1Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c80_AsOf31Dec2017_FairValueInputsLevel2Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c81_AsOf31Dec2017_FairValueInputsLevel3Member_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c82_AsOf31Dec2017_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c83_AsOf31Dec2017_FairValueInputsLevel1Member_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c84_AsOf31Dec2017_FairValueInputsLevel2Member_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c85_AsOf31Dec2017_FairValueInputsLevel3Member_ConvertiblePreferredStockWarrantLiabilityMember" decimals="-3">67000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c86_AsOf31Dec2017_ConvertiblePreferredStockWarrantLiabilityMember" decimals="-3">67000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c76_AsOf31Dec2017_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c77_AsOf31Dec2017_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c78_AsOf31Dec2017_FairValueInputsLevel3Member" decimals="-3">67000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
  <us-gaap:FinancialLiabilitiesFairValueDisclosure unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">67000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 9.35pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 9.35pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Convertible&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Preferred Stock&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Warrant Liability&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Convertible Promissory&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Notes Embedded&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Derivative Liability&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.95pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 9.95pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.35pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 9.35pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Total&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.95pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 9.95pt; width: 57%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%; height: 11.1pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Balance at January&amp;#xa0;1, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 10.55pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Issuances&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.9pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%; height: 9.9pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Revaluation loss included in (loss) gain on revaluation &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#xa0;&amp;#xa0; of financial instruments, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 10.55pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Settlements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(70)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(70)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%; height: 11.1pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Balance at December 31, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 57%; height: 10.55pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 22.3pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%; height: 22.3pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Total losses included in other income and (expenses) attributable &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; to liabilities still held as of December 31, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 9.35pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 9.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.6%; height: 9.35pt; white-space: nowrap;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Convertible&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Preferred Stock&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Warrant Liability&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.38%; height: 9.35pt; white-space: nowrap;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Convertible Promissory&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Notes Embedded&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Derivative Liability&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.62%; height: 9.35pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.95pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 9.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.62%; height: 9.95pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.35pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 9.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.62%; height: 9.35pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 8pt; font-weight: bold; page-break-after: avoid;&quot;&gt;Total&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.95pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 9.95pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 10.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.22%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12.16%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 1.8%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 10.82%; height: 9.95pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.8%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Balance at January&amp;#xa0;1, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;134&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.22%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3,280&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3,414&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 10.55pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Issuances&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.22%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.9pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.8%; height: 9.9pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Revaluation gains included in (loss) gain on revaluation &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; of financial instruments, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 10.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(67)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.22%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12.16%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(3,280)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 10.82%; height: 9.9pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;(3,347)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 10.55pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Settlements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.8%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Balance at December 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 11.1pt; white-space: nowrap;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.55pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.8%; height: 10.55pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 10.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.22%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12.16%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 1.8%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 10.82%; height: 10.55pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 22.3pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.8%; height: 22.3pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;Total gains included in other income and (expenses) attributable&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; &amp;#xa0;to liabilities still held as of December&amp;#xa0;31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3,280&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid; text-align: left;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 22.3pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 9pt;&quot;&gt;3,347&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c86_AsOf31Dec2017_ConvertiblePreferredStockWarrantLiabilityMember" decimals="-3">67000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c82_AsOf31Dec2017_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">67000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues unitRef="usd" contextRef="c87_From1Jan2018To31Dec2018_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues unitRef="usd" contextRef="c88_From1Jan2018To31Dec2018_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings unitRef="usd" contextRef="c87_From1Jan2018To31Dec2018_ConvertiblePreferredStockWarrantLiabilityMember" decimals="-3">3000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings unitRef="usd" contextRef="c88_From1Jan2018To31Dec2018_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">3000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements unitRef="usd" contextRef="c87_From1Jan2018To31Dec2018_ConvertiblePreferredStockWarrantLiabilityMember" decimals="-3">-70000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements unitRef="usd" contextRef="c88_From1Jan2018To31Dec2018_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-70000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c67_AsOf31Dec2018_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c63_AsOf31Dec2018_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements unitRef="usd" contextRef="c87_From1Jan2018To31Dec2018_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements unitRef="usd" contextRef="c88_From1Jan2018To31Dec2018_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c89_AsOf31Dec2016_ConvertiblePreferredStockWarrantLiabilityMember" decimals="-3">134000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c90_AsOf31Dec2016_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" decimals="-3">3280000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c14_AsOf31Dec2016" decimals="-3">3414000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues unitRef="usd" contextRef="c91_From1Jan2017To31Dec2017_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues unitRef="usd" contextRef="c92_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings unitRef="usd" contextRef="c91_From1Jan2017To31Dec2017_ConvertiblePreferredStockWarrantLiabilityMember" decimals="-3">-67000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings unitRef="usd" contextRef="c92_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" decimals="-3">-3280000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">-3347000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements unitRef="usd" contextRef="c91_From1Jan2017To31Dec2017_ConvertiblePreferredStockWarrantLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements unitRef="usd" contextRef="c92_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements unitRef="usd" contextRef="c91_From1Jan2017To31Dec2017_ConvertiblePreferredStockWarrantLiabilityMember" decimals="-3">67000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements unitRef="usd" contextRef="c92_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" decimals="-3">3280000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">3347000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZi7YfzVIAspPbJuDylcYRVpSzHijjkNCYpD7o9WcfUwu/9uo1X+/k4jp6oPRfpgx2gurzW//2t+l3nLsqChCk2dbDArpcIr4CikQhf0AXguBDQTnCrO4B9rKkWv2LsFu37D0Y4AbkakUysJfA1nyojRaau3myU6jtG] CSR-->
  <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:12pt 0in&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;5.&amp;#xa0;&amp;#xa0;Balance Sheet Components&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 12pt 0in 12pt 0.5in; text-indent: -0.25in;&quot;&gt;&lt;strong&gt;&lt;em&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(a)&lt;font style=&quot;font: 7pt &apos;Times New Roman&apos;;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Cash &lt;/font&gt;&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Equivalents and Short-Term Investments&lt;/font&gt;&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:12pt 0in&quot;&gt;Cash equivalents and short&amp;#x2011;term investments, all of which are classified as held&amp;#x2011;to&amp;#x2011;maturity securities and mature within one year, consisted of the following:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 64.9%;&quot; colspan=&quot;14&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December 31, 2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 12.18%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gross&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Unrecognized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gains&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.88%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gross&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Unrecognized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Losses&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.12%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Estimated&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Fair&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.04%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Carrying&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.92%;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Amortized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Cost&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Money market funds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Corporate bonds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 35.1%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Reported as:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.46%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.74%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.9%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Short-term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.65pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 64.9%;&quot; colspan=&quot;14&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December 31, 2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12.18%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gross&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.88%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gross&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Estimated&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.04%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 10.92%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Amortized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.18%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Unrecognized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.88%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Unrecognized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Fair&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.04%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Carrying&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.92%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Cost&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12.18%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gains&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.88%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Losses&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.04%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Money market funds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Corporate bonds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.75pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 35.1%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Reported as:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.46%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.74%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.9%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Short-term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.65pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in&quot;&gt;&lt;b&gt;&lt;i&gt;(b)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Accounts Receivable&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:12pt 0in&quot;&gt;Accounts receivable comprises the following:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December &lt;/font&gt;&lt;/strong&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Royalties receivable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,776&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Government contract &amp;#x2013; billed&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;20&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;477&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Government contract &amp;#x2013; unbilled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;153&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.75pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 70%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accounts receivable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,796&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 10.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;630&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in&quot;&gt;&lt;b&gt;&lt;i&gt;(c)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Property and Equipment, Net&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in&quot;&gt;Property and equipment, net consists of the following:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 10.9pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%; height: 10.9pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.9pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December &lt;/font&gt;&lt;/strong&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.9pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.9pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 8.95pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%; height: 8.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 37%;&quot; colspan=&quot;5&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;, &apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Laboratory equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,076&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,565&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 12.2pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Office and computer equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;227&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;175&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;333&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;226&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt; width: 70%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total property and equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,636&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,966&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 19.35pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt; width: 70%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Less: accumulated depreciation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(1,570)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 19.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(1,236)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 20.25pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,066&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;730&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;Depreciation expense was $476,000 and $376,000 for the years ended December&amp;#xa0;31, 2018 and 2017, respectively. Leasehold improvements and furniture at the Company&amp;#8217;s leased premises in Georgia, which has been subleased, commencing in November 2018, for less than the rental that the Company is obligated to pay (see Note 10), were assessed as impaired as of September 30, 2018, and accordingly an impairment charge of $106,000 was recorded as a component of costs of &lt;font style=&quot;FONT-SIZE:9.5pt&quot;&gt;exit from leased premises&lt;/font&gt; within operating expenses.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in&quot;&gt;&lt;b&gt;&lt;i&gt;(d)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Intangible Assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:12pt 0in&quot;&gt;Intangible assets consist of the following:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 36.55pt; text-indent: -9pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December&lt;/font&gt;&lt;/strong&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;February 13,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.7pt; text-indent: -0.7pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.35pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%; height: 9.35pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 36.55pt; text-indent: -9pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 9.35pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 9.35pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 1.45pt 0in 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Purchased technology&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;22,100&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;22,400&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;In-process research and development&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,600&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Intellectual property&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;80&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;80&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;80&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total cost&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;22,180&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;24,080&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 1.45pt 0in 0in; border: 0px currentColor; width: 11%; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;80&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.2in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%; height: 0.2in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Less accumulated amortization&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.2in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,767&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.2in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;40&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; height: 0.2in; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;40&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 17.5pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0.7pt 10pt; width: 57%; height: 17.5pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Intangible assets, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 17.5pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;19,413&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 17.5pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;24,040&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; height: 17.5pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;40&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 10pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;Intangible asset amortization expense was $2,727,000 and $4,000 for the years ended December 31, 2018 and 2017, respectively. Following the results of Phase 2 trials in June 2018, the in-process research and development was assessed as fully impaired in the three months ended June&amp;#xa0;30, 2018, with the $1.6 million acquired in the Merger (see Note 3) being charged to operating expenses.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;As of December 31, 2018, the estimated future amortization expense by year is as follows (in thousands):&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Year Ending December 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,320&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2020&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,732&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2021&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,732&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2022&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,732&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2023&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,731&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Thereafter&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;10,166&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 82%; height: 13pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 13pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 16%; height: 13pt; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;19,413&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in&quot;&gt;&lt;b&gt;&lt;i&gt;(e)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Other Accrued Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in&quot;&gt;Accrued liabilities consist of the following:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&amp;#xa0;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&amp;#xa0;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accrued compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;632&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,320&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accrued clinical and manufacturing expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;75&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;69&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accrued professional and consulting services&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;166&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;113&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Reserve for return of royalties&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;339&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred rent and lease loss accrual, current portion&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;111&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;21&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible preferred stock warrant liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;195&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; border: 0px currentColor; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,518&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,605&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
  <us-gaap:Depreciation unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="0">476000</us-gaap:Depreciation>
  <us-gaap:Depreciation unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="0">376000</us-gaap:Depreciation>
  <vxrt:ImpairmentofPropertyAndEquipment unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="0">106000</vxrt:ImpairmentofPropertyAndEquipment>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="0">2727000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="0">4000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:ResearchAndDevelopmentInProcess unitRef="usd" contextRef="c93_From1Apr2018To30Jun2018" decimals="-5">1600000</us-gaap:ResearchAndDevelopmentInProcess>
  <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 64.9%;&quot; colspan=&quot;14&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December 31, 2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 12.18%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gross&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Unrecognized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gains&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.88%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gross&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Unrecognized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Losses&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.12%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Estimated&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Fair&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.04%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Carrying&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.92%;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Amortized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Cost&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Money market funds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Corporate bonds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 35.1%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Reported as:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.46%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.74%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.9%; height: 11.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Short-term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.65pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 64.9%;&quot; colspan=&quot;14&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December 31, 2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12.18%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gross&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.88%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gross&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Estimated&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.04%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 10.92%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Amortized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.18%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Unrecognized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.88%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Unrecognized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Fair&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.04%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Carrying&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.92%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Cost&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12.18%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Gains&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.88%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Losses&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.04%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Money market funds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Corporate bonds&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.75pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 35.1%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Reported as:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.46%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.74%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.9%; height: 9.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,192&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 35.1%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Short-term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,415&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.65pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,607&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c94_AsOf31Dec2018_MoneyMarketFundsMember" decimals="-3">15000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c94_AsOf31Dec2018_MoneyMarketFundsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c94_AsOf31Dec2018_MoneyMarketFundsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c94_AsOf31Dec2018_MoneyMarketFundsMember" decimals="-3">15000</us-gaap:HeldToMaturitySecuritiesFairValue>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c94_AsOf31Dec2018_MoneyMarketFundsMember" decimals="-3">15000</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c95_AsOf31Dec2018_CorporateBondsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c95_AsOf31Dec2018_CorporateBondsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c95_AsOf31Dec2018_CorporateBondsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c95_AsOf31Dec2018_CorporateBondsMember" xs:nil="true"/>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c95_AsOf31Dec2018_CorporateBondsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">15000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">15000</us-gaap:HeldToMaturitySecuritiesFairValue>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">15000</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c96_AsOf31Dec2018_CashEquivalentsMember" decimals="-3">15000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c96_AsOf31Dec2018_CashEquivalentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c96_AsOf31Dec2018_CashEquivalentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c96_AsOf31Dec2018_CashEquivalentsMember" decimals="-3">15000</us-gaap:HeldToMaturitySecuritiesFairValue>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c96_AsOf31Dec2018_CashEquivalentsMember" decimals="-3">15000</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c97_AsOf31Dec2018_ShortTermInvestmentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c97_AsOf31Dec2018_ShortTermInvestmentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c97_AsOf31Dec2018_ShortTermInvestmentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c97_AsOf31Dec2018_ShortTermInvestmentsMember" xs:nil="true"/>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c97_AsOf31Dec2018_ShortTermInvestmentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c98_AsOf31Dec2017_MoneyMarketFundsMember" decimals="-3">1192000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c98_AsOf31Dec2017_MoneyMarketFundsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c98_AsOf31Dec2017_MoneyMarketFundsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c98_AsOf31Dec2017_MoneyMarketFundsMember" decimals="-3">1192000</us-gaap:HeldToMaturitySecuritiesFairValue>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c98_AsOf31Dec2017_MoneyMarketFundsMember" decimals="-3">1192000</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c99_AsOf31Dec2017_CorporateBondsMember" decimals="-3">1415000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c99_AsOf31Dec2017_CorporateBondsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c99_AsOf31Dec2017_CorporateBondsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c99_AsOf31Dec2017_CorporateBondsMember" decimals="-3">1415000</us-gaap:HeldToMaturitySecuritiesFairValue>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c99_AsOf31Dec2017_CorporateBondsMember" decimals="-3">1415000</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">2607000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">2607000</us-gaap:HeldToMaturitySecuritiesFairValue>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">2607000</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c100_AsOf31Dec2017_CashEquivalentsMember" decimals="-3">1192000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c100_AsOf31Dec2017_CashEquivalentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c100_AsOf31Dec2017_CashEquivalentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c100_AsOf31Dec2017_CashEquivalentsMember" decimals="-3">1192000</us-gaap:HeldToMaturitySecuritiesFairValue>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c100_AsOf31Dec2017_CashEquivalentsMember" decimals="-3">1192000</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount unitRef="usd" contextRef="c101_AsOf31Dec2017_ShortTermInvestmentsMember" decimals="-3">1415000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain unitRef="usd" contextRef="c101_AsOf31Dec2017_ShortTermInvestmentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss unitRef="usd" contextRef="c101_AsOf31Dec2017_ShortTermInvestmentsMember" xs:nil="true"/>
  <us-gaap:HeldToMaturitySecuritiesFairValue unitRef="usd" contextRef="c101_AsOf31Dec2017_ShortTermInvestmentsMember" decimals="-3">1415000</us-gaap:HeldToMaturitySecuritiesFairValue>
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="usd" contextRef="c101_AsOf31Dec2017_ShortTermInvestmentsMember" decimals="-3">1415000</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December &lt;/font&gt;&lt;/strong&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Royalties receivable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,776&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Government contract &amp;#x2013; billed&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;20&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;477&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Government contract &amp;#x2013; unbilled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;153&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.75pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 70%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accounts receivable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,796&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 10.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;630&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
  <vxrt:RoyaltiesReceivable unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1776000</vxrt:RoyaltiesReceivable>
  <vxrt:RoyaltiesReceivable unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:BilledContractReceivables unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">20000</us-gaap:BilledContractReceivables>
  <us-gaap:BilledContractReceivables unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">477000</us-gaap:BilledContractReceivables>
  <us-gaap:UnbilledContractsReceivable unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:UnbilledContractsReceivable unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">153000</us-gaap:UnbilledContractsReceivable>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 10.9pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%; height: 10.9pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.9pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December &lt;/font&gt;&lt;/strong&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.9pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.9pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 8.95pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%; height: 8.95pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 37%;&quot; colspan=&quot;5&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;, &apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Laboratory equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,076&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,565&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 12.2pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Office and computer equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;227&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.2pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;175&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;333&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;226&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt; width: 70%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total property and equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,636&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,966&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 19.35pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt; width: 70%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Less: accumulated depreciation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(1,570)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 19.35pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(1,236)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 20.25pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,066&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 20.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;730&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <vxrt:LaboratoryEquipmentGross unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">2076000</vxrt:LaboratoryEquipmentGross>
  <vxrt:LaboratoryEquipmentGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1565000</vxrt:LaboratoryEquipmentGross>
  <vxrt:OfficeAndComputerEquipmentGross unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">227000</vxrt:OfficeAndComputerEquipmentGross>
  <vxrt:OfficeAndComputerEquipmentGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">175000</vxrt:OfficeAndComputerEquipmentGross>
  <us-gaap:LeaseholdImprovementsGross unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">333000</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:LeaseholdImprovementsGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">226000</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">2636000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1966000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1570000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1236000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 36.55pt; text-indent: -9pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;December&lt;/font&gt;&lt;/strong&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;February 13,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.7pt; text-indent: -0.7pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.35pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%; height: 9.35pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 36.55pt; text-indent: -9pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 9.35pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 9.35pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 1.45pt 0in 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Purchased technology&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;22,100&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;22,400&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;In-process research and development&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,600&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Intellectual property&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;80&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;80&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;80&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total cost&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;22,180&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;24,080&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 1.45pt 0in 0in; border: 0px currentColor; width: 11%; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;80&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.2in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%; height: 0.2in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Less accumulated amortization&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.2in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,767&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.2in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;40&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; height: 0.2in; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;40&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 17.5pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0.7pt 10pt; width: 57%; height: 17.5pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Intangible assets, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 17.5pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;19,413&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 17.5pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;24,040&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; height: 17.5pt; white-space: nowrap; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;40&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c102_AsOf31Dec2018_PurchasedTechnologyMember" decimals="-3">22100000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c103_AsOf13Feb2018_PurchasedTechnologyMember" decimals="-3">22400000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c104_AsOf31Dec2017_PurchasedTechnologyMember" xs:nil="true"/>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c105_AsOf31Dec2018_InProcessResearchAndDevelopmentMember" xs:nil="true"/>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c106_AsOf13Feb2018_InProcessResearchAndDevelopmentMember" decimals="-3">1600000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c107_AsOf31Dec2017_InProcessResearchAndDevelopmentMember" xs:nil="true"/>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c108_AsOf31Dec2018_IntellectualPropertyMember" decimals="-3">80000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c109_AsOf13Feb2018_IntellectualPropertyMember" decimals="-3">80000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c110_AsOf31Dec2017_IntellectualPropertyMember" decimals="-3">80000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">22180000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c111_AsOf13Feb2018" decimals="-3">24080000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">80000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">2767000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c111_AsOf13Feb2018" decimals="-3">40000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">40000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="usd" contextRef="c111_AsOf13Feb2018" decimals="-3">24040000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Year Ending December 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,320&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2020&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,732&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2021&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,732&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2022&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,732&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2023&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,731&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt 10pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Thereafter&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;10,166&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 82%; height: 13pt; width: 82%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 13pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 16%; height: 13pt; white-space: nowrap; width: 16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;19,413&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">2320000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1732000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1732000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1732000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1731000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">10166000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
  <us-gaap:FiniteLivedIntangibleAssetsNet unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">19413000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&amp;#xa0;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31,&amp;#xa0;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accrued compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;632&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,320&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accrued clinical and manufacturing expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;75&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;69&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accrued professional and consulting services&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;166&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;113&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Reserve for return of royalties&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;339&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred rent and lease loss accrual, current portion&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;111&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;21&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible preferred stock warrant liability&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;67&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;195&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; border: 0px currentColor; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,518&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,605&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <vxrt:AccruedCompensationCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">632000</vxrt:AccruedCompensationCurrent>
  <vxrt:AccruedCompensationCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1320000</vxrt:AccruedCompensationCurrent>
  <vxrt:AccruedClinicalAndManufacturingExpensesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">75000</vxrt:AccruedClinicalAndManufacturingExpensesCurrent>
  <vxrt:AccruedClinicalAndManufacturingExpensesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">69000</vxrt:AccruedClinicalAndManufacturingExpensesCurrent>
  <vxrt:AccruedProfessionalAndConsultingServicesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">166000</vxrt:AccruedProfessionalAndConsultingServicesCurrent>
  <vxrt:AccruedProfessionalAndConsultingServicesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">113000</vxrt:AccruedProfessionalAndConsultingServicesCurrent>
  <vxrt:ReserveForReturnOfRoyaltiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">339000</vxrt:ReserveForReturnOfRoyaltiesCurrent>
  <vxrt:ReserveForReturnOfRoyaltiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:DeferredRentCreditCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">111000</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">21000</us-gaap:DeferredRentCreditCurrent>
  <vxrt:ConvertiblePreferredStockWarrantLiabilityCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <vxrt:ConvertiblePreferredStockWarrantLiabilityCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">67000</vxrt:ConvertiblePreferredStockWarrantLiabilityCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">195000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">15000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <vxrt:RevenueTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:24pt 0in 12pt&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;6.&amp;#xa0;&amp;#xa0;Revenue&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:12pt 0in&quot;&gt;&lt;i&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;U.S. Government HHS BARDA Contract&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;In September&amp;#xa0;2015, HHS BARDA awarded the Company a contract to support the advanced development of a more effective and universal influenza vaccine to improve seasonal and pandemic influenza preparedness. On each of May&amp;#xa0;25 and July 18, 2017, and June 28, 2018, the Company entered into a Modification of Contract with HHS BARDA, the combined effect being to increase the value of the existing $14&amp;#xa0;million contract by $1.7&amp;#xa0;million and to extend it through September 30, 2018. The modified contract is a cost-plus-fixed-fee contract, which reimburses the Company for allowable direct contract costs plus allowable indirect costs and a fixed-fee, totaling $15.7&amp;#xa0;million. The Company recognized revenue of $1,344,000 and $5,839,000 during the years ended December 31, 2018 and 2017, respectively. As of December 31, 2018, the cumulative revenue recorded from inception under the HHS BARDA contract represents the maximum amount billable under the contract as presently modified, with no further change orders envisaged.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Billings under the contract are based on approved provisional indirect billing rates, which permit recovery of fringe benefits, overhead and general and administrative expenses. Indirect rates as well as allowable costs are subject to audit by HHS BARDA on an annual basis. Management believes that revenues recognized to date have been recorded in amounts that are expected to be realized upon final audit and settlement. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly in the period that the adjustments are known and collection is probable. Costs relating to contract acquisition are expensed as incurred. The Company does not consider any of the revenue recorded as of December 31, 2018 or 2017, to be at risk of reversal. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;i&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Royalty agreements&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;Aviragen entered into a royalty-bearing research and license agreement with GlaxoSmithKline, plc (&amp;#x201c;GSK&amp;#x201d;) in 1990 for the development and commercialization of zanamivir, a neuraminidase inhibitor marketed by GSK as Relenza to treat influenza. Most of the Company&amp;#x2019;s Relenza patents have expired and the only substantial remaining intellectual property related to the Relenza patent portfolio, which is solely owned by the Company and exclusively licensed to GSK, is scheduled to expire in July 2019 in Japan, at which time royalty revenue will cease. The post-Merger royalty revenue related to Relenza recognized in the year ended &lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;December &lt;font style=&quot;color: black;&quot;&gt;31, 2018, was $788,000, representing 7% of net sales in Japan.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;The Company also generates royalty revenue from the sale of Inavir in Japan, pursuant to a collaboration and license agreement that Aviragen entered into with Daiichi Sankyo Company, Limited, or Daiichi Sankyo, in 2009. In September 2010, laninamivir octanoate was approved for sale by the Japanese Ministry of Health and Welfare for the treatment of influenza in adults and children, which Daiichi Sankyo markets as Inavir. Under the agreement, the Company currently receives a 4% royalty on net sales of Inavir in Japan and was eligible to earn sales milestone payments, including a one-off payment of $5.0 million if net sales exceeded 20 billion Yen in one year. This target was achieved in the three months ended March 31, 2018, prior to the Merger, and Aviragen recognized the related $5.0 million as royalty revenue prior to the Merger. The last patent related to Inavir is set to expire in December 2029 in Japan, at which time royalty revenue will cease. The post-Merger royalty revenue related to Inavir recognized in the year ended December 31, 2018, was $552,000. In addition, the Company recognized non-cash royalty revenue related to the sale of future royalties (see Note 7) of $1,475,000. Both the royalty revenue and the non-cash royalty revenue related to the sale of future royalties have been subjected to a 5% withholding tax in Japan, for which $102,000 was included in income tax expense in the year ended December 31, 2018.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</vxrt:RevenueTextBlock>
  <us-gaap:ContractWithCustomerLiability unitRef="usd" contextRef="c112_AsOf25May2017_EntityLoanModificationProgramMember_HHSBARDAMember" decimals="-6">14000000</us-gaap:ContractWithCustomerLiability>
  <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract unitRef="usd" contextRef="c113_From25May2017To25May2017_EntityLoanModificationProgramMember_HHSBARDAMember" decimals="-5">1700000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract>
  <us-gaap:CostOfGoodsAndServicesSold unitRef="usd" contextRef="c113_From25May2017To25May2017_EntityLoanModificationProgramMember_HHSBARDAMember" decimals="-5">15700000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:ContractWithCustomerLiabilityRevenueRecognized unitRef="usd" contextRef="c114_From1Jan2018To31Dec2018_EntityLoanModificationProgramMember_HHSBARDAMember" decimals="0">1344000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
  <us-gaap:ContractWithCustomerLiabilityRevenueRecognized unitRef="usd" contextRef="c115_From1Jan2017To31Dec2017_EntityLoanModificationProgramMember_HHSBARDAMember" decimals="0">5839000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
  <us-gaap:Revenues unitRef="usd" contextRef="c116_From1Jan2018To31Dec2018_RoyaltyMember_RelenzaRecognizedMember" decimals="0">788000</us-gaap:Revenues>
  <vxrt:RoyaltyPercentage unitRef="pure" contextRef="c116_From1Jan2018To31Dec2018_RoyaltyMember_RelenzaRecognizedMember" decimals="2">0.07</vxrt:RoyaltyPercentage>
  <vxrt:RoyaltyPercentage unitRef="pure" contextRef="c117_From1Jan2018To31Dec2018_RoyaltyMember_AviragenTherapeuticsIncMember" decimals="2">0.04</vxrt:RoyaltyPercentage>
  <us-gaap:Revenues unitRef="usd" contextRef="c117_From1Jan2018To31Dec2018_RoyaltyMember_AviragenTherapeuticsIncMember" decimals="-5">5000000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="jpy" contextRef="c117_From1Jan2018To31Dec2018_RoyaltyMember_AviragenTherapeuticsIncMember" decimals="-9">20000000000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c118_From1Jan2018To31Mar2018_RoyaltyMember_AviragenTherapeuticsIncMember" decimals="-5">5000000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c119_From1Jan2018To31Dec2018_RoyaltyMember_InavirRecognizedMember" decimals="0">552000</us-gaap:Revenues>
  <vxrt:NonCashRoyaltyRevenue unitRef="usd" contextRef="c119_From1Jan2018To31Dec2018_RoyaltyMember_InavirRecognizedMember" decimals="0">1475000</vxrt:NonCashRoyaltyRevenue>
  <vxrt:RoyaltyPercentage unitRef="pure" contextRef="c120_From1Jan2018To31Dec2018_RoyaltyMember_JP" decimals="2">0.05</vxrt:RoyaltyPercentage>
  <us-gaap:Revenues unitRef="usd" contextRef="c120_From1Jan2018To31Dec2018_RoyaltyMember_JP" decimals="0">102000</us-gaap:Revenues>
  <us-gaap:DeferredRevenueDisclosureTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:24pt 0in 12pt&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;7.&amp;#xa0; &lt;font style=&quot;COLOR:black&quot;&gt;Liabilities Related to Sale of Future Royalties&lt;/font&gt;&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;In April 2016, Aviragen entered into a Royalty Interest Acquisition Agreement (the &amp;#8220;HCRP Agreement&amp;#8221;) with HCRP. Under the Agreement, HCRP made a $20.0 million cash payment to Aviragen in consideration for acquiring certain royalty rights (&amp;#8220;Royalty Rights&amp;#8221;) related to the approved product Inavir in the Japanese market. The Royalty Rights were obtained pursuant to the collaboration and license agreements (the &amp;#8220;License Agreement&amp;#8221;) and a commercialization agreement that the Company entered into with Daiichi Sankyo. Per the terms of the HCRP Agreement, HCRP is entitled to the first $3.0 million plus 15% of the next $1.0 million in royalties earned in each year commencing on April 1, with any excess revenue being retained by the Company.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;Under the relevant accounting guidance, due to a limit on the amount of royalties that HCRP can earn under the arrangement, this transaction was accounted for as a liability that will be amortized using the interest method over the life of the arrangement. The Company has no obligation to pay any amounts to HCRP other than to pass through to HCRP its share of royalties as they are received from Daiichi Sankyo. In order to record the amortization of the liability, the Company is required to estimate the total amount of future royalty payments to be received under the License Agreement and the payments that will be passed through to HCRP over the life of this agreement. The sum of the pass-through amounts less the net proceeds received will be recorded as non-cash interest expense over the life of the liability. Consequently, the Company imputes interest on the unamortized portion of the liability and records non-cash interest expense using an estimated effective interest rate. The Company will periodically assess the expected royalty payments, and to the extent such payments are greater or less than the initial estimate, the Company will adjust the amortization of the liability and interest rate. As a result of this accounting, even though the Company does not retain HCRP&amp;#8217;s share of the royalties, it will continue to record non-cash revenue related to those royalties until the amount of the associated liability and related interest is fully amortized.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The following table shows the activity within the liability account since the Merger (in thousands):&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 84%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total Liability related to sale of future royalties, February 13, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15,900&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 84%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Non-cash royalty revenue paid to HCRP&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(18)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 84%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Non-cash interest expense recognized&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,859&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.65pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 84%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total &lt;font style=&quot;color: black;&quot;&gt;Liability related to sale of future royalties, &lt;/font&gt;December &lt;font style=&quot;color: black;&quot;&gt;31, 2018&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 14%; height: 11.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;17,741&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:DeferredRevenueDisclosureTextBlock>
  <vxrt:DebtAdditions unitRef="usd" contextRef="c121_From1Apr2016To30Apr2016_HCRPMember_RoyaltyArrangementMember" decimals="-5">20000000</vxrt:DebtAdditions>
  <vxrt:HCRPAgreementRevenueTerms contextRef="c121_From1Apr2016To30Apr2016_HCRPMember_RoyaltyArrangementMember">HCRP is entitled to the first $3.0 million plus 15% of the next $1.0 million in royalties earned in each year commencing on April 1</vxrt:HCRPAgreementRevenueTerms>
  <us-gaap:Revenues unitRef="usd" contextRef="c121_From1Apr2016To30Apr2016_HCRPMember_RoyaltyArrangementMember" decimals="-5">3000000</us-gaap:Revenues>
  <vxrt:RoyaltyPercentage unitRef="pure" contextRef="c121_From1Apr2016To30Apr2016_HCRPMember_RoyaltyArrangementMember" decimals="2">0.15</vxrt:RoyaltyPercentage>
  <us-gaap:RoyaltyIncomeNonoperating unitRef="usd" contextRef="c121_From1Apr2016To30Apr2016_HCRPMember_RoyaltyArrangementMember" decimals="-5">1000000</us-gaap:RoyaltyIncomeNonoperating>
  <us-gaap:DeferredRevenueByArrangementDisclosureTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 84%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total Liability related to sale of future royalties, February 13, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;15,900&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 84%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Non-cash royalty revenue paid to HCRP&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(18)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 84%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Non-cash interest expense recognized&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 14%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,859&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.65pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 0in 10pt; width: 84%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total &lt;font style=&quot;color: black;&quot;&gt;Liability related to sale of future royalties, &lt;/font&gt;December &lt;font style=&quot;color: black;&quot;&gt;31, 2018&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 14%; height: 11.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;17,741&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:DeferredRevenueByArrangementDisclosureTextBlock>
  <us-gaap:LongTermDebt unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">15900000</us-gaap:LongTermDebt>
  <vxrt:DebtRevenueNonCashRoyaltyRevenuePaid unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">-18000</vxrt:DebtRevenueNonCashRoyaltyRevenuePaid>
  <vxrt:DebtNoncashInterestExpenseRecognized unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">1859000</vxrt:DebtNoncashInterestExpenseRecognized>
  <us-gaap:LongTermDebt unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">17741000</us-gaap:LongTermDebt>
  <vxrt:ConvertiblePromissoryNotesRelatedPartyTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:24pt 0in 0pt&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;8.&amp;#xa0;&amp;#xa0;Convertible Promissory Notes, Related Parties&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;On December&amp;#xa0;10, 2014, the Company entered into a note purchase agreement with certain existing preferred stockholders under which the Company issued convertible promissory notes during December&amp;#xa0;2014 for total proceeds of $18.4&amp;#xa0;million.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;On November&amp;#xa0;20, 2015, the Company entered into a second note purchase agreement with certain existing preferred stockholders under which the Company issued convertible promissory notes during November&amp;#xa0;and December&amp;#xa0;2015 for total proceeds of $11.0&amp;#xa0;million. These notes were issued with the same terms as the notes issued in 2014.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;As the holders of the convertible promissory notes each have an equity ownership in the Company, the convertible promissory notes were considered to be a related&amp;#x2011;party transaction.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The convertible promissory notes bore interest at a rate of 8.0% per annum. The principal and accrued interest on the notes were automatically convertible, upon a future issuance of convertible preferred stock having total proceeds of at least $25.0&amp;#xa0;million, into that same stock at a conversion price equal to 90% of the price paid by other investors in the financing event. Upon a liquidation event, such as an acquisition or initial public offering, at the election of the majority of the noteholders in each issuance, the principal and accrued interest on the notes could either (i)&amp;#xa0;be paid in full at the initial closing of the liquidation event, or (ii)&amp;#xa0;automatically convert into the Company&amp;#8217;s Series&amp;#xa0;C convertible preferred stock at a conversion price based on a specified valuation.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;After two&amp;#xa0;years, if the notes had not been converted, the holders of a majority of the principal amount had the option to require the entire principal balance and accrued interest to become due and payable. However, in December&amp;#xa0;2016, in conjunction with the loan agreement with Oxford Finance (see note&amp;#xa0;9), all of the holders of convertible promissory notes signed subordination agreements, under which they agreed not to demand or receive any payment until all amounts owed to Oxford Finance under the loan agreement were fully paid in cash, thus extending the due dates of the promissory notes potentially to January 2021. This change reflected a &lt;font style=&quot;COLOR:black&quot;&gt;debt modification that was not considered substantially significant. Accordingly, the Company did not apply extinguishment accounting, but accounted for the modification on a prospective basis.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The convertible promissory notes had redemption features that were determined to be a compound embedded derivative requiring bifurcation and separate accounting at estimated fair value. The estimated fair value of the embedded derivative upon issuance was a liability of $1.9&amp;#xa0;million for the notes issued in 2014 and $1.3&amp;#xa0;million for the notes issued in 2015. The estimated fair value of these derivative instruments was recognized as a debt discount and as an embedded derivative liability on the balance sheet upon issuance of the convertible promissory notes. The embedded derivative required periodic re&amp;#x2011;measurements to fair value while the instruments were still outstanding (see Note 4). There was no beneficial conversion feature as the conversion feature value was accounted for in the embedded derivative.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The Company estimated the fair value of the compound embedded derivative utilizing a Monte Carlo Simulation model. The inputs used to determine the estimated fair value of the embedded derivative instrument included the probability of an underlying event triggering the redemption event and its timing prior to the maturity date of the convertible promissory notes. The fair value measurement was based upon significant inputs not observable in the market, including a valuation of the Company performed by an independent third-party at each balance sheet date. By December 31, 2017, the embedded derivative had zero value because the Merger (see Note 1), which was considered 90% probable of occurring, would not have triggered redemption and, had the Merger not occurred, it was unlikely that the Company would have found an alternative source of financing on favorable terms, so there would have been zero redemption value. The embedded derivative was extinguished when the Merger occurred on February 13, 2018.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The Company incurred total debt issuance costs of $20,000 in connection with the 2014 issuance and $7,000 in connection with the 2015 issuance. The debt issuance costs, which were recorded as an additional debt discount, were being amortized over the term of the notes.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;As of December 31, 2017, the balance of the convertible promissory notes was $35.3 million, comprising principal of $29.4 million plus accrued interest associated with the convertible promissory notes of $6.3&amp;#xa0;million, offset by unamortized debt discount of $0.4 million. Interest expense related to the convertible promissory notes, including amortization of debt discount, totaled $0.3 million and $2.5 million in the years ended December 31, 2018 and 2017, respectively. The charge in 2018 related to the 43 days prior to the Merger, whereas the charge in 2017 related the full year.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;On February&amp;#xa0;13, 2018, the balance of the convertible promissory notes was $35.6 million, comprising accrued interest associated with the convertible promissory notes amounted to $6.6&amp;#xa0;million plus principal of $29.4 million, offset by the unamortized debt discount to $0.4 million. On that date, in conjunction with the Merger, the convertible promissory notes were exchanged for 1,571,702 shares of the Company&amp;#8217;s common stock which, based on the closing stock price of $9.05, had a value of $14.2 million. The difference of $21.4 million was recorded as a capital contribution&lt;font style=&quot;COLOR:black&quot;&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</vxrt:ConvertiblePromissoryNotesRelatedPartyTextBlock>
  <us-gaap:ProceedsFromConvertibleDebt unitRef="usd" contextRef="c122_From10Dec2014To10Dec2014_NotePurchaseAgreementMember" decimals="1">18.4</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ProceedsFromConvertibleDebt unitRef="usd" contextRef="c123_From20Nov2015To20Nov2015_SecondNotePurchaseAgreementMember" decimals="1">11.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c0_AsOf31Dec2018" decimals="3">0.080</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:ProceedsFromConvertibleDebt unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="1">25.0</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability unitRef="usd" contextRef="c124_AsOf31Dec2018_NotesIssuedIn2014Member" decimals="1">1.9</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
  <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability unitRef="usd" contextRef="c125_AsOf31Dec2018_NotesIssuedIn2015Member" decimals="1">1.3</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
  <us-gaap:DeferredFinanceCostsNet unitRef="usd" contextRef="c124_AsOf31Dec2018_NotesIssuedIn2014Member" decimals="0">20000</us-gaap:DeferredFinanceCostsNet>
  <us-gaap:DeferredFinanceCostsNet unitRef="usd" contextRef="c125_AsOf31Dec2018_NotesIssuedIn2015Member" decimals="0">7000</us-gaap:DeferredFinanceCostsNet>
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c126_AsOf31Dec2017_ConvertiblePromissoryNotesMember" decimals="-5">35300000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentPeriodicPaymentInterest unitRef="usd" contextRef="c127_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesMember" decimals="-5">29400000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
  <us-gaap:DebtInstrumentIncreaseAccruedInterest unitRef="usd" contextRef="c127_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesMember" decimals="1">6.3</us-gaap:DebtInstrumentIncreaseAccruedInterest>
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c126_AsOf31Dec2017_ConvertiblePromissoryNotesMember" decimals="-5">400000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-5">300000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-5">2500000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c128_AsOf13Feb2018_ConvertiblePromissoryNotesMember" decimals="-5">35600000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentPeriodicPaymentInterest unitRef="usd" contextRef="c129_From13Feb2018To13Feb2018_ConvertiblePromissoryNotesMember" decimals="1">6.6</us-gaap:DebtInstrumentPeriodicPaymentInterest>
  <us-gaap:DebtInstrumentPeriodicPaymentPrincipal unitRef="usd" contextRef="c129_From13Feb2018To13Feb2018_ConvertiblePromissoryNotesMember" decimals="-5">29400000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c128_AsOf13Feb2018_ConvertiblePromissoryNotesMember" decimals="-5">400000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c32_From13Feb2018To13Feb2018" decimals="INF">1571702</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 unitRef="usdPershares" contextRef="c111_AsOf13Feb2018" decimals="2">9.05</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 unitRef="usd" contextRef="c32_From13Feb2018To13Feb2018" decimals="-5">14200000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:OtherOwnershipInterestsValue unitRef="usd" contextRef="c111_AsOf13Feb2018" decimals="-5">21400000</us-gaap:OtherOwnershipInterestsValue>
  <vxrt:SecuredPromissoryNotePayableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;9.&amp;#xa0;&amp;#xa0;&lt;/font&gt;&lt;/b&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Secured Promissory Note Payable to Oxford Finance&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;On December&amp;#xa0;22, 2016, the Company entered into a loan and security agreement (the&amp;#xa0;&amp;#8220;Loan Agreement&amp;#8221;) with Oxford Finance, under which the Company borrowed $5.0&amp;#xa0;million. The $5.0&amp;#xa0;million loan, which bears interest at 30-day U.S. LIBOR plus 6.17%, is evidenced by a secured promissory note and is repayable over four&amp;#xa0;years, with interest only payable over the first 12 months and the balance fully amortized over the subsequent 36 months. The loan is secured by substantially all the Company&amp;#8217;s assets, except for intellectual property.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;In conjunction with the execution of the Loan Agreement, all the holders of convertible promissory notes signed subordination agreements, under which they agreed to subordinate in favor of Oxford Finance all amounts due under their promissory notes and any security interest in the Company&amp;#8217;s property. In addition, the holders of the notes agreed that they would not demand or receive any payment until all amounts owed to Oxford Finance under the Loan Agreement have been fully paid in cash. Upon repayment, an additional final payment equal to $325,000 is due, which is being accreted as interest expense over the term of the loan using the effective&amp;#x2011;interest method.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;In connection with the Loan Agreement, the Company issued a warrant to Oxford Finance to purchase 7,563&amp;#xa0;shares of its Series&amp;#xa0;C convertible preferred stock at an exercise price of $33.11&amp;#xa0;per share (the&amp;#xa0;&amp;#8220;Warrant&amp;#8221;). The fair value of the Warrant at the date of issuance was approximately $134,000, which was recorded as debt discount and is being amortized as interest expense over the term of the loan using the effective&amp;#x2011;interest method. The annual effective interest rate of the note, including the accretion of the final payment and the amortization of the debt discount, is approximately 10.5%. The Company recorded interest expense related to the Loan Agreement of $469,000 and $518,000 during the years ended December 31, 2018 and 2017, respectively, of which $356,000 and $335,000 was paid, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The Warrant provided that if the share price at the next equity financing was less than the Warrant exercise price, then the Warrant would be for the new class of shares, the exercise price would be the new class share price, and the number of shares would be calculated by dividing $250,000 by the new class share price. Due to this anti-dilution protection, the Company determined that the Warrant needed to be recorded as a liability, and therefore estimated the fair value of the Warrant upon issuance and at each balance sheet date, with any changes in the fair value being recorded within (loss) gain on revaluation of financial instruments, net in other income and (expenses) in the statements of operations and comprehensive loss. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;Due to the antidilution protection, following the Merger, the Warrant was amended to allow the holder to purchase 10,914 shares of common stock at an exercise price of $22.99 per share. Since the amended Warrant contains no non-standard antidilution protections or similar features, the fair value of approximately $70,000 on February 13, 2018, was reclassified to equity.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</vxrt:SecuredPromissoryNotePayableTextBlock>
  <us-gaap:DebtInstrumentCarryingAmount unitRef="usd" contextRef="c130_AsOf22Dec2016_LoanAgreementMember_OxfordFinanceMember" decimals="1">5.0</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="c131_From22Dec2016To22Dec2016_LoanAgreementMember_OxfordFinanceMember_LondonInterbankOfferedRateLIBORMember">30-day U.S. LIBOR plus 6.17%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 unitRef="pure" contextRef="c131_From22Dec2016To22Dec2016_LoanAgreementMember_OxfordFinanceMember_LondonInterbankOfferedRateLIBORMember" decimals="4">0.0617</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentPaymentTerms contextRef="c132_From22Dec2016To22Dec2016_LoanAgreementMember_OxfordFinanceMember">a secured promissory note and is repayable over four&amp;#xa0;years, with interest only payable over the first 12 months and the balance fully amortized over the subsequent 36 months</us-gaap:DebtInstrumentPaymentTerms>
  <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid unitRef="usd" contextRef="c133_AsOf31Dec2018_LoanAgreementMember_OxfordFinanceMember" decimals="0">325000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c134_AsOf31Dec2018_ConvertiblePreferredStockMember_LoanAgreementMember_OxfordFinanceMember_SeriesCPreferredStockMember" decimals="INF">7563</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c134_AsOf31Dec2018_ConvertiblePreferredStockMember_LoanAgreementMember_OxfordFinanceMember_SeriesCPreferredStockMember" decimals="2">33.11</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure unitRef="usd" contextRef="c134_AsOf31Dec2018_ConvertiblePreferredStockMember_LoanAgreementMember_OxfordFinanceMember_SeriesCPreferredStockMember" decimals="0">134000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c134_AsOf31Dec2018_ConvertiblePreferredStockMember_LoanAgreementMember_OxfordFinanceMember_SeriesCPreferredStockMember" decimals="3">0.105</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:InterestExpenseDebt unitRef="usd" contextRef="c135_From1Jan2018To31Dec2018_LoanAgreementMember_OxfordFinanceMember" decimals="0">469000</us-gaap:InterestExpenseDebt>
  <us-gaap:InterestExpenseDebt unitRef="usd" contextRef="c136_From1Jan2017To31Dec2017_LoanAgreementMember_OxfordFinanceMember" decimals="0">518000</us-gaap:InterestExpenseDebt>
  <us-gaap:InterestPaid unitRef="usd" contextRef="c135_From1Jan2018To31Dec2018_LoanAgreementMember_OxfordFinanceMember" decimals="0">356000</us-gaap:InterestPaid>
  <us-gaap:InterestPaid unitRef="usd" contextRef="c136_From1Jan2017To31Dec2017_LoanAgreementMember_OxfordFinanceMember" decimals="0">335000</us-gaap:InterestPaid>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 unitRef="usd" contextRef="c135_From1Jan2018To31Dec2018_LoanAgreementMember_OxfordFinanceMember" decimals="0">250000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight unitRef="shares" contextRef="c137_AsOf31Dec2018_WarrantMember_CommonStockMember_LoanAgreementMember_OxfordFinanceMember" decimals="INF">10914</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c137_AsOf31Dec2018_WarrantMember_CommonStockMember_LoanAgreementMember_OxfordFinanceMember" decimals="2">22.99</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure unitRef="usd" contextRef="c137_AsOf31Dec2018_WarrantMember_CommonStockMember_LoanAgreementMember_OxfordFinanceMember" decimals="0">70000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
  <us-gaap:DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear contextRef="c138_From1Jan2018To31Dec2018_WarrantMember_CommonStockMember_LoanAgreementMember_OxfordFinanceMember">2018-02-13</us-gaap:DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 10pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:24pt 0in 0pt&quot;&gt;&lt;b&gt;NOTE 10.&amp;#xa0; Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in&quot;&gt;&lt;b&gt;&lt;i&gt;(a)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The Company has four&amp;#xa0;office and research and development facilities in South San Francisco, California, under noncancelable operating leases. The principal lease, for office and research and development premises, expires on April&amp;#xa0;30, 2020, subject to the Company&amp;#8217;s option to extend the lease at the then market rate for an additional five&amp;#x2011;year period. The remaining three leases all expire on August 31, 2019. In addition, as a result of the Merger, the Company also leases office space in Alpharetta, Georgia, under a lease expiring on February 28, 2021, which, commencing in November 2018, the Company has subleased for the remainder of the lease term for less than it is required to pay under the head lease and accordingly it recorded a lease loss charge of $253,000 on the cease-use date in the three months ending December 31, 2018, which, along with the related impairment of property and equipment (see Note 5), was recorded as a component of costs of &lt;font style=&quot;FONT-SIZE:9.5pt&quot;&gt;exit from leased premises&lt;/font&gt; within operating expenses.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt&quot;&gt;Liabilities related to costs of exit from leased premises are summarized as follows (in thousands):&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 27pt; text-indent: -9pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9.5pt;&quot;&gt;Balance as of January 1, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9.5pt;&quot;&gt;Costs of exit from leased premises&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;359&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred rent on cease-use date&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;19&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Impairment of property and equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(106)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Cash paid, net of receipts&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(41)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt 10pt; width: 78.74%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accretion charges, included in rent expense&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.78%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 19.48%; height: 11.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.2in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 78.74%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Balance as of December 31, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.78%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 19.48%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;233&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;Rent expense is recognized on a straight&amp;#x2011;line basis over the noncancelable term of each operating lease and, accordingly, the Company records the difference between cash rent payments and the recognition of rent expense as a deferred rent liability, which is included within accrued expenses. Rent expense was $875,000 and $564,000 for the years ended December&amp;#xa0;31, 2018 and 2017, respectively. Under the terms of the lease agreements, the Company is also responsible for certain insurance, property tax and maintenance expenses. The Company also leases equipment under three operating leases that expire between May and September 2019.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;Future minimum payments and sublease income under operating leases as of December&amp;#xa0;31, 2018, are as follows: &lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Years Ending December 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Lease Payments&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Sublease Income&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;859&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;213&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2020&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;411&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;219&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2021&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;56&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;38&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Thereafter&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 14.35pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%; height: 14.35pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 14.35pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,326&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 14.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;470&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in&quot;&gt;&lt;b&gt;&lt;i&gt;(b)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Indemnifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend indemnified parties for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third&amp;#x2011;party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors&amp;#8217; and officers&amp;#8217; insurance.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in&quot;&gt;&lt;b&gt;&lt;i&gt;(c)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;From time to time the Company may be involved in claims arising in connection with its business. Based on information currently available, the Company believes that the amount, or range, of reasonably possible losses in connection with any pending actions against it in excess of established reserves, in the aggregate, not to be material to its consolidated financial condition or cash flows. However, losses may be material to the Company&amp;#8217;s operating results for any particular future period, depending on the level of income or loss for such period.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:LeaseExpirationDate1 contextRef="c139_From1Jan2018To31Dec2018_TheFirstLeaseMember_OfficeSpaceInSanFranciscoCaliforniaMember">2020-04-30</us-gaap:LeaseExpirationDate1>
  <us-gaap:LeaseExpirationDate1 contextRef="c140_From1Jan2018To31Dec2018_RemainingThreeLeasesMember_OfficeSpaceInSanFranciscoCaliforniaMember">2019-08-31</us-gaap:LeaseExpirationDate1>
  <us-gaap:LeaseExpirationDate1 contextRef="c141_From1Jan2018To31Dec2018_OfficeSpaceInAlpharettaGeorgiaMember">2021-02-28</us-gaap:LeaseExpirationDate1>
  <us-gaap:OperatingLeaseImpairmentLoss unitRef="usd" contextRef="c142_From1Oct2018To31Dec2018" decimals="0">253000</us-gaap:OperatingLeaseImpairmentLoss>
  <us-gaap:LeaseAndRentalExpense unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="0">875000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:LeaseAndRentalExpense unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="0">564000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 27pt; text-indent: -9pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9.5pt;&quot;&gt;Balance as of January 1, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 9.5pt;&quot;&gt;Costs of exit from leased premises&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;359&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred rent on cease-use date&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;19&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Impairment of property and equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(106)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 78.74%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Cash paid, net of receipts&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 19.48%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(41)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.5pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0in 1pt 10pt; width: 78.74%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accretion charges, included in rent expense&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.78%; height: 11.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 19.48%; height: 11.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.2in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 78.74%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Balance as of December 31, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.78%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 19.48%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;233&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
  <us-gaap:RestructuringReserve unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <vxrt:DeferredRentOnCeaseuseDate unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">19000</vxrt:DeferredRentOnCeaseuseDate>
  <us-gaap:ImpairmentOfLeasehold unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">106000</us-gaap:ImpairmentOfLeasehold>
  <us-gaap:PaymentsForRestructuring unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">41000</us-gaap:PaymentsForRestructuring>
  <us-gaap:AccretionExpense unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">2000</us-gaap:AccretionExpense>
  <us-gaap:RestructuringReserve unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">233000</us-gaap:RestructuringReserve>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Years Ending December 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Lease Payments&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Sublease Income&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 1in; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2019&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;859&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;213&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2020&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;411&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;219&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2021&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;56&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;38&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Thereafter&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 14.35pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%; height: 14.35pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 14.35pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,326&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 14.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;470&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">859000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">213000</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">411000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">219000</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">56000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">38000</us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1326000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">470000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:9.5pt; COLOR:black&quot;&gt;NOTE&amp;#xa0;11.&amp;#xa0;&amp;#xa0;Stockholders&amp;#8217; Equity&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in&quot;&gt;&lt;b&gt;&lt;i&gt;(a)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 10pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; page-break-after: avoid; text-align: justify; margin: 12pt 0in; line-height: 12pt;&quot;&gt;The Company is authorized to issue 5,000,000 shares of preferred stock, $0.10 par value per share. The Company&amp;#x2019;s board of directors may, without further action by the stockholders, fix the rights, preferences, privileges and restrictions of up to an aggregate of 5,000,000 shares of preferred stock in one or more series and authorize their issuance. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of our common stock. The issuance of preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deterring or preventing a change of control or other corporate action. No shares of preferred stock are currently outstanding, and the Company has no present plan to issue any shares of preferred stock.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;All of Private Vaxart&amp;#8217;s convertible preferred stock was converted into common stock on February 13, 2018, in conjunction with the Merger. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt&quot;&gt;As of December&amp;#xa0;31, 2017, convertible preferred stock consisted of the following:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; margin-left: 0.5in; border-collapse: collapse;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 33.3pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 75pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;Shares&lt;br /&gt;authorized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;Shares&lt;br /&gt;outstanding&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16.4pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74.3pt; height: 33.3pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;Net&lt;br /&gt;carrying&lt;br /&gt;value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 77.2pt; height: 33.3pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;Liquidation&lt;br /&gt;preference&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 8.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 75pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 74pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 73pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16.4pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 74.3pt; height: 8.5pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 77.2pt; height: 8.5pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.1in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 75pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Series A&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 74pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;94,988&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 73pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;94,988&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 58.5pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,949&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 61.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,737&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.1in;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 75pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Series B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 74pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;747,095&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 73pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;520,973&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 58.5pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;16,115&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 61.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;17,219&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.1in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 75pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Series C&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;820,088&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;605,103&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.5pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;19,877&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 61.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;20,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.7pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 75pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,662,171&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,221,064&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16.4pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.5pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;38,941&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 61.4pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;39,956&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;Significant provisions of the convertible preferred stock were as follows:&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;i&gt;Dividends&lt;/i&gt; &amp;#8211; The holders of Series&amp;#xa0;C convertible preferred stock were entitled to receive non-compounding cumulative dividends, in preference to any dividends payable to holders of Series&amp;#xa0;B and Series&amp;#xa0;A convertible preferred stock or common stock, at an annual dividend rate of $2.64416 per share, as adjusted for any stock splits, stock dividends, recapitalizations, or the like. Such cumulative dividends were payable within ten days of demand of the holders of at least a majority of the then outstanding Series&amp;#xa0;C convertible preferred stock, or automatically upon a liquidation event. Dividends accumulated from the date of issuance and were payable, whether or not declared, before any dividend on Series&amp;#xa0;B and Series&amp;#xa0;A convertible preferred stock or common stock could be paid or declared. Series&amp;#xa0;C convertible preferred stock shares issued as stock dividends were not entitled to cumulative dividends. The holders of Series&amp;#xa0;C convertible preferred stock could elect whether the cumulative dividends would be paid in cash or in shares of Series&amp;#xa0;C convertible preferred stock based on the original issue price of Series&amp;#xa0;C convertible preferred stock of $33.05196 per share. In the event the board of directors declared a cash dividend in addition to the above cumulative dividends (a Special Dividend), the holders of Series&amp;#xa0;C convertible preferred stock would have been entitled to receive, in preference to any dividends payable to the holders of Series&amp;#xa0;B and Series&amp;#xa0;A convertible preferred stock or common stock, a per share amount equal to the sum of: (a)&amp;#xa0;the original issue price of Series&amp;#xa0;C convertible preferred stock, and (b)&amp;#xa0;all accrued and/or declared but unpaid dividends on such Series&amp;#xa0;C convertible preferred stock, including the cumulative dividends. No dividends were declared during any of the periods presented. As of February 13, 2018, when the convertible preferred stock was converted into common stock, and December&amp;#xa0;31, 2017, accumulated and undeclared dividends for Series&amp;#xa0;C convertible preferred stock were $7.3&amp;#xa0;million and $7.1&amp;#xa0;million, respectively ($12.06 per share and $11.74 per share, respectively, of the outstanding Series&amp;#xa0;C convertible preferred stock). On February 13, 2018, in conjunction with the Merger, the Series&amp;#xa0;C convertible preferred stock and the related accumulated dividends were converted into 696,028 and 253,851 shares of common stock, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The holders of Series&amp;#xa0;B convertible preferred stock were entitled to receive non-compounding cumulative dividends, in preference to any dividends payable to holders of Series&amp;#xa0;A convertible preferred stock or common stock, at the annual dividend rate of $2.64416 per share, as adjusted for any stock splits, stock dividends, recapitalizations, or the like. Such cumulative dividends were payable within ten days of demand of the holders of at least a majority of the then outstanding Series&amp;#xa0;B convertible preferred stock or automatically upon a liquidation event. Dividends accumulated from the date of issuance and were payable, whether or not declared, before any dividend on Series&amp;#xa0;A convertible preferred stock or common stock could be paid or declared. Series&amp;#xa0;B convertible preferred shares issued as stock dividends were not entitled to cumulative dividends. The holders of Series&amp;#xa0;B convertible preferred stock could elect whether the cumulative dividends would be paid in cash or in shares of Series&amp;#xa0;B convertible preferred stock based on the original issue price of Series&amp;#xa0;B convertible preferred stock of $33.05196 per share. In the event the board of directors declared a cash dividend in addition to the above cumulative dividends (a Special Dividend), the holders of Series&amp;#xa0;B convertible preferred stock would have been entitled to receive, in preference to any dividends payable to the holders of Series&amp;#xa0;A convertible preferred stock or common stock, a per share amount equal to the sum of: (a)&amp;#xa0;the original issue price of Series&amp;#xa0;B convertible preferred stock, and (b)&amp;#xa0;all accrued and/or declared but unpaid dividends on such Series&amp;#xa0;B convertible preferred stock, including the cumulative dividends. No dividends were declared during any of the periods presented. As of February 13, 2018, when the convertible preferred stock was converted into common stock, and December&amp;#xa0;31, 2017, accumulated and undeclared dividends for Series&amp;#xa0;B convertible preferred stock were $7.6&amp;#xa0;million and $7.5&amp;#xa0;million, respectively ($15.78 per share and $15.46 per share, respectively, of the 483,387 shares of outstanding Series&amp;#xa0;B convertible preferred stock on which dividends accrued). On February 13, 2018, in conjunction with the Merger, the Series&amp;#xa0;B convertible preferred stock and the related accumulated dividends were converted into 599,259 and 265,340 shares of common stock, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The holders of Series&amp;#xa0;A convertible preferred stock were entitled to receive noncumulative dividends, in preference to any dividends payable to holders of common stock, at the annual dividend rate of $2.30449 per share, as adjusted for any stock splits, stock dividends, recapitalizations, or the like, if declared by the board of directors. On February 13, 2018, in conjunction with the Merger, the Series&amp;#xa0;A convertible preferred stock was converted into 104,065 shares of common stock.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;i&gt;Conversion&lt;/i&gt; &amp;#8211; At the option of the holder, each share of convertible preferred stock was convertible, one&amp;#x2011;for&amp;#x2011;one, subject to adjustment for anti&amp;#x2011;dilution protection, into shares of common stock. Each share automatically converted into the number of shares of common stock into which the shares were convertible at the then applicable conversion ratio upon: (1)&amp;#xa0;the closing of the sale of the Company&amp;#8217;s common stock in a public offering provided the offering price per share was not less than three&amp;#xa0;times the Series&amp;#xa0;C convertible preferred stock original issue price of $33.05196 and the aggregate gross proceeds were not less than $30.0&amp;#xa0;million, or (2)&amp;#xa0;upon receipt of a written consent of the holders of a majority of the then outstanding shares of convertible preferred stock voting as a single class on an as&amp;#x2011;converted basis.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;i&gt;Liquidation&lt;/i&gt; &amp;#8211; In the event of any liquidation, dissolution or winding up of the Company, including a merger or acquisition where the beneficial owners of the Company&amp;#8217;s common and convertible preferred stock owned less than 50% of the surviving entity, or a sale of all or substantially all assets, the holders of Series&amp;#xa0;C convertible preferred stock would have been entitled to receive a per share amount equal to $33.05196 (subject to adjustment for stock splits, stock dividends, recapitalizations, or the like), plus all dividends accrued, payable and/or in arrears (whether or not declared) minus the amount of any Special Dividends previously paid. After payment of the full liquidation preference of Series&amp;#xa0;C convertible preferred stock, the holders of Series&amp;#xa0;B convertible preferred stock would have been entitled to receive a per share amount equal to $33.05196 (subject to adjustment for stock splits, stock dividends, recapitalizations, or the like), plus all dividends accrued, payable and/or in arrears (whether or not declared) minus the amount of any Special Dividends previously paid. After payment of the full liquidation preference of Series&amp;#xa0;B convertible preferred stock, the holders of Series&amp;#xa0;A convertible preferred stock would have been entitled to receive an amount equal to $28.80613 per share, as adjusted, plus all declared but unpaid dividends prior and in preference to any distribution to the holders of common stock. In each case, if the proceeds of such an event were insufficient to permit the liquidation payment to a particular class, any proceeds legally available for distribution to that class would have been distributed ratably among the holders of that class in proportion to the preferential amounts that each holder was entitled to receive. Following payment of all convertible preferred stock preferences, any remaining legally available assets of the Company would have been distributed to the holders of common stock and convertible preferred stock pro rata, based on the greatest number of shares of common stock held on an as&amp;#x2011;converted basis.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;i&gt;Voting&lt;/i&gt; &amp;#8211; The holders of convertible preferred stock were entitled to the number of votes equal to the number of shares of common stock into which each share of Series&amp;#xa0;A, Series&amp;#xa0;B, and Series&amp;#xa0;C convertible preferred stock could have been converted on the record date for the vote or consent of the stockholders, except as otherwise required by law, and had voting rights and powers equal to the voting rights and powers of the common stockholders. The holders of Series&amp;#xa0;A convertible preferred stock, voting as a separate class, were entitled to elect one&amp;#xa0;member of the board of directors. As long as a specified investor held at least one&amp;#xa0;share of Series&amp;#xa0;C convertible preferred stock, the specified investor was able to designate one&amp;#xa0;member of the board of directors, who would have been elected by the holders of Series&amp;#xa0;C convertible preferred stock voting as a separate class. As long as a specified investor held least one&amp;#xa0;share of Series&amp;#xa0;B convertible preferred stock, the specified investor was able to designate one&amp;#xa0;member of the board of directors, who would have been elected by the holders of Series&amp;#xa0;B convertible preferred stock voting as a separate class. The holders of common stock, voting as a separate class, were entitled to elect two&amp;#xa0;members of the board of directors, one of whom was the duly appointed chief executive officer of the Company.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;i&gt;Protective Provisions&lt;/i&gt; &amp;#8211; So long as at least 20,134&amp;#xa0;shares of Series&amp;#xa0;C convertible preferred stock remained outstanding and for so long as at least 20,134&amp;#xa0;shares of Series&amp;#xa0;B convertible preferred stock remained outstanding, Series&amp;#xa0;C holders and Series&amp;#xa0;B holders, voting as a single class on an as&amp;#x2011;converted basis, needed to approve certain specified corporate actions such as amending the certificate of incorporation, authorizing additional shares of stock or additional directors, redeeming stock and entering into certain strategic relationships.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;i&gt;Redemption&lt;/i&gt; &amp;#8211; The convertible preferred stock was not redeemable. There were no liquidation events under the control of preferred stockholders that could have resulted in liquidation in which only the preferred stockholders would have participated. Accordingly, the convertible preferred stock was classified within stockholders&amp;#8217; equity (deficit) on the Company&amp;#8217;s consolidated balance sheets.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in&quot;&gt;&lt;b&gt;&lt;i&gt;(b)&lt;font style=&quot;FONT:7pt &amp;quot;Times New Roman&amp;quot;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;Except as otherwise required by law or as otherwise provided in any certificate of designation for any series of preferred stock, the holders of common stock possess all voting power for the election of the Company&amp;#8217;s directors and all other matters requiring stockholder action. Holders of common stock are entitled to one vote per share on matters to be voted on by stockholders. Holders of common stock are entitled to receive such dividends, if any, as may be declared from time to time by the Company&amp;#8217;s board of directors in its discretion out of funds legally available therefore. In no event will any stock dividends or stock splits or combinations of stock be declared or made on common stock unless the shares of common stock at the time outstanding are treated equally and identically. As of December&amp;#xa0;31, 2018, no dividends had been declared by the board of directors.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;In the event of the Company&amp;#8217;s voluntary or involuntary liquidation, dissolution, distribution of assets or winding-up, the holders of the common stock will be entitled to receive an equal amount per share of all of the Company&amp;#8217;s assets of whatever kind available for distribution to stockholders, after the rights of the holders of the preferred stock have been satisfied. There are no sinking fund provisions applicable to the common stock.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The Company had shares of common stock reserved for issuance as follows:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 11.25pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 11.25pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 11.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;December 31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 11.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 11.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;December 31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.2pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 70%; height: 9.2pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 12%; height: 9.2pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.2pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 12%; height: 9.2pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.35pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 11.35pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Convertible preferred stock outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 11.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 11.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,221,064&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.35pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 10.35pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Options issued and outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;865,163&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;304,850&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.35pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 10.35pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Available for future grants of equity awards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;223,377&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 10.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 3.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 3.5pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Cumulative convertible preferred stock dividends&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 3.5pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 3.5pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 3.5pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;441,096&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 7.4pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 7.4pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Common stock warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 7.4pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;10,914&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 7.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 7.4pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;10,914&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 16.75pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,099,454&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 2.25pt; border-style: solid none double; border-color: windowtext currentColor; padding: 0in; width: 12%; height: 16.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,977,924&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:PreferredStockDividendRatePerDollarAmount unitRef="usdPershares" contextRef="c143_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="5">2.64416</us-gaap:PreferredStockDividendRatePerDollarAmount>
  <us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears unitRef="usdPershares" contextRef="c143_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="5">33.05196</us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears>
  <us-gaap:DividendsPreferredStock unitRef="usd" contextRef="c144_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="-5">7300000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock unitRef="usd" contextRef="c145_From31Dec2017To31Dec2017_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="-5">7100000</us-gaap:DividendsPreferredStock>
  <us-gaap:PreferredStockDividendsPerShareDeclared unitRef="usdPershares" contextRef="c144_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="2">12.06</us-gaap:PreferredStockDividendsPerShareDeclared>
  <us-gaap:PreferredStockDividendsPerShareDeclared unitRef="usdPershares" contextRef="c145_From31Dec2017To31Dec2017_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="2">11.74</us-gaap:PreferredStockDividendsPerShareDeclared>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c146_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember_CommonStockMember" decimals="INF">696028</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c147_From13Feb2018To13Feb2018_DividendPaidMember_ConvertiblePreferredStockMember_SeriesCPreferredStockMember_CommonStockMember" decimals="INF">253851</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:PreferredStockDividendRatePerDollarAmount unitRef="usdPershares" contextRef="c148_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="5">2.64416</us-gaap:PreferredStockDividendRatePerDollarAmount>
  <us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears unitRef="usdPershares" contextRef="c148_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="5">33.05196</us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears>
  <us-gaap:DividendsPreferredStock unitRef="usd" contextRef="c149_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="-5">7600000</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock unitRef="usd" contextRef="c150_From31Dec2017To31Dec2017_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="-5">7500000</us-gaap:DividendsPreferredStock>
  <us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears unitRef="usdPershares" contextRef="c149_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="2">15.78</us-gaap:PreferredStockPerShareAmountsOfPreferredDividendsInArrears>
  <us-gaap:PreferredStockDividendsPerShareDeclared unitRef="usdPershares" contextRef="c150_From31Dec2017To31Dec2017_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="2">15.46</us-gaap:PreferredStockDividendsPerShareDeclared>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c151_AsOf13Feb2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="INF">483387</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c152_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember_CommonStockMember" decimals="INF">599259</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c153_From13Feb2018To13Feb2018_DividendPaidMember_ConvertiblePreferredStockMember_SeriesBPreferredStockMember_CommonStockMember" decimals="INF">265340</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:PreferredStockDividendRatePerDollarAmount unitRef="usdPershares" contextRef="c154_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember_SeriesAPreferredStockMember" decimals="5">2.30449</us-gaap:PreferredStockDividendRatePerDollarAmount>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c155_From13Feb2018To13Feb2018_ConvertiblePreferredStockMember_SeriesAPreferredStockMember_CommonStockMember" decimals="INF">104065</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:ConvertiblePreferredStockTermsOfConversion contextRef="c8_From1Jan2018To31Dec2018">At the option of the holder, each share of convertible preferred stock was convertible, one&amp;#x2011;for&amp;#x2011;one, subject to adjustment for anti&amp;#x2011;dilution protection, into shares of common stock. Each share automatically converted into the number of shares of common stock into which the shares were convertible at the then applicable conversion ratio upon: (1)&amp;#xa0;the closing of the sale of the Company&amp;#8217;s common stock in a public offering provided the offering price per share was not less than three&amp;#xa0;times the Series&amp;#xa0;C convertible preferred stock original issue price of $33.05196 and the aggregate gross proceeds were not less than $30.0&amp;#xa0;million, or (2)&amp;#xa0;upon receipt of a written consent of the holders of a majority of the then outstanding shares of convertible preferred stock voting as a single class on an as&amp;#x2011;converted basis</us-gaap:ConvertiblePreferredStockTermsOfConversion>
  <us-gaap:SharesIssuedPricePerShare unitRef="usdPershares" contextRef="c156_AsOf31Dec2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="5">33.05196</us-gaap:SharesIssuedPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock unitRef="usd" contextRef="c157_From1Jan2018To31Dec2018_MinimumMember_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="-5">30000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
  <us-gaap:PreferredStockLiquidationPreference unitRef="usdPershares" contextRef="c156_AsOf31Dec2018_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="5">33.05196</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:PreferredStockLiquidationPreference unitRef="usdPershares" contextRef="c158_AsOf31Dec2018_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="5">33.05196</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:PreferredStockLiquidationPreference unitRef="usdPershares" contextRef="c159_AsOf31Dec2018_ConvertiblePreferredStockMember_SeriesAPreferredStockMember" decimals="5">28.80613</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:PreferredStockVotingRights contextRef="c160_From1Jan2018To31Dec2018_ConvertiblePreferredStockMember">The holders of convertible preferred stock were entitled to the number of votes equal to the number of shares of common stock into which each share of Series&amp;#xa0;A, Series&amp;#xa0;B, and Series&amp;#xa0;C convertible preferred stock could have been converted on the record date for the vote or consent of the stockholders, except as otherwise required by law, and had voting rights and powers equal to the voting rights and powers of the common stockholders. The holders of Series&amp;#xa0;A convertible preferred stock, voting as a separate class, were entitled to elect one&amp;#xa0;member of the board of directors. As long as a specified investor held at least one&amp;#xa0;share of Series&amp;#xa0;C convertible preferred stock, the specified investor was able to designate one&amp;#xa0;member of the board of directors, who would have been elected by the holders of Series&amp;#xa0;C convertible preferred stock voting as a separate class. As long as a specified investor held least one&amp;#xa0;share of Series&amp;#xa0;B convertible preferred stock, the specified investor was able to designate one&amp;#xa0;member of the board of directors, who would have been elected by the holders of Series&amp;#xa0;B convertible preferred stock voting as a separate class. The holders of common stock, voting as a separate class, were entitled to elect two&amp;#xa0;members of the board of directors, one of whom was the duly appointed chief executive officer of the Company</us-gaap:PreferredStockVotingRights>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c161_AsOf31Dec2018_MinimumMember_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="INF">20134</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c162_AsOf31Dec2018_MinimumMember_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="INF">20134</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockVotingRights contextRef="c22_From1Jan2018To31Dec2018_CommonStockMember">Holders of common stock are entitled to one vote per share on matters to be voted on by stockholders</us-gaap:CommonStockVotingRights>
  <vxrt:ScheduleOfConvertiblePreferredStockTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; margin-left: 0.5in; border-collapse: collapse;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 33.3pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 75pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;Shares&lt;br /&gt;authorized&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;Shares&lt;br /&gt;outstanding&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16.4pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74.3pt; height: 33.3pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;Net&lt;br /&gt;carrying&lt;br /&gt;value&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 33.3pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 77.2pt; height: 33.3pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 9pt;&quot;&gt;Liquidation&lt;br /&gt;preference&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 8.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 75pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 74pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 73pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16.4pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 74.3pt; height: 8.5pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 8.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 77.2pt; height: 8.5pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.1in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 75pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Series A&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 74pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;94,988&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 73pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;94,988&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 58.5pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,949&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 61.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,737&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.1in;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 75pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Series B&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 74pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;747,095&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 73pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;520,973&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 58.5pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;16,115&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 61.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;17,219&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.1in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 75pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Series C&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;820,088&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;605,103&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.5pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;19,877&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 61.4pt; height: 0.1in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;20,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.7pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 75pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,662,171&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 13pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,221,064&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16.4pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.5pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;38,941&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15.8pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 61.4pt; height: 15.7pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;39,956&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</vxrt:ScheduleOfConvertiblePreferredStockTableTextBlock>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c163_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesAPreferredStockMember" decimals="INF">94988</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c163_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesAPreferredStockMember" decimals="INF">94988</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c163_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesAPreferredStockMember" decimals="0">2949</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockLiquidationPreferenceValue unitRef="usd" contextRef="c163_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesAPreferredStockMember" decimals="0">2737</us-gaap:PreferredStockLiquidationPreferenceValue>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c164_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="INF">747095</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c164_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="INF">520973</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c164_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="0">16115</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockLiquidationPreferenceValue unitRef="usd" contextRef="c164_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesBPreferredStockMember" decimals="0">17219</us-gaap:PreferredStockLiquidationPreferenceValue>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c165_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="INF">820088</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c165_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="INF">605103</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c165_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="0">19877</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockLiquidationPreferenceValue unitRef="usd" contextRef="c165_AsOf31Dec2017_ConvertiblePreferredStockMember_SeriesCPreferredStockMember" decimals="0">20000</us-gaap:PreferredStockLiquidationPreferenceValue>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c166_AsOf31Dec2017_ConvertiblePreferredStockMember" decimals="INF">1662171</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c166_AsOf31Dec2017_ConvertiblePreferredStockMember" decimals="INF">1221064</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c166_AsOf31Dec2017_ConvertiblePreferredStockMember" decimals="0">38941</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockLiquidationPreferenceValue unitRef="usd" contextRef="c166_AsOf31Dec2017_ConvertiblePreferredStockMember" decimals="0">39956</us-gaap:PreferredStockLiquidationPreferenceValue>
  <vxrt:ScheduleOfCommonStockReservedForIssuanceTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 11.25pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 11.25pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 11.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;December 31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 11.25pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 11.25pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;December 31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.2pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 70%; height: 9.2pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 12%; height: 9.2pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 2%; height: 9.2pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 12%; height: 9.2pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 11.35pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 11.35pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Convertible preferred stock outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 11.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 11.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 11.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,221,064&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.35pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 10.35pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Options issued and outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;865,163&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 10.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;304,850&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10.35pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 10.35pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Available for future grants of equity awards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;223,377&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 10.35pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 3.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 3.5pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Cumulative convertible preferred stock dividends&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 3.5pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 3.5pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 3.5pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;441,096&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 7.4pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 7.4pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Common stock warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 7.4pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;10,914&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 7.4pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 7.4pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;10,914&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 16.75pt; white-space: nowrap; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,099,454&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 2.25pt; border-style: solid none double; border-color: windowtext currentColor; padding: 0in; width: 12%; height: 16.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,977,924&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</vxrt:ScheduleOfCommonStockReservedForIssuanceTableTextBlock>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c167_AsOf31Dec2018_ConvertiblePreferredStockOutstandingMember" xs:nil="true"/>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c168_AsOf31Dec2017_ConvertiblePreferredStockOutstandingMember" decimals="INF">1221064</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c169_AsOf31Dec2018_OptionsIssuedAndOutstandingMember" decimals="INF">865163</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c170_AsOf31Dec2017_OptionsIssuedAndOutstandingMember" decimals="INF">304850</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c171_AsOf31Dec2018_OptionsAvailableForFutureGrantsMember" decimals="INF">223377</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c172_AsOf31Dec2017_OptionsAvailableForFutureGrantsMember" xs:nil="true"/>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c173_AsOf31Dec2018_CumulativeConvertiblePreferredStockDividendsMember" xs:nil="true"/>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c174_AsOf31Dec2017_CumulativeConvertiblePreferredStockDividendsMember" decimals="INF">441096</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c175_AsOf31Dec2018_CommonStockWarrantsMember" decimals="INF">10914</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c176_AsOf31Dec2017_CommonStockWarrantsMember" decimals="INF">10914</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c0_AsOf31Dec2018" decimals="INF">1099454</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">1977924</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;12.&amp;#xa0;&amp;#xa0;Equity Incentive Plans&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;Prior to the Merger, the Company issued equity awards for compensation purposes to employees, directors and consultants under the Company&amp;#8217;s 2007 Equity Incentive Plan (the &amp;#8220;2007 Plan&amp;#8221;). The 2007 Plan expired in July 2017, since when the Company has had no shares of common stock available for issuance under the 2007 Plan since awards under the 2007 Plan no longer become available for future issuance if such awards are forfeited or otherwise terminate. Each outstanding stock option to acquire shares of Private Vaxart stock, whether vested or unvested, was assumed in the Merger after adjustment for the impact of the Conversion and the Reverse Stock Split.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;In November 2016, Aviragen&amp;#8217;s stockholders approved the 2016 Equity Incentive Plan (&amp;#8220;2016 Equity Plan&amp;#8221;), under which all outstanding awards under their previous plans became available for issuance under the 2016 Equity Plan if such awards are forfeited or otherwise terminate. The purpose of the 2016 Equity Plan is to assist the Company in attracting and retaining valued employees, consultants and non-employee directors by offering them a greater stake in the Company&amp;#8217;s success and a closer identity with it, and to encourage ownership of the Company&amp;#8217;s shares by such persons.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;Under the 2016 Equity Plan, the Company is authorized to issue incentive stock options (&amp;#8220;ISOs&amp;#8221;), non-qualified stock options (&amp;#8220;NQSOs&amp;#8221;), restricted stock (&amp;#8220;RSAs&amp;#8221;) and restricted stock units (&amp;#8220;RSUs&amp;#8221;). Awards that expire or are canceled generally become available for issuance again under the 2016 Equity Plan. All awards outstanding, along with the number of shares of the Company&amp;#8217;s common stock available under the 2016 Equity Plan, were adjusted for the impact of the Reverse Stock Split and remain subject to adjustment in the event of a stock split, stock dividend or other extraordinary dividend, or other similar change in the Company&amp;#8217;s common stock or capital structure. Awards may vest over varying periods, as specified by the Company&amp;#8217;s Board of Directors for each grant, and have a maximum term of ten years from the grant date.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;A summary of stock option &lt;font style=&quot;COLOR:black&quot;&gt;transactions in each of the two years ended December 31, 2018, is as follows:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; margin-left: 0.5in; border-collapse: collapse;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; colspan=&quot;2&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Weighted&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Average&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Exercise&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Price&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Shares&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Available&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;For&amp;#xa0;Grant&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Number&amp;#xa0;of&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Options&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Outstanding&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 5.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%; height: 5.75pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 5.75pt; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 5.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 5.75pt; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 5.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 5.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 5.75pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Balance at January&amp;#xa0;1, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;99,644&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;275,539&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;11.32&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(78,406)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;78,406&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;4.07&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2,834)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8.58&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;33,012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(33,012)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;11.49&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Canceled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;13,249&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(13,249)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;12.00&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Termination of Plan&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(67,499)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-indent: 0.25in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Balance at December&amp;#xa0;31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;304,850&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;9.50&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 27pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Assumed on consummation of Merger&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;291,102&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;627,106&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;26.33&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(431,100)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;431,100&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;5.17&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2,013)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6.49&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;71,500&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(89,903)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;5.90&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Canceled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;269,148&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(405,977)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;34.64&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.1in;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%; height: 0.1in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-indent: 0.25in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 13%; height: 0.1in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 0.1in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.1in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Balance at &lt;font style=&quot;color: black;&quot;&gt;December&lt;/font&gt; 31, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;200,650&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;865,163&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8.13&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;In addition, the 2016 Equity Plan has a reserve of 22,727 shares available for future issuance as RSAs and RSUs. As of &lt;font style=&quot;COLOR:black&quot;&gt;December&lt;/font&gt; 31, 2018, no such awards have been granted under the 2016 Equity Plan.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;As of December&amp;#xa0;31, 2018, there were 865,163 options outstanding with a weighted average exercise price of $8.13, a weighted average remaining term of 6.14 years and zero aggregate intrinsic value. Of these options, 452,905 were vested, with a weighted average exercise price of $10.58, a weighted average remaining term of 3.35 years and zero aggregate intrinsic value.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in -0.9pt 0pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The aggregate intrinsic value represents the total pre-tax value (i.e., the difference between the Company&amp;#8217;s stock price and the exercise price) of stock options outstanding as of December&amp;#xa0;31, 2018, based on our common stock closing price of $1.88, which would have been received by the option holders had all their in-the-money options been exercised as of that date.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;The grant date fair value of options vested in the years ended December&amp;#xa0;31, 2018 and 2017, was $332,000 and $533,000, respectively. The intrinsic value of options exercised in the years ended December&amp;#xa0;31, 2018 and 2017, was zero and $1,000, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The weighted average grant date fair value of options awarded in the years ended December&amp;#xa0;31, 2018 and 2017, was $3.59 and $2.99, respectively. Fair values were estimated using the following assumptions:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 9.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; width: 67.26%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 32.74%; height: 9.5pt;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; width: 67.26%; height: 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2.04%; height: 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 15.36%; height: 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; width: 67.26%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 15.34%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; width: 2.04%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 15.36%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13.65pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: #cceeff; margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2.80%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: #cceeff; margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1.87%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13.65pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Expected term&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: white; margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;5.96&amp;#xa0;Years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: white; margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6.09&amp;#xa0;Years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13.65pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: #cceeff; margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;79%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: #cceeff; margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;91&lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13.65pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: white; margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: white; margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;Total stock&amp;#x2011;based compensation recognized for options was as follows:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 65.8%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 34.2%; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 2.15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 65.8%; height: 2.15pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 16.22%; height: 2.15pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.34%; height: 2.15pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.62%; height: 2.15pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 65.8%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 34.2%; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 65.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Research and development&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.72%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 14.5%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;254&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.34%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 13.4%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;262&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 65.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;General and administrative&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.72%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.5%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;285&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.34%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2.22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 13.4%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;215&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.2in; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 65.8%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total stock-based compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.72%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.5%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;539&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.34%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2.22%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 13.4%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;477&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;As of December 31, 2018, the unrecognized stock-based compensation cost related to outstanding stock options that are expected to vest was $1.1&amp;#xa0;million, which the Company expects to recognize over an estimated weighted average period of 2.75 years.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c177_From1Jan2018To31Dec2018_MaximumMember_EmployeeStockOptionMember">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c178_AsOf31Dec2018_RestrictedStockMember" decimals="INF">22727</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c179_AsOf31Dec2018_EmployeeStockOptionMember" decimals="INF">865163</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c179_AsOf31Dec2018_EmployeeStockOptionMember" decimals="2">8.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c180_From1Jan2018To31Dec2018_EmployeeStockOptionMember">P6Y51D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue unitRef="usd" contextRef="c179_AsOf31Dec2018_EmployeeStockOptionMember" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber unitRef="shares" contextRef="c179_AsOf31Dec2018_EmployeeStockOptionMember" decimals="INF">452905</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c179_AsOf31Dec2018_EmployeeStockOptionMember" decimals="2">10.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c180_From1Jan2018To31Dec2018_EmployeeStockOptionMember">P3Y127D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue unitRef="usd" contextRef="c179_AsOf31Dec2018_EmployeeStockOptionMember" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue unitRef="usdPershares" contextRef="c180_From1Jan2018To31Dec2018_EmployeeStockOptionMember" decimals="2">1.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 unitRef="usd" contextRef="c180_From1Jan2018To31Dec2018_EmployeeStockOptionMember" decimals="0">332000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 unitRef="usd" contextRef="c181_From1Jan2017To31Dec2017_EmployeeStockOptionMember" decimals="0">533000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue unitRef="usd" contextRef="c180_From1Jan2018To31Dec2018_EmployeeStockOptionMember" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue unitRef="usd" contextRef="c181_From1Jan2017To31Dec2017_EmployeeStockOptionMember" decimals="0">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c180_From1Jan2018To31Dec2018_EmployeeStockOptionMember" decimals="2">3.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c181_From1Jan2017To31Dec2017_EmployeeStockOptionMember" decimals="2">2.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions unitRef="usd" contextRef="c179_AsOf31Dec2018_EmployeeStockOptionMember" decimals="-5">1100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c180_From1Jan2018To31Dec2018_EmployeeStockOptionMember">P2Y9M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; margin-left: 0.5in; border-collapse: collapse;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; colspan=&quot;2&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Weighted&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Average&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Exercise&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Price&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Shares&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Available&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;For&amp;#xa0;Grant&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Number&amp;#xa0;of&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Options&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Outstanding&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 5.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 57%; height: 5.75pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 5.75pt; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 5.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 5.75pt; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; height: 5.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 5.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 5.75pt; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Balance at January&amp;#xa0;1, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;99,644&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;275,539&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;11.32&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(78,406)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;78,406&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;4.07&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2,834)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8.58&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;33,012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(33,012)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;11.49&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Canceled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;13,249&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(13,249)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;12.00&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Termination of Plan&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(67,499)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-indent: 0.25in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Balance at December&amp;#xa0;31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;304,850&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;9.50&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 27pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Assumed on consummation of Merger&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;291,102&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;627,106&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;26.33&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(431,100)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;431,100&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;5.17&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2,013)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6.49&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;71,500&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(89,903)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;5.90&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Canceled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;269,148&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(405,977)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;34.64&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.1in;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 57%; height: 0.1in; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-indent: 0.25in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 13%; height: 0.1in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 0.1in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.1in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 57%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Balance at &lt;font style=&quot;color: black;&quot;&gt;December&lt;/font&gt; 31, 2018&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;200,650&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;865,163&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8.13&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant unitRef="shares" contextRef="c14_AsOf31Dec2016" decimals="INF">99644</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c14_AsOf31Dec2016" decimals="INF">275539</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c14_AsOf31Dec2016" decimals="2">11.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">78406</vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">78406</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c9_From1Jan2017To31Dec2017" decimals="2">4.07</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">2834</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c9_From1Jan2017To31Dec2017" decimals="2">8.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">33012</vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">33012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c9_From1Jan2017To31Dec2017" decimals="2">11.49</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">13249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">13249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c9_From1Jan2017To31Dec2017" decimals="2">12.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">67499</vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">304850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c1_AsOf31Dec2017" decimals="2">9.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">291102</vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">627106</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c8_From1Jan2018To31Dec2018" decimals="2">26.33</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice>
  <vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">431100</vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">431100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c8_From1Jan2018To31Dec2018" decimals="2">5.17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">2013</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c8_From1Jan2018To31Dec2018" decimals="2">6.49</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">71500</vxrt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">89903</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c8_From1Jan2018To31Dec2018" decimals="2">5.90</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">269148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">405977</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c8_From1Jan2018To31Dec2018" decimals="2">34.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant unitRef="shares" contextRef="c0_AsOf31Dec2018" decimals="INF">200650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c0_AsOf31Dec2018" decimals="INF">865163</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_AsOf31Dec2018" decimals="2">8.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 9.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; width: 67.26%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 32.74%; height: 9.5pt;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 10pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; width: 67.26%; height: 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2.04%; height: 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 15.36%; height: 10pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;color: black; font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; width: 67.26%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 15.34%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; width: 2.04%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 15.36%; height: 9.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13.65pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: #cceeff; margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2.80%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: #cceeff; margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1.87%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13.65pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Expected term&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: white; margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;5.96&amp;#xa0;Years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: white; margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6.09&amp;#xa0;Years&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13.65pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: #cceeff; margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;79%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: #cceeff; margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;91&lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 13.65pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: white; margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;background: white; margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="4">0.0280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="4">0.0187</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c8_From1Jan2018To31Dec2018">P5Y350D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c9_From1Jan2017To31Dec2017">P6Y32D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="2">0.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="2">0.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 65.8%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 34.2%; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 2.15pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 65.8%; height: 2.15pt;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 16.22%; height: 2.15pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.34%; height: 2.15pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.62%; height: 2.15pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 65.8%;&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 34.2%; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 65.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Research and development&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 1.72%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 14.5%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;254&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.34%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 13.4%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;262&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 65.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;General and administrative&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.72%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.5%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;285&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; width: 2.34%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2.22%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 13.4%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;215&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.2in; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 65.8%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Total stock-based compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.72%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.5%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;539&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; width: 2.34%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2.22%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 13.4%; height: 0.2in; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;477&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c182_From1Jan2018To31Dec2018_ResearchAndDevelopmentExpenseMember" decimals="-3">254000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c183_From1Jan2017To31Dec2017_ResearchAndDevelopmentExpenseMember" decimals="-3">262000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c184_From1Jan2018To31Dec2018_GeneralAndAdministrativeExpenseMember" decimals="-3">285000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c185_From1Jan2017To31Dec2017_GeneralAndAdministrativeExpenseMember" decimals="-3">215000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">539000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">477000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:24pt 0in 12pt&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;13.&amp;#xa0;&amp;#xa0;Income Taxes&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The provision for income taxes consists of the following for the years ended December&amp;#xa0;31, 2018 and 2017:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 34.06%; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16.5%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 15.3%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 34.06%; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(In thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Current:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Federal&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;State&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Foreign&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;106&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 37pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 20pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;109&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 37pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Federal&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;State&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Foreign&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 37pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 37pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 30pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Provision for income taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;109&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The components of the deferred tax assets as of December&amp;#xa0;31, 2018 and 2017, are as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31, 2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31, 2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred tax assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(In thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net operating loss carry-forwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;43,822&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;19,441&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Research and development tax credits&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;3,357&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,979&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Capitalized research and development&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,326&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Sale of future royalties&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8,383&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accruals, reserves and other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;714&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;544&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total deferred tax assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;58,602&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;22,964&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(48,626)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(22,964)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred tax assets net of valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;9,976&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred tax liabilities:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Intangible assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(9,976)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total deferred tax liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(9,976)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 22.85pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net deferred tax assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;A reconciliation of the provision for income taxes with the expected provision for income taxes computed by applying the federal statutory income tax rate of 21% and 34% to the net loss before provision for income taxes for the years ended December&amp;#xa0;31, 2018 and 2017, respectively:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;U.S. federal taxes at statutory rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;21.0&amp;#xa0; %&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;34.0 %&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 17.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;State taxes (net of federal benefit)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 8.65pt 0in 0in; width: 12%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;0.6&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 8.65pt 0in 0in; width: 12%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;14.2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Foreign rate differential&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;3.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Global intangible low-taxed income&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(8.8)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Permanent items:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible note interest&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(0.4)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(10.8)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Revaluation of derivative liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;11.9&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Others&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2.1)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(1.4)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Tax credits&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8.0&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Change in valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(20.4)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;43.4&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Impact of tax reform rate change&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(97.0)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;NOL and credit adjustments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(3.8)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2.4)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Bargain purchase gain&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;0.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 20pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Provision for income taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(0.6)%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; text-align: right; text-indent: -0.25in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;font style=&quot;font: 7pt/normal &apos;Times New Roman&apos;; font-size-adjust: none; font-stretch: normal;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;The Company&amp;#x2019;s actual tax expense differed from the statutory federal income tax expense using a tax rate of 21% for the year ended December 31, 2018, primarily due to, state and foreign income taxes, nondeductible expenses, research and development tax credits, and the change in valuation allowance. The Company&amp;#x2019;s actual tax expense differed from the statutory federal income tax expense using a tax rate of 21% for the year ended December 31, 2017, primarily due to remeasurement of deferred taxes due to change in federal tax rate under the Tax Cuts and Jobs Act (the &quot;TCJA&quot;), state income taxes, nondeductible expenses, research and development tax credits, and the change in valuation allowance.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;On December 22, 2017, the TCJA was signed into law. The TCJA decreased the U.S. corporate federal income tax rate from 35% to 21% effective January 1, 2018. The TCJA also includes a number of other provisions including the elimination of loss carrybacks and limitations on the use of future losses, repeal of the Alternative Minimum Tax regime, and the introduction of a base erosion, anti-abuse tax and 100% expense allowance for certain properties. These provisions are not expected to have immediate effect on the Company.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;The key impact of the TCJA on the Company&amp;#x2019;s financial statements was the re-measurement of the deferred tax balances to the new corporate tax rate in the year ended December 31, 2017. U.S. GAAP requires the re-measurement of the Company&amp;#x2019;s deferred tax balances as of the enactment date of the TCJA, based on the rates at which the balances are expected to reverse in the future. The TCJA reduced the corporate tax rate to 21%, effective January 1, 2018. The Company recorded a decrease in its deferred tax assets of $4.2 million with a corresponding reduction to its valuation allowance of $4.2 million for the year ending December 31, 2017, primarily related to the impact of the TCJA.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;As of December 31, 2018 and 2017, the Company had a net operating loss (&amp;#x201c;NOL&amp;#x201d;) carryforwards of $92.3 million and $69.5 million for federal purposes, and $76.9 million and $75.0 million for state purposes, respectively. If not utilized, these carryforwards will begin to expire in 2024 for federal, and 2028 for state purposes.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;As of December 31, 2018, the Company also has accumulated tax losses of $14.4 million for Australia, $24.7 million for the United Kingdom and $37.7 million for France available for carry forward against future earnings, which under relevant tax laws do not expire but may not be available under certain circumstances. As of December 31, 2018, the Company&amp;#x2019;s foreign subsidiaries have no positive accumulated earnings. As such, no federal or state income taxes have been provided on the losses of its foreign subsidiaries. If in the future there are positive earnings generated from the Company&amp;#x2019;s foreign subsidiaries, the Company will evaluate whether to record any applicable federal and state income taxes on such earnings.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;As of December 31, 2018 and 2017, the Company had federal research and development tax credit carryforwards of $3.0 million and $2.7 million, respectively and state research and development tax credit carryforwards of $2.3 million and $2.0 million, respectively, before offset for unrecognized tax benefits, to offset future income tax liabilities. The federal research and development tax credits will start to expire in 2027, if not utilized, while the state research and development tax credit can be carried forward indefinitely.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Sections 382 and 383 of the Internal Revenue Code provides for a limitation on the annual use of NOL and research and development tax credit carryforwards following certain ownership changes that could limit the Company&amp;#8217;s ability to utilize these carryforwards. The Company&amp;#8217;s losses and credit carryforwards may be subject to these limitations. The Company has not performed an analysis to determine if such ownership changes have occurred. An analysis will be performed prior to recognizing the benefits of any losses or credits in the financial statements&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;The Company is required to reduce its deferred tax assets by a valuation allowance if it is more likely than not that some or all of its deferred tax assets will not be realized. Management must use judgment in assessing the potential need for a valuation allowance, which requires an evaluation of both negative and positive evidence. The weight given to the potential effect of negative and positive evidence should be commensurate with the extent to which it can be objectively verified. In determining the need for and amount of the valuation allowance, if any, the Company assesses the likelihood that it will be able to recover its deferred tax assets using historical levels of income, estimates of future income and tax planning strategies. As a result of historical cumulative losses, the Company determined that, based on all available evidence, there was substantial uncertainty as to whether it will recover recorded net deferred taxes in future periods. Accordingly, the Company recorded a valuation allowance against all of its net deferred tax assets as of December 31, 2018 and 2017. The net change in total valuation allowance was an increase of approximately $25.7 million for the year ended December 31, 2018&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 31.14%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.4%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 14.58%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 31.14%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Beginning Balance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.32%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,404&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,231&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Additions based on tax positions related to the current year&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.32%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;181&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;173&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Decreases related to prior years&amp;#x2019; tax positions&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.32%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(3)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.32%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.2in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 68.86%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Ending Balance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.32%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.08%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,582&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.86%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.72%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,404&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The Company&amp;#8217;s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. During the year ended December 31, 2017 and 2018, the Company recognized no interest and penalties associated with unrecognized tax benefits. There are no tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within twelve months of the reporting date.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The Company files income tax returns in the U.S, Australia, France and the United Kingdom, as well as with various U.S. states. The Company is subject to tax audits in all jurisdictions in which it files income tax returns. Tax audits by their very nature are often complex and can require several years to complete. There are currently no tax audits that have commenced with respect to income tax returns in any jurisdiction.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Under the tax statute of limitations applicable to the Internal Revenue Code, the Company and its U.S. subsidiary, either standalone or as part of the consolidated group, is no longer subject to U.S. federal income tax examinations by the Internal Revenue Service for tax years before tax year 2016. Under the statute of limitations applicable to most state income tax laws, the Company is no longer subject to state income tax examinations by tax authorities for tax years before 2015 in states in which it has filed income tax returns. However, because the Company is carrying forward income tax attributes, such as net operating losses and tax credits from 2004 and earlier tax years, these attributes can still be audited when utilized on returns filed in the future. The Company is subject to foreign tax examinations by tax authorities for fiscal year 2014 and forward&lt;/font&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationDeductions unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="2">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationDeductions>
  <us-gaap:EffectiveIncomeTaxRateReconciliationDeductions unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="2">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationDeductions>
  <vxrt:IncreaseDecreaseInDeferredTaxes unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-5">4200000</vxrt:IncreaseDecreaseInDeferredTaxes>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-5">4200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c186_AsOf31Dec2018_DomesticCountryMember" decimals="-5">92300000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c187_AsOf31Dec2017_DomesticCountryMember" decimals="-5">69500000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c188_AsOf31Dec2018_StateAndLocalJurisdictionMember" decimals="-5">76900000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c189_AsOf31Dec2017_StateAndLocalJurisdictionMember" decimals="-5">75000000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:TaxCreditCarryforwardAmount unitRef="usd" contextRef="c190_AsOf31Dec2018_AU" decimals="-5">14400000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:TaxCreditCarryforwardAmount unitRef="usd" contextRef="c191_AsOf31Dec2018_GB" decimals="-5">24700000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:TaxCreditCarryforwardAmount unitRef="usd" contextRef="c192_AsOf31Dec2018_FR" decimals="-5">37700000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:TaxCreditCarryforwardAmount unitRef="usd" contextRef="c186_AsOf31Dec2018_DomesticCountryMember" decimals="-5">3000000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:TaxCreditCarryforwardAmount unitRef="usd" contextRef="c187_AsOf31Dec2017_DomesticCountryMember" decimals="-5">2700000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:TaxCreditCarryforwardAmount unitRef="usd" contextRef="c188_AsOf31Dec2018_StateAndLocalJurisdictionMember" decimals="-5">2300000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:TaxCreditCarryforwardAmount unitRef="usd" contextRef="c189_AsOf31Dec2017_StateAndLocalJurisdictionMember" decimals="-5">2000000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-5">25700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 34.06%; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16.5%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 15.3%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 34.06%; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(In thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Current:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Federal&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;State&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Foreign&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;106&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 37pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 20pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;109&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 37pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Federal&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;State&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Foreign&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 37pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 37pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 30pt; width: 65.94%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; page-break-after: avoid;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Provision for income taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;109&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; page-break-after: avoid;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
  <us-gaap:CurrentFederalTaxExpenseBenefit unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:CurrentFederalTaxExpenseBenefit unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">3000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:CurrentForeignTaxExpenseBenefit unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">106000</us-gaap:CurrentForeignTaxExpenseBenefit>
  <us-gaap:CurrentForeignTaxExpenseBenefit unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:CurrentIncomeTaxExpenseBenefit unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">109000</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:DeferredIncomeTaxExpenseBenefit unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:DeferredIncomeTaxExpenseBenefit unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31, 2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;December&amp;#xa0;31, 2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred tax assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;top&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(In thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net operating loss carry-forwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;43,822&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;19,441&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Research and development tax credits&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;3,357&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,979&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Capitalized research and development&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,326&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Sale of future royalties&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8,383&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Accruals, reserves and other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;714&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;544&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total deferred tax assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;58,602&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;22,964&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(48,626)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(22,964)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 20pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred tax assets net of valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;9,976&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Deferred tax liabilities:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Intangible assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(9,976)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total deferred tax liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(9,976)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 22.85pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net deferred tax assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">43822000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">19441000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">3357000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">2979000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">2326000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
  <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <vxrt:DeferredTaxAssetsSaleOfFutureRoyalties unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">8383000</vxrt:DeferredTaxAssetsSaleOfFutureRoyalties>
  <vxrt:DeferredTaxAssetsSaleOfFutureRoyalties unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">714000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">544000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
  <us-gaap:DeferredTaxAssetsGross unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">58602000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">22964000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">48626000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">22964000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsNet unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">9976000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsNet unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">9976000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
  <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:DeferredTaxLiabilities unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">9976000</us-gaap:DeferredTaxLiabilities>
  <us-gaap:DeferredTaxLiabilities unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet unitRef="usd" contextRef="c0_AsOf31Dec2018" xs:nil="true"/>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet unitRef="usd" contextRef="c1_AsOf31Dec2017" xs:nil="true"/>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;U.S. federal taxes at statutory rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;21.0&amp;#xa0; %&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;34.0 %&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 17.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;State taxes (net of federal benefit)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 8.65pt 0in 0in; width: 12%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;0.6&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 8.65pt 0in 0in; width: 12%; height: 17.1pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;14.2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Foreign rate differential&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;3.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Global intangible low-taxed income&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(8.8)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Permanent items:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible note interest&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(0.4)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(10.8)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Revaluation of derivative liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;11.9&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 10pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Others&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2.1)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(1.4)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Tax credits&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8.0&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Change in valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(20.4)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;43.4&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Impact of tax reform rate change&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(97.0)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;NOL and credit adjustments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(3.8)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.75pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2.4)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Bargain purchase gain&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;8.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 8.65pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;0.1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 20pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Provision for income taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(0.6)%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 0.5in; text-align: right; text-indent: -0.25in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;font style=&quot;font: 7pt/normal &apos;Times New Roman&apos;; font-size-adjust: none; font-stretch: normal;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">0.340</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">0.142</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">0.031</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
  <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">-0.088</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <vxrt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">-0.004</vxrt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest>
  <vxrt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">-0.108</vxrt:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">0.119</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">-0.021</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">0.080</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">-0.204</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">0.434</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">-0.970</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">-0.038</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <vxrt:EffectiveIncomeTaxRateReconciliationBargainPurchaseGain unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">0.081</vxrt:EffectiveIncomeTaxRateReconciliationBargainPurchaseGain>
  <vxrt:EffectiveIncomeTaxRateReconciliationBargainPurchaseGain unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" xs:nil="true"/>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" decimals="3">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c8_From1Jan2018To31Dec2018" decimals="3">-0.006</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 31.14%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.4%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 14.58%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 31.14%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Beginning Balance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.32%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,404&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,231&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Additions based on tax positions related to the current year&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.32%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;181&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;173&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Decreases related to prior years&amp;#x2019; tax positions&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.32%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(3)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in; width: 68.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 24pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.32%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12.08%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2.86%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 11.72%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 0.2in;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 68.86%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Ending Balance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.32%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.08%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,582&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.86%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.72%; height: 0.2in;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,404&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
  <us-gaap:UnrecognizedTaxBenefits unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="-3">1404000</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:UnrecognizedTaxBenefits unitRef="usd" contextRef="c14_AsOf31Dec2016" decimals="-3">1231000</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">181000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
  <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">173000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
  <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">3000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
  <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" xs:nil="true"/>
  <us-gaap:UnrecognizedTaxBenefits unitRef="usd" contextRef="c0_AsOf31Dec2018" decimals="-3">1582000</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:EarningsPerShareTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;NOTE 14.&amp;#xa0;&amp;#xa0;Net Loss Per Share Attributable to Common Stockholders&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;The &lt;font style=&quot;COLOR:black&quot;&gt;f&lt;/font&gt;ollowing table presents the calculation of basic and diluted net loss per share (in thousands, except share and per share amounts):&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; border=&quot;1&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 10.05pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 10.05pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 10.05pt; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.3pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.3pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.3pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2%; height: 9.3pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 12%; height: 9.3pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.3pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.3pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.3pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.3pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.3pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(18,007)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(9,582)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Series B and C preferred dividend&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in -0.5pt 0pt 0in; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(339)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2,878)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net loss attributable to common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(18,346)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(12,460)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Shares used to compute net loss per share, basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6,316,065&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;135,953&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18.9pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 18.9pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 18.9pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 18.9pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2.90)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 18.9pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 2%; height: 18.9pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 12%; height: 18.9pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(91.65)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 12pt 0in;&quot;&gt;&lt;font style=&quot;font-size: 10pt; color: black;&quot;&gt;No adjustment has been made to the net loss &lt;/font&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;attributable to common stockholders &lt;font style=&quot;color: black;&quot;&gt;as the effect would be anti-dilutive due to the net loss. &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt; COLOR:black&quot;&gt;The following potentially dilutive securities were excluded from the computation of diluted weighted average shares outstanding because they would have been antidilutive:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; border=&quot;1&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 30.86%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.9%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 13.8%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Options to purchase common stock &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;839,396&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;295,243&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Warrant to purchase common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;9,658&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Warrant to purchase convertible preferred stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;891&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;7,563&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Series B and C convertible preferred stock outstanding, &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0;&amp;#xa0; including cumulative dividends&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;213,760&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,567,172&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Series A convertible preferred stock outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;12,260&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;94,988&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible promissory notes, related party (as converted)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;185,159&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;754,289&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total potentially dilutive securities excluded from &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0; denominator of the diluted earnings per share computation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,261,124&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,719,255&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; border=&quot;1&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 10.05pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 10.05pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 10.05pt; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.3pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.3pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.3pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2%; height: 9.3pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 12%; height: 9.3pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.3pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.3pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.3pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.3pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.3pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(18,007)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(9,582)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Series B and C preferred dividend&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in -0.5pt 0pt 0in; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(339)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2,878)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net loss attributable to common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(18,346)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(12,460)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Shares used to compute net loss per share, basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;6,316,065&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;135,953&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 9.1pt;&quot;&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 18.9pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 18.9pt; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 18.9pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 18.9pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(2.90)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 18.9pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 2%; height: 18.9pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 12%; height: 18.9pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;(91.65)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:PreferredStockDividendsAndOtherAdjustments unitRef="usd" contextRef="c8_From1Jan2018To31Dec2018" decimals="-3">339000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
  <us-gaap:PreferredStockDividendsAndOtherAdjustments unitRef="usd" contextRef="c9_From1Jan2017To31Dec2017" decimals="-3">2878000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; border=&quot;1&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 30.86%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended&amp;#xa0;December&amp;#xa0;31,&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.9%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 13.8%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Options to purchase common stock &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;839,396&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;295,243&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Warrant to purchase common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;9,658&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Warrant to purchase convertible preferred stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;891&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;7,563&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Series B and C convertible preferred stock outstanding, &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0;&amp;#xa0; including cumulative dividends&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;213,760&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,567,172&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Series A convertible preferred stock outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;12,260&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;94,988&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Convertible promissory notes, related party (as converted)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;185,159&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;754,289&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;Total potentially dilutive securities excluded from &lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;&amp;#xa0; denominator of the diluted earnings per share computation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.66%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;1,261,124&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 14.04%;&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;font-size: 10pt;&quot;&gt;2,719,255&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c193_From1Jan2018To31Dec2018_EmployeeStockOptionMember" decimals="INF">839396</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c194_From1Jan2017To31Dec2017_EmployeeStockOptionMember" decimals="INF">295243</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c195_From1Jan2018To31Dec2018_WarrantMember_CommonStockMember" decimals="INF">9658</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c196_From1Jan2017To31Dec2017_WarrantMember_CommonStockMember" xs:nil="true"/>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c197_From1Jan2018To31Dec2018_WarrantMember_ConvertiblePreferredStockMember" decimals="INF">891</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c198_From1Jan2017To31Dec2017_WarrantMember_ConvertiblePreferredStockMember" decimals="INF">7563</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c199_From1Jan2018To31Dec2018_CumulativeConvertiblePreferredStockDividendsMember_SeriesBAndCPreferredStockMember" decimals="INF">213760</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c200_From1Jan2017To31Dec2017_CumulativeConvertiblePreferredStockDividendsMember_SeriesBAndCPreferredStockMember" decimals="INF">1567172</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c201_From1Jan2018To31Dec2018_ConvertiblePreferredStockOutstandingMember_SeriesAPreferredStockMember" decimals="INF">12260</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c202_From1Jan2017To31Dec2017_ConvertiblePreferredStockOutstandingMember_SeriesAPreferredStockMember" decimals="INF">94988</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c203_From1Jan2018To31Dec2018_ConvertiblePromissoryNotesRelatedPartyMember" decimals="INF">185159</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c204_From1Jan2017To31Dec2017_ConvertiblePromissoryNotesRelatedPartyMember" decimals="INF">754289</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c8_From1Jan2018To31Dec2018" decimals="INF">1261124</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c9_From1Jan2017To31Dec2017" decimals="INF">2719255</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:24pt 0in 12pt&quot;&gt;&lt;b&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;NOTE&amp;#xa0;15.&amp;#xa0;&amp;#xa0;Quarterly Financial Data (Unaudited)&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;FONT-SIZE:10pt&quot;&gt;Selected summarized quarterly financial information for fiscal 2018 and 2017 is as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.52%; white-space: nowrap;&quot; colspan=&quot;11&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended December&amp;#xa0;31,&amp;#xa0;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;First&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.48%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Second&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Third&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.38%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Fourth&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Revenue&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,503&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;608&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;281&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,767&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Operating expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;5,418&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;8,383&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;6,161&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;5,953&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net income (loss)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,314&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(8,871)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(6,548)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(4,902)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net income (loss) attributable to common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,975&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(8,871)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(6,548)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(4,902)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net income (loss) per share &amp;#x2013; basic&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;0.54&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(1.24)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(0.92)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(0.69)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net income (loss) per share &amp;#x2013; diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;0.49&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(1.24)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(0.92)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(0.69)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.52%; white-space: nowrap;&quot; colspan=&quot;11&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year Ended December 31, 2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;First&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.48%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Second&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Third&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.36%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Fourth&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Revenue&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,310&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,854&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;915&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;760&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Operating expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;4,557&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;4,977&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,871&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;3,449&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(2,796)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(3,538)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(2,173)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(1,075)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net loss attributable to common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(3,506)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(4,256)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(2,898)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(1,800)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net loss per share &amp;#x2013; basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(25.84)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(31.37)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(21.36)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(13.16)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="c8_From1Jan2018To31Dec2018">&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.52%; white-space: nowrap;&quot; colspan=&quot;11&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year&amp;#xa0;Ended December&amp;#xa0;31,&amp;#xa0;2018&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;First&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.48%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Second&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Third&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.38%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: center;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Fourth&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Revenue&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,503&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;608&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;281&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,767&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Operating expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;5,418&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;8,383&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;6,161&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;5,953&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net income (loss)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,314&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(8,871)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(6,548)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(4,902)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net income (loss) attributable to common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,975&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(8,871)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(6,548)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(4,902)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net income (loss) per share &amp;#x2013; basic&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;0.54&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(1.24)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(0.92)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(0.69)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net income (loss) per share &amp;#x2013; diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;0.49&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(1.24)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(0.92)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt; text-align: left;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: right;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(0.69)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;800&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.52%; white-space: nowrap;&quot; colspan=&quot;11&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Year Ended December 31, 2017&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;First&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.48%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Second&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Third&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.36%; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&lt;strong&gt;&lt;font style=&quot;font-size: 8pt;&quot;&gt;Fourth&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Revenue&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,310&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;1,854&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;915&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;760&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Operating expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;4,557&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;4,977&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;2,871&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.05in 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;3,449&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(2,796)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(3,538)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(2,173)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(1,075)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net loss attributable to common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(3,506)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(4,256)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(2,898)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(1,800)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 41.48%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;Net loss per share &amp;#x2013; basic and diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(25.84)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(31.37)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(21.36)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: left; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 10pt;&quot;&gt;$&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black; font-size: 10pt;&quot;&gt;(13.16)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
  <us-gaap:Revenues unitRef="usd" contextRef="c205_From1Jan2018To31Mar2018" decimals="-3">1503000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c93_From1Apr2018To30Jun2018" decimals="-3">608000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c206_From1Jul2018To30Sep2018" decimals="-3">281000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c142_From1Oct2018To31Dec2018" decimals="-3">1767000</us-gaap:Revenues>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c205_From1Jan2018To31Mar2018" decimals="-3">5418000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c93_From1Apr2018To30Jun2018" decimals="-3">8383000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c206_From1Jul2018To30Sep2018" decimals="-3">6161000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c142_From1Oct2018To31Dec2018" decimals="-3">5953000</us-gaap:OperatingExpenses>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c205_From1Jan2018To31Mar2018" decimals="-3">2314000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c93_From1Apr2018To30Jun2018" decimals="-3">-8871000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c206_From1Jul2018To30Sep2018" decimals="-3">-6548000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c142_From1Oct2018To31Dec2018" decimals="-3">-4902000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c205_From1Jan2018To31Mar2018" decimals="-3">1975000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c93_From1Apr2018To30Jun2018" decimals="-3">-8871000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c206_From1Jul2018To30Sep2018" decimals="-3">-6548000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c142_From1Oct2018To31Dec2018" decimals="-3">-4902000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c205_From1Jan2018To31Mar2018" decimals="2">0.54</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c93_From1Apr2018To30Jun2018" decimals="2">-1.24</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c206_From1Jul2018To30Sep2018" decimals="2">-0.92</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c142_From1Oct2018To31Dec2018" decimals="2">-0.69</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted unitRef="usdPershares" contextRef="c205_From1Jan2018To31Mar2018" decimals="2">0.49</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted unitRef="usdPershares" contextRef="c93_From1Apr2018To30Jun2018" decimals="2">-1.24</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted unitRef="usdPershares" contextRef="c206_From1Jul2018To30Sep2018" decimals="2">-0.92</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted unitRef="usdPershares" contextRef="c142_From1Oct2018To31Dec2018" decimals="2">-0.69</us-gaap:EarningsPerShareDiluted>
  <us-gaap:Revenues unitRef="usd" contextRef="c207_From1Jan2017To31Mar2017" decimals="-3">2310000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c208_From1Apr2017To30Jun2017" decimals="-3">1854000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c209_From1Jul2017To30Sep2017" decimals="-3">915000</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c210_From1Oct2017To31Dec2017" decimals="-3">760000</us-gaap:Revenues>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c207_From1Jan2017To31Mar2017" decimals="-3">4557000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c208_From1Apr2017To30Jun2017" decimals="-3">4977000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c209_From1Jul2017To30Sep2017" decimals="-3">2871000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c210_From1Oct2017To31Dec2017" decimals="-3">3449000</us-gaap:OperatingExpenses>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c207_From1Jan2017To31Mar2017" decimals="-3">-2796000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c208_From1Apr2017To30Jun2017" decimals="-3">-3538000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c209_From1Jul2017To30Sep2017" decimals="-3">-2173000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c210_From1Oct2017To31Dec2017" decimals="-3">-1075000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c207_From1Jan2017To31Mar2017" decimals="-3">-3506000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c208_From1Apr2017To30Jun2017" decimals="-3">-4256000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c209_From1Jul2017To30Sep2017" decimals="-3">-2898000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic unitRef="usd" contextRef="c210_From1Oct2017To31Dec2017" decimals="-3">-1800000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c207_From1Jan2017To31Mar2017" decimals="2">-25.84</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c208_From1Apr2017To30Jun2017" decimals="2">-31.37</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c209_From1Jul2017To30Sep2017" decimals="2">-21.36</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c210_From1Oct2017To31Dec2017" decimals="2">-13.16</us-gaap:EarningsPerShareBasicAndDiluted>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>29
<FILENAME>vxrt-20181231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Feb 06 15:31:57 EST 2019 -->
<xs:schema xmlns:vxrt="http://www.vaxart.com/20181231" elementFormDefault="qualified" xmlns:num="http://www.xbrl.org/dtr/type/numeric" targetNamespace="http://www.vaxart.com/20181231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="vxrt-20181231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="vxrt-20181231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="vxrt-20181231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="vxrt-20181231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.vaxart.com/role/ConsolidatedBalanceSheet" id="vxrt_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ConsolidatedBalanceSheet_Parentheticals" id="vxrt_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ConsolidatedIncomeStatement" id="vxrt_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ShareholdersEquityType2or3" id="vxrt_r_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - Consolidated Statements of Stockholders` Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ConsolidatedCashFlow" id="vxrt_r_ConsolidatedCashFlow">
        <link:definition>005 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/OrganizationandBasisofPresentation" id="vxrt_r_OrganizationandBasisofPresentation">
        <link:definition>006 - Disclosure - Organization and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/SummaryofSignificantAccountingPolicies" id="vxrt_r_SummaryofSignificantAccountingPolicies">
        <link:definition>007 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/BusinessCombination" id="vxrt_r_BusinessCombination">
        <link:definition>008 - Disclosure - Business Combination</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/FairValueofFinancialInstruments" id="vxrt_r_FairValueofFinancialInstruments">
        <link:definition>009 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/BalanceSheetComponents" id="vxrt_r_BalanceSheetComponents">
        <link:definition>010 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/Revenue" id="vxrt_r_Revenue">
        <link:definition>011 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyalties" id="vxrt_r_LiabilitiesRelatedtoSaleofFutureRoyalties">
        <link:definition>012 - Disclosure - Liabilities Related to Sale of Future Royalties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedParties" id="vxrt_r_ConvertiblePromissoryNotesRelatedParties">
        <link:definition>013 - Disclosure - Convertible Promissory Notes, Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinance" id="vxrt_r_SecuredPromissoryNotePayabletoOxfordFinance">
        <link:definition>014 - Disclosure - Secured Promissory Note Payable to Oxford Finance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/CommitmentsandContingencies" id="vxrt_r_CommitmentsandContingencies">
        <link:definition>015 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/StockholdersEquity" id="vxrt_r_StockholdersEquity">
        <link:definition>016 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/EquityIncentivePlans" id="vxrt_r_EquityIncentivePlans">
        <link:definition>017 - Disclosure - Equity Incentive Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/IncomeTaxes" id="vxrt_r_IncomeTaxes">
        <link:definition>018 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholders" id="vxrt_r_NetLossPerShareAttributabletoCommonStockholders">
        <link:definition>019 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/QuarterlyFinancialDataUnaudited" id="vxrt_r_QuarterlyFinancialDataUnaudited">
        <link:definition>020 - Disclosure - Quarterly Financial Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/AccountingPoliciesByPolicy" id="vxrt_r_AccountingPoliciesByPolicy">
        <link:definition>021 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesTables" id="vxrt_r_SummaryofSignificantAccountingPoliciesTables">
        <link:definition>022 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/BusinessCombinationTables" id="vxrt_r_BusinessCombinationTables">
        <link:definition>023 - Disclosure - Business Combination (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/FairValueofFinancialInstrumentsTables" id="vxrt_r_FairValueofFinancialInstrumentsTables">
        <link:definition>024 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/BalanceSheetComponentsTables" id="vxrt_r_BalanceSheetComponentsTables">
        <link:definition>025 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesTables" id="vxrt_r_LiabilitiesRelatedtoSaleofFutureRoyaltiesTables">
        <link:definition>026 - Disclosure - Liabilities Related to Sale of Future Royalties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/CommitmentsandContingenciesTables" id="vxrt_r_CommitmentsandContingenciesTables">
        <link:definition>027 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/StockholdersEquityTables" id="vxrt_r_StockholdersEquityTables">
        <link:definition>028 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/EquityIncentivePlansTables" id="vxrt_r_EquityIncentivePlansTables">
        <link:definition>029 - Disclosure - Equity Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/IncomeTaxesTables" id="vxrt_r_IncomeTaxesTables">
        <link:definition>030 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" id="vxrt_r_NetLossPerShareAttributabletoCommonStockholdersTables">
        <link:definition>031 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/QuarterlyFinancialDataUnauditedTables" id="vxrt_r_QuarterlyFinancialDataUnauditedTables">
        <link:definition>032 - Disclosure - Quarterly Financial Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/OrganizationandBasisofPresentationDetails" id="vxrt_r_OrganizationandBasisofPresentationDetails">
        <link:definition>033 - Disclosure - Organization and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesDetails" id="vxrt_r_SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>034 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/EstimatedUsefulLivesTable" id="vxrt_r_EstimatedUsefulLivesTable">
        <link:definition>035 - Disclosure - Summary of Significant Accounting Policies (Details) - Estimated Useful Lives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/BusinessCombinationDetails" id="vxrt_r_BusinessCombinationDetails">
        <link:definition>036 - Disclosure - Business Combination (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/TotalpurchasepriceforAviragenTable" id="vxrt_r_TotalpurchasepriceforAviragenTable">
        <link:definition>037 - Disclosure - Business Combination (Details) - Total purchase price for Aviragen</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" id="vxrt_r_AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable">
        <link:definition>038 - Disclosure - Business Combination (Details) - Allocation of the purchase price to the fair value of the respective assets and liabilities acquired</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/SelectedamountsrelatedtoAviragensbusinessincludedintheCompanysconsolidatedstatementofoperationsTable" id="vxrt_r_SelectedamountsrelatedtoAviragensbusinessincludedintheCompanysconsolidatedstatementofoperationsTable">
        <link:definition>039 - Disclosure - Business Combination (Details) - Selected amounts related to Aviragen's business included in the Company's consolidated statement of operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/UnauditedproformainformationissummarizedTable" id="vxrt_r_UnauditedproformainformationissummarizedTable">
        <link:definition>040 - Disclosure - Business Combination (Details) - Unaudited pro forma information is summarized</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/CompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" id="vxrt_r_CompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable">
        <link:definition>041 - Disclosure - Fair Value of Financial Instruments (Details) - Company's financial assets and liabilities measured at fair value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/AreconciliationofallliabilitiesmeasuredatfairvalueonarecurringbasisusingsignificantunobservableinputsLevel3Table" id="vxrt_r_AreconciliationofallliabilitiesmeasuredatfairvalueonarecurringbasisusingsignificantunobservableinputsLevel3Table">
        <link:definition>042 - Disclosure - Fair Value of Financial Instruments (Details) - A reconciliation of all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/BalanceSheetComponentsDetails" id="vxrt_r_BalanceSheetComponentsDetails">
        <link:definition>043 - Disclosure - Balance Sheet Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/CashequivalentsandshortterminvestmentsTable" id="vxrt_r_CashequivalentsandshortterminvestmentsTable">
        <link:definition>044 - Disclosure - Balance Sheet Components (Details) - Cash equivalents and short-term investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/AccountsreceivablenetofallowanceTable" id="vxrt_r_AccountsreceivablenetofallowanceTable">
        <link:definition>045 - Disclosure - Balance Sheet Components (Details) - Accounts receivable net of allowance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/PropertyandequipmentnetTable" id="vxrt_r_PropertyandequipmentnetTable">
        <link:definition>046 - Disclosure - Balance Sheet Components (Details) - Property and equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/IntangibleassetsTable" id="vxrt_r_IntangibleassetsTable">
        <link:definition>047 - Disclosure - Balance Sheet Components (Details) - Intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/TheestimatedfutureamortizationexpensebyyearTable" id="vxrt_r_TheestimatedfutureamortizationexpensebyyearTable">
        <link:definition>048 - Disclosure - Balance Sheet Components (Details) - The estimated future amortization expense by year</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/AccruedliabilitiesTable" id="vxrt_r_AccruedliabilitiesTable">
        <link:definition>049 - Disclosure - Balance Sheet Components (Details) - Accrued liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/RevenueDetails" id="vxrt_r_RevenueDetails">
        <link:definition>050 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZi7YfzVIAspPbJuDylcYRVpSzHijjkNCYpD7o9WcfUwu/9uo1X+/k4jp6oPRfpgx2gurzW//2t+l3nLsqChCk2dbDArpcIr4CikQhf0AXguBDQTnCrO4B9rKkWv2LsFu37D0Y4AbkakUxzj2n1wrriMaMV3XPp8CEP] CSR-->
      <link:roleType roleURI="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesDetails" id="vxrt_r_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetails">
        <link:definition>051 - Disclosure - Liabilities Related to Sale of Future Royalties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/LiabilityrelatedtosaleoffutureRoyaltiesTable" id="vxrt_r_LiabilityrelatedtosaleoffutureRoyaltiesTable">
        <link:definition>052 - Disclosure - Liabilities Related to Sale of Future Royalties (Details) - Liability related to sale of future Royalties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedPartiesDetails" id="vxrt_r_ConvertiblePromissoryNotesRelatedPartiesDetails">
        <link:definition>053 - Disclosure - Convertible Promissory Notes, Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinanceDetails" id="vxrt_r_SecuredPromissoryNotePayabletoOxfordFinanceDetails">
        <link:definition>054 - Disclosure - Secured Promissory Note Payable to Oxford Finance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/CommitmentsandContingenciesDetails" id="vxrt_r_CommitmentsandContingenciesDetails">
        <link:definition>055 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/LiabilitiesrelatedtocostsofexitfromleasedpremisesTable" id="vxrt_r_LiabilitiesrelatedtocostsofexitfromleasedpremisesTable">
        <link:definition>056 - Disclosure - Commitments and Contingencies (Details) - Liabilities related to costs of exit from leased premises</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable" id="vxrt_r_FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable">
        <link:definition>057 - Disclosure - Commitments and Contingencies (Details) - Future minimum payments and sublease income under operating leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/StockholdersEquityDetails" id="vxrt_r_StockholdersEquityDetails">
        <link:definition>058 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ConvertiblepreferredstockTable" id="vxrt_r_ConvertiblepreferredstockTable">
        <link:definition>059 - Disclosure - Stockholders' Equity (Details) - Convertible preferred stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/CommonstockreservedforissuanceTable" id="vxrt_r_CommonstockreservedforissuanceTable">
        <link:definition>060 - Disclosure - Stockholders' Equity (Details) - Common stock reserved for issuance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/EquityIncentivePlansDetails" id="vxrt_r_EquityIncentivePlansDetails">
        <link:definition>061 - Disclosure - Equity Incentive Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/SummaryofstockoptionTable" id="vxrt_r_SummaryofstockoptionTable">
        <link:definition>062 - Disclosure - Equity Incentive Plans (Details) - Summary of stock option</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/FairvaluesestimatedassumptionsTable" id="vxrt_r_FairvaluesestimatedassumptionsTable">
        <link:definition>063 - Disclosure - Equity Incentive Plans (Details) - Fair values estimated assumptions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/TotalstockbasedcompensationrecognizedforoptionsTable" id="vxrt_r_TotalstockbasedcompensationrecognizedforoptionsTable">
        <link:definition>064 - Disclosure - Equity Incentive Plans (Details) - Total stock-based compensation recognized for options</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/IncomeTaxesDetails" id="vxrt_r_IncomeTaxesDetails">
        <link:definition>065 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ComponentsofincometaxesTable" id="vxrt_r_ComponentsofincometaxesTable">
        <link:definition>066 - Disclosure - Income Taxes (Details) - Components of income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ComponentsofthedeferredtaxassetsTable" id="vxrt_r_ComponentsofthedeferredtaxassetsTable">
        <link:definition>067 - Disclosure - Income Taxes (Details) - Components of the deferred tax assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ReconciliationoftheprovisionforincometaxesTable" id="vxrt_r_ReconciliationoftheprovisionforincometaxesTable">
        <link:definition>068 - Disclosure - Income Taxes (Details) - Reconciliation of the provision for income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/ReconciliationoftheunrecognizedtaxbenefitsTable" id="vxrt_r_ReconciliationoftheunrecognizedtaxbenefitsTable">
        <link:definition>069 - Disclosure - Income Taxes (Details) - Reconciliation of the unrecognized tax benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/CalculationofbasicanddilutednetlosspershareTable" id="vxrt_r_CalculationofbasicanddilutednetlosspershareTable">
        <link:definition>070 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Calculation of basic and diluted net loss per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/PotentiallydilutivesecuritiesexcludedfromthecomputationofdilutedweightedaveragesharesTable" id="vxrt_r_PotentiallydilutivesecuritiesexcludedfromthecomputationofdilutedweightedaveragesharesTable">
        <link:definition>071 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Potentially dilutive securities excluded from the computation of diluted weighted average shares</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/SelectedsummarizedquarterlyfinancialTable" id="vxrt_r_SelectedsummarizedquarterlyfinancialTable">
        <link:definition>072 - Disclosure -  Quarterly Financial Data (Unaudited) (Details) - Selected summarized quarterly financial</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vaxart.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="EstimatedUsefulLivesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_EstimatedUsefulLivesAbstract"/>
  <xs:element name="TotalPurchasePriceForAviragenAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_TotalPurchasePriceForAviragenAbstract"/>
  <xs:element name="AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract"/>
  <xs:element name="SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract"/>
  <xs:element name="UnauditedProFormaInformationIsSummarizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_UnauditedProFormaInformationIsSummarizedAbstract"/>
  <xs:element name="CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract"/>
  <xs:element name="AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract"/>
  <xs:element name="CashEquivalentsAndShortTermInvestmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CashEquivalentsAndShortTermInvestmentsAbstract"/>
  <xs:element name="AccountsReceivableNetOfAllowanceAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AccountsReceivableNetOfAllowanceAbstract"/>
  <xs:element name="PropertyAndEquipmentNetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_PropertyAndEquipmentNetAbstract"/>
  <xs:element name="IntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_IntangibleAssetsAbstract"/>
  <xs:element name="TheEstimatedFutureAmortizationExpenseByYearAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract"/>
  <xs:element name="AccruedLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AccruedLiabilitiesAbstract"/>
  <xs:element name="RevenueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RevenueAbstract"/>
  <xs:element name="LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract"/>
  <xs:element name="ConvertiblePromissoryNotesRelatedPartyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract"/>
  <xs:element name="SecuredPromissoryNotePayableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SecuredPromissoryNotePayableAbstract"/>
  <xs:element name="LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract"/>
  <xs:element name="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract"/>
  <xs:element name="ConvertiblePreferredStockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePreferredStockAbstract"/>
  <xs:element name="CommonStockReservedForIssuanceAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CommonStockReservedForIssuanceAbstract"/>
  <xs:element name="SummaryOfStockOptionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SummaryOfStockOptionAbstract"/>
  <xs:element name="FairValuesEstimatedAssumptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_FairValuesEstimatedAssumptionsAbstract"/>
  <xs:element name="TotalStockBasedCompensationRecognizedForOptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_TotalStockBasedCompensationRecognizedForOptionsAbstract"/>
  <xs:element name="ComponentsOfIncomeTaxesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ComponentsOfIncomeTaxesAbstract"/>
  <xs:element name="ComponentsOfTheDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract"/>
  <xs:element name="ReconciliationOfTheProvisionForIncomeTaxesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract"/>
  <xs:element name="ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract"/>
  <xs:element name="CalculationOfBasicAndDilutedNetLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract"/>
  <xs:element name="PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract"/>
  <xs:element name="SelectedSummarizedQuarterlyFinancialAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SelectedSummarizedQuarterlyFinancialAbstract"/>
  <xs:element name="IntangibleAssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_IntangibleAssetsAbstract0"/>
  <xs:element name="RecurringFinancialAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RecurringFinancialAssetsAbstract"/>
  <xs:element name="RecurringFinancialLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RecurringFinancialLiabilitiesAbstract"/>
  <xs:element name="RecurringFinancialAssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RecurringFinancialAssetsAbstract0"/>
  <xs:element name="RecurringFinancialLiabilitiesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RecurringFinancialLiabilitiesAbstract0"/>
  <xs:element name="ReportedAsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ReportedAsAbstract"/>
  <xs:element name="ReportedAsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ReportedAsAbstract0"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_UnlabeledAbstract"/>
  <xs:element name="CurrentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CurrentAbstract"/>
  <xs:element name="DeferredAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_DeferredAbstract"/>
  <xs:element name="PermanentItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_PermanentItemsAbstract"/>
  <xs:element name="SecuredPromissoryNoteClassifiedCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SecuredPromissoryNoteClassifiedCurrent"/>
  <xs:element name="ConvertibleLongTermNotesPayableRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertibleLongTermNotesPayableRelatedParties"/>
  <xs:element name="NoncashInterestExpenseOnLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_NoncashInterestExpenseOnLiability"/>
  <xs:element name="GainlossOnRevaluationOfFinancialInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_GainlossOnRevaluationOfFinancialInstruments"/>
  <xs:element name="StockIssuedDuringPeriodValueConversionOfPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock"/>
  <xs:element name="StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock"/>
  <xs:element name="ImpairmentofPropertyAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ImpairmentofPropertyAndEquipment"/>
  <xs:element name="AmortizationOfDiscountOnShorttermInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AmortizationOfDiscountOnShorttermInvestments"/>
  <xs:element name="LossgainOnRevaluationOfFinancialInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_LossgainOnRevaluationOfFinancialInstruments"/>
  <xs:element name="NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties"/>
  <xs:element name="NoncashRevenueRelatedToSaleOfFutureRoyalties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties"/>
  <xs:element name="ProceedsFromSaleOfEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ProceedsFromSaleOfEquipment"/>
  <xs:element name="CashAcquiredInReverseMerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CashAcquiredInReverseMerger"/>
  <xs:element name="PaymentsForfractionalsharesinmerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_PaymentsForfractionalsharesinmerger"/>
  <xs:element name="StockIssuedDuringPeriodValueUponReverseMerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_StockIssuedDuringPeriodValueUponReverseMerger"/>
  <xs:element name="ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger"/>
  <xs:element name="ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity"/>
  <xs:element name="RevenueTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RevenueTextBlock"/>
  <xs:element name="ConvertiblePromissoryNotesRelatedPartyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock"/>
  <xs:element name="SecuredPromissoryNotePayableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SecuredPromissoryNotePayableTextBlock"/>
  <xs:element name="AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock"/>
  <xs:element name="ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock"/>
  <xs:element name="ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
  <xs:element name="ScheduleOfConvertiblePreferredStockTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock"/>
  <xs:element name="ScheduleOfCommonStockReservedForIssuanceTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems"/>
  <xs:element name="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable"/>
  <xs:element name="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems"/>
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties"/>
  <xs:element name="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable"/>
  <xs:element name="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems"/>
  <xs:element name="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable"/>
  <xs:element name="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems"/>
  <xs:element name="RoyaltiesReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RoyaltiesReceivable"/>
  <xs:element name="LaboratoryEquipmentGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_LaboratoryEquipmentGross"/>
  <xs:element name="OfficeAndComputerEquipmentGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_OfficeAndComputerEquipmentGross"/>
  <xs:element name="AccruedCompensationCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AccruedCompensationCurrent"/>
  <xs:element name="AccruedClinicalAndManufacturingExpensesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AccruedClinicalAndManufacturingExpensesCurrent"/>
  <xs:element name="AccruedProfessionalAndConsultingServicesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AccruedProfessionalAndConsultingServicesCurrent"/>
  <xs:element name="ReserveForReturnOfRoyaltiesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ReserveForReturnOfRoyaltiesCurrent"/>
  <xs:element name="ConvertiblePreferredStockWarrantLiabilityCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent"/>
  <xs:element name="DebtRevenueNonCashRoyaltyRevenuePaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid"/>
  <xs:element name="DebtNoncashInterestExpenseRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_DebtNoncashInterestExpenseRecognized"/>
  <xs:element name="DeferredRentOnCeaseuseDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_DeferredRentOnCeaseuseDate"/>
  <xs:element name="StockholdersEquityDetailsConvertiblepreferredstockTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable"/>
  <xs:element name="StockholdersEquityDetailsConvertiblepreferredstockLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems"/>
  <xs:element name="CommonStockReservedForIssuanceDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CommonStockReservedForIssuanceDomain"/>
  <xs:element name="StockholdersEquityDetailsCommonstockreservedforissuanceTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable"/>
  <xs:element name="StockholdersEquityDetailsCommonstockreservedforissuanceLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger"/>
  <xs:element name="DeferredTaxAssetsSaleOfFutureRoyalties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties"/>
  <xs:element name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest"/>
  <xs:element name="EffectiveIncomeTaxRateReconciliationBargainPurchaseGain" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain"/>
  <xs:element name="OrganizationandBasisofPresentationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_OrganizationandBasisofPresentationDetailsTable"/>
  <xs:element name="OrganizationandBasisofPresentationDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_OrganizationandBasisofPresentationDetailsLineItems"/>
  <xs:element name="ExchangeRatioNumberOfSharesExchangedPerShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare"/>
  <xs:element name="LoanAgreementBorrowedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_LoanAgreementBorrowedAmount"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="IncreaseDecreaseInAccumulatedDeficit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_IncreaseDecreaseInAccumulatedDeficit"/>
  <xs:element name="BusinessCombinationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_BusinessCombinationDetailsTable"/>
  <xs:element name="BusinessCombinationDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_BusinessCombinationDetailsLineItems"/>
  <xs:element name="RevenueDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_RevenueDetailsTable"/>
  <xs:element name="RevenueDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RevenueDetailsLineItems"/>
  <xs:element name="RoyaltyPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RoyaltyPercentage"/>
  <xs:element name="NonCashRoyaltyRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_NonCashRoyaltyRevenue"/>
  <xs:element name="DeferredRevenueArrangementType_Domain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_DeferredRevenueArrangementType_Domain"/>
  <xs:element name="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable"/>
  <xs:element name="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems"/>
  <xs:element name="DebtAdditions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_DebtAdditions"/>
  <xs:element name="HCRPAgreementRevenueTerms" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_HCRPAgreementRevenueTerms"/>
  <xs:element name="ConvertiblePromissoryNotesRelatedPartiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable"/>
  <xs:element name="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems"/>
  <xs:element name="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable"/>
  <xs:element name="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems"/>
  <xs:element name="CommitmentsandContingenciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_CommitmentsandContingenciesDetailsTable"/>
  <xs:element name="CommitmentsandContingenciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CommitmentsandContingenciesDetailsLineItems"/>
  <xs:element name="StockholdersEquityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_StockholdersEquityDetailsTable"/>
  <xs:element name="StockholdersEquityDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_StockholdersEquityDetailsLineItems"/>
  <xs:element name="EquityIncentivePlansDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_EquityIncentivePlansDetailsTable"/>
  <xs:element name="EquityIncentivePlansDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_EquityIncentivePlansDetailsLineItems"/>
  <xs:element name="IncomeTaxesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="vxrt_IncomeTaxesDetailsTable"/>
  <xs:element name="IncomeTaxesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_IncomeTaxesDetailsLineItems"/>
  <xs:element name="IncreaseDecreaseInDeferredTaxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="vxrt_IncreaseDecreaseInDeferredTaxes"/>
  <xs:element name="CommonStockReservedForIssuanceAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="vxrt_CommonStockReservedForIssuanceAxis"/>
  <xs:element name="AviragenTherapeuticsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AviragenTherapeuticsIncMember"/>
  <xs:element name="AviragensStockholderrsAndOptionsholdersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_AviragensStockholderrsAndOptionsholdersMember"/>
  <xs:element name="CommonStockWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CommonStockWarrantsMember"/>
  <xs:element name="ConversionMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConversionMember"/>
  <xs:element name="ConvertiblePreferredStockOutstandingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePreferredStockOutstandingMember"/>
  <xs:element name="ConvertiblePreferredStockWarrantLiabilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePreferredStockWarrantLiabilityMember"/>
  <xs:element name="ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember"/>
  <xs:element name="ConvertiblePromissoryNotesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePromissoryNotesMember"/>
  <xs:element name="ConvertiblePromissoryNotesRelatedPartyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_ConvertiblePromissoryNotesRelatedPartyMember"/>
  <xs:element name="CorporateBondsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CorporateBondsMember"/>
  <xs:element name="CumulativeConvertiblePreferredStockDividendsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_CumulativeConvertiblePreferredStockDividendsMember"/>
  <xs:element name="DerecognizeLeaseLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_DerecognizeLeaseLiabilitiesMember"/>
  <xs:element name="HCRPMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_HCRPMember"/>
  <xs:element name="HHSBARDAMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_HHSBARDAMember"/>
  <xs:element name="InavirRecognizedMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_InavirRecognizedMember"/>
  <xs:element name="LaboratoryEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_LaboratoryEquipmentMember"/>
  <xs:element name="LoanAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_LoanAgreementMember"/>
  <xs:element name="NonCashRoyaltyRevenueMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_NonCashRoyaltyRevenueMember"/>
  <xs:element name="NotePurchaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_NotePurchaseAgreementMember"/>
  <xs:element name="NotesIssuedIn2014Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_NotesIssuedIn2014Member"/>
  <xs:element name="NotesIssuedIn2015Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_NotesIssuedIn2015Member"/>
  <xs:element name="OfficeSpaceInAlpharettaGeorgiaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_OfficeSpaceInAlpharettaGeorgiaMember"/>
  <xs:element name="OfficeSpaceInSanFranciscoCaliforniaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember"/>
  <xs:element name="OptionsAvailableForFutureGrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_OptionsAvailableForFutureGrantsMember"/>
  <xs:element name="OptionsIssuedAndOutstandingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_OptionsIssuedAndOutstandingMember"/>
  <xs:element name="OxfordFinanceMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_OxfordFinanceMember"/>
  <xs:element name="PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember"/>
  <xs:element name="PurchasedTechnologyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_PurchasedTechnologyMember"/>
  <xs:element name="RecognizeLeaseLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RecognizeLeaseLiabilitiesMember"/>
  <xs:element name="RelenzaRecognizedMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RelenzaRecognizedMember"/>
  <xs:element name="RemainingThreeLeasesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_RemainingThreeLeasesMember"/>
  <xs:element name="SecondNotePurchaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SecondNotePurchaseAgreementMember"/>
  <xs:element name="SeriesBAndCPreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_SeriesBAndCPreferredStockMember"/>
  <xs:element name="TheFirstLeaseMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_TheFirstLeaseMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="vxrt_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>30
<FILENAME>vxrt-20181231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Feb 06 15:31:57 EST 2019 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedBalanceSheet" roleURI="http://www.vaxart.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedIncomeStatement" roleURI="http://www.vaxart.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedCashFlow" roleURI="http://www.vaxart.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_TotalpurchasepriceforAviragenTable" roleURI="http://www.vaxart.com/role/TotalpurchasepriceforAviragenTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" roleURI="http://www.vaxart.com/role/AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AccountsreceivablenetofallowanceTable" roleURI="http://www.vaxart.com/role/AccountsreceivablenetofallowanceTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_PropertyandequipmentnetTable" roleURI="http://www.vaxart.com/role/PropertyandequipmentnetTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_IntangibleassetsTable" roleURI="http://www.vaxart.com/role/IntangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_TheestimatedfutureamortizationexpensebyyearTable" roleURI="http://www.vaxart.com/role/TheestimatedfutureamortizationexpensebyyearTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AccruedliabilitiesTable" roleURI="http://www.vaxart.com/role/AccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable" roleURI="http://www.vaxart.com/role/FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ComponentsofincometaxesTable" roleURI="http://www.vaxart.com/role/ComponentsofincometaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ComponentsofthedeferredtaxassetsTable" roleURI="http://www.vaxart.com/role/ComponentsofthedeferredtaxassetsTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNoteClassifiedCurrent" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNoteClassifiedCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="vxrt_SecuredPromissoryNoteClassifiedCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertibleLongTermNotesPayableRelatedParties" xlink:href="vxrt-20181231.xsd#vxrt_ConvertibleLongTermNotesPayableRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="vxrt_ConvertibleLongTermNotesPayableRelatedParties" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermNotesPayable" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_BusinessExitCosts1" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingCostsAndExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_GainlossOnRevaluationOfFinancialInstruments" xlink:href="vxrt-20181231.xsd#vxrt_GainlossOnRevaluationOfFinancialInstruments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="vxrt_GainlossOnRevaluationOfFinancialInstruments" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="vxrt_NoncashInterestExpenseOnLiability" xlink:href="vxrt-20181231.xsd#vxrt_NoncashInterestExpenseOnLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="vxrt_NoncashInterestExpenseOnLiability" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_ImpairmentofPropertyAndEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ImpairmentofPropertyAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="vxrt_ImpairmentofPropertyAndEquipment" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_AmortizationOfDiscountOnShorttermInvestments" xlink:href="vxrt-20181231.xsd#vxrt_AmortizationOfDiscountOnShorttermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="vxrt_AmortizationOfDiscountOnShorttermInvestments" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashExpense" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="vxrt_LossgainOnRevaluationOfFinancialInstruments" xlink:href="vxrt-20181231.xsd#vxrt_LossgainOnRevaluationOfFinancialInstruments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="vxrt_LossgainOnRevaluationOfFinancialInstruments" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="17" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="vxrt_ProceedsFromSaleOfEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ProceedsFromSaleOfEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="vxrt_ProceedsFromSaleOfEquipment" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_CashAcquiredInReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_CashAcquiredInReverseMerger"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="vxrt_CashAcquiredInReverseMerger" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="vxrt_PaymentsForfractionalsharesinmerger" xlink:href="vxrt-20181231.xsd#vxrt_PaymentsForfractionalsharesinmerger"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="vxrt_PaymentsForfractionalsharesinmerger" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" weight="1"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZi7YfzVIAspPbJuDylcYRVpSzHijjkNCYpD7o9WcfUwu/9uo1X+/k4jp6oPRfpgx2gurzW//2t+l3nLsqChCk2dbDArpcIr4CikQhf0AXguBDQTnCrO4B9rKkWv2LsFu37D0Y4AbkakUzGAsVmVCWIYmc/Dj8HnBZZ] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/TotalpurchasepriceforAviragenTable">
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="1" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable">
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" order="4" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AccountsreceivablenetofallowanceTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <loc xlink:type="locator" xlink:label="vxrt_RoyaltiesReceivable" xlink:href="vxrt-20181231.xsd#vxrt_RoyaltiesReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="vxrt_RoyaltiesReceivable" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BilledContractReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BilledContractReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_BilledContractReceivables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnbilledContractsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_UnbilledContractsReceivable" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/PropertyandequipmentnetTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <loc xlink:type="locator" xlink:label="vxrt_LaboratoryEquipmentGross" xlink:href="vxrt-20181231.xsd#vxrt_LaboratoryEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="vxrt_LaboratoryEquipmentGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_OfficeAndComputerEquipmentGross" xlink:href="vxrt-20181231.xsd#vxrt_OfficeAndComputerEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="vxrt_OfficeAndComputerEquipmentGross" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_LeaseholdImprovementsGross" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/IntangibleassetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/TheestimatedfutureamortizationexpensebyyearTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="6" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedCompensationCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedCompensationCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="vxrt_AccruedCompensationCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedClinicalAndManufacturingExpensesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedClinicalAndManufacturingExpensesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="vxrt_AccruedClinicalAndManufacturingExpensesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedProfessionalAndConsultingServicesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedProfessionalAndConsultingServicesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="vxrt_AccruedProfessionalAndConsultingServicesCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_ReserveForReturnOfRoyaltiesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_ReserveForReturnOfRoyaltiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="vxrt_ReserveForReturnOfRoyaltiesCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="7" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ComponentsofincometaxesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ComponentsofthedeferredtaxassetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_DeferredTaxAssetsSaleOfFutureRoyalties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" order="2" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>31
<FILENAME>vxrt-20181231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Feb 06 15:31:57 EST 2019 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedBalanceSheet" roleURI="http://www.vaxart.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.vaxart.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedIncomeStatement" roleURI="http://www.vaxart.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ShareholdersEquityType2or3" roleURI="http://www.vaxart.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedCashFlow" roleURI="http://www.vaxart.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_OrganizationandBasisofPresentation" roleURI="http://www.vaxart.com/role/OrganizationandBasisofPresentation"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.vaxart.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BusinessCombination" roleURI="http://www.vaxart.com/role/BusinessCombination"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_FairValueofFinancialInstruments" roleURI="http://www.vaxart.com/role/FairValueofFinancialInstruments"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BalanceSheetComponents" roleURI="http://www.vaxart.com/role/BalanceSheetComponents"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_Revenue" roleURI="http://www.vaxart.com/role/Revenue"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilitiesRelatedtoSaleofFutureRoyalties" roleURI="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyalties"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConvertiblePromissoryNotesRelatedParties" roleURI="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SecuredPromissoryNotePayabletoOxfordFinance" roleURI="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinance"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CommitmentsandContingencies" roleURI="http://www.vaxart.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_StockholdersEquity" roleURI="http://www.vaxart.com/role/StockholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_EquityIncentivePlans" roleURI="http://www.vaxart.com/role/EquityIncentivePlans"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_IncomeTaxes" roleURI="http://www.vaxart.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_NetLossPerShareAttributabletoCommonStockholders" roleURI="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholders"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_QuarterlyFinancialDataUnaudited" roleURI="http://www.vaxart.com/role/QuarterlyFinancialDataUnaudited"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AccountingPoliciesByPolicy" roleURI="http://www.vaxart.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BusinessCombinationTables" roleURI="http://www.vaxart.com/role/BusinessCombinationTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_FairValueofFinancialInstrumentsTables" roleURI="http://www.vaxart.com/role/FairValueofFinancialInstrumentsTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BalanceSheetComponentsTables" roleURI="http://www.vaxart.com/role/BalanceSheetComponentsTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilitiesRelatedtoSaleofFutureRoyaltiesTables" roleURI="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CommitmentsandContingenciesTables" roleURI="http://www.vaxart.com/role/CommitmentsandContingenciesTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_StockholdersEquityTables" roleURI="http://www.vaxart.com/role/StockholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_EquityIncentivePlansTables" roleURI="http://www.vaxart.com/role/EquityIncentivePlansTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_IncomeTaxesTables" roleURI="http://www.vaxart.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_QuarterlyFinancialDataUnauditedTables" roleURI="http://www.vaxart.com/role/QuarterlyFinancialDataUnauditedTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_EstimatedUsefulLivesTable" roleURI="http://www.vaxart.com/role/EstimatedUsefulLivesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_TotalpurchasepriceforAviragenTable" roleURI="http://www.vaxart.com/role/TotalpurchasepriceforAviragenTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" roleURI="http://www.vaxart.com/role/AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SelectedamountsrelatedtoAviragensbusinessincludedintheCompanysconsolidatedstatementofoperationsTable" roleURI="http://www.vaxart.com/role/SelectedamountsrelatedtoAviragensbusinessincludedintheCompanysconsolidatedstatementofoperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_UnauditedproformainformationissummarizedTable" roleURI="http://www.vaxart.com/role/UnauditedproformainformationissummarizedTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" roleURI="http://www.vaxart.com/role/CompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AreconciliationofallliabilitiesmeasuredatfairvalueonarecurringbasisusingsignificantunobservableinputsLevel3Table" roleURI="http://www.vaxart.com/role/AreconciliationofallliabilitiesmeasuredatfairvalueonarecurringbasisusingsignificantunobservableinputsLevel3Table"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CashequivalentsandshortterminvestmentsTable" roleURI="http://www.vaxart.com/role/CashequivalentsandshortterminvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AccountsreceivablenetofallowanceTable" roleURI="http://www.vaxart.com/role/AccountsreceivablenetofallowanceTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_PropertyandequipmentnetTable" roleURI="http://www.vaxart.com/role/PropertyandequipmentnetTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_IntangibleassetsTable" roleURI="http://www.vaxart.com/role/IntangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_TheestimatedfutureamortizationexpensebyyearTable" roleURI="http://www.vaxart.com/role/TheestimatedfutureamortizationexpensebyyearTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AccruedliabilitiesTable" roleURI="http://www.vaxart.com/role/AccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilityrelatedtosaleoffutureRoyaltiesTable" roleURI="http://www.vaxart.com/role/LiabilityrelatedtosaleoffutureRoyaltiesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilitiesrelatedtocostsofexitfromleasedpremisesTable" roleURI="http://www.vaxart.com/role/LiabilitiesrelatedtocostsofexitfromleasedpremisesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable" roleURI="http://www.vaxart.com/role/FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConvertiblepreferredstockTable" roleURI="http://www.vaxart.com/role/ConvertiblepreferredstockTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CommonstockreservedforissuanceTable" roleURI="http://www.vaxart.com/role/CommonstockreservedforissuanceTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SummaryofstockoptionTable" roleURI="http://www.vaxart.com/role/SummaryofstockoptionTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_FairvaluesestimatedassumptionsTable" roleURI="http://www.vaxart.com/role/FairvaluesestimatedassumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_TotalstockbasedcompensationrecognizedforoptionsTable" roleURI="http://www.vaxart.com/role/TotalstockbasedcompensationrecognizedforoptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ComponentsofincometaxesTable" roleURI="http://www.vaxart.com/role/ComponentsofincometaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ComponentsofthedeferredtaxassetsTable" roleURI="http://www.vaxart.com/role/ComponentsofthedeferredtaxassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ReconciliationoftheprovisionforincometaxesTable" roleURI="http://www.vaxart.com/role/ReconciliationoftheprovisionforincometaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ReconciliationoftheunrecognizedtaxbenefitsTable" roleURI="http://www.vaxart.com/role/ReconciliationoftheunrecognizedtaxbenefitsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CalculationofbasicanddilutednetlosspershareTable" roleURI="http://www.vaxart.com/role/CalculationofbasicanddilutednetlosspershareTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_PotentiallydilutivesecuritiesexcludedfromthecomputationofdilutedweightedaveragesharesTable" roleURI="http://www.vaxart.com/role/PotentiallydilutivesecuritiesexcludedfromthecomputationofdilutedweightedaveragesharesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SelectedsummarizedquarterlyfinancialTable" roleURI="http://www.vaxart.com/role/SelectedsummarizedquarterlyfinancialTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_OrganizationandBasisofPresentationDetails" roleURI="http://www.vaxart.com/role/OrganizationandBasisofPresentationDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BusinessCombinationDetails" roleURI="http://www.vaxart.com/role/BusinessCombinationDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BalanceSheetComponentsDetails" roleURI="http://www.vaxart.com/role/BalanceSheetComponentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_RevenueDetails" roleURI="http://www.vaxart.com/role/RevenueDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetails" roleURI="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConvertiblePromissoryNotesRelatedPartiesDetails" roleURI="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SecuredPromissoryNotePayabletoOxfordFinanceDetails" roleURI="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinanceDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CommitmentsandContingenciesDetails" roleURI="http://www.vaxart.com/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_StockholdersEquityDetails" roleURI="http://www.vaxart.com/role/StockholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_EquityIncentivePlansDetails" roleURI="http://www.vaxart.com/role/EquityIncentivePlansDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_IncomeTaxesDetails" roleURI="http://www.vaxart.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#DocumentAndEntityInformation" roleURI="http://www.vaxart.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNoteClassifiedCurrent" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNoteClassifiedCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="vxrt_SecuredPromissoryNoteClassifiedCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertibleLongTermNotesPayableRelatedParties" xlink:href="vxrt-20181231.xsd#vxrt_ConvertibleLongTermNotesPayableRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="vxrt_ConvertibleLongTermNotesPayableRelatedParties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermNotesPayable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_StockholdersEquityAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GovernmentContractMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_GovernmentContractMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_NonCashRoyaltyRevenueMember" xlink:href="vxrt-20181231.xsd#vxrt_NonCashRoyaltyRevenueMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="vxrt_NonCashRoyaltyRevenueMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_BusinessExitCosts1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessExitCosts1" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InterestExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_NoncashInterestExpenseOnLiability" xlink:href="vxrt-20181231.xsd#vxrt_NoncashInterestExpenseOnLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="vxrt_NoncashInterestExpenseOnLiability" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_GainlossOnRevaluationOfFinancialInstruments" xlink:href="vxrt-20181231.xsd#vxrt_GainlossOnRevaluationOfFinancialInstruments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="vxrt_GainlossOnRevaluationOfFinancialInstruments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock" xlink:href="vxrt-20181231.xsd#vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock" xlink:href="vxrt-20181231.xsd#vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ImpairmentofPropertyAndEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ImpairmentofPropertyAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="vxrt_ImpairmentofPropertyAndEquipment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_AmortizationOfDiscountOnShorttermInvestments" xlink:href="vxrt-20181231.xsd#vxrt_AmortizationOfDiscountOnShorttermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="vxrt_AmortizationOfDiscountOnShorttermInvestments" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_LossgainOnRevaluationOfFinancialInstruments" xlink:href="vxrt-20181231.xsd#vxrt_LossgainOnRevaluationOfFinancialInstruments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="vxrt_LossgainOnRevaluationOfFinancialInstruments" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashExpense" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ProceedsFromSaleOfEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ProceedsFromSaleOfEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="vxrt_ProceedsFromSaleOfEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_CashAcquiredInReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_CashAcquiredInReverseMerger"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="vxrt_CashAcquiredInReverseMerger" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_PaymentsForfractionalsharesinmerger" xlink:href="vxrt-20181231.xsd#vxrt_PaymentsForfractionalsharesinmerger"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="vxrt_PaymentsForfractionalsharesinmerger" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockIssuedDuringPeriodValueUponReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_StockIssuedDuringPeriodValueUponReverseMerger"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="vxrt_StockIssuedDuringPeriodValueUponReverseMerger" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity" xlink:href="vxrt-20181231.xsd#vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/OrganizationandBasisofPresentation">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BusinessCombination">
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/FairValueofFinancialInstruments">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BalanceSheetComponents">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/Revenue">
    <loc xlink:type="locator" xlink:label="vxrt_RevenueAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="vxrt_RevenueTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_RevenueTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RevenueAbstract" xlink:to="vxrt_RevenueTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyalties">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedParties">
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinance">
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNotePayableAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayableAbstract"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNotePayableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayableAbstract" xlink:to="vxrt_SecuredPromissoryNotePayableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CommitmentsandContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/StockholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/EquityIncentivePlans">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholders">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/QuarterlyFinancialDataUnaudited">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="18" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BusinessCombinationTables">
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/FairValueofFinancialInstrumentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BalanceSheetComponentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueByArrangementDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CommitmentsandContingenciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/StockholdersEquityTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/EquityIncentivePlansTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/IncomeTaxesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholdersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/QuarterlyFinancialDataUnauditedTables">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/EstimatedUsefulLivesTable">
    <loc xlink:type="locator" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" xlink:to="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_LaboratoryEquipmentMember" xlink:href="vxrt-20181231.xsd#vxrt_LaboratoryEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="vxrt_LaboratoryEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/TotalpurchasepriceforAviragenTable">
    <loc xlink:type="locator" xlink:label="vxrt_TotalPurchasePriceForAviragenAbstract" xlink:href="vxrt-20181231.xsd#vxrt_TotalPurchasePriceForAviragenAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_TotalPurchasePriceForAviragenAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_TotalPurchasePriceForAviragenAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable">
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" xlink:to="srt_RestatementAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_IntangibleAssetsAbstract0" xlink:href="vxrt-20181231.xsd#vxrt_IntangibleAssetsAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="vxrt_IntangibleAssetsAbstract0" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_IntangibleAssetsAbstract0" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_IntangibleAssetsAbstract0" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SelectedamountsrelatedtoAviragensbusinessincludedintheCompanysconsolidatedstatementofoperationsTable">
    <loc xlink:type="locator" xlink:label="vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/UnauditedproformainformationissummarizedTable">
    <loc xlink:type="locator" xlink:label="vxrt_UnauditedProFormaInformationIsSummarizedAbstract" xlink:href="vxrt-20181231.xsd#vxrt_UnauditedProFormaInformationIsSummarizedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_UnauditedProFormaInformationIsSummarizedAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_UnauditedProFormaInformationIsSummarizedAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable">
    <loc xlink:type="locator" xlink:label="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" xlink:href="vxrt-20181231.xsd#vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:href="vxrt-20181231.xsd#vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" xlink:to="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_CorporateBondsMember" xlink:href="vxrt-20181231.xsd#vxrt_CorporateBondsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="vxrt_CorporateBondsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_RecurringFinancialAssetsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RecurringFinancialAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" xlink:to="vxrt_RecurringFinancialAssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RecurringFinancialAssetsAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_RecurringFinancialLiabilitiesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RecurringFinancialLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" xlink:to="vxrt_RecurringFinancialLiabilitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RecurringFinancialLiabilitiesAbstract" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AreconciliationofallliabilitiesmeasuredatfairvalueonarecurringbasisusingsignificantunobservableinputsLevel3Table">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CashequivalentsandshortterminvestmentsTable">
    <loc xlink:type="locator" xlink:label="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" xlink:href="vxrt-20181231.xsd#vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_CorporateBondsMember" xlink:href="vxrt-20181231.xsd#vxrt_CorporateBondsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="vxrt_CorporateBondsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CashEquivalentsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AccountsreceivablenetofallowanceTable">
    <loc xlink:type="locator" xlink:label="vxrt_AccountsReceivableNetOfAllowanceAbstract" xlink:href="vxrt-20181231.xsd#vxrt_AccountsReceivableNetOfAllowanceAbstract"/>
    <loc xlink:type="locator" xlink:label="vxrt_RoyaltiesReceivable" xlink:href="vxrt-20181231.xsd#vxrt_RoyaltiesReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccountsReceivableNetOfAllowanceAbstract" xlink:to="vxrt_RoyaltiesReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BilledContractReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BilledContractReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccountsReceivableNetOfAllowanceAbstract" xlink:to="us-gaap_BilledContractReceivables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnbilledContractsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccountsReceivableNetOfAllowanceAbstract" xlink:to="us-gaap_UnbilledContractsReceivable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnbilledContractsReceivable" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/PropertyandequipmentnetTable">
    <loc xlink:type="locator" xlink:label="vxrt_PropertyAndEquipmentNetAbstract" xlink:href="vxrt-20181231.xsd#vxrt_PropertyAndEquipmentNetAbstract"/>
    <loc xlink:type="locator" xlink:label="vxrt_LaboratoryEquipmentGross" xlink:href="vxrt-20181231.xsd#vxrt_LaboratoryEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_PropertyAndEquipmentNetAbstract" xlink:to="vxrt_LaboratoryEquipmentGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_OfficeAndComputerEquipmentGross" xlink:href="vxrt-20181231.xsd#vxrt_OfficeAndComputerEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_PropertyAndEquipmentNetAbstract" xlink:to="vxrt_OfficeAndComputerEquipmentGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_PropertyAndEquipmentNetAbstract" xlink:to="us-gaap_LeaseholdImprovementsGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_PropertyAndEquipmentNetAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/IntangibleassetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_PurchasedTechnologyMember" xlink:href="vxrt-20181231.xsd#vxrt_PurchasedTechnologyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="vxrt_PurchasedTechnologyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IntellectualPropertyMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/TheestimatedfutureamortizationexpensebyyearTable">
    <loc xlink:type="locator" xlink:label="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:href="vxrt-20181231.xsd#vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="vxrt_AccruedLiabilitiesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_AccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedCompensationCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedCompensationCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccruedLiabilitiesAbstract" xlink:to="vxrt_AccruedCompensationCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedClinicalAndManufacturingExpensesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedClinicalAndManufacturingExpensesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccruedLiabilitiesAbstract" xlink:to="vxrt_AccruedClinicalAndManufacturingExpensesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedProfessionalAndConsultingServicesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedProfessionalAndConsultingServicesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccruedLiabilitiesAbstract" xlink:to="vxrt_AccruedProfessionalAndConsultingServicesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ReserveForReturnOfRoyaltiesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_ReserveForReturnOfRoyaltiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccruedLiabilitiesAbstract" xlink:to="vxrt_ReserveForReturnOfRoyaltiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccruedLiabilitiesAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccruedLiabilitiesAbstract" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_AccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilityrelatedtosaleoffutureRoyaltiesTable">
    <loc xlink:type="locator" xlink:label="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:to="us-gaap_LongTermDebt" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid" xlink:href="vxrt-20181231.xsd#vxrt_DebtRevenueNonCashRoyaltyRevenuePaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:to="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_DebtNoncashInterestExpenseRecognized" xlink:href="vxrt-20181231.xsd#vxrt_DebtNoncashInterestExpenseRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:to="vxrt_DebtNoncashInterestExpenseRecognized" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilitiesrelatedtocostsofexitfromleasedpremisesTable">
    <loc xlink:type="locator" xlink:label="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_RestructuringReserve" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_BusinessExitCosts1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredRentOnCeaseuseDate" xlink:href="vxrt-20181231.xsd#vxrt_DeferredRentOnCeaseuseDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="vxrt_DeferredRentOnCeaseuseDate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLeasehold" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfLeasehold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_ImpairmentOfLeasehold" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_PaymentsForRestructuring" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccretionExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccretionExpense"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZi7YfzVIAspPbJuDylcYRVpSzHijjkNCYpD7o9WcfUwu/9uo1X+/k4jp6oPRfpgx2gurzW//2t+l3nLsqChCk2dbDArpcIr4CikQhf0AXguBDQTnCrO4B9rKkWv2LsFu37D0Y4AbkakUyiT+lP5J4idrBGJBSOIY4c] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_AccretionExpense" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable">
    <loc xlink:type="locator" xlink:label="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConvertiblepreferredstockTable">
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="us-gaap_PreferredStockValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CommonstockreservedforissuanceTable">
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems" xlink:to="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommonStockReservedForIssuanceAxis" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockReservedForIssuanceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable" xlink:to="vxrt_CommonStockReservedForIssuanceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommonStockReservedForIssuanceDomain" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockReservedForIssuanceDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="vxrt_CommonStockReservedForIssuanceAxis" xlink:to="vxrt_CommonStockReservedForIssuanceDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommonStockReservedForIssuanceDomain_0" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockReservedForIssuanceDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="vxrt_CommonStockReservedForIssuanceAxis" xlink:to="vxrt_CommonStockReservedForIssuanceDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockOutstandingMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockOutstandingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CommonStockReservedForIssuanceDomain" xlink:to="vxrt_ConvertiblePreferredStockOutstandingMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_OptionsIssuedAndOutstandingMember" xlink:href="vxrt-20181231.xsd#vxrt_OptionsIssuedAndOutstandingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CommonStockReservedForIssuanceDomain" xlink:to="vxrt_OptionsIssuedAndOutstandingMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_OptionsAvailableForFutureGrantsMember" xlink:href="vxrt-20181231.xsd#vxrt_OptionsAvailableForFutureGrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CommonStockReservedForIssuanceDomain" xlink:to="vxrt_OptionsAvailableForFutureGrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_CumulativeConvertiblePreferredStockDividendsMember" xlink:href="vxrt-20181231.xsd#vxrt_CumulativeConvertiblePreferredStockDividendsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CommonStockReservedForIssuanceDomain" xlink:to="vxrt_CumulativeConvertiblePreferredStockDividendsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommonStockWarrantsMember" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CommonStockReservedForIssuanceDomain" xlink:to="vxrt_CommonStockWarrantsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SummaryofstockoptionTable">
    <loc xlink:type="locator" xlink:label="vxrt_SummaryOfStockOptionAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SummaryOfStockOptionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan" order="17" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/FairvaluesestimatedassumptionsTable">
    <loc xlink:type="locator" xlink:label="vxrt_FairValuesEstimatedAssumptionsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_FairValuesEstimatedAssumptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FairValuesEstimatedAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FairValuesEstimatedAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FairValuesEstimatedAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_FairValuesEstimatedAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/TotalstockbasedcompensationrecognizedforoptionsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ComponentsofincometaxesTable">
    <loc xlink:type="locator" xlink:label="vxrt_ComponentsOfIncomeTaxesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ComponentsOfIncomeTaxesAbstract"/>
    <loc xlink:type="locator" xlink:label="vxrt_CurrentAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfIncomeTaxesAbstract" xlink:to="vxrt_CurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CurrentAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CurrentAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CurrentAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CurrentAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredAbstract" xlink:href="vxrt-20181231.xsd#vxrt_DeferredAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfIncomeTaxesAbstract" xlink:to="vxrt_DeferredAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_DeferredAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_DeferredAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_DeferredAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_DeferredAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfIncomeTaxesAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ComponentsofthedeferredtaxassetsTable">
    <loc xlink:type="locator" xlink:label="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ComponentsOfTheDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_DeferredTaxAssetsSaleOfFutureRoyalties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ReconciliationoftheprovisionforincometaxesTable">
    <loc xlink:type="locator" xlink:label="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_PermanentItemsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_PermanentItemsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="vxrt_PermanentItemsAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest" xlink:href="vxrt-20181231.xsd#vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_PermanentItemsAbstract" xlink:to="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_PermanentItemsAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_PermanentItemsAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain" xlink:href="vxrt-20181231.xsd#vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ReconciliationoftheunrecognizedtaxbenefitsTable">
    <loc xlink:type="locator" xlink:label="vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CalculationofbasicanddilutednetlosspershareTable">
    <loc xlink:type="locator" xlink:label="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/PotentiallydilutivesecuritiesexcludedfromthecomputationofdilutedweightedaveragesharesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_SeriesBAndCPreferredStockMember" xlink:href="vxrt-20181231.xsd#vxrt_SeriesBAndCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vxrt_SeriesBAndCPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_CumulativeConvertiblePreferredStockDividendsMember" xlink:href="vxrt-20181231.xsd#vxrt_CumulativeConvertiblePreferredStockDividendsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="vxrt_CumulativeConvertiblePreferredStockDividendsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockOutstandingMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockOutstandingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="vxrt_ConvertiblePreferredStockOutstandingMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartyMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SelectedsummarizedquarterlyfinancialTable">
    <loc xlink:type="locator" xlink:label="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SelectedSummarizedQuarterlyFinancialAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_OperatingExpenses" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_NetIncomeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/OrganizationandBasisofPresentationDetails">
    <loc xlink:type="locator" xlink:label="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_OrganizationandBasisofPresentationDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_OrganizationandBasisofPresentationDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_OrganizationandBasisofPresentationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="vxrt_OrganizationandBasisofPresentationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsTable" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConversionMember" xlink:href="vxrt-20181231.xsd#vxrt_ConversionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="vxrt_ConversionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember" xlink:href="vxrt-20181231.xsd#vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_AviragensStockholderrsAndOptionsholdersMember" xlink:href="vxrt-20181231.xsd#vxrt_AviragensStockholderrsAndOptionsholdersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="vxrt_AviragensStockholderrsAndOptionsholdersMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_OxfordFinanceMember" xlink:href="vxrt-20181231.xsd#vxrt_OxfordFinanceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="vxrt_OxfordFinanceMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare" xlink:href="vxrt-20181231.xsd#vxrt_ExchangeRatioNumberOfSharesExchangedPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_LoanAgreementBorrowedAmount" xlink:href="vxrt-20181231.xsd#vxrt_LoanAgreementBorrowedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="vxrt_LoanAgreementBorrowedAmount" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_LeaseArrangementTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_RecognizeLeaseLiabilitiesMember" xlink:href="vxrt-20181231.xsd#vxrt_RecognizeLeaseLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="vxrt_RecognizeLeaseLiabilitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_DerecognizeLeaseLiabilitiesMember" xlink:href="vxrt-20181231.xsd#vxrt_DerecognizeLeaseLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="vxrt_DerecognizeLeaseLiabilitiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IntellectualPropertyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCash" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_RestrictedCash" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_IncreaseDecreaseInAccumulatedDeficit" xlink:href="vxrt-20181231.xsd#vxrt_IncreaseDecreaseInAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="vxrt_IncreaseDecreaseInAccumulatedDeficit" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BusinessCombinationDetails">
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_BusinessCombinationDetailsLineItems" xlink:to="vxrt_BusinessCombinationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_BusinessCombinationDetailsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_BusinessCombinationDetailsLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BalanceSheetComponentsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_Depreciation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ImpairmentofPropertyAndEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ImpairmentofPropertyAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="vxrt_ImpairmentofPropertyAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/RevenueDetails">
    <loc xlink:type="locator" xlink:label="vxrt_RevenueDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_RevenueDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_RevenueDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_RevenueDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_RevenueDetailsLineItems" xlink:to="vxrt_RevenueDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_RevenueDetailsTable" xlink:to="srt_ProductOrServiceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanRestructuringModificationNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LoanRestructuringModificationNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_RevenueDetailsTable" xlink:to="us-gaap_LoanRestructuringModificationNameAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanRestructuringModificationNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LoanRestructuringModificationNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LoanRestructuringModificationNameAxis" xlink:to="us-gaap_LoanRestructuringModificationNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanRestructuringModificationNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LoanRestructuringModificationNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LoanRestructuringModificationNameAxis" xlink:to="us-gaap_LoanRestructuringModificationNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_RevenueDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EntityLoanModificationProgramMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EntityLoanModificationProgramMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LoanRestructuringModificationNameDomain" xlink:to="us-gaap_EntityLoanModificationProgramMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_HHSBARDAMember" xlink:href="vxrt-20181231.xsd#vxrt_HHSBARDAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="vxrt_HHSBARDAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_RelenzaRecognizedMember" xlink:href="vxrt-20181231.xsd#vxrt_RelenzaRecognizedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="vxrt_RelenzaRecognizedMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_AviragenTherapeuticsIncMember" xlink:href="vxrt-20181231.xsd#vxrt_AviragenTherapeuticsIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="vxrt_AviragenTherapeuticsIncMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_InavirRecognizedMember" xlink:href="vxrt-20181231.xsd#vxrt_InavirRecognizedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="vxrt_InavirRecognizedMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_JP" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="country_JP" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RevenueDetailsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RevenueDetailsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RevenueDetailsLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RevenueDetailsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RevenueDetailsLineItems" xlink:to="us-gaap_Revenues" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_RoyaltyPercentage" xlink:href="vxrt-20181231.xsd#vxrt_RoyaltyPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RevenueDetailsLineItems" xlink:to="vxrt_RoyaltyPercentage" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_NonCashRoyaltyRevenue" xlink:href="vxrt-20181231.xsd#vxrt_NonCashRoyaltyRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_RevenueDetailsLineItems" xlink:to="vxrt_NonCashRoyaltyRevenue" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesDetails">
    <loc xlink:type="locator" xlink:label="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" xlink:to="srt_CounterpartyNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredRevenueArrangementType_Domain" xlink:href="vxrt-20181231.xsd#vxrt_DeferredRevenueArrangementType_Domain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="vxrt_DeferredRevenueArrangementType_Domain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredRevenueArrangementType_Domain_0" xlink:href="vxrt-20181231.xsd#vxrt_DeferredRevenueArrangementType_Domain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="vxrt_DeferredRevenueArrangementType_Domain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyArrangementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyArrangementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_DeferredRevenueArrangementType_Domain" xlink:to="us-gaap_RoyaltyArrangementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_HCRPMember" xlink:href="vxrt-20181231.xsd#vxrt_HCRPMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="vxrt_HCRPMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_DebtAdditions" xlink:href="vxrt-20181231.xsd#vxrt_DebtAdditions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="vxrt_DebtAdditions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_HCRPAgreementRevenueTerms" xlink:href="vxrt-20181231.xsd#vxrt_HCRPAgreementRevenueTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="vxrt_HCRPAgreementRevenueTerms" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="us-gaap_Revenues" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_RoyaltyPercentage" xlink:href="vxrt-20181231.xsd#vxrt_RoyaltyPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="vxrt_RoyaltyPercentage" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyIncomeNonoperating" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="us-gaap_RoyaltyIncomeNonoperating" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_NotesIssuedIn2014Member" xlink:href="vxrt-20181231.xsd#vxrt_NotesIssuedIn2014Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="vxrt_NotesIssuedIn2014Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_NotesIssuedIn2015Member" xlink:href="vxrt-20181231.xsd#vxrt_NotesIssuedIn2015Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="vxrt_NotesIssuedIn2015Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_NotePurchaseAgreementMember" xlink:href="vxrt-20181231.xsd#vxrt_NotePurchaseAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="vxrt_NotePurchaseAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecondNotePurchaseAgreementMember" xlink:href="vxrt-20181231.xsd#vxrt_SecondNotePurchaseAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="vxrt_SecondNotePurchaseAgreementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="vxrt_ConvertiblePromissoryNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentInterest" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOwnershipInterestsValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_OtherOwnershipInterestsValue" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinanceDetails">
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_VariableRateAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_LoanAgreementMember" xlink:href="vxrt-20181231.xsd#vxrt_LoanAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="vxrt_LoanAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_OxfordFinanceMember" xlink:href="vxrt-20181231.xsd#vxrt_OxfordFinanceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="vxrt_OxfordFinanceMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPaymentTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_InterestPaid" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CommitmentsandContingenciesDetails">
    <loc xlink:type="locator" xlink:label="vxrt_CommitmentsandContingenciesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_CommitmentsandContingenciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommitmentsandContingenciesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_CommitmentsandContingenciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_CommitmentsandContingenciesDetailsLineItems" xlink:to="vxrt_CommitmentsandContingenciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_LeaseArrangementTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_TheFirstLeaseMember" xlink:href="vxrt-20181231.xsd#vxrt_TheFirstLeaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="vxrt_TheFirstLeaseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_RemainingThreeLeasesMember" xlink:href="vxrt-20181231.xsd#vxrt_RemainingThreeLeasesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="vxrt_RemainingThreeLeasesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember" xlink:href="vxrt-20181231.xsd#vxrt_OfficeSpaceInSanFranciscoCaliforniaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_OfficeSpaceInAlpharettaGeorgiaMember" xlink:href="vxrt-20181231.xsd#vxrt_OfficeSpaceInAlpharettaGeorgiaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="vxrt_OfficeSpaceInAlpharettaGeorgiaMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_OperatingLeaseImpairmentLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/StockholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="vxrt_StockholdersEquityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_StockholdersEquityDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_StockholdersEquityDetailsTable" xlink:to="srt_RangeAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_StockholdersEquityDetailsTable" xlink:to="us-gaap_DividendsAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendPaidMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendPaidMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DividendsDomain" xlink:to="us-gaap_DividendPaidMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePerDollarAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendRatePerDollarAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockDividendRatePerDollarAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_DividendsPreferredStock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockDividendsPerShareDeclared" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreference" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockVotingRights" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockVotingRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockVotingRights" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockVotingRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/EquityIncentivePlansDetails">
    <loc xlink:type="locator" xlink:label="vxrt_EquityIncentivePlansDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_EquityIncentivePlansDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_EquityIncentivePlansDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_EquityIncentivePlansDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="vxrt_EquityIncentivePlansDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_EquityIncentivePlansDetailsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_EquityIncentivePlansDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:label="vxrt_IncomeTaxesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_IncomeTaxesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="vxrt_IncomeTaxesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_IncomeTaxesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vxrt_IncomeTaxesDetailsLineItems" xlink:to="vxrt_IncomeTaxesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vxrt_IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_AU" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_AU"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="country_AU" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_GB"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="country_GB" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_FR" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_FR"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="country_FR" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="vxrt_IncreaseDecreaseInDeferredTaxes" xlink:href="vxrt-20181231.xsd#vxrt_IncreaseDecreaseInDeferredTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_IncomeTaxesDetailsLineItems" xlink:to="vxrt_IncreaseDecreaseInDeferredTaxes" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vxrt_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="19" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>32
<FILENAME>vxrt-20181231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Feb 06 15:31:57 EST 2019 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and cash equivalents at beginning of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and cash equivalents at end of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl0" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other long-term assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNoteClassifiedCurrent" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNoteClassifiedCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SecuredPromissoryNoteClassifiedCurrent_lbl" xml:lang="en-US">Current portion of secured promissory note payable to Oxford Finance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SecuredPromissoryNoteClassifiedCurrent" xlink:to="vxrt_SecuredPromissoryNoteClassifiedCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Liability related to sale of future royalties, current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other accrued current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertibleLongTermNotesPayableRelatedParties" xlink:href="vxrt-20181231.xsd#vxrt_ConvertibleLongTermNotesPayableRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertibleLongTermNotesPayableRelatedParties_lbl" xml:lang="en-US">Convertible promissory notes, long-term, related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertibleLongTermNotesPayableRelatedParties" xlink:to="vxrt_ConvertibleLongTermNotesPayableRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Liability related to sale of future royalties, net of current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Secured promissory note payable to Oxford Finance, net of current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock: $0.10 par value; 5,000,000 shares authorized; none issued and outstanding as of December 31, 2018; 1,221,064 issued and outstanding as of December 31, 2017, with aggregate liquidation value of $39,956</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred stock, net carrying value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred Stock, Shares Authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US">Preferred Stock, Shares Outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xml:lang="en-US">Liquidation Preference (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl0" xml:lang="en-US">Preferred stock, liquidation preference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock: $0.10 par value; 200,000,000 shares authorized; 7,141,189 and 138,492 shares issued and outstanding as of December 31, 2018 and 2017, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Balances (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US">Balances (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GovernmentContractMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GovernmentContractMember_lbl" xml:lang="en-US">Government Contract [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GovernmentContractMember" xlink:to="us-gaap_GovernmentContractMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyMember_lbl" xml:lang="en-US">Royalty [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyMember" xlink:to="us-gaap_RoyaltyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_NonCashRoyaltyRevenueMember" xlink:href="vxrt-20181231.xsd#vxrt_NonCashRoyaltyRevenueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_NonCashRoyaltyRevenueMember_lbl" xml:lang="en-US">Non Cash Royalty Revenue [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NonCashRoyaltyRevenueMember" xlink:to="vxrt_NonCashRoyaltyRevenueMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Impairment of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessExitCosts1_lbl" xml:lang="en-US">Costs of exit from leased premises</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessExitCosts1" xlink:to="us-gaap_BusinessExitCosts1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessExitCosts1_lbl0" xml:lang="en-US">Costs of exit from leased premises</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessExitCosts1" xlink:to="us-gaap_BusinessExitCosts1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl" xml:lang="en-US">Bargain purchase gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl0" xml:lang="en-US">Bargain purchase gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl1" xml:lang="en-US">Bargain purchase gain (3)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_NoncashInterestExpenseOnLiability" xlink:href="vxrt-20181231.xsd#vxrt_NoncashInterestExpenseOnLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="vxrt_NoncashInterestExpenseOnLiability_lbl" xml:lang="en-US">Non-cash interest expense related to sale of future royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NoncashInterestExpenseOnLiability" xlink:to="vxrt_NoncashInterestExpenseOnLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">(Loss) gain on sale of equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0" xml:lang="en-US">Loss (gain) on sale of equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="vxrt_GainlossOnRevaluationOfFinancialInstruments" xlink:href="vxrt-20181231.xsd#vxrt_GainlossOnRevaluationOfFinancialInstruments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_GainlossOnRevaluationOfFinancialInstruments_lbl" xml:lang="en-US">(Loss) gain on revaluation of financial instruments, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_GainlossOnRevaluationOfFinancialInstruments" xlink:to="vxrt_GainlossOnRevaluationOfFinancialInstruments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign exchange loss, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income and (expenses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Net loss before provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net income (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xml:lang="en-US">Series B and C preferred dividend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net comprehensive loss attributable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0" xml:lang="en-US">Net loss attributable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1" xml:lang="en-US">Net income (loss) attributable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Net loss per share &#8211; basic and diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl0" xml:lang="en-US">Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Shares used to compute net loss per share &#8211; basic and diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0" xml:lang="en-US">Shares used to compute net loss per share, basic and diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock upon exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock upon exercise of stock options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of common stock upon conversion of convertible promissory notes, related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of common stock upon conversion of convertible promissory notes, related parties (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock" xlink:href="vxrt-20181231.xsd#vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock_lbl" xml:lang="en-US">Issuance of common stock upon conversion of convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock" xlink:to="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock" xlink:href="vxrt-20181231.xsd#vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock_lbl" xml:lang="en-US">Issuance of common stock upon conversion of convertible preferred stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock" xlink:to="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Reclassification of warrant to equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Issuance of common stock uponreverse merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Issuance of common stock uponreverse merger (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ImpairmentofPropertyAndEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ImpairmentofPropertyAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ImpairmentofPropertyAndEquipment_lbl" xml:lang="en-US">Impairment of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ImpairmentofPropertyAndEquipment" xlink:to="vxrt_ImpairmentofPropertyAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AmortizationOfDiscountOnShorttermInvestments" xlink:href="vxrt-20181231.xsd#vxrt_AmortizationOfDiscountOnShorttermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AmortizationOfDiscountOnShorttermInvestments_lbl" xml:lang="en-US">Amortization of discount on short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AmortizationOfDiscountOnShorttermInvestments" xlink:to="vxrt_AmortizationOfDiscountOnShorttermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_LossgainOnRevaluationOfFinancialInstruments" xlink:href="vxrt-20181231.xsd#vxrt_LossgainOnRevaluationOfFinancialInstruments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="vxrt_LossgainOnRevaluationOfFinancialInstruments_lbl" xml:lang="en-US">Loss (gain) on revaluation of financial instruments, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LossgainOnRevaluationOfFinancialInstruments" xlink:to="vxrt_LossgainOnRevaluationOfFinancialInstruments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashExpense_lbl" xml:lang="en-US">Non-cash interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of note discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties_lbl" xml:lang="en-US">Non-cash interest expense related to sale of future royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" xlink:to="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties_lbl" xml:lang="en-US">Non-cash revenue related to sale of future royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties" xlink:to="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ProceedsFromSaleOfEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ProceedsFromSaleOfEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ProceedsFromSaleOfEquipment_lbl" xml:lang="en-US">Proceeds from sale of equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ProceedsFromSaleOfEquipment" xlink:to="vxrt_ProceedsFromSaleOfEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CashAcquiredInReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_CashAcquiredInReverseMerger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CashAcquiredInReverseMerger_lbl" xml:lang="en-US">Cash acquired in reverse merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CashAcquiredInReverseMerger" xlink:to="vxrt_CashAcquiredInReverseMerger_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_PaymentsForfractionalsharesinmerger" xlink:href="vxrt-20181231.xsd#vxrt_PaymentsForfractionalsharesinmerger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="vxrt_PaymentsForfractionalsharesinmerger_lbl" xml:lang="en-US">Cash paid for fractional shares in merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PaymentsForfractionalsharesinmerger" xlink:to="vxrt_PaymentsForfractionalsharesinmerger_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Purchases of short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl" xml:lang="en-US">Proceeds from maturities of short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of principal on secured promissory note payable to Oxford Finance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl" xml:lang="en-US">Repayment of short-term note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockIssuedDuringPeriodValueUponReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_StockIssuedDuringPeriodValueUponReverseMerger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_StockIssuedDuringPeriodValueUponReverseMerger_lbl" xml:lang="en-US">Issuance of common stock upon reverse merger, net of cash paid for partial shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockIssuedDuringPeriodValueUponReverseMerger" xlink:to="vxrt_StockIssuedDuringPeriodValueUponReverseMerger_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger_lbl" xml:lang="en-US">Conversion of convertible promissory notes, related parties into common stock upon reverse merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger" xlink:to="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity" xlink:href="vxrt-20181231.xsd#vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity_lbl" xml:lang="en-US">Reclassification of convertible preferred stock warrant liability to equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity" xlink:to="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_lbl" xml:lang="en-US">Acquisition of property and equipment included in accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_EstimatedUsefulLivesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_EstimatedUsefulLivesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_EstimatedUsefulLivesAbstract_lbl" xml:lang="en-US">Estimated Useful Lives [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_EstimatedUsefulLivesAbstract" xlink:to="vxrt_EstimatedUsefulLivesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_LaboratoryEquipmentMember" xlink:href="vxrt-20181231.xsd#vxrt_LaboratoryEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_LaboratoryEquipmentMember_lbl" xml:lang="en-US">Laboratory Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LaboratoryEquipmentMember" xlink:to="vxrt_LaboratoryEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Lives, Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US">Business Combinations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_TotalPurchasePriceForAviragenAbstract" xlink:href="vxrt-20181231.xsd#vxrt_TotalPurchasePriceForAviragenAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_TotalPurchasePriceForAviragenAbstract_lbl" xml:lang="en-US">Total purchase price for Aviragen [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_TotalPurchasePriceForAviragenAbstract" xlink:to="vxrt_TotalPurchasePriceForAviragenAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xml:lang="en-US">Common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl0" xml:lang="en-US">Purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl0"/>
    <loc xlink:type="locator" xlink:label="vxrt_AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract" xlink:href="vxrt-20181231.xsd#vxrt_AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract_lbl" xml:lang="en-US">Allocation of the purchase price to the fair value of the respective assets and liabilities acquired [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract" xlink:to="vxrt_AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Developed technology (1)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xml:lang="en-US">In-process research and development (2)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl" xml:lang="en-US">Other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties_lbl" xml:lang="en-US">Liability related to sale of future royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" xlink:to="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Net assets acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Restatement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAdjustmentMember_lbl" xml:lang="en-US">Restatement Adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract_lbl" xml:lang="en-US">Selected amounts related to Aviragen&apos;s business included in the Company&apos;s consolidated statement of operations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract" xlink:to="vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_UnauditedProFormaInformationIsSummarizedAbstract" xlink:href="vxrt-20181231.xsd#vxrt_UnauditedProFormaInformationIsSummarizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_UnauditedProFormaInformationIsSummarizedAbstract_lbl" xml:lang="en-US">Unaudited pro forma information is summarized [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_UnauditedProFormaInformationIsSummarizedAbstract" xlink:to="vxrt_UnauditedProFormaInformationIsSummarizedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Total revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Company&apos;s financial assets and liabilities measured at fair value [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract" xlink:to="vxrt_CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Financial Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CorporateBondsMember" xlink:href="vxrt-20181231.xsd#vxrt_CorporateBondsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_CorporateBondsMember_lbl" xml:lang="en-US">Corporate Bonds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CorporateBondsMember" xlink:to="vxrt_CorporateBondsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US">Liability Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember_lbl" xml:lang="en-US">Convertible Promissory Notes Embedded Derivative Liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xlink:to="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Financial Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityMember_lbl" xml:lang="en-US">Convertible Preferred Stock Warrant Liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePreferredStockWarrantLiabilityMember" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract" xlink:href="vxrt-20181231.xsd#vxrt_AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract_lbl" xml:lang="en-US">A reconciliation of all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract" xlink:to="vxrt_AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Balance at January 1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0" xml:lang="en-US">Balance at December 31</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xml:lang="en-US">Issuances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US">Revaluation loss gains included in (loss) gain on revaluation of financial instruments, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_lbl" xml:lang="en-US">Settlements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_lbl" xml:lang="en-US">Total gain (losses) included in other income and (expenses) attributable to liabilities still held</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract_lbl" xml:lang="en-US">Disclosure Text Block Supplement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_DisclosureTextBlockSupplementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CashEquivalentsAndShortTermInvestmentsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CashEquivalentsAndShortTermInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CashEquivalentsAndShortTermInvestmentsAbstract_lbl" xml:lang="en-US">Cash equivalents and short-term investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="vxrt_CashEquivalentsAndShortTermInvestmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_lbl" xml:lang="en-US">Amortized Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_lbl" xml:lang="en-US">Gross Unrecognized Gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:to="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_lbl" xml:lang="en-US">Gross Unrecognized Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:to="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue_lbl" xml:lang="en-US">Estimated Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsMember_lbl" xml:lang="en-US">Cash Equivalents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsMember" xlink:to="us-gaap_CashEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xml:lang="en-US">Short-term Investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccountsReceivableNetOfAllowanceAbstract" xlink:href="vxrt-20181231.xsd#vxrt_AccountsReceivableNetOfAllowanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AccountsReceivableNetOfAllowanceAbstract_lbl" xml:lang="en-US">Accounts receivable net of allowance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccountsReceivableNetOfAllowanceAbstract" xlink:to="vxrt_AccountsReceivableNetOfAllowanceAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RoyaltiesReceivable" xlink:href="vxrt-20181231.xsd#vxrt_RoyaltiesReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RoyaltiesReceivable_lbl" xml:lang="en-US">Royalties receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RoyaltiesReceivable" xlink:to="vxrt_RoyaltiesReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BilledContractReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BilledContractReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BilledContractReceivables_lbl" xml:lang="en-US">Government contract &#8211; billed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BilledContractReceivables" xlink:to="us-gaap_BilledContractReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnbilledContractsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnbilledContractsReceivable_lbl" xml:lang="en-US">Government contract &#8211; unbilled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnbilledContractsReceivable" xlink:to="us-gaap_UnbilledContractsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_PropertyAndEquipmentNetAbstract" xlink:href="vxrt-20181231.xsd#vxrt_PropertyAndEquipmentNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_PropertyAndEquipmentNetAbstract_lbl" xml:lang="en-US">Property and equipment, net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PropertyAndEquipmentNetAbstract" xlink:to="vxrt_PropertyAndEquipmentNetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_LaboratoryEquipmentGross" xlink:href="vxrt-20181231.xsd#vxrt_LaboratoryEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_LaboratoryEquipmentGross_lbl" xml:lang="en-US">Laboratory equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LaboratoryEquipmentGross" xlink:to="vxrt_LaboratoryEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_OfficeAndComputerEquipmentGross" xlink:href="vxrt-20181231.xsd#vxrt_OfficeAndComputerEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_OfficeAndComputerEquipmentGross_lbl" xml:lang="en-US">Office and computer equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OfficeAndComputerEquipmentGross" xlink:to="vxrt_OfficeAndComputerEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US">Leasehold improvements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Total property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_IntangibleAssetsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_IntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_IntangibleAssetsAbstract_lbl" xml:lang="en-US">Intangible assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_IntangibleAssetsAbstract" xlink:to="vxrt_IntangibleAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_PurchasedTechnologyMember" xlink:href="vxrt-20181231.xsd#vxrt_PurchasedTechnologyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_PurchasedTechnologyMember_lbl" xml:lang="en-US">Purchased Technology [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PurchasedTechnologyMember" xlink:to="vxrt_PurchasedTechnologyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Intangible assets, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xml:lang="en-US">In Process Research and Development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xml:lang="en-US">Intellectual Property [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntellectualPropertyMember" xlink:to="us-gaap_IntellectualPropertyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less accumulated amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:href="vxrt-20181231.xsd#vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract_lbl" xml:lang="en-US">The estimated future amortization expense by year [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2019</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2020</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedLiabilitiesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_AccruedLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AccruedLiabilitiesAbstract_lbl" xml:lang="en-US">Accrued liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccruedLiabilitiesAbstract" xlink:to="vxrt_AccruedLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedCompensationCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedCompensationCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AccruedCompensationCurrent_lbl" xml:lang="en-US">Accrued compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccruedCompensationCurrent" xlink:to="vxrt_AccruedCompensationCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedClinicalAndManufacturingExpensesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedClinicalAndManufacturingExpensesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AccruedClinicalAndManufacturingExpensesCurrent_lbl" xml:lang="en-US">Accrued clinical and manufacturing expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccruedClinicalAndManufacturingExpensesCurrent" xlink:to="vxrt_AccruedClinicalAndManufacturingExpensesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedProfessionalAndConsultingServicesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedProfessionalAndConsultingServicesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AccruedProfessionalAndConsultingServicesCurrent_lbl" xml:lang="en-US">Accrued professional and consulting services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccruedProfessionalAndConsultingServicesCurrent" xlink:to="vxrt_AccruedProfessionalAndConsultingServicesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ReserveForReturnOfRoyaltiesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_ReserveForReturnOfRoyaltiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ReserveForReturnOfRoyaltiesCurrent_lbl" xml:lang="en-US">Reserve for return of royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ReserveForReturnOfRoyaltiesCurrent" xlink:to="vxrt_ReserveForReturnOfRoyaltiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRentCreditCurrent_lbl" xml:lang="en-US">Deferred rent and lease loss accrual, current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent_lbl" xml:lang="en-US">Convertible preferred stock warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RevenueAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RevenueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RevenueAbstract_lbl" xml:lang="en-US">Revenue [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RevenueAbstract" xlink:to="vxrt_RevenueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract_lbl" xml:lang="en-US">Liability related to sale of future Royalties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:to="vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Total Liability related to sale of future royalties, February 13, 2018</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_LongTermDebt_lbl0" xml:lang="en-US">TotalLiability related to sale of future royalties, December 31, 2018</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl0"/>
    <loc xlink:type="locator" xlink:label="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid" xlink:href="vxrt-20181231.xsd#vxrt_DebtRevenueNonCashRoyaltyRevenuePaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid_lbl" xml:lang="en-US">Non-cash royalty revenue paid to HCRP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid" xlink:to="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_DebtNoncashInterestExpenseRecognized" xlink:href="vxrt-20181231.xsd#vxrt_DebtNoncashInterestExpenseRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_DebtNoncashInterestExpenseRecognized_lbl" xml:lang="en-US">Non-cash interest expense recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DebtNoncashInterestExpenseRecognized" xlink:to="vxrt_DebtNoncashInterestExpenseRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract_lbl" xml:lang="en-US">Convertible Promissory Notes, Related Party [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNotePayableAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayableAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SecuredPromissoryNotePayableAbstract_lbl" xml:lang="en-US">Secured Promissory Note Payable [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SecuredPromissoryNotePayableAbstract" xlink:to="vxrt_SecuredPromissoryNotePayableAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract_lbl" xml:lang="en-US">Liabilities related to costs of exit from leased premises [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_RestructuringReserve_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="us-gaap_RestructuringReserve_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RestructuringReserve_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="us-gaap_RestructuringReserve_lbl0"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredRentOnCeaseuseDate" xlink:href="vxrt-20181231.xsd#vxrt_DeferredRentOnCeaseuseDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_DeferredRentOnCeaseuseDate_lbl" xml:lang="en-US">Deferred rent on cease-use date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DeferredRentOnCeaseuseDate" xlink:to="vxrt_DeferredRentOnCeaseuseDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLeasehold" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfLeasehold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_ImpairmentOfLeasehold_lbl" xml:lang="en-US">Impairment of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLeasehold" xlink:to="us-gaap_ImpairmentOfLeasehold_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRestructuring_lbl" xml:lang="en-US">Cash paid, net of receipts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRestructuring" xlink:to="us-gaap_PaymentsForRestructuring_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccretionExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccretionExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpense_lbl" xml:lang="en-US">Accretion charges, included in rent expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract_lbl" xml:lang="en-US">Future minimum payments and sublease income under operating leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2019</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_lbl" xml:lang="en-US">2019</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2020</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_lbl" xml:lang="en-US">2020</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_lbl" xml:lang="en-US">2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xml:lang="en-US">Thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter_lbl" xml:lang="en-US">Thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePreferredStockAbstract_lbl" xml:lang="en-US">Convertible preferred stock [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePreferredStockAbstract" xlink:to="vxrt_ConvertiblePreferredStockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl" xml:lang="en-US">Equity Interest Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US">Series C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommonStockReservedForIssuanceAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockReservedForIssuanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CommonStockReservedForIssuanceAbstract_lbl" xml:lang="en-US">Common stock reserved for issuance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CommonStockReservedForIssuanceAbstract" xlink:to="vxrt_CommonStockReservedForIssuanceAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommonStockReservedForIssuanceAxis" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockReservedForIssuanceAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_CommonStockReservedForIssuanceAxis_lbl" xml:lang="en-US">Common Stock Reserved For Issuance [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CommonStockReservedForIssuanceAxis" xlink:to="vxrt_CommonStockReservedForIssuanceAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockOutstandingMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockOutstandingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_ConvertiblePreferredStockOutstandingMember_lbl" xml:lang="en-US">Convertible Preferred Stock Outstanding [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePreferredStockOutstandingMember" xlink:to="vxrt_ConvertiblePreferredStockOutstandingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock reserved for issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_OptionsIssuedAndOutstandingMember" xlink:href="vxrt-20181231.xsd#vxrt_OptionsIssuedAndOutstandingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_OptionsIssuedAndOutstandingMember_lbl" xml:lang="en-US">Options Issued And Outstanding [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OptionsIssuedAndOutstandingMember" xlink:to="vxrt_OptionsIssuedAndOutstandingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_OptionsAvailableForFutureGrantsMember" xlink:href="vxrt-20181231.xsd#vxrt_OptionsAvailableForFutureGrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_OptionsAvailableForFutureGrantsMember_lbl" xml:lang="en-US">Options Available For Future Grants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OptionsAvailableForFutureGrantsMember" xlink:to="vxrt_OptionsAvailableForFutureGrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CumulativeConvertiblePreferredStockDividendsMember" xlink:href="vxrt-20181231.xsd#vxrt_CumulativeConvertiblePreferredStockDividendsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_CumulativeConvertiblePreferredStockDividendsMember_lbl" xml:lang="en-US">Cumulative Convertible Preferred Stock Dividends [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CumulativeConvertiblePreferredStockDividendsMember" xlink:to="vxrt_CumulativeConvertiblePreferredStockDividendsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommonStockWarrantsMember" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_CommonStockWarrantsMember_lbl" xml:lang="en-US">Common Stock Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CommonStockWarrantsMember" xlink:to="vxrt_CommonStockWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SummaryOfStockOptionAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SummaryOfStockOptionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SummaryOfStockOptionAbstract_lbl" xml:lang="en-US">Summary of stock option [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SummaryOfStockOptionAbstract" xlink:to="vxrt_SummaryOfStockOptionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod_lbl" xml:lang="en-US">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod_lbl" xml:lang="en-US">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_lbl" xml:lang="en-US">Canceled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Canceled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Canceled (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan_lbl" xml:lang="en-US">Termination of Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger_lbl" xml:lang="en-US">Assumed on consummation of Merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_lbl" xml:lang="en-US">Assumed on consummation of Merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Assumed on consummation of Merger (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_FairValuesEstimatedAssumptionsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_FairValuesEstimatedAssumptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_FairValuesEstimatedAssumptionsAbstract_lbl" xml:lang="en-US">Fair values estimated assumptions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_FairValuesEstimatedAssumptionsAbstract" xlink:to="vxrt_FairValuesEstimatedAssumptionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_TotalStockBasedCompensationRecognizedForOptionsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_TotalStockBasedCompensationRecognizedForOptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_TotalStockBasedCompensationRecognizedForOptionsAbstract_lbl" xml:lang="en-US">Total stock-based compensation recognized for options [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_TotalStockBasedCompensationRecognizedForOptionsAbstract" xlink:to="vxrt_TotalStockBasedCompensationRecognizedForOptionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ComponentsOfIncomeTaxesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ComponentsOfIncomeTaxesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ComponentsOfIncomeTaxesAbstract_lbl" xml:lang="en-US">Components of income taxes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ComponentsOfIncomeTaxesAbstract" xlink:to="vxrt_ComponentsOfIncomeTaxesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total Deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ComponentsOfTheDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Components of the deferred tax assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="vxrt_ComponentsOfTheDeferredTaxAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carry-forwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Research and development tax credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Capitalized research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_DeferredTaxAssetsSaleOfFutureRoyalties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties_lbl" xml:lang="en-US">Sale of future royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties" xlink:to="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xml:lang="en-US">Accruals, reserves and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax assets net of valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract_lbl" xml:lang="en-US">Reconciliation of the provision for income taxes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">U.S. federal taxes at statutory rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes (net of federal benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign rate differential</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther_lbl" xml:lang="en-US">Global intangible low-taxed income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest" xlink:href="vxrt-20181231.xsd#vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest_lbl" xml:lang="en-US">Convertible note interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest" xlink:to="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_lbl" xml:lang="en-US">Revaluation of derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xml:lang="en-US">Tax credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Impact of tax reform rate change</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">NOL and credit adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain" xlink:href="vxrt-20181231.xsd#vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain_lbl" xml:lang="en-US">Bargain purchase gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain" xlink:to="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract_lbl" xml:lang="en-US">Reconciliation of the unrecognized tax benefits [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:to="vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Beginning Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl0" xml:lang="en-US">Ending Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US">Additions based on tax positions related to the current year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US">Decreases related to prior years&#8217; tax positions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract_lbl" xml:lang="en-US">Calculation of basic and diluted net loss per share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xml:lang="en-US">Series B and C preferred dividend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract_lbl" xml:lang="en-US">Potentially dilutive securities excluded from the computation of diluted weighted average shares [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract" xlink:to="vxrt_PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Employee Stock Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Potentially dilutive securities excluded from denominator of the diluted earnings per share computation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SeriesBAndCPreferredStockMember" xlink:href="vxrt-20181231.xsd#vxrt_SeriesBAndCPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_SeriesBAndCPreferredStockMember_lbl" xml:lang="en-US">Series B And C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SeriesBAndCPreferredStockMember" xlink:to="vxrt_SeriesBAndCPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyMember_lbl" xml:lang="en-US">Convertible Promissory Notes Related Party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartyMember" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SelectedSummarizedQuarterlyFinancialAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SelectedSummarizedQuarterlyFinancialAbstract_lbl" xml:lang="en-US">Selected summarized quarterly financial [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="vxrt_SelectedSummarizedQuarterlyFinancialAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net income (loss) per share &#8211; basic (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net income (loss) per share &#8211; diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity (Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; equity (deficit):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenue:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operatingexpenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other income and (expenses):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US">Schedule Of Property Plant And Equipment Useful Life [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Business Combination Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock_lbl" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_IntangibleAssetsAbstract0" xlink:href="vxrt-20181231.xsd#vxrt_IntangibleAssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_IntangibleAssetsAbstract0_lbl" xml:lang="en-US">Intangible assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_IntangibleAssetsAbstract0" xlink:to="vxrt_IntangibleAssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RecurringFinancialAssetsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RecurringFinancialAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RecurringFinancialAssetsAbstract_lbl" xml:lang="en-US">Recurring Financial Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RecurringFinancialAssetsAbstract" xlink:to="vxrt_RecurringFinancialAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RecurringFinancialLiabilitiesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RecurringFinancialLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RecurringFinancialLiabilitiesAbstract_lbl" xml:lang="en-US">Recurring Financial Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RecurringFinancialLiabilitiesAbstract" xlink:to="vxrt_RecurringFinancialLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RecurringFinancialAssetsAbstract0" xlink:href="vxrt-20181231.xsd#vxrt_RecurringFinancialAssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_RecurringFinancialAssetsAbstract0_lbl" xml:lang="en-US">Recurring Financial Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RecurringFinancialAssetsAbstract0" xlink:to="vxrt_RecurringFinancialAssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RecurringFinancialLiabilitiesAbstract0" xlink:href="vxrt-20181231.xsd#vxrt_RecurringFinancialLiabilitiesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_RecurringFinancialLiabilitiesAbstract0_lbl" xml:lang="en-US">Recurring Financial Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RecurringFinancialLiabilitiesAbstract0" xlink:to="vxrt_RecurringFinancialLiabilitiesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ReportedAsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ReportedAsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ReportedAsAbstract_lbl" xml:lang="en-US">Reported as:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ReportedAsAbstract" xlink:to="vxrt_ReportedAsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ReportedAsAbstract0" xlink:href="vxrt-20181231.xsd#vxrt_ReportedAsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_ReportedAsAbstract0_lbl" xml:lang="en-US">Reported as:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ReportedAsAbstract0" xlink:to="vxrt_ReportedAsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</label>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZi7YfzVIAspPbJuDylcYRVpSzHijjkNCYpD7o9WcfUwu/9uo1X+/k4jp6oPRfpgx2gurzW//2t+l3nLsqChCk2dbDArpcIr4CikQhf0AXguBDQTnCrO4B9rKkWv2LsFu37D0Y4AbkakUwTuLYs/E3V1keGj5YpcgNG] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RevenueTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_RevenueTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RevenueTextBlock_lbl" xml:lang="en-US">Revenue [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RevenueTextBlock" xlink:to="vxrt_RevenueTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock_lbl" xml:lang="en-US">Deferred Revenue Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueByArrangementDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock_lbl" xml:lang="en-US">Deferred Revenue, by Arrangement, Disclosure [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:to="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock_lbl" xml:lang="en-US">Convertible Promissory Notes, Related Party [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNotePayableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SecuredPromissoryNotePayableTextBlock_lbl" xml:lang="en-US">Secured Promissory Note Payable [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SecuredPromissoryNotePayableTextBlock" xlink:to="vxrt_SecuredPromissoryNotePayableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_lbl" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl" xml:lang="en-US">Schedule Of Convertible Preferred Stock [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:to="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" xml:lang="en-US">Schedule Of Common Stock Reserved For Issuance [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:to="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_UnlabeledAbstract" xlink:href="vxrt-20181231.xsd#vxrt_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_UnlabeledAbstract" xlink:to="vxrt_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CurrentAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CurrentAbstract_lbl" xml:lang="en-US">Current:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CurrentAbstract" xlink:to="vxrt_CurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredAbstract" xlink:href="vxrt-20181231.xsd#vxrt_DeferredAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_DeferredAbstract_lbl" xml:lang="en-US">Deferred:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DeferredAbstract" xlink:to="vxrt_DeferredAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_PermanentItemsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_PermanentItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_PermanentItemsAbstract_lbl" xml:lang="en-US">Permanent items:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PermanentItemsAbstract" xlink:to="vxrt_PermanentItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">Quarterly Financial Information [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_lbl" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConversionMember" xlink:href="vxrt-20181231.xsd#vxrt_ConversionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_ConversionMember_lbl" xml:lang="en-US">Conversion [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConversionMember" xlink:to="vxrt_ConversionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember" xlink:href="vxrt-20181231.xsd#vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember_lbl" xml:lang="en-US">Private Vaxarts Stockholders Warrantholders And Optionsholders [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember" xlink:to="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AviragensStockholderrsAndOptionsholdersMember" xlink:href="vxrt-20181231.xsd#vxrt_AviragensStockholderrsAndOptionsholdersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_AviragensStockholderrsAndOptionsholdersMember_lbl" xml:lang="en-US">Aviragens Stockholderrs And Optionsholders [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AviragensStockholderrsAndOptionsholdersMember" xlink:to="vxrt_AviragensStockholderrsAndOptionsholdersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_OxfordFinanceMember" xlink:href="vxrt-20181231.xsd#vxrt_OxfordFinanceMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_OxfordFinanceMember_lbl" xml:lang="en-US">Oxford Finance [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OxfordFinanceMember" xlink:to="vxrt_OxfordFinanceMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseArrangementTypeAxis_lbl" xml:lang="en-US">Lease Arrangement, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RecognizeLeaseLiabilitiesMember" xlink:href="vxrt-20181231.xsd#vxrt_RecognizeLeaseLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_RecognizeLeaseLiabilitiesMember_lbl" xml:lang="en-US">Recognize Lease Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RecognizeLeaseLiabilitiesMember" xlink:to="vxrt_RecognizeLeaseLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_DerecognizeLeaseLiabilitiesMember" xlink:href="vxrt-20181231.xsd#vxrt_DerecognizeLeaseLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_DerecognizeLeaseLiabilitiesMember_lbl" xml:lang="en-US">Derecognize Lease Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DerecognizeLeaseLiabilitiesMember" xlink:to="vxrt_DerecognizeLeaseLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanRestructuringModificationNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LoanRestructuringModificationNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoanRestructuringModificationNameAxis_lbl" xml:lang="en-US">Loan Restructuring Modification Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoanRestructuringModificationNameAxis" xlink:to="us-gaap_LoanRestructuringModificationNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EntityLoanModificationProgramMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EntityLoanModificationProgramMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EntityLoanModificationProgramMember_lbl" xml:lang="en-US">Entity Loan Modification Program [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityLoanModificationProgramMember" xlink:to="us-gaap_EntityLoanModificationProgramMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_HHSBARDAMember" xlink:href="vxrt-20181231.xsd#vxrt_HHSBARDAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_HHSBARDAMember_lbl" xml:lang="en-US">HHSBARDA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_HHSBARDAMember" xlink:to="vxrt_HHSBARDAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RelenzaRecognizedMember" xlink:href="vxrt-20181231.xsd#vxrt_RelenzaRecognizedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_RelenzaRecognizedMember_lbl" xml:lang="en-US">Relenza Recognized [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RelenzaRecognizedMember" xlink:to="vxrt_RelenzaRecognizedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AviragenTherapeuticsIncMember" xlink:href="vxrt-20181231.xsd#vxrt_AviragenTherapeuticsIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_AviragenTherapeuticsIncMember_lbl" xml:lang="en-US">Aviragen Therapeutics Inc [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AviragenTherapeuticsIncMember" xlink:to="vxrt_AviragenTherapeuticsIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_InavirRecognizedMember" xlink:href="vxrt-20181231.xsd#vxrt_InavirRecognizedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_InavirRecognizedMember_lbl" xml:lang="en-US">Inavir Recognized [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_InavirRecognizedMember" xlink:to="vxrt_InavirRecognizedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_JP" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_JP_lbl" xml:lang="en-US">JAPAN</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_JP" xlink:to="country_JP_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_HCRPMember" xlink:href="vxrt-20181231.xsd#vxrt_HCRPMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_HCRPMember_lbl" xml:lang="en-US">HCRP [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_HCRPMember" xlink:to="vxrt_HCRPMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis_lbl" xml:lang="en-US">Deferred Revenue Arrangement Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyArrangementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyArrangementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyArrangementMember_lbl" xml:lang="en-US">Royalty Arrangement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyArrangementMember" xlink:to="us-gaap_RoyaltyArrangementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_NotePurchaseAgreementMember" xlink:href="vxrt-20181231.xsd#vxrt_NotePurchaseAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_NotePurchaseAgreementMember_lbl" xml:lang="en-US">Note Purchase Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NotePurchaseAgreementMember" xlink:to="vxrt_NotePurchaseAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecondNotePurchaseAgreementMember" xlink:href="vxrt-20181231.xsd#vxrt_SecondNotePurchaseAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_SecondNotePurchaseAgreementMember_lbl" xml:lang="en-US">Second Note Purchase Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SecondNotePurchaseAgreementMember" xlink:to="vxrt_SecondNotePurchaseAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl" xml:lang="en-US">Debt Conversion Description [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_NotesIssuedIn2014Member" xlink:href="vxrt-20181231.xsd#vxrt_NotesIssuedIn2014Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_NotesIssuedIn2014Member_lbl" xml:lang="en-US">Notes Issued In 2014 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NotesIssuedIn2014Member" xlink:to="vxrt_NotesIssuedIn2014Member_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_NotesIssuedIn2015Member" xlink:href="vxrt-20181231.xsd#vxrt_NotesIssuedIn2015Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_NotesIssuedIn2015Member_lbl" xml:lang="en-US">Notes Issued In 2015 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NotesIssuedIn2015Member" xlink:to="vxrt_NotesIssuedIn2015Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_ConvertiblePromissoryNotesMember_lbl" xml:lang="en-US">Convertible Promissory Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesMember" xlink:to="vxrt_ConvertiblePromissoryNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_LoanAgreementMember" xlink:href="vxrt-20181231.xsd#vxrt_LoanAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_LoanAgreementMember_lbl" xml:lang="en-US">Loan Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LoanAgreementMember" xlink:to="vxrt_LoanAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US">Variable Rate [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_TheFirstLeaseMember" xlink:href="vxrt-20181231.xsd#vxrt_TheFirstLeaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_TheFirstLeaseMember_lbl" xml:lang="en-US">The First Lease [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_TheFirstLeaseMember" xlink:to="vxrt_TheFirstLeaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember" xlink:href="vxrt-20181231.xsd#vxrt_OfficeSpaceInSanFranciscoCaliforniaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember_lbl" xml:lang="en-US">Office Space In San Francisco California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember" xlink:to="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RemainingThreeLeasesMember" xlink:href="vxrt-20181231.xsd#vxrt_RemainingThreeLeasesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_RemainingThreeLeasesMember_lbl" xml:lang="en-US">Remaining Three Leases [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RemainingThreeLeasesMember" xlink:to="vxrt_RemainingThreeLeasesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_OfficeSpaceInAlpharettaGeorgiaMember" xlink:href="vxrt-20181231.xsd#vxrt_OfficeSpaceInAlpharettaGeorgiaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="vxrt_OfficeSpaceInAlpharettaGeorgiaMember_lbl" xml:lang="en-US">Office Space In Alpharetta Georgia [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OfficeSpaceInAlpharettaGeorgiaMember" xlink:to="vxrt_OfficeSpaceInAlpharettaGeorgiaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsAxis_lbl" xml:lang="en-US">Dividends [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendPaidMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendPaidMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendPaidMember_lbl" xml:lang="en-US">Dividend Paid [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendPaidMember" xlink:to="us-gaap_DividendPaidMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Authority [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State and Local Jurisdiction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_AU" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_AU"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AU_lbl" xml:lang="en-US">AUSTRALIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_GB"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GB_lbl" xml:lang="en-US">UNITED KINGDOM</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl"/>
    <loc xlink:type="locator" xlink:label="country_FR" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_FR"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_FR_lbl" xml:lang="en-US">FRANCE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_FR" xlink:to="country_FR_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Conversion of Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Stockholders&apos; Equity, Reverse Stock Split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Stock Splits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare" xlink:href="vxrt-20181231.xsd#vxrt_ExchangeRatioNumberOfSharesExchangedPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare_lbl" xml:lang="en-US">Exchange Ratio, Number of Shares Exchanged Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare" xlink:to="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_LoanAgreementBorrowedAmount" xlink:href="vxrt-20181231.xsd#vxrt_LoanAgreementBorrowedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_LoanAgreementBorrowedAmount_lbl" xml:lang="en-US">Loan Agreement, Borrowed Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LoanAgreementBorrowedAmount" xlink:to="vxrt_LoanAgreementBorrowedAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCash" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US">Restricted Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_IncreaseDecreaseInAccumulatedDeficit" xlink:href="vxrt-20181231.xsd#vxrt_IncreaseDecreaseInAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_IncreaseDecreaseInAccumulatedDeficit_lbl" xml:lang="en-US">Increase (Decrease) In Accumulated Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_IncreaseDecreaseInAccumulatedDeficit" xlink:to="vxrt_IncreaseDecreaseInAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xml:lang="en-US">Business Combination, Acquisition Related Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xml:lang="en-US">Research and Development in Process</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentInProcess" xlink:to="us-gaap_ResearchAndDevelopmentInProcess_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xml:lang="en-US">Contract with Customer, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_lbl" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Modification of Contract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:to="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of Goods and Services Sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RoyaltyPercentage" xlink:href="vxrt-20181231.xsd#vxrt_RoyaltyPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RoyaltyPercentage_lbl" xml:lang="en-US">Royalty Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RoyaltyPercentage" xlink:to="vxrt_RoyaltyPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_NonCashRoyaltyRevenue" xlink:href="vxrt-20181231.xsd#vxrt_NonCashRoyaltyRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_NonCashRoyaltyRevenue_lbl" xml:lang="en-US">Non Cash Royalty Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NonCashRoyaltyRevenue" xlink:to="vxrt_NonCashRoyaltyRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_DebtAdditions" xlink:href="vxrt-20181231.xsd#vxrt_DebtAdditions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_DebtAdditions_lbl" xml:lang="en-US">Debt, Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DebtAdditions" xlink:to="vxrt_DebtAdditions_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_HCRPAgreementRevenueTerms" xlink:href="vxrt-20181231.xsd#vxrt_HCRPAgreementRevenueTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_HCRPAgreementRevenueTerms_lbl" xml:lang="en-US">HCRP Agreement, Revenue Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_HCRPAgreementRevenueTerms" xlink:to="vxrt_HCRPAgreementRevenueTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyIncomeNonoperating" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyIncomeNonoperating_lbl" xml:lang="en-US">Royalty Income, Nonoperating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyIncomeNonoperating" xlink:to="us-gaap_RoyaltyIncomeNonoperating_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US">Embedded Derivative, Fair Value of Embedded Derivative Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Debt Issuance Costs, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentInterest_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment, Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Debt Instrument, Unamortized Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOwnershipInterestsValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOwnershipInterestsValue_lbl" xml:lang="en-US">Other Ownership Interests, Contributed Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsValue" xlink:to="us-gaap_OtherOwnershipInterestsValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Long-term Debt, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPaymentTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xml:lang="en-US">Debt Instrument, Payment Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPaymentTerms" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xml:lang="en-US">Warrants Not Settleable in Cash, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest Expense, Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear_lbl" xml:lang="en-US">Debt Conversion, Converted Instrument, Issuance Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear" xlink:to="us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US">Operating Lease, Impairment Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePerDollarAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendRatePerDollarAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePerDollarAmount_lbl" xml:lang="en-US">Preferred Stock, Dividend Rate, Per-Dollar-Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePerDollarAmount" xlink:to="us-gaap_PreferredStockDividendRatePerDollarAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears_lbl" xml:lang="en-US">Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" xlink:to="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStock_lbl" xml:lang="en-US">Dividends, Preferred Stock (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsPerShareDeclared" xlink:to="us-gaap_PreferredStockDividendsPerShareDeclared_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl" xml:lang="en-US">Convertible Preferred Stock, Terms of Conversion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreference_lbl" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreference" xlink:to="us-gaap_PreferredStockLiquidationPreference_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockVotingRights" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockVotingRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockVotingRights_lbl" xml:lang="en-US">Preferred Stock, Voting Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockVotingRights" xlink:to="us-gaap_PreferredStockVotingRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockVotingRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common Stock, Voting Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_IncreaseDecreaseInDeferredTaxes" xlink:href="vxrt-20181231.xsd#vxrt_IncreaseDecreaseInDeferredTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_IncreaseDecreaseInDeferredTaxes_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_IncreaseDecreaseInDeferredTaxes" xlink:to="vxrt_IncreaseDecreaseInDeferredTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US">Tax Credit Carryforward, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">Receivables, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock_lbl" xml:lang="en-US">Accrued Clinical And Manufacturing Expenses Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" xlink:to="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock_lbl" xml:lang="en-US">Convertible Preferred Stock Warrant Liability Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US">Product and Service [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Estimated Useful Lives [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" xlink:to="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Estimated Useful Lives [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" xlink:to="vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementDomain_lbl" xml:lang="en-US">Restatement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable_lbl" xml:lang="en-US">Business Combination (Details) - Allocation of the purchase price to the fair value of the respective assets and liabilities acquired [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" xlink:to="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems_lbl" xml:lang="en-US">Business Combination (Details) - Allocation of the purchase price to the fair value of the respective assets and liabilities acquired [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xml:lang="en-US">Asset Class [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xml:lang="en-US">Fair Value by Liability Class [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:href="vxrt-20181231.xsd#vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable_lbl" xml:lang="en-US">Fair Value of Financial Instruments (Details) - Company&apos;s financial assets and liabilities measured at fair value [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:to="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" xlink:href="vxrt-20181231.xsd#vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems_lbl" xml:lang="en-US">Fair Value of Financial Instruments (Details) - Company&apos;s financial assets and liabilities measured at fair value [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" xlink:to="vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xml:lang="en-US">Investments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" xlink:href="vxrt-20181231.xsd#vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable_lbl" xml:lang="en-US">Balance Sheet Components (Details) - Cash equivalents and short-term investments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" xlink:to="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems_lbl" xml:lang="en-US">Balance Sheet Components (Details) - Cash equivalents and short-term investments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable_lbl" xml:lang="en-US">Stockholders&apos; Equity (Details) - Convertible preferred stock [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable" xlink:to="vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems_lbl" xml:lang="en-US">Stockholders&apos; Equity (Details) - Convertible preferred stock [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommonStockReservedForIssuanceDomain" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockReservedForIssuanceDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CommonStockReservedForIssuanceDomain_lbl" xml:lang="en-US">CommonStockReservedForIssuance [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CommonStockReservedForIssuanceDomain" xlink:to="vxrt_CommonStockReservedForIssuanceDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable_lbl" xml:lang="en-US">Stockholders&apos; Equity (Details) - Common stock reserved for issuance [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable" xlink:to="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems_lbl" xml:lang="en-US">Stockholders&apos; Equity (Details) - Common stock reserved for issuance [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems" xlink:to="vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_lbl" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_OrganizationandBasisofPresentationDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_OrganizationandBasisofPresentationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_OrganizationandBasisofPresentationDetailsTable_lbl" xml:lang="en-US">Organization and Basis of Presentation (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsTable" xlink:to="vxrt_OrganizationandBasisofPresentationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_OrganizationandBasisofPresentationDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_OrganizationandBasisofPresentationDetailsLineItems_lbl" xml:lang="en-US">Organization and Basis of Presentation (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OrganizationandBasisofPresentationDetailsLineItems" xlink:to="vxrt_OrganizationandBasisofPresentationDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseArrangementTypeDomain_lbl" xml:lang="en-US">Lease Arrangement, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="us-gaap_LeaseArrangementTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="vxrt_SummaryofSignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_BusinessCombinationDetailsTable_lbl" xml:lang="en-US">Business Combination (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_BusinessCombinationDetailsTable" xlink:to="vxrt_BusinessCombinationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_BusinessCombinationDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_BusinessCombinationDetailsLineItems_lbl" xml:lang="en-US">Business Combination (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_BusinessCombinationDetailsLineItems" xlink:to="vxrt_BusinessCombinationDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanRestructuringModificationNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LoanRestructuringModificationNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoanRestructuringModificationNameDomain_lbl" xml:lang="en-US">Loan Restructuring Modification Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoanRestructuringModificationNameDomain" xlink:to="us-gaap_LoanRestructuringModificationNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RevenueDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_RevenueDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RevenueDetailsTable_lbl" xml:lang="en-US">Revenue (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RevenueDetailsTable" xlink:to="vxrt_RevenueDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_RevenueDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_RevenueDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RevenueDetailsLineItems_lbl" xml:lang="en-US">Revenue (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RevenueDetailsLineItems" xlink:to="vxrt_RevenueDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_DeferredRevenueArrangementType_Domain" xlink:href="vxrt-20181231.xsd#vxrt_DeferredRevenueArrangementType_Domain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_DeferredRevenueArrangementType_Domain_lbl" xml:lang="en-US">DeferredRevenueArrangementType_ [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DeferredRevenueArrangementType_Domain" xlink:to="vxrt_DeferredRevenueArrangementType_Domain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xml:lang="en-US">Counterparty Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable_lbl" xml:lang="en-US">Liabilities Related to Sale of Future Royalties (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" xlink:to="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems_lbl" xml:lang="en-US">Liabilities Related to Sale of Future Royalties (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionNameDomain_lbl" xml:lang="en-US">Debt Conversion, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="us-gaap_DebtConversionNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable_lbl" xml:lang="en-US">Convertible Promissory Notes, Related Parties (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems_lbl" xml:lang="en-US">Convertible Promissory Notes, Related Parties (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateDomain_lbl" xml:lang="en-US">Variable Rate [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable_lbl" xml:lang="en-US">Secured Promissory Note Payable to Oxford Finance (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems_lbl" xml:lang="en-US">Secured Promissory Note Payable to Oxford Finance (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommitmentsandContingenciesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_CommitmentsandContingenciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CommitmentsandContingenciesDetailsTable_lbl" xml:lang="en-US">Commitments and Contingencies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CommitmentsandContingenciesDetailsTable" xlink:to="vxrt_CommitmentsandContingenciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_CommitmentsandContingenciesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_CommitmentsandContingenciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CommitmentsandContingenciesDetailsLineItems_lbl" xml:lang="en-US">Commitments and Contingencies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CommitmentsandContingenciesDetailsLineItems" xlink:to="vxrt_CommitmentsandContingenciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsDomain_lbl" xml:lang="en-US">Dividends [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsDomain" xlink:to="us-gaap_DividendsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_StockholdersEquityDetailsTable_lbl" xml:lang="en-US">Stockholders&apos; Equity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockholdersEquityDetailsTable" xlink:to="vxrt_StockholdersEquityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_StockholdersEquityDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_StockholdersEquityDetailsLineItems_lbl" xml:lang="en-US">Stockholders&apos; Equity (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockholdersEquityDetailsLineItems" xlink:to="vxrt_StockholdersEquityDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Equity Award [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_EquityIncentivePlansDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_EquityIncentivePlansDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_EquityIncentivePlansDetailsTable_lbl" xml:lang="en-US">Equity Incentive Plans (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_EquityIncentivePlansDetailsTable" xlink:to="vxrt_EquityIncentivePlansDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_EquityIncentivePlansDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_EquityIncentivePlansDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_EquityIncentivePlansDetailsLineItems_lbl" xml:lang="en-US">Equity Incentive Plans (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_EquityIncentivePlansDetailsLineItems" xlink:to="vxrt_EquityIncentivePlansDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US">Income Tax Authority [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_IncomeTaxesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_IncomeTaxesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_IncomeTaxesDetailsTable_lbl" xml:lang="en-US">Income Taxes (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_IncomeTaxesDetailsTable" xlink:to="vxrt_IncomeTaxesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="vxrt_IncomeTaxesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_IncomeTaxesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_IncomeTaxesDetailsLineItems_lbl" xml:lang="en-US">Income Taxes (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_IncomeTaxesDetailsLineItems" xlink:to="vxrt_IncomeTaxesDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_AccruedClinicalAndManufacturingExpensesCurrent_lbl0" xml:lang="en-US">Accrued clinical and manufacturing expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccruedClinicalAndManufacturingExpensesCurrent" xlink:to="vxrt_AccruedClinicalAndManufacturingExpensesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for inclusion of significant items in the accrued clinical and manufacturing expense report caption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" xlink:to="vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_AccruedCompensationCurrent_lbl0" xml:lang="en-US">Accrued Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccruedCompensationCurrent" xlink:to="vxrt_AccruedCompensationCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_AccruedProfessionalAndConsultingServicesCurrent_lbl0" xml:lang="en-US">Accrued Professional And Consulting Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AccruedProfessionalAndConsultingServicesCurrent" xlink:to="vxrt_AccruedProfessionalAndConsultingServicesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_AmortizationOfDiscountOnShorttermInvestments_lbl0" xml:lang="en-US">Amount of amortization of discount on short term investment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AmortizationOfDiscountOnShorttermInvestments" xlink:to="vxrt_AmortizationOfDiscountOnShorttermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties_lbl0" xml:lang="en-US">Amount of liabilities related to sale of future royalties  assumed at the acquisition date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" xlink:to="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_CashAcquiredInReverseMerger_lbl0" xml:lang="en-US">The cash inflow associated with Reverse Merger of business during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CashAcquiredInReverseMerger" xlink:to="vxrt_CashAcquiredInReverseMerger_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger_lbl0" xml:lang="en-US">Amount of convertible promissory notes after conversion related to the related parties into common stock upon reverse merger.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger" xlink:to="vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ConvertibleLongTermNotesPayableRelatedParties_lbl0" xml:lang="en-US">Carrying value as of the balance sheet date of long-term debts identified as Convertible Notes Payable Related Parties, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertibleLongTermNotesPayableRelatedParties" xlink:to="vxrt_ConvertibleLongTermNotesPayableRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent_lbl0" xml:lang="en-US">Convertible preferred stock warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for convertible preferred stock warrant liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock_lbl0" xml:lang="en-US">The entire disclosure of the convertible promissory note related to the related party.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_DebtAdditions_lbl0" xml:lang="en-US">Amount of additions in debt.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DebtAdditions" xlink:to="vxrt_DebtAdditions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_DebtNoncashInterestExpenseRecognized_lbl0" xml:lang="en-US">Amount of non-cash interest expense recognized in relation to the sale of future royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DebtNoncashInterestExpenseRecognized" xlink:to="vxrt_DebtNoncashInterestExpenseRecognized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid_lbl0" xml:lang="en-US">Amount of non-cash royalty revenue paid on liability in relation to the sale of future royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid" xlink:to="vxrt_DebtRevenueNonCashRoyaltyRevenuePaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_DeferredRentOnCeaseuseDate_lbl0" xml:lang="en-US">Deferred rent on cease use date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DeferredRentOnCeaseuseDate" xlink:to="vxrt_DeferredRentOnCeaseuseDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties_lbl0" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to sale of future royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties" xlink:to="vxrt_DeferredTaxAssetsSaleOfFutureRoyalties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain_lbl0" xml:lang="en-US">Percentage of the effective income tax rate reconciliation of bargain purchase gain.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain" xlink:to="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest_lbl0" xml:lang="en-US">Percentage of the effective income tax rate reconciliation nondeductible expense for convertible note interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest" xlink:to="vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare_lbl0" xml:lang="en-US">Number of shares exchanged per share based on the exchange ratio.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare" xlink:to="vxrt_ExchangeRatioNumberOfSharesExchangedPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_GainlossOnRevaluationOfFinancialInstruments_lbl0" xml:lang="en-US">Gain (loss) on revaluation of financial instruments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_GainlossOnRevaluationOfFinancialInstruments" xlink:to="vxrt_GainlossOnRevaluationOfFinancialInstruments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_HCRPAgreementRevenueTerms_lbl0" xml:lang="en-US">Description of revenue terms in royalties earned.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_HCRPAgreementRevenueTerms" xlink:to="vxrt_HCRPAgreementRevenueTerms_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ImpairmentofPropertyAndEquipment_lbl0" xml:lang="en-US">The aggregate amount of write-downs for impairments recognized during the period for property and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ImpairmentofPropertyAndEquipment" xlink:to="vxrt_ImpairmentofPropertyAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_IncreaseDecreaseInAccumulatedDeficit_lbl0" xml:lang="en-US">Increase decrease amount related to accumulated deficit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_IncreaseDecreaseInAccumulatedDeficit" xlink:to="vxrt_IncreaseDecreaseInAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_IncreaseDecreaseInDeferredTaxes_lbl0" xml:lang="en-US">The increase (decrease) during the reporting period in the account that represents the temporary difference related to deferred tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_IncreaseDecreaseInDeferredTaxes" xlink:to="vxrt_IncreaseDecreaseInDeferredTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_LaboratoryEquipmentGross_lbl0" xml:lang="en-US">Laboratory equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LaboratoryEquipmentGross" xlink:to="vxrt_LaboratoryEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_LoanAgreementBorrowedAmount_lbl0" xml:lang="en-US">Amount of loan borrowed under the loan agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LoanAgreementBorrowedAmount" xlink:to="vxrt_LoanAgreementBorrowedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_LossgainOnRevaluationOfFinancialInstruments_lbl0" xml:lang="en-US">The net realized gain (loss) on RevaluationOfFinancialInstruments sold during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LossgainOnRevaluationOfFinancialInstruments" xlink:to="vxrt_LossgainOnRevaluationOfFinancialInstruments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_NonCashRoyaltyRevenue_lbl0" xml:lang="en-US">Amount of non cash royalty revenue recognized.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NonCashRoyaltyRevenue" xlink:to="vxrt_NonCashRoyaltyRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_NoncashInterestExpenseOnLiability_lbl0" xml:lang="en-US">Amount of non-cash accounted for as interest expense on liability in relation to the sale of future royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NoncashInterestExpenseOnLiability" xlink:to="vxrt_NoncashInterestExpenseOnLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties_lbl0" xml:lang="en-US">Amount of non-cash accounted for as interest expense on liability in relation to the sale of future royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" xlink:to="vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties_lbl0" xml:lang="en-US">Amount of non-cash accounted for as Revenue in relation to the sale of future royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties" xlink:to="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_OfficeAndComputerEquipmentGross_lbl0" xml:lang="en-US">Office and computer equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OfficeAndComputerEquipmentGross" xlink:to="vxrt_OfficeAndComputerEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_PaymentsForfractionalsharesinmerger_lbl0" xml:lang="en-US">The amount of cash paid associated with the mergers.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PaymentsForfractionalsharesinmerger" xlink:to="vxrt_PaymentsForfractionalsharesinmerger_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ProceedsFromSaleOfEquipment_lbl0" xml:lang="en-US">The cash inflow from the sale of equipment that are used in the normal conduct of business to produce goods and services and not intended for resale.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ProceedsFromSaleOfEquipment" xlink:to="vxrt_ProceedsFromSaleOfEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity_lbl0" xml:lang="en-US">Amount of the reclassification of preferred stock warrant liability to equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity" xlink:to="vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ReserveForReturnOfRoyaltiesCurrent_lbl0" xml:lang="en-US">Reserve For Return Of Royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ReserveForReturnOfRoyaltiesCurrent" xlink:to="vxrt_ReserveForReturnOfRoyaltiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_RevenueTextBlock_lbl0" xml:lang="en-US">The entire disclosure for revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RevenueTextBlock" xlink:to="vxrt_RevenueTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_RoyaltiesReceivable_lbl0" xml:lang="en-US">Amount receivable as royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RoyaltiesReceivable" xlink:to="vxrt_RoyaltiesReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_RoyaltyPercentage_lbl0" xml:lang="en-US">Royalty percentage received on net sales.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RoyaltyPercentage" xlink:to="vxrt_RoyaltyPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of common stock reserved for issuance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:to="vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of convertible preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:to="vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale, which acts as the basis for calculation of depreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_SecuredPromissoryNoteClassifiedCurrent_lbl0" xml:lang="en-US">The current portion of secured promissory note payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SecuredPromissoryNoteClassifiedCurrent" xlink:to="vxrt_SecuredPromissoryNoteClassifiedCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_SecuredPromissoryNotePayableTextBlock_lbl0" xml:lang="en-US">The entire disclosure related to the secured promissory note payable to the oxford finance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SecuredPromissoryNotePayableTextBlock" xlink:to="vxrt_SecuredPromissoryNotePayableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger_lbl0" xml:lang="en-US">Number of shares available for grant assumed on consumption of merger.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod_lbl0" xml:lang="en-US">Number of options forfeited during the period under shares available for grant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod_lbl0" xml:lang="en-US">Number of options granted during the period under shares available for grant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan_lbl0" xml:lang="en-US">Number of shares available for grant for termination of plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock_lbl0" xml:lang="en-US">Number of share issued during the period as a result of conversion of convertible preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock" xlink:to="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock_lbl0" xml:lang="en-US">Value of stock issued during the period for conversion of convertible preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock" xlink:to="vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="vxrt_StockIssuedDuringPeriodValueUponReverseMerger_lbl0" xml:lang="en-US">Value of the stock issued during the period related to the reverse merger.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockIssuedDuringPeriodValueUponReverseMerger" xlink:to="vxrt_StockIssuedDuringPeriodValueUponReverseMerger_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CommonStockReservedForIssuanceAxis_lbl0" xml:lang="en-US">Common Stock Reserved For Issuance [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CommonStockReservedForIssuanceAxis" xlink:to="vxrt_CommonStockReservedForIssuanceAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AviragenTherapeuticsIncMember_lbl0" xml:lang="en-US">Aviragen Therapeutics Inc [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AviragenTherapeuticsIncMember" xlink:to="vxrt_AviragenTherapeuticsIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_AviragensStockholderrsAndOptionsholdersMember_lbl0" xml:lang="en-US">Aviragens Stockholderrs And Optionsholders [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_AviragensStockholderrsAndOptionsholdersMember" xlink:to="vxrt_AviragensStockholderrsAndOptionsholdersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CommonStockWarrantsMember_lbl0" xml:lang="en-US">Common Stock Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CommonStockWarrantsMember" xlink:to="vxrt_CommonStockWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConversionMember_lbl0" xml:lang="en-US">Conversion [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConversionMember" xlink:to="vxrt_ConversionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePreferredStockOutstandingMember_lbl0" xml:lang="en-US">Convertible Preferred Stock Outstanding [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePreferredStockOutstandingMember" xlink:to="vxrt_ConvertiblePreferredStockOutstandingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePreferredStockWarrantLiabilityMember_lbl0" xml:lang="en-US">Convertible Preferred Stock Warrant Liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePreferredStockWarrantLiabilityMember" xlink:to="vxrt_ConvertiblePreferredStockWarrantLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember_lbl0" xml:lang="en-US">Convertible Promissory Notes Embedded Derivative Liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xlink:to="vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePromissoryNotesMember_lbl0" xml:lang="en-US">Convertible Promissory Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesMember" xlink:to="vxrt_ConvertiblePromissoryNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ConvertiblePromissoryNotesRelatedPartyMember_lbl0" xml:lang="en-US">Convertible Promissory Notes Related Party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ConvertiblePromissoryNotesRelatedPartyMember" xlink:to="vxrt_ConvertiblePromissoryNotesRelatedPartyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CorporateBondsMember_lbl0" xml:lang="en-US">Corporate Bonds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CorporateBondsMember" xlink:to="vxrt_CorporateBondsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_CumulativeConvertiblePreferredStockDividendsMember_lbl0" xml:lang="en-US">Cumulative Convertible Preferred Stock Dividends [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_CumulativeConvertiblePreferredStockDividendsMember" xlink:to="vxrt_CumulativeConvertiblePreferredStockDividendsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_DerecognizeLeaseLiabilitiesMember_lbl0" xml:lang="en-US">Derecognize Lease Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DerecognizeLeaseLiabilitiesMember" xlink:to="vxrt_DerecognizeLeaseLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_HCRPMember_lbl0" xml:lang="en-US">HCRP [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_HCRPMember" xlink:to="vxrt_HCRPMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_HHSBARDAMember_lbl0" xml:lang="en-US">HHSBARDA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_HHSBARDAMember" xlink:to="vxrt_HHSBARDAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_InavirRecognizedMember_lbl0" xml:lang="en-US">Inavir Recognized [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_InavirRecognizedMember" xlink:to="vxrt_InavirRecognizedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_LaboratoryEquipmentMember_lbl0" xml:lang="en-US">Laboratory Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LaboratoryEquipmentMember" xlink:to="vxrt_LaboratoryEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_LoanAgreementMember_lbl0" xml:lang="en-US">Loan Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LoanAgreementMember" xlink:to="vxrt_LoanAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_NonCashRoyaltyRevenueMember_lbl0" xml:lang="en-US">Non Cash Royalty Revenue [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NonCashRoyaltyRevenueMember" xlink:to="vxrt_NonCashRoyaltyRevenueMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_NotePurchaseAgreementMember_lbl0" xml:lang="en-US">Note Purchase Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NotePurchaseAgreementMember" xlink:to="vxrt_NotePurchaseAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_NotesIssuedIn2014Member_lbl0" xml:lang="en-US">Notes Issued In 2014 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NotesIssuedIn2014Member" xlink:to="vxrt_NotesIssuedIn2014Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_NotesIssuedIn2015Member_lbl0" xml:lang="en-US">Notes Issued In 2015 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NotesIssuedIn2015Member" xlink:to="vxrt_NotesIssuedIn2015Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_OfficeSpaceInAlpharettaGeorgiaMember_lbl0" xml:lang="en-US">Office Space In Alpharetta Georgia [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OfficeSpaceInAlpharettaGeorgiaMember" xlink:to="vxrt_OfficeSpaceInAlpharettaGeorgiaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember_lbl0" xml:lang="en-US">Office Space In San Francisco California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember" xlink:to="vxrt_OfficeSpaceInSanFranciscoCaliforniaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_OptionsAvailableForFutureGrantsMember_lbl0" xml:lang="en-US">Options Available For Future Grants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OptionsAvailableForFutureGrantsMember" xlink:to="vxrt_OptionsAvailableForFutureGrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_OptionsIssuedAndOutstandingMember_lbl0" xml:lang="en-US">Options Issued And Outstanding [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OptionsIssuedAndOutstandingMember" xlink:to="vxrt_OptionsIssuedAndOutstandingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_OxfordFinanceMember_lbl0" xml:lang="en-US">Oxford Finance [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_OxfordFinanceMember" xlink:to="vxrt_OxfordFinanceMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember_lbl0" xml:lang="en-US">Private Vaxarts Stockholders Warrantholders And Optionsholders [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember" xlink:to="vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_PurchasedTechnologyMember_lbl0" xml:lang="en-US">Purchased Technology [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PurchasedTechnologyMember" xlink:to="vxrt_PurchasedTechnologyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RecognizeLeaseLiabilitiesMember_lbl0" xml:lang="en-US">Recognize Lease Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RecognizeLeaseLiabilitiesMember" xlink:to="vxrt_RecognizeLeaseLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RelenzaRecognizedMember_lbl0" xml:lang="en-US">Relenza Recognized [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RelenzaRecognizedMember" xlink:to="vxrt_RelenzaRecognizedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RemainingThreeLeasesMember_lbl0" xml:lang="en-US">Remaining Three Leases [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RemainingThreeLeasesMember" xlink:to="vxrt_RemainingThreeLeasesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SecondNotePurchaseAgreementMember_lbl0" xml:lang="en-US">Second Note Purchase Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SecondNotePurchaseAgreementMember" xlink:to="vxrt_SecondNotePurchaseAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_SeriesBAndCPreferredStockMember_lbl0" xml:lang="en-US">Series B And C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_SeriesBAndCPreferredStockMember" xlink:to="vxrt_SeriesBAndCPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_TheFirstLeaseMember_lbl0" xml:lang="en-US">The First Lease [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_TheFirstLeaseMember" xlink:to="vxrt_TheFirstLeaseMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="vxrt_DocumentAndEntityInformationAbstract" xlink:href="vxrt-20181231.xsd#vxrt_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DocumentAndEntityInformationAbstract" xlink:to="vxrt_DocumentAndEntityInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_LossgainOnRevaluationOfFinancialInstruments_lbl1" xml:lang="en-US">LossgainOnRevaluationOfFinancialInstruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_LossgainOnRevaluationOfFinancialInstruments" xlink:to="vxrt_LossgainOnRevaluationOfFinancialInstruments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock" xlink:to="vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RecurringFinancialLiabilitiesAbstract0_lbl0" xml:lang="en-US">RecurringFinancialLiabilitiesAbstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RecurringFinancialLiabilitiesAbstract0" xlink:to="vxrt_RecurringFinancialLiabilitiesAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_PaymentsForfractionalsharesinmerger_lbl1" xml:lang="en-US">PaymentsForfractionalsharesinmerger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_PaymentsForfractionalsharesinmerger" xlink:to="vxrt_PaymentsForfractionalsharesinmerger_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_RecurringFinancialAssetsAbstract0_lbl0" xml:lang="en-US">RecurringFinancialAssetsAbstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_RecurringFinancialAssetsAbstract0" xlink:to="vxrt_RecurringFinancialAssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties_lbl1" xml:lang="en-US">NoncashRevenueRelatedToSaleOfFutureRoyalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties" xlink:to="vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_NoncashInterestExpenseOnLiability_lbl1" xml:lang="en-US">NoncashInterestExpenseOnLiability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_NoncashInterestExpenseOnLiability" xlink:to="vxrt_NoncashInterestExpenseOnLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain_lbl1" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationBargainPurchaseGain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain" xlink:to="vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod_lbl1" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan_lbl1" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan" xlink:to="vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties_lbl1" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" xlink:to="vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_ReportedAsAbstract0_lbl0" xml:lang="en-US">ReportedAsAbstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_ReportedAsAbstract0" xlink:to="vxrt_ReportedAsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="vxrt_DeferredRentOnCeaseuseDate_lbl1" xml:lang="en-US">DeferredRentOnCeaseuseDate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vxrt_DeferredRentOnCeaseuseDate" xlink:to="vxrt_DeferredRentOnCeaseuseDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter_lbl0" xml:lang="en-US">Future Minimum Sublease Rentals, Sale Leaseback Transactions, Thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl1" xml:lang="en-US">Long-term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl0" xml:lang="en-US">Repayments of Short-term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized_lbl0" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Revenues and Gains Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl0" xml:lang="en-US">Repayments of Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRestructuring_lbl0" xml:lang="en-US">Payments for Restructuring</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRestructuring" xlink:to="us-gaap_PaymentsForRestructuring_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLeasehold_lbl0" xml:lang="en-US">Impairment of Leasehold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLeasehold" xlink:to="us-gaap_ImpairmentOfLeasehold_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl0" xml:lang="en-US">Payments to Acquire Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_lbl0" xml:lang="en-US">Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Three Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xml:lang="en-US">Business Combination, Consideration Transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Allocated Share-based Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl0" xml:lang="en-US">Preferred Stock Dividends and Other Adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_lbl0" xml:lang="en-US">Future Minimum Sublease Rentals, Sale Leaseback Transactions, Next Twelve Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl0" xml:lang="en-US">Operating Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses_lbl0" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Net Gains and Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl1" xml:lang="en-US">Unrecognized Tax Benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl0" xml:lang="en-US">Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl0" xml:lang="en-US">Preferred Stock Dividends, Income Statement Impact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets [Standard Label]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_lbl0" xml:lang="en-US">Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Two Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringReserve_lbl1" xml:lang="en-US">Restructuring Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="us-gaap_RestructuringReserve_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>33
<FILENAME>vxrt-20181231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Wed Feb 06 15:31:57 EST 2019 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedBalanceSheet" roleURI="http://www.vaxart.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.vaxart.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedIncomeStatement" roleURI="http://www.vaxart.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ShareholdersEquityType2or3" roleURI="http://www.vaxart.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConsolidatedCashFlow" roleURI="http://www.vaxart.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_OrganizationandBasisofPresentation" roleURI="http://www.vaxart.com/role/OrganizationandBasisofPresentation"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.vaxart.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BusinessCombination" roleURI="http://www.vaxart.com/role/BusinessCombination"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_FairValueofFinancialInstruments" roleURI="http://www.vaxart.com/role/FairValueofFinancialInstruments"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BalanceSheetComponents" roleURI="http://www.vaxart.com/role/BalanceSheetComponents"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_Revenue" roleURI="http://www.vaxart.com/role/Revenue"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilitiesRelatedtoSaleofFutureRoyalties" roleURI="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyalties"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConvertiblePromissoryNotesRelatedParties" roleURI="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SecuredPromissoryNotePayabletoOxfordFinance" roleURI="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinance"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CommitmentsandContingencies" roleURI="http://www.vaxart.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_StockholdersEquity" roleURI="http://www.vaxart.com/role/StockholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_EquityIncentivePlans" roleURI="http://www.vaxart.com/role/EquityIncentivePlans"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_IncomeTaxes" roleURI="http://www.vaxart.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_NetLossPerShareAttributabletoCommonStockholders" roleURI="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholders"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_QuarterlyFinancialDataUnaudited" roleURI="http://www.vaxart.com/role/QuarterlyFinancialDataUnaudited"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AccountingPoliciesByPolicy" roleURI="http://www.vaxart.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BusinessCombinationTables" roleURI="http://www.vaxart.com/role/BusinessCombinationTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_FairValueofFinancialInstrumentsTables" roleURI="http://www.vaxart.com/role/FairValueofFinancialInstrumentsTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BalanceSheetComponentsTables" roleURI="http://www.vaxart.com/role/BalanceSheetComponentsTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilitiesRelatedtoSaleofFutureRoyaltiesTables" roleURI="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CommitmentsandContingenciesTables" roleURI="http://www.vaxart.com/role/CommitmentsandContingenciesTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_StockholdersEquityTables" roleURI="http://www.vaxart.com/role/StockholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_EquityIncentivePlansTables" roleURI="http://www.vaxart.com/role/EquityIncentivePlansTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_IncomeTaxesTables" roleURI="http://www.vaxart.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_QuarterlyFinancialDataUnauditedTables" roleURI="http://www.vaxart.com/role/QuarterlyFinancialDataUnauditedTables"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_EstimatedUsefulLivesTable" roleURI="http://www.vaxart.com/role/EstimatedUsefulLivesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_TotalpurchasepriceforAviragenTable" roleURI="http://www.vaxart.com/role/TotalpurchasepriceforAviragenTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" roleURI="http://www.vaxart.com/role/AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SelectedamountsrelatedtoAviragensbusinessincludedintheCompanysconsolidatedstatementofoperationsTable" roleURI="http://www.vaxart.com/role/SelectedamountsrelatedtoAviragensbusinessincludedintheCompanysconsolidatedstatementofoperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_UnauditedproformainformationissummarizedTable" roleURI="http://www.vaxart.com/role/UnauditedproformainformationissummarizedTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" roleURI="http://www.vaxart.com/role/CompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AreconciliationofallliabilitiesmeasuredatfairvalueonarecurringbasisusingsignificantunobservableinputsLevel3Table" roleURI="http://www.vaxart.com/role/AreconciliationofallliabilitiesmeasuredatfairvalueonarecurringbasisusingsignificantunobservableinputsLevel3Table"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CashequivalentsandshortterminvestmentsTable" roleURI="http://www.vaxart.com/role/CashequivalentsandshortterminvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AccountsreceivablenetofallowanceTable" roleURI="http://www.vaxart.com/role/AccountsreceivablenetofallowanceTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_PropertyandequipmentnetTable" roleURI="http://www.vaxart.com/role/PropertyandequipmentnetTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_IntangibleassetsTable" roleURI="http://www.vaxart.com/role/IntangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_TheestimatedfutureamortizationexpensebyyearTable" roleURI="http://www.vaxart.com/role/TheestimatedfutureamortizationexpensebyyearTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_AccruedliabilitiesTable" roleURI="http://www.vaxart.com/role/AccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilityrelatedtosaleoffutureRoyaltiesTable" roleURI="http://www.vaxart.com/role/LiabilityrelatedtosaleoffutureRoyaltiesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilitiesrelatedtocostsofexitfromleasedpremisesTable" roleURI="http://www.vaxart.com/role/LiabilitiesrelatedtocostsofexitfromleasedpremisesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable" roleURI="http://www.vaxart.com/role/FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConvertiblepreferredstockTable" roleURI="http://www.vaxart.com/role/ConvertiblepreferredstockTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CommonstockreservedforissuanceTable" roleURI="http://www.vaxart.com/role/CommonstockreservedforissuanceTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SummaryofstockoptionTable" roleURI="http://www.vaxart.com/role/SummaryofstockoptionTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_FairvaluesestimatedassumptionsTable" roleURI="http://www.vaxart.com/role/FairvaluesestimatedassumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_TotalstockbasedcompensationrecognizedforoptionsTable" roleURI="http://www.vaxart.com/role/TotalstockbasedcompensationrecognizedforoptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ComponentsofincometaxesTable" roleURI="http://www.vaxart.com/role/ComponentsofincometaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ComponentsofthedeferredtaxassetsTable" roleURI="http://www.vaxart.com/role/ComponentsofthedeferredtaxassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ReconciliationoftheprovisionforincometaxesTable" roleURI="http://www.vaxart.com/role/ReconciliationoftheprovisionforincometaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ReconciliationoftheunrecognizedtaxbenefitsTable" roleURI="http://www.vaxart.com/role/ReconciliationoftheunrecognizedtaxbenefitsTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CalculationofbasicanddilutednetlosspershareTable" roleURI="http://www.vaxart.com/role/CalculationofbasicanddilutednetlosspershareTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_PotentiallydilutivesecuritiesexcludedfromthecomputationofdilutedweightedaveragesharesTable" roleURI="http://www.vaxart.com/role/PotentiallydilutivesecuritiesexcludedfromthecomputationofdilutedweightedaveragesharesTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SelectedsummarizedquarterlyfinancialTable" roleURI="http://www.vaxart.com/role/SelectedsummarizedquarterlyfinancialTable"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_OrganizationandBasisofPresentationDetails" roleURI="http://www.vaxart.com/role/OrganizationandBasisofPresentationDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BusinessCombinationDetails" roleURI="http://www.vaxart.com/role/BusinessCombinationDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_BalanceSheetComponentsDetails" roleURI="http://www.vaxart.com/role/BalanceSheetComponentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_RevenueDetails" roleURI="http://www.vaxart.com/role/RevenueDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetails" roleURI="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_ConvertiblePromissoryNotesRelatedPartiesDetails" roleURI="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_SecuredPromissoryNotePayabletoOxfordFinanceDetails" roleURI="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinanceDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_CommitmentsandContingenciesDetails" roleURI="http://www.vaxart.com/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_StockholdersEquityDetails" roleURI="http://www.vaxart.com/role/StockholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_EquityIncentivePlansDetails" roleURI="http://www.vaxart.com/role/EquityIncentivePlansDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#vxrt_r_IncomeTaxesDetails" roleURI="http://www.vaxart.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="vxrt-20181231.xsd#DocumentAndEntityInformation" roleURI="http://www.vaxart.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SecuredPromissoryNoteClassifiedCurrent" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNoteClassifiedCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="SecuredPromissoryNoteClassifiedCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleLongTermNotesPayableRelatedParties" xlink:href="vxrt-20181231.xsd#vxrt_ConvertibleLongTermNotesPayableRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="ConvertibleLongTermNotesPayableRelatedParties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermNotesPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_StockholdersEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GovernmentContractMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="us-gaap_GovernmentContractMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="us-gaap_RoyaltyMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="NonCashRoyaltyRevenueMember" xlink:href="vxrt-20181231.xsd#vxrt_NonCashRoyaltyRevenueMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="NonCashRoyaltyRevenueMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_BusinessExitCosts1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessExitCosts1" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InterestExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NoncashInterestExpenseOnLiability" xlink:href="vxrt-20181231.xsd#vxrt_NoncashInterestExpenseOnLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="NoncashInterestExpenseOnLiability" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="GainlossOnRevaluationOfFinancialInstruments" xlink:href="vxrt-20181231.xsd#vxrt_GainlossOnRevaluationOfFinancialInstruments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="GainlossOnRevaluationOfFinancialInstruments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueConversionOfPreferredStock" xlink:href="vxrt-20181231.xsd#vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueConversionOfPreferredStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock" xlink:href="vxrt-20181231.xsd#vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_0" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ImpairmentofPropertyAndEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ImpairmentofPropertyAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ImpairmentofPropertyAndEquipment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AmortizationOfDiscountOnShorttermInvestments" xlink:href="vxrt-20181231.xsd#vxrt_AmortizationOfDiscountOnShorttermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AmortizationOfDiscountOnShorttermInvestments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="LossgainOnRevaluationOfFinancialInstruments" xlink:href="vxrt-20181231.xsd#vxrt_LossgainOnRevaluationOfFinancialInstruments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="LossgainOnRevaluationOfFinancialInstruments" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashExpense" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NoncashInterestExpenseRelatedToSaleOfFutureRoyalties" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NoncashRevenueRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NoncashRevenueRelatedToSaleOfFutureRoyalties" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromSaleOfEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ProceedsFromSaleOfEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSaleOfEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CashAcquiredInReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_CashAcquiredInReverseMerger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="CashAcquiredInReverseMerger" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PaymentsForfractionalsharesinmerger" xlink:href="vxrt-20181231.xsd#vxrt_PaymentsForfractionalsharesinmerger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsForfractionalsharesinmerger" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueUponReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_StockIssuedDuringPeriodValueUponReverseMerger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="StockIssuedDuringPeriodValueUponReverseMerger" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger" xlink:href="vxrt-20181231.xsd#vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity" xlink:href="vxrt-20181231.xsd#vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/OrganizationandBasisofPresentation">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BusinessCombination">
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/FairValueofFinancialInstruments">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BalanceSheetComponents">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/Revenue">
    <loc xlink:type="locator" xlink:label="RevenueAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="RevenueTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_RevenueTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="RevenueTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyalties">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedParties">
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotesRelatedPartyAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotesRelatedPartyTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartyAbstract" xlink:to="ConvertiblePromissoryNotesRelatedPartyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinance">
    <loc xlink:type="locator" xlink:label="SecuredPromissoryNotePayableAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayableAbstract"/>
    <loc xlink:type="locator" xlink:label="SecuredPromissoryNotePayableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayableAbstract" xlink:to="SecuredPromissoryNotePayableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CommitmentsandContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/StockholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/EquityIncentivePlans">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholders">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/QuarterlyFinancialDataUnaudited">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BusinessCombinationTables">
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/FairValueofFinancialInstrumentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BalanceSheetComponentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueByArrangementDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DeferredRevenueByArrangementDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CommitmentsandContingenciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/StockholdersEquityTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfConvertiblePreferredStockTableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ScheduleOfConvertiblePreferredStockTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:href="vxrt-20181231.xsd#vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ScheduleOfCommonStockReservedForIssuanceTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/EquityIncentivePlansTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/IncomeTaxesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholdersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/QuarterlyFinancialDataUnauditedTables">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/EstimatedUsefulLivesTable">
    <loc xlink:type="locator" xlink:label="EstimatedUsefulLivesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_EstimatedUsefulLivesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedUsefulLivesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="LaboratoryEquipmentMember" xlink:href="vxrt-20181231.xsd#vxrt_LaboratoryEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="LaboratoryEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_OfficeEquipmentMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/TotalpurchasepriceforAviragenTable">
    <loc xlink:type="locator" xlink:label="TotalPurchasePriceForAviragenAbstract" xlink:href="vxrt-20181231.xsd#vxrt_TotalPurchasePriceForAviragenAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TotalPurchasePriceForAviragenAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TotalPurchasePriceForAviragenAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable">
    <loc xlink:type="locator" xlink:label="AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract" xlink:href="vxrt-20181231.xsd#vxrt_AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllocationOfThePurchasePriceToTheFairValueOfTheRespectiveAssetsAndLiabilitiesAcquiredAbstract" xlink:to="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" xlink:to="srt_RestatementAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAdjustmentMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable" xlink:to="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsAbstract0" xlink:href="vxrt-20181231.xsd#vxrt_IntangibleAssetsAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="IntangibleAssetsAbstract0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsAbstract0" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsAbstract0" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SelectedamountsrelatedtoAviragensbusinessincludedintheCompanysconsolidatedstatementofoperationsTable">
    <loc xlink:type="locator" xlink:label="SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/UnauditedproformainformationissummarizedTable">
    <loc xlink:type="locator" xlink:label="UnauditedProFormaInformationIsSummarizedAbstract" xlink:href="vxrt-20181231.xsd#vxrt_UnauditedProFormaInformationIsSummarizedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnauditedProFormaInformationIsSummarizedAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnauditedProFormaInformationIsSummarizedAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable">
    <loc xlink:type="locator" xlink:label="CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:href="vxrt-20181231.xsd#vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable"/>
    <loc xlink:type="locator" xlink:label="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" xlink:href="vxrt-20181231.xsd#vxrt_FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompanysFinancialAssetsAndLiabilitiesMeasuredAtFairValueAbstract" xlink:to="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_MoneyMarketFundsMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="CorporateBondsMember" xlink:href="vxrt-20181231.xsd#vxrt_CorporateBondsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="CorporateBondsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockWarrantLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="ConvertiblePreferredStockWarrantLiabilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable" xlink:to="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="RecurringFinancialAssetsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RecurringFinancialAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" xlink:to="RecurringFinancialAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RecurringFinancialAssetsAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RecurringFinancialLiabilitiesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RecurringFinancialLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueofFinancialInstrumentsDetailsCompanysfinancialassetsandliabilitiesmeasuredatfairvalueLineItems" xlink:to="RecurringFinancialLiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RecurringFinancialLiabilitiesAbstract" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AreconciliationofallliabilitiesmeasuredatfairvalueonarecurringbasisusingsignificantunobservableinputsLevel3Table">
    <loc xlink:type="locator" xlink:label="AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract" xlink:href="vxrt-20181231.xsd#vxrt_AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AReconciliationOfAllLiabilitiesMeasuredAtFairValueOnARecurringBasisUsingSignificantUnobservableInputsLevel3Abstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockWarrantLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="ConvertiblePreferredStockWarrantLiabilityMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CashequivalentsandshortterminvestmentsTable">
    <loc xlink:type="locator" xlink:label="CashEquivalentsAndShortTermInvestmentsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CashEquivalentsAndShortTermInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" xlink:href="vxrt-20181231.xsd#vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable"/>
    <loc xlink:type="locator" xlink:label="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_MoneyMarketFundsMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashEquivalentsMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CorporateBondsMember" xlink:href="vxrt-20181231.xsd#vxrt_CorporateBondsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="CorporateBondsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_ShortTermInvestmentsMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsTable" xlink:to="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AccountsreceivablenetofallowanceTable">
    <loc xlink:type="locator" xlink:label="AccountsReceivableNetOfAllowanceAbstract" xlink:href="vxrt-20181231.xsd#vxrt_AccountsReceivableNetOfAllowanceAbstract"/>
    <loc xlink:type="locator" xlink:label="RoyaltiesReceivable" xlink:href="vxrt-20181231.xsd#vxrt_RoyaltiesReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsReceivableNetOfAllowanceAbstract" xlink:to="RoyaltiesReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BilledContractReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BilledContractReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsReceivableNetOfAllowanceAbstract" xlink:to="us-gaap_BilledContractReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnbilledContractsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsReceivableNetOfAllowanceAbstract" xlink:to="us-gaap_UnbilledContractsReceivable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnbilledContractsReceivable" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/PropertyandequipmentnetTable">
    <loc xlink:type="locator" xlink:label="PropertyAndEquipmentNetAbstract" xlink:href="vxrt-20181231.xsd#vxrt_PropertyAndEquipmentNetAbstract"/>
    <loc xlink:type="locator" xlink:label="LaboratoryEquipmentGross" xlink:href="vxrt-20181231.xsd#vxrt_LaboratoryEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyAndEquipmentNetAbstract" xlink:to="LaboratoryEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OfficeAndComputerEquipmentGross" xlink:href="vxrt-20181231.xsd#vxrt_OfficeAndComputerEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyAndEquipmentNetAbstract" xlink:to="OfficeAndComputerEquipmentGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyAndEquipmentNetAbstract" xlink:to="us-gaap_LeaseholdImprovementsGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyAndEquipmentNetAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/IntangibleassetsTable">
    <loc xlink:type="locator" xlink:label="IntangibleAssetsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_IntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PurchasedTechnologyMember" xlink:href="vxrt-20181231.xsd#vxrt_PurchasedTechnologyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="PurchasedTechnologyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IntellectualPropertyMember" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/TheestimatedfutureamortizationexpensebyyearTable">
    <loc xlink:type="locator" xlink:label="TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:href="vxrt-20181231.xsd#vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheEstimatedFutureAmortizationExpenseByYearAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/AccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="AccruedLiabilitiesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_AccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="AccruedCompensationCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedCompensationCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="AccruedCompensationCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccruedClinicalAndManufacturingExpensesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedClinicalAndManufacturingExpensesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="AccruedClinicalAndManufacturingExpensesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccruedProfessionalAndConsultingServicesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_AccruedProfessionalAndConsultingServicesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="AccruedProfessionalAndConsultingServicesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ReserveForReturnOfRoyaltiesCurrent" xlink:href="vxrt-20181231.xsd#vxrt_ReserveForReturnOfRoyaltiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="ReserveForReturnOfRoyaltiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockWarrantLiabilityCurrent" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="ConvertiblePreferredStockWarrantLiabilityCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilityrelatedtosaleoffutureRoyaltiesTable">
    <loc xlink:type="locator" xlink:label="LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZi7YfzVIAspPbJuDylcYRVpSzHijjkNCYpD7o9WcfUwu/9uo1X+/k4jp6oPRfpgx2gurzW//2t+l3nLsqChCk2dbDArpcIr4CikQhf0AXguBDQTnCrO4B9rKkWv2LsFu37D0Y4AbkakUwudm02nim+LyAPChoHtRSv] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:to="us-gaap_LongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="DebtRevenueNonCashRoyaltyRevenuePaid" xlink:href="vxrt-20181231.xsd#vxrt_DebtRevenueNonCashRoyaltyRevenuePaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:to="DebtRevenueNonCashRoyaltyRevenuePaid" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DebtNoncashInterestExpenseRecognized" xlink:href="vxrt-20181231.xsd#vxrt_DebtNoncashInterestExpenseRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilityRelatedToSaleOfFutureRoyaltiesAbstract" xlink:to="DebtNoncashInterestExpenseRecognized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtNoncashInterestExpenseRecognized" xlink:to="us-gaap_LongTermDebt_0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilitiesrelatedtocostsofexitfromleasedpremisesTable">
    <loc xlink:type="locator" xlink:label="LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_RestructuringReserve" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserve_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_RestructuringReserve_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_BusinessExitCosts1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredRentOnCeaseuseDate" xlink:href="vxrt-20181231.xsd#vxrt_DeferredRentOnCeaseuseDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="DeferredRentOnCeaseuseDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLeasehold" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfLeasehold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_ImpairmentOfLeasehold" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_PaymentsForRestructuring" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccretionExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccretionExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract" xlink:to="us-gaap_AccretionExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable">
    <loc xlink:type="locator" xlink:label="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConvertiblepreferredstockTable">
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockAbstract"/>
    <loc xlink:type="locator" xlink:label="StockholdersEquityDetailsConvertiblepreferredstockTable" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsConvertiblepreferredstockTable"/>
    <loc xlink:type="locator" xlink:label="StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredStockAbstract" xlink:to="StockholdersEquityDetailsConvertiblepreferredstockTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsConvertiblepreferredstockTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsConvertiblepreferredstockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsConvertiblepreferredstockTable" xlink:to="StockholdersEquityDetailsConvertiblepreferredstockLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="us-gaap_PreferredStockValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsConvertiblepreferredstockLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CommonstockreservedforissuanceTable">
    <loc xlink:type="locator" xlink:label="CommonStockReservedForIssuanceAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockReservedForIssuanceAbstract"/>
    <loc xlink:type="locator" xlink:label="StockholdersEquityDetailsCommonstockreservedforissuanceTable" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceTable"/>
    <loc xlink:type="locator" xlink:label="StockholdersEquityDetailsCommonstockreservedforissuanceLineItems" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockReservedForIssuanceAbstract" xlink:to="StockholdersEquityDetailsCommonstockreservedforissuanceTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="CommonStockReservedForIssuanceAxis" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockReservedForIssuanceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsCommonstockreservedforissuanceTable" xlink:to="CommonStockReservedForIssuanceAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockReservedForIssuanceDomain" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockReservedForIssuanceDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockReservedForIssuanceAxis" xlink:to="CommonStockReservedForIssuanceDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockOutstandingMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockOutstandingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockReservedForIssuanceAxis" xlink:to="ConvertiblePreferredStockOutstandingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsIssuedAndOutstandingMember" xlink:href="vxrt-20181231.xsd#vxrt_OptionsIssuedAndOutstandingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockReservedForIssuanceAxis" xlink:to="OptionsIssuedAndOutstandingMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsAvailableForFutureGrantsMember" xlink:href="vxrt-20181231.xsd#vxrt_OptionsAvailableForFutureGrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockReservedForIssuanceAxis" xlink:to="OptionsAvailableForFutureGrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CumulativeConvertiblePreferredStockDividendsMember" xlink:href="vxrt-20181231.xsd#vxrt_CumulativeConvertiblePreferredStockDividendsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockReservedForIssuanceAxis" xlink:to="CumulativeConvertiblePreferredStockDividendsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockWarrantsMember" xlink:href="vxrt-20181231.xsd#vxrt_CommonStockWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockReservedForIssuanceAxis" xlink:to="CommonStockWarrantsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsCommonstockreservedforissuanceTable" xlink:to="StockholdersEquityDetailsCommonstockreservedforissuanceLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsCommonstockreservedforissuanceLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SummaryofstockoptionTable">
    <loc xlink:type="locator" xlink:label="SummaryOfStockOptionAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SummaryOfStockOptionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="15.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan" xlink:href="vxrt-20181231.xsd#vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryOfStockOptionAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan" order="20.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/FairvaluesestimatedassumptionsTable">
    <loc xlink:type="locator" xlink:label="FairValuesEstimatedAssumptionsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_FairValuesEstimatedAssumptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValuesEstimatedAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValuesEstimatedAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValuesEstimatedAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValuesEstimatedAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/TotalstockbasedcompensationrecognizedforoptionsTable">
    <loc xlink:type="locator" xlink:label="TotalStockBasedCompensationRecognizedForOptionsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_TotalStockBasedCompensationRecognizedForOptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TotalStockBasedCompensationRecognizedForOptionsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ComponentsofincometaxesTable">
    <loc xlink:type="locator" xlink:label="ComponentsOfIncomeTaxesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ComponentsOfIncomeTaxesAbstract"/>
    <loc xlink:type="locator" xlink:label="CurrentAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxesAbstract" xlink:to="CurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredAbstract" xlink:href="vxrt-20181231.xsd#vxrt_DeferredAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxesAbstract" xlink:to="DeferredAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxesAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ComponentsofthedeferredtaxassetsTable">
    <loc xlink:type="locator" xlink:label="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ComponentsOfTheDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsSaleOfFutureRoyalties" xlink:href="vxrt-20181231.xsd#vxrt_DeferredTaxAssetsSaleOfFutureRoyalties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsSaleOfFutureRoyalties" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfTheDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ReconciliationoftheprovisionforincometaxesTable">
    <loc xlink:type="locator" xlink:label="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PermanentItemsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_PermanentItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="PermanentItemsAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest" xlink:href="vxrt-20181231.xsd#vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PermanentItemsAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PermanentItemsAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PermanentItemsAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EffectiveIncomeTaxRateReconciliationBargainPurchaseGain" xlink:href="vxrt-20181231.xsd#vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationBargainPurchaseGain" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheProvisionForIncomeTaxesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ReconciliationoftheunrecognizedtaxbenefitsTable">
    <loc xlink:type="locator" xlink:label="ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits_0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheUnrecognizedTaxBenefitsAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CalculationofbasicanddilutednetlosspershareTable">
    <loc xlink:type="locator" xlink:label="CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:href="vxrt-20181231.xsd#vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CalculationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/PotentiallydilutivesecuritiesexcludedfromthecomputationofdilutedweightedaveragesharesTable">
    <loc xlink:type="locator" xlink:label="PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract" xlink:href="vxrt-20181231.xsd#vxrt_PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PotentiallyDilutiveSecuritiesExcludedFromTheComputationOfDilutedWeightedAverageSharesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_WarrantMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="CumulativeConvertiblePreferredStockDividendsMember" xlink:href="vxrt-20181231.xsd#vxrt_CumulativeConvertiblePreferredStockDividendsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="CumulativeConvertiblePreferredStockDividendsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockOutstandingMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePreferredStockOutstandingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="ConvertiblePreferredStockOutstandingMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotesRelatedPartyMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="ConvertiblePromissoryNotesRelatedPartyMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="SeriesBAndCPreferredStockMember" xlink:href="vxrt-20181231.xsd#vxrt_SeriesBAndCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesBAndCPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SelectedsummarizedquarterlyfinancialTable">
    <loc xlink:type="locator" xlink:label="SelectedSummarizedQuarterlyFinancialAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SelectedSummarizedQuarterlyFinancialAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_OperatingExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_NetIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedSummarizedQuarterlyFinancialAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/OrganizationandBasisofPresentationDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="OrganizationandBasisofPresentationDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_OrganizationandBasisofPresentationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="OrganizationandBasisofPresentationDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_OrganizationandBasisofPresentationDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="OrganizationandBasisofPresentationDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsTable" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConversionMember" xlink:href="vxrt-20181231.xsd#vxrt_ConversionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="ConversionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember" xlink:href="vxrt-20181231.xsd#vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AviragensStockholderrsAndOptionsholdersMember" xlink:href="vxrt-20181231.xsd#vxrt_AviragensStockholderrsAndOptionsholdersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="AviragensStockholderrsAndOptionsholdersMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OxfordFinanceMember" xlink:href="vxrt-20181231.xsd#vxrt_OxfordFinanceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="OxfordFinanceMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsTable" xlink:to="OrganizationandBasisofPresentationDetailsLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ExchangeRatioNumberOfSharesExchangedPerShare" xlink:href="vxrt-20181231.xsd#vxrt_ExchangeRatioNumberOfSharesExchangedPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsLineItems" xlink:to="ExchangeRatioNumberOfSharesExchangedPerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LoanAgreementBorrowedAmount" xlink:href="vxrt-20181231.xsd#vxrt_LoanAgreementBorrowedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsLineItems" xlink:to="LoanAgreementBorrowedAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBasisofPresentationDetailsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_LeaseArrangementTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RecognizeLeaseLiabilitiesMember" xlink:href="vxrt-20181231.xsd#vxrt_RecognizeLeaseLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="RecognizeLeaseLiabilitiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DerecognizeLeaseLiabilitiesMember" xlink:href="vxrt-20181231.xsd#vxrt_DerecognizeLeaseLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="DerecognizeLeaseLiabilitiesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntellectualPropertyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IntellectualPropertyMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCash" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_RestrictedCash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInAccumulatedDeficit" xlink:href="vxrt-20181231.xsd#vxrt_IncreaseDecreaseInAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="IncreaseDecreaseInAccumulatedDeficit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BusinessCombinationDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_BusinessCombinationDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="BusinessCombinationDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsTable" xlink:to="srt_RangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsTable" xlink:to="BusinessCombinationDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDetailsLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/BalanceSheetComponentsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ImpairmentofPropertyAndEquipment" xlink:href="vxrt-20181231.xsd#vxrt_ImpairmentofPropertyAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="ImpairmentofPropertyAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/RevenueDetails">
    <loc xlink:type="locator" xlink:label="RevenueAbstract" xlink:href="vxrt-20181231.xsd#vxrt_RevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="RevenueDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_RevenueDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RevenueDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_RevenueDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="RevenueDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsTable" xlink:to="srt_ProductOrServiceAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="us-gaap_RoyaltyMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanRestructuringModificationNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LoanRestructuringModificationNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsTable" xlink:to="us-gaap_LoanRestructuringModificationNameAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoanRestructuringModificationNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LoanRestructuringModificationNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LoanRestructuringModificationNameAxis" xlink:to="us-gaap_LoanRestructuringModificationNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EntityLoanModificationProgramMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EntityLoanModificationProgramMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LoanRestructuringModificationNameAxis" xlink:to="us-gaap_EntityLoanModificationProgramMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="HHSBARDAMember" xlink:href="vxrt-20181231.xsd#vxrt_HHSBARDAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="HHSBARDAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelenzaRecognizedMember" xlink:href="vxrt-20181231.xsd#vxrt_RelenzaRecognizedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelenzaRecognizedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AviragenTherapeuticsIncMember" xlink:href="vxrt-20181231.xsd#vxrt_AviragenTherapeuticsIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="AviragenTherapeuticsIncMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InavirRecognizedMember" xlink:href="vxrt-20181231.xsd#vxrt_InavirRecognizedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="InavirRecognizedMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_JP" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="country_JP" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsTable" xlink:to="RevenueDetailsLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsLineItems" xlink:to="us-gaap_Revenues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltyPercentage" xlink:href="vxrt-20181231.xsd#vxrt_RoyaltyPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsLineItems" xlink:to="RoyaltyPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NonCashRoyaltyRevenue" xlink:href="vxrt-20181231.xsd#vxrt_NonCashRoyaltyRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueDetailsLineItems" xlink:to="NonCashRoyaltyRevenue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" xlink:to="srt_CounterpartyNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="HCRPMember" xlink:href="vxrt-20181231.xsd#vxrt_HCRPMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="HCRPMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyArrangementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyArrangementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_RoyaltyArrangementMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsTable" xlink:to="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="DebtAdditions" xlink:href="vxrt-20181231.xsd#vxrt_DebtAdditions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="DebtAdditions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="HCRPAgreementRevenueTerms" xlink:href="vxrt-20181231.xsd#vxrt_HCRPAgreementRevenueTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="HCRPAgreementRevenueTerms" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="us-gaap_Revenues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltyPercentage" xlink:href="vxrt-20181231.xsd#vxrt_RoyaltyPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="RoyaltyPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyIncomeNonoperating" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems" xlink:to="us-gaap_RoyaltyIncomeNonoperating" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotesRelatedPartyAbstract" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartyAbstract" xlink:to="ConvertiblePromissoryNotesRelatedPartiesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NotesIssuedIn2014Member" xlink:href="vxrt-20181231.xsd#vxrt_NotesIssuedIn2014Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="NotesIssuedIn2014Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NotesIssuedIn2015Member" xlink:href="vxrt-20181231.xsd#vxrt_NotesIssuedIn2015Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="NotesIssuedIn2015Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotesMember" xlink:href="vxrt-20181231.xsd#vxrt_ConvertiblePromissoryNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertiblePromissoryNotesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NotePurchaseAgreementMember" xlink:href="vxrt-20181231.xsd#vxrt_NotePurchaseAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="NotePurchaseAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecondNotePurchaseAgreementMember" xlink:href="vxrt-20181231.xsd#vxrt_SecondNotePurchaseAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="SecondNotePurchaseAgreementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsTable" xlink:to="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOwnershipInterestsValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems" xlink:to="us-gaap_OtherOwnershipInterestsValue" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinanceDetails">
    <loc xlink:type="locator" xlink:label="SecuredPromissoryNotePayableAbstract" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayableAbstract"/>
    <loc xlink:type="locator" xlink:label="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayableAbstract" xlink:to="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_WarrantMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_VariableRateAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_CommonStockMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="5.0"/>
    <loc xlink:type="locator" xlink:label="LoanAgreementMember" xlink:href="vxrt-20181231.xsd#vxrt_LoanAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="LoanAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="6.0"/>
    <loc xlink:type="locator" xlink:label="OxfordFinanceMember" xlink:href="vxrt-20181231.xsd#vxrt_OxfordFinanceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="OxfordFinanceMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsTable" xlink:to="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" order="7.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPaymentTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_InterestPaid" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/CommitmentsandContingenciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_CommitmentsandContingenciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_CommitmentsandContingenciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsandContingenciesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OfficeSpaceInSanFranciscoCaliforniaMember" xlink:href="vxrt-20181231.xsd#vxrt_OfficeSpaceInSanFranciscoCaliforniaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="OfficeSpaceInSanFranciscoCaliforniaMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficeSpaceInAlpharettaGeorgiaMember" xlink:href="vxrt-20181231.xsd#vxrt_OfficeSpaceInAlpharettaGeorgiaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="OfficeSpaceInAlpharettaGeorgiaMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_LeaseArrangementTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseArrangementTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TheFirstLeaseMember" xlink:href="vxrt-20181231.xsd#vxrt_TheFirstLeaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="TheFirstLeaseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RemainingThreeLeasesMember" xlink:href="vxrt-20181231.xsd#vxrt_RemainingThreeLeasesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="RemainingThreeLeasesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="CommitmentsandContingenciesDetailsLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_OperatingLeaseImpairmentLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/StockholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="StockholdersEquityDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="StockholdersEquityDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_StockholdersEquityDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="StockholdersEquityDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="3.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="srt_RangeAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="us-gaap_DividendsAxis" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendPaidMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendPaidMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendPaidMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsTable" xlink:to="StockholdersEquityDetailsLineItems" order="6.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePerDollarAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendRatePerDollarAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockDividendRatePerDollarAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_DividendsPreferredStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockDividendsPerShareDeclared" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreference" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockVotingRights" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockVotingRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockVotingRights" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockVotingRights" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockVotingRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/EquityIncentivePlansDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="EquityIncentivePlansDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_EquityIncentivePlansDetailsTable"/>
    <loc xlink:type="locator" xlink:label="EquityIncentivePlansDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_EquityIncentivePlansDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="EquityIncentivePlansDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsTable" xlink:to="srt_RangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsTable" xlink:to="EquityIncentivePlansDetailsLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityIncentivePlansDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsTable" xlink:href="vxrt-20181231.xsd#vxrt_IncomeTaxesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsLineItems" xlink:href="vxrt-20181231.xsd#vxrt_IncomeTaxesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_DomesticCountryMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="country_AU" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_AU"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="country_AU" order="3.0"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_GB"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="country_GB" order="4.0"/>
    <loc xlink:type="locator" xlink:label="country_FR" xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_FR"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="country_FR" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="IncomeTaxesDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInDeferredTaxes" xlink:href="vxrt-20181231.xsd#vxrt_IncreaseDecreaseInDeferredTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="IncreaseDecreaseInDeferredTaxes" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vaxart.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="vxrt-20181231.xsd#vxrt_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="3.0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="4.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" order="6.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="7.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentDescription" order="8.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="9.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="14.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="15.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="16.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntitySmallBusiness" order="17.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="18.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityShellCompany" order="19.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityExTransitionPeriod" order="20.0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823296720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Feb. 04, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Vaxart, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,141,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,181,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000072444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if company meets the shell company criteria: a company with no or nominal operations, and with no or nominal assets or assets consisting solely of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823136368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 11,506<span></span>
</td>
<td class="nump">$ 1,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,796<span></span>
</td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">14,645<span></span>
</td>
<td class="nump">3,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,066<span></span>
</td>
<td class="nump">730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">19,413<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">103<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">35,227<span></span>
</td>
<td class="nump">4,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">962<span></span>
</td>
<td class="nump">1,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SecuredPromissoryNoteClassifiedCurrent', window );">Current portion of secured promissory note payable to Oxford Finance</a></td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Liability related to sale of future royalties, current portion</a></td>
<td class="nump">3,328<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued current liabilities</a></td>
<td class="nump">1,518<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">7,475<span></span>
</td>
<td class="nump">4,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertibleLongTermNotesPayableRelatedParties', window );">Convertible promissory notes, long-term, related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">35,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Liability related to sale of future royalties, net of current portion</a></td>
<td class="nump">14,413<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Secured promissory note payable to Oxford Finance, net of current portion</a></td>
<td class="nump">1,944<span></span>
</td>
<td class="nump">3,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">157<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">23,989<span></span>
</td>
<td class="nump">43,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock: $0.10 par value; 5,000,000 shares authorized; none issued and outstanding as of December 31, 2018; 1,221,064 issued and outstanding as of December 31, 2017, with aggregate liquidation value of $39,956</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock: $0.10 par value; 200,000,000 shares authorized; 7,141,189 and 138,492 shares issued and outstanding as of December 31, 2018 and 2017, respectively</a></td>
<td class="nump">714<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">108,513<span></span>
</td>
<td class="nump">41,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(97,989)<span></span>
</td>
<td class="num">(79,982)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="nump">11,238<span></span>
</td>
<td class="num">(38,722)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 35,227<span></span>
</td>
<td class="nump">$ 4,523<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ConvertibleLongTermNotesPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debts identified as Convertible Notes Payable Related Parties, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ConvertibleLongTermNotesPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_SecuredPromissoryNoteClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of secured promissory note payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_SecuredPromissoryNoteClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823730176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,221,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,221,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference (in Dollars)</a></td>
<td class="nump">$ 39,956<span></span>
</td>
<td class="nump">$ 39,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">7,141,189<span></span>
</td>
<td class="nump">138,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">7,141,189<span></span>
</td>
<td class="nump">138,492<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823597584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 4,159<span></span>
</td>
<td class="nump">$ 5,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operatingexpenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">17,275<span></span>
</td>
<td class="nump">12,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,681<span></span>
</td>
<td class="nump">3,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Costs of exit from leased premises</a></td>
<td class="nump">359<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">25,915<span></span>
</td>
<td class="nump">15,854<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(21,756)<span></span>
</td>
<td class="num">(10,015)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income and (expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Bargain purchase gain</a></td>
<td class="nump">6,760<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(821)<span></span>
</td>
<td class="num">(3,036)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_NoncashInterestExpenseOnLiability', window );">Non-cash interest expense related to sale of future royalties</a></td>
<td class="num">(1,859)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">(Loss) gain on sale of equipment</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_GainlossOnRevaluationOfFinancialInstruments', window );">(Loss) gain on revaluation of financial instruments, net</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">3,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange loss, net</a></td>
<td class="num">(266)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income and (expenses)</a></td>
<td class="nump">3,858<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Net loss before provision for income taxes</a></td>
<td class="num">(17,898)<span></span>
</td>
<td class="num">(9,582)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">109<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(18,007)<span></span>
</td>
<td class="num">(9,582)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Series B and C preferred dividend</a></td>
<td class="num">(339)<span></span>
</td>
<td class="num">(2,878)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net comprehensive loss attributable to common stockholders</a></td>
<td class="num">$ (18,346)<span></span>
</td>
<td class="num">$ (12,460)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share &#8211; basic and diluted (in Dollars per share)</a></td>
<td class="num">$ (2.90)<span></span>
</td>
<td class="num">$ (91.65)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used to compute net loss per share &#8211; basic and diluted (in Shares)</a></td>
<td class="nump">6,316,065<span></span>
</td>
<td class="nump">135,953<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember', window );">Government Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 1,344<span></span>
</td>
<td class="nump">$ 5,839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">1,340<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vxrt_NonCashRoyaltyRevenueMember', window );">Non Cash Royalty Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 1,475<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6571-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6527-128477<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30700-110894<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_GainlossOnRevaluationOfFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on revaluation of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_GainlossOnRevaluationOfFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_NoncashInterestExpenseOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non-cash accounted for as interest expense on liability in relation to the sale of future royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_NoncashInterestExpenseOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vxrt_NonCashRoyaltyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vxrt_NonCashRoyaltyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6821699600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders` Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2016</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,758<span></span>
</td>
<td class="num">$ (70,400)<span></span>
</td>
<td class="num">$ (29,641)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in Shares) at Dec. 31, 2016</a></td>
<td class="nump">1,221,064<span></span>
</td>
<td class="nump">135,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,582)<span></span>
</td>
<td class="num">(9,582)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2017</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,259<span></span>
</td>
<td class="num">(79,982)<span></span>
</td>
<td class="num">$ (38,722)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in Shares) at Dec. 31, 2017</a></td>
<td class="nump">1,221,064<span></span>
</td>
<td class="nump">138,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of convertible promissory notes, related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
<td class="nump">35,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of convertible promissory notes, related parties (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,571,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock', window );">Issuance of common stock upon conversion of convertible preferred stock</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock', window );">Issuance of common stock upon conversion of convertible preferred stock (in Shares)</a></td>
<td class="num">(1,221,064)<span></span>
</td>
<td class="nump">1,918,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Reclassification of warrant to equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock uponreverse merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">31,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock uponreverse merger (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,510,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,007)<span></span>
</td>
<td class="num">(18,007)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 108,513<span></span>
</td>
<td class="num">$ (97,989)<span></span>
</td>
<td class="nump">$ 11,238<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in Shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,141,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,141,189<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79507207&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share issued during the period as a result of conversion of convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period for conversion of convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_StockIssuedDuringPeriodValueConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823449568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (18,007,000)<span></span>
</td>
<td class="num">$ (9,582,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Bargain purchase gain</a></td>
<td class="num">(6,760,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,203,000<span></span>
</td>
<td class="nump">380,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss (gain) on sale of equipment</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="num">(69,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ImpairmentofPropertyAndEquipment', window );">Impairment of property and equipment</a></td>
<td class="nump">106,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">539,000<span></span>
</td>
<td class="nump">477,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_AmortizationOfDiscountOnShorttermInvestments', window );">Amortization of discount on short-term investments</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_LossgainOnRevaluationOfFinancialInstruments', window );">Loss (gain) on revaluation of financial instruments, net</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="num">(3,347,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Non-cash interest expense</a></td>
<td class="nump">448,000<span></span>
</td>
<td class="nump">2,557,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of note discount</a></td>
<td class="nump">18,000<span></span>
</td>
<td class="nump">144,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties', window );">Non-cash interest expense related to sale of future royalties</a></td>
<td class="nump">1,859,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties', window );">Non-cash revenue related to sale of future royalties</a></td>
<td class="num">(18,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">13,500,000<span></span>
</td>
<td class="nump">960,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(873,000)<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(3,784,000)<span></span>
</td>
<td class="num">(1,559,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(6,393,000)<span></span>
</td>
<td class="num">(77,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(14,548,000)<span></span>
</td>
<td class="num">(10,040,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(707,000)<span></span>
</td>
<td class="num">(117,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ProceedsFromSaleOfEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CashAcquiredInReverseMerger', window );">Cash acquired in reverse merger</a></td>
<td class="nump">25,525,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_PaymentsForfractionalsharesinmerger', window );">Cash paid for fractional shares in merger</a></td>
<td class="num">(21,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of short-term investments</a></td>
<td class="num">(573,000)<span></span>
</td>
<td class="num">(7,351,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturities of short-term investments</a></td>
<td class="nump">1,988,000<span></span>
</td>
<td class="nump">10,580,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">26,212,000<span></span>
</td>
<td class="nump">3,182,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of principal on secured promissory note payable to Oxford Finance</a></td>
<td class="num">(1,528,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayment of short-term note</a></td>
<td class="num">(214,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon exercise of stock options</a></td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(1,729,000)<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">9,935,000<span></span>
</td>
<td class="num">(6,834,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of the period</a></td>
<td class="nump">1,571,000<span></span>
</td>
<td class="nump">8,405,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of the period</a></td>
<td class="nump">11,506,000<span></span>
</td>
<td class="nump">1,571,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">356,000<span></span>
</td>
<td class="nump">335,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockIssuedDuringPeriodValueUponReverseMerger', window );">Issuance of common stock upon reverse merger, net of cash paid for partial shares</a></td>
<td class="nump">31,768,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger', window );">Conversion of convertible promissory notes, related parties into common stock upon reverse merger</a></td>
<td class="nump">35,577,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity', window );">Reclassification of convertible preferred stock warrant liability to equity</a></td>
<td class="nump">70,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Acquisition of property and equipment included in accounts payable</a></td>
<td class="nump">$ 52,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6571-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6527-128477<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_AmortizationOfDiscountOnShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of discount on short term investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_AmortizationOfDiscountOnShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_CashAcquiredInReverseMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with Reverse Merger of business during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_CashAcquiredInReverseMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of convertible promissory notes after conversion related to the related parties into common stock upon reverse merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ConversionOfConvertiblePromissoryNotesRelatedPartiesIntoCommonStockUponReverseMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ImpairmentofPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for property and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ImpairmentofPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_LossgainOnRevaluationOfFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on RevaluationOfFinancialInstruments sold during the period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_LossgainOnRevaluationOfFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non-cash accounted for as interest expense on liability in relation to the sale of future royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_NoncashInterestExpenseRelatedToSaleOfFutureRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non-cash accounted for as Revenue in relation to the sale of future royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_NoncashRevenueRelatedToSaleOfFutureRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_PaymentsForfractionalsharesinmerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid associated with the mergers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_PaymentsForfractionalsharesinmerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ProceedsFromSaleOfEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of equipment that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ProceedsFromSaleOfEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the reclassification of preferred stock warrant liability to equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_StockIssuedDuringPeriodValueUponReverseMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the stock issued during the period related to the reverse merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_StockIssuedDuringPeriodValueUponReverseMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814439680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 12pt"><a name="Notes"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;1.&#xa0;&#xa0;Organization and Basis of Presentation</font></b></a></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Arial&quot;,&quot;sans-serif&quot;; PAGE-BREAK-AFTER:avoid; FONT-STYLE:italic; MARGIN:12pt 0in; LINE-HEIGHT:12pt"><font style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">General&#xa0;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">Vaxart Biosciences, Inc. was originally incorporated in California in March&#xa0;2004, under the name West Coast Biologicals, Inc. The Company changed its name to Vaxart, Inc. (&#8220;Private Vaxart&#8221;) in July&#xa0;2007, and reincorporated in the state of Delaware. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt">On February 13,&#xa0;2018, Private Vaxart <font style="COLOR:black">completed a business combination </font>with <font style="COLOR:black">Aviragen Therapeutics, Inc. (&#8220;Aviragen&#8221;)</font>, <font style="COLOR:black">pursuant to which Aviragen merged with Private Vaxart, with Private Vaxart surviving as a wholly-owned subsidiary of Aviragen (the &#8220;Merger&#8221;). Pursuant to the terms of the Merger, Aviragen changed its name to Vaxart, Inc. (together with its subsidiaries, the &#8220;Company&#8221; or &#8220;Vaxart&#8221;) and Private Vaxart changed its name to Vaxart Biosciences, Inc</font>. All of Private Vaxart&#8217;s convertible promissory notes and convertible preferred stock was converted into common stock, following which each share of common stock was converted into approximately 0.22148 shares of the Company&#8217;s common stock (the &#8220;Conversion&#8221;). Except as otherwise noted in these Financial Statements, all shares, equity securities and per share amounts of Private Vaxart are presented to give retroactive effect to the <font style="COLOR:black">Conversion</font>.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">I<font style="color: black;">mmediately following the completion of the Merger, the Company effected a reverse stock split at a ratio of one new share for every eleven shares of the Company&#x2019;s common stock outstanding</font> (the &#x201c;Reverse Stock Split&#x201d;). Except as otherwise noted in these Financial Statements, all share, equity security and per share amounts are presented to give retroactive effect to the <font style="color: black;">Reverse </font><font style="color: black;">Stock Split</font>.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">Immediately after the </font><font style="font-size: 10pt;">Reverse Stock Split </font><font style="font-size: 10pt; color: black;">there were approximately 7.1&#xa0;million shares of the Company&#x2019;s common stock outstanding. Private Vaxart&#x2019;s stockholders, warrantholders and optionholders owned approximately 51% of the fully-diluted common stock of the Company, with Aviragen&#x2019;s stockholders and optionholders immediately prior to the Merger owning approximately 49% of the fully-diluted common stock of the Company</font><font style="font-size: 10pt;">. The Company also assumed all of Private Vaxart&#x2019;s outstanding stock options and warrants with proportionate adjustments to the number of underlying shares and exercise prices based on an exchange ratio, based on the combined impact of the Conversion and the Reverse Stock Split, of <font style="color: black;">approximately 0.0201346 shares of the Company for each share of Private Vaxart.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">The Company&#8217;s principal operations are based in South San Francisco, California, and it operates in one&#xa0;reportable segment, which is the discovery and development of oral recombinant protein vaccines, based on its proprietary oral vaccine platform.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Arial&quot;,&quot;sans-serif&quot;; PAGE-BREAK-AFTER:avoid; FONT-STYLE:italic; MARGIN:12pt 0in; LINE-HEIGHT:12pt"><font style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Liquidity and Going Concern</font></p><br/><p style="font-size: 10pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in; line-height: 12pt;"><font style="color: black;">Since incorporation, the Company has been involved primarily in performing research and development activities, hiring personnel, and raising capital to support these activities. The Company has experienced losses and negative cash flows from operations since its inception. As of December 31, 2018, the Company had an accumulated deficit of $98.0 million and a loan with an outstanding balance of $3.6 million from Oxford Finance, LLC (&#x201c;Oxford Finance&#x201d;), repayable in monthly installments by January 2021 (see Note 9).</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt"><font style="COLOR:black">The Company expects to incur increasing costs as research and clinical trials are advanced and, therefore, expects to continue to incur losses and negative operating cash flows for the next several years. Absent additional funding or adjustments to currently planned operating activities, and in view of the uncertainties regarding future royalty revenue on sales of Relenza and Inavir, management believes that the Company&#8217;s cash and cash equivalents of $11.5 million held as of December 31, 2018, are sufficient to fund the Company into, but possibly not beyond, the second quarter of 2019.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt"><font style="COLOR:black">The Company reviews its operations and clinical plans on a continuing basis, including its commitments for upcoming clinical trials. The Company plans to finance its operations with royalty revenue on sales of Relenza and Inavir, additional equity or debt financing arrangements, </font>and potentially with additional funding from government contracts or strategic alliances with partner companies. The availability and amount of such funding is not certain.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt"><font style="COLOR:black">The uncertainties inherent in the Company&#8217;s future operations and in its ability to obtain additional funding raise substantial doubt about its ability to continue as a going concern beyond one year from the date these financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in -0.9pt 0pt 0in"><a name="_Hlk510097426"><font style="FONT-SIZE:10pt">While management believes its plan to raise additional funds will alleviate the conditions that raise substantial doubt, these plans are not entirely within its control and cannot be assessed as being probable of occurring.&#xa0;If adequate funds are not available, the Company may be required to reduce operating expenses, delay or reduce the scope of its product development programs, obtain funds through arrangements with others that may require the Company to relinquish rights to certain of its technologies or products that the Company would otherwise seek to develop or commercialize itself, or cease operations</font></a><font style="FONT-SIZE:10pt">.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806312832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:24pt 0in 12pt"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;2.&#xa0;&#xa0;Summary of Significant Accounting Policies</font></b></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Basis of Presentation</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;</font><font style="FONT-SIZE:10pt">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America <font style="COLOR:black">(&#8220;U.S. GAAP&#8221;)</font>.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Basis of Consolidation</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;The consolidated financial statements include the financial statements of Vaxart, Inc. and its subsidiaries. All significant transactions and balances between Vaxart, Inc. and its subsidiaries have been eliminated in consolidation.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Use of Estimates</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;</font><font style="FONT-SIZE:10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Actual results and outcomes could differ from these estimates and assumptions<font style="COLOR:black">.</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><strong><font style="font-size: 10pt; color: black;">Foreign Currencies</font></strong><font style="font-size: 10pt; color: black;">&#xa0;&#x2013;&#xa0;</font><font style="font-size: 10pt;">Foreign exchange gains and losses for assets and liabilities of the Company&#x2019;s <font style="color: black;">non-U.S. </font>subsidiaries for which the functional currency is the U.S. dollar are recorded in <font style="color: black;">foreign exchange gain or loss, net</font> within other income and (expenses) in the Company&#x2019;s statements of operations and comprehensive loss<font style="color: black;">. The Company has no subsidiaries </font>for which the local currency is the functional currency.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Cash and Cash Equivalents</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company considers all highly liquid debt investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents, which may consist of amounts invested in money market funds, corporate bonds and commercial paper, are stated at fair value. Cash and cash equivalents as of December 31, 2018 and 2017, includes $50,000 of restricted cash.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Short-Term Investments</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company&#8217;s short-term investments have only comprised commercial paper and corporate bonds. The short-term investments are classified as held-to-maturity based on the Company&#8217;s positive intent and ability to hold the securities to maturity. This classification is reevaluated at each balance sheet date. Short-term investments are stated at amortized cost, adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is presented as interest income in the statement of operations and comprehensive loss. The specific identification method is used to determine the realized gain or loss on securities sold or otherwise disposed. When the fair value of a debt security classified as held-to-maturity is less than its amortized cost, the Company assesses whether or not: (i)&#xa0;it has the intent to sell the security or (ii)&#xa0;it is more likely than not that the Company will be required to sell the security before its anticipated recovery. If either of these conditions is met, the Company must recognize an other-than-temporary impairment through earnings for the difference between the debt security&#8217;s amortized cost basis and its fair value. Gains and losses are recognized in earnings when the investments are sold or impaired.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt"><b><font style="COLOR:black">Concentration of Credit Risk</font></b>&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. The Company places its cash, cash equivalents and short&#x2011;term investments at financial institutions that management believes are of high credit quality. The Company is exposed to credit risk in the event of default by the financial institutions holding the cash and cash equivalents to the extent such amounts are in excess of the federally insured limits. The Company has not experienced any losses on its deposits since inception.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one&#xa0;corporate issuer or sector and establishing a minimum allowable credit rating. The Company generally requires no collateral from its customers.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><strong><font style="font-size: 10pt; color: black;">Accounts Receivable</font></strong><font style="font-size: 10pt;">&#xa0;<font style="color: black;">&#x2013;</font>&#xa0;Accounts receivable arise from the Company&#x2019;s royalty revenue receivable for sales, <font style="color: black;">net of estimated returns,</font> of <font style="color: black;">Inavir and Relenza, and from its </font>contract with the Department of Health and Human Services, Office of Biomedical Advanced Research and Development Authority (&#x201c;HHS BARDA&#x201d;) (see Note 6), and are reported at amounts expected to be collected in future periods. <a name="_Hlk521491497"></a>An allowance for uncollectible accounts will be recorded based on a combination of historical experience, aging analysis, and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. Account balances will be written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company has provided no allowance for uncollectible accounts as of December 31, 2018 and 2017.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Property and Equipment</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;Property and equipment is carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Depreciation begins at the time the asset is placed in service. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is reflected in other income and (expenses) in the period realized.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The useful lives of the property and equipment are as follows:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in; width: 181.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Laboratory equipment</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 322.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">5 years</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 181.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Office and computer equipment</font></p>
</td>
<td style="padding: 0in; width: 322.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">3 years</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 181.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Leasehold improvements</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 322.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Shorter of remaining lease term or estimated useful life</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><a name="_Hlk513886420"><b><font style="FONT-SIZE:10pt; COLOR:black">Intangible Assets</font></b></a><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;<font style="COLOR:black">Intangible assets comprise developed technology, intellectual property and, until it was considered fully impaired (see Note 5), in-process research and development. Intangible assets are carried at cost less accumulated amortization. Amortization is computed using the straight-line method over useful lives ranging from 1.3 to 11.75 years for developed technology and 20&#xa0;years for intellectual property. In-process research and development is considered to be indefinite-lived and is not amortized, but is subject to impairment testing</font>. The Company assessed its in-process research and development as fully impaired in the year ended December&#xa0;31, 2018 (see Note 5)<font style="COLOR:black">.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Impairment of Long-Lived Assets</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company reviews its long-lived assets, including <a name="_Hlk529199618">property and equipment and intangible assets</a> with finite lives, for impairment whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate over its remaining life. When indications of impairment are present and the estimated undiscounted future cash flows from the use of these assets is less than the assets&#8217; carrying value, the related assets will be written down to fair value. The Company assessed leasehold improvements and furniture at its leased offices in Alpharetta, Georgia as impaired in the year ended December&#xa0;31, 2018 (see Notes 5 and 10). There have been no other impairments of the Company&#8217;s long-lived assets for the periods presented<font style="COLOR:black">.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Accrued Clinical and Manufacturing Expenses</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company accrues for estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials, and contract manufacturing activities. The Company records the estimated costs of research and development activities based upon the estimated amount of services provided and includes the costs incurred but not yet invoiced within other accrued liabilities in the balance sheets and within research and development expense in the consolidated statements of operations and comprehensive loss. These costs can be a significant component of the Company&#8217;s research and development expenses<font style="COLOR:black">.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">The </font><font style="FONT-SIZE:10pt">Company estimates the amount of services provided through discussions with internal personnel and external service providers as to the progress or stage of completion of the services and the agreed-upon fee to be paid for such services. The Company makes significant judgments and estimates in determining the accrued balance in each reporting period. As actual costs become known, it adjusts its accrued estimates. Although the Company does not expect its estimates to be materially different from amounts actually incurred, its understanding of the status and timing of services performed, the number of subjects enrolled, and the rate of enrollment may vary from its estimates and could result in the Company reporting amounts that are too high or too low in any particular period. The Company&#8217;s accrued expenses are dependent, in part, upon the receipt of timely and accurate reporting from contract research organizations and other third-party service providers. To date, the Company has not experienced any material differences between accrued costs and actual costs incurred<font style="COLOR:black">.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Convertible Preferred Stock Warrant Liability</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company has issued certain convertible preferred stock warrants. These warrants were recorded within other accrued liabilities in the balance sheets at fair value due to down-round protection features contained in the convertible preferred stock into which the warrants were exercisable. At the end of each reporting period, changes in fair value of the warrants since the prior period were recorded as a component of (loss) gain on revaluation of financial instruments, net within other income and (expenses) in the consolidated statements of operations and comprehensive loss<font style="COLOR:black">. In the event that the terms of the warrant change such that liability accounting is no longer required, the fair value on the date of such change is released to equity.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Convertible Promissory Notes Embedded Derivative Liability</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company recorded derivative instruments related to redemption features embedded within the outstanding convertible promissory notes. The embedded derivatives were accounted for as liabilities at their estimated fair value when the convertible promissory notes were issued and were re-measured to fair value as of each balance sheet date, with the related re-measurement adjustment being recognized as a component of (loss) gain on revaluation of <font style="COLOR:black">financial instruments</font> in the consolidated statements of operations and comprehensive loss<font style="COLOR:black">.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Revenue Recognition</font></b><font style="COLOR:black">&#xa0;</font><font style="FONT-SIZE:10pt">&#8211;&#xa0;The Company recognizes revenue when it transfers control of promised goods or services to its customers, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition, the Company performs the following five steps:</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(i)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">identification of the promised goods or services in the contract;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(ii)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(iii)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">measurement of the transaction price, including the constraint on variable consideration;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(iv)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">allocation of the transaction price to the performance obligations based on estimated selling prices; and</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(v)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:normal"><font style="COLOR:black">Revenue from royalties earned as a percentage of sales, including milestone payments based on achieving a specified level of sales, where a license is deemed to be the predominant item to which the royalties relate, is recognized as revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied), as required under the sales- and usage-based royalty exception.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt">The Company performed research and development work under its cost&#x2011;plus&#x2011;fixed&#x2011;fee contract with HHS BARDA. The Company recognizes revenue under research contracts only when a contract has been executed and the contract price is fixed or determinable. <font style="COLOR:#212121">Revenue from the HHS BARDA contract is recognized in the period during which the related costs are incurred and the related services are rendered, provided that the applicable conditions under the contract have been met. Costs of contract revenue are recorded as a component of operating expenses in the consolidated statements of operations</font> and comprehensive loss<font style="COLOR:#212121">.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><font style="FONT-SIZE:10pt">Under the cost reimbursable contract with HHS BARDA, the Company is reimbursed for allowable costs, and recognizes revenue as allowable costs are incurred and the fixed-fee is earned. Reimbursable costs under the contract primarily include direct labor, subcontract costs, materials, equipment, travel, and approved overhead and indirect costs. Fixed fees under cost reimbursable contracts are earned in proportion to the allowable costs incurred in performance of the work relative to total estimated contract costs, with such costs incurred representing a reasonable measurement of the proportional performance of the work completed. Under the HHS BARDA contract, certain activities must be pre-approved in order for their costs to be deemed allowable direct costs. The HHS BARDA contract provides the U.S.&#xa0;government the ability to terminate the contract for convenience or to terminate for default if the Company fails to meet its obligations as set forth in the statement of work. </font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt -0.9pt 12pt 0in;"><font style="font-size: 10pt;">Payments to the Company under cost reimbursable contracts, such as this contract, are provisional payments subject to adjustment upon annual audit by the government. Management believes that revenue for periods not yet audited has been recorded in amounts that are expected to be realized upon final audit and settlement. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly in the period that the adjustment is known.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Research and Development Costs</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;</font><font style="FONT-SIZE:10pt">Research and development costs are expensed as incurred. Research and development costs consist primarily of salaries and benefits, stock-based compensation, consultant fees, third-party costs for conducting clinical trials and the manufacture of clinical trial materials, certain facility costs and other costs associated with clinical trials. Payments made to other entities are under agreements that are generally cancelable by the Company. Advance payments for research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related services are performed.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Stock-Based Compensation</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;The Company measures the fair value of all stock-based awards, including stock options, to employees and, since April 1, 2018, to nonemployees, on the grant date and records the fair value of these awards, net of estimated forfeitures, to compensation expense over the service period. Prior to April 1, 2018, the </font><font style="FONT-SIZE:10pt">fair value of awards to nonemployees was measured on the date of performance at the fair value of the consideration received or the fair value of the equity instruments issued, whichever was more reliably measured. The fair value of options is estimated using the Black-Scholes valuation model<font style="COLOR:black">. The expected term of each option is estimated by taking the arithmetic average of its original contractual term and its average vesting term.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Net Income (Loss) Per Share Attributable to Common Stockholders</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;Basic net income (loss) per share is computed by dividing net income (loss), as adjusted for dividends on the Series&#xa0;B and Series&#xa0;C convertible preferred stock in the period, by the weighted average number of common shares outstanding during the period, without consideration of potential common shares.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">Diluted net income (loss) per common share is computed giving effect to all potential dilutive common shares, comprising common stock issuable upon exercise of stock options and warrants. The Company uses the treasury-stock method to compute diluted income (loss) per share with respect to its stock options and warrants. For purposes of this calculation, options and warrants to purchase common stock are considered to be potential common shares and are only included in the calculation of diluted net income per share when their effect is dilutive. In the event of a net loss, the effects of all potentially dilutive shares are excluded from the diluted net loss per share calculation as their inclusion would be antidilutive.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Recently Adopted Accounting Pronouncements</font></b></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt -0.9pt 12pt 0in;"><font style="font-size: 10pt;">In June 2018, the FASB issued ASU 2018-07, <em>Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. </em>This update simplifies the accounting for share-based payment transactions by changing the guidance for accounting for nonemployee share-based awards so that, instead of revaluing each award at each balance sheet date during the period over which it vests, the value will be fixed on the grant date and expensed over the vesting period in the same way that employee awards are already accounted for. This guidance is effective for annual periods beginning after December 15, 2018, including interim periods within that year, with early adoption permitted for entities that had already adopted Topic 606 (see ASU 2014-09 below). The Company adopted ASU 2018-07 effective April 1, 2018, and since it had no unvested awards granted to nonemployees, its adoption had no effect on the Company&#x2019;s financial condition or results of operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><font style="FONT-SIZE:10pt">In May 2017, the FASB issued ASU 2017-09, <i>Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. </i>This update provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. This guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that year, and must be applied prospectively to an award modified on or after the adoption date. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&#8217;s financial condition or results of operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><font style="FONT-SIZE:10pt">In January&#xa0;2017, the FASB&#xa0;issued ASU No.&#xa0;2017-04, <i>Intangibles-Goodwill and Other (Topic&#xa0;350) Simplifying the Test for Goodwill Impairment</i>&#xa0;(&#8220;ASU&#xa0;2017-04&#8221;), which will simplify the goodwill impairment calculation by eliminating Step 2 from the current goodwill impairment test. The new standard does not change how a goodwill impairment is identified. The standard will be effective January&#xa0;1, 2020, with early adoption permitted, and is to be applied prospectively from the date of adoption. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&#8217;s financial condition or results of operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><font style="FONT-SIZE:10pt">In January&#xa0;2017, the FASB&#xa0;issued ASU No.&#xa0;2017-01, <i>Business Combinations (Topic&#xa0;805) Clarifying the Definition of a Business</i>&#xa0;(&#8220;ASU&#xa0;2017-01&#8221;). The new standard <font style="COLOR:black">clarifies the definition of a business to help companies evaluate whether acquisition or disposal transactions should be accounted for as asset groups or as businesses</font>. The Company adopted this standard when it became effective on January 1, 2018, and it was applied in connection with the Company&#8217;s accounting for the Merger as a business combination.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">In August 2016, the FASB issued Accounting Standards Update (ASU) 2016-15, <i>Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</i>, which provides additional guidance on the presentation and classification of certain items in the statement of cash flows. The standard is effective for fiscal years beginning after December&#xa0;15, 2017, with early adoption permitted. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&#8217;s financial condition or results of operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">In May&#xa0;2014, the FASB issued ASU&#xa0;2014-09</font><font style="FONT-SIZE:10pt">, <i>Revenue from Contracts with Customers (Topic&#xa0;606)</i>, which supersedes nearly all existing revenue recognition guidance under Topic&#xa0;605, <i>Revenue</i> <i>Recognition</i>. The new standard requires a company to recognize revenue when it transfers goods and services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. ASU&#xa0;2014-09 defines a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when (or as) the entity satisfies the performance obligations. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The Company has <font style="COLOR:#212121">determined that its HHS BARDA government contract is not within the scope of ASU 2014-09 as the government entity is not a customer under the agreement. </font>The Company adopted <font style="COLOR:#212121">ASU 2014-09</font> with respect to its royalty revenue using the modified retrospective method on January&#xa0;1, 2018. Under the modified retrospective transition method, the cumulative effect of applying the standard is recognized at the date of initial application for all contracts not completed as of the date of adoption. The adoption of ASU&#xa0;2014-09&#xa0;did not have any effect on the Company&#8217;s financial condition or results of operations and therefore no cumulative effect adjustment was recorded, although the Company has modified its accounting policies to reflect the requirements of this standard and make additional disclosures<font style="COLOR:black">.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Recent Accounting Pronouncements</font></b></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">In February 2016, the FASB issued ASU 2016 02 Leases (Topic 842), which replaces most current lease guidance when it becomes effective. This standard update intends to increase transparency and improve comparability by requiring entities to recognize assets and liabilities on the balance sheet for all leases, with certain exceptions. The new standard states that a lessee will recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statements of operations. The new guidance will be effective for the Company starting in the first quarter of fiscal 2019, with early adoption permitted. The Company plans to adopt the new guidance effective January 1, 2019, using the modified retrospective method, and to use the effective date method of adoption, as permitted by ASU 2018-11, Targeted Improvements, which the FASB issued in July 2018, which reduces the disclosure requirements on transition. The Company has elected the short-term lease recognition exemption for all classes of assets, which means that it will not recognize right-of-use assets or lease liabilities for leases with a duration of one year or less. Further, the Company has elected to use all of the practical expedients available on transition, whereby it has not reassessed under the new standard its prior conclusions about lease identification, lease classification and initial direct costs.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">We expect that this standard will have a material effect on our consolidated financial statements. The most significant effects relate to the recognition of new right-of-use assets and lease liabilities on our consolidated balance sheet. The Company currently expects to recognize lease liabilities of $1,207,000, $766,000 of which is current, and right-of-use assets of $941,000 based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases, to derecognize liabilities of $239,000, $100,000 of which is current, and recognize an increase of $27,000 to accumulated deficit on adoption of the new accounting policy.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">The increase in accumulated deficit arises because the right-of-use asset impairment charge that would have been recorded in the three months ended December 31, 2018, under Topic 842 exceeds the lease loss accrual, net of accretion, that was recorded (see Note 10). This impact aside, the adoption will have no effect on the Company&#x2019;s statements of operations or cash flows, other than on related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt; COLOR:black">The Company has reviewed all other significant newly-issued accounting pronouncements and concluded that they either are not applicable to the Company&#8217;s operations or no material effect is expected on its consolidated financial statements as a result of future adoption.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814442432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">NOTE 3.&#xa0;&#xa0;Business Combination</font></b></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">On February&#xa0;13, 2018, the Company acquired Aviragen in a reverse merger (see Note&#xa0;1). On the date of the Merger, </font><font style="FONT-SIZE:10pt">Aviragen had in-process research and development as it was conducting a Phase 2 trial, it had previously developed drugs that were licensed to others who brought them to market and it had a workforce that was considered to have the necessary skills, knowledge, and experience to perform a process that, when applied to the in-process research and development, was critical to the ability to convert it into outputs. Based on this evaluation, the Company determined that the Merger should be accounted for as a business combination.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">Since the date of the Merger, the results of Aviragen&#8217;s operations have been included in the consolidated financial statements. As a result of the acquisition, the Company eliminated the majority of its debt and acquired a significant cash balance in exchange for equity securities.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The total purchase price for Aviragen is summarized as follows (in thousands):</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Common stock</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">31,789</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total </font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">31,789</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt">In connection with the Aviragen acquisition, the Company allocated the total purchase consideration to the net assets and liabilities acquired, including identifiable intangible assets, based on their respective fair values at the acquisition date. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt">The following table summarizes the preliminary allocation of the purchase price to the fair value of the respective assets and liabilities acquired, adjustments made since the acquisition date and the final allocation as of December 31, 2018:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">As of February 13, </font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Adjustments</font></strong></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">As of December 31, </font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2018</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Cash and cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">25,525</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">25,525</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accounts receivable</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">14,666</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">14,666</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Prepaid expenses</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">446</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(10)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">436</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Property and equipment</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">170</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">170</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Intangible assets:</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 20pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Developed technology <sup>(1)</sup></font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">22,400</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(300)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">22,100</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">In-process research and development <sup>(2)</sup></font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,600</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,600</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 30pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total assets</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">64,807</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(310)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">64,497</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accounts payable</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(3,379)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">75</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(3,304)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Other current liabilities</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(6,351)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(393)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(6,744) </font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">L<font style="color: black;">iability related to sale of future royalties</font></font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(16,300)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">400</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(15,900)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net assets acquired</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">38,777</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(228)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">38,549</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Purchase price</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(31,789)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(31,789)</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Bargain purchase gain <sup>(3)</sup></font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6,988</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(228)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6,760</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">__________</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.25in; TEXT-INDENT:-0.25in"><font style="FONT-SIZE:10pt">(1)&#xa0;&#xa0; <font style="COLOR:black">Developed technology comprises Inavir and Relenza, both influenza vaccines on which the Company is presently receiving royalty revenue, which, based on valuations prepared by an independent third party based on estimated discounted cash flows based on probability-weighted future development expenditures and revenue streams provided by the Company&#8217;s management, are being amortized on a straight-line basis over the estimated periods of future royalties of 11.75 and 1.3 years, respectively.</font> </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.25in; TEXT-INDENT:-0.25in"><font style="FONT-SIZE:10pt">(2)&#xa0;&#xa0; In-process research and development (see Note 5) related to teslexivir, or BTA074, a direct-acting antiviral that, at the time of the Merger, was being actively developed as a treatment for genital warts. The <font style="COLOR:black">valuation was prepared by an independent third party based on estimated discounted cash flows based on probability-weighted future development expenditures and revenue streams provided by the Company&#8217;s management.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.25in; TEXT-INDENT:-0.25in"><font style="FONT-SIZE:10pt">(3)&#xa0;&#xa0; <font style="COLOR:black">The bargain purchase gain represents the excess of the fair value of tangible and identified intangible assets, less liabilities, acquired over the purchase price.</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">In addition, the Company incurred and expensed costs directly related to the Merger totaling approximately <font style="color: black;">$0.5 million and $0.9 million in the years ended </font>December&#xa0;31<font style="color: black;">, 2018 and 2017, respectively, which are included in </font>general and administrative expenses <font style="color: black;">in the consolidated statement of operations and comprehensive loss</font>.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">Selected amounts related to Aviragen&#8217;s business included in the Company&#8217;s consolidated statement of operations for the year ended December 31, 2018, are as follows (in thousands):</font></p><br/><table style="border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" border="1" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 80.44%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Revenue</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">2,815</p>
</td>
</tr>
<tr>
<td style="padding: 0in; border: 0px currentColor; width: 80.44%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 80.44%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net loss</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">(3,847)</p>
</td>
</tr>
</table><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">The unaudited pro forma information in the table below summarizes the combined results of operations of Vaxart Biosciences, Inc. with those of Aviragen as though these entities were combined as of January&#xa0;1, 2017. The results of Aviragen&#x2019;s business for the year ended </font><font style="font-size: 10pt;">December </font><font style="font-size: 10pt; color: black;">31, 2017, are based on information used to prepare its audited consolidated financial statements prepared for the year ended </font><font style="font-size: 10pt;">June 30</font><font style="font-size: 10pt; color: black;">, 2017, as adjusted by information used to prepare its unaudited condensed consolidated financial statements prepared for the six months ended </font><font style="font-size: 10pt;">December 31</font><font style="font-size: 10pt; color: black;">, 2017 and 2016. The results of Aviragen&#x2019;s business for the year ended </font><font style="font-size: 10pt;">December </font><font style="font-size: 10pt; color: black;">31, 2018, are based on the Company&#x2019;s results of operations, with the results increased by Aviragen&#x2019;s activities in the forty-three days prior to the closing of the Merger. The pro forma financial information for both years presented also includes the removal of direct acquisition-related costs, the reduction in interest expense on borrowing converted into equity in the reverse merger, and the actual depreciation and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets had been applied as of January&#xa0;1, 2017. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt; COLOR:black">This unaudited pro forma information is summarized as follows:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; white-space: nowrap; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December 31,</font></strong></p>
</td>
</tr>
<tr style="height: 2.15pt; page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 70%; height: 2.15pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 2.15pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2%; height: 2.15pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 2.15pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 12%; white-space: nowrap; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr style="height: 12.25pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total revenue</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">15,695</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">13,527</p>
</td>
</tr>
<tr style="height: 12.25pt; page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 27pt; text-indent: -9.35pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
</tr>
<tr style="height: 12.25pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net loss</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">(13,162)</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">(29,270)</p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; FONT-FAMILY:&quot;inherit&quot;,&quot;serif&quot;">The pro forma financial information as presented above is for informational purposes only and is not indicative of the consolidated results of operations of future periods or the results of operations that would have been achieved had the acquisition had taken place on January&#xa0;1, 2017. </font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806359296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">NOTE 4.&#xa0;&#xa0;</font></b><b><font style="FONT-SIZE:10pt">Fair Value of Financial Instruments</font></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt">Fair value accounting is applied for all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). Financial instruments include cash and cash equivalents, short&#x2011;term investments, accounts receivable, accounts payable and accrued liabilities that approximate fair value due to their relatively short maturities. As short&#x2011;term investments are classified as held&#x2011;to&#x2011;maturity, they are recorded at their amortized cost.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt">Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance also establishes a three&#x2011;level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows<font style="COLOR:black">:</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.45pt 12pt 0.5in"><font style="FONT-SIZE:10pt">Level&#xa0;1&#xa0;&#8211;&#xa0;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.45pt 12pt 0.5in"><font style="FONT-SIZE:10pt">Level&#xa0;2&#xa0;&#8211;&#xa0;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.45pt 12pt 0.5in"><font style="FONT-SIZE:10pt">Level&#xa0;3&#xa0;&#8211;&#xa0;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The Company&#8217;s money market funds are classified within Level&#xa0;1 of the fair value hierarchy and are valued based on quoted prices in active markets for identical securities. The Company&#8217;s corporate bonds and commercial paper are classified within Level&#xa0;2 of the fair value hierarchy and are valued based on quoted prices for similar assets or prices derived from observable market data. Level&#xa0;3 liabilities consist of convertible promissory notes embedded derivative liabilities and a convertible preferred stock warrant liability as they are valued by using inputs that are unobservable in the market. The determination of the fair values of the convertible promissory notes embedded derivative is discussed in Note&#xa0;8.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">The following tables present the Company&#8217;s financial assets and liabilities that are measured at fair value at December 31, 2018 and 2017:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.7%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;1</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;2</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;3</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 8pt;">Total</font></strong></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 10pt;">December 31<font style="color: black;">, 2018</font></font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 24.12%;" colspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Recurring Financial Assets:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Money Market Funds</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Corporate Bonds</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
</table><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Recurring Financial Liabilities:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible promissory notes embedded </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#xa0; derivative liability</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible preferred stock warrant liability</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total liabilities</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
</table><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.7%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;1</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;2</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;3</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.62%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Total</font></strong></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 10pt;">December 31, 2017</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 24.12%;" colspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Recurring Financial Assets:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Money Market Funds</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Corporate Bonds</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
</tr>
</table><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Recurring Financial Liabilities:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible promissory notes embedded </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#xa0; derivative liability</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible preferred stock warrant liability</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">67</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total liabilities</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">67</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">The following tables present a reconciliation of all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level&#xa0;3) for the years ended </font><font style="FONT-SIZE:10pt">December 31<font style="COLOR:black">, 2018 and 2017:</font></font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 9.35pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 9.35pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Convertible</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Preferred Stock</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Warrant Liability</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Convertible Promissory</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Notes Embedded</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Derivative Liability</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.95pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 9.95pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.35pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 9.35pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Total</p>
</td>
</tr>
<tr style="height: 9.95pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 9.95pt; width: 57%;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 11.1pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 57%; height: 11.1pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Balance at January&#xa0;1, 2018</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 10.55pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Issuances</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 9.9pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 57%; height: 9.9pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Revaluation loss included in (loss) gain on revaluation </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">&#xa0;&#xa0; of financial instruments, net</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 10.55pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Settlements</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(70)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(70)</font></p>
</td>
</tr>
<tr style="height: 11.1pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%; height: 11.1pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Balance at December 31, 2018</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 10.55pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 22.3pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 57%; height: 22.3pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Total losses included in other income and (expenses) attributable </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">&#xa0;&#xa0;&#xa0; to liabilities still held as of December 31, 2018</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
</table><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 9.35pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 9.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.6%; height: 9.35pt; white-space: nowrap;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Convertible</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Preferred Stock</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Warrant Liability</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.38%; height: 9.35pt; white-space: nowrap;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Convertible Promissory</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Notes Embedded</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Derivative Liability</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12.62%; height: 9.35pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.95pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 9.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12.62%; height: 9.95pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.35pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 9.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.62%; height: 9.35pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Total</p>
</td>
</tr>
<tr style="height: 9.95pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 9.95pt;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 10.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.22%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12.16%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 10.82%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 11.1pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 56.8%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Balance at January&#xa0;1, 2017</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">134</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.22%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3,280</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3,414</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 10.55pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Issuances</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.22%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 9.9pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 56.8%; height: 9.9pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Revaluation gains included in (loss) gain on revaluation </font></p>
<p style="margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">&#xa0;&#xa0;&#xa0; of financial instruments, net</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 10.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(67)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.22%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12.16%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(3,280)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 10.82%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(3,347)</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 10.55pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Settlements</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 11.1pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.8%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Balance at December 31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 10.55pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 10.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.22%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12.16%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 10.82%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 22.3pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 56.8%; height: 22.3pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Total gains included in other income and (expenses) attributable</font></p>
<p style="margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">&#xa0;&#xa0;&#xa0; &#xa0;to liabilities still held as of December&#xa0;31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3,280</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3,347</font></p>
</td>
</tr>
</table><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6591701264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Supplemental Balance Sheet Disclosures [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:12pt 0in"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;5.&#xa0;&#xa0;Balance Sheet Components</font></b></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 12pt 0in 12pt 0.5in; text-indent: -0.25in;"><strong><em><font style="font-size: 10pt;">(a)<font style="font: 7pt 'Times New Roman';">&#xa0;&#xa0;&#xa0;&#xa0; </font></font></em></strong><strong><em><font style="font-size: 10pt;">Cash </font></em></strong><strong><em><font style="font-size: 10pt;">Equivalents and Short-Term Investments</font></em></strong></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:12pt 0in">Cash equivalents and short&#x2011;term investments, all of which are classified as held&#x2011;to&#x2011;maturity securities and mature within one year, consisted of the following:</p><br/><table style="width: 600pt; border-collapse: collapse;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 64.9%;" colspan="14" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">December 31, 2018</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 12.18%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gross</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Unrecognized</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gains</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.88%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gross</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Unrecognized</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Losses</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.12%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Estimated</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Fair</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Value</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.04%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Carrying</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Value</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.92%;" colspan="2" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Amortized</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Cost</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Money market funds</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Corporate bonds</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 10.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr style="height: 11.1pt;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 35.1%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Reported as:</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.46%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.74%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.9%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Short-term investments</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 11.65pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
</table><br/><table style="width: 600pt; border-collapse: collapse;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 64.9%;" colspan="14" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">December 31, 2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12.18%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gross</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.88%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gross</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Estimated</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.04%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 10.92%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Amortized</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.18%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Unrecognized</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.88%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Unrecognized</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Fair</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.04%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Carrying</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.92%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Cost</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12.18%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gains</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.88%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Losses</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Value</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.04%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Value</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Money market funds</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Corporate bonds</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
</tr>
<tr style="height: 10.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
</tr>
<tr style="height: 9.75pt;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 35.1%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Reported as:</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.46%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.74%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.9%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Short-term investments</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
</tr>
<tr style="height: 11.65pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><b><i>(b)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0; </font></i></b><b><i>Accounts Receivable</i></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:12pt 0in">Accounts receivable comprises the following:</p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 9pt;">December </font></strong><strong><font style="font-size: 8pt;">31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">December&#xa0;31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Royalties receivable</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,776</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Government contract &#x2013; billed</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">20</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">477</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Government contract &#x2013; unbilled</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">153</font></p>
</td>
</tr>
<tr style="height: 10.75pt;">
<td style="background: white; padding: 0in 0in 0in 10pt; width: 70%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accounts receivable</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,796</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 10.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">630</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><b><i>(c)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0; </font></i></b><b><i>Property and Equipment, Net</i></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in">Property and equipment, net consists of the following:</p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 10.9pt;">
<td style="padding: 0in 0.7pt 0in 0in; width: 70%; height: 10.9pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.9pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 9pt;">December </font></strong><strong><font style="font-size: 8pt;">31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.9pt;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.9pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">December&#xa0;31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 8.95pt;">
<td style="padding: 0in 0.7pt 0in 0in; width: 70%; height: 8.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 37%;" colspan="5">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman', 'serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Laboratory equipment</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2,076</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,565</font></p>
</td>
</tr>
<tr style="height: 12.2pt;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Office and computer equipment</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">227</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">175</font></p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Leasehold improvements</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">333</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">226</font></p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: white; padding: 0in 0in 1pt; width: 70%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total property and equipment</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2,636</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,966</font></p>
</td>
</tr>
<tr style="height: 19.35pt;">
<td style="background: white; padding: 0in 0in 1pt; width: 70%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Less: accumulated depreciation</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(1,570)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 19.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(1,236)</font></p>
</td>
</tr>
<tr style="height: 20.25pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Property and equipment, net</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,066</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">730</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">Depreciation expense was $476,000 and $376,000 for the years ended December&#xa0;31, 2018 and 2017, respectively. Leasehold improvements and furniture at the Company&#8217;s leased premises in Georgia, which has been subleased, commencing in November 2018, for less than the rental that the Company is obligated to pay (see Note 10), were assessed as impaired as of September 30, 2018, and accordingly an impairment charge of $106,000 was recorded as a component of costs of <font style="FONT-SIZE:9.5pt">exit from leased premises</font> within operating expenses.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><b><i>(d)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0; </font></i></b><b><i>Intangible Assets</i></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:12pt 0in">Intangible assets consist of the following:</p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 36.55pt; text-indent: -9pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">December</font></strong><strong><font style="font-size: 8pt;">&#xa0;31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">February 13,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.7pt; text-indent: -0.7pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">December&#xa0;31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 9.35pt;">
<td style="padding: 0in 0.7pt 0in 0in; width: 57%; height: 9.35pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 36.55pt; text-indent: -9pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 9.35pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 9.35pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 1.45pt 0in 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Purchased technology</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">22,100</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">22,400</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">In-process research and development</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,600</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Intellectual property</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">80</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">80</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">80</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total cost</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">22,180</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">24,080</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 1.45pt 0in 0in; border: 0px currentColor; width: 11%; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">80</font></p>
</td>
</tr>
<tr style="height: 0.2in;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%; height: 0.2in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Less accumulated amortization</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.2in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,767</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.2in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">40</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; height: 0.2in; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">40</font></p>
</td>
</tr>
<tr style="height: 17.5pt;">
<td style="background: white; padding: 0in 0in 0.7pt 10pt; width: 57%; height: 17.5pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Intangible assets, net</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 17.5pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">19,413</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 17.5pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">24,040</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; height: 17.5pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">40</font></p>
</td>
</tr>
</table><br/><p style="font-size: 10pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;">Intangible asset amortization expense was $2,727,000 and $4,000 for the years ended December 31, 2018 and 2017, respectively. Following the results of Phase 2 trials in June 2018, the in-process research and development was assessed as fully impaired in the three months ended June&#xa0;30, 2018, with the $1.6 million acquired in the Merger (see Note 3) being charged to operating expenses.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">As of December 31, 2018, the estimated future amortization expense by year is as follows (in thousands):</p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Year Ending December 31,</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2019</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,320</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2020</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,732</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2021</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,732</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2022</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,732</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2023</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,731</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 1pt 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Thereafter</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">10,166</font></p>
</td>
</tr>
<tr style="height: 13pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 82%; height: 13pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 13pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 16%; height: 13pt; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">19,413</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><b><i>(e)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0; </font></i></b><b><i>Other Accrued Liabilities</i></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in">Accrued liabilities consist of the following:</p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">December&#xa0;31,&#xa0;2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">December&#xa0;31,&#xa0;2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accrued compensation</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">632</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,320</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accrued clinical and manufacturing expenses</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">75</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">69</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accrued professional and consulting services</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">166</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">113</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Reserve for return of royalties</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">339</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred rent and lease loss accrual, current portion</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">111</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">21</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible preferred stock warrant liability</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">67</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Other</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">195</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; border: 0px currentColor; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,518</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,605</font></p>
</td>
</tr>
</table><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806271120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RevenueAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RevenueTextBlock', window );">Revenue [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:24pt 0in 12pt"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;6.&#xa0;&#xa0;Revenue</font></b></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:12pt 0in"><i><font style="FONT-SIZE:10pt">U.S. Government HHS BARDA Contract</font></i></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">In September&#xa0;2015, HHS BARDA awarded the Company a contract to support the advanced development of a more effective and universal influenza vaccine to improve seasonal and pandemic influenza preparedness. On each of May&#xa0;25 and July 18, 2017, and June 28, 2018, the Company entered into a Modification of Contract with HHS BARDA, the combined effect being to increase the value of the existing $14&#xa0;million contract by $1.7&#xa0;million and to extend it through September 30, 2018. The modified contract is a cost-plus-fixed-fee contract, which reimburses the Company for allowable direct contract costs plus allowable indirect costs and a fixed-fee, totaling $15.7&#xa0;million. The Company recognized revenue of $1,344,000 and $5,839,000 during the years ended December 31, 2018 and 2017, respectively. As of December 31, 2018, the cumulative revenue recorded from inception under the HHS BARDA contract represents the maximum amount billable under the contract as presently modified, with no further change orders envisaged.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">Billings under the contract are based on approved provisional indirect billing rates, which permit recovery of fringe benefits, overhead and general and administrative expenses. Indirect rates as well as allowable costs are subject to audit by HHS BARDA on an annual basis. Management believes that revenues recognized to date have been recorded in amounts that are expected to be realized upon final audit and settlement. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly in the period that the adjustments are known and collection is probable. Costs relating to contract acquisition are expensed as incurred. The Company does not consider any of the revenue recorded as of December 31, 2018 or 2017, to be at risk of reversal. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><i><font style="FONT-SIZE:10pt; COLOR:black">Royalty agreements</font></i></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">Aviragen entered into a royalty-bearing research and license agreement with GlaxoSmithKline, plc (&#x201c;GSK&#x201d;) in 1990 for the development and commercialization of zanamivir, a neuraminidase inhibitor marketed by GSK as Relenza to treat influenza. Most of the Company&#x2019;s Relenza patents have expired and the only substantial remaining intellectual property related to the Relenza patent portfolio, which is solely owned by the Company and exclusively licensed to GSK, is scheduled to expire in July 2019 in Japan, at which time royalty revenue will cease. The post-Merger royalty revenue related to Relenza recognized in the year ended </font><font style="font-size: 10pt;">December <font style="color: black;">31, 2018, was $788,000, representing 7% of net sales in Japan.</font></font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">The Company also generates royalty revenue from the sale of Inavir in Japan, pursuant to a collaboration and license agreement that Aviragen entered into with Daiichi Sankyo Company, Limited, or Daiichi Sankyo, in 2009. In September 2010, laninamivir octanoate was approved for sale by the Japanese Ministry of Health and Welfare for the treatment of influenza in adults and children, which Daiichi Sankyo markets as Inavir. Under the agreement, the Company currently receives a 4% royalty on net sales of Inavir in Japan and was eligible to earn sales milestone payments, including a one-off payment of $5.0 million if net sales exceeded 20 billion Yen in one year. This target was achieved in the three months ended March 31, 2018, prior to the Merger, and Aviragen recognized the related $5.0 million as royalty revenue prior to the Merger. The last patent related to Inavir is set to expire in December 2029 in Japan, at which time royalty revenue will cease. The post-Merger royalty revenue related to Inavir recognized in the year ended December 31, 2018, was $552,000. In addition, the Company recognized non-cash royalty revenue related to the sale of future royalties (see Note 7) of $1,475,000. Both the royalty revenue and the non-cash royalty revenue related to the sale of future royalties have been subjected to a 5% withholding tax in Japan, for which $102,000 was included in income tax expense in the year ended December 31, 2018.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_RevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_RevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6639300400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities Related to Sale of Future Royalties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueDisclosureTextBlock', window );">Deferred Revenue Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:24pt 0in 12pt"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;7.&#xa0; <font style="COLOR:black">Liabilities Related to Sale of Future Royalties</font></font></b></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt; COLOR:black">In April 2016, Aviragen entered into a Royalty Interest Acquisition Agreement (the &#8220;HCRP Agreement&#8221;) with HCRP. Under the Agreement, HCRP made a $20.0 million cash payment to Aviragen in consideration for acquiring certain royalty rights (&#8220;Royalty Rights&#8221;) related to the approved product Inavir in the Japanese market. The Royalty Rights were obtained pursuant to the collaboration and license agreements (the &#8220;License Agreement&#8221;) and a commercialization agreement that the Company entered into with Daiichi Sankyo. Per the terms of the HCRP Agreement, HCRP is entitled to the first $3.0 million plus 15% of the next $1.0 million in royalties earned in each year commencing on April 1, with any excess revenue being retained by the Company.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt; COLOR:black">Under the relevant accounting guidance, due to a limit on the amount of royalties that HCRP can earn under the arrangement, this transaction was accounted for as a liability that will be amortized using the interest method over the life of the arrangement. The Company has no obligation to pay any amounts to HCRP other than to pass through to HCRP its share of royalties as they are received from Daiichi Sankyo. In order to record the amortization of the liability, the Company is required to estimate the total amount of future royalty payments to be received under the License Agreement and the payments that will be passed through to HCRP over the life of this agreement. The sum of the pass-through amounts less the net proceeds received will be recorded as non-cash interest expense over the life of the liability. Consequently, the Company imputes interest on the unamortized portion of the liability and records non-cash interest expense using an estimated effective interest rate. The Company will periodically assess the expected royalty payments, and to the extent such payments are greater or less than the initial estimate, the Company will adjust the amortization of the liability and interest rate. As a result of this accounting, even though the Company does not retain HCRP&#8217;s share of the royalties, it will continue to record non-cash revenue related to those royalties until the amount of the associated liability and related interest is fully amortized.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt; COLOR:black">The following table shows the activity within the liability account since the Merger (in thousands):</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 84%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total Liability related to sale of future royalties, February 13, 2018</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 14%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15,900</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 84%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Non-cash royalty revenue paid to HCRP</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 14%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(18)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 84%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Non-cash interest expense recognized</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 14%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,859</font></p>
</td>
</tr>
<tr style="height: 11.65pt;">
<td style="background: white; padding: 0in 0in 0in 10pt; width: 84%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total <font style="color: black;">Liability related to sale of future royalties, </font>December <font style="color: black;">31, 2018</font></font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 14%; height: 11.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">17,741</font></p>
</td>
</tr>
</table><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 430<br> -URI http://asc.fasb.org/topic&amp;trid=2122452<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806271120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Promissory Notes, Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract', window );"><strong>Convertible Promissory Notes, Related Party [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock', window );">Convertible Promissory Notes, Related Party [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:24pt 0in 0pt"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;8.&#xa0;&#xa0;Convertible Promissory Notes, Related Parties</font></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">On December&#xa0;10, 2014, the Company entered into a note purchase agreement with certain existing preferred stockholders under which the Company issued convertible promissory notes during December&#xa0;2014 for total proceeds of $18.4&#xa0;million.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">On November&#xa0;20, 2015, the Company entered into a second note purchase agreement with certain existing preferred stockholders under which the Company issued convertible promissory notes during November&#xa0;and December&#xa0;2015 for total proceeds of $11.0&#xa0;million. These notes were issued with the same terms as the notes issued in 2014.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">As the holders of the convertible promissory notes each have an equity ownership in the Company, the convertible promissory notes were considered to be a related&#x2011;party transaction.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">The convertible promissory notes bore interest at a rate of 8.0% per annum. The principal and accrued interest on the notes were automatically convertible, upon a future issuance of convertible preferred stock having total proceeds of at least $25.0&#xa0;million, into that same stock at a conversion price equal to 90% of the price paid by other investors in the financing event. Upon a liquidation event, such as an acquisition or initial public offering, at the election of the majority of the noteholders in each issuance, the principal and accrued interest on the notes could either (i)&#xa0;be paid in full at the initial closing of the liquidation event, or (ii)&#xa0;automatically convert into the Company&#8217;s Series&#xa0;C convertible preferred stock at a conversion price based on a specified valuation.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">After two&#xa0;years, if the notes had not been converted, the holders of a majority of the principal amount had the option to require the entire principal balance and accrued interest to become due and payable. However, in December&#xa0;2016, in conjunction with the loan agreement with Oxford Finance (see note&#xa0;9), all of the holders of convertible promissory notes signed subordination agreements, under which they agreed not to demand or receive any payment until all amounts owed to Oxford Finance under the loan agreement were fully paid in cash, thus extending the due dates of the promissory notes potentially to January 2021. This change reflected a <font style="COLOR:black">debt modification that was not considered substantially significant. Accordingly, the Company did not apply extinguishment accounting, but accounted for the modification on a prospective basis.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">The convertible promissory notes had redemption features that were determined to be a compound embedded derivative requiring bifurcation and separate accounting at estimated fair value. The estimated fair value of the embedded derivative upon issuance was a liability of $1.9&#xa0;million for the notes issued in 2014 and $1.3&#xa0;million for the notes issued in 2015. The estimated fair value of these derivative instruments was recognized as a debt discount and as an embedded derivative liability on the balance sheet upon issuance of the convertible promissory notes. The embedded derivative required periodic re&#x2011;measurements to fair value while the instruments were still outstanding (see Note 4). There was no beneficial conversion feature as the conversion feature value was accounted for in the embedded derivative.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">The Company estimated the fair value of the compound embedded derivative utilizing a Monte Carlo Simulation model. The inputs used to determine the estimated fair value of the embedded derivative instrument included the probability of an underlying event triggering the redemption event and its timing prior to the maturity date of the convertible promissory notes. The fair value measurement was based upon significant inputs not observable in the market, including a valuation of the Company performed by an independent third-party at each balance sheet date. By December 31, 2017, the embedded derivative had zero value because the Merger (see Note 1), which was considered 90% probable of occurring, would not have triggered redemption and, had the Merger not occurred, it was unlikely that the Company would have found an alternative source of financing on favorable terms, so there would have been zero redemption value. The embedded derivative was extinguished when the Merger occurred on February 13, 2018.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">The Company incurred total debt issuance costs of $20,000 in connection with the 2014 issuance and $7,000 in connection with the 2015 issuance. The debt issuance costs, which were recorded as an additional debt discount, were being amortized over the term of the notes.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">As of December 31, 2017, the balance of the convertible promissory notes was $35.3 million, comprising principal of $29.4 million plus accrued interest associated with the convertible promissory notes of $6.3&#xa0;million, offset by unamortized debt discount of $0.4 million. Interest expense related to the convertible promissory notes, including amortization of debt discount, totaled $0.3 million and $2.5 million in the years ended December 31, 2018 and 2017, respectively. The charge in 2018 related to the 43 days prior to the Merger, whereas the charge in 2017 related the full year.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">On February&#xa0;13, 2018, the balance of the convertible promissory notes was $35.6 million, comprising accrued interest associated with the convertible promissory notes amounted to $6.6&#xa0;million plus principal of $29.4 million, offset by the unamortized debt discount to $0.4 million. On that date, in conjunction with the Merger, the convertible promissory notes were exchanged for 1,571,702 shares of the Company&#8217;s common stock which, based on the closing stock price of $9.05, had a value of $14.2 million. The difference of $21.4 million was recorded as a capital contribution<font style="COLOR:black">.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ConvertiblePromissoryNotesRelatedPartyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the convertible promissory note related to the related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ConvertiblePromissoryNotesRelatedPartyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806392576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Secured Promissory Note Payable to Oxford Finance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SecuredPromissoryNotePayableAbstract', window );"><strong>Secured Promissory Note Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SecuredPromissoryNotePayableTextBlock', window );">Secured Promissory Note Payable [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;9.&#xa0;&#xa0;</font></b><b><font style="FONT-SIZE:10pt">Secured Promissory Note Payable to Oxford Finance</font></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">On December&#xa0;22, 2016, the Company entered into a loan and security agreement (the&#xa0;&#8220;Loan Agreement&#8221;) with Oxford Finance, under which the Company borrowed $5.0&#xa0;million. The $5.0&#xa0;million loan, which bears interest at 30-day U.S. LIBOR plus 6.17%, is evidenced by a secured promissory note and is repayable over four&#xa0;years, with interest only payable over the first 12 months and the balance fully amortized over the subsequent 36 months. The loan is secured by substantially all the Company&#8217;s assets, except for intellectual property.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">In conjunction with the execution of the Loan Agreement, all the holders of convertible promissory notes signed subordination agreements, under which they agreed to subordinate in favor of Oxford Finance all amounts due under their promissory notes and any security interest in the Company&#8217;s property. In addition, the holders of the notes agreed that they would not demand or receive any payment until all amounts owed to Oxford Finance under the Loan Agreement have been fully paid in cash. Upon repayment, an additional final payment equal to $325,000 is due, which is being accreted as interest expense over the term of the loan using the effective&#x2011;interest method.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">In connection with the Loan Agreement, the Company issued a warrant to Oxford Finance to purchase 7,563&#xa0;shares of its Series&#xa0;C convertible preferred stock at an exercise price of $33.11&#xa0;per share (the&#xa0;&#8220;Warrant&#8221;). The fair value of the Warrant at the date of issuance was approximately $134,000, which was recorded as debt discount and is being amortized as interest expense over the term of the loan using the effective&#x2011;interest method. The annual effective interest rate of the note, including the accretion of the final payment and the amortization of the debt discount, is approximately 10.5%. The Company recorded interest expense related to the Loan Agreement of $469,000 and $518,000 during the years ended December 31, 2018 and 2017, respectively, of which $356,000 and $335,000 was paid, respectively.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">The Warrant provided that if the share price at the next equity financing was less than the Warrant exercise price, then the Warrant would be for the new class of shares, the exercise price would be the new class share price, and the number of shares would be calculated by dividing $250,000 by the new class share price. Due to this anti-dilution protection, the Company determined that the Warrant needed to be recorded as a liability, and therefore estimated the fair value of the Warrant upon issuance and at each balance sheet date, with any changes in the fair value being recorded within (loss) gain on revaluation of financial instruments, net in other income and (expenses) in the statements of operations and comprehensive loss. </p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">Due to the antidilution protection, following the Merger, the Warrant was amended to allow the holder to purchase 10,914 shares of common stock at an exercise price of $22.99 per share. Since the amended Warrant contains no non-standard antidilution protections or similar features, the fair value of approximately $70,000 on February 13, 2018, was reclassified to equity.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_SecuredPromissoryNotePayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_SecuredPromissoryNotePayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_SecuredPromissoryNotePayableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to the secured promissory note payable to the oxford finance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_SecuredPromissoryNotePayableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806295360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 10pt; ">
<p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:24pt 0in 0pt"><b>NOTE 10.&#xa0; Commitments and Contingencies</b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><b><i>(a)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0; </font></i></b><b><i>Leases</i></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">The Company has four&#xa0;office and research and development facilities in South San Francisco, California, under noncancelable operating leases. The principal lease, for office and research and development premises, expires on April&#xa0;30, 2020, subject to the Company&#8217;s option to extend the lease at the then market rate for an additional five&#x2011;year period. The remaining three leases all expire on August 31, 2019. In addition, as a result of the Merger, the Company also leases office space in Alpharetta, Georgia, under a lease expiring on February 28, 2021, which, commencing in November 2018, the Company has subleased for the remainder of the lease term for less than it is required to pay under the head lease and accordingly it recorded a lease loss charge of $253,000 on the cease-use date in the three months ending December 31, 2018, which, along with the related impairment of property and equipment (see Note 5), was recorded as a component of costs of <font style="FONT-SIZE:9.5pt">exit from leased premises</font> within operating expenses.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt">Liabilities related to costs of exit from leased premises are summarized as follows (in thousands):</p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt 27pt; text-indent: -9pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9.5pt;">Balance as of January 1, 2018</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9.5pt;">Costs of exit from leased premises</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">359</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred rent on cease-use date</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">19</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Impairment of property and equipment</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(106)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Cash paid, net of receipts</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(41)</font></p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: white; padding: 0in 0in 1pt 10pt; width: 78.74%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accretion charges, included in rent expense</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.78%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 19.48%; height: 11.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2</font></p>
</td>
</tr>
<tr style="height: 0.2in;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 78.74%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Balance as of December 31, 2018</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.78%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 19.48%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">233</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">Rent expense is recognized on a straight&#x2011;line basis over the noncancelable term of each operating lease and, accordingly, the Company records the difference between cash rent payments and the recognition of rent expense as a deferred rent liability, which is included within accrued expenses. Rent expense was $875,000 and $564,000 for the years ended December&#xa0;31, 2018 and 2017, respectively. Under the terms of the lease agreements, the Company is also responsible for certain insurance, property tax and maintenance expenses. The Company also leases equipment under three operating leases that expire between May and September 2019.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">Future minimum payments and sublease income under operating leases as of December&#xa0;31, 2018, are as follows: </p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Years Ending December 31,</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Lease Payments</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Sublease Income</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2019</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">859</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">213</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2020</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">411</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">219</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2021</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">56</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">38</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Thereafter</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 14.35pt;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%; height: 14.35pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 14.35pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,326</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 14.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">470</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><b><i>(b)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0; </font></i></b><b><i>Indemnifications</i></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend indemnified parties for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third&#x2011;party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors&#8217; and officers&#8217; insurance.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><b><i>(c)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0; </font></i></b><b><i>Litigation</i></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="COLOR:black">From time to time the Company may be involved in claims arising in connection with its business. Based on information currently available, the Company believes that the amount, or range, of reasonably possible losses in connection with any pending actions against it in excess of established reserves, in the aggregate, not to be material to its consolidated financial condition or cash flows. However, losses may be material to the Company&#8217;s operating results for any particular future period, depending on the level of income or loss for such period.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804325888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:9.5pt; COLOR:black">NOTE&#xa0;11.&#xa0;&#xa0;Stockholders&#8217; Equity</font></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><b><i>(a)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0; </font></i></b><b><i>Convertible Preferred Stock</i></b></p><br/><p style="font-size: 10pt; font-family: 'Times New Roman','serif'; page-break-after: avoid; text-align: justify; margin: 12pt 0in; line-height: 12pt;">The Company is authorized to issue 5,000,000 shares of preferred stock, $0.10 par value per share. The Company&#x2019;s board of directors may, without further action by the stockholders, fix the rights, preferences, privileges and restrictions of up to an aggregate of 5,000,000 shares of preferred stock in one or more series and authorize their issuance. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of our common stock. The issuance of preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deterring or preventing a change of control or other corporate action. No shares of preferred stock are currently outstanding, and the Company has no present plan to issue any shares of preferred stock.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt">All of Private Vaxart&#8217;s convertible preferred stock was converted into common stock on February 13, 2018, in conjunction with the Merger. </p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt">As of December&#xa0;31, 2017, convertible preferred stock consisted of the following:</p><br/><table style="width: 600pt; margin-left: 0.5in; border-collapse: collapse;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 33.3pt;">
<td style="padding: 0in; width: 75pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 13pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 33.3pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">Shares<br />authorized</font></strong></p>
</td>
<td style="padding: 0in; width: 13pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 33.3pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">Shares<br />outstanding</font></strong></p>
</td>
<td style="padding: 0in; width: 16.4pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74.3pt; height: 33.3pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">Net<br />carrying<br />value</font></strong></p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 77.2pt; height: 33.3pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">Liquidation<br />preference</font></strong></p>
</td>
</tr>
<tr style="height: 8.5pt;">
<td style="padding: 0in; width: 75pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 13pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 74pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 13pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 73pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 16.4pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 74.3pt; height: 8.5pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black; font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 77.2pt; height: 8.5pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black; font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr style="height: 0.1in;">
<td style="background: #cceeff; padding: 0in; width: 75pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Series A</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 74pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">94,988</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 73pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">94,988</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 58.5pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">2,949</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 61.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">2,737</font></p>
</td>
</tr>
<tr style="height: 0.1in;">
<td style="padding: 0in; width: 75pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Series B</font></p>
</td>
<td style="padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 74pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">747,095</font></p>
</td>
<td style="padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 73pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">520,973</font></p>
</td>
<td style="padding: 0in; width: 16.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 58.5pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">16,115</font></p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 61.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">17,219</font></p>
</td>
</tr>
<tr style="height: 0.1in;">
<td style="background: #cceeff; padding: 0in; width: 75pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Series C</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">820,088</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">605,103</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.5pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">19,877</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 61.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">20,000</font></p>
</td>
</tr>
<tr style="height: 15.7pt;">
<td style="padding: 0in 0in 0in 10pt; width: 75pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total</font></p>
</td>
<td style="padding: 0in; width: 13pt; height: 15.7pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,662,171</font></p>
</td>
<td style="padding: 0in; width: 13pt; height: 15.7pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,221,064</font></p>
</td>
<td style="padding: 0in; width: 16.4pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.5pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">38,941</font></p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 61.4pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">39,956</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">Significant provisions of the convertible preferred stock were as follows:</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><i>Dividends</i> &#8211; The holders of Series&#xa0;C convertible preferred stock were entitled to receive non-compounding cumulative dividends, in preference to any dividends payable to holders of Series&#xa0;B and Series&#xa0;A convertible preferred stock or common stock, at an annual dividend rate of $2.64416 per share, as adjusted for any stock splits, stock dividends, recapitalizations, or the like. Such cumulative dividends were payable within ten days of demand of the holders of at least a majority of the then outstanding Series&#xa0;C convertible preferred stock, or automatically upon a liquidation event. Dividends accumulated from the date of issuance and were payable, whether or not declared, before any dividend on Series&#xa0;B and Series&#xa0;A convertible preferred stock or common stock could be paid or declared. Series&#xa0;C convertible preferred stock shares issued as stock dividends were not entitled to cumulative dividends. The holders of Series&#xa0;C convertible preferred stock could elect whether the cumulative dividends would be paid in cash or in shares of Series&#xa0;C convertible preferred stock based on the original issue price of Series&#xa0;C convertible preferred stock of $33.05196 per share. In the event the board of directors declared a cash dividend in addition to the above cumulative dividends (a Special Dividend), the holders of Series&#xa0;C convertible preferred stock would have been entitled to receive, in preference to any dividends payable to the holders of Series&#xa0;B and Series&#xa0;A convertible preferred stock or common stock, a per share amount equal to the sum of: (a)&#xa0;the original issue price of Series&#xa0;C convertible preferred stock, and (b)&#xa0;all accrued and/or declared but unpaid dividends on such Series&#xa0;C convertible preferred stock, including the cumulative dividends. No dividends were declared during any of the periods presented. As of February 13, 2018, when the convertible preferred stock was converted into common stock, and December&#xa0;31, 2017, accumulated and undeclared dividends for Series&#xa0;C convertible preferred stock were $7.3&#xa0;million and $7.1&#xa0;million, respectively ($12.06 per share and $11.74 per share, respectively, of the outstanding Series&#xa0;C convertible preferred stock). On February 13, 2018, in conjunction with the Merger, the Series&#xa0;C convertible preferred stock and the related accumulated dividends were converted into 696,028 and 253,851 shares of common stock, respectively.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">The holders of Series&#xa0;B convertible preferred stock were entitled to receive non-compounding cumulative dividends, in preference to any dividends payable to holders of Series&#xa0;A convertible preferred stock or common stock, at the annual dividend rate of $2.64416 per share, as adjusted for any stock splits, stock dividends, recapitalizations, or the like. Such cumulative dividends were payable within ten days of demand of the holders of at least a majority of the then outstanding Series&#xa0;B convertible preferred stock or automatically upon a liquidation event. Dividends accumulated from the date of issuance and were payable, whether or not declared, before any dividend on Series&#xa0;A convertible preferred stock or common stock could be paid or declared. Series&#xa0;B convertible preferred shares issued as stock dividends were not entitled to cumulative dividends. The holders of Series&#xa0;B convertible preferred stock could elect whether the cumulative dividends would be paid in cash or in shares of Series&#xa0;B convertible preferred stock based on the original issue price of Series&#xa0;B convertible preferred stock of $33.05196 per share. In the event the board of directors declared a cash dividend in addition to the above cumulative dividends (a Special Dividend), the holders of Series&#xa0;B convertible preferred stock would have been entitled to receive, in preference to any dividends payable to the holders of Series&#xa0;A convertible preferred stock or common stock, a per share amount equal to the sum of: (a)&#xa0;the original issue price of Series&#xa0;B convertible preferred stock, and (b)&#xa0;all accrued and/or declared but unpaid dividends on such Series&#xa0;B convertible preferred stock, including the cumulative dividends. No dividends were declared during any of the periods presented. As of February 13, 2018, when the convertible preferred stock was converted into common stock, and December&#xa0;31, 2017, accumulated and undeclared dividends for Series&#xa0;B convertible preferred stock were $7.6&#xa0;million and $7.5&#xa0;million, respectively ($15.78 per share and $15.46 per share, respectively, of the 483,387 shares of outstanding Series&#xa0;B convertible preferred stock on which dividends accrued). On February 13, 2018, in conjunction with the Merger, the Series&#xa0;B convertible preferred stock and the related accumulated dividends were converted into 599,259 and 265,340 shares of common stock, respectively.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">The holders of Series&#xa0;A convertible preferred stock were entitled to receive noncumulative dividends, in preference to any dividends payable to holders of common stock, at the annual dividend rate of $2.30449 per share, as adjusted for any stock splits, stock dividends, recapitalizations, or the like, if declared by the board of directors. On February 13, 2018, in conjunction with the Merger, the Series&#xa0;A convertible preferred stock was converted into 104,065 shares of common stock.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><i>Conversion</i> &#8211; At the option of the holder, each share of convertible preferred stock was convertible, one&#x2011;for&#x2011;one, subject to adjustment for anti&#x2011;dilution protection, into shares of common stock. Each share automatically converted into the number of shares of common stock into which the shares were convertible at the then applicable conversion ratio upon: (1)&#xa0;the closing of the sale of the Company&#8217;s common stock in a public offering provided the offering price per share was not less than three&#xa0;times the Series&#xa0;C convertible preferred stock original issue price of $33.05196 and the aggregate gross proceeds were not less than $30.0&#xa0;million, or (2)&#xa0;upon receipt of a written consent of the holders of a majority of the then outstanding shares of convertible preferred stock voting as a single class on an as&#x2011;converted basis.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><i>Liquidation</i> &#8211; In the event of any liquidation, dissolution or winding up of the Company, including a merger or acquisition where the beneficial owners of the Company&#8217;s common and convertible preferred stock owned less than 50% of the surviving entity, or a sale of all or substantially all assets, the holders of Series&#xa0;C convertible preferred stock would have been entitled to receive a per share amount equal to $33.05196 (subject to adjustment for stock splits, stock dividends, recapitalizations, or the like), plus all dividends accrued, payable and/or in arrears (whether or not declared) minus the amount of any Special Dividends previously paid. After payment of the full liquidation preference of Series&#xa0;C convertible preferred stock, the holders of Series&#xa0;B convertible preferred stock would have been entitled to receive a per share amount equal to $33.05196 (subject to adjustment for stock splits, stock dividends, recapitalizations, or the like), plus all dividends accrued, payable and/or in arrears (whether or not declared) minus the amount of any Special Dividends previously paid. After payment of the full liquidation preference of Series&#xa0;B convertible preferred stock, the holders of Series&#xa0;A convertible preferred stock would have been entitled to receive an amount equal to $28.80613 per share, as adjusted, plus all declared but unpaid dividends prior and in preference to any distribution to the holders of common stock. In each case, if the proceeds of such an event were insufficient to permit the liquidation payment to a particular class, any proceeds legally available for distribution to that class would have been distributed ratably among the holders of that class in proportion to the preferential amounts that each holder was entitled to receive. Following payment of all convertible preferred stock preferences, any remaining legally available assets of the Company would have been distributed to the holders of common stock and convertible preferred stock pro rata, based on the greatest number of shares of common stock held on an as&#x2011;converted basis.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><i>Voting</i> &#8211; The holders of convertible preferred stock were entitled to the number of votes equal to the number of shares of common stock into which each share of Series&#xa0;A, Series&#xa0;B, and Series&#xa0;C convertible preferred stock could have been converted on the record date for the vote or consent of the stockholders, except as otherwise required by law, and had voting rights and powers equal to the voting rights and powers of the common stockholders. The holders of Series&#xa0;A convertible preferred stock, voting as a separate class, were entitled to elect one&#xa0;member of the board of directors. As long as a specified investor held at least one&#xa0;share of Series&#xa0;C convertible preferred stock, the specified investor was able to designate one&#xa0;member of the board of directors, who would have been elected by the holders of Series&#xa0;C convertible preferred stock voting as a separate class. As long as a specified investor held least one&#xa0;share of Series&#xa0;B convertible preferred stock, the specified investor was able to designate one&#xa0;member of the board of directors, who would have been elected by the holders of Series&#xa0;B convertible preferred stock voting as a separate class. The holders of common stock, voting as a separate class, were entitled to elect two&#xa0;members of the board of directors, one of whom was the duly appointed chief executive officer of the Company.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><i>Protective Provisions</i> &#8211; So long as at least 20,134&#xa0;shares of Series&#xa0;C convertible preferred stock remained outstanding and for so long as at least 20,134&#xa0;shares of Series&#xa0;B convertible preferred stock remained outstanding, Series&#xa0;C holders and Series&#xa0;B holders, voting as a single class on an as&#x2011;converted basis, needed to approve certain specified corporate actions such as amending the certificate of incorporation, authorizing additional shares of stock or additional directors, redeeming stock and entering into certain strategic relationships.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><i>Redemption</i> &#8211; The convertible preferred stock was not redeemable. There were no liquidation events under the control of preferred stockholders that could have resulted in liquidation in which only the preferred stockholders would have participated. Accordingly, the convertible preferred stock was classified within stockholders&#8217; equity (deficit) on the Company&#8217;s consolidated balance sheets.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; MARGIN:12pt 0in 12pt 0.5in; TEXT-INDENT:-0.25in"><b><i>(b)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0; </font></i></b><b><i>Common Stock</i></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">Except as otherwise required by law or as otherwise provided in any certificate of designation for any series of preferred stock, the holders of common stock possess all voting power for the election of the Company&#8217;s directors and all other matters requiring stockholder action. Holders of common stock are entitled to one vote per share on matters to be voted on by stockholders. Holders of common stock are entitled to receive such dividends, if any, as may be declared from time to time by the Company&#8217;s board of directors in its discretion out of funds legally available therefore. In no event will any stock dividends or stock splits or combinations of stock be declared or made on common stock unless the shares of common stock at the time outstanding are treated equally and identically. As of December&#xa0;31, 2018, no dividends had been declared by the board of directors.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">In the event of the Company&#8217;s voluntary or involuntary liquidation, dissolution, distribution of assets or winding-up, the holders of the common stock will be entitled to receive an equal amount per share of all of the Company&#8217;s assets of whatever kind available for distribution to stockholders, after the rights of the holders of the preferred stock have been satisfied. There are no sinking fund provisions applicable to the common stock.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:12pt 0in">The Company had shares of common stock reserved for issuance as follows:</p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 11.25pt;">
<td style="padding: 0in; width: 70%; height: 11.25pt; white-space: nowrap; width: 70%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 11.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">December 31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in; width: 2%; height: 11.25pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 11.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">December 31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 9.2pt;">
<td style="background: white; padding: 0in; width: 70%; height: 9.2pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 12%; height: 9.2pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.2pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 12%; height: 9.2pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr style="height: 11.35pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 11.35pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="color: black; font-size: 10pt;">Convertible preferred stock outstanding</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 11.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.35pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 11.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,221,064</font></p>
</td>
</tr>
<tr style="height: 10.35pt;">
<td style="padding: 0in; width: 70%; height: 10.35pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="color: black; font-size: 10pt;">Options issued and outstanding</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">865,163</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.35pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">304,850</font></p>
</td>
</tr>
<tr style="height: 10.35pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 10.35pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="color: black; font-size: 10pt;">Available for future grants of equity awards</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">223,377</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 10.35pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 3.5pt;">
<td style="padding: 0in; width: 70%; height: 3.5pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="color: black; font-size: 10pt;">Cumulative convertible preferred stock dividends</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 3.5pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 3.5pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 3.5pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">441,096</font></p>
</td>
</tr>
<tr style="height: 7.4pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 7.4pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Common stock warrants</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 7.4pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">10,914</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 7.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 7.4pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">10,914</font></p>
</td>
</tr>
<tr style="height: 16.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 16.75pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,099,454</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 16.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 2.25pt; border-style: solid none double; border-color: windowtext currentColor; padding: 0in; width: 12%; height: 16.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,977,924</font></p>
</td>
</tr>
</table><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814488864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;12.&#xa0;&#xa0;Equity Incentive Plans</font></b></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">Prior to the Merger, the Company issued equity awards for compensation purposes to employees, directors and consultants under the Company&#8217;s 2007 Equity Incentive Plan (the &#8220;2007 Plan&#8221;). The 2007 Plan expired in July 2017, since when the Company has had no shares of common stock available for issuance under the 2007 Plan since awards under the 2007 Plan no longer become available for future issuance if such awards are forfeited or otherwise terminate. Each outstanding stock option to acquire shares of Private Vaxart stock, whether vested or unvested, was assumed in the Merger after adjustment for the impact of the Conversion and the Reverse Stock Split.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">In November 2016, Aviragen&#8217;s stockholders approved the 2016 Equity Incentive Plan (&#8220;2016 Equity Plan&#8221;), under which all outstanding awards under their previous plans became available for issuance under the 2016 Equity Plan if such awards are forfeited or otherwise terminate. The purpose of the 2016 Equity Plan is to assist the Company in attracting and retaining valued employees, consultants and non-employee directors by offering them a greater stake in the Company&#8217;s success and a closer identity with it, and to encourage ownership of the Company&#8217;s shares by such persons.</p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">Under the 2016 Equity Plan, the Company is authorized to issue incentive stock options (&#8220;ISOs&#8221;), non-qualified stock options (&#8220;NQSOs&#8221;), restricted stock (&#8220;RSAs&#8221;) and restricted stock units (&#8220;RSUs&#8221;). Awards that expire or are canceled generally become available for issuance again under the 2016 Equity Plan. All awards outstanding, along with the number of shares of the Company&#8217;s common stock available under the 2016 Equity Plan, were adjusted for the impact of the Reverse Stock Split and remain subject to adjustment in the event of a stock split, stock dividend or other extraordinary dividend, or other similar change in the Company&#8217;s common stock or capital structure. Awards may vest over varying periods, as specified by the Company&#8217;s Board of Directors for each grant, and have a maximum term of ten years from the grant date.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">A summary of stock option <font style="COLOR:black">transactions in each of the two years ended December 31, 2018, is as follows:</font></font></p><br/><table style="width: 600pt; margin-left: 0.5in; border-collapse: collapse;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" colspan="2" rowspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Weighted</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Average</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Exercise</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Price</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Shares</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Available</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">For&#xa0;Grant</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Number&#xa0;of</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Options</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Outstanding</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr style="height: 5.75pt;">
<td style="padding: 0in 0.7pt 0in 0in; width: 57%; height: 5.75pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 5.75pt; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 5.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 5.75pt; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 5.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 5.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 5.75pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Balance at January&#xa0;1, 2017</font></p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">99,644</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">275,539</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">11.32</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Granted</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(78,406)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">78,406</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">4.07</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Exercised</font></p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(2,834)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">8.58</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Forfeited</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">33,012</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(33,012)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">11.49</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Canceled</font></p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">13,249</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(13,249)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">12.00</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Termination of Plan</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(67,499)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-indent: 0.25in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Balance at December&#xa0;31, 2017</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">304,850</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">9.50</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 27pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Assumed on consummation of Merger</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">291,102</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">627,106</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">26.33</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Granted</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(431,100)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">431,100</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">5.17</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Exercised</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(2,013)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6.49</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Forfeited</font></p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">71,500</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(89,903)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">5.90</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Canceled</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">269,148</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(405,977)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">34.64</font></p>
</td>
</tr>
<tr style="height: 0.1in;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%; height: 0.1in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-indent: 0.25in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 13%; height: 0.1in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 0.1in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.1in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Balance at <font style="color: black;">December</font> 31, 2018</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">200,650</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">865,163</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">8.13</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">In addition, the 2016 Equity Plan has a reserve of 22,727 shares available for future issuance as RSAs and RSUs. As of <font style="COLOR:black">December</font> 31, 2018, no such awards have been granted under the 2016 Equity Plan.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">As of December&#xa0;31, 2018, there were 865,163 options outstanding with a weighted average exercise price of $8.13, a weighted average remaining term of 6.14 years and zero aggregate intrinsic value. Of these options, 452,905 were vested, with a weighted average exercise price of $10.58, a weighted average remaining term of 3.35 years and zero aggregate intrinsic value.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in -0.9pt 0pt 0in"><font style="FONT-SIZE:10pt">The aggregate intrinsic value represents the total pre-tax value (i.e., the difference between the Company&#8217;s stock price and the exercise price) of stock options outstanding as of December&#xa0;31, 2018, based on our common stock closing price of $1.88, which would have been received by the option holders had all their in-the-money options been exercised as of that date.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in">The grant date fair value of options vested in the years ended December&#xa0;31, 2018 and 2017, was $332,000 and $533,000, respectively. The intrinsic value of options exercised in the years ended December&#xa0;31, 2018 and 2017, was zero and $1,000, respectively.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">The weighted average grant date fair value of options awarded in the years ended December&#xa0;31, 2018 and 2017, was $3.59 and $2.99, respectively. Fair values were estimated using the following assumptions:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 9.5pt;">
<td style="padding: 0in 0.7pt; width: 67.26%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 32.74%; height: 9.5pt;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr style="height: 10pt;">
<td style="padding: 0in 0.7pt; width: 67.26%; height: 10pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 10pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2018</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2.04%; height: 10pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 15.36%; height: 10pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 9.5pt;">
<td style="padding: 0in 0.7pt; width: 67.26%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 15.34%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; width: 2.04%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 15.36%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr style="height: 13.65pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Risk-free interest rate</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="background: #cceeff; margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">2.80%</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;" valign="bottom">
<p style="background: #cceeff; margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1.87%</font></p>
</td>
</tr>
<tr style="height: 13.65pt;">
<td style="background: white; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Expected term</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="background: white; margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">5.96&#xa0;Years</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;" valign="bottom">
<p style="background: white; margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6.09&#xa0;Years</font></p>
</td>
</tr>
<tr style="height: 13.65pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Expected volatility</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="background: #cceeff; margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">79%</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;" valign="bottom">
<p style="background: #cceeff; margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">91</font><font style="font-size: 10pt;">%</font></p>
</td>
</tr>
<tr style="height: 13.65pt;">
<td style="background: white; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Dividend yield</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="background: white; margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">0%</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;" valign="bottom">
<p style="background: white; margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">0%</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:12pt 0in">Total stock&#x2011;based compensation recognized for options was as follows:</p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 65.8%;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 34.2%; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr style="height: 2.15pt; page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 65.8%; height: 2.15pt;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 16.22%; height: 2.15pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.34%; height: 2.15pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.62%; height: 2.15pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 65.8%;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 34.2%; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 65.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Research and development</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.72%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 14.5%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">254</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.34%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.22%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 13.4%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">262</p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 65.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">General and administrative</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.72%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.5%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">285</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.34%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2.22%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 13.4%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">215</p>
</td>
</tr>
<tr style="height: 0.2in; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 65.8%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total stock-based compensation</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.72%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.5%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">539</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.34%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2.22%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 13.4%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">477</p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">As of December 31, 2018, the unrecognized stock-based compensation cost related to outstanding stock options that are expected to vest was $1.1&#xa0;million, which the Company expects to recognize over an estimated weighted average period of 2.75 years.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6660098640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:24pt 0in 12pt"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;13.&#xa0;&#xa0;Income Taxes</font></b></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The provision for income taxes consists of the following for the years ended December&#xa0;31, 2018 and 2017:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 34.06%; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16.5%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 15.3%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 34.06%; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;"><font style="font-size: 8pt;">(In thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Current:</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Federal</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">State</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">3</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Foreign</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">106</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt 37pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 20pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Total Current</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">109</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt 37pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Deferred:</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Federal</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">State</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Foreign</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt 37pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Total Deferred</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt 37pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 30pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Provision for income taxes</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">109</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The components of the deferred tax assets as of December&#xa0;31, 2018 and 2017, are as follows:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">December&#xa0;31, 2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">December&#xa0;31, 2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred tax assets:</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(In thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net operating loss carry-forwards</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">43,822</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">19,441</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Research and development tax credits</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">3,357</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2,979</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Capitalized research and development</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2,326</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Sale of future royalties</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">8,383</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accruals, reserves and other</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">714</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">544</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total deferred tax assets</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">58,602</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">22,964</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Valuation allowance</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(48,626)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(22,964)</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred tax assets net of valuation allowance</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">9,976</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred tax liabilities:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Intangible assets</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(9,976)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total deferred tax liabilities</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(9,976)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 22.85pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net deferred tax assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
</table><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">A reconciliation of the provision for income taxes with the expected provision for income taxes computed by applying the federal statutory income tax rate of 21% and 34% to the net loss before provision for income taxes for the years ended December&#xa0;31, 2018 and 2017, respectively:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">U.S. federal taxes at statutory rate</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">21.0&#xa0; %</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">34.0 %</font></p>
</td>
</tr>
<tr style="height: 17.1pt;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">State taxes (net of federal benefit)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 8.65pt 0in 0in; width: 12%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">0.6</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 8.65pt 0in 0in; width: 12%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">14.2</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Foreign rate differential</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">3.1</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Global intangible low-taxed income</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(8.8)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Permanent items:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible note interest</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(0.4)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(10.8)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Revaluation of derivative liabilities</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">11.9</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Others</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(2.1)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(1.4)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Tax credits</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2.1</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">8.0</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Change in valuation allowance</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(20.4)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">43.4</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Impact of tax reform rate change</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(97.0)</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">NOL and credit adjustments</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(3.8)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(2.4)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Bargain purchase gain</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">8.1</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Other</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">0.1</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 20pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Provision for income taxes</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(0.6)%</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; text-align: right; text-indent: -0.25in; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;<font style="font: 7pt/normal 'Times New Roman'; font-size-adjust: none; font-stretch: normal;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="font-size: 10pt;">%</font></p>
</td>
</tr>
</table><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">The Company&#x2019;s actual tax expense differed from the statutory federal income tax expense using a tax rate of 21% for the year ended December 31, 2018, primarily due to, state and foreign income taxes, nondeductible expenses, research and development tax credits, and the change in valuation allowance. The Company&#x2019;s actual tax expense differed from the statutory federal income tax expense using a tax rate of 21% for the year ended December 31, 2017, primarily due to remeasurement of deferred taxes due to change in federal tax rate under the Tax Cuts and Jobs Act (the "TCJA"), state income taxes, nondeductible expenses, research and development tax credits, and the change in valuation allowance.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">On December 22, 2017, the TCJA was signed into law. The TCJA decreased the U.S. corporate federal income tax rate from 35% to 21% effective January 1, 2018. The TCJA also includes a number of other provisions including the elimination of loss carrybacks and limitations on the use of future losses, repeal of the Alternative Minimum Tax regime, and the introduction of a base erosion, anti-abuse tax and 100% expense allowance for certain properties. These provisions are not expected to have immediate effect on the Company.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">The key impact of the TCJA on the Company&#x2019;s financial statements was the re-measurement of the deferred tax balances to the new corporate tax rate in the year ended December 31, 2017. U.S. GAAP requires the re-measurement of the Company&#x2019;s deferred tax balances as of the enactment date of the TCJA, based on the rates at which the balances are expected to reverse in the future. The TCJA reduced the corporate tax rate to 21%, effective January 1, 2018. The Company recorded a decrease in its deferred tax assets of $4.2 million with a corresponding reduction to its valuation allowance of $4.2 million for the year ending December 31, 2017, primarily related to the impact of the TCJA.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">As of December 31, 2018 and 2017, the Company had a net operating loss (&#x201c;NOL&#x201d;) carryforwards of $92.3 million and $69.5 million for federal purposes, and $76.9 million and $75.0 million for state purposes, respectively. If not utilized, these carryforwards will begin to expire in 2024 for federal, and 2028 for state purposes.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">As of December 31, 2018, the Company also has accumulated tax losses of $14.4 million for Australia, $24.7 million for the United Kingdom and $37.7 million for France available for carry forward against future earnings, which under relevant tax laws do not expire but may not be available under certain circumstances. As of December 31, 2018, the Company&#x2019;s foreign subsidiaries have no positive accumulated earnings. As such, no federal or state income taxes have been provided on the losses of its foreign subsidiaries. If in the future there are positive earnings generated from the Company&#x2019;s foreign subsidiaries, the Company will evaluate whether to record any applicable federal and state income taxes on such earnings.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt">As of December 31, 2018 and 2017, the Company had federal research and development tax credit carryforwards of $3.0 million and $2.7 million, respectively and state research and development tax credit carryforwards of $2.3 million and $2.0 million, respectively, before offset for unrecognized tax benefits, to offset future income tax liabilities. The federal research and development tax credits will start to expire in 2027, if not utilized, while the state research and development tax credit can be carried forward indefinitely.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">Sections 382 and 383 of the Internal Revenue Code provides for a limitation on the annual use of NOL and research and development tax credit carryforwards following certain ownership changes that could limit the Company&#8217;s ability to utilize these carryforwards. The Company&#8217;s losses and credit carryforwards may be subject to these limitations. The Company has not performed an analysis to determine if such ownership changes have occurred. An analysis will be performed prior to recognizing the benefits of any losses or credits in the financial statements</font><font style="FONT-SIZE:10pt">.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt;">The Company is required to reduce its deferred tax assets by a valuation allowance if it is more likely than not that some or all of its deferred tax assets will not be realized. Management must use judgment in assessing the potential need for a valuation allowance, which requires an evaluation of both negative and positive evidence. The weight given to the potential effect of negative and positive evidence should be commensurate with the extent to which it can be objectively verified. In determining the need for and amount of the valuation allowance, if any, the Company assesses the likelihood that it will be able to recover its deferred tax assets using historical levels of income, estimates of future income and tax planning strategies. As a result of historical cumulative losses, the Company determined that, based on all available evidence, there was substantial uncertainty as to whether it will recover recorded net deferred taxes in future periods. Accordingly, the Company recorded a valuation allowance against all of its net deferred tax assets as of December 31, 2018 and 2017. The net change in total valuation allowance was an increase of approximately $25.7 million for the year ended December 31, 2018</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 31.14%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.4%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 14.58%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 31.14%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Beginning Balance</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.32%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,404</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,231</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Additions based on tax positions related to the current year</font></p>
</td>
<td style="padding: 0in; width: 2.32%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">181</font></p>
</td>
<td style="padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">173</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Decreases related to prior years&#x2019; tax positions</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.32%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(3)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.32%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 12.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 0.2in;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 68.86%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Ending Balance</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.32%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.08%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,582</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.86%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.72%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,404</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt">The Company&#8217;s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. During the year ended December 31, 2017 and 2018, the Company recognized no interest and penalties associated with unrecognized tax benefits. There are no tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within twelve months of the reporting date.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The Company files income tax returns in the U.S, Australia, France and the United Kingdom, as well as with various U.S. states. The Company is subject to tax audits in all jurisdictions in which it files income tax returns. Tax audits by their very nature are often complex and can require several years to complete. There are currently no tax audits that have commenced with respect to income tax returns in any jurisdiction.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">Under the tax statute of limitations applicable to the Internal Revenue Code, the Company and its U.S. subsidiary, either standalone or as part of the consolidated group, is no longer subject to U.S. federal income tax examinations by the Internal Revenue Service for tax years before tax year 2016. Under the statute of limitations applicable to most state income tax laws, the Company is no longer subject to state income tax examinations by tax authorities for tax years before 2015 in states in which it has filed income tax returns. However, because the Company is carrying forward income tax attributes, such as net operating losses and tax credits from 2004 and earlier tax years, these attributes can still be audited when utilized on returns filed in the future. The Company is subject to foreign tax examinations by tax authorities for fiscal year 2014 and forward</font><font style="FONT-SIZE:10pt">.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806359296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:24pt 0in 12pt; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">NOTE 14.&#xa0;&#xa0;Net Loss Per Share Attributable to Common Stockholders</font></b></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The <font style="COLOR:black">f</font>ollowing table presents the calculation of basic and diluted net loss per share (in thousands, except share and per share amounts):</font></p><br/><table style="border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" border="1" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 10.05pt;">
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 10.05pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 10.05pt; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr style="height: 9.3pt;">
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.3pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.3pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2%; height: 9.3pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 12%; height: 9.3pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 9.3pt;">
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.3pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.3pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.3pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.3pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net loss</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(18,007)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(9,582)</font></p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Series B and C preferred dividend</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in -0.5pt 0pt 0in; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(339)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(2,878)</font></p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net loss attributable to common stockholders</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(18,346)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(12,460)</font></p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Shares used to compute net loss per share, basic and diluted</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6,316,065</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">135,953</font></p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 18.9pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 18.9pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net loss per share attributable to common stockholders, basic and diluted</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 18.9pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 18.9pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(2.90)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 18.9pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 2%; height: 18.9pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 12%; height: 18.9pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(91.65)</font></p>
</td>
</tr>
</table><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">No adjustment has been made to the net loss </font><font style="font-size: 10pt;">attributable to common stockholders <font style="color: black;">as the effect would be anti-dilutive due to the net loss. </font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">The following potentially dilutive securities were excluded from the computation of diluted weighted average shares outstanding because they would have been antidilutive:</font></p><br/><table style="border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" border="1" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 30.86%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.9%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 13.8%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Options to purchase common stock </font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">839,396</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">295,243</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Warrant to purchase common stock</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">9,658</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Warrant to purchase convertible preferred stock</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">891</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">7,563</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Series B and C convertible preferred stock outstanding, </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#xa0;&#xa0; including cumulative dividends</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">213,760</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,567,172</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Series A convertible preferred stock outstanding</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">12,260</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">94,988</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible promissory notes, related party (as converted)</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">185,159</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">754,289</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total potentially dilutive securities excluded from </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#xa0; denominator of the diluted earnings per share computation</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,261,124</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,719,255</font></p>
</td>
</tr>
</table><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806347152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Information [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:24pt 0in 12pt"><b><font style="FONT-SIZE:10pt">NOTE&#xa0;15.&#xa0;&#xa0;Quarterly Financial Data (Unaudited)</font></b></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">Selected summarized quarterly financial information for fiscal 2018 and 2017 is as follows:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.52%; white-space: nowrap;" colspan="11" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended December&#xa0;31,&#xa0;2018</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">First</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.48%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Second</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Third</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.38%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Fourth</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt 12pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Revenue</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,503</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">608</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">281</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,767</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Operating expenses</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">5,418</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">8,383</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">6,161</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">5,953</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net income (loss)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">2,314</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(8,871)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(6,548)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(4,902)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net income (loss) attributable to common stockholders</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,975</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(8,871)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(6,548)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(4,902)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net income (loss) per share &#x2013; basic</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">0.54</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(1.24)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(0.92)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(0.69)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net income (loss) per share &#x2013; diluted</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">0.49</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(1.24)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(0.92)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(0.69)</font></p>
</td>
</tr>
</table><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.52%; white-space: nowrap;" colspan="11" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;"><strong><font style="font-size: 8pt;">Year Ended December 31, 2017</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">First</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.48%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;"><strong><font style="font-size: 8pt;">Second</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">Third</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.36%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;"><strong><font style="font-size: 8pt;">Fourth</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt 12pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Revenue</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">2,310</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">1,854</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">915</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">760</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Operating expenses</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">4,557</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">4,977</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">2,871</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">3,449</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net loss</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(2,796)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(3,538)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(2,173)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(1,075)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net loss attributable to common stockholders</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(3,506)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(4,256)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(2,898)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(1,800)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net loss per share &#x2013; basic and diluted</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(25.84)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(31.37)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(21.36)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(13.16)</font></p>
</td>
</tr>
</table><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823416944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Basis of Presentation</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;</font><font style="FONT-SIZE:10pt">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America <font style="COLOR:black">(&#8220;U.S. GAAP&#8221;)</font>.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Basis of Consolidation</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;The consolidated financial statements include the financial statements of Vaxart, Inc. and its subsidiaries. All significant transactions and balances between Vaxart, Inc. and its subsidiaries have been eliminated in consolidation.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Use of Estimates</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;</font><font style="FONT-SIZE:10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Actual results and outcomes could differ from these estimates and assumptions<font style="COLOR:black">.</font></font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions and Translations Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><strong><font style="font-size: 10pt; color: black;">Foreign Currencies</font></strong><font style="font-size: 10pt; color: black;">&#xa0;&#x2013;&#xa0;</font><font style="font-size: 10pt;">Foreign exchange gains and losses for assets and liabilities of the Company&#x2019;s <font style="color: black;">non-U.S. </font>subsidiaries for which the functional currency is the U.S. dollar are recorded in <font style="color: black;">foreign exchange gain or loss, net</font> within other income and (expenses) in the Company&#x2019;s statements of operations and comprehensive loss<font style="color: black;">. The Company has no subsidiaries </font>for which the local currency is the functional currency.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Cash and Cash Equivalents</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company considers all highly liquid debt investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents, which may consist of amounts invested in money market funds, corporate bonds and commercial paper, are stated at fair value. Cash and cash equivalents as of December 31, 2018 and 2017, includes $50,000 of restricted cash.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Short-Term Investments</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company&#8217;s short-term investments have only comprised commercial paper and corporate bonds. The short-term investments are classified as held-to-maturity based on the Company&#8217;s positive intent and ability to hold the securities to maturity. This classification is reevaluated at each balance sheet date. Short-term investments are stated at amortized cost, adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is presented as interest income in the statement of operations and comprehensive loss. The specific identification method is used to determine the realized gain or loss on securities sold or otherwise disposed. When the fair value of a debt security classified as held-to-maturity is less than its amortized cost, the Company assesses whether or not: (i)&#xa0;it has the intent to sell the security or (ii)&#xa0;it is more likely than not that the Company will be required to sell the security before its anticipated recovery. If either of these conditions is met, the Company must recognize an other-than-temporary impairment through earnings for the difference between the debt security&#8217;s amortized cost basis and its fair value. Gains and losses are recognized in earnings when the investments are sold or impaired.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt"><b><font style="COLOR:black">Concentration of Credit Risk</font></b>&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. The Company places its cash, cash equivalents and short&#x2011;term investments at financial institutions that management believes are of high credit quality. The Company is exposed to credit risk in the event of default by the financial institutions holding the cash and cash equivalents to the extent such amounts are in excess of the federally insured limits. The Company has not experienced any losses on its deposits since inception.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one&#xa0;corporate issuer or sector and establishing a minimum allowable credit rating. The Company generally requires no collateral from its customers.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><strong><font style="font-size: 10pt; color: black;">Accounts Receivable</font></strong><font style="font-size: 10pt;">&#xa0;<font style="color: black;">&#x2013;</font>&#xa0;Accounts receivable arise from the Company&#x2019;s royalty revenue receivable for sales, <font style="color: black;">net of estimated returns,</font> of <font style="color: black;">Inavir and Relenza, and from its </font>contract with the Department of Health and Human Services, Office of Biomedical Advanced Research and Development Authority (&#x201c;HHS BARDA&#x201d;) (see Note 6), and are reported at amounts expected to be collected in future periods. <a name="_Hlk521491497"></a>An allowance for uncollectible accounts will be recorded based on a combination of historical experience, aging analysis, and information on specific accounts, with related amounts recorded as a reserve against revenue recognized. Account balances will be written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company has provided no allowance for uncollectible accounts as of December 31, 2018 and 2017.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Property and Equipment</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;Property and equipment is carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Depreciation begins at the time the asset is placed in service. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is reflected in other income and (expenses) in the period realized.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The useful lives of the property and equipment are as follows:</font></p><br/><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in; width: 181.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Laboratory equipment</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 322.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">5 years</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 181.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Office and computer equipment</font></p>
</td>
<td style="padding: 0in; width: 322.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">3 years</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 181.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Leasehold improvements</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 322.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Shorter of remaining lease term or estimated useful life</font></p>
</td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><a name="_Hlk513886420"><b><font style="FONT-SIZE:10pt; COLOR:black">Intangible Assets</font></b></a><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;<font style="COLOR:black">Intangible assets comprise developed technology, intellectual property and, until it was considered fully impaired (see Note 5), in-process research and development. Intangible assets are carried at cost less accumulated amortization. Amortization is computed using the straight-line method over useful lives ranging from 1.3 to 11.75 years for developed technology and 20&#xa0;years for intellectual property. In-process research and development is considered to be indefinite-lived and is not amortized, but is subject to impairment testing</font>. The Company assessed its in-process research and development as fully impaired in the year ended December&#xa0;31, 2018 (see Note 5)<font style="COLOR:black">.</font></font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Impairment of Long-Lived Assets</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company reviews its long-lived assets, including <a name="_Hlk529199618">property and equipment and intangible assets</a> with finite lives, for impairment whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate over its remaining life. When indications of impairment are present and the estimated undiscounted future cash flows from the use of these assets is less than the assets&#8217; carrying value, the related assets will be written down to fair value. The Company assessed leasehold improvements and furniture at its leased offices in Alpharetta, Georgia as impaired in the year ended December&#xa0;31, 2018 (see Notes 5 and 10). There have been no other impairments of the Company&#8217;s long-lived assets for the periods presented<font style="COLOR:black">.</font></font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock', window );">Accrued Clinical And Manufacturing Expenses Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Accrued Clinical and Manufacturing Expenses</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company accrues for estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials, and contract manufacturing activities. The Company records the estimated costs of research and development activities based upon the estimated amount of services provided and includes the costs incurred but not yet invoiced within other accrued liabilities in the balance sheets and within research and development expense in the consolidated statements of operations and comprehensive loss. These costs can be a significant component of the Company&#8217;s research and development expenses<font style="COLOR:black">.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">The </font><font style="FONT-SIZE:10pt">Company estimates the amount of services provided through discussions with internal personnel and external service providers as to the progress or stage of completion of the services and the agreed-upon fee to be paid for such services. The Company makes significant judgments and estimates in determining the accrued balance in each reporting period. As actual costs become known, it adjusts its accrued estimates. Although the Company does not expect its estimates to be materially different from amounts actually incurred, its understanding of the status and timing of services performed, the number of subjects enrolled, and the rate of enrollment may vary from its estimates and could result in the Company reporting amounts that are too high or too low in any particular period. The Company&#8217;s accrued expenses are dependent, in part, upon the receipt of timely and accurate reporting from contract research organizations and other third-party service providers. To date, the Company has not experienced any material differences between accrued costs and actual costs incurred<font style="COLOR:black">.</font></font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock', window );">Convertible Preferred Stock Warrant Liability Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Convertible Preferred Stock Warrant Liability</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company has issued certain convertible preferred stock warrants. These warrants were recorded within other accrued liabilities in the balance sheets at fair value due to down-round protection features contained in the convertible preferred stock into which the warrants were exercisable. At the end of each reporting period, changes in fair value of the warrants since the prior period were recorded as a component of (loss) gain on revaluation of financial instruments, net within other income and (expenses) in the consolidated statements of operations and comprehensive loss<font style="COLOR:black">. In the event that the terms of the warrant change such that liability accounting is no longer required, the fair value on the date of such change is released to equity.</font></font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Convertible Promissory Notes Embedded Derivative Liability</font></b><font style="FONT-SIZE:10pt">&#xa0;<font style="COLOR:black">&#8211;</font>&#xa0;The Company recorded derivative instruments related to redemption features embedded within the outstanding convertible promissory notes. The embedded derivatives were accounted for as liabilities at their estimated fair value when the convertible promissory notes were issued and were re-measured to fair value as of each balance sheet date, with the related re-measurement adjustment being recognized as a component of (loss) gain on revaluation of <font style="COLOR:black">financial instruments</font> in the consolidated statements of operations and comprehensive loss<font style="COLOR:black">.</font></font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Revenue Recognition</font></b><font style="COLOR:black">&#xa0;</font><font style="FONT-SIZE:10pt">&#8211;&#xa0;The Company recognizes revenue when it transfers control of promised goods or services to its customers, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition, the Company performs the following five steps:</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(i)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">identification of the promised goods or services in the contract;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(ii)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(iii)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">measurement of the transaction price, including the constraint on variable consideration;</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(iv)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">allocation of the transaction price to the performance obligations based on estimated selling prices; and</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:6pt 0in 6pt 0.75in; TEXT-INDENT:-0.5in"><font style="FONT-SIZE:10pt">(v)<font style="FONT:7pt &quot;Times New Roman&quot;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="FONT-SIZE:10pt">recognition of revenue when (or as) the Company satisfies each performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:normal"><font style="COLOR:black">Revenue from royalties earned as a percentage of sales, including milestone payments based on achieving a specified level of sales, where a license is deemed to be the predominant item to which the royalties relate, is recognized as revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied), as required under the sales- and usage-based royalty exception.</font></p><br/><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; LINE-HEIGHT:12pt">The Company performed research and development work under its cost&#x2011;plus&#x2011;fixed&#x2011;fee contract with HHS BARDA. The Company recognizes revenue under research contracts only when a contract has been executed and the contract price is fixed or determinable. <font style="COLOR:#212121">Revenue from the HHS BARDA contract is recognized in the period during which the related costs are incurred and the related services are rendered, provided that the applicable conditions under the contract have been met. Costs of contract revenue are recorded as a component of operating expenses in the consolidated statements of operations</font> and comprehensive loss<font style="COLOR:#212121">.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><font style="FONT-SIZE:10pt">Under the cost reimbursable contract with HHS BARDA, the Company is reimbursed for allowable costs, and recognizes revenue as allowable costs are incurred and the fixed-fee is earned. Reimbursable costs under the contract primarily include direct labor, subcontract costs, materials, equipment, travel, and approved overhead and indirect costs. Fixed fees under cost reimbursable contracts are earned in proportion to the allowable costs incurred in performance of the work relative to total estimated contract costs, with such costs incurred representing a reasonable measurement of the proportional performance of the work completed. Under the HHS BARDA contract, certain activities must be pre-approved in order for their costs to be deemed allowable direct costs. The HHS BARDA contract provides the U.S.&#xa0;government the ability to terminate the contract for convenience or to terminate for default if the Company fails to meet its obligations as set forth in the statement of work. </font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt -0.9pt 12pt 0in;"><font style="font-size: 10pt;">Payments to the Company under cost reimbursable contracts, such as this contract, are provisional payments subject to adjustment upon annual audit by the government. Management believes that revenue for periods not yet audited has been recorded in amounts that are expected to be realized upon final audit and settlement. When the final determination of the allowable costs for any year has been made, revenue and billings may be adjusted accordingly in the period that the adjustment is known.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Research and Development Costs</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;</font><font style="FONT-SIZE:10pt">Research and development costs are expensed as incurred. Research and development costs consist primarily of salaries and benefits, stock-based compensation, consultant fees, third-party costs for conducting clinical trials and the manufacture of clinical trial materials, certain facility costs and other costs associated with clinical trials. Payments made to other entities are under agreements that are generally cancelable by the Company. Advance payments for research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related services are performed.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Stock-Based Compensation</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;The Company measures the fair value of all stock-based awards, including stock options, to employees and, since April 1, 2018, to nonemployees, on the grant date and records the fair value of these awards, net of estimated forfeitures, to compensation expense over the service period. Prior to April 1, 2018, the </font><font style="FONT-SIZE:10pt">fair value of awards to nonemployees was measured on the date of performance at the fair value of the consideration received or the fair value of the equity instruments issued, whichever was more reliably measured. The fair value of options is estimated using the Black-Scholes valuation model<font style="COLOR:black">. The expected term of each option is estimated by taking the arithmetic average of its original contractual term and its average vesting term.</font></font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><b><font style="FONT-SIZE:10pt; COLOR:black">Net Income (Loss) Per Share Attributable to Common Stockholders</font></b><font style="FONT-SIZE:10pt; COLOR:black">&#xa0;&#8211;&#xa0;Basic net income (loss) per share is computed by dividing net income (loss), as adjusted for dividends on the Series&#xa0;B and Series&#xa0;C convertible preferred stock in the period, by the weighted average number of common shares outstanding during the period, without consideration of potential common shares.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">Diluted net income (loss) per common share is computed giving effect to all potential dilutive common shares, comprising common stock issuable upon exercise of stock options and warrants. The Company uses the treasury-stock method to compute diluted income (loss) per share with respect to its stock options and warrants. For purposes of this calculation, options and warrants to purchase common stock are considered to be potential common shares and are only included in the calculation of diluted net income per share when their effect is dilutive. In the event of a net loss, the effects of all potentially dilutive shares are excluded from the diluted net loss per share calculation as their inclusion would be antidilutive.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Recently Adopted Accounting Pronouncements</font></b></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt -0.9pt 12pt 0in;"><font style="font-size: 10pt;">In June 2018, the FASB issued ASU 2018-07, <em>Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. </em>This update simplifies the accounting for share-based payment transactions by changing the guidance for accounting for nonemployee share-based awards so that, instead of revaluing each award at each balance sheet date during the period over which it vests, the value will be fixed on the grant date and expensed over the vesting period in the same way that employee awards are already accounted for. This guidance is effective for annual periods beginning after December 15, 2018, including interim periods within that year, with early adoption permitted for entities that had already adopted Topic 606 (see ASU 2014-09 below). The Company adopted ASU 2018-07 effective April 1, 2018, and since it had no unvested awards granted to nonemployees, its adoption had no effect on the Company&#x2019;s financial condition or results of operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><font style="FONT-SIZE:10pt">In May 2017, the FASB issued ASU 2017-09, <i>Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. </i>This update provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. This guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that year, and must be applied prospectively to an award modified on or after the adoption date. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&#8217;s financial condition or results of operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><font style="FONT-SIZE:10pt">In January&#xa0;2017, the FASB&#xa0;issued ASU No.&#xa0;2017-04, <i>Intangibles-Goodwill and Other (Topic&#xa0;350) Simplifying the Test for Goodwill Impairment</i>&#xa0;(&#8220;ASU&#xa0;2017-04&#8221;), which will simplify the goodwill impairment calculation by eliminating Step 2 from the current goodwill impairment test. The new standard does not change how a goodwill impairment is identified. The standard will be effective January&#xa0;1, 2020, with early adoption permitted, and is to be applied prospectively from the date of adoption. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&#8217;s financial condition or results of operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt -0.9pt 12pt 0in"><font style="FONT-SIZE:10pt">In January&#xa0;2017, the FASB&#xa0;issued ASU No.&#xa0;2017-01, <i>Business Combinations (Topic&#xa0;805) Clarifying the Definition of a Business</i>&#xa0;(&#8220;ASU&#xa0;2017-01&#8221;). The new standard <font style="COLOR:black">clarifies the definition of a business to help companies evaluate whether acquisition or disposal transactions should be accounted for as asset groups or as businesses</font>. The Company adopted this standard when it became effective on January 1, 2018, and it was applied in connection with the Company&#8217;s accounting for the Merger as a business combination.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">In August 2016, the FASB issued Accounting Standards Update (ASU) 2016-15, <i>Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</i>, which provides additional guidance on the presentation and classification of certain items in the statement of cash flows. The standard is effective for fiscal years beginning after December&#xa0;15, 2017, with early adoption permitted. The Company adopted this standard effective January 1, 2018, and its adoption had no effect on the Company&#8217;s financial condition or results of operations.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt; COLOR:black">In May&#xa0;2014, the FASB issued ASU&#xa0;2014-09</font><font style="FONT-SIZE:10pt">, <i>Revenue from Contracts with Customers (Topic&#xa0;606)</i>, which supersedes nearly all existing revenue recognition guidance under Topic&#xa0;605, <i>Revenue</i> <i>Recognition</i>. The new standard requires a company to recognize revenue when it transfers goods and services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. ASU&#xa0;2014-09 defines a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when (or as) the entity satisfies the performance obligations. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><font style="FONT-SIZE:10pt">The Company has <font style="COLOR:#212121">determined that its HHS BARDA government contract is not within the scope of ASU 2014-09 as the government entity is not a customer under the agreement. </font>The Company adopted <font style="COLOR:#212121">ASU 2014-09</font> with respect to its royalty revenue using the modified retrospective method on January&#xa0;1, 2018. Under the modified retrospective transition method, the cumulative effect of applying the standard is recognized at the date of initial application for all contracts not completed as of the date of adoption. The adoption of ASU&#xa0;2014-09&#xa0;did not have any effect on the Company&#8217;s financial condition or results of operations and therefore no cumulative effect adjustment was recorded, although the Company has modified its accounting policies to reflect the requirements of this standard and make additional disclosures<font style="COLOR:black">.</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in; TEXT-AUTOSPACE:"><b><font style="FONT-SIZE:10pt; COLOR:black">Recent Accounting Pronouncements</font></b></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">In February 2016, the FASB issued ASU 2016 02 Leases (Topic 842), which replaces most current lease guidance when it becomes effective. This standard update intends to increase transparency and improve comparability by requiring entities to recognize assets and liabilities on the balance sheet for all leases, with certain exceptions. The new standard states that a lessee will recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statements of operations. The new guidance will be effective for the Company starting in the first quarter of fiscal 2019, with early adoption permitted. The Company plans to adopt the new guidance effective January 1, 2019, using the modified retrospective method, and to use the effective date method of adoption, as permitted by ASU 2018-11, Targeted Improvements, which the FASB issued in July 2018, which reduces the disclosure requirements on transition. The Company has elected the short-term lease recognition exemption for all classes of assets, which means that it will not recognize right-of-use assets or lease liabilities for leases with a duration of one year or less. Further, the Company has elected to use all of the practical expedients available on transition, whereby it has not reassessed under the new standard its prior conclusions about lease identification, lease classification and initial direct costs.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">We expect that this standard will have a material effect on our consolidated financial statements. The most significant effects relate to the recognition of new right-of-use assets and lease liabilities on our consolidated balance sheet. The Company currently expects to recognize lease liabilities of $1,207,000, $766,000 of which is current, and right-of-use assets of $941,000 based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases, to derecognize liabilities of $239,000, $100,000 of which is current, and recognize an increase of $27,000 to accumulated deficit on adoption of the new accounting policy.</font></p><br/><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 12pt 0in;"><font style="font-size: 10pt; color: black;">The increase in accumulated deficit arises because the right-of-use asset impairment charge that would have been recorded in the three months ended December 31, 2018, under Topic 842 exceeds the lease loss accrual, net of accretion, that was recorded (see Note 10). This impact aside, the adoption will have no effect on the Company&#x2019;s statements of operations or cash flows, other than on related disclosures.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in"><font style="FONT-SIZE:10pt; COLOR:black">The Company has reviewed all other significant newly-issued accounting pronouncements and concluded that they either are not applicable to the Company&#8217;s operations or no material effect is expected on its consolidated financial statements as a result of future adoption.</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investments in financial assets, including marketable securities (debt and equity securities with readily determinable fair values), investments accounted for under the equity method and cost method, securities borrowed and loaned, and repurchase and resale agreements. For marketable securities, the disclosure may include the entity's accounting treatment for transfers between investment categories and how the fair values for such securities are determined. Also, for all investments, an entity may describe its policy for assessing, recognizing and measuring impairment of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.M)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877573&amp;loc=d3e87990-122713<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2,12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e4975-111524<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the accrued clinical and manufacturing expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_AccruedClinicalAndManufacturingExpensesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for convertible preferred stock warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ConvertiblePreferredStockWarrantLiabilityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814308624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock', window );">Schedule Of Property Plant And Equipment Useful Life [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in; width: 181.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Laboratory equipment</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 322.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">5 years</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 181.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Office and computer equipment</font></p>
</td>
<td style="padding: 0in; width: 322.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">3 years</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 181.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Leasehold improvements</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 322.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Shorter of remaining lease term or estimated useful life</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale, which acts as the basis for calculation of depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6604989344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Common stock</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">31,789</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total </font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">31,789</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">As of February 13, </font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Adjustments</font></strong></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">As of December 31, </font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2018</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Cash and cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">25,525</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">25,525</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accounts receivable</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">14,666</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">14,666</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Prepaid expenses</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">446</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(10)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">436</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Property and equipment</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">170</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">170</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Intangible assets:</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 20pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Developed technology <sup>(1)</sup></font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">22,400</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(300)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">22,100</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">In-process research and development <sup>(2)</sup></font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,600</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,600</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 30pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total assets</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">64,807</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(310)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">64,497</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accounts payable</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(3,379)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">75</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(3,304)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Other current liabilities</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(6,351)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(393)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(6,744) </font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">L<font style="color: black;">iability related to sale of future royalties</font></font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(16,300)</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">400</font></p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(15,900)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net assets acquired</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">38,777</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(228)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">38,549</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Purchase price</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(31,789)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(31,789)</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Bargain purchase gain <sup>(3)</sup></font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6,988</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(228)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6,760</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock', window );">Business Combination, Separately Recognized Transactions [Table Text Block]</a></td>
<td class="text"><table style="border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" border="1" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 80.44%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Revenue</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">2,815</p>
</td>
</tr>
<tr>
<td style="padding: 0in; border: 0px currentColor; width: 80.44%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 80.44%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net loss</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 1.76%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 17.8%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">(3,847)</p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; white-space: nowrap; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December 31,</font></strong></p>
</td>
</tr>
<tr style="height: 2.15pt; page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 70%; height: 2.15pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 2.15pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2%; height: 2.15pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 2.15pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 12%; white-space: nowrap; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr style="height: 12.25pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total revenue</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">15,695</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">13,527</p>
</td>
</tr>
<tr style="height: 12.25pt; page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 27pt; text-indent: -9.35pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
</tr>
<tr style="height: 12.25pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 70%; height: 12.25pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net loss</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">(13,162)</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2%; height: 12.25pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 12%; height: 12.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">(29,270)</p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the equity interest issued or issuable in a business acquisition (or series of individually immaterial business acquisitions) planned, initiated, or completed during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806295504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.7%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;1</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;2</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;3</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 8pt;">Total</font></strong></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 10pt;">December 31<font style="color: black;">, 2018</font></font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 24.12%;" colspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Recurring Financial Assets:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Money Market Funds</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Corporate Bonds</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
</table><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Recurring Financial Liabilities:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible promissory notes embedded </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#xa0; derivative liability</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible preferred stock warrant liability</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total liabilities</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
</table><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.7%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;1</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;2</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.64%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Level&#xa0;3</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 11.62%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Total</font></strong></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 10pt;">December 31, 2017</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 24.12%;" colspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Recurring Financial Assets:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Money Market Funds</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Corporate Bonds</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
</tr>
</table><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Recurring Financial Liabilities:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible promissory notes embedded </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#xa0; derivative liability</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible preferred stock warrant liability</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">67</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.8in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 47.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total liabilities</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.3%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.36%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.24%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 10.4%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">67</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 9.35pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 9.35pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Convertible</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Preferred Stock</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Warrant Liability</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Convertible Promissory</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Notes Embedded</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Derivative Liability</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.95pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 9.95pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.35pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 9.35pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.35pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Total</p>
</td>
</tr>
<tr style="height: 9.95pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 9.95pt; width: 57%;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 9.95pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 11%; height: 9.95pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 11.1pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 57%; height: 11.1pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Balance at January&#xa0;1, 2018</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 10.55pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Issuances</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 9.9pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 57%; height: 9.9pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Revaluation loss included in (loss) gain on revaluation </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">&#xa0;&#xa0; of financial instruments, net</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 9.9pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 11%; height: 9.9pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 10.55pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Settlements</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(70)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(70)</font></p>
</td>
</tr>
<tr style="height: 11.1pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 57%; height: 11.1pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Balance at December 31, 2018</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 11.1pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 11.1pt; white-space: nowrap; width: 11%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 57%; height: 10.55pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 10.55pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 11%; height: 10.55pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 22.3pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 57%; height: 22.3pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Total losses included in other income and (expenses) attributable </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">&#xa0;&#xa0;&#xa0; to liabilities still held as of December 31, 2018</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 22.3pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 11%; height: 22.3pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
</table><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 9.35pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 9.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.6%; height: 9.35pt; white-space: nowrap;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Convertible</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Preferred Stock</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Warrant Liability</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.38%; height: 9.35pt; white-space: nowrap;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Convertible Promissory</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Notes Embedded</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Derivative Liability</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12.62%; height: 9.35pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.95pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 9.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12.62%; height: 9.95pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.35pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 9.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 1.8%; height: 9.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.1in; text-align: center; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.62%; height: 9.35pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 8pt; font-weight: bold; page-break-after: avoid;">Total</p>
</td>
</tr>
<tr style="height: 9.95pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 9.95pt;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 10.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.22%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12.16%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 1.8%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 10.82%; height: 9.95pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr style="height: 11.1pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 56.8%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Balance at January&#xa0;1, 2017</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">134</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.22%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3,280</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3,414</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 10.55pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Issuances</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.22%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 9.9pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 56.8%; height: 9.9pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Revaluation gains included in (loss) gain on revaluation </font></p>
<p style="margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">&#xa0;&#xa0;&#xa0; of financial instruments, net</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 10.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(67)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.22%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12.16%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(3,280)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 10.82%; height: 9.9pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">(3,347)</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 10.55pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Settlements</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 11.1pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.8%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Balance at December 31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 11.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 11.1pt; white-space: nowrap;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
</tr>
<tr style="height: 10.55pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 56.8%; height: 10.55pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 10.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.22%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12.16%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 1.8%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;">&#xa0;</p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 10.82%; height: 10.55pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 22.3pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 56.8%; height: 22.3pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">Total gains included in other income and (expenses) attributable</font></p>
<p style="margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9pt;">&#xa0;&#xa0;&#xa0; &#xa0;to liabilities still held as of December&#xa0;31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">67</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.22%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12.16%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3,280</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.8%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid; text-align: left;"><font style="font-size: 9pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 10.82%; height: 22.3pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 9pt;">3,347</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806531504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Cash, Cash Equivalents and Investments [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 64.9%;" colspan="14" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">December 31, 2018</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 12.18%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gross</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Unrecognized</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gains</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.88%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gross</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Unrecognized</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Losses</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.12%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Estimated</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Fair</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Value</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 11.04%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Carrying</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Value</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.92%;" colspan="2" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Amortized</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Cost</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Money market funds</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Corporate bonds</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 10.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr style="height: 11.1pt;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 35.1%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Reported as:</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.46%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.74%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.9%; height: 11.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Short-term investments</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 11.65pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
</table><table style="width: 600pt; border-collapse: collapse;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 64.9%;" colspan="14" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">December 31, 2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12.18%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gross</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.88%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gross</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Estimated</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11.04%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 10.92%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Amortized</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.18%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Unrecognized</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.88%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Unrecognized</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Fair</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.04%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Carrying</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.92%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Cost</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12.18%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Gains</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.88%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Losses</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Value</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11.04%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Value</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Money market funds</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Corporate bonds</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
</tr>
<tr style="height: 10.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
</tr>
<tr style="height: 9.75pt;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 35.1%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Reported as:</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.28%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.72%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.46%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 10.74%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.48%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.64%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 1.14%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 9.9%; height: 9.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,192</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 0in 10pt; width: 35.1%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Short-term investments</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,415</font></p>
</td>
</tr>
<tr style="height: 11.65pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 35.1%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.28%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.72%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.46%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 10.74%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.48%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.64%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.94%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.14%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 9.9%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,607</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 9pt;">December </font></strong><strong><font style="font-size: 8pt;">31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">December&#xa0;31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Royalties receivable</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,776</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Government contract &#x2013; billed</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">20</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">477</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Government contract &#x2013; unbilled</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">153</font></p>
</td>
</tr>
<tr style="height: 10.75pt;">
<td style="background: white; padding: 0in 0in 0in 10pt; width: 70%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accounts receivable</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,796</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 10.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">630</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 10.9pt;">
<td style="padding: 0in 0.7pt 0in 0in; width: 70%; height: 10.9pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.9pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="color: black; font-size: 9pt;">December </font></strong><strong><font style="font-size: 8pt;">31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 10.9pt;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 10.9pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">December&#xa0;31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 8.95pt;">
<td style="padding: 0in 0.7pt 0in 0in; width: 70%; height: 8.95pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 37%;" colspan="5">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman', 'serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Laboratory equipment</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2,076</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,565</font></p>
</td>
</tr>
<tr style="height: 12.2pt;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Office and computer equipment</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">227</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 12%; height: 12.2pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">175</font></p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Leasehold improvements</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">333</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">226</font></p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: white; padding: 0in 0in 1pt; width: 70%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total property and equipment</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2,636</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,966</font></p>
</td>
</tr>
<tr style="height: 19.35pt;">
<td style="background: white; padding: 0in 0in 1pt; width: 70%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Less: accumulated depreciation</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(1,570)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 19.35pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 19.35pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(1,236)</font></p>
</td>
</tr>
<tr style="height: 20.25pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Property and equipment, net</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,066</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 20.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">730</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 36.55pt; text-indent: -9pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">December</font></strong><strong><font style="font-size: 8pt;">&#xa0;31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">February 13,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.7pt; text-indent: -0.7pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">December&#xa0;31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 9.35pt;">
<td style="padding: 0in 0.7pt 0in 0in; width: 57%; height: 9.35pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 36.55pt; text-indent: -9pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 9.35pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 9.35pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 9.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 1.45pt 0in 0in; width: 11%; height: 9.35pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Purchased technology</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">22,100</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">22,400</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">In-process research and development</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,600</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Intellectual property</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">80</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">80</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">80</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total cost</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">22,180</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">24,080</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 1.45pt 0in 0in; border: 0px currentColor; width: 11%; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">80</font></p>
</td>
</tr>
<tr style="height: 0.2in;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 57%; height: 0.2in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Less accumulated amortization</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.2in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,767</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.2in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">40</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.2in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; height: 0.2in; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">40</font></p>
</td>
</tr>
<tr style="height: 17.5pt;">
<td style="background: white; padding: 0in 0in 0.7pt 10pt; width: 57%; height: 17.5pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Intangible assets, net</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 17.5pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">19,413</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%; height: 17.5pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">24,040</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 11%; height: 17.5pt; white-space: nowrap; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">40</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Year Ending December 31,</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2019</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,320</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2020</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,732</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2021</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,732</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2022</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,732</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2023</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,731</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 1pt 10pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Thereafter</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 16%; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">10,166</font></p>
</td>
</tr>
<tr style="height: 13pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 82%; height: 13pt; width: 82%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 13pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 16%; height: 13pt; white-space: nowrap; width: 16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">19,413</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">December&#xa0;31,&#xa0;2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">December&#xa0;31,&#xa0;2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accrued compensation</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">632</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,320</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accrued clinical and manufacturing expenses</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">75</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">69</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accrued professional and consulting services</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">166</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">113</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Reserve for return of royalties</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">339</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred rent and lease loss accrual, current portion</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">111</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">21</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible preferred stock warrant liability</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">67</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Other</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">195</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">15</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0in 1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.6in; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; border: 0px currentColor; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,518</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,605</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640137952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities Related to Sale of Future Royalties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueByArrangementDisclosureTextBlock', window );">Deferred Revenue, by Arrangement, Disclosure [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 84%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total Liability related to sale of future royalties, February 13, 2018</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 14%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">15,900</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 84%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Non-cash royalty revenue paid to HCRP</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 14%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(18)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 84%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Non-cash interest expense recognized</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 14%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">1,859</font></p>
</td>
</tr>
<tr style="height: 11.65pt;">
<td style="background: white; padding: 0in 0in 0in 10pt; width: 84%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total <font style="color: black;">Liability related to sale of future royalties, </font>December <font style="color: black;">31, 2018</font></font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 11.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 14%; height: 11.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">17,741</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueByArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the type of arrangements and the corresponding amounts that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueByArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804378608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt 27pt; text-indent: -9pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9.5pt;">Balance as of January 1, 2018</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 9.5pt;">Costs of exit from leased premises</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">359</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred rent on cease-use date</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">19</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Impairment of property and equipment</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(106)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 78.74%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Cash paid, net of receipts</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 1.78%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 19.48%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(41)</font></p>
</td>
</tr>
<tr style="height: 11.5pt;">
<td style="background: white; padding: 0in 0in 1pt 10pt; width: 78.74%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accretion charges, included in rent expense</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.78%; height: 11.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 19.48%; height: 11.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2</font></p>
</td>
</tr>
<tr style="height: 0.2in;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 78.74%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Balance as of December 31, 2018</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 1.78%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 19.48%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">233</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Years Ending December 31,</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Lease Payments</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Sublease Income</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 1in; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2019</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">859</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">213</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2020</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">411</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">219</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2021</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">56</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">38</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Thereafter</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 14.35pt;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%; height: 14.35pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%; height: 14.35pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,326</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;" valign="top">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%; height: 14.35pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 1.45pt 0in 0in; width: 12%; height: 14.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">470</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806293968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock', window );">Schedule Of Convertible Preferred Stock [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; margin-left: 0.5in; border-collapse: collapse;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 33.3pt;">
<td style="padding: 0in; width: 75pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 13pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 33.3pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">Shares<br />authorized</font></strong></p>
</td>
<td style="padding: 0in; width: 13pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 33.3pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">Shares<br />outstanding</font></strong></p>
</td>
<td style="padding: 0in; width: 16.4pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74.3pt; height: 33.3pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">Net<br />carrying<br />value</font></strong></p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 33.3pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 77.2pt; height: 33.3pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 9pt;">Liquidation<br />preference</font></strong></p>
</td>
</tr>
<tr style="height: 8.5pt;">
<td style="padding: 0in; width: 75pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 13pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 74pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 13pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 73pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 16.4pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 74.3pt; height: 8.5pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black; font-size: 8pt;">(in thousands)</font></p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 8.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 77.2pt; height: 8.5pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black; font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr style="height: 0.1in;">
<td style="background: #cceeff; padding: 0in; width: 75pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Series A</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 74pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">94,988</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 73pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">94,988</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 58.5pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">2,949</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 61.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">2,737</font></p>
</td>
</tr>
<tr style="height: 0.1in;">
<td style="padding: 0in; width: 75pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Series B</font></p>
</td>
<td style="padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 74pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">747,095</font></p>
</td>
<td style="padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 73pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">520,973</font></p>
</td>
<td style="padding: 0in; width: 16.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 58.5pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">16,115</font></p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 61.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">17,219</font></p>
</td>
</tr>
<tr style="height: 0.1in;">
<td style="background: #cceeff; padding: 0in; width: 75pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Series C</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">820,088</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 13pt; height: 0.1in;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">605,103</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.5pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">19,877</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 61.4pt; height: 0.1in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">20,000</font></p>
</td>
</tr>
<tr style="height: 15.7pt;">
<td style="padding: 0in 0in 0in 10pt; width: 75pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total</font></p>
</td>
<td style="padding: 0in; width: 13pt; height: 15.7pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 74pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,662,171</font></p>
</td>
<td style="padding: 0in; width: 13pt; height: 15.7pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 73pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,221,064</font></p>
</td>
<td style="padding: 0in; width: 16.4pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.5pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">38,941</font></p>
</td>
<td style="padding: 0in; width: 15.8pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 15.8pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 61.4pt; height: 15.7pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">39,956</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock', window );">Schedule Of Common Stock Reserved For Issuance [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 11.25pt;">
<td style="padding: 0in; width: 70%; height: 11.25pt; white-space: nowrap; width: 70%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 11.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">December 31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in; width: 2%; height: 11.25pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 11.25pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">December 31,</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 9.2pt;">
<td style="background: white; padding: 0in; width: 70%; height: 9.2pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 12%; height: 9.2pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 2%; height: 9.2pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in; width: 12%; height: 9.2pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr style="height: 11.35pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 11.35pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="color: black; font-size: 10pt;">Convertible preferred stock outstanding</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 11.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 11.35pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 11.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,221,064</font></p>
</td>
</tr>
<tr style="height: 10.35pt;">
<td style="padding: 0in; width: 70%; height: 10.35pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="color: black; font-size: 10pt;">Options issued and outstanding</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">865,163</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 10.35pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">304,850</font></p>
</td>
</tr>
<tr style="height: 10.35pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 10.35pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="color: black; font-size: 10pt;">Available for future grants of equity awards</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">223,377</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 10.35pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 10.35pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr style="height: 3.5pt;">
<td style="padding: 0in; width: 70%; height: 3.5pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="color: black; font-size: 10pt;">Cumulative convertible preferred stock dividends</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 3.5pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 3.5pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 3.5pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">441,096</font></p>
</td>
</tr>
<tr style="height: 7.4pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 7.4pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Common stock warrants</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 7.4pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">10,914</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 7.4pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 7.4pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">10,914</font></p>
</td>
</tr>
<tr style="height: 16.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 16.75pt; white-space: nowrap; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,099,454</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 16.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 2.25pt; border-style: solid none double; border-color: windowtext currentColor; padding: 0in; width: 12%; height: 16.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,977,924</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of common stock reserved for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ScheduleOfCommonStockReservedForIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ScheduleOfConvertiblePreferredStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6594762064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; margin-left: 0.5in; border-collapse: collapse;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 11%;" colspan="2" rowspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Weighted</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Average</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Exercise</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Price</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Shares</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Available</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">For&#xa0;Grant</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Number&#xa0;of</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Options</font></strong></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Outstanding</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr style="height: 5.75pt;">
<td style="padding: 0in 0.7pt 0in 0in; width: 57%; height: 5.75pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 5.75pt; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 5.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 5.75pt; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; height: 5.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%; height: 5.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 11%; height: 5.75pt; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Balance at January&#xa0;1, 2017</font></p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">99,644</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">275,539</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">11.32</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Granted</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(78,406)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">78,406</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">4.07</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Exercised</font></p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(2,834)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">8.58</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Forfeited</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">33,012</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(33,012)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">11.49</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Canceled</font></p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">13,249</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(13,249)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">12.00</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Termination of Plan</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(67,499)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-indent: 0.25in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Balance at December&#xa0;31, 2017</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">304,850</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">9.50</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt 27pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Assumed on consummation of Merger</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">291,102</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">627,106</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">26.33</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Granted</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(431,100)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">431,100</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">5.17</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Exercised</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(2,013)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6.49</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Forfeited</font></p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">71,500</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(89,903)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">5.90</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Canceled</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">269,148</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(405,977)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">34.64</font></p>
</td>
</tr>
<tr style="height: 0.1in;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 57%; height: 0.1in; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-indent: 0.25in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 13%; height: 0.1in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13%; height: 0.1in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 0.1in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 11%; height: 0.1in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 57%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Balance at <font style="color: black;">December</font> 31, 2018</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">200,650</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 13%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">865,163</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">8.13</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 9.5pt;">
<td style="padding: 0in 0.7pt; width: 67.26%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 32.74%; height: 9.5pt;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr style="height: 10pt;">
<td style="padding: 0in 0.7pt; width: 67.26%; height: 10pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 10pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2018</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2.04%; height: 10pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 15.36%; height: 10pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="color: black; font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 9.5pt;">
<td style="padding: 0in 0.7pt; width: 67.26%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 15.34%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; width: 2.04%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 15.36%; height: 9.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr style="height: 13.65pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Risk-free interest rate</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="background: #cceeff; margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">2.80%</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;" valign="bottom">
<p style="background: #cceeff; margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1.87%</font></p>
</td>
</tr>
<tr style="height: 13.65pt;">
<td style="background: white; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Expected term</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="background: white; margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">5.96&#xa0;Years</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;" valign="bottom">
<p style="background: white; margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6.09&#xa0;Years</font></p>
</td>
</tr>
<tr style="height: 13.65pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Expected volatility</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="background: #cceeff; margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">79%</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;" valign="bottom">
<p style="background: #cceeff; margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">91</font><font style="font-size: 10pt;">%</font></p>
</td>
</tr>
<tr style="height: 13.65pt;">
<td style="background: white; padding: 0in 0.7pt; width: 67.26%; height: 13.65pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Dividend yield</font></p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.34%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="background: white; margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">0%</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.04%; height: 13.65pt;" valign="bottom">
<p style="background: white; margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.36%; height: 13.65pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">0%</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 65.8%;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 34.2%; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr style="height: 2.15pt; page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 65.8%; height: 2.15pt;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 16.22%; height: 2.15pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.34%; height: 2.15pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 15.62%; height: 2.15pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 65.8%;" valign="top">
<p style="margin: 0in 0in 0pt 0.1in; text-indent: -0.1in; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 34.2%; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0.7pt; width: 65.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Research and development</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 1.72%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 14.5%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">254</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.34%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.22%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 13.4%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">262</p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: white; padding: 0in 0.7pt; width: 65.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">General and administrative</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.72%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.5%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">285</p>
</td>
<td style="background: white; padding: 0in 0.7pt; width: 2.34%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2.22%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 13.4%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">215</p>
</td>
</tr>
<tr style="height: 0.2in; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 65.8%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Total stock-based compensation</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 1.72%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.5%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">539</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; width: 2.34%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2.22%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 13.4%; height: 0.2in; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">477</p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823316144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 34.06%; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16.5%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 15.3%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 34.06%; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;"><font style="font-size: 8pt;">(In thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Current:</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Federal</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">State</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">3</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Foreign</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">106</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt 37pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 20pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Total Current</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">109</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt 37pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Deferred:</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Federal</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">State</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Foreign</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt 37pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Total Deferred</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt 37pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0in 0in 30pt; width: 65.94%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; page-break-after: avoid;"><font style="font-size: 10pt;">Provision for income taxes</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 14.26%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">109</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.26%; white-space: nowrap;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.24%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; page-break-after: avoid;">$</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 13.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">December&#xa0;31, 2018</font></strong></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">December&#xa0;31, 2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred tax assets:</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="top">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 8pt;">(In thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net operating loss carry-forwards</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">43,822</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">19,441</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Research and development tax credits</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">3,357</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2,979</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Capitalized research and development</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2,326</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Sale of future royalties</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">8,383</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Accruals, reserves and other</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">714</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">544</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total deferred tax assets</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">58,602</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">22,964</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 30pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Valuation allowance</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(48,626)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(22,964)</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 20pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred tax assets net of valuation allowance</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">9,976</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Deferred tax liabilities:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Intangible assets</font></p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(9,976)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 20pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total deferred tax liabilities</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(9,976)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 22.85pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.05in 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net deferred tax assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.05in 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">U.S. federal taxes at statutory rate</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">21.0&#xa0; %</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">34.0 %</font></p>
</td>
</tr>
<tr style="height: 17.1pt;">
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">State taxes (net of federal benefit)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 8.65pt 0in 0in; width: 12%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">0.6</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 8.65pt 0in 0in; width: 12%; height: 17.1pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">14.2</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Foreign rate differential</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">3.1</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Global intangible low-taxed income</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(8.8)</font></p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Permanent items:</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible note interest</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(0.4)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(10.8)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Revaluation of derivative liabilities</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">11.9</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 10pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Others</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(2.1)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(1.4)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Tax credits</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">2.1</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">8.0</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Change in valuation allowance</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(20.4)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">43.4</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Impact of tax reform rate change</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(97.0)</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">NOL and credit adjustments</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(3.8)</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 5.75pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(2.4)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Bargain purchase gain</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">8.1</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Other</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 8.65pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">0.1</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; border: 0px currentColor; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt 0in 20pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Provision for income taxes</font></p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">(0.6)%</font></p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 2%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt 0in 0in; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt 0.5in; text-align: right; text-indent: -0.25in; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#x2014;<font style="font: 7pt/normal 'Times New Roman'; font-size-adjust: none; font-stretch: normal;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></font><font style="font-size: 10pt;">%</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 31.14%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.4%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 14.58%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 31.14%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="font-size: 8pt;">(in thousands)</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Beginning Balance</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.32%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,404</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,231</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Additions based on tax positions related to the current year</font></p>
</td>
<td style="padding: 0in; width: 2.32%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">181</font></p>
</td>
<td style="padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 11.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">173</font></p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Decreases related to prior years&#x2019; tax positions</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.32%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(3)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="padding: 0in; width: 68.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt 24pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.32%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 12.08%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.16%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2.86%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 11.72%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 0.2in;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 68.86%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Ending Balance</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.32%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.08%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,582</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2.86%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.72%; height: 0.2in;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,404</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=109238393&amp;loc=d3e36027-109320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814439680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text"><table style="border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" border="1" width="800" cellspacing="0" cellpadding="0">
<tr style="height: 10.05pt;">
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 10.05pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 10.05pt; width: 12%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
</tr>
<tr style="height: 9.3pt;">
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.3pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.3pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2%; height: 9.3pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 12%; height: 9.3pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr style="height: 9.3pt;">
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.3pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.3pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.3pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.3pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net loss</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(18,007)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(9,582)</font></p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Series B and C preferred dividend</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in -0.5pt 0pt 0in; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(339)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(2,878)</font></p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net loss attributable to common stockholders</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(18,346)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(12,460)</font></p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Shares used to compute net loss per share, basic and diluted</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">6,316,065</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">135,953</font></p>
</td>
</tr>
<tr style="height: 9.1pt;">
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 9.1pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 9.1pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 12%; height: 9.1pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr style="height: 18.9pt;">
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 70%; height: 18.9pt; width: 70%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Net loss per share attributable to common stockholders, basic and diluted</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 2%; height: 18.9pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 12%; height: 18.9pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(2.90)</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2%; height: 18.9pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 2%; height: 18.9pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 12%; height: 18.9pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">(91.65)</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</a></td>
<td class="text"><table style="border: 0px currentColor; width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" border="1" width="800" cellspacing="0" cellpadding="0">
<tr>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 30.86%;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended&#xa0;December&#xa0;31,</font></strong></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext;">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.9%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2018</font></strong></p>
</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in 0.7pt; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in 0.7pt; width: 13.8%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">2017</font></strong></p>
</td>
</tr>
<tr>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Options to purchase common stock </font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">839,396</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">295,243</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Warrant to purchase common stock</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">9,658</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">&#x2014;</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Warrant to purchase convertible preferred stock</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">891</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">7,563</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Series B and C convertible preferred stock outstanding, </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#xa0;&#xa0; including cumulative dividends</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">213,760</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,567,172</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Series A convertible preferred stock outstanding</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">12,260</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">94,988</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Convertible promissory notes, related party (as converted)</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">185,159</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">754,289</font></p>
</td>
</tr>
<tr>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt 34.55pt; text-indent: -0.2in; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: white; padding: 0in 0.7pt; border: 0px currentColor; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
</tr>
<tr>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 68.8%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">Total potentially dilutive securities excluded from </font></p>
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="font-size: 10pt;">&#xa0; denominator of the diluted earnings per share computation</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.5pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 0.7pt; width: 14.66%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">1,261,124</font></p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt; border: 0px currentColor; width: 2.5%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1.5pt; border-style: none none double; border-color: currentColor currentColor black; padding: 0in 0.7pt; width: 14.04%;" colspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="font-size: 10pt;">2,719,255</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6660051216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Quarterly Financial Information [Table Text Block]</a></td>
<td class="text"><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.52%; white-space: nowrap;" colspan="11" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Year&#xa0;Ended December&#xa0;31,&#xa0;2018</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">First</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.48%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Second</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><strong><font style="font-size: 8pt;">Third</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.38%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: center;"><strong><font style="font-size: 8pt;">Fourth</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt 12pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Revenue</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,503</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">608</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">281</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,767</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Operating expenses</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">5,418</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">8,383</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">6,161</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">5,953</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net income (loss)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">2,314</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(8,871)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(6,548)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(4,902)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net income (loss) attributable to common stockholders</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">1,975</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(8,871)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(6,548)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(4,902)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net income (loss) per share &#x2013; basic</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">0.54</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(1.24)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(0.92)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(0.69)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net income (loss) per share &#x2013; diluted</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">0.49</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(1.24)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(0.92)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt; text-align: left;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.32%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: right;"><font style="color: black; font-size: 10pt;">(0.69)</font></p>
</td>
</tr>
</table><table style="width: 600pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="800" cellspacing="0" cellpadding="0">
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 58.52%; white-space: nowrap;" colspan="11" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;"><strong><font style="font-size: 8pt;">Year Ended December 31, 2017</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">First</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12.48%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;"><strong><font style="font-size: 8pt;">Second</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.22%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><strong><font style="font-size: 8pt;">Third</font></strong></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 13.36%; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 10pt;"><strong><font style="font-size: 8pt;">Fourth</font></strong></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt 12pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Revenue</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">2,310</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">1,854</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">915</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.05in 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">760</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Operating expenses</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">4,557</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">4,977</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">2,871</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.05in 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">3,449</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net loss</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(2,796)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(3,538)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(2,173)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(1,075)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net loss attributable to common stockholders</font></p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(3,506)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(4,256)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(2,898)</font></p>
</td>
<td style="padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(1,800)</font></p>
</td>
</tr>
<tr style="page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 41.48%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">Net loss per share &#x2013; basic and diluted</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(25.84)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 11.42%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(31.37)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.16%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(21.36)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.08%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 10pt;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.06%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: left; font-family: 'Times New Roman','serif'; font-size: 10pt;">$</p>
</td>
<td style="background: #cceeff; padding: 0in 0.7pt 0in 0in; width: 12.3%; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black; font-size: 10pt;">(13.16)</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109225645&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823820112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 13, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_OrganizationandBasisofPresentationDetailsLineItems', window );"><strong>Organization and Basis of Presentation (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' Equity, Reverse Stock Split</a></td>
<td class="text">the Company effected a reverse stock split at a ratio of one new share for every eleven shares of the Company&#x2019;s common stock outstanding<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Stock Issued During Period, Shares, Reverse Stock Splits | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ExchangeRatioNumberOfSharesExchangedPerShare', window );">Exchange Ratio, Number of Shares Exchanged Per Share | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0201346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (97,989)<span></span>
</td>
<td class="num">$ (79,982)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,506<span></span>
</td>
<td class="nump">$ 1,571<span></span>
</td>
<td class="nump">$ 8,405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember', window );">Private Vaxarts Stockholders Warrantholders And Optionsholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_OrganizationandBasisofPresentationDetailsLineItems', window );"><strong>Organization and Basis of Presentation (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_AviragensStockholderrsAndOptionsholdersMember', window );">Aviragens Stockholderrs And Optionsholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_OrganizationandBasisofPresentationDetailsLineItems', window );"><strong>Organization and Basis of Presentation (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_OxfordFinanceMember', window );">Oxford Finance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_OrganizationandBasisofPresentationDetailsLineItems', window );"><strong>Organization and Basis of Presentation (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_LoanAgreementBorrowedAmount', window );">Loan Agreement, Borrowed Amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=vxrt_ConversionMember', window );">Conversion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_OrganizationandBasisofPresentationDetailsLineItems', window );"><strong>Organization and Basis of Presentation (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of Stock, Shares Issued | shares</a></td>
<td class="nump">0.22148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ExchangeRatioNumberOfSharesExchangedPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares exchanged per share based on the exchange ratio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ExchangeRatioNumberOfSharesExchangedPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_LoanAgreementBorrowedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loan borrowed under the loan agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_LoanAgreementBorrowedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_OrganizationandBasisofPresentationDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_OrganizationandBasisofPresentationDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_PrivateVaxartsStockholdersWarrantholdersAndOptionsholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_AviragensStockholderrsAndOptionsholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_AviragensStockholderrsAndOptionsholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_OxfordFinanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_OxfordFinanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=vxrt_ConversionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=vxrt_ConversionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823540368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 109 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years 9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=vxrt_RecognizeLeaseLiabilitiesMember', window );">Recognize Lease Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 1,207,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">766,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">941,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=vxrt_DerecognizeLeaseLiabilitiesMember', window );">Derecognize Lease Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">239,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IncreaseDecreaseInAccumulatedDeficit', window );">Increase (Decrease) In Accumulated Deficit</a></td>
<td class="nump">$ 27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_IncreaseDecreaseInAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease amount related to accumulated deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_IncreaseDecreaseInAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_SummaryofSignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=vxrt_RecognizeLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=vxrt_RecognizeLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=vxrt_DerecognizeLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=vxrt_DerecognizeLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806633344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - Estimated Useful Lives<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vxrt_LaboratoryEquipmentMember', window );">Laboratory Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Estimated Useful Lives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Estimated Useful Lives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Estimated Useful Lives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Useful Lives, Description</a></td>
<td class="text">Shorter of remaining lease term or estimated useful life<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_SummaryofSignificantAccountingPoliciesDetailsEstimatedUsefulLivesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vxrt_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=vxrt_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6821618032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BusinessCombinationDetailsLineItems', window );"><strong>Business Combination (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BusinessCombinationDetailsLineItems', window );"><strong>Business Combination (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">11 years 9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BusinessCombinationDetailsLineItems', window );"><strong>Business Combination (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">1 year 109 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_BusinessCombinationDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_BusinessCombinationDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6591701264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - Total purchase price for Aviragen<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_TotalPurchasePriceForAviragenAbstract', window );"><strong>Total purchase price for Aviragen [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock</a></td>
<td class="nump">$ 31,789<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total</a></td>
<td class="nump">$ 31,789<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_TotalPurchasePriceForAviragenAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_TotalPurchasePriceForAviragenAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824973696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - Allocation of the purchase price to the fair value of the respective assets and liabilities acquired - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 13, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems', window );"><strong>Business Combination (Details) - Allocation of the purchase price to the fair value of the respective assets and liabilities acquired [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,525<span></span>
</td>
<td class="nump">$ 25,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,666<span></span>
</td>
<td class="nump">14,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IntangibleAssetsAbstract0', window );"><strong>Intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Developed technology (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,100<span></span>
</td>
<td class="nump">22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development (2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,497<span></span>
</td>
<td class="nump">64,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,304)<span></span>
</td>
<td class="num">(3,304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,744)<span></span>
</td>
<td class="num">(6,744)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties', window );">Liability related to sale of future royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,900)<span></span>
</td>
<td class="num">(15,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,549<span></span>
</td>
<td class="nump">38,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,789)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Bargain purchase gain (3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,760<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems', window );"><strong>Business Combination (Details) - Allocation of the purchase price to the fair value of the respective assets and liabilities acquired [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 25,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">14,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses</a></td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IntangibleAssetsAbstract0', window );"><strong>Intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Developed technology (1)</a></td>
<td class="nump">22,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development (2)</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">64,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(3,379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="num">(6,351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties', window );">Liability related to sale of future royalties</a></td>
<td class="num">(16,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">38,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="num">(31,789)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Bargain purchase gain (3)</a></td>
<td class="nump">$ 6,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Restatement Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems', window );"><strong>Business Combination (Details) - Allocation of the purchase price to the fair value of the respective assets and liabilities acquired [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IntangibleAssetsAbstract0', window );"><strong>Intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Developed technology (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(393)<span></span>
</td>
<td class="num">(393)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties', window );">Liability related to sale of future royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(228)<span></span>
</td>
<td class="num">$ (228)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Bargain purchase gain (3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (228)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6571-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6527-128477<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_BusinessCombinationDetailsAllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities related to sale of future royalties  assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_IntangibleAssetsAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_IntangibleAssetsAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814421568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - Selected amounts related to Aviragen's business included in the Company's consolidated statement of operations<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract', window );"><strong>Selected amounts related to Aviragen's business included in the Company's consolidated statement of operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized', window );">Revenue</a></td>
<td class="nump">$ 2,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses', window );">Net loss</a></td>
<td class="num">$ (3,847)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gains or losses recognized for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The revenues and gains recognized recorded for each transaction with the acquiree that is recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_SelectedAmountsRelatedToAviragensBusinessIncludedInTheCompanysConsolidatedStatementOfOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804472352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - Unaudited pro forma information is summarized - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_UnauditedProFormaInformationIsSummarizedAbstract', window );"><strong>Unaudited pro forma information is summarized [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total revenue</a></td>
<td class="nump">$ 15,695<span></span>
</td>
<td class="nump">$ 13,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (13,162)<span></span>
</td>
<td class="num">$ (29,270)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_UnauditedProFormaInformationIsSummarizedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_UnauditedProFormaInformationIsSummarizedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825203184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Details) - Company's financial assets and liabilities measured at fair value - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 2,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember', window );">Convertible Promissory Notes Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember', window );">Convertible Promissory Notes Embedded Derivative Liability [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember', window );">Convertible Promissory Notes Embedded Derivative Liability [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember', window );">Convertible Promissory Notes Embedded Derivative Liability [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePreferredStockWarrantLiabilityMember', window );">Convertible Preferred Stock Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePreferredStockWarrantLiabilityMember', window );">Convertible Preferred Stock Warrant Liability [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePreferredStockWarrantLiabilityMember', window );">Convertible Preferred Stock Warrant Liability [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePreferredStockWarrantLiabilityMember', window );">Convertible Preferred Stock Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialLiabilitiesAbstract', window );"><strong>Recurring Financial Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=vxrt_CorporateBondsMember', window );">Corporate Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=vxrt_CorporateBondsMember', window );">Corporate Bonds [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=vxrt_CorporateBondsMember', window );">Corporate Bonds [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=vxrt_CorporateBondsMember', window );">Corporate Bonds [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RecurringFinancialAssetsAbstract', window );"><strong>Recurring Financial Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_RecurringFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_RecurringFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_RecurringFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_RecurringFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePreferredStockWarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePreferredStockWarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=vxrt_CorporateBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=vxrt_CorporateBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824552016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Details) - A reconciliation of all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at January 1</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 3,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuances</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Revaluation loss gains included in (loss) gain on revaluation of financial instruments, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(3,347)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(70)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Total gain (losses) included in other income and (expenses) attributable to liabilities still held</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePreferredStockWarrantLiabilityMember', window );">Convertible Preferred Stock Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at January 1</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuances</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Revaluation loss gains included in (loss) gain on revaluation of financial instruments, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(70)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Total gain (losses) included in other income and (expenses) attributable to liabilities still held</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember', window );">Convertible Promissory Notes Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at January 1</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuances</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Revaluation loss gains included in (loss) gain on revaluation of financial instruments, net</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(3,280)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Total gain (losses) included in other income and (expenses) attributable to liabilities still held</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,280<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePreferredStockWarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePreferredStockWarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=vxrt_ConvertiblePromissoryNotesEmbeddedDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806351568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 476,000<span></span>
</td>
<td class="nump">$ 376,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ImpairmentofPropertyAndEquipment', window );">Impairment of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,727,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Research and Development in Process</a></td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ImpairmentofPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for property and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ImpairmentofPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812044240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - Cash equivalents and short-term investments - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems', window );"><strong>Balance Sheet Components (Details) - Cash equivalents and short-term investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Amortized Cost</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 2,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrecognized Gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrecognized Losses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Estimated Fair Value</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">2,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying Value</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">2,607<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=vxrt_CorporateBondsMember', window );">Corporate Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems', window );"><strong>Balance Sheet Components (Details) - Cash equivalents and short-term investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Amortized Cost</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrecognized Gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrecognized Losses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Estimated Fair Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems', window );"><strong>Balance Sheet Components (Details) - Cash equivalents and short-term investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Amortized Cost</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrecognized Gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrecognized Losses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Estimated Fair Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems', window );"><strong>Balance Sheet Components (Details) - Cash equivalents and short-term investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Amortized Cost</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrecognized Gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrecognized Losses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Estimated Fair Value</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying Value</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember', window );">Cash Equivalents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems', window );"><strong>Balance Sheet Components (Details) - Cash equivalents and short-term investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Amortized Cost</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrecognized Gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrecognized Losses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Estimated Fair Value</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Carrying Value</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 1,192<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_BalanceSheetComponentsDetailsCashequivalentsandshortterminvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=vxrt_CorporateBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=vxrt_CorporateBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637697440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - Accounts receivable net of allowance - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_AccountsReceivableNetOfAllowanceAbstract', window );"><strong>Accounts receivable net of allowance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RoyaltiesReceivable', window );">Royalties receivable</a></td>
<td class="nump">$ 1,776<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Government contract &#8211; billed</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Government contract &#8211; unbilled</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 1,796<span></span>
</td>
<td class="nump">$ 630<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BilledContractReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054760&amp;loc=d3e55302-109406<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_AccountsReceivableNetOfAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_AccountsReceivableNetOfAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_RoyaltiesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount receivable as royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_RoyaltiesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811335232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - Property and equipment, net - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_PropertyAndEquipmentNetAbstract', window );"><strong>Property and equipment, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_LaboratoryEquipmentGross', window );">Laboratory equipment</a></td>
<td class="nump">$ 2,076<span></span>
</td>
<td class="nump">$ 1,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_OfficeAndComputerEquipmentGross', window );">Office and computer equipment</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">333<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">2,636<span></span>
</td>
<td class="nump">1,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(1,570)<span></span>
</td>
<td class="num">(1,236)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 1,066<span></span>
</td>
<td class="nump">$ 730<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_LaboratoryEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Laboratory equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_LaboratoryEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_OfficeAndComputerEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Office and computer equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_OfficeAndComputerEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_PropertyAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_PropertyAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812128416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - Intangible assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Feb. 13, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 22,180<span></span>
</td>
<td class="nump">$ 24,080<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="nump">2,767<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">19,413<span></span>
</td>
<td class="nump">24,040<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vxrt_PurchasedTechnologyMember', window );">Purchased Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">22,100<span></span>
</td>
<td class="nump">22,400<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vxrt_PurchasedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=vxrt_PurchasedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806478736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - The estimated future amortization expense by year<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract', window );"><strong>The estimated future amortization expense by year [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2019</a></td>
<td class="nump">$ 2,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2020</a></td>
<td class="nump">1,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2021</a></td>
<td class="nump">1,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2022</a></td>
<td class="nump">1,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2023</a></td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">10,166<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 19,413<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_TheEstimatedFutureAmortizationExpenseByYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6659789376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - Accrued liabilities - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_AccruedLiabilitiesAbstract', window );"><strong>Accrued liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_AccruedCompensationCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 632<span></span>
</td>
<td class="nump">$ 1,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_AccruedClinicalAndManufacturingExpensesCurrent', window );">Accrued clinical and manufacturing expenses</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_AccruedProfessionalAndConsultingServicesCurrent', window );">Accrued professional and consulting services</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ReserveForReturnOfRoyaltiesCurrent', window );">Reserve for return of royalties</a></td>
<td class="nump">339<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Deferred rent and lease loss accrual, current portion</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent', window );">Convertible preferred stock warrant liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,518<span></span>
</td>
<td class="nump">$ 1,605<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902458&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_AccruedClinicalAndManufacturingExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued clinical and manufacturing expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_AccruedClinicalAndManufacturingExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_AccruedCompensationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_AccruedCompensationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_AccruedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_AccruedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_AccruedProfessionalAndConsultingServicesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Professional And Consulting Services</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_AccruedProfessionalAndConsultingServicesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible preferred stock warrant liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ConvertiblePreferredStockWarrantLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ReserveForReturnOfRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reserve For Return Of Royalties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ReserveForReturnOfRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812475200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details)<br> &#165; in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 25, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoanRestructuringModificationNameAxis=us-gaap_EntityLoanModificationProgramMember', window );">Entity Loan Modification Program [Member] | HHSBARDA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RevenueDetailsLineItems', window );"><strong>Revenue (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract', window );">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Modification of Contract</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="nump">$ 15,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,344,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,839,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty [Member] | Relenza Recognized [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RevenueDetailsLineItems', window );"><strong>Revenue (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 788,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RoyaltyPercentage', window );">Royalty Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty [Member] | Aviragen Therapeutics Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RevenueDetailsLineItems', window );"><strong>Revenue (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">&#165; 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RoyaltyPercentage', window );">Royalty Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty [Member] | Inavir Recognized [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RevenueDetailsLineItems', window );"><strong>Revenue (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 552,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_NonCashRoyaltyRevenue', window );">Non Cash Royalty Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty [Member] | JAPAN</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RevenueDetailsLineItems', window );"><strong>Revenue (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RoyaltyPercentage', window );">Royalty Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130531-203044<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130532-203044<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_NonCashRoyaltyRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non cash royalty revenue recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_NonCashRoyaltyRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_RevenueDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_RevenueDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_RoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty percentage received on net sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_RoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanRestructuringModificationNameAxis=us-gaap_EntityLoanModificationProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanRestructuringModificationNameAxis=us-gaap_EntityLoanModificationProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_HHSBARDAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_HHSBARDAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_RelenzaRecognizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_RelenzaRecognizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_AviragenTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_AviragenTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_InavirRecognizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_InavirRecognizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811723696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities Related to Sale of Future Royalties (Details) - HCRP [Member] - Royalty Arrangement [Member]<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems', window );"><strong>Liabilities Related to Sale of Future Royalties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_DebtAdditions', window );">Debt, Additions</a></td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_HCRPAgreementRevenueTerms', window );">HCRP Agreement, Revenue Terms</a></td>
<td class="text">HCRP is entitled to the first $3.0 million plus 15% of the next $1.0 million in royalties earned in each year commencing on April 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_RoyaltyPercentage', window );">Royalty Percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_DebtAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additions in debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_DebtAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_HCRPAgreementRevenueTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of revenue terms in royalties earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_HCRPAgreementRevenueTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_LiabilitiesRelatedtoSaleofFutureRoyaltiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_RoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty percentage received on net sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_RoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=vxrt_HCRPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=vxrt_HCRPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=us-gaap_RoyaltyArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=us-gaap_RoyaltyArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6803817728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities Related to Sale of Future Royalties (Details) - Liability related to sale of future Royalties<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract', window );"><strong>Liability related to sale of future Royalties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total Liability related to sale of future royalties, February 13, 2018</a></td>
<td class="nump">$ 15,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_DebtRevenueNonCashRoyaltyRevenuePaid', window );">Non-cash royalty revenue paid to HCRP</a></td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_DebtNoncashInterestExpenseRecognized', window );">Non-cash interest expense recognized</a></td>
<td class="nump">1,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">TotalLiability related to sale of future royalties, December 31, 2018</a></td>
<td class="nump">$ 17,741<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_DebtNoncashInterestExpenseRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non-cash interest expense recognized in relation to the sale of future royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_DebtNoncashInterestExpenseRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_DebtRevenueNonCashRoyaltyRevenuePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non-cash royalty revenue paid on liability in relation to the sale of future royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_DebtRevenueNonCashRoyaltyRevenuePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_LiabilityRelatedToSaleOfFutureRoyaltiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825404320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Promissory Notes, Related Parties (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 13, 2018</div></th>
<th class="th"><div>Nov. 20, 2015</div></th>
<th class="th"><div>Dec. 10, 2014</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems', window );"><strong>Convertible Promissory Notes, Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued (in Shares)</a></td>
<td class="nump">1,571,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price (in Dollars per share)</a></td>
<td class="nump">$ 9.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt Conversion, Converted Instrument, Amount</a></td>
<td class="nump">$ 14,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsValue', window );">Other Ownership Interests, Contributed Capital</a></td>
<td class="nump">21,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=vxrt_NotePurchaseAgreementMember', window );">Note Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems', window );"><strong>Convertible Promissory Notes, Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=vxrt_SecondNotePurchaseAgreementMember', window );">Second Note Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems', window );"><strong>Convertible Promissory Notes, Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vxrt_ConvertiblePromissoryNotesMember', window );">Convertible Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems', window );"><strong>Convertible Promissory Notes, Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">35,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Debt Instrument, Periodic Payment, Interest</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Debt Instrument, Increase, Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="nump">$ 29,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionByUniqueDescriptionAxis=vxrt_NotesIssuedIn2014Member', window );">Notes Issued In 2014 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems', window );"><strong>Convertible Promissory Notes, Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded Derivative, Fair Value of Embedded Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionByUniqueDescriptionAxis=vxrt_NotesIssuedIn2015Member', window );">Notes Issued In 2015 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems', window );"><strong>Convertible Promissory Notes, Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded Derivative, Fair Value of Embedded Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of capital contributed by other unit holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70434-108055<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187171-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ConvertiblePromissoryNotesRelatedPartiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=vxrt_NotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=vxrt_NotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=vxrt_SecondNotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=vxrt_SecondNotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vxrt_ConvertiblePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vxrt_ConvertiblePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=vxrt_NotesIssuedIn2014Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=vxrt_NotesIssuedIn2014Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=vxrt_NotesIssuedIn2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=vxrt_NotesIssuedIn2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824255632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Secured Promissory Note Payable to Oxford Finance (Details) - Loan Agreement [Member] - Oxford Finance [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 22, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems', window );"><strong>Secured Promissory Note Payable to Oxford Finance (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Debt Instrument, Payment Terms</a></td>
<td class="text">a secured promissory note and is repayable over four&#xa0;years, with interest only payable over the first 12 months and the balance fully amortized over the subsequent 36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 325,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,000<span></span>
</td>
<td class="nump">$ 518,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">356,000<span></span>
</td>
<td class="nump">$ 335,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt Conversion, Converted Instrument, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member] | Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems', window );"><strong>Secured Promissory Note Payable to Oxford Finance (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrants Not Settleable in Cash, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems', window );"><strong>Secured Promissory Note Payable to Oxford Finance (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">30-day U.S. LIBOR plus 6.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">6.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems', window );"><strong>Secured Promissory Note Payable to Oxford Finance (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrants Not Settleable in Cash, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear', window );">Debt Conversion, Converted Instrument, Issuance Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 13,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the financial instrument was issued in exchange for the original debt being converted in a noncash or part noncash transaction, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentIssuanceDateDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_SecuredPromissoryNotePayabletoOxfordFinanceDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=vxrt_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=vxrt_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_OxfordFinanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vxrt_OxfordFinanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812767072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Operating Lease, Impairment Loss</a></td>
<td class="nump">$ 253,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 875,000<span></span>
</td>
<td class="nump">$ 564,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=vxrt_OfficeSpaceInSanFranciscoCaliforniaMember', window );">Office Space In San Francisco California [Member] | The First Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=vxrt_OfficeSpaceInSanFranciscoCaliforniaMember', window );">Office Space In San Francisco California [Member] | Remaining Three Leases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=vxrt_OfficeSpaceInAlpharettaGeorgiaMember', window );">Office Space In Alpharetta Georgia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 28,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888369&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_CommitmentsandContingenciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_CommitmentsandContingenciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=vxrt_OfficeSpaceInSanFranciscoCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=vxrt_OfficeSpaceInSanFranciscoCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=vxrt_TheFirstLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=vxrt_TheFirstLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=vxrt_RemainingThreeLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=vxrt_RemainingThreeLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=vxrt_OfficeSpaceInAlpharettaGeorgiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=vxrt_OfficeSpaceInAlpharettaGeorgiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811166256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - Liabilities related to costs of exit from leased premises - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract', window );"><strong>Liabilities related to costs of exit from leased premises [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">233<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Costs of exit from leased premises</a></td>
<td class="nump">359<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_DeferredRentOnCeaseuseDate', window );">Deferred rent on cease-use date</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLeasehold', window );">Impairment of property and equipment</a></td>
<td class="num">(106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash paid, net of receipts</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion charges, included in rent expense</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLeasehold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLeasehold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_DeferredRentOnCeaseuseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred rent on cease use date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_DeferredRentOnCeaseuseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_LiabilitiesRelatedToCostsOfExitFromLeasedPremisesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811589760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - Future minimum payments and sublease income under operating leases<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract', window );"><strong>Future minimum payments and sublease income under operating leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2019</a></td>
<td class="nump">$ 859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear', window );">2019</a></td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2020</a></td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears', window );">2020</a></td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2021</a></td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears', window );">2021</a></td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">1,326<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals', window );">Total</a></td>
<td class="nump">$ 470<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77914019&amp;loc=d3e50824-112756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77914019&amp;loc=d3e50824-112756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77914019&amp;loc=d3e50824-112756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77914019&amp;loc=d3e50824-112756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractually required future rental payments receivable on noncancelable subleasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_FutureMinimumPaymentsAndSubleaseIncomeUnderOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825580592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 13, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,221,064<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible Preferred Stock, Terms of Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">At the option of the holder, each share of convertible preferred stock was convertible, one&#x2011;for&#x2011;one, subject to adjustment for anti&#x2011;dilution protection, into shares of common stock. Each share automatically converted into the number of shares of common stock into which the shares were convertible at the then applicable conversion ratio upon: (1)&#xa0;the closing of the sale of the Company&#8217;s common stock in a public offering provided the offering price per share was not less than three&#xa0;times the Series&#xa0;C convertible preferred stock original issue price of $33.05196 and the aggregate gross proceeds were not less than $30.0&#xa0;million, or (2)&#xa0;upon receipt of a written consent of the holders of a majority of the then outstanding shares of convertible preferred stock voting as a single class on an as&#x2011;converted basis<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,662,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,221,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockVotingRights', window );">Preferred Stock, Voting Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The holders of convertible preferred stock were entitled to the number of votes equal to the number of shares of common stock into which each share of Series&#xa0;A, Series&#xa0;B, and Series&#xa0;C convertible preferred stock could have been converted on the record date for the vote or consent of the stockholders, except as otherwise required by law, and had voting rights and powers equal to the voting rights and powers of the common stockholders. The holders of Series&#xa0;A convertible preferred stock, voting as a separate class, were entitled to elect one&#xa0;member of the board of directors. As long as a specified investor held at least one&#xa0;share of Series&#xa0;C convertible preferred stock, the specified investor was able to designate one&#xa0;member of the board of directors, who would have been elected by the holders of Series&#xa0;C convertible preferred stock voting as a separate class. As long as a specified investor held least one&#xa0;share of Series&#xa0;B convertible preferred stock, the specified investor was able to designate one&#xa0;member of the board of directors, who would have been elected by the holders of Series&#xa0;B convertible preferred stock voting as a separate class. The holders of common stock, voting as a separate class, were entitled to elect two&#xa0;members of the board of directors, one of whom was the duly appointed chief executive officer of the Company<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member] | Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">820,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePerDollarAmount', window );">Preferred Stock, Dividend Rate, Per-Dollar-Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.64416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears', window );">Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.05196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends, Preferred Stock (in Dollars)</a></td>
<td class="nump">$ 7.3<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareDeclared', window );">Preferred Stock, Dividends Per Share, Declared</a></td>
<td class="nump">$ 12.06<span></span>
</td>
<td class="nump">$ 11.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">605,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.05196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.05196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member] | Series C Preferred Stock [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from Issuance of Convertible Preferred Stock (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member] | Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePerDollarAmount', window );">Preferred Stock, Dividend Rate, Per-Dollar-Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.64416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears', window );">Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears</a></td>
<td class="nump">$ 15.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.05196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends, Preferred Stock (in Dollars)</a></td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareDeclared', window );">Preferred Stock, Dividends Per Share, Declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding (in Shares)</a></td>
<td class="nump">483,387<span></span>
</td>
<td class="nump">520,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.05196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member] | Series B Preferred Stock [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePerDollarAmount', window );">Preferred Stock, Dividend Rate, Per-Dollar-Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.30449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.80613<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,510,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Holders of common stock are entitled to one vote per share on matters to be voted on by stockholders<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Convertible Preferred Stock [Member] | Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions (in Shares)</a></td>
<td class="nump">696,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Convertible Preferred Stock [Member] | Series C Preferred Stock [Member] | Dividend Paid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions (in Shares)</a></td>
<td class="nump">253,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Convertible Preferred Stock [Member] | Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions (in Shares)</a></td>
<td class="nump">599,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Convertible Preferred Stock [Member] | Series B Preferred Stock [Member] | Dividend Paid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions (in Shares)</a></td>
<td class="nump">265,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Convertible Preferred Stock [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsLineItems', window );"><strong>Stockholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions (in Shares)</a></td>
<td class="nump">104,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockTermsOfConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific terms relevant to convertibility. Includes class of preferred stock and number of shares convertible into, exercise (or conversion) price or rates, dates relevant to conversion timing and events relevant to conversion. Describe also any beneficial conversion features. where convertible preferred stock with a nondetachable conversion feature is in-the-money at commitment date. For contingently convertible preferred stock, discuss the circumstances of the contingency, including the events or changes in circumstance that would cause the contingency to be met and any of the significant features necessary to understand the conversion rights and the timing of those rights. Include also an events or changes in circumstance, if any, that could adjust or change the contingency, conversion price, or number of shares, including significant terms of those changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockTermsOfConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePerDollarAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount per share used to calculated dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePerDollarAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(d)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of cumulative preferred dividends in arrears.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21488-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_StockholdersEquityDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_StockholdersEquityDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=us-gaap_DividendPaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=us-gaap_DividendPaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825640240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - Convertible preferred stock - Convertible Preferred Stock [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 13, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems', window );"><strong>Stockholders' Equity (Details) - Convertible preferred stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,662,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,221,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, net carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,956<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems', window );"><strong>Stockholders' Equity (Details) - Convertible preferred stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,988<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, net carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems', window );"><strong>Stockholders' Equity (Details) - Convertible preferred stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">483,387<span></span>
</td>
<td class="nump">520,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, net carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems', window );"><strong>Stockholders' Equity (Details) - Convertible preferred stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">820,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">605,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, net carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_StockholdersEquityDetailsConvertiblepreferredstockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812420624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - Common stock reserved for issuance - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems', window );"><strong>Stockholders' Equity (Details) - Common stock reserved for issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance</a></td>
<td class="nump">1,099,454<span></span>
</td>
<td class="nump">1,977,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_ConvertiblePreferredStockOutstandingMember', window );">Convertible Preferred Stock Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems', window );"><strong>Stockholders' Equity (Details) - Common stock reserved for issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,221,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_OptionsIssuedAndOutstandingMember', window );">Options Issued And Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems', window );"><strong>Stockholders' Equity (Details) - Common stock reserved for issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance</a></td>
<td class="nump">865,163<span></span>
</td>
<td class="nump">304,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_OptionsAvailableForFutureGrantsMember', window );">Options Available For Future Grants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems', window );"><strong>Stockholders' Equity (Details) - Common stock reserved for issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance</a></td>
<td class="nump">223,377<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_CumulativeConvertiblePreferredStockDividendsMember', window );">Cumulative Convertible Preferred Stock Dividends [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems', window );"><strong>Stockholders' Equity (Details) - Common stock reserved for issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">441,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_CommonStockWarrantsMember', window );">Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems', window );"><strong>Stockholders' Equity (Details) - Common stock reserved for issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance</a></td>
<td class="nump">10,914<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_StockholdersEquityDetailsCommonstockreservedforissuanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_ConvertiblePreferredStockOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_CommonStockReservedForIssuanceAxis=vxrt_ConvertiblePreferredStockOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_OptionsIssuedAndOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_CommonStockReservedForIssuanceAxis=vxrt_OptionsIssuedAndOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_OptionsAvailableForFutureGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_CommonStockReservedForIssuanceAxis=vxrt_OptionsAvailableForFutureGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_CumulativeConvertiblePreferredStockDividendsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_CommonStockReservedForIssuanceAxis=vxrt_CumulativeConvertiblePreferredStockDividendsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_CommonStockReservedForIssuanceAxis=vxrt_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_CommonStockReservedForIssuanceAxis=vxrt_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812688848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_EquityIncentivePlansDetailsLineItems', window );"><strong>Equity Incentive Plans (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)</a></td>
<td class="nump">865,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 51 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in Shares)</a></td>
<td class="nump">452,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 10.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">3 years 127 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value (in Dollars per share)</a></td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</a></td>
<td class="nump">$ 332,000<span></span>
</td>
<td class="nump">$ 533,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="nump">$ 3.59<span></span>
</td>
<td class="nump">$ 2.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years 9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_EquityIncentivePlansDetailsLineItems', window );"><strong>Equity Incentive Plans (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)</a></td>
<td class="nump">22,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_EquityIncentivePlansDetailsLineItems', window );"><strong>Equity Incentive Plans (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_EquityIncentivePlansDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_EquityIncentivePlansDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823959728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Details) - Summary of stock option - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SummaryOfStockOptionAbstract', window );"><strong>Summary of stock option [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance</a></td>
<td class="nump">304,850<span></span>
</td>
<td class="nump">275,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance (in Dollars per share)</a></td>
<td class="nump">$ 9.50<span></span>
</td>
<td class="nump">$ 11.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger', window );">Assumed on consummation of Merger</a></td>
<td class="nump">291,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod', window );">Assumed on consummation of Merger</a></td>
<td class="nump">627,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice', window );">Assumed on consummation of Merger (in Dollars per share)</a></td>
<td class="nump">$ 26.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod', window );">Granted</a></td>
<td class="num">(431,100)<span></span>
</td>
<td class="num">(78,406)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">431,100<span></span>
</td>
<td class="nump">78,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in Dollars per share)</a></td>
<td class="nump">$ 5.17<span></span>
</td>
<td class="nump">$ 4.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(2,013)<span></span>
</td>
<td class="num">(2,834)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in Dollars per share)</a></td>
<td class="nump">$ 6.49<span></span>
</td>
<td class="nump">$ 8.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod', window );">Forfeited</a></td>
<td class="nump">71,500<span></span>
</td>
<td class="nump">33,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(89,903)<span></span>
</td>
<td class="num">(33,012)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in Dollars per share)</a></td>
<td class="nump">$ 5.90<span></span>
</td>
<td class="nump">$ 11.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease', window );">Canceled</a></td>
<td class="nump">269,148<span></span>
</td>
<td class="nump">13,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Canceled</a></td>
<td class="num">(405,977)<span></span>
</td>
<td class="num">(13,249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled (in Dollars per share)</a></td>
<td class="nump">$ 34.64<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Balance</a></td>
<td class="nump">200,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance</a></td>
<td class="nump">865,163<span></span>
</td>
<td class="nump">304,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance (in Dollars per share)</a></td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="nump">$ 9.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan', window );">Termination of Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67,499)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The addition or reduction in the number of reserved shares that could potentially be issued under the option plan attributable to reasons other than grants, exercises, forfeitures, and expirations during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other than shares newly issued, the number of additional shares issued (for example, a stock split) or canceled (for example, to correct a share issuance), during the period under the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could acquire or could have acquired the underlying shares with respect to any other type of change in shares reserved for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares available for grant assumed on consumption of merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options forfeited during the period under shares available for grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options granted during the period under shares available for grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares available for grant for termination of plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantTerminationOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_SummaryOfStockOptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_SummaryOfStockOptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804386032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Details) - Fair values estimated assumptions<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_FairValuesEstimatedAssumptionsAbstract', window );"><strong>Fair values estimated assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">1.87%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years 350 days<span></span>
</td>
<td class="text">6 years 32 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">91.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_FairValuesEstimatedAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_FairValuesEstimatedAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823845728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Details) - Total stock-based compensation recognized for options - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">$ 539<span></span>
</td>
<td class="nump">$ 477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">$ 285<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812369408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IncomeTaxesDetailsLineItems', window );"><strong>Income Taxes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductions', window );">Effective Income Tax Rate Reconciliation, Deduction, Percent</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IncreaseDecreaseInDeferredTaxes', window );">Increase (Decrease) in Deferred Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</a></td>
<td class="nump">$ 25.7<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IncomeTaxesDetailsLineItems', window );"><strong>Income Taxes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">92.3<span></span>
</td>
<td class="nump">69.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IncomeTaxesDetailsLineItems', window );"><strong>Income Taxes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">76.9<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IncomeTaxesDetailsLineItems', window );"><strong>Income Taxes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_GB', window );">UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IncomeTaxesDetailsLineItems', window );"><strong>Income Taxes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">24.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_FR', window );">FRANCE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_IncomeTaxesDetailsLineItems', window );"><strong>Income Taxes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">$ 37.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deductions. Including, but not limited to, extraterritorial income exclusion deduction, qualified production activity deduction, dividend deduction, deduction for dividend paid to employee stock ownership plan, Medicare prescription drug benefit subsidy deduction, and other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_IncomeTaxesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_IncomeTaxesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_IncreaseDecreaseInDeferredTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference related to deferred tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_IncreaseDecreaseInDeferredTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6809307680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - Components of income taxes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CurrentAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">3<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">106<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total Current</a></td>
<td class="nump">109<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_DeferredAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total Deferred</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_CurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_CurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_DeferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_DeferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6651428800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details) - Components of the deferred tax assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ComponentsOfTheDeferredTaxAssetsAbstract', window );"><strong>Components of the deferred tax assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry-forwards</a></td>
<td class="nump">$ 43,822<span></span>
</td>
<td class="nump">$ 19,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credits</a></td>
<td class="nump">3,357<span></span>
</td>
<td class="nump">2,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized research and development</a></td>
<td class="nump">2,326<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_DeferredTaxAssetsSaleOfFutureRoyalties', window );">Sale of future royalties</a></td>
<td class="nump">8,383<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals, reserves and other</a></td>
<td class="nump">714<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">58,602<span></span>
</td>
<td class="nump">22,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(48,626)<span></span>
</td>
<td class="num">(22,964)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets net of valuation allowance</a></td>
<td class="nump">9,976<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(9,976)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(9,976)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ComponentsOfTheDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ComponentsOfTheDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_DeferredTaxAssetsSaleOfFutureRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to sale of future royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_DeferredTaxAssetsSaleOfFutureRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812836576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - Reconciliation of the provision for income taxes<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract', window );"><strong>Reconciliation of the provision for income taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal taxes at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes (net of federal benefit)</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">14.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther', window );">Global intangible low-taxed income</a></td>
<td class="num">(8.80%)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_PermanentItemsAbstract', window );"><strong>Permanent items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest', window );">Convertible note interest</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(10.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges', window );">Revaluation of derivative liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Others</a></td>
<td class="num">(2.10%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(20.40%)<span></span>
</td>
<td class="nump">43.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Impact of tax reform rate change</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(97.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">NOL and credit adjustments</a></td>
<td class="num">(3.80%)<span></span>
</td>
<td class="num">(2.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain', window );">Bargain purchase gain</a></td>
<td class="nump">8.10%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Provision for income taxes</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other income tax settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the effective income tax rate reconciliation of bargain purchase gain.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_EffectiveIncomeTaxRateReconciliationBargainPurchaseGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the effective income tax rate reconciliation nondeductible expense for convertible note interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseConvertibleNoteInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_PermanentItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_PermanentItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ReconciliationOfTheProvisionForIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806381840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - Reconciliation of the unrecognized tax benefits - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract', window );"><strong>Reconciliation of the unrecognized tax benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning Balance</a></td>
<td class="nump">$ 1,404<span></span>
</td>
<td class="nump">$ 1,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to the current year</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior years&#8217; tax positions</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending Balance</a></td>
<td class="nump">$ 1,582<span></span>
</td>
<td class="nump">$ 1,404<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_ReconciliationOfTheUnrecognizedTaxBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813294064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Details) - Calculation of basic and diluted net loss per share - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract', window );"><strong>Calculation of basic and diluted net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (4,902)<span></span>
</td>
<td class="num">$ (6,548)<span></span>
</td>
<td class="num">$ (8,871)<span></span>
</td>
<td class="nump">$ 2,314<span></span>
</td>
<td class="num">$ (1,075)<span></span>
</td>
<td class="num">$ (2,173)<span></span>
</td>
<td class="num">$ (3,538)<span></span>
</td>
<td class="num">$ (2,796)<span></span>
</td>
<td class="num">$ (18,007)<span></span>
</td>
<td class="num">$ (9,582)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Series B and C preferred dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(339)<span></span>
</td>
<td class="num">(2,878)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (4,902)<span></span>
</td>
<td class="num">$ (6,548)<span></span>
</td>
<td class="num">$ (8,871)<span></span>
</td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="num">$ (1,800)<span></span>
</td>
<td class="num">$ (2,898)<span></span>
</td>
<td class="num">$ (4,256)<span></span>
</td>
<td class="num">$ (3,506)<span></span>
</td>
<td class="num">$ (18,346)<span></span>
</td>
<td class="num">$ (12,460)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used to compute net loss per share, basic and diluted (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,316,065<span></span>
</td>
<td class="nump">135,953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13.16)<span></span>
</td>
<td class="num">$ (21.36)<span></span>
</td>
<td class="num">$ (31.37)<span></span>
</td>
<td class="num">$ (25.84)<span></span>
</td>
<td class="num">$ (2.90)<span></span>
</td>
<td class="num">$ (91.65)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_CalculationOfBasicAndDilutedNetLossPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813571968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Details) - Potentially dilutive securities excluded from the computation of diluted weighted average shares - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from denominator of the diluted earnings per share computation</a></td>
<td class="nump">1,261,124<span></span>
</td>
<td class="nump">2,719,255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from denominator of the diluted earnings per share computation</a></td>
<td class="nump">839,396<span></span>
</td>
<td class="nump">295,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from denominator of the diluted earnings per share computation</a></td>
<td class="nump">891<span></span>
</td>
<td class="nump">7,563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from denominator of the diluted earnings per share computation</a></td>
<td class="nump">9,658<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vxrt_CumulativeConvertiblePreferredStockDividendsMember', window );">Cumulative Convertible Preferred Stock Dividends [Member] | Series B And C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from denominator of the diluted earnings per share computation</a></td>
<td class="nump">213,760<span></span>
</td>
<td class="nump">1,567,172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vxrt_ConvertiblePreferredStockOutstandingMember', window );">Convertible Preferred Stock Outstanding [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from denominator of the diluted earnings per share computation</a></td>
<td class="nump">12,260<span></span>
</td>
<td class="nump">94,988<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vxrt_ConvertiblePromissoryNotesRelatedPartyMember', window );">Convertible Promissory Notes Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from denominator of the diluted earnings per share computation</a></td>
<td class="nump">185,159<span></span>
</td>
<td class="nump">754,289<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vxrt_CumulativeConvertiblePreferredStockDividendsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vxrt_CumulativeConvertiblePreferredStockDividendsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vxrt_SeriesBAndCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vxrt_SeriesBAndCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vxrt_ConvertiblePreferredStockOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vxrt_ConvertiblePreferredStockOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vxrt_ConvertiblePromissoryNotesRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vxrt_ConvertiblePromissoryNotesRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813404832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Data (Unaudited) (Details) - Selected summarized quarterly financial - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vxrt_SelectedSummarizedQuarterlyFinancialAbstract', window );"><strong>Selected summarized quarterly financial [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 1,767<span></span>
</td>
<td class="nump">$ 281<span></span>
</td>
<td class="nump">$ 608<span></span>
</td>
<td class="nump">$ 1,503<span></span>
</td>
<td class="nump">$ 760<span></span>
</td>
<td class="nump">$ 915<span></span>
</td>
<td class="nump">$ 1,854<span></span>
</td>
<td class="nump">$ 2,310<span></span>
</td>
<td class="nump">$ 4,159<span></span>
</td>
<td class="nump">$ 5,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">5,953<span></span>
</td>
<td class="nump">6,161<span></span>
</td>
<td class="nump">8,383<span></span>
</td>
<td class="nump">5,418<span></span>
</td>
<td class="nump">3,449<span></span>
</td>
<td class="nump">2,871<span></span>
</td>
<td class="nump">4,977<span></span>
</td>
<td class="nump">4,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(4,902)<span></span>
</td>
<td class="num">(6,548)<span></span>
</td>
<td class="num">(8,871)<span></span>
</td>
<td class="nump">2,314<span></span>
</td>
<td class="num">(1,075)<span></span>
</td>
<td class="num">(2,173)<span></span>
</td>
<td class="num">(3,538)<span></span>
</td>
<td class="num">(2,796)<span></span>
</td>
<td class="num">(18,007)<span></span>
</td>
<td class="num">(9,582)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) attributable to common stockholders</a></td>
<td class="num">$ (4,902)<span></span>
</td>
<td class="num">$ (6,548)<span></span>
</td>
<td class="num">$ (8,871)<span></span>
</td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="num">$ (1,800)<span></span>
</td>
<td class="num">$ (2,898)<span></span>
</td>
<td class="num">$ (4,256)<span></span>
</td>
<td class="num">$ (3,506)<span></span>
</td>
<td class="num">$ (18,346)<span></span>
</td>
<td class="num">$ (12,460)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share &#8211; basic and diluted (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13.16)<span></span>
</td>
<td class="num">$ (21.36)<span></span>
</td>
<td class="num">$ (31.37)<span></span>
</td>
<td class="num">$ (25.84)<span></span>
</td>
<td class="num">$ (2.90)<span></span>
</td>
<td class="num">$ (91.65)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share &#8211; basic (in Dollars per share)</a></td>
<td class="num">$ (0.69)<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="num">$ (1.24)<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share &#8211; diluted (in Dollars per share)</a></td>
<td class="num">$ (0.69)<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="num">$ (1.24)<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vxrt_SelectedSummarizedQuarterlyFinancialAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vxrt_SelectedSummarizedQuarterlyFinancialAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vxrt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>108
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O)FR]-@?SCXVO@ET+O^ZB^P)02P,$%     @ KH9&3IE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MS&]WU\\"UYW!G>=/'LGMN\OF+U!+ P04    " "NAD9.4E'__DX"  #\!P
M&    'AL+W=O<FMS:&5E=',O<VAE970S+GAM;(V5VXZ;,!"&7P7Q  OF3$0B
M-515*[52M%6WUT[B!+0&4]L)V[>O;0@%VTK"17S@GYEOS,13](2^LPHA[GPT
MN&5KM^*\6WD>.U2H@>R%=*@5;TZ$-I"+)3U[K*,('I51@[W ]Q.O@77K;@JU
MMZ.;@EPXKENTHPZ[- VD?[<(DW[M O>V\5J?*RXWO$W1P3/ZB?BO;D?%RIN\
M'.L&M:PFK4/1:>U^ JL2^-) *=YJU+/9W)&I[ EYEXMOQ[7K2R*$T8%+%U ,
M5U0BC*4GP?%G=.I.,:7A?'[S_D4E+Y+90X9*@G_71UZMW<QUCN@$+YB_DOXK
M&A.*76?,_CNZ(BSDDD3$.!#,U*]SN#!.FM&+0&G@QS#6K1K[T?_-S&X0C ;!
M9 "BNP;A:!!J!MY IE+]##G<%)3T#AV^5@=E48!5* [S(#?5V:EW(ELF=J^;
M)"Z\J_0S2K:#))A)@J6B-!7A?R>>B#]!!%:(0-E'<XA$@Q@DJ9*T2N*_  WC
MOF;!$5HY0I,CU3@&23R+$?OJT5@>ZQ8\D94G,GDRC2<RXN@DI@($ ?"3R$X2
M6TEBDR372.*')*;B+DEB)4D,DE2+LQTDR2Q.F.>Q5E'E(]6");6RI":+5I/;
M](FZO:]9<&16CLSDT/ZBV\PX^\#WK97[C'+!E%N9<I,IU)AR(U(*(@ RK;)*
M4P?"+,H#.XYH*M:+SC>!(OVF\Y\DL@BM2-[L&I9]\0>DY[IESIYP<:.K>_=$
M"$?"I_\BO%6B%4\+C$Y<3E,QIT,_&A:<=&.O]::&O_D'4$L#!!0    ( *Z&
M1DZ-5^A)- 0  , 3   8    >&PO=V]R:W-H965T<R]S:&5E=#0N>&ULC9A=
MCZLV$(;_"N(^"V.#P:LDTB95U4JMM#K5::_9Q/G0 9P"V9S^^YJ/S9*9\='9
MBTT@[XS?&>P'\/)FFV_MR9@N^%Z5=;L*3UUW>8ZB=G<R5=$^V8NIW2\'VU1%
MYPZ;8]1>&E/LAZ"JC$0<JZ@JSG6X7@[G7IOUTEZ[\ER;UR9HKU55-/]M3&EO
MJQ#"CQ-?SL=3UY^(ULM+<31_F>[KY;5Q1]$]R_Y<F;H]VSIHS&$5OL#S5JH^
M8%#\?3:W=O8]Z$MYL_9;?_#[?A7&O2-3FEW7IRC<Q[O9FK+L,SD?_TY)P_N8
M?>#\^T?V7X?B73%O16NVMOSGO.].JS /@[TY%->R^V)OOYFIH#0,INK_,.^F
M=/+>B1MC9\MV^!_LKFUGJRF+LU(5W\?/<SU\WJ;\'V%\@)@"Q#T U \#Y!0@
M/P.2H?C1V5#J+T57K)>-O07->+4N13\IX%FZ9N[ZDT/OAM]<M:T[^[[.TF7T
MWN>9))M1(F82N"LBE_P^@N!&V @2+AX'V%*%3/D1)%N#'.+EO ;%QR=L?#+$
M)_/X#/5@E*A!4@^2!%*-ZJ"B-)>:=Y*R3E):2<['*S9>T4J0R<TH26<F(1/X
MFF\9E9"IYZIDK)>,>,ECY"4CHRB5 [)"13+1GJ[FK).<.D&#;'):KXJ1W2W-
MX[NZFO6AJ0^T%#::%DNF&4WCLP$QO^9C:D3B11\3)R+5@.<)(X,T3Q./'P^#
M@/I)L!\@ RT$9*G"AA@=Q#%XIBZPS'H!019B[LO ,PDDK4GAFB2=_YG"LX[)
MY+W>/-^  B['@)LTZ0.\L!-&(SU.>+Y!2IWDV$E*KV N,!4XE8REA_O XQ(H
M+W/,2Z H7$!.%B63RGN5>%X"!:;&P 0*PP60UC!8]5GA@0F4=!H3$R@R%Q([
MH1HID\SCA8<F4-QI3$V@V%P(1=#P\^ 4/#@%!:?&X!24B#(G2XE1)=*SE@1/
M34&IJ3$U!4?#+-?$#J/3Z>SN]&B(AZ80U!!^EIPT#_>+&*\E)I'W0O'T%929
M&M-74/JZA1W'&7;#Z'[0&Q[!@B)88P0+BM>%E*0YC$KDOL=$P7-84 [C.;&9
M-.JQ/S+!RXK5B61V'WMTQ*-84'YJC.))DSV4_D0:Q*@T/*DT_OSSO<#P9!:4
MS( ?#C>"H:YT#Y$*/S(Q0G />;X[J> 1+2BBP5L63U:A?_J]2?(\E)2'Y,UI
MTJB'<A,$JBVC\K\[21Z(D@(18L\RE3S")'WN\[;$\RY*R4-;0HGB6H*?^YA,
MWH;PT)$4.A![IIGD02&9-U)?0_B%+9EW4M(01>=(0MY)F4RD(=%LWZ,RS7'8
M(FJ#G;W67;_%,#M[WX9Z$?V^"3J_@>?MN)GTF6;<V_JS:([GN@W>;-?9:M@[
M.5C;&6<Q?G+M.IEB?S\HS:'KOV;N>S/N*8T'G;U,^V71?=-N_3]02P,$%
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MLM3PGHD>XZC*=OCTCN]MIRJ315.I\A_C=U$/WS>3_S,,#Z F@$X!E-\-8":
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MDSII^$6GN\C\--V4\MSUET)?-^/A>[SIU-7\L1!,_VYL_P-02P,$%     @
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MGXE]ME'!N(#C]M_OP*[G=MX7X(Y[[]X=1SH8^^P: $]>M6I=1AOONP-CKFA
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M@LZ_;.Q_C>C 2TGN_ BU_H,MAH+:A>-'?S;3F$V&PW[^06SYQL4_4$L#!!0
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MG7_9V/\*T8&7DMSY$6K\!YL-!94+QX,_FW',1L-A-_T@-G_C_"]02P,$%
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M_VM$!U[*[L:/4.L_V&(HJ%TXWOFSF<9L,ASV\P]BRS<N_@%02P,$%     @
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M5.V.VR 0?!7$ QP)B2]59%NZ7%6U4BM%5[7]3>RUC8X/%W!\??L"=GQNRI_
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M%=@Y@=T_+1Y7+2*8.,!-]JC)'A'8K$PPS ='<4!-#HC =F6"87:X282:1(C
M?F6"80ZX28R:Q(A M#+!,#%N<D1-CHC ^N(1S'%]\63QF#C(RHT1Y>6B;]T(
M6V3G2?48NL?X%SZ.N6]45DVKO*O0YDF[AU<*H<&4$CR8_T=M)NL<,"BUW49F
M+\?Y,@9:=-/H)//\SOX 4$L#!!0    ( *Z&1D[0/5^HMP$  -(#   9
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;&U3VV[<(!#]%<0'A%W6V:8KVU(V
M5=5*C;1*U>29M<<V"GA<P.OD[PO8<9S4+\ ,YYRY,*0#FF?; #CRHE5K,]HX
MUQT8LT4#6M@K[*#U-Q4:+9PW3<UL9T"4D:05XYO-GFDA6YJGT7<R>8J]4[*%
MDR&VUUJ8UR,H'#*ZI6^.!UDW+CA8GG:BAM_@_G0GXRTVJY120VLEML1 E=';
M[>&8!'P$/$H8[.),0B5GQ.=@_"PSN@D)@8+"!07AMPO<@5)!R*?Q=]*D<\A
M7)[?U+_'VGTM9V'A#M63+%V3T1M*2JA$K]P##C]@JN>:DJGX7W !Y>$A$Q^C
M0&7C2HK>.M23BD]%BY=QEVW<A_%FGTRT=0*?"'PFW,0X; P4,_\FG,A3@P,Q
M8^\[$9YX>^"^-T5PQE;$.Y^\]=Y+SK]N4W8)0A/F.&+X O..8%Y]#L'70ASY
M?W2^3M^M9KB+]-TR^OYZ72!9%4BB0/*A1/ZIQ#7,[E,0MNBI!E/':;*DP+Z-
MD[SPS@-[R^.;O,/':;\7II:M)6=T_F5C_RM$!SZ5S94?H<9_L-E04+EP_.+/
M9ARST7#833^(S=\X_P=02P,$%     @ KH9&3D (W[G# 0  -P0  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL;53;;N,@$/T5Q >4A,1M$]F6FE;5
MKK0K15WM]IG8XXO*Q04<=_]^ 3M>-^4E,.,SYYP!)NF@])MI "SZ$%R:##?6
M=GM"3-& 8.9&=2#=ETIIP:P+=4U,IX&5H4AP0E>K6R)8*W&>AMQ1YZGJ+6\E
M'#4RO1!,_ST 5T.&U_B2>&GKQOH$R=..U? +[._NJ%U$9I:R%2!-JR324&7X
M8;T_)!X? ']:&,QBCWPG)Z7>?/"]S/#*&P(.A?4,S"UG> 3./9&S\3YQXEG2
M%R[W%_;GT+OKY<0,/"K^VI:VR? ]1B54K.?V10W?8.HGP6AJ_@><@3NX=^(T
M"L5-^$5%;ZP2$XNS(MC'N+8RK,/$?RF+%]"I@%X5D%$H.']BEN6I5@/2X]EW
MS%_Q>D_=V10^&8XB?'/FC<N><[K;IN3LB2;,8<30!68](XACGR5H3.) OY33
M>/DFZG 3RC=+]=TN3K"-$FP#P?93B\E5BS',;5PDB8HD$8*[*Y$8YOY*A"PN
M3H"NPY,UJ%"]#..RR,Y3\4##Q?^'CR/UD^FZE0:=E'7/)UQRI90%9V5UX[PT
M;HKG@$-E_?;.[?7XEL? JFX:4S+_5^3_ %!+ P04    " "NAD9.J^S>Y<8!
M   W!   &0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6QU5&%OVR 0_2N(
M'U <G&1M9%MJ.DV=M$E1I[6?B7VV4<&X@./NWP^PZUH9^V*XX[UW=QSG;%3Z
MU;0 %KU+T9D<M];V!T),V8)DYD;UT+F36FG)K#-U0TRO@56!) 6A2;(GDO$.
M%UGPG721J<$*WL%)(S-(R?2?(P@UYGB#/QQ/O&FM=Y BZUD#O\#^[D_:6611
MJ;B$SG#5(0UUCN\WA^/.XP/@F<-H5GOD*SDK]>J-[U6.$Y\0""BM5V!NN< #
M".&%7!IOLR9>0GKB>O^A_BW4[FHY,P,/2KSPRK8YOL6H@IH-PCZI\1'F>G88
MS<7_@ L(!_>9N!BE$B9\43D8J^2LXE*1['U:>1?6<3K9[V=:G$!G ET(MR$.
MF0*%S+\RRXI,JQ'IZ>Y[YEN\.5!W-Z5WAJL(9RYYX[R7@M[=9>3BA6;,<<+0
M%6:S((A37T+06(@C_8=.X_0TFF$:Z.F:GJ1Q@6U48!L$MBN!-$FN2HQA_E/D
M+AID%Q&@5T%BF.M*R*IQ$G03GJQ!I1JZ,"XK[S(5]S0T_A,^C=1/IAO>&716
MUCV?T.1:*0LNE>3&Y=*Z*5X, ;7UVR]NKZ>W/!E6]?.8DN5?4?P%4$L#!!0
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M'NU>30,S!4;V\UM E@>I^ -02P,$%     @ KH9&3B5931C> 0   04  !D
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MCG=XMM.8388W_?R#V/*-BS]02P,$%     @ KH9&3C&'Q6"V @  C H  !D
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M#+B(U23B68CS7QB_3>.2"XBY0&^/#D\C.T#1 ?8.]+6#B.1YAI@><CAG$89
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MR[*QK<?@2YO:SF:;RTUNMTUW&;77U?D[Z/FF*8_#-U[_\J%Y^2]02P,$%
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MRKCMSN[5^)S'P,ANFE0R_UWD?P%02P,$%     @ KH9&3JWU?0?X 0  ] 0
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ME=[*=L.5G"O0+KTG;;/65] TH5 J,]SHL1@.XC!1O!OO&#1==-D_4$L#!!0
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M4)")%D/UO[L/E[?R+I/V._8^K_O7Q?Z];GPQ1&E3*=(?U_>L[-\O0_S/87B
M' ;(VP"A)P>H88!Z&!!?,^M+_3EMTMVF\I=%=9VM<]K]*,23:LW<=Q=[[_K/
MVFKK]NK'3B=Z$W]T@0;-UZM&WFGD6/%,%<K<)'&;P"T+";.0_7@URH()H&
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ML//!00C%-<GP7I,\Z9&QV^3\H,QRIM=U,S<U&R6J=B8,NL%T_1]02P,$%
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M[\(3YXIJQ^A)%];HYW$9,'I2IEOHOIC>B&F@^#"_?VAYA-?_ %!+ P04
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MN=+-9ENBYER!3B1XTL_6ZIFW&A1J9;9[O1=SY\^&XL,RU- Z68N_4$L#!!0
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M5Z83"EU'9_^='5DNX2H2R;'F>=/^.^M#(WBAO<A0BO2MNV9E>SUU;^)W,]P
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M$/T5Q'O7@+DD*X*T256U4BM%6[5]=L@DH#68VD[8_GUM0UC6.%5?P![F7&;
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M8(TJ6M9^FMBUHT@3?E6LK.$H/'FM*BK^'H#Q=N]C_[[P6EX*9190FC3T K]
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M^F_\RDL--YEHC;TH6_L=["^M$I5CT:E4[+4[%K4]WAS_6Q@<@%T [@-0]L\
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MHIU&VXWBQV[2#OMQ?_D?4$L#!!0    ( *Z&1DXVQAD'= (  .L(   9
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M# ,")Z%N$WG/NO;;#01M^J,%&LXWV7]02P,$%     @ KH9&3D9)P6&/ @
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MO;/O=+52KUY6>4RJZ&*,1LUZT. [#7Y4;'P%22=)I $F"@Q28!M/'B@2V("
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MT..B9D=E;@M]+_HYLE\HW@TS<C0.ZJM_4$L#!!0    ( *Z&1DX6Q=D2'P(
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MVMR]$V,2E,;@0;6R5=-X/A X2;W-U9[;F60/D@W3N$7SS"__ E!+ P04
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M3,OJO[4ZE$IFC17M2A;_KI])7CU/C?VS#!=XC<!K!7KM6P+:".A%X-\4^(W
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M7K7#5[LPLND&RZB?;E?_ %!+ P04    " "NAD9.Q=8I3-$#  !?$   &0
M 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6R5F%MSHS84Q[\*PWM!0@BDC.V9
MM1-?XNY,9CO=/A-;OLQR<0''VV]?"0B!H[.IZX<8Y-__Z-Q 4B:WHOQ1G92J
MG9]9FE=3]U37EP??KW8GE2655UQ4KG\Y%&66U/JV//K5I53)OA%EJ1\0$OE9
M<L[=V:09>REGD^):I^=<O91.=<VRI/QGKM+B-G6I^S[P[7P\U6; GTTNR5']
MH>H_+R^EOO-[*_MSIO+J7.1.J0Y3]PM]V%)B! WQ_:QNU>#:,:&\%L4/<[/9
M3UUB/%*IVM7&1**_WM1"I:FQI/WXNS/J]G,:X?#ZW?JR"5X'\YI4:E&D?YWW
M]6GJ"M?9JT-R3>MOQ6VMNH"XZW31_Z[>5*IQXXF>8U>D5?/7V5VKNL@Z*]J5
M+/G9?I_SYOO6V7^7X8*@$P2]0,_]F8!U O8A"#\5A)T@O%? .P&_5Q!U@NA>
M0=P)XGL%HA.(>P6R$\A[!;HEN\J1#TGTN:0O-@6S^&V7-&WWF-3);%(6-Z=L
MGYQ+8AY0^J!5VK@9;1JY^5&W7J5'WV9Q'$S\-V.I8^8M$PR8D,5CYMEF:$_X
MVH7>CP#U8QY8>N#%PB9B'HV91YL)Q\039@7$LK09QL?("C,CQLP:8^28V2!,
M1$!J_S,UVT\='F6?X5W &@-LU 4,MQ#B%L+&0CBR -JH1:(&R=L6B2, +6PH
M$!14V68B I+_A$S&"0.%MB$K^RN;D11TPQJ93'#0>1LD,D9AK6THI+!IMC;$
M!9-XN3A>+HZ4"S@\;QD^G$9RD,*%#44T@@6S(<$$L/2$3!=24-:E#;$P!/E9
MV5 @8N#3VH9""5MV@T!\\+H893K",QTAF0;],X^L:7X+)8$O0(2*> @R](A0
MPHK^R:9T,X(&6"*F*('.KQ JH#&H[AJA&&? ^0UF*Y;@+?^,^24( <7;(ICD
M(L"K%^/5BY'J 7?FL?4X8M5#**1Z"(54SZ:HA'59(J9,ED#U$"H0$BYE6(@!
M7'TW",4X@=5#_6(AP+88%H2#U_.H? (OG[#*)\'+8MDB\6@>YE'@S@K! NHQ
M@*T1C&D,OE<P:]P3X %\QC /K@8()*D7<?+Q^<563.))DTC/P[5<VI,2+Q)R
M] %/ *J1X#EY1"CJ!7 ;9U/$&ZRXHS#-MAK=^A(D4-#Y\P[Z?Y'B(BM4#$-B
M13#BA7"]]P=;_DR5Q^:D6CF[XIK79FLW&.U/PU\"<V0 XW/ZL*'(^+,Y/3='
MC _S[='[:U(>SWGEO!:U/JHTIXE#4=1*.Z^KXCHG?=KO;U)UJ,UEK*_+]LC;
MWM3%I3O.^_W_%&;_ E!+ P04    " "NAD9.\F*Y=%>/  #*1@( %    'AL
M+W-H87)E9%-T<FEN9W,N>&ULY+U[<QO)D2_Z]\&GZ/#1G$M&-&&\06B\&T%1
MH[%L::0C:NS8V+AQ;Q-HD&T!W70W0(G^]#>?55G] $!Y'&=C[X9W1!*-ZJJL
MK*Q\_O(/5;6+OFTW>?5OO[O?[1Y>_O[WU?(^W295OWA(<_AD793;9 >_EG>_
MKQ[*-%E5]VFZVVY^/QH,9K_?)EG^NVB?9W_?I]?%/M_]V^_F\\7O_OT/5?;O
M?]C]^^MBN=^F^2ZZRE?13_DNVSU%;W,>,RORZ"+Z]>9U=/;B_ ^_W_W['WZ/
M7^(O#D?1^R+?W5?PK56ZJG_\.EWVH_$PCD:#X67]PS?I;3\:3.C#1?W#/^US
M^.:@_9MNNDG[=/_SZK;:E<ER]W_7ORD/?TKO,GP"AO@EV:;UI_Z2?$O*70QC
M+ON=[_[\]-#XXG!P\>?ZWZ[W98G/O\FJ9;*)_B--2B16]#K9-;Y_<3$<78R'
M';.^+K9;6-W-KEA^B:.;^Z1,J^C#?E?M@ Y9?M?QM8_[VTVVC-YLBF17?^0*
MEK*BY;S9)(T!ULFF:LQ1)P-?*F$];V'?OT5_3I^ZGI/E?TH?BG('LX3Y)[M]
M57_\/]+&GV2$OQ0;8-BD? (2;M*R\=@O1<<7Z?'H&NA\5Y2-^?U2Y!?)<IG"
M,_#$BI_N&.FOZ69S\24OO@+UTZ0J<GC^;57MFU]P[/$Q+;-BU;G3>C)Z_^-_
M'.1PRS5OX(^-U=>?E/>V/OOF/SK6=[---IOHU;[*\K1J?&U7[KNXX*=M6M[A
MIOY<%E]W]\BB#TG>Q0LW]T#'(\_\]"WZ# >SRN@D\VH:1ZH ILLKV 3XJ2HV
MV8IV\%6R2?)EBJ])=Y476M&+*,NCS_?%OH*#TJ2@$5+SKM.;5!6,^;+Q<5+=
MDQ1:X@_IW_?98[*!YQLON;D'[K_8I>46YO*85KMMRU,HXE]6#\DR_;??@0RO
MTO(Q_=V_1XU#NURB"*^B,EVF\,+;36-[/I;I0Y*MHO3; Q*JHCD6NWLX#\M@
M1?4O?BYVP$2'G_E8PJ53PE[AH+CF!UQ,'.5I0[Z\A8.;WV4P0QFK]:D/-+%-
MD=\QA0Y-K?TSW:9-EMQF&^"=M+E7CFP/R5,;S70,DE/ >\4ZJE*@!'#60UEL
MLZH"*1+EQ2[5$:)=$7WX!O<.2H\<>:\^YCN9SQ/LU8:8%+Y2 8O@Z.O]#D:/
MRN(IV>",8T=WF4([G4!HP8%<N8?-F@_OYH$'X1P]PI;21M46"]-R.Q.[93S
M!=DRSC/7"[R 'QQ9]LUS=^'4@>M\=Y22!QZ@6_F^V*S@AOI?__-R-)S_2&<#
M2'&V2M?9,MN=-U@2CNDZ+7%M]/67T8M!?SA XD8@1_;IC]$T'@P&^/]1Q?=]
MLM^!*,G^D:Y^!"KD:93A/;3B ^YU 3@G2 "0;>GV%A:I2MB/T3 >C8;Q8#9Y
MWC?G<?0U PF?W-V5Z1UL+1 #EK=BC8MFBU][,5[$B^FLR5]>=6E9Y8C7V+7.
M>3R<#./AY8+F.AQ?QI/%2!]\WOKI.5X.?/DA7>ZRQW33N(RN5BNZ@&#/48Y>
MP/VQ3!XRX($6J;+?[IG799_;>:<Z@4&.<AU-_WM&.NW*//N8X'FY3W<9Z!+5
M^<EWJ&?DBK53M[G1&7SO=;'9)"5(7M@)VK;&_!H#--C@U&\P/YSZ=-&M/K\S
M_,U?3Y%49CTM5"8V_TX:A-\^2H#6Q]M7W_KH@:4'/(+Z>DKJ"IZH#P^H+P--
MF!=1F2O3>V M.$?1NZ(Z7>_ZE#ZF^3YM"$7Y>T-8\XOS.]5I6KY8@9J\9(5L
M!:-L"M),ZL_]G.8IFB[X6++:9CG9@B@(&NH+:*I92>HU+#VK*S--LE5,I/1;
MMHO6<%U%&S 7Z.I*X>KJNE8*79K3USH7#[=54T'G>RS+E\4VI56=Z3C-*^=5
M4MXEL"T/>Z 4S"W"WUK4-N#V:B=C=GXLKVDSK4@ASFH/GJ(5U <[0Z8ZIVE&
MR,/R-:=W'GF^3/$()JK1K4E#R(#H60Z[3J93NU+ZIBC3["Z'J0.=@.N(\JU/
MRB9V;T*#/J"=X&C1;0IJ"VE<CUF%,X1?=8A=\JU)C(\G/ZGO:"I3)=XCK_CT
M(F.*7%QECQE<$0W9@0,M@U-.4T]VNS*[W>]4 UL:$2-W4^>RG0B,Z/H:_AC=
M)E6VY'.;;?;((:>)3'&"["OF*9PG?)O4OV>]B<=I#/]S 5IQ3N<?1"*YE*+_
M?$\:1<.U](D8^*GS<S@4$9F+^J#(N<XO'!#"5MG\?Z.?Y.Y_+7?_=]S:-."!
MF7CMK?,AHS)]%)7IFE6F;I*E.SBE\/J?DC('X59U/DE'K"G*2'E!7HRL$=_0
M/MV#9JN/?@G].Z0;H1UAF#O:/Q0H%=)R"1*=K$3Z<_% M^)O-,PAKJ1]N+BE
MBP4Y'HYETF;>=-&GX>0XA3Z-+QU>V)(,RDJD[O*@>7G$IOR7O>@0C;__I8&>
M^2\:]M#,/Z7+#:@G&<@"=^M]34IR=H.(9$/A6?."*Q1FE4;HZVMZ/)_QU4/3
M[F+6AFOT%&9M?.F +"69_&93?*VZPQSTS)J>(:W.*VP)&I =_J;5W_;BYT/"
MERELZ#+;F-L)_HH_DZI$5QBJ+*<,_3H%A@ MAO:7U-@M>CC^T2H&2"D_0WWH
M_"0%*E1Z'UJ=?<TX@G\_?FN55>1LHQ>>XOJLS_*[U;9.W?/8E,FEI//N'+64
M2_L[%-EK5B/#/28[@FA[R'5YP)W;;HE<B8_P@,/JEU,X[]A!X T]PJT?U=0X
MF9U S5VFZ4I><I1CV0N_A(]+7LIAB46/$SU1B5ZC5L=ZB]K0><<7=2$D-TYC
MZW EVP18A!TY)X_@]HFLA!4L\/:IE>[']DK.T.&]^@2,]N3//E@8V0,:-_D_
M[PL/AC9KQU$.DRW[;50Q1\DS8?GS@*9M]&D; FA2HE6/SC;^Z3PB_^")H:#.
MF!'>8K?I79:C+HRK@0..%DQ;!.S0&"D*AT/?OMD_/&SH!H2M19$'MQ&*+B2O
M,@TLR074&USB' !XBIXQ>NZ%L^-?F&R#\D_--QYD@?"\>_=_<-!)ZW.GO#T"
M\GUZ)%PUQ=%9G:*G'5+Y5(?;N!!+IS9WA:)0(JB=,A?Y>+-?L<!,CL3&/I1W
M2:Z7)0[S"LQH$F(?,4X)6]VF>;SVF_\Y_;:+7FW(@.S,SK!OB8VC6E]JWX7O
M?N.T J/2F9?^IW]KTQS_\/FG:-B/3EM9I#Y#3@V)7F5%M<S0'UQQF@AL#WRI
MS.#T)IO-$[EFRH>"4PO(%-YDP(1YEN!O[\E-.1I@]LL^!RN>#FN>;-/HKWBL
MKHNDHI=LBCORQ,M+/L-3$CZ/V"L%@\.:Z9O #C9Q)3I#E\=H\./'$H0#"&K^
MD/XX_)%$UI_V,%.8Q3RFE9=I?=8XJPI)R[&430),F +-\NA->EON,2=C.&:-
M.X["]Y!ENDEQH"2ZE<P"_.,M4(A(>O68E<E=BOX)(.U#NM]ERZHV=WW&S?IA
M7Z(@(%/FZWT&5'3#T#%;<90JG$O<]L<(6.01A W'BA(8K8"-NRB^HD.BVM]6
MV2K#!<+*W2O.D" RM?=TJG5B_>BCF1D^AG=;I7+XO0@F-]+QW=L5=REI>#1W
M?,Y-BF*G9BK"$C(78$/]H+;E?(;"7>J<1X/'(R,BWT;;;0I3V:7 06L@7/$5
M"8ESDGV7(VH7OS/<FZ[7Z9*90\4DB[GJ 60;WF+P ?()#H)ASCS]*IX\E.7X
M%1AD@]JXBV>L[1LD,%:%<ME&"#_)>]FM=4/O?6N6E:QW<C#;GL2M2:.O^)_D
M 23LMVS+7YOWA]$VVVRRXGMGUH^:1Y:^8)VKL5X(\CN;!*3XZ%^8E</938<_
MZ'36>^1W]8*&DPDF+,?'GL7&=%I>GQE:@B8)NR8G@_D!IT>'+YC?9/'\^46A
M8 1Q6:!9!$8BK'ZS85G>2E#+#J'[#9<C!*YX^7B+<AH!#I2$QCV)[SU%FN%M
M)-(W3S2J1/'PYE4]%8B!_@MVX-&MXX,,Q/.Q_TQ.U"VY23-8X'+G5^^.(P[?
MP:@Q/A[2>- ?@,0>3V;M_,D'+ '1RN>M0;Z W(Z6QE@P(4+X/J\%G35 [OOH
M!I;[IL1[&TSMV%R,? G!T>+OLR&&1[^DU$$R,JKTCG.-6/;#18T3)ZN=)$(M
M\D?" Z]M=+[0S8/)("5H<1GF+"R7>"L9:J,4Q'T&"4L)A_1=>2YZ *4/5>)^
MQ)'A3#2JGPO<:-B-95K"(C/44OU%2JJ,I2X8D*#E@]@"';C8/))%!3M39J0U
MH,:.+\$ARXYXIK%/XN@^*_%9^%I5Y'FZD:L\ ?T/_BQ)"^2F +4<R(AS 0[Q
M0X2'!V>'7H:2!/^*_%3"OSFF?6#\9]GN#</]KGCU.]R[94IGJ1]=M:=BU,F"
M.1RHB-;3*2BM9''9'SBQ2AXOF!H\SSDI>7"2;R6I@=)1^C/W-9IL/5/HW;MK
MIVV$G^FUB?J^&KGH&L!\9]HK>.%FPR( S,<_)3DI1*/!:!B=56D:_8+F\>(\
M)# 2=\E" TBT+]6<I-VB^'%2A3N_W&0Y*H'1K@15E\]4LGI,:'_@@9CO(HPD
MQG9X,"; PMJG_E5MF^F]/G9;"]%(47^N4*C ZY]@2L MH+T3#_IPSWK/=(<O
MU<2BY%_A!0!;@B*LS<DD!Q].9 :7O BC/1XG# ^1A84I1R6])/"R/3E_G#@V
MB=,^@5Z0_R.A4=_F"5Q;<;1-<KB[Z/3<IIL,OH6B(]FU7\R=UC6RU'#8GSJ>
MND\WJZY<HYBVJMJOD8U3U@R15@'?H^T($FB/26I@#=YNR,J$23X5LK7H>8&?
MH[\#>^WX@L&,^9"M@ Y O(J.7A&F:#C^P3VHZ,)1WN#3 O9.+-8@_@&'P-LV
MDWU$9M@_P%^(24)F#"?!+\!5\@FJSX8.ZW-WSC":)#G!?%;I[<ZZ#?"BYNV%
MI7QNL$^6XPDAF[=UPX6I:H3+^$(PYG9QBT.V\3X*W)0T=)!"Y&98%7N88W(+
MDJD^C#N99'C<%7SV^?[@C:=[#P\<"RVZY/ "9N'MO>&5MWN1USC[AS>E]:%5
M0=PEIG]$ZI(]LG@BMMG=_0Y%T'ZS\Z^'95"R 1U/N'<]@9_ZT5_O,:[1=L;H
M1@6VH @(T:A&/.0*T-% D@('RQ*1&/R03*F#NK'0@_D."8"+@_=G)>HYR&ZR
MATCQLMC(H<[YA)'OO,*KGZYDND;+XI8$/2H.2Q1?I(^_!15J!=R'\^-)Z\N2
MQR3;X#?"VVR;/.$+RE1\TA3_6>V7:4NN3PS<O$F(K>49.O1+>)*RCE@G@0]V
M@1( ?[LKDRU\7;B2)[:[+XO]W7UP)/C@4;Q ]SAYTLD%\Z9YPA%'_Q$<5>0$
M%N2\USJ?7;J\S\DY@>>VU/DU16KTM=AO)%3QE?8P3;_@@+(2_#+*&M2,01'\
M!XF,=+..Z0/RLII#V2C&N=EOMV*CWV1W.?G2L(J)O5E(Y(_%!H5O6X"D_L@!
MQ]21P8\[FD;]Z/2Y=KB@-(,%#S?ZZXC (CI\<+/UV-\G<-.3TOF NDSIG7[E
MB@0UJU%^*J+,HUB^8\\7&L1+5.F\9^C7/'/A5)KN%>PCK,KI4[_V;_K1SU=7
M'YT'PJTL=.[9I1U?C4JO79>4@_$#7PK;%:$#!109$#N5V0FL!ZLX%L3R_U8C
MS;?I[BL2[^B@AM!PBK;HZ6)R+>UR^]&O'*WXJ=J1358%!. M:@E]!B3 (<E0
MV+&@BQRQ]6!75B##D=LF7](H=:\D)1JMY <C:!-RRQ!EV>I**;:\%ZIJ#8<)
M*\9ZD:N1:R*4M= "W7IWOJZD'O94OFJ_WG"ZENO)%P^[N-SMR<##ZZK2-'"\
MJE#JH_!99; H?Y%6AXC0CS3MCZM!Z#CJYC0R C%:+:M@S1I5I8ZU=?B ,")"
M.[=N&QREH$L[C)J66EZ$[.?"0O3#3T9QU35P'=)GC+N]]3%']S%9L?G.<]\U
MR HPP3YEU9<:DV8DS=989]:U.!_5C"C#-KU[(I.]B+2ZR1FH..EMBHD1SK86
M-J8)MKL<S/@/*#M1F5F5*6T%S@?=@^3^6?(J@#F9&\%<P^.Y\SY+NVP4C4!@
M5,&<.YQ5JQ(W!-3Q'>XS<GN%;@FX*DD)C3"5>+O?HC)3?"4U0E[,-WZX?UZN
MNO.:HVJX0>,7[2T.?:+R OH9\#,97QJG^>1*O]RV2-!+F1O]^:#5YN2\156:
M9BP:-IM<[@U!1==/+D)D-WQ?I>L]UB(\>F;N""R1@5J)6[AZV7L'2C!0  -H
M[J'>E.W)W@>TCCAA5K(W2_/46)YZAZH .A;1!U86C\P5/>)F-HF 4># 4(8T
MJ0T46D9'EB.'6\$ZC4Q=VA6?5UUKHV*-DU]1=Q&=!=4YU7^>8LHS >65Q9"E
M"(9V=MD&/5H8',(K(%NE>/>29Y.\>:0<>F?!]!S'NWC Z'=5=3J ^BVS1*(O
M0>G+4&+OR)4 E,!$7>-1L6E"P$PV R:KE/Y(*3T8>&Q1";S8H =LF^[N"Y"O
MCT#R@!]0U23C'!EJV!_C$0<S>2Z;3'*QC7I2C6.>:J4FKO<H47@%CL8P@UOT
MUZ 3"?64"YPIEPEE%:ONO/QTQ>9W1E?YW^CZ*V1S^.J42#7,(LB,>H=U8^]H
MU!H/=9T+LBGK&T>'FI)UKM6VQ@??)_E^#=K(GMQ[/^FUJJ^H.97<A8:;QA<V
MUR^6C^1K=GD.:A[@U;RO*F^64[H4U3NI)U'N<_FS#*4CE>2G$L\WF2*X-R@=
M=Z!R2)2^%@=RLU%W=0+?2E<7%"Q?IZGLF0O85WOT0<N7P@6C+E,%VMO?]JL[
MKREX@H P7Z4H#%@X[%AY)GJKGQ >(7=WZ4K4.6V"/)<)LR*[YFY3LH&I$CS&
M@\W&,YNY.JQ[-ZJ8<&"0W-8D6A4I,R#[ZNB[9@.)!O@S.EA 3+#Z@OQ#ITNU
M,9X71YI155G%-!"%'IPG5 E/%?=,]FPK'WC>8(]S*MXF'\:0XP"SR\%VWN #
MNG.EQ(3Y$^)N-"D?22706R54LU@9$[="Z(<QE-?EL3:*UFE11/<@@B**'Q41
MIZ;0!4WI%TL0;:7;L#8MP>V+4TU+E.7PRXI"">AT)[6>^)!57[A<'SC0DFTI
M%LC:YY[6[6=+2UUJ98"33(7)*;"Y>KO[K%Q=X,N>FN<))E^0DZ<9+E!F4:<\
MGP#F$,<?UE!Q)<+L4*;)&S96E@$I8@M_Z^4 ?Y6,$U_4ZZ7/6Z84JOX[;_4'
M,6]-6!%]EDXS/>DS6(S%24*9:G'3TOE-F!1K$+I:89I[7QAQ*(PIXV=X-4BY
ME<N,J2_09?+@=5M%/P&KKU LODXIPD4U;(W5MB:? @VT@ -TL0($4<.2]=Q-
MG_^#_-C\E:_W&  2FW.-TE0]5)RO@\5BJ^BN*%8L5/6LXLUD-<*8SX**?':6
MI>L-QP#$FD;VXDN>HV9!'-['"QA-@,6A&B$<""BP3*P^%^97$:VI28QUQ @9
M6<0,3\NG#*SQE=4N?:A>1F?9>80U2+L@*4INF"Z29!HDY5/X(XP"P^C$? K\
M?2IG\.!H*!MDIAQ# O7^3@ZR=Y&;P9Y8G&2H(RQW=C;H$I+I!Y.#V6V!3?=L
MVN@CQOO  6+KDM>=1&V,DZI!TF9L8=@-QO$?S\G^".G7&-U=W1UK=2%1KS]7
MH)B);P@H]2/7N,';S(ZS(FY8_(P,XO. $;!8I5JCN4JW;OL,X.[L^ 0/>J);
M2.SO)3 N2DX4_-EM"FZSV65=NYXB50HY[,0!1Y%,_I"3J'>YW3#U,F?'<8+S
M1.M1]!X*9MC-VV;PAQU:DY+_:D/_R_LLY1RD"*O1@?$QZ*IVJXSUE7)-$A"<
M2ZJBA+FNTG3KM%SFZ72%(1J4N*#N;GV"%-UH;N*<NQBSN!2YM.*8(R]41#E9
MH3@'/)2TEWPSLB$A$1N\$<E52V?./=6Q<6Y&%0422DW.\!,TT7'A87B7^Y,R
MSHK82M(Y-YZA5F ]T4+$Z>XSZVBZ%[3/^PKV28JG]*4@[C16_;DIL<B2[K Y
MOA;E%WD/AQDJ2BX9+'Y\V.PK^7&=?4M7^G/JI0$KWG_\XTWTZNK3ZZMZ0*]Q
M:?![W%QT& SI8;0#J6_.@B-;^BU=DEFGRIM[A"4!< +-D.-J(C9!M-1X'[_I
MYNK'"/DH<PR ($0K-EX,&PK[B%Y2IEX5<9JE<IB5R"7J:J0/&$-&&#5Y>(!S
MH;)0PT9^[PU!U#<+=BPJ!E*L;?0W.0$E7V/E2D\XVC)P@"6AI!'!,5+?NZY#
M?[2-8D2_FLE5^-YL>[LO*UU#&W.$=RD1G;^4LJUD7$ZX+DWH;/ 0+B=\M'T;
MB",ND%LS%7;(#\%$JUTKG6TZ"SOJ5W <X8,-^H%B-"O<LS)956;A1X,G!(\\
M:D(+93"AJ8W.A_LT$4L^EZ%IG'[TAO@89JT3ZZ8OKUO$.)H +KU+KX<ZG1R-
M?):.IIF0NHNB@+@7-1H<@\K"_?U97S1M,&NPX?AE^L!Q'[X72D(<HXFTZ TF
M+6W3.2V7BVMYKWF88Q?G\\D9T19N23++R_3"[0*YIG$@R13)2ED$7TAR.WD*
MAMOTN5V4R-GFBYB<XG>^_IIVQ(?05;M+0]Y;4SP1-/Z<3*5(D@[=P^R(6B=D
M@]:RWI)L0_,G-S1E+AA]",Y-E=+XY"MQ9K7;"Z1S/_JH-[SPD Y^E!MCY@3T
MJ=QGE=F1Q.(#$!R-O,$XJWP(GVW8),_1V$OVZ'N^?:*9>%+VT;?4G@RC4H+*
M)4B&L_'Y!$NGT>QU[$1DEC?-=K8KG(8"/+RA"X)]/9@D+],C0)MTM^.*$4PE
M2'T4:-/4X]M.)@E H#(E3+CY;9-5&GO!AP&]C#382L/S3+=T)9%0^(AS\,P5
MYJ\93V/8'_( H4 T>L%KHQ?PY:+&8!<PB1' <I70?:."H'_LBZ3[5U;BLL[(
MP2!:<9JGZXS8JZ-H/*91X#R@XHB2,P[<%)[ >+GNE[N6)"!W:6R=SY(]@,%C
M5LBKF(&'^41[1X6 U$DF7%5@E:MF]3>2C]QQP[VF!!WZ-HI.1DLJ56LB5Z-)
M<L%/? 1FB1*3TCCTN,C!!3.$,^W\N5L79;<^:.1F78MXJ-5P]GVP-_-!UCHO
M=*I$3CGML[?FXE7"Z$Y^:UN=$7*%5 W/RIK4<<LF6.VQ"DR9($<Z)C<+7"S%
M4\KL%DO^YQ4PY";R:9X%(97ID[%Z<>[(/42^'-56RE7;Q#AJJ]-IQ+F #NLT
M0Z[C.5GV=L@S%+0P7FCG,ORHJ>GU63?I0Q.H+X>".T+55=U!92]D$22-I=5\
M-.*&(76\_7E)@[/.*$[\DK1HS-?D617$@^AOV[B=U_2P8%A->\^J(&"FOH=7
MFP2XXF9Y7Z#9YRNSM\4*#%4>T$M\BKRMV;KG@<-Q\8@E7YPWOH2CO47$L2C!
M1-,[E_6DY53N-L1+C0$B)?="OZ#%A/AA/\(BS;<,C2-@0!^!( 05$%W58&LL
MM(D6+NBQ>450,7FJ,$C1V89&\Z R-FAV^\00.I2;4/\.&:;NNB$M1.!V*F69
M )A'?KD^6!$8W%2Q2JZO*0;L\/@*<;Q#7VLH&OA?:JG9X5#B8NYBR)W(T\4N
MY22\8+Q^]%I*-=HI9A\."'?'15BII)X4)(?\2Z@ A-+.[=MB#<MR I2I#:%B
M8237$8 56^$1FMY[S1_8E71DGB[XFQ+^-#A#6IS2Q1^<\,HX@^J[/32+-ZAW
M[<N'HM(@.Q(JV6"0@R_KUOH43*C0&ON %A04KL=$._:/S2R\N7-ONCF+WDR"
M\1T:6VU6+2H<"!C95'18R3;60@<H5AT@!@M=_DZE-Y*;+L7"A!=TRG1;RDQ]
MIJR97 T%RBZ#;]>LY+52'0UG*Z)F"&_T,\9D"\IBOUH5E !GD_;*(B\P&98%
M\5NLJLQ3<X>\N;IYI2"55S>_TB<76'(97-47$G,)_GCVN7@ "30?7IZ_Q."S
M2WS G?S%WT$LVT0#$)W(S)%(_CYY$MS+CDG-+P:+9T_J1K-4WQ<K[[2OO=I7
M1G2]_I>B+U.8Q":WH;KXN2A6G!\,S,DP=_+^\71P'MUD0(%L_:2RZS,6SZ)T
M==\S(?MGS@04 07$1@)HV6JE$[@<3,^C:]2U_?M?<[*!')+$#["DYS*1*ZO:
M8ZX\%K;U/MT\1)SF1GYFOFQ3%W)(;&TW7B,52 M2B4WV8G7O&)FW0KU$%6<=
M@.I5[!\H\H'6DKP^)?:]VM^AQ8^06"TD\HQ_@W<'*42_/I"Z<P;T.Z?O70RG
ML2_)KH'L"/E&XP'PSW6C!/Y:3 .&2N- ;.5SVIS&[UEZTLG2$V#I* [=F-?.
M_T/"^5HC:3JOV6!VWAK9LS<$VI@N]"5&(LIV[]0PG@OK*D5C6M+221?5XV,G
M+%J_&2%E:'3-6_&!"^]]<_9-/QA+9==AB>6*N3LVG0><18-11(E8_@Q,1N=:
MBP>&#&B)Z#!"+X?#G*9DK#L$4J4\8XE[<B)%);*>A.QGO.LJ82JXO(FG,"LE
M7VFU%,-N$*=C$G.^Y,"\I(3QJ2G5272KB76D7*A%*$!,Y!7M3-7DS='T$&JD
MH4Y67I!Z[]2.=0$$T22H6%F74NTD,X>*FC$G*TVYZ,',1 CE0^-:@A7&3RB'
MEQ]U!BE7PU&N_D6QOMA7LC W!'V$W\:/.,CEZE/#)WWJ7%]WFB8*@D3!*M@L
M!7,+A9'6^<#7G5=<21.>;$XL=CIFLL.T(K(2'#*H/VIU_UK-@^YI[/E*9NGX
MR2W)11UW">=LN"3C$MC4U%2MN7\"EE;)$L#$Q]2/E=@P#WC<=[MTU6\O>J('
M.87&3LU/26\?-C'A+=[ VM+UR3F;9:&XU*)Q2MJ-WS\_)!T23<M;N[F2N>'F
MBT?!:1Y#>/OGI+PC9 :K4\0F3F-/O\>)0(U&SSK6J?CB6TGRMAF[=(I<(X>6
M(M.-6(NXT1X,B#G0,@-H\)R=[8X@L58:)*3SM,#"U41V3+I$GD"!Z8]9\Y#0
M'1B>O4P2N3=Z + T BTD=T>YXBQZJD+%?5_B@6BF[KAE\NZ9B.<#X4XAR^$1
M6&5\EK6<*"2?A( 1^&GG,H)0&DK]DL$0L9*'2X<R=MZ)CEM)21JO.<RVB.6O
M];-+D99,K#'KR/^KFOWJ)[4BG.A/0;?$9RN)08!TW)?':SV8;^A&L<E^:B*P
M9TR=[;5$!"1%VX:3N&_L>-N,@AN@AK[B*EO##!IAM);QL7(T'H'BCT#WT8OY
M;$9P]Y2:(K7L,J@$[]IX%2NA)T/Z8@ 1( &CT$_D4Z(U,;UD4"9W=4A8PMS5
M[.53S8Z0 +YE[%SQ<4^] ZF.RRRZMMS1>"&+'0JV?_=B_4V8^YN>!B&"D7QM
M*PW/O7R65>.VVTHF*@S@S7,#9^V%Y@FF>5.69Z*BMN5:-:G!8'*#)&7F9]O1
M!YEM>(2<"?>@H7'U.&94<M99HV*8=\1I5Z19I*O*W,Z,OHP)?LG&.4/Q]U1S
MKA)..'<3\/GEP\&Y*%H")9&@:R"6 (?0T9_;O##GU4@V@P#2$>-&D>/*R6.7
M_I@()+>0W=T<+2 $7-"<"H('?=]* -CES=.%]GZPA6N!<LN)I^K+T&#.D^HO
MKHK3YQ"$@3N/%!*L+2\:$BVKO >T<$6G1RK9*+E 4F(+AR"I.]$H=VRS1T]Y
MYE!I8]OS)V)HM;<KHGK'<;_5>.Y CK*7IH-Q=%!)E.)5!Y+U+'U.>%36Z8X_
M-P"7$%_BA-(*BK^Y@@T->"711W*NC3CR%/,U3+#^CUFQK] UY<H;5N7^3K00
M@@>2K*V5BT]5B#45W5(B/O'CEE7[\DNZ4PP4@L.@H#+(X&7J3W7HSJ-CRE(/
MEX5DK;[ ^84SAR'*3;JZ2V-7F,?YP^0NY+@$)](10? %L201X6G@\7<D-8]2
M+>:I(;3EDM%&:N%Z<6/CR@@L#S20ASU>[Z_\+98Y;T<C=[1N:_L=/NCJ:,4=
MZPM$2Q?'\,W)U80&^ZM-$GAAWW"7'E=LKL*S3P3SOIT:6I8O)N4XZ]^*DI 0
M.%!": B<Y2V')PF$)8EB6^U@TWLEFD3PG@80AK-7G%N94\7P>7\N,0<!:YHU
M@U *O@B8>:>8\^<O>]?&)=U[T8/+;GZYZ!&DN_L5W1!++#M9RAVT8TO$O:V3
M-CY1<-><=AB\4*"FM+,"50D8X&&(CBP ,(V&9E81RTK35LC$V"J-_EGW'7*'
M!.,\@AK#'"E=*]7NF '*IY;<WMH>R2*;84,SL:.KMZ 0%%NOW)FIK\"DC%%6
MAY]?!RS*RQX# C4N@IY!S.YU@ ;U0N;J=0*A F>-IO%T-(4?Z.R.?O1_:NF@
MUQM.XMELYIZ57^O(R[W)9-8[ SVJ-QGCIVV%7KWA?.#'@9\;U7HO>Z_;JN'.
MAN>]T2B># :]L_%@0+^ ZMP[I?KM;'3>&\:S@7DS_6:[YO5FD_AR,(?!<0'P
MRV0Q][00C"/X-![/%^>]^91^'$S.>^QY;^DCUSN;Q>,I3/MLO!B?XV_S"3S_
M+GI.'SB@)XR"ZZ65#Z?Q G_YQ1Q38<S>^#*>SV$!H]'E.?XRG2QZ'P/^Q\6A
M0#EW='!_:&U]$YW!O%_T9O'B\A+^Y9'Q]_EL$/T_[O]P;Z+63=/RT*JUS/:V
MH'RQ-9Q#!+91S+&HM1@CJ]20HZI@9$W"E@D1<\3;802/NS4KC^]P^\2FE"MT
MXK2>B--Z6M+[%?H\75DD*/<@(Z/0GEZX$+/LI.5#.B@KSL80TXY]Z15&4[>F
M%#',M''WJP<MX.0W!F9QQ9J,7Q36I=XRJH1F>/@U:0Y;"]/AW[A$%2>)-:M4
MA!JVA>OCL3JI^-36\%J>WZ75!BQH0C*"R_/5YZO!?!)3<0(Z4BX243!SS!O"
MJF_6P[2>*MLV]).O#JPFD5D:W9.T'B0T9ZKA?0V7)U78?X6-E[O=)W!\3?Y[
ML4P?CS.M\;;UL+O46KY8T;JN7,%:[<IT(ALU<M$!TI8*WICKK -,#*>(.:8,
M;VF*BRH24BVWVZ9BNU0P3HACIMD$4M7HPJ3\-#$U7PP,8!F."G]8N#^(QLHE
MV.R7.-@J49VMDC;NU-Z#.? U]X!6^]=Z2MVHMU2SX<PR&WJXT^WKNG<39O6$
M&6FX@-RZG=Z9$-F@H>A*V!#UC/AR..UIPRN\5\;QY61^+MADFDL+NQ11?IA%
M6W<.(\Y'3+'BM:80.D108ZA8#\7Z $XU:]8%N]>\>EU%OE09(5(T8$8FK'L?
MJW1A(&/.0N60S>3VZ@0RSV.#&DK4\)31/E\BLC@'3&AYW-OB!%W++"AI8SR(
MW!1,NA;U6S@\";^E2]=H\SLF5&7?.CV$,C4]E;/?ENJ7-:JW':169HN]K::?
MJYN5 T_U69D460W%P=7^=,'^T57RI#$+K=*#$V1JV5G4:?*L'A];HNMW"M=-
M"A@+-Q']Y%.L"I4;FF.[+1Z3#><V48C#V#D70=V2N@C(.<3'M='G$/Y\6Y0E
MVW3B_."[H_#IFS).V+K 82-PNN/J4*>?=L<S.Z4%UT@#C.9NJV%T/@NL MU2
M7)XG/J).@9!5Q^5<AP/A98_:W?_48-0>68#XAKH9R%9.Z>0OV!"S!9I^8%M.
M1_- $L.?AK/1.2G[BW@T'YR?Q$Q)P$"WF'"0*6:)>XI]#Y*_EPMP@.1M8+'2
M4D!7U\V[LE.4B\;D=-FR[J(RC[<R!!>9IBO:O;H)3W]+OB T'*9O(.<V=K/1
M&A.9Z2^J*/DN#&]]1O*!KWCG\B&_=-<7CB'M3?K1"=/C9^0\!" $RM@:;/;,
MT.4T033=(C_ZG"L[,.62G,"%BTL)M<><TD-8: 5[Q 6>4LR?LX0C>#LI_]D\
MG??-XH-L<:G+Z\2YC3DD+S6K]0Y%L6\7XOTGYH\*EBR@&?5&5$()KZ+:9:_V
MZL$B5QI7TV&-+\[']$\B_^FA27+N:Y"T@EB]^G0A/\B(3S''A<*BC9W,PQN?
M> 'T%>ZGOL/VBR%F17.WLI8<(P5QVJ5WW/%9KF.'2^+JPA7LIE$AD^7H5G<J
MBJ3\RS*,.[+O4"2%\UVZ"K7$\I-W-7D)-LK:IE1.B,_PT(3@8(X2&6^"9J;)
M42;,)[D']Z#16E:WR71]>S3ID[5JGNP*S99!P/4V]143Z&-**5E40K54)IZM
M:K@ /LGJC*#W,ZF$/A<P#:IL!)ZSH F*K")1&H:>R1X2:;G$$EEA8;QCMXW"
MI'PXY#@B+>D^PI&\R=Y$!]E=HLOAB5=-NE&V<Z: [#BLT'^%O%/9W]'M7.<$
M0W;#7)I<2C6(,B*E@M]B4(_S43#;T/_>CS[XS^0; CRB- (J)()-FRK6G/$M
M5 58Q(QN@.#!=O". 2U0(SFEQ1W@"<^)DA+ 0)I>,#4]#545/D(V8+S;,H/7
M/W7$.%Y&[VCDH0&.<V0#Q4=LASCZ^[Y@#4C!2A))[:(UB0)!WH6EOSLPK\A>
M,<Q@MOH76>Q'F<.H;0Z>FK&9STG3J;)MAJ!*K9,Y,%JXE&,#X<OUK>YNI& \
MS8C<9=I3F_=*'PJY<IGDE)^(ZO:MM"X"QC /67YD7#&'([UA#D) /E>WQ"PE
M@'EM,V?H$Z;]V-'^UQ8&=E,.<&:+QFZV.Z#NTP[*^6&YIP.O&#[<,4GRPJZY
M'14+S,ST21_SF-;FQI0\9>7SYAS]J=+2$?K[REN1SV/^>@BRZ<A1,,[;@N;+
M7B0!CP:9_" I'5V+&/T&BV@_(/+A"F&D5-BU<V#?,8[=4:WD+0ZWGHM2!:Q:
M><"JNC*:'"P::[:1XYOU*5C[D^2FUOFX)J4E&HV+XRUK+=>V85!O^3QOD51!
M1)"%[.@C5_ME:_34V6FM3HS3]717TQFJ<]QJ.'2>.%?IRYX<%_EW)/^.)=S=
M\.<T IJ?G*+H=?<K"1J^IS/[GIGI#9Y9,G6#"*?_"3ZX=B?F%9X8]V'7OT&P
M\/#0;?-\Y\F(4?_OY..GCI<V?[I^#I^?N'@;W#QU'B?O.1O4__R6Q\/%J&MK
MZ+.NC1_&$]B[\+?ZILO@_&$0/(]G@_E_@XV?S?%_IVXW/(K_.2QIR,"C]MZ9
M$WU4+6($2X<\:34/6?I:K:%-/SX31CL//+R=OF,KIIZ%^UA[^CD@BG(&:APO
M/=R1$J&SZ5()'M!?F[]V"[!/IETXA9)L4$C*<AE0_1FMQ7MC-_ZX=^,P2JK>
MV7Q@T@OP%[.@9LK*85X6/F0 >3MM57ZINI; ]C0)!?O=AV7LEL^J'27P'FA,
M](S3]5^(-^;DSIU@RE@\NAS0OY/AY)G<P9C]OPE[G,WFF/B"DZ%_QQ/XW?))
MUWP.<,N\]0 PCS2G_B]C$3<-3VI872-W6-9Q0Q5RUPJ2UG#^MO<!]GVB#W5>
ML<VDP_<]RRT\[4==LXW.DO-FPP1"86AOEG#=Z+F-&$:'':9<]^,CYZ=[)HU9
MQ%T2$@H'B&&CI4BQFA"IZ_WM+JN7#17DLO=SB5+RU]PXHW]&]FK[X!W)IMY/
M+N_#.]A[UR /J)"0?[URGE)$0*H?[?<-F_.(DEE38F]/4F(#P7K*"SZY3B>H
MO33S"(\.<./KU\RN__83;9Y2VBWYK]L?OPL]NX_A+[B';O=ZM%O, ++;O)_\
MWY.V\:A.VM1->3]#G33438V&ZA30]G?H9ZJD'MG2DV?;L;?_@DE'9[?GK0T^
M6K)53=;AT:-^W/XPX+ N'1;7/Y_/S'1_;BEI5^<7(JL!4XT&O<E\?O#)?2[/
M.II-QZWYN#2!!4Y@-AY$9\OSCBXE,>']M&?B<GV42,;J),%XE%JMW4QP"P=$
MK6$\G4V/=#49C>:]X7S:U=5D/![#(S.Y]=OC\\@RXQF\;3&;P3A5];)6T>;3
M!GIG,"=44N'?T7AVWI&US#H-+F PPX7,@>JO;?:!YC9@SN"+R9S+%RF=;"R_
M'+%"#J:52<%Y@QK<J&9?YAG71K5[=03W'6:[S020]>>T*.^PJS!?NAY%>'_+
M3\?L/.0.DN12>N29<CK,6HI[(RI;8Z<P:2&-'G>9@XJ4Q*#D*:RYBZ5/N&DW
MZ)J_L/YU@XW5F$P#EX^3A\"$F)O9*#VDLM(!DS\H^FOBUBX5\)8B7N2BK)/M
M;'7>TAJGK26.<U<>/5#--/^C1TPSNFV>-1XQSH9_H3GR7C2=D*%;2XOWWVSI
M-],#E9?_QT<0*4=OA[^,)O& /WMWJ+L.G,\Y*-"3 ?ZO04!WUA9P58QQ13#J
M!%<T&33(':;\!*<07B+UL70.)[_!*7SC71QAEDE0 5<Q+$  ='1*==U70:#1
M8U#KA-1=*BOY>7HV7,[9BZ%I\.RR;F6<]_5BP?&YI$YKCA26HC7@G(]TK#;
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M_S^AJC.Y"5==;FY2RR5/7/NR:]L.S@QEH>CYS:0U=V.J6VG@6O%IG3@MV.4
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ML>AQCZJ]*ZO!82YT$-T6";(R+AM%D!#PU$U:IV#-<'<K-POOV]C&49C:@5=
M55)O:_2F,'WEAY23LL\]NVJ'R/JX0?^J[LDQMR<60L=[L]W3I:L>U*D1"=AU
M@O$0C 53#$T\O^(3JN^^@PWGITB1I (_CQR/3=#0R$@=E+6/=BOBL\XUI!8W
MY2#OS7'&5C !N[X&_&%6&?D54WN8R$.2-%TV+!B)#YWCP!U9K])1R9JB@:.K
M*,M9(,JI] I>FV*',"G^^./<-C7QN>,J+:W"K;,$C^76GFG(T_%4!P#@/48+
M:6R&RWBR;2/,2YAB!IY/8YZU0",'LGUO^Q-@V>(6A#Y"5E@,!KU?NO1BK;?%
M?>F=#2_/_:.-\V#2T8;QY73Q?;,T6<W#>3R?#.NZYJ$,Y=AIG1^QI+>IX)[^
MY:<#4;=GC7),;;XD,7;ZDC">Y0R!(<=U)@>C55BKX1&K:KY&W_1"0DZUF*:V
M4>/;I@WEKN( \($R$0F[&(MV.&&_B.9$\2U!YMQE?^*#/1^"1)Y88I$'UEIA
MX<;JO\R2W>23?!6L?]JY?J.$DC2I4AF2-'AYM\N8J)*M:L524\\/^W8/2&P2
MT/BA+NVDPKV$$JTH-*LP-^@\+:O[[*$&SQ4?'TZ@IVKMRQ*5"I(GS>AT1AEE
MB7IPY-NB-!<N]64I!0KXLC_X@1J&851GJSA#(%ZS!XTL2;)!75$PDT[VNP(!
M8?BR-E.)I4&OBK%,:A>:A9]AF@ 0E:,=]=UWH!\O1L;1%#-SDPI'^RWMX':N
M.)3:G3&8 FP48S8O!LZZX4](EF,M]8[+###]M2@];A.71F ZQB-I>[_RVC;9
MW]'ZX'281S(8M+EQ$@#Y1@2>PVK&PQYT]R6\']9-"H!8?*E&@61F%OM8J:X\
MJM:64C76M9R\>TO"E!!T^+/LG'7?C(X%%8G+K'36-7"JEI47. X,U,H2NDW-
M$,A)#2#;]].'7",,1'/<WM6TP,'&Y*!H][50Q,ML;2B >$"H7C&4E")7Q759
MD#0VPI"9E2-%&Y*V J1RD3W#^PJZ5&F_I5 HK9M$1Y_\72MQS@G(3#_Z8_$5
MHVQQS0.*WB%VM/QMG]= I3=%DM=%_(=O:U0'WTA'(W(:TIVP.(]MVQ9#@X,B
M!FOW<*/VMQ0#K7DTJKA^5TAHD(E/C36VN$S*32)+B$Q9=2>Q)HK34BNJ^,H2
MLK8.;_+5%XURBG5197!4TG"C]Y5DAJAMCC1?423'[75MM;9)(TS"]]D;#<7]
M+AD$ NF!9AS#EF]M8HQ#N;<Q6::B06PP99%]2HZ7(',-,SY;N=X.Z%O!>QL$
MS[WT:?:6QNU^5_-=[%S&BR;LY(R4[P"T)=9_]*+!,P +<!V,TF0GS9>U.X"%
MMI?[C;)V]QA?;"F6]3W-;K,UJ"O>_U9A"A,!<GLW$+S%I"NZHE/IV-ORB<LG
M:GDU75WNQOI:\_"0*F)P1960;=H%9]D@Z.X)3T^/SK9* Z@ @W2E*=$22Z I
M$]LI="V+&[J8#I8FMS>%"RER@HHD2^G<UW3E['SXBU:">:00<NF8]3-V#M](
M9M7(6%SC9YO\^D#(A-K X%-\V"2A9LE-8=U](NRJ>F++)S*+AO=/-(26A8:>
M#;^II%"TM,8^<!3VL,+L'QPT? ^6/0R;E)L"NX)JCU=J4*W-?P)H+'?N>*+/
M/ J>VCXF(X+QUAR()+>]]KCC[:[,[NY2EU5FI -_GDAOZUVV94O#Q ==3:!M
M7'&<W\R:+.H,(4E[$"A;;2[$0OG9!?@1!FV#FEDKAEV?^BYXZ0M6X%%2H>X6
M'C!&TGKUU(82V[4W*'/_D9:%PER9;DZ-A/"A:U]9ZZV"NK F'1'&XE(*]&/!
M'4/2</<5WL\T$/2PB;%3@.2M1,PEIR'%VF1FGV^R+^GFJ1GB,"B.:SH">'UO
ML&TB+Y/QLTR),H<5ULEC47+-+]IXH'H3Z^!1K\%"$HW,G.W-T$)6BNB[6Q0M
M2LTID_7IVG 6#<]1>.P=QC4;-"21G1AU=2HO1MPU+&MO#4(7B?L6W2CS(\]/
MW?,*5]-XL>.'M Q]SHF/5>N4]1*1^IX&4OVCB4%9>Z6SPD"X6L_ *38W!=3'
M4W^5!IW1O7I-]%QX3XDDU]85[3J@X-'WX[@S^W:PX# S 2&$C.<\O'3Q2P/K
MM7G;= T&X<Q#4P@$4<T-7=LF8K>4 -#'(2+ZR$"DMR"BGY[O2RHAUV:Q^G)9
M7\MDW()R[-#]J7Q#[EL[S-P/<R^ 99S<\J&SI=;WL-&LE8W^>39A,X6) /PR
M"]FPFTTM/]6C,2%/X<"#FB>0A.J*@A==MJ!M^W3<&Z6=DUC+P;K*83P?C+0?
M?4<^X](T0&HT[Z 7BQN!GV S'BFQZ ^FL?0"<SK)B^&D/PJSV\%46:=E*IO]
M HPN?\Y;J@*3AXS+VG*&B,#'&HDA-P@[@$[DT+V,';@54B*T-9\[P '0AV/?
M/.8A7_2C9T\_\)*/1K%IAMWA.6:+FBRO):ME26MFR3M\KB.S))Q#PRO@7LUH
MXK5\,M[\(,,,YZ17V"T),.OF' \N0/1P/<^[MZ\^?.+C-^L/YS]0QFJ*8*]4
M?(/:&B^,DTCL85!4:RR:86K25;?&!JKB4Q(T6N=C(S>#>9;]AYAE,1QIYIV&
MH%5NU2)E_HOH#N @;C2>R;<E:0Y)3;EQ//';IYKO %TF;4=4ZS*YD[?8,"U9
MQ'UI5-84).DW>*?5@,-MC]VK_^4>)*JGTB_1_4%*(;ZPQO+6@81.'N<MRLH6
M$4XZZ)/G=A_5;.\7$- LS/.K117D!3)]UZ73:]J_N3<LW!RC%3==8N+7)F:7
MG0Q402ZIT+DX;_J+\6C*ZBC1UJ25:_<>;-F:2G5"5QJ#51V)N7W&C$L=$#=!
M+8-&.;6A!]?YLB50E;BZQ"8-,65&PV3S>#H;F\L/[=:3/=?4VKM<9JYS'5Y=
MXW%_.*3X"\?RK1P5["D5H W;5LBD$%5B3ZFI'#JNP@8YP_&$<]V]+6BOS*;'
MR.^BDT[_LFW$54J)44>VB#U&5AO>4?Z = 9VY;L!N[IV$RWY&S7E.:N3;3CH
M3W]HEM=)]=)AA;YV_G#K)[.%J< ;7OX6]7>Q1UT"[=9"5HRG+JL6#WN;&J^,
MY-I/<6=Y)@ZS)S.N<!JE!$K8T]OD^(8PLT;'#=F?#F+X@$,X=][1]"LC1^&R
M^-C%>OG8D^2^&'[)S-DW&LGW1$@WH/_R,MDL!=K@%OWI0 2JKAQ-V2X7E;QU
M_'[T6I'\D6] 0%^LL@W?CT#/'0NEXUU>E10Y9_F[A#:CSIK\.5D3"!NJ%#[B
M7-2Q0R\N77.=SBB3KLF6@(^&&F1UR=R464KFSO?BS!T#>I/W=_;B;F^V938H
MI?UIW9YU@ 9A;27'H[@'6SZ5J!7C\^:*#ZZ+X2!>#"?FO@@,H\X[833J+Q;^
M3K -?/7-.ALT:0@E+R\HLTM;V7>ML+(PY1J=B5OXI79AS*6??:OM+=>'1WAS
M37\:1A:VQLVT_C%?45DX5K@")[2E(AUX.$B\/Y"'=.H0QTPL$/[1X=$05H\P
M?:I&JBY9"H7'2.K$"UDG2P,7?U/LX>S= )>\*?&PP,T41]?))H/CGB/4#^MW
ML/%+/+9<].SQ/0BRH:JG=-!?N>+BE!DI5DXLA3>5S^7FDGE,.C)5PVV*L8^(
M2P4^J054V*^-'^]]KPFZX;D8-U0[G<I V>4<-]*N8%H*R:5-O'+2D*5<"">]
MO\/L3;E!%S4M/:GG9X;'/ZCTD^&%?-01'K?K:O. YW6W@YUQ:$R\18DLEV8C
MGFMWDAA0831TC4X/XC3M:KSE\)W<K<G46/$EYTE-.EF(\I3MZFG7F$/NK0:J
M-)>-JJ$S2:$Z7TL6'<0 -8VF8Q4;Y/7!ARXP-K$2.XVW/BQ&JT/#J)!ATB2;
M G4,WX)-$DX]4!2\N*/%E^U9&O\&Z%&VEL>H>R=\DROM3^DE[J!36_J.65S;
MZZ,O[8VGBQJN"Q;M!'O2&RYZ;T\@)7:$GDDS:M8F\=ZF G"P5A\0,G@R9.P;
MUL69*9SKFF/=- >YUWNCVE+;0'Q'XW'TR7R)F==WE[*=<K6[3$N_W%!>JJG"
M""BA\.2X5M*5<J$9\+O0):F]<R3-&H6HRT#/M5J29JW*D*6$!NWM1AF5SUG5
MCI*B;JG/VB,_!*0BA_<EUP&*R3'[+?"S?%E.4'DDY#/>F]#L9D&*0V$,$O<!
MIZ%YIZ#1[$MV$#H&Q,(_!D9"6XMM<[_6SQTRVI]^E6HH;>IW).O?<E7H]KU/
MF.N#2FBX-J1&#R$!$'0DV%L5QJJZ\DL;K^M@\7K#5<;+JEH!LTC30.\N8RC>
MZ(O?THOK*%0"KX4YYW",AF.&V)H07M."0;:FL][XTL)I=<*VQN,1 B9.Y@."
M\'R+Z$*Y2QZBFD7<;';(E9C\AW XN&+MT-GB9J[$R^R+Z6A/$&-#V[=EX8L\
ML@KL_T=3KL?)EQVLQP/R0'"<"'\1A-.6+D56?M8$$J0O2[DA=":]4 2XO-K3
M<5]Q2J=$=\5 K'\53LE-X1M;^VESD0;7J<FXK@HCD5"48 =D99C_RZF_!.\2
M53CX,JE4DZ_3*2P%23@=4@YL'1,E+&528!V7[M:LP3+U4Z:BWK<J\ZK%-OEB
M/))50 AI&>EP6BC3L:Y%YYCWZ*F-MDF9"5QAQ3DNM'6;Y&NUS[A1#8/"H+V>
M;:N:4Z8ZS%+UUW,?,QL2J7_;,"_' UP+:\PB)H<NJ8RE86Z;(ZIO,T,_'1HD
M(83T70!>YP9&!B(HAI*PP&2'P<9#PWDOQ"&(.'+YN3<XNZ"L7'GH?K-AWQ9#
MAQ!.D;A)7@-)OQ+"MX,YAC^$U/, "_?V56(?!&O2O[D;H$]0N.]@<5+H^(8.
M!%;VX^SHW]KQOL5]?2PV@G@@>Z\'JB5; DFLH@EQTULZ,?LE)(])MN$^8T'
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MC'+DHX"&Z=<6,Z2]V(3]A4!MC.)]R?!4.@["4QW,'\.X@8/8ARV]5[%E+2U
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MLX%!-SQRJ4I=)@L*-6MX7IP70"F&,0U$&>#.]:Z$YR:+1':T%.]"WM L1 Z
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M=]U )2W.(XISC[DCA7[,-PP.8[)*U?1@9Z&&-FII'TB*M@TG<=_8\;89!3=
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M:1H;U2-73>+YM-4C6TTRE"6E"_G?(;^3^E+#E":W-C"WC]#HV U*F@,*/BA
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MB^]L/V8_,26HUPI)F5R&[TZ01V0H!&RGFZ@.Y59O:M0@U>>4]]1U-_DV?UR
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M6<'Q#)8Y.%!I+8Q"IRA]2W^RD%;VQB+G$KL""<)IH#U\6#OTXEC":'2D7>.
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MECECUAMR3(-I.FIXKSOTW,S@,((50Y-X.5_]3WY*L!#7C'+1>7W\_/3\(/V
M,4*6L<OOY[=+:BK51OY/QW'6.[R>?\L)_(+>QO>24;<<-RLPG"QVL8'3AGRM
MUOOJI;U5RHDS5IL%I[?_%?82;T_U4HT:4[-RHPZC(T_?97!N]K>_^97O*+)H
ML[*=6D%,_CLY%P8*Z&O/45#'T2P(;5-*M(!7Y&*#*A <Q!=P6/YTB\YLT'MQ
M>I9P9*V6<W,EH#V;\EM%0D<P58J^A1<O!:^Q;PJD?8&FH'(P,W=IW[D*_7]+
MA*@23S30S-G]1[)F\B)PDI[J+9C=;'!!WMW-\U>+]>U'X]W>Y55-1-_: M=Z
M;NM+&][CJA%9-MFXO_L;(B&Q?,K'[>D.T*W7O>M%LO7Y!!(Q;7>?"F%5D73'
MBN>8G/,29E:$7S#3;IW4N,DW]_ 7A*?$#T'K36SYATS3A<:^6RU1D8^:$1NJ
M;D@R,/47=6V>W=]]6G/D<N0@<$J?,6VZL :P J!R=5/?;0!Z1E6=L*I6L/XI
MK/_BF'+6++$%YS:_-(]BP19%SJ&&;V+@'5\U[ 9;#-:KA4ZH+I^!D#3_A&\+
M7$S_(E[UM0'81$XQ.(*7YN.,T8&VT5NX)%QQ,A*H_FLCD]M,V.[R:2X 9^[O
MUAB,?D5P'PH;A,N3@54I!O[:^$DF]::[ 3_U=7%K ZTP\3+^MS+9EJ^T[83S
MT^\WZ]6/F%NBKS2$J@3Z(5EL>0ZDS<[)4)\P6W.MA?D\W\#FA,O'&C5%P1.-
MD"Q\XS$^Q=-$PR/@S"$_] WZLXF^FEB\C;8M/R^8G)OU??U- V3,[?+C$KVB
M!"XLWHMTY_U^MS<LIR-U&YM_A-OQ1U1%R9.?;Z11CH;8;MR3?J_;TTT0)O$"
M]UNG,D84!UD*:@IWR;^"RG>W8.A7D5BAU_J6G_D\_Q<T^^Z;_)+FTLC^MU9(
MN.M?UGS=0NIKG%-<!:R8(I@"?&XN;KTB+WV*>,I=K%&FO.<&\?7&%QY@C$)T
MF^.$U'T8>O]\8:+%WS!=>H?-98N;^FJ;%<Y'SPOIL6RQ+J]J)/9Z_ 4#/)/*
MDRY T@@_PYX1X[N]>&S4*B2RW]P12#W:+K\NR5PODMS@BG$S_\H-_C2_EFOD
MEF^<^.EF_16GP!J^X%.B 1ZL%.:9-R;4&<C8\!3VXA7\P;Q\"W?^*?O)$/:X
M)1=RQLG2LD98.\01A%&XNEMC^V;;_&:M7K%97#&)-\<3PB SQ]P=:1.URH.K
M(SKG!4^6^R84?M(X=KW 0&3L;*ONP*!\@@5<6U0R*PQF_2X^&_'%&IZ,Q&%L
M,X;/_[^.8;3AT3%T9)_>3COMA+NOZWJWM[%^(U -? +=_TP#2>!B]VB3W&S6
M:-R\AKO$<H'WG\45XY2MZ3YX6],-&H\ A87-KBK01P_9Q'7H=SRX6JW&612I
MCHP&))Z2]9.^/H.//%GYZIG".<H,DUNS@JW?92 T'BU@:CP9KY8+K!!VOW1U
MW."J$(U>K&(5[,MV"L\TP7_8SDME:%K'"3MB(]VN\<_3#;][JC=A4-J]:I;<
MA12@)P,?(6Z?-DR9#<K9SW[AE,]KX@<%"2DI6K.'9^'><X>EV>. WY.6 Q+5
MU!ABS;,ML(_D%GCD]\$S2OJAR^21&])F6SSN^_[@CK?<3#$S4"Q<]3"M64&C
M^(->GF9&$@H$V@NO9*K)%U^JB5/DQCAN-NJX<7V];0>\[=)LO8D31M407[>2
M#HE M>7)=1B"&-M#W?%8W:;B;4X9TW(71LGB0T*<)P0>UZ*8S0DD++:OV!L9
MW.-&\'"D]5JW2A(6R@G:@,'G$"TU.Z\T&XM!2K/[>Z((E0&>%RN:%4[-"'..
MXLPY-:&2A=,QH@L\VJL;Z*42G=Q_7/.TUTP&F:,=!$W8CL=8P-8-2R_LW:,U
M^1BCSE:((AM(&]S?>]_#W7K!A&R:!6E-'_^I*RR]77^]Y?> MJ>O38%'EY?5
M^-$79WJ'9LK"_@>N87$>8?JSN"?1)^2%K[?CSUL.1O/"^<+[?*_<!];(_*G3
MXBQW8YZ,&*:T*6K!H7:R)ALBOIAHG0J[;QA6]6UQ9V3+U/CI'N_5E!7E>[]@
M=T/54'SL2[:K&G%5%>QL@U+]\'EW\*/3G-IU[%BXY;73Q_;0=/I!^U0;6]SP
M.3\ :(+::>"C"H\E]^C0"#YP>A4HTQB$DKA[&BDJ6Q=(?+%@N Q\G+KW)0MF
M\(O$BA1;9O"+Q(HDJV;H\\1J/.2D.RRXGQ0<SM;(QYYK9DVGMTT%8M@-?H)-
M1U0AWZ:SJ9!^TYU#@XVS_J6 \<W[PYY7[9$J>[_R?NUA\:P_,O:"ID^]&.TV
M[V?]VYZO2,+TQ1DSC<0L.A[68H92 ^#V("_=(ZP!^]R/72!9.4.2W207G5GD
MHHU%;>K0MGC&@=*Q3J8R!1)/@2#NI, MYO:K%2ID:I>SB[S+L.]-"TYOTM'B
M^EX$.P7>ZX,I1X%FT'FZ9YA!ZBLQ8 H/ ZC.%S)J#R5K'4%'0$!=<7'6,"*H
M?T:,, ;\$!R/)/=T9"_4^()Y_<SG0BUA[D4B+UTCI,,O][?+[?7R*JJLS-Y=
MO#V?O3Z>U;]X=W+\]N51_L_CDU='IV\<^7P^.WGQ,GF1VSRX)I5@LI209+9N
MI"\M7>]@>,Y0Y)MTQMFDMPW%S#HOMBEJ=QP*\GI[*$R31R6IMO!9V4@X&Y6=
M ;995^5H)IQUYB\1^#E&.>N?,<\ A>6$PHH*+8LTWMEHZ9L(U*V#^9/0IPC&
M=H"%-GGQGCL@B 2,'B0*=5=/N_*1E9M"3NN7D'%V6E=G&GG4Q$&W<C\-TMDZ
MQV.W=$LWT]S62R#K;>^I&S12H[^->7 L-ERG_EYWX*F?V'(]GR?1YSHC67:G
M'D8@HM5U7ESAN'G:XVWFV[! JGSC'^7H=9OB'QOD\'6K;B+U=6J?$F"+BR 0
M)/MU:NA[IPC)@#T?3WSCT?-]V*'MX.$&:"4P[DTL0QR22TD)W )]O%6]$2M%
MG238.6$>P!'LROT=J((=-=IB"_:)^%W8@2WXRYLK<ICRR#KT@1Y2W*3\E0B5
MP$8AW3BI@!8L5JSDN/[E+_>K\)=FM<Z7NXQ 7,E*Y7OT7HYWI"6.63GWQD^<
M:$?:P[(\:\5=*V+$39ICV>*OTNH_%U9_L5Q#01A[XU2.1=#\,<2\]==ZLXW;
MIUWL'&%AQG+-B(MY'X&5OH"278*UHA@G)NQ.^+Z?QG+LXW@QR$-^4Y5HN.L'
M"MRTEX1EFLN3Z]OQ%N5OXP.[R,=DDN(6<BJ1J+BQQG]LMW?_^7]02P,$%
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M7G-5"A9 )@ R&1#RGR2 3 %D2@[YBK;H(+HW6*97[&HC3 "9 <AL,,B%TV4
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "NAD9.5%\U<>\    K @  $0
M            @ &9 0  9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "N
MAD9.F5R<(Q &  "<)P  $P              @ &W @  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( *Z&1D[K&6>4QP(  #8+   8
M  "  ?@(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "N
MAD9.1YOZ5+H#  "#$0  &               @ 'U"P  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ KH9&3E)1__Y. @  _ <  !@
M         ( !Y0\  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( *Z&1DZ-5^A)- 0  , 3   8              "  6D2  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "NAD9.8S(N<-(#  #I$
M&               @ '3%@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ KH9&3F40VI@"!0  @1H  !@              ( !VQH  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( *Z&1DYR'L8 L@$
M -(#   8              "  1,@  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " "NAD9.+\_2:[<!  #2 P  &               @ '[
M(0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ KH9&3C?F
M(#"V 0  T@,  !@              ( !Z",  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( *Z&1DZS:12/MP$  -(#   9
M  "  =0E  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
MKH9&3GET*Z>V 0  T@,  !D              ( !PB<  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " "NAD9.&M7Q^;8!  #1 P  &0
M            @ &O*0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( *Z&1DYDPX>YMP$  -(#   9              "  9PK  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ KH9&3@EJ ;*V 0
MT@,  !D              ( !BBT  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " "NAD9.K@T^KK8!  #2 P  &0              @ %W
M+P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( *Z&1D[,
MW$;/M@$  -(#   9              "  60Q  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ KH9&3LEN[WVU 0  T@,  !D
M     ( !43,  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *Z&1DY\UP<_H@(  !0+   9              "
M ?0\  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ KH9&
M3C2_J.&W 0  T@,  !D              ( !S3\  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " "NAD9.GW=%T-T!   !!0  &0
M        @ &[00  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( *Z&1DY?C>JWP0$  #<$   9              "  <]#  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ KH9&3GEB*,OV 0  RP4
M !D              ( !QT4  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " "NAD9.T#U?J+<!  #2 P  &0              @ 'T1P
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( *Z&1DY "-^Y
MPP$  #<$   9              "  >))  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ KH9&3JOLWN7& 0  -P0  !D
M ( !W$L  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " "N
MAD9.XXP%VL\!  "<!   &0              @ '930  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( *Z&1DXE64T8W@$   $%   9
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M  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ KH9&3C;
M@+V7 @  = H  !D              ( !QE@  'AL+W=O<FMS:&5E=',O<VAE
M970S-2YX;6Q02P$"% ,4    " "NAD9.D[M._/P!  #G!0  &0
M    @ &46P  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M *Z&1DXQS"9*&0(  #8&   9              "  <==  !X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ KH9&3F\1CXW- 0  /00  !D
M             ( !%V   'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " "NAD9.4T8=ZT\$  !T%@  &0              @ $;8@  >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( *Z&1DXX0\:1TP$
M #H$   9              "  :%F  !X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ KH9&3JWU?0?X 0  ] 0  !D              ( !
MJV@  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " "NAD9.
M?I'7TDH$  !(&P  &0              @ '::@  >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( *Z&1D[H7/*P, ,  *0.   9
M      "  5MO  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ KH9&3CWSP)0R @  808  !D              ( !PG(  'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " "NAD9.8;;6%6X#  #Y$@
M&0              @ $K=0  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( *Z&1DZGJZ-<\P$  &D%   9              "  =!X  !X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ KH9&3DSDF,<A
M @  A08  !D              ( !^GH  'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " "NAD9.\U<^[',"  !$"0  &0
M@ %2?0  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( *Z&
M1DX.8].P_@$  ,8%   9              "  ?Q_  !X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ KH9&3D+EI4A' @  D <  !D
M         ( !,8(  'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
M    " "NAD9.7B!['^<"  ![#   &0              @ &OA   >&PO=V]R
M:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( *Z&1DXQ5'K*\P$  &4%
M   9              "  <V'  !X;"]W;W)K<VAE971S+W-H965T-3(N>&UL
M4$L! A0#%     @ KH9&3MZG%.WS 0  " 4  !D              ( !]XD
M 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "NAD9.(/8!
MJ%$#  #W#@  &0              @ $AC   >&PO=V]R:W-H965T<R]S:&5E
M=#4T+GAM;%!+ 0(4 Q0    ( *Z&1DZ$QW$ YP(  /\+   9
M  "  :F/  !X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
MKH9&3GX]L'Q< @  "0@  !D              ( !QY(  'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    " "NAD9.2U$O##T"  #B!@  &0
M            @ %:E0  >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( *Z&1DY\]D,T'P(  /0&   9              "  <Z7  !X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ KH9&3F?FGWG,!
M#AH  !D              ( !))H  'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6Q02P$"% ,4    " "NAD9.>\MT0-X"  "/"P  &0              @ $G
MGP  >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( *Z&1DZ&
M<41%= (  #D)   9              "  3RB  !X;"]W;W)K<VAE971S+W-H
M965T-C$N>&UL4$L! A0#%     @ KH9&3J<@MA$, P  )PP  !D
M     ( !YZ0  'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *Z&1DXVQAD'= (  .L(   9              "
M ;6S  !X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ KH9&
M3D9)P6&/ @  C@D  !D              ( !8+8  'AL+W=O<FMS:&5E=',O
M<VAE970V."YX;6Q02P$"% ,4    " "NAD9.-R##[=$"  "T"P  &0
M        @ $FN0  >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0
M   ( *Z&1DX6Q=D2'P(  /\%   9              "  2Z\  !X;"]W;W)K
M<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ KH9&3@W"R'4U P  C@P
M !D              ( !A+X  'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q0
M2P$"% ,4    " "NAD9.0,_5MLD"  #I"@  &0              @ 'PP0
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( *Z&1D[%UBE,
MT0,  %\0   9              "  ?#$  !X;"]W;W)K<VAE971S+W-H965T
M-S,N>&UL4$L! A0#%     @ KH9&3O)BN717CP  RD8" !0
M ( !^,@  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ KH9&3LK]
MS&6* @  B X   T              ( !@5@! 'AL+W-T>6QE<RYX;6Q02P$"
M% ,4    " "NAD9.&]6R844%  "J,   #P              @ $V6P$ >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ KH9&3DW.S.U< @  T"L  !H
M         ( !J& ! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ KH9&3LX6WG8. @  URH  !,              ( !/&,! %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     %( 4@!P%@  >V4!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.10.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>211</ContextCount>
  <ElementCount>397</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>80</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Stockholders` Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Stockholders` Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/OrganizationandBasisofPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Business Combination</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/BusinessCombination</Role>
      <ShortName>Business Combination</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Liabilities Related to Sale of Future Royalties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyalties</Role>
      <ShortName>Liabilities Related to Sale of Future Royalties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Convertible Promissory Notes, Related Parties</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedParties</Role>
      <ShortName>Convertible Promissory Notes, Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Secured Promissory Note Payable to Oxford Finance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinance</Role>
      <ShortName>Secured Promissory Note Payable to Oxford Finance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Equity Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/EquityIncentivePlans</Role>
      <ShortName>Equity Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholders</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Quarterly Financial Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/QuarterlyFinancialDataUnaudited</Role>
      <ShortName>Quarterly Financial Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Business Combination (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/BusinessCombinationTables</Role>
      <ShortName>Business Combination (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BusinessCombination</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BalanceSheetComponents</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Liabilities Related to Sale of Future Royalties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesTables</Role>
      <ShortName>Liabilities Related to Sale of Future Royalties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyalties</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/CommitmentsandContingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/StockholdersEquity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Equity Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/EquityIncentivePlansTables</Role>
      <ShortName>Equity Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/EquityIncentivePlans</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/IncomeTaxes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholders</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Quarterly Financial Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/QuarterlyFinancialDataUnauditedTables</Role>
      <ShortName>Quarterly Financial Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/QuarterlyFinancialDataUnaudited</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Organization and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/OrganizationandBasisofPresentationDetails</Role>
      <ShortName>Organization and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/OrganizationandBasisofPresentation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Summary of Significant Accounting Policies (Details) - Estimated Useful Lives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/EstimatedUsefulLivesTable</Role>
      <ShortName>Summary of Significant Accounting Policies (Details) - Estimated Useful Lives</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Business Combination (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/BusinessCombinationDetails</Role>
      <ShortName>Business Combination (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BusinessCombinationTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Business Combination (Details) - Total purchase price for Aviragen</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/TotalpurchasepriceforAviragenTable</Role>
      <ShortName>Business Combination (Details) - Total purchase price for Aviragen</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BusinessCombinationTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Business Combination (Details) - Allocation of the purchase price to the fair value of the respective assets and liabilities acquired</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/AllocationofthepurchasepricetothefairvalueoftherespectiveassetsandliabilitiesacquiredTable</Role>
      <ShortName>Business Combination (Details) - Allocation of the purchase price to the fair value of the respective assets and liabilities acquired</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BusinessCombinationTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - Business Combination (Details) - Selected amounts related to Aviragen's business included in the Company's consolidated statement of operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/SelectedamountsrelatedtoAviragensbusinessincludedintheCompanysconsolidatedstatementofoperationsTable</Role>
      <ShortName>Business Combination (Details) - Selected amounts related to Aviragen's business included in the Company's consolidated statement of operations</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BusinessCombinationTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - Business Combination (Details) - Unaudited pro forma information is summarized</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/UnauditedproformainformationissummarizedTable</Role>
      <ShortName>Business Combination (Details) - Unaudited pro forma information is summarized</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BusinessCombinationTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Fair Value of Financial Instruments (Details) - Company's financial assets and liabilities measured at fair value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/CompanysfinancialassetsandliabilitiesmeasuredatfairvalueTable</Role>
      <ShortName>Fair Value of Financial Instruments (Details) - Company's financial assets and liabilities measured at fair value</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Fair Value of Financial Instruments (Details) - A reconciliation of all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/AreconciliationofallliabilitiesmeasuredatfairvalueonarecurringbasisusingsignificantunobservableinputsLevel3Table</Role>
      <ShortName>Fair Value of Financial Instruments (Details) - A reconciliation of all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Balance Sheet Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/BalanceSheetComponentsDetails</Role>
      <ShortName>Balance Sheet Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Balance Sheet Components (Details) - Cash equivalents and short-term investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/CashequivalentsandshortterminvestmentsTable</Role>
      <ShortName>Balance Sheet Components (Details) - Cash equivalents and short-term investments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Balance Sheet Components (Details) - Accounts receivable net of allowance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/AccountsreceivablenetofallowanceTable</Role>
      <ShortName>Balance Sheet Components (Details) - Accounts receivable net of allowance</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Balance Sheet Components (Details) - Property and equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/PropertyandequipmentnetTable</Role>
      <ShortName>Balance Sheet Components (Details) - Property and equipment, net</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Balance Sheet Components (Details) - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/IntangibleassetsTable</Role>
      <ShortName>Balance Sheet Components (Details) - Intangible assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Balance Sheet Components (Details) - The estimated future amortization expense by year</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/TheestimatedfutureamortizationexpensebyyearTable</Role>
      <ShortName>Balance Sheet Components (Details) - The estimated future amortization expense by year</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - Balance Sheet Components (Details) - Accrued liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/AccruedliabilitiesTable</Role>
      <ShortName>Balance Sheet Components (Details) - Accrued liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/Revenue</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - Liabilities Related to Sale of Future Royalties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesDetails</Role>
      <ShortName>Liabilities Related to Sale of Future Royalties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - Liabilities Related to Sale of Future Royalties (Details) - Liability related to sale of future Royalties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/LiabilityrelatedtosaleoffutureRoyaltiesTable</Role>
      <ShortName>Liabilities Related to Sale of Future Royalties (Details) - Liability related to sale of future Royalties</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/LiabilitiesRelatedtoSaleofFutureRoyaltiesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>053 - Disclosure - Convertible Promissory Notes, Related Parties (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedPartiesDetails</Role>
      <ShortName>Convertible Promissory Notes, Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/ConvertiblePromissoryNotesRelatedParties</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>054 - Disclosure - Secured Promissory Note Payable to Oxford Finance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinanceDetails</Role>
      <ShortName>Secured Promissory Note Payable to Oxford Finance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/SecuredPromissoryNotePayabletoOxfordFinance</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>055 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/CommitmentsandContingenciesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>056 - Disclosure - Commitments and Contingencies (Details) - Liabilities related to costs of exit from leased premises</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/LiabilitiesrelatedtocostsofexitfromleasedpremisesTable</Role>
      <ShortName>Commitments and Contingencies (Details) - Liabilities related to costs of exit from leased premises</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/CommitmentsandContingenciesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>057 - Disclosure - Commitments and Contingencies (Details) - Future minimum payments and sublease income under operating leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/FutureminimumpaymentsandsubleaseincomeunderoperatingleasesTable</Role>
      <ShortName>Commitments and Contingencies (Details) - Future minimum payments and sublease income under operating leases</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/CommitmentsandContingenciesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>058 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/StockholdersEquityTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>059 - Disclosure - Stockholders' Equity (Details) - Convertible preferred stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ConvertiblepreferredstockTable</Role>
      <ShortName>Stockholders' Equity (Details) - Convertible preferred stock</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/StockholdersEquityTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>060 - Disclosure - Stockholders' Equity (Details) - Common stock reserved for issuance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/CommonstockreservedforissuanceTable</Role>
      <ShortName>Stockholders' Equity (Details) - Common stock reserved for issuance</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/StockholdersEquityTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>061 - Disclosure - Equity Incentive Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/EquityIncentivePlansDetails</Role>
      <ShortName>Equity Incentive Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/EquityIncentivePlansTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>062 - Disclosure - Equity Incentive Plans (Details) - Summary of stock option</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/SummaryofstockoptionTable</Role>
      <ShortName>Equity Incentive Plans (Details) - Summary of stock option</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/EquityIncentivePlansTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>063 - Disclosure - Equity Incentive Plans (Details) - Fair values estimated assumptions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/FairvaluesestimatedassumptionsTable</Role>
      <ShortName>Equity Incentive Plans (Details) - Fair values estimated assumptions</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/EquityIncentivePlansTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>064 - Disclosure - Equity Incentive Plans (Details) - Total stock-based compensation recognized for options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/TotalstockbasedcompensationrecognizedforoptionsTable</Role>
      <ShortName>Equity Incentive Plans (Details) - Total stock-based compensation recognized for options</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/EquityIncentivePlansTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>065 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/IncomeTaxesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>066 - Disclosure - Income Taxes (Details) - Components of income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ComponentsofincometaxesTable</Role>
      <ShortName>Income Taxes (Details) - Components of income taxes</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/IncomeTaxesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>067 - Disclosure - Income Taxes (Details) - Components of the deferred tax assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ComponentsofthedeferredtaxassetsTable</Role>
      <ShortName>Income Taxes (Details) - Components of the deferred tax assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/IncomeTaxesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>068 - Disclosure - Income Taxes (Details) - Reconciliation of the provision for income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ReconciliationoftheprovisionforincometaxesTable</Role>
      <ShortName>Income Taxes (Details) - Reconciliation of the provision for income taxes</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/IncomeTaxesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>069 - Disclosure - Income Taxes (Details) - Reconciliation of the unrecognized tax benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/ReconciliationoftheunrecognizedtaxbenefitsTable</Role>
      <ShortName>Income Taxes (Details) - Reconciliation of the unrecognized tax benefits</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/IncomeTaxesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>070 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Calculation of basic and diluted net loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/CalculationofbasicanddilutednetlosspershareTable</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Details) - Calculation of basic and diluted net loss per share</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>071 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Potentially dilutive securities excluded from the computation of diluted weighted average shares</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/PotentiallydilutivesecuritiesexcludedfromthecomputationofdilutedweightedaveragesharesTable</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Details) - Potentially dilutive securities excluded from the computation of diluted weighted average shares</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="vxrt-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>072 - Disclosure -  Quarterly Financial Data (Unaudited) (Details) - Selected summarized quarterly financial</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vaxart.com/role/SelectedsummarizedquarterlyfinancialTable</Role>
      <ShortName>Quarterly Financial Data (Unaudited) (Details) - Selected summarized quarterly financial</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vaxart.com/role/QuarterlyFinancialDataUnauditedTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>vxrt-20181231.xml</File>
    <File>vxrt-20181231.xsd</File>
    <File>vxrt-20181231_cal.xml</File>
    <File>vxrt-20181231_def.xml</File>
    <File>vxrt-20181231_lab.xml</File>
    <File>vxrt-20181231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>113
<FILENAME>0001513162-19-000041-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001513162-19-000041-xbrl.zip
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MOE7V,=WVC?M]E*7W4>S+J8*J45'9WK;'_!KFW)J[JWJIGLS#O-<).1!G,,"
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MQ1/OZ>3%G&!]G]:S']':QGFW.O.JIDA89C,W*? /<X/=7YC"M"IXSZXP'>4
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MZ">@&:?B&,X-JG GJ5!AEY]J-4V68. :ZU7!"RC+G$?X'UMT#/>Z6HWCYQX
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M+!Z((DZAV33#Q"6^Y8D_]I'T__OH<*_C2#T)H'$Y:/QY%([\OZ8LO74#%\"
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M&TNPT*4B/"QFPU%SMX%_)S0*'>(W%IN3&\N'/)9Q:F(Q3!B3 >X=4N>1^B?
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MYF(?&<A0)F:QXT7#W,LV9OP2!IK(P+ZK+K%2*PEP.)(Y3I[ FC*\"M)6"2=
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M;!8-X;=\]TZ9G O^K1C'H'A8UB38I,B@\1BJ4(EL*!9:8]5>>FI4D]6)-*8
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MG7Z0I1'=O$'HXM1_M)!@H#%R>\T=A Y^BT!^"V2H"\;FT,>QNWU3(957I[$
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M%.Y%<L2 >%:(W]-:&088YE-P^RF >/2YT5W*>@[HLZ@Z\V\+.'6J-P?X 'H
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MO$'HXM1_M)!@H#%R>\T=A Y^BT!^"V2H"\;FT,>QNWU3(957I[$ <  X !P
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M';A:7,''+D1N'MQUYT(;IN./J$>^;E*.#]@@^%*<XU6%3'C86;,L<V%:U+W
M-!OY4I3=Z?.Y"SRAX6$27]ISQET\$5/W$OLK'D'3WH?I(W]-7 >P2&IQHR,6
M^5O*)+E3I*WA<&F%K07?VPL+8LCW=1'U3KUWTNTIO*R[]9J_$3O 'SJ>H1AF
MU!+Z@BF0\?Q[;6ZP/_B\T]GT-?903 -'1;Z,5JZQW(NPB-N.89N<+U(T%<[I
M-$[$EZ'O!U$"GL^+31<V"4G\V#!K_)@"MI0 I(5)!T\"8'.S018-E+?*EGC4
M>9YHR.")TIG4_Q#[[#0(H#YF.E7UDX,:Q:Q=)9T8;0H2_/(1AR_D.!(2 FTT
M'&=9SX1+\??(CMHEB?/H+6G O9?E4!*70%Y31VQ,)*'XI%@606@8B7CAS7-,
M",\226<^[&$\X25[(*=/Z2DR"*8\)V]/[';P5N&').$8#N9<FV@'W_@S_F8H
MS%GG\)^1DB0Z\-QFHCW'.UX4FX!-&-C)0%K^G)C/Y\DT _XKNMM;(BEI>A&2
M.T]QRM-4(VISB2(]GX[7,(VG?7E2;^D7ZRU;.>IH!=^Z*O>GU?:B\JDI_>C6
MT\Q"IO@FN[V <P_P6=T>F)=9]@>S6A?9 3S%P3,95T(/AVJJ"SE#0 X@!Y!3
M CDC0 X@!Y"3!SET]WQNN.383\!WZ-.8.K*+*2.Q\G%%AC_SXNHC2URULUZ.
M]KDC;MLLG8;Z9)+@\>@O27V4\$("3%)?2'#9+'B8^@;]_!W?.:@RSK4)5Y Y
MFW<C/60V_2%[LQ%8'L-Q/[.9TEA@#^(TC9, FB>:: N MC6B@JGVY%,MN_,M
M=O^\):Q2GG_SCG\!5_]N5WL;EGA[);Q9RV+U;%8KX),W+>#3[(PLA%[!\5MU
M$VF1&;DKYE-H[NV(3 !2 "F %$ *(,6+^0"D.@TIMBLU]-6P(X';)UH]_<DK
MX'U/JJ=/F ,K$*X))=2?,F7(7()B)V>*B=4_8_@4<H7LK+@+)X!5#L0:[K0>
M9VV#!-0":@&U@%I +: 64'LROYCE*B>+<%DP&[[>;==]:QZ(EDLF=/BI+>[F
M2BH_\A<]?=>XXP')="'LO*NI>WXT $P#3-,%.P>F:5H#P#3 -%VP<V":IC4
M3%-;*JBA':[X'K.T\^Z'+,^[/^U9F;#%E)F@"N&=/[C#?E#N+*J3F\X ?  ^
M'BP*P ?@ _ !^'@757? 5TO5P*@S50.T&97?=C@S0F>;=AGV+PXE7I:FN]#W
MN@6<LFY * 6R*EWB4VE0+07)^%.D@IOB)"BH%%%M76(E6"P$?@)^$DMMP$_
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M'?!Y.FKYP#U-:Z!M-1FU.SPB;=R%T[.XSB_#(08\ECS"F@YLN0,X AS;:&,
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MIH8<6(%P32BALBJ!SB%!L9,SQ<0J7YQ,KI"=%7?A!+#*@5AS-?($U )J ;6
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MZ!G9>!,@ 8M=CR?MP8N"OEH *8"4@.93Y+SQKLBDP&'>@">P'9BB8(JJ9X,
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M!E?K6QC%._<"\0FNSV3GWIJ\$X&HCX>Z2* _3N&2Z. &]">X/I.=>X'^@/Z
M_@ZO00#]M46?$/9"V O$!WY?!XEO7EJ=0'O["RNO' 6K*_CAPGH5O(S+Z?V7
MS_?GWV[_?7/I;1F@?[^_^G3[\8]+2B'T6WLB"3[HA2]]T01_OI:^7GVX.7][
M=W/U/^=7[^]O[BZ51Y.LQ7VZNOMP^_F2B(RJQGO1OR#&<'_SK_OSV\_O;C[?
M7YX/^D/\9ER$B^"%1EZ<+5ZFRI4\Q26QLAR/D$J9!U])^WK1=J\6Z2.]4E4,
M0L>6[I"*M$>JFXP?>DIN2FL)[832V3V!M7L"234W6TNS\5V<-<)XT'7SB> \
M\S&H4<8>Q8?_9#"(D \F%UW9VA@6P:O7DH?H<QVM,#\HKF/NWK(\SJ#O^81!
MK^K?8388^.^J2-?MK:+B(?J?13_Q22K^272^.+ O)P?!30?,EXHEF5P_RCHJ
MIE]DG=2GR.F$\;9T+X<E[/C2V"H"?0SKFW-JU@X>D.U8IO&0.=_X0ESHV"N(
M76H>N]([C/#- EDI1!>_P9';16XPB]U@)/>.73J^8TLT06<^^7 @SXH]^D%8
MY3#TC*T:CKF-F#.'0BX9OP#/\&S^ ;.$VBU"!6V3!B:#%!\_/QGDWC8,[DEU
M'LT$\H7(0,YOK&=X@,[:=&W%6-HOJX2FU=I55K->H1(_=^:SHCL:BL9<IU\
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M->9Y$A[K:8?E-2R4?EDE@#E6I5Q!E^)S:V\Z9[B.5"BCDDOH;7/W. 8"<)J
MJCSD,R:5V=U<W624G4>'S1[>9@]5E,T>7RUSBRSG65*,I73SMZMM27:PAP?D
M9%V@V4T?.;472B_VA"A\0@/1)*BMV=CC-E=MWQ9R-(*+U]5'?E&J/E-*O3(3
M9A2H5I.[-%1R*HNHIE3)-Z>EHK"WA ]!'RHG/_W>DCR<5#)$@LTFP$2P^T28
MW2>I/M"L/[^HQP>*7;EK/E!46 &;> P4I8^PX?'T\-Z5NI(D4@YYI D\?QA=
M<H]*^549N9_3GJL4R4BIMV.UPXB+A,='!5NMXIC6<Q@_9BFLUB7\4K(62M3U
MUL@/B9=QQ!.IPXIYS>0->X,&-[[DD7FR4%;X)0M /""^T27*B\FA0S#*.QO#
M_K"XLU%LPXR4>K.V58%\6:TT%=%L->E9Y&(G\[C;<;+5Y6*2%YZNTZ24AU-J
M,E!>:64X+%:^?TJ[+-<]1BB+!-P";LNY ],#S@#D'9K..R#%1FM37TK:9FN9
MCXAX #8KHN6A2+M5<4\[ZN8A8HJ#<#0J5C /^1'A(0"LQ)U*@)62 =>!O.UI
M';>LG3S4+BH[;'E5A4$[V2V)8BO")G4ID4I-\N9)UT29AW-'ETQ+HZ -$T:.
M2.^H $OS"'\T4J%6L7J2(:^?TDJC ]0":D^ VM.G8(+Y/'M7KCC><#$OBQY(
M+FU3-Q <6(EI/"KD3>IU+9M#5+!W$L\(ZCDX,$Q +Z"W^&),;SXIBMY\WL"\
M/V+4GB,[J(_=@W\7MNA*C&U?2HJJNAM75QRTE)9H:R%54QS--+)T5LHEYCOO
M*9B6:VXQP,WVF2)J$9TFS^3>Q72073%_DDP'X( 3'(!6FM5*KI89OEZZW'<-
ML]9P-"G$6KE\NR%I1E',MRN;YHG?JE65-@=Z1)RHW(:?;D7%U-P\BQ;3=,L.
MJ,X10Q?2I^@T*_<&A6/H&K([AV2^U_M?>"^$$RP M0&UM9C:IH*W7:,MU*X^
MWG[X?/F7:SO:ZOE TZYWD?2:A'YLD6$CZ4FQI9_&TTEO,!A03^VGD?_'"AL2
MZ=_UC!3+EI"Q1$LIM8.&1!K/T-^2EA(]R4+V%JF.]HCTY[Z47G!-O[YR+4-S
M7 M)BD-O=6UNMHKQ[%U]-I2GKVU))[]?2GCH&WK2/#:I#\C$-J;T2.RCKJ4U
M?H0%0H9D$Y20;_?(+B]\']+2B_S@,[DM:3I$1MJC3Z8CFYQ:KQCTQ@0ZBD[^
MC@U$TFS)7&"SI>E)Q\1@>I;.;(3P%1V$C>DE'@,BX[?QT,@P\5#P8RJ:Y;TV
M5](WM'6\FX\&/7\ Y.$55<5HQ@/4B8?L_\H[16*-(83(;W^2!YXNB):P[@C\
MZ745NHT-4P/^.OZ>:OK]UE+-/[2_.:&9T"#0#\V15I:Y20HYA@G,$LX:"Y%X
M\]AVL$1]V['[(5R: L I^@XN1>D[>(N-V'C02"^]*VR-_K8&[KH-9A)49/P*
M'7_02[ +K03]A$1FMB&'6W8Q97^&\VC2O[C83>&[(M#YB9UG,1L#RNTX^_UX
MBQZVO0'WJ8]-:\!2?;]:HX1,L332-S O3PDB_K8T$ 3&.@*6]VAAN8KU+,FC
MO!32?J&T@$&\^^SO=9F"HP.T41TA;6D]6BN'U-^.=+]HKT([4A)N28DKEPC%
MVA>(,=O"DQ!J;M(7<_4GQNHR$9K'[$E6IUP><GN2U4/NSB;XW*R>I8H(XPM2
M99)R_:.FSLQ7J6K10AHTT #00#4::,:#R>^SY.XW#3P"/-(='LFJ7TTEDI3R
MU1+L(HJ2DE%*YG)/V8JIW(&'4&4X7UU+7=,E:@>I:P/;W,-S%MW66HTFBCD6
M$V^]_:*/YHR$J#$Z'#\4D_=PV),'!RJ/:BZI%,6(3[Z36!3! +HY1_<8T WH
M;@.Z#[GR)W?=!>( W[J' WG\NH"C6BH\R+_=MDB!F% @N#7.MY:IDII>"]E(
MP=$"+;)=HD>DFPP/ERJTM9EQ9HPK'F;I P '<%8,(9ZM@0@Z#S>Y-SGH=8.=
M@0@*B^ 4_F\+L7A*]Q>RX[>&@W0=J8X;Z:S).BSDKNA0H(B^'><%0*8O";Q9
MIK\!B:R6FSVH@0LU /L ^W30[$$-G+3D@W40AAP%JQ_EA.P=J4":@)QLD2-/
MW:4@LN;CY)JN$P4IB<HF"\C?,LC?LL1L!Z73Y5!C..X- )V SN867G+!$USQ
MNESQU-W4WDF@*;ADN%HCQ6]6V_YJ3EQY<BA*[$P496-:CO:?@V>B5"@IY3&S
MD:'R5N]Q$T,YL1U<<>VT;4-X0?^H-YVD=*\X\>F%@!?.\ +*X5@Y0&899#9N
M9ET)D,(K4D Y7"@GS[;Z0#T0![.AMWQG@4[+G R>=1RHA\'8D5&Q0-B_6]LC
MX;UFX-5/CN+\))6$8L5)AA93;*4-BQRJ,,:_"1UV><U GO?&\N@4:P95$22F
M=\(A%(#-@,U:RF9D!33;<P0V S8#-FM2A7F"XYT2V43'+62Y"K%QSL/PDO>N
M)(KHD^_.OPMT$)PO=2"FC*VNQH_$&_:FPVEX*-[XZ)%XTM&3\-X'IU?Y1\[9
MKNZ=VO:5M+:3AI)C:8I.3[C[U<78\,Z*(]_5CK>WH*..'D.W<G7].3R,3O,.
MNG/6%D+2!LM\'3P N5>D+?WND#IR[!O]S4]R?R)A_>A$2(KZMQN]X"=D/>"'
M#P_%&[V4%H@\I'>,'3TVC\NCXPJ=G7A%%;6G:T\]"/]Z0U?K5ZYWG&&:62V>
MJ=V0,P6)>J@QV%*\A6P'SS4K5\L]:^L,_ <QD1N#/'_,W-C5?D +FYQ"R7(I
M)L<*S2;M<B'R]\:O9?]^+!.>'_="H1[/)?,:JKO:M9/LA*%,Z;YX#+E!$'8H
M6B@U&A9LTE/#KK"2E"(:!(:#@[(&OP'\!GZ80>Y-1\,3, .X&Y089' W&NI/
M#*X#WP0!KH/'$(=D#:X#N [=8P9P'2@Q5*SI =<!7(<&".*0PUNKZT#TEBSH
M+> X",4.]VMD(67E(*O .O)Q@?*X(T(,]3%S4SC<]P!.T4'.&_3DR:3@5)UO
MN\,HN=FAY#3O_QLFF5&*W:DP9XK%F*1W%QNR/+)'B:-BNJA:A:'2AI>?^"RO
MF^RKE0DCMY&0R^R'*%5C5V/1U->K#S?G;^]NKO[G_.K]_<W=I?)HDDD^43CE
M%]_U+XBMT$*KV\_O;C[?7YX/^L.+:&$5?9#@A49>G*&7J9(E3W%)J"7'(Z1Z
M0 =?2?N*T7:O%NDC_>)@=U>Z4E7+14OIHZ8L-%US-&1G_;S9@K><N@ME%SR9
M'CZ9I)J&K=D.J88CI6^KH*:Q@Y5K.6:]Z8!YX"W)Y/HIA]C71WS^#8Z$%3FS
M/[R%<G+H@.!+8U,)=#2L;Z9J0&-XD+9CF<9#GIEK%INX@C+$2)&PW O_('6P
M^^09O]EI3F%RS&V),(!#* &,>-56K3!*Z2!5 $:Y,Y8P;Y68MZI X*)M$,AO
M]/'M#1RLT96R<J$R#X'7KIH;LO'D8.=(6*UK/K%3C%DZM_%Z<F!I_^3F&_<P
MFS;<NI:9 =$GV"DP/+9Z58>\!<*]S,5.@;).L5  V'D,NF9HJJ+3O<7XUNY*
M41W7BN[;+:80* FL2RA%V*&%Y#"]8./15K;"A$/0+2/L.#)/,+.W$+J3S(VN
MD )@/:%O+7.%;%LS#7]2)ZMWKDX[<> [/VKJP1D=@HG31UE=#O4/U:M!J ^A
M/@^E]A"V'\'P@1(G"-F9S?!WB,S?B'8DLQ .T@U2D6.9SXJ^*T"J3J,0"D"0
M7MY&1Z/LGC80ID.8#F$ZQ^#UE3$<R./7$+#7/9V_0RMDD:Z:I/Z*1NHZ(CU!
M==,[#M)R%;T7U&=)6])=\N!QD! :0.!^4J<_>W<M!.X0N$/@SC^&LSM"0=C.
M;)Z_-HU'A"=OLB-F:P63ONV8ZG?I2;$L!5\IV&WSS,D29U?B!(CAV84!$,L#
M1B&6YP7$V4>30P3/:F:G>X'9,"0/9\U">,&Q&CJ=:IAGEOY!JJ&])@_,PTG3
M+4BC'.&G(I7)K)L,EDF@Y-,!AN5DMW\7VPPVH$OIW#]M_H1 JF'EV(.*!Z\H
M-@0\[/$DD>A1>;6/ O*?@ 2)#X!GPSF17/AD-H>W#+_U]P7//S4+E?_H4!]+
M,1*PQ=37LG:5L):3NJ/Z(JU35W-%0QU+GP!Q 7%QD'9I);--!MEIX1R.7F9C
MW5=+[9&\_OF5:Y\_*,KV\IN[W>J('+FNZ&\573%4]&V-D/-.LU7=M%T+V??X
MR=[JIOK]#;FW)/T<_/8=VEI(U;QSP5U#<^[0ZI<7KKU\079F$H'0-]39G^\M
M<R/_JABDN>*].9+?(96\?"$M\>\WBF[_\F+PXLUX.AD,!N'8HM=_4^K.\^B=
MI^&=IXD[CX[>^?&'Y5S>TN/GB;#,U5>+' /O/%\9RYN_7<T[M9Z!$.2!-Y1<
M-WSCQ<T1R5Q%SFK_LKK%:C4>2'W.E6TCQV8QP.%T.(T)Z_ MDT93?H!YE3DN
M.+KX^,A6),52UUC,[] CTDTJZ%L#BU]%]N$!CKP17FTM7X2#7UTC*<+S"ZQD
MHN/H*(_<]4U\C-_4-5JZ.OJRNE;L-?E'+ (S)?Z-C2_Q;8V?^1Y9FUOC$=D.
MN91]3RAA!^6\JG]#YYG2+8]]#F?>R_AH/)O#@QA=]&5!8M>6-%6=C/OSC)Z2
M\KC6%"N7K55]\2YT[+?%+C]/;*;P&JU*([DG%>M.7"DE!! Z+(/CB<G^<%:K
M&\M)Q]FB3$2.#_/9*,E$E']"/DHR4<@WV:24BXGF_<FXSK,[0#-E-2/WYZ"9
M3,UD:R6G0G(F%OOR+&.B#OJ?6^93Y-T1S-Z[R\<[1G^P3#NE?T'&C-TUZ?QF
MX##;?##P1\NB;DV'Q/1!T8R"1@2L#ZQ?4 =R?P:L#ZP/K-_8F2H?L=6D=3LJ
M$M\#U0/5YZ#ZHP<< =7G([,;V]$VBI.?R5HCH$R1O%>TE+UC;9_\,L7QNZ*[
M*#^I Z?SH&\1.7TP!DYGPNG7BF4]8WGG!&UKQ%,CA<&RD\@KM_*@/R_F,';M
MG,R<S.)7HW306\Q+O:;M%))-Y6,NP7<!68&L0%:-R K<(K D0!W("F35!ED!
MFPM=6\F5>+A+\M91,\F5Q!NB-F%DD .44V&V9;8$E/*@/YZT6^8 R\JPE'-+
M1TSQ\ C+J3 R+[02=(8'XZQ-UU:,I?UR/U-;8!D;@%T9V&-P@L$)AMF6+U#"
M;'MR4,YS2EP,>;/LVN;_B_5L$RBU5&@E.=%&Y1.VN6<)C_8[<J05%M*!P^%S
M6'W9@]0$RE0=\03K[E7$>/XME5SFO350D7[,S"PX_WS?M 6?^)!$@1)>_&.[
M6"ZKC>AF?SP5X)R-9,3QZ87 >8'D&. <<'XZG(N34.,?Y^"K [9YPC;,X2RQ
MG3?EUGED,ST5J5(N3S3#OC:MK6DI#I(6YH'L73$K]R7+WQ:K_'E"X7F;5QT4
M\%A:R&KLHY("YY+G]UO ^FMCH-S93-!!?1MM\^= @8. @]IF__FC--!!?1R4
M/S\+' 0<U#;[SY\%!AU ) 8,!-8/7E#K=% @P]W.Y:N2))1,=\?NMD9D3)Z+
M>1&[6\7ZUN%^3EQ*OQGWQVH7TU)7#BKVTN-E=2J42EMV!N@A!Z]N?0I$M\U5
M"Y0FRJ9AU?(CCKU\/%!>:_3IY?9K]TL$(CT>"B&!_CB%"PV"@?Y:HT]O60'H
M#^@/Z"_O*@307UOT"0$O!+Q >>#Q=8KRYJ75V77"R[>,@A$37T79D123M>#D
M0DKT=@(V#LE6S1W:FI:#EI)B7V8BD_V2>\XVM^44T+0&F"T-5Y)@TNVJ18*-
MDE":G.LPU@P72B!.X,,BDVE]P'1A"283Z85$"*@&5->!:KG^>:;=$DSFAP'5
M@.JF;3*1A 54@_\-F!;;(F&FKH[I>=T6* BBH5-OR83;M6*O)?2WJ^&'PO:5
MW9FWSK4@:,S+3IK0[*NIU4PQ+!@:\XJ+;6C,RT.AEAC6#$W]A,8Y-.8%G'.)
M<VC,"[XZ^.KMQ#;,X2RQ#8UYH3%OS8;];6U:SKF#K(VD&8_(=C8'<WCE4M3<
M=02!#KW-ZP#Z0D%?J.Y:/W3HY4 'T*$7.*C+]@^]Z9K7 73H!0[JLOU#A][&
M=0"1&#!0=ZT?O*#F=0 =>NOLT"OW)Z?KT!N[&73H%;+;P_Y>]2(Z%4JE'>G>
MD=RY4X<^!:);'AH6%23*IF'5^H9%R:W\0'E"ZW._L4 M?HE I,=#1230'Z=P
MV=M)"?0GM#[W.S  _0'] ?WEZ] +]">V/B'@A8 7* \\ODY1WKRT.KM.>/%E
ME%>.@A45_(K^$;NI+_#)8!!1-U:GKFQM/)#@52![^G7_I[/!P']71?\_>^_:
MW#9R+ S_%93+><JNHK@ >)=/7"7+]D:);?FUM,G)^;(%DD,)NR# X")9^?5O
M]\S@2@#$C21 3BJ[2Y' 3$_?IKNGI]LPG(VV *KRWZ*_<'K'?XF<W&1?<"A<
M"KA9SFB7#F[;\>9X&#G?A,&!\#[*E6'C^V%4BA8 ,K'W**9\@KB<.JYMF0^9
M4LO1.S= M\:&G\6H_Y$LR'I.;&F@]"1PVR;;$AV?**SO4^N.D!"A?!P4+'6]
M1V/["%S=A"92$(M,&R4U$=4_H3Y*:J)0WV0KI<;O"PO*')(R96X5"\H<E#)J
M7YEF;-^JV+V#X:>QC>=7VW)2[I%F[-A=9 LAL&VEC-*?"H$5 BL$MBN44?J*
M*@2VI,!^<EQ]K;ED651HN\@90F;;2AFE+P_/168+TDR$F!H*,859+#.Q+Y3=
M%Z[6ENW"]PWN"T)3-\O7(J)0@:]_,VVRL![,,JQ=R%,1W-TL=POW6W#WL>FR
M3^X6OFIJ!D:<GS]KNMU@-$EP<=-<?#[>6V,Z^EJS[1? ;$&^%AYBDS&/%N3Q
M"'^TDM18CBM<T>,'#=L@0,+QK7(RI^EFDR=S0H2Z+$+"NR[D?WRQ'(<4EQHA
M-Z<O-\)O+R W_]0,CQ07&R$UIRXU(DYP$*D1D8%.7T]H%7I:ERRRCVL'K<+X
MD3:YSN"@@%!VI\WOB0AEN5[ G<2Y$,O:8MF=CGZG(Y8E6O<>&>>EC.0W (S[
M:'F.9BZ=M]O6<ON=RE9Q;DW![DX;WA,1;&$$"Z$4NVWKA+)HYX%NX+M2)]S\
M<O^5>^&VT#;)/'%-E _Z"CSW(@&T?Q)76@&2&FN)6ZZ"6G<B53LLP5;TTRZ^
M_U8*6;>])%9/F:FUK.YZE0"[P<<-EOUKM@WLT3'3?@DO%]$Z11EO0Y'C;G#S
MH>6\.Y9])^2\1(A,R+F0\\/)>7?":NV7<V&Q"XN]?1(N=O(F);QPXT\AWY7C
M>ZD-B>M&][K&WM>6O;%LS272W,J)YY7C];8VU"T1.>R\]FXK#<Z[K;K2&V;7
MX"]MNXB6ZEWB_!)134&#_3; /%O;JOD(B=!!G>+_XGZ:H,%^NU *'21TT'GR
M?_%HL*"!\,*$%R8X7UA )T6#$O'M4SW"*JV DB'NV$Q!@TO ]R@V4\TL5W4[
M#BZE3]9<PD$KXN+WEJL9#><0M+%!*@N)5Z5IITAZ)@UOXSV^]T//#JE:M3>6
M4WID'BQ;H+*Z/+9PG7RG;XS&"\5W,O1DD?V]6R<=4GUM2(<4ZJ^EXD+=8*'^
M3H:>[%!!J#^A_H3Z*WH&(=3?J=!3N+W"[16*3]A]9ZCX9I7)*=1>X8.5V=:Y
M2C!:(R?#B:.5V3[(V JA_$$VENV2I:0YE]ET:OP OF#YVVH$.#8%&CLHKH7!
MA FV'PP>516EX7GOV2*=U GMX,A$B%_(='D,)H+JY5 HI%I(]3ZD6MG_/G/:
M&$S$BH54"ZD^.D_& [)"JH7]+62ZXQPI=NKZ,CW;-P=V1*)%!=^* ;=KS7F4
MR'\\'18%_)5=L7>?)T*B8&]SV!3EOT3YKX,>8XJ"O:)@[QFF;G6#FT69OT[+
MN2C8*^2\E7(N"O8*BUU8[*<LX6(G;U+"1<'>4O(M"O961?;=HV6[%RZQUY)N
M/A''7>=&]:H%K5M7,414[CT^#43-*%$SZCPY7U3N;0$-1.5>437SG/E?U*T[
M/@U$Y5ZA@\Z9_T7EWJ/30'AAP@L[3\X7%M#Q:2 J]^ZK<J_2'Q^N<F]L,E&Y
MMY.5'Y*5>\O1M%,D/9-*'O$21ONA9X=4;7M*&)54E\<6KI,O812OW"L47\?I
MF:S<NR?KI$.JKPUYD4+]M51<$A7<A/KK.#V3E7N%^A/J3ZB__#,(H?Y.A9["
M[15NKU!\PNX[0\4WJTQ.H?:V#U9^<34@%W[Q/[]XSL6#IFTN[Q:/9.D9Y':%
M93#PGT]A)8PK<TF3Z>^)O;X)4^GO<9A[6-@'PUK\^1Y&EZ3_\0?\&S&6]]97
MS?5LW7VY(PO\KTZ<CV3N\F_AKW_I[J-NWIKDWT2SOQ'W6K/M%V"'JS7PI2MY
MIN[^(*N_OO*<Y2MI <N%V>@7B]GP]ROG=C50/I(%F+_3W[\")[Y\U>P_B?L9
M>-KY2M9S8K^2EF2AKS7#^>NKB\&K]\I(EN5PV4U 67#A5XN%M_8,S27+WTR;
M+*P'$ZB[_)ME(/__J@$G-K'<G\ZEJ1M_?>7:'GGURWO*$+6A^V(YSC&A^ZSI
M]C\UPR/'XX@ A 2YDZ(2,,>!X,V?__UA97*46-&U96\L&YCJ@Y7'! <0GZ-!
MME-T]@A9,;%I ( :0E!Q]L-N-G(<R,-L*@<0BZUUI>#Y #+0&!B%&+X98D;W
M@X9DH1Q@NQ3_837_."G&<>@.:(P=8#,IN-AM+C[ =K)7V(IM*/ODA8C8-;0!
M-0'M3ED\\'XUFR06E>:^[9--=XK0L0'<*4?[!["8,#4'1PT9J0?$@7E_&@-V
M4M2M4F;J7JRX0TA3T24?)SBP9^B*R=&>N2)F#C8E=@W!O'MW.JA\SA*K2O?X
M$FL:=C9P5VRYQX@\[!&R8C*Y5T[80\"N$7C;%+!3X@M*PJZ.Y<E^]L0#"-[6
MVHX3VV@,C$(BU11!X]M90_)3%K@"7M5!A466D_)?R%7LL&%9>,E',2SW#5TQ
MB=LS5^S#L&P*YG89EHJ<4#"Y;NIA[,O#"&F9=1])4@\ 8D%Q/0"3[$=F&P2\
MG."&N2' !<C8SC?+)<X72S,Q->2S;FKF E[^018$AHPFA<37,/W]LVVME;]K
M)D:1[JWPJ.,]S4_"5V-),#P!:"S+D?2CA648VL8AEY+_Z9W$<GHN#+)R+R7-
M<ZW@*YME#='O>,H0'97/,)5E_NV"&(:ST7 A_+?H+SQ-*?Y+[+)RYDWD AE.
M$[GQN^*2@N-'TXX60&IB'S2IL& 69MON[BMA#3L8&IC"IX>ZOZ2S/5,' ')<
MVS(?,A/..!+GAK;X,S;4+#822"S5,=)V!EI\@AW312:8QB88*+U=0\=+MG8-
MT9DK1TU8;NFY8E6 T3-J-;K6)L+.+41RQ01FH6?:S/Z^9@FI6T85G!HVT,2K
MHPP*UPT7YDE]/9HIR*,N"W)Q9GT# +J/EN=HYM)Y6R<WO5Z_RGK<VZF;'S^L
M%\U 9U.R [?K\#= B_>R._>+->6T2"?*%59&KM*;3,8Y6N+P#!NW>(_-JH=M
M<"-DN!(RE?YPE"'$K"CA!4:3J#?Q;&N;CMW3K8ST(A4)&C,#BI<E+6/"=HK)
M?[6>B&UB\)?&6FUMX4HA#0;@N^J&09;-:=OB..],H]N#M+ ON\F?@"Y0Y88T
M<&V>2^SOY\5R9RZ'>]FHNRZ:PTG.%7+AI1]L=_;,'?MSHW4<CACK[I"7L??R
M*.TX<CAM!5?5#Q%QAM-@=*%O#DP&$0])CW6.!K4,K?0>",#S)7L@%&X)C(:8
ME#Y1^T6I'&W\=+8"1RB5XR1M+*BE5J=PI^C;5 "XQ:14:M"R^[JU-YDU>(Y4
M*J)2".FG9NZU6!"$3NL@*?-LQB0QSS=6-QYDQ]'K5GLLG=$?7@A\^FF[ET$:
M2OAHG1)'D\F87E3(&OM]Y9D+W,.,WGGX0*-RUSQF%TY1KHY5XH*C'+N$D3G%
M^P9 V7'7<CB9%(8E!LQO/%[I/UJ5[CON^%2<9L>JP1>+K3IGE@0-OMO6AMCN
MRW=#,UV0$+P\L\&P[CG>=,ER2>,7!4(#K%K"J90Z<B.JOD/)IZV+JR7WY@AI
M*N6PMS3W55R6:0>B\_+C#W]9IHA.JNCSB=LS0A.)ZS2=N4Z3:@--^[/1?FR@
MV,CG9@-%D>5K$Z:!HNHC;.$\R;^,LZ^HCU0 'VD(+QX7J'CIIOHQD](OR,]U
MLGZDU.F:NC+5B@C.%VV.=<(L^T4BON>81;"]YB14PG6G4+W?I'\5K8P=EL@^
MN+BMH4FU)Q_Q)D\1G"<S?SM_!B,D7DC\4<]<1^/17HP-M:^6-S;*W0"24B<[
MM;26V]5*7Q )S$(P@-<;#XS,W6;'P8[+RV&^\^HZ#4M%=,J>&+2M:D55R]U'
M."1?5BN'TRF.%'(KY+::.3#),09$W.'8<0>B.>31,I:2OM[8UA.A12*;4K1M
MR#H_*;_G-"X""(\I+H2#0;D; "(^TGD1$%JI=2016BGI<.7$;0]KN&5=3:)\
M4=M@*THJ$-IQ<"0*7 0L=2E=R'T5OSSHF6CC[MS.(]/*4G *&T8!3V\G BOK
MD?:ID1JYBO6##$7ME)-D.B&U0FH/(+6'#\'X^WGV->/N6,/EK*Q[R]4,:<-O
M#] CF2(G,4?W"MN&]7T=FPNO()G/,1Z(?(X6,*:07B&]Y0]C>K-Q6>DM9@W,
M^H.&ZHUD._6Q.=IOPI8]B7&<2TD+NZA)2[*QR4+77-TRLVA6R21N=]RS8U3>
M<\V$UER?*4.6KJO)-TIO-)&S,^8/$ND0<M 2.1!4.2Y5"M4 X70YYT)RH+74
MP;B4UBIDVZER7RUIVU4-\\2G.JE,F^^I(9Z>9)*<.$^CIZCM*;]4CLS'UZ+E
M*-WX=8/CDK. #UV*GEU7LTI/+NU#[R&ZDX?SK68&G;="6B(+0K4)U7;"JFW2
M>!VYW66Q$N7BPHO0P:._VI93KZI:M&9<U@3OZ\&PL[#8>%0*!G9%"S!VS2]H
M-8<.=1)"LF.:]S':U(!I%WHFH_(P^3P6Y+#?1%+8ZV)I,(A7@LN>)&3@>@#M
M0)&JCBL#E"F%M7EI/(A#E3_3%NFJ [:+H6;C6H!=A7'XCY$P/'PV"'Z $:[6
MENWJ_Z7?9XY>I]3E:!(O!]D43,F*C8=8ZRYRJ0D^VM=:P[JFGW6 EGS1G\CR
MQG0U\T&'S>O*<8CKW,?JF9Y#W<8@ )09W2E@!H\FS3<!'XS[HU%@,@5)M[,#
M.RN%[-NVQ:T5):/,4<%R9U6LV7V4B-I=$JG96HS;)G SI1@KU5D[&2)DHN4H
M=1J+ZJF.H/]4"C8*C;5#6#Z3N>UI]HND#(JJD--'R@EH$#;/]MVBB3!TA-JH
M+R&G4NIUKSID_^5?MY,DL^Y,%'2WI,3(%5RQTW/$&KLRE4!J8:7?S=.VF%97
M$&E,LR>U.M7EH6Y/:O50=V<K^,):/8L4$8W?D:R>E/%WLGICMDI=CNXD0PLU
M(-1 /35P' NFN,U2N+ZWT"-"CYR/'LG*%TY5)"GIPA6T2U>(E/12,H][JF:H
M%78\.I7V]-VS%X^:0Y:@O1>/)O#<PTN6NMUK]E]7V/'(667E8D:=R.G*]Q_*
MX5M5>XJ<D^FUYQ36KC#QP6]N=P4Q0KI;+MU#(=U"ND]!NO-,^8.;[AW2 9R[
M55D9OBMAJ%9R#XI?;RZ3(-8I(;@Q+S:VM2".(]G$(1IX"_2:WY(\$<-JL)E7
MJ:OD#4?&6J6'F[0!A YH63)$]WA-H.#LQ4WIC7.M;L%G @6E47 (^_<$9?&0
MYJ^(CM^8+C$,LG"]2"73IMW"UB4==LBC/XW^#"+2EQ2\:::](0)9)\[V@@RM
M((/0/D+[G"';"S*TI 2B. =I4$>)TX]J2&8M+!:6<[A#CB)YEQW!=3LZ!9V[
MHL"4J&QE(>*W#<1OFY39,\3..;L:ZK G"^D4TGF\@Y="XBE,\7V9XJFWJ5GG
MU12Y;/"T1HI/MK?[U2TQY;$)3:P'C18ILE9/_[;-I=Y]R2U.\I.^X]8-XL1N
M<,6I<VH7PDO:1[W).*5ZQ8&[10IY:9F\".*TF#A"F64HL^%QSI6$I+154@1Q
M6D&<(M?J??((/[@9]5:L]^JD2B?VK/:K3 9C+;IBCC"?[=0]X; FN*31HN#U
M.W6UO'--@K#="8:6(VRM"XLM)&%,_R9H>,YG!LJL-U0&AS@SJ"M!W;1.6B@*
M0IL);7:BV@Q/0+,M1Z'-A#83VNR8)"SB' =$;,8[/D$M5\,W3FL^6*'9TWLI
MUBXJY[W='<ID-=[@Z_>@C-Q]4$7N*RW+OMWK39'CO;]V =(HW ,*MS+X3.9E
MX1X>$^YAO,E8'MP_G4M3-_[ZRK4]\NJ71J$8):A^@]W)L#;(#UX:Y,I<?@P+
M@V1"U"1,XP1%"\*4:-(V+D_<!M<P25"W#7B=;M$ZO KK]Z1+1^:T/"J;!'RV
MQ1#= %R1M[B@$X#O[,FJ5 &O.;0J<7[8@F\HEX:O,>#R6T?N"ZY(!\IHI\DZ
M1)Z,)T5AS9B]#-4K+& G'PP+(_M("\CGE2; CP*??.L;<3_]7!@>^@6_6M;R
M63>,NG*7@+G(E%M(]@UA*\\0_NRYGDVBJ_WT<T-,AXAVJ!5.TE)=^NFI.N[_
M!@-,^F3B^B6_UY24VF*J:LJHJ'Q7$"E9D8CQKOST\6E%'HJWU-E+V9_8 7IQ
MN>^4U(.>G^TA*?RT+J ?, ):N9QN@[JA(]JA;'[U0"U9VV\/E\DKJI2NB8 J
MY^):V W";FB/9E!ZDX%Z ,T@S VJ&!1A;ARIK8$P'=JM((3IP#1$'JZ%Z2!,
MA_/3#,)TH(JA9BJP,!V$Z7 $!9%G\.[5=$"Z)>\!E3 <.J4=[A^)3;252^P2
MZ6>[$=K&BY3=(%]C9DH+KTL*HRA7Y\D]93PNN547NR4Y2-Z1K+C-\W_4I&:4
M8C.5UIG=TIA8\K,99;GC:G.+<O"C9.V,*CWR\5,[L_+'VV1M1".?HD*N<HVR
M>&I^$QE)Q;.W4X;Z!J/</Q/CB7R%Y3W62N(<J,7SRW9#4B)[.F4TS,BY?[9J
M+$>9T/5470X'H%0:;=8PCS8A1UX)@E J>3%]G,^69Q]W)0A!+8FA@\"S]9:A
MU%T&/%MK&5?H[S6Q%AD,UAJ+B<%10N:_$;<.U#/0ZD6AAJFVQ3B\7'6U6-@>
M67[1M;ENZ*Y.G'/,&-T9<BE@;D[DQB->DH+C1PV"!=A-Q-ZCQ<$GV.'/%PR[
MMBV&HH26/PP-O.+32-V?B7@$B@&0CFM;YD,1DW$:LQC]_-^0ZI@('/R!HKYM
M3L8G.TS75-?:5/"_6RA*0HS:2JV]BE%*Q=<28E3XJ$#L6Q7VK3HB,#HU$2C.
M]&\ :/?1\AS-7#IO6W X7HG+.Q7RX]8[\. :_9'<2N_BF/SX$=5RFN7L"B6-
M<W)J#LZ^<0OSV(R[K_P.(=$'N**C[CHVW@>^.R3W2BNNZ%0UBCLE ('%8.BF
MOM ,"8PU":;V5MK"]6R\ TQ8;-,I1Q"1B[LOI)31#B>H'":C1A.[&C,(SHL)
MSUPR#["SGZ#HCC-OF(L00-,;^L:V5L1Q=,ODF_K",AW/<'%'AYF?]$7NCBZ<
MB<-[6>?LZN<EB@I77[CZ;;CC(MSV'3*<DULH7/;&=G@LD6H_$1C0EFP"3KHI
M62O)MEXT _-U&E*CPA403GIU'AT,LHM)"3==N.G"36^Q\')BJ+(R?"<<]GUO
MYQ_)BM@V>.R8?T4]=8-H#I$,B[5OMSW-Z/GY6=(&<XYSV[<+UT X[@<U^K.O
MM0O'73CNPG%OOPQGEV(3;GMC^_RU93X1V+SQ2LS&]C=]Q\5+-<^:;6LPDL&O
MW;RTY(CS7/P$X<,WYP8(7U[(J/#EVR+$XY2+)<*#;W9GOW4?FZHVM:/61B?J
M39V _FDO&<XZU##+3/T3H8;397FA>5I2[4Z$47;HIS*9R4U7]ZP20"E& Q#+
M<7!_%W@&&.A2NI#[*GYY0$':P\DQ$Q4F7E'9Z&!S]H-XHCOQ=7HJH'CK,1'X
M$.)YY)A((?EL; \_,?G=?T'^XEMSI^(?9U1 MAL!V'+D.[$ZL>(L)_5&]2BM
M4M?QDH;.+'PB%)=07"T(NYRD9AO+V6'A H9>7D7KW?50_2*O3S]M]Y(_?!VI
MOG3-\S:K5W<=\RK!.V8(ZAG7@$2)03+9JC/KU\0N LHV++S"Q)6Y_!JM+\%+
MYSKU,349;4-7;-)4*M:'=P<^Q[,FX?T>N? +KU\'UWWO^&W?^@CVBR-7F?;]
M7@#>Q;&\+G)-@/F-J\^6_8/>M[I=_?!O6]5'ZF 088/=,R6$JQYH6^C[Z5R:
MNO'75RY@ZM4OR0K6?JKZ#]S,X+^ZVP!/*?'JX9ES- +,#GY1B\,24""2U_?=
M3^N[PZR^?[&D/G_K>*F"JRUZ[&7:77IJ$C)HV6D39=UIJL3VGMH &\U&,=+E
M3Y3DI>I@[5) ):&*R/43,;V*==>7^M.V]13:;N#LT*^W[#?_AU[XD=MQ_I\I
MMMQ.W_GS[;?[B[N;__MTR5Z@?W^^^GKSY=^7-8'Y>O7CUYMOE^K0C[;!!'%+
M<IYI4D; DJ-O?;N]_Q0ZA.-^Q#D,/G'J;)N=\[@!2B&P?_$_'AHO."[B)8X2
MO31*?NO?]:5?+1!\<XWR\+>_W4D?KGY\O)) ';@V&"G;F-!+8&*+I^HX&U'?
MX@_/<?75B]\[@ U/O:O*_L:-*=V1C9LHYPRR-^I%\*(]:^ -+B60=PDM9,U\
MD30JPX@MR;4DQ]O@72[ZA+9\TLP%/+X$OC*L#46RM8(WUI9-)/!-R<+%SA9X
M.PR4$1#"T0Q)-U>&1\S_:N#W+18Z^*(PKK[>V$ IR2&:$]1^@?F79*TO(J]L
M;++10'F;8 OUI5M3(MKB$2?]JKU$UC6B[__=,UXD9=J34,?U^%<PG\J^@G]'
M%TK+!L-J=!/@T:2OUE)?@5&+'@).X/,,^*_N8X@S-L;"6L]A)4N^:&E.L& -
MKLM<V/1>'#X%?JY'<"S\@_S4'5K6YK4R#"$'WC%PP@#G\Q=XH#_9?@)7 Q,
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M&US*,)T/^K-P$54!>W^(]8UVK&^4L;Y!X^OST^YXB)QVWOY&=LAN!?+(O!C
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MV#KH,KP'H*E_>#M+),'0<S)8L&>X_N%7]'#$)S3LLI8_/$<HK6./!+PR-F@
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M>V/1%DOP11Q[W$8P&!Z#J2*MG&+KBGX?7#1OP;7N0VQ>BZYL7E^ W1XHVY_
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MG#;*C="&W=:&HHU<N]K(I=W>K''#;/OZ7N+QV-C^J!\]<LVXI\:MNNEHEM/
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M?CHC0%"&<TY?])7>>*SVE$F=CL^"PR95%WL6'*:J2D\>#QOGL(237PKM)Y_
MVP[!2%K!)6G4X9V[3K)?.VB7C 'LB7:=56R#:6\VS.L"WM 1\"'T6H?\_78(
MAU!LW55LR7" 4&P)Q3;KS;([RA<)!X0M9_"O8Y0!+5#N,USP'>!07^D+#4O+
MVM:3[O@5G;%69VX556(327,D5L_3R:[FV<Z%(V2T'OE'7F^8EI1C)<JEH)2L
M\HX628Y4-V;9#:$2O]Z-)*P?[!JL#+A?Y1C$&\1YO<&((1877GAKS]#<: %D
MA]:<#:LOL0+;+^'O6!295DJ%'W(@_$!+"B>_O<J%VXJ7BNY)FDN+>YNFIQF1
M.MJ\SO=KM3\>#I5Q6*J\AZRA+9$.,.@*JU5CJ6(ZN+,Q=*RMS?Z*+!>0HVUT
M%P3[O[0*%7S%JV%C^>B^=(=%H],PQ?#LH^.9-C0!)6%*2^W%8=6=UX@$SM81
M9,&ZL-,$K$Y::W]8MNZ^^$_!/V:T-',YTE/0-0]4*,"ZT SCA96NUF+5PVEQ
MZ;X4\*"D+?CZ$&NVM6:UP#F:@\+6N);HDGO2\R.A=:AA4M-RL26' 518]J0Y
M66%9]2CC8('C/3 )KZT]1ZCT)?[J0]$O*36\HC4M<;U$1DIP"EL[KC,J6FF,
MT:\GOFQ%Q, :X3Z&J5Y,Y<'8\K%<M.8\(AK@8UBCNQP <\TAE%XX*W G;+4@
M?ZSV]\;668WS<D.BN X&?7FDS,;1U@(W;!+*D?132DL!GZ!8"QT7%W"4'M9@
M1U+@Z]K<>LK U!M-NMN0A0Y+\3G_;2\IF245;5C7?4Y ;E-T;AEUN@.69E1J
MB'U)6\-& .S\'U2O?'['6\/<EQ+V_PCF:(P/6*'Y-_/(V-A/ /2/387.7/X2
MD6!I[F'/.LK9(<)P+:B22T[,VC&@1LV2)5H]/R'N 2A+S_9;)G!-#7C4+20@
MJY&/"H<5+4\IX_Z,6GVG;9-?(9[A+J\B>E2-X[.PRP?@!\O"7;&".?%ZTA^$
M+X!!;:#4X2SPB[+U"VZK#D@;8A@VH3>O%;4OCZ.\AV\J2G\RC&[?T9=Z/J(K
M[X9O^])MA:KZ3"F4PY'?/\$F'/T14B18*D'B\6S<D]4I'4$=#7K3D1)1W'$&
MB**G!7T62IF^.[;$#ZVW:,O;KG1#$L9K82IWRG;=FY6:B:/#V:?Y9#J ?9H/
M0"7[= ?K==0^W:$V#VJ?MLT2S<7-/BW1'1,+2S3;$BU@!H"].<ZT1$<%+-%1
M?S+=LD1'_>%XIR4ZG YZ@^DDHKAJ;'8F[Z&VC&YER'R-FJWY0%0W6T>S64\=
MS9C9.A[U!D/Y',W6?)V79[8V:*F6-3P'\G XVZOA"0M9193G2\;6V22C[Z#$
MMD93Y&%/'H\RN+9K?!J<+%P'W24SCA:N&']8&[_+8[BM]R2B8<='JA=9P\$B
M&-6I06V9Y/\%W4&5=\!'T3_A5^ B;_X'[>5H<7[#[HJ<XUP]^OA2-SS>Z=)R
MR8*U6:1DRR"7]"F$/.Y$),B>VA8SV4"2/LG4,S5%V%-1/4AQPD6-NCW:!D1E
M0:4SVN 3A8/Z,6#(* E#!CM'TXZ/C :.9A#_<ZS=:M!=, 8A&E#>'.:$=X R
MM#$FGJ4M"=/ID6_10 HWO&?:VQ&].,?Q6W;:A$1@H]Q:/@B299B%EK6_WX3]
M6A]LRT'+Q5H0$O5A0N!>#^2^G+*M ]>\42,8I<XB5; ;VEM3DY[!-T67%KL!
M(J.E^+*[7=@HAV0OG7<F146*_5@?D L,S:$V(AYA.5'F#CD2/!G=Z:RJ2;1N
M2=$U,?<)\0T;2\2;[\%6X#@6%W6>2H!X]#8)08A:S4 TN@_0>,$"!G.8BP6F
MK<T:K,Z)258Z=:6L9Y/3>H=8(6OF,C<,M(RPY4C^2R"XGOT$.R. 1O?Z%W8*
M%\@S[9AKH_)#IG)UJI6HL^$XA+;[W?,91*ZK%0KGFVSU7,L8 "]V8W@.7?*6
ML=L+;!KN<J%B@^5I@(LW&3&:M]):-SVFH?AR.&\E'6CJ$SWIEN< RM%[ \\(
M&W#[G7V#]J >P);>8+G"&<>^?79!SX;IN<-AKQ7W*$1/<YN,ZK0_E<?*(,-.
MC](@-T@!NS"UKY99O@6V5)][T2!5AFM!HV'40%QH#C/Q:?3!W[O]AN$:C]*R
MS5PW'6^%RIA&T"Q<SEIW.3-%",0)B&!A%WJPWL ]LMDNRIJ/!Q,98#I0'?JD
MZ0;E->3I[96 ><8VX20-@D<)]8M@B!<D (_(1)8?&8-BS]I8=A13/CY1J7,2
M.NPEBB<V$C6X4LC>ES[[78FC_(LDS6.H6.]WQ(M-UIINXBC;B&%;3&+[R\5'
M/@_LW"8!1Q2EO7B4EG6(=]S=IO<C,98G;37]DYJ*Q?*^2@47XIX-6*2PHEA$
MM8S;$W<$MU1>;UN']E+3$XJDNH2,&-*8\PV(BF4OV7G.BN]!N#(63HZ9]71$
MCCMP9'\N")  ),_"+>=9=W PT#<\(&%HSPS@1VWI6^\TJ=.AWVZL9R1!#'V9
M3P5YBR$J.1P[3UIR]XY>W*T@H!81#UPE;M&?G<B$;C@Z2\2G>%8 Y@K4J15,
M@=OM2J>N\A-(*R"9BF-PY!<;/),["IA'*3.AEO2#6TOBZ \FC5B560Z&MZWM
M'1?Q$H:A*EO:V<0HB,8R."Q@DK03A_G6;1X.MW1?-*I901+<9RNY;"=OW9C[
M#M_ \M<4D?0@V</M=+.Q=#Q7D1:/.EF!;B$+CT9N+;1L0FSR_;6S6]-W'FR#
ME7T/TK(S=JH[*^1X7SVH<D\9#!/<74'2F$6#NT D$(,*E_HNM2;.9\^TB;>W
MNNN 3=-VO ]2L G5B0KU)!.,7<;/P( V/3>&WS4\. \D'W9',$E1%C0:)'6X
M"0XS@CT9'C+B@C'AGJ=%F/Y[- BC>>ZC9>O_I;#R VO8]D(DAND9X:\1P0'\
M$;*FP;+ 1J37*O$K=GKH ^XBK _Z@ITX(<"/^J:[MMP/6/EZDQ, NR]PTHJN
M,$,AJFZJ!S%*RR*AV\DO#CU-M?U#7->V#*118F2?0YD'$VISH*AGL&!X;&C=
M/XZT3.,EXMML#1C9&9B;IF\T=N2\0%,-N?RE5^R$&46!L3'//XI.%(G1H1F&
M(=HW2QK5<]_ZUF%Z.,^DY4PT)DD&3?]Q'@FX02U@L^]7OWZZ^/#CT]4_+JX^
MWW_Z<:D]65AZ)<%J$OO0'^$M*LJ:-]\^?OIV?WDA]]51DA7G,9[$G(:TVTBX
MBLL)#%M@":D7!W,_2=O7E_3@TSP=TFNVP]\AU;/>Z)!6^+3;Y: Z-/I[<&*#
M83+PS!.*VK?A4$*#@UE6Z71;Y+<"53'?;F,Y#@:O,;S ]R7JO@1N%36:(D>"
M:<(5)CVACJ>!;1K06VNNBY.RY08[ 8]_L*VI+_TM*Z:0,-_0$*-.7ACEA&?]
M.>"!.?N=>HGSEX3'5706/_A&-\SH$3P-/=)@VUI[P;F" !O++P1&HBXA_I?;
MPVFX2LD4 R+K+F+16=B$X=JC_NO*,U/C6HA<FHY(8V^P&_# FHZG!\$A?20C
M*1[:Y4E7<YVQ4&0OCZ[*0OHM*8YC"/-,?MI!LN(%_ODG8B)FJN$Y#(WX+)D+
MC8O"".02"4"/9?T4I<PLHFD/UQLN#?UT%JS:G5;0,<61/"7+XJ@GR_!,%U,E
M:%P]_#/K2*T7#XIB<)'' X.CM@MOLZ4WDL$,QF_S=/'!:"^-DO (=D1F^=%7
M]H+"Z.0SF"FP?EOZ4T?%DAO8C0=Z-!K_I[$B%IC9/N5-L68BKJT#>'/0"O$M
M+XT97F"P_XG,C+(9O:4:.>CG@:&6Y8UDV1BE\Y[\<#&*7H8&P(Q#^XFG#879
MU@4NZ-(;RS&4^+?%93ER.WT!XV@;AUQ*_J=W$KO]?6&0E7M)DSV"KVQVP9Q^
MQZ^7TU'Y#%-9YM\NB(&=GA= 8/Y;]!=^BSW^2Z*<6D8!-H5=KD]60RO4X$;^
M2^2./!\(K7*77""L])+^LZUM8F_4*/%4O&3 82LYJF7Q@&\T6IGN^*VZ0>59
MYD/YT@+QQMW^[BK!IKIMH,?G2!:Y.R,TH;E1%#T5B\R4YNF"+)TAVJ7*MPGI
M[B;;"NDN*MTIE:,+2W>APJNS?KSB3Y%>"I3GLPH<1FT!-G@CEL#Q2R'%]565
M2L=Y>(MIEP)X*ZQ;3AQO)='6M$;N),[.GM>*E:16^H,"'E&)_E8)-VG0F)MT
M'+S#*A_(Q=PFVI\7-)@!_BMUV!NJ+G:=E]0<!NW*E1^KWEM!+4N]XF+3V4)Q
MV<0+#XB'[[(HU"1Y2E.GEILB6*E;5:*+*7RYD,(OH-OE)G7[*:KVVPT[UO%K
M0IC+@AJ]<JE<M2Q]]NJ\MT+B<IH!CD<]99S9A*V)2%(1$NPEDB38HS9[#.1A
M;SK*; .S9_U;U>!N5"F?I%:^BIU>KCS7L_$"A&:RPTF>S*0]:S8O_WIHJ[M1
MP3Q%R53506^0W6YN;P;WWK6YX*+V^VZ%E/R@GU#Q9;;IF$)G(S457#Y)A7X=
MEFK)RVD-<I6RE7H39G<!@I6(- K!JVQ\%R!$3=-;,,@A0B'#H=*39WG]%RJK
MZ0EM?+%;35<TQMGPC>GN8Q\[U(MR1_,5-9N:VPT;<&W+GBA _C*"?OJ2KLB]
MF9(=\6S6YRI)J;I1F@9->\%7!^"K8K&<<7]2,I:>T<PW%L/AHW;:Z&^(= TT
M_,WJLG7@!FEJ60H+(S!V'B;/9KWAJ/&NJ:7)<H#$3P6S_3,[P5&;)8]+0UZ,
M\>@Q&/,,^'(VF?1F:HUSVLSF<+\L]2?\_#^_>,[%@Z9M+N\B5VL^T3CU-\LE
M'W4'2U5Z-KF'97XPX)GWC-,DZ7_\5[_[T1 ZAE^PZX?FDN_$_HAW-^PK=D/(
M,W7W!UG]]97G+.$W=K/D%;W+#,/37Q;*</#[9]M:*W_73,S.OK<&RD>RP(^_
M1Q):XI-^I=FPO[,+^==IO[W"VV/Z6C.<O[X:O7K/>S"$ZR^\B/<Y:X='[W!-
M[$GG=A7\')0QNS&O>$VT]B##KQN7A8TRRXJC)_@]/F!L[5M+'K(E#SZ3.5MS
M\+&I-5_ HB<#&?\7KCD#UO<);J^TI!%=DD^[24C&2:-+4JHM*9WW'9_L'_UK
ME\4X=O_D4U^]ITV%=DGOU@KR9+?NLO=/8EPVMDVJN6SZ[ W-&_E(&PI\ITT$
MZ!O.55A5-:*A,I8\W@NE?V<!G0PDW'S[_.K]>#:6U6EB\RJRI.W-JSEL3+*Q
MX5/FNZ8O@T7N$T'J:# =*541M,_-?5IS/_MP2IO[(9#1LLU]5E=G[%PSW0G'
MA]O<1W)=S5]L2:,F-O<],/'^*8H;'[9N:8:%]VG\'( 7&#*&S1H_;".XC13R
MV+';C93?KP#1C9.:[E[#Z6 PG60M< O6/9DW(W4OC%U@]Q[-9NIHUB[S9C38
M@WE3%4'J>#08RBTT;T;#FCOZ52'SAK;QJ6W>-,<;H[J2DKKL HR@R$-Y/&I$
M4C(!O2?V&E1=V%TGOOI,&^[5>]%O1_3;$?UV6M1O)U04Q:4]H3,IC$S#?$>L
M^U96P?UA3,VFPP1Q,V%-"^$SKD!5=L-K.?E(2 $NWQ^:9.Z!7W537WOK^B&0
MI'/$8KE1[ZCDBG:=:D0:'K$?:">-]M&\ -3[7.JTTE*;"&,<?*FS2DLM9-_Q
M_B^-+I7UGOC!"N7%ES*6JQJMK]Z+KA6B:X7H6B&Z5HBN%1WN6I&UT43WC/=Y
MFTOI\.%82>R>>[$,6:Q(5@:91Z8IL<3<7;3\0M4&%EHL:EISH9%@2[:MH*HY
MID(R6//^$%6_HRY=Z@*"A3[]M-W+N\4C 1G)<P7N42$%Z4Z%@STT]6Y'9=M8
M^5I>XS^[VBU/A#ML&5NPLP=;%U=*7#"D*7ZI@S68W9Z>;3@XQ-0MN DR&59<
MZ%E4@)S%N)?I/9;]*-'T1[_E#5ENYU6F5H:L>G/S;-BQZD(%.\(WN55[&JU#
MK(S[515'B9("+>#'83^'(V%\V#;]A:K%^/3<V/0;<:,\NM!L^X4SJ/\=8,PC
M13FV,LN.^M.S8-D)JR$J6+8RRT:"HE$VW00!TNJ[?:'[>M-:93EB5G-TJ#96
M4<H4L@;MI?/$0=RRWP<.CBSNG>*7T\'51."JLIE<!EMGA2]F_3"+*7X9-,,0
MCV'RQ(V:XF9,O&/%&QW/$2W/ 9?0>9M].[TA@UHP=V7F3ICL@KGWRMR%;'"Y
MKP#M=MO@)6HNQ0SSZ/AM;^10Y^8Y.W62KNJHGQ(%: ;5<+RG>CAQ&WPO).]L
M28+9L#>;IO1+VT_EVI;Q145P!%\TS1<) [T4*3JSS=9O8+0#BPE+<$]8;.'N
M]CJ+3YM$[XC9@X=DTDYI#+4W&\X.9%\<AM./2HHT;=%--)ZKPA@K!]_5.J8P
M)H/,LOS[=QD;]@X[+ W<.?S0?&RJ87N_XJG+/LC86:F;#"<]>3;*L>R[1^W*
M?MS)4WNDRKW9)+-K51UJU_+9.H'XRB;8'JRMTSD1K^='=8)QZDBL,NXI2IYZ
M;C7["7D].7FMY\9T@G%JR>NDIRHY<0]Q]-4.[^;ZU(^^VI#T*@[:,MEP"I:X
MG'NB(OAP/_=7!!]&7Q[+HYXBU_0(6WVTUQV[LZWRT^V#@0;/65M "W'LN,/^
MGO6FV=U]NWEB)K29T&:GJ<W$F>B.,U%P$F1Y#]$$K+8=FRG$9_G^<[$-*3;R
M#AIV.(S00&^Y HY:"60V4%0@O678'OO:Q0,$93CG]$5?Z8W':D^9*)E,)CBL
MK.LO."S.8:JJ].1QXVT1DTY^*;2?? )O.P0C:067I%&'=^XZR7[MH%TR!K G
MVG56L0VFO=DP>]]L[ CX$'JM0_Y^.X1#*+;N*K9D.$ HMH1BF_5FHW&=<$#8
M+_A_?JE6+K- F=BKH #?SN*I@UCQU*(MM';66*?E4F?#V32SHU@2TORF:N6K
MPAYY8<DZL'EUX['.5VZ_AWTM1G[U7IUEMSFB@%4J\'_<)4T&F9W-LJ%M5JR&
ME597K KQ9#B19Z,R<M6H8.US:2-5GDTRNS+L:$M76JKVM!)@066L*)D4XNS6
MO$CM<3T35<E4$[DRU:10C2JMKU@-\ZDJR^4VJT:%:I]+&\LC13Z84.UI)<B$
ML^DD4['O3:CVMQXUV4[I*$(U+K>^[?Z X[&J3)02DM.DW-2&7E45>=Q8\X("
M_%0#8N"9P70VS,1U ?:H*@4UH9Z!UU2-TZ7TQ@)!'X(?!%S!)[+\;-E^#[(]
M=A?([B00;SR 31N#KVSF2]/ON"?=>,.!W*-FA841DN>^A:[RR7^)1 /X0-@/
MRB47""H-1SS;VB;V1HW#K.+!D</FK*AE\8!O-'H&?_RB9%7+",=+E(' L7Y#
M Z6W'4G)J&[=F3.IQM"$2JDH>BJ&TTOS=$&6SCRG%M)]\FPKI+NH=*?DR!:6
M[D(I9K-^_&RCR*T1RO-9J1Q16X -WH@E</Q#G_HYG7EXBVF7 G@KK%M.'&\E
MT=:T1NXDSLZ>UXHEWRK]00&/J,1-WH2;-&C,33H.WF&5#^1B;A/MSPMMY6*9
M9NW) INKH7/4ZYQ^H+GMFO9SBT0M2[WB8M/9(_%LXG%1!!-F^*Y&QD-A\I2F
M3BTW1;!2M_)ABRE\N9#"+Z#;Y29U^RFJ]ML-1G(=27<<#W0Z]D0OIM$K)P6J
M9>FS5^>]%1*74_9@/.HIX\SKYDU$DHJ08"^1),$>M=EC( ][TU'FA;<]Z]^J
M!G>C2ODDM?+5DZ8;]'!K9=G2RG,]FT@/MF:ZM'<X^8^GNR^2]JS92^<H5G>C
M@GF*DJFJ@]X@^V+]W@SNO6MSP47M]]T**?E!K?Z<487.1FHJN'R2"OW:6WN&
MYNI/!!,<,H,I2_U)7Q(S3ZDW8787(%B)2*,0O,K&=P%"U#2]!8,<(A0R'"H]
M>99WTZ2RFI[0*SZ[U71%8YP-WYCN/O:Q0[TH-Z:I<4T,IC4UMQLVX-J6/5&
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M7_Y+;$O2'AYL\J"YP%.F:^NFHR]0)7FD+]VN$%R8C$/8DX8CM3>31PS^)^+
M=+TRL"IR?S0M".R@/Q@5!S9#H;24[2YD9O,EE44I9KL'B<M$""!T@RK%=!TJ
MFJ[E:@90@ERXVD_^R!N]3_I,*2WUU0IHBAIE3MQG%&_\^MI:;S3SA3'R5%4F
M[QP S5K\R6F*A,'GXJ1^B^1CCZ7QMK932.::PZK^6!X8T=9Z#1_9> O#<G",
M"$OUI_#&\Z,.*NK9\HQE1$/9,(?^!$/-7RB8#!KIT3) 8Z$J _XS#/Q)MP&!
M%_#A N8B+P'<=!A_=4L.NOL([OP2D%Z7ZXZZ,2'[4!5.ER*M-, !XPM8HK]^
M)N. &XH_)HT$]/TRAWZ4*[!8-I %$/9Z,%![LBS3KU^/L#$Y>+>XWVW(P@7R
M&"]]"8%)<G $C) "=2!A*@2A4%)@:+72\,E7;Z-Z)Z5: (C\+86\DS6H/5";
M-_JC&2,)>,&S)%=\#B9VV)8#W*BO-6IT4#6 $Z\LP[">F6)QO#6#[K*89%)3
M,H8P;I^/93GB^X-O;V@;!TQ9_],[B5GA%P99N9>2YKE6\)7-(L?T.V[CTU'Y
M#%-9YM\NB&$X&VT!L//?HK]P+R+^R^ZC\!F-6NP^"M]V4@+G9#SIJ^-(##PZ
M9/N=OXI>\9&SP +D#]3^9)B%?)@$&,;'_F!_YXX+ )O8>_0A^01Q]>6XMF4^
M9"JS6+ \.OPTQ@'_!DT4<L$GU$CAGZFJ:5M9Q"$ID[Z<*I0)#[B^2$8&;/UY
M7\<%4AGU!\-]H_Y49"_]>"I=FLKR@$(])LH'21Z@E \Y(<D#(:6SV2&7!]2^
M7)4%3D#X..*SD5X0WSO%K**&.T,A2RGQ4EC("NU8PHRL)#AIZ-B=79;884H@
MZF20E*YHR[',R2"C$,=4%*UN(*F853WHCQ-:JL897;:M'9NF[1M^N;.X'[KS
MY\7*)C3Z1FSBN)*MN23[>*Z;*18[+'I.8)8C>($A&0K&LZUMJIL@J6CHQMEM
MIAV23%/J3^6_-,\K)0SQ4J)9BTCMO8/16AE+4Z+-RMAIB9/2GTYRQ.F VV1F
MLG0SFV2GMLA//_%$@BSIP71CRHYCN&TBV_"VF&X.I>#AM 1YU)^-0\V.\6@G
MBW$:NL30S 99CUR'W"%/1=X:WB)/,Q=XW)=G!<7IH+ND<"8S=LHGR]!<W=#=
MEYS]\E2L7.%)-K!C3F;9AJ_P(H47*;S(PJ(T4[8DJ80.SQ1#X7T>94_]J#_I
M2V(NI1>=&,W7S&V;L O_LPD5T&!05GB<)R9APN,LH'6S!:@#U].^7_WZZ>+#
MCT]7_[BX^GS_Z<>E]F1A7ERYVP'TO@B]=!'V7E'>L9L9"VN](:;#FC';9&$]
MF(#%);V@YJ>'8WHW_)]E9_-\[!-*P9;2K9Z-]D NYC;1_KS JPQ+@)=A/_7=
M6B;0J#]-OT/J6IM*$NK7.HF5(+O@7S8EJ:EM?9*JMD%%>XP,[F$?R_3DZ-1X
M&O>H4:MUGTEN61/$]>R.)+=CY&U7]E[4OD(WR")RW91,2XG)=\NXD.^#)H2/
M^ZJZ3:;B J\V'/SMKLB721??@^,2<S<+D+%]2:L%Q*WCPC;JCX6P-25LA=/&
M2V^8PO ]VL8H3-%,42DN'&_H-6;+<S1SZ>14GS^:8!0Z;,X4C59L5@4"X44C
MG#^( ]X"5J4QE]*2/!'#VJR! QJ+>Q9!M]*?[)"NYN4(@QU[E"(Z? CBZQK:
MJ1 &A_W1H3'8<.@QD1$]&NX99=QJW3O*6FNA%D.2*B2SGF0.^@=AL\-)YECM
MO(';]02Q7XE);,V@F[:V7.NF#MZ'AM5>,O?M_[^]=V]N$]GVAO]_/@7EFEV5
M724K7(2$G(RK%,?.ZWF3.,?V[+/G_)/"J!6S!X$>0$Y\/OW3W8 $$DA<&FC0
MFJJ9D76ANU>OW[KUZK4Z[KU6M!!*^J7-BB*&?43XV;B*A@D?QZ([$E!3FXBG
M-4$S;HT3WOBXJB$$ J@M 531_N)2 $E'!5#.;E\RB<PU$%FAKR1QSS@3DE/A
M5;PQ#+C$\D'.]Y- #H1=>I&&')AQ._S7;Z'*Q,'D:A,#DZ[E3:Q5P*K*M)GH
M$RLB=M[>XY+3Y61^ HBK+FYB: #V65R-)I-B]F#QW-K.E6C>?CG92T!(M! 0
MUG8L[3;+*L-_D'H^R*(5DWTG484]69^=EC37287E3;4#AQ;_#LHT2T-I*RPQ
M%UBTFT50=#U6)S[\M4=^O)F?X+S@Z>MVK'CS7K'I%::S,Z>]+X:3L.I_SN+J
M;^?F"WG]_NW:._^AZZN+CZ9'RL2O772WN(J1XSX@Q!4FBO= >FM\(!3[IK^2
M@T/O$7/]!PO3Y))B11#>1\_;?C?^M)GKZO8/1'[[X77O<3-2')O^YU]DV?:/
M;W2%$MX2F^#K'BU^/S.DR>3[C>LLI3]TF^SMHZ-(>,/)R^]?]%_F<KW\0G?_
M^_5R93FO"#V07;NCFQ9\<G;Y31+_VBZ>Y60O&='AZYK,]&Y!/_5F:__9<2GC
MKFTSH$30ZN1LESK:]YEWM]C2Y!Y/SS4)>U(ZA!00YLC C&5YOY_=?KTYNY3E
MB3QA0)&L:;,B2["-WMT6E,&(1\DRW2%+-G/LDD8;J])884";K+G71YO_#F7&
M+! 9UV%'@&^T$<2&8FMOCIF7)=UD3+6A5 _-#JWI,DT*/1T?]JGPL/=1ZY4K
M3"Y7-_RU;CTB=RGOT$\3,X75(?$T_DN5/NZ0K]EUI)*2S0[>1CTK_D7;(\3Y
MD W[B6>78BV\EYPY:Q+]B_8-F=GSJ";$HT/>:E+6C51Y*JKL:)=W2<V3LD71
M2!LZ-4GC8R*3K= L/)\L&;1K^)64I<I?DCQA*$S9K2^#]K7RPBQJ?M4Q*5QZ
M98RMJT^DQ8]W:P?F/OWKXV%J9@J04OR\(TJ&&D-)DFMMZ:Y>93Q%HY+V170<
MZ2!+5J4=9DY%D45QET-K6,<E!]22XM2:;*DUR4TM55':HE8%CHY4W8:IZ9%<
M =''@,\8"L$\RV&O5*H3L3K[2?O,UP =ZU,<.R;"1M9N@-"8"B'=Y.I2(4=7
MR2YN6"N5*_(OIC+IU,</E3>S1NX+]@'2I_/5L8-.EG1DCT(D_CF)"7]U_+\0
M)E,45H^1P:O!I#Q7L20@HB N#!I93',D#!6BXX9OD>\Q\H3DOZ9?&J!;Z@IV
MS7#C&<W7%@HCQ7OCQFD_([TM3?_UD1QD;8X<DB31L@AR=DD/,H\43$E41<'N
M.3F1RBZB$AX>UE8=97NF?K3O270*N3D"52?=N<S&JOG+'A$DI08BM-P)JS9B
MR?EI=>JD KX"ONI<4\Y]+I8V.Y->]L%U?L;>'?5L%ZWRU2 B2WL_R^) (\%>
M4R3T.7(2I/_TB"(+P"'1;^DI4UYRY+K? .9QM]3-UFA**I93:\6>"9$@62H_
M1DZ )+,7W;1HXFI>JO2?)C=.K)(CC?(5TC)@S_?5G@<!>P0Y09+1=K^=!=AG
MT6_#("M8\!$]MADE134R2-B2$A8L?(B]09@20 >@ZR0G :E*@RZU5H<ZG.QT
M_\HJR9$3FL+.DTO MG>@#9RQP(&+>U\)MRJ+<$4. GM'N2V&L\B3%]Z](PTP
M%3!5\TS%@&C=I%HR%"<1H@7AN-U0' W ;0-RNZ&X;< M.RJ7^V@]$]Y2SY1M
M;@<B5TG$2CX%AT7"LDMX?- MW3:0H/O"'[J]UMW7+<6#@A4I+2<J%%9,T%H>
M3BLF-G%0$H5UZ\+I=# >C;*(7KP@6WXFS^\(=4,F #?FY<:\103EB3J(:I0!
M<S;)G!TG2C$1^%LF@]5%R +V4'=1GDUP21HJ\@%4LS*X4BL4EC"R.L7--#LB
M+4^3>97'\LJKASS]9J(-1N(XNQ54?60O$%%NFY7K:N=2T9CJ(3\&[,C.= *&
M/"W"M&-"%=(V>8VH'J)[-!0S R7L[*<4@[:3Q][%:!O=8SA@0K'P#$[8_\^F
M?2B/95$:O:LO$-AQ[[9)E__$^?&-/-"44:91#ZP(T2=>3">(/N4DN#94M?IM
MIY.,/=TX[@*9!Z-/;#P"\/=W2:\H U$Z%%0%M[9Y?_^4&?)-P)$0$.6('SM$
M&(@_\0QN21J.#IW+0P2J"C=?D1PIZZ 5!?&G>OA:&<@'&1N\6X@^-6="!>S(
MRH0"9CP-HD#\B6M42_)0%!NPG4XR D6:BYAVT,[060C?++VY9M-\U$$Y.5_D
MS7@R&$V9:<F>^M.U]RYNA/LA[EO_B3D X+0( Y&V'N*[@Q<4*=&PX,=:X(+T
M+Z>="!H4!NS]G5Q7XIF+B5:9.Y6P$*AHY@XA\!OP&P3&^"!*[X)<^9'&+EH5
MHZU,*=#OX%6L.L)'9*!DX5;E2'T$2*SBR@ _/3\2[O8UENLGC@::FGF& -P(
MX1X(]W03VM-A-JYK3:MJ+- CR!.N87_"N5+@3 -3 5-UFJF *!"A@7PB=O;O
MS//62S07')LTW<:OEYO<HB_(_8'<;&,-G-]:+&1Y*@TD,?.F&_AX$(IID!O'
M\@1S8V:=)>!&",5 **:;T);'0T4IIM[ACEM;92KA3E'>;.F10NPG,3M=&KQ0
MB/<T5\@NX$8V]A.PXFD0I1V[Z80C2\4(K@X+9JE .*K%VI3@Z4,>$&<J"THL
MY;3EY8$H*8RJ4P(WGA9A(/C$,[3'!^LK0>BI"B_74*42_/V<M)]( _5@]0OP
M;J' 4G,&E#8=3,5L"PJ8$>)/W)A.$'_*'7^:-I!#?9+Q)^:5*:&H#(\(DL?3
M@33*K)(/_C/;P *4$^.(]]^,1'4PG4R8'9 #_Y\682"PQC.\E=%P?*C=?0[S
M,#'2,R+S(06+)$SA%-N:V34\(3E484NST&9VNPY3F;HX&>3-'R'I!%B:OXV5
M0=<" KWSBHY5J3!@46!1'J)TG:=7%P)X66#OE>T&1:5JY]Y84:G47X:Q@R<+
MTRWVLTT!JCCO"V$1*M:1H?0 B#Q4#X5 YL[ZR4+MQ__Z&42717$PAAI#[88
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MISN3AW&<Y+\55CP-:7$. %_I"DTH!K"3.WJ7R:&<!'QXD)#E2=%&^G6/L,I
M.Y\J5MDY\0QT>D^4^H-_H LK>/+=L?I[XLDSO)JA'(A1@<</'G]_L-\3CY]O
MHP)B FDQ <=%>)558@(<I%R<4@2B@GAJ^0XPQ#W26GF+X^8#<KV,=_ AATXF
MNM(G.00Q'0YB.C4G9@C*I#L)1SF(%6 AP$\R^XZ1470*DJBHPW:4Z)5-&O[D
M".1<\ [SQ@L: LRK6@R=AGFUD(M\XB&7H.)0F(=Y(,3-LR%]DI&7XN?)_'DZ
M)Q-QR7O()(E32#>!\ L((PB[0-@%PBX0=NFF/P9A%PB[0-BE]S"'L$O1L$O?
M+G 7,Z\^H@7"?#0_=-T5KKW4*01.-BA17G]#4 'NL#0#O%XZX'5H5+B0TN0M
M4[B4PBKD!Y=16K^1"MXX7$/A'.UP_:2!0#Q</V%_>Q7\<O#+^10+X-*#2P\N
M?;<P"]$ /N^7YN]HU;74QU,06IQM'T0\(.+1M@G$&21.,[[2>XD&49V&HSKU
MIEIT*I&RX9S)$Q$\[:9(\BD/(,VB%;B"G5 W7/NIOMM-SBA_];0GX9C@[FF4
M%9D=E>F@&7R:Q@2C4V+^O)=^6BL0C^'1_.$,$J=I9_56DO73D(,X#,1ANBUP
M( X#<1C.#!&(P_ 'UWZJ[W;C,,JIQV&^N<Z+Z9F.C<=R!=,VG"42?/T7\EC[
M>>GVL#Q4#UG$<V?]9.VU^VXU)M,9.56K']/0OM47E.%/$A8#[J%R81"*:304
MTX(,JVAM@0SC0(95M^>Z+L/8!&/>^CK>I^AG3^[;Z&62,C=W7Q_/'V[_Y_HB
M,*7HWS>S+[>?_[J@$Z'?VB-"],%@^S(D1O3G.^'Q^M^/Y[//MY^^7OQG[?GF
MXO6=\&5V_^GV*QTKV/;@2W\^WCU\FUU=7QPA6FRVF&:Q<[-G)& ;;849U/8]
MP5D(/GYG'IZC$<M-T#T/X8]T^NE'9*#E$W*W4E"1!@*FN";H]IR\F P$W47D
MZPO'LIR?7E:)DAWJ4JHGYAR9T:(8@Q6&C:6O/+SYT:MW0L"DYT2B8,BO?6?S
M%N7.\+T0!/2IX0B:*(;O&LBR"&8PR,+/XI^$\$M^$G,7\EZ.2P7N1&1>FZY1
M[RJ'#.4N="UO2(X?C?<]HKF<;R/*"$H#3Q:Y=4I*SW<=^T<>N:DE?IN-Z7WD
M)L=@W8-6;B,>4?/& &1."3*3:I I>>FZ\WJEF)WW<=\\R:R#QN;R81;SJVD$
M]IU5.4^V6=[/S^UO;FUL%CIK#YMXWC^SPP1U!UDW>Y.X?9B?SSO%Y%^1+S@K
MY.H^)H!@.9XG&+KKOIXO'/>G[LZS ZI,XC79&KJ?,N4WUO'I'6**ZO:8($VN
MU* ^>7+-1\I D^7R0KH"O]9?5)4ORQ&0#<AN\N!@.AB-I +(+F414 RSM@>Z
MQLGWR$.Z:SS34-L<O2#+62VQG4CM8 ,;Q*;/ZICU,+W+R8W.B]-THE3$?P_B
M[LI 45,<W[+'+(5XKY&",!WC2( IP#0%IO)@.CEPR _N.TMB7^DKT\?K^5\T
M%]P,O5VS8=IQ*[\^]^?$+79YH,AC=NH:W'$ *@"5WWP6\+#S4_Q!MQ!)<UFL
M_;6+!-=YU2W?/)"\7*]S Q;[:5OLVD#1%'"LN>%(@"G M&T]#<ZU_VYF&.Y:
MM[P!=:W=%SP\<:T=_QFY!\0ETVSO%G.Q3M,W:'4;3MP3F4BC;%Q!N*#/G \"
MB(MM.'$!I(Z*": :0B#R:81 @DIZ*3> LNC/W+$Z7AZ"[V[/C?M<QVL]Y*58
MY\6$-AB+C-(,(5H"H 90<P!J61Y,QYGJOZFXBG("<95_Z=9:]TGU%IU<W=5M
M([.'(<13.BI[^-V&DQ%H;T;83)''!VY204CEU)@?9! 7VW Z,BBPJHK)((BJ
ME"5WRI5EP28W/!=DI;F-KE)N!G<@.[TC\RZ'CGMP0#\=3"<,,UXA,M0I_@<1
MU/H6@ CB*D<HO@NY;:[NVEN6J3^9EDD2>2O4B2E,8&8A[\Z+(#;DZO)I=_DN
M A#H 8!R<@&'(4*[#5&X8%-6+]_:OF[_,$FIU\-9)1#KZ)P0X74+BO@9_(FE
M@F%=&NK(CNI"H./$F!_D#P0Z3C?04?)TJ5,F54K";BS@P3C>T6'YUOJVPKEY
M 5>95_'&UL""@$[W61\D4->LK*[+(([JPI0Z2<H-!$&6AYK:,"#J2 > VP]P
M^X'Q61#$9@"@ -"V 0KI&:4L&-+<I, 58]9WC=KMU-F9D&RQ/67>9Z'MO8-8
M;EE' R(>];O:(,- AH$,:RI8DK,I].ZL*Y$@3M%-'^B(]IM&T*4),Q-<9#BV
M85IF</TH;/Z\<IT7TR-O+#!OF;;A+!&QT?"D?YK^,_T.^K5"AH]MMP-?)FVE
MU^0[3Z^"OEI9KZ2/'?GQ F&NUBT\3=U?^X[[&ON=X.H^K< K2_^@-?V4T3\$
MWZ&_(_>E:!^\)X0'.SA1\@;YR2O274] ]AQ/(U?K:A=Y9&7F"\(;EL$N.QS0
MS<;5&VASUV14D$?\Z67>#AV*=23M>SO>OS#,MSM[3>"^_3,5]_O0SFK36\7I
M!P!U#T GV<^Z4+/WHKLM$?('.[Z[VW2/MWN^N]O;/<W>^$9"X#QN-PL@AEN3
MO2TY=Z01R/&Y#=50E[]?/.@A%NS?U!D0CYS*4&"T*<MKCUYPN0V@Y #E@/+>
M;0.<'Y>*7?XY?!ANXHA!R$_W8P%%$D5LY\"*.<_R)29*$J;#R2#%&%.6AN*6
MML(_LI@0#DW;9TI ZZFC51D-Q4(8W577B7&>47!H(TV&4F*8V&$+JSQK(74P
M_AFYV/X\^.0T,-#O;\)RB9'6?T(V6IA^.U>=2U*_\U(DC4K:<*QF")%2=.JZ
M4!&'!TH--LB4S<0".L6J &@ ='% 2Z-A9DL9R IG2.@;Q\7L90<Y0'-SL4 D
M9F3J5BM>U.F(RG3"'! #^4C3==PK0XF5(@<''D *(.4WO;<#=Z$YH?<GRWG"
MWK>YK>-G.3_/B8L^#U-P#YA*=9KP.:G=>3F01A1U.*DF!7J0Y_]&&VH'NIG
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MMKN1-D 2\UA=.?://(:<EMC=O[!@W.[P-9&0VS\C4;E]!\O,?50GQV;?2@C
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MY5OKVPKGY@5<95[%&UL#"P(ZW6=]D$!=L[*Z+H,XJ@M3ZB0I-Q $61YJ:L.
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M_\@3G=$2O_T+>U/;G;VVYVB^_1-#%2V?4.P+BC38#^$DQSYX8I3[M X U#T
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MKW>?!=V>AV%F09__9^WYI-$?',^"?\L,NTKE:Z_@X@+6 &OY4B'@>+894G_
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M"7AYX"(/1>WP]@"$VH:03"5:+R%4K[;#GJ=CS_-C"$#47Q"!'BH)HL=GTRV
M(8!0CR&D@!XJ9<HY:]=_KJ:'>N!%A9**Y9Y5QE4ZIP_%<0O"B'%67@[Z%!?8
M0?IBM(:XC2KU@&0-M5MN0^L!ZGJ(.BRECQBU)TLRP!A@##0;:#9 74=1IYRT
M9JO-W3MZF:RL#]CVW; TCSP,>H37L+)WYAZ]('N-,E(EF-S18RD,2K$VR<^H
M,6!"'[^=YF\)%F=VQ[$6]<R#I"AWA2XO?TL#53S0N8@E>S-0_-W4_" !ZI<
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M;$=VSJK6I6V[\\EV;=OW%6FP_8.(B'VY6*!S2"^2C "LT)[G:*=5IE"%5F\
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MZBPTV.F-&V?M^L_5]$8/O)0P8L05AGB*:W+3_/.DSR28DPS.#@!C<')?+\D
M8X QT&.@QP!CG<"84HUBG288W']O,LO\'KT@>XTRTPC@1LMASOZML 0X^6:Z
MC#B7%,D7,_D6KJO!=;5.@;NJ\]HO<$L#[4!%"@ W@+M3X ;-'?_Q5,JN+@O
M!F!W"M@5774NG'6&V)Z,LVWR?I[:<KD-T-&^&<EQ:OUS&;'G:*"J*2GI'4I^
MXDK? SXKX;-')>*8X7,Z 7P"/OG )^C/_=BW-CG0;![P"?AL%)]5G>!^H5,9
MC X4-X)#[]8WB)16(R75JOC$$&-C'V/K>_%61NS[1AY,IN/,T@\00H<0>G?@
M#<[W'KR5@:IDMWX"> .\NP-OT-XIVEN:* !O@'<OX VN?P+<TD"<J$7 #2?@
M]?KXU=JS0_"07?#P=.Z35;7^Q2K./43V 9R,P-F/"]4LP3D:R"J $\#) 3A!
M<^X[UMJT2MP,P G@9 ;.[E_A9NL6:Z+(A5L,!^*'G.5#S<\%W9X?;S8&T3F>
MHG,0?-^U$=2AEMVY"(+O$'SO#KSAZ'P_>"8-E0G &^#= WB#]M[7WAC>D/@&
M\.X'O.'H/!DC4+# *Q\CV'8S>_]V[9W_T/75Q8/QC.9K"]TM_FNMNSYRK=<;
MT]9MP]2M6WOAN$O=-QW[D?SR$5/I@^48?U]2V@K"^^@I88TT3UC;IG^/%K^?
MK;WYF6#@2>+?T#<,652_W[C.4OI#M['/K#TZBO1%=\G+,V&.#'.I6][O9^?*
MV:6DBHHHBMM91L^_+#[L5 E&G:W<<%3QC[6=-NI8U+(&+;7<<;C<M14-_(!6
M:0/+FI0Q<-%!I9$<#'IG^!&-/R(CE<:3\20/C3?WY*_#:_*,]E@=24ER[PVT
M3_="<\F_\9JB*3FF4H$JN5EA+(VE6JE2@$/4J9J'+(FY?$7^K6TX2_29Q,K8
M<(JL2*/$/!*#7):<0'[V.->TB<1^ @6XXGRLCK2#,R@WA0+,<#Z:BG+)*<Q>
M=-.B"L2YHJE%#[',H@\T<,I(;TPG:O8<CT_C"#]76P<SAFMY'>SX-L]":EH$
M.\XONHAKW;6Q"/6^(?>!'"/L3Q5_0@\8O') D,\NQ:$ZVDXW=<1=P):?5CZ^
MQK,ZEX9R<]/*R:9D7J31=XYY,9I83M8+)C:>5IW8Q^ XBCF'C0[,+!SSDMW,
M6#$9^YDQX[/MU)C-C1FK9<PMGQ\TB?/49,M3DQ1#3V3E]LFB%N>8R99C]H:5
M-'7$;MAIG!LF6V[8&W8JJ8R\/ED2X]L\V6[SWJ"3<1:%*W@WN3=XI*J36KV;
M KL^FD[JGDMN5I!W[3WF<\G/(<H(VSOU>7VY>>5<GDS'-?@\!5CD7%&5.MRN
M IQQ+DL3I8XIY&>(<TD\Y%75ZOGEYQ9%%0]P2XN>1A%^&\DJKXLHP+':E$^?
MKQ#/DR74Z_/-['DQ.S,7&(@M1S-XCO@-V]'WQ3F;Z>9B>S)=FI'0^G1S,3BE
M+CEA;7NZ^5B9^D/DS*CH=-^__?7D6E2T_S]02P,$%     @ KH9&3A8_'LS5
M&P  T34! !$   !V>')T+3(P,3@Q,C,Q+GAS9.U=ZW?;-K+_WK\"UU\V>UI7
M?B9-3I(]LAVGWG4BU8^DN7OV]$(D*+&A0 4D;2M__<6 X$L$0%*R'63++VU,
MX?$;#!XS@YG!RW_<S0-T0UCDA_35UN[/.UN(4"=T?3I]M75]N3V\/#X[V_K'
M:X1^>/D_V]OH+:&$X9BX:+)$_O&3>/YWM(V.P_GBTO'1&8WYKT[LWQ#^C?)V
M^=_\]UD<+UX,!K>WMS\[O&CD^(Q$8<(<$L$'M+W-.T!9'\>,0 \OT$?>S2F9
MH)VG:/?PQ?[NB\-GZ,WE%=K;V7V>UOGAY5WT(G)F9(X1IX1&+V[N6/QJJ]3A
M#;[#+(9N!KS>+[M[^[N<QH#,"8U/0S8_(1Y. E[G2X(#W_.)NR6;HLF\TM+=
MA 4_AVPZ<&,VB)<+,N E"/.=+11C-B7Q>SPGT0([I!E VD/@T\_J+O9V=O8'
M\/,$1R0K?E<K?[LO2N\^?_Y\('[-BB;1-B",\M(>CB:B;/:+ +.]L[M=P*$A
M;4%S2+=SNB6N2 6*D[ [^/W=^:5@3UZ6-^@6'"H3?#A(?RP7]0W#X],HQM0A
M6V+R_( 03 9,:1CCF$_GU^E'^7FQ\*D7OI:?^$<8K1?9"%\0#XGQ>P$TOMJ*
M_/DB@'$7WV:,>*^V8&9M9QS\(\"3GSG,K AF#@L#8F;.8,'"!5\3/A_]$F]%
M [7:55KAYP'ODP3G!>2MP>O[(F?!R*.3P_N,^"(4S%JAZM[8Y!+OT>GB??K4
M5U!U3S0Y.'ATFGB?3A(H656A"@I?<3H0_./ZXDRW$XI&^1$1A8'OPFY_A -8
MRY<S0O@&X+LIT7^P/[2%\O',^B[&_37?>OBQ<\GGEMCGQ1%%74(C?J*4&T2R
M122:C%X.5AM"Q53,NDEX(R/Z6OQ[=0K+!F018]7J+%FM:.YVA1LKE3.&#"H<
MJ2VJ>V'5'V/,^ #,2.QS4%$KSJW6,3-R;QU&HB?5/OZNX&S/UBI;S[C<-R?Y
M4&M9N5JN/AX5_NW7^5=P+?\A0J&'1@N0+7FU"&'J"JF2D1EG-LB3YV&D7)\]
M&\G@<L9G^RP,7"[(O_F2^/$2JNZ%;+_"14,Q)5$5/AZTY^-E'#J?93__A]*>
MT!,N:/N.'ZN68K_)UE;C,8YFIT%XJUV&>8'7=3(JC#MLSSAH$T&C_4FH9=*(
M33'UOXHN^2YUA",_"KUQB?P*RUH4-Y]_3SG+3OS("<(H883_46Y1[).B36!?
MN=7^P%/OE,E\CMDR]"[]*>7:OH-I/'2<,*&Q3Z=COBX<+B)7=\UV550+I,+(
M9ZN,E V+';-H&A5MHZQQ]6KL&<H9>I1$/B51Q(6%B4_KZT_UNWG!_;+*IZP)
M5&I#R9&>'V1PBGWV 0<)";U3/E;4\7%P1J.8)>*4J?"FJ6RS4/)\E5?0)!)M
MPK+*6T6E9GO6Z99224<#V3ND-8YIBIA5@-V=VHHJ*VNH:*B7[]6<N2 WA":D
MPHKL6\/8[ZZ.O:S7'RG:T3[W\<0/?+"579  Q.0XO,0![%))S ?Q(ESB(%X5
M$]K7:MS6=O=6F59J',G641PB:%_L<Z('E'?1,]>D8\&UE#\)R)B%<S^*0K9\
M'\8YU\:8U7C;NE*#+K:[O\K84LNH:!J)MG_*62V;[T\NG51/'#Z<;I4W8[S$
M?%CC<'3GA<Q-98'J'MJE7I-\OWM0D^_3UE?YBF0'L(#3+J2<HMR3>_;"FIW/
M_5@(;US?Y4L&E"-":YJ:J5S#,7E87YAY6](866JM9Y1F'98,?ZG9K[K<ZC\W
MKJJ:^:/<R-^D<;'?&#4,28?GC.\M%)PRQESLKBX998&F4ZQFR9 FWKP9)-KI
MI1 M7]([E"M\M[*#E;\WBXDU2T5:'8GZ_>AK1_\]B>$V:4R8N!$9QC'S)TF<
MGOJP\8>TO,M4.-2U;L.Y4S-@\/;%51?B/2#1!2KW 4)#VDME(^P/)#6G?TLP
MN* %R]P2=()C?$UQXOHQ>'J5.-M4MG$][M7L''F3)4L4-(J>Y,WVUV%:YM6-
M[$=+\:^J5&$HULRRFGE$87W_"7P=TQ;1D^QCS[<-[UBN8#M;YZ9%5C0:\?=J
M%I3VERWH2=I#S^$NERX*=NI+-0B8>S4SB>H*QLBGGDN-5S$*CK6K819I]FIV
MD!9W,CTOU[J;42TZ4\$F;7NO9@;1W=28&-;SJ\,=@H*%7>LVK,>:!:7C94)_
M'FYBH%3PM[ETXSJM66",YLI^L78U6ZJ$4UTALR!:L]&H[)?]\;>&'5/!(T.Q
M9E6P9HI16S7[[;"+=5/!I/JOY@-LOV96*9LY>W;<M[E3P;+U6F@ZQ?9KQI?U
MC)_]\;:1$53![W8U&I9MS033QAIJ7LX]-]OXGY^0&/LKL5CM:S4>E/LUZTP[
MCW2( !%=].MT$[NIBKO=:C98W_;KCBP=;*<&'C<,^%^&SV^BV)^#UGT=$2\)
MSKEHF1Z955E66ZJ)?S4CSCK\ _DW0X!2"$A@Z!G;Q2RN6JV&8LV;;\V:HS:-
M&Y=ASRLRN IC'"P2YLQP1!;,=X@7LN&-S_"4T/IJ;%'<: ?8KUELS'SC!427
M*.L3B4X1[Q5EW?8:C_;F. A"1W08>O&,5/@6A_R+AWUVDUYT\+_XL"R(R%J#
MHX@(JUQ0V$BQ\R7QF91ZJS?/#]=-TQ[?*DBI,IT*L' .<#BK4XLK5_ 5,*.;
M[+8&OA2X40I<R'@EZ"C#W@MV&O?D@(\?<?$<SMN(94;];"%'$\D\GSI!XA+7
MA\P%<-F"Z3)R2O&Z41:N&WIA'BQ?GYB/TF'3%*W9TQJG: 8;2=R(%;<3&?2_
M12@#CS+T_!]BHDH">)$R"2BG 29T044_6963-=?%%XSSG,TQY$WB_P,(?A0)
M4=+_JMH.N]5LF#X']:"QINF3]\\WM!")KE$) N(J:0&BY[[N)DOL 5YFH5$=
M57-^@$%D X[S ZX^&S9KJ5$0/J@9#UNY&92F2[%;Y!!UYUL&$^&X=#[V4T@M
M?#'"MU^'CYT4C7 0F%D>4LP@5H9Q570"IB-8Z=.H4%43&DXBP@OSJ>'311)'
MY^2&!/L*D>RQ.S<;00]J1M"NLW2(JA1!+4Y3B^F)P!B'<MJ0( X)ZE")/%2F
M#Z4$HB>"1+3?ZX_=''*4ZKZQI%%K/*@[PFG]<4P:?\\P?K+A:$:XFL+7AO2\
MB&8ABV/"YCZ](5%<N+A5S[$.]9INO YJIM5F?L))!6EY2AC$^210; ,,5,+1
MKU>S,SG7A1SBB[V.<AT=CH?P%CB@.$I:U6C8_SLXU)4W?=DU*OI&O'.Y]Z?=
M]]*'DL_C-,_EDB\16#$+6!5\Z.KL-19L7,AU,VP;OF9]B@6<]_H3\+;?MG6^
M)#&F4XB/3V7S.B/5)9H5B+I%M@T+B]ZDLM S3F-@YZ.872!YPJ44S_F)):^)
MR=T"DGA.EDN"F<+<WK5RXX*M&TS;<)OC0#D0E")!92A(8H$0(4#3V^0-!S!+
M2%GY5QZYRC*-W*W;&EL>L]!=69?J^=>0@TBEX:S\9%1I#FMV/5G[K^0Z()XY
M^/?'=Q\._O/OWYU%<O>)'CYWOSZ[F7Y:TNN3Y/;M,_;\V;_V_KR^6D;!LQOG
MZT[PS_C'W0]?]K_.9M>!=T+&@XO?KK]>_Z__[)/W]</9,%J,)_],3I:!\^GB
MP^+RZZ_^GW]^?G_\:7'R+'S^T?&N;Y/!\R3<_?W'P>>#/Q=/P_&%MYC>[4T3
M]O7C8+ 7_QCLT_/HR_'L^/.>.SD9LH5SQ@Z._<^_S;R=X>_3Y.CDMRMZS$8'
M1\_9OSY_O-D[CTZ3_6<G.Y\.AI//^//UW=<_]^CN+6/^._SNP_[OX\4OQV_&
M_T''EQ?Y P]K3[_601&J"=JY<M.&<UBS/G8.JOCKS/:->;[,+[ BP31/$0:C
MY'>KBN;M:M-47)4#)\=5OMF*9$VO31*O?EJT3^&EV@FZUC6K]X>;Y?/JW73N
M,[.7TC&R>_6&>\G#S=-\];;:#>+IU(NZL;AYD^^6_:OG7P=A+3^!G3"*H] C
M=W[L\94"UAKP%"!\S9B.\(Y-F/E<L]JUY//*L5\ZO 4D.+T!% )4*(6%,ES]
M'-%D)Q#BSIPCGB?S!5YFRS=*A"6/^"+(*Z$N8=)GAT[%#XK)LFE;C>)^UWC;
MTL21 J$$AS)TZ1V.Q(=2@$@@1#G$="KUCDIMHW:5$H"V5--!WS)RMQ?AVHOK
MG&:/, 9NA7PH53Y#QJ)-'*M9 <T<6Q'7\QZ1Z++GIT$X"ZD8(R"9W1"72[?@
MX*>^1VU3OH&S3VM&PQ:<%7&BHEN4]2O<Y[.>>\-+IW![U>9J*F?6G)_6#&BZ
M:/O>3M8^<%#,]G !72N<PK6EFE9?S0;6Q*MJS%FZ!M,.>UE&FZI+..U%^6TC
M!H]I,68J@;=%^2:NUFQ7+;AZFGL71J5[T5+7/7_UT69B'<#+J2[_#K?& @&X
M=TXIN*3SPRG4,7RM!AJVX)HEJ\4$2(/2!)!M@025H: "BSAJPWY2M$N3HCI<
M%3\WZ:E/:X:L:JJ4_BQM%0"1N@J$7JJ5QWFFFEI\@[9@(Z-JEB@UHV28@O1=
MX&>I-!3$^@S?/1.K3(QGQ)6*'1\UG1-9NQH-&VK-2M22J1"[EO4(K#5XEO4,
MELXHU2@/B+YEX8T?\;] N30MW*YU&YAN3,)?8?I%+9!#1.%F?:?*J7E]][Q7
M\CXI"4%\Z":$<HI4R[QKW0;>UPQ.'7E?[ELL_*SW?ND;XCCR'D,/8IH<3%W7
M#Q*NB5 2<U9$"\(B2!ZF"N;H6+GI(']6LTRMF\.L$N^1HX29(G"*^P*)5,0"
M %;$P2*!MM\KU-$ 80RJ# Z"I1@[2& #U_7B'H_<I>'C<&O'5R,H,DDLYX8<
MZ5OB3V>@7-\0B#X70ZW85AZPFP8M_MF]Y= KARD4Y*",'E00A#**TOM.V,A*
M1,&,S>9I1A>2A*5SM3_8S&DBBB#U+UG&O#Q"69_KH;E68TC$LYJAKV7./E4.
MAP(/R@$5D=;]K;AZ#IR$C@@"'E+W#5^"8%S/$QBD;#>6,,LK.^*PDO7+_^1M
MH;0Q5&KM+\"CEX.[Z 5>+"!-A/R8?J(T3"G)!("7_*O/E386(XKG)%I@AU0X
M>3=AP<\AFP[V=G;V!SZ-XO2YR<B9D3D^E[EW#%7@K^VLWC9\VM[=V][?_?DN
M<K<&K]=! 42#E:XKBJS>.B@\'$U$<TFT'?.QCGB[N[]L[^SR1K0X!(9RS2G&
M"U%Q0((XRMO:+MK* 74;%S=F VAJ0/G49[[3;FA6:\' /(>!V7VZ,8Z0;J^)
M):3O#7": 94Y?RC^<N/64R6K 'T?U@:!GP)B9X%.7VVI<AD.)U',L,,[!&)>
M;4%K_@O^S:?3LYC,89UN(2Q+O=J*&3R G9;B8J\?NE>BGILPN3M2/PC@H,O*
M1@FO[,<)_/J6A<DBZX2?6O/2&6I$5QW**EG"&#Z66;3&D$3KM$@*9P]][6#J
MN5=D#AMY5S-2:>DJY%_R9V/$[Q=YNK"A,&/QPZ7D/#>4J<+L&9Z')<\T?S)9
M:9BFNY+>X5=%FJXLY=&93'1U1J^*-%W'I1Q7EUF*JY$WRA-<V3/$CT6H:;!S
M>77,PE,0<4J2SEETF4NK]HQ:9\0F\K/!S,5XU>Q])Q/)#.-\SMLS'!M34))>
M5C:XJG5NY/$MP=SFB$*=-+&.2'9]#6EU2LEUKTM)=<Y*28/L&<YO0?3@M7Y^
MXFCVIDAQPKEZ"0E.K@B;GQ7I3>P9OHYX!Z\U4T]F^KC($WV\)['@19KEPQZ"
M6R,U,#G+?P&Z:Y;]@K=B#Y%- '5L++)"R$W)&HJTR+2[(3]Y<XDX=5X?EA(>
MO$GS'1PM/Q',["%S'="&-0EI <I2G35T&K#IR)'Q]?;0L K(L&'D ;.YR AQ
MMJ/5L&U[:.L*6*]UM8I47=I#>4>\NMEJBMBTA]A6*'4DUK,17(7'$$<V\M[<
M^?$I;_1<Q)"-90B9/72O#UT_T=.E\2Z-CQK+\"B0IV1P5'JG?@VA4:,L,DIT
M8M&XW ,-NME265?224C<W-E#?3/$!LTT>S_L0L9I<&WW3$9IV$1E*YQ&@T_J
M%#_R1"LCX1UK#X%&=":R<@TQRF6P8>$2;@^!+7$VFGS%^!S!-G=<<GZ^R%UY
M^+08V4;[NL!-*GONQ#CR2L[*]M#<!%"_Y1;UN&)Q(K<T7MDV[:XU4@,;5^U
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M09B"GLBE7[<IV:Y !2TV^P:PJ-B-J 4M]CJ^-]IVG*6!"*!:).$YFS2???V
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M?EBMTS.^,ANSMO$:T@9)D*LX2?LX*4IY+]9LXRD;<)4A*>X4P@I_,]84._B
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MV7$7$;*-D@>XEFE6^/+810;*66@7-]=:M0B"?)V+ACJ?$E(WM/EG&H>,J_=
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M:8T68"KOW=":=9X@41/5KZ-2PLT7X420(:'PU@ZE'&*O6X2_Y303-U=?:G'
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M<J"'S;V6L*VNGLL\HQG;N-C.NS=1" TPY,1;RK,=/3"5/U@._#DB"2-8,^\
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M14.Z7=^;B'0E(NV<*<PEZ!:3"--35QM!'SF?YD7NJVQY4/N$!53Q\6?$F^<
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M,H$2C A0105C;N:^GK4D/^QN'>7O:[,&ZO7;(S4[%*4R&R[L;,\,TTI[SG#
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MSYB_Q.!P\80)>L#GSY@$$<4B4F'B2M;+NL<GL@FH7S^J4-4F!'?WPQ.XUYY
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MD4?D,^E]R&MV&R*[$?EV<?RGX\7QG[^CMQK';_Z\^--WK_M'#]V;$OH=N_C
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M+.E[$/;OBN1^NX4Q_I*\T/1M-0\+Y-'7/DI0*ULC;JFRO[=T21#Q.BW+ NU
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MX!ZDSH&F<*H2!^2$0U-ZDC*\35,0M6T#+X+F^M]+BFXR1):A27AE;1[0D9<
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MHN@!YD8.+#U*_JY$M>21@(>V!9LF.\:&M*;1,4W[>?BVC)37GBKU!V;$Q:0
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MK<\\P"N70:%T=^KYX4VH6%W4'8Z!_2.1-E-#5_[#:>9#)3_/F0]5LDB@19H
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MNCY\@KEC.A/,M@))H/FVK-(U3<7=Q>C.$Y4'^M0!7[_[H\Y@O"W>FB+. #;
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MDJP, FL'6$. 6PXLBOZ716V=M:NAWF!8&6\UZ>53E&;$_=_"\QVIZE&:@VB
MDN?=5DNH 2BUC:D)5S_09NU%> H$)ST-[D-*8V!LEZ;3[7J;157Z!*6;^5GZ
ME"8P3TQ@9D'60=U@M8EG+*)LPVP) 975UQ*;Q?)FK_?.^K,;P)&.D;J2D1$8
MI:V]8TXFB<X9M6DQBS/#@#Y$YU%!CRV]KET>T:L57_>V3M=(DS52>^Z>IFEL
M4E XC  ;*9%7W^TX667YX[H\ML4*\&3;5-^4\ )0TD>4-FB(S\!W-RVV>K4
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M6#PK8ZX5F:*LW1<X255 =#Y/I;KQGH&B"2TF)^[FL%TVI^U9GW*'1'Z&]O-
MEY[7[/4,S4D#[37TX&RF#OF?Y<ZQV9Z3'7?I&5[WC.NQ[4+P/%^<^9D0D]X1
M3:!>&Z/]/$K1CU&VA>7;LDK7Y"A(,5'G/C5)6:9)RJ>AK">2[&84-P9/M#6
M37,0=>UGDM#,3(6MH6HP-MY-S%8V3J*;M/SU'$'85&6\P1+/RLC4%MIOL2#7
MW9','O+IT0I_"]*F,BC"7S_;)RVFD)S$N#32P9B(@?MAX>YUA'O[>0-C=L.W
M/G8V.]U(&^!]MY..2&/9V3< PV8] _O-*>0.9I^[D9[%YMB(]6-!DH)G:;5[
M%MNC1&R?E5L\]&=H0CZU7\]@6OI!I+/=4:&!$-'J*A&;_/S/:J;VA'Z^AJRH
M.]+DZNP3L$MA]CQC\$Q1Z'QV'@R[C>OBKB"5HTA>[@/Q;F!</.3I[[26U)6%
M+\.6MA\;<HR(LFMV0HVE:Z^S^<1\UA_44J3%R JY \2W]V,D"EIWR)CAM#QY
M7>1XC&%;O?V2?$SFUD$YT&GV Q4[KRNY0A ).ED+T#8!39N#*J%!#"<-1?)+
MZE#_+>%$RN=AH1^7>7(&GV!6; AULN3F)717%EN'K=^CM89$,J=5W1)$>+_G
MVH*Z\6'UGP!H,] SCSK=4;$]SRXS^G>8B"V&FI$+!&IR]EF@T4PT61T5R6X<
M-.N F9IY !J,A75 ^3N80Q1E&./+9)WF*=FD29$TYZN@'F.OVZR62+(4-ZPM
M70?[K>5+8:#-UTCE/![UQV>4?7<7?>Z*4+DL@Z9B%\"^$PJBMN]P$\#5,@M^
MO6J@R$/[3MY_RR*,FR(G<017JY8^-#O4#M&8N.*'].0Z((>\'&/=BD2GI PQ
M%6DX@P)V)CKBRS,.CH/U3GBZ10B3/H<)6>0PX7I9.\&KWBIUL@ -L?2 +TU1
M9!$?[// )=;U%-<KJ*[16_OZ1S5U>E[%FR4YKGK%TP!CKUN;EDA2<[X7_Q .
M6GJ:% !,H]N6IE*#X +!]"'WNEK)6 98K22BR#-WD,_GL5H-*$ZT6JEZ.WJU
M:O=3;T"2<73PJ("XJE5>![5$RAN NNDL0#6@0P&F5#VV]6N=U375Z]W5([ T
M.8?P:^F)IFUFA2DV;:387E%I_=Y;V^\-C]Z>&P!\6ORG#MC1QI^.='KF6% (
MFBA9!$3M81@1 ]."GNW;(=9!->>@ZZ!2-&T#+NPZJ*58X3HXW/O1ZV  O"F
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M F;+DL9"9 >G&_@$\ZTL*G4:$!WP\ B=?=[RK,/DL^\#'ZEDVN"A(.S1A)Y
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MZ\LUF/&< SQU\5)C1^C("81^<P3PF#8<*<L[><EV=9$_P3*X&:228A9FD$)
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M_#D-4=[J)W0-TNJ&]=%8 TKBAK$;9:LT>]<0K2-RQKBHX-HL?:*DJ;_+*;$
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M2>]*_X[UMF&)KR(:,X5MNJR^?\?8C6)L -',+[J61Q#!?*6["M$Y65J%6A3
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M+UO15")+*_=0\H#2[YX2[;D,R%++\:'K+^5T1%B!E,=Z: ?@U(#J0C6FU$3
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MZ@:LY#9J8]VX<8P&:U]=U 'U\+CJQH;T?&G68)6$U;W%L#"B4R<FA+V<%&.
MTPXAT_APQHMA%1-E825W2@>V&&1"=8M<E!%9E=+T8VJ$JQBR3=/Z0&QU\H<\
M30IB>G])RL,NX>_O/[R "8^;LT-=$S"PS)\43.)04,K!4-_THPP(80XIZNZ=
MANV(@3[$6M[UMQ1/::VA5_;?6_S2OB?:YP\=A\_S)BVJ!EX853N4].6:]G0\
M:TA8IL6AX47;&ZFZ4PXB3OZ,V@<,8QUE!=5X7]4M2I,]H/IC1)-R#DE]Q<C
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MMF&?LTVYW#XDP.H]08MN8?A;BQ_)(.CIF^7$IJPQA-8E<9#O[5$=+A:R.<B
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MNJB(XAT5[Y'(KT T MZEH:L(6;S+[7GT:<3F>Z.U**['&M1"7J?.N=?QFDC
M97D&X:I#@\^) .AT@'Y$W$"+=EGC\(H%YS!NUT/S]CY)]G^7T]WZKJ@_ZQSM
M_,O_3/95\[^(#4#;MJWSNT,K&K%<);"CHYBO>K1D/MB0'[# *4J:X?SO+%CV
MX>66'.!-#GIQ:.>RP"A@UQ#T*&H-3G^\KY[^1(;_"8*E\ \:-7W[T[NW/&YJ
M!!W C#7-KXF.\H#HAQ?4#T 1+S4NW &YL*(:XN 1PLE.OB]YF3\>'F\.9&\1
M30%*(RD:.!MI</\N2?^@*V6NYP:*A^)DU^H3&OC#!0X7"<"(0]X@@(TZX$B&
MOD$]_!B'VT*D4:F"1:@=5G7_4G9%.K+;Y.4]+O$N;YMSG-8T*^V:%JL'!S@A
MWA61X9I),OGVJF*BK:UZ+,-&9  2T#=(P$<=?-:]GL[ =SD=TDT24U26())*
M7I8C?N#SWG9A;70W5I[[?MD2H:=?7)0,5X&S<+#\AO/[![ LGS#4P_WP@NLT
M;S A0JKM\TL!OKVC6>KRPI"\,G3WBN0/^>H07=Y&/%0@_X ELB^16"3Z02SS
M#?2@O.+-M\5:$5\L$JM%=+F1G/(K89;29%J#_(0\AKT]/!S?#R_[O$[8$RY+
M2R:73>"Z!Z1I>WF/J8A/0$<O^?1E5U@UO:23A?<&95_VW=^U9[^8&TF3;^37
M$O+\B(%%8@4T(5)^X<(7L4%\&7P !2A6$NOJ'I+:*F$-Q^4@@5B!UN>JO <'
M]CF^:_7IF.7]6VC>A>"KJ+X">;DJ+HW1"7G^7.,]3S&"8$%5M_)2-(Y(/@ :
MTM A*D+'V6E:;%2$MZ >5*;'QLHV3:M#*>\U?0$XI0TJ $B:,+*]Z8*DBE'N
MQ GD7#8HV!LB5%!-MGCM5:U\I^>)1_#:%_(:FOZK:>=E/X]\= Z]*6(N>FC2
MV:1O8V_516GG>/K-94XLQ4QK"O$NW6YZF=51XD.B'G\Z/&P:>8QS &>T6(@(
MHMPF+\SB^56\=]@61?4,91OT]7KY<SKP40ECM!N.NO$Q+TL.Z*G8XTR5H$>G
ME")]C>$%2MK29PG:>@5BFT#CQ,&(F"S18:'B@QGC@-OD<H_A,EO>LW?* R>W
M6.3Y0;M5NN'\L?8&'44/.E81(+'/*T=<5?R:1*: [)OM;!MFOD5WS/)J6?\^
M_E=W^I_$USJ5_4'#FV1[M?AS_@1E&%N"4=[[.1[)72__%\669Y9O(<CV?SBI
M/Y(!VM F!?F6PD0]T.Z0E^$B#GB#:/P. 6P$P".+W RR*,.:<ZG<:[N)>1!7
MA[LB3S\657+T,GQ& H0,,X2L*F<VYSRP#Q'],G*N@X(#PR2'8Z1DJ]"9V^*U
M^,>\29.""@_Y3;, SW60PWCB#2NPU01@GW.5 @-BF48._!$284(UL-/&Y_WR
M#3SVRT6&J-*0H<53>&E(!K>S0ACH#9(Z<)(KNMR@IX<?V\R=1QUM%MQ,>H>T
M',Z[I^I)BR$60G13T;U6XD<93\BP.@$H$!:T C"(P:&^ 0X)_<!AO8F3 NZ#
MMLDYX$ZV@#<=Z ( Y8'(_R 1\RDIP+QE@GCL7=;VUH*&",!)^@\)S$9D)2D<
M\7%Y.@5M%4^GDRT@3R\>]TE>PZ%RN:,7:\BTU<9(NH]!]7:?Q]:V2AR4(1 ]
MLAY%EZ1$5*@A0'3RI[IZ;A_@'IB4KPL85R;H84UKY1HLB<5\"&)C$!\49R\[
M\NHHOUB+M)<1SH#R% #VLH, !TV_B"5N!!_.'#<MPRPP(O>D&X38J)B&N0O/
MAD)CP#RPB2Z<HK<5STFY()9ATW:EI8QN_;82V4)(&A9;TYM0,OGX]20(FS'F
ME<#^6]X^Y"6M9 I7/BWOYCT:>*:S\+*O=)[8S%Z$6$I_VW)<"&BIG2 /3?X#
MSP6QQ,=/G'8H_7'3I]Z, O!K2;4X'?T=4S%.+0!QQ?N,;+L\PRS3E^Y%=CE^
M9WM[/I3. 1@DP8F:T3$%7T=IL- K(#._XA:NNU=U!=VBL_>OOS00VV"G+S&*
MME"\QN@))!"8BT# @/#E#P &Y>4;U$%"/:C(^L$=9Q4[IU(LI"]/GSEH.2UL
M.95CQ;ZJ?$J#+G8D25CK<I191"ZNC7:'*5.LZ(C(&TF-AE,JE83P2L+D9%_[
M1L+)T*CO=XU(38QC=V0(FM0V+; .9OWM<[5LX@*-+Q*H*^6DG@SS$Q4&]%S9
M UJ7]X]"Q_?OA4.^#63O8[LU]$=H\T;Q5C!2F/.T9/9*MUJ"LT&5%&3]IE!-
M28T:WTPZD>M&(ZWP<0@Q-9 ;CBI^3Z%.6!TSK,9^GH/=7F:T 1W(V#;[Q\'F
M;#UJ&M/!H(X2I@ D,+']<>X(*UVQ$\D5(UFALR,EOXC!@%-:T)&M-@LJ3E:T
M"OM9\=%?JX)<C9+Z]6->X'JY8-<QW$ !%NT"S/&M[F/$OHX?U]+P91C04N'H
MG7!*89P1?7Y?U<M%R(=0@Y;;&DQMYC_]%(EO8R@)"Q^&?!]C]BU5](!6#SB'
M.$]0JUV:]ONHZ*&@XRG,<BV[HGG0I$/0Z?P?A*YD(R"R%2"MRW+XCS"6]OM$
M-7^-[W.H5UJV7Y-'O)B>/P(;Y)JFF]VLZ_MO$7P<.^E)S8^AOE>@]XTX;2QE
MNHU%U^?I?38S*^$!<Z-N<OHNEDX?M\3JB6BZZ!G@Q+\YY5[/R$PUY%%G^.6O
M>#F[\QAN\/O'T0(L^77L8T2_1N3SN":HABE'V70*!#TN'ULB:QE].5,D]PNP
M?P@O7'+E8%X-M[MO$'P4[^11TEQP=XQ(X.3(::&,K_BEO7W&Q1/^4I7M@SX%
MSRM&!- 1 X\8_-BNOGG4F1\Z4M,[Y/USE#EZ55=[7+>OT.>#=MTEO]W#)U-2
M:060#:)@-JPSL8 4-P_"'6.E>W<BO?SO%C</N"B6?F,Q !HZ65Z>W'R$TR\5
M+RGBG. J3@R/[Q%FGFYDGJ[8OWO]4&9RWX89_->"#N1&U,VO$021*2L_7R8C
MT%%SC<#R8../D HCLJNOV\]2P"]+FMEPFBQ\DRGP;:7@<S(I;8&%B!_89!2N
MLH\8<FR]'S/SX:Z/F&.Z#\V8FMR)+C0*ZUWJRD>=54T+86>^)*TMW]?5HB.8
MJ<;'1.:/%A<52RR(!\UUF5TL2=1#6D^YK&Y%GA6S5ND57)0-7K["$PA"4$GW
MJ)OZ%;>T7BHM^] 8-)-_+5MX5<%*V+)B&LU EZWC%<QD,JGD:SGRKZ)=D"Z$
MH>T %/F TJ"AXI01XPAM]G0U=N@?CY2/N??T8DU"1@=,U(2"R412ZG]/4H=]
M/I#D-13GQ5_(A83<6( ]< WYI:SN&ES3BND7Y?Y *ZA+G=?A1W+1)5B1TROO
MTNE>*2R=R,!DM,(QWB!I/OHN&\DS(C8E&LY)'^&R21&===-E)+PRL'&]BR>A
MI?)R>3JF!>YET&("L[7D?XO/1EG><9[2#=:L8H\2K:"$_5J5E;@2L?NIA<3R
M '%K_X&/>1/;E-=BHR*^!?70O3K(_&!I0?.]LZHDBSJ0=?'K*MF0[_&NH@W(
MF L!-U_RLJK)EA0R1"RU(136'O8+;A^@LI:UV(G@)0Q_P_HC]NM _4+0'5V)
MZ*3+X,ME43:2,X>F?Q&^$4"$!@63&;;>V+(2D.3JK1^8X]]HOBIST1PW.#N5
MH\,GLY6[PL:]ZR9X/M;H]C@ECQ;-F%I.:+PJF9%K<P:EK5X?[ZJ.UC-B<$-X
MX<*O@WDU 3?^#6(?Q0NQ*6DNXFIC1.+W</*N36-X<76B\D.#=.TX9_/"!'3T
MB<WGT;?4:$/QR"!Z^$#Y8.2[;[DQD1,GB2!X2<-*JHKHJBU =;I3U*\ N+$U
MI"<YYB<C'E$V;%LN]:MI=@FB1<)!K*&N<:I/1-0],^^NK1T@Q"#%9O44K)7)
MB).I%K**.LN!FI@^(O*^W+)&8E1)-Z*EXI(+(69U.V%*?;E4037<@(\^E NP
M-3KA9?5'28*16IPHF7+<X&2,8)RVE9+A^ZFJLN>\**@+:GAF'/\\_;WHZ#A>
M20*8-PE,N6$SZ1JV. ^=F&LJ;0T>;D'QSR+S;K!D%1\4.(6-LTO<MU!VL$G6
M0=[QXE4TUJ$8EM!+WOC-JNU$CIDC9?B-^V7TJO%4C/)Y92/.X%ORW8)&$P47
MJFF)/*G-/H)O8AM%,JV/;:$.AP4Z_S&[ZC2]_V38P2HS:)?@V/Z/&\>C!H!1
M^_\IN*3N 'B,;[1CG"@B>M6&?DJX;EA4UN%0[]X_MJ^Q?0XV;"RGO($",2K9
M^3Y.^08>I7B\1G%XAA*,0Q]V.PRUW/LTAVMRQU5E0^B8U4&0N05 1BF!1#^D
M.'(%$G=\51R<2JV0>TTJ67E;;;,LAW40I9SD1.#.DGW>)@6-0-P=1RFN,5$/
M3=[B&UP_Y2EF>IQ;?/!!EW2HO&[V\]*WY=W,"*:&*!*??*.M"0NF.5\"XFL0
M1Z&TBJAR<VKJ*F_&03@:6.&8+V[\*O;[34N.XJ0F]S 8_;?8I['^JC1R!7D7
M!:H>'ZN2'MHL[?SRT#9 !:)6%C".'28)6JC2M!)+W2 ZD@6/1!MF)(V.7H?
MA9-'985LQ AYCBQY^>>]9J4^LZ$[>8G^OM(2UO;";$'JGMJ9H^-GP'!(]WZ8
M/LMO!H_W1=67\P,V/>JW/[%FL#?HJ'I"5T/G')[%6$HKQ'03+D DE2@M1GL?
M1V!7H^L<-VF=TZR9!0Y&)=A@#B/5[-9":M*W4729C1NCJFK'R$7N0^510Q]J
M:H+-S#/KBJ)Z3LHT\B,V%6*62*>A_=%$>_4W7!1_+:OG\H;L[JHD1PD\GZP7
MV)%F^$&M5,TBS 8J#'K[!XQ"8AABXV+7W;7P;&B4FG"?42[M,2D*89(L)BQ#
MJ$%%9#"UI5P:?(K$MW'+G2KY<%0M;819R&N(0\%SZ9.XBMA2U%Q9R3S@ =B9
M;?UC-;L)/'B-&)>\BO4;K=-C- />3N;T\GZN O13?ZZ.NJE_6V7<!)%4_%^,
M]B'5G*;1[D=R4R_3)5H3=Y!6WYI8@;.*S5,IM@)N=III-C=[_;QV;BIPGL!-
M+<5"<E,=[1M&-6FWN.Y7Y.QI\6/# YVS(Z:LYYX$'5'PBDCJ>D*I[N1Q#[!.
M)7G  W_<>?NJQOLDS\2EF\?XN\:"QO"7ID,Y!]GE0$C]&$?IV9$J.7@00<7_
M.>0,R/5MFAX>#P4T CW'^QJG3#+)OPM,W_V5F?QR:W*Q=@D^DB?8H&X**@3R
M)!OG<NXQ J@+$4P9@EV4&3'2HSY6-<[O2^\2OFSXMY M9<;4Y+QTH=&WF\[.
ML_*E/U#U%CI:RE_U#=XYT(7$M30"4/KDD5,3@P.>7%KM]ZDVN(6.3I;AP;)!
M=&S4\\6,EHJY+H0(^K;K&C=M?4A;6G^2_(#K)VUUQL&WB'\<E0&JU:O(KL=R
M<BRJ+][)7U#?PEX<QQ1$2&&7-'<4-SZ0Q15PT3;B-\<!!LT,00MY#:;6Q!?Z
M!_._T\_^%M.[IV;'L-KJ"">/U+D1M,]$6=.[X$E%H)\EL!=_O *[-,"GS&<0
M/852SR:E: R1G*\;;E)<)G5>;5_RT\K'8**0Y8A4"]!)"/\$_0X?K4-;J!BD
ME(P1?IW5S_$@HO,'%W/R&_(#I$>#ROY_4$L#!!0    ( *Z&1DY_QX$%"5T
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M5(J%A8"_=[%?;0NS36P3D%N[A/ZH+J&4)9K<F.[#/)65A3MY%*_,9_V"+&W
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MSI=Y>4J9(_7.2I!1BQ#7UTI(/3(4"<S]9*!)!W.R\N*B]MZ+@S,O"1/6@^F
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M77P3TE4&7C[XF/T!Q3X:2,X=N$_1EG>Q&C 7:]  _V:#8\X'DA=\!DMZ3K&
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M1> *%0HF39)?,LW=R=MBBKE9/_XVN@83ZNF($J07)80 !]R7U>*?*=I@(>M
M^CL.=YN;DY47A[]S:%X<,'U,\/*V@N,"I?2$231N<R6O+L+$CW"2$71/Z3N+
M6(#*YLS%#G3*SHTT?UI** 1W4D60BGM;&OI1< .&Z)MZ,8+#27;]6L<VM*J
MZ\\*.MOA+$LHCY*$NFL/U-0P% M$U^.E*-K='1HV$"].*+&L$8>MIU5=4AR)
M5F\S5LVV-N]!2D0TL-M[E=4GQNWK@.'V,=0&T?NO>FY@(LC5[\S_JWS)Y0,B
M@ R.F: ?9@)X3ZSF#%;)/MM5_V++#BM@=[/YS"VO"H/K.7JFXK1G0ENPN$YL
M4==CD9#,,_5N2?A(P?W(KQQ)-2Y55&$4/[&F*[R*)BE^H6 637%,4U[&G(6R
MM2KJ,'L,67EO7*773/AJ$!W?1_0DK<@TN%XT2G?.IR5%G,=-D(+\VK[G-%]
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MX-<L;R9\CXO%5^\>\V4);G %,"!U#+<&?=TQD9&CXCJ65C-??L(XJ(90%_C
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M<G0M,C Q.#$R,S$N>&UL4$L! A0#%     @ KH9&3A8_'LS5&P  T34! !$
M             ( !Y;H! '9X<G0M,C Q.#$R,S$N>'-D4$L! A0#%     @
MKH9&3NAG#S\)%   /PT! !4              ( !Z=8! '9X<G0M,C Q.#$R
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( *Z&1DY[L:>1%5T  -3U!0 5
M      "  27K 0!V>')T+3(P,3@Q,C,Q7V1E9BYX;6Q02P$"% ,4    " "N
MAD9.[RWKQ%*>  "\20@ %0              @ %M2 ( =GAR="TR,#$X,3(S
M,5]L86(N>&UL4$L! A0#%     @ KH9&3G_'@04)70  J/@% !4
M     ( !\N8" '9X<G0M,C Q.#$R,S%?<')E+GAM;%!+!08     !@ & (H!
(   N1 ,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
